PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hatanaka, T; Ohzono, S; Park, M; Sakamoto, K; Tsukamoto, S; Sugita, R; Ishitobi, H; Mori, T; Ito, O; Sorajo, K; Sugimura, K; Ham, S; Ito, Y				Hatanaka, Takaaki; Ohzono, Shinji; Park, Mirae; Sakamoto, Kotaro; Tsukamoto, Shogo; Sugita, Ryohei; Ishitobi, Hiroyuki; Mori, Toshiyuki; Ito, Osamu; Sorajo, Koichi; Sugimura, Kazuhisa; Ham, Sihyun; Ito, Yuji			Human IgA-binding Peptides Selected from Random Peptide Libraries AFFINITY MATURATION AND APPLICATION IN IGA PURIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCI; FC-ALPHA-RI; EFFECTOR MECHANISMS; MUCOSAL IMMUNITY; SURFACE PROTEIN; RECEPTOR; ANTIBODIES; CHROMATOGRAPHY; PYOGENES; COMPLEX	Phage display system is a powerful tool to design specific ligands for target molecules. Here, we used disulfide-constrained random peptide libraries constructed with the T7 phage display system to isolate peptides specific to human IgA. The binding clones (A1-A4) isolated by biopanning exhibited clear specificity to human IgA, but the synthetic peptide derived from the A2 clone exhibited a low specificity/affinity (K-d = 1.3 mu M). Therefore, we tried to improve the peptide using a partial randomized phage display library and mutational studies on the synthetic peptides. The designed Opt-1 peptide exhibited a 39-fold higher affinity (K-d = 33 nM) than the A2 peptide. An Opt-1 peptide-conjugated column was used to purify IgA from human plasma. However, the recovered IgA fraction was contaminated with other proteins, indicating nonspecific binding. To design a peptide with increased binding specificity, we examined the structural features of Opt-1 and the Opt-1-IgA complex using all-atom molecular dynamics simulations with explicit water. The simulation results revealed that the Opt-1 peptide displayed partial helicity in the N-terminal region and possessed a hydrophobic cluster that played a significant role in tight binding with IgA-Fc. However, these hydrophobic residues of Opt-1 may contribute to nonspecific binding with other proteins. To increase binding specificity, we introduced several mutations in the hydrophobic residues of Opt-1. The resultant Opt-3 peptide exhibited high specificity and high binding affinity for IgA, leading to successful isolation of IgA without contamination.	[Park, Mirae; Ham, Sihyun] Sookmyung Womens Univ, Dept Chem, Seoul 140742, South Korea; [Sugimura, Kazuhisa; Ito, Yuji] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Ohzono, Shinji; Ishitobi, Hiroyuki; Ito, Osamu; Sorajo, Koichi] Otsuka Chem Co Ltd, Gen Res Lab, Tokyo 7710193, Japan; [Mori, Toshiyuki] NCI, Mol Targets Lab, Ctr Canc Res, Frederick, MD 21702 USA	Sookmyung Women's University; Kagoshima University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ham, S (corresponding author), Sookmyung Womens Univ, Dept Chem, Hyochangwon Gil 52, Seoul 140742, South Korea.	sihyun@sookmyung.ac.kr; k2174603@kadai.jp		Hatanaka, Takaaki/0000-0002-1154-6004	Japan Science and Technology Agency; Basic Science Research Program of the National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0012096]; Japan Society for the Promotion of Science [238036]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by funds from the Japan Science and Technology Agency. This work was also supported by the Basic Science Research Program of the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 2011-0012096 and by Japan Society for the Promotion of Science Grant-in-Aid 238036 (to T. H.).	ALBRECHTSEN M, 1988, IMMUNOLOGY, V64, P201; Beyer T, 2009, J IMMUNOL METHODS, V346, P26, DOI 10.1016/j.jim.2009.05.002; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dechant M, 2007, J IMMUNOL, V179, P2936, DOI 10.4049/jimmunol.179.5.2936; Durrer P, 2003, VACCINE, V21, P4328, DOI 10.1016/S0264-410X(03)00457-2; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; FRITHZ E, 1989, MOL MICROBIOL, V3, P1111, DOI 10.1111/j.1365-2958.1989.tb00261.x; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; HOLMGREN J, 1991, FEMS MICROBIOL IMMUN, V89, P1, DOI 10.1016/0378-1097(91)90057-H; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huls G, 1999, CANCER RES, V59, P5778; KERR MA, 1990, BIOCHEM J, V271, P285, DOI 10.1042/bj2710285; KONDOH H, 1987, MOL IMMUNOL, V24, P1219; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Li RX, 1998, NAT BIOTECHNOL, V16, P190, DOI 10.1038/nbt0298-190; LINDAHL G, 1990, EUR J IMMUNOL, V20, P2241, DOI 10.1002/eji.1830201013; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Morton HC, 1996, CRIT REV IMMUNOL, V16, P423; Pack T. D., 2001, CURRENT PROTOCOLS IM; Palombo G, 1998, J MOL RECOGNIT, V11, P243, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<243::AID-JMR431>3.0.CO;2-#; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; PLAUT AG, 1974, J CLIN INVEST, V54, P1295, DOI 10.1172/JCI107875; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; RUSSELLJONES GJ, 1984, J EXP MED, V160, P1467, DOI 10.1084/jem.160.5.1467; Sandin C, 2002, J IMMUNOL, V169, P1357, DOI 10.4049/jimmunol.169.3.1357; SCOTT JK, 1992, TRENDS BIOCHEM SCI, V17, P241, DOI 10.1016/0968-0004(92)90401-T; STENBERG L, 1994, J BIOL CHEM, V269, P13458; Zhao J, 2008, ONCOL RES, V17, P217, DOI 10.3727/096504008786111374	33	28	31	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43126	43136		10.1074/jbc.M112.389742	http://dx.doi.org/10.1074/jbc.M112.389742			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23076147	Green Published, hybrid			2022-12-25	WOS:000312501600068
J	Kaplan, FM; Kugel, CH; Dadpey, N; Shao, YP; Abel, EV; Aplin, AE				Kaplan, Fred M.; Kugel, Curtis H., III; Dadpey, Neda; Shao, Yongping; Abel, Ethan V.; Aplin, Andrew E.			SHOC2 and CRAF Mediate ERK1/2 Reactivation in Mutant NRAS-mediated Resistance to RAF Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-RAF; MELANOMA-CELLS; MAP KINASE; SIGNALING PATHWAY; PROTEIN; BRAF; ACTIVATION; PHOSPHATASE; MECHANISM; PHOSPHORYLATION	ERK1/2 signaling is frequently dysregulated in tumors through BRAF mutation. Targeting mutant BRAF with vemurafenib frequently elicits therapeutic responses; however, durable effects are often limited by ERK1/2 pathway reactivation via poorly defined mechanisms. We generated mutant BRAF(V600E) melanoma cells that exhibit resistance to PLX4720, the tool compound for vemurafenib, that co-expressed mutant (Q61K) NRAS. In these BRAF(V600E)/NRAS(Q61K) co-expressing cells, reactivation of the ERK1/2 pathway during PLX4720 treatment was dependent on NRAS. Expression of mutant NRAS in parental BRAF(V600) cells was sufficient to by-pass PLX4720 effects on ERK1/2 signaling, entry into S phase and susceptibility to apoptosis in a manner dependent on the RAF binding site in NRAS. ERK1/2 activation in BRAF(V600E)/NRAS(Q61K) cells required CRAF only in the presence of PLX4720, indicating a switch in RAF isoform requirement. Both ERK1/2 activation and resistance to apoptosis of BRAF(V600E)/NRAS(Q61K) cells in the presence of PLX4720 was modulated by SHOC-2/Sur-8 expression, a RAS-RAF scaffold protein. These data show that NRAS mutations confer resistance to RAF inhibitors in mutant BRAF cells and alter RAF isoform and scaffold molecule requirements to re-activate the ERK1/2 pathway.	[Kaplan, Fred M.; Kugel, Curtis H., III; Dadpey, Neda; Shao, Yongping; Abel, Ethan V.; Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Aplin, Andrew E.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Aplin, AE (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	Andrew.Aplin@KimmelCancerCenter.Org	Shao, Yongping/D-9966-2011		National Institutes of Health [GM067893, CA125103]; Pennsylvania Commonwealth Universal Research Enhancement [AF0301]; Department of Defense Grant [CA101019]; Outrun the Sun; Joanna M. Nicolay Melanoma Research Foundation; National Cancer Institute [1P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA125103, R01CA101019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Universal Research Enhancement; Department of Defense Grant(United States Department of Defense); Outrun the Sun; Joanna M. Nicolay Melanoma Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM067893 and CA125103, Pennsylvania Commonwealth Universal Research Enhancement Grant AF0301, and Department of Defense Grant CA101019. This work was also supported by fellowships from Outrun the Sun (to Y.S.) and the Joanna M. Nicolay Melanoma Research Foundation (to E.A.), respectively.; We thank Dr. Gideon Bollag and Plexxikon Inc. for providing PLX4720, and Dr. Meenhard Herlyn (Wistar Institute, Philadelphia, PA) for supplying the WM melanoma cell lines. The Kimmel Cancer Center is funded by National Cancer Institute Support Grant 1P30CA56036.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Aebersold DM, 2004, MOL CELL BIOL, V24, P10000, DOI 10.1128/MCB.24.22.10000-10015.2004; Aplin AE, 2011, J INVEST DERMATOL, V131, P1817, DOI 10.1038/jid.2011.147; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hingorani SR, 2003, CANCER RES, V63, P5198; Hu R, 2010, PIGM CELL MELANOMA R, V23, P201, DOI 10.1111/j.1755-148X.2010.00668.x; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Li WQ, 2000, GENE DEV, V14, P895; Muda M, 1996, J BIOL CHEM, V271, P4319; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Papin C, 1998, J BIOL CHEM, V273, P24939, DOI 10.1074/jbc.273.38.24939; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stinchcombe TE, 2011, LANCET ONCOL, V12, P717, DOI 10.1016/S1470-2045(11)70200-5; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3	42	40	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41797	41807		10.1074/jbc.M112.390906	http://dx.doi.org/10.1074/jbc.M112.390906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076151	hybrid, Green Published			2022-12-25	WOS:000312103000021
J	Han, DP; Zhang, M; Ma, J; Hong, JS; Chen, C; Zhang, BR; Huang, LQ; Lv, WL; Yin, LJ; Zhang, A; Zhang, HS; Zhang, ZH; Vidyasagar, S; Okunieff, P; Zhang, LR				Han, Deping; Zhang, Mei; Ma, Jun; Hong, Jingshen; Chen, Chun; Zhang, Bingrong; Huang, Luqiang; Lv, Wenlong; Yin, Liangjie; Zhang, Amy; Zhang, Hengshan; Zhang, Zhenhuan; Vidyasagar, Sadasivan; Okunieff, Paul; Zhang, Lurong			Transition Pattern and Mechanism of B-lymphocyte Precursors in Regenerated Mouse Bone Marrow after Subtotal Body Irradiation	PLOS ONE			English	Article							CELL-DEVELOPMENT; STEM-CELLS; LIGHT-CHAIN; MICE; PROGENITORS; RECEPTOR; DIFFERENTIATION; RECOMBINATION; SYK	Little is known about the effects of ionizing radiation on the transition and the related signal transduction of progenitor B cells in the bone marrow. Thus, using an NIH Swiss mouse model, we explored the impact of ionizing radiation on the early stage of B-cell development via an examination of the transition of CLP to pro-B to pre-B cells within bone marrow as a function of radiation doses and times. Our results showed that while the total number of bone marrow lymphoid cells at different stages were greatly reduced by subtotal body irradiation (sub-TBI), the surviving cells continued to transition from common lymphoid progenitors to pro-B and then to pre-B in a reproducible temporal pattern. The rearrangement of the immunoglobulin heavy chain increased significantly 1-2 weeks after irradiation, but no change occurred after 3-4 weeks. The rearrangement of the immunoglobulin light chain decreased significantly 1-2 weeks after sub-TBI but increased dramatically after 3-4 weeks. In addition, several key transcription factors and signaling pathways were involved in B-precursor transitions after sub-TBI. The data indicate that week 2 after irradiation is a critical time for the transition from proB cells to pre-B cells, reflecting that the functional processes for different B-cell stages are well preserved even after high-dose irradiation.	[Han, Deping; Hong, Jingshen; Chen, Chun; Lv, Wenlong; Zhang, Hengshan] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Zhang, Mei; Zhang, Bingrong; Huang, Luqiang; Yin, Liangjie; Zhang, Amy; Zhang, Zhenhuan; Vidyasagar, Sadasivan; Okunieff, Paul; Zhang, Lurong] UF Shands Canc Ctr, Dept Radiat Oncol, Gainesville, FL USA; [Ma, Jun] Zhengzhou Univ, Inst Digest Dis, Zhengzhou, Henan, Peoples R China	Fujian Medical University; State University System of Florida; University of Florida; Zhengzhou University	Han, DP (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.	hdp20012004@163.com; lurongzhang@ufl.edu		Zhang, Hengshan/0000-0002-2226-4774; Ma, Jun/0000-0002-5510-6895	National Institutes of Health [NIAID: RC2-AI-087580, 1RC1AI078519, RC1-AI081274]; Shands Cancer Center startup funds (University of Florida); BARDA (Biomedical Advanced Research and Development Authority, Department of Health and Human Services) [HHSO100201000003C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI078519, RC1AI081274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shands Cancer Center startup funds (University of Florida); BARDA (Biomedical Advanced Research and Development Authority, Department of Health and Human Services); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported in part by grant supports from National Institutes of Health (NIAID: RC2-AI-087580, 1RC1AI078519, and RC1-AI081274), Shands Cancer Center startup funds (University of Florida) and BARDA (Biomedical Advanced Research and Development Authority, Department of Health and Human Services) under contract number HHSO100201000003C. The authors have no commercial affiliations and conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RE, 1977, J IMMUNOL, V118, P1191; ANKLESARIA P, 1989, BLOOD, V74, P1144; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713; Greenberger JS, 2009, SEMIN RADIAT ONCOL, V19, P133, DOI 10.1016/j.semradonc.2008.11.006; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Karasuyama H, 1996, ADV IMMUNOL, V63, P1, DOI 10.1016/S0065-2776(08)60853-6; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; LEBOUTEILLER PP, 1981, IMMUNOLOGY, V42, P267; MAISIN JR, 1988, RADIAT RES, V113, P300, DOI 10.2307/3577205; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nishii K, 1998, CELL DEATH DIFFER, V5, P77, DOI 10.1038/sj.cdd.4400317; NOSSAL GJV, 1973, IMMUNOLOGY, V25, P33; Otero DC, 2003, J IMMUNOL, V171, P5921, DOI 10.4049/jimmunol.171.11.5921; Quesenberry PJ, 2005, EXP HEMATOL, V33, P9, DOI 10.1016/j.exphem.2004.10.012; Rolink AG, 1999, IMMUNOL LETT, V68, P89, DOI 10.1016/S0165-2478(99)00035-8; SCARANTINO CW, 1984, RADIOTHER ONCOL, V2, P215, DOI 10.1016/S0167-8140(84)80062-6; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; SCHWARTZ GN, 1988, EXP HEMATOL, V16, P752; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46560	10.1371/journal.pone.0046560	http://dx.doi.org/10.1371/journal.pone.0046560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082125	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900020
J	Chountala, M; Vakaloglou, KM; Zervas, CG				Chountala, Maria; Vakaloglou, Katerina M.; Zervas, Christos G.			Parvin Overexpression Uncovers Tissue-Specific Genetic Pathways and Disrupts F-Actin to Induce Apoptosis in the Developing Epithelia in Drosophila	PLOS ONE			English	Article							JNK SIGNALING PATHWAY; INTEGRIN ADHESION; CELL MORPHOLOGY; IMAGINAL DISCS; LONG LIVE; PROTEIN; KINASE; EXPRESSION; SURVIVAL; MORPHOGENESIS	Parvin is a putative F-actin binding protein important for integrin-mediated cell adhesion. Here we used overexpression of Drosophila Parvin to uncover its functions in different tissues in vivo. Parvin overexpression caused major defects reminiscent of metastatic cancer cells in developing epithelia, including apoptosis, alterations in cell shape, basal extrusion and invasion. These defects were closely correlated with abnormalities in the organization of F-actin at the basal epithelial surface and of integrin-matrix adhesion sites. In wing epithelium, overexpressed Parvin triggered increased Rho1 protein levels, predominantly at the basal side, whereas in the developing eye it caused a rough eye phenotype and severely disrupted F-actin filaments at the retina floor of pigment cells. We identified genes that suppressed these Parvin-induced dominant effects, depending on the cell type. Co-expression of both ILK and the apoptosis inhibitor DIAP1 blocked Parvin-induced lethality and apoptosis and partially ameliorated cell delamination in epithelia, but did not rescue the elevated Rho1 levels, the abnormal organization of F-actin in the wing and the assembly of integrin-matrix adhesion sites. The rough eye phenotype was suppressed by coexpression of either PTEN or Wech, or by knock-down of Xrp1. Two main conclusions can be drawn from our studies: (1), high levels of cytoplasmic Parvin are toxic in epithelial cells; (2) Parvin in a dose dependent manner affects the organization of actin cytoskeleton in both wing and eye epithelia, independently of its role as a structural component of the ILK-PINCH-Parvin complex that mediates the integrin-actin link. Thus, distinct genetic interactions of Parvin occur in different cell types and second site modifier screens are required to uncover such genetic circuits.	[Chountala, Maria; Vakaloglou, Katerina M.; Zervas, Christos G.] BRFAA, Div Genet, Athens, Greece		Zervas, CG (corresponding author), BRFAA, Div Genet, Athens, Greece.	czervas@bioacademy.gr		Zervas, Christos/0000-0003-0531-9515	Greek Secretariat for Research and Technology [PENED-03ED777]; Association Francaise contre les Myopathies (AFM) [12641]; BRFAA	Greek Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); BRFAA	This research was supported by Greek Secretariat for Research and Technology (PENED-03ED777), Association Francaise contre les Myopathies (AFM;12641) and BRFAA intramural funds to CGZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Agnes F, 1999, DEVELOPMENT, V126, P5453; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; Chen GC, 2005, MOL CELL BIOL, V25, P979, DOI 10.1128/MCB.25.3.979-987.2005; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dominguez-Gimenez P, 2007, J CELL SCI, V120, P1061, DOI 10.1242/jcs.03404; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Grzeschik NA, 2005, DEVELOPMENT, V132, P2035, DOI 10.1242/dev.01800; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Huang H, 1999, DEVELOPMENT, V126, P5365; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Janody F, 2006, DEVELOPMENT, V133, P3349, DOI 10.1242/dev.02511; Johnstone CN, 2008, MOL CELL BIOL, V28, P687, DOI 10.1128/MCB.01617-06; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; LaLonde DP, 2006, CURR BIOL, V16, P1375, DOI 10.1016/j.cub.2006.05.057; Lee SB, 2003, DEVELOPMENT, V130, P4001, DOI 10.1242/dev.00595; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Loer B, 2008, NAT CELL BIOL, V10, P422, DOI 10.1038/ncb1704; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; Mishima W, 2004, GENES CELLS, V9, P193, DOI 10.1111/j.1356-9597.2004.00717.x; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; Vakaloglou KM, 2012, J CELL SCI, V125, P3221, DOI 10.1242/jcs.102384; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Widmann TJ, 2009, J CELL SCI, V122, P1362, DOI 10.1242/jcs.044271; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	51	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47355	10.1371/journal.pone.0047355	http://dx.doi.org/10.1371/journal.pone.0047355			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077599	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100098
J	Cox, WA; Thompson, FR; Root, B; Faaborg, J				Cox, W. Andrew; Thompson, Frank R., III; Root, Brian; Faaborg, John			Declining Brown-Headed Cowbird (Molothrus ater) Populations Are Associated with Landscape-Specific Reductions in Brood Parasitism and Increases in Songbird Productivity	PLOS ONE			English	Article							NEST PREDATION; BIOTIC INTERACTIONS; PATTERNS; SUCCESS; CLIMATE; FRAGMENTATION; ABUNDANCE; HABITAT; MODELS; IMPACT	Many songbird species have experienced significant population declines, partly because of brood parasitism by the Brown-headed Cowbird (Molothrus ater), which is positively associated with increasing landscape forest cover in the midwestern United States. However, cowbirds are also experiencing long-term population declines, which should reduce parasitism pressure and thus increase productivity of host species. We used 20 years of nest monitoring data from five sites in Missouri across a gradient of landscape forest cover to assess temporal trends in the rate and intensity of brood parasitism for Acadian Flycatchers (Empidonax virescens), Indigo Buntings (Passerina cyanea), and Northern Cardinals (Cardinalis cardinalis). We evaluated whether there were concomitant changes in fledging brood size, nest survival, a combination of the two metrics (i.e., host young produced per nest attempt), and whether such changes were more substantial with decreasing landscape forest cover. Parasitism rates and intensities declined substantially during 1991-2010. Fledging brood size and nest survival rates were positively associated with landscape forest cover, confirming the fragmentation hypothesis for Midwest forest birds. Declining parasitism rates were associated with increased fledging brood sizes, with more pronounced increases as landscape forest cover decreased. Nest survival increased insubstantially across time during laying and incubation, but not during the nestling stage. The best predictor of nest survival was parasitism status, with parasitized nests surviving at lower rates than unparasitized nests. Overall, productivity increased during 1991-2010, with more pronounced increases associated with lower levels of landscape forest cover. The negative effects of cowbirds on nest survival in addition to fledging brood size in less forested landscapes suggest that cowbirds may be a primary cause of forest fragmentation effects on songbird productivity in the Midwest. Our results underscore the dynamic nature of demographic parameters, which should be accounted for in predictive models of wildlife responses to future environmental conditions.	[Cox, W. Andrew] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA; [Thompson, Frank R., III] Univ Missouri, USDA, US Forest Serv, No Res Stn, Columbia, MO USA; [Root, Brian] Missouri Dept Conservat, Columbia, MO USA; [Faaborg, John] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Cox, WA (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA.	wac253@mail.missouri.edu		Cox, William/0000-0002-1205-5979	U.S.D.A. Forest Service; Missouri Department of Conservation; U.S. Fish and Wildlife Service	U.S.D.A. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Missouri Department of Conservation; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	Funding for this project was provided by the U.S.D.A. Forest Service. Funding sources for the original field studies included the U.S.D.A. Forest Service, Missouri Department of Conservation, and U.S. Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; Annand EM, 1997, J WILDLIFE MANAGE, V61, P159, DOI 10.2307/3802425; Benson TJ, 2010, J ANIM ECOL, V79, P225, DOI 10.1111/j.1365-2656.2009.01604.x; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chace Jameson F., 2005, Ornithological Monographs, V57, P45; Cox WA, 2012, LANDSCAPE ECOL, V27, P659, DOI 10.1007/s10980-012-9711-x; Cox WA, 2012, AUK, V129, P147, DOI 10.1525/auk.2012.11169; De Marsico MC, 2010, CONDOR, V112, P407, DOI 10.1525/cond.2010.090118; Dearborn DC, 1999, AUK, V116, P448, DOI 10.2307/4089378; Dearborn DC, 1998, CONDOR, V100, P326, DOI 10.2307/1370273; Dearborn DC, 1996, CONDOR, V98, P645, DOI 10.2307/1369581; Donovan TM, 2001, ECOL APPL, V11, P871; Donovan TM, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P255; Efron B., 1994, INTRO BOOTSTRAP; ESRI , 2008, ARCGIS 9 3; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Friedmann H., 1929, COWBIRDS STUDY BIOL; Goguen CB, 2000, CONSERV BIOL, V14, P1862, DOI 10.1046/j.1523-1739.2000.99313.x; HALKIN S. L., 1999, BIRDS N AM ONLINE; HOOVER JP, 1993, WILSON BULL, V105, P228; Lloyd P, 2005, ECOL APPL, V15, P1504, DOI 10.1890/04-1243; Lorenzana JC, 1999, STUD AVIAN BIOL, P241; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; MARVIL RE, 1989, AUK, V106, P476; MAYFIELD HAROLD, 1965, LIVING BIRD, V4, P13; McDonald TL, 2010, J WILDLIFE MANAGE, V74, P514, DOI 10.2193/2009-270; McLaren CM, 2006, CONDOR, V108, P238, DOI 10.1650/0010-5422(2006)108[0238:CTCITF]2.0.CO;2; Payne R. B., 2006, BIRDS N AM ONLINE; Peterjohn BG, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P21; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Reidy JL, 2012, STUD AVIAN BIOL, P135; Rivers JW, 2010, AUK, V127, P263, DOI 10.1525/auk.2009.09053; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Rodewald AD, 2011, CONDOR, V113, P899, DOI 10.1525/cond.2011.100132; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 2011, N AM BREEDING BIRD S; Schmidt KA, 2008, ECOLOGY, V89, P635, DOI 10.1890/07-0199.1; Shaffer Terry L., 2007, Studies in Avian Biology, V34, P84; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sherry Thomas W., 1995, P85; Shifley S. R., 2000, P 2 MISS OZ FOR EC P; SMITH JNM, 1981, CONDOR, V83, P152, DOI 10.2307/1367420; Stumpf KJ, 2012, J WILDLIFE MANAGE, V76, P269, DOI 10.1002/jwmg.246; Thompson FR, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P271; THOMPSON FR, 1994, AUK, V111, P979, DOI 10.2307/4088830; Thompson FR, 2003, J WILDLIFE MANAGE, V67, P408, DOI 10.2307/3802781; Trine CL, 2000, ECOLOGY AND MANAGEMENT OF COWBIRDS AND THEIR HOSTS, P135; U.S. Department of Agriculture, 2012, NAT AGR STAT SERV WE; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VanHorn MA, 1995, AUK, V112, P98; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; ZIMMERMAN JL, 1983, WILSON BULL, V95, P7	58	10	10	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47591	10.1371/journal.pone.0047591	http://dx.doi.org/10.1371/journal.pone.0047591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077647	gold, Green Published			2022-12-25	WOS:000309995100142
J	Glineur, S; Dao, BTA; Sarlet, M; Michaux, C; Desmecht, D				Glineur, Stephanie; Dao Bui Tran Anh; Sarlet, Michael; Michaux, Charles; Desmecht, Daniel			Characterization of the Resistance of SJL/J Mice to Pneumonia Virus of Mice, a Model for Infantile Bronchiolitis Due to a Respiratory Syncytial Virus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TOTAL-BODY IRRADIATION; KILLER CELL-ACTIVITY; INNATE IMMUNE GENES; ALVEOLAR MACROPHAGES; INFLUENZA-VIRUS; DEMYELINATING DISEASE; PNEUMOVIRUS INFECTION; BIOMETRICAL GENETICS; THEILERS VIRUS	Respiratory syncytial virus (RSV), a prominent cause of airway morbidity in children, maintains an excessive hospitalization rate despite decades of research. Host factors are assumed to influence the disease severity. As a first step toward identifying the underlying resistance mechanisms, we recently showed that inbred mouse strains differ dramatically as regards their susceptibility to pneumonia virus of mice (PVM), the murine counterpart of RSV. PVM infection in mice has been shown to faithfully mimic the severe RSV disease in human infants. This study aimed at dissecting the remarkable PVM-resistance shown by the SJL/J strain. To characterize its genetic component, we assessed clinical, physiopathological, and virological resistance/susceptibility traits in large first (F1) and second (F2) generations obtained by crossing the SJL/J (resistant) and 129/Sv (susceptible) strains. Then, to acquire conclusive in vivo evidence in support of the hypothesis that certain radiosensitive hematopoietic cells might play a significant role in PVM-resistance, we monitored the same resistance/susceptibility traits in mock-and gamma-irradiated SJL/J mice. Segregation analysis showed that (i) PVM-resistance is polygenic, (ii) the resistance alleles are recessive, and (iii) all resistance-encoding alleles are concentrated in SJL/J. Furthermore, there was no alteration of SJL/J PVM-resistance after immunosuppression by gamma-irradiation, which suggests that adaptive immunity is not involved. We conclude that host resistance to pneumoviruses should be amenable to genetic dissection in this mouse model and that radioresistant lung epithelial cells and/or alveolar macrophages may control the clinical severity of pneumovirus-associated lung disease.	[Glineur, Stephanie; Dao Bui Tran Anh; Sarlet, Michael; Michaux, Charles; Desmecht, Daniel] Univ Liege, Coll Vet Med, Dept Morphol & Pathol, Sart Tilman Par Liege, Belgium	University of Liege	Desmecht, D (corresponding author), Univ Liege, Coll Vet Med, Dept Morphol & Pathol, Sart Tilman Par Liege, Belgium.	Daniel.Desmecht@ulg.ac.be		Glineur, Stephanie/0000-0002-4053-0255; Tran Anh Dao, Bui/0000-0002-4639-8945	Fonds National de la Recherche Scientifique	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the "Fonds National de la Recherche Scientifique"; http://www1.frs-fnrs.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanatidou V, 2008, PEDIATR INFECT DIS J, V27, P38, DOI 10.1097/INF.0b013e31814d4e42; Amanatidou V, 2006, PEDIATR INFECT DIS J, V25, P410, DOI 10.1097/01.inf.0000214998.16248.b7; Anh DBT, 2006, AM J PHYSIOL-LUNG C, V291, pL426, DOI 10.1152/ajplung.00483.2005; Aurivillius M, 2005, ACTA PAEDIATR, V94, P414, DOI 10.1080/08035250410023656; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Bodmer W. F., 1976, GENETICS EVOLUTION M; BOGMAN MJJT, 1984, J IMMUNOL METHODS, V70, P31, DOI 10.1016/0022-1759(84)90386-7; BOWDEN DH, 1980, LAB INVEST, V42, P511; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Buchholz UJ, 2009, J VIROL, V83, P1969, DOI 10.1128/JVI.02041-08; Ceccaldi PE, 1996, INT J RADIAT BIOL, V70, P69, DOI 10.1080/095530096145346; Chambers KA, 1998, CYTOMETRY, V31, P45, DOI 10.1002/(SICI)1097-0320(19980101)31:1<45::AID-CYTO6>3.0.CO;2-I; Choi EH, 2002, J INFECT DIS, V186, P1207, DOI 10.1086/344310; Claassen EAW, 2005, J IMMUNOL, V175, P6597, DOI 10.4049/jimmunol.175.10.6597; Claassen EAW, 2007, VIROLOGY, V368, P17, DOI 10.1016/j.virol.2007.06.002; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; CULLEN SE, 1972, P NATL ACAD SCI USA, V69, P1394, DOI 10.1073/pnas.69.6.1394; Dahlberg A, 2006, VIROLOGY, V353, P422, DOI 10.1016/j.virol.2006.05.034; Downing L, 2010, RADIAT RES, V173, P536, DOI 10.1667/RR1712.1; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; El Saleeby CM, 2010, J PEDIATR-US, V156, P409, DOI 10.1016/j.jpeds.2009.09.043; Evans DM, 2002, BIOL PSYCHOL, V61, P33, DOI 10.1016/S0301-0511(02)00051-0; Flandre TD, 2003, J APPL PHYSIOL, V94, P1129, DOI 10.1152/japplphysiol.00561.2002; Forton JT, 2009, THORAX, V64, P345, DOI 10.1136/thx.2008.102111; FULKER DW, 1981, BRIT MED BULL, V37, P115, DOI 10.1093/oxfordjournals.bmb.a071686; Garg S, 2010, RADIAT RES, V173, P469, DOI 10.1667/RR1742.1; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Glineur S, 2011, IMMUNOBIOLOGY, V216, P213, DOI 10.1016/j.imbio.2010.04.005; GROSS NJ, 1977, RADIAT RES, V72, P325, DOI 10.2307/3574702; Guenet Jean-Louis, 2005, Briefings in Functional Genomics & Proteomics, V4, P225, DOI 10.1093/bfgp/4.3.225; Hacking D, 2004, GENES IMMUN, V5, P274, DOI 10.1038/sj.gene.6364067; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Heinze B, 2011, J VIROL; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Hull J, 2003, J INFECT DIS, V188, P904, DOI 10.1086/377587; Hull J, 2001, AM J HUM GENET, V69, P413, DOI 10.1086/321291; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; KAMINSKY SG, 1985, J IMMUNOL, V135, P665; KAMINSKY SG, 1983, J IMMUNOL, V130, P1980; KAPLAN C, 1980, J HYG-CAMBRIDGE, V84, P285, DOI 10.1017/S0022172400026784; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; LINDENMANN J, 1964, P SOC EXP BIOL MED, V116, P506, DOI 10.3181/00379727-116-29292; Lofgren J, 2002, J INFECT DIS, V185, P283, DOI 10.1086/338473; Lu AZ, 2010, J TROP PEDIATRICS, V56, P242, DOI 10.1093/tropej/fmp101; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; Mather K, 1982, BIOMETRICAL GENETICS; Matsushima G. K., 1991, Immunological disorders in mice., P77; MEYER OT, 1970, J RETICULOENDOTH SOC, V7, P79; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ogra Pearay L, 2004, Paediatr Respir Rev, V5 Suppl A, pS119, DOI 10.1016/S1526-0542(04)90023-1; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; PELKA A, 1993, CELL IMMUNOL, V152, P440, DOI 10.1006/cimm.1993.1303; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Puthothu Beena, 2007, BMC Pulm Med, V7, P6, DOI 10.1186/1471-2466-7-6; Puthothu B, 2007, PEDIATR INFECT DIS J, V26, P1094, DOI 10.1097/INF.0b013e3181453579; Puthothu B, 2006, DIS MARKERS, V22, P303, DOI 10.1155/2006/865890; Puthothu B, 2006, PEDIAT ALLERG IMM-UK, V17, P572, DOI 10.1111/j.1399-3038.2006.00467.x; Reed JL, 2008, J INFECT DIS, V198, P1783, DOI 10.1086/593173; Rigaux P, 2011, VIROLOGY; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rosenberg HF, 2008, IMMUNOL LETT, V118, P6, DOI 10.1016/j.imlet.2008.03.013; Rube CE, 2005, INT J RADIAT ONCOL, V61, P1482, DOI 10.1016/j.ijrobp.2004.12.072; Russel PJ, 2006, IGENETICS MOL APPROA; Sandor C, 2008, GENETICS, V180, P1167, DOI 10.1534/genetics.108.092551; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; SAS Institute Inc, 1989, SAS STAT US GUID, V2; Schuurhof A, 2010, PEDIATR PULM, V45, P608, DOI 10.1002/ppul.21229; SHANLEY JD, 1984, J GEN VIROL, V65, P2121, DOI 10.1099/0022-1317-65-12-2121; Siezen CLE, 2009, PEDIATR INFECT DIS J, V28, P333, DOI 10.1097/INF.0b013e31818e2aa9; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Spindler KR, 2001, J VIROL, V75, P12039, DOI 10.1128/JVI.75.24.12039-12046.2001; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Thomas NJ, 2009, PEDIATR RES, V66, P70, DOI 10.1203/PDR.0b013e3181a1d768; Thomsen SF, 2008, PEDIATRICS, V121, P493, DOI 10.1542/peds.2007-1889; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; TROWSDALE J, 2001, CURR PROTOC IMMUNOL; Welliver TP, 2008, PEDIATR INFECT DIS J, V27, pS92, DOI 10.1097/INF.0b013e318168b706; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Welton AR, 2005, J VIROL, V79, P11517, DOI 10.1128/JVI.79.17.11517-11522.2005; Wilson J, 2005, J INFECT DIS, V191, P1705, DOI 10.1086/429636	89	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e44581	10.1371/journal.pone.0044581	http://dx.doi.org/10.1371/journal.pone.0044581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077483	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100011
J	Miyazaki, S; Tashiro, F; Fujikura, J; Yamato, E; Miyazaki, J				Miyazaki, Satsuki; Tashiro, Fumi; Fujikura, Junji; Yamato, Eiji; Miyazaki, Jun-ichi			Acinar-to-Ductal Metaplasia Induced by Adenovirus-Mediated Pancreatic Expression of Isl1	PLOS ONE			English	Article							INSULIN GENE-TRANSCRIPTION; BETA-CELLS; TUBULAR COMPLEXES; PROGENITOR CELLS; ENDOCRINE PANCREAS; SIGNAL TRANSDUCER; TRANSGENIC MICE; ADULT EXOCRINE; MOUSE PANCREAS; RAT PANCREAS	Tubular complexes (TCs) are aggregates of duct-like monolayered cells in the developing and regenerating pancreas. Recent studies showed that TCs have regenerative potential, including islet neogenesis. We previously delivered adenovirus vector (AdV) into exocrine cells of the pancreas by intra-common bile ductal (ICBD) injection, and found that AdV expressing Pdx1, a pancreas-specific transcription factor, causes TC formation and islet neogenesis. We also established RTF-Pdx1-EGFP mice, which ubiquitously express Pdx1 when tetracycline is removed from the drinking water. However, exogenous Pdx1 expression in adult RTF-Pdx1-EGFP mice did not cause any pathological changes in the pancreas during three weeks of observation after tetracycline withdrawal. To examine whether the host immune response induced by AdV was involved in TC formation, we delivered AdVs expressing pancreas-related transcription factors or an irrelevant protein into the pancreas of RTF-Pdx1-EGFP mice. Histological analyses showed that both AdV injection and Pdx1 expression are required for TC formation. We also analyzed the effects of these ICBD-injected AdVs. AdV expressing Isl1, a proendocrine transcription factor, effectively induced TC formation through acinar-to-ductal metaplasia, and exogenous Pdx1 expression facilitated this process. Considering the regenerative potential of TCs, a strategy that efficiently induces TC formation may lead to novel therapies for diabetes.	[Miyazaki, Satsuki; Tashiro, Fumi; Fujikura, Junji; Yamato, Eiji; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan	Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Fujikura, Junji/AAR-2684-2020; Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Yamato, Eiji/0000-0002-9075-6869; Miyazaki, Satsuki/0000-0003-1781-1590	Japanese Society for the Promotion of Science [05J09752]; NICHD	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Grant-in-Aid (No. 05J09752) from the Japanese Society for the Promotion of Science(http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Masaomi Ashida for technical assistance. Rat anti-cytokeratin 19 monoclonal antibody (TROMA III) and mouse anti-Isl1 monoclonal antibodies 40.2D6 and 39.4D5, developed by Thomas M. Jessell, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Bockman DE, 2003, LAB INVEST, V83, P853, DOI 10.1097/01.LAB.0000074918.31303.5A; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; DELAPORTE PL, 1991, PANCREAS, V6, P298, DOI 10.1097/00006676-199105000-00007; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; GU DL, 1993, DEVELOPMENT, V118, P33; GUZ Y, 1995, DEVELOPMENT, V121, P11; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hao AJ, 2005, MOL BIOL CELL, V16, P1569, DOI 10.1091/mbc.e04-08-0664; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Krizik MR, 1999, J ENDOCRINOL, V163, P523, DOI 10.1677/joe.0.1630523; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Tashiro F, 1999, HUM GENE THER, V10, P1845, DOI 10.1089/10430349950017527; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; Tokoro T, 2003, PANCREATOLOGY, V3, P487, DOI 10.1159/000075580; Trucco M, 2005, J CLIN INVEST, V115, P5, DOI 10.1172/JCI200523935; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; WILLEMER S, 1989, DIGEST DIS SCI, V34, P46, DOI 10.1007/BF01536153; Worgall S, 2005, PEDIATR NEPHROL, V20, P118, DOI 10.1007/s00467-004-1680-0; Yamamoto T, 2006, DIABETOLOGIA, V49, P2359, DOI 10.1007/s00125-006-0372-7; Yamato E, 2012, J DIABETES INVEST, V3, P41, DOI 10.1111/j.2040-1124.2011.00136.x; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47536	10.1371/journal.pone.0047536	http://dx.doi.org/10.1371/journal.pone.0047536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077629	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100125
J	O'Kelly, HJ; Evans, TD; Stokes, EJ; Clements, TJ; Dara, A; Gately, M; Menghor, N; Pollard, EHB; Soriyun, M; Walston, J				O'Kelly, Hannah J.; Evans, Tom D.; Stokes, Emma J.; Clements, Tom J.; Dara, An; Gately, Mark; Menghor, Nut; Pollard, Edward H. B.; Soriyun, Men; Walston, Joe			Identifying Conservation Successes, Failures and Future Opportunities; Assessing Recovery Potential of Wild Ungulates and Tigers in Eastern Cambodia	PLOS ONE			English	Article							NATIONAL-PARK; ABUNDANCE; CARNIVORE; PREY; DENSITIES; DISTANCE; MAMMALS; FOREST	Conservation investment, particularly for charismatic and wide-ranging large mammal species, needs to be evidence-based. Despite the prevalence of this theme within the literature, examples of robust data being generated to guide conservation policy and funding decisions are rare. We present the first published case-study of tiger conservation in Indochina, from a site where an evidence-based approach has been implemented for this iconic predator and its prey. Despite the persistence of extensive areas of habitat, Indochina's tiger and ungulate prey populations are widely supposed to have precipitously declined in recent decades. The Seima Protection Forest (SPF), and broader Eastern Plains Landscape, was identified in 2000 as representing Cambodia's best hope for tiger recovery; reflected in its designation as a Global Priority Tiger Conservation Landscape. Since 2005 distance sampling, camera-trapping and detection-dog surveys have been employed to assess the recovery potential of ungulate and tiger populations in SPF. Our results show that while conservation efforts have ensured that small but regionally significant populations of larger ungulates persist, and density trends in smaller ungulates are stable, overall ungulate populations remain well below theoretical carrying capacity. Extensive field surveys failed to yield any evidence of tiger, and we contend that there is no longer a resident population within the SPF. This local extirpation is believed to be primarily attributable to two decades of intensive hunting; but importantly, prey densities are also currently below the level necessary to support a viable tiger population. Based on these results and similar findings from neighbouring sites, Eastern Cambodia does not currently constitute a Tiger Source Site nor meet the criteria of a Global Priority Tiger Landscape. However, SPF retains global importance for many other elements of biodiversity. It retains high regional importance for ungulate populations and potentially in the future for Indochinese tigers, given adequate prey and protection.	[O'Kelly, Hannah J.; Evans, Tom D.; Dara, An; Gately, Mark; Pollard, Edward H. B.] Wildlife Conservat Soc Cambodia Program, Phnom Penh, Cambodia; [Menghor, Nut; Soriyun, Men] Royal Govt Cambodia, Forestry Adm, Phnom Penh, Cambodia; [Evans, Tom D.; Stokes, Emma J.; Clements, Tom J.; Gately, Mark; Walston, Joe] Wildlife Conservat Soc Global Conservat Program, Bronx, NY USA; [O'Kelly, Hannah J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [O'Kelly, Hannah J.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Clements, Tom J.] Univ Cambridge, Dept Zool, Cambridge, England	Wildlife Conservation Society; Imperial College London; Zoological Society of London; University of Cambridge	O'Kelly, HJ (corresponding author), Wildlife Conservat Soc Cambodia Program, Phnom Penh, Cambodia.	hokelly@wcs.org			Asian Development Bank; Eleanor Briggs; East Asia and Pacific Environmental Initiative, an initiative of the U.S. Agency for International Development (USAID); Elyssa Kellerman, The John D. and Catherine T. MacArthur Foundation; Liz Claiborne and Art Ortenberg Foundation; Panthera; U.S. Fish and Wildlife Service; ESRC/NERC	Asian Development Bank; Eleanor Briggs; East Asia and Pacific Environmental Initiative, an initiative of the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Elyssa Kellerman, The John D. and Catherine T. MacArthur Foundation; Liz Claiborne and Art Ortenberg Foundation; Panthera; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC))	Sources of funding for this biological monitoring program were (in alphabetical order): Asian Development Bank; Eleanor Briggs; East Asia and Pacific Environmental Initiative, an initiative of the U.S. Agency for International Development (USAID); Elyssa Kellerman, The John D. and Catherine T. MacArthur Foundation; The Liz Claiborne and Art Ortenberg Foundation; Panthera; and the U.S. Fish and Wildlife Service. HJOK is also supported by an ESRC/NERC research studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckland S.T., 2001, pi; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Clements TJ, 2002, DEV MONITORING PROGR; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Danell K., 2006, LARGE HERBIVORE ECOL; Datta A, 2008, BIOL CONSERV, V141, P1429, DOI 10.1016/j.biocon.2008.02.022; Delacour J., 1940, MAMMALIA, V4, P46, DOI 10.1515/mamm.1940.4.2.46; DESAI A, 1996, STATUS DISTRIBUTION; Dickinson, 2010, CARBON BIODIVERSITY; DUCKWORTH JW, 1998, TRACKING TIGERS REV; Evans TD, EVIDENCE BASED CONSE, pxxx; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Gray TNE, 2011, ESTABLISHING BASELIN; Guerin Mathieu, 2010, REPENSER SAUVAGE GRA, P211; IUCN, 2019, IUCN RED LIST THREAT; Jenks KE, 2011, TROP CONSERV SCI, V4, P113, DOI 10.1177/194008291100400203; Johnson A, 2006, ANIM CONSERV, V9, P421, DOI 10.1111/j.1469-1795.2006.00049.x; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Karanth K. Ullas, 2002, P111; Karanth K. Ullas, 1999, P100; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth U, 2002, MONITORING TIGERS TH; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Kerley LL, 2010, INTEGR ZOOL, V5, P390, DOI 10.1111/j.1749-4877.2010.00217.x; Lynam AJ, 2004, CONSERVATION MANAGEM; Lynam AJ, 2010, INTEGR ZOOL, V5, P324, DOI 10.1111/j.1749-4877.2010.00220.x; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; MOE, 1996, NAT TIG ACT PL UNPUB; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Nowell Kristin, 1999, Cat News, V30, P4; Pollard E., 2008, STATUS CONSERVATION; Rabinowitz Alan, 1999, P148; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reed SE, 2011, J WILDLIFE MANAGE, V75, P243, DOI 10.1002/jwmg.8; Sanderson E., 2006, SETTING PRIORITIES C; Sanderson EW, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P143, DOI 10.1016/B978-0-8155-1570-8.00009-8; SRIKOSAMATARA S, 1993, J TROP ECOL, V9, P33, DOI 10.1017/S026646740000691X; Steinmetz R, 2006, CONSERV BIOL, V20, P1391, DOI 10.1111/j.1523-1739.2006.00505.x; Sunquist Mel, 1999, P5; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Timmins RJ, 2008, BOS JAVANICUS VERSIO; Timmins RJ, 2001, IMPORTANCE PHNOM PRI; Timmins RJ, 2008, BOS SAUVELI VERSION; Walston J, 2010, AVOIDING UNTHINKABLE; Walston J., 2001, WILDLIFE SURVEY SO M; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Weiler H, 2006, FINAL REPORT CAMBODI; Wharton C. H., 1966, Proceedings, 5th Annual Tall Timbers Fire Ecology Conference, Tallahassee, Fla., P23; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x	51	43	46	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e40482	10.1371/journal.pone.0040482	http://dx.doi.org/10.1371/journal.pone.0040482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077476	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100004
J	Schulz, E; Gottschling, M; Ulrich, RG; Richter, D; Stockfleth, E; Nindl, I				Schulz, Eric; Gottschling, Marc; Ulrich, Rainer G.; Richter, Dania; Stockfleth, Eggert; Nindl, Ingo			Isolation of Three Novel Rat and Mouse Papillomaviruses and Their Genomic Characterization	PLOS ONE			English	Article							MASTOMYS-NATALENSIS PAPILLOMAVIRUS; NUCLEOTIDE-SEQUENCE; MICROMYS-MINUTUS; E6 PROTEINS; CLONING; LESIONS; SKIN; BETAPAPILLOMAVIRUS; ORGANIZATION; INFECTION	Despite a growing knowledge about the biological diversity of papillomaviruses (PV), only little is known about non-human PV in general and about PV mice models in particular. We cloned and sequenced the complete genomes of two novel PV types from the Norway rat (Rattus norvegicus; RnPV2) and the wood mouse (Apodemus sylvaticus; AsPV1) as well as a novel variant of the recently described MmuPV1 (originally designated as MusPV) from a house mouse (Mus musculus; MmuPV1 variant). In addition, we conducted phylogenetic analyses using a systematically representative set of 79 PV types, including the novel sequences. As inferred from concatenated amino acid sequences of six proteins, MmuPV1 variant and AsPV1 nested within the Beta+Xi-PV super taxon as members of the Pi-PV. RnPV2 is a member of the Iota-PV that has a distant phylogenetic position from Pi-PV. The phylogenetic results support a complex scenario of PV diversification driven by different evolutionary forces including co-divergence with hosts and adaptive radiations to new environments. PV types particularly isolated from mice and rats are the basis for new animal models, which are valuable to study PV induced tumors and new treatment options.	[Schulz, Eric; Stockfleth, Eggert; Nindl, Ingo] Univ Hosp, Dept Dermatol Venereol & Allergy, DKFZ Charite Cooperat, Viral Skin Carcinogenesis Grp,Charite, Berlin, Germany; [Gottschling, Marc] Univ Munich, Dept Biol Systemat Bot & Mycol, GeoBio Ctr, Munich, Germany; [Ulrich, Rainer G.] Inst Novel & Emerging Infect Dis, Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Richter, Dania] Univ Hosp, Dept Parasitol, Inst Pathol, Charite, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Friedrich Loeffler Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nindl, I (corresponding author), Univ Hosp, Dept Dermatol Venereol & Allergy, DKFZ Charite Cooperat, Viral Skin Carcinogenesis Grp,Charite, Berlin, Germany.	ingo.nindl@charite.de	Ulrich, Rainer/A-4411-2013; Gottschling, Marc/K-2186-2014	Ehrke-Schulz, Eric/0000-0001-8154-9860	European Skin Cancer Foundation (ESCF); Deutsche Krebshilfe [109125-Ni]; Wilhelm Sander-Stiftung	European Skin Cancer Foundation (ESCF); Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm Sander-Stiftung	The work of Eric Schulz was supported by the European Skin Cancer Foundation (ESCF). The Nindl laboratory is supported by grants of the Deutsche Krebshilfe (109125-Ni) and the Wilhelm Sander-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2002, J VIROL, V76, P12537, DOI 10.1128/JVI.76.24.12537-12542.2002; Bernard H U, 1990, FEMS Microbiol Immunol, V2, P201; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; CHONG T, 1990, NUCLEIC ACIDS RES, V18, P465, DOI 10.1093/nar/18.3.465; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ENSSER A, 1990, NUCLEIC ACIDS RES, V18, P3919, DOI 10.1093/nar/18.13.3919; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; Gasteiger E, 2005, PROTEOMIC PROTOCOLS; Giampieri S, 2004, BRIT J CANCER, V90, P2203, DOI 10.1038/sj.bjc.6601829; GLOSS B, 1990, J VIROL, V64, P5577, DOI 10.1128/JVI.64.11.5577-5584.1990; Gottschling M, 2008, VIRUS GENES, V36, P281, DOI 10.1007/s11262-008-0200-x; Gottschling M, 2007, MOL BIOL EVOL, V24, P1242, DOI 10.1093/molbev/msm039; Gottschling M, 2011, MOL BIOL EVOL, V28, P2101, DOI 10.1093/molbev/msr030; Iftner T, 2002, EMBO J, V21, P4741, DOI 10.1093/emboj/cdf443; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Ingle A, 2011, VET PATHOL, V48, P500, DOI 10.1177/0300985810377186; Iwasaki T, 1997, J GEN VIROL, V78, P1087, DOI 10.1099/0022-1317-78-5-1087; Jackson AP, 2005, SYST BIOL, V54, P127, DOI 10.1080/10635150590905911; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Joh J, 2011, J GEN VIROL, V92, P692, DOI 10.1099/vir.0.026138-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kohler A, 2010, VIROLOGY, V399, P129, DOI 10.1016/j.virol.2009.12.023; MULLER H, 1978, J GEN VIROL, V41, P315, DOI 10.1099/0022-1317-41-2-315; Muschik D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027655; Nafz J, 2008, VIROLOGY, V374, P186, DOI 10.1016/j.virol.2007.12.012; Nafz J, 2007, J GEN VIROL, V88, P2670, DOI 10.1099/vir.0.82955-0; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; OBANION MK, 1988, J VIROL, V62, P226, DOI 10.1128/JVI.62.1.226-233.1988; OCONNOR M, 1995, VIROLOGY, V207, P77, DOI 10.1006/viro.1995.1053; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Schulz E, 2009, J GEN VIROL, V90, P626, DOI 10.1099/vir.0.008011-0; Schulz E, 2009, J GEN VIROL, V90, P2609, DOI 10.1099/vir.0.012583-0; TAN CH, 1994, VIROLOGY, V198, P534, DOI 10.1006/viro.1994.1064; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Van Doorslaer K, 2007, J GEN VIROL, V88, P1484, DOI 10.1099/vir.0.82615-0; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	43	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47164	10.1371/journal.pone.0047164	http://dx.doi.org/10.1371/journal.pone.0047164			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077564	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100070
J	Tian, J; Ma, J; Ma, K; Ma, B; Tang, XY; Baidoo, SE; Tong, J; Yan, J; Lu, LW; Xu, HX; Wang, SJ				Tian, Jie; Ma, Jie; Ma, Ke; Ma, Bin; Tang, Xinyi; Baidoo, Samuel Essien; Tong, Jia; Yan, Jun; Lu, Liwei; Xu, Huaxi; Wang, Shengjun			Up-Regulation of GITRL on Dendritic Cells by WGP Improves Anti-Tumor Immunity in Murine Lewis Lung Carcinoma	PLOS ONE			English	Article							INDUCED TNF RECEPTOR; BETA-GLUCAN; T-CELLS; MONOCLONAL-ANTIBODY; DECTIN-1; RECOGNITION; RESPONSES; STIMULATION; EXPRESSION; INDUCTION	Background: beta-Glucans have been shown to function as a potent immunomodulator to stimulate innate and adaptive immune responses, which contributes to their anti-tumor property. However, their mechanisms of action are still elusive. Glucocorticoid-induced TNF receptor ligand (GITRL), a member of the TNF superfamily, binds to its receptor, GITR, on both effector and regulatory T cells, generates a positive co-stimulatory signal implicated in a wide range of T cell functions, which is important for the development of immune responses. Methodology/Principal Findings: In this study, we found that whole beta-glucan particles (WGPs) could activate dendritic cells (DCs) via dectin-1 receptor, and increase the expression of GITRL on DCs in vitro and in vivo. Furthermore, we demonstrated that the increased GITRL on DCs could impair the regulartory T cell (Treg)-mediated suppression and enhance effector T cell proliferation in a GITR/GITRL dependent way. In tumor models, DCs with high levels of GITRL were of great potential to prime cytotoxic T lymphocyte (CTL) responses and down-regulate the suppressive activity of Treg cells, thereby leading to the delayed tumor progression. Conclusions/Significance: These findings suggest that particulate beta-glucans can be used as an immunomodulator to stimulate potent T cell-mediated adaptive immunity while down-regulate suppressive immune activity via GITR/GITRL interaction, leading to a more efficient defense mechanism against tumor development.	[Tian, Jie; Ma, Jie; Ma, Ke; Ma, Bin; Tang, Xinyi; Baidoo, Samuel Essien; Tong, Jia; Xu, Huaxi; Wang, Shengjun] Jiangsu Univ, Sch Med Sci & Lab Med, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China; [Yan, Jun] Univ Louisville, James Graham Brown Canc Ctr, Tumor Immunobiol Program, Louisville, KY 40292 USA; [Lu, Liwei] Univ Hong Kong, Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China; [Lu, Liwei] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	Jiangsu University; University of Louisville; University of Hong Kong; University of Hong Kong	Wang, SJ (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Peoples R China.	sjwjs@ujs.edu.cn	Yan, Jun/A-8988-2008; tian, jie/H-2497-2011; Lu, Liwei/C-4357-2009	Lu, Liwei/0000-0002-8634-0967; Wang, Shengjun/0000-0001-6584-1183	National Natural Science Foundation of China [31170849, 81072453, 30972748]; Natural Science Foundation of Jiangsu [BK2011472]; Graduate Student Research and Innovation Program of Jiangsu Province [CXZZ12_0710, CXLX11_0608]; Jiangsu Province Qinglan Project; Top Talent Program of Jiangsu University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Graduate Student Research and Innovation Program of Jiangsu Province; Jiangsu Province Qinglan Project; Top Talent Program of Jiangsu University	This work was supported by the National Natural Science Foundation of China 31170849 and 81072453 (SW), 30972748(HX), Natural Science Foundation of Jiangsu BK2011472 (SW), Graduate Student Research and Innovation Program of Jiangsu Province CXZZ12_0710 (JT) and CXLX11_0608 (SEB), Jiangsu Province Qinglan Project, and Top Talent Program of Jiangsu University (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf DJ, 2005, J IMMUNOL, V174, P7050, DOI 10.4049/jimmunol.174.11.7050; Baran J, 2007, FOLIA HISTOCHEM CYTO, V45, P107; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Cheung NKV, 2002, CLIN CANCER RES, V8, P1217; Cohen AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010436; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Hong F, 2003, CANCER RES, V63, P9023; Ji HB, 2004, J IMMUNOL, V172, P5823, DOI 10.4049/jimmunol.172.10.5823; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Karumuthil-Melethil S, 2008, J IMMUNOL, V181, P8323, DOI 10.4049/jimmunol.181.12.8323; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Li B, 2006, J IMMUNOL, V177, P1661, DOI 10.4049/jimmunol.177.3.1661; Li B, 2010, CLIN CANCER RES, V16, P5153, DOI 10.1158/1078-0432.CCR-10-0820; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Modak S, 2005, LEUKEMIA RES, V29, P679, DOI 10.1016/j.leukres.2004.10.008; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Nocentini G, 2007, EUR J IMMUNOL, V37, P1165, DOI 10.1002/eji.200636933; Nocentini G, 2009, ADV EXP MED BIOL, V647, P156, DOI 10.1007/978-0-387-89520-8_11; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140; Ronchetti S, 2004, EUR J IMMUNOL, V34, P613, DOI 10.1002/eji.200324804; Ross GD, 2000, CRIT REV IMMUNOL, V20, P197; Shevach EM, 2006, NAT REV IMMUNOL, V6, P613, DOI 10.1038/nri1867; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tian J, 2011, CELL IMMUNOL, V270, P183, DOI 10.1016/j.cellimm.2011.05.003; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Xia Y, 1999, J IMMUNOL, V162, P2281; Yan J, 1999, J IMMUNOL, V163, P3045; You S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007848; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	45	12	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46936	10.1371/journal.pone.0046936	http://dx.doi.org/10.1371/journal.pone.0046936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077535	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100048
J	Lindquist, S; Andersson, EL; Lundberg, L; Hernell, O				Lindquist, Susanne; Andersson, Eva-Lotta; Lundberg, Lennart; Hernell, Olle			Bile Salt-Stimulated Lipase Plays an Unexpected Role in Arthritis Development in Rodents	PLOS ONE			English	Article							CARBOXYL-ESTER-LIPASE; COLLAGEN-INDUCED ARTHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRISTANE-INDUCED ARTHRITIS; CHEMOKINE RECEPTOR CXCR4; HUMAN-MILK; DEPENDENT LIPASE; KNOCKOUT MICE; II COLLAGEN; T-CELLS	Objective: The present study aimed to explore the hypothesis that bile salt-stimulated lipase (BSSL), in addition to being a key enzyme in dietary fat digestion during early infancy, plays an important role in inflammation, notably arthritis. Methods: Collagen-induced arthritis (CIA) and pristane-induced arthritis (PIA) in rodents are commonly used experimental models that reproduce many of the pathogenic mechanisms of human rheumatoid arthritis, i.e. increased cellular infiltration, synovial hyperplasia, pannus formation, and erosion of cartilage and bone in the distal joints. We used the CIA model to compare the response in BSSL wild type (BSSL-WT) mice with BSSL-deficient 'knock-out' (BSSL-KO) and BSSL-heterozygous (BSSL-HET) littermates. We also investigated if intraperitoneal injection of BSSL-neutralizing antibodies affected the development or severity of CIA and PIA in mice and rats, respectively. Results: In two consecutive studies, we found that BSSL-KO male mice, in contrast to BSSL-WT littermates, were significantly protected from developing arthritis. We also found that BSSL-HET mice were less prone to develop disease compared to BSSL-WT mice, but not as resistant as BSSL-KO mice, suggesting a gene-dose effect. Moreover, we found that BSSL-neutralizing antibody injection reduced both the incidence and severity of CIA and PIA in rodents. Conclusion: Our data strongly support BSSL as a key player in the inflammatory process, at least in rodents. It also suggests the possibility that BSSL-neutralizing agents could serve as a therapeutic model to reduce the inflammatory response in humans.	[Lindquist, Susanne; Andersson, Eva-Lotta; Lundberg, Lennart; Hernell, Olle] Umea Univ, Dept Clin Sci, Umea, Sweden	Umea University	Lindquist, S (corresponding author), Umea Univ, Dept Clin Sci, Umea, Sweden.	susanne.lindquist@pediatri.umu.se			Swedish Research Council/Medicine, Swedish Orphan Biovitrum AB, Vasterbotten County Council (ALF); Oscar foundation; Umea Biotech Incubator	Swedish Research Council/Medicine, Swedish Orphan Biovitrum AB, Vasterbotten County Council (ALF); Oscar foundation; Umea Biotech Incubator	Funding for this study was provided by the Swedish Research Council/Medicine, Swedish Orphan Biovitrum AB, Vasterbotten County Council (ALF), the Oscar foundation, and Umea Biotech Incubator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; BLACKBERG L, 1983, FEBS LETT, V157, P337, DOI 10.1016/0014-5793(83)80571-7; BLACKBERG L, 1985, J PEDIATR GASTR NUTR, V4, P441, DOI 10.1097/00005176-198506000-00020; BLIND PJ, 1987, PANCREAS, V2, P597, DOI 10.1097/00006676-198709000-00017; Bruneau N, 2003, GASTROENTEROLOGY, V124, P470, DOI 10.1053/gast.2003.50051; Camarota LM, 2011, FASEB J, V25, P1370, DOI 10.1096/fj.10-169680; Chung SH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3158; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Falt H, 2002, PEDIATR RES, V52, P509, DOI 10.1203/01.PDR.0000030878.20888.12; Gilham D, 2007, J BIOL CHEM, V282, P24642, DOI 10.1074/jbc.M702530200; GJELLESVIK DR, 1992, BIOCHIM BIOPHYS ACTA, V1124, P123, DOI 10.1016/0005-2760(92)90088-D; HOLMDAHL R, 1985, CLIN EXP IMMUNOL, V62, P639; HOLMDAHL R, 1986, IMMUNOGENETICS, V24, P84, DOI 10.1007/BF00373114; Holmdahl R., 1997, HUMAN GENOME METHODS, P215; Howles PN, 1999, AM J PHYSIOL-GASTR L, V277, pG653, DOI 10.1152/ajpgi.1999.277.3.G653; Howles PN, 1996, J BIOL CHEM, V271, P7196, DOI 10.1074/jbc.271.12.7196; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Jirholt J, 1998, EUR J IMMUNOL, V28, P3321, DOI 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M; Kanbe K, 2002, ARTHRITIS RHEUM-US, V46, P130, DOI 10.1002/1529-0131(200201)46:1<130::AID-ART10020>3.0.CO;2-D; Kirby RJ, 2002, J BIOL CHEM, V277, P4104, DOI 10.1074/jbc.M107549200; Kodvawala A, 2005, J BIOL CHEM, V280, P38592, DOI 10.1074/jbc.M502266200; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lande R, 2004, J IMMUNOL, V173, P2815, DOI 10.4049/jimmunol.173.4.2815; Li F, 1998, BIOCHEM J, V329, P675, DOI 10.1042/bj3290675; Li X, 2007, PEDIATR RES, V62, P537, DOI 10.1203/PDR.0b013e3181559e75; LIDMER AS, 1995, GENOMICS, V29, P115, DOI 10.1006/geno.1995.1221; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Mas E, 1997, GLYCOBIOLOGY, V7, P745, DOI 10.1093/glycob/7.6.745; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Miller R, 2008, J NUTR, V138, P927, DOI 10.1093/jn/138.5.927; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Nyberg L, 1998, J PEDIATR GASTR NUTR, V27, P560, DOI 10.1097/00005176-199811000-00013; Olofsson Peter, 2007, V136, P255; Panicot-Dubois L, 2007, J CLIN INVEST, V117, P3708, DOI 10.1172/JCI32655; PATTON JS, 1977, BIOCHIM BIOPHYS ACTA, V486, P322, DOI 10.1016/0005-2760(77)90028-5; SAXNE T, 1992, BRIT J RHEUMATOL, V31, P583; Shamir R, 1996, J CLIN INVEST, V97, P1696, DOI 10.1172/JCI118596; Shamir R, 2003, J PEDIATR ENDOCR MET, V16, P1289; SMITH BD, 1975, ARCH BIOCHEM BIOPHYS, V166, P181, DOI 10.1016/0003-9861(75)90378-1; Stax MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032534; Stax MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017316; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; Xiao XJ, 2011, J BIOL CHEM, V286, P26353, DOI 10.1074/jbc.M111.249813; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	51	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47006	10.1371/journal.pone.0047006	http://dx.doi.org/10.1371/journal.pone.0047006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071697	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700046
J	Hird, SM				Hird, Sarah M.			IociNGS: A Lightweight Alternative for Assessing Suitability of Next-Generation Loci for Evolutionary Analysis	PLOS ONE			English	Article							DE-NOVO; FRAMEWORK; FORMAT	Genomic enrichment methods and next-generation sequencing produce uneven coverage for the portions of the genome (the loci) they target; this information is essential for ascertaining the suitability of each locus for further analysis. LOCINGS is a user-friendly accessory program that takes multi-FASTA formatted loci, next-generation sequence alignments and demographic data as input and collates, displays and outputs information about the data. Summary information includes the parameters coverage per locus, coverage per individual and number of polymorphic sites, among others. The program can output the raw sequences used to call loci from next-generation sequencing data. LOCINGS also reformats subsets of loci in three commonly used formats for multi-locus phylogeographic and population genetics analyses - NEXUS, IMa2 and Migrate. LOCINGS is available at https://github.com/SHird/lociNGS and is dependent on installation of MongoDB (freely available at http://www.mongodb.org/downloads). LOCINGS is written in Python and is supported on MacOSX and Unix; it is distributed under a GNU General Public License.	[Hird, Sarah M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Hird, Sarah M.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Hird, SM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	shird1@tigers.lsu.edu		Hird, Sarah/0000-0002-1998-9387	Google Inc.; Div Of Biological Infrastructure [0956069] Funding Source: National Science Foundation	Google Inc.(Google Incorporated); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Google Inc. through the 2011 Google Summer Of CodeTM Program (http://code.google.com/soc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beerli P, 1999, GENETICS, V152, P763; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drummond A. J., 2012, GENEIOUS V5 6; EDGAR RC, 2004, NUCLEIC ACIDS RES, V32, P6; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hird SM, 2011, MOL ECOL RESOUR, V11, P743, DOI 10.1111/j.1755-0998.2011.03005.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maddison DR, 1997, SYST BIOL, V46, P590, DOI 10.2307/2413497; McCormack JE, 2012, MOL PHYLOGE IN PRESS, DOI 10.1016/j.ympev.2011.12.007; McCormack JE, 2012, MOL PHYLOGENET EVOL, V62, P397, DOI 10.1016/j.ympev.2011.10.012; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	18	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46847	10.1371/journal.pone.0046847	http://dx.doi.org/10.1371/journal.pone.0046847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071651	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200048
J	Micera, A; Puxeddu, I; Balzamino, BO; Bonini, S; Levi-Schaffer, F				Micera, Alessandra; Puxeddu, Ilaria; Balzamino, Bijorn Omar; Bonini, Stefano; Levi-Schaffer, Francesca			Chronic Nerve Growth Factor Exposure Increases Apoptosis in a Model of In Vitro Induced Conjunctival Myofibroblasts	PLOS ONE			English	Article							MUSCLE ACTIN EXPRESSION; TISSUE; P75; INVOLVEMENT; TRKA; FIBROBLASTS; P75(NTR); INSIGHTS; BIOLOGY; CELLS	In the conjunctiva, repeated or prolonged exposure to injury leads to tissue remodeling and fibrosis associated with dryness, lost of corneal transparency and defect of ocular function. At the site of injury, fibroblasts (FB) migrate and differentiate into myofibroblasts (myoFB), contributing to the healing process together with other cell types, cytokines and growth factors. While the physiological deletion of MyoFB is necessary to successfully end the healing process, myoFB prolonged survival characterizes the pathological process of fibrosis. The reason for myoFB persistence is poorly understood. Nerve Growth Factor (NGF), often increased in inflamed stromal conjunctiva, may represent an important molecule both in many inflammatory processes characterized by tissue remodeling and in promoting wound-healing and well-balanced repair in humans. NGF effects are mediated by the specific expression of the NGF neurotrophic tyrosine kinase receptor type 1 (trkA(NGFR)) and/or the pan-neurotrophin glycoprotein receptor (p75(NTR)). Therefore, a conjunctival myoFB model (TGF beta 1-induced myoFB) was developed and characterized for cell viability/proliferation as well as alpha SMA, p75(NTR) and trkA(NGFR) expression. MyoFB were exposed to acute and chronic NGF treatment and examined for their p75(NTR)/trkA(NGFR), alpha SMA/TGF beta 1 expression, and apoptosis. Both NGF treatments significantly increased the expression of p75(NTR), associated with a deregulation of both alpha SMA/TGF beta 1 genes. Acute and chronic NGF exposures induced apoptosis in p75(NTR) expressing myoFB, an effect counteracted by the specific trkA(NGFR) and/or p75(NTR) inhibitors. Focused single p75(NTR) and double trkA(NGFR)/p75(NTR) knocking-down experiments highlighted the role of p75(NTR) in NGF-induced apoptosis. Our current data indicate that NGF is able to trigger in vitro myoFB apoptosis, mainly via p75(NTR). The trkA(NGFR)/p75(NTR) ratio in favor of p75(NTR) characterizes this process. Due to the lack of effective pharmacological agents for balanced tissue repairs, these new findings suggest that NGF might be a suitable therapeutic tool in conditions with impaired tissue healing.	[Puxeddu, Ilaria; Levi-Schaffer, Francesca] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol & Expt Therapeut, Inst Drug Res,Fac Med, IL-91120 Jerusalem, Israel; [Micera, Alessandra; Balzamino, Bijorn Omar] IRCCS GB Bietti Fdn, Rome, Italy; [Bonini, Stefano] Univ Campus Biomed, Dept Ophthalmol, Rome, Italy	Hebrew University of Jerusalem; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University Campus Bio-Medico - Rome Italy	Levi-Schaffer, F (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol & Expt Therapeut, Inst Drug Res,Fac Med, IL-91120 Jerusalem, Israel.	francescal@ekmd.huji.ac.il	Micera, Alessandra/J-3373-2013; Bonini, Stefano/A-2250-2012; balzamino, bijorn omar/A-4433-2013; Bonini, Sergio/T-6594-2019; Puxeddu, Ilaria/AAB-3263-2019; micera, alessandra/AAY-4696-2020	Bonini, Stefano/0000-0002-7787-2144; balzamino, bijorn omar/0000-0002-2254-1647; Bonini, Sergio/0000-0003-0079-3031; micera, alessandra/0000-0002-9375-6071; Levi-Schaffer, Francesca/0000-0003-0620-2810	Aimwell Charitable Trust Foundation (UK)	Aimwell Charitable Trust Foundation (UK)	This work was funded in part by the Aimwell Charitable Trust Foundation (UK) to FLS. No other external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; Arora PD, 1999, AM J PATHOL, V155, P2087, DOI 10.1016/S0002-9440(10)65527-7; Bandtlow Christine, 2004, Sci STKE, V2004, ppe24, DOI 10.1126/stke.2352004pe24; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Chou TT, 2000, J BIOL CHEM, V275, P565, DOI 10.1074/jbc.275.1.565; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Desmouliere A, 1997, INT J BIOCHEM CELL B, V29, P19, DOI 10.1016/S1357-2725(96)00117-3; Frade JM, 1996, NATURE, V383, P166; Fukuda Ken, 2006, Allergol Int, V55, P121, DOI 10.2332/allergolint.55.121; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Hasan W, 2000, CELL TISSUE RES, V300, P97, DOI 10.1007/s004410050051; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272; Kaur H, 2009, EXP EYE RES, V89, P152, DOI 10.1016/j.exer.2009.03.001; Kawamoto K, 2004, PROG BRAIN RES, V146, P369; Lambiase A, 1998, INVEST OPHTH VIS SCI, V39, P1272; Lambiase A, 2011, ARCH ITAL BIOL, V149, P283, DOI 10.4449/aib.v149i2.1363; Lambiase A, 2000, INVEST OPHTH VIS SCI, V41, P1063; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lorena D, 2002, WOUND REPAIR REGEN, V10, P86, DOI 10.1046/j.1524-475X.2002.00201.x; Matsuda H, 1998, J EXP MED, V187, P297, DOI 10.1084/jem.187.3.297; McCarthy MJ, 1997, J CELL SCI, V110, P2165; Micera A, 2005, CLIN EXP ALLERGY, V35, P650, DOI 10.1111/j.1365-2222.2005.02241.x; Micera A, 2004, CYTOKINE GROWTH F R, V15, P411, DOI 10.1016/j.cytogfr.2004.09.003; Micera A, 2003, CYTOKINE GROWTH F R, V14, P369, DOI 10.1016/S1359-6101(03)00047-9; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Micera A, 2006, EXP EYE RES, V83, P747, DOI 10.1016/j.exer.2006.03.010; Milhavet O, 2003, PHARMACOL REV, V55, P629, DOI 10.1124/pr.55.4.1; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Solomon A, 2003, CURR OPIN ALLERGY CL, V3, P389, DOI 10.1097/01.a11.0000092611.76804.c3; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Wang SY, 2000, AM J PATHOL, V157, P1247, DOI 10.1016/S0002-9440(10)64640-8; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720	43	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47316	10.1371/journal.pone.0047316	http://dx.doi.org/10.1371/journal.pone.0047316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071784	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200104
J	Wang, D; Gilbert, JR; Cray, JJ; Kubala, AA; Shaw, MA; Billiar, TR; Cooper, GM				Wang, Dan; Gilbert, James R.; Cray, James J., Jr.; Kubala, Adam A.; Shaw, Melissa A.; Billiar, Timothy R.; Cooper, Gregory M.			Accelerated Calvarial Healing in Mice Lacking Toll-Like Receptor 4	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IMMUNE-SYSTEM; OSTEOCLAST DIFFERENTIATION; BONE DESTRUCTION; GENE-EXPRESSION; FRACTURE; INTERLEUKIN-6; OSTEOIMMUNOLOGY; OSTEOGENESIS; MECHANISMS	The bone and immune systems are closely interconnected. The immediate inflammatory response after fracture is known to trigger a healing cascade which plays an important role in bone repair. Toll-like receptor 4 (TLR4) is a member of a highly conserved receptor family and is a critical activator of the innate immune response after tissue injury. TLR4 signaling has been shown to regulate the systemic inflammatory response induced by exposed bone components during long-bone fracture. Here we tested the hypothesis that TLR4 activation affects the healing of calvarial defects. A 1.8 mm diameter calvarial defect was created in wild-type (WT) and TLR4 knockout (TLR4(-/-)) mice. Bone healing was tested using radiographic, histologic and gene expression analyses. Radiographic and histomorphometric analyses revealed that calvarial healing was accelerated in TLR4(-/-) mice. More bone was observed in TLR4(-/-) mice compared to WT mice at postoperative days 7 and 14, although comparable healing was achieved in both groups by day 21. Bone remodeling was detected in both groups on postoperative day 28. In TLR4(-/-) mice compared to WT mice, gene expression analysis revealed that higher expression levels of IL-1 beta, IL-6, TNF-alpha, TGF-beta 1, TGF-beta 3, PDGF and RANKL and lower expression level of RANK were detected at earlier time points (<= postoperative 4 days); while higher expression levels of IL-1 beta and lower expression levels of VEGF, RANK, RANKL and OPG were detected at late time points (> postoperative 4 days). This study provides evidence of accelerated bone healing in TLR4(-/-) mice with earlier and higher expression of inflammatory cytokines and with increased osteoclastic activity. Further work is required to determine if this is due to inflammation driven by TLR4 activation.	[Wang, Dan; Gilbert, James R.; Kubala, Adam A.; Shaw, Melissa A.; Cooper, Gregory M.] Univ Pittsburgh, Dept Plast Surg, Pittsburgh, PA 15260 USA; [Wang, Dan] Tongji Univ, Peoples Hosp 9, Dept Stomatol, Shanghai 200092, Peoples R China; [Cray, James J., Jr.] Georgia Hlth Sci Univ, Dept Oral Biol, Augusta, GA USA; [Cray, James J., Jr.] Georgia Hlth Sci Univ, Dept Orthodont, Augusta, GA USA; [Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Cooper, Gregory M.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA USA; [Cooper, Gregory M.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tongji University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cooper, GM (corresponding author), Univ Pittsburgh, Dept Plast Surg, Pittsburgh, PA 15260 USA.	greg.cooper@chp.edu	Gilbert, James/K-2823-2019; Wang, Dan/R-5941-2018	Wang, Dan/0000-0002-5934-9085	Children's Hospital of Pittsburgh	Children's Hospital of Pittsburgh	This study is funded by the Children's Hospital of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Balto K, 2001, INFECT IMMUN, V69, P744, DOI 10.1128/IAI.69.2.744-750.2001; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Choudhary S, 2007, J BONE MINER RES, V22, P1002, DOI 10.1359/JBMR.070321; Darowish M, 2009, BONE, V45, P661, DOI 10.1016/j.bone.2009.06.004; de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018; Hayashi SI, 2003, J IMMUNOL, V171, P5130, DOI 10.4049/jimmunol.171.10.5130; HOYLAND JA, 1994, J BONE MINER RES, V9, P75; Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574; Kobbe P, 2008, SHOCK, V30, P686, DOI 10.1097/SHK.0b013e31816f257e; Kobbe P, 2008, SHOCK, V30, P43, DOI [10.1097/SHK.0b013e318d190b, 10.1097/SHK.0b013e31815d190b]; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996; Nakashima T, 2009, J CLIN IMMUNOL, V29, P555, DOI 10.1007/s10875-009-9316-6; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Strecker W, 1999, J TRAUMA, V47, P358, DOI 10.1097/00005373-199908000-00025; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; Wallace A, 2011, J ORTHOP RES, V29, P1437, DOI 10.1002/jor.21367; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	29	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46945	10.1371/journal.pone.0046945	http://dx.doi.org/10.1371/journal.pone.0046945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071670	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000312385200052
J	Wray, H; Mackenzie, IC; Storey, A; Navsaria, H				Wray, Helen; Mackenzie, Ian C.; Storey, Alan; Navsaria, Harshad			alpha 6 Integrin and CD44 Enrich for a Primary Keratinocyte Population That Displays Resistance to UV-Induced Apoptosis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DOUBLE-STRAND BREAKS; B-INDUCED APOPTOSIS; CANCER STEM-CELLS; PROSPECTIVE IDENTIFICATION; CLEAVAGE COMPLEXES; P53 HOMOLOG; HUMAN-SKIN; P63; DIFFERENTIATION	Epidermal human keratinocytes are exposed to a wide range of environmental genotoxic insults, including the UV component of solar radiation. Epidermal homeostasis in response to cellular or tissue damage is maintained by a population of keratinocyte stem cells (KSC) that reside in the basal layer of the epithelium. Using cell sorting based on cell-surface markers, we have identified a novel alpha 6 integrin(high+)/CD44(+) sub-population of basal keratinocytes. These alpha 6 integrin(high+)/CD44(+) keratinocytes have both high proliferative potential, form colonies in culture that have characteristics of holoclones and have a unique pattern of resistance to apoptosis induced by UVB radiation or by agents that induce single- or double strand DNA breaks. Resistance to UVB induced apoptosis in the alpha 6 integrin(high+)/CD44(+) cells involved increased expression ofTAp63 and was overcome by PI-3 kinase inhibition. In marked contrast, the alpha 6 integrin(high+)/CD44(+) cells were sensitive to apoptosis induced by the cross-linking agent cisplatin, and imatinib inhibition of c-Abl blocked the ability of cisplatin to kill alpha 6 integrin(high+)/CD44(+) cells. Our findings reveal a population of basal keratinocytes with long-term proliferative properties that display specific patterns of apoptotic resistance that is dependent upon the genotoxic stimulus, and provide insights into how these cells can be targeted with chemotherapeutic agents. Citation: Wray H, Mackenzie IC, Storey A, Navsaria H (2012) alpha 6 Integrin and CD44 Enrich for a Primary Keratinocyte Population That Displays Resistance to UV-Induced Apoptosis. PLoS ONE 7(10): e46968. doi:10.1371/journal.pone.0046968	[Wray, Helen; Mackenzie, Ian C.; Navsaria, Harshad] Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England; [Storey, Alan] Univ Oxford, John Radcliffe Hosp, Dept Mol Oncol, WIMM, Oxford OX3 9DU, England	University of London; Queen Mary University London; University of Oxford	Navsaria, H (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England.	h.navsaria@qmul.ac.uk	Mackenzie, Ian C/B-9653-2013	Mackenzie, Ian C/0000-0003-1373-062X; Storey, Alan/0000-0003-2001-9772	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/B/15384, C20349] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balajee AS, 2000, GENE, V250, P15, DOI 10.1016/S0378-1119(00)00172-4; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Harper LJ, 2007, J ORAL PATHOL MED, V36, P594, DOI 10.1111/j.1600-0714.2007.00617.x; HERTLE MD, 1991, DEVELOPMENT, V112, P193; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liefer KM, 2000, CANCER RES, V60, P4016; Ogawa E, 2008, ONCOGENE, V27, P848, DOI 10.1038/sj.onc.1210682; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; PIERCE GB, 1988, CANCER RES, V48, P1996; POVIRK LF, 1977, NUCLEIC ACIDS RES, V4, P3573, DOI 10.1093/nar/4.10.3573; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; SUTHERLAND BM, 1980, CANCER RES, V40, P3181; WANG C, 1992, HISTOCHEMISTRY, V98, P105, DOI 10.1007/BF00717001; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; YOUNG AR, 1987, PHOTODERMATOLOGY, V4, P127	30	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46968	10.1371/journal.pone.0046968	http://dx.doi.org/10.1371/journal.pone.0046968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071680	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200057
J	La Flamme, AC; Kharkrang, M; Stone, S; Mirmoeini, S; Chuluundorj, D; Kyle, R				La Flamme, Anne Camille; Kharkrang, Marie; Stone, Sarrabeth; Mirmoeini, Sara; Chuluundorj, Delgertsetseg; Kyle, Ryan			Type II-Activated Murine Macrophages Produce IL-4	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; ALTERNATIVE ACTIVATION; MULTIPLE-SCLEROSIS; RESPONSES; INTERLEUKIN-4; RECEPTORS; CYTOKINES; MONOCYTE; MANSONI	Background: Type II activation of macrophages is known to support Th2 responses development; however, the role of Th2 cytokines (esp. IL-4) on type II activation is unknown. To assess whether the central Th2 cytokine IL-4 can alter type II activation of macrophages, we compared the ability of bone marrow-derived macrophages from wild type (WT) and IL-4R alpha-deficient mice to be classically or type II-activated in vitro. Results: We found that although both WT and IL-4R alpha-deficient macrophages could be classically activated by LPS or type II activated by immune complexes plus LPS, IL-4R alpha-deficient macrophages consistently produced much higher levels of IL-12p40 and IL-10 than WT macrophages. Additionally, we discovered that type II macrophages from both strains were capable of producing IL-4; however, this IL-4 was not responsible for the reduced IL-12p40 and IL-10 levels produced by WT mice. Instead, we found that derivation culture conditions (GM-CSF plus IL-3 versus M-CSF) could explain the different responses of BALB/c and IL-4R alpha-/- macrophages, and these cytokines shaped the ensuing macrophage such that GM-CSF plus IL-3 promoted more IL-12 and IL-4 while M-CSF led to higher IL-10 production. Finally, we found that enhanced IL-4 production is characteristic of the type II activation state as other type II-activating products showed similar results. Conclusions: Taken together, these results implicate type II activated macrophages as an important innate immune source of IL-4 that may play an important role in shaping adaptive immune responses.	[La Flamme, Anne Camille; Kharkrang, Marie; Stone, Sarrabeth; Mirmoeini, Sara; Chuluundorj, Delgertsetseg] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [La Flamme, Anne Camille; Kyle, Ryan] Malaghan Inst Med Res, Wellington, New Zealand	Victoria University Wellington; Malaghan Institute; Victoria University Wellington	La Flamme, AC (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	anne.laflamme@vuw.ac.nz		Kyle, Ryan/0000-0002-8146-7504; Stone, Sarrabeth/0000-0001-7866-8228	Neurological Foundation of New Zealand [0828-PG]	Neurological Foundation of New Zealand	This work was supported by a grant from the Neurological Foundation of New Zealand (0828-PG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2002, J NEUROIMMUNOL, V126, P58, DOI 10.1016/S0165-5728(02)00053-X; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Bonder CS, 1999, IMMUNOLOGY, V96, P529; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Crume KP, 2007, EXP BIOL MED, V232, P607; DING AH, 1988, J IMMUNOL, V141, P2407; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; La Flamme AC, 2004, MEM I OSWALDO CRUZ, V99, P33, DOI 10.1590/S0074-02762004000900006; La Flamme AC, 2006, IMMUNOL CELL BIOL, V84, P522, DOI 10.1111/j.1440-1711.2006.01464.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukherjee S, 2009, J BIOL CHEM, V284, P29391, DOI 10.1074/jbc.M109.005272; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Tierney JB, 2009, IMMUNOL CELL BIOL, V87, P235, DOI 10.1038/icb.2008.99; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620	22	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46989	10.1371/journal.pone.0046989	http://dx.doi.org/10.1371/journal.pone.0046989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071691	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300076
J	Lopera-Mesa, TM; Mita-Mendoza, NK; van de Hoef, DL; Doumbia, S; Konate, D; Doumbouya, M; Gu, WJ; Traore, K; Diakite, SAS; Remaley, AT; Anderson, JM; Rodriguez, A; Fay, MP; Long, CA; Diakite, M; Fairhurst, RM				Lopera-Mesa, Tatiana M.; Mita-Mendoza, Neida K.; van de Hoef, Diana L.; Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Gu, Wenjuan; Traore, Karim; Diakite, Seidina A. S.; Remaley, Alan T.; Anderson, Jennifer M.; Rodriguez, Ana; Fay, Michael P.; Long, Carole A.; Diakite, Mahamadou; Fairhurst, Rick M.			Plasma Uric Acid Levels Correlate with Inflammation and Disease Severity in Malian Children with Plasmodium falciparum Malaria	PLOS ONE			English	Article							CEREBRAL MALARIA; DANGER SIGNAL; SERUM-LEVELS; CELLS; TRANSPORT; EXPRESSION; MORTALITY; MEDIATOR; IMMUNITY; FAILURE	Background: Plasmodium falciparum elicits host inflammatory responses that cause the symptoms and severe manifestations of malaria. One proposed mechanism involves formation of immunostimulatory uric acid (UA) precipitates, which are released from sequestered schizonts into microvessels. Another involves hypoxanthine and xanthine, which accumulate in parasitized red blood cells (RBCs) and may be converted by plasma xanthine oxidase to UA at schizont rupture. These two forms of 'parasite-derived' UA stimulate immune cells to produce inflammatory cytokines in vitro. Methods and Findings: We measured plasma levels of soluble UA and inflammatory cytokines and chemokines (IL-6, IL-10, sTNFRII, MCP-1, IL-8, TNF alpha, IP-10, IFN gamma, GM-CSF, IL-1 beta) in 470 Malian children presenting with uncomplicated malaria (UM), non-cerebral severe malaria (NCSM) or cerebral malaria (CM). UA levels were elevated in children with NCSM (median 5.74 mg/dl, 1.21-fold increase, 95% CI 1.09-1.35, n = 23, p = 0.0007) and CM (median 5.69 mg/dl, 1.19-fold increase, 95% CI 0.97-1.41, n = 9, p = 0.0890) compared to those with UM (median 4.60 mg/dl, n = 438). In children with UM, parasite density and plasma creatinine levels correlated with UA levels. These UA levels correlated with the levels of seven cytokines [IL-6 (r = 0.259, p<0.00001), IL-10 (r = 0.242, p<0.00001), sTNFRII (r = 0.221, p<0.00001), MCP-1 (r = 0.220, p<0.00001), IL-8 (r = 0.147, p = 0.002), TNF alpha (r = 0.132, p = 0.006) and IP-10 (r = 0.120, p = 0.012)]. In 39 children, UA levels were 1.49-fold (95% CI 1.34-1.65; p<0.0001) higher during their malaria episode [geometric mean titer (GMT) 4.67 mg/dl] than when they were previously healthy and aparasitemic (GMT 3.14 mg/dl). Conclusions: Elevated UA levels may contribute to the pathogenesis of P. falciparum malaria by activating immune cells to produce inflammatory cytokines. While this study cannot identify the cause of elevated UA levels, their association with parasite density and creatinine levels suggest that parasite-derived UA and renal function may be involved. Defining pathogenic roles for parasite-derived UA precipitates, which we have not directly studied here, requires further investigation.	[Lopera-Mesa, Tatiana M.; Mita-Mendoza, Neida K.; Anderson, Jennifer M.; Long, Carole A.; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Mita-Mendoza, Neida K.] Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [van de Hoef, Diana L.; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Doumbia, Saibou; Konate, Drissa; Doumbouya, Mory; Traore, Karim; Diakite, Seidina A. S.; Diakite, Mahamadou] Univ Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, Bamako, Mali; [Gu, Wenjuan] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Gu, Wenjuan; Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA; [Remaley, Alan T.] NIH, Dept Lab Med, NIH Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; New York University; University of Bamako; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Fairhurst, RM (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rfairhurst@niaid.nih.gov	Fay, Michael P/A-2974-2008	Fay, Michael P/0000-0002-8643-9625; Diakite, Seidina A. S./0000-0003-1193-6501	National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001062, ZIAAI001020, ZIAAI001000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Atoh Y, 2011, VIOPOINTS 1 D SCATTE; Awandare GA, 2006, J INFECT DIS, V194, P1438, DOI 10.1086/508547; Bertrand Kouam Eric, 2008, Pak J Biol Sci, V11, P1646, DOI 10.3923/pjbs.2008.1646.1649; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Fay MP, 2010, BIOSTATISTICS, V11, P373, DOI 10.1093/biostatistics/kxp050; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Higgins SJ, 2011, EXPERT REV ANTI-INFE, V9, P803, DOI [10.1586/eri.11.96, 10.1586/ERI.11.96]; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HOLM S, 1979, SCAND J STAT, V6, P65; Iwalokun BA, 2006, APMIS, V114, P842, DOI 10.1111/j.1600-0463.2006.apm_457.x; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; John CC, 2008, CYTOKINE, V41, P204, DOI 10.1016/j.cyto.2007.12.008; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kobayashi T, 2010, J IMMUNOL, V184, P6350, DOI 10.4049/jimmunol.0902673; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Leyva F, 1998, EUR HEART J, V19, P1814, DOI 10.1053/euhj.1998.1188; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mishra SK, 2008, SEMIN NEPHROL, V28, P395, DOI 10.1016/j.semnephrol.2008.04.007; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Sarma PSA, 1998, AM J TROP MED HYG, V58, P454, DOI 10.4269/ajtmh.1998.58.454; Schofield L, 1996, J IMMUNOL, V156, P1886; SHERMAN IW, 1977, B WORLD HEALTH ORGAN, V55, P211; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; TING AW, 1981, INT J BIOCHEM, V13, P955, DOI 10.1016/0020-711X(81)90025-2; van de Hoef DL, 2012, INFLAMMATORY U UNPUB; Van Den Steen P E, 2011, Verh K Acad Geneeskd Belg, V73, P123; Vannaphan S, 2010, SE ASIAN J TROP MED, V41, P1042; WHO, 2012, WORLD MALARIA REPORT 2012, P1	38	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46424	10.1371/journal.pone.0046424	http://dx.doi.org/10.1371/journal.pone.0046424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071567	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300027
J	Yeom, HJ; Koo, OJ; Yang, J; Cho, B; Hwang, JI; Park, SJ; Hurh, S; Kim, H; Lee, EM; Ro, H; Kang, JT; Kim, SJ; Won, JK; O'Connell, PJ; Kim, H; Surh, CD; Lee, BC; Ahn, C				Yeom, Hye-Jung; Koo, Ok Jae; Yang, Jaeseok; Cho, Bumrae; Hwang, Jong-Ik; Park, Sol Ji; Hurh, Sunghoon; Kim, Hwajung; Lee, Eun Mi; Ro, Han; Kang, Jung Taek; Kim, Su Jin; Won, Jae-Kyung; O'Connell, Philip J.; Kim, Hyunil; Surh, Charles D.; Lee, Byeong-Chun; Ahn, Curie			Generation and Characterization of Human Heme Oxygenase-1 Transgenic Pigs	PLOS ONE			English	Article							NEONATAL PORCINE ISLETS; AORTIC ENDOTHELIAL-CELLS; HAMSTER-TO-RAT; ORGAN-TRANSPLANTATION; UP-REGULATION; ISCHEMIA/REPERFUSION INJURY; XENOGRAFT SURVIVAL; INDUCED APOPTOSIS; SKIN XENOGRAFTS; CARBON-MONOXIDE	Xenotransplantation using transgenic pigs as an organ source is a promising strategy to overcome shortage of human organ for transplantation. Various genetic modifications have been tried to ameliorate xenograft rejection. In the present study we assessed effect of transgenic expression of human heme oxygenase-1 (hHO-1), an inducible protein capable of cytoprotection by scavenging reactive oxygen species and preventing apoptosis caused by cellular stress during inflammatory processes, in neonatal porcine islet-like cluster cells (NPCCs). Transduction of NPCCs with adenovirus containing hHO-1 gene significantly reduced apoptosis compared with the GFP-expressing adenovirus control after treatment with either hydrogen peroxide or hTNF-alpha and cycloheximide. These protective effects were diminished by co-treatment of hHO-1 antagonist, Zinc protoporphyrin IX. We also generated transgenic pigs expressing hHO-1 and analyzed expression and function of the transgene. Human HO-1 was expressed in most tissues, including the heart, kidney, lung, pancreas, spleen and skin, however, expression levels and patterns of the hHO-1 gene are not consistent in each organ. We isolate fibroblast from transgenic pigs to analyze protective effect of the hHO-1. As expected, fibroblasts derived from the hHO-1 transgenic pigs were significantly resistant to both hydrogen peroxide damage and hTNF-alpha and cycloheximide-mediated apoptosis when compared with wild-type fibroblasts. Furthermore, induction of RANTES in response to hTNF-alpha or LPS was significantly decreased in fibroblasts obtained from the hHO-1 transgenic pigs. These findings suggest that transgenic expression of hHO-1 can protect xenografts when exposed to oxidative stresses, especially from ischemia/reperfusion injury, and/or acute rejection mediated by cytokines. Accordingly, hHO-1 could be an important candidate molecule in a multi-transgenic pig strategy for xenotransplantation.	[Cho, Bumrae; Park, Sol Ji; Kang, Jung Taek; Kim, Su Jin; Lee, Byeong-Chun] Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul, South Korea; [Yeom, Hye-Jung; Koo, Ok Jae; Yang, Jaeseok; Cho, Bumrae; Hurh, Sunghoon; Kim, Hwajung; Lee, Eun Mi; Ro, Han; Ahn, Curie] Seoul Natl Univ, Coll Med, Transplantat Res Inst, Seoul, South Korea; [Koo, Ok Jae; Ahn, Curie] Seoul Natl Univ, Designed Anim Resource Ctr, Gangwon Do, South Korea; [Koo, Ok Jae; Ahn, Curie] Seoul Natl Univ, Biotransplant Res Inst, Gangwon Do, South Korea; [Yang, Jaeseok; Ro, Han; Ahn, Curie] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul 110744, South Korea; [Hwang, Jong-Ik] Korea Univ, Grad Sch Med, Lab Prot Coupled Receptors G, Seoul, South Korea; [Won, Jae-Kyung] Seoul Natl Univ, Canc Hosp, Mol Pathol Ctr, Seoul, South Korea; [O'Connell, Philip J.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Transplant Renal Res, Westmead, NSW 2145, Australia; [Kim, Hyunil] Optifarm Solut Inc, Seonggeoeup, Cheonan, South Korea; [Surh, Charles D.] Scripps Res Inst, La Jolla, CA 92037 USA; [Ahn, Curie] Seoul Natl Univ, Coll Med, Div Nephrol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); University of Sydney; Westmead Institute for Medical Research; Scripps Research Institute; Seoul National University (SNU)	Lee, BC (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul, South Korea.	bclee@snu.ac.kr; curie@snu.ac.kr	Ahn, Curie/J-5527-2012; O'Connell, Philip John/AFK-9353-2022; Koo, Ok Jae/I-4267-2013	O'Connell, Philip John/0000-0002-2036-283X; Hwang, Jong-Ik/0000-0002-0729-1782; Won, Jae-Kyung/0000-0003-1459-8093; Yang, Jeaseok/0000-0002-5378-7797; Kang, Jung-Taek/0000-0001-9185-165X; Koo, Ok Jae/0000-0001-6399-6472	Ministry of the Knowledge Economy [2009-67-10033838, 2009-67-10033805]	Ministry of the Knowledge Economy	This study was supported by the Ministry of the Knowledge Economy (grant #2009-67-10033838, #2009-67-10033805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach FH, 2006, HUM IMMUNOL, V67, P430, DOI 10.1016/j.humimm.2006.03.006; BALLA G, 1992, J BIOL CHEM, V267, P18148; Bhang SH, 2011, TISSUE ENG PT A, V17, P915, DOI [10.1089/ten.tea.2010.0493, 10.1089/ten.TEA.2010.0493]; Blumenthal SB, 2005, FASEB J, V19, P1272, DOI 10.1096/fj.04-3259com; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Bosio E, 2008, CELL TRANSPLANT, V17, P587, DOI 10.3727/096368908786092784; Brouard S, 1999, TRANSPLANTATION, V67, P1614, DOI 10.1097/00007890-199906270-00017; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Charniot JC, 2007, FREE RADICAL RES, V41, P911, DOI 10.1080/10715760701429775; Cho B, 2011, TRANSPLANTATION, V92, P139, DOI 10.1097/TP.0b013e3182215e7e; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; DRUMMOND GS, 1981, P NATL ACAD SCI-BIOL, V78, P6466, DOI 10.1073/pnas.78.10.6466; Elliott RB, 2011, CURR OPIN ORGAN TRAN, V16, P195, DOI 10.1097/MOT.0b013e3283449dec; Emamaullee JA, 2006, TRANSPLANTATION, V82, P945, DOI 10.1097/01.tp.0000238677.00750.32; Hwang JI, 2005, BIOCHEM J, V389, P181, DOI 10.1042/BJ20041677; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Katori M, 2002, TRANSPLANTATION, V74, P905, DOI 10.1097/00007890-200210150-00001; Kawamura K, 2005, ARTERIOSCL THROM VAS, V25, P155, DOI 10.1161/01.ATV.0000148405.18071.6a; Keshavan P, 2005, J IMMUNOL, V174, P3709, DOI 10.4049/jimmunol.174.6.3709; Kim JY, 2003, TRANSPL IMMUNOL, V12, P63, DOI 10.1016/S0966-3274(03)00013-3; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Koo OJ, 2009, ZYGOTE, V17, P203, DOI 10.1017/S0967199409005267; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee EM, 2006, XENOTRANSPLANTATION, V13, P328, DOI 10.1111/j.1399-3089.2006.00311.x; Lee S, 2008, TRANSPLANTATION, V86, P1257, DOI 10.1097/TP.0b013e318188ab04; Lee S, 2007, INT IMMUNOL, V19, P1349, DOI 10.1093/intimm/dxm104; Li LP, 2010, CHINESE MED J-PEKING, V123, P2128, DOI 10.3760/cma.j.issn.0366-6999.2010.15.031; Miyagawa S, 2010, XENOTRANSPLANTATION, V17, P11, DOI 10.1111/j.1399-3089.2010.00569.x; Niemann H, 2011, XENOTRANSPLANTATION, V18, P64, DOI 10.1111/j.1399-3089.2010.00607_6.x; Ollinger R, 2010, TRANSPL INT, V23, P1071, DOI 10.1111/j.1432-2277.2010.01158.x; Oropeza M, 2009, XENOTRANSPLANTATION, V16, P522, DOI 10.1111/j.1399-3089.2009.00556.x; Perfettini JL, 2003, NAT IMMUNOL, V4, P308, DOI 10.1038/ni0403-308; Petersen B, 2011, XENOTRANSPLANTATION, V18, P355, DOI 10.1111/j.1399-3089.2011.00674.x; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; RAMOS KS, 1989, BIOCHEM PHARMACOL, V38, P1368, DOI 10.1016/0006-2952(89)90347-X; Ritter T, 2005, CURR GENE THER, V5, P101; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Shen Z, 2011, TRANSPL P, V43, P1994, DOI 10.1016/j.transproceed.2011.03.037; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Tabata T, 2003, TRANSPLANTATION, V75, P607, DOI 10.1097/01.TP.0000053353.03389.1C; Tsuchihashi Sei-ichiro, 2004, Ann Transplant, V9, P84; Tu CF, 2010, TRANSPL P, V42, P2138, DOI 10.1016/j.transproceed.2010.05.104; Tu CF, 2005, TRANSPL P, V37, P3463, DOI 10.1016/j.transproceed.2005.09.022; Wang N, 2002, TRANSPLANTATION, V74, P334, DOI 10.1097/00007890-200208150-00008; Watanabe S, 2004, PLACENTA, V25, P387, DOI 10.1016/j.placenta.2003.10.012; Xia ZW, 2007, PEDIATR TRANSPLANT, V11, P850, DOI 10.1111/j.1399-3046.2007.00701; Yang TS, 2007, XENOTRANSPLANTATION, V14, P382; Zhu M, 2008, TRANSPL IMMUNOL, V19, P202, DOI 10.1016/j.trim.2008.06.002	50	49	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46646	10.1371/journal.pone.0046646	http://dx.doi.org/10.1371/journal.pone.0046646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071605	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300043
J	Solinski, HJ; Zierler, S; Gudermann, T; Breit, A				Solinski, Hans Juergen; Zierler, Susanna; Gudermann, Thomas; Breit, Andreas			Human Sensory Neuron-specific Mas-related G Protein-coupled Receptors-X1 Sensitize and Directly Activate Transient Receptor Potential Cation Channel V1 via Distinct Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CURRENTS; KINASE-C-EPSILON; CAPSAICIN RECEPTOR; CELL-LINE; VANILLOID RECEPTOR-1; POSSIBLE MECHANISM; PROTON ACTIVATION; HYBRID-CELLS; GENE FAMILY; TRPV1	Sensory neuron-specific Mas-related G protein-coupled receptors-X1 (MRGPR-X1) are primate-specific proteins that are exclusively expressed in primary sensory neurons and provoke pain in humans. Hence, MRGPR-X1 represent promising targets for future pain therapy, but signaling pathways activated by MRGPR-X1 are poorly understood. The transient receptor potential cation channel V1 (TRPV1) is also expressed in primary sensory neurons and detects painful stimuli such as protons and heat. G(q)-promoted signaling has been shown to sensitize TRPV1 via protein kinase C (PKC)-dependent phosphorylation. In addition, recent studies suggested TRPV1 activation via a G(q)-mediated mechanism involving diacylglycerol (DAG) or phosphatidylinositol-4,5-bisphosphate (PIP2). However, it is not clear if DAG-promoted TRPV1 activation occurs independently from classic TRPV1 activation modes induced by heat and protons. Herein, we analyzed putative functional interactions between MRGPR-X1 and TRPV1 in a previously reported F11 cell line stably over-expressing MRGPR-X1. First, we found that MRGPR-X1 sensitized TRPV1 to heat and protons in a PKC-dependent manner. Second, we observed direct MRGPR-X1-mediated TRPV1 activation independent of MRGPR-X1-induced Ca2+-release and PKC activity or other TRPV1 affecting enzymes such as lipoxygenase, extracellular signal-regulated kinases-1/2, sarcoma, or phosphoinositide 3-kinase. Investigating several TRPV1 mutants, we observed that removal of the TRPV1 binding site for DAG and of the putative PIP2 sensor decreased MRGPR-X1-induced TRPV1 activation by 71 and 43%, respectively. Therefore, we demonstrate dual functional interactions between MRGPR-X1 and TRPV1, resulting in PKC-dependent TRPV1 sensitization and DAG/PIP2-mediated activation. The molecular discrimination between TRPV1 sensitization and activation may help improve the specificity of current pain therapies.	[Solinski, Hans Juergen; Zierler, Susanna; Gudermann, Thomas; Breit, Andreas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany	University of Munich	Breit, A (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de	Zierler, Susanna/E-2070-2012	Zierler, Susanna/0000-0002-4684-0385	Deutsche Forschungsgemeinschaft [BR 3346/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant BR 3346/3-1.	Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; BOLAND LM, 1991, J NEUROSCI, V11, P1140; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chen HM, 2004, J NEUROSCI, V24, P5044, DOI 10.1523/JNEUROSCI.0990-04.2004; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; FAN SF, 1993, BRAIN RES, V605, P214, DOI 10.1016/0006-8993(93)91743-C; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, MOL PHARMACOL, V68, P1524, DOI 10.1124/mol.105.015727; Grazzini E, 2004, P NATL ACAD SCI USA, V101, P7175, DOI 10.1073/pnas.0307185101; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hao LL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-316; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang JH, 2006, CURR NEUROPHARMACOL, V4, P197, DOI 10.2174/157015906778019554; Jow F, 2006, ASSAY DRUG DEV TECHN, V4, P49, DOI 10.1089/adt.2006.4.49; Jung HT, 2008, MOL CELL NEUROSCI, V37, P170, DOI 10.1016/j.mcn.2007.09.004; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Kleibeuker W, 2007, EUR J NEUROSCI, V25, P1696, DOI 10.1111/j.1460-9568.2007.05423.x; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; McIlvain HB, 2006, BRAIN RES, V1077, P16, DOI 10.1016/j.brainres.2005.12.130; Mizumura K, 2009, EXP BRAIN RES, V196, P53, DOI 10.1007/s00221-009-1814-5; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Puttfarcken PS, 1997, J NEUROCHEM, V69, P930; Rothe K, 2012, J PHARMACOL EXP THER, V342, P41, DOI 10.1124/jpet.112.192757; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Turner H, 2003, BIOCHEM J, V371, P341, DOI 10.1042/BJ20021381; Valenzano KJ, 2003, J PHARMACOL EXP THER, V306, P377, DOI 10.1124/jpet.102.045674; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	59	15	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40956	40971		10.1074/jbc.M112.408617	http://dx.doi.org/10.1074/jbc.M112.408617			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23074220	hybrid, Green Published			2022-12-25	WOS:000311887600014
J	Leung, YY; Chang, CQ; Hung, YS				Leung, Yuk Yee; Chang, Chun Qi; Hung, Yeung Sam			An Integrated Approach for Identifying Wrongly Labelled Samples When Performing Classification in Microarray Data	PLOS ONE			English	Article							GENE-EXPRESSION; FEATURE-SELECTION; OUTLIER DETECTION; PROSTATE-CANCER; BREAST-CANCER; GROWTH-FACTOR; LUNG-CANCER; DISCOVERY; POLYMORPHISMS; PREDICTION	Background: Using hybrid approach for gene selection and classification is common as results obtained are generally better than performing the two tasks independently. Yet, for some microarray datasets, both classification accuracy and stability of gene sets obtained still have rooms for improvement. This may be due to the presence of samples with wrong class labels (i.e. outliers). Outlier detection algorithms proposed so far are either not suitable for microarray data, or only solve the outlier detection problem on their own. Results: We tackle the outlier detection problem based on a previously proposed Multiple-Filter-Multiple-Wrapper (MFMW) model, which was demonstrated to yield promising results when compared to other hybrid approaches (Leung and Hung, 2010). To incorporate outlier detection and overcome limitations of the existing MFMW model, three new features are introduced in our proposed MFMW-outlier approach: 1) an unbiased external Leave-One-Out Cross-Validation framework is developed to replace internal cross-validation in the previous MFMW model; 2) wrongly labeled samples are identified within the MFMW-outlier model; and 3) a stable set of genes is selected using an L1-norm SVM that removes any redundant genes present. Six binary-class microarray datasets were tested. Comparing with outlier detection studies on the same datasets, MFMW-outlier could detect all the outliers found in the original paper (for which the data was provided for analysis), and the genes selected after outlier removal were proven to have biological relevance. We also compared MFMW-outlier with PRAPIV (Zhang et al., 2006) based on same synthetic datasets. MFMW-outlier gave better average precision and recall values on three different settings. Lastly, artificially flipped microarray datasets were created by removing our detected outliers and flipping some of the remaining samples' labels. Almost all the 'wrong' (artificially flipped) samples were detected, suggesting that MFMW-outlier was sufficiently powerful to detect outliers in high-dimensional microarray datasets.	[Leung, Yuk Yee; Chang, Chun Qi; Hung, Yeung Sam] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China; [Leung, Yuk Yee] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Leung, Yuk Yee] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Hong Kong; University of Pennsylvania; University of Pennsylvania	Leung, YY (corresponding author), Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China.	yyleung@eee.hku.hk	Chang, CQ/C-1845-2009	Leung, Yuk Yee/0000-0002-3047-5440; Chang, Chunqi/0000-0003-1172-6491	Research Grants Council of the Hong Kong Special Administration Region, China (GRF) [HKU 710709E, HKU 762111M]; CRCG of the University of Hong Kong; NIA [U01-AG-032984-02, RC2-AG036528-01]; NATIONAL INSTITUTE ON AGING [RC2AG036528, U01AG032984] Funding Source: NIH RePORTER	Research Grants Council of the Hong Kong Special Administration Region, China (GRF); CRCG of the University of Hong Kong; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YYL, YSH and CQC are supported by the Research Grants Council of the Hong Kong Special Administration Region, China (GRF projects HKU 710709E and HKU 762111M) and CRCG of the University of Hong Kong for their work in this paper. YYL is also supported by NIA (U01-AG-032984-02 and RC2-AG036528-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1998, J CLIN ONCOL, V16, P1397, DOI 10.1200/JCO.1998.16.4.1397; Aggarwal CC, 2001, SIGMOD RECORD, V30, P37; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; BOISSARD C, 1986, CANCER RES, V46, P4406; Borst L, 2012, J PEDIAT HEMATOL ONC, V34, P38, DOI 10.1097/MPH.0b013e3182346cdd; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Desmond JC, 2007, LEUKEMIA, V21, P1026, DOI 10.1038/sj.leu.2404611; DiLella AG, 2001, J HISTOCHEM CYTOCHEM, V49, P669, DOI 10.1177/002215540104900517; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dunlap J, 2012, HUM PATHOL IN PRESS; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Grate LR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-97; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jenssen TK, 2005, LANCET, V365, P634; Kadota K., 2003, CHEM BIO INFORM J, V3, P30; Knorr E. M., 1998, Proceedings of the Twenty-Fourth International Conference on Very-Large Databases, P392; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Krizek P, 2007, LECT NOTES COMPUT SC, V4673, P929; Leung Y, 2010, IEEE ACM T COMPUT BI, V7, P108, DOI 10.1109/TCBB.2008.46; Leung YY, 2009, P 8 INT C COMP SYST, P32; Li T, 2004, BIOINFORMATICS, V20, P2429, DOI 10.1093/bioinformatics/bth267; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; Lu XS, 2004, I C CONT AUTOMAT ROB, P1331; Ma HX, 2009, CANCER LETT, V273, P172, DOI 10.1016/j.canlet.2008.08.002; Malossini A, 2006, BIOINFORMATICS, V22, P2114, DOI 10.1093/bioinformatics/btl346; Manenti G, 1997, CARCINOGENESIS, V18, P1917, DOI 10.1093/carcin/18.10.1917; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Pal P, 2006, HUM GENET, V120, P187, DOI 10.1007/s00439-006-0204-3; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Ramaswamy S, 2000, SIGMOD REC, V29, P427, DOI 10.1145/335191.335437; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Shieh AD, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1426; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sontrop HMJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-389; Sra S, 2006, LECT NOTES COMPUT SC, V4212, P767; Unger G, 2008, IEEE ACM T COMPUT BI, V7, P375; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yang AJ, 2010, BIOINFORMATICS, V26, P215, DOI 10.1093/bioinformatics/btp638; Zhang WS, 2006, BIOINFORMATICS, V22, P317, DOI 10.1093/bioinformatics/bti738; Zhou Y, 2011, COMM COM INF SC, V215, P513; Zhu J, 2004, ADV NEUR IN, V16, P49	53	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46700	10.1371/journal.pone.0046700	http://dx.doi.org/10.1371/journal.pone.0046700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082127	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900022
J	Parsa, S; Kondo, T; Winotai, A				Parsa, Soroush; Kondo, Takumasa; Winotai, Amporn			The Cassava Mealybug (Phenacoccus manihoti) in Asia: First Records, Potential Distribution, and an Identification Key	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; HOMOPTERA; PSEUDOCOCCIDAE; TEMPERATURE; POPULATION; PEST; PREDICTION; MANAGEMENT; HEMIPTERA; INVASIONS	Phenacoccus manihoti Matile-Ferrero (Hemiptera: Pseudococcidae), one of the most serious pests of cassava worldwide, has recently reached Asia, raising significant concern over its potential spread throughout the region. To support management decisions, this article reports recent distribution records, and estimates the climatic suitability for its regional spread using a CLIMEX distribution model. The article also presents a taxonomic key that separates P. manihoti from all other mealybug species associated with the genus Manihot. Model predictions suggest P. manihoti imposes an important, yet differential, threat to cassava production in Asia. Predicted risk is most acute in the southern end of Karnataka in India, the eastern end of the Ninh Thuan province in Vietnam, and in most of West Timor in Indonesia. The model also suggests P. manihoti is likely to be limited by cold stress across Vietnam's northern regions and in the entire Guangxi province in China, and by high rainfall across the wet tropics in Indonesia and the Philippines. Predictions should be particularly important to guide management decisions for high risk areas where P. manihoti is absent (e. g., India), or where it has established but populations remain small and localized (e. g., South Vietnam). Results from this article should help decision-makers assess site-specific risk of invasion, and develop proportional prevention and surveillance programs for early detection and rapid response.	[Parsa, Soroush] CIAT, Cali, Colombia; [Kondo, Takumasa] Corp Colombiana Invest Agr CORPOICA, Ctr Invest Palmira, Palmira, Valle, Colombia; [Winotai, Amporn] Dept Agr, Plant Protect Res & Dev Off, Entomol & Zool Grp, Bangkok, Thailand	Alliance; International Center for Tropical Agriculture - CIAT; Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Ministry of Agriculture & Cooperatives - Thailand	Parsa, S (corresponding author), CIAT, Cali, Colombia.	s.parsa@cgiar.org			Roots, Tubers, and Bananas for Food Security and Income Research Program of the Consultative Group on International Agricultural Research (CGIAR)	Roots, Tubers, and Bananas for Food Security and Income Research Program of the Consultative Group on International Agricultural Research (CGIAR)	The research was funded by the Roots, Tubers, and Bananas for Food Security and Income Research Program of the Consultative Group on International Agricultural Research (CGIAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellotti AC, 1999, ANNU REV ENTOMOL, V44, P343, DOI 10.1146/annurev.ento.44.1.343; Bellotti A, 2012, TROP PLANT BIOL, V5, P39, DOI 10.1007/s12042-011-9091-4; Ben-Dov Y, 2012, SCALENET DATABASE SC; CABI-Plantwise, 2012, CASS MEAL PHEN MAN F; Calatayud P.A., 2006, CASSAVA MEALYBUG INT; CALATAYUD PA, 1994, B ENTOMOL RES, V84, P453, DOI 10.1017/S0007485300032673; COX JM, 1981, B ENTOMOL RES, V71, P247, DOI 10.1017/S0007485300008270; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Frison E. A., 1991, FAO IBPGR TECHNICAL; GUTIERREZ AP, 1988, J APPL ECOL, V25, P921, DOI 10.2307/2403755; HENNESSEY RD, 1990, TROP PEST MANAGE, V36, P103, DOI 10.1080/09670879009371451; HERREN HR, 1991, ANNU REV ENTOMOL, V36, P257, DOI 10.1146/annurev.en.36.010191.001353; Herren HR, 1983, BIOL CONTR HOST PLAN; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IHEAGWAM E U, 1981, Revue de Zoologie Africaine, V95, P959; IHEAGWAM EU, 1983, DEUT ENTOMOL Z, V30, P17; Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kriticos DJ, 2011, METHODS ECOL EVOL; LEMA KM, 1985, ENTOMOL EXP APPL, V38, P165, DOI 10.1007/BF00361928; LERU B, 1990, ACTA OECOL, V11, P741; LERU B, 1987, ACTA OECOL-OEC APPL, V8, P165; Leuschner K., 1977, P CASS PROT WORKSH C, P195; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; LOHR B, 1990, B ENTOMOL RES, V80, P417, DOI 10.1017/S0007485300050677; Malumphy Chris, 2005, Entomologist's Gazette, V56, P53; MATILEFERRERO D, 1977, ANN SOC ENTOMOL FR, V13, P145; Minko D. Obame, 2009, Tropicultura, V27, P21; Muniappan R, 2009, J AGR URBAN ENTOMOL, V26, P167, DOI 10.3954/1523-5475-26.4.167; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; NEUENSCHWANDER P, 1988, PHILOS T ROY SOC B, V318, P319, DOI 10.1098/rstb.1988.0012; Neuenschwander P, 2001, BIOL CONTROL, V21, P214, DOI 10.1006/bcon.2001.0937; NORGAARD RB, 1988, AM J AGR ECON, V70, P366, DOI 10.2307/1242077; NWANZE KF, 1982, TROP PEST MANAGE, V28, P27, DOI 10.1080/09670878209370669; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; SCHULTHESS F, 1987, INSECT SCI APPL, V8, P851, DOI 10.1017/S1742758400023055; Sutherst RW, 2007, GLOBAL CHANGE BIOL, V13, P1843, DOI 10.1111/j.1365-2486.2007.01396.x; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2000, AGR ECOSYST ENVIRON, V82, P303, DOI 10.1016/S0167-8809(00)00234-6; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Williams D., 1992, MEALYBUGS CENTRAL S; Williams D.J., 2004, MEALYBUGS SO ASIA; Williams DJ, 1981, BIOCONTROL NEWS INF, V2, P146; Winotai A., 2010, BIOCONTROL NEWS INFO, V31, p10N; Wittenberg R, 2001, INVASIVE ALIEN SPECI; [武三安 Wu Sanan], 2011, [环境昆虫学报, Journal of Environmental Entomology], V33, P122; Yaseen M, 1982, BIOL CONTR HOST PLAN, P81; Zeddies J, 2001, AGR ECON, V24, P209, DOI 10.1111/j.1574-0862.2001.tb00024.x	56	35	39	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47675	10.1371/journal.pone.0047675	http://dx.doi.org/10.1371/journal.pone.0047675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077659	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100152
J	Joung, YH; Lim, EJ; Darvin, P; Chung, SC; Jang, JW; Park, KD; Lee, HK; Kim, HS; Park, T; Yang, YM				Joung, Youn Hee; Lim, Eun Joung; Darvin, Pramod; Chung, So Chung; Jang, Ju Woong; Park, Kyung Do; Lee, Hak Kyo; Kim, Heui Soo; Park, Taekyu; Yang, Young Mok			MSM Enhances GH Signaling via the Jak2/STAT5b Pathway in Osteoblast-Like Cells and Osteoblast Differentiation through the Activation of STAT5b in MSCs	PLOS ONE			English	Article							GROWTH-FACTOR-I; HORMONE STIMULATES PROLIFERATION; TYROSINE KINASE; BONE MASS; RECEPTOR; EXPRESSION; MINERALIZATION; TRANSCRIPTION; METHYLSULFONYLMETHANE; IDENTIFICATION	Methylsulfonylmethane (MSM) is a naturally occurring sulfur compound with well-known anti-oxidant properties and anti-inflammatory activities. But, its effects on bone are unknown. Growth hormone (GH) is regulator of bone growth and bone metabolism. GH activates several signaling pathways such as the Janus kinase (Jak)/signal transducers and activators of transcription (STAT) pathway, thereby regulating expression of genes including insulin-like growth factor (IGF)-1. GH exerts effects both directly and via IGF-1, which signals by activating the IGF-1 receptor (IGF-1R). In this study, we investigated the effects of MSM on the GH signaling via the Jak/STAT pathway in osteoblasts and the differentiation of primary bone marrow mesenchymal stem cells (MSCs). MSM was not toxic to osteoblastic cells and MSCs. MSM increased the expression of GH-related proteins including IGF-1R, p-IGF-1R, STAT5b, p-STAT5b, and Jak2 in osteoblastic cells and MSCs. MSM increased IGF1R and GHR mRNA expression in osteoblastic cells. The expression of MSM-induced IGF-1R and GHR was inhibited by AG490, a Jak2 kinase inhibitor. MSM induced binding of STAT5 to the IGF-1R and increased IGF-1 and IGF-1R promoter activities. Analysis of cell extracts by immunoprecipitation and Western blot showed that MSM enhanced GH-induced activation of Jak2/STAT5b. We found that MSM and GH, separately or in combination, activated GH signaling via the Jak2/ STAT5b pathway in UMR-106 cells. Using siRNA analysis, we found that STAT5b plays an essential role in GH signaling activation in C3H10T1/2 cells. Osteogenic marker genes (ALP, ON, OCN, BSP, OSX, and Runx2) were activated by MSM, and siRNA-mediated STAT5b knockdown inhibited MSM-induced expression of osteogenic markers. Furthermore, MSM increased ALP activity and the mineralization of MSCs. Taken together, these results indicated that MSM can promote osteogenic differentiation of MSCs through activation of STAT5b.	[Joung, Youn Hee; Lim, Eun Joung; Darvin, Pramod; Yang, Young Mok] Konkuk Univ, Dept Pathol, Sch Med, Inst Biomed Sci & Technol, Seoul, South Korea; [Chung, So Chung] Konkuk Univ, Dept Pediat, Sch Med, Seoul, South Korea; [Jang, Ju Woong] Korea Bone Bank Co Ltd, Seoul, South Korea; [Park, Kyung Do; Lee, Hak Kyo] Hankyong Natl Univ, Genom Informat Ctr, Anseong, South Korea; [Kim, Heui Soo] Pusan Natl Univ, Dept Biol Sci, Coll Nat Sci, Pusan, South Korea; [Park, Taekyu] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Hankyong National University; Pusan National University; Konkuk University	Yang, YM (corresponding author), Konkuk Univ, Dept Pathol, Sch Med, Inst Biomed Sci & Technol, Seoul, South Korea.	ymyang@kku.ac.kr	Kim, Heui-Soo/ABF-3773-2021; Darvin, Pramod/M-1730-2019	Kim, Heui-Soo/0000-0002-5226-6594; Darvin, Pramod/0000-0003-3746-109X	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0004568]; Fundamental R&D Program for Technology of World Premier Materials; Ministry of Knowledge Economy, Republic of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Fundamental R&D Program for Technology of World Premier Materials; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0004568), and was partially supported by a grant from the Fundamental R&D Program for Technology of World Premier Materials funded by the Ministry of Knowledge Economy, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Audran M, 2006, JOINT BONE SPINE, V73, P374, DOI 10.1016/j.jbspin.2006.02.004; Baroncelli GI, 2003, J PEDIATR ENDOCR MET, V16, P327; Brien S, 2008, OSTEOARTHR CARTILAGE, V16, P1277, DOI 10.1016/j.joca.2008.03.002; Caron JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011788; CARTERSU C, 1994, P SOC EXP BIOL MED, V206, P210; CHENU C, 1990, BONE, V11, P81, DOI 10.1016/8756-3282(90)90054-3; Davey HW, 2001, ENDOCRINOLOGY, V142, P3836, DOI 10.1210/en.142.9.3836; DiGirolamo DJ, 2007, J BIOL CHEM, V282, P31666, DOI 10.1074/jbc.M705219200; Gan YJ, 2010, MOL ENDOCRINOL, V24, P644, DOI 10.1210/me.2009-0357; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Golub E. E, 2007, CURR OPIN ORTHOP, V18, P444, DOI [DOI 10.1097/BCO.0b013e3282630851, DOI 10.1097/BCO.0B013E3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415, 10.1097/BCO.0b013e3282630851]; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Horvath K, 2002, FOOD CHEM TOXICOL, V40, P1459, DOI 10.1016/S0278-6915(02)00086-8; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Joung YH, 2008, INT J ONCOL, V33, P477, DOI 10.3892/ijo_00000030; Joung YH, 2007, BIOCHEM BIOPH RES CO, V358, P733, DOI 10.1016/j.bbrc.2007.04.201; KASSEM M, 1994, GROWTH REGULAT, V4, P131; KASSEM M, 1993, CALCIFIED TISSUE INT, V52, P222, DOI 10.1007/BF00298723; Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020; Kim YH, 2009, BIOL PHARM BULL, V32, P651, DOI 10.1248/bpb.32.651; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lim EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033361; Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431; Mathews S, 2011, CELL PROLIFERAT, V44, P537, DOI 10.1111/j.1365-2184.2011.00788.x; Monson JP, 2002, HORM RES, V58, P52, DOI 10.1159/000064765; Morales O, 2000, J BONE MINER RES, V15, P2284, DOI 10.1359/jbmr.2000.15.11.2284; Morales O, 2002, J BIOL CHEM, V277, P34879, DOI 10.1074/jbc.M204819200; MOREL G, 1993, CELL TISSUE RES, V273, P279, DOI 10.1007/BF00312829; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; NILSSON A, 1995, J CLIN ENDOCR METAB, V80, P3483, DOI 10.1210/jc.80.12.3483; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Parcell Stephen, 2002, Altern Med Rev, V7, P22; Park JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040531; Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105; Sila-Asna Monnipha, 2007, Kobe J Med Sci, V53, P25; STRED SE, 1992, ENDOCRINOLOGY, V130, P1626, DOI 10.1210/en.130.3.1626; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; TURNER CH, 1991, OSTEOPOROSIS INT, V2, P12, DOI 10.1007/BF01627073; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3; Zohar R, 1997, BLOOD, V90, P3471, DOI 10.1182/blood.V90.9.3471	50	49	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47477	10.1371/journal.pone.0047477	http://dx.doi.org/10.1371/journal.pone.0047477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071812	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700084
J	Lee, JS; Park, AH; Lee, SH; Lee, SH; Kim, JH; Yang, SJ; Il Yeom, Y; Kwak, TH; Lee, D; Lee, SJ; Lee, CH; Kim, JM; Kim, D				Lee, Jeong-sook; Park, Ah Hyung; Lee, Sang-Hee; Lee, Seoung-Hoon; Kim, Jin-Hwan; Yang, Suk-Jin; Il Yeom, Young; Kwak, Tae Hwan; Lee, Dongyeop; Lee, Seung-Jae; Lee, Chul-Ho; Kim, Jin Man; Kim, Daesoo			Beta-Lapachone, a Modulator of NAD Metabolism, Prevents Health Declines in Aged Mice	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; CALORIE RESTRICTION; LIFE-SPAN; SKELETAL-MUSCLE; CELL-DEATH; CANCER-CELLS; EXTENDS LIFE; MITOCHONDRIAL; YEAST; ANTIOXIDANT	NADH-quinone oxidoreductase 1 (NQO1) modulates cellular NAD(+)/NADH ratio which has been associated with the aging and anti-aging mechanisms of calorie restriction (CR). Here, we demonstrate that the facilitation of NQO1 activity by feeding beta-lapachone (beta L), an exogenous NQO1 co-substrate, prevented age-dependent decline of motor and cognitive function in aged mice. beta L-fed mice did not alter their food-intake or locomotor activity but did increase their energy expenditure as measured by oxygen consumption and heat generation. Mitochondrial structure and numbers were disorganized and decreased in the muscles of control diet group but those defects were less severe in beta L-fed aged mice. Furthermore, for a subset of genes associated with energy metabolism, mice fed the beta L-diet showed similar changes in gene expression to the CR group (fed 70% of the control diet). These results support the potentiation of NQO1 activity by a beta L diet and could be an option for preventing age-related decline of muscle and brain functions.	[Lee, Jeong-sook; Park, Ah Hyung; Kim, Daesoo] KAIST Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Lee, Sang-Hee; Kim, Jin Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Lee, Sang-Hee; Kim, Jin Man] Chungnam Natl Univ, Sch Med, Infect Signaling Network Res Ctr, Taejon, South Korea; [Lee, Seoung-Hoon; Kim, Jin-Hwan; Kwak, Tae Hwan] Mazence Inc, R&D Inst, Suwon, South Korea; [Yang, Suk-Jin; Il Yeom, Young] KRIBB Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Lee, Dongyeop; Lee, Seung-Jae] POSTECH Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, Kyungbuk, South Korea; [Lee, Chul-Ho] KRIBB Korea Res Inst Biosci & Biotechnol, Anim Model Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Chungnam National University; Pohang University of Science & Technology (POSTECH)	Kim, D (corresponding author), KAIST Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	daesoo@kaist.ac.kr	Kim, Daesoo/C-1625-2011; Lee, Seung Jae V/E-2468-2019	Kim, Daesoo/0000-0001-9915-1463; KIM, JIN MAN/0000-0003-0905-9730; Lee, Seung-Jae/0000-0002-6103-156X	National Research Foundation of Korea (NRF); Korean government (Ministry of Education, Science and Technology; MEST) [20110028772, 2011k000273, 20110006229]; KRIBB (Korea Research Institute Bioscience and Biotechnology) Research Initiative Program of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Education, Science and Technology; MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); KRIBB (Korea Research Institute Bioscience and Biotechnology) Research Initiative Program of Korea	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (Ministry of Education, Science and Technology; MEST) (to D.K., 20110028772, 2011k000273; and to J.M.K., 20110006229; and to S.-J.L., 20110004739), and the KRIBB (Korea Research Institute Bioscience and Biotechnology) Research Initiative Program of Korea (to C.H.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; CADENAS E, 1995, BIOCHEM PHARMACOL, V49, P127, DOI 10.1016/S0006-2952(94)00333-5; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777; De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Humphries KM, 2006, FREE RADICAL RES, V40, P1239, DOI 10.1080/10715760600913184; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; Kluger A, 1997, J GERONTOL B-PSYCHOL, V52, pP28, DOI 10.1093/geronb/52B.1.P28; Lass A, 1999, BIOFACTORS, V9, P199, DOI 10.1002/biof.5520090215; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Li YZ, 2003, P NATL ACAD SCI USA, V100, P2674, DOI 10.1073/pnas.0538044100; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028; Marzetti E, 2009, BIOFACTORS, V35, P28, DOI 10.1002/biof.5; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Park HJ, 2005, CLIN CANCER RES, V11, P8866, DOI 10.1158/1078-0432.CCR-05-0818; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Rezende EL, 2005, J EXP BIOL, V208, P2447, DOI 10.1242/jeb.01631; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038	40	46	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47122	10.1371/journal.pone.0047122	http://dx.doi.org/10.1371/journal.pone.0047122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071729	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700055
J	Mutanen, M; Hausmann, A; Hebert, PDN; Landry, JF; de Waard, JR; Huemer, P				Mutanen, Marko; Hausmann, Axel; Hebert, Paul D. N.; Landry, Jean-Francois; de Waard, Jeremy R.; Huemer, Peter			Allopatry as a Gordian Knot for Taxonomists: Patterns of DNA Barcode Divergence in Arctic-Alpine Lepidoptera	PLOS ONE			English	Article							NOCTUIDAE; BUTTERFLIES; DELIMITATION; REVISION; INSECTA; NORTH	Many cold adapted species occur in both montane settings and in the subarctic. Their disjunct distributions create taxonomic complexity because there is no standardized method to establish whether their allopatric populations represent single or different species. This study employs DNA barcoding to gain new perspectives on the levels and patterns of sequence divergence among populations of 122 arctic-alpine species of Lepidoptera from the Alps, Fennoscandia and North America. It reveals intraspecific variability in the barcode region ranging from 0.00-10.08%. Eleven supposedly different species pairs or groups show close genetic similarity, suggesting possible synonymy in many cases. However, a total of 33 species show evidence of cryptic diversity as evidenced by the presence of lineages with over 2% maximum barcode divergence in Europe, in North America or between the two continents. Our study also reveals cases where taxonomic names have been used inconsistently between regions and exposes misidentifications. Overall, DNA barcodes have great potential to both increase taxonomic resolution and to make decisions concerning the taxonomic status of allopatric populations more objective.	[Mutanen, Marko] Univ Oulu, Zool Museum, Dept Biol, Oulu, Finland; [Hausmann, Axel] Zool Staatssammlung Munchen, Sekt Lepidoptera, Munich, Germany; [Hebert, Paul D. N.; de Waard, Jeremy R.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON, Canada; [Landry, Jean-Francois] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Huemer, Peter] Tiroler Landesmuseen Betriebsges mbH, Innsbruck, Austria	University of Oulu; University of Guelph; Agriculture & Agri Food Canada	Mutanen, M (corresponding author), Univ Oulu, Zool Museum, Dept Biol, Oulu, Finland.	marko.mutanen@oulu.fi	deWaard, Jeremy R/G-8112-2014; Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700	Genome Canada; Ontario Genomics Institute; Ontario Ministry of Economic Development and Innovation; NSERC; Emil Aaltonen Foundation; Kone Foundation	Genome Canada(Genome Canada); Ontario Genomics Institute; Ontario Ministry of Economic Development and Innovation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Emil Aaltonen Foundation; Kone Foundation	This work was supported by: Genome Canada (http://www.genomecanada.ca/), Ontario Genomics Institute (http://www.ontariogenomics.ca/), Ontario Ministry of Economic Development and Innovation (http://www.ontariocanada.com/ontcan/1medt/en/home_en.jsp), NSERC (http://www.nserc-crsng.gc.ca/), Emil Aaltonen Foundation (http://www.emilaaltonen.fi/), and Kone Foundation (http://www.koneensaatio.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOLA M, 1990, ENTOMOL SCAND, V21, P77; ARENBERGER E., 2005, MICROLEPIDOPTERA PAL, V12; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; BYERS JR, 1978, CAN J ZOOL, V56, P1981, DOI 10.1139/z78-266; Cook LG, 2010, INVERTEBR SYST, V24, P322, DOI 10.1071/IS10011; de Jong YSDM, 2011, FAUNA EUROPAEA VERSI; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eldredge N, 1980, PHYLOGENETIC PATTERS; Eliasson C.U., 2005, NATIONALNYCKELN SVER; Fibiger M., 2010, NOCTUIDAE EUROPAEAE, V12; Fibiger M, 1993, NOCTUIDAE EUROPAEAE, V2; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GIELIS C., 1996, MICROLEPIDOPTERA EUR, V1; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Heinrich C., 1926, B US NATL MUSEUM, V132, P1, DOI [10.5479/si.03629236.132.1, DOI 10.5479/SI.03629236.132.1]; Higgins LG, 1975, CLASSIFICATION EUROE; Hodges RW, 1983, CHECK LIST LEPIDOPTE; Huemer P., 1988, Bulletin of the British Museum (Natural History) Entomology, V57, P439; Huemer P, 2010, MICROLEPIDOPTERA EUR, V2; Huemer P, 1997, FERDINANDEUM, V77, P203; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Kerr KCR, 2007, MOL ECOL NOTES, V7, P535, DOI 10.1111/j.1471-8286.2006.01670.x; Kullberg J., 2002, SAHLBERGIA, V6, P45; Lafontaine JD, 2010, ZOOKEYS, P6, DOI 10.3897/zookeys.40.414; LAFONTAINE JD, 1987, ENTOMOL SCAND, V18, P305; LAFONTAINE JD, 1998, MOTHS AM N MEXICO; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; MIKKOLA K, 1991, ENTOMOL FENNICA, V2, P157, DOI 10.33338/ef.83545; Mikkola K, 2009, MOTHS AM N MEXICO IN; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Mutanen M, 2005, SYST ENTOMOL, V30, P632, DOI 10.1111/j.1365-3113.2005.00296.x; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Ponomarenko M.G., 1998, Far Eastern Entomologist, V67, P1; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Poyry Juha, 1997, Nota Lepidopterologica, V20, P45; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razowski J., 2003, TORTRICIDAE LEPIDOPT, V2; Ronkay G, 1995, NOCTUIDAE EUROPAEAE, V7; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Schmidt BC, 2008, SYST ENTOMOL, V33, P613, DOI 10.1111/J.1365-3113.2008.00433.x; Schmidt BC, 2009, ZOOL J LINN SOC-LOND, V156, P507, DOI 10.1111/j.1096-3642.2008.00496.x; Schmitt T, 2006, J EVOLUTION BIOL, V19, P108, DOI 10.1111/j.1420-9101.2005.00980.x; Schmitt T, 2004, J BIOGEOGR, V31, P885, DOI 10.1111/j.1365-2699.2004.01079.x; SHAPIRO AM, 1989, ANNU REV ENTOMOL, V34, P231, DOI 10.1146/annurev.en.34.010189.001311; Skou P, 1991, NORDENS UGLER DANMAR, V5; Svensson I., 2006, NORDENS VECKLARE NOR; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Warren BCS, 1936, NAT HIST; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Witt TJ, 2012, NOCTUIDAE EUROPAEAE, V13; Zilli A, 2005, NOCTUIDAE EUROPAEAE	63	95	104	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47214	10.1371/journal.pone.0047214	http://dx.doi.org/10.1371/journal.pone.0047214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071761	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700065
J	Chuang, TW; Wimberly, MC				Chuang, Ting-Wu; Wimberly, Michael C.			Remote Sensing of Climatic Anomalies and West Nile Virus Incidence in the Northern Great Plains of the United States	PLOS ONE			English	Article							SPATIOTEMPORAL ANALYSIS; DISEASE INCIDENCE; LAND-COVER; RISK; MOSQUITOS; TRANSMISSION; INFECTION; OUTBREAK; MALARIA; DAKOTA	The northern Great Plains (NGP) of the United States has been a hotspot of West Nile virus (WNV) incidence since 2002. Mosquito ecology and the transmission of vector-borne disease are influenced by multiple environmental factors, and climatic variability is an important driver of inter-annual variation in WNV transmission risk. This study applied multiple environmental predictors including land surface temperature (LST), the normalized difference vegetation index (NDVI) and actual evapotranspiration (ETa) derived from Moderate-Resolution Imaging Spectroradiometer (MODIS) products to establish prediction models for WNV risk in the NGP. These environmental metrics are sensitive to seasonal and inter-annual fluctuations in temperature and precipitation, and are hypothesized to influence mosquito population dynamics and WNV transmission. Non-linear generalized additive models (GAMs) were used to evaluate the influences of deviations of cumulative LST, NDVI, and ETa on inter-annual variations of WNV incidence from 2004-2010. The models were sensitive to the timing of spring green up (measured with NDVI), temperature variability in early spring and summer (measured with LST), and moisture availability from late spring through early summer (measured with ETa), highlighting seasonal changes in the influences of climatic fluctuations on WNV transmission. Predictions based on these variables indicated a low WNV risk across the NGP in 2011, which is concordant with the low case reports in this year. Environmental monitoring using remote-sensed data can contribute to surveillance of WNV risk and prediction of future WNV outbreaks in space and time.	[Chuang, Ting-Wu; Wimberly, Michael C.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Pierre, SD 57501 USA; [Chuang, Ting-Wu] Taipei Med Univ, Coll Med, Dept Parasitol, Taipei, Taiwan; [Chuang, Ting-Wu] Taipei Med Univ, Coll Med, Ctr Int Trop Med, Taipei, Taiwan	South Dakota State University; Taipei Medical University; Taipei Medical University	Chuang, TW (corresponding author), S Dakota State Univ, Geog Informat Sci Ctr Excellence, Pierre, SD 57501 USA.	chtingwu@tmu.edu.tw		Wimberly, Michael/0000-0003-1549-3891	National Institute of Allergy and Infectious Diseases [R01-AI079411]; NASA Applied Science Program [NNX11AF67G]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079411] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NASA Applied Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number R01-AI079411 from the National Institute of Allergy and Infectious Diseases and grant NNX11AF67G from the NASA Applied Science Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-125; Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; [Anonymous], 2010, MMWR, V60, P1009; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Beck LR, 2000, EMERG INFECT DIS, V6, P217, DOI 10.3201/eid0603.000301; Bell JA, 2005, VECTOR-BORNE ZOONOT, V5, P373, DOI 10.1089/vbz.2005.5.373; Bell JA, 2006, EMERG INFECT DIS, V12, P1245, DOI 10.3201/eid1708.060129; Berrang-Ford L, 2010, VECTOR-BORNE ZOONOT, V10, P977, DOI 10.1089/vbz.2008.0196; Bisanzio D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-230; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Brown H, 2008, VECTOR-BORNE ZOONOT, V8, P197, DOI 10.1089/vbz.2007.0154; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chuang TW, 2012, AM J TROP MED HYG, V86, P724, DOI 10.4269/ajtmh.2012.11-0515; Chuang TW, 2011, J MED ENTOMOL, V48, P669, DOI 10.1603/ME10246; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; DeGroote John P, 2008, Int J Health Geogr, V7, P19, DOI 10.1186/1476-072X-7-19; Ford TE, 2009, EMERG INFECT DIS, V15, P1341, DOI 10.3201/eid1509.081334; Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651; Gibney KB, 2012, AM J TROP MED HYG, V86, P895, DOI 10.4269/ajtmh.2012.11-0502; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Isserman AM, 2005, INT REGIONAL SCI REV, V28, P465, DOI 10.1177/0160017605279000; Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; LaDeau SL, 2011, ECOL APPL, V21, P1443, DOI 10.1890/09-1409.1; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Liu H, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-66; MARSHALL RJ, 1991, APPL STAT-J ROY ST C, V40, P283; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Monaco F, 2011, RES VET SCI, V91, P321, DOI 10.1016/j.rvsc.2011.01.008; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Neghina AM, 2011, VECTOR-BORNE ZOONOT, V11, P1289, DOI 10.1089/vbz.2010.0206; Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261; Planitzer CB, 2009, EMERG INFECT DIS, V15, P1668, DOI [10.3201/eid1510.080711, 10.3201/eid1510.081668]; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Ruiz Marilyn O, 2004, Int J Health Geogr, V3, P8, DOI 10.1186/1476-072X-3-8; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Senay GB, 2011, AGR WATER MANAGE, V98, P606, DOI 10.1016/j.agwat.2010.10.014; Senay GB, 2007, SENSORS-BASEL, V7, P979, DOI 10.3390/s7060979; Shaman J, 2010, INT J ENV RES PUB HE, V7, P494, DOI 10.3390/ijerph7020494; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Torti VM, 2005, OECOLOGIA, V145, P486, DOI 10.1007/s00442-005-0175-4; Trawinski PR, 2008, VECTOR-BORNE ZOONOT, V8, P505, DOI 10.1089/vbz.2007.0202; Uejio CK, 2012, VECTOR-BORNE ZOONOT, V12, P117, DOI 10.1089/vbz.2011.0655; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Wimberly MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003744; Winters AM, 2008, AM J TROP MED HYG, V79, P581, DOI 10.4269/ajtmh.2008.79.581; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	53	36	37	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46882	10.1371/journal.pone.0046882	http://dx.doi.org/10.1371/journal.pone.0046882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071656	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300067
J	Fan, CM; Foster, BK; Hui, SK; Xian, CJ				Fan, Chia-Ming; Foster, Bruce K.; Hui, Susanta K.; Xian, Cory J.			Prevention of Bone Growth Defects, Increased Bone Resorption and Marrow Adiposity with Folinic Acid in Rats Receiving Long-Term Methotrexate	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; NECROSIS-FACTOR-ALPHA; MINERAL DENSITY; CHEMOTHERAPEUTIC-AGENTS; OSTEOCLAST FORMATION; CANCER-CHEMOTHERAPY; YOUNG-RATS; MECHANISMS; SURVIVORS; EXPRESSION	The underlying pathophysiology for bone growth defects in paediatric cancer patients receiving high dose methotrexate chemotherapy remains unclear and currently there are no standardized preventative treatments for patients and survivors. Using a model in young rats, we investigated damaging effects of long-term treatment with methotrexate on growth plate and metaphyseal bone, and the potential protective effects of antidote folinic acid. This study demonstrated that chronic folinic acid supplementation can prevent methotrexate-induced chondrocyte apoptosis and preserve chondrocyte columnar arrangement and number in the growth plate. In the metaphysis, folinic acid supplementation can preserve primary spongiosa heights and secondary spongiosa trabecular volume by preventing osteoblasts from undergoing apoptosis and suppressing methotrexate-induced marrow adiposity and osteoclast formation. Systemically, plasma of folinic acid supplemented rats, in comparison to plasma from rats treated with MTX alone, contained a significantly lower level of IL-1 beta and suppressed osteoclast formation in vitro in normal bone marrow cells. The importance of IL-1 beta in supporting plasma-induced osteoclast formation was confirmed as the presence of an anti-IL-1 beta neutralizing antibody attenuated the ability of the plasma (from MTX-treated rats) in inducing osteoclast formation. Findings from this study suggest that folinic acid supplementation during chronic methotrexate treatment can alleviate growth plate and metaphyseal damages and therefore may be potentially useful in paediatric patients who are at risk of skeletal growth suppression due to chronic methotrexate chemotherapy.	[Fan, Chia-Ming; Xian, Cory J.] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Fan, Chia-Ming; Xian, Cory J.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Fan, Chia-Ming; Foster, Bruce K.; Xian, Cory J.] Univ Adelaide, Discipline Paediat, Adelaide, SA, Australia; [Foster, Bruce K.; Xian, Cory J.] Womens & Childrens Hosp, Dept Orthopaed Surg, Adelaide, SA, Australia; [Hui, Susanta K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Hui, Susanta K.] Univ Minnesota, Dept Therapeut Radiol, Minneapolis, MN USA	University of South Australia; University of South Australia; University of Adelaide; Womens & Childrens Hospital Australia; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Xian, CJ (corresponding author), Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	cory.xian@unisa.edu.au	Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845	Bone Health Foundation (Australia); Channel-7 Children's Research Foundation of South Australia; NHMRC Australia (National Health and Medical Research Council)	Bone Health Foundation (Australia); Channel-7 Children's Research Foundation of South Australia; NHMRC Australia (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded in part by grants from Bone Health Foundation (Australia), Channel-7 Children's Research Foundation of South Australia, and NHMRC Australia (National Health and Medical Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apeland T, 2002, J INTERN MED, V252, P456, DOI 10.1046/j.1365-2796.2002.01056.x; Borchers AT, 2004, SEMIN ARTHRITIS RHEU, V34, P465, DOI 10.1016/j.semarthrit.2003.12.003; Brennan BMD, 1999, BRIT J CANCER, V79, P1859, DOI 10.1038/sj.bjc.6690296; Crofton PM, 2000, PEDIATR RES, V48, P490, DOI 10.1203/00006450-200010000-00012; Davies JH, 2004, CLIN ENDOCRINOL, V60, P358, DOI 10.1111/j.1365-2265.2003.01986.x; Fan C, 2011, CURR MOL MED, V11, P140, DOI 10.2174/156652411794859223; Fan CM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/903097; Fan CM, 2009, BONE, V44, P61, DOI 10.1016/j.bone.2008.09.014; Farquharson C, 2000, POULTRY SCI, V79, P994, DOI 10.1093/ps/79.7.994; FRIEDLAENDER GE, 1984, J BONE JOINT SURG AM, V66A, P602, DOI 10.2106/00004623-198466040-00016; Georgiou KR, 2011, J CELL PHYSL; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Haddy TB, 2001, ONCOLOGIST, V6, P278, DOI 10.1634/theoncologist.6-3-278; Hoekstra M, 2003, ANN RHEUM DIS, V62, P423, DOI 10.1136/ard.62.5.423; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Jarfelt M, 2006, EUR J ENDOCRINOL, V154, P303, DOI 10.1530/eje.1.02092; Jhaveri MS, 2004, MOL CANCER THER, V3, P1505; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; JIMI E, 1995, ENDOCRINOLOGY, V136, P808, DOI 10.1210/en.136.2.808; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; King TJ, 2012, AM J PATHOL, V181, P121, DOI 10.1016/j.ajpath.2012.03.037; Kita Karol, 2002, Pol Merkur Lekarski, V12, P122; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lecka-Czernik B, 2010, IBMS BONEKEY, V7, P171, DOI DOI 10.1138/20100443; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P84, DOI 10.1007/s11914-010-0016-1; Mandel K, 2004, J CLIN ONCOL, V22, P1215, DOI 10.1200/JCO.2004.04.199; Marinovic D, 2005, PEDIATRICS, V116, pE102, DOI 10.1542/peds.2004-1838; Matherly LH, 2001, PROG NUCLEIC ACID RE, V67, P131, DOI 10.1016/S0079-6603(01)67027-2; Minaur NJ, 2002, RHEUMATOLOGY, V41, P714; Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144; Olney RC, 2009, HORM RES, V72, P30, DOI 10.1159/000229761; Robson H, 1998, J ENDOCRINOL, V157, P225, DOI 10.1677/joe.0.1570225; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Tillmann V, 2002, J BONE MINER RES, V17, P1073, DOI 10.1359/jbmr.2002.17.6.1073; van Leeuwen BL, 2003, EUR J SURG ONCOL, V29, P49, DOI 10.1053/ejso.2002.1337; Veerman AJ, 2009, LANCET ONCOL, V10, P957, DOI 10.1016/S1470-2045(09)70228-1; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; WHEELER DL, 1995, BONE, V16, P215, DOI 10.1016/8756-3282(94)00032-U; Xian CJ, 2008, J CELL PHYSIOL, V214, P777, DOI 10.1002/jcp.21274; Xian CJ, 2007, BONE, V41, P842, DOI 10.1016/j.bone.2007.07.021; Xian CJ, 2007, ENDOCR REV, V28, P284, DOI 10.1210/er.2006-0049; Xian CJ, 2006, J CELL BIOCHEM, V99, P1688, DOI 10.1002/jcb.20889; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Zhou FH, 2004, BONE, V35, P1307, DOI 10.1016/j.bone.2004.09.014; Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410	45	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46915	10.1371/journal.pone.0046915	http://dx.doi.org/10.1371/journal.pone.0046915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071661	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000309827300069
J	Fealey, ME; Gauer, JW; Kempka, SC; Miller, K; Nayak, K; Sutton, RB; Hinderliter, A				Fealey, Michael E.; Gauer, Jacob W.; Kempka, Sarah C.; Miller, Katie; Nayak, Kamakshi; Sutton, R. Bryan; Hinderliter, Anne			Negative Coupling as a Mechanism for Signal Propagation between C2 Domains of Synaptotagmin I	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; NEUROTRANSMITTER RELEASE; INTRINSIC DISORDER; PROTEIN-STRUCTURE; BINDING; ASSOCIATION; EXOCYTOSIS; DROSOPHILA; ALLOSTERY; COOPERATIVITY	Synaptotagmin I (Syt I) is a vesicle-localized protein implicated in sensing the calcium influx that triggers fast synchronous release of neurotransmitter. How Syt I utilizes its two C2 domains to integrate signals and mediate neurotransmission has continued to be a controversial area of research, though prevalent hypotheses favor independent function. Using differential scanning calorimetry and fluorescence lifetime spectroscopy in a thermodynamic denaturation approach, we tested an alternative hypothesis in which both domains interact to cooperatively disseminate binding information. The free energy of stability was determined for C2A, C2B, and C2AB constructs by globally fitting both methods to a two-state model of unfolding. By comparing the additive free energies of C2A and C2B with C2AB, we identified a negative coupling interaction between the C2 domains of Syt I. This interaction not only provides a mechanistic means for propagating signals, but also a possible means for coordinating the molecular events of neurotransmission.	[Fealey, Michael E.; Gauer, Jacob W.; Kempka, Sarah C.; Miller, Katie; Hinderliter, Anne] Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA; [Nayak, Kamakshi; Sutton, R. Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol, Lubbock, TX 79430 USA	University of Minnesota System; University of Minnesota Duluth; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Hinderliter, A (corresponding author), Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA.	ahinderl@d.umn.edu		Fealey, Michael E./0000-0002-1264-8037	National Science Foundation CAREER Award [MCB-0845676]	National Science Foundation CAREER Award(National Science Foundation (NSF))	A.H. acknowledges support from a National Science Foundation CAREER Award (MCB-0845676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; Damer CK, 1996, J NEUROCHEM, V67, P1661; de Levie R, 1999, J CHEM EDUC, V76, P1594, DOI 10.1021/ed076p1594; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Freiburger LA, 2011, NAT STRUCT MOL BIOL, V18, P288, DOI 10.1038/nsmb.1978; Freire E, 1995, Methods Mol Biol, V40, P191; Freire E, 2001, Methods Mol Biol, V168, P37; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gauer JW, 2012, BIOPHYS J, V103, P238, DOI 10.1016/j.bpj.2012.05.051; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hill T.L., 1986, INTRO STAT THERMODYN; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Huang H, 2008, BIOCHEMISTRY-US, V47, P12380, DOI 10.1021/bi801470m; Kertz JA, 2007, BIOPHYS J, V92, P1409, DOI 10.1529/biophysj.106.087197; Khan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021939; KINGSLEY PB, 1979, CHEM PHYS LIPIDS, V24, P135, DOI 10.1016/0009-3084(79)90083-5; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kumar S, 2002, BIOCHEMISTRY-US, V41, P5359, DOI 10.1021/bi012154c; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lai AL, 2011, J MOL BIOL, V405, P696, DOI 10.1016/j.jmb.2010.11.015; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li J, 2012, J BIOL CHEM, V287, P26777, DOI 10.1074/jbc.M112.355651; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Montes M, 2006, ACTA CRYSTALLOGR F, V62, P926, DOI 10.1107/S1744309106029253; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Rogasevskaia TP, 2012, CELL CALCIU IN PRESS; Rosengarth A, 1999, J MOL BIOL, V288, P1013, DOI 10.1006/jmbi.1999.2732; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Sevcsik E, 2011, J AM CHEM SOC, V133, P7152, DOI 10.1021/ja2009554; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Streicher WW, 2007, BIOCHEMISTRY-US, V46, P2876, DOI 10.1021/bi602424x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	57	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46748	10.1371/journal.pone.0046748	http://dx.doi.org/10.1371/journal.pone.0046748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071627	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300058
J	Rice, DS; Hansen, GM; Liu, F; Crist, MJ; Newhouse, MM; Potter, D; Xu, NH; Abuin, A; Vogel, PJ; Zambrowicz, BP				Rice, Dennis S.; Hansen, Gwenn M.; Liu, Feng; Crist, Mike J.; Newhouse, Matthew M.; Potter, David; Xu, Nianhua; Abuin, Alejandro; Vogel, Peter J.; Zambrowicz, Brian P.			Keratinocyte Migration in the Developing Eyelid Requires LIMK2	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; EPIDERMAL-GROWTH-FACTOR; VENTRAL BODY-WALL; KINASE 2; COFILIN PHOSPHORYLATION; ACTIN DYNAMICS; MICE LACKING; GERM-CELLS; ROCK-I; CLOSURE	In vitro studies have identified LIMK2 as a key downstream effector of Rho GTPase-induced changes in cytoskeletal organization. LIMK2 is phosphorylated and activated by Rho associated coiled-coil kinases (ROCKs) in response to a variety of growth factors. The biochemical targets of LIMK2 belong to a family of actin binding proteins that are potent modulators of actin assembly and disassembly. Although numerous studies have suggested that LIMK2 regulates cell morphology and motility, evidence supportive of these functions in vivo has remained elusive. In this study, a knockout mouse was created that abolished LIMK2 biochemical activity resulting in a profound inhibition of epithelial sheet migration during eyelid development. In the absence of LIMK2, nascent eyelid keratinocytes differentiate and acquire a pre-migratory phenotype but the leading cells fail to nucleate filamentous actin and remain immobile causing an eyes open at birth (EOB) phenotype. The failed nucleation of actin was associated with significant reductions in phosphorylated cofilin, a major LIMK2 biochemical substrate and potent modulator of actin dynamics. These results demonstrate that LIMK2 activity is required for keratinocyte migration in the developing eyelid.	[Rice, Dennis S.; Hansen, Gwenn M.; Liu, Feng; Crist, Mike J.; Newhouse, Matthew M.; Potter, David; Xu, Nianhua; Abuin, Alejandro; Vogel, Peter J.; Zambrowicz, Brian P.] Lexicon Pharmaceut Inc, The Woodlands, TX USA	Lexicon Pharmaceuticals	Rice, DS (corresponding author), Lexicon Pharmaceut Inc, The Woodlands, TX USA.	drice@lexpharma.com	Vogel, Peter/N-2490-2018	Vogel, Peter/0000-0002-7535-0545	Lexicon Pharmaceuticals	Lexicon Pharmaceuticals	The study was conducted at and financially supported by Lexicon Pharmaceuticals. All authors were employees of Lexicon Pharmaceuticals when conducting the research presented in this manuscript. Authors designed the study, conducted data collection and analysis, and prepared the manuscript. Lexicon Pharmaceuticals communications committee approved the decision to publish this manuscript.	Acevedo K, 2006, J HISTOCHEM CYTOCHEM, V54, P487, DOI 10.1369/jhc.5C6813.2006; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; FINDLATER GS, 1993, J ANAT, V183, P121; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; HARRIS MJ, 1986, J EMBRYOL EXP MORPH, V91, P1; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Ikebe C, 1998, BIOCHEM BIOPH RES CO, V246, P307, DOI 10.1006/bbrc.1998.8609; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Joyner AL, 2000, GENE TARGETING PRACT; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MACONNACHIE E, 1979, J EMBRYOL EXP MORPH, V49, P259; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Manetti F, 2011, MED RES REV; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Rice DS, 1998, DEVELOPMENT, V125, P3719; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Takahashi H, 2002, DEV BIOL, V241, P259, DOI 10.1006/dbio.2001.0512; Takahashi H, 1998, BIOCHEM BIOPH RES CO, V249, P138, DOI 10.1006/bbrc.1998.9094; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Verdoni AM, 2010, MAMM GENOME, V21, P64, DOI 10.1007/s00335-009-9245-y; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Whitlock NA, 2009, J OCUL PHARMACOL TH, V25, P187, DOI 10.1089/jop.2008.0142; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47168	10.1371/journal.pone.0047168	http://dx.doi.org/10.1371/journal.pone.0047168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071748	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300086
J	Manna, P; Jain, SK				Manna, Prasenjit; Jain, Sushil K.			Vitamin D Up-regulates Glucose Transporter 4 (GLUT4) Translocation and Glucose Utilization Mediated by Cystathionine-gamma-lyase (CSE) Activation and H2S Formation in 3T3L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; KNOCKOUT MICE; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; CELLS; RATS; ISCHEMIA; PROTEIN	A scientific explanation for the beneficial role of vitamin D supplementation in the lowering of glycemia in diabetes remains to be determined. This study examined the biochemical mechanism by which vitamin D supplementation regulates glucose metabolism in diabetes. 3T3L1 adipocytes were treated with high glucose (HG, 25 mM) in the presence or absence of 1,25-dihydroxyvitamin D-3(1,25(OH)(2)D-3) (25, 50 nM), the active form of vitamin D. 1,25(OH)(2)D-3 treatment caused significant up-regulation of GLUT4 total protein expression and its trans-location to cell surface, and an increase in glucose uptake as well as glucose utilization in HG-treated cells. 1,25(OH)(2)D-3 also caused cystathionine-gamma-lyase (CSE) activation and H2S formation in HG-treated adipocytes. The effect of 1,25(OH)(2)D-3 on GLUT4 translocation, glucose utilization, and H2S formation was prevented by propargylglycine, an inhibitor of CSE that catalyzes H2S formation. Studies using antisense CSE also demonstrated the inhibition of GLUT4 translocation as well as glucose uptake and utilization in 1,25(OH)(2)D-3-supplemented CSE-siRNA-transfected adipocytes compared with controls. 1,25(OH)(2)D-3 treatment along with insulin enhanced GLUT4 translocation and glucose utilization compared with either insulin or 1,25(OH)(2)D-3 alone in HG-treated adipocytes. 1,25(OH)(2)D-3 supplementation also inhibited monocyte chemoattractant protein-1 and stimulated adiponectin secretion in HG-treated adipocytes, and this positive effect was prevented in propargylglycine-treated or CSE-knockdown adipocytes. This is the first report to demonstrate that 1,25(OH)(2)D-3 up-regulates GLUT4 translocation and glucose utilization and decreases inflammatory markers, which is mediated by CSE activation and H2S formation in adipocytes. This study provides evidence for a novel molecular mechanism by which 1,25(OH)(2)D-3 can up-regulate the GLUT4 translocation essential for maintenance of glucose metabolism.	[Manna, Prasenjit; Jain, Sushil K.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, Shreveport, LA 71103 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jain, SK (corresponding author), Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, 1501 Kings Hwy, Shreveport, LA 71103 USA.	sjain@lsuhsc.edu		Jain, Sushil/0000-0002-9574-0436; Manna, Prasenjit/0000-0003-1952-6531	National Institutes of Health Grant through the NIDDK and the Office of Dietary Supplements [R01 DK072433]; Malcolm Feist Chair in Diabetes; Malcolm Feist Cardiovascular research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072433] Funding Source: NIH RePORTER	National Institutes of Health Grant through the NIDDK and the Office of Dietary Supplements; Malcolm Feist Chair in Diabetes; Malcolm Feist Cardiovascular research fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK072433 through the NIDDK and the Office of Dietary Supplements. This work was also supported by the Malcolm Feist Chair in Diabetes and the Malcolm Feist Cardiovascular research fellowship.	Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; CANDILOROS H, 1995, DIABETES CARE, V18, P549, DOI 10.2337/diacare.18.4.549; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jain SK, 2010, ANTIOXID REDOX SIGN, V12, P1333, DOI 10.1089/ars.2009.2956; Jung DW, 2011, MOL BIOSYST, V7, P346, DOI 10.1039/c0mb00089b; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Koshy S., 2010, JOVE-J VIS EXP, V45, pe2429; Lamendola CA, 2012, AM J CLIN NUTR, V95, P1055, DOI 10.3945/ajcn.111.032060; Li J, 2000, FASEB J, V14, P1117, DOI 10.1096/fasebj.14.9.1117; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Manna P, 2011, J BIOL CHEM, V286, P39848, DOI 10.1074/jbc.M111.270884; Pittas AG, 2010, J STEROID BIOCHEM, V121, P425, DOI 10.1016/j.jsbmb.2010.03.042; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Schwalfenberg G, 2008, CAN FAM PHYSICIAN, V54, P864; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2010, DIABETOLOGIA, V53, P1722, DOI 10.1007/s00125-010-1761-5; Willheim M, 1999, J CLIN ENDOCR METAB, V84, P3739, DOI 10.1210/jc.84.10.3739; Xu ZB, 2009, AM J PHYSIOL-RENAL, V297, pF27, DOI 10.1152/ajprenal.00096.2009; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; YANG J, 1993, J BIOL CHEM, V268, P4600; Yaturu S., 2011, ISRN ENDOCRINOL, V2011; Zhu YZ, 2007, J APPL PHYSIOL, V102, P261, DOI 10.1152/japplphysiol.00096.2006	31	108	114	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42324	42332		10.1074/jbc.M112.407833	http://dx.doi.org/10.1074/jbc.M112.407833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074218	hybrid, Green Published			2022-12-25	WOS:000312103000067
J	Fleitas, T; Martinez-Sales, V; Vila, V; Reganon, E; Mesado, D; Martin, M; Gomez-Codina, J; Montalar, J; Reynes, G				Fleitas, Tania; Martinez-Sales, Vicenta; Vila, Virtudes; Reganon, Edelmiro; Mesado, David; Martin, Maria; Gomez-Codina, Jose; Montalar, Joaquin; Reynes, Gaspar			Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PLATELET-DERIVED MICROPARTICLES; THROMBIN GENERATION; COAGULATION ACTIVATION; 1ST-LINE TREATMENT; MEMBRANE-VESICLES; PERIPHERAL-BLOOD; EMERGING ROLE; CHEMOTHERAPY; ASSOCIATION; ENUMERATION	Background: Circulating endothelial cells and microparticles have prognostic value in cancer, and might be predictors of response to chemotherapy and antiangiogenic treatments. We have investigated the prognostic value of circulating endothelial cells and microparticles in patients treated for advanced non-small cell lung cancer. Methodology/Principal Findings: Peripheral blood samples were obtained from 60 patients before first line, platinum-based chemotherapy +/- bevacizumab, and after the third cycle of treatment. Blood samples from 60 healthy volunteers were also obtained as controls. Circulating endothelial cells were measured by an immunomagnetic technique and immunofluorescence microscopy. Phosphatidylserine-positive microparticles were evaluated by flow cytometry. Microparticle-mediated procoagulant activity was measured by the endogen thrombin generation assay. Results: pre- and posttreatment levels of markers were higher in patients than in controls (p<0.0001). Elevated levels of microparticles were associated with longer survival. Elevated pretreatment levels of circulating endothelial cells were associated with shorter survival. Conclusions/Significance: Circulating levels of microparticles and circulating endothelial cells correlate with prognosis, and could be useful as prognostic markers in patients with advanced non-small cell lung cancer.	[Fleitas, Tania; Martin, Maria; Gomez-Codina, Jose; Montalar, Joaquin; Reynes, Gaspar] Hosp Univ & Politecn La Fe Valencia, Dept Med Oncol, Valencia, Spain; [Martinez-Sales, Vicenta; Vila, Virtudes; Reganon, Edelmiro; Mesado, David] Hosp Univ & Politecn La Fe Valencia, Res Ctr, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Fleitas, T (corresponding author), Hosp Univ & Politecn La Fe Valencia, Dept Med Oncol, Valencia, Spain.	tfleitask@gmail.com		Reynes, Gaspar/0000-0001-8636-6094; Fleitas kanonnikoff, Tania/0000-0002-2789-9082	Fundacion para la Investigacion, Hospital Universitario La Fe - Bancaja; Roche Pharma; Amgen; Lilly; MSD; Bayer	Fundacion para la Investigacion, Hospital Universitario La Fe - Bancaja; Roche Pharma; Amgen(Amgen); Lilly(Eli Lilly); MSD; Bayer(Bayer AG)	This study was supported in part by a grant of Fundacion para la Investigacion, Hospital Universitario La Fe - Bancaja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following industries: Roche Pharma, Amgen, Lilly, MSD, and Bayer contributed financially to the purchase of reagents and for hiring a laboratory technician, in accordance with legal procedure of the foundation of Hospital La Fe for donations, without any kind of interest in the results of the study, and they did not participated in any other aspect in the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bidot L, 2008, J THROMB HAEMOST, V6, P913, DOI 10.1111/j.1538-7836.2008.02963.x; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; Erdbruegger U, 2010, CURR STEM CELL RES T, V5, P294, DOI 10.2174/157488810793351721; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goon PKY, 2006, NEOPLASIA, V8, P79, DOI 10.1593/neo.05592; Guervilly C, 2011, CRIT CARE, V15, DOI 10.1186/cc9978; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Helley D, 2009, EUR UROL, V56, P479, DOI 10.1016/j.eururo.2008.06.038; Hron G, 2007, THROMB HAEMOSTASIS, V97, P119, DOI 10.1160/TH06-03-0141; Kawaishi M, 2009, J THORAC ONCOL, V4, P208, DOI 10.1097/JTO.0b013e318193030d; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Macey MG, 2011, CYTOM PART B-CLIN CY, V80B, P57, DOI 10.1002/cyto.b.20551; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Mancuso P, 2010, MICROVASC RES, V79, P224, DOI 10.1016/j.mvr.2010.02.007; Matsusaka S, 2011, CANCER CHEMOTH PHARM, V68, P763, DOI 10.1007/s00280-010-1543-2; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Pereira J, 2006, THROMB HAEMOSTASIS, V95, P94, DOI 10.1160/TH05-05-0310; Ronzoni M, 2010, ANN ONCOL, V21, P2382, DOI 10.1093/annonc/mdq261; Rossi A, 2010, CURR MED CHEM, V17, P1030; Rowand JL, 2007, CYTOM PART A, V71A, P105, DOI 10.1002/cyto.a.20364; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Toth B, 2008, THROMB HAEMOSTASIS, V100, P663, DOI 10.1160/TH07-10-0602; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Yang C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12533; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	37	55	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47365	10.1371/journal.pone.0047365	http://dx.doi.org/10.1371/journal.pone.0047365			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077602	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100101
J	Gupta, K; Subramanian, H; Klos, A; Ali, H				Gupta, Kshitij; Subramanian, Hariharan; Klos, Andreas; Ali, Hydar			Phosphorylation of C3a Receptor at Multiple Sites Mediates Desensitization, beta-Arrestin-2 Recruitment and Inhibition of NF-kappa B Activity in Mast Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SIGNAL-REGULATED KINASE; CHEMOKINE PRODUCTION; BETA-ARRESTINS; ACTIVATION; INTERNALIZATION; GENERATION; PATHWAYS; ROLES	Background: Phosphorylation of G protein coupled receptors (GPCRs) by G protein coupled receptor kinases (GRKs) and the subsequent recruitment of beta-arrestins are important for their desensitization. Using shRNA-mediated gene silencing strategy, we have recently shown that GRK2, GRK3 and beta-arrestin-2 promote C3a receptor (C3aR) desensitization in human mast cells. We also demonstrated that beta-arrestin-2 provides an inhibitory signal for NF-kappa B activation. C3aR possesses ten potential phosphorylation sites within its carboxyl terminus but their role on desensitization, beta-arrestin recruitment and NF-kappa B activation has not been determined. Methodology/Principal Findings: We utilized a site directed mutagenesis approach in transfected HEK293 cells to determine the role of receptor phosphorylation on beta-arrestin-2 recruitment and RBL-2H3 cells for functional studies. We found that although Ala substitution of Ser475/479, Thr480/481 residues resulted in 58 +/- 3.8% decrease in agonist-induced C3aR phosphorylation there was no change in beta-arrestin-2 binding or receptor desensitization. By contrast, Ala substitution of Thr463, Ser465, Thr466 and Ser470 led to 40 +/- 1.3% decrease in agonist-induced receptor phosphorylation but this was associated with 74 +/- 2.4% decreases in beta-arrestin-2 binding, significantly reduced desensitization and enhanced NF-kappa B activation. Combined mutation of these Ser/Thr residues along with Ser459 (mutant MT7), resulted in complete loss of receptor phosphorylation and beta-arrestin-2 binding. RBL-2H3 cells expressing MT7 responded to C3a for greater Ca2+ mobilization, degranulation and NF-kappa B activation when compared to the wild-type receptor. Interestingly, co-expression of MT7 with a constitutively active mutant of beta-arrestin (R169E) inhibited C3a-induced degranulation by 28 +/- 2.4% and blocked NF-kappa B activation by 80 +/- 2.4%. Conclusion/Significance: This study demonstrates that although C3a causes phosphorylation of its receptor at multiple sites, Ser459, Thr463, Ser465, Thr466 and Ser470 participate in C3aR desensitization, beta-arrestin-2 recruitment and inhibition of NF-kappa B activity. Furthermore, beta-arrestin-2 inhibits C3a-induced NF-kappa B activation via receptor desensitization-dependent and independent pathways.	[Gupta, Kshitij; Subramanian, Hariharan; Ali, Hydar] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Klos, Andreas] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany	University of Pennsylvania; Hannover Medical School	Ali, H (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [HL-085774];  [SFB587];  [TP16]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to HA from the National Institutes of Health (HL-085774) and a grant for AK from the SFB587, TP16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2002, J BIOL CHEM, V277, P22685, DOI 10.1074/jbc.M110210200; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; ALI H, 1994, J BIOL CHEM, V269, P24557; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gray JA, 2003, MOL PHARMACOL, V63, P961, DOI 10.1124/mol.63.5.961; Guo Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022559; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Langkabel P, 1999, EUR J IMMUNOL, V29, P3035, DOI 10.1002/(SICI)1521-4141(199909)29:09<3035::AID-IMMU3035>3.0.CO;2-Z; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Potter RM, 2002, J BIOL CHEM, V277, P8970, DOI 10.1074/jbc.M111086200; Rivera J, 2008, CURR ALLERGY ASTHM R, V8, P14, DOI 10.1007/s11882-008-0004-z; Schafer B, 2012, J ALLERGY CLIN IMMUN, DOI org/10.1016/j.jaci.2012.05.009; Settmacher B, 2003, EUR J IMMUNOL, V33, P920, DOI 10.1002/eji.200323293; Subramanian H, 2011, J BIOL CHEM, V286, P44739, DOI 10.1074/jbc.M111.277152; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Venkatesha RT, 2004, J BIOL CHEM, V279, P44606, DOI 10.1074/jbc.M408035200; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; WITHEROW DS, 2004, P NATL ACAD SCI US; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561	28	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46369	10.1371/journal.pone.0046369	http://dx.doi.org/10.1371/journal.pone.0046369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077507	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100029
J	Miller, GW; Ulatowski, L; Labut, EM; Lebold, KM; Manor, D; Atkinson, J; Barton, CL; Tanguay, RL; Traber, MG				Miller, Galen W.; Ulatowski, Lynn; Labut, Edwin M.; Lebold, Katie M.; Manor, Danny; Atkinson, Jeffrey; Barton, Carrie L.; Tanguay, Robert L.; Traber, Maret G.			The alpha-Tocopherol Transfer Protein Is Essential for Vertebrate Embryogenesis	PLOS ONE			English	Article							VITAMIN-E-DEFICIENCY; MATERNAL DIETARY LOADS; ZEBRAFISH DANIO-RERIO; EMBRYONIC-DEVELOPMENT; MORPHOLINO OLIGOS; GENE; ATAXIA; LOCALIZATION; TROPHOBLAST; EXPRESSION	The hepatic alpha-tocopherol transfer protein (TTP) is required for optimal alpha-tocopherol bioavailability in humans; mutations in the human TTPA gene result in the heritable disorder ataxia with vitamin E deficiency (AVED, OMIM #277460). TTP is also expressed in mammalian uterine and placental cells and in the human embryonic yolk-sac, underscoring TTP's significance during fetal development. TTP and vitamin E are essential for productive pregnancy in rodents, but their precise physiological role in embryogenesis is unknown. We hypothesize that TTP is required to regulate delivery of alpha-tocopherol to critical target sites in the developing embryo. We tested to find if TTP is essential for proper vertebrate development, utilizing the zebrafish as a non-placental model. We verify that TTP is expressed in the adult zebrafish and its amino acid sequence is homologous to the human ortholog. We show that embryonic transcription of TTP mRNA increases >7-fold during the first 24 hours following fertilization. In situ hybridization demonstrates that Ttpa transcripts are localized in the developing brain, eyes and tail bud at 1-day post fertilization. Inhibiting TTP expression using oligonucleotide morpholinos results in severe malformations of the head and eyes in nearly all morpholino-injected embryos (88% compared with 5.6% in those injected with control morpholinos or 1.7% in non-injected embryos). We conclude that TTP is essential for early development of the vertebrate central nervous system.	[Miller, Galen W.; Labut, Edwin M.; Lebold, Katie M.; Traber, Maret G.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Miller, Galen W.; Tanguay, Robert L.; Traber, Maret G.] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA; [Lebold, Katie M.; Traber, Maret G.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Barton, Carrie L.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Traber, Maret G.] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Ulatowski, Lynn; Manor, Danny] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Atkinson, Jeffrey] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University; Case Western Reserve University; Case Western Reserve University; Brock University	Traber, MG (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.	maret.traber@oregonstate.edu	Traber, Maret G./ABI-2511-2020; Ulatowski, Lynn/ABI-5652-2020	Traber, Maret G./0000-0002-2892-4024; Atkinson, Jeffrey/0000-0003-3710-4893	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD062109]; Aquatic Biomedical Models Facility Core of the Environmental Health Sciences Center, Oregon State University (National Institute of Environmental Health Sciences) [P30 ES000210]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD062109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Aquatic Biomedical Models Facility Core of the Environmental Health Sciences Center, Oregon State University (National Institute of Environmental Health Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This publication was made possible, in part, by the Aquatic Biomedical Models Facility Core of the Environmental Health Sciences Center, Oregon State University (National Institute of Environmental Health Sciences, P30 ES000210) and by a grant from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD062109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini P, 2011, PHYSIOL BEHAV, V104, P809, DOI 10.1016/j.physbeh.2011.07.026; AMES SR, 1979, J NUTR, V109, P2198, DOI 10.1093/jn/109.12.2198; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Betti M, 2011, J NUTR BIOCHEM, V22, P60, DOI 10.1016/j.jnutbio.2009.11.014; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Food and Nutrition Board. Institute of Medicine, 2000, ACADEMY; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Jauniaux E, 2004, J CLIN ENDOCR METAB, V89, P1452, DOI 10.1210/jc.2003-031332; Jishage K, 2001, J BIOL CHEM, V276, P1669, DOI 10.1074/jbc.C000676200; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LETH T, 1977, J NUTR, V107, P2236, DOI 10.1093/jn/107.12.2236; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Mariotti C, 2004, NEUROL SCI, V25, P130, DOI 10.1007/s10072-004-0246-z; Martin E, 2012, NEUROBIOL DIS, V48, P299, DOI 10.1016/j.nbd.2012.07.003; McBurney MI, 2011, J NUTR, V141, P1920, DOI 10.3945/jn.111.147330; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Miller GW, 2012, J NUTR BIOCHEM, V23, P478, DOI 10.1016/j.jnutbio.2011.02.002; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Min KC, 2007, VITAM HORM, V76, P23; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Morley S, 2004, BIOCHEMISTRY-US, V43, P4143, DOI 10.1021/bi0363073; Muller-Schmehl K, 2004, FREE RADICAL RES, V38, P413, DOI 10.1080/10715760310001659611; Nava P, 2006, BIOORGAN MED CHEM, V14, P3721, DOI 10.1016/j.bmc.2006.01.053; Neto A, 2012, DEVELOPMENT, V139, P301, DOI 10.1242/dev.074856; Panagabko C, 2002, PROTEIN EXPRES PURIF, V24, P395, DOI 10.1006/prep.2001.1576; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Shichiri M, 2011, FREE RADICAL BIO MED, V50, P1801, DOI 10.1016/j.freeradbiomed.2011.03.023; Tallafuss A, 2012, DEVELOPMENT, V139, P1691, DOI 10.1242/dev.072702; Terasawa Y, 2000, P NATL ACAD SCI USA, V97, P13830, DOI 10.1073/pnas.240462697; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Usuki F, 2000, J NEUROL NEUROSUR PS, V69, P254, DOI 10.1136/jnnp.69.2.254; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435	39	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47402	10.1371/journal.pone.0047402	http://dx.doi.org/10.1371/journal.pone.0047402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077608	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100106
J	Russell, SE; Moore, AC; Fallon, PG; Walsh, PT				Russell, Shane E.; Moore, Anne C.; Fallon, Padraic G.; Walsh, Patrick T.			Soluble IL-2R alpha (sCD25) Exacerbates Autoimmunity and Enhances the Development of Th17 Responses in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERLEUKIN-2 RECEPTOR-ALPHA; RHEUMATOID-ARTHRITIS; CUTTING EDGE; IL-2; DISEASE; ACTIVATION; ANTIBODY; BETA	A strong association exists between mutations at the IL2 receptor alpha chain (CD25) gene locus and susceptibility to a number of T cell driven autoimmune diseases. Interestingly, the presence of certain CD25 susceptibility alleles has been correlated with significantly increased levels of the soluble form of CD25 (sCD25) in the serum of patients. However, the functional consequences, if any, of this observation are unknown. We have demonstrated that elevated levels of sCD25 in vivo resulted in exacerbated experimental autoimmune encephalomyelitis (EAE) and enhanced antigen-specific Th17 responses in the periphery. sCD25 exerted its effects early during the Th17 developmental programme in vitro, through inhibiting signalling downstream of the IL-2R. Although, sCD25 did not interact with the T cell surface, it specifically bound to secreted IL-2 demonstrating its ability to act as a decoy receptor for IL-2 in the T cell microenvironment. These data identify the ability of sCD25 to promote autoimmune disease pathogenesis and enhance Th17 responses through its ability to sequester local IL-2.	[Russell, Shane E.; Fallon, Padraic G.; Walsh, Patrick T.] Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin, Ireland; [Russell, Shane E.; Fallon, Padraic G.; Walsh, Patrick T.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Moore, Anne C.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Cork	Walsh, PT (corresponding author), Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin, Ireland.	walshp10@tcd.ie	Walsh, Patrick/I-7909-2014; Fallon, Padraic/Y-2711-2019	Walsh, Patrick/0000-0002-0130-8766; Fallon, Padraic/0000-0002-8401-7293; Moore, Anne/0000-0003-3656-4230	Science Foundation Ireland [10/YI/B1827]; Marie Curie Reintegration fellowship [Pirg05-GA-2009-246738]; National Childrens Research Centre	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie Reintegration fellowship; National Childrens Research Centre	This work was supported by funding from Science Foundation Ireland (PIYRA award 10/YI/B1827) and a Marie Curie Reintegration fellowship (Pirg05-GA-2009-246738) and the National Childrens Research Centre (PRiTI programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chistiakov DA, 2011, SCAND J IMMUNOL, V74, P496, DOI 10.1111/j.1365-3083.2011.02608.x; Dummer R, 1996, J INTERF CYTOK RES, V16, P315, DOI 10.1089/jir.1996.16.315; Heaney ML, 1998, J LEUKOCYTE BIOL, V64, P135, DOI 10.1002/jlb.64.2.135; JACQUES Y, 1990, J BIOL CHEM, V265, P20252; Junghans RP, 1998, P NATL ACAD SCI USA, V95, P1752, DOI 10.1073/pnas.95.4.1752; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; OSAWA H, 1986, EUR J IMMUNOL, V16, P467, DOI 10.1002/eji.1830160426; Pandiyan P, 2011, IMMUNITY, V34, P422, DOI 10.1016/j.immuni.2011.03.002; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rouse M, 2012, IMMUNOBIOLOGY; RUBIN L A, 1990, Cytokine, V2, P330, DOI 10.1016/1043-4666(90)90062-X; RUBIN LA, 1986, J IMMUNOL, V137, P3841; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Suzuki H, 1999, J EXP MED, V190, P1561, DOI 10.1084/jem.190.11.1561; SYMONS JA, 1988, J IMMUNOL, V141, P2612; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Witkowska AM, 2005, MEDIAT INFLAMM, P121, DOI 10.1155/MI.2005.121; Yang ZZ, 2011, BLOOD, V118, P2809, DOI 10.1182/blood-2011-03-340885; ZORN U, 1994, CYTOKINE, V6, P358, DOI 10.1016/1043-4666(94)90058-2	34	40	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47748	10.1371/journal.pone.0047748	http://dx.doi.org/10.1371/journal.pone.0047748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077668	Green Published, gold			2022-12-25	WOS:000309995100160
J	de Vries, MR; Niessen, HWM; Lowik, CWGM; Hamming, JF; Jukema, JW; Quax, PHA				de Vries, Margreet R.; Niessen, Hans W. M.; Lowik, Clemens W. G. M.; Hamming, Jaap F.; Jukema, J. Wouter; Quax, Paul H. A.			Plaque Rupture Complications in Murine Atherosclerotic Vein Grafts Can Be Prevented by TIMP-1 Overexpression	PLOS ONE			English	Article							INTRAPLAQUE MICROVASCULAR LEAKAGE; PROMOTES COLLAGEN ACCUMULATION; APOE-DEFICIENT MICE; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; GENE-TRANSFER; MOUSE MODEL; HEMORRHAGE; MATRIX-METALLOPROTEINASE-9; INFLAMMATION	The current study describes the incidence and phenotype of plaque rupture complications in murine vein grafts. Since matrix metalloproteinases (MMPs) are highly involved in atherosclerotic plaque vulnerability and plaque rupture, we hypothesized that this model can be validated by overexpression of the MMP inhibitor TIMP-1. First we studied 47 vein grafts in hypercholesterolemic ApoE3*Leiden mice for the incidence of plaque complications. In 79% of these grafts, extensive lesions with plaque rupture complications like dissections, intraplaque hemorrhages or erosions with intramural thrombi were found. Next, in vivo Near-InfraRed-Fluorescence imaging demonstrated that electroporation mediated TIMP1-overexpression reduced local MMP activity in vein grafts by 73% (p < 0.01). This led to a 40% reduction in lesion-size after 28d (p = 0.01) and a more stable lesion phenotype with significant more smooth muscle cells (135%), collagen (47%) and significant less macrophages (44%) and fibrin (55%) than controls. More importantly, lesions in the TIMP-1 group showed a 90% reduction of plaque complications (10/18 of control mice showed plaque complications versus 1/18 in TIMP-1 treated mice). Murine vein grafts are a relevant spontaneous model to study plaque stability and subsequent hemorrhagic complications, resulting in plaque instability. Moreover, inhibition of MMPs by TIMP-1-overexpression resulted in decreased plaque progression, increased stabilization and decreased plaque rupture complications in murine vein grafts.	[de Vries, Margreet R.; Jukema, J. Wouter; Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [de Vries, Margreet R.; Hamming, Jaap F.; Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, ICaR VU, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands; [Lowik, Clemens W. G. M.] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Quax, PHA (corresponding author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	p.h.a.quax@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019; de Vries, Margreet/Z-5653-2019	Jukema, J. Wouter/0000-0002-3246-8359; Quax, Paul/0000-0002-6853-5760; Niessen, Hans/0000-0001-9404-9822				Bot I, 2010, CIRC RES, V106, P89, DOI 10.1161/CIRCRESAHA.109.204875; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Cecchi E, 2011, ATHEROSCLEROSIS, V214, P249, DOI 10.1016/j.atherosclerosis.2010.09.008; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Dietrich H, 2000, AM J PATHOL, V157, P659, DOI 10.1016/S0002-9440(10)64576-2; Eefting D, 2010, CARDIOVASC RES, V88, P367, DOI 10.1093/cvr/cvq203; Eefting D, 2010, J VASC SURG, V51, P429, DOI 10.1016/j.jvs.2009.09.026; Ewing MM, 2011, ARTERIOSCL THROM VAS, V31, P95, DOI 10.1161/ATVBAHA.110.216747; Falk E, 2007, ARTERIOSCL THROM VAS, V27, P969, DOI 10.1161/01.ATV.0000261572.33474.e0; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hu YH, 2001, ARTERIOSCL THROM VAS, V21, P1275, DOI 10.1161/hq0801.093658; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P714, DOI 10.1161/01.ATV.0000261873.86623.e1; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P973, DOI 10.1161/01.ATV.0000261545.53586.f0; Johnson JL, 2006, CIRCULATION, V113, P2435, DOI 10.1161/CIRCULATIONAHA.106.613281; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; Karper JC, 2011, ARTERIOSCL THROM VAS, V31, P1033, DOI 10.1161/ATVBAHA.111.223271; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Lardenoye J H P, 2005, EuroIntervention, V1, P236; Lardenoye JHP, 2002, CIRC RES, V91, P577, DOI 10.1161/01.RES.0000036901.58329.D7; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Owens CD, 2010, J VASC SURG, V51, P736, DOI 10.1016/j.jvs.2009.07.102; Rouis M, 1999, CIRCULATION, V100, P533, DOI 10.1161/01.CIR.100.5.533; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Shah P K, 1998, Vasc Med, V3, P199, DOI 10.1177/1358836X9800300304; Sluimer JC, 2009, J AM COLL CARDIOL, V53, P1517, DOI 10.1016/j.jacc.2008.12.056; Thomas AC, 2010, J VASC RES, V47, P299, DOI 10.1159/000265564; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; van der Laan WH, 2003, GENE THER, V10, P234, DOI 10.1038/sj.gt.3301871; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; van Lammeren GW, 2012, ATHEROSCLEROSIS, V222, P355, DOI 10.1016/j.atherosclerosis.2012.03.008; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; Zhu YH, 1999, CIRCULATION, V99, P3050, DOI 10.1161/01.CIR.99.23.3050; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	40	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47134	10.1371/journal.pone.0047134	http://dx.doi.org/10.1371/journal.pone.0047134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071737	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700059
J	Scolari, F; Gomulski, LM; Ribeiro, JMC; Siciliano, P; Meraldi, A; Falchetto, M; Bonomi, A; Manni, M; Gabrieli, P; Malovini, A; Bellazzi, R; Aksoy, S; Gasperi, G; Malacrida, AR				Scolari, Francesca; Gomulski, Ludvik M.; Ribeiro, Jose M. C.; Siciliano, Paolo; Meraldi, Alice; Falchetto, Marco; Bonomi, Angelica; Manni, Mose; Gabrieli, Paolo; Malovini, Alberto; Bellazzi, Riccardo; Aksoy, Serap; Gasperi, Giuliano; Malacrida, Anna R.			Transcriptional Profiles of Mating-Responsive Genes from Testes and Male Accessory Glands of the Mediterranean Fruit Fly, Ceratitis capitata	PLOS ONE			English	Article							SEMINAL FLUID PROTEINS; JUVENILE-HORMONE ESTERASE; RICH SECRETORY PROTEINS; DENGUE VECTOR MOSQUITO; DROSOPHILA-MELANOGASTER; BINDING-PROTEIN; REPRODUCTIVE PROTEINS; AEDES-AEGYPTI; POSITIVE SELECTION; PROTEOMIC ANALYSIS	Background: Insect seminal fluid is a complex mixture of proteins, carbohydrates and lipids, produced in the male reproductive tract. This seminal fluid is transferred together with the spermatozoa during mating and induces post-mating changes in the female. Molecular characterization of seminal fluid proteins in the Mediterranean fruit fly, Ceratitis capitata, is limited, although studies suggest that some of these proteins are biologically active. Methodology/Principal Findings: We report on the functional annotation of 5914 high quality expressed sequence tags (ESTs) from the testes and male accessory glands, to identify transcripts encoding putative secreted peptides that might elicit post-mating responses in females. The ESTs were assembled into 3344 contigs, of which over 33% produced no hits against the nr database, and thus may represent novel or rapidly evolving sequences. Extraction of the coding sequences resulted in a total of 3371 putative peptides. The annotated dataset is available as a hyperlinked spreadsheet. Four hundred peptides were identified with putative secretory activity, including odorant binding proteins, protease inhibitor domain-containing peptides, antigen 5 proteins, mucins, and immunity-related sequences. Quantitative RT-PCR-based analyses of a subset of putative secretory protein-encoding transcripts from accessory glands indicated changes in their abundance after one or more copulations when compared to virgin males of the same age. These changes in abundance, particularly evident after the third mating, may be related to the requirement to replenish proteins to be transferred to the female. Conclusions/Significance: We have developed the first large-scale dataset for novel studies on functions and processes associated with the reproductive biology of Ceratitis capitata. The identified genes may help study genome evolution, in light of the high adaptive potential of the medfly. In addition, studies of male recovery dynamics in terms of accessory gland gene expression profiles and correlated remating inhibition mechanisms may permit the improvement of pest management approaches.	[Scolari, Francesca; Gomulski, Ludvik M.; Siciliano, Paolo; Meraldi, Alice; Falchetto, Marco; Bonomi, Angelica; Manni, Mose; Gabrieli, Paolo; Gasperi, Giuliano; Malacrida, Anna R.] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Ribeiro, Jose M. C.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, Rockville, MD USA; [Malovini, Alberto] Fdn Salvatore Maugeri, IRCCS, Pavia, Italy; [Malovini, Alberto] IUSS, Pavia, Italy; [Malovini, Alberto; Bellazzi, Riccardo] Univ Pavia, Dept Ind & Informat Engn, I-27100 Pavia, Italy; [Aksoy, Serap] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	University of Pavia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; IUSS PAVIA; University of Pavia; Yale University	Malacrida, AR (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Via Palestro 3, I-27100 Pavia, Italy.	malacrid@unipv.it	Scolari, Francesca/ABC-2285-2020; Gasperi, Giuliano/Y-1894-2019; Gabrieli, Paolo/A-3206-2016; Ribeiro, Jose/J-7011-2015; Bellazzi, Riccardo/J-6432-2018; Malovini, Alberto/I-8727-2018; Aksoy, Serap/K-2244-2019; Gomulski, Ludvik/AFK-3930-2022; Gomulski, Ludvik/AAG-2709-2022	Scolari, Francesca/0000-0003-3085-9038; Gasperi, Giuliano/0000-0001-6972-8591; Gabrieli, Paolo/0000-0002-4996-2468; Bellazzi, Riccardo/0000-0002-6974-9808; Malovini, Alberto/0000-0003-2857-5773; Aksoy, Serap/0000-0001-9941-143X; Ribeiro, Jose/0000-0002-9107-0818; GOMULSKI, LUDVIK/0000-0002-1506-7051; malacrida, anna/0000-0003-4566-8795	Italian Ministry of Universities and Research PRIN [2004053427, 2008FLZZ37]; International Atomic Energy Agency (IAEA) [16966]; Intramural Research Program of the Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health (JMCR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, R01AI081774] Funding Source: NIH RePORTER	Italian Ministry of Universities and Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Intramural Research Program of the Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (JMCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was partially funded by Italian Ministry of Universities and Research PRIN grants 2004053427 and 2008FLZZ37 (LMG, ARM, GG) and International Atomic Energy Agency (IAEA) contract 16966. The work was also carried out within the IAEA CRP programme "Development and evaluation of improved strains of insect pests for SIT'' (GG). It was also in part supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (JMCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Because JMCR is a government employee and this is a government work, the work is in the public domain in the United States. Notwithstanding any other agreements, the United States National Institutes of Health reserves the right to provide the work to PubMedCentral for display and use by the public, and PubMedCentral may tag or modify the work consistent with its customary practices, or establish rights outside of the U.S. subject to a government use license.	Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameri M, 2008, J MED ENTOMOL, V45, P94, DOI 10.1603/0022-2585(2008)45[94:AIBPAO]2.0.CO;2; Andres JA, 2001, P ROY SOC B-BIOL SCI, V268, P399, DOI 10.1098/rspb.2000.1392; Andres JA, 2008, P ROY SOC B-BIOL SCI, V275, P1975, DOI 10.1098/rspb.2008.0423; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arunkumar KP, 2009, GENETICS, V182, P493, DOI 10.1534/genetics.108.099994; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Azevedo RVDM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034495; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; BAO SN, 1989, CYTOBIOS, V58, P93; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Begun DJ, 2006, GENETICS, V172, P1675, DOI 10.1534/genetics.105.050336; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Bonilla E, 2008, MOL HUM REPROD, V14, P137, DOI 10.1093/molehr/gan002; BOROVSKY D, 1994, INSECT BIOCHEM MOLEC, V24, P437, DOI 10.1016/0965-1748(94)90038-8; Braswell WE, 2006, GENOME, V49, P1069, DOI 10.1139/G06-061; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P501, DOI 10.1016/S0965-1748(98)00037-X; CAMPBELL PM, 1992, INSECT BIOCHEM MOLEC, V22, P665, DOI 10.1016/0965-1748(92)90045-G; Carey JR, 2003, HDB SOCIAL PHYCOLOGY, P625; Cavalloro R, 1970, Redia (Ser. 3), V52, P511; Chapman T, 2008, PLOS BIOL, V6, P1379, DOI 10.1371/journal.pbio.0060179; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chen GS, 2010, ENVIRON MOL MUTAGEN, V51, P330, DOI 10.1002/em.20540; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CHEN PS, 1984, ANNU REV ENTOMOL, V29, P233, DOI 10.1146/annurev.en.29.010184.001313; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cho KS, 2000, MOL CELLS, V10, P180, DOI 10.1007/s10059-000-0180-8; Christophides GK, 2000, INSECT MOL BIOL, V9, P185, DOI 10.1046/j.1365-2583.2000.00176.x; Christophides GK, 2000, GENETICS, V156, P173; Civetta A, 2003, MOL BIOL EVOL, V20, P21, DOI 10.1093/molbev/msg002; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COUCHE GA, 1985, CAN J ZOOL, V63, P2789, DOI 10.1139/z85-417; Coyne JA, 2004, SPECIATION, V37; DAPPLES C C, 1974, International Journal of Insect Morphology and Embryology, V3, P279, DOI 10.1016/0020-7322(74)90023-3; Davey K.G., 1985, P1; Davies SJ, 2006, INSECT BIOCHEM MOLEC, V36, P846, DOI 10.1016/j.ibmb.2006.08.009; deKort CAD, 1996, ARCH INSECT BIOCHEM, V33, P1, DOI 10.1002/(SICI)1520-6327(1996)33:1&lt;1::AID-ARCH1&gt;3.0.CO;2-2; Delrio G., 1979, Entomologica (Bari), V15, P127; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Dorus S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-177; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Ellis LL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-558; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fischer BE, 2012, P ROY SOC B-BIOL SCI, V279, P2636, DOI 10.1098/rspb.2012.0153; Fricke C, 2006, FUNCT ECOL, V20, P360, DOI 10.1111/j.1365-2435.2006.01102.x; Gabrieli P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-12; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gillott C., 1988, P319; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; GOLD SMW, 1989, INSECT BIOCHEM, V19, P139, DOI 10.1016/0020-1790(89)90084-X; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Goodman W.G., 2005, P319; Guo YJ, 2009, BIOINFORMATICS, V25, P1195, DOI 10.1093/bioinformatics/btp129; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Harris E.J., 1989, FRUIT FLIES THEIR BI, P73; Haynes SR, 1997, MOL CELL BIOL, V17, P2708, DOI 10.1128/MCB.17.5.2708; HAZELRIGG T, 1994, P NATL ACAD SCI USA, V91, P10752, DOI 10.1073/pnas.91.22.10752; HAZELRIGG T, 1990, GENETICS, V126, P607; Heifetz Y, 2005, P NATL ACAD SCI USA, V102, P743, DOI 10.1073/pnas.0407692102; Herndon LA, 1997, J INSECT PHYSIOL, V43, P1117, DOI 10.1016/S0022-1910(97)00062-0; Intra J, 2011, INSECT BIOCHEM MOLEC, V41, P90, DOI 10.1016/j.ibmb.2010.10.004; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; JONES JC, 1965, BIOL BULL, V129, P134, DOI 10.2307/1539773; Kelleher ES, 2009, INSECT BIOCHEM MOLEC, V39, P366, DOI 10.1016/j.ibmb.2009.03.003; Kern AD, 2004, GENETICS, V167, P725, DOI 10.1534/genetics.103.020883; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kovalick GE, 2005, INSECT BIOCHEM MOLEC, V35, P825, DOI 10.1016/j.ibmb.2005.03.003; Krzywinska E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-300; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LaFlamme BA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002435; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEOPOLD RA, 1976, ANNU REV ENTOMOL, V21, P199, DOI 10.1146/annurev.en.21.010176.001215; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; Lung O, 2002, GENETICS, V160, P211; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; Malacrida AR, 2007, GENETICA, V131, P1, DOI 10.1007/s10709-006-9117-2; Marchini D, 2003, ARTHROPOD STRUCT DEV, V31, P313, DOI 10.1016/S1467-8039(03)00003-3; Marchini D, 2001, ARTHROPOD STRUCT DEV, V30, P39, DOI 10.1016/S1467-8039(01)00018-4; Marchini D, 2006, ITAL J ZOOL, V73, P15, DOI 10.1080/11250000500502319; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Markow TA, 2001, P ROY SOC B-BIOL SCI, V268, P1527, DOI 10.1098/rspb.2001.1673; MEIKLE DB, 1990, J INSECT PHYSIOL, V36, P93, DOI 10.1016/0022-1910(90)90179-J; Mikhaylova LM, 2008, GENETICS, V179, P305, DOI 10.1534/genetics.107.080267; Miyatake T, 1999, J INSECT PHYSIOL, V45, P1021, DOI 10.1016/S0022-1910(99)00083-9; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; MONSMA SA, 1990, DEV BIOL, V142, P465, DOI 10.1016/0012-1606(90)90368-S; Moreira PL, 2006, BEHAV ECOL SOCIOBIOL, V60, P166, DOI 10.1007/s00265-005-0153-1; Moshitzky P, 2003, J INSECT PHYSIOL, V49, P603, DOI 10.1016/S0022-1910(03)00047-7; Mueller JL, 2008, GENETICS, V178, P1605, DOI 10.1534/genetics.107.083766; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Mueller JL, 2004, P NATL ACAD SCI USA, V101, P13542, DOI 10.1073/pnas.0405579101; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Oppelt A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-273; ORR AG, 1991, J NAT HIST, V25, P703, DOI 10.1080/00222939100770461; Panhuis TM, 2006, PHILOS T R SOC B, V361, P261, DOI 10.1098/rstb.2005.1793; Papadopoulos NT, 2010, J INSECT PHYSIOL, V56, P283, DOI 10.1016/j.jinsphys.2009.10.014; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; PARK M, 1995, DEV BIOL, V171, P694, DOI 10.1006/dbio.1995.1315; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Pasini ME, 2011, GENE, V473, P44, DOI 10.1016/j.gene.2010.11.003; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pilch B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r40; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Ram KR, 2007, PLOS GENET, V3, P2428, DOI 10.1371/journal.pgen.0030238; RAMALINGAM S, 1983, INT J INSECT MORPHOL, V12, P87, DOI 10.1016/0020-7322(83)90002-8; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; REGIS L, 1985, INSECT SCI APPL, V6, P579, DOI 10.1017/S1742758400009139; Reinhardt K, 2009, P NATL ACAD SCI USA, V106, P21743, DOI 10.1073/pnas.0905347106; Ribeiro JMC, 2012, INSECT BIOCHEM MOLEC, V42, P332, DOI 10.1016/j.ibmb.2012.01.003; Roberts KP, 2007, ASIAN J ANDROL, V9, P508, DOI 10.1111/j.1745-7262.2007.00318.x; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rosetto M, 2003, INSECT MOL BIOL, V12, P501, DOI 10.1046/j.1365-2583.2003.00436.x; SAUL SH, 1982, ANN ENTOMOL SOC AM, V75, P480, DOI 10.1093/aesa/75.4.480; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schreiber MC, 1997, GENE, V191, P135, DOI 10.1016/S0378-1119(97)00010-3; Schully SD, 2006, J MOL EVOL, V62, P793, DOI 10.1007/s00239-005-0239-4; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; SIMMERL E, 1995, INSECT BIOCHEM MOLEC, V25, P127, DOI 10.1016/0965-1748(94)00034-F; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989; Sirot LK, 2009, ADV GENET, V68, P23, DOI 10.1016/S0065-2660(09)68002-0; Smith JR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002375; South A, 2011, INSECT MOL BIOL, V20, P447, DOI 10.1111/j.1365-2583.2011.01083.x; Stanfield GM, 2006, CURR BIOL, V16, P252, DOI 10.1016/j.cub.2005.12.041; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2003, P NATL ACAD SCI USA, V100, P9643, DOI 10.1073/pnas.1834127100; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor PW, 1999, ANIM BEHAV, V58, P247, DOI 10.1006/anbe.1999.1137; Teal PEA, 2000, P NATL ACAD SCI USA, V97, P3708, DOI 10.1073/pnas.060034397; Team R. D. C, 2011, R LANG ENV STAT COMP; Theodoraki M, 2008, ARCH INSECT BIOCHEM, V67, P20, DOI 10.1002/arch.20216; TOBE SS, 1985, ADV INSECT PHYSIOL, V18, P305; TROWELL SC, 1992, COMP BIOCHEM PHYS B, V103, P795, DOI 10.1016/0305-0491(92)90196-X; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vannini L, 2010, ARCH INSECT BIOCHEM, V75, P92, DOI 10.1002/arch.20382; Vera MT, 2003, ANN ENTOMOL SOC AM, V96, P563, DOI 10.1603/0013-8746(2003)096[0563:ROWCCD]2.0.CO;2; Walker MJ, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-9; Walters JR, 2010, MOL BIOL EVOL, V27, P2000, DOI 10.1093/molbev/msq092; Walters JR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-592; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; White-Cooper H, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P151, DOI 10.1016/B978-0-12-372568-4.00004-5; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007; Wolberg J., 2005, DATA ANAL USING METH; Wolfner M.F., 2005, P179; Wolfner M.F., 2007, P183; Wong A, 2012, MOL BIOL EVOL, V29, P229, DOI 10.1093/molbev/msr197; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; Yamamoto MT, 2010, FLY, V4, P36, DOI 10.4161/fly.4.1.10838; Zalewska M, 2011, ACTA BIOCHIM POL, V58, P119; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681	170	33	33	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46812	10.1371/journal.pone.0046812	http://dx.doi.org/10.1371/journal.pone.0046812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071645	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700034
J	Cox, KH; Cox, ME; Woo-Rasberry, V; Hasty, DL				Cox, Kathleen H.; Cox, Michelle E.; Woo-Rasberry, Virginia; Hasty, David L.			Pathways Involved in the Synergistic Activation of Macrophages by Lipoteichoic Acid and Hemoglobin	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; I-KAPPA-B; GROUP BOX-1 PROTEIN; LIPOPOLYSACCHARIDE-BINDING-PROTEIN; DAVID BIOINFORMATICS RESOURCES; GLYCATION END-PRODUCTS; LARGE GENE LISTS; STAPHYLOCOCCUS-AUREUS; PROINFLAMMATORY ACTIVITY; BIOLOGICAL-ACTIVITY	Lipoteichoic acid (LTA) is a Gram-positive cell surface molecule that is found in both a cell-bound form and cell-free form in the host during an infection. Hemoglobin (Hb) can synergize with LTA, a TLR2 ligand, to potently activate macrophage innate immune responses in a TLR2- and TLR4-dependent way. At low levels of LTA, the presence of Hb can result in a 200-fold increase in the secretion of IL-6 following macrophage activation. Six hours after activation, the macrophage genes that are most highly up-regulated by LTA plus Hb activation compared to LTA alone are cytokines, chemokines, receptors and interferon-regulated genes. Several of these genes exhibit a unique TLR4-dependent increase in mRNA levels that continued to rise more than eight hours after stimulation. This prolonged increase in mRNA levels could be the result of an extended period of NF-kappa B nuclear localization and the concurrent absence of the NF-kappa B inhibitor, I kappa B alpha, after stimulation with LTA plus Hb. Dynasore inhibition experiments indicate that an endocytosis-dependent pathway is required for the TLR4-dependent up-regulation of IL-6 secretion following activation with LTA plus Hb. In addition, interferon-beta mRNA is present after activation with LTA plus Hb, suggesting that the TRIF/TRAM-dependent pathway may be involved. Hb alone can elicit the TLR4-dependent secretion of TNF-alpha from macrophages, so it may be the TLR4 ligand. Hb also led to secretion of high mobility group box 1 protein (HMGB1), which synergized with LTA to increase secretion of IL-6. The activation of both the TLR2 and TLR4 pathways by LTA plus Hb leads to an enhanced innate immune response.	[Cox, Kathleen H.; Cox, Michelle E.; Woo-Rasberry, Virginia; Hasty, David L.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Hasty, DL (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	dhasty@uthsc.edu			National Institutes of Health [1 R01 075074]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant 1 R01 075074 to DLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; ALKAN ML, 1978, J CLIN INVEST, V61, P671, DOI 10.1172/JCI108979; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Biber K, 2003, J LEUKOCYTE BIOL, V74, P243, DOI 10.1189/jlb.0802415; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; Bodet C, 2007, J DENT RES, V86, P878, DOI 10.1177/154405910708600914; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Buttari B, 2007, ANN NY ACAD SCI, V1107, P42, DOI 10.1196/annals.1381.005; Carrillo EH, 2002, J TRAUMA, V52, P449, DOI 10.1097/00005373-200203000-00006; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Cox KH, 2007, INFECT IMMUN, V75, P2638, DOI 10.1128/IAI.01320-06; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Fernandez PL, 2010, J BIOL CHEM, V285, P32844, DOI 10.1074/jbc.M110.146076; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Garg R, 2010, J IMMUNOL, V184, P5980, DOI 10.4049/jimmunol.0903512; Gerber J, 2003, ANTIMICROB AGENTS CH, V47, P1313, DOI 10.1128/AAC.47.4.1313-1317.2003; Hasty DL, 2006, J IMMUNOL, V176, P5567, DOI 10.4049/jimmunol.176.9.5567; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Howe J, 2008, INNATE IMMUN-LONDON, V14, P39, DOI 10.1177/1753425907087257; Howe J, 2007, MED CHEM, V3, P13, DOI 10.2174/157340607779317625; Howe J, 2008, MED CHEM, V4, P520, DOI 10.2174/157340608786242089; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; JOSEPH R, 1975, INFECT IMMUN, V12, P333, DOI 10.1128/IAI.12.2.333-338.1975; KACA W, 1994, J BIOL CHEM, V269, P25078; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Korb M, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-7; Levy AP, 2010, ANTIOXID REDOX SIGN, V12, P293, DOI 10.1089/ars.2009.2793; Lin TA, 2010, J INFECT DIS, V202, P624, DOI 10.1086/654929; Long EM, 2011, P NATL ACAD SCI USA, V108, P16357, DOI 10.1073/pnas.1100702108; Long EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005601; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahtout H, 2011, J PERIODONTOL, V82, P311, DOI 10.1902/jop.2010.100458; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Molloy EM, 2011, NAT REV MICROBIOL, V9, P670, DOI 10.1038/nrmicro2624; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; ROTH RI, 1993, TRANSFUSION, V33, P919, DOI 10.1046/j.1537-2995.1993.331194082383.x; Schneider O, 1999, NEUROLOGY, V53, P1584, DOI 10.1212/WNL.53.7.1584; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Su DH, 1999, CRIT CARE MED, V27, P771, DOI 10.1097/00003246-199904000-00034; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Tsan MF, 2011, J LEUKOCYTE BIOL, V89, P847, DOI 10.1189/jlb.0810471; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	81	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47333	10.1371/journal.pone.0047333	http://dx.doi.org/10.1371/journal.pone.0047333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071790	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200108
J	Kim, DW; Lee, SA; Hwang, ES; Kook, YH; Kim, BJ				Kim, Dong-Won; Lee, Seoung-Ae; Hwang, Eung-Soo; Kook, Yoon-Hoh; Kim, Bum-Joon			Naturally Occurring Precore/Core Region Mutations of Hepatitis B Virus Genotype C Related to Hepatocellular Carcinoma	PLOS ONE			English	Article							CORE NUCLEOTIDE-SEQUENCE; T-CELL EPITOPES; SURFACE-ANTIGEN; ASYMPTOMATIC CARRIERS; NUCLEOCAPSID ANTIGEN; INFECTION; GENE; KOREA; PREVALENCE; PROMOTER	Previous studies have proved the presence of several distinct types of mutations in hepatitis B virus (HBV) infections, which are related to the progression of liver disease. However, few reports have detailed the mutation frequencies and mutation patterns in the precore/core (preC/C) region, which are based on the clinical status and HBeAg serostatus. Our aim in this study is to investigate the relationships between the preC/C mutations and clinical severity or HBeAg serostatus from patients chronically infected with HBV genotype C. A total of 70 Korean chronic patients, including 35 with hepatocellular carcinoma (HCC), participated in this study. HBV genotyping and precore/core mutations were analyzed by direct sequencing. All patients were confirmed to have genotype C infections. Mutations in the C region were distributed in a non-random manner. In particular, mutations in the MHC class II restricted region were found to be significantly related to HCC. Six (preC-W28*, C-P5H/L/T, C-E83D, C-I97F/L, C-L100I and C-Q182K/*) and seven types (preC-W28*, preC-G29D, C-D32N/H, C-E43K, C-P50A/H/Y, C-A131G/N/P and C-S181H/P) of mutations in the preC/C region were found to be related to HCC and to affect the HBeAg serostatus, respectively. In conclusion, our data indicated that HBV variants in the C region, particularly in the MHC class II restricted region, may contribute to the progress of HCC in chronic patients infected with genotype C. In addition, we found several distinct preC/C mutations in the Korean chronic cohort, which affect the clinical status of HCC and HBeAg serostatus of patients infected with genotype C.	[Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Liver Res Inst, Seoul, South Korea; Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Liver Res Inst, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/J-2739-2012; Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709; Hwang, Eung Soo/0000-0001-9562-4577	National Research Foundation of Korea (NRF); Korea government (MEST) [2010-014269]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (number 2010-014269). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista M, 1999, HEPATOLOGY, V29, P946, DOI 10.1002/hep.510290336; Bock CT, 2003, GASTROENTEROLOGY, V124, P1809, DOI 10.1016/S0016-5085(03)00396-2; Bozkaya H, 1996, HEPATOLOGY, V24, P32, DOI 10.1053/jhep.1996.v24.pm0008707278; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; CARMAN WF, 1989, LANCET, V2, P588; Ceres P, 2004, J VIROL, V78, P9538, DOI 10.1128/JVI.78.17.9538-9543.2004; DILELIO A, 1989, RADIOLOGY, V172, P389, DOI 10.1148/radiology.172.2.2526349; EHATA T, 1993, J CLIN INVEST, V91, P1206, DOI 10.1172/JCI116281; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; FERRARI C, 1987, J IMMUNOL, V139, P2050; HOSONO S, 1995, VIROLOGY, V212, P151, DOI 10.1006/viro.1995.1463; Kao JH, 2003, INTERVIROLOGY, V46, P400, DOI 10.1159/000074999; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Kim D, 2011, J MED VIROL, V83, P2082, DOI 10.1002/jmv.22226; Kim H, 2007, J MED VIROL, V79, P212, DOI 10.1002/jmv.20789; Kim H, 2007, INTERVIROLOGY, V50, P52, DOI 10.1159/000096313; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lay MJ, 1997, CLIN CHEM, V43, P2262; Lee DH, 2002, J KOREAN MED SCI, V17, P457, DOI 10.3346/jkms.2002.17.4.457; Lee DH, 2011, HEPATO-GASTROENTEROL, V58, P1643, DOI 10.5754/hge08631; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405; Lim SG, 2007, GASTROENTEROLOGY, V133, P951, DOI 10.1053/j.gastro.2007.06.011; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Mun HS, 2008, J MED VIROL, V80, P1189, DOI 10.1002/jmv.21208; Mun HS, 2011, J VIROL, V85, P123, DOI 10.1128/JVI.01524-10; Ning B, 2004, J VIROL, V78, P13653, DOI 10.1128/JVI.78.24.13653-13668.2004; NORDER H, 1992, J GEN VIROL, V73, P1201, DOI 10.1099/0022-1317-73-5-1201; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Okumura A, 1996, J MED VIROL, V49, P103, DOI 10.1002/(SICI)1096-9071(199606)49:2<103::AID-JMV6>3.0.CO;2-9; Preikschat P, 2002, HEPATOLOGY, V35, P466, DOI 10.1053/jhep.2002.30698; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Song BC, 2005, J MED VIROL, V75, P13, DOI 10.1002/jmv.20230; Sung FY, 2009, GASTROENTEROLOGY, V137, P1687, DOI 10.1053/j.gastro.2009.07.063; Thimme R, 2001, J VIROL, V75, P3984, DOI 10.1128/JVI.75.8.3984-3987.2001; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Yoo BC, 2003, J HEPATOL, V38, P98, DOI 10.1016/S0168-8278(02)00349-5; Yuan TTT, 1999, J VIROL, V73, P5731, DOI 10.1128/JVI.73.7.5731-5740.1999; ZHOU S, 1992, P NATL ACAD SCI USA, V89, P10046, DOI 10.1073/pnas.89.21.10046	46	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47372	10.1371/journal.pone.0047372	http://dx.doi.org/10.1371/journal.pone.0047372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071796	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200112
J	Kumar, R; Ansari, KM; Chaudhari, BP; Dhawan, A; Dwivedi, PD; Jain, SK; Das, M				Kumar, Rahul; Ansari, Kausar M.; Chaudhari, Bhushan P.; Dhawan, Alok; Dwivedi, Premendra D.; Jain, Swatantra K.; Das, Mukul			Topical Application of Ochratoxin A Causes DNA Damage and Tumor Initiation in Mouse Skin	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; HISTONE H2AX; APOPTOSIS; P53; PATHWAYS; CEREALS; SUPEROXIDE; EXPRESSION; INDUCTION; TOXICITY	Skin cancer is one of the most common forms of cancer and 2-3 million new cases are being diagnosed globally each year. Along with UV rays, environmental pollutants/chemicals including mycotoxins, contaminants of various foods and feed stuffs, could be one of the aetiological factors of skin cancer. In the present study, we evaluated the DNA damaging potential and dermal carcinogenicity of a mycotoxin, ochratoxin A (OTA), with the rationale that dermal exposure to OTA in workers may occur during their involvement in pre and post harvest stages of agriculture. A single topical application of OTA (20-80 mu g/mouse) resulted in significant DNA damage along with elevated gamma-H2AX level in skin. Alteration in oxidative stress markers such as lipid peroxidation, protein carbonyl, glutathione content and antioxidant enzymes was observed in a dose (20-80 mu g/mouse) and time-dependent (12-72 h) manner. The oxidative stress was further emphasized by the suppression of Nrf2 translocation to nucleus following a single topical application of OTA (80 mu g/mouse) after 24 h. OTA (80 mu g/mouse) application for 12-72 h caused significant enhancement in- (a) reactive oxygen species generation, (b) activation of ERK1/2, p38 and JNK MAPKs, (c) cell cycle arrest at G0/G1 phase (37-67%), (d) induction of apoptosis (2.0-11.0 fold), (e) expression of p53, p21/waf1, (f) Bax/Bcl-2 ratio, (g) cytochrome c level, (h) activities of caspase 9 (1.2-1.8 fold) and 3 (1.7-2.2 fold) as well as poly ADP ribose polymerase cleavage. In a two-stage mouse skin tumorigenesis protocol, it was observed that a single topical application of OTA (80 mu g/mouse) followed by twice weekly application of 12-O-tetradecanoylphorbol-13-acetate for 24 week leads to tumor formation. These results suggest that OTA has skin tumor initiating property which may be related to oxidative stress, MAPKs signaling and DNA damage.	[Kumar, Rahul; Ansari, Kausar M.; Dwivedi, Premendra D.; Das, Mukul] CSIR IITR, Food Drug & Chem Toxicol Grp, Lucknow, Uttar Pradesh, India; [Kumar, Rahul; Jain, Swatantra K.] Jamia Hamdard, Fac Sci, Dept Biotechnol, New Delhi, India; [Chaudhari, Bhushan P.] CSIR IITR, Pathol Lab, Lucknow, Uttar Pradesh, India; [Dhawan, Alok] CSIR IITR, Nanotoxicol Grp, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Jamia Hamdard University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Ansari, KM (corresponding author), CSIR IITR, Food Drug & Chem Toxicol Grp, Lucknow, Uttar Pradesh, India.	kmansari@iitr.res.in; mditrc@rediffmail.com	KUMAR, RAHUL/ABC-1812-2020; Dhawan, Alok/AAF-7376-2019; kumar, rahul/GZG-2171-2022; Dhawan, Alok/A-6588-2010	KUMAR, RAHUL/0000-0002-2600-0055; Dhawan, Alok/0000-0002-4405-9608	Council of Scientific and Industrial Research (CSIR), Network Project [NWP-17]; Council of Scientific and Industrial Research (CSIR)	Council of Scientific and Industrial Research (CSIR), Network Project; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Funding Agency-Council of Scientific and Industrial Research (CSIR), Network Project Number- NWP-17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Director of our institute for his keen interest in this study. One of us (RK) is thankful to the Council of Scientific and Industrial Research (CSIR) for the award of Senior Research Fellowship. The manuscript is IITR communication # 3004.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Allen SM, 2003, CANCER RES, V63, P567; [Anonymous], 1993, IARC Monogr Eval Carcinog Risks Hum, V56, P445; [Anonymous], 1998, WHO FOOD ADD SER, V47; Assaf H, 2004, TOXICOL SCI, V79, P335, DOI 10.1093/toxsci/kfh123; Atroshi F, 2000, J PHARM PHARM SCI, V3, P281; Barlow S, 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.438; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; CAST, 2003, 139 CAST MYC RISK PL; Cavin C, 2007, TOXICOL SCI, V96, P30, DOI [10.1093/toxscikfl169, 10.1093/toxsci/kfl169]; Cecconi F, 1999, CELL DEATH DIFFER, V6, P1087, DOI 10.1038/sj.cdd.4400602; Chopra M, 2010, CELL BIOL TOXICOL, V26, P239, DOI 10.1007/s10565-009-9131-0; Czerwiecki L, 2002, FOOD ADDIT CONTAM, V19, P1051, DOI 10.1080/02652030210156313; De Flora S, 2006, INT J ONCOL, V29, P521; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Fink-Gremmels J, 2005, FOOD ADDIT CONTAM, V22, P1, DOI 10.1080/02652030500358415; FRENKEL K, 1995, FREE RADICAL BIO MED, V19, P373, DOI 10.1016/0891-5849(95)00046-Z; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Hobbs CA, 2003, EXP CELL RES, V290, P427, DOI 10.1016/S0014-4827(03)00352-5; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Jiang Lingyan, 2010, Mol Cell Pharmacol, V2, P69; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kamp HG, 2005, TOXICOLOGY, V206, P413, DOI 10.1016/j.tox.2004.08.004; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim SJ, 2005, ARCH BIOCHEM BIOPHYS, V444, P121, DOI 10.1016/j.abb.2005.10.009; Kuiper-Goodman T, 1989, Biomed Environ Sci, V2, P179; Kumar R, 2011, TOXICOL SCI, V122, P557, DOI 10.1093/toxsci/kfr143; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Mally A, 2005, CHEM RES TOXICOL, V18, P1253, DOI 10.1021/tx049650x; Mantle PG, 1998, LANCET, V352, P1118, DOI 10.1016/S0140-6736(05)79758-0; Marin-Kuan M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/645361; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; O'Brien E, 2005, CRIT REV TOXICOL, V35, P33, DOI 10.1080/10408440590905948; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petrik J, 2003, ARCH TOXICOL, V77, P685, DOI 10.1007/s00204-003-0501-8; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; POHLAND AE, 1992, PURE APPL CHEM, V64, P1029, DOI 10.1351/pac199264071029; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; RAMET M, 1995, CARCINOGENESIS, V16, P2117, DOI 10.1093/carcin/16.9.2117; Rastogi S, 2006, FOOD CHEM TOXICOL, V44, P670, DOI 10.1016/j.fct.2005.09.008; Rizzo A, 2002, EUR J PLANT PATHOL, V108, P631, DOI 10.1023/A:1020683130901; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rumora L, 2009, ARH HIG RADA TOKSIKO, V60, P449, DOI 10.2478/10004-1254-60-2009-1969; Saxena N, 2011, TOXICOL APPL PHARM, V257, P264, DOI 10.1016/j.taap.2011.09.012; Saxena N, 2009, TOXICOL APPL PHARM, V234, P192, DOI 10.1016/j.taap.2008.09.033; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; SLAGA TJ, 1980, P NATL ACAD SCI-BIOL, V77, P3659, DOI 10.1073/pnas.77.6.3659; Turesky RJ, 2005, CHEM RES TOXICOL, V18, P1082, DOI 10.1021/tx050076e; UTLEY HG, 1967, ARCH BIOCHEM BIOPHYS, V118, P29, DOI 10.1016/0003-9861(67)90273-1; VESELA D, 1978, VET MED-CZECH, V23, P431; Vrabcheva T, 2000, J AGR FOOD CHEM, V48, P2483, DOI 10.1021/jf990891y; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; World Health Organization (WHO), 2011, ULTR RAD INT PROGR; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477	63	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47280	10.1371/journal.pone.0047280	http://dx.doi.org/10.1371/journal.pone.0047280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071775	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200098
J	Adalsteinsson, BT; Gudnason, H; Aspelund, T; Harris, TB; Launer, LJ; Eiriksdottir, G; Smith, AV; Gudnason, V				Adalsteinsson, Bjorn T.; Gudnason, Haukur; Aspelund, Thor; Harris, Tamara B.; Launer, Lenore J.; Eiriksdottir, Gudny; Smith, Albert V.; Gudnason, Vilmundur			Heterogeneity in White Blood Cells Has Potential to Confound DNA Methylation Measurements	PLOS ONE			English	Article							LEUKOCYTE COUNT; FACTOR-BETA; HUMAN GENES; PROFILES; PATTERNS; CANCER; ALPHA	Epigenetic studies are commonly conducted on DNA from tissue samples. However, tissues are ensembles of cells that may each have their own epigenetic profile, and therefore inter-individual cellular heterogeneity may compromise these studies. Here, we explore the potential for such confounding on DNA methylation measurement outcomes when using DNA from whole blood. DNA methylation was measured using pyrosequencing-based methodology in whole blood (n = 50-179) and in two white blood cell fractions (n = 20), isolated using density gradient centrifugation, in four CGIs (CpG Islands) located in genes HHEX (10 CpG sites assayed), KCNJ11 (8 CpGs), KCNQ1 (4 CpGs) and PM20D1 (7 CpGs). Cellular heterogeneity (variation in proportional white blood cell counts of neutrophils, lymphocytes, monocytes, eosinophils and basophils, counted by an automated cell counter) explained up to 40% (p<0.0001) of the inter-individual variation in whole blood DNA methylation levels in the HHEX CGI, but not a significant proportion of the variation in the other three CGIs tested. DNA methylation levels in the two cell fractions, polymorphonuclear and mononuclear cells, differed significantly in the HHEX CGI; specifically the average absolute difference ranged between 3.4-15.7 percentage points per CpG site. In the other three CGIs tested, methylation levels in the two fractions did not differ significantly, and/or the difference was more moderate. In the examined CGIs, methylation levels were highly correlated between cell fractions. In summary, our analysis detects region-specific differential DNA methylation between white blood cell subtypes, which can confound the outcome of whole blood DNA methylation measurements. Finally, by demonstrating the high correlation between methylation levels in cell fractions, our results suggest a possibility to use a proportional number of a single white blood cell type to correct for this confounding effect in analyses.	[Adalsteinsson, Bjorn T.; Gudnason, Haukur; Aspelund, Thor; Eiriksdottir, Gudny; Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Adalsteinsson, Bjorn T.; Aspelund, Thor; Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA	Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Gudnason, V (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	v.gudnason@hjarta.is	Gudnason, Vilmundur/K-6885-2015; Smith, Albert Vernon/K-5150-2015; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/K-7022-2019; Aspelund, Thor/C-5983-2008	Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Adalsteinsson, Bjorn/0000-0001-9777-1714	Icelandic Heart Association; Icelandic Parliament; National Institutes of Health (NIH) [N01-AG-1-2100]; National Institute on Ageing (NIA); Icelandic Center for Research (RANNIS) [072012001]; NATIONAL INSTITUTE ON AGING [N01AG012100, ZIAAG007270] Funding Source: NIH RePORTER	Icelandic Heart Association; Icelandic Parliament; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Ageing (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Icelandic Center for Research (RANNIS); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Age, Gene/Environment Susceptibility (AGES)-Reykjavik and the Risk Evaluation For Infarct Estimates (REFINE)-Reykjavik studies were funded by the Icelandic Heart Association (www.hjarta.is) and the Icelandic Parliament (www.althingi.is). Additionally, AGES-Reykjavik has been funded by the National Institutes of Health (NIH), www.nih.gov, contract N01-AG-1-2100 and the National Institute on Ageing (NIA), www.nia.nih.gov, Intramural Research Program. REFINE-Reykjavik was also funded by the Icelandic Center for Research (RANNIS), www.rannis.is, contract 072012001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDFORD FK, 1993, NUCLEIC ACIDS RES, V21, P1245, DOI 10.1093/nar/21.5.1245; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; CROMPTON MR, 1992, NUCLEIC ACIDS RES, V20, P5661, DOI 10.1093/nar/20.21.5661; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fan SC, 2009, BIOCHEM BIOPH RES CO, V383, P421, DOI 10.1016/j.bbrc.2009.04.023; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; KOCHANEK S, 1990, P NATL ACAD SCI USA, V87, P8830, DOI 10.1073/pnas.87.22.8830; KOCHANEK S, 1991, P NATL ACAD SCI USA, V88, P5759, DOI 10.1073/pnas.88.13.5759; Koestler DC, 2012, CANC EPIDEM IN PRESS; MANFIOLETTI G, 1995, BLOOD, V85, P1237, DOI 10.1182/blood.V85.5.1237.bloodjournal8551237; Margolis KL, 2007, ARCH INTERN MED, V167, P1837, DOI 10.1001/archinte.167.17.1837; Martin GM, 2005, P NATL ACAD SCI USA, V102, P10413, DOI 10.1073/pnas.0504743102; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Wu HC, 2011, EPIGENETICS-US, V6, P76, DOI 10.4161/epi.6.1.13391	23	152	154	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46705	10.1371/journal.pone.0046705	http://dx.doi.org/10.1371/journal.pone.0046705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071618	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300052
J	Tran, BX; Nhung, PTN				Bach Xuan Tran; Nhung Phuong Thi Nguyen			Patient Satisfaction with HIV/AIDS Care and Treatment in the Decentralization of Services Delivery in Vietnam	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HEALTH-CARE; HIV TREATMENT; QUESTIONNAIRE; CLINICS; PEOPLE; AIDS	Objective: We evaluated the patient satisfaction with HIV/AIDS care and treatment and its determinants across levels of health service administration in Vietnam. Methods: We interviewed 1016 patients at 7 hospitals and health centers in three epicenters, including Hanoi, Hai Phong, and Ho Chi Minh City. The Satisfaction with HIV/AIDS Treatment Interview Scale (SATIS) was developed, and 3 dimensions were constructed using factor analysis, namely "Quality and Convenience''; "Availability and Responsiveness''; and "Competence of health care workers''. Results: In a band score of (0; 10), the mean scores of all domains were large; it was the highest in "Competence of health workers'' (9.34 +/- 0.84), and the lowest in "Quality and Convenience'' (9.03 +/- 1.04). The percentages of respondents completely satisfied with overall service quality and treatment outcomes were 42.4% and 18.8%, respectively. In multivariate analysis, factors related to higher satisfaction included female sex, older age, and living with spouses or partners. Meanwhile, lower satisfaction was found among patients who were attending provincial and district clinics; in the richest group; had higher CD4 count; and drug users. Conclusion: This study highlights the importance of improving the quality of HIV/AIDS services at the provincial and district clinics. Potential strategies include capacity building for health workers, integrative service delivery, engagements of family members in treatment supports, and additional attention and comprehensive care for drug users with HIV/AIDS.	[Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Nhung Phuong Thi Nguyen] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	Hanoi Medical University; University of Alberta; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.	bach@hmu.edu.vn	Nguyen, Nhung/J-8012-2019	Nguyen, Nhung/0000-0002-8661-9597				Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; Burrage J, 2008, J ASSOC NURSE AIDS C, V19, P228, DOI 10.1016/j.jana.2008.03.001; Chander Vishav, 2011, Indian J Sex Transm Dis AIDS, V32, P19, DOI 10.4103/0253-7184.81249; Chow MYK, 2012, ASIA-PAC J PUBLIC HE, V24, P406, DOI 10.1177/1010539510384843; Crane HM, 2007, CURR HIV RES, V5, P109, DOI 10.2174/157016207779316369; Devnani M, 2012, AIDS CARE, V24, P100, DOI 10.1080/09540121.2011.592816; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; Duc Duong Bui, 2011, ADAPTING TREATMENT 2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kagashe GAB, 2011, AFR HEALTH SCI, V11, pS60; Karunamoorthi K, 2009, EUR REV MED PHARMACO, V13, P331; Land L, 2011, INT J STD AIDS, V22, P430, DOI 10.1258/ijsa.2011.010450; Lyatuu M B, 2008, East Afr J Public Health, V5, P174; Milloy MJ, 2012, CURR OPIN HIV AIDS, V7, P332, DOI 10.1097/COH.0b013e328354bcc8; Moore BR, 2010, AM J MED QUAL, V25, P384, DOI 10.1177/1062860610371974; Morin D, 2008, AIDS CARE, V20, P388, DOI 10.1080/09540120701583761; Nabbuye-Sekandi J, 2011, INT J QUAL HEALTH C, V23, P516, DOI 10.1093/intqhc/mzr040; Njilele AC, 2012, INT J CLIN PHARM-NET, V34, P98, DOI 10.1007/s11096-011-9596-9; Olowookere SA, 2011, J INT ASS PHYS AIDS; Preau M, 2012, AIDS CARE, V24, P434, DOI 10.1080/09540121.2011.613909; Preau M, 2011, AIDS CARE; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Tat S, 2006, SOC SCI MED, V62, P1229, DOI 10.1016/j.socscimed.2005.07.015; Tran BX, 2012, DRUG ALCOHOL DEPEND; Tran BX, 2012, AIDS CARE; Vietnam Administration of HIV/AIDS Control, 2010, REP CURR SIT HIV INF; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Woodcock A, 2006, VALUE HEALTH, V9, P320, DOI 10.1111/j.1524-4733.2006.00121.x; World Health Organization, 1997, WHOTB97224; World Health Organization, 2011, TREATM 2 0 CAT NEXT; Yan ZH, 2011, INT J QUAL HEALTH C, V23, P384, DOI 10.1093/intqhc/mzr034	35	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46680	10.1371/journal.pone.0046680	http://dx.doi.org/10.1371/journal.pone.0046680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020QD	23071611	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300047
J	Jeong, YI; Hong, SH; Cho, SH; Lee, WJ; Lee, SE				Jeong, Young-Il; Hong, Sung-Hee; Cho, Shin-Hyeong; Lee, Won-Ja; Lee, Sang-Eun			Induction of IL-10-Producing CD1d(high)CD(5+) Regulatory B Cells following Babesia microti-Infection	PLOS ONE			English	Article							AIRWAY INFLAMMATION; HELMINTH INFECTION; PROTECTS MICE; T-CELLS; RESPONSES; MODEL	Background: Understanding the induction of immune regulatory cells upon helminth infection is important for understanding the control of autoimmunity and allergic inflammation in helminth infection. Babesia microti, an intraerythrocytic protozoan of the genus Babesia, is a major cause of the emerging human disease babesiosis, an asymptomatic malaria-like disease. We examined the influence of acute B. microti infection on the development of regulatory B cells together with regulatory T cells. Principal Findings: Our data demonstrate that B cells stimulated in vitro with B. microti produce interleukin (IL)-10. This cytokine is also secreted by B cells isolated from B. microti-infected mice in response to lipopolysaccharide stimulation. In addition, high levels of IL-10 were detected in the serum of mice after infection with B. microti. The frequency of IL-10-producing CD1d(high)CD5(+) regulatory B cells (Bregs) and CD4(+)CD25(+)FoxP3(+) T cells increased during the course of B. microti infection. Furthermore, adoptive transfer of IL-10-producing B cells induced by B. microti infection led to increased susceptibility of recipient mice to infection with B. microti. In contrast, experiments with B cell-deficient (mMT) mice demonstrated that lack of B cells enhances susceptibility to B. microti infection. Conclusions: This study is the first demonstration of the expansion of Bregs following infection by an intraerythrocytic protozoan parasite. These data suggest that B. microti infection in mice provides an excellent model for studying Breg-mediated immune responses and begins to elucidate the mechanism by which helminth infection regulates autoimmunity and allergic inflammation.	[Jeong, Young-Il; Hong, Sung-Hee; Cho, Shin-Hyeong; Lee, Won-Ja; Lee, Sang-Eun] Korea Natl Inst Hlth, Div Malaria & Parasit Dis, Chungbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH)	Lee, SE (corresponding author), Korea Natl Inst Hlth, Div Malaria & Parasit Dis, Chungbuk, South Korea.	ondalgal@cdc.go.kr			Korea Centers for Disease Control and Prevention [4847-302-210-13]	Korea Centers for Disease Control and Prevention	This work is supported by funding (4847-302-210-13, 2010) from the Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Birkenheuer AJ, 2010, VET PARASITOL, V172, P179, DOI 10.1016/j.vetpar.2010.05.020; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Fallon PG, 2007, NAT REV IMMUNOL, V7, P220, DOI 10.1038/nri2039; Gillan V, 2005, INT IMMUNOL, V17, P373, DOI 10.1093/intimm/dxh217; Gubernot DM, 2009, TRANSFUSION, V49, P2759, DOI 10.1111/j.1537-2995.2009.02429.x; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; INCHLEY CJ, 1987, IMMUNOLOGY, V60, P57; Jeong YI, 2011, BIOCHEM BIOPH RES CO, V407, P793, DOI 10.1016/j.bbrc.2011.03.102; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Mangan NE, 2004, J IMMUNOL, V173, P6346, DOI 10.4049/jimmunol.173.10.6346; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Palanivel V, 1996, EXP PARASITOL, V84, P168, DOI 10.1006/expr.1996.0102; Park SK, 2009, J IMMUNOL, V182, P6907, DOI 10.4049/jimmunol.0803533; Ronet C, 2010, J IMMUNOL, V184, P886, DOI 10.4049/jimmunol.0901114; SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169; Smith P, 2004, J IMMUNOL, V173, P1240, DOI 10.4049/jimmunol.173.2.1240; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Welc-Faleciak R, 2007, ANN AGR ENV MED, V14, P287; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	24	44	50	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46553	10.1371/journal.pone.0046553	http://dx.doi.org/10.1371/journal.pone.0046553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071588	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300036
J	Shen, GH; Wang, JL; Wen, FS; Chang, KM; Kuo, CF; Lin, CH; Luo, HR; Hung, CH				Shen, Gwan-Han; Wang, Jiun-Ling; Wen, Fu-Shyan; Chang, Kai-Ming; Kuo, Chih-Feng; Lin, Chun-Hung; Luo, Huei-Ru; Hung, Chih-Hsin			Isolation and Characterization of phi km18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; BACTERIOPHAGE THERAPY; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; CONTINUOUS-CULTURE; MICE; INFECTIONS; BIOCONTROL; PROTEIN; SALMONELLA	Aims: To isolate phages against extensively drug resistant Acinetobacter baumannii (XDRAB) and characterize the highest lytic capability phage as a model to evaluate the potential on phage therapy. Methods and Results: Eight phages were isolated from hospital sewage and showed narrow host spectrum. Phage phi km18p was able to effectively lyse the most XDRAB. It has a dsDNA genome of 45 kb in size and hexagonal head of about 59 nm in diameter and no tail. Bacterial population decreased quickly from 10(8) CFU ml(-1) to 10(3) CFU ml(-1) in 30 min by phi km18p. The 185 kDa lysis protein encoded by phi km18p genome was detected when the extracted protein did not boil before SDS-PAGE; it showed that the lysis protein is a complex rather than a monomer. Phage phi km18p improved human lung epithelial cells survival rates when they were incubated with A. baumannii. Combination of phages (phi km18p, phi TZ1 and phi 314) as a cocktail could lyse all genotype-varying XDRAB isolates. Conclusion: Infections with XDRAB are extremely difficult to treat and development of a phage cocktails therapy could be a therapeutic alternative in the future. Phage phi km18p is a good candidate for inclusion in phage cocktails.	[Lin, Chun-Hung; Luo, Huei-Ru; Hung, Chih-Hsin] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Shen, Gwan-Han] Taichung Vet Gen Hosp, Dept Internal Med, Div Resp & Crit Care Med, Taichung, Taiwan; [Shen, Gwan-Han] China Med Univ, Coll Hlth Care, Dept Resp Therapy, Taichung, Taiwan; [Wang, Jiun-Ling] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Wang, Jiun-Ling] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Wen, Fu-Shyan; Chang, Kai-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan; [Lin, Chun-Hung; Luo, Huei-Ru; Hung, Chih-Hsin] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan	I Shou University; Taichung Veterans General Hospital; China Medical University Taiwan; I Shou University; E-Da Hospital; National Chung Hsing University; I Shou University; I Shou University	Hung, CH (corresponding author), I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan.	chhung@isu.edu.tw	Wang, 竣令王 Jiun-Ling/L-9627-2015	Wang, 竣令王 Jiun-Ling/0000-0002-9465-8692	National Science Council, Republic of China [NSC 94-2311-B-214-001]; I-Shou University [ISU93-02-17]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); I-Shou University	This work was supported by grants from the National Science Council, Republic of China (No. NSC 94-2311-B-214-001) and I-Shou University (ISU93-02-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN HW, 1994, ARCH VIROL, V135, P345, DOI 10.1007/BF01310019; Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2; Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; [Anonymous], 2006, GASTROENTEROLOGY, V131, P1370, DOI 10.1053/j.gastro.2006.10.039; Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294, DOI 10.1128/CDLI.5.3.294-298.1998; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; BOUVET PJM, 1990, J CLIN MICROBIOL, V28, P170, DOI 10.1128/JCM.28.2.170-176.1990; Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0; BUCHENOSMOND C, 2006, ICTVDB UNIVERSAL VIR; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002; Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0; Cisneros JM, 2005, CLIN MICROBIOL INFEC, V11, P874, DOI 10.1111/j.1469-0691.2005.01256.x; Fischer CR, 2004, FEMS MICROBIOL LETT, V241, P171, DOI 10.1016/j.femsle.2004.10.017; Fortuna W, 2008, MED SCI MONITOR, V14, pRA126; Gadagkar R., 1980, J BIOSCIENCES, V2, P253, DOI DOI 10.1007/BF02703251; Garcia P, 2007, INT DAIRY J, V17, P1232, DOI 10.1016/j.idairyj.2007.03.014; Garnacho-Montero J, 2010, CURR OPIN INFECT DIS, V23, P332, DOI 10.1097/QCO.0b013e32833ae38b; Giske CG, 2008, ANTIMICROB AGENTS CH, V52, P813, DOI 10.1128/AAC.01169-07; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Hartzell JD, 2009, CLIN INFECT DIS, V48, P1724, DOI 10.1086/599225; HERMAN NJ, 1974, J VIROL, V13, P46, DOI 10.1128/JVI.13.1.46-52.1974; Hsueh PR, 2002, EMERG INFECT DIS, V8, P827; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; JOLYGUILLOU ML, 1990, J HOSP INFECT, V16, P49, DOI 10.1016/0195-6701(90)90048-S; Jyothisri K, 1999, FEBS LETT, V443, P57, DOI 10.1016/S0014-5793(98)01679-2; Karageorgopoulos DE, 2008, J ANTIMICROB CHEMOTH, V62, P45, DOI 10.1093/jac/dkn165; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Kivela HM, 2002, J VIROL, V76, P8169, DOI 10.1128/JVI.76.16.8169-8178.2002; Klovins J, 2002, J GEN VIROL, V83, P1523, DOI 10.1099/0022-1317-83-6-1523; Kocharunchitt C, 2009, INT J FOOD MICROBIOL, V128, P453, DOI 10.1016/j.ijfoodmicro.2008.10.014; Kudva IT, 1999, APPL ENVIRON MICROB, V65, P3767; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Matsuzaki Shigenobu, 2005, Journal of Infection and Chemotherapy, V11, P211, DOI 10.1007/s10156-005-0408-9; Mizoguchi K, 2003, APPL ENVIRON MICROB, V69, P170, DOI 10.1128/AEM.69.1.170-176.2003; Park SC, 2000, APPL ENVIRON MICROB, V66, P1416, DOI 10.1128/AEM.66.4.1416-1422.2000; SOOTHILL JS, 1992, J MED MICROBIOL, V37, P258, DOI 10.1099/00222615-37-4-258; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Tseng YH, 1999, J BACTERIOL, V181, P117, DOI 10.1128/JB.181.1.117-125.1999; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Vinodkumar CS, 2008, INDIAN J PATHOL MICR, V51, P360, DOI 10.4103/0377-4929.42511; Watanabe R, 2007, ANTIMICROB AGENTS CH, V51, P446, DOI 10.1128/AAC.00635-06; WEISS BD, 1994, J BACTERIOL, V176, P3354, DOI 10.1128/jb.176.11.3354-3359.1994; YOUNG RY, 1992, MICROBIOL REV, V56, P430, DOI 10.1128/MMBR.56.3.430-481.1992	48	58	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46537	10.1371/journal.pone.0046537	http://dx.doi.org/10.1371/journal.pone.0046537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071586	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300035
J	Dai, MX; Freeman, B; Shikani, HJ; Bruno, FP; Collado, JE; Macias, R; Reznik, SE; Davies, P; Spray, DC; Tanowitz, HB; Weiss, LM; Desruisseaux, MS				Dai, Minxian; Freeman, Brandi; Shikani, Henry J.; Bruno, Fernando Pereira; Elias Collado, J.; Macias, Rolando; Reznik, Sandra E.; Davies, Peter; Spray, David Conover; Tanowitz, Herbert Bernard; Weiss, Louis Martin; Desruisseaux, Mahalia Sabrina			Altered Regulation of Akt Signaling with Murine Cerebral Malaria, Effects on Long-Term Neuro-Cognitive Function, Restoration with Lithium Treatment	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SEVERE FALCIPARUM-MALARIA; PAIRED HELICAL FILAMENTS; N-ACETYL ASPARTATE; ALZHEIMERS-DISEASE; PLASMODIUM-FALCIPARUM; CELL-SURVIVAL; CEREBROSPINAL-FLUID; TAU PATHOLOGY; BLOOD-FLOW	Neurological and cognitive impairment persist in more than 20% of cerebral malaria (CM) patients long after successful antiparasitic treatment. We recently reported that long term memory and motor coordination deficits are also present in our experimental cerebral malaria model (ECM). We also documented, in a murine model, a lack of obvious pathology or inflammation after parasite elimination, suggesting that the long-term negative neurological outcomes result from potentially reversible biochemical and physiological changes in brains of ECM mice, subsequent to acute ischemic and inflammatory processes. Here, we demonstrate for the first time that acute ECM results in significantly reduced activation of protein kinase B (PKB or Akt) leading to decreased Akt phosphorylation and inhibition of the glycogen kinase synthase (GSK3 beta) in the brains of mice infected with Plasmodium berghei ANKA (PbA) compared to uninfected controls and to mice infected with the non-neurotrophic P. berghei NK65 (PbN). Though Akt activation improved to control levels after chloroquine treatment in PbA-infected mice, the addition of lithium chloride, a compound which inhibits GSK3 beta activity and stimulates Akt activation, induced a modest, but significant activation of Akt in the brains of infected mice when compared to uninfected controls treated with chloroquine with and without lithium. In addition, lithium significantly reversed the long-term spatial and visual memory impairment as well as the motor coordination deficits which persisted after successful anti-parasitic treatment. GSK3 beta inhibition was significantly increased after chloroquine treatment, both in lithium and non-lithium treated PbA-infected mice. These data indicate that acute ECM is associated with abnormalities in cell survival pathways that result in neuronal damage. Regulation of Akt/GSK3 beta with lithium reduces neuronal degeneration and may have neuroprotective effects in ECM. Aberrant regulation of Akt/GSK3 beta signaling likely underlies long-term neurological sequelae observed in ECM and may yield adjunctive therapeutic targets for the management of CM.	[Dai, Minxian; Freeman, Brandi; Shikani, Henry J.; Bruno, Fernando Pereira; Davies, Peter; Tanowitz, Herbert Bernard; Weiss, Louis Martin; Desruisseaux, Mahalia Sabrina] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Dai, Minxian; Reznik, Sandra E.] St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Queens, NY USA; [Elias Collado, J.] Pontificia Univ Catolica Madrey Maestra, Santiago, Dominican Rep; [Macias, Rolando] Meharry Med Coll, Nashville, TN 37208 USA; [Davies, Peter; Spray, David Conover] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Davies, Peter] Feinstein Inst Med Res, Litwin Zucker Ctr Study Alzheimers Dis & Memory D, Manhasset, NY USA; [Spray, David Conover; Tanowitz, Herbert Bernard; Weiss, Louis Martin; Desruisseaux, Mahalia Sabrina] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Saint John's University; Pontificia Universidad Catolica Madre y Maestra; Meharry Medical College; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Desruisseaux, MS (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	m.desruis@einstein.yu.edu	Bruno, Fernando P/H-1073-2015; Desruisseaux, Mahalia S/GOK-0005-2022	Bruno, Fernando P/0000-0002-4561-5290; Spray, David/0000-0001-8368-5073; Desruisseaux, Mahalia/0000-0003-2060-412X	National Institutes of Health (NIH) Training Grant in Mechanisms of Cardiovascular Diseases [T32 HL07675]; Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine; Burroughs-Wellcome Fund's Career Awards for Medical Scientists; Einstein-Montefiore Institute for Clinical and Translational Research Career Development Award; NIH Training Grant in Geographic Medicine and Emerging Infections [T32AI070117]; NIH Training Grant in Molecular Neuropathology [T32 NS007098-31]; NIH Global Infectious Disease Research Training Program [D43 TW007129, NS069577, AI076248, AI39454, NS041282]; Department of Psychiatry and Behavioral Sciences Neuroscience Fellowship, Albert Einstein College of Medicine; FOGARTY INTERNATIONAL CENTER [D43TW007129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070117, R01AI076248, R01AI039454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, R01NS069577] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Training Grant in Mechanisms of Cardiovascular Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine; Burroughs-Wellcome Fund's Career Awards for Medical Scientists(Burroughs Wellcome Fund); Einstein-Montefiore Institute for Clinical and Translational Research Career Development Award; NIH Training Grant in Geographic Medicine and Emerging Infections; NIH Training Grant in Molecular Neuropathology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Global Infectious Disease Research Training Program; Department of Psychiatry and Behavioral Sciences Neuroscience Fellowship, Albert Einstein College of Medicine; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) Training Grant in Mechanisms of Cardiovascular Diseases T32 HL07675 (MSD) (NIH.gov); Dominick P. Purpura Department of Neuroscience and Department of Psychiatry and Behavioral Sciences Neuroscience Fellowship (MSD), Albert Einstein College of Medicine; Burroughs-Wellcome Fund's Career Awards for Medical Scientists (MSD) (http://www.bwfund.org/pages/188/Career-Awards-for-Medical-Scientists/); Einstein-Montefiore Institute for Clinical and Translational Research Career Development Award (MSD) (http://www.einstein.yu.edu/ictr/home.aspx); the NIH Training Grant in Geographic Medicine and Emerging Infections T32AI070117 (BF, HBT); the NIH Training Grant in Molecular Neuropathology T32 NS007098-31 (HJS); the NIH Global Infectious Disease Research Training Program D43 TW007129 (FPB, HBT); NS069577 (MSD); AI076248 (HBT); AI39454 (LMW); NS041282 (DCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Beare NAV, 2006, J NEUROL NEUROSUR PS, V77, P1288, DOI 10.1136/jnnp.2005.083956; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; Carter JA, 2006, DEV MED CHILD NEUROL, V48, P51, DOI 10.1017/S0012162206000107; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen-Gadol AA, 2004, J NEUROSURG, V101, P613, DOI 10.3171/jns.2004.101.4.0613; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Crawley J, 2001, ARCH DIS CHILD, V84, P247, DOI 10.1136/adc.84.3.247; Dai M, 2010, MICROBES INFECT; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; Desruisseaux Mahalia S, 2010, J Neuroparasitology, V1, DOI 10.4303/jnp/N100803; Desruisseaux MS, 2010, AM J PATHOL, V176, P1075, DOI 10.2353/ajpath.2010.091090; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Falchook GS, 2003, CLIN INFECT DIS, V37, pE22, DOI 10.1086/375269; Fernando D, 2003, T ROY SOC TROP MED H, V97, P633, DOI 10.1016/S0035-9203(03)80093-7; FLAMENT S, 1990, BRAIN RES, V516, P15, DOI 10.1016/0006-8993(90)90891-E; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; de Barreda EG, 2010, NEUROBIOL DIS, V37, P622, DOI 10.1016/j.nbd.2009.11.017; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Hugon J, 1999, DRUG METAB REV, V31, P635, DOI 10.1081/DMR-100101939; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Kampfl A, 1997, AM J TROP MED HYG, V56, P585, DOI 10.4269/ajtmh.1997.56.585; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kennan RP, 2005, PARASITOL RES, V96, P302, DOI 10.1007/s00436-005-1349-z; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; Lacerda-Queiroz N, 2011, ACTA TROP, V120, P31, DOI 10.1016/j.actatropica.2011.04.020; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li XH, 2002, J AFFECT DISORDERS, V69, P1, DOI 10.1016/S0165-0327(00)00361-X; Liu Y, 2009, J NEUROCHEM, V111, P242, DOI 10.1111/j.1471-4159.2009.06320.x; Machado FS, 2006, EXP BIOL MED, V231, P1176; Mandelkow EM, 1996, ANN NY ACAD SCI, V777, P96, DOI 10.1111/j.1749-6632.1996.tb34407.x; Medana IM, 2005, T ROY SOC TROP MED H, V99, P610, DOI 10.1016/j.trstmh.2004.11.017; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; MeierRuge W, 1996, REV NEUROSCIENCE, V7, P1; Meremikwu M M, 1997, Cent Afr J Med, V43, P231; Minami M, 2011, MOL BIOL CELL; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nonaka S, 1998, P NATL ACAD SCI USA, V95, P2642, DOI 10.1073/pnas.95.5.2642; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pan JW, 2005, ANN NEUROL, V57, P92, DOI 10.1002/ana.20317; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Richardson ED, 1997, APPL NEUROPSYCHOL, V4, P238, DOI 10.1207/s15324826an0404_5; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; SENANAYAKE N, 1994, J NEUROL, V241, P456, DOI 10.1007/BF00900965; Serghides L, 2009, J INFECT DIS, V199, P1536, DOI 10.1086/598222; Sorrentino G, 2007, NEUROL SCI, V28, P63, DOI 10.1007/s10072-007-0789-x; Sugiyama M, 2004, AM J TROP MED HYG, V71, P542, DOI 10.4269/ajtmh.2004.71.542; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang YB, 2009, CELL MICROBIOL, V11, P983, DOI 10.1111/j.1462-5822.2009.01305.x; Weber SM, 2000, J IMMUNOL, V165, P1534, DOI 10.4049/jimmunol.165.3.1534; Weber SM, 2002, J IMMUNOL, V168, P5303, DOI 10.4049/jimmunol.168.10.5303; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zakaria NA, 2010, TROP BIOMED, V27, P624	90	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e44117	10.1371/journal.pone.0044117	http://dx.doi.org/10.1371/journal.pone.0044117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082110	gold, Green Submitted, Green Published			2022-12-25	WOS:000311146900005
J	Helikar, T; Kowal, B; Madrahimov, A; Shrestha, M; Pedersen, J; Limbu, K; Thapa, I; Rowley, T; Satalkar, R; Kochi, N; Konvalina, J; Rogers, JA				Helikar, Tomas; Kowal, Bryan; Madrahimov, Alex; Shrestha, Manish; Pedersen, Jay; Limbu, Kahani; Thapa, Ishwor; Rowley, Thaine; Satalkar, Rahul; Kochi, Naomi; Konvalina, John; Rogers, Jim A.			Bio-Logic Builder: A Non-Technical Tool for Building Dynamical, Qualitative Models	PLOS ONE			English	Article							RHO-FAMILY GTPASES; BINDING; RAC; EXCHANGE; PHOSPHORYLATION; SIMULATION; NETWORKS; PROTEIN; IDENTIFICATION; DISSOCIATION	Computational modeling of biological processes is a promising tool in biomedical research. While a large part of its potential lies in the ability to integrate it with laboratory research, modeling currently generally requires a high degree of training in mathematics and/or computer science. To help address this issue, we have developed a web-based tool, Bio-Logic Builder, that enables laboratory scientists to define mathematical representations (based on a discrete formalism) of biological regulatory mechanisms in a modular and non-technical fashion. As part of the user interface, generalized "biologic" modules have been defined to provide users with the building blocks for many biological processes. To build/modify computational models, experimentalists provide purely qualitative information about a particular regulatory mechanisms as is generally found in the laboratory. The Bio-Logic Builder subsequently converts the provided information into a mathematical representation described with Boolean expressions/rules. We used this tool to build a number of dynamical models, including a 130-protein large-scale model of signal transduction with over 800 interactions, influenza A replication cycle with 127 species and 200+ interactions, and mammalian and budding yeast cell cycles. We also show that any and all qualitative regulatory mechanisms can be built using this tool.	[Helikar, Tomas; Madrahimov, Alex; Shrestha, Manish; Rowley, Thaine; Konvalina, John; Rogers, Jim A.] Univ Nebraska, Dept Math, Omaha, NE 68182 USA; [Kowal, Bryan; Pedersen, Jay; Limbu, Kahani; Thapa, Ishwor; Satalkar, Rahul] Univ Nebraska, Coll Informat Sci & Technol, Omaha, NE 68182 USA; [Madrahimov, Alex; Rowley, Thaine; Kochi, Naomi] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Rogers, Jim A.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska System; University of Nebraska System; University of Nebraska System; University of Nebraska Medical Center	Helikar, T (corresponding author), Univ Nebraska, Dept Math, Omaha, NE 68182 USA.	thelikar@unomaha.edu		Helikar, Tomas/0000-0003-3653-1906; Thapa, Ishwor/0000-0002-3594-1631; Madrahimov, Alex/0000-0003-4724-6844	University of Nebraska at Omaha; University of Nebraska Foundation; Patrick J. Kerrigan Foundation; Donald F. Dillon Foundation; National Institutes of Health [5R01DA030962]; National Aeronautics and Space Administration Nebraska Space Grant Consortium; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030962] Funding Source: NIH RePORTER	University of Nebraska at Omaha; University of Nebraska Foundation; Patrick J. Kerrigan Foundation; Donald F. Dillon Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration Nebraska Space Grant Consortium; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported and funded by the University of Nebraska at Omaha, the University of Nebraska Foundation, Patrick J. Kerrigan and Donald F. Dillon Foundations, National Institutes of Health grant #5R01DA030962, and the National Aeronautics and Space Administration Nebraska Space Grant Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Beyer T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002121; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchel F, 2012, BIOINFORMATICS; CANTOR SB, 1995, MOL CELL BIOL, V15, P4578; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Faeder JR, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-68; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Helikar T, 2011, OPEN BIOINFORMATICS, V4, P16, DOI [DOI 10.1186/1687-4153-2011-797251, 10.2174/1875036201105010016, DOI 10.2174/1875036201105010016]; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Helikar T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-58; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Irons D, 2009, J THEORETICAL BIOL; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kahlem P, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100080; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rodriguez A, 2012, BIOINFORMATICS, V28, P858, DOI 10.1093/bioinformatics/bts036; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahin O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Todd R, PLOS ONE IN PRESS; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Zheng J, 2010, BIOINFORMATICS, V26, P141, DOI 10.1093/bioinformatics/btp617	43	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46417	10.1371/journal.pone.0046417	http://dx.doi.org/10.1371/journal.pone.0046417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082121	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900016
J	Ai, LS; Sun, CY; Zhang, L; Zhou, SC; Chu, ZB; Qin, Y; Wang, YD; Zeng, W; Yan, H; Guo, T; Chen, L; Yang, D; Hu, Y				Ai, Li-Sha; Sun, Chun-Yan; Zhang, Lu; Zhou, Shun-Chang; Chu, Zhang-Bo; Qin, You; Wang, Ya-Dan; Zeng, Wei; Yan, Han; Guo, Tao; Chen, Lei; Yang, Di; Hu, Yu			Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In Vivo	PLOS ONE			English	Article							NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; BONE DESTRUCTION; PERINEURAL INVASION; RECEPTOR ACTIVATOR; GROWTH-FACTOR; B RECEPTOR; BRAIN; MAPK; ERK	Brain-derived neurotrophic factor (BDNF) was recently identified as a factor produced by multiple myeloma (MM) cells, which may contribute to bone resorption and disease progression in MM, though the molecular mechanism of this process is not well understood. The purpose of this study was to test the effect of BDNF on bone disease and growth of MM cells both in vitro and in vivo. Co- and triple-culture systems were implemented. The in vitro results demonstrate that BDNF augmented receptor activator of nuclear factor kappa B ligand (RANKL) expression in human bone marrow stromal cells, thus contributing to osteoclast formation. To further clarify the effect of BDNF on myeloma bone disease in vivo, ARH-77 cells were stably transfected with an antisense construct to BDNF (AS-ARH) or empty vector (EV-ARH) to test their capacity to induce MM bone disease in SCID-rab mice. Mice treated with AS-ARH cells were preserved, exhibited no radiologically identifiable lytic lesions and, unlike the controls treated with EV-ARH cells, lived longer and showed reduced tumor burden. Consistently, bones harboring AS-ARH cells showed marked reductions of RANKL expression and osteoclast density compared to the controls harboring EV-ARH cells. These results provide further support for the potential osteoclastogenic effects of BDNF, which may mediate stromal-MM cell interactions to upregulate RANKL secretion, in myeloma bone diseases.	[Ai, Li-Sha; Sun, Chun-Yan; Zhang, Lu; Chu, Zhang-Bo; Wang, Ya-Dan; Zeng, Wei; Yan, Han; Guo, Tao; Chen, Lei; Yang, Di; Hu, Yu] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430074, Peoples R China; [Zhou, Shun-Chang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Expt Anim, Wuhan 430074, Peoples R China; [Qin, You] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430074, Peoples R China.	dr_huyu@126.com	Qin, You/AAZ-9172-2020		National Natural Science Funds for Distinguished Young Scholar [30825018]; National Natural Sciences Foundation of People's Republic of China [30700331]	National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Sciences Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science Funds for Distinguished Young Scholar (No. 30825018 to YH) and a grant from National Natural Sciences Foundation of People's Republic of China (No. 30700331 to C-YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Basak GW, 2009, CURR PHARM BIOTECHNO, V10, P335, DOI 10.2174/138920109787847493; Choi SJ, 2000, BLOOD, V96, P671; Christoulas D, 2009, EXPERT REV HEMATOL, V2, P385, DOI 10.1586/ehm.09.36; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Farrugia AN, 2003, CANCER RES, V63, P5438; Fauchais AL, 2008, J IMMUNOL, V181, P3027, DOI 10.4049/jimmunol.181.5.3027; Feng X, 2001, J NEUROSCI RES, V64, P355, DOI 10.1002/jnr.1086; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hjertner O, 1999, BLOOD, V94, P3883; Hu Y, 2007, CANCER GENET CYTOGEN, V178, P1, DOI 10.1016/j.cancergencyto.2007.05.028; Hu Y, 2006, CANCER GENET CYTOGEN, V169, P12, DOI 10.1016/j.cancergencyto.2006.02.018; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Johnson-Farley NN, 2007, BRAIN RES, V1154, P40, DOI 10.1016/j.brainres.2007.04.026; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kowalski PJ, 2002, HUM PATHOL, V33, P933, DOI 10.1053/hupa.2002.128249; Kumamaru E, 2011, FEBS LETT, V585, P3224, DOI 10.1016/j.febslet.2011.09.010; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lai FPL, 2004, BRIT J HAEMATOL, V126, P192, DOI 10.1111/j.1365-2141.2004.05018.x; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Patani N, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-23; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Roodman GD, 2010, J CELL BIOCHEM, V109, P283, DOI 10.1002/jcb.22403; Sakamoto Y, 2001, ONCOL REP, V8, P477; Satoh F, 2001, INT J UROL, V8, pS28, DOI 10.1046/j.1442-2042.2001.00331.x; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Sun CY, 2012, INT J CANCER, V130, P827, DOI 10.1002/ijc.26059; Sun CY, 2010, TUMOR BIOL, V31, P121, DOI 10.1007/s13277-010-0016-x; Takami M, 2005, FEBS LETT, V579, P832, DOI 10.1016/j.febslet.2004.12.066; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Tsubaki M, 2007, MOL CELL BIOCHEM, V304, P53, DOI 10.1007/s11010-007-9485-7; Wooten MW, 1999, CELL DEATH DIFFER, V6, P753, DOI 10.1038/sj.cdd.4400548; Yaghoobi MM, 2006, NEUROSCI LETT, V397, P149, DOI 10.1016/j.neulet.2005.12.009; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zannettino ACW, 2005, CANCER RES, V65, P1700, DOI 10.1158/0008-5472.CAN-04-1687; Zhang L, 2010, CANCER SCI, V101, P1117, DOI 10.1111/j.1349-7006.2010.01515.x	42	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46287	10.1371/journal.pone.0046287	http://dx.doi.org/10.1371/journal.pone.0046287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077504	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100026
J	Bastani, A; Jaberzadeh, S				Bastani, Andisheh; Jaberzadeh, Shapour			A Higher Number of TMS-Elicited MEP from a Combined Hotspot Improves Intra- and Inter-Session Reliability of the Upper Limb Muscles in Healthy Individuals	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; TEST-RETEST RELIABILITY; EXCITABILITY; CORTEX; BRAIN; REPRESENTATIONS; CONTRACTION; SIZE	We aimed to determine, using transcranial magnetic stimulation (TMS), the number of elicited motor evoked potentials (MEPs) that induces the highest intra- and inter-sessions reliability for the extensor carpi radialis (ECR) and first dorsal interosseus (FDI) muscles. Twelve healthy subjects participated in this study on two separate days. Single pulse magnetic stimuli were triggered with Magstim 200(2) to obtain MEPs from the muscles of interest, with the subjects in a relaxed position. Reliability of MEP responses was investigated in three blocks of 5, 10 and 15 trials. The intra- and inter-session reliability of the MEPs' amplitudes and latencies were assessed using intraclass correlation coefficients (ICCs). Repeated measures ANOVA and paired t-tests revealed no significant time effect in the MEP amplitude and latency measurements (P>0.05). The ICCs indicated high intra-session reliability in the MEPs' amplitudes for the ECR and FDI muscles (0.77 to 0.99, 0.90 to 0.99, respectively) and latency (0.80 to 1.00, 0.75 to 0.97, respectively). The MEPs' amplitudes also had high inter-session reliability (0.84 to 0.97, 0.88 to 0.93, respectively), as did their latency (0.80 to 0.90, 0.75 to 0.97, respectively). Highest intra- and inter-session reliability was achieved for blocks of 10 and 15 trials. Our data suggest that intra- and inter-session comparisons should be performed using at least 10 MEPs in "combined hotspot" stimulation technique to ensure highest reliability.	[Bastani, Andisheh; Jaberzadeh, Shapour] Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia	Monash University	Bastani, A (corresponding author), Monash Univ, Dept Physiotherapy, Sch Primary Hlth Care, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia.	andisheh.bastanijahromi@monash.edu		jaberzadeh, shapour/0000-0003-2957-4510				BARKER AT, 1985, LANCET, V1, P1106; BARKER AT, 1987, NEUROSURGERY, V20, P100; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Corneal SF, 2005, ARCH PHYS MED REHAB, V86, P1670, DOI 10.1016/j.apmr.2004.12.039; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Deuschl G., 1999, RECOMMENDATIONS PRAC; Devanne H, 2006, EUR J NEUROSCI, V23, P2467, DOI 10.1111/j.1460-9568.2006.04760.x; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Fleming MK, 2012, IEEE T NEUR IN PRESS; FUHR P, 1991, ELECTROEN CLIN NEURO, V81, P81, DOI 10.1016/0168-5597(91)90001-E; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; Hallett M., 2005, MAGNETIC STIMULATION, V2nd; Harvill L.M., 1991, EDUC MEAS-ISSUES PRA, V10, P33, DOI [DOI 10.1111/J.1745-3992.1991.TB00195.X, 10.1111/j.1745-3992.1991.tb00195.x]; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kendall F., 2010, MUSCLES TESTING FUNC, V5th ed; Lefebvre R, 2004, J MANIP PHYSIOL THER, V27, P97, DOI 10.1016/j.jmpt.2003.12.004; Lexell JE, 2005, AM J PHYS MED REHAB, V84, P719, DOI 10.1097/01.phm.0000176452.17771.20; Liepert J, 2000, CLIN NEUROPHYSIOL, V111, P1157, DOI 10.1016/S1388-2457(00)00308-4; Livingston SC, 2008, INT J NEUROSCI, V118, P239, DOI 10.1080/00207450701668020; Maeda F, 2002, CLIN NEUROPHYSIOL, V113, P376, DOI 10.1016/S1388-2457(02)00008-1; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Marconi B, 2008, J NEUROL SCI, V275, P51, DOI 10.1016/j.jns.2008.07.025; McKay DR, 2002, EXP BRAIN RES, V143, P342, DOI 10.1007/s00221-001-0995-3; Ngomo S, 2012, J NEUROSCI METH, V205, P65, DOI 10.1016/j.jneumeth.2011.12.012; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patterson CH, 1955, J EXP EDUC, V23, P247, DOI 10.1080/00220973.1955.11010510; Perotto A, 2005, ANATOMICAL GUIDE ELE; Plowman-Prine EK, 2008, CLIN NEUROPHYSIOL, V119, P2298, DOI 10.1016/j.clinph.2008.06.006; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Pourtney L, 2000, FDN CLIN RES APPL PR; RAVNBORG M, 1991, ACTA NEUROL SCAND, V84, P491, DOI 10.1111/j.1600-0404.1991.tb05001.x; Ridding MC, 2001, CLIN NEUROPHYSIOL, V112, P1461, DOI 10.1016/S1388-2457(01)00592-2; Robertson V, 2006, ELECTROTHERAPY EXPLA, V4th; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROTHSTEIN JM, 1985, MEASUREMENT PHYSICAL, P1; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wolf SL, 2004, CLIN NEUROPHYSIOL, V115, P1740, DOI 10.1016/j.clinph.2004.02.027; Wu L, 2002, CLIN NEUROPHYSIOL, V113, P1286, DOI 10.1016/S1388-2457(02)00160-8	50	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47582	10.1371/journal.pone.0047582	http://dx.doi.org/10.1371/journal.pone.0047582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077645	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100140
J	Hepp, GR; Kennamer, RA				Hepp, Gary R.; Kennamer, Robert A.			Warm Is Better: Incubation Temperature Influences Apparent Survival and Recruitment of Wood Ducks (Aix sponsa)	PLOS ONE			English	Article							EMBRYONIC TEMPERATURE; TREE SWALLOWS; EGG SIZE; DUCKLINGS; PHILOPATRY; PATTERNS; FITNESS; GROWTH; COSTS; BIRDS	Avian parents that physically incubate their eggs must balance demands of self-maintenance with providing the proper thermal environment for egg development. Low incubation temperatures can lengthen the incubation period and produce changes in neonate phenotype that may influence subsequent survival and reproduction. We artificially incubated wood duck (Aix sponsa) eggs at three temperature regimes (low, 35.0; mid, 35.9; and high, 37.3 degrees C) that are within the range of temperatures of naturally-incubated nests. We tested the effect of incubation temperature on duckling body composition, fledging success, the probability that females were recruited to the breeding population, and their subsequent reproductive success. Incubation period was inversely related to incubation temperature, and body mass and lipid mass for newly-hatched ducklings incubated at the lowest temperature were lower than for ducklings produced at higher temperatures. In 2008, ducklings (n = 412) were individually marked and broods (n = 38) containing ducklings from each temperature treatment were placed with wild foster mothers within 24 hrs of hatching. Ducklings incubated at the lowest temperature were less likely to fledge from nest sites than ducklings incubated at the higher temperatures. We recaptured female ducklings as adults when they were either prospecting for nest sites (n = 171; 2009-2011) or nesting (n = 527; 2009-2012). Female ducklings incubated at the lowest temperature were less likely to survive and be recruited to the breeding population than females incubated at higher temperatures. Reproductive success of surviving females also was greater for females that had been incubated at warmer temperatures. To our knowledge, this is the first avian study to link developmental conditions experienced by neonates during incubation with their survival and recruitment to the breeding population, and subsequent reproductive success. These results advance our understanding of incubation as an important reproductive cost in birds and support the potential significance of incubation in influencing the evolution of avian life histories.	[Hepp, Gary R.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Kennamer, Robert A.] Savannah River Ecol Lab, Aiken, SC USA	Auburn University System; Auburn University; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Hepp, GR (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	heppgar@auburn.edu			National Science Foundation [IOB-0615361]; Department of Energy [DE-FC09-07SR22506]	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE))	Research was supported by National Science Foundation grant IOB-0615361 to GRH. Logistical support of research activities was also provided by the Department of Energy through Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson CL, 2011, J WILDLIFE MANAGE, V75, P1330, DOI 10.1002/jwmg.166; Ardia DR, 2010, P ROY SOC B-BIOL SCI, V277, P1881, DOI 10.1098/rspb.2009.2138; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; Bellrose F.C., 1994, ECOLOGY MANAGEMENT W; BOOTH DT, 1987, PHYSIOL ZOOL, V60, P437, DOI 10.1086/physzool.60.4.30157905; Brown GP, 2004, ECOLOGY, V85, P1627, DOI 10.1890/03-0107; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Deeming D.C., 2002, AVIAN INCUBATION BEH; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; DuRant SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P451, DOI 10.1086/661749; DuRant SE, 2010, J EXP BIOL, V213, P45, DOI 10.1242/jeb.034488; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; DuRant SE, 2012, BIOL LETTERS, V8, P108, DOI 10.1098/rsbl.2011.0735; Eiby YA, 2009, J COMP PHYSIOL B, V179, P875, DOI 10.1007/s00360-009-0370-4; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Hepp GR, 2011, AUK, V128, P258, DOI 10.1525/auk.2011.10189; HEPP GR, 1989, ECOLOGY, V70, P897, DOI 10.2307/1941357; HEPP GR, 1987, J WILDLIFE MANAGE, V51, P401, DOI 10.2307/3801026; Hopkins BC, 2011, J EXP ZOOL PART A, V315A, P274, DOI 10.1002/jez.673; JANZEN FJ, 1993, ECOLOGY, V74, P332, DOI 10.2307/1939296; Korschgen CE, 1996, J WILDLIFE MANAGE, V60, P120, DOI 10.2307/3802046; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Manlove CA, 2000, CONDOR, V102, P286, DOI 10.1650/0010-5422(2000)102[0286:PONAIF]2.0.CO;2; Martin TE, 2008, P NATL ACAD SCI USA, V105, P9268, DOI 10.1073/pnas.0709366105; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moller AP, 2004, OIKOS, V104, P299, DOI 10.1111/j.0030-1299.2004.12844.x; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Nord A, 2010, FUNCT ECOL, V24, P1031, DOI 10.1111/j.1365-2435.2010.01719.x; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; Pelayo JT, 2003, AUK, V120, P384, DOI 10.1642/0004-8038(2003)120[0384:COESFO]2.0.CO;2; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; Reid JM, 2002, OX ORN SER, V13, P314; SAS Institute, 2007, SAS STAT US GUID VER; Tinbergen JM, 2002, AVIAN INCUBATION BEH; Traylor JJ, 2006, AUK, V123, P67, DOI 10.1642/0004-8038(2006)123[0067:EOIAEF]2.0.CO;2; Vleck Carol M., 1996, P417; Warner DA, 2009, OECOLOGIA, V161, P209, DOI 10.1007/s00442-009-1366-1; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; ZICUS MC, 1989, J FIELD ORNITHOL, V60, P109	42	55	56	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47777	10.1371/journal.pone.0047777	http://dx.doi.org/10.1371/journal.pone.0047777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077669	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100161
J	Katz, G; Wei, H; Alimova, A; Katz, A; Morgan, DG; Gottlieb, P				Katz, Garrett; Wei, Hui; Alimova, Alexandra; Katz, Al; Morgan, David Gene; Gottlieb, Paul			Protein P7 of the Cystovirus phi 6 Is Located at the Three-Fold Axis of the Unexpanded Procapsid	PLOS ONE			English	Article							RNA BACTERIOPHAGE PHI-6; CRYOELECTRON MICROSCOPY; ELECTRON-MICROSCOPY; POLYMERASE COMPLEX; PURIFIED PROTEIN; REPLICATION; TRANSCRIPTION; PARTICLES; SEGMENT	The objective of this study was to determine the location of protein P7, the RNA packaging factor, in the procapsid of the phi 6 cystovirus. A comparison of cryo-electron microscopy high-resolution single particle reconstructions of the phi 6 complete unexpanded procapsid, the protein P2-minus procapsid (P2 is the RNA directed RNA-polymerase), and the P7-minus procapsid, show that prior to RNA packaging the P7 protein is located near the three-fold axis of symmetry. Difference maps highlight the precise position of P7 and demonstrate that in P7-minus particles the P2 proteins are less localized with reduced densities at the three-fold axes. We propose that P7 performs the mechanical function of stabilizing P2 on the inner protein P1 shell which ensures that entering viral single-stranded RNA is replicated.	[Katz, Garrett; Wei, Hui; Alimova, Alexandra; Gottlieb, Paul] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Katz, Al] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Morgan, David Gene] Indiana Univ, Dept Chem, Bloomington, IN USA	City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; City College of New York (CUNY); Indiana University System; Indiana University Bloomington	Gottlieb, P (corresponding author), CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.	pgottl@med.cuny.edu	Morgan, David Gene/W-3429-2019; Katz, Garrett/S-8037-2019		National Institute of General Medical Science [SC1-GM092781]; Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant [G12-RR03060]; New York State Foundation for Science, Technology and Innovation (NYSTAR) [C000087]; National Institutes of Health [S10 RR017291]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017291, G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092781] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant; New York State Foundation for Science, Technology and Innovation (NYSTAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is support in part by the National Institute of General Medical Science - Grant SC1-GM092781 and the Research Centers in Minority Institutions (NIH/NCRR/RCMI) CCNY/Grant G12-RR03060. The electron microscopy facilities at the New York Structural Biology Center are supported by grant C000087 from the New York State Foundation for Science, Technology and Innovation (NYSTAR), and National Institutes of Health grant S10 RR017291. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; Eryilmaz E, 2008, J MOL BIOL, V382, P402, DOI 10.1016/j.jmb.2008.07.006; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1988, J VIROL, V62, P181, DOI 10.1128/JVI.62.1.181-187.1988; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Hu GB, 2008, VIROLOGY, V372, P1, DOI 10.1016/j.virol.2007.10.013; Huiskonen JT, 2006, STRUCTURE, V14, P1039, DOI 10.1016/j.str.2006.03.018; Juuti JT, 1997, J MOL BIOL, V266, P891, DOI 10.1006/jmbi.1996.0817; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008; MINDICH L, 1994, VIROLOGY, V202, P258, DOI 10.1006/viro.1994.1341; Nemecek D, 2011, J MOL BIOL; Nemecek D, 2010, J STRUCT BIOL, V171, P389, DOI 10.1016/j.jsb.2010.06.005; OLKKONEN VM, 1987, J VIROL, V61, P2362, DOI 10.1128/JVI.61.8.2362-2367.1987; PAATERO AO, 1995, J VIROL, V69, P6729, DOI 10.1128/JVI.69.11.6729-6734.1995; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poranen MM, 2008, J MOL BIOL, V383, P529, DOI 10.1016/j.jmb.2008.08.082; Poranen MM, 2001, MOL CELL, V7, P845, DOI 10.1016/S1097-2765(01)00228-3; Sen A, 2008, J BIOL CHEM, V283, P12227, DOI 10.1074/jbc.M710508200; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Swanson MI, 2002, RAPID COMMUN MASS SP, V16, P2317, DOI 10.1002/rcm.866; Wei H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006850; Yan X, 2007, J STRUCT BIOL, V157, P73, DOI 10.1016/j.jsb.2006.08.007; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009	30	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47489	10.1371/journal.pone.0047489	http://dx.doi.org/10.1371/journal.pone.0047489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077625	gold, Green Published			2022-12-25	WOS:000309995100121
J	Lin, SF; Huang, YY; Lin, JD; Chou, TC; Hsueh, C; Wong, RJ				Lin, Shu-Fu; Huang, Yu-Yao; Lin, Jen-Der; Chou, Ting-Chao; Hsueh, Chuen; Wong, Richard J.			Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT; GENETIC ALTERATIONS; PI3K/AKT PATHWAY; 3-KINASE/MAMMALIAN TARGET; INCREASING INCIDENCE; MAMMALIAN TARGET; UNITED-STATES; CELL-LINES; IN-VITRO; MTOR	Background: We assessed the utility of the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) as single agent therapy and in combination with conventional chemotherapy for thyroid cancer. Methodology/Principal Findings: Eight cell lines from four types of thyroid cancer (papillary, follicular, anaplastic, medullary) were studied. The cytotoxicity of BEZ235 and five conventional chemotherapeutic agents alone and in combination was measured using LDH assay. Quantitative western blot assessed expression of proteins associated with cell cycle, apoptosis and signaling pathways. Cell cycle distribution and apoptosis were measured by flow cytometry. Murine flank anaplastic thyroid cancers (ATC) were treated with oral BEZ235 daily. We found that BEZ235 effectively inhibited cell proliferation of all cancer lines, with ATC exhibiting the greatest sensitivity. BEZ235 consistently inactivated signaling downstream of mTORC1. BEZ235 generally induced cell cycle arrest at G0/G1 phase, and also caused apoptosis in the most sensitive cell lines. Baseline levels of p-S6 ribosomal protein (Ser235/236) and p27 correlated with BEZ235 sensitivity. Growth of 8505C ATC xenograft tumors was inhibited with BEZ235, without any observed toxicity. Combination therapy of BEZ235 and paclitaxel consistently demonstrated synergistic effects against ATC in vitro. Conclusions: BEZ235 as a single therapeutic agent inhibits thyroid cancer proliferation and has synergistic effects in combination with paclitaxel in treating ATC. These findings encourage future clinical trials using BEZ235 for patients with this fatal disease.	[Lin, Shu-Fu; Huang, Yu-Yao; Lin, Jen-Der] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Hsueh, Chuen] Chang Gung Univ, Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Chou, Ting-Chao] Mem Sloan Kettering Canc Ctr, Lab Preclin Pharmacol Core, New York, NY 10021 USA; [Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lin, SF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Tao Yuan, Taiwan.	mmg@cgmh.org.tw; wongr@mskcc.org	Chou, Ting-Chao/AAA-7881-2020; Chou, Ting-Chao/B-4111-2009	Chou, Ting-Chao/0000-0002-3340-1594; Chou, Ting-Chao/0000-0002-3340-1594; Huang, Yu-Yao/0000-0002-4501-6140; Hsueh, Chuen/0000-0001-7860-5964; Lin, Shu-Fu/0000-0001-8877-9685	National Science Council of Taiwan, Republic of China [NSC 98-2314-B-182A-012 -MY3]; Chang Gung Memorial Hospital and Chang Gung University [CMRPG370581, CMRPG370582, CMRPG370583, CMRPG3A0161]	National Science Council of Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital and Chang Gung University	This work was supported by National Science Council of Taiwan, Republic of China (NSC 98-2314-B-182A-012 -MY3) (http://web1.nsc.gov.tw/) and partly by grants from Chang Gung Memorial Hospital and Chang Gung University (CMRPG370581, CMRPG370582, CMRPG370583, CMRPG3A0161) (http://www.cgmh.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Carlomagno F, 2011, NAT REV ENDOCRINOL, V7, P65, DOI 10.1038/nrendo.2010.232; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2005, COMPUSYN DRUG COMBIN; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fekete M, 2012, ANTICANCER RES, V32, P445; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Huang YY, 2007, J CLIN ENDOCR METAB, V92, P1965, DOI 10.1210/jc.2007-0040; Hughes AN, 2000, BRIT J CANCER, V82, P1519; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Iwenofu OH, 2008, MODERN PATHOL, V21, P231, DOI 10.1038/modpathol.3800995; Jin N, 2011, CLIN CANCER RES, V17, P6482, DOI 10.1158/1078-0432.CCR-11-0933; Jin N, 2009, J CLIN ENDOCR METAB, V94, P4107, DOI 10.1210/jc.2009-0662; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Liu DX, 2010, INT J CANCER, V127, P2965, DOI 10.1002/ijc.25304; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Ohta K, 1997, J CLIN ENDOCR METAB, V82, P2633, DOI 10.1210/jc.82.8.2633; Rapa I, 2011, J CLIN ENDOCR METAB, V96, P2146, DOI 10.1210/jc.2010-2655; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Rothenberg ML, 2001, ANN ONCOL, V12, P1631, DOI 10.1023/A:1013157727506; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shafer A, 2010, INT J CANCER, V126, P1144, DOI 10.1002/ijc.24837; Sippel RS, 2008, ONCOLOGIST, V13, P539, DOI 10.1634/theoncologist.2007-0239; Sprinz E, 2001, AM J CLIN ONCOL-CANC, V24, P177, DOI 10.1097/00000421-200104000-00016; Wang YG, 2007, J CLIN ENDOCR METAB, V92, P2387, DOI 10.1210/jc.2006-2019; Wu GJ, 2005, J CLIN ENDOCR METAB, V90, P4688, DOI 10.1210/jc.2004-2281	48	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46726	10.1371/journal.pone.0046726	http://dx.doi.org/10.1371/journal.pone.0046726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077520	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100037
J	Yuan, Y; Liu, YJ; Wu, C; Chen, SQ; Wang, ZY; Yang, ZC; Qin, SS; Huang, LQ				Yuan, Yuan; Liu, Yunjun; Wu, Chong; Chen, Shunqin; Wang, Zhouyong; Yang, Zhaochun; Qin, Shuangshuang; Huang, Luqi			Water Deficit Affected Flavonoid Accumulation by Regulating Hormone Metabolism in Scutellaria baicalensis Georgi Roots	PLOS ONE			English	Article							PHENYLALANINE-AMMONIA-LYASE; AUXIN TRANSPORT; ANTHOCYANIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; GIBBERELLIC-ACID; ARABIDOPSIS; STRESS; EXPRESSION; RESPONSES; TEMPERATURE	The content of flavonoids especially baicalin and baicalein determined the medical quality of Scutellaria baicalensis which is a Chinese traditional medicinal plant. Here, we investigated the mechanism responsible for the content and composition of flavonoids in S. baicalensis under water deficit condition. The transcription levels of several genes which are involved in flavonoid biosynthesis were stimulated by water deficit. Under water deficit condition, fifteen up-regulated proteins, three down-regulated proteins and other six proteins were detected by proteomic analysis. The identified proteins include three gibberellin (GA)-or indoleacetic acid (IAA)-related proteins. Decreased endogenous GAs level and increased IAA level were observed in leaves of S. baicalensis which was treated with water deficit. Exogenous application of GA or alpha-naphthalene acelic acid (NAA) to plants grown under water deficit conditions led to the increase of endogenous GAs and the decrease of IAA and flavonoids, respectively. When the synthesis pathway of GA or IAA in plants was inhibited by application with the inhibitors, flavonoid levels were recovered. These results indicate that water deficit affected flavonoid accumulation might through regulating hormone metabolism in S. baicalensis Georgi.	[Yuan, Yuan; Wu, Chong; Chen, Shunqin; Wang, Zhouyong; Yang, Zhaochun; Qin, Shuangshuang; Huang, Luqi] Chinese Acad Med Sci, Inst Chinese Mat Med, Beijing 100730, Peoples R China; [Liu, Yunjun] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Chinese Materia Medica, CACMS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Huang, LQ (corresponding author), Chinese Acad Med Sci, Inst Chinese Mat Med, Beijing 100730, Peoples R China.	huangluqi@263.net			Scientific and technological research of Chinese medicine Program [06-07ZP51]; Beijing nova program [2008B82]; Self-selection program of Scientific and technological research of Chinese medicine Program [06-07ZP51, ZZ2008062]	Scientific and technological research of Chinese medicine Program; Beijing nova program(Beijing Municipal Science & Technology Commission); Self-selection program of Scientific and technological research of Chinese medicine Program	This work was supported by the Scientific and technological research of Chinese medicine Program (06-07ZP51), Beijing nova program (2008B82) and the Self-selection program of Scientific and technological research of Chinese medicine Program (06-07ZP51) (ZZ2008062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Ban T, 2003, J HORTIC SCI BIOTECH, V78, P586, DOI 10.1080/14620316.2003.11511668; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Blach-Olszewska Z, 2008, J INTERF CYTOK RES, V28, P571, DOI 10.1089/jir.2008.0125; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braidot E, 2008, PLANT SIGNAL BEHAV, V3, P626, DOI 10.4161/psb.3.9.6686; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Castellarin SD, 2007, PLANT CELL ENVIRON, V30, P1381, DOI 10.1111/j.1365-3040.2007.01716.x; Chen SQ, 2010, CHINA J CHIN MAT MED, V35, P49; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Feng X. F., 2010, J TRADIT MED RUSSI S, V3s, P241; Gazanchian A, 2007, J EXP BOT, V58, P291, DOI 10.1093/jxb/erl226; Guidi L, 2008, TREE PHYSIOL, V28, P873, DOI 10.1093/treephys/28.6.873; Hajheidari M, 2005, PROTEOMICS, V5, P950, DOI 10.1002/pmic.200401101; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; He Z., 1993, LAB GUIDE CHEM CONTR, P60, DOI 10.1002/jsfa.10700; Hernandez I, 2004, TREE PHYSIOL, V24, P1303, DOI 10.1093/treephys/24.11.1303; HINDERER W, 1984, PLANTA, V160, P544, DOI 10.1007/BF00411143; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Kottapalli KR, 2009, PLANT CELL ENVIRON, V32, P380, DOI 10.1111/j.1365-3040.2009.01933.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Li S. M., 2009, CHINESE J EXP TRADIT, V8, P11; Li XJ, 2003, PLANT SCI, V164, P549, DOI 10.1016/S0168-9452(03)00004-9; Marinova D., 2005, J U CHEM TECHNOL MET, V40, P255; MATTHEWS MA, 1988, AM J ENOL VITICULT, V39, P313; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Murch SJ, 2004, PLANT CELL REP, V23, P419, DOI 10.1007/s00299-004-0862-3; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Olsen KM, 2009, PLANT CELL ENVIRON, V32, P286, DOI 10.1111/j.1365-3040.2008.01920.x; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Qin S.S., 2010, CHIN J EXP TRADIT ME, V16, P99; Ribnicky DM, 1996, PLANT PHYSIOL, V112, P549, DOI 10.1104/pp.112.2.549; Roby G, 2004, AUST J GRAPE WINE R, V10, P100, DOI 10.1111/j.1755-0238.2004.tb00012.x; RUSSELL DW, 1969, PLANT PHYSIOL, V44, P1211, DOI 10.1104/pp.44.9.1211; Sasaki K, 2000, J BIOL CHEM, V275, P27466; Singh K, 2009, FUNCT INTEGR GENOMIC, V9, P125, DOI 10.1007/s10142-008-0092-9; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Wehmeyer N, 1996, PLANT PHYSIOL, V112, P747, DOI 10.1104/pp.112.2.747; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Xu H, 2010, BIORESOURCE TECHNOL, V101, P9715, DOI 10.1016/j.biortech.2010.07.083; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yang Y, 2007, Z NATURFORSCH C, V62, P410; Yang YM, 2001, PLANT GROWTH REGUL, V35, P233; Yuan Y, 2011, AFR J BIOTECHNOL, V10, P5182	54	46	54	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e42946	10.1371/journal.pone.0042946	http://dx.doi.org/10.1371/journal.pone.0042946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077481	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100009
J	Zhang, Y; Sun, LP; Xing, CZ; Xu, Q; He, CY; Li, P; Gong, YH; Liu, YP; Yuan, Y				Zhang, Ye; Sun, Li-Ping; Xing, Cheng-Zhong; Xu, Qian; He, Cai-Yun; Li, Ping; Gong, Yue-Hua; Liu, Yun-Peng; Yuan, Yuan			Interaction between GSTP1 Val Allele and H. pylori Infection, Smoking and Alcohol Consumption and Risk of Gastric Cancer among the Chinese Population	PLOS ONE			English	Article							TRANSFERASE P1 POLYMORPHISMS; GENETIC-POLYMORPHISM; PROSTATE-CANCER; BREAST-CANCER; SUSCEPTIBILITY; ASSOCIATION; LUNG; CELLS; EXPRESSION; VARIANTS	Glutathione S-transferase P1 (GSTP1) is a critical enzyme in the phase II detoxification pathway. One of the common functional polymorphisms of GSTP1 is A -> G at nucleotide 313, which results in an amino acid substitution (Ile105Val) at the substrate binding site and reduced catalytic activity. We evaluated the interaction between GSTP1 Val allele and Helicobacter pylori infection, smoking and alcohol consumption, increasing the risk of gastric cancer among the Chinese population. Information on potential gastric cancer risk factors and blood specimens were collected from 618 incident gastric cancer cases and 1,830 non-cancer controls between March 2002 and December 2011 in Liaoning Province, China. GSTP1 Ile105Val was genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and polymerase chain reaction-restriction fragment length polymorphism. Serum levels of anti-H. pylori IgG were measured by ELISA. Odds ratio (OR) and 95% confidence interval (CI) were calculated using multivariate logistic regression, adjusted by sex and age. The risk of gastric cancer was significantly elevated in patients with the GSTP1 Val/Val genotype (adjusted OR = 3.324; 95% CI = 1.790-6.172). An elevated risk of gastric cancer was observed in patients with H. pylori infection, smoking, or alcohol consumption, and together with the GSTP1 Ile/Val + Val/Val genotype (OR = 3.696; 95% CI = 2.475-5.521; OR = 1.638; 95% CI = 1.044-2.571; OR = 1.641; 95% CI = 0.983-2.739, respectively) (p<0.05). The GSTP1 Val allele shows an interaction with smoking, alcohol consumption, and especially H. pylori infection for increasing the risk of gastric cancer. These findings could demonstrate new pathophysiological pathways for the development of gastric cancer.	[Zhang, Ye; Sun, Li-Ping; Xing, Cheng-Zhong; Xu, Qian; He, Cai-Yun; Li, Ping; Gong, Yue-Hua; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Shenyang, Peoples R China; [Zhang, Ye; Sun, Li-Ping; Xing, Cheng-Zhong; Xu, Qian; He, Cai-Yun; Li, Ping; Gong, Yue-Hua; Yuan, Yuan] Key Lab Canc Control Liaoning Prov, Shenyang, Peoples R China; [Liu, Yun-Peng] China Med Univ, Affiliated Hosp 1, Dept Med Oncol, Shenyang, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Shenyang, Peoples R China.	yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Basic Research Program of China (973 Program) [2010CB529304]; Foundation of the Key Laboratory in Liaoning Province [LS2010167]; Foundation for the Scientific Research Fund of Liaoning Provincial Education Department [L2010641]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Foundation of the Key Laboratory in Liaoning Province; Foundation for the Scientific Research Fund of Liaoning Provincial Education Department	This study was supported by grants from the National Basic Research Program of China (973 Program) (no. 2010CB529304), the Foundation of the Key Laboratory in Liaoning Province (no. LS2010167), and the Foundation for the Scientific Research Fund of Liaoning Provincial Education Department (no. L2010641). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darazy M, 2011, GENET TEST MOL BIOMA, V15, P423, DOI 10.1089/gtmb.2010.0206; Ding WQ, 1998, ALCOHOL CLIN EXP RES, V22, P225, DOI 10.1111/j.1530-0277.1998.tb03642.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P314, DOI 10.1158/1055-9965.EPI-08-0627; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029007; Hauptstock V, 2011, BIOCHEM BIOPH RES CO, V412, P606, DOI 10.1016/j.bbrc.2011.08.007; Hu X, 1999, CANCER RES, V59, P2358; Huang BF, 2012, INT J CANCER, V131, pE744, DOI 10.1002/ijc.27407; Ihsan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029431; Jana S, 2009, CURR DRUG METAB, V10, P595, DOI 10.2174/138920009789375379; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karen-Ng LP, 2011, ASIAN PAC J CANCER P, V12, P1161; Katoh T, 1999, PHARMACOGENETICS, V9, P165; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; Luo YP, 2011, TUMOR BIOL, V32, P215, DOI 10.1007/s13277-010-0115-8; McCullough MJ, 2008, AUST DENT J, V53, P302, DOI 10.1111/j.1834-7819.2008.00070.x; Mikko S, 2012, J GASTROEN HEPATOL, V27, P135, DOI 10.1111/j.1440-1746.2012.07017.x; Ramalhinho ACM, 2012, DNA CELL BIOL, V31, P1100, DOI 10.1089/dna.2011.1538; Moyer AM, 2007, CLIN CANCER RES, V13, P7207, DOI 10.1158/1078-0432.CCR-07-0635; Niwa T, 2010, ADV GENET, V71, P41, DOI [10.1016/S0065-2660(10)71002-6, 10.1016/B978-0-12-380864-6.00002-X]; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Persson C, 2011, AM J EPIDEMIOL, V173, P259, DOI 10.1093/aje/kwq370; Qadri Q, 2011, GENET MOL RES, V10, P3038, DOI 10.4238/2011.December.6.4; Romero A, 2012, ANN ONCOL, V23, P1750, DOI 10.1093/annonc/mdr483; Schistosomes liver flukes and Helicobacter pylori, 1994, IARC MONOGR EVAL CAR, V61, P1; Setiawan VW, 2001, CANCER CAUSE CONTROL, V12, P673, DOI 10.1023/A:1011261602940; Song HR, 2011, GASTRIC CANCER, V14, P242, DOI 10.1007/s10120-011-0034-4; Souiden Y, 2010, CANCER EPIDEMIOL, V34, P598, DOI 10.1016/j.canep.2010.06.002; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Strange R C, 1999, IARC Sci Publ, P231; Sweeney C, 2000, CANCER RES, V60, P5621; Vaughn MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025707; Vecanova J, 2011, BRATISL MED J, V112, P67; Vural B, 2012, GENET TEST MOL BIOMA, V16, P701, DOI 10.1089/gtmb.2011.0315; Wang GH, 2009, CANCER-AM CANCER SOC, V115, P2430, DOI 10.1002/cncr.24255; Wang ZY, 2012, ASIAN PAC J CANCER P, V13, P1515, DOI 10.7314/APJCP.2012.13.4.1515; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Yamada H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-63; Yu J, 2011, CANCER INVEST, V29, P564, DOI 10.3109/07357907.2011.605411; Zhang Y, 2009, ANTI-CANCER DRUG, V20, P208, DOI 10.1097/CAD.0b013e328322fbaa; Zhang Ye, 2007, Yichuan, V29, P293, DOI 10.1360/yc-007-0299; Zhang YJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-256	41	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47178	10.1371/journal.pone.0047178	http://dx.doi.org/10.1371/journal.pone.0047178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077566	Green Published, gold			2022-12-25	WOS:000309995100072
J	Neto, JFD; Negretto, CC; Netto, LES				da Silva Neto, Jose F.; Negretto, Caroline C.; Netto, Luis E. S.			Analysis of the Organic Hydroperoxide Response of Chromobacterium violaceum Reveals That OhrR Is a Cys-Based Redox Sensor Regulated by Thioredoxin	PLOS ONE			English	Article							RESISTANCE PROTEIN; ESCHERICHIA-COLI; TRANSCRIPTION REGULATOR; SALMONELLA-TYPHIMURIUM; LIPID HYDROPEROXIDE; GENE; REPRESSOR; PEROXIDE; REDUCTASE; MECHANISM	Organic hydroperoxides are oxidants generated during bacterial-host interactions. Here, we demonstrate that the peroxidase OhrA and its negative regulator OhrR comprise a major pathway for sensing and detoxifying organic hydroperoxides in the opportunistic pathogen Chromobacterium violaceum. Initially, we found that an ohrA mutant was hypersensitive to organic hydroperoxides and that it displayed a low efficiency for decomposing these molecules. Expression of ohrA and ohrR was specifically induced by organic hydroperoxides. These genes were expressed as monocistronic transcripts and also as a bicistronic ohrR-ohrA mRNA, generating the abundantly detected ohrA mRNA and the barely detected ohrR transcript. The bicistronic transcript appears to be processed. OhrR repressed both the ohrA and ohrR genes by binding directly to inverted repeat sequences within their promoters in a redox-dependent manner. Site-directed mutagenesis of each of the four OhrR cysteine residues indicated that the conserved Cys21 is critical to organic hydroperoxide sensing, whereas Cys126 is required for disulfide bond formation. Taken together, these phenotypic, genetic and biochemical data indicate that the response of C. violaceum to organic hydroperoxides is mediated by OhrA and OhrR. Finally, we demonstrated that oxidized OhrR, inactivated by intermolecular disulfide bond formation, is specifically regenerated via thiol-disulfide exchange by thioredoxin (but not other thiol reducing agents such as glutaredoxin, glutathione and lipoamide), providing a physiological reducing system for this thiol-based redox switch.	[da Silva Neto, Jose F.; Negretto, Caroline C.; Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil	Universidade de Sao Paulo	Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil.	nettoles@ib.usp.br	da Silva Neto, José F/H-6279-2012; Netto, Luis/A-3783-2008	da Silva Neto, José F/0000-0002-7946-2747; Netto, Luis/0000-0002-4250-9177	INCT de Processos Redox em Biomedicina-Redoxoma (FAPESP/CNPq/CAPES) [2008/57721-3, 2008/573530]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/58147-6]; CNPq	INCT de Processos Redox em Biomedicina-Redoxoma (FAPESP/CNPq/CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are members of the INCT de Processos Redox em Biomedicina-Redoxoma (FAPESP/CNPq/CAPES) [grant numbers 2008/57721-3 and 2008/573530]. This work was also supported by grants 07/58147-6 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and a post-doctoral fellowship from CNPq to Jose Freire da Silva Neto. The funders (FAPESP/CNPq/CAPES) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2005, PROSTAG LEUKOTR ESS, V73, P283, DOI 10.1016/j.plefa.2005.05.018; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; Atichartpongkul S, 2010, J BACTERIOL, V192, P2093, DOI 10.1128/JB.01510-09; Chuchue T, 2006, J BACTERIOL, V188, P842, DOI 10.1128/JB.188.3.842-851.2006; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Neto JFD, 2009, NUCLEIC ACIDS RES, V37, P4812, DOI 10.1093/nar/gkp509; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Duarte V, 2010, MOL BIOSYST, V6, P316, DOI 10.1039/b915042k; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Girotti AW, 1998, J LIPID RES, V39, P1529; Gobel C, 2003, J BIOL CHEM, V278, P52834, DOI 10.1074/jbc.M310833200; GUTIERREZ C, 1991, J MOL BIOL, V220, P959, DOI 10.1016/0022-2836(91)90366-E; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hungria Mariangela, 2004, Genet Mol Res, V3, P102; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Konzen M, 2006, BIOORGAN MED CHEM, V14, P8307, DOI 10.1016/j.bmc.2006.09.013; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Lima-Bittencourt CI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-58; Llewellyn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024201; Medeiros MHG, 2009, CHEM RES TOXICOL, V22, P419, DOI 10.1021/tx800367d; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; Miyamoto S, 2003, J AM CHEM SOC, V125, P4510, DOI 10.1021/ja029262m; Mongkolsuk S, 1998, J BACTERIOL, V180, P2636, DOI 10.1128/JB.180.10.2636-2643.1998; Mongkolsuk S, 2002, MOL MICROBIOL, V44, P793, DOI 10.1046/j.1365-2958.2002.02919.x; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Oh SY, 2007, J BACTERIOL, V189, P6284, DOI 10.1128/JB.00632-07; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Panmanee W, 2002, MOL MICROBIOL, V45, P1647, DOI 10.1046/j.1365-2958.2002.03116.x; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Segal BH, 2003, INFECT IMMUN, V71, P205, DOI 10.1128/IAI.71.1.205-210.2003; Shea RJ, 2002, INFECT IMMUN, V70, P794, DOI 10.1128/IAI.70.2.794-802.2002; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Soonsanga S, 2008, MOL MICROBIOL, V68, P978, DOI 10.1111/j.1365-2958.2008.06200.x; Sukchawalit R, 2001, J BACTERIOL, V183, P4405, DOI 10.1128/JB.183.15.4405-4412.2001; Swem LR, 2009, MOL CELL, V35, P143, DOI 10.1016/j.molcel.2009.05.029; Ta P, 2011, J BACTERIOL, V193, P1981, DOI 10.1128/JB.01402-10; Vattanaviboon P, 2007, J BACTERIOL, V189, P6477, DOI 10.1128/JB.00623-07; Vazquez-Torres A, 2012, ANTIOXID RE IN PRESS, V00; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	62	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47090	10.1371/journal.pone.0047090	http://dx.doi.org/10.1371/journal.pone.0047090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071722	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700052
J	Kaieda, S; Wang, JX; Shnayder, R; Fishgal, N; Hei, H; Lee, RT; Stevens, RL; Nigrovic, PA				Kaieda, Shinjiro; Wang, Jun-Xia; Shnayder, Ruslan; Fishgal, Nadia; Hei, Hillary; Lee, Richard T.; Stevens, Richard L.; Nigrovic, Peter A.			Interleukin-33 Primes Mast Cells for Activation by IgG Immune Complexes	PLOS ONE			English	Article							AUTOANTIBODY-MEDIATED ARTHRITIS; CONNECTIVE-TISSUE-TYPE; GROWTH-FACTOR; IL-33; FIBROBLASTS; CYTOKINE; CONTRIBUTE; PROMOTE; DIFFERENTIATION; RECRUITMENT	Mast cells (MCs) are heterogeneous cells whose phenotype is modulated by signals received from the local microenvironment. Recent studies have identified the mesenchymal-derived cytokine IL-33 as a potent direct activator of MCs, as well as regulator of their effector phenotype, and have implicated this activity in the ability of mast cells to contribute to murine experimental arthritis. We explored the hypothesis that IL-33 enables participation of synovial MCs in murine K/BxN arthritis by promoting their activation by IgG immune complexes. Compared to wild-type (WT) control mice, transgenic animals lacking the IL-33 receptor ST2 exhibited impaired MC-dependent immune complex-induced vascular permeability ( flare) and attenuated K/BxN arthritis. Whereas participation of MCs in this model is mediated by the activating IgG receptor Fc gamma RIII, we pre-incubated bone marrow-derived MCs with IL-33 and found not only direct induction of cytokine release but also a marked increase in FccRIII-driven production of critical arthritogenic mediators including IL-1 beta and CXCL2. This "priming" effect was associated with mRNA accumulation rather than altered expression of Fc gamma receptors, could be mimicked by co-culture of WT but not ST2(-/-) MCs with synovial fibroblasts, and was blocked by antibodies against IL-33. In turn, WT but not ST2(-/-) MCs augmented fibroblast expression of IL-33, forming a positive feedback circuit. Together, these findings confirm a novel role for IL-33 as an amplifier of IgG immune complex-mediated inflammation and identify a potential MC-fibroblast amplification loop dependent on IL-33 and ST2.	[Kaieda, Shinjiro; Wang, Jun-Xia; Shnayder, Ruslan; Fishgal, Nadia; Stevens, Richard L.; Nigrovic, Peter A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hei, Hillary; Lee, Richard T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Cardiovasc Med, Boston, MA 02115 USA; [Nigrovic, Peter A.] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp,Div Immunol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Nigrovic, PA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	pnigrovic@partners.org		Lee, Richard/0000-0003-4687-1381; Hei, Hillary/0000-0002-2381-6817	NIH [AR051321, AI059746, HL092930, AI065858]; Cogan Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059746, P01AI065858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR051321] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cogan Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants AR051321 (to P.A.N.), AI059746 (to P.A.N. and R.L.S.), HL092930 (to R.T.L.), and AI065858 (to R.L.S.), and by the Cogan Family Foundation (to P.A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; Andrade MV, 2011, EUR J IMMUNOL, V41, P760, DOI 10.1002/eji.201040718; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Blatner NR, 2010, P NATL ACAD SCI USA, V107, P6430, DOI 10.1073/pnas.0913683107; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; DAYTON ET, 1989, J IMMUNOL, V142, P4307; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; GURISH MF, 1995, IMMUNITY, V3, P175, DOI 10.1016/1074-7613(95)90087-X; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Koma Y, 2005, LAB INVEST, V85, P426, DOI 10.1038/labinvest.3700231; Komai-Koma M, 2012, ALLERGY, V67, P1118, DOI 10.1111/j.1398-9995.2012.02859.x; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P494; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nigrovic PA, 2006, RHEUMATOID ARTHRITIS, P135; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2010, ARTHRITIS RHEUM-US, V62, P3322, DOI 10.1002/art.27659; Ohno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018404; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; RAZIN E, 1984, J IMMUNOL, V132, P1479; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Smith DE, 2011, J LEUKOCYTE BIOL, V89, P383, DOI 10.1189/jlb.0810470; SONODA S, 1986, J IMMUNOL, V137, P1319; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Wang JX, 2012, BLOOD, V120, P1489, DOI 10.1182/blood-2012-01-404046; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685	53	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47252	10.1371/journal.pone.0047252	http://dx.doi.org/10.1371/journal.pone.0047252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071771	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700071
J	Guo, WX; Wu, GT; Yan, F; Lu, YW; Zheng, HY; Lin, L; Chen, HR; Chen, JP				Guo, Weixia; Wu, Gentu; Yan, Fei; Lu, Yuwen; Zheng, Hongying; Lin, Lin; Chen, Hairu; Chen, Jianping			Identification of Novel Oryza sativa miRNAs in Deep Sequencing-Based Small RNA Libraries of Rice Infected with Rice Stripe Virus	PLOS ONE			English	Article							MICRORNAS; PLANT; EXPRESSION; PROTEIN; BIOGENESIS; MECHANISM; MOVEMENT; CLEAVAGE; ROLES	MicroRNAs (miRNAs) play essential regulatory roles in the development of eukaryotes. Methods based on deep-sequencing have provided a powerful high-throughput strategy for identifying novel miRNAs and have previously been used to identify over 100 novel miRNAs from rice. Most of these reports are related to studies of rice development, tissue differentiation, or abiotic stress, but novel rice miRNAs related to viral infection have rarely been identified. In previous work, we constructed and pyrosequenced the small RNA (sRNA) libraries of rice infected with Rice stripe virus and described the character of the small interfering RNAs (siRNA) derived from the RSV RNA genome. We now report the identification of novel miRNAs from the abundant sRNAs (with a minimum of 100 sequencing reads) in the sRNA library of RSV-infected rice. 7 putative novel miRNAs (pn-miRNAs) whose precursor sequences have not previously been described were identified and could be detected by Northern blot or RT-PCR, and were recognized as novel miRNAs (n-miRNAs). Further analysis showed that 5 of the 7 n-miRNAs were up-expressed while the other 2 n-miRNAs were down-expressed in RSV-infected rice. In addition, 23 pn-miRNAs that were newly produced from 19 known miRNA precursors were also identified. This is first report of novel rice miRNAs produced from new precursors related to RSV infection.	[Guo, Weixia; Yan, Fei; Lu, Yuwen; Zheng, Hongying; Lin, Lin; Chen, Jianping] Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Key Lab Biotechnol Plant Protect, Minist China,Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Guo, Weixia; Chen, Hairu] Yunnan Agr Univ, Plant Protect Coll, Kunming, Peoples R China; [Wu, Gentu] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Yunnan Agricultural University; Zhejiang University	Yan, F (corresponding author), Zhejiang Acad Agr Sci, State Key Lab Breeding Base Zhejiang Sustainable, Key Lab Biotechnol Plant Protect, Minist China,Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	fei.yan@mail.zaas.ac.cn; jpchen2001@yahoo.com.cn		Yan, Fei/0000-0002-0049-8588	State Basic Research Program of China [2010CB126203, 2012CB722504]; International Science & Technology Cooperation Program of China [2007DFB30350, 2012DFA30900]; Major Project of New Varieties of Genetically Modified Organism of China [2009ZX08001-006B, 2011ZX08001-002]; Special Fund for Agro-scientific Research in the Public Interest of China [201003031]; National Natural Science Foundation of China [31101414]	State Basic Research Program of China(National Basic Research Program of China); International Science & Technology Cooperation Program of China; Major Project of New Varieties of Genetically Modified Organism of China; Special Fund for Agro-scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the State Basic Research Program of China (2010CB126203, 2012CB722504), the International Science & Technology Cooperation Program of China (2007DFB30350, 2012DFA30900), Major Project of New Varieties of Genetically Modified Organism of China (2009ZX08001-006B, 2011ZX08001-002), the Special Fund for Agro-scientific Research in the Public Interest of China (201003031), the National Natural Science Foundation of China (31101414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lertpanyasampatha M, 2012, PLANTA; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu YD, 2008, PLANT CELL REP, V27, P1571, DOI 10.1007/s00299-008-0584-z; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mica E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-558; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-25; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang HD, 2008, PLANT DIS, V92, P1190, DOI 10.1094/PDIS-92-8-1190; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Xiong RY, 2008, J VIROL, V82, P12304, DOI 10.1128/JVI.01696-08; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yao M, 2012, J GEN VIROL, V93, P194, DOI 10.1099/vir.0.033902-0; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Yuan ZJ, 2011, VIRUS RES, V159, P62, DOI 10.1016/j.virusres.2011.04.023; Zhang C, 2012, VIROLOGY, V425, P113, DOI 10.1016/j.virol.2012.01.007; Zhang HM, 2007, ARCH VIROL, V152, P1917, DOI 10.1007/s00705-007-1013-2; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	52	34	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46443	10.1371/journal.pone.0046443	http://dx.doi.org/10.1371/journal.pone.0046443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071571	gold, Green Submitted, Green Published			2022-12-25	WOS:000312385200025
J	Tseng, TL; Chen, MF; Tsai, MJ; Hsu, YH; Chen, CP; Lee, TJF				Tseng, Tzu-Ling; Chen, Mei-Fang; Tsai, Ming-Jen; Hsu, Yung-Hsiang; Chen, Chin-Piao; Lee, Tony J. F.			Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-kappa B Signaling Pathway in Rodents	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATORY RESPONSES; GENE-EXPRESSION; RATS; LIPOPOLYSACCHARIDE; INHIBITION; HMGB1; PATHOGENESIS; ENDOTOXEMIA	Background and Purpose: Successful drug treatment for sepsis-related acute lung injury (ALI) remains a major clinical problem. This study was designed to assess the beneficial effects of post-treatment of oroxylin A (OroA), a flavonoid, in ameliorating lipopolysaccharides (LPS)-induced lung inflammation and fatality. Experimental Approach: Rats were injected with LPS (10 mg/kg, iv) to induce ALI, and OroA was given (15 mg/kg, iv) 1 hr or 6 hrs after LPS challenge. Twenty four hrs after LPS challenge, biochemical changes in the blood and lung tissues, and morphological/histological alterations in the lung associated with inflammation and injury were examined. Therapeutic effect of OroA was assessed by measuring the survival rate in endotoxemic mice. Key Results: LPS (10 mg/kg, iv) significantly altered WBC counts, elevated plasma tumor necrosis factor (TNF)-alpha and nitric oxide (NO), increased pulmonary edema, thickened alveolar septa, and decreased survival rate. These changes were ameliorated by OroA (15 mg/kg, iv) administered 1 hr or 6 hrs after LPS challenge. This post-treatment also significantly attenuated LPS-induced activation of nuclear factor-kappa B (NF-kappa B) and the release of high mobility group box 1 (HMGB1) in lung tissues. Furthermore, post-treatment with OroA (60 mg/kg, ip) administered 1 hr or 6 hrs after LPS challenge in mice significantly increased survival rate. Conclusion and Implication: OroA administered after induction of ALI by LPS significantly prevent and revere lung tissues injuries with increased survival rate. Positive post-treatment effects of OroA suggest that OroA is a potentially useful candidate for managing lung inflammation in LPS-induced endotoxemia and septic shock.	[Tsai, Ming-Jen; Lee, Tony J. F.] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan; [Tseng, Tzu-Ling; Hsu, Yung-Hsiang] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lee, Tony J. F.] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Tseng, Tzu-Ling; Chen, Mei-Fang; Lee, Tony J. F.] Tzu Chi Univ, Coll Life Sci, Ctr Vasc Med, Hualien, Taiwan; [Hsu, Yung-Hsiang] Tzu Chi Univ, Coll Med, Dept Pathol, Hualien, Taiwan; [Chen, Mei-Fang; Lee, Tony J. F.] Buddhist Tzu Chi Gen Hosp, Dept Res, Hualien, Taiwan; [Tsai, Ming-Jen] Buddhist Tzu Chi Gen Hosp, Dept Emergency Med, Hualien, Taiwan; [Chen, Mei-Fang] Tzu Chi Coll Technol, Hualien, Taiwan; [Chen, Chin-Piao] Natl Dong Hwa Univ, Dept Chem, Hualien, Taiwan; [Lee, Tony J. F.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Tzu Chi University; Tzu Chi University; Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University of Science & Technology; National Dong Hwa University; Southern Illinois University System; Southern Illinois University	Lee, TJF (corresponding author), Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan.	tlee@mail.tcu.edu.tw	Tsai, Ming-Jen/AEQ-2150-2022; Tsai, Ming-Jen/AAG-9212-2022	Tsai, Ming-Jen/0000-0002-2662-1206; Tsai, Ming-Jen/0000-0002-2662-1206	Tzu-Chi University [TCMRC-C95005-01, TCRPP99006, TCIRP 98005-01, TCIRP 98005-02]; National Science Council of Taiwan [NSC-NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC 100-2320-B-320-007-MY2]; Buddhist Tzu Chi General Hospital [TCRD98-34]; Tzu Chi Foundation	Tzu-Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Buddhist Tzu Chi General Hospital; Tzu Chi Foundation	Tzu-Chi University Grants TCMRC-C95005-01, TCRPP99006, TCIRP 98005-01 and TCIRP 98005-02, and National Science Council of Taiwan Grants NSC-NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3 and NSC 100-2320-B-320-007-MY2, Buddhist Tzu Chi General Hospital Grant TCRD98-34, and the Tzu Chi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi Kazem, 2007, Iran J Immunol, V4, P220; Baumgarten G, 2006, EUR J ANAESTH, V23, P1041, DOI 10.1017/S0265021506001098; Bhattacharyya J, 2004, CURR MED CHEM, V11, P359, DOI 10.2174/0929867043456098; Chen HI, 2003, J BIOMED SCI, V10, P588, DOI 10.1159/000073523; Chen YC, 2001, BIOCHEM PHARMACOL, V61, P1417, DOI 10.1016/S0006-2952(01)00594-9; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Cheng PY, 2007, BIOCHEM PHARMACOL, V73, P793, DOI 10.1016/j.bcp.2006.11.025; Ding JQ, 2009, J IMMUNOL, V183, P4031, DOI 10.4049/jimmunol.0900105; Dreyfuss D, 2005, CLIN CHEST MED, V26, P105, DOI 10.1016/j.ccm.2004.10.014; Farley KS, 2008, MICROVASC RES, V76, P208, DOI 10.1016/j.mvr.2008.07.004; Galani V, 2010, PATHOL RES PRACT, V206, P145, DOI 10.1016/j.prp.2009.12.002; Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088; Guo Zhu-ying, 2009, Yaoxue Xuebao, V44, P586; Iba T, 2006, SHOCK, V26, P95, DOI 10.1097/01.shk.0000223126.34017.d9; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; KITAJIMA S, 1995, TOXICOL LETT, V78, P135, DOI 10.1016/0378-4274(94)03246-4; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kotanidou A, 1996, J APPL PHYSIOL, V81, P2304, DOI 10.1152/jappl.1996.81.5.2304; Lamontagne F, 2009, J CRIT CARE; Lange M, 2010, BIOCH BIOPHYS RES CO; Luan Zheng-gang, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P456; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Malleo G, 2007, THESCIENTIFICWORLDJO, V7, P431, DOI 10.1100/tsw.2007.98; Martinez FE, 2000, INFLAMM RES, V49, P727, DOI 10.1007/s000110050653; Munir TA, 2010, J PAK MED ASSOC, V60, P548; Ni YF, 2010, RESPIRATION; Numata M, 1998, J IMMUNOL, V160, P3031; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Prows DR, 2007, PHYSIOL GENOMICS, V30, P262, DOI 10.1152/physiolgenomics.00232.2006; Shapiro H, 2009, NUTRITION, V25, P981, DOI 10.1016/j.nut.2009.02.010; Silva E, 2007, INTENS CARE MED, V33, P1829, DOI 10.1007/s00134-007-0748-2; Speyer CL, 2003, AM J PATHOL, V163, P2319, DOI 10.1016/S0002-9440(10)63588-2; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Su CF, 2007, CLIN EXP PHARMACOL P, V34, P339, DOI 10.1111/j.1440-1681.2007.04553.x; Taniguchi T, 2000, CRIT CARE MED, V28, P1101, DOI 10.1097/00003246-200004000-00032; Taniguchi T, 2003, TOHOKU J EXP MED, V200, P85, DOI 10.1620/tjem.200.85; Tsuji C, 1998, LUNG, V176, P1, DOI 10.1007/PL00007587; Unoshima Masako, 2004, Nihon Rinsho, V62, P2323; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yi C, 2009, INFLAMM RES, V58, P855, DOI 10.1007/s00011-009-0056-0; Zheng S, 2001, J PEDIATR SURG, V36, P980, DOI 10.1053/jpsu.2001.24721	44	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47403	10.1371/journal.pone.0047403	http://dx.doi.org/10.1371/journal.pone.0047403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071799	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200115
J	Casarini, L; Lispi, M; Longobardi, S; Milosa, F; La Marca, A; Tagliasacchi, D; Pignatti, E; Simoni, M				Casarini, Livio; Lispi, Monica; Longobardi, Salvatore; Milosa, Fabiola; La Marca, Antonio; Tagliasacchi, Daniela; Pignatti, Elisa; Simoni, Manuela			LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; FOLLICLE-STIMULATING-HORMONE; HUMAN LUTEINIZING-HORMONE; HUMAN GRANULOSA-CELLS; STEROID-PRODUCTION; LUTROPIN RECEPTOR; OOCYTE MATURATION; OVARIAN-FOLLICLES; GENE-EXPRESSION; GROWTH-FACTORS	Human luteinizing hormone (hLH) and chorionic gonadotropin (hCG) act on the same receptor (LHCGR) but it is not known whether they elicit the same cellular and molecular response. This study compares for the first time the activation of cell-signalling pathways and gene expression in response to hLH and hCG. Using recombinant hLH and recombinant hCG we evaluated the kinetics of cAMP production in COS-7 and hGL5 cells permanently expressing LHCGR (COS-7/LHCGR, hGL5/LHCGR), as well as cAMP, ERK1/2, AKT activation and progesterone production in primary human granulosa cells (hGLC). The expression of selected target genes was measured in the presence or absence of ERK- or AKT-pathways inhibitors. In COS-7/LHCGR cells, hCG is 5-fold more potent than hLH (cAMP ED50: 107.1 +/- 14.3 pM and 530.0 +/- 51.2 pM, respectively). hLH maximal effect was significantly faster (10 minutes by hLH; 1 hour by hCG). In hGLC continuous exposure to equipotent doses of gonadotropins up to 36 hours revealed that intracellular cAMP production is oscillating and significantly higher by hCG versus hLH. Conversely, phospho-ERK1/2 and -AKT activation was more potent and sustained by hLH versus hCG. ERK1/2 and AKT inhibition removed the inhibitory effect on NRG1 (neuregulin) expression by hLH but not by hCG; ERK1/2 inhibition significantly increased hLH-but not hCG-stimulated CYP19A1 (aromatase) expression. We conclude that: i) hCG is more potent on cAMP production, while hLH is more potent on ERK and AKT activation; ii) hGLC respond to equipotent, constant hLH or hCG stimulation with a fluctuating cAMP production and progressive progesterone secretion; and iii) the expression of hLH and hCG target genes partly involves the activation of different pathways depending on the ligand. Therefore, the LHCGR is able to differentiate the activity of hLH and hCG.	[Casarini, Livio; Milosa, Fabiola; Pignatti, Elisa; Simoni, Manuela] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Casarini, Livio; Pignatti, Elisa; Simoni, Manuela] Univ Modena & Reggio Emilia, Ctr Genom Res, Modena, Italy; [Lispi, Monica; Longobardi, Salvatore] Merck Serono SpA, Med Liaison Off, Rome, Italy; [La Marca, Antonio; Tagliasacchi, Daniela] Univ Hosp Modena, Inst Obstet & Gynecol, Mother Infant Dept, Modena, Italy; [Simoni, Manuela] Azienda USL Modena, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Merck KGaA; EMD Serono Inc.; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Simoni, M (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	manuela.simoni@unimore.it	Simoni, Manuela/A-9600-2013; Casarini, Livio/D-6181-2016; La Marca, Antonio/A-5940-2015	Simoni, Manuela/0000-0002-2133-4304; Casarini, Livio/0000-0001-5571-392X; La Marca, Antonio/0000-0001-7921-9547	Fondazione Cassa di Risparmio di Modena; Italian Ministry of University and Research [IDEAS RBID08777T]	Fondazione Cassa di Risparmio di Modena; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by: Fondazione Cassa di Risparmio di Modena (http://www.fondazione-crmo.it) and IDEAS RBID08777T from Italian Ministry of University and Research (http://www.istruzione.it/web/hub). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONI D, 1995, EXP CELL RES, V218, P271, DOI 10.1006/excr.1995.1156; ALBRECHT ED, 1990, ENDOCR REV, V11, P124, DOI 10.1210/edrv-11-1-124; Almeida BE, 2010, J PHARMACEUT BIOMED, V53, P90, DOI 10.1016/j.jpba.2010.03.013; Amoresano A, 1996, EUR J BIOCHEM, V242, P608, DOI 10.1111/j.1432-1033.1996.0608r.x; Amsterdam A, 2003, STEROIDS, V68, P861, DOI 10.1016/j.steroids.2003.09.003; Amsterdam A, 2003, BIOCHEM PHARMACOL, V66, P1355, DOI 10.1016/S0006-2952(03)00485-4; AMSTERDAM A, 1994, ENDOCRINOLOGY, V135, P1205, DOI 10.1210/en.135.3.1205; Amsterdam A, 2002, MOL CELL ENDOCRINOL, V187, P69, DOI 10.1016/S0303-7207(01)00701-8; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Baer LG, 2003, CURR MED RES OPIN, V19, P83, DOI 10.1185/030079902125001498; Ben-Ami I, 2009, HUM REPROD, V24, P176, DOI 10.1093/humrep/den359; Birken S, 1996, ENDOCRINOLOGY, V137, P1402, DOI 10.1210/en.137.4.1402; Brown C, 2010, BIOL REPROD, V82, P246, DOI 10.1095/biolreprod.109.077925; Cailleux-Bounacer A, 2008, EUR J ENDOCRINOL, V159, P171, DOI 10.1530/EJE-07-0876; Chin EC, 2004, J ENDOCRINOL, V183, P51, DOI 10.1677/joe.1.05550; Choi JH, 2009, ENDOCR-RELAT CANCER, V16, P179, DOI 10.1677/ERC-07-0238; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Cole LA, 2009, J REPROD IMMUNOL, V82, P112, DOI 10.1016/j.jri.2009.04.007; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; Craig J, 2007, FRONT BIOSCI-LANDMRK, V12, P3628, DOI 10.2741/2339; DIEBEL ND, 1978, ENDOCRINOLOGY, V103, P665; Donadeu FX, 2005, ENDOCRINOLOGY, V146, P3907, DOI 10.1210/en.2005-0403; DUIJKERS IJM, 1995, HUM REPROD, V10, P1367, DOI 10.1093/HUMREP/10.6.1367; Evans ACO, 2000, ANIM REPROD SCI, V64, P221, DOI 10.1016/S0378-4320(00)00210-4; Fan HY, 2011, MOL ENDOCRINOL, V25, P253, DOI 10.1210/me.2010-0318; Galet C, 2005, MOL ENDOCRINOL, V19, P1263, DOI 10.1210/me.2004-0410; Gervais A, 2003, GLYCOBIOLOGY, V13, P179, DOI 10.1093/glycob/cwg020; GIBSONBERRY KL, 1990, ENDOCRINOLOGY, V126, P3107, DOI 10.1210/endo-126-6-3107; Godinho RO, 2003, BRIT J PHARMACOL, V138, P995, DOI 10.1038/sj.bjp.0705130; Gromoll J, 2000, J CLIN ENDOCR METAB, V85, P2281, DOI 10.1210/jc.85.6.2281; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Gupta C, 2012, INDIAN J MED RES, V135, P331; Hofer AM, 2007, PHYSIOLOGY, V22, P320, DOI 10.1152/physiol.00019.2007; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Johnson AL, 2001, BIOL REPROD, V64, P1566, DOI 10.1095/biolreprod64.5.1566; Karlsson AB, 2010, MOL ENDOCRINOL, V24, P1765, DOI 10.1210/me.2009-0487; KERENTAL I, 1995, EXP CELL RES, V218, P283, DOI 10.1006/excr.1995.1157; Khan-Sabir N., 2008, ENDOTEXT; Krishnamurthy H, 2003, MOL ENDOCRINOL, V17, P2162, DOI 10.1210/me.2003-0118; LAHTEENMAKI P, 1978, CLIN ENDOCRINOL, V9, P101, DOI 10.1111/j.1365-2265.1978.tb02188.x; Lambert A, 1998, MOL HUM REPROD, V4, P619, DOI 10.1093/molehr/4.7.619; LAWRENCE TS, 1979, J CELL BIOL, V80, P21, DOI 10.1083/jcb.80.1.21; le Cotonnec JY, 1998, FERTIL STERIL, V69, P189, DOI 10.1016/S0015-0282(97)00501-3; Lin PC, 2003, J CLIN ENDOCR METAB, V88, P3409, DOI 10.1210/jc.2002-021966; Lindeberg M, 2007, HUM REPROD, V22, P401, DOI 10.1093/humrep/del408; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lottersberger C, 2003, HORM RES, V59, P125, DOI 10.1159/000069070; Ludwig M, 2003, BEST PRACT RES CL OB, V17, P231, DOI 10.1016/S1521-6934(02)00168-2; Lunenfeld Bruno, 2002, Reprod Biomed Online, V4 Suppl 1, P11; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; MANN K, 1980, ONCODEV BIOL MED, V1, P301; MCALLISTER JM, 1990, J CLIN ENDOCR METAB, V71, P26, DOI 10.1210/jcem-71-1-26; Menon B, 2011, MOL ENDOCRINOL, V25, P282, DOI 10.1210/me.2010-0366; MOLSKNESS TA, 1991, BIOL REPROD, V45, P273, DOI 10.1095/biolreprod45.2.273; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motola S, 2008, MOL CELL ENDOCRINOL, V282, P26, DOI 10.1016/j.mce.2007.11.002; Muller T, 2003, J CLIN ENDOCR METAB, V88, P2242, DOI 10.1210/jc.2002-021946; Nagirnaja L, 2010, MOL CELL ENDOCRINOL, V329, P4, DOI 10.1016/j.mce.2010.04.024; Noma N, 2011, MOL ENDOCRINOL, V25, P104, DOI 10.1210/me.2010-0225; Nordhoff V, 2011, REPROD BIOMED ONLINE, V23, P196, DOI 10.1016/j.rbmo.2011.04.009; Norman RJ, 2000, J ENDOCRINOL, V164, P299, DOI 10.1677/joe.0.1640299; Palaniappan M, 2010, MOL ENDOCRINOL, V24, P1782, DOI 10.1210/me.2010-0044; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; PENNY R, 1977, J CLIN ENDOCR METAB, V45, P307, DOI 10.1210/jcem-45-2-307; Peter AT, 2003, REPROD DOMEST ANIM, V38, P209, DOI 10.1046/j.1439-0531.2003.00438.x; Quellari M, 2003, EUR J BIOCHEM, V270, P3486, DOI 10.1046/j.1432-1033.2003.03718.x; RAINEY WH, 1994, J CLIN ENDOCR METAB, V78, P705, DOI 10.1210/jc.78.3.705; Rose MP, 2000, ENDOCR REV, V21, P5, DOI 10.1210/er.21.1.5; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Ryan KE, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-2; SANTEN RJ, 1973, J CLIN INVEST, V52, P2617, DOI 10.1172/JCI107454; Schiffer Z, 1996, MOL CELL ENDOCRINOL, V118, P145, DOI 10.1016/0303-7207(96)03774-4; Segaloff DL, 2010, METHOD ENZYMOL, V484, P231, DOI [10.1016/S0076-6879(10)84012-1, 10.1016/B978-0-12-381298-8.00012-5]; Sekiguchi T, 2004, J MOL ENDOCRINOL, V33, P281, DOI 10.1677/jme.0.0330281; Stanton PG, 1996, MOL CELL ENDOCRINOL, V125, P133, DOI 10.1016/S0303-7207(96)03958-5; STANTON PG, 1993, J ENDOCRINOL, V138, P529, DOI 10.1677/joe.0.1380529; STEWART F, 1981, J REPROD FERTIL, V62, P527, DOI 10.1530/jrf.0.0620527; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Talbot JA, 1996, MOL HUM REPROD, V2, P799, DOI 10.1093/molehr/2.10.799; Trinchard-Lugan I, 2002, Reprod Biomed Online, V4, P106; Ulloa-Aguirre A, 2011, REV ENDOCR METAB DIS, V12, P259, DOI 10.1007/s11154-011-9176-2; VANHELL H, 1964, ACTA ENDOCRINOL-COP, V47, P409, DOI 10.1530/acta.0.0470409; Yamashita S, 2011, MOL ENDOCRINOL, V25, P1211, DOI 10.1210/me.2011-0059; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20; Zamah AM, 2010, HUM REPROD, V25, P2569, DOI 10.1093/humrep/deq212; Zeleznik AJ, 1998, P NATL ACAD SCI USA, V95, P11002, DOI 10.1073/pnas.95.18.11002	86	155	160	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46682	10.1371/journal.pone.0046682	http://dx.doi.org/10.1371/journal.pone.0046682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071612	gold, Green Submitted, Green Published			2022-12-25	WOS:000309827300048
J	Xiao, CY; Wang, RH; Lahusen, TJ; Park, O; Bertola, A; Maruyama, T; Reynolds, D; Chen, Q; Xu, XL; Young, HA; Chen, WJ; Gao, B; Deng, CX				Xiao, Cuiying; Wang, Rui-Hong; Lahusen, Tyler J.; Park, Ogyi; Bertola, Adeline; Maruyama, Takashi; Reynolds, Della; Chen, Qiang; Xu, Xiaoling; Young, Howard A.; Chen, Wan-Jun; Gao, Bin; Deng, Chu-Xia			Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL DEFECTS; MAMMALIAN SIRTUINS; TUMOR-SUPPRESSOR; TRANSCRIPTION 3; EFFECTOR-CELLS; CANCER; METABOLISM; EXPRESSION; ABSENCE; TUMORIGENESIS	The human body has a remarkable ability to regulate inflammation, a biophysical response triggered by virus infection and tissue damage. Sirt6 is critical for metabolism and lifespan; however, its role in inflammation is unknown. Here we show that Sirt6-null (Sirt6(-/-)) mice developed chronic liver inflammation starting at similar to 2 months of age, and all animals were affected by 7-8 months of age. Deletion of Sirt6 in T cells or myeloid-derived cells was sufficient to induce liver inflammation and fibrosis, albeit to a lesser degree than that in the global Sirt6(-/-) mice, suggesting that Sirt6 deficiency in the immune cells is the cause. Consistently, macrophages derived from the bone marrow of Sirt6(-/-) mice showed increased MCP-1, IL-6, and TNF alpha expression levels and were hypersensitive to LPS stimulation. Mechanistically, SIRT6 interacts with c-JUN and deacetylates histone H3 lysine 9 (H3K9) at the promoter of proinflammatory genes whose expression involves the c-JUN signaling pathway. Sirt6-deficient macrophages displayed hyperacetylation of H3K9 and increased occupancy of c-JUN in the promoter of these genes, leading to their elevated expression. These data suggest that Sirt6 plays an anti-inflammatory role in mice by inhibiting c-JUN-dependent expression of proinflammatory genes.	[Xiao, Cuiying; Wang, Rui-Hong; Lahusen, Tyler J.; Chen, Qiang; Xu, Xiaoling; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Xiao, Cuiying; Park, Ogyi; Bertola, Adeline; Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD 20892 USA; [Maruyama, Takashi; Chen, Wan-Jun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Reynolds, Della; Young, Howard A.] Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016; chen, qiang/HGU-5418-2022; Young, Howard/R-5140-2019; chen, qiang/GWZ-7308-2022; MaruYama, Takashi/N-5994-2014; Young, Howard/A-6350-2008	MaruYama, Takashi/0000-0003-0820-3219; Bertola, Adeline/0000-0002-4885-8423; Young, Howard/0000-0002-3118-5111	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056010, ZIADK056009, ZIADK056011] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Clemmesen O, 2002, DAN MED BULL, V49, P177; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Graziadei Ivo W, 2011, Liver Int, V31 Suppl 3, P24, DOI 10.1111/j.1478-3231.2011.02585.x; Grimley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039847; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Jagger AL, 2012, J AUTOIMMUN, V38, P29, DOI 10.1016/j.jaut.2011.11.015; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; McBurney MW, 2003, MOL CANCER RES, V1, P402; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nikolaou K, 2012, CANCER CELL, V21, P738, DOI 10.1016/j.ccr.2012.04.026; Oo YH, 2010, DIGEST DIS, V28, P31, DOI 10.1159/000282062; Pan K, 2010, INT J BIOL SCI, V6, P639; Peng H, 2012, CURR OPIN PHARMACOL, V12, P491, DOI 10.1016/j.coph.2012.03.002; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Van Meter M, 2011, AGING-US, V3, P829, DOI 10.18632/aging.100389; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang RH, 2010, INT J BIOL SCI, V6, P682; Weber A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13197; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zamarron BF, 2011, INT J BIOL SCI, V7, P651, DOI 10.7150/ijbs.7.651; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	56	120	126	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41903	41913		10.1074/jbc.M112.415182	http://dx.doi.org/10.1074/jbc.M112.415182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076146	Green Published, hybrid			2022-12-25	WOS:000312103000030
J	Kabagambe, EK; Ordovas, JM; Hopkins, PN; Tsai, MY; Arnett, DK				Kabagambe, Edmond K.; Ordovas, Jose M.; Hopkins, Paul N.; Tsai, Michael Y.; Arnett, Donna K.			The Relation between Erythrocyte Trans Fat and Triglyceride, VLDL- and HDL-Cholesterol Concentrations Depends on Polyunsaturated Fat	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; ADIPOSE-TISSUE; DIETARY-FAT; CARDIOVASCULAR-DISEASE; RICAN ADULTS; YOUNG MEN; ACIDS; RISK	Background: Trans fatty acids (TFA) lower HDL and increase triglyceride concentrations while polyunsaturated fatty acids (PUFA) lower triglycerides and may decrease HDL concentrations. The effect of the interaction between trans fat and PUFA on lipids is uncertain. Methods: Men and women (n = 1032) in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN) study were included. Fatty acids in erythrocyte membranes were measured with gas chromatography while data on potential confounders were obtained from questionnaires. To test the interaction between total erythrocyte PUFA (ePUFA) and TFA (eTFA) on lipid concentrations we distributed eTFA into tertiles and dichotomized ePUFA at the median concentration. Results: For the 1st, 2nd and 3rd tertiles of eTFA, multivariate-adjusted means+/-s.e.m for HDL were 46.2+/-1.1, 46.3+/-1.1 and 45.5+/-1.0 mg/dL among those with low ePUFA, respectively, while they were 50.0+/-1.1, 46.9+/-1.1 and 44.7+/-1.1 mg/dL among those with high ePUFA, respectively (P for interaction = 0.01). For the 1st, 2nd and 3rd tertiles of eTFA, multivariate-adjusted means+/-s.e.m for triglycerides were 178.6+/-11.3, 144.7+/-10.9 and 140.8+/-10.6, respectively, among those with low ePUFA, while they were 133.8+/-11.3, 145.7+/-10.9 and 149.3+/-11.5, respectively, among those with high ePUFA (P for interaction = 0.005). Results for VLDL were similar to those for triglycerides. No significant interactions were observed for LDL or total cholesterol. Conclusions: The relation between trans fat and HDL, VLDL and triglycerides may depend on PUFA. The benefit of avoiding trans fat may be greater among individuals with higher PUFA intake. Supplementation with PUFA among individuals with relatively high trans fat intake may have limited benefits on lipid profiles.	[Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Hopkins, Paul N.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Tufts University; United States Department of Agriculture (USDA); Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Kabagambe, EK (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	edmond.kabagambe@vanderbilt.edu	; Ordovas, Jose/B-8727-2013	Tsai, Michael/0000-0001-7553-3408; Kabagambe, Edmond/0000-0002-8993-3186; Ordovas, Jose/0000-0002-7581-5680	National Heart, Lung, and Blood Institute [U01HL072524]; American Heart Association grant NSDG [0635323N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association grant NSDG; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Heart, Lung, and Blood Institute grant no. U01HL072524. EKK is supported by the American Heart Association grant NSDG # 0635323N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8; Baylin A, 2003, J NUTR, V133, P1186, DOI 10.1093/jn/133.4.1186; Borba EF, 2006, CLIN DEV IMMUNOL, V13, P203, DOI 10.1080/17402520600876945; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2001, J AM COLL NUTR, V20, P5, DOI 10.1080/07315724.2001.10719008; Kabagambe E, 2010, J HOPKINS U TXB DYSL, P238; Kabagambe EK, 2008, CLIN CHEM, V54, P154, DOI 10.1373/clinchem.2007.095059; Kabagambe EK, 2009, ATHEROSCLEROSIS, V203, P633, DOI 10.1016/j.atherosclerosis.2008.08.005; Kabagambe EK, 2003, EUR J CLIN NUTR, V57, P1447, DOI 10.1038/sj.ejcn.1601709; Khan S, 2002, J LIPID RES, V43, P979; KrisEtherton PM, 1997, AM J CLIN NUTR, V65, P1628, DOI 10.1093/ajcn/65.5.1628S; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606; NCI, 2007, DIET HIST QUEST VERS; Noel SE, 2010, J NUTR, V140, P1846, DOI 10.3945/jn.110.124297; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Saravanan N, 2005, EUR J ENDOCRINOL, V153, P159, DOI 10.1530/eje.1.01946; Shen J, 2007, J NUTR, V137, P1846, DOI 10.1093/jn/137.8.1846; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Tholstrup T, 2006, AM J CLIN NUTR, V83, P237; Tholstrup T, 2003, EUR J CLIN NUTR, V57, P735, DOI 10.1038/sj.ejcn.1601605; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Tsai MY, 2005, J LAB CLIN MED, V145, P323, DOI 10.1016/j.lab.2005.03.009; Warensjo E, 2006, AM J CLIN NUTR, V84, P442; Williams CM, 1998, ATHEROSCLEROSIS, V141, pS87, DOI 10.1016/S0021-9150(98)00224-X	27	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47430	10.1371/journal.pone.0047430	http://dx.doi.org/10.1371/journal.pone.0047430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077615	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100111
J	Lv, XX; Yu, XH; Wang, YY; Wang, FQ; Li, HM; Wang, YP; Lu, DX; Qi, RB; Wang, HD				Lv, Xiuxiu; Yu, Xiaohui; Wang, Yiyang; Wang, Faqiang; Li, Hongmei; Wang, Yanping; Lu, Daxiang; Qi, Renbin; Wang, Huadong			Berberine Inhibits Doxorubicin-Triggered Cardiomyocyte Apoptosis via Attenuating Mitochondrial Dysfunction and Increasing Bcl-2 Expression	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CONGESTIVE-HEART-FAILURE; INDUCED CARDIOTOXICITY; IN-VIVO; CELL-DEATH; MICE; P53; PATHWAY; MANAGEMENT; SECONDARY	Cardiomyocyte apoptosis is an important event in doxorubicin (DOX)-induced cardiac injury. The aim of the present study was to investigate the protection of berberine (Ber) against DOX-triggered cardiomyocyte apoptosis in neonatal rat cardiomyocytes and rats. In neonatal rat cardiomyocytes, Ber attenuated DOX-induced cellular injury and apoptosis in a dose-dependent manner. However, Ber has no significant effect on viability of MCF-7 breast cancer cells treated with DOX. Ber reduced caspase-3 and caspase-9, but not caspase-8 activity in DOX-treated cardiomyocytes. Furthermore, Ber decreased adenosine monophosphate-activated protein kinase alpha (AMPK alpha) and p53 phosphorylation at 2 h, cytosolic cytochrome c and mitochondrial Bax levels and increased Bcl-2 level at 6 h in DOX-stimulated cardiomyocytes. Pretreatment with compound C, an AMPK inhibitor, also suppressed p53 phosphorylation and apoptosis in DOX-treated cardiomyocytes. DOX stimulation for 30 min led to a loss of mitochondrial membrane potential and a rise in the AMP/ATP ratio. Ber markedly reduced DOX-induced mitochondrial membrane potential loss and an increase in the AMP/ATP ratio at 1 h and 2 h post DOX exposure. In in vivo experiments, Ber significantly improved survival, increased stroke volume and attenuated myocardial injury in DOX-challenged rats. TUNEL and Western blot assays showed that Ber not only decreased myocardial apoptosis, caspase-3 activation, AMPKa and p53 phosphorylation, but also increased Bcl-2 expression in myocardium of rats exposed to DOX for 84 h. These findings indicate that Ber attenuates DOX-induced cardiomyocyte apoptosis via protecting mitochondria, inhibiting an increase in the AMP/ATP ratio and AMPKa phosphorylation as well as elevating Bcl-2 expression, which offer a novel mechanism responsible for protection of Ber against DOX-induced cardiomyopathy.	[Lv, Xiuxiu; Yu, Xiaohui; Wang, Yiyang; Wang, Faqiang; Li, Hongmei; Wang, Yanping; Lu, Daxiang; Qi, Renbin; Wang, Huadong] Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Lu, Daxiang; Qi, Renbin; Wang, Huadong] Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Wang, HD (corresponding author), Jinan Univ, Sch Med, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	owanghd@jnu.edu.cn		wang, yiyang/0000-0002-0318-6715	National Natural Science Foundation of China [30670826]; Fundamental Research Funds for the Central Universities [21609405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Natural Science Foundation of China (grant no. 30670826), Leading Academic Discipline Program, 211 Project for Jinan University (the 3rd phase) and the Fundamental Research Funds for the Central Universities (21609405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arola OJ, 2000, CANCER RES, V60, P1789; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Childs AC, 2002, CANCER RES, V62, P4592; Christiansen S, 2011, J CARDIOVASC SURG, V52, P133; Chua CC, 2009, CARDIOVASC RES, V81, P20, DOI 10.1093/cvr/cvn257; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; GOORMAGHTIGH E, 1987, BIOCHEMISTRY-US, V26, P1789, DOI 10.1021/bi00380a043; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hardie DG, 2004, J CLIN INVEST, V114, P465, DOI 10.1172/JCI200422683; Jang YM, 2004, FEBS LETT, V577, P483, DOI 10.1016/j.febslet.2004.10.053; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Ludke ARL, 2009, CAN J PHYSIOL PHARM, V87, P756, DOI 10.1139/Y09-059; Ma XA, 2010, METABOLISM, V59, P1619, DOI 10.1016/j.metabol.2010.03.009; Mahata S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-39; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; MARINNETO JA, 1988, CLIN CARDIOL, V11, P253, DOI 10.1002/clc.4960110411; MIYASHITA T, 1995, CELL, V80, P293; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Pointon AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012733; Sardao VA, 2009, CANCER CHEMOTH PHARM, V64, P811, DOI 10.1007/s00280-009-0932-x; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Thomas L, 2004, FUND CLIN PHARMACOL, V18, P649, DOI 10.1111/j.1472-8206.2004.00282.x; Wang SB, 2012, J BIOL CHEM, V287, P8001, DOI 10.1074/jbc.M111.315812; Wang YY, 2011, SHOCK, V35, P322, DOI 10.1097/SHK.0b013e3181facf73; Wang YQ, 2009, CARDIOVASC RES, V82, P484, DOI 10.1093/cvr/cvp078; Wu YJ, 2008, J MATH MED, V21, P217; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zeng XH, 2003, AM J CARDIOL, V92, P173, DOI 10.1016/S0002-9149(03)00533-2; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhao X, 2011, J INT MED RES, V39, P1720, DOI 10.1177/147323001103900514; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	40	93	102	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47351	10.1371/journal.pone.0047351	http://dx.doi.org/10.1371/journal.pone.0047351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077597	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100097
J	Schache, M; Baird, PN				Schache, Maria; Baird, Paul N.			Assessment of the Association of Matrix Metalloproteinases with Myopia, Refractive Error and Ocular Biometric Measures in an Australian Cohort	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; FORM-DEPRIVATION MYOPIA; GENE POLYMORPHISMS; COL1A1 GENE; SUSCEPTIBILITY; EXPRESSION; SCLERA; RECRUITMENT; JAPANESE; LUMICAN	Extracellular matrix proteins have been implicated in protein remodelling of the sclera in refractive error. The matrix metalloproteinases (MMPs) falling into the collagenase (MMP1, MMP8, MMP13), gelatinase (MMP2, MMP9) and stromelysin (MMP3, MMP10, MMP11) functional groups are particularly important. We wished to assess their association with myopia, refractive error and ocular biometric measures in an Australian cohort. A total of 543 unrelated individuals of Caucasian ethnicity were genotyped including 269 myopes (<=-1.0D) and 274 controls (>-1.0D). Tag single nucleotide polymorphisms (SNPs) (n = 53) were chosen to encompass these eight MMPs. Association tests were performed using linear and logistic regression analysis with age and gender as covariates. Spherical equivalent, myopia, axial length, anterior chamber depth and corneal curvature were the phenotypes of interest. Initial findings indicated that the best p values for each trait were 0.02 for myopia at rs2274755 (MMP9), 0.02 for SE at both rs3740938 (MMP8) and rs131451 (MMP11), 0.01 for axial length at rs11225395 (MMP8), 0.01 for anterior chamber depth at rs498186 (MMP1) and 0.02 at rs10488 (MMP1). However, following correction for multiple testing, none of these SNPs remained statistically significant. Our data suggests that the MMPs in the collagenase, gelatinase and stromelysin categories do not appear to be associated with myopia, refractive error or ocular biometric measures in this cohort.	[Schache, Maria; Baird, Paul N.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Schache, M (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.	mschache@unimelb.edu.au		Baird, Paul/0000-0002-1305-3502	National Health and Medical Research Council (NHMRC) Canberra, Australia through the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases [529923]; NHMRC [1028444]	National Health and Medical Research Council (NHMRC) Canberra, Australia through the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this work came from the National Health and Medical Research Council (NHMRC) Canberra, Australia through the Centre for Clinical Research Excellence in Translational Clinical Research in Eye Diseases (grant no.: 529923) and an NHMRC research fellowship to PNB (No. 1028444). The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird PN, 2010, PROGR RETINAL EYE RE, P31; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Biino G, 2005, HUM GENET, V116, P152, DOI 10.1007/s00439-004-1231-6; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; Dirani M, 2008, OPHTHAL EPIDEMIOL, V15, P140, DOI 10.1080/09286580801939338; Garoufalis P, 2005, OPHTHAL EPIDEMIOL, V12, P383, DOI 10.1080/09286580500281222; Gauderman WJ, 2006, COMPUTER PROGRAM POW; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; Hall NF, 2009, INVEST OPHTH VIS SCI, V50, P2632, DOI 10.1167/iovs.08-2427; Inamori Y, 2007, HUM GEN         0608; Leung KH, 2011, INVEST OPHTH VIS SCI, V52, P3893, DOI 10.1167/iovs.11-7286; Liang CL, 2007, J HUM GENET, V52, P374, DOI 10.1007/s10038-007-0117-6; Liang CL, 2006, AM J OPHTHALMOL, V142, P518, DOI 10.1016/j.ajo.2006.03.063; Majava M, 2006, HUM MUTAT; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P4080, DOI 10.1167/iovs.08-3346; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P1552, DOI 10.1167/iovs.08-2455; Meyer KJ, 2011, HUM GENET, V129, P91, DOI 10.1007/s00439-010-0904-6; Mutti DO, 2007, MOL VIS, V13, P1012; Nakanishi H, 2009, INVEST OPHTH VIS SCI, V50, P544, DOI 10.1167/iovs.08-2425; Nakanishi H, 2010, INVEST OPHTH VIS SCI, V51, P4432, DOI 10.1167/iovs.09-4871; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; Rada JA, 1998, INVEST OPHTH VIS SCI, V39, P1990; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Richardson AJ, 2006, J LAB CLIN MED, V147, P290, DOI 10.1016/j.lab.2006.01.005; Schache M, 2009, MOL VIS, V15, P2599; Schippert R, 2006, EXP EYE RES, V82, P710, DOI 10.1016/j.exer.2005.09.010; Siegwart JT, 2005, INVEST OPHTH VIS SCI, V46, P3484, DOI 10.1167/iovs.05-0194; Wang IJ, 2006, MOL VIS, V12, P852; Wang J, 2012, MOL MED REP, V5, P133, DOI 10.3892/mmr.2011.626; Wang PF, 2009, INVEST OPHTH VIS SCI, V50, P1546, DOI 10.1167/iovs.08-2537; Wojciechowski R, 2010, INVEST OPHTH VIS SCI, V51, P4989, DOI 10.1167/iovs.10-5474; Yip SP, 2011, INVEST OPHTH VIS SCI, V52, P6396, DOI 10.1167/iovs.11-7639; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38; Young TL, 2004, MOL VIS, V10, P163; Zhang DD, 2011, MOL VIS, V17, P3379	38	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47181	10.1371/journal.pone.0047181	http://dx.doi.org/10.1371/journal.pone.0047181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077567	Green Published, gold			2022-12-25	WOS:000309995100073
J	Shi, WF; Zhu, CD; Zheng, WM; Zheng, W; Ling, C; Carr, MJ; Higgins, DG; Zhang, Z				Shi, Weifeng; Zhu, Chaodong; Zheng, Weimin; Zheng, Wei; Ling, Cheng; Carr, Michael J.; Higgins, Desmond G.; Zhang, Zhong			Subgenotyping of Genotype C Hepatitis B Virus: Correcting Misclassifications and Identifying a Novel Subgenotype	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CLINICAL-SIGNIFICANCE; MAXIMUM-LIKELIHOOD; INFECTION; DISEASE; PAPUA; CLASSIFICATION; RECOMBINANT; PHILIPPINES; MUTATIONS	Background: More than ten subgenotypes of genotype C Hepatitis B virus (HBV) have been reported, including C1 to C16 and two C/D recombinant subgenotypes (CD1 and CD2), however, inconsistent designations of these subgenotypes still exist. Methodology/Principal Findings: We performed a phylogenetic analysis of all full-length genotype C HBV genome sequences to correct the misclassifications of HBV subgenotypes and to study the influence of recombination on HBV subgenotyping. Our results showed that although inclusion of the recombinant sequences changed the topology of the phylogenetic tree, it did not affect the subgenotyping of the non-recombinant sequences, except subgenotype C2. In addition, most of the subgenotypes have been properly designated. However, several misclassifications of HBV subgenotypes have been identified and corrected. For example, C11 proposed by Utsumi and colleagues in 2011 was found to be grouped with C12 proposed by Mulyanto and colleagues. Two sequences, GQ358157 and GU721029, previously designated as C6 have been re-designated as C12 and C7, respectively. Moreover, a quasi-subgenotype C2 was proposed, which included the old C2, several previously unclassified sequences and previously designated C14. In particular, we identified a novel subgenotype, tentative C14, which was well supported by phylogenetic analysis and sequence divergence of >4%. Conclusions/Significance: A number of misclassifications in the subgenotyping of genotype C HBV have been identified in this study. After correcting the misclassifications, we proposed a better classification for the subgenotyping of genotype C HBV, in which a novel quasi-subgenotype C2 and a novel subgenotype, tentative C14, were described. Based on this large-scale analysis, we propose that a novel subgenotype should only be reported after a complete comparison of all relevant sequences rather than a few representative sequences only.	[Shi, Weifeng; Zheng, Weimin; Ling, Cheng] Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China; [Zhu, Chaodong; Zheng, Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Zheng, Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Carr, Michael J.] Natl Univ Ireland Univ Coll Dublin, Natl Virus Reference Lab, Dublin 4, Ireland; [Higgins, Desmond G.] Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Zhang, Zhong] Taishan Med Coll, Dept Basic Med, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University College Dublin; University College Dublin; Shandong First Medical University & Shandong Academy of Medical Sciences	Shi, WF (corresponding author), Chinese Acad Sci, Guangzhou Inst Adv Technol, Guangzhou, Guangdong, Peoples R China.	wf.shi@giat.ac.cn; zh.tsmc@yahoo.com.cn	ZHU, Chao-Dong/E-5961-2011	ZHU, Chao-Dong/0000-0002-9347-3178; Carr, Michael/0000-0003-0011-6209; Higgins, Des/0000-0002-3952-3285	Science Foundation Ireland [07/IN.1/B1783]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was partly supported by Science Foundation Ireland (PI grant 07/IN.1/B1783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn SH, 2009, INTERVIROLOGY, V52, P321, DOI 10.1159/000237739; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Cavinta L, 2009, J CLIN MICROBIOL, V47, P3068, DOI 10.1128/JCM.01079-09; Cavinta L, 2009, J MED VIROL, V81, P983, DOI 10.1002/jmv.21475; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Elkady A, 2008, J GASTROEN HEPATOL, V23, P474, DOI 10.1111/j.1440-1746.2008.05321.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guettouche T, 2005, ANTIVIR THER, V10, P593; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Juniastuti S, 2011, J MED VIROL, V83, P225, DOI 10.1002/jmv.21963; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Lusida MI, 2008, J CLIN MICROBIOL, V46, P2160, DOI 10.1128/JCM.01681-07; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Mulyanto, 2011, J MED VIROL, V83, P54, DOI 10.1002/jmv.21931; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; Ni YH, 2004, GASTROENTEROLOGY, V127, P1733, DOI 10.1053/j.gastro.2004.09.048; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Pourkarim MR, 2010, J MED VIROL, V82, P379, DOI 10.1002/jmv.21726; Sakamoto T, 2007, J INFECT DIS, V196, P1487, DOI 10.1086/523111; Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0; Schaefer S, 2005, J VIRAL HEPATITIS, V12, P111, DOI 10.1111/j.1365-2893.2005.00584.x; Schaefer S, 2009, INTERVIROLOGY, V52, P323, DOI 10.1159/000242353; Shi WF, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-116; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A., 2006, P 20 INT PAR DISTR P, DOI DOI 10.1109/IPDPS.2006.1639535; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Sugauchi F, 2001, J GEN VIROL, V82, P883, DOI 10.1099/0022-1317-82-4-883; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thedja MD, 2011, ARCH VIROL, V156, P855, DOI 10.1007/s00705-011-0926-y; Utsumi T, 2009, J CLIN MICROBIOL, V47, P1842, DOI 10.1128/JCM.02328-08; Wang Z, 2007, J VIRAL HEPATITIS, V14, P426, DOI 10.1111/j.1365-2893.2006.00813.x; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Zhou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018708	47	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47271	10.1371/journal.pone.0047271	http://dx.doi.org/10.1371/journal.pone.0047271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077582	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100084
J	Snijders, AM; Marchetti, F; Bhatnagar, S; Duru, N; Han, J; Hu, Z; Mao, JH; Gray, JW; Wyrobek, AJ				Snijders, Antoine M.; Marchetti, Francesco; Bhatnagar, Sandhya; Duru, Nadire; Han, Ju; Hu, Zhi; Mao, Jian-Hua; Gray, Joe W.; Wyrobek, Andrew J.			Genetic Differences in Transcript Responses to Low-Dose Ionizing Radiation Identify Tissue Functions Associated with Breast Cancer Susceptibility	PLOS ONE			English	Article							ADAPTIVE RESPONSE; TGF-BETA; EXPRESSION; CELLS; HYPOXIA; ACTIVATION; PATHWAYS; MOUSE; RISK; CARCINOGENESIS	High dose ionizing radiation (IR) is a well-known risk factor for breast cancer but the health effects after low-dose (LD,,10 cGy) exposures remain highly uncertain. We explored a systems approach that compared LD-induced chromosome damage and transcriptional responses in strains of mice with genetic differences in their sensitivity to radiation-induced mammary cancer (BALB/c and C57BL/6) for the purpose of identifying mechanisms of mammary cancer susceptibility. Unirradiated mammary and blood tissues of these strains differed significantly in baseline expressions of DNA repair, tumor suppressor, and stress response genes. LD exposures of 7.5 cGy (weekly for 4 weeks) did not induce detectable genomic instability in either strain. However, the mammary glands of the sensitive strain but not the resistant strain showed early transcriptional responses involving: (a) diminished immune response, (b) increased cellular stress, (c) altered TGF beta-signaling, and (d) inappropriate expression of developmental genes. One month after LD exposure, the two strains showed opposing responses in transcriptional signatures linked to proliferation, senescence, and microenvironment functions. We also discovered a pre-exposure expression signature in both blood and mammary tissues that is predictive for poor survival among human cancer patients (p = 0.0001), and a post-LD-exposure signature also predictive for poor patient survival (p<0.0001). There is concordant direction of expression in the LD-exposed sensitive mouse strain, in biomarkers of human DCIS and in biomarkers of human breast tumors. Our findings support the hypothesis that genetic mechanisms that determine susceptibility to LD radiation induced mammary cancer in mice are similar to the tissue mechanisms that determine poor-survival in breast cancer patients. We observed non-linearity of the LD responses providing molecular evidence against the LNT risk model and obtained new evidence that LD responses are strongly influenced by genotype. Our findings suggest that the biological assumptions concerning the mechanisms by which LD radiation is translated into breast cancer risk should be reexamined and suggest a new strategy to identify genetic features that predispose or protect individuals from LD-induced breast cancer.	[Snijders, Antoine M.; Marchetti, Francesco; Bhatnagar, Sandhya; Duru, Nadire; Han, Ju; Hu, Zhi; Mao, Jian-Hua; Gray, Joe W.; Wyrobek, Andrew J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wyrobek, AJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ajwyrobek@lbl.gov	Gray, Joe/AAX-9549-2020; Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Marchetti, Francesco/0000-0002-9435-4867; Wyrobek, Andrew/0000-0002-5921-5298	Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory Directed Research and Development (LDRD) [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory Directed Research and Development (LDRD)	This work was supported by the Director, Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231, with additional support from the Lawrence Berkeley National Laboratory Directed Research and Development (LDRD) program funding to AJW and with separate funding to AMS under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2010, BIOMARK INSIGHTS, V5, P103, DOI 10.4137/BMI.S5740; Agrawal-Singh S, 2011, BLOOD; [Anonymous], 2006, HLTH RISKS EXPOSURE; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bhilwade HN, 2004, MUTAT RES-GEN TOX EN, V560, P19, DOI 10.1016/j.mrgentox.2004.01.009; BOICE JD, 1992, NEW ENGL J MED, V326, P781, DOI 10.1056/NEJM199203193261201; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Bonin F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-417; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; Dertinger SD, 1997, MUTAT RES-GEN TOX EN, V390, P257, DOI 10.1016/S1383-5718(97)00022-3; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Forzati, 2012, J CLIN INVEST; Furuya M, 2012, CANC SCI; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Helms MW, 2008, BRIT J CANCER, V99, P774, DOI 10.1038/sj.bjc.6604556; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Ina Y, 2005, RADIAT RES, V163, P153, DOI 10.1667/RR3289; Jiang YD, 2003, MOL CANCER RES, V1, P453; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Liu ZB, 2009, TUMORI J, V95, P53; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lowe XR, 2009, RADIAT RES, V171, P53, DOI 10.1667/RR1389.1; McBryan J, 2007, ONCOGENE, V26, P6406, DOI 10.1038/sj.onc.1210468; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; MOLE RH, 1978, BRIT J RADIOL, V51, P401, DOI 10.1259/0007-1285-51-606-401; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; Nguyen DH, 2011, CANCER CELL, V19, P640, DOI 10.1016/j.ccr.2011.03.011; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Ou K, 2006, J PROTEOME RES, V5, P2194, DOI 10.1021/pr060115n; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pedraza V, 2010, CANCER-AM CANCER SOC, V116, P486, DOI 10.1002/cncr.24805; Ponnaiya B, 1997, RADIAT RES, V147, P121, DOI 10.2307/3579411; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; SELVANAYAGAM CS, 1995, CANCER RES, V55, P3310; Shankar B, 1999, IMMUNOL LETT, V68, P237, DOI 10.1016/S0165-2478(99)00074-7; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STORER JB, 1988, RADIAT RES, V114, P331, DOI 10.2307/3577229; Symmans WF, 2005, ENDOCR-RELAT CANCER, V12, P1059, DOI 10.1677/erc.1.01051; Ullrich RL, 1998, INT J RADIAT BIOL, V74, P747, DOI 10.1080/095530098141023; ULLRICH RL, 1987, RADIAT RES, V111, P179, DOI 10.2307/3577031; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang LX, 2011, P NATL ACAD SCI USA, V108, pE803, DOI 10.1073/pnas.1103423108; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wolff S, 1998, ENVIRON HEALTH PERSP, V106, P277, DOI 10.2307/3433927; Wu Q, 2002, J BIOL CHEM, V277, P36329, DOI 10.1074/jbc.M204962200; Wyrobek AJ, 2011, MUTAT RES-GEN TOX EN, V722, P119, DOI 10.1016/j.mrgentox.2011.03.002; Xu XL, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-12; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Yu YJ, 2001, CANCER RES, V61, P1820; Zhong H, 1999, CANCER RES, V59, P5830	61	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45394	10.1371/journal.pone.0045394	http://dx.doi.org/10.1371/journal.pone.0045394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077491	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100016
J	Takeuchi, E; Sato, Y; Miura, E; Yamaura, H; Yuzaki, M; Yanagihara, D				Takeuchi, Eri; Sato, Yamato; Miura, Eriko; Yamaura, Hiroshi; Yuzaki, Michisuke; Yanagihara, Dai			Characteristics of Gait Ataxia in delta 2 Glutamate Receptor Mutant Mice, ho15J	PLOS ONE			English	Article							LONG-TERM DEPRESSION; CEREBELLAR INTERMEDIATE CORTEX; MOTOR COORDINATION; SPINOCEREBELLAR ACTIVITY; TREADMILL LOCOMOTION; PURKINJE-CELLS; WALKING CATS; LURCHER; MOUSE; HINDLIMB	The cerebellum plays a fundamental, but as yet poorly understood, role in the control of locomotion. Recently, mice with gene mutations or knockouts have been used to investigate various aspects of cerebellar function with regard to locomotion. Although many of the mutant mice exhibit severe gait ataxia, kinematic analyses of limb movements have been performed in only a few cases. Here, we investigated locomotion in ho15J mice that have a mutation of the delta 2 glutamate receptor. The cerebellum of ho15J mice shows a severe reduction in the number of parallel fiber-Purkinje synapses compared with wild-type mice. Analysis of hindlimb kinematics during treadmill locomotion showed abnormal hindlimb movements characterized by excessive toe elevation during the swing phase, and by severe hyperflexion of the ankles in ho15J mice. The great trochanter heights in ho15J mice were lower than in wild-type mice throughout the step cycle. However, there were no significant differences in various temporal parameters between ho15J and wild-type mice. We suggest that dysfunction of the cerebellar neuronal circuits underlies the observed characteristic kinematic abnormality of hindlimb movements during locomotion of ho15J mice.	[Takeuchi, Eri; Sato, Yamato; Yamaura, Hiroshi; Yanagihara, Dai] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Miura, Eriko; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Yuzaki, Michisuke; Yanagihara, Dai] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Keio University; Japan Science & Technology Agency (JST)	Yanagihara, D (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	dai-y@idaten.c.u-tokyo.ac.jp	Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding provided by Grants-in-Aid for Scientific Research (A) and (B) and Priority Areas "Emergence of Adaptive Motor Function through Interaction between Body, Brain and Environment" from The Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; ARSHAVSKY YI, 1983, TRENDS NEUROSCI, V6, P417, DOI 10.1016/0166-2236(83)90191-1; BOSCO G, 1993, J NEUROPHYSIOL, V70, P863, DOI 10.1152/jn.1993.70.2.863; Bosco G, 1997, J NEUROPHYSIOL, V78, P1421, DOI 10.1152/jn.1997.78.3.1421; Bosco G, 1996, J NEUROPHYSIOL, V76, P715, DOI 10.1152/jn.1996.76.2.715; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CADDY KWT, 1975, BRAIN RES, V91, P276, DOI 10.1016/0006-8993(75)90548-X; CADDY KWT, 1976, BRAIN RES, V111, P396, DOI 10.1016/0006-8993(76)90783-6; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Earhart GM, 2001, J NEUROPHYSIOL, V85, P759, DOI 10.1152/jn.2001.85.2.759; FORTIER PA, 1987, EXP BRAIN RES, V66, P271, DOI 10.1007/bf00243304; GRUNER JA, 1980, EXP BRAIN RES, V40, P361; GUASTAVINO JM, 1990, BRAIN RES, V523, P199, DOI 10.1016/0006-8993(90)91488-3; Hirai H, 2005, EMBO REP, V6, P90, DOI 10.1038/sj.embor.7400312; Hirai H, 2003, NAT NEUROSCI, V6, P869, DOI 10.1038/nn1086; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kurihara H, 1997, J NEUROSCI, V17, P9613; Lalouette A, 2001, NEUROSCIENCE, V105, P443, DOI 10.1016/S0306-4522(01)00193-2; Le Marec N, 2000, NEUROBIOL LEARN MEM, V73, P195, DOI 10.1006/nlme.1999.3926; Leblond H, 2003, J NEUROSCI, V23, P11411; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Motohashi J, 2007, BRAIN RES, V1140, P153, DOI 10.1016/j.brainres.2006.03.068; Orlovsky GN, 1999, NEURONAL CONTROL LOC, P215; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Pereira JE, 2006, BEHAV BRAIN RES, V172, P212, DOI 10.1016/j.bbr.2006.04.027; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119; UDO M, 1979, BRAIN RES, V160, P559, DOI 10.1016/0006-8993(79)91087-4; UDO M, 1979, BRAIN RES, V166, P405, DOI 10.1016/0006-8993(79)90228-2	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47553	10.1371/journal.pone.0047553	http://dx.doi.org/10.1371/journal.pone.0047553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077633	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100128
J	Wang, J; Spitz, MR; Amos, CI; Wu, XF; Wetter, DW; Cinciripini, PM; Shete, S				Wang, Jian; Spitz, Margaret R.; Amos, Christopher I.; Wu, Xifeng; Wetter, David W.; Cinciripini, Paul M.; Shete, Sanjay			Method for Evaluating Multiple Mediators: Mediating Effects of Smoking and COPD on the Association between the CHRNA5-A3 Variant and Lung Cancer Risk	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; SECONDARY PHENOTYPE; ODDS RATIOS; PREVALENCE; 15Q25; METAANALYSIS	A mediation model explores the direct and indirect effects between an independent variable and a dependent variable by including other variables (or mediators). Mediation analysis has recently been used to dissect the direct and indirect effects of genetic variants on complex diseases using case-control studies. However, bias could arise in the estimations of the genetic variant-mediator association because the presence or absence of the mediator in the study samples is not sampled following the principles of case-control study design. In this case, the mediation analysis using data from case-control studies might lead to biased estimates of coefficients and indirect effects. In this article, we investigated a multiple-mediation model involving a three-path mediating effect through two mediators using case-control study data. We propose an approach to correct bias in coefficients and provide accurate estimates of the specific indirect effects. Our approach can also be used when the original case-control study is frequency matched on one of the mediators. We employed bootstrapping to assess the significance of indirect effects. We conducted simulation studies to investigate the performance of the proposed approach, and showed that it provides more accurate estimates of the indirect effects as well as the percent mediated than standard regressions. We then applied this approach to study the mediating effects of both smoking and chronic obstructive pulmonary disease (COPD) on the association between the CHRNA5-A3 gene locus and lung cancer risk using data from a lung cancer case-control study. The results showed that the genetic variant influences lung cancer risk indirectly through all three different pathways. The percent of genetic association mediated was 18.3% through smoking alone, 30.2% through COPD alone, and 20.6% through the path including both smoking and COPD, and the total genetic variant-lung cancer association explained by the two mediators was 69.1%.	[Wang, Jian; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Spitz, Margaret R.] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Wang, Jian; Wu, Xifeng; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wetter, David W.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Houston, TX 77030 USA; [Cinciripini, Paul M.] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shete, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA.	sshete@mdanderson.org	Cinciripini, Paul M/I-5773-2012; Wang, Jian/A-3276-2013	Cinciripini, Paul M/0000-0003-2877-9928; Wetter, David/0000-0002-6366-0108	United States National Institutes of Health (NIH) [R01CA131324]; University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; NIH [U19CA148127, R01CA121197]; NATIONAL CANCER INSTITUTE [R01CA121197, R01CA131324, U19CA148127] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States National Institutes of Health (NIH) grant R01CA131324 (SS) and by a faculty fellowship from The University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment (JW). This study makes use of lung cancer data generated by support from NIH grants U19CA148127 and R01CA121197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWIN DF, 1975, AM SOCIOL REV, V40, P37, DOI 10.2307/2094445; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Blackburn EH, 2011, CANCER PREV RES, V4, P473, DOI 10.1158/1940-6207.CAPR-11-0066; Chen LS, 2012, GENET EPIDEMIOL, V36, P340, DOI 10.1002/gepi.21627; Chen LS, 2012, AM J PSYCHIAT; Efron B., 1994, INTRO BOOTSTRAP; Eisner MD, 2005, CHEST, V127, P1890, DOI 10.1378/chest.127.6.1890; Fairchild AJ, 2009, BEHAV RES METHODS, V41, P486, DOI 10.3758/BRM.41.2.486; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Hayes AF, 2012, ANAL PRIMER CO UNPUB; Hayes AF, 2011, COMMUN SER, P434; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; Kaur-Knudsen D, 2011, J CLIN ONCOL, V29, P2875, DOI 10.1200/JCO.2010.32.9870; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Li HL, 2010, GENET EPIDEMIOL, V34, P427, DOI 10.1002/gepi.20495; Lin DY, 2009, GENET EPIDEMIOL, V33, P256, DOI 10.1002/gepi.20377; Lindberg A, 2006, RESP MED, V100, P264, DOI 10.1016/j.rmed.2005.04.029; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; MacKinnon DP, 2007, CLIN TRIALS, V4, P499, DOI 10.1177/1740774507083434; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Mathworks, 2002, MATLAB; Maurice E., 2005, Morbidity and Mortality Weekly Report, V54, P1121; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; POWELL M. J. D., 1970, NUMERICAL METHODS NO; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c; Rothman K., 1998, MODERN EPIDEMIOLOGY; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Spitz MR, 2012, J NATL CANCER I, V104, P720, DOI 10.1093/jnci/djs211; Stav D, 2007, ISR MED ASSOC J, V9, P800; Straus SE, 2002, J GEN INTERN MED, V17, P684, DOI 10.1046/j.1525-1497.2002.20102.x; Taylor AB, 2008, ORGAN RES METHODS, V11, P241, DOI 10.1177/1094428107300344; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; VILLENEUVE PJ, 1994, CAN J PUBLIC HEALTH, V85, P385; Wacholder S, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn380; Wang J, 2012, ANAL SECOND IN PRESS; Wang J, 2011, GENET EPIDEMIOL, V35, P739, DOI 10.1002/gepi.20611; Wang JA, 2011, GENET EPIDEMIOL, V35, P190, DOI 10.1002/gepi.20568; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Young RP, 2008, EUR RESPIR J, V32, P1158, DOI 10.1183/09031936.00093908; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Young RP, 2011, APPL CLIN GENET, V4, P1, DOI 10.2147/TACG.S15758; Zaas D, 2004, CHEST, V125, P106, DOI 10.1378/chest.125.1.106; Zhu WS, 2009, J KOREAN STAT SOC, V38, P1, DOI 10.1016/j.jkss.2008.10.006	61	13	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47705	10.1371/journal.pone.0047705	http://dx.doi.org/10.1371/journal.pone.0047705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077662	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100154
J	Wojgani, H; Kehsa, C; Cloutman-Green, E; Gray, C; Gant, V; Klein, N				Wojgani, Hedieh; Kehsa, Catherine; Cloutman-Green, Elaine; Gray, Colin; Gant, Vanya; Klein, Nigel			Hospital Door Handle Design and Their Contamination with Bacteria: A Real Life Observational Study. Are We Pulling against Closed Doors?	PLOS ONE			English	Article								Objective: To determine whether microbial contamination of door handles in two busy intensive care units and one high dependency unit was related to their design, location, and usage. Design: Observational study of the number of viable bacteria on existing door handles of different design at defined entry/exit points with simultaneous data collection of who used these doors and how often. Setting: Two busy specialised intensive care units and one high dependency unit in a tertiary referral NHS neurological hospital. Main outcome measures: Surface bacterial density on door handles with reference to design, location, and intensity of use. Results: We found a significant correlation between the frequency of movements through a door and the degree to which it was contaminated (p = <0.01). We further found that the door's location, design and mode of use all influenced contamination. When compared to push plate designs, pull handles revealed on average a five fold higher level of contamination; lever handles, however, displayed the highest levels of bacterial contamination when adjusted for frequency of use. We also observed differences in contamination levels at doors between clinical areas, particularly between the operating theatres and one of the ICUs. Conclusions: Door handles in busy, "real life" high acuity clinical environments were variably contaminated with bacteria, and the number of bacteria found related to design, location, mode and frequency of operation. Largely ignored issues of handle and environmental design can support or undermine strategies designed to limit avoidable pathogen transmission, especially in locations designed to define "thresholds" and impose physical barriers to pathogen transmission between clinical areas. Developing a multidisciplinary approach beyond traditional boundaries for purposes of infection control may release hitherto unappreciated options and beneficial outcomes for the control of at least some hospital acquired infections.	[Gant, Vanya] Univ Coll London Hosp NHS Fdn Trust, Dept Microbiol, London, England; [Wojgani, Hedieh; Gray, Colin] Univ Reading, Sch Construct Management & Engn, Reading, Berks, England; [Kehsa, Catherine; Cloutman-Green, Elaine; Klein, Nigel] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Reading; University of London; University College London	Gant, V (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Dept Microbiol, London, England.	Vanya.gant@uclh.nhs.uk		Klein, Nigel/0000-0003-3925-9258; Cloutman-Green, Elaine/0000-0001-7534-3196	EPSRC through the Health and Care Research and Innovation Centre (HaCIRIC); British Council through Foreign and Commonwealth Office Fellowship; UCLH Comprehensive Biomedical Research Centre; HaCIRIC HCAI group; Engineering and Physical Sciences Research Council [EP/I029788/1] Funding Source: researchfish; National Institute for Health Research [HCS/D10/010] Funding Source: researchfish; EPSRC [EP/I029788/1] Funding Source: UKRI	EPSRC through the Health and Care Research and Innovation Centre (HaCIRIC); British Council through Foreign and Commonwealth Office Fellowship; UCLH Comprehensive Biomedical Research Centre; HaCIRIC HCAI group; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the EPSRC through the Health and Care Research and Innovation Centre (HaCIRIC). Hedieh Wojgani is a HaCIRIC Research Fellow. Catherine Kesah was funded by the British Council through Foreign and Commonwealth Office Fellowship. Vanya Gant was partly funded by the UCLH Comprehensive Biomedical Research Centre.; We acknowledge the support and discussions with the HaCIRIC HCAI group and particularly Katherine Harris, John Hartley, Serge Guillas, Kaman Lai and Bunny Hilton. We also gratefully acknowledge the medical, nursing and Allied Health Professional staff of MITU/SITU for their willing and enthusiastic collaboration.	Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4; Dettenkofer M, 2004, INFECT CONT HOSP EP, V25, P21, DOI 10.1086/502286; Gould DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005186.pub3; Hamilton D, 2010, J HOSP INFECT, V74, P62, DOI 10.1016/j.jhin.2009.08.006; NHS Scotland National HAI Prevalence Survey NHS Scotland, 2007, NHS SCOTL NAT HAI PR; Oelberg DG, 2000, PEDIATRICS, V105, P311, DOI 10.1542/peds.105.2.311; UK Department of Health, 2003, WINN WAYS DH 2003; UK Department of Health, 2002, GETT AH CURV DH 2002; UK National Health Service Estates, 2003, IMP BUILT ENV CAR A; UK National Health Service Estates, 2003, A E DES EV EV 2 PROP; UK National Institute for Clinical Excellence, 2003, INF CONTR PREV HEALT; Ulrich R, 2008, HERD, V1, P27; Ulrich R, 2000, P C HEAL DES HEAL IM; Weaver L, 2008, J HOSP INFECT, V68, P145, DOI 10.1016/j.jhin.2007.11.011; World Health Organization, 2009, WHO GUID HAND HYG HL; Youngster I, 2009, AM J INFECT CONTROL, V37, P861, DOI 10.1016/j.ajic.2009.03.006	17	23	24	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e40171	10.1371/journal.pone.0040171	http://dx.doi.org/10.1371/journal.pone.0040171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077475	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100003
J	Zeng, JM; Wang, YJ; Zhang, QL				Zeng, Jianmin; Wang, Yujiao; Zhang, Qinglin			An ERP Study on Decisions between Attractive Females and Money	PLOS ONE			English	Article							PREFRONTAL CORTEX; MONETARY REWARDS; BRAIN; STIMULI; MEN; INHIBITION; POTENTIALS; ATTENTION; RESPONSES; COMPONENT	To investigate the neural processes of decision-makings between attractive females and money, we recorded 18 male participants' brain event-related potentials (ERPs) when they performed a novel task of deciding between viewing an attractive female's fuzzy picture in clear and gaining a certain amount of money. Two types of attractive females were included: sexy females and beautiful females. Several new electrophysiological discoveries were obtained as following. First, the beautiful females vs. money task (task B) elicited a larger positive ERP deflection (P2) than the sexy females vs. money task (task S) between 290 and 340 ms, and this probably related to the perception matching process between a visual input and an internal representation or expectation. Second, task S evoked greater negative ERP waves (N2) than task B during the time window of 340-390 ms, and this might relate to response conflict and cognitive monitoring for impulsive tendency. Third, the ERP positivity in task S was larger than task B in the time interval of 550-1000 ms, reflecting that sexy female images may have higher decision value for males than beautiful female images. Fourth, compared with choosing to gain money, choosing to view an attractive female evoked a larger late positive component (LPC) during the same time window, possibly because attractive females are more direct and evolutionarily earlier rewards for males than money amounts.	[Zeng, Jianmin; Wang, Yujiao; Zhang, Qinglin] Southwest Univ, Sch Psychol, Chongqing, Peoples R China	Southwest University - China	Zeng, JM (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.	james_psych@yeah.net; zhangql@swu.edu.cn		Zeng, Jianmin/0000-0003-0440-6684	National Natural Science Foundation [30970892]; Key Discipline Fund of National 211 Project; Major Program for Key Research Institutes of Humanities and Social Sciences of the Ministry of Education of China [2009JJD720023]; Fundamental Research Funds for the Central Universities [SWU1009095]; Doctoral Foundation of Southwest University [SWUB2007069]; Post-doctoral Foundation of Southwest University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Discipline Fund of National 211 Project; Major Program for Key Research Institutes of Humanities and Social Sciences of the Ministry of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Doctoral Foundation of Southwest University(Southwest University - China); Post-doctoral Foundation of Southwest University	This work was supported by National Natural Science Foundation (30970892), Key Discipline Fund of National 211 Project, Major Program for Key Research Institutes of Humanities and Social Sciences of the Ministry of Education of China (2009JJD720023), Fundamental Research Funds for the Central Universities (SWU1009095), Doctoral Foundation of Southwest University (SWUB2007069), and Post-doctoral Foundation of Southwest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Anokhin AP, 2006, BRAIN RES, V1093, P167, DOI 10.1016/j.brainres.2006.03.108; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Evans KM, 2007, NEUROPSYCHOLOGIA, V45, P1777, DOI 10.1016/j.neuropsychologia.2006.12.014; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Freunberger R, 2007, NEUROSCI LETT, V426, P181, DOI 10.1016/j.neulet.2007.08.062; Goyer JP, 2008, J COGNITIVE NEUROSCI, V20, P2058, DOI 10.1162/jocn.2008.20134; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hayden BY, 2007, P R SOC B, V274, P1751, DOI 10.1098/rspb.2007.0368; Kable AC, 2010, INT J NUMBER THEORY, V6, P1215, DOI 10.1142/S1793042110003460; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Krug R, 2000, PSYCHOPHYSIOLOGY, V37, P111, DOI 10.1017/S0048577200980594; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lawler EJ, 1999, ANNU REV SOCIOL, V25, P217, DOI 10.1146/annurev.soc.25.1.217; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Martin LE, 2009, PERS INDIV DIFFER, V46, P303, DOI 10.1016/j.paid.2008.10.019; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Smith DV, 2010, J NEUROSCI, V30, P2490, DOI 10.1523/JNEUROSCI.3319-09.2010; Spreckelmeyer KN, 2009, SOC COGN AFFECT NEUR, V4, P158, DOI 10.1093/scan/nsn051; van Lankveld JJDM, 2008, BIOL PSYCHOL, V79, P200, DOI 10.1016/j.biopsycho.2008.04.016; Waismann R, 2003, ARCH SEX BEHAV, V32, P135, DOI 10.1023/A:1022448308791; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]	31	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45945	10.1371/journal.pone.0045945	http://dx.doi.org/10.1371/journal.pone.0045945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077499	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100023
J	Zhou, QL; Liu, KH; Wu, HY; Chen, LH; Pouranan, V; Yuan, MX; Xiao, Z; Peng, WS; Xiang, A; Tang, R; Zhang, WZ				Zhou, Qiaoling; Liu, Kanghan; Wu, Hongyu; Chen, Lihe; Pouranan, Veeraragoo; Yuan, Mingxia; Xiao, Zhou; Peng, Weisheng; Xiang, Ao; Tang, Rong; Zhang, Wenzheng			Spironolactone Rescues Dot1a-Af9-Mediated Repression of Endothelin-1 and Improves Kidney Injury in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; DUCT-SPECIFIC KNOCKOUT; HISTONE H3; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; FUSION PARTNER; RENAL INJURY; ENAC-ALPHA; ALDOSTERONE; METHYLATION	The molecular mechanism linking aldosterone and endothelin-1 in the development of diabetic nephropathy has not been completely elucidated. Here, we provide evidence showing that streptozotocin-induced diabetic rats have significantly increased aldosterone and endothelin-1 in the kidney tissue and markedly decreased expression of Dot1a and Af9. Blocking aldosterone with spironolactone significantly reduced proteinuria, glomerulosclerosis, tubulointerstitial injury and endothelin-1 expression, and significantly increased Dot1a and Af9 expression. Increasing Dot1a and Af9 expression by spironolactone or by stable transfection led to impaired endothelin-1 expression in NRK-52 cells. In contrast, downregulation of Dot1a and Af9 by aldosterone in NRK-52E cells caused upregulation of endothelin-1. Genetic inactivation of Dot1l, which encodes Dot1a, in Aqp2-expressing principal cells of mouse kidney impaired association of Dot1a and H3 dimethyl K79 with the specific subregions of endothelin-1 promoter, and upregulates endothelin-1 mRNA and protein expression. Our data suggest that Dot1a and Af9 repress endothelin-1 in vitro and in vivo. Excessive aldosterone induces kidney injury, in part possibly by downregulating Dot1a and Af9, and thus relieving Dot1a-Af9-mediated repression to increase endothelin-1 transcription. Spironolactone ameliorates kidney injury in Streptozotocin-induced diabetic rats, possibly by restoring Dot1a-Af9-mediated repression to reduce endothelin-1 expression. Therefore, Dot1a and Af9 as aldosterone-downregulated targets are negative regulators of endothelin-1 transcription in vitro and in vivo, and may be considered as new potential therapeutic targets of kidney injury in diabetes.	[Zhou, Qiaoling; Liu, Kanghan; Pouranan, Veeraragoo; Yuan, Mingxia; Xiao, Zhou; Peng, Weisheng; Xiang, Ao; Tang, Rong] Cent S Univ, Xiangya Hosp, Dept Nephropathy, Changsha, Hunan, Peoples R China; [Wu, Hongyu; Zhang, Wenzheng] Univ Texas Med Sch Houston, Dept Internal Med, Houston, TX USA; [Chen, Lihe; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA	Central South University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Zhou, QL (corresponding author), Cent S Univ, Xiangya Hosp, Dept Nephropathy, Changsha, Hunan, Peoples R China.	zhouqling@yahoo.com.cn; wenzheng.zhang@uth.tmc.edu	Chen, Lihe/N-3186-2018	Chen, Lihe/0000-0002-6207-6364	National Natural Science Foundation of China (NSFC) [81070552]; National Institutes of Health [R01 DK080236]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080236] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Natural Science Foundation of China (NSFC) grant 81070552 (to Q.Z.), and National Institutes of Health Grants R01 DK080236 (to W.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; Doi T, 2008, AM J PHYSIOL-HEART C, V295, pH1279, DOI 10.1152/ajpheart.00148.2008; EMORI T, 1991, HYPERTENSION, V18, P165, DOI 10.1161/01.HYP.18.2.165; Erfurth F, 2004, LEUKEMIA, V18, P92, DOI 10.1038/sj.leu.2403200; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Fujisawa G, 2004, KIDNEY INT, V66, P1493, DOI 10.1111/j.1523-1755.2004.00913.x; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Giunti Sara, 2006, J Clin Hypertens (Greenwich), V8, P108, DOI 10.1111/j.1524-6175.2005.04508.x; Gumz ML, 2003, AM J PHYSIOL-RENAL, V285, pF664, DOI 10.1152/ajprenal.00353.2002; Han KH, 2006, KIDNEY INT, V70, P111, DOI 10.1038/sj.ki.5000438; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; IIDA S, 1993, ONCOGENE, V8, P3085; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kohan DE, 1997, AM J KIDNEY DIS, V29, P2, DOI 10.1016/S0272-6386(97)90004-4; Kolkhof P, 2012, MOL CELL ENDOCRINOL, V350, P310, DOI 10.1016/j.mce.2011.06.025; Li JJ, 2009, AM J PHYSIOL-RENAL, V297, pF200, DOI 10.1152/ajprenal.90649.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; MORITA T, 1994, CIRC RES, V75, P630, DOI 10.1161/01.RES.75.4.630; Nakagawa T, 2005, J CELL BIOCHEM, V95, P589, DOI 10.1002/jcb.20422; Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863; Nakamaki S, 2011, EXP BIOL MED, V236, P614, DOI 10.1258/ebm.2011.010218; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Park JY, 2003, BIOCHEM BIOPH RES CO, V303, P891, DOI 10.1016/S0006-291X(03)00436-4; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Reisenauer MR, 2010, AM J PHYSIOL-RENAL, V299, pF63, DOI 10.1152/ajprenal.00105.2010; Reisenauer MR, 2009, J BIOL CHEM, V284, P35659, DOI 10.1074/jbc.M109.038448; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Salber D, 2008, J NUCL MED, V49, P995, DOI 10.2967/jnumed.108.050880; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; Schwarz U, 1998, KIDNEY INT, V53, P1696, DOI 10.1046/j.1523-1755.1998.00951.x; Singer MS, 1998, GENETICS, V150, P613; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Stow LR, 2009, J BIOL CHEM, V284, P30087, DOI 10.1074/jbc.M109.030718; Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Taira M, 2008, EUR J PHARMACOL, V589, P264, DOI 10.1016/j.ejphar.2008.06.019; Trachtman H, 2004, J UROLOGY, V172, P1590, DOI 10.1097/01.ju.0000140445.82949.54; Vallender TW, 2006, FEBS LETT, V580, P4560, DOI 10.1016/j.febslet.2006.07.017; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; WANG DL, 1995, J CELL PHYSIOL, V163, P400, DOI 10.1002/jcp.1041630220; WHORWOOD CB, 1995, J MOL ENDOCRINOL, V15, P93, DOI 10.1677/jme.0.0150093; Wolf SC, 2006, BIOCHEM PHARMACOL, V71, P1175, DOI 10.1016/j.bcp.2006.01.001; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027429; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839	58	16	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47360	10.1371/journal.pone.0047360	http://dx.doi.org/10.1371/journal.pone.0047360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077601	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100100
J	Otieno, S; Kriwacki, R				Otieno, Steve; Kriwacki, Richard			Probing the Role of Nascent Helicity in p27 Function as a Cell Cycle Regulator	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; DEPENDENT-KINASE INHIBITOR; CDK INHIBITOR; CONFORMATIONAL DISORDER; P27(KIP1); ARREST; PROGRESSION; P57(KIP2); MECHANISM; APOPTOSIS	p27 regulates the activity of Cdk complexes which are the principal governors of phase transitions during cell division. Members of the p27 family of proteins, which also includes p21 and p57, are called the Cip/Kip cyclin-dependent kinase regulators (CKRs). Interestingly, the Cip/Kip CKRs play critical roles in cell cycle regulation by being intrinsically unstructured, a characteristic contrary to the classical structure-function paradigm. They exhibit nascent helicity which has been localized to a segment referred to as sub-domain LH. The nascent helicity of this sub-domain is conserved and we hypothesize that it is an important determinant of their functional properties. To test this hypothesis, we successfully designed and prepared p27 variants in which domain LH was either more or less helical with respect to the wild-type protein. Thermal denaturation experiments showed that the ternary complexes of the p27 variants bound to Cdk2/Cyclin A were less stable compared to the wild-type complex. Isothermal titration calorimetry experiments showed a decrease in the enthalpy of binding for all the mutants with respect to p27. The free energies of binding varied within a much narrower range. In vitro Cdk2 inhibition assays showed that the p27 variants exhibited disparate inhibitory potencies. Furthermore, when over-expressed in NIH 3T3 mouse fibroblast cells, the less helical p27 variants were less effective in causing cell cycle arrest relative to the wild-type p27. Our results indicate that the nascent helicity of sub-domain LH plays a key role mediating the biological function of p27.	[Otieno, Steve; Kriwacki, Richard] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Kriwacki, Richard] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, R (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org	Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018	NIH (Cancer Center Support Core) [P30CA21765, R01CA082491]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA082491, P30CA021765] Funding Source: NIH RePORTER	NIH (Cancer Center Support Core); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by the NIH (Cancer Center Support Core Grant P30CA21765 to St Jude Children's Research Hospital and R01CA082491 to R.W.K.), www.nih.gov, and the American Lebanese Syrian Associated Charities (ALSAC), www.stjude.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JN, 2002, PROTEINS, V46, P1, DOI 10.1002/prot.10018; Bowman P, 2006, BBA-PROTEINS PROTEOM, V1764, P182, DOI 10.1016/j.bbapap.2005.12.016; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; DRAETTA GF, 1994, CURR OPIN CELL BIOL, V6, P842, DOI 10.1016/0955-0674(94)90054-X; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Otieno S, 2011, BIOPHYS J, V100, P2486, DOI 10.1016/j.bpj.2011.04.014; Ou L, 2011, J BIOL CHEM, P27; Ou L, 2012, ACS CHEM BIOL, V7, P678, DOI 10.1021/cb200487h; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; SOLOMON MJ, 1994, TRENDS BIOCHEM SCI, V19, P496, DOI 10.1016/0968-0004(94)90137-6; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	36	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47177	10.1371/journal.pone.0047177	http://dx.doi.org/10.1371/journal.pone.0047177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071750	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500034
J	Chen, JJ; Zhang, LJ; Wen, WG; Hao, JQ; Zeng, PM; Qian, XP; Zhang, Y; Yin, YH				Chen, Juanjuan; Zhang, Lijie; Wen, Weigang; Hao, Jiaqing; Zeng, Pumei; Qian, Xiaoping; Zhang, Yu; Yin, Yanhui			Induction of HCA587-Specific Antitumor Immunity with HCA587 Protein Formulated with CpG and ISCOM in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; HEPATOCELLULAR-CARCINOMA; MELANOMA PATIENT; DENDRITIC CELLS; MAGE-3 PROTEIN; EXPRESSION; CD4(+); IDENTIFICATION; VACCINATION	HCA587 (also known as MAGE-C2) is a "cancer-testis" antigen highly expressed in a number of malignancies with unique immunological properties, making it a promising target for tumor immunotherapy. In this report, we demonstrated that HCA587 protein, when formulated with adjuvants CpG-containing oligodeoxynucleotides (CpG ODN) and ISCOM, was capable of inducing a potent cellular and humoral immune response as indicated by the presence of a large number of HCA587-specific, IFN-gamma-producing CD4(+) T cells and high levels of HCA587-specific antibodies. More importantly, vaccination with HCA587 conferred protection against challenge with HCA587-expressing B16 melanoma in prophylactic and therapeutic settings. In analysis of the mechanisms underlying the protective effect, we showed that the vaccination was followed by enhanced accumulation of tumor-infiltrating lymphocytes (TILs) with enrichment of conventional CD4(+) T cells but reduced representation of Treg cells. Further, the antitumor effect was largely abrogated in mice either depleted of CD4(+) T cells or deficient for IFN-gamma. These results indicate that HCA587 protein vaccine possesses evident antitumor activity in a mouse model and holds promise for treatment of human cancers.	[Zhang, Yu] Peking Univ, Hlth Sci Ctr, Minist Hlth, Dept Immunol,Sch Basic Med Sci, Beijing 100871, Peoples R China; Peking Univ, Hlth Sci Ctr, Minist Hlth, Key Lab Med Immunol, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Hlth, Dept Immunol,Sch Basic Med Sci, Beijing 100871, Peoples R China.	zhangyu007@bjmu.edu.cn; yinyanhui@bjmu.edu.cn	Hao, Jiaqing/F-1266-2017	Hao, Jiaqing/0000-0002-2834-7255	Ministry of Science and Technology [2006AA02Z486, 2011CB946100]; Beijing Municipal Government Foundation for Natural Sciences [7071006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Beijing Municipal Government Foundation for Natural Sciences	This work is supported by grants from the Ministry of Science and Technology (2006AA02Z486; 2011CB946100) and Beijing Municipal Government Foundation for Natural Sciences (7071006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Atanackovic D, 2004, J IMMUNOL, V172, P3289, DOI 10.4049/jimmunol.172.5.3289; Atanackovic D, 2008, P NATL ACAD SCI USA, V105, P1650, DOI 10.1073/pnas.0707140104; Benchetrit F, 2003, B CANCER, V90, P677; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Carrasco J, 2008, J IMMUNOL, V180, P3585, DOI 10.4049/jimmunol.180.5.3585; Chang JCC, 1998, ADV DRUG DELIVER REV, V32, P173, DOI 10.1016/S0169-409X(98)00009-X; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; Godelaine D, 2007, CANCER IMMUNOL IMMUN, V56, P753, DOI 10.1007/s00262-006-0244-5; Haanen JBAG, 2006, CANCER IMMUNOL IMMUN, V55, P451, DOI 10.1007/s00262-005-0018-5; Hinrichs CS, 2006, CURR OPIN IMMUNOL, V18, P363, DOI 10.1016/j.coi.2006.03.009; Jahnisch H, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/517493; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kariyama K, 1999, BRIT J CANCER, V81, P1080, DOI 10.1038/sj.bjc.6690810; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Kruit WHJ, 2005, INT J CANCER, V117, P596, DOI 10.1002/ijc.21264; Li B, 2005, CLIN EXP IMMUNOL, V140, P310, DOI 10.1111/j.1365-2249.2005.02786.x; Li B, 2004, SCAND J IMMUNOL, V60, P506, DOI 10.1111/j.0300-9475.2004.01503.x; Li B, 2003, LAB INVEST, V83, P1185, DOI 10.1097/01.LAB.0000080605.73839.96; Li B, 2003, WORLD J GASTROENTERO, V9, P678, DOI 10.3748/wjg.v9.i4.678; Lucas S, 2000, INT J CANCER, V87, P55, DOI 10.1002/1097-0215(20000701)87:1<55::AID-IJC8>3.3.CO;2-A; Lugade AA, 2008, J IMMUNOL, V180, P3132, DOI 10.4049/jimmunol.180.5.3132; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Ma WB, 2004, INT J CANCER, V109, P698, DOI 10.1002/ijc.20038; Ma WB, 2011, INT J CANCER, V129, P2427, DOI 10.1002/ijc.25911; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nakamura S, 2006, J GASTROEN HEPATOL, V21, P1281, DOI 10.1111/j.1440-1746.2006.04271.x; Nishimura T, 2000, CANCER CHEMOTH PHARM, V46, pS52, DOI 10.1007/PL00014051; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Pearse MJ, 2005, ADV DRUG DELIVER REV, V57, P465, DOI 10.1016/j.addr.2004.09.006; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Qin ZH, 2003, CANCER RES, V63, P4095; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Sharma P, 2008, J IMMUNOTHER, V31, P849, DOI 10.1097/CJI.0b013e3181891574; Steitz J, 2001, CANCER RES, V61, P8643; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Wen WG, 2011, CANCER SCI, V102, P1455, DOI 10.1111/j.1349-7006.2011.01986.x; Xing Q, 2008, BIOCHEM BIOPH RES CO, V372, P331, DOI 10.1016/j.bbrc.2008.05.049; Xu H, 2012, ONCOL LETT, V3, P39, DOI 10.3892/ol.2011.441; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhuang Ran, 2006, Cancer Immun, V6, P7	52	11	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47219	10.1371/journal.pone.0047219	http://dx.doi.org/10.1371/journal.pone.0047219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071764	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700068
J	Chin, E; Kirker, K; Zuck, M; James, G; Hybiske, K				Chin, Elizabeth; Kirker, Kelly; Zuck, Meghan; James, Garth; Hybiske, Kevin			Actin Recruitment to the Chlamydia Inclusion Is Spatiotemporally Regulated by a Mechanism That Requires Host and Bacterial Factors	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; TRACHOMATIS; CYTOSKELETON; SEPTINS; ENTRY; RISK; FORCHLORFENURON; IDENTIFICATION; PNEUMONIAE; NUCLEATOR	The ability to exit host cells at the end of their developmental growth is a critical step for the intracellular bacterium Chlamydia. One exit strategy, extrusion, is mediated by host signaling pathways involved with actin polymerization. Here, we show that actin is recruited to the chlamydial inclusion as a late event, occurring after 20 hours post-infection (hpi) and only within a subpopulation of cells. This event increases significantly in prevalence and extent from 20 to 68 hpi, and actin coats strongly correlated with extrusions. In contrast to what has been reported for other intracellular pathogens, actin nucleation on Chlamydia inclusions did not 'flash', but rather exhibited moderate depolymerization dynamics. By using small molecule agents to selectively disrupt host signaling pathways involved with actin nucleation, modulate actin polymerization dynamics and also to disable the synthesis and secretion of chlamydial proteins, we further show that host and bacterial proteins are required for actin coat formation. Transient disruption of either host or bacterial signaling pathways resulted in rapid loss of coats in all infected cells and a reduction in extrusion formation. Inhibition of Chlamydia type III secretion also resulted in rapid loss of actin association on inclusions, thus implicating chlamydial effector proteins(s) as being central factors for engaging with host actin nucleating factors, such as formins. In conclusion, our data illuminate the host and bacterial driven process by which a dense actin matrix is dynamically nucleated and maintained on the Chlamydia inclusion. This late stage event is not ubiquitous for all infected cells in a population, and escalates in prevalence and extent throughout the developmental cycle of Chlamydia, culminating with their exit from the host cell by extrusion. The initiation of actin recruitment by Chlamydia appears to be novel, and may serve as an upstream determinant of the extrusion mechanism.	[Chin, Elizabeth; Zuck, Meghan; Hybiske, Kevin] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; [Kirker, Kelly; James, Garth] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA	University of California System; University of California Berkeley; Montana State University System; Montana State University Bozeman	Hybiske, K (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.	khybiske@berkeley.edu			National Institutes of Health [AI095603]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI095603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; DELAMAZA LM, 1982, EXP MOL PATHOL, V36, P217, DOI 10.1016/0014-4800(82)90095-8; Demay BS, 2010, CYTOSKELETON, V67, P383, DOI 10.1002/cm.20452; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Hackstadt T, 1999, CHLAMYDIA, P101; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Huang YW, 2008, MOL BIOL CELL, V19, P1717, DOI 10.1091/mbc.E07-07-0641; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Johnston SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001041; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Kim JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002285; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; KOEHLER JE, 1990, J BIOL CHEM, V265, P13206; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Liebl D, 2009, J CELL SCI, V122, P2935, DOI 10.1242/jcs.048355; LIPKIN ES, 1986, J CLIN MICROBIOL, V23, P114, DOI 10.1128/JCM.23.1.114-117.1986; Madeleine MM, 2007, INT J CANCER, V120, P650, DOI 10.1002/ijc.22325; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mital J, 2011, MBIO, V2, DOI 10.1128/mBio.00031-11; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Mostowy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004196; Mostowy S, 2009, J BIOL CHEM, V284, P11613, DOI 10.1074/jbc.M900231200; Nightingale TD, 2012, TRENDS CELL BIOL; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Schachter J, 1999, CHLAMYDIA, P139; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Stamm WE, 1999, J INFECT DIS, V179, pS380, DOI 10.1086/513844; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Svitkina T, 2009, METHODS MOL BIOL, V586, P187, DOI 10.1007/978-1-60761-376-3_10; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; Thalmann J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009887; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wu XY, 2011, MICROFLUID NANOFLUID, V11, P11, DOI 10.1007/s10404-011-0768-7; Yam PT, 2004, MOL BIOL CELL, V15, P5647, DOI 10.1091/mbc.E04-06-0509; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007	56	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46949	10.1371/journal.pone.0046949	http://dx.doi.org/10.1371/journal.pone.0046949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071671	gold, Green Published			2022-12-25	WOS:000309807700044
J	Hunsberger, ML; Donatelle, RJ; Lindsay, K; Rosenberg, KD				Hunsberger, Monica L.; Donatelle, Rebecca J.; Lindsay, Karen; Rosenberg, Kenneth D.			Physician Care Patterns and Adherence to Postpartum Glucose Testing after Gestational Diabetes Mellitus in Oregon	PLOS ONE			English	Article							LIFE-STYLE; CLINICAL-PRACTICE; FOLLOW-UP; WOMEN; HEALTH; MANAGEMENT; PREVENTION; PREVALENCE; BEHAVIORS; BARRIERS	Objective: This study examines obstetrician/gynecologists and family medicine physicians' reported care patterns, attitudes and beliefs and predictors of adherence to postpartum testing in women with a history of gestational diabetes mellitus. Research Design and Methods: In November-December 2005, a mailed survey went to a random, cross-sectional sample of 683 Oregon licensed physicians in obstetrician/gynecologists and family medicine from a population of 2171. Results: Routine postpartum glucose tolerance testing by both family physicians (19.3%) and obstetrician/gynecologists physicians (35.3%) was reportedly low among the 285 respondents (42% response rate). Factors associated with high adherence to postpartum testing included physician stated priority (OR 4.39, 95% CI: 1.69-7.94) and physician beliefs about norms or typical testing practices (OR 3.66, 95% CI: 1.65-11.69). Specialty, sex of physician, years of practice, location, type of practice, other attitudes and beliefs were not associated with postpartum glucose tolerance testing. Conclusions: Postpartum glucose tolerance testing following a gestational diabetes mellitus pregnancy was not routinely practiced by responders to this survey. Our findings indicate that physician knowledge, attitudes and beliefs may in part explain suboptimal postpartum testing. Although guidelines for postpartum care are established, some physicians do not prioritize these guidelines in practice and do not believe postpartum testing is the norm among their peers.	[Hunsberger, Monica L.] Univ Gothenburg, Gothenburg, Sweden; [Hunsberger, Monica L.; Donatelle, Rebecca J.] Oregon State Univ, Dept Publ Hlth, Corvallis, OR 97331 USA; [Lindsay, Karen] Natl Matern Hosp, UCD Dept Obstet & Gynaecol, Dublin 2, Ireland; [Rosenberg, Kenneth D.] Oregon Publ Hlth Div, Portland, OR USA; [Rosenberg, Kenneth D.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	University of Gothenburg; Oregon State University; National Maternity Hospital, Dublin; Oregon Health & Science University	Hunsberger, ML (corresponding author), Univ Gothenburg, Gothenburg, Sweden.	monica.hunsberger@gu.se	Lindsay, Karen/J-4383-2019	Lindsay, Karen/0000-0002-4481-9363; Hunsberger, Monica/0000-0003-1779-1286				ACOG Committee, 2009, OBSTET GYNECOL, V113, P1419, DOI [10.1097/AOG.0b013e3181ac06b6, DOI 10.1097/A0G.0B013E3181AC06B6)]; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S062]; American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2009, INT DIAB FED GLOB GU; Barfield Wanda D, 2012, Prev Chronic Dis, V9, pE34; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bennett WL, 2011, J WOMENS HEALTH, V20, P239, DOI 10.1089/jwh.2010.2233; Blatt AJ, 2011, OBSTET GYNECOL, V117, P61, DOI 10.1097/AOG.0b013e3181fe424b; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Cheung NW, 2003, DIABETES CARE, V26, P2005, DOI 10.2337/diacare.26.7.2005; Chin MH, 2001, DIABETES CARE, V24, P268, DOI 10.2337/diacare.24.2.268; Collier SA, 2011, J WOMENS HEALTH, V20, P1333, DOI 10.1089/jwh.2010.2676; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Dietz PM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.051; Drass J, 1998, DIABETES CARE, V21, P1282, DOI 10.2337/diacare.21.8.1282; Ferrara A, 2009, DIABETES CARE, V32, P269, DOI 10.2337/dc08-1184; Ferrara A, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.04.019; Gabbe SG, 2012, OBSTET GYNECOL, V119, P171, DOI 10.1097/AOG.0b013e3182393208; Hjelm K, 2012, J CLIN NURS, V21, P1374, DOI 10.1111/j.1365-2702.2011.03834.x; Jones EJ, 2009, JOGNN-J OBST GYN NEO, V38, P516, DOI 10.1111/j.1552-6909.2009.01051.x; Kaaja Risto, 2008, Rev Diabet Stud, V5, P194, DOI 10.1900/RDS.2008.5.194; Keely E, 2010, CAN FAM PHYSICIAN, V56, P558; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kjos SL, 2000, CLIN OBSTET GYNECOL, V43, P75, DOI 10.1097/00003081-200003000-00008; Ko J, 2012, APR MCH EPI GRAND RO; Korpi-Hyovalti E, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/519267; Lapolla A, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/784726; Lawrence JM, 2010, DIABETES CARE, V33, P569, DOI 10.2337/dc09-2095; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Mittman B S, 1992, QRB Qual Rev Bull, V18, P413; Morrison MK, 2009, AUST NZ J OBSTET GYN, V49, P494, DOI 10.1111/j.1479-828X.2009.01056.x; Moulding NT, 1999, QUAL HEALTH CARE, V8, P177, DOI 10.1136/qshc.8.3.177; Picon MJ, 2012, HEMOGLOBIN A1C VERSU, DOI [10.2337/dc11-2111, DOI 10.2337/DC11-2111]; Pierce M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X601316; Russell MA, 2006, OBSTET GYNECOL, V108, P1456, DOI 10.1097/01.AOG.0000245446.85868.73; Saaristo T, 2010, DIABETES CARE, V33, P2146, DOI 10.2337/dc10-0410; Serlin DC, 2009, AM FAM PHYSICIAN, V80, P57; Shea AK, 2011, CHRONIC DIS CAN, V31, P58; Stasenko M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.057; Stasenko M, 2010, AM J PERINAT, V27, P737, DOI 10.1055/s-0030-1253557; Tovar A, 2011, PREV CHRONIC DIS, V8; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Weaver SP, 2004, FAM MED, V36, P159	45	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47052	10.1371/journal.pone.0047052	http://dx.doi.org/10.1371/journal.pone.0047052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071709	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700048
J	Love, AJ; Geri, C; Laird, J; Carr, C; Yun, BW; Loake, GJ; Tada, Y; Sadanandom, A; Milner, JJ				Love, Andrew J.; Geri, Chiara; Laird, Janet; Carr, Craig; Yun, Byung-Wook; Loake, Gary J.; Tada, Yasuomi; Sadanandom, Ari; Milner, Joel J.			Cauliflower mosaic virus Protein P6 Inhibits Signaling Responses to Salicylic Acid and Regulates Innate Immunity	PLOS ONE			English	Article							GENE-VI; INDUCED RESISTANCE; DEFENSE RESPONSES; ARABIDOPSIS MUTANTS; JASMONIC ACID; PLANT DEFENSE; III EFFECTORS; NPR1; PATHWAYS; TRANSACTIVATOR/VIROPLASMIN	Cauliflower mosaic virus (CaMV) encodes a multifunctional protein P6 that is required for translation of the 35S RNA and also acts as a suppressor of RNA silencing. Here we demonstrate that P6 additionally acts as a pathogenicity effector of an unique and novel type, modifying NPR1 (a key regulator of salicylic acid (SA)- and jasmonic acid (JA)-dependent signaling) and inhibiting SA-dependent defence responses We find that that transgene-mediated expression of P6 in Arabidopsis and transient expression in Nicotiana benthamiana has profound effects on defence signaling, suppressing expression of representative SA-responsive genes and increasing expression of representative JA-responsive genes. Relative to wild-type Arabidopsis P6-expressing transgenics had greatly reduced expression of PR-1 following SA-treatment, infection by CaMV or inoculation with an avirulent bacterial pathogen Pseudomonas syringae pv tomato (Pst). Similarly transient expression in Nicotiana benthamiana of P6 (including a mutant form defective in translational transactivation activity) suppressed PR-1a transcript accumulation in response to Agrobacterium infiltration and following SA-treatment. As well as suppressing the expression of representative SA-regulated genes, P6-transgenic Arabidopsis showed greatly enhanced susceptibility to both virulent and avirulent Pst (titres elevated 10 to 30-fold compared to non-transgenic controls) but reduced susceptibility to the necrotrophic fungus Botrytis cinerea. Necrosis following SA-treatment or inoculation with avirulent Pst was reduced and delayed in P6-transgenics. NPR1 an important regulator of SA/JA crosstalk, was more highly expressed in the presence of P6 and introduction of the P6 transgene into a transgenic line expressing an NPR1:GFP fusion resulted in greatly increased fluorescence in nuclei even in the absence of SA. Thus in the presence of P6 an inactive form of NPR1 is mislocalized in the nucleus even in uninduced plants. These results demonstrate that P6 is a new type of pathogenicity effector protein that enhances susceptibility to biotrophic pathogens by suppressing SA-but enhancing JA-signaling responses.	[Love, Andrew J.; Geri, Chiara; Laird, Janet; Carr, Craig; Sadanandom, Ari; Milner, Joel J.] Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Love, Andrew J.; Geri, Chiara; Laird, Janet; Carr, Craig; Sadanandom, Ari; Milner, Joel J.] Univ Glasgow, Inst Mol Cellular & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Geri, Chiara] Consiglio Nazl Richerche, Ist Biol & Biotechnol Agr, Pisa, Italy; [Yun, Byung-Wook; Loake, Gary J.] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland; [Tada, Yasuomi] Duke Univ, Dept Biol, Durham, NC USA	University of Glasgow; University of Glasgow; University of Edinburgh; Duke University	Milner, JJ (corresponding author), Univ Glasgow, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	joel.milner@glasgow.ac.uk	Tada, Yasuomi/M-5041-2014	Tada, Yasuomi/0000-0001-9900-069X; Loake, Gary/0000-0002-7989-9180	BBSRC [BB/D017319, BB/C005561]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC (www.bbsrc.ac.uk) grants BB/D017319 (to JJM and AS) and BB/C005561 (to JJM, AS and GJL). AJL was supported by BB/D017319; JL was supported by BB/D017319 and BB/C005561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzini AA, 2007, ELECTRON J BIOTECHN, V10, P178, DOI 10.2225/vol10-issue2-fulltext-11; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Cawly J, 2005, MOL PLANT MICROBE IN, V18, P212, DOI 10.1094/MPMI-18-0212; Cecchini E, 1997, MOL PLANT MICROBE IN, V10, P1094, DOI 10.1094/MPMI.1997.10.9.1094; Cecchini E, 1998, J EXP BOT, V49, P731, DOI 10.1093/jexbot/49.321.731; Chivasa S, 1997, PLANT CELL, V9, P547, DOI 10.1105/tpc.9.4.547; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Covey SN, 2000, MOL PLANT PATHOL, V1, P77, DOI 10.1046/j.1364-3703.2000.00011.x; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Geri C, 2004, PLANT MOL BIOL, V56, P111, DOI 10.1007/s11103-004-2649-x; Glazebrook J, 2002, ARABIDOPSIS LAB MANU, P86; Grant JJ, 2003, MOL PLANT MICROBE IN, V16, P669, DOI 10.1094/MPMI.2003.16.8.669; Grant JJ, 2000, PLANT J, V24, P569, DOI 10.1046/j.1365-313x.2000.00902.x; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; Haas M, 2005, PLANT CELL, V17, P927, DOI 10.1105/tpc.104.029017; Haas M, 2002, MOL PLANT PATHOL, V3, P419, DOI 10.1046/j.1364-3703.2002.00136.x; Hapiak M, 2008, VIRUS RES, V138, P119, DOI 10.1016/j.virusres.2008.09.002; Harries PA, 2009, PLANT PHYSIOL, V149, P1005, DOI 10.1104/pp.108.131755; Hohn T, 1997, CRIT REV PLANT SCI, V16, P133, DOI 10.1080/713608145; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Ji LH, 2001, MOL PLANT MICROBE IN, V14, P715, DOI 10.1094/MPMI.2001.14.6.715; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kobayashi K, 2004, MOL PLANT MICROBE IN, V17, P475, DOI 10.1094/MPMI.2004.17.5.475; Kobayashi K, 2003, J VIROL, V77, P8577, DOI 10.1128/JVI.77.15.8577-8583.2003; Laird J, 2004, PLANTA, V219, P1089, DOI 10.1007/s00425-004-1355-x; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Lewsey MG, 2009, J GEN VIROL, V90, P3010, DOI 10.1099/vir.0.014555-0; Love AJ, 2005, PLANT PHYSIOL, V139, P935, DOI 10.1104/pp.105.066803; Love AJ, 2007, J GEN VIROL, V88, P3439, DOI 10.1099/vir.0.83090-0; Love AJ, 2007, MOL PLANT MICROBE IN, V20, P659, DOI 10.1094/MPMI-20-6-0659; Love AJ, 2008, PLANT SIGNAL BEHAV, V3, P740, DOI 10.4161/psb.3.9.6632; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Mayers CN, 2005, MOL PLANT MICROBE IN, V18, P428, DOI 10.1094/MPMI-18-0428; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Murphy AM, 2002, PLANT PHYSIOL, V128, P552, DOI 10.1104/pp.010688; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Palanichelvam K, 2002, VIROLOGY, V293, P225, DOI 10.1006/viro.2001.1293; Park HS, 2001, CELL, V106, P723, DOI 10.1016/S0092-8674(01)00487-1; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Shivaprasad PV, 2008, NUCLEIC ACIDS RES, V36, P5896, DOI 10.1093/nar/gkn590; Smith LA, 2007, THESIS U GLASGOW; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Volko SM, 1998, GENETICS, V149, P537; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yang JY, 2008, GENE DEV, V22, P2564, DOI 10.1101/gad.1682208; Yu DQ, 2003, MOL PLANT MICROBE IN, V16, P206, DOI 10.1094/MPMI.2003.16.3.206; Yu WC, 2003, MOL PLANT MICROBE IN, V16, P35, DOI 10.1094/MPMI.2003.16.1.35; Zhang XD, 2010, J PLANT PHYSIOL, V167, P144, DOI 10.1016/j.jplph.2009.08.002; Ziebell H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00187	68	83	85	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47535	10.1371/journal.pone.0047535	http://dx.doi.org/10.1371/journal.pone.0047535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071821	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700091
J	He, F; Han, K; Liu, LG; Sun, W; Zhang, LJ; Zhu, BP; Ma, HL				He, Fan; Han, Ke; Liu, Lunguang; Sun, Wei; Zhang, Lijie; Zhu, Baoping; Ma, Huilai			Shigellosis Outbreak Associated with Contaminated Well Water in a Rural Elementary School: Sichuan Province, China, June 7-16, 2009	PLOS ONE			English	Article							EPIDEMIOLOGY; DYSENTERY; THAILAND; CHILDREN	Objectives: We investigated a shigellosis outbreak in an elementary school to identify the source of infection, mode of transmission and risk factors for illness. Methods: In a case-control investigation, we compared the source of drinking water, consumption of untreated well water and suspected food items, and hygienic habits between case-students and randomly selected asymptomatic controlstudents, frequency-matched by class on a 1:1 ratio. Results: 18% of the 533 students and no teachers developed Shigella. 52%(44/85) of case-students and 17% (12/71) of control-students drank untreated well water (OR = 2.3, 95% CI = 1.1-5.8); 47% (n = 40/85) of case-students and 14% (10/71) of control-students drank untreated water from Well A (OR = 3.7, 95% CI = 1.3-11). The odds ratio increased with the amount of untreated Well A water consumed (p = 0.035, chi(2) test for trend). Rectal swabs from 5 of 6 case-students and water from Well A yielded Shigella flexneri 2b. Conclusions: This shigellosis outbreak was caused by drinking untreated water from a well polluted by Shigella flexneri 2b.	[Zhang, Lijie; Zhu, Baoping; Ma, Huilai] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [He, Fan] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Han, Ke] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Liu, Lunguang; Sun, Wei] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China	Chinese Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Ma, HL (corresponding author), Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China.	cfetpmhl@126.com		Zhu, Baoping/0000-0003-0065-0153	Program for Zhejiang Leading Team of Science and Technology Innovation; General Funds for Emergency Public Health Response from the Ministry of Health of China	Program for Zhejiang Leading Team of Science and Technology Innovation; General Funds for Emergency Public Health Response from the Ministry of Health of China	This investigation was supported by the Program for Zhejiang Leading Team of Science and Technology Innovation, and the General Funds for Emergency Public Health Response from the Ministry of Health of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CDCP, 1999, MMWR-MORBID MORTAL W, V48, P241; EGOZ N, 1991, J INFECTION, V22, P87, DOI 10.1016/0163-4453(91)91122-E; EWALD PW, 1991, EPIDEMIOL INFECT, V106, P83, DOI 10.1017/S0950268800056478; Faruque ASG, 1998, ANN TROP PAEDIATR, V18, P197, DOI 10.1080/02724936.1998.11747947; Gao JinXia, 2008, Disease Surveillance, V23, P698; Gaudio PA, 1997, J INFECT DIS, V176, P1013, DOI 10.1086/516531; Hoge CW, 1995, INT J EPIDEMIOL, V24, P1228, DOI 10.1093/ije/24.6.1228; LEVINE MM, 1973, J INFECT DIS, V127, P261, DOI 10.1093/infdis/127.3.261; Longfield R, 1983, MMWR-MORBID MORTAL W, V32, P250; MAHONEY FJ, 1991, AM J PREV MED, V7, P292, DOI 10.1016/S0749-3797(18)30902-4; Mandomando I, 2007, PEDIATR INFECT DIS J, V26, P1059, DOI 10.1097/INF.0b013e31812e55a2; Richen D, 1983, CAN DIS WKLY REP, V9, P65; SORVILLO FJ, 1988, AM J TROP MED HYG, V38, P613, DOI 10.4269/ajtmh.1988.38.613; SWADDIWUDHIPONG W, 1995, J TROP MED HYG, V98, P145; TAYLOR DN, 1989, AM J TROP MED HYG, V40, P77, DOI 10.4269/ajtmh.1989.40.77; Wang LD, 2012, CHINA INFORM SYSTEM; WHO, 2012, GLOB COSTS BEN DRINK; Yuan H, 2004, STRAIT J PREV MED, V10, P20; Zhang LJ, 2009, EPIDEMIOL INFECT, V137, P428, DOI 10.1017/S0950268808001337	19	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47239	10.1371/journal.pone.0047239	http://dx.doi.org/10.1371/journal.pone.0047239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071767	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200094
J	Thuy, B; Gale, AS; Kroh, A; Kucera, M; Numberger-Thuy, LD; Reich, M; Stohr, S				Thuy, Ben; Gale, Andy S.; Kroh, Andreas; Kucera, Michal; Numberger-Thuy, Lea D.; Reich, Mike; Stohr, Sabine			Ancient Origin of the Modern Deep-Sea Fauna	PLOS ONE			English	Article							ANOXIC EVENT; ECHINODERMATA; PRODUCTIVITY; EXTINCTIONS; RECORD; OCEAN	The origin and possible antiquity of the spectacularly diverse modern deep-sea fauna has been debated since the beginning of deep-sea research in the mid-nineteenth century. Recent hypotheses, based on biogeographic patterns and molecular clock estimates, support a latest Mesozoic or early Cenozoic date for the origin of key groups of the present deep-sea fauna (echinoids, octopods). This relatively young age is consistent with hypotheses that argue for extensive extinction during Jurassic and Cretaceous Oceanic Anoxic Events (OAEs) and the mid-Cenozoic cooling of deep-water masses, implying repeated re-colonization by immigration of taxa from shallow-water habitats. Here we report on a well-preserved echinoderm assemblage from deep-sea (1000-1500 m paleodepth) sediments of the NE-Atlantic of Early Cretaceous age (114 Ma). The assemblage is strikingly similar to that of extant bathyal echinoderm communities in composition, including families and genera found exclusively in modern deep-sea habitats. A number of taxa found in the assemblage have no fossil record at shelf depths postdating the assemblage, which precludes the possibility of deep-sea recolonization from shallow habitats following episodic extinction at least for those groups. Our discovery provides the first key fossil evidence that a significant part of the modern deep-sea fauna is considerably older than previously assumed. As a consequence, most major paleoceanographic events had far less impact on the diversity of deep-sea faunas than has been implied. It also suggests that deep-sea biota are more resilient to extinction events than shallow-water forms, and that the unusual deep-sea environment, indeed, provides evolutionary stability which is very rarely punctuated on macroevolutionary time scales.	[Thuy, Ben; Reich, Mike] Univ Gottingen, Geosci Ctr, Dept Geobiol, Gottingen, Germany; [Gale, Andy S.] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England; [Kroh, Andreas] Nat Hist Museum Vienna, Dept Geol & Palaeontol, Vienna, Austria; [Kucera, Michal] Univ Bremen, Marum Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Numberger-Thuy, Lea D.; Reich, Mike] Univ Gottingen, Geosci Ctr, Museum Collect & Geopk, Gottingen, Germany; [Stohr, Sabine] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden	University of Gottingen; University of Portsmouth; University of Bremen; University of Gottingen; Swedish Museum of Natural History	Thuy, B (corresponding author), Univ Gottingen, Geosci Ctr, Dept Geobiol, Gottingen, Germany.	nebyuht@yahoo.com	Stöhr, Sabine/B-8629-2011; Kucera, Michal/B-9277-2009; Kucera, Michal/ABH-6065-2020; Reich, Mike/A-3745-2012; Kucera, Michal/AAE-8115-2020; Kroh, Andreas/AAI-3650-2020	Stöhr, Sabine/0000-0002-2586-7239; Kucera, Michal/0000-0002-7817-9018; Kucera, Michal/0000-0002-7817-9018; Kroh, Andreas/0000-0002-8566-8848; Reich, Mike/0000-0003-3837-3497	German Research Foundation [RE2599/6-1]; European Union [SE-TAF-2674, SE-TAF-2969]; German Research Foundation; Gottingen University	German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); German Research Foundation(German Research Foundation (DFG)); Gottingen University	The study was funded by the German Research Foundation (http://www.dfg.de/index.jsp), grant RE2599/6-1, and by the European Union funded Synthesys program (http://www.synthesys.info/), grants SE-TAF-2674 and SE-TAF-2969. Deposition of the described material in the collections of the Natural History Museum in London (UK), the micropaleontological collection at the University of Tubingen (D) and the Geoscientific Museum at the University of Gottingen (D) was done with the permission of the respective institutes. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barras CG, 2007, J SYST PALAEONTOL, V5, P133, DOI 10.1017/S147720190600201X; Thuy B, 2011, ZOOTAXA, P1; BENSON RH, 1975, LETHAIA, V8, P69, DOI 10.1111/j.1502-3931.1975.tb00919.x; Blake Daniel B., 2005, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V75, P183; Blake DB, 1998, J PALEONTOL, V72, P512, DOI 10.1017/S002233600002429X; Boos K, 2006, J MAR BIOL ASSOC UK, V86, P1187, DOI 10.1017/S0025315406014184; Charbonnier S, 2007, PALAEOGEOGR PALAEOCL, V250, P216, DOI 10.1016/j.palaeo.2007.03.013; Clark AM, 1992, STARFISHES ATLANTIC; Clark HL., 1911, B US NATL MUSEUM, V75, P1, DOI DOI 10.5479/SI.03629236.75.1; CLARK HUBERT LYMAN, 1939, SCI REPTS JOHN MURRAY EXPED 1933 34 BRIT MUS [NAT HIST], V6, P29; Cronin TM, 1997, NATURE, V385, P624, DOI 10.1038/385624a0; Erbacher J, 2001, NATURE, V409, P325, DOI 10.1038/35053041; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gale AS, 2011, SPEC PAP PALAEONTOL, P5; Gammon PR, 2000, GEOLOGY, V28, P855, DOI 10.1130/0091-7613(2000)028<0855:ESASIS>2.3.CO;2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen B., 1975, Galathea Report, V13, P1; Hess H., 1970, Eclog. geol. Helv., V63, P1069; Hess H, 1975, VEROFFENTLICHUNGEN N, V8, P1; Hess H., 2011, TREATISE INVERTEBRAT, P1; Holbourn A, 2001, GEOL SOC SPEC PUBL, V183, P73, DOI 10.1144/GSL.SP.2001.183.01.04; Huber BT, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002178; Huber BT, 2011, J FORAMIN RES, V41, P53, DOI 10.2113/gsjfr.41.1.53; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; Jagt John W.M., 2000, Scripta Geologica, V121, P377; Jenkyns HC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002788; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Kiel S, 2006, SCIENCE, V313, P1429, DOI 10.1126/science.1126286; Koehler R, 1914, SIBOGA EXPED, V45, P1; Koehler R, 1901, ANVERS RAPPORTS SCI; Koehler R., 1914, B US NATL MUSEUM, V84, P1, DOI DOI 10.5479/SI.03629236.84.1; Koehler R, 1922, B US NATL MUSEUM, V100, P1, DOI DOI 10.5962/BHL.TITLE.32917; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; LITVINOVA NM, 1992, ZOOL ZH, V71, P47; Manjon-Cabeza ME, 2003, POLAR BIOL, V26, P691, DOI 10.1007/s00300-003-0539-3; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; Menzies R.J., 1973, ABYSSAL ENV ECOLOGY; Norris R.D., 1998, P OCEAN DRILLING P B, V171, P1; Rex M. A, 2010, DEEP SEA BIODIVERSIT; Smith AB, 2005, P ROY SOC B-BIOL SCI, V272, P865, DOI 10.1098/rspb.2004.2996; Storc R, 2008, B GEOSCI, V83, P123, DOI 10.3140/bull.geosci.2008.02.123; Strugnell JM, 2008, CLADISTICS, V24, P853, DOI 10.1111/j.1096-0031.2008.00234.x; Tyler P.A., 1980, Oceanography and Marine Biology an Annual Review, V18, P125; Tyler PA, 1996, OCEANOGRAPHY ILLUSTR, P195; Vera J.A., 2004, GEOLOGIA ESPANA, P345; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; Wilson GDF, 1999, CRUSTACEANA, V72, P1019, DOI 10.1163/156854099503915; Wyville Thomson C., 1873, DEPTHS SEA; Young J.Y., 2010, FIELD GUIDES FOSSILS, V12, P1	51	43	45	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46913	10.1371/journal.pone.0046913	http://dx.doi.org/10.1371/journal.pone.0046913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071660	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200050
J	Chang, HL; Chio, CP; Su, HJ; Liao, CM; Lin, CY; Shau, WY; Chi, YC; Cheng, YT; Chou, YL; Li, CY; Chen, KL; Chen, KT				Chang, Hsiao-Ling; Chio, Chia-Pin; Su, Huey-Jen; Liao, Chung-Min; Lin, Chuan-Yao; Shau, Wen-Yi; Chi, Yun-Chan; Cheng, Ya-Ting; Chou, Yuan-Lin; Li, Chung-Yi; Chen, Kwo-Liang; Chen, Kow-Tong			The Association between Enterovirus 71 Infections and Meteorological Parameters in Taiwan	PLOS ONE			English	Article							FOOT-MOUTH DISEASE; RISK-FACTORS; HAND; TRANSMISSION; HERPANGINA; INFLUENZA; EPIDEMIC; FLUCTUATIONS; SEASONALITY; HUMIDITY	Background: Enterovirus 71 (EV71) infections are a significant cause of neurological disorder and death in children worldwide. Seasonal variations in EV71 infections have been recognized, but the mechanisms responsible for this phenomenon remain unknown. The purpose of this study was to examine the relationship between meteorological parameters and EV71 infection. Methods and Findings: We analyzed the number of EV71 infections and daily climate data collected in Taiwan between 1998 and 2008 and used Poisson regression analysis and case-crossover methodology to evaluate the association between weather variability and the incidence of EV71 infection. A total of 1,914 EV71-infected patients were reported between 1998 and 2008. The incidence of EV71 infections reflected significant summertime seasonality (for oscillation, p<0.001). The incidence of EV71 infections began to rise at temperatures above 13 degrees C (r(2) = 0.76, p<0.001); at temperatures higher than approximately 26 degrees C (r(2) = 0.94, p<0.05), the incidence began to decline, producing an inverted V-shaped relationship. The increase in the incidence with increasing relative humidity was positive and linear (r(2) = 0.68, p<0.05). EV71 infection was most highly correlated with temperature and relative humidity in the period that likely preceded the infection. Conclusion: Our study provides quantitative evidence that the rate of EV71 infection increased significantly with increasing mean temperature and relative humidity in Taiwan.	[Cheng, Ya-Ting; Chou, Yuan-Lin; Li, Chung-Yi; Chen, Kow-Tong] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Chang, Hsiao-Ling] Ctr Dis Control, Div Surveillance, Dept Hlth, Taipei, Taiwan; [Chang, Hsiao-Ling] Natl Def Univ, Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chio, Chia-Pin; Liao, Chung-Min] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Lin, Chuan-Yao] Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; [Shau, Wen-Yi] Ctr Drug Evaluat, Div Hlth Technol Assessment, Taipei, Taiwan; [Chi, Yun-Chan] Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan; [Chen, Kwo-Liang] China Univ Sci & Technol, Dept Ind Engn & Management, Taipei, Taiwan	National Cheng Kung University; Centers For Disease Control - Taiwan; National Defense Medical Center; National Defense University - Taiwan; National Taiwan University; National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University	Chen, KT (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	ktchen@mail.ncku.edu.tw	lin, chuan/HHD-2571-2022; Chio, Chia-Pin/HGD-2055-2022; LI, CHUNG-YI/ABI-1419-2020; Lin, CY/K-6503-2014	Chio, Chia-Pin/0000-0001-6986-3611; LI, CHUNG-YI/0000-0002-0321-8908; Lin, CY/0000-0002-0005-7088; Su, Huey-Jen/0000-0003-3589-9987	National Science Council, Taiwan [NSC 99-2621-M-006-009]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant (NSC 99-2621-M-006-009) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1984, J HYG-CAMBRIDGE, V93, P587, DOI 10.1017/S0022172400065177; Anderson RM, 2006, INFECT DIS HUMANS DY; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Bi P, 2007, J INFECTION, V55, P551, DOI 10.1016/j.jinf.2007.07.004; CDC A, NAT NOT DIS SURV SYS; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chen TC, 2006, J CLIN MICROBIOL, V44, P2212, DOI 10.1128/JCM.02393-05; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; HASHIMOTO I, 1983, ACTA NEUROPATHOL, V60, P266, DOI 10.1007/BF00691875; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Kinlin LM, 2009, AM J EPIDEMIOL, V169, P588, DOI 10.1093/aje/kwn383; Kung YH, 2010, VIROLOGY, V396, P1, DOI 10.1016/j.virol.2009.10.017; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Murray EL, 2012, EPIDEMIOL INFECT, V140, P78, DOI 10.1017/S0950268811000252; Pallansch, 2007, FIELDS VIROLOGY, P839; Park SK, 2010, J KOREAN MED SCI, V25, P677, DOI 10.3346/jkms.2010.25.5.677; Prince A., 2002, NELSON ESSENTIALS PE, V4 th; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Ruan F, 2011, PEDIATRICS, V127, pE898, DOI 10.1542/peds.2010-1497; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Woodward M, 2005, EPIDEMIOLOGY STUDY D, P515; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8	39	52	55	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46845	10.1371/journal.pone.0046845	http://dx.doi.org/10.1371/journal.pone.0046845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071650	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300065
J	Crete-Lafreniere, A; Weir, LK; Bernatchez, L				Crete-Lafreniere, Alexis; Weir, Laura K.; Bernatchez, Louis			Framing the Salmonidae Family Phylogenetic Portrait: A More Complete Picture from Increased Taxon Sampling	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MITOCHONDRIAL-DNA; GENUS SALVELINUS; PACIFIC SALMON; MISSING DATA; MOLECULAR PHYLOGENETICS; FOSSIL CALIBRATIONS; THYMALLUS-ARCTICUS; TROUT ONCORHYNCHUS; COREGONUS-ARTEDI	Considerable research efforts have focused on elucidating the systematic relationships among salmonid fishes; an understanding of these patterns of relatedness will inform conservation-and fisheries-related issues, as well as provide a framework for investigating evolutionary mechanisms in the group. However, uncertainties persist in current Salmonidae phylogenies due to biological and methodological factors, and a comprehensive phylogeny including most representatives of the family could provide insight into the causes of these difficulties. Here we increase taxon sampling by including nearly all described salmonid species (n = 63) to present a time-calibrated and more complete portrait of Salmonidae using a combination of molecular markers and analytical techniques. This strategy improved resolution by increasing the signal-to-noise ratio and helped discriminate methodological and systematic errors from sources of difficulty associated with biological processes. Our results highlight novel aspects of salmonid evolution. First, we call into question the widely-accepted evolutionary relationships among sub-families and suggest that Thymallinae, rather than Coregoninae, is the sister group to the remainder of Salmonidae. Second, we find that some groups in Salmonidae are older than previously thought and that the mitochondrial rate of molecular divergence varies markedly among genes and clades. We estimate the age of the family to be 59.1 MY (CI: 63.2-58.1 MY) old, which likely corresponds to the timing of whole genome duplication in salmonids. The average, albeit highly variable, mitochondrial rate of molecular divergence was estimated as,0.31%/MY (CI: 0.27-0.36%/MY). Finally, we suggest that some species require taxonomic revision, including two monotypic genera, Stenodus and Salvethymus. In addition, we resolve some relationships that have been notoriously difficult to discern and present a clearer picture of the evolution of the group. Our findings represent an important contribution to the systematics of Salmonidae, and provide a useful tool for addressing questions related to fundamental and applied evolutionary issues.	[Crete-Lafreniere, Alexis; Weir, Laura K.; Bernatchez, Louis] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Weir, Laura K.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Laval University; University of British Columbia	Weir, LK (corresponding author), Univ Laval, Inst Biol Integrat & Syst, Pavillon Charles Eugene Marchand, Quebec City, PQ, Canada.	lweir@zoology.ubc.ca		Bernatchez, Louis/0000-0002-8085-9709	National Sciences and Engineering Research Council; Canada Research Chairs	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs(Canada Research ChairsCGIAR)	Funding sources that supported this work were the National Sciences and Engineering Research Council and Canada Research Chairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Allendorf F.W., 1984, P1; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Angers B, 1997, MOL BIOL EVOL, V14, P230, DOI 10.1093/oxfordjournals.molbev.a025759; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Behnke R.J., 1980, Perspectives in Vertebrate Science, V1, P441; BEHNKE RJ, 1972, J FISH RES BOARD CAN, V29, P639, DOI 10.1139/f72-112; BEHNKE RJ, 1970, T AM FISH SOC, V99, P237, DOI 10.1577/1548-8659(1970)99<237:TAOCAB>2.0.CO;2; BERNATCHEZ L, 1991, J FISH BIOL, V39, P283, DOI 10.1111/j.1095-8649.1991.tb05091.x; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Bernatchez L, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P175; Bernatchez L, 1999, BIOL J LINN SOC, V68, P173, DOI 10.1111/j.1095-8312.1999.tb01165.x; BERNATCHEZ L, 1991, CAN J ZOOL, V69, P311, DOI 10.1139/z91-050; Bevan RB, 2007, SYST BIOL, V56, P194, DOI 10.1080/10635150701291804; Bevan RB, 2005, SYST BIOL, V54, P900, DOI 10.1080/10635150500354829; Blouin C, 2005, MOL BIOL EVOL, V22, P784, DOI 10.1093/molbev/msi065; BODALY RA, 1991, J FISH BIOL, V38, P37, DOI 10.1111/j.1095-8649.1991.tb03089.x; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Brunner PC, 2001, EVOLUTION, V55, P573, DOI 10.1554/0014-3820(2001)055[0573:HPOACS]2.0.CO;2; Burleigh JG, 2007, INT J PLANT SCI, V168, P111, DOI 10.1086/509586; Burleigh JG, 2007, INT J PLANT SCI, V168, P125, DOI 10.1086/509588; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Cavender TM, 1972, U OREGON B; Chereshnev IA, 1990, PROBL ICHTHY, V30, P201; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Cope ED, 1869, P AM PHILOS SOC, V11, P538; Crespi BJ, 2004, MOL PHYLOGENET EVOL, V31, P658, DOI 10.1016/j.ympev.2003.08.012; Crespi BJ, 2002, EVOLUTION, V56, P1008, DOI 10.1111/j.0014-3820.2002.tb01412.x; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2005, EVOLUTION, V59, P24; DEVLIN RH, 1993, CAN J FISH AQUAT SCI, V50, P1738, DOI 10.1139/f93-195; Domanico MJ, 1997, CAN J FISH AQUAT SCI, V54, P1865, DOI 10.1139/cjfas-54-8-1865; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Douglas MR, 1999, MOL ECOL, V8, P589, DOI 10.1046/j.1365-294x.1999.00581.x; DOYLE JA, 1993, PALEOBIOLOGY, V19, P141, DOI 10.1017/S0094837300015840; DRUMMOND A. J., 2007, GENEIOUS V3 8, P8; Eiting TP, 2007, PALAEOGEOGR PALAEOCL, V249, P412, DOI 10.1016/j.palaeo.2007.02.011; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FERGUSON A, 1978, J FISH BIOL, V12, P221, DOI 10.1111/j.1095-8649.1978.tb04168.x; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Froufe E, 2005, MOL PHYLOGENET EVOL, V34, P106, DOI 10.1016/j.ympev.2004.09.009; Gatesy J, 2005, SYST BIOL, V54, P483, DOI 10.1080/10635150590945368; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; HUTCHINGS JA, 1985, OIKOS, V45, P118, DOI 10.2307/3565229; Ishiguro NB, 2003, MOL PHYLOGENET EVOL, V27, P476, DOI 10.1016/S1055-7903(02)00418-9; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; JOHNSON KR, 1987, GENETICS, V116, P579; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P142; KIMMEL P.G., 1975, U MICHIGAN MUSEUM PA, V14, P69; Kinnison MT, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P208; Kitano T, 1997, GENES GENET SYST, V72, P25, DOI 10.1266/ggs.72.25; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Kottelat M, 1997, BIOLOGIA, V52, P1; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; LINDSEY C C, 1988, Finnish Fisheries Research, V9, P1; Lopez JA, 2004, COPEIA, P449, DOI 10.1643/CG-03-087R1; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Matveev V, 2007, MOL BIOL EVOL, V24, P1656, DOI 10.1093/molbev/msm083; McKay SJ, 1996, CAN J FISH AQUAT SCI, V53, P1165, DOI 10.1139/cjfas-53-5-1165; MURATA S, 1993, P NATL ACAD SCI USA, V90, P6995, DOI 10.1073/pnas.90.15.6995; Murata S, 1996, GENETICS, V142, P915; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Near TJ, 2005, EVOLUTION, V59, P1768, DOI 10.1111/j.0014-3820.2005.tb01825.x; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; NORDEN CR, 1961, J FISH RES BOARD CAN, V18, P679, DOI 10.1139/f61-052; Oakley TH, 1999, MOL PHYLOGENET EVOL, V11, P381, DOI 10.1006/mpev.1998.0599; Osinov AG, 2000, J FISH BIOL, V57, P354, DOI 10.1006/jfbi.2000.1307; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Ott M, 2007, P ACM IEEE SUP C; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Phillips RB, 2002, ENVIRON BIOL FISH, V64, P223, DOI 10.1023/A:1016053902036; PHILLIPS RB, 1992, CAN J FISH AQUAT SCI, V49, P2345, DOI 10.1139/f92-258; PHILLIPS RB, 1994, CAN J FISH AQUAT SCI, V51, P198, DOI 10.1139/f94-305; Phillips RB, 1995, J FISH BIOL, V47, P956, DOI 10.1111/j.1095-8649.1995.tb06021.x; Phillips Ruth B., 1997, P145, DOI 10.1016/B978-012417540-2/50011-7; Phillips Ruth B., 1995, Nordic Journal of Freshwater Research, V71, P378; Pleyte KA, 1992, MOL PHYLOGENET EVOL, V1, P223, DOI 10.1016/1055-7903(92)90019-D; Politov DV, 2000, J FISH BIOL, V57, P51, DOI 10.1111/j.1095-8649.2000.tb02244.x; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Radchenko OA, 2004, RUSS J GENET+, V40, P1392, DOI 10.1007/s11177-005-0068-y; Redenbach Z, 2003, J EVOLUTION BIOL, V16, P1135, DOI 10.1046/j.1420-9101.2003.00619.x; Redenbach Z, 2002, EVOLUTION, V56, P1021, DOI 10.1111/j.0014-3820.2002.tb01413.x; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruber L, 2006, SYST BIOL, V55, P374, DOI 10.1080/10635150500541664; Sajdak SL, 1997, CAN J FISH AQUAT SCI, V54, P1494, DOI 10.1139/cjfas-54-7-1494; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1996, SYST BIOL, V45, P168, DOI 10.2307/2413613; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Shedko SV, 1996, J FISH BIOL, V49, P815, DOI 10.1111/j.1095-8649.1996.tb00081.x; Shedlock AM, 1992, MOL PHYLOGENET EVOL, V1, P179, DOI 10.1016/1055-7903(92)90014-8; Shi XF, 2005, MOL BIOL EVOL, V22, P2285, DOI 10.1093/molbev/msi226; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Smith G. R., 1975, U MICH MUS PALEO PAP, V14, P1; SMITH GR, 1992, SYST BIOL, V41, P41, DOI 10.2307/2992505; SMITH GR, 1981, ANNU REV ECOL SYST, V12, P163, DOI 10.1146/annurev.es.12.110181.001115; Spruell P, 2001, COPEIA, P1093, DOI 10.1643/0045-8511(2001)001[1093:DOHBBT]2.0.CO;2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEARLEY RF, 1993, T AM FISH SOC, V122, P1, DOI 10.1577/1548-8659(1993)122<0001:POTPTA>2.3.CO;2; Sukhanova LV, 2004, ANN ZOOL FENN, V41, P41; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Taylor EB, 2003, EVOLUTION ILLUMINATED: SALMON AND THEIR RELATIVES, P232; Taylor EB, 2001, CAN J FISH AQUAT SCI, V58, P406, DOI 10.1139/cjfas-58-2-406; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turgeon J, 2003, CONSERV GENET, V4, P67, DOI 10.1023/A:1021860910719; Turgeon J, 2001, EVOLUTION, V55, P2274; Turgeon J, 2001, MOL ECOL, V10, P987, DOI 10.1046/j.1365-294X.2001.01248.x; Turgeon J, 1999, EVOLUTION, V53, P1857, DOI 10.1111/j.1558-5646.1999.tb04568.x; Vuorinen JA, 1998, J FISH BIOL, V53, P917, DOI 10.1006/jfbi.1998.0763; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x; Wilson M.V.H., 1993, P224; Wilson M. V. H., 1977, Life Sci. Contr. R. Ont. Mus., VNo. 113, P1; Wilson MVH, 1999, ZOOL J LINN SOC-LOND, V125, P279, DOI 10.1111/j.1096-3642.1999.tb00594.x; Wilson WD, 2009, MOL PHYLOGENET EVOL, V52, P406, DOI 10.1016/j.ympev.2009.03.018; WOESE CR, 1991, SYST APPL MICROBIOL, V14, P364, DOI 10.1016/S0723-2020(11)80311-5; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yasuike M, 2010, J FISH BIOL, V76, P395, DOI 10.1111/j.1095-8649.2009.02494.x; Zelinsky YP, 2002, RUSS J GENET+, V38, P1115, DOI 10.1023/A:1020693617449; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	149	157	170	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46662	10.1371/journal.pone.0046662	http://dx.doi.org/10.1371/journal.pone.0046662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071608	Green Published, gold			2022-12-25	WOS:000309827300045
J	Granek, JA; Pisella, L; Blangero, A; Rossetti, Y; Sergio, LE				Granek, Joshua A.; Pisella, Laure; Blangero, Annabelle; Rossetti, Yves; Sergio, Lauren E.			The Role of the Caudal Superior Parietal Lobule in Updating Hand Location in Peripheral Vision: Further Evidence from Optic Ataxia	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; VISUOMOTOR INTEGRATION; REACHING MOVEMENTS; AREA V6A; EYE; TARGET; ERRORS; MECHANISMS; DEFICIT; SACCADE	Patients with optic ataxia (OA), who are missing the caudal portion of their superior parietal lobule (SPL), have difficulty performing visually-guided reaches towards extra-foveal targets. Such gaze and hand decoupling also occurs in commonly performed non-standard visuomotor transformations such as the use of a computer mouse. In this study, we test two unilateral OA patients in conditions of 1) a change in the physical location of the visual stimulus relative to the plane of the limb movement, 2) a cue that signals a required limb movement 180 degrees opposite to the cued visual target location, or 3) both of these situations combined. In these non-standard visuomotor transformations, the OA deficit is not observed as the well-documented field-dependent misreach. Instead, OA patients make additional eye movements to update hand and goal location during motor execution in order to complete these slow movements. Overall, the OA patients struggled when having to guide centrifugal movements in peripheral vision, even when they were instructed from visual stimuli that could be foveated. We propose that an intact caudal SPL is crucial for any visuomotor control that involves updating ongoing hand location in space without foveating it, i.e. from peripheral vision, proprioceptive or predictive information.	[Granek, Joshua A.; Sergio, Lauren E.] York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Pisella, Laure; Rossetti, Yves] CNRS, Impact Ctr Rech Neurosci Lyon, INSERM, U1028,UMR 5092, Bron, France; [Granek, Joshua A.; Rossetti, Yves] Univ Lyon 1, F-69365 Lyon, France; [Rossetti, Yves] Hop Henry Gabrielle, Hosp Civils Lyon, St Genis Laval, France; [Blangero, Annabelle] CUNY, Dept Biol, New York, NY 10021 USA	York University - Canada; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; City University of New York (CUNY) System	Sergio, LE (corresponding author), York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	lsergio@yorku.ca	Sergio, Lauren/AAK-3274-2020; Rossetti, Yves/H-3693-2017; Pisella, Laure/H-6072-2017	Rossetti, Yves/0000-0001-8867-4496; Pisella, Laure/0000-0001-6550-3774; Granek, Joshua/0000-0002-7361-5095	Canadian Institutes of Health Research [MOP74634]; Institut National de la Sante et de la Recherche Medicale, France	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Canadian Institutes of Health Research (MOP74634 to L. S., CGS-D to J.G.), Canada (http://www.cihr-irsc.gc.ca/e/193.html), and Institut National de la Sante et de la Recherche Medicale (http://u864.lyon. inserm.fr/), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; BEDFORD FL, 1993, J EXP PSYCHOL HUMAN, V19, P517, DOI 10.1037/0096-1523.19.3.517; Blangero A, 2007, NEUROIMAGE, V36, pT61, DOI 10.1016/j.neuroimage.2007.03.039; Blangero A, 2009, NEUROPSYCHOLOGIA, V47, P1500, DOI 10.1016/j.neuropsychologia.2008.11.030; Blangero A, 2008, CORTEX, V44, P560, DOI 10.1016/j.cortex.2007.09.004; Blangero A, 2011, VISION RES, V51, P932, DOI 10.1016/j.visres.2011.01.012; Blangero A, 2010, CORTEX, V46, P77, DOI 10.1016/j.cortex.2009.02.015; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Butler SH, 2009, NEUROPSYCHOLOGIA, V47, P2488, DOI 10.1016/j.neuropsychologia.2009.04.022; Clower DM, 2000, J NEUROPHYSIOL, V84, P2703, DOI 10.1152/jn.2000.84.5.2703; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Culham JC, 2005, NEURON, V48, P713, DOI 10.1016/j.neuron.2005.11.020; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Dijkerman HC, 2006, NEUROPSYCHOLOGIA, V44, P2766, DOI 10.1016/j.neuropsychologia.2005.10.018; Fattori P, 2004, EUR J NEUROSCI, V20, P2457, DOI 10.1111/j.1460-9568.2004.03697.x; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Gaveau V, 2008, NEUROPSYCHOLOGIA, V46, P475, DOI 10.1016/j.neuropsychologia.2007.08.028; Ghilardi MF, 1999, NEUROSCI LETT, V260, P45, DOI 10.1016/S0304-3940(98)00957-4; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Granek JA, 2010, CORTEX, V46, P1165, DOI 10.1016/j.cortex.2009.10.009; Hanakawa T, 2006, EXP BRAIN RES, V172, P275, DOI 10.1007/s00221-005-0336-z; Heath M, 2009, EXP BRAIN RES, V192, P275, DOI 10.1007/s00221-008-1612-5; Heath M, 2009, J MOTOR BEHAV, V41, P383, DOI 10.3200/35-08-016; Inoue K, 2000, NEUROIMAGE, V11, P505, DOI 10.1006/nimg.2000.0554; Jackson SR, 2005, CURR BIOL, V15, P42, DOI 10.1016/S0960-9822(04)01046-2; Jackson SR, 2009, NEUROPSYCHOLOGIA, V47, P1397, DOI 10.1016/j.neuropsychologia.2009.01.035; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kelley TA, 2008, CEREB CORTEX, V18, P114, DOI 10.1093/cercor/bhm036; Khan AZ, 2007, J VISION, V7, DOI 10.1167/7.5.8; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; KINSBOURNE M, 1970, ACTA PSYCHOL, V33, P193, DOI 10.1016/0001-6918(70)90132-0; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; McIntosh RD, 2011, NEUROPSYCHOLOGIA, V49, P131, DOI 10.1016/j.neuropsychologia.2010.11.017; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Messier J, 1997, EXP BRAIN RES, V115, P469, DOI 10.1007/PL00005716; Milner AD, 2003, PROG BRAIN RES, V142, P223; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Newport R, 2001, CURR BIOL, V11, P975, DOI 10.1016/S0960-9822(01)00266-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 2006, NEUROPSYCHOLOGIA, V44, P2734, DOI 10.1016/j.neuropsychologia.2006.03.027; Pisella L, 2009, NEUROPSYCHOLOGIA; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Ren L, 2006, J NEUROPHYSIOL, V96, P1464, DOI 10.1152/jn.01012.2005; Revol P, 2003, SPATIAL VISION, V16, P347, DOI 10.1163/156856803322467572; Rice NJ, 2008, NEUROPSYCHOLOGIA, V46, P1549, DOI 10.1016/j.neuropsychologia.2008.01.012; Rossetti Y, 2005, NEUROPSYCHOLOGIA, V43, P162, DOI 10.1016/j.neuropsychologia.2004.11.004; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Rossit S, 2011, CEREB CORTEX, V21, P2751, DOI 10.1093/cercor/bhr073; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; Sergio LE, 2009, CORTICAL MECHANISMS OF VISION, P81; Striemer C, 2007, NEUROREPORT, V18, P1171, DOI 10.1097/WNR.0b013e32820049bd; Tagaris GA, 1996, NEUROREPORT, V7, P773, DOI 10.1097/00001756-199602290-00022; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Thaler L, 2011, EXP BRAIN RES, V211, P313, DOI 10.1007/s00221-011-2691-2; Tippett WJ, 2007, EUR NEUROL, V58, P1, DOI 10.1159/000102160; Tippett WJ, 2006, BRAIN RES, V1102, P92, DOI 10.1016/j.brainres.2006.04.049; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vesia M, 2008, J NEUROPHYSIOL, V100, P2005, DOI 10.1152/jn.90519.2008; Vesia M, 2010, J NEUROSCI, V30, P13053, DOI 10.1523/JNEUROSCI.1644-10.2010; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	83	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46619	10.1371/journal.pone.0046619	http://dx.doi.org/10.1371/journal.pone.0046619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071599	Green Published, gold			2022-12-25	WOS:000309827300041
J	Das, S; Dey, KK; Dey, G; Pal, I; Majumder, A; MaitiChoudhury, S; Kundu, SC; Mandal, M				Das, Subhasis; Dey, Kaushik Kumar; Dey, Goutam; Pal, Ipsita; Majumder, Abhijit; MaitiChoudhury, Sujata; Kundu, Subhas C.; Mandal, Mahitosh			Antineoplastic and Apoptotic Potential of Traditional Medicines Thymoquinone and Diosgenin in Squamous Cell Carcinoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; COLON-CANCER; IN-VITRO; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; ACTIVATION; PATHWAY; VIVO; BEVACIZUMAB; GROWTH	Thymoquinone (TQ) and diosgenin (DG), the active ingredients obtained from black cumin (Nigella sativa) and fenugreek (Trigonella foenum graecum), respectively, exert potent bioactivity, including anticancer effects. This study investigated the antineoplastic activity of these agents against squamous cell carcinoma in vitro and sarcoma 180-induced tumors in vivo. TQ and DG inhibited cell proliferation and induced cytotoxicity in A431 and Hep2 cells. These agents induced apoptosis by increasing the sub-G1 population, LIVE/DEAD cytotoxicity, chromatin condensation, DNA laddering and TUNEL-positive cells significantly (P < 0.05). Increased Bax/Bcl-2 ratio, activation of caspases and cleavage of poly ADP ribose polymerase were observed in treated cells. These drugs inhibited Akt and JNK phosphorylations, thus inhibiting cell proliferation while inducing apoptosis. In combination, TQ and DG had synergistic effects, resulting in cell viability as low as 10%. In a mouse xenograft model, a combination of TQ and DG significantly (P<0.05) reduced tumor volume, mass and increased apoptosis. TQ and DG, alone and in combination, inhibit cell proliferation and induce apoptosis in squamous cell carcinoma. The combination of TQ and DG is a potential antineoplastic therapy in this common skin cancer.	[Das, Subhasis; Dey, Kaushik Kumar; Dey, Goutam; Pal, Ipsita; Mandal, Mahitosh] Indian Inst Technol Kharagpur, Sch Med Sci & Technol, Kharagpur, W Bengal, India; [Majumder, Abhijit] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [MaitiChoudhury, Sujata] Vidyasagar Univ, Dept Human Physiol Community Hlth, W Midnapur, W Bengal, India; [Kundu, Subhas C.] Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Texas System; UTMD Anderson Cancer Center; Vidyasagar University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Mandal, M (corresponding author), Indian Inst Technol Kharagpur, Sch Med Sci & Technol, Kharagpur, W Bengal, India.	mahitosh@smst.iitkgp.ernet.in	Pal, Ipsita/AAX-4410-2020; Kundu, Subhas C/AAC-1317-2020; Mandal, Mahitosh/GMW-6195-2022; DAS, SUBHASIS/O-8421-2017; Dey, Kaushik Kumar/H-5997-2018	Kundu, Subhas C/0000-0002-7170-2291; Mandal, Mahitosh/0000-0003-3861-3323; DAS, SUBHASIS/0000-0003-1032-4407; Dey, Kaushik Kumar/0000-0002-9594-6362; Dey, Goutam/0000-0002-8210-3219	Department of Science and Technolgy; Department of Biotechnology, Government of India	Department of Science and Technolgy; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors are very thankful to the Department of Science and Technolgy, and the Department of Biotechnology, Government of India for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shabanah OA, 1998, J EXP CLIN CANC RES, V17, P193; Badary OA, 2003, DRUG CHEM TOXICOL, V26, P87, DOI 10.1081/DCT-120020404; Chen Pin-Shern, 2011, PLoS One, V6, pe20164, DOI 10.1371/journal.pone.0020164; Chiang CT, 2007, FEBS LETT, V581, P5735, DOI 10.1016/j.febslet.2007.11.021; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Chou TC, 1984, ADV ENZYME REGUL, V22, P22; Corbiere C, 2004, CELL RES, V14, P188, DOI 10.1038/sj.cr.7290219; Effenberger-Neidnicht K, 2011, CANCER CHEMOTH PHARM, V67, P867, DOI 10.1007/s00280-010-1386-x; El-Mahdy MA, 2005, INT J CANCER, V117, P409, DOI 10.1002/ijc.21205; El-Najjar N, 2010, APOPTOSIS, V15, P183, DOI 10.1007/s10495-009-0421-z; Gali-Muhtasib HU, 2004, ANTI-CANCER DRUG, V15, P389, DOI 10.1097/00001813-200404000-00012; Gasparini G, 2005, NAT CLIN PRACT ONCOL, V2, P562, DOI 10.1038/ncponc0342; Ito H, 1997, ANTICANCER RES, V17, P277; Ivankovic S., 2006, Experimental Oncology, V28, P220; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Jaganathan SK, 2011, CELL BIOL INT, V35, P607, DOI 10.1042/CBI20100118; JOHNSON TM, 1992, J AM ACAD DERMATOL, V26, P467, DOI 10.1016/0190-9622(92)70074-P; Kaseb AO, 2007, CANCER RES, V67, P7782, DOI 10.1158/0008-5472.CAN-07-1483; Kerr DJ, 2004, NAT CLIN PRACT ONCOL, V1, P39, DOI 10.1038/ncponc0026; Lee J, 2007, LIFE SCI, V81, P249, DOI 10.1016/j.lfs.2007.05.009; Lee YL, 2003, EXP ANIM TOKYO, V52, P371, DOI 10.1538/expanim.52.371; Lei XF, 2012, BIOCHEM BIOPH RES CO, V417, P864, DOI 10.1016/j.bbrc.2011.12.063; Li F, 2010, CANCER LETT, V292, P197, DOI 10.1016/j.canlet.2009.12.003; Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897; McAnuff MA, 2005, FOOD CHEM TOXICOL, V43, P1667, DOI 10.1016/j.fct.2005.05.008; Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575; Salehi Z, 2007, CELL BIOL INT, V31, P1400, DOI 10.1016/j.cellbi.2007.06.006; Sarkar S, 2011, J CELL PHYSIOL, V226, P375, DOI 10.1002/jcp.22343; Sarkar S, 2010, CANCER BIOL THER, V9, P592, DOI 10.4161/cbt.9.8.11103; Sethi G, 2008, MOL CANCER RES, V6, P1059, DOI 10.1158/1541-7786.MCR-07-2088; Shishodia S, 2006, ONCOGENE, V25, P1463, DOI 10.1038/sj.onc.1209194; Tornita K, 1979, CANCER RES, V39, P4407; VanDeWater B, 1996, AM J PHYSIOL-RENAL, V270, pF593, DOI 10.1152/ajprenal.1996.270.4.F593; Velho-Pereira R, 2011, CELL BIOL INT, V35, P1025, DOI 10.1042/CBI20100701; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Woo CC, 2011, BIOCHEM PHARMACOL, V82, P464, DOI 10.1016/j.bcp.2011.05.030; Yang SX, 2008, CLIN CANCER RES, V14, P5893, DOI 10.1158/1078-0432.CCR-07-4762	37	100	105	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46641	10.1371/journal.pone.0046641	http://dx.doi.org/10.1371/journal.pone.0046641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077516	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100034
J	Hoeschele, M; Cook, RG; Guillette, LM; Hahn, AH; Sturdy, CB				Hoeschele, Marisa; Cook, Robert G.; Guillette, Lauren M.; Hahn, Allison H.; Sturdy, Christopher B.			Auditory Same/Different Concept Learning and in Black-Capped Chickadees (Poecile atricapillus)	PLOS ONE			English	Article							SAME-DIFFERENT DISCRIMINATION; A-DEE CALL; BUDGERIGARS MELOPSITTACUS-UNDULATUS; NOTE-TYPE PERCEPTION; PARID VOCALIZATIONS; ABSOLUTE PITCH; RELATIVE PITCH; MECHANISMS; SPEECH; MEMORY	The concept learning was thought to be uniquely human, but has since been observed in many other species. Discriminating same from different is one abstract relation that has been studied frequently. In the current experiment, using operant conditioning, we tested whether black-capped chickadees (Poecile atricapillus) could discriminate sets of auditory stimuli based on whether all the sounds within a sequence were the same or different from one another. The chickadees were successful at solving this same/different relational task, and transferred their learning to same/different sequences involving novel combinations of training notes and novel notes within the range of pitches experienced during training. The chickadees showed limited transfer to pitches that was not used in training, suggesting that the processing of absolute pitch may constrain their relational performance. Our results indicate, for the first time, that black-capped chickadees readily form relational auditory same and different categories, adding to the list of perceptual, behavioural, and cognitive abilities that make this species an important comparative model for human language and cognition.	[Hoeschele, Marisa; Guillette, Lauren M.; Hahn, Allison H.; Sturdy, Christopher B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Cook, Robert G.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Sturdy, Christopher B.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada	University of Alberta; Tufts University; University of Alberta	Sturdy, CB (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	csturdy@ualberta.ca	Hoeschele, Marisa/R-2176-2019; Hoeschele, Marisa/R-6198-2018; Sturdy, Christopher B/A-4407-2009; Guillette, Lauren/K-8154-2013	Hoeschele, Marisa/0000-0002-2102-0882; Hoeschele, Marisa/0000-0002-2102-0882; Guillette, Lauren/0000-0002-8777-6543; Sturdy, Christopher/0000-0003-2721-3770	Natural Sciences and Engineering Research Council of Canada (NSERC); Discovery Accelerator Supplement (DAS); Alberta Ingenuity Fund (AIF); Canada Foundation for Innovation (CFI) Infrastructure Operating Fund (IOF); CFI; University of Alberta; NSERC; AIF; Izaak Walton Killam Memorial Scholarship (IWKMS) at the University of Alberta; National Science Foundation [0718804]; IWKMS at the University of Alberta	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Discovery Accelerator Supplement (DAS); Alberta Ingenuity Fund (AIF); Canada Foundation for Innovation (CFI) Infrastructure Operating Fund (IOF); CFI(Canada Foundation for Innovation); University of Alberta(University of Alberta); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); AIF; Izaak Walton Killam Memorial Scholarship (IWKMS) at the University of Alberta; National Science Foundation(National Science Foundation (NSF)); IWKMS at the University of Alberta	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant and Discovery Accelerator Supplement (DAS), an Alberta Ingenuity Fund (AIF) New Faculty Grant, the Canada Foundation for Innovation (CFI) Infrastructure Operating Fund (IOF) and a CFI New Opportunities Grant along with start-up funding and CFI partner funding from the University of Alberta to CBS. MH was supported by a NSERC post-graduate scholarship, an AIF graduate student scholarship, and an Izaak Walton Killam Memorial Scholarship (IWKMS) at the University of Alberta. RGC's participation in this project was supported by a grant from the National Science Foundation # 0718804. LMG is supported by an IWKMS at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YS, 2011, BEHAVIOUR, V148, P55, DOI 10.1163/000579510X545829; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Bloomfield LL, 2008, BEHAV PROCESS, V77, P73, DOI 10.1016/j.beproc.2007.06.011; Bloomfield LL, 2005, CAN J ZOOL, V83, P820, DOI 10.1139/Z05-067; Bloomfield LL, 2004, CAN J ZOOL, V82, P780, DOI 10.1139/Z04-046; Bregman MR, 2012, COGNITION, V122, P51, DOI 10.1016/j.cognition.2011.08.008; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; Charrier I, 2005, J COMP PSYCHOL, V119, P371, DOI 10.1037/0735-7036.119.4.371; Charrier I, 2004, CAN J ZOOL, V82, P769, DOI 10.1139/Z04-045; Comins JA, 2010, COGNITION, V117, P38, DOI 10.1016/j.cognition.2010.06.009; Cook R. G., 2006, COMP COGNITION EXPT, P307; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; Cook RG, 2003, BEHAV PROCESS, V62, P125, DOI 10.1016/S0376-6357(03)00022-6; Cook RG, 2009, J EXP PSYCHOL-ANIM B, V35, P108, DOI 10.1037/a0012621; CYNX J, 1986, J EXP PSYCHOL ANIM B, V12, P394; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2004, MUSIC PERCEPT, V21, P339, DOI 10.1525/mp.2004.21.3.339; Deutsch D., 2006, ACOUST TODAY, V2, P11, DOI DOI 10.1121/1.2961141; DOOLING RJ, 1987, J COMP PSYCHOL, V101, P139, DOI 10.1037/0735-7036.101.2.139; DOOLING RJ, 1992, J COMP PSYCHOL, V106, P20, DOI 10.1037/0735-7036.106.1.20; Doumas LAA, 2008, PSYCHOL REV, V115, P1, DOI 10.1037/0033-295X.115.1.1; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FICKEN MS, 1978, AUK, V95, P34, DOI 10.2307/4085493; Foote JR, 2008, BEHAV ECOL, V19, P1192, DOI 10.1093/beheco/arn087; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Gibson BM, 2004, LEARN BEHAV, V32, P183; Gibson BM, 2003, J EXP PSYCHOL ANIM B, V29, P84, DOI 10.1037//0097-7403.29.1.84; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; Guillette LM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00229; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Guillette LM, 2010, J COMP PSYCHOL, V124, P109, DOI 10.1037/a0017741; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; HITCHCOCK CL, 1990, ANIM BEHAV, V40, P701, DOI 10.1016/S0003-3472(05)80699-2; Hoeschele M, 2012, ANIM COGN IN PRESS; Hoeschele M, 2012, J COMP PSYCHOL, V126, P57, DOI 10.1037/a0024627; Hoeschele M, 2009, J ACOUST SOC AM, V126, P2088, DOI 10.1121/1.3203736; Howell S. N, 1997, IDENTIFICATION GUIDE; HULSE SH, 1985, J COMP PSYCHOL, V99, P176, DOI 10.1037/0735-7036.99.2.176; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; KEANE M, 1987, Q J EXP PSYCHOL-A, V39, P29, DOI 10.1080/02724988743000015; Khallad Y, 2004, INT J PSYCHOL, V39, P73, DOI 10.1080/00207590344000349; Lee TTY, 2006, J COMP PSYCHOL, V120, P217, DOI 10.1037/0735-7036.120.3.217; Lohr B, 1998, J COMP PSYCHOL, V112, P36, DOI 10.1037/0735-7036.112.1.36; Moscicki MK, 2011, J ACOUST SOC AM, V129, P3327, DOI 10.1121/1.3560925; Moscicki MK, 2010, ACTA ORNITHOL, V45, P147, DOI 10.3161/000164510X551282; Murphy MS, 2008, BEHAV PROCESS, V77, P210, DOI 10.1016/j.beproc.2007.10.008; Njegovan M, 1997, J COMP PSYCHOL, V111, P294; NJEGOVAN M, 1994, BEHAV RES METH INSTR, V26, P26, DOI 10.3758/BF03204558; OKANOYA K, 1991, J COMP PSYCHOL, V105, P60, DOI 10.1037/0735-7036.105.1.60; Palya W.L., 2001, DOCUMENT SET HIGH PE; PARK TJ, 1985, J COMP PSYCHOL, V99, P391, DOI 10.1037/0735-7036.99.4.391; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; Saffran JR, 2001, DEV PSYCHOL, V37, P74, DOI 10.1037//0012-1649.37.1.74; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; SHERRY DF, 1989, WILSON BULL, V101, P289; SHETTLEWORTH SJ, 1982, J EXP PSYCHOL ANIM B, V8, P354, DOI 10.1037/0097-7403.8.4.354; Smith S.M., 1991, BLACK CAPPED CHICKAD; Sturz BR, 2009, J COMP PSYCHOL, V123, P90, DOI 10.1037/a0012905; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; Wasserman EA, 2002, J EXP PSYCHOL ANIM B, V28, P347, DOI 10.1037//0097-7403.28.4.347; Wasserman EA, 2010, J EXP PSYCHOL-ANIM B, V36, P3, DOI 10.1037/a0016327; Weisman R, 2004, AM SCI, V92, P532; Weisman Ronald G., 2006, P71; Weisman RG, 2010, LEARN MOTIV, V41, P156, DOI 10.1016/j.lmot.2010.04.002; Wright AA, 2007, J COMP PSYCHOL, V121, P387, DOI 10.1037/0735-7036.121.4.387; Young ME, 2001, PSYCHON B REV, V8, P677, DOI 10.3758/BF03196203; Young ME, 1999, J EXP PSYCHOL ANIM B, V25, P475, DOI 10.1037/0097-7403.25.4.475; Zentall TR, 2008, COMP COGN BEHAV REV, V3, P13, DOI 10.3819/ccbr.2008.30002	72	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47691	10.1371/journal.pone.0047691	http://dx.doi.org/10.1371/journal.pone.0047691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077660	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100153
J	Kisos, H; Pukass, K; Ben-Hur, T; Richter-Landsberg, C; Sharon, R				Kisos, Haya; Pukass, Katharina; Ben-Hur, Tamir; Richter-Landsberg, Christiane; Sharon, Ronit			Increased Neuronal alpha-Synuclein Pathology Associates with Its Accumulation in Oligodendrocytes in Mice Modeling alpha-Synucleinopathies	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; TRANSGENIC MOUSE MODEL; PARKINSONS-DISEASE; FATTY-ACIDS; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; ELEVATED LEVELS; EXPRESSION; PROTEIN	Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by striatonigral degeneration and olivo-pontocerebellar atrophy. The histopathological hallmark of MSA is glial cytoplasmic inclusions (GCI) within oligodendrocytes, accompanied by neuronal degeneration. MSA is a synucleinopathy, and alpha-Synuclein (alpha-Syn) is the major protein constituent of the GCI. It is unclear how the neuronal alpha-Syn protein accumulates in oligodendrocytes. We tested the hypothesis that oligodendrocytes can take up neuronal-secreted alpha-Syn as part of the pathogenic mechanisms leading to MSA. We report that increases in the degree of alpha-Syn soluble oligomers or intracellular alpha-Syn levels, enhance its secretion from cultured MN9D dopaminergic cells, stably expressing the protein. In accord, we show that primary oligodendrocytes from rat brain and oligodendroglial cell lines take-up neuronal-secreted or exogenously added alpha-Syn from their conditioning medium. This uptake is concentration-, time-, and clathrin-dependent. Utilizing the demonstrated effect of polyunsaturated fatty acids (PUFA) to enhance alpha-Syn neuropathology, we show an in vivo effect for brain docosahexaenoic acid (DHA) levels on alpha-Syn localization to oligodendrocytes in brains of a mouse model for synucleinopathies, expressing human A53T alpha-Syn cDNA under the PrP promoter. Hence, pathogenic mechanisms leading to elevated levels of alpha-Syn in neurons underlie neuronal secretion and subsequent uptake of alpha-Syn by oligodendrocytes in MSA.	[Kisos, Haya; Sharon, Ronit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel; [Pukass, Katharina; Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, D-2900 Oldenburg, Germany; [Ben-Hur, Tamir] Hadassah Univ, Med Ctr, Jerusalem, Israel	Hebrew University of Jerusalem; Carl von Ossietzky Universitat Oldenburg; Hebrew University of Jerusalem; Hadassah University Medical Center	Sharon, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel.	ronitsh@ekmd.huji.ac.il			German Science Foundation (DFG); Rosetrees Trust; USAID's American Schools and Hospitals Abroad (ASHA) Program [LSM710]	German Science Foundation (DFG)(German Research Foundation (DFG)); Rosetrees Trust(Rosetrees Trust); USAID's American Schools and Hospitals Abroad (ASHA) Program(United States Agency for International Development (USAID))	This work was supported by a grant from the German Science Foundation (DFG) to CRL; The Rosetrees Trust (RS); and the USAID's American Schools and Hospitals Abroad (ASHA) Program for the procurement of the confocal microscope LSM710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.001; Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Bajaj A, 2010, CANCER CAUSE CONTROL, V21, P697, DOI 10.1007/s10552-009-9497-6; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand A, 2010, J NEUROCHEM, V113, P465, DOI 10.1111/j.1471-4159.2010.06611.x; Bruggink KA, 2011, NEUROLOGY, V77, P510, DOI 10.1212/WNL.0b013e318219dd92; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Devine MJ, 2011, MOVEMENT DISORD, V26, P2160, DOI 10.1002/mds.23948; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Foulds PG, 2012, NEUROBIOL DIS, V45, P188, DOI 10.1016/j.nbd.2011.08.003; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hoepken HH, 2008, EXP NEUROL, V212, P307, DOI 10.1016/j.expneurol.2008.04.004; Israeli E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019622; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P657, DOI 10.1007/s00401-010-0672-3; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Miller DW, 2005, J NEURAL TRANSM, V112, P1613, DOI 10.1007/s00702-005-0378-1; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nakai M, 2007, BIOCHEM BIOPH RES CO, V358, P104, DOI 10.1016/j.bbrc.2007.04.108; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Sierks MR, 2011, INTEGR BIOL-UK, V3, P1188, DOI 10.1039/c1ib00018g; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Suzuki K, 2009, BIOL PHARM BULL, V32, P1177, DOI 10.1248/bpb.32.1177; Tateno F, 2011, ALZ DIS ASSOC DIS, V26, P213; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Yakunin Y, 2011, BRAIN PATHO IN PRESS; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032	57	72	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46817	10.1371/journal.pone.0046817	http://dx.doi.org/10.1371/journal.pone.0046817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077527	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100043
J	Lahlou, O; Millet, J; Chaoui, I; Sabouni, R; Filali-Maltouf, A; Akrim, M; El Mzibri, M; Rastogi, N; El Aouad, R				Lahlou, Ouafae; Millet, Julie; Chaoui, Imane; Sabouni, Radia; Filali-Maltouf, Abdelkarim; Akrim, Mohammed; El Mzibri, Mohammed; Rastogi, Nalin; El Aouad, Rajae			The Genotypic Population Structure of Mycobacterium tuberculosis Complex from Moroccan Patients Reveals a Predominance of Euro-American Lineages	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; BEIJING GENOTYPE; GLOBAL DISTRIBUTION; STRAINS; TRANSMISSION; DATABASE; OKINAWA; FAMILY; VNTR	Background: Tuberculosis (TB) remains a major health problem in Morocco. Characterization of circulating Mycobacterium tuberculosis genotypic lineages, important to understand the dynamic of the disease, was hereby addressed for the first time at a national level. Methodology/Principal Findings: Spoligotyping was performed on a panel of 592 M. tuberculosis complex strains covering a 2-year period (2004-2006). It identified 129 patterns: 105 (n = 568 strains) corresponded to a SIT number in the SITVIT2 database, while 24 patterns were labeled as orphan. A total of 523 (88.3%) strains were clustered vs. 69 or 11.7% unclustered. Classification of strains within 3 large phylogenetical groups was as follows: group 1-ancestral/TbD1+/PGG1 (EAI, Bovis, Africanum), group 2-modern/TbD1-/PGG1 group (Beijing, CAS), group 3-evolutionary recent/TbD1-/PGG2/3 (Haarlem, X, S, T, LAM; alternatively designated as the Euro-American lineage). As opposed to group 3 strains (namely LAM, Haarlem, and T) that predominated (86.5% of all isolates), 6 strains belonged to group 2 (Beijing n = 5, CAS n = 1), and 3 strains (BOV_1 n = 2, BOV_4-CAPRAE) belonged to ancestral group 1 (EAI and AFRI lineage strains were absent). 12-loci MIRU-VNTR typing of the Casablanca subgroup (n = 114 strains) identified 71 patterns: 48 MITs and 23 orphan patterns; it allowed to reduce the clustering rate from 72.8% to 29.8% and the recent transmission rate from 64% to 20.2%. Conclusion: The M. tuberculosis population structure in Morocco is highly homogeneous, and is characterized by the predominance of the Euro-American lineages, namely LAM, Haarlem, and T, which belong to the "evolutionary recent'' TbD1-/PGG2/3 phylogenetic group. The combination of spoligotyping and MIRUs decreased the clustering rate significantly, and should now be systematically applied in larger studies. The methods used in this study appear well suited to monitor the M. tuberculosis population structure for an enhanced TB management program in Morocco.	[Millet, Julie; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranatl TB Reference Lab, Unite TB & Mycobacteries, Abymes, Guadeloupe, France; [Lahlou, Ouafae; Sabouni, Radia; Akrim, Mohammed; El Aouad, Rajae] Natl Inst Hyg, Natl TB Reference Lab, Rabat, Morocco; [Chaoui, Imane; El Mzibri, Mohammed] Natl Ctr Energy Nucl Sci & Tech, Biol & Med Res Unit, Rabat, Morocco; [Filali-Maltouf, Abdelkarim] Univ Mohammed V Agdal, Lab Microbiol & Mol Biol, Fac Sci, Rabat, Morocco	Mohammed V University in Rabat	Rastogi, N (corresponding author), Inst Pasteur Guadeloupe, WHO Supranatl TB Reference Lab, Unite TB & Mycobacteries, Abymes, Guadeloupe, France.	nrastogi@pasteur-guadeloupe.fr	Filali-Maltouf, Abdelkarim/AAD-3681-2022; RASTOGI, NALIN/AAP-1958-2020	Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; RASTOGI, NALIN/0000-0002-7199-7747; EL AOUAD, Rajae/0000-0002-2686-6924	International Atomic Energy Agency (IAEA) [RAF0029]; Euro Mediterranean Network against Tuberculosis (EUMEDNETvsTB), European Commission	International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Euro Mediterranean Network against Tuberculosis (EUMEDNETvsTB), European Commission	The work performed on MIRU-VNTRs was funded by the International Atomic Energy Agency (IAEA), Project RAF0029 "Human Development and Nuclear Technology Support''. The collaboration between National Institute of Hygiene and Institut Pasteur de la Guadeloupe was partly financed through the Euro Mediterranean Network against Tuberculosis (EUMEDNETvsTB; http://www.eumednet-tb.org/index.html), European Commission, 7th Framework (FP7) program, with the aim to build a Euro Mediterranean TB network in order to optimize research and control of tuberculosis. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2009, HIST MAROC, P756; Alonso-Rodriguez N, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-34; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Bennett DE, 2002, EMERG INFECT DIS, V8, P1224; Bhanu NV, 2002, TUBERCULOSIS, V82, P105, DOI 10.1054/tube.2002.0332; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; David H, 1987, METHODES LAB MYCOBAC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diel R, 2002, J CLIN MICROBIOL, V40, P532, DOI 10.1128/JCM.40.2.532-539.2002; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; ElBaghdadi J, 1997, B SOC PATHOL EXOT, V90, P156; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kulkani S, 2005, INDIA RES MICROBIOL, V156, P588; Lahlou O, 1998, MYCOBACTERIUM TUBERC; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Millet J, 2007, J CLIN MICROBIOL, V45, P3606, DOI 10.1128/JCM.00348-07; Millet J, 2012, INFECT GENET EVOL, V12, P637, DOI 10.1016/j.meegid.2011.06.013; Mokrousov I, 2006, J CLIN MICROBIOL, V44, P2851, DOI 10.1128/JCM.00705-06; Namouchi A, 2008, J MED MICROBIOL, V57, P864, DOI 10.1099/jmm.0.47483-0; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Ottmani S, 1998, B EPIDEM, V35, P2811; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Soini H, 2000, J CLIN MICROBIOL, V38, P669, DOI 10.1128/JCM.38.2.669-676.2000; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tazi L, 2007, INFECT GENET EVOL, V7, P636, DOI 10.1016/j.meegid.2007.06.005; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; WHO, 2011, GLOB TUB CONTR 2011, P246; *WHO, 2008, 4 WHOIUATLD GLOB PRO, P142	48	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47113	10.1371/journal.pone.0047113	http://dx.doi.org/10.1371/journal.pone.0047113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077552	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100062
J	Thompson, ME; Zhou, A; Knott, CD				Thompson, Melissa Emery; Zhou, Amy; Knott, Cheryl D.			Low Testosterone Correlates with Delayed Development in Male Orangutans	PLOS ONE			English	Article							CAPTIVE MALE ORANGUTANS; CORTISOL-LEVELS; REPRODUCTIVE STRATEGIES; URINARY TESTOSTERONE; SUMATRAN ORANGUTANS; WILD ORANGUTANS; DOMINANCE RANK; LIFE-HISTORY; PATTERNS; BEHAVIOR	Male orangutans (Pongo spp.) display an unusual characteristic for mammals in that some adult males advance quickly to full secondary sexual development while others can remain in an adolescent-like form for a decade or more past the age of sexual maturity. Remarkably little is understood about how and why differences in developmental timing occur. While fully-developed males are known to produce higher androgen levels than arrested males, the longer-term role of steroid hormones in male life history variation has not been examined. We examined variation in testosterone and cortisol production among 18 fully-developed ("flanged") male orangutans in U. S. captive facilities. Our study revealed that while testosterone levels did not vary significantly according to current age, housing condition, and species origin, males that had undergone precocious development had higher testosterone levels than males that had experienced developmental arrest. While androgen variation had previously been viewed as a state-dependent characteristic of male developmental status, our study reveals that differences in the physiology of early and late developing males are detectable long past the developmental transition and may instead be trait-level characteristics associated with a male's life history strategy. Further studies are needed to determine how early in life differences in testosterone levels emerge and what consequences this variation may have for male behavioral strategies.	[Thompson, Melissa Emery] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Thompson, Melissa Emery; Zhou, Amy; Knott, Cheryl D.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Zhou, Amy] Univ Massachusetts, Sch Med, Worcester, MA USA; [Knott, Cheryl D.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA	University of New Mexico; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Thompson, ME (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	memery@unm.edu	Emery Thompson, Melissa/A-1450-2008; Thompson, Melissa Emery/ABF-1790-2020	Emery Thompson, Melissa/0000-0003-2451-6397; Thompson, Melissa Emery/0000-0003-2451-6397	National Science Foundation [0936199]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation (grant 0936199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 2010, ANN NY ACAD SCI, V1204, P127, DOI 10.1111/j.1749-6632.2010.05531.x; Anderson HB, 2008, J HUM EVOL, V54, P34, DOI 10.1016/j.jhevol.2007.05.014; Beehner JC, 2006, BEHAV ECOL SOCIOBIOL, V59, P469, DOI 10.1007/s00265-005-0071-2; Chrousos GP, 1998, ANN NY ACAD SCI, V851, P311, DOI 10.1111/j.1749-6632.1998.tb09006.x; Creel SF, 2005, J MAMMAL, V86, P255, DOI 10.1644/BHE-002.1; CZEKALA NM, 1994, AM J PRIMATOL, V34, P29, DOI 10.1002/ajp.1350340107; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GALDIKAS BMF, 1985, AM J PRIMATOL, V8, P87, DOI 10.1002/ajp.1350080202; GRAHAM CE, 1990, MG PRIMATOL, V13, P33; Hacklander K, 2003, ANIM BEHAV, V65, P1133, DOI 10.1006/anbe.2003.2159; Hardy MP, 2002, BIOL REPROD, V67, P1750, DOI 10.1095/biolreprod.102.006312; Hauser B, 2008, GEN COMP ENDOCR, V158, P77, DOI 10.1016/j.ygcen.2008.05.006; Kingsley S., 1982, Perspectives in Vertebrate Science, V2, P215; Knott Cheryl, 1999, P50; Knott Cheryl D., 2009, P81; Knott Cheryl D., 2009, P171; Knott CD, 2010, P ROY SOC B-BIOL SCI, V277, P105, DOI 10.1098/rspb.2009.1552; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Maggioncalda AN, 1999, AM J PHYS ANTHROPOL, V109, P19, DOI 10.1002/(SICI)1096-8644(199905)109:1&lt;19::AID-AJPA3&gt;3.0.CO;2-3; Maggioncalda AN, 2002, AM J PHYS ANTHROPOL, V118, P25, DOI 10.1002/ajpa.10074; Maggioncalda AN, 2000, AM J PRIMATOL, V50, P67, DOI 10.1002/(SICI)1098-2345(200001)50:1<67::AID-AJP6>3.0.CO;2-V; Maple T.L., 1980, ORANGUTAN BEHAV; MITANI JC, 1985, ANIM BEHAV, V33, P392, DOI 10.1016/S0003-3472(85)80063-4; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muller MN, 2003, AM J PRIMATOL, V60, P161, DOI 10.1002/ajp.10103; Munro C J, 1988, Prog Clin Biol Res, V285, P289; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Rijksen HD, 1978, MEDEDELINGEN LANDBOU; Robbins MM, 1997, AM J PRIMATOL, V43, P51, DOI 10.1002/(SICI)1098-2345(1997)43:1<51::AID-AJP4>3.0.CO;2-X; SAPOLSKY RM, 1992, BEHAV ENDOCRINOLOGY, P284; SCHURMANN CL, 1986, INT J PRIMATOL, V7, P265, DOI 10.1007/BF02736392; Setchell JM, 2002, AM J PRIMATOL, V56, P9, DOI 10.1002/ajp.1060; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; Strier KB, 1999, HORM BEHAV, V35, P125, DOI 10.1006/hbeh.1998.1505; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; TEBOEKHORST IJA, 1990, ANIM BEHAV, V39, P1098, DOI 10.1016/S0003-3472(05)80782-1; Utami Atmoko SS, 2000, BIMATURISM ORANG UTA; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Whitten PL, 1998, YEARB PHYS ANTHROPOL, V41, P1, DOI 10.1002/(SICI)1096-8644(1998)107:27+<1::AID-AJPA2>3.0.CO;2-H; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; WICKINGS EJ, 1992, PHYSIOL BEHAV, V52, P909, DOI 10.1016/0031-9384(92)90370-H; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; ZIEGLER TE, 1995, HORM BEHAV, V29, P407, DOI 10.1006/hbeh.1995.1028	46	24	25	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47282	10.1371/journal.pone.0047282	http://dx.doi.org/10.1371/journal.pone.0047282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077585	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100086
J	Zancarini, A; Mougel, C; Voisin, AS; Prudent, M; Salon, C; Munier-Jolain, N				Zancarini, Anouk; Mougel, Christophe; Voisin, Anne-Sophie; Prudent, Marion; Salon, Christophe; Munier-Jolain, Nathalie			Soil Nitrogen Availability and Plant Genotype Modify the Nutrition Strategies of M. truncatula and the Associated Rhizosphere Microbial Communities	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; ARABIDOPSIS-THALIANA; N-2 FIXATION; CV JEMALONG; BACTERIAL; GROWTH; FUNGAL; MICROORGANISMS; DIVERSITY; MODEL	Plant and soil types are usually considered as the two main drivers of the rhizosphere microbial communities. The aim of this work was to study the effect of both N availability and plant genotype on the plant associated rhizosphere microbial communities, in relation to the nutritional strategies of the plant-microbe interactions, for six contrasted Medicago truncatula genotypes. The plants were provided with two different nutrient solutions varying in their nitrate concentrations (0 mM and 10 mM). First, the influence of both nitrogen availability and Medicago truncatula genotype on the genetic structure of the soil bacterial and fungal communities was determined by DNA fingerprint using Automated Ribosomal Intergenic Spacer Analysis (ARISA). Secondly, the different nutritional strategies of the plant-microbe interactions were evaluated using an ecophysiological framework. We observed that nitrogen availability affected rhizosphere bacterial communities only in presence of the plant. Furthermore, we showed that the influence of nitrogen availability on rhizosphere bacterial communities was dependent on the different genotypes of Medicago truncatula. Finally, the nutritional strategies of the plant varied greatly in response to a modification of nitrogen availability. A new conceptual framework was thus developed to study plant-microbe interactions. This framework led to the identification of three contrasted structural and functional adaptive responses of plant-microbe interactions to nitrogen availability.	[Zancarini, Anouk; Mougel, Christophe; Voisin, Anne-Sophie; Prudent, Marion; Salon, Christophe; Munier-Jolain, Nathalie] INRA, Agroecol UMR1347, F-21034 Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Munier-Jolain, N (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	nathalie.munier-jolain@dijon.inra.fr	PRUDENT, Marion/A-6132-2010; Salon, Christophe/AAH-5285-2021; Salon, Christophe/C-3460-2014; Voisin, Anne-Sophie/AAL-4472-2020; Mougel, Christophe/D-5118-2017	PRUDENT, Marion/0000-0003-4696-2558; Voisin, Anne-Sophie/0000-0002-0979-7162; Mougel, Christophe/0000-0001-8675-3115; Shang, Rachel/0000-0002-2296-608X	INRA; Regional Council of Burgundy (France) [089201PPO24S00901]	INRA; Regional Council of Burgundy (France)(Region Bourgogne-Franche-Comte)	This work was supported by INRA and the Regional Council of Burgundy (France), through a PhD grant to A. Zancarini (project no089201PPO24S00901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BERTA G, 1995, TREE PHYSIOL, V15, P281, DOI 10.1093/treephys/15.5.281; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bezemer TM, 2006, J ECOL, V94, P893, DOI 10.1111/j.1365-2745.2006.01158.x; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Cook DR, 1999, CURR OPIN PLANT BIOL, V2, P301, DOI 10.1016/S1369-5266(99)80053-3; de Boer W, 2006, NEW PHYTOL, V170, P3, DOI 10.1111/j.1469-8137.2006.01674.x; Franche C., 2009, Plant and Soil, V321, P35, DOI 10.1007/s11104-008-9833-8; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gastal F, 2002, J EXP BOT, V53, P789, DOI 10.1093/jexbot/53.370.789; Harrison MJ, 1999, J EXP BOT, V50, P1013, DOI 10.1093/jexbot/50.suppl_1.1013; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Jeudy C, 2010, NEW PHYTOL, V185, P817, DOI 10.1111/j.1469-8137.2009.03103.x; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; KAPULNIK Y, 1985, CAN J MICROBIOL, V31, P881, DOI 10.1139/m85-165; Kraiser T, 2011, J EXP BOT, V62, P1455, DOI 10.1093/jxb/erq425; Lemaire G, 2007, FIELD CROP RES, V100, P91, DOI 10.1016/j.fcr.2006.05.009; LILJEROTH E, 1990, PLANT SOIL, V127, P81, DOI 10.1007/BF00010839; LILJEROTH E, 1990, SOIL BIOL BIOCHEM, V22, P1015, DOI 10.1016/0038-0717(90)90026-V; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Miki T, 2010, P NATL ACAD SCI USA, V107, P14251, DOI 10.1073/pnas.0914281107; Miransari M, 2011, APPL MICROBIOL BIOT, V92, P875, DOI 10.1007/s00253-011-3521-y; Moreau D, 2007, REPONSE DEV CROISSAN; Moreau D, 2008, J EXP BOT, V59, P3509, DOI 10.1093/jxb/ern203; Moreau D, 2006, PLANT CELL ENVIRON, V29, P1087, DOI 10.1111/j.1365-3040.2005.01483.x; Moreau D, 2012, THEOR APPL GENET, V124, P755, DOI 10.1007/s00122-011-1744-z; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Neuhauser C, 2004, ECOL MODEL, V177, P337, DOI 10.1016/j.ecolmodel.2004.02.010; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Normand P., 1996, MOL MICROBIAL ECOLOG; Offre P, 2007, APPL ENVIRON MICROB, V73, P913, DOI 10.1128/AEM.02042-06; Persello-Cartieaux F, 2001, PLANTA, V212, P190, DOI 10.1007/s004250000384; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ranjard L, 2003, ENVIRON MICROBIOL, V5, P1111, DOI 10.1046/j.1462-2920.2003.00521.x; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Ronfort J, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-28; Ryan PR, 2009, PLANT SOIL, V321, P363, DOI 10.1007/s11104-009-0001-6; RYLE GJA, 1979, J EXP BOT, V30, P145, DOI 10.1093/jxb/30.1.145; Schulze J, 1999, PLANT BIOLOGY, V1, P625, DOI 10.1111/j.1438-8677.1999.tb00273.x; Sequerra J, 1997, MYCOL RES, V101, P465, DOI 10.1017/S0953756296002857; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P1867, DOI 10.1111/j.1462-2920.2006.01141.x; SILSBURY JH, 1977, NATURE, V267, P149, DOI 10.1038/267149a0; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TISSERANT B, 1993, MYCOL RES, V97, P245, DOI 10.1016/S0953-7562(09)80248-7; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Trouvelot A., 1986, MYCORRHIZAE PHYSL GE, V1986, P217, DOI DOI 10.1177/004057368303900411; VANRHIJN P, 1995, MICROBIOL REV, V59, P124, DOI 10.1128/MMBR.59.1.124-142.1995; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; Vos J, 2007, WAG UR FRON, V22, P1; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Wakelin SA, 2007, FEMS MICROBIOL ECOL, V59, P661, DOI 10.1111/j.1574-6941.2006.00235.x; Yevdokimov I, 2008, BIOL FERT SOILS, V44, P1103, DOI 10.1007/s00374-008-0315-1; Zancarini A, 2012, PLANT SOIL IN PRESS	63	30	32	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47096	10.1371/journal.pone.0047096	http://dx.doi.org/10.1371/journal.pone.0047096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077550	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100060
J	Acevedo, R; Perez, O; Zayas, C; Perez, JL; Callico, A; Cedre, B; Garcia, L; Mckee, D; Mullen, AB; Ferro, VA				Acevedo, Reinaldo; Perez, Oliver; Zayas, Caridad; Perez, Jose L.; Callico, Adriana; Cedre, Barbara; Garcia, Luis; Mckee, David; Mullen, Alexander B.; Ferro, Valerie A.			Cochleates Derived from Vibrio cholerae O1 Proteoliposomes: The Impact of Structure Transformation on Mucosal Immunisation	PLOS ONE			English	Article							DELIVERY-SYSTEMS; LIPID VESICLES; DRUG-DELIVERY; ANTIGENS; VACCINES	Cochleates are phospholipid-calcium precipitates derived from the interaction of anionic lipid vesicles with divalent cations. Proteoliposomes from bacteria may also be used as a source of negatively charged components, to induce calcium-cochleate formation. In this study, proteoliposomes from V. cholerae O1 (PLc) (sized 160.7 +/- 61.6 nm) were transformed into larger (16.3 +/- 64.6 mm) cochleate-like structures (named Adjuvant Finlay Cochleate 2, AFCo2) and evaluated by electron microscopy (EM). Measurements from transmission EM (TEM) showed the structures had a similar size to that previously reported using light microscopy, while observations from scanning electron microscopy (SEM) indicated that the structures were multilayered and of cochleate-like formation. The edges of the AFCo2 structures appeared to have spaces that allowed penetration of negative stain or Ovalbumin labeled with Texas Red (OVA-TR) observed by epi-fluorescence microscopy. In addition, freeze fracture electron microscopy confirmed that the AFCo2 structures consisted of multiple overlapping layers, which corresponds to previous descriptions of cochleates. TEM also showed that small vesicles co-existed with the larger cochleate structures, and in vitro treatment with a calcium chelator caused the AFCo2 to unfold and reassemble into small proteoliposome-like structures. Using OVA as a model antigen, we demonstrated the potential loading capacity of a heterologous antigen and in vivo studies showed that with simple admixing and administration via intragastric and intranasal routes AFCo2 provided enhanced adjuvant properties compared with PLc.	[Acevedo, Reinaldo; Perez, Oliver; Zayas, Caridad; Perez, Jose L.; Callico, Adriana; Cedre, Barbara; Garcia, Luis] Res & Dev Vice Presidency Finlay Inst, Havana, Cuba; [Mckee, David] Univ Strathclyde, Dept Phys, Glasgow, Lanark, Scotland; [Mullen, Alexander B.; Ferro, Valerie A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	University of Strathclyde; University of Strathclyde	Acevedo, R (corresponding author), Res & Dev Vice Presidency Finlay Inst, Havana, Cuba.	racevedo@finlay.edu.cu	Acevedo, Reinaldo/AAL-4180-2020; McKee, David/D-6244-2013	McKee, David/0000-0001-8023-5923; Mullen, Alexander/0000-0001-7475-5543; Ferro, Valerie/0000-0003-1967-3603	Research and Development Fund from Strathclyde University	Research and Development Fund from Strathclyde University	This research was supported by the Research and Development Fund from Strathclyde University and monies provided by the Finlay Institute. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Acevedo R, 2009, METHODS, V49, P309, DOI 10.1016/j.ymeth.2009.03.027; Alcon V, 2005, AAPS J, V7, pE566, DOI 10.1208/aapsj070357; Borges O, 2010, PHARM RES-DORDR, V27, P211, DOI 10.1007/s11095-009-0011-3; Brewer JM, 2004, J IMMUNOL, V173, P6143, DOI 10.4049/jimmunol.173.10.6143; Davis SS, 2003, CLIN PHARMACOKINET, V42, P1107, DOI 10.2165/00003088-200342130-00003; Garidel P, 2001, PHYS CHEM CHEM PHYS, V3, P1504, DOI 10.1039/b009881g; Giles DK, 2011, MOL MICROBIOL, V79, P716, DOI 10.1111/j.1365-2958.2010.07476.x; Gould-Fogerite S, 1998, ADV DRUG DELIVER REV, V32, P273, DOI 10.1016/S0169-409X(98)00014-3; Leng J, 2003, BIOPHYS J, V85, P1624, DOI 10.1016/S0006-3495(03)74593-7; Lewis D, 2008, MUCOSAL ADJUVANTS; Mann JFS, 2009, EXPERT REV VACCINES, V8, P103, DOI 10.1586/14760584.8.1.103; Marone P.A., 2005, MICROSC MICROANAL, V11, P1244, DOI [10.1017/S1431927605500138, DOI 10.1017/S1431927605500138]; Meyer HW, 2000, CHEM PHYS LIPIDS, V105, P149, DOI 10.1016/S0009-3084(00)00124-9; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P438; Pérez José Luis, 2006, Vaccimonitor, V15, P1; Perez O, 2007, SCAND J IMMUNOL, V66, P271, DOI 10.1111/j.1365-3083.2007.01981.x; Perez O, 2008, Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof, Patent No. [WO/2004/047805, 2004047805]; Rimoldi M, 2005, VACCINE, V23, P1793, DOI 10.1016/j.vaccine.2004.11.007; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Saptarshi P, 1992, J GEN MICROBIOL, V138, P755; Wang W, 2004, MACROMOLECULES, V37, P9114, DOI 10.1021/ma049042o; Yuki Y, 2009, EXPERT REV VACCINES, V8, P1083, DOI [10.1586/erv.09.61, 10.1586/ERV.09.61]; Zarif L, 2002, J CONTROL RELEASE, V81, P7, DOI 10.1016/S0168-3659(02)00010-X	23	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46461	10.1371/journal.pone.0046461	http://dx.doi.org/10.1371/journal.pone.0046461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077508	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000309809500014
J	Achiron, A; Feldman, A; Magalashvili, D; Dolev, M; Gurevich, M				Achiron, Anat; Feldman, Anna; Magalashvili, David; Dolev, Mark; Gurevich, Michael			Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TERM-FOLLOW-UP; CLINICAL-COURSE; TRANSCRIPTION; INHIBITION; NFAT; IDENTIFICATION; ACTIVATION; EXPRESSION; APOPTOSIS	Benign multiple sclerosis (BMS) occurs in about 15% of patients with relapsing-remitting multiple sclerosis (RRMS) that over time do not develop significant neurological disability. The molecular events associated with BMS are not clearly understood. This study sought to underlie the biological mechanisms associated with BMS. Blood samples obtained from a cohort of 31 patients with BMS and 36 patients with RRMS were applied for gene expression microarray analysis using HG-U133A-2 array (Affymetrix). Data were analyzed by Partek and pathway reconstruction was performed by Ingenuity for the most informative genes (MIGs). We identified a differing gene expression signature of 406 MIGs between BMS patients, mean +/- SE age 44.5 +/- 1.5 years, 24 females, 7 males, EDSS 1.9 +/- 0.2, disease duration 17.0 +/- 1.3 years, and RRMS patients, age 40.3 +/- 1.8 years, 24 females, 12 males, EDSS 3.5 +/- 0.2, disease duration 10.9 +/- 1.4 years. The signature was enriched by genes related RNA polymerase I (POL-1) transcription, general inflammatory response and activation of cell death. The most significant under-expressed pathway operating in BMS was the POL-1 pathway (p = 4.0*10(-5)) known while suppressed to activate P53 dependent apoptosis and to suppress NF kappa B induced inflammation. In accordance, of the 30 P53 target genes presented within the BMS signature, 19 had expression direction consistent with P53 activation. The transcripts within the pathway include POL-1 transcription factor 3 (RRN3, p = 4.8*10(-5)), POL-1 polypeptide D (POLR1D, p = 2.2*10(-4)), leucine-rich PPR-motif containing protein (LRPPRC p = 2.3*10(-5)), followed by suppression of the downstream family of ribosomal genes like RPL3, 6,13,22 and RPS6. In accordance POL-1 transcript and release factor PTRF that terminates POL-1 transcription, was over-expressed (p = 4.4*10(-3)). Verification of POL-1 pathway key genes was confirmed by qRT-PCR, and RRN3 silencing resulted in significant increase in the apoptosis level of PBMC sub-populations in RRMS patients. Our findings demonstrate that suppression of POL-1 pathway induce the low disease activity of BMS.	[Achiron, Anat; Feldman, Anna; Magalashvili, David; Dolev, Mark; Gurevich, Michael] Tel Aviv Univ, Multiple Sclerosis Ctr, Tel Hashomer & Sackler Sch Med, Sheba Med Ctr,Neurogen Lab, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Achiron, A (corresponding author), Tel Aviv Univ, Multiple Sclerosis Ctr, Tel Hashomer & Sackler Sch Med, Sheba Med Ctr,Neurogen Lab, IL-69978 Tel Aviv, Israel.	Anat.Achiron@sheba.health.gov.il	Gurevich, Michael/H-1157-2014	Gurevich, Michael/0000-0003-1529-4876	United States of America National Multiple Sclerosis Society Pilot Research Grant [PP1615]; Sheba Medical Center Research Grant [AA2011]	United States of America National Multiple Sclerosis Society Pilot Research Grant; Sheba Medical Center Research Grant	This study was supported by the United States of America National Multiple Sclerosis Society Pilot Research Grant (PP1615) and by Sheba Medical Center Research Grant (AA2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2007, CLIN EXP IMMUNOL, V149, P235, DOI 10.1111/j.1365-2249.2007.03405.x; Achiron A, 2004, ANN NEUROL, V55, P410, DOI 10.1002/ana.20008; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brynedal B, 2010, NEUROBIOL DIS, V37, P613, DOI 10.1016/j.nbd.2009.11.014; Confavreux C, 2008, NEUROIMAG CLIN N AM, V18, P589, DOI 10.1016/j.nic.2008.09.002; Esposito M, 2010, J NEUROIMMUNOL, V220, P52, DOI 10.1016/j.jneuroim.2010.01.001; Glad SB, 2009, MULT SCLER J, V15, P942, DOI 10.1177/1352458509106511; Hawkins SA, 1999, J NEUROL NEUROSUR PS, V67, P148, DOI 10.1136/jnnp.67.2.148; Hirschler-Laszkiewicz I, 2003, J BIOL CHEM, V278, P18953, DOI 10.1074/jbc.M301093200; HUTCHINSON M, 1986, IRISH MED J, V79, P48; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Lisi L, 2012, J NEUROIMMUNOL, V243, P43, DOI 10.1016/j.jneuroim.2011.12.018; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Philippi A, 2010, NUCLEIC ACIDS RES, V38, P5315, DOI 10.1093/nar/gkq264; POSER S, 1979, J NEUROL SCI, V40, P159, DOI 10.1016/0022-510X(79)90201-6; Ramsaransing GSM, 2007, EUR J NEUROL, V14, P885, DOI 10.1111/j.1468-1331.2007.01810.x; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Satoh J, 2007, NEUROSCI LETT, V422, P30, DOI 10.1016/j.neulet.2007.05.056; Shinmen N, 2009, FEBS LETT, V583, P1916, DOI 10.1016/j.febslet.2009.04.041; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Wagner AJ, 2010, J CLIN ONCOL, V28, P835, DOI 10.1200/JCO.2009.25.2981; Wang Y, 2008, J NEUROSCI RES, V86, P2441, DOI 10.1002/jnr.21683; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Weinstock-Guttman B, 2008, J NEUROIMMUNOL, V205, P113, DOI 10.1016/j.jneuroim.2008.09.004; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023	27	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46871	10.1371/journal.pone.0046871	http://dx.doi.org/10.1371/journal.pone.0046871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077530	gold, Green Published, Green Submitted			2022-12-25	WOS:000309809500021
J	Piyaphongkul, J; Pritchard, J; Bale, J				Piyaphongkul, Jiranan; Pritchard, Jeremy; Bale, Jeff			Heat Stress Impedes Development and Lowers Fecundity of the Brown Planthopper Nilaparvata lugens (Stal)	PLOS ONE			English	Article							GLOSSINA-PALLIDIPES DIPTERA; RHODNIUS-PROLIXUS STAL; YEAST-LIKE SYMBIOTE; THERMAL TOLERANCE; CLIMATE-CHANGE; HIGH-TEMPERATURE; LOCOMOTOR PERFORMANCE; EMBRYONIC-DEVELOPMENT; LARVAL DEVELOPMENT; OXYGEN LIMITATION	This study investigated the effects of sub-lethal high temperatures on the development and reproduction of the brown plant hopper Nilaparvata lugens (Stal). When first instar nymphs were exposed at their ULT50 (41.8 degrees C) mean development time to adult was increased in both males and females, from 15.2 +/- 0.3 and 18.2 +/- 0.3 days respectively in the control to 18.7 +/- 0.2 and 19 +/- 0.2 days in the treated insects. These differences in development arising from heat stress experienced in the first instar nymph did not persist into the adult stage (adult longevity of 23.5 +/- 1.1 and 24.4 +/- 1.1 days for treated males and females compared with 25.7 +/- 1.0 and 20.6 +/- 1.1 days in the control groups), although untreated males lived longer than untreated females. Total mean longevity was increased from 38.8 +/- 0.1 to 43.4 +/- 1.0 days in treated females, but male longevity was not affected (40.9 +/- 0.9 and 42.2 +/- 1.1 days respectively). When male and female first instar nymphs were exposed at their ULT50 of 41.8 degrees C and allowed to mate on reaching adult, mean fecundity was reduced from 403.8 +/- 13.7 to 128.0 +/- 16.6 eggs per female in the treated insects. Following exposure of adult insects at their equivalent ULT50 (42.5 degrees C), the three mating combinations of treated male x treated female, treated male x untreated female, and untreated male x treated female produced 169.3 +/- 14.7, 249.6 +/- 21.3 and 233.4 +/- 17.2 eggs per female respectively, all significantly lower than the control. Exposure of nymphs and adults at their respective ULT50 temperatures also significantly extended the time required for their progeny to complete egg development for all mating combinations compared with control. Overall, sub-lethal heat stress inhibited nymphal development, lowered fecundity and extended egg development time.	[Piyaphongkul, Jiranan; Pritchard, Jeremy; Bale, Jeff] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Bale, J (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	J.S.Bale@bham.ac.uk			Royal Thai Government and School of Biosciences, University of Birmingham	Royal Thai Government and School of Biosciences, University of Birmingham	This work is funded by the Royal Thai Government and School of Biosciences, University of Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2012, AM NAT, V179, P178, DOI 10.1086/663677; Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Bale JS, 1996, EUR J ENTOMOL, V93, P369; Bale JS, 2000, POLAR BIOL, V23, P77, DOI 10.1007/s003000050011; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; Blanckenhorn WU, 1997, OECOLOGIA, V111, P318, DOI 10.1007/s004420050241; BLOCK W, 1990, PHILOS T ROY SOC B, V326, P613, DOI 10.1098/rstb.1990.0035; Bonebrake TC, 2012, ECOLOGY, V93, P449, DOI 10.1890/11-1187.1; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; CASEY TM, 1992, AM ZOOL, V32, P225; CHEN CC, 1981, Z ANGEW ENTOMOL, V92, P440; CHEN Y, 1999, INSECT SCIENCE, V6, P164; CHEN YH, 2009, PLANTHOPPERS NEW THR, P315; Chen YH, 2011, J INSECT PHYSIOL, V57, P1375, DOI 10.1016/j.jinsphys.2011.07.002; Cheng C.-H., 1985, Journal of Agricultural Research of China, V34, P299; CHENG CH, 1985, RES, V34, P299, DOI DOI 10.1073/PNAS.0709472105; Chidawanyika F, 2011, J INSECT PHYSIOL, V57, P108, DOI 10.1016/j.jinsphys.2010.09.013; Chu YI, 1985, CHINESE J ENTOMOLOGY, V4, P23; Cohen MB, 1997, ENTOMOL EXP APPL, V85, P221, DOI 10.1023/A:1003177914842; Contreras HL, 2011, J EXP BIOL, V214, P1086, DOI 10.1242/jeb.050971; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; DAVIDSON J, 1944, ANNU REV ENTOMOL; DIGBY PSB, 1955, J EXP BIOL, V32, P279; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; Dupo A. L., 2009, PLANTHOPPERS NEW THR, P3; Dyck V. A., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P3; DYCK VA, 1979, RICE, P3, DOI DOI 10.1631/JZUS.B0900193; Elnitsky MA, 2008, J INSECT PHYSIOL, V54, P1432, DOI 10.1016/j.jinsphys.2008.08.004; Estay SA, 2009, J APPL ENTOMOL, V133, P491, DOI 10.1111/j.1439-0418.2008.01380.x; Fischer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015284; Folk DG, 2007, J EXP BIOL, V210, P2649, DOI 10.1242/jeb.003350; Forsman A, 2000, EVOL ECOL, V14, P25, DOI 10.1023/A:1011024320725; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Giese A, 2011, GLOBAL TEMPERATURE P; Giorgi F, 2000, GEOPHYS RES LETT, V27, P1295, DOI 10.1029/1999GL011016; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Hallman GJ, 2005, J ECON ENTOMOL, V98, P1905, DOI 10.1603/0022-0493-98.6.1905; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hanna CJ, 2009, J ARACHNOL, V35, P193; HARCOURT DG, 1969, ANNU REV ENTOMOL, V14, P175, DOI 10.1146/annurev.en.14.010169.001135; HARRINGTON R, 1984, B ENTOMOL RES, V74, P633, DOI 10.1017/S0007485300014000; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; Hazell SP, 2011, J INSECT PHYSIOL, V57, P1085, DOI 10.1016/j.jinsphys.2011.04.004; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; HEATH JE, 1971, AM ZOOL, V11, P145; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Hou R.F., 1985, Chinese Journal of Entomology, V4, P107; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; Huey R.B., 1990, Cold Spring Harbor Monograph Series, V19, P37; Huey RB, 2001, AM NAT, V158, P204, DOI 10.1086/321314; Iranipour S, 2010, EUR J ENTOMOL, V107, P47, DOI 10.14411/eje.2010.005; Irwin JT, 2000, J INSECT PHYSIOL, V46, P655, DOI 10.1016/S0022-1910(99)00153-5; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Kersting U, 1999, J APPL ENTOMOL, V123, P23, DOI 10.1046/j.1439-0418.1999.00309.x; Kingsolver JG, 1997, PHYSIOL ZOOL, V70, P631, DOI 10.1086/515872; Kingsolver JG, 2007, AM NAT, V169, P163, DOI 10.1086/510631; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; Klose MK, 2008, J NEUROPHYSIOL, V99, P2420, DOI 10.1152/jn.01251.2007; KNAPP R, 1986, ECOLOGY, V67, P598, DOI 10.2307/1937683; Krishnaiah N.V., 2005, Indian Journal of Plant Protection, V33, P181; Lailvaux SP, 2007, FUNCT ECOL, V21, P534, DOI 10.1111/j.1365-2435.2007.01263.x; Lailvaux SP, 2003, PHYSIOL BIOCHEM ZOOL, V76, P511, DOI 10.1086/376423; Lal M, 2001, CLIMATE CHANGE 2001, P535; Lalouette L, 2011, POLAR BIOL, P1; Lapointe SL, 2007, ENVIRON ENTOMOL, V36, P73, DOI 10.1603/0046-225X(2007)36[73:EOLTOM]2.0.CO;2; Leary N, 2007, CLIMATE CHANGE ASSES, P88; LEE YH, 1987, J INSECT PHYSIOL, V33, P851, DOI 10.1016/0022-1910(87)90033-3; Lekovic S, 2001, EUR J ENTOMOL, V98, P13, DOI 10.14411/eje.2001.002; Li J, 2011, PEST MANAG SCI, V67, P528, DOI 10.1002/ps.2089; Liefting M, 2010, FUNCT ECOL, V24, P1291, DOI 10.1111/j.1365-2435.2010.01732.x; Liu XM, 2012, LECT NOTES ARTIF INT, V7390, P1, DOI 10.1007/978-3-642-31576-3_1; MacMillan HA, 2011, J INSECT PHYSIOL, V57, P12, DOI 10.1016/j.jinsphys.2010.10.004; McDonald JR, 1997, ANN APPL BIOL, V131, P189, DOI 10.1111/j.1744-7348.1997.tb05150.x; MCNABB A, 1991, IMA J APPL MATH, V47, P193, DOI 10.1093/imamat/47.2.193; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; MILES DB, 1994, AM ZOOL, V34, P422; MILKMAN R, 1963, J GEN PHYSIOL, V46, P1151, DOI 10.1085/jgp.46.6.1151; Mochida O, 1979, TAXONOMY BIOL NILAPA, P21; MOCHIDA O, 1979, RICE, P21, DOI DOI 10.1093/ICB/ICJ003; Morgan Derek, 2000, Agricultural and Forest Entomology, V2, P297, DOI 10.1046/j.1461-9563.2000.00079.x; Mualler E., 2012, PSYCHE, V12, P1; MULLER E, 2012, PLATYSAURUS INTERMED; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; Nespolo RF, 2003, J EXP BIOL, V206, P4309, DOI 10.1242/jeb.00687; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; NODA H, 1995, INSECT BIOCHEM MOLEC, V25, P639, DOI 10.1016/0965-1748(94)00107-S; O'Neill KM, 2007, J INSECT SCI, V7; OKASHA AYK, 1968, J EXP BIOL, V48, P455; OKASHA AYK, 1970, J EXP BIOL, V53, P37; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029409; Potter K, 2009, J EXP BIOL, V212, P3448, DOI 10.1242/jeb.033365; Powell SJ, 2005, J EXP BIOL, V208, P2615, DOI 10.1242/jeb.01685; Preap V., 2006, CAMBODIAN J AGR, V7, P17; Renault D, 2005, J THERM BIOL, V30, P611, DOI 10.1016/j.jtherbio.2005.09.003; REYNOLDSON TB, 1965, J ANIM ECOL, V34, P23, DOI 10.2307/2367; Reznik SY, 2009, EUR J ENTOMOL, V106, P535, DOI 10.14411/eje.2009.067; Sanuy D., 2008, Animal Biodiversity and Conservation, V31, P41; Saxena R.C., 1983, Korean Journal of Plant Protection, V22, P52; Shreve SM, 2004, J EXP BIOL, V207, P1797, DOI 10.1242/jeb.00951; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Speight MR, 1999, INSECTS CLIMATE ECOL, P26; Tanaka K, 2005, ZOOL SCI, V22, P1173, DOI 10.2108/zsj.22.1173; TEMPERATURES, PSYCHE, DOI DOI 10.1098/RSPB.2004.2891; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; Terblanche JS, 2006, J EXP BIOL, V209, P1064, DOI 10.1242/jeb.02129; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; UNFCCC, 2007, REG IMP VULN CLIM CH; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; WIN SS, 2011, RES, V8, P183; Win SS, 2011, TRENDS APPL SCI RES, V8, P183; Woodrow RJ, 1998, SOCIOBIOLOGY, V32, P17; Woods HA, 2004, J EXP BIOL, V207, P2267, DOI 10.1242/jeb.00991; Zani PA, 2005, J EVOLUTION BIOL, V18, P101, DOI 10.1111/j.1420-9101.2004.00793.x; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zhang XJ, 2008, RICE SCI, V15, P326, DOI 10.1016/S1672-6308(09)60011-1	126	29	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47413	10.1371/journal.pone.0047413	http://dx.doi.org/10.1371/journal.pone.0047413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071803	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700078
J	Requena, GS; Buzatto, BA; Martins, EG; Machado, G				Requena, Gustavo S.; Buzatto, Bruno A.; Martins, Eduardo G.; Machado, Glauco			Paternal Care Decreases Foraging Activity and Body Condition, but Does Not Impose Survival Costs to Caring Males in a Neotropical Arachnid	PLOS ONE			English	Article							MALE PARENTAL CARE; SEXUAL SELECTION; CAPTURE-RECAPTURE; ENERGY RESERVES; MATERNAL-CARE; BENEFITS; EVOLUTION; REPRODUCTION; OPILIONES; HARVESTMAN	Exclusive paternal care is the rarest form of parental investment in nature and theory predicts that the maintenance of this behavior depends on the balance between costs and benefits to males. Our goal was to assess costs of paternal care in the harvestman Iporangaia pustulosa, for which the benefits of this behavior in terms of egg survival have already been demonstrated. We evaluated energetic costs and mortality risks associated to paternal egg-guarding in the field. We quantified foraging activity of males and estimated how their body condition is influenced by the duration of the caring period. Additionally, we conducted a one-year capture-mark-recapture study and estimated apparent survival probabilities of caring and non-caring males to assess potential survival costs of paternal care. Our results indicate that caring males forage less frequently than non-caring individuals (males and females) and that their body condition deteriorates over the course of the caring period. Thus, males willing to guard eggs may provide to females a fitness-enhancing gift of cost-free care of their offspring. Caring males, however, did not show lower survival probabilities when compared to both non-caring males and females. Reduction in mortality risks as a result of remaining stationary, combined with the benefits of improving egg survival, may have played an important and previously unsuspected role favoring the evolution of paternal care. Moreover, males exhibiting paternal care could also provide an honest signal of their quality as offspring defenders, and thus female preference for caring males could be responsible for maintaining the trait.	[Requena, Gustavo S.; Machado, Glauco] Univ Sao Paulo, Dept Ecol, Inst Biociencias, Sao Paulo, Brazil; [Buzatto, Bruno A.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, WA, Australia; [Martins, Eduardo G.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Martins, Eduardo G.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Martins, Eduardo G.] Univ British Columbia, Dept Forest Sci, Ctr Appl Conservat Res, Vancouver, BC V6T 1W5, Canada	Universidade de Sao Paulo; University of Western Australia; Carleton University; Carleton University; University of British Columbia	Requena, GS (corresponding author), Univ Sao Paulo, Dept Ecol, Inst Biociencias, Sao Paulo, Brazil.	billy.requena@gmail.com	Buzatto, Bruno Alves/B-6583-2011; Requena, Gustavo/D-5576-2012; Machado, Glauco/D-6983-2012	Buzatto, Bruno Alves/0000-0002-2711-0336; Requena, Gustavo/0000-0002-7573-6085; Requena, Gustavo/0000-0003-3746-5306	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [02/00381-0, 03/05418-1, 08/54833-5, 08/50466-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, process number: 02/00381-0, 03/05418-1, 08/54833-5, and 08/50466-8) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta Luis E., 2007, P309; Alonzo SH, 2012, P ROY SOC B-BIOL SCI, V279, P1784, DOI 10.1098/rspb.2011.2237; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bolker B., 2011, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burris ZP, 2011, MAR BIOL, V158, P381, DOI 10.1007/s00227-010-1566-6; Buzatto BA, 2007, J ANIM ECOL, V76, P937, DOI 10.1111/j.1365-2656.2007.01273.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Cokendolpher James C., 2007, P339; Cooke SJ, 2006, OECOLOGIA, V148, P235, DOI 10.1007/s00442-006-0375-6; CRESPI BJ, 1988, BEHAV ECOL SOCIOBIOL, V22, P293, DOI 10.1007/BF00299845; CROWL TA, 1989, CAN J ZOOL, V67, P513, DOI 10.1139/z89-074; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Elkin CM, 2005, FUNCT ECOL, V19, P102, DOI 10.1111/j.0269-8463.2005.00935.x; Forsgren E, 1996, BEHAV ECOL SOCIOBIOL, V39, P91, DOI 10.1007/s002650050270; Gilbert JDJ, 2010, ECOL ENTOMOL, V35, P639, DOI 10.1111/j.1365-2311.2010.01221.x; Gilg MR, 2003, AM MIDL NAT, V149, P306, DOI 10.1674/0003-0031(2003)149[0306:RDLSIT]2.0.CO;2; GROSS MR, 1985, AM ZOOL, V25, P807; Hanson KC, 2009, PHYSIOL BIOCHEM ZOOL, V82, P617, DOI 10.1086/605934; HOELZER GA, 1989, ANIM BEHAV, V38, P1067, DOI 10.1016/S0003-3472(89)80146-0; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; JAMIESON I, 1995, AM NAT, V145, P824, DOI 10.1086/285770; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kendall W.L., 2012, PROGRAM MARK GENTLE; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Kolliker M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1489, DOI 10.1007/s00265-007-0381-7; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindstrom K, 2006, BEHAV ECOL SOCIOBIOL, V60, P46, DOI 10.1007/s00265-005-0138-0; Machado G, 2004, SOCIOBIOLOGY, V44, P577; Machado G, 1998, J ZOOL, V246, P359, DOI 10.1111/j.1469-7998.1998.tb00166.x; Mackereth RW, 1999, ENVIRON BIOL FISH, V56, P263, DOI 10.1023/A:1007580323816; Manica A, 2004, AM NAT, V164, P517, DOI 10.1086/423792; Maynard-Smith J, 1977, ANIM BEHAV, V25, P1, DOI [10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8)]; MCCAULEY DE, 1986, AM NAT, V127, P112, DOI 10.1086/284472; MORA G, 1990, ANIM BEHAV, V39, P582, DOI 10.1016/S0003-3472(05)80425-7; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Munguia-Steyer R, 2007, CAN J ZOOL, V85, P49, DOI 10.1139/Z06-196; Munguia-Steyer R, 2008, ETHOLOGY, V114, P693, DOI 10.1111/j.1439-0310.2008.01507.x; Nazareth TM, 2010, ANIM BEHAV, V79, P547, DOI 10.1016/j.anbehav.2009.11.026; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Polis GA, 1998, ECOLOGY, V79, P2560, DOI 10.1890/0012-9658(1998)079[2560:PAAMCO]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Requena GS, 2012, INVESTIMENTO PARENTA, P154; Requena GS, 2009, ANIM BEHAV, V78, P1169, DOI 10.1016/j.anbehav.2009.07.035; RIDLEY M, 1981, BEHAVIOUR, V76, P152, DOI 10.1163/156853981X00059; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; SMITH R L, 1976, Journal of the Kansas Entomological Society, V49, P333; Stiver KA, 2009, ETHOLOGY, V115, P1101, DOI 10.1111/j.1439-0310.2009.01707.x; Tallamy DW, 2001, ANNU REV ENTOMOL, V46, P139, DOI 10.1146/annurev.ento.46.1.139; TALLAMY DW, 1982, ECOLOGY, V63, P616, DOI 10.2307/1936779; Tallamy DW, 1999, ANIM BEHAV, V57, P727, DOI 10.1006/anbe.1998.1008; Thomas LK, 2003, ANIM BEHAV, V66, P205, DOI 10.1006/anbe.2003.2202; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Zink AG, 2003, BEHAV ECOL, V14, P687, DOI 10.1093/beheco/arg044	60	22	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46701	10.1371/journal.pone.0046701	http://dx.doi.org/10.1371/journal.pone.0046701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071616	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200041
J	Wang, QZ; Chen, G; Yersaiyiti, H; Liu, Y; Cui, J; Wu, CH; Zhang, YW; He, XQ				Wang, Quanzhen; Chen, Guo; Yersaiyiti, Hayixia; Liu, Yuan; Cui, Jian; Wu, Chunhui; Zhang, Yunwei; He, Xueqing			Modeling Analysis on Germination and Seedling Growth Using Ultrasound Seed Pretreatment in Switchgrass	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; ALPHA-AMYLASE ACTIVITY; PANICUM VIRGATUM L.; BARLEY SEED; PLANT-GROWTH; GREAT-PLAINS; BIOMASS; OPTIMIZATION; STIMULATION; IMPROVE	Switchgrass is a perennial C4 plant with great potential as a bioenergy source and, thus, a high demand for establishment from seed. This research investigated the effects of ultrasound treatment on germination and seedling growth in switchgrass. Using an orthogonal matrix design, conditions for the ultrasound pretreatment in switchgrass seed, including sonication time (factor A), sonication temperature (factor B) and ultrasound output power (factor C), were optimized for germinating and stimulating seedling growth (indicated as plumular and radicular lengths) through modeling analysis. The results indicate that sonication temperature (B) was the most effective factor for germination, whereas output power (C) had the largest effect on seedling growth when ultrasound treatment was used. Combined with the analyses of range, variance and models, the final optimal ultrasonic treatment conditions were sonication for 22.5 min at 39.7 degrees C and at an output power of 348 W, which provided the greatest germination percentage and best seedling growth. For this study, the orthogonal matrix design was an efficient method for optimizing the conditions of ultrasound seed treatment on switchgrass. The electrical conductivity of seed leachates in three experimental groups (control, soaked in water only, and ultrasound treatment) was determined to investigate the effects of ultrasound on seeds and eliminate the effect of water in the ultrasound treatments. The results showed that the electrical conductivity of seed leachates during either ultrasound treatment or water bath treatment was significantly higher than that of the control, and that the ultrasound treatment had positive effects on switchgrass seeds.	[Wang, Quanzhen; Chen, Guo; Yersaiyiti, Hayixia; Liu, Yuan; Wu, Chunhui; He, Xueqing] NW A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China; [Cui, Jian] NW A&F Univ, Coll Life Sci, Dept Plant Sci, Yangling, Shaanxi Provinc, Peoples R China; [Zhang, Yunwei] China Agr Univ, Coll Anim Sci & Technol, Inst Grassland Sci, Beijing 100094, Peoples R China; [He, Xueqing] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; China Agricultural University; Lanzhou University	Wang, QZ (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi Provinc, Peoples R China.	wangquanzhen191@163.com			National Natural Science Foundation of China [30772532]; National Basic Research and Development Programme (973 project) [2012CB215300]; National Science & Technology Pillar Program of China [2009BADA7B04, 2008BAD95B12]; International Cooperation Research Project between China and Serbia [2011-1-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Programme (973 project)(National Basic Research Program of China); National Science & Technology Pillar Program of China; International Cooperation Research Project between China and Serbia	This work was supported by the National Natural Science Foundation of China (30772532) URL: http://www.nsfc.gov.cn/Portal0/default152.htm; the National Basic Research and Development Programme (973 project, 2012CB215300) URL: http://www.doc88.com/p-301295735181.html; the National Science & Technology Pillar Program of China (2009BADA7B04 and 2008BAD95B12) URL: http://www.dost.moe.edu.cn/ and the International Cooperation Research Project between China and Serbia (2011-1-7) URL: http://www.istcp.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinola JO, 2000, EXP AGR, V36, P63, DOI 10.1017/S0014479700361075; Alexopoulou E, 2008, BIOMASS BIOENERG, V32, P926, DOI 10.1016/j.biombioe.2008.01.015; Ashraf M, 2005, ADV AGRON, V88, P223, DOI 10.1016/S0065-2113(05)88006-X; Balachandran S, 2006, ULTRASON SONOCHEM, V13, P471, DOI 10.1016/j.ultsonch.2005.11.006; Barney JN, 2009, PLANT SCI, V177, P724, DOI 10.1016/j.plantsci.2009.09.003; Boe A, 2011, BIOENERG RES, V4, P77, DOI 10.1007/s12155-010-9102-6; Caseiro R, 2004, SEED SCI TECHNOL, V32, P365, DOI 10.15258/sst.2004.32.2.09; Chatterjee S, 1977, REGRESSION ANAL EXAM; Demirbas A, 2011, APPL ENERG, V88, P17, DOI 10.1016/j.apenergy.2010.07.016; Ding YF, 2008, SCI CHINA SER C, V51, P842, DOI 10.1007/s11427-008-0107-8; Farooq M, 2006, SEED SCI TECHNOL, V34, P507, DOI 10.15258/sst.2006.34.2.25; Farooq M, 2011, ACTA PHYSIOL PLANT, V33, P1707, DOI 10.1007/s11738-010-0707-3; Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z; Ghimire SR, 2009, BIOENERG RES, V2, P51, DOI 10.1007/s12155-009-9033-2; Goussous SJ, 2010, EXP AGR, V46, P231, DOI 10.1017/S0014479709991062; Gregory S, 1978, STAT METHODS GEOGRAP; Haynes JG, 1997, HORTSCIENCE, V32, P1222, DOI 10.21273/HORTSCI.32.7.1222; Hazra CR, 1996, FORAGE SEED PRODUCTI, P252; Hedayat AS, 1999, ORTHOGONAL ARRAYS TH, P363; KARABASCHEFF N., 1966, COMPT REND ACAD BULG SCI, V19, P305; Kim HJ, 2006, J FOOD SCI, V71, pM168, DOI 10.1111/j.1750-3841.2006.00064.x; Lattin J., 2003, ANAL MULTIVARIATE DA; Liu HX, 2008, NEW ZEAL J AGR RES, V51, P69, DOI 10.1080/00288230809510436; Mitchell RB, 2010, BIOENERG RES, V3, P321, DOI 10.1007/s12155-010-9084-4; MULIMANI VH, 1994, PLANT FOOD HUM NUTR, V46, P27, DOI 10.1007/BF01088458; RUBTSOVA I. D., 1967, BIOFIZIKA, V12, P489; Saathoff AJ, 2011, BIOENERG RES, V4, P120, DOI 10.1007/s12155-010-9106-2; Sarath G, 2006, PLANTA, V223, P1154, DOI 10.1007/s00425-005-0162-3; SAS-Institute-Inc, 1988, SAS STAT US GUID; Schmer MR, 2010, BIOENERG RES, V3, P159, DOI 10.1007/s12155-009-9045-y; Schmer MR, 2010, BIOENERG RES, V3, P243, DOI 10.1007/s12155-009-9070-x; Scouten AJ, 2002, J APPL MICROBIOL, V92, P668, DOI 10.1046/j.1365-2672.2002.01571.x; Shen ZX, 2001, CROP SCI, V41, P1546, DOI 10.2135/cropsci2001.4151546x; Shin YK, 2011, AUST J CROP SCI, V5, P582; SOSSOUNTZOV L, 1954, CR SOC BIOL, V148, P293; Srivastava AC, 2010, BIOENERG RES, V3, P278, DOI 10.1007/s12155-010-9080-8; TIMONIN MI, 1966, CAN J BOTANY, V44, P113, DOI 10.1139/b66-017; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Yaldagard M, 2007, PROC WRLD ACAD SCI E, V23, P489; Yaldagard M, 2008, AFR J BIOTECHNOL, V7, P2465; Yaldagard M, 2008, J I BREWING, V114, P14, DOI 10.1002/j.2050-0416.2008.tb00300.x; Yang JD, 2009, BIOENERG RES, V2, P257, DOI 10.1007/s12155-009-9055-9; ZARNSTORFF ME, 1994, AGRON J, V86, P667, DOI 10.2134/agronj1994.00021962008600040015x	43	17	23	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47204	10.1371/journal.pone.0047204	http://dx.doi.org/10.1371/journal.pone.0047204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071756	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200091
J	Adler, C; Corbalan, NS; Seyedsayamdost, MR; Pomares, MF; de Cristobal, RE; Clardy, J; Kolter, R; Vincent, PA				Adler, Conrado; Corbalan, Natalia S.; Seyedsayamdost, Mohammad R.; Pomares, Maria Fernanda; de Cristobal, Ricardo E.; Clardy, Jon; Kolter, Roberto; Vincent, Paula A.			Catecholate Siderophores Protect Bacteria from Pyochelin Toxicity	PLOS ONE			English	Article							IRON-TRANSPORT-SYSTEM; ESCHERICHIA-COLI; AZOTOBACTER-VINELANDII; ENTEROBACTIN; ACQUISITION; GROWTH; ORGANIZATION; MECHANISMS; PYOCYANIN; AFFINITY	Background: Bacteria produce small molecule iron chelators, known as siderophores, to facilitate the acquisition of iron from the environment. The synthesis of more than one siderophore and the production of multiple siderophore uptake systems by a single bacterial species are common place. The selective advantages conferred by the multiplicity of siderophore synthesis remains poorly understood. However, there is growing evidence suggesting that siderophores may have other physiological roles besides their involvement in iron acquisition. Methods and Principal Findings: Here we provide the first report that pyochelin displays antibiotic activity against some bacterial strains. Observation of differential sensitivity to pyochelin against a panel of bacteria provided the first indications that catecholate siderophores, produced by some bacteria, may have roles other than iron acquisition. A pattern emerged where only those strains able to make catecholate-type siderophores were resistant to pyochelin. We were able to associate pyochelin resistance to catecholate production by showing that pyochelin-resistant Escherichia coli became sensitive when biosynthesis of its catecholate siderophore enterobactin was impaired. As expected, supplementation with enterobactin conferred pyochelin resistance to the entE mutant. We observed that pyochelin-induced growth inhibition was independent of iron availability and was prevented by addition of the reducing agent ascorbic acid or by anaerobic incubation. Addition of pyochelin to E. coli increased the levels of reactive oxygen species (ROS) while addition of ascorbic acid or enterobactin reduced them. In contrast, addition of the carboxylate-type siderophore, citrate, did not prevent pyochelin-induced ROS increases and their associated toxicity. Conclusions: We have shown that the catecholate siderophore enterobactin protects E. coli against the toxic effects of pyochelin by reducing ROS. Thus, it appears that catecholate siderophores can behave as protectors of oxidative stress. These results support the idea that siderophores can have physiological roles aside from those in iron acquisition.	[Adler, Conrado; Corbalan, Natalia S.; Pomares, Maria Fernanda; de Cristobal, Ricardo E.; Vincent, Paula A.] Univ Nacl Tucuman San Miguel Tucuman, INSIBIO, Dept Bioquim Nutr, CONICET, San Miguel De Tucuman, Argentina; [Seyedsayamdost, Mohammad R.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Universidad Nacional de Tucuman; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vincent, PA (corresponding author), Univ Nacl Tucuman San Miguel Tucuman, INSIBIO, Dept Bioquim Nutr, CONICET, San Miguel De Tucuman, Argentina.	pvincent@fbqf.unt.edu.ar	Seyedsayamdost, Mohammad/AHD-0859-2022	Seyedsayamdost, Mohammad/0000-0003-2707-4854; Corbalan, Natalia/0000-0002-3588-3099	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2107, 1939]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112]; Consejo de Investigaciones de la U.N.T. [CIUNT 26/D439]; National Institutes of Health (NIH) [GM58213, GM82137, 5K99 GM098299-02]; CONICET; Fulbright and Fundacion Bunge y Born; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058213, R01GM082137, K99GM098299] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigaciones de la U.N.T.; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fulbright and Fundacion Bunge y Born; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants PICT 2107 and 1939 from the Agencia Nacional de Promocion Cientifica y Tecnologica, PIP 112 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, CIUNT 26/D439 from the Consejo de Investigaciones de la U.N.T., and the National Institutes of Health (NIH) (grants GM58213 and GM82137 to Roberto Kolter and GM82137 to Jon Clardy). Conrado Adler, Natalia S. Corbalan and Maria Fernanda Pomares were recipients of a fellowship from CONICET. Conrado Adler was also a recipient of a fellowship from Fulbright and Fundacion Bunge y Born. Ricardo de Cristobal and Paula Andrea Vincent are Career Investigators from CONICET. Mohammad R. Seyedsayamdost acknowledges support from the NIH Pathway to Independence Award (Grant 5K99 GM098299-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Braud A, 2009, J BACTERIOL, V191, P3517, DOI 10.1128/JB.00010-09; Braun V, 2009, BIOMETALS, V22, P3, DOI 10.1007/s10534-008-9199-7; BRITIGAN BE, 1992, J CLIN INVEST, V90, P2187, DOI 10.1172/JCI116104; BRITIGAN BE, 1994, AM J PHYSIOL, V266, pL192, DOI 10.1152/ajplung.1994.266.2.L192; Buysens S, 1996, APPL ENVIRON MICROB, V62, P865, DOI 10.1128/AEM.62.3.865-871.1996; CHENAULT SS, 1991, MOL MICROBIOL, V5, P1405, DOI 10.1111/j.1365-2958.1991.tb00787.x; Chin-A-Woeng TFC, 2001, MOL PLANT MICROBE IN, V14, P969, DOI 10.1094/MPMI.2001.14.8.969; Clarke Teresa E., 2001, Current Topics in Medicinal Chemistry, V1, P7, DOI 10.2174/1568026013395623; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Cornish AS, 1998, MICROBIOL-UK, V144, P1747, DOI 10.1099/00221287-144-7-1747; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Etchegaray A, 2004, MICROBIOL RES, V159, P425, DOI 10.1016/j.micres.2004.09.009; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; HUSSEIN S, 1981, EUR J BIOCHEM, V117, P431, DOI 10.1111/j.1432-1033.1981.tb06357.x; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; MATZANKE BF, 1986, J BACTERIOL, V167, P674, DOI 10.1128/jb.167.2.674-680.1986; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Negre VL, 2004, INFECT IMMUN, V72, P1216, DOI 10.1128/IAI.72.2.1216-1220.2004; NEILANDS JB, 1992, CAN J MICROBIOL, V38, P728, DOI 10.1139/m92-119; OZENBERGER BA, 1987, J BACTERIOL, V169, P3638, DOI 10.1128/jb.169.8.3638-3646.1987; Pandey A, 2010, J BACTERIOL, V192, P3187, DOI 10.1128/JB.01558-09; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Povie G, CHEM COMMUN CAMB, V46, P803; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Sasaki T, 2002, J ANTIBIOT, V55, P249, DOI 10.7164/antibiotics.55.249; Sebbane F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014379; Sontag B, 2006, J ANTIBIOT, V59, P659, DOI 10.1038/ja.2006.88; Sorsa LJ, 2003, INFECT IMMUN, V71, P3285, DOI 10.1128/IAI.71.6.3285-3293.2003; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Vinckx T, 2011, BIOMETALS, V24, P523, DOI 10.1007/s10534-010-9403-4; Wang WL, 2009, BIORESOURCE TECHNOL, V100, P2639, DOI 10.1016/j.biortech.2008.12.010; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; WINKELMANN G, 1994, BIOMETALS, V7, P149; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W	44	70	74	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46754	10.1371/journal.pone.0046754	http://dx.doi.org/10.1371/journal.pone.0046754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071628	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300059
J	Ghaffar, O; Fiati, M; Feinstein, A				Ghaffar, Omar; Fiati, Marty; Feinstein, Anthony			Occupational Attainment as a Marker of Cognitive Reserve in Multiple Sclerosis	PLOS ONE			English	Article							BRAIN ATROPHY; INTELLECTUAL ENRICHMENT; AUTOMATIC SEGMENTATION; EDUCATION; DYSFUNCTION; EFFICIENCY; DECLINE; MEMORY; MRI	Cognitive dysfunction affects half of MS patients. Although brain atrophy generally yields the most robust MRI correlations with cognition, significant variance in cognition between individual MS patients remains unexplained. Recently, markers of cognitive reserve such as premorbid intelligence have emerged as important predictors of neuropsychological performance in MS. In the present study, we aimed to extend the cognitive reserve construct by examining the potential contribution of occupational attainment to cognitive decline in MS patients. Brain atrophy, estimated premorbid IQ, and occupational attainment were assessed in 72 MS patients. The Minimal Assessment of Cognitive Functioning in MS was used to evaluate indices of information processing speed, memory, and executive function. Results showed that occupational attainment was a significant predictor of information processing speed, memory, and executive function in hierarchical linear regressions after accounting for brain atrophy and premorbid IQ. These data suggest that MS patients with low occupational attainment fare worse cognitively than those with high occupational attainment after controlling for brain atrophy and premorbid IQ. Occupation, like premorbid IQ, therefore may make an independent contribution to cognitive outcome in MS. Information regarding an individual's occupation is easily acquired and may serve as a useful proxy for cognitive reserve in clinical settings.	[Ghaffar, Omar; Fiati, Marty; Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Neuropsychiat Program, Toronto, ON M4N 3M5, Canada; [Ghaffar, Omar; Fiati, Marty; Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Brain Sci Program, Toronto, ON M4N 3M5, Canada; [Ghaffar, Omar] Ontario Shores Ctr Mental Hlth Sci, Neuropsychiat Serv, Whitby, ON, Canada; [Ghaffar, Omar; Feinstein, Anthony] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Ghaffar, O (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Psychiat, Neuropsychiat Program, Toronto, ON M4N 3M5, Canada.	omar.ghaffar@utoronto.ca			Canadian Institutes of Health Research (CIHR); Merck/Serono; Teva Neuroscience; Bayer-Schering; Biogen; University of Toronto; Multiple Sclerosis Society of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Merck/Serono(Merck & Company); Teva Neuroscience(Teva Pharmaceutical Industries); Bayer-Schering(Bayer AG); Biogen(Biogen); University of Toronto(University of Toronto); Multiple Sclerosis Society of Canada	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to Anthony Feinstein and salary support and a research stipend to OG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AF served on the scientific advisory boards of Merck/Serono and Avenir Pharmaceuticals; received travel funding from Merck/Serono, Teva Neuroscience, Bayer-Schering, and Biogen; served on the editorial boards of Multiple Sclerosis and the African Journal of Psychiatry; received publishing royalties from Cambridge University Press; received honoraria for speaking engagements or educational activities from Merck/Serono, Teva Neuroscience, Bayer-Schering, and Biogen; serves on the Medical Advisory Committee of the Multiple Sclerosis Society of Canada; and received research support from Teva Neuroscience, Merck-Serono, the Canadian Institutes of Health Research, the University of Toronto, and the Multiple Sclerosis Society of Canada. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. MF has no competing interests to declare.	Albert SM, 1999, AM J PUBLIC HEALTH, V89, P95, DOI 10.2105/AJPH.89.1.95; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2011, NAT REV NEUROL, V7, P332, DOI 10.1038/nrneurol.2011.61; Benedict RHB, 2010, J INT NEUROPSYCH SOC, V16, P829, DOI 10.1017/S1355617710000688; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Elkins JS, 2006, NEUROLOGY, V67, P435, DOI 10.1212/01.wnl.0000228246.89109.98; Esiri MM, 2001, LANCET, V357, P169; Feinstein A, 2010, MULT SCLER J, V16, P189, DOI 10.1177/1352458509355461; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Ghaffar O, 2011, NEUROIMAGE, V58, P724, DOI 10.1016/j.neuroimage.2011.06.024; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kovacevic N, 2002, NEUROIMAGE, V17, P1087, DOI 10.1006/nimg.2002.1221; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reed BR, 2010, BRAIN, V133, P2196, DOI 10.1093/brain/awq154; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Stern Y, 2011, J INT NEUROPSYCH SOC, V17, P639, DOI 10.1017/S1355617711000579; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2010, NEUROLOGY, V75, P1428, DOI 10.1212/WNL.0b013e3181f881a6; Sumowski JF, 2010, NEUROLOGY, V74, P1942, DOI 10.1212/WNL.0b013e3181e396be; Sumowski JF, 2010, BRAIN, V133, P362, DOI 10.1093/brain/awp307; Sumowski JF, 2009, J CLIN EXP NEUROPSYC, V31, P913, DOI 10.1080/13803390902740643; Sumowski JF, 2009, J INT NEUROPSYCH SOC, V15, P606, DOI 10.1017/S1355617709090912; U.S. Department of Labor, 1991, DICT OCC TITL; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264	40	35	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47206	10.1371/journal.pone.0047206	http://dx.doi.org/10.1371/journal.pone.0047206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071757	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300089
J	Mei, Q; Li, X; Meng, YG; Wu, ZQ; Guo, MZ; Zhao, YL; Fu, XB; Han, WD				Mei, Qian; Li, Xiang; Meng, Yuanguang; Wu, Zhiqiang; Guo, Mingzhou; Zhao, Yali; Fu, Xiaobing; Han, Weidong			A Facile and Specific Assay for Quantifying MicroRNA by an Optimized RT-qPCR Approach	PLOS ONE			English	Article							EXPRESSION; PCR; RNA; DNA; QUANTIFICATION; MIRNAS; CANCER; LOOP	Background: The spatiotemporal expression patterns of microRNAs (miRNAs) are important to the verification of their predicted function. RT-qPCR is the accepted technique for the quantification of miRNA expression; however, stem-loop RT-PCR and poly(T)-adapter assay, the two most frequently used methods, are not very convenient in practice and have poor specificity, respectively. Results: We have developed an optimal approach that integrates these two methods and allows specific and rapid detection of tiny amounts of sample RNA and reduces costs relative to other techniques. miRNAs of the same sample are polyuridylated and reverse transcribed into cDNAs using a universal poly(A)-stem-loop RT primer and then used as templates for SYBR (R) Green real-time PCR. The technique has a dynamic range of eight orders of magnitude with a sensitivity of up to 0.2 fM miRNA or as little as 10 pg of total RNA. Virtually no cross-reaction is observed among the closely-related miRNA family members and with miRNAs that have only a single nucleotide difference in this highly specific assay. The spatial constraint of the stem-loop structure of the modified RT primer allowed detection of miRNAs directly from cell lysates without laborious total RNA isolation, and the poly(U) tail made it possible to use multiplex RT reactions of mRNA and miRNAs in the same run. Conclusions: The cost-effective RT-qPCR of miRNAs with poly(A)-stem-loop RT primer is simple to perform and highly specific, which is especially important for samples that are precious and/or difficult to obtain.	[Mei, Qian; Li, Xiang; Wu, Zhiqiang; Zhao, Yali; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China; [Meng, Yuanguang] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Dept Gynecol Oncol, Inst Basic Med, Beijing, Peoples R China; [Guo, Mingzhou] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Dept Canc Epigenet, Inst Basic Med, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Fu, XB (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing, Peoples R China.	fuxiaobing@vip.sina.com; hanwdrsw69@yahoo.com	May, Mere/HIK-1050-2022		National Natural Science Foundation of China [81101486, 81272867, 31270820, 81230061]; National Basic Science and Development Programme of China [2010CB912802, 2012CB518103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science and Development Programme of China	This work is supported by the grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm) (No. 81101486, 81272867, 31270820 and 81230061) and is partially supported by National Basic Science and Development Programme of China (http://www.973.gov.cn/Default_3.aspx) (No. 2010CB912802 and 2012CB518103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bishop JA, 2010, CLIN CANCER RES, V16, P610, DOI 10.1158/1078-0432.CCR-09-2638; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang PC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/104716; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Liang RQ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni019; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McCarthy N, 2010, NAT REV GENET, V11, P8, DOI 10.1038/nrg2722; Nielsen KE, 2000, BIOCONJUGATE CHEM, V11, P228, DOI 10.1021/bc990121s; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Veedu RN, 2007, CHEMBIOCHEM, V8, P490, DOI 10.1002/cbic.200600501; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Yang F, 2007, P NATL ACAD SCI USA, V104, P18952, DOI 10.1073/pnas.0709173104; Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139	26	47	49	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46890	10.1371/journal.pone.0046890	http://dx.doi.org/10.1371/journal.pone.0046890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071657	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300068
J	Leon-Sarmiento, FE; Bayona, EA; Bayona-Prieto, J; Osman, A; Doty, RL				Leon-Sarmiento, Fidias E.; Bayona, Edgardo A.; Bayona-Prieto, Jaime; Osman, Allen; Doty, Richard L.			Profound Olfactory Dysfunction in Myasthenia Gravis	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SMELL IDENTIFICATION TEST; OF-PENNSYLVANIA SMELL; PARKINSONISM-DEMENTIA COMPLEX; NUCLEUS BASALIS; ODOR IDENTIFICATION; DISEASE; ALZHEIMERS; MEYNERT; BRAIN	In this study we demonstrate that myasthenia gravis, an autoimmune disease strongly identified with deficient acetylcholine receptor transmission at the post-synaptic neuromuscular junction, is accompanied by a profound loss of olfactory function. Twenty-seven MG patients, 27 matched healthy controls, and 11 patients with polymiositis, a disease with peripheral neuromuscular symptoms analogous to myasthenia gravis with no known central nervous system involvement, were tested. All were administered the University of Pennsylvania Smell Identification Test (UPSIT) and the Picture Identification Test (PIT), a test analogous in content and form to the UPSIT designed to control for non-olfactory cognitive confounds. The UPSIT scores of the myasthenia gravis patients were markedly lower than those of the age-and sex-matched normal controls [respective means (SDs) = 20.15 (6.40) & 35.67 (4.95); p<0.0001], as well as those of the polymiositis patients who scored slightly below the normal range [33.30 (1.42); p<0.0001]. The latter finding, along with direct monitoring of the inhalation of the patients during testing, implies that the MG-related olfactory deficit is unlikely due to difficulties sniffing, per se. All PIT scores were within or near the normal range, although subtle deficits were apparent in both the MG and PM patients, conceivably reflecting influences of mild cognitive impairment. No relationships between performance on the UPSIT and thymectomy, time since diagnosis, type of treatment regimen, or the presence or absence of serum anti-nicotinic or muscarinic antibodies were apparent. Our findings suggest that MG influences olfactory function to the same degree as observed in a number of neurodegenerative diseases in which central nervous system cholinergic dysfunction has been documented.	[Leon-Sarmiento, Fidias E.; Osman, Allen; Doty, Richard L.] Univ Penn, Perelman Sch Med, Ctr Smell & Taste, Philadelphia, PA 19104 USA; [Leon-Sarmiento, Fidias E.; Osman, Allen; Doty, Richard L.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Leon-Sarmiento, Fidias E.] IPS Ramon & Cajal Univ Nacl, Mediciencias Res Grp, Bogota, Colombia; [Bayona, Edgardo A.] Neuro Net, Lab Neurociencias Clin & Func, Bogota, Colombia; [Bayona-Prieto, Jaime] Grp Cirineoneurorehabil, Bucaramanga, Colombia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Leon-Sarmiento, FE (corresponding author), Univ Penn, Perelman Sch Med, Ctr Smell & Taste, Philadelphia, PA 19104 USA.	feleones@gmail.com	Doty, Richard L/G-1602-2013		Department of Defense, USA [W81XWH-09-1-0467]	Department of Defense, USA(United States Department of Defense)	This work was partially supported by a grant from the Department of Defense, USA No. W81XWH-09-1-0467. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Alkondon M, 1996, J PHARMACOL EXP THER, V278, P1460; ARENDT T, 1983, ACTA NEUROPATHOL, V61, P101, DOI 10.1007/BF00697388; ARENDT T, 1984, LANCET, V1, P173; Balestra B, 2000, J NEUROIMMUNOL, V102, P89, DOI 10.1016/S0165-5728(99)00145-9; BOHAN A, 1977, MEDICINE, V56, P255, DOI 10.1097/00005792-197707000-00001; Bohnen NI, 2010, BRAIN, V133, P1747, DOI 10.1093/brain/awq079; BURDACH KJ, 1987, PHYSIOL BEHAV, V41, P353, DOI 10.1016/0031-9384(87)90400-8; Chi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025016; Dalakas MC, 1987, POLYMYOSITIS DERMATO; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Devanand DP, 2010, NEUROBIOL AGING, V31, P1593, DOI 10.1016/j.neurobiolaging.2008.09.008; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; DOTY RL, 1992, ANN NEUROL, V32, P97, DOI 10.1002/ana.410320116; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1991, NEUROLOGY, V41, P77, DOI 10.1212/WNL.41.5_Suppl_2.77; Doty RL, 1999, PHYSIOL BEHAV, V65, P801; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Fotiou F, 2000, J NEUROPSYCH CLIN N, V12, P514, DOI 10.1176/appi.neuropsych.12.4.514; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Hawkins BT, 2005, AM J PHYSIOL-HEART C, V289, pH212, DOI 10.1152/ajpheart.01210.2004; Hellier JL, 2010, BRAIN RES, V1358, P140, DOI 10.1016/j.brainres.2010.08.027; HOKKANEN E, 1969, ACTA NEUROL SCAND, V45, P556; Iseki K, 2007, NEUROL SCI, V28, P114, DOI 10.1007/s10072-007-0799-8; IWASAKI Y, 1993, J NEUROL SCI, V114, P223, DOI 10.1016/0022-510X(93)90302-F; JACOB A, 1968, Journal of Medical Genetics, V5, P257, DOI 10.1136/jmg.5.4.257; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Jech R, 1996, J NEUROL, V243, P547, DOI 10.1007/BF00886878; Keesey JC, 1999, J NEUROL SCI, V170, P77, DOI 10.1016/S0022-510X(99)00205-1; KEESEY JC, 1978, LANCET, V1, P777; KNOPF PM, 1995, NEUROPATH APPL NEURO, V21, P175, DOI 10.1111/j.1365-2990.1995.tb01047.x; Kortekaas R, 2005, ANN NEUROL, V57, P176, DOI 10.1002/ana.20369; Leon F, 1995, Invest Clin, V36, P99; Leon-S FE, 2001, REV NEUROLOGIA, V32, P145, DOI 10.33588/rn.3202.2000280; Leon-S FE, 1996, ACTA NEUROL COLOMB, V12, P38; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lindstrom JM, 2000, MUSCLE NERVE, V23, P453, DOI 10.1002/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O; Mandairon N, 2006, EUR J NEUROSCI, V24, P3234, DOI 10.1111/j.1460-9568.2006.05212.x; Mandairon N, 2011, NEUROBIOL AGING, V32, P2254, DOI 10.1016/j.neurobiolaging.2009.12.024; McKeown DA, 1996, J NEUROL NEUROSUR PS, V61, P412, DOI 10.1136/jnnp.61.4.412; NAKANO I, 1983, ANN NEUROL, V13, P87, DOI 10.1002/ana.410130118; Paul RH, 2001, NEUROSCI BIOBEHAV R, V25, P75, DOI 10.1016/S0149-7634(00)00052-X; PESTRONK A, 1985, MUSCLE NERVE, V8, P233, DOI 10.1002/mus.880080309; Plomp JJ, 1996, J PHYSIOL-LONDON, V493, P175, DOI 10.1113/jphysiol.1996.sp021373; Pradilla G, 1983, ACTA PEDIAT COLOMB, V1, P7; RICHMAN DP, 1994, SEMIN NEUROL, V14, P106, DOI 10.1055/s-2008-1041066; ROGERS JD, 1985, ANN NEUROL, V17, P163, DOI 10.1002/ana.410170210; SAPHIER D, 1993, J NEUROL SCI, V114, P200, DOI 10.1016/0022-510X(93)90298-D; Steiner I, 1994, HDB MYASTHENIA GRAVI, P277; TAGLIAVINI F, 1984, NEUROSCI LETT, V44, P37, DOI 10.1016/0304-3940(84)90217-9; Tanaka S, 2007, BIOL PHARM BULL, V30, P291, DOI 10.1248/bpb.30.291; TUCKER DM, 1988, NEUROLOGY, V38, P1173, DOI 10.1212/WNL.38.8.1173; Vaknin-Dembinsky A, 2011, ARCH NEUROL-CHICAGO, V68, P1557, DOI 10.1001/archneurol.2011.200; Velayudhan L, 2009, J CLIN PSYCHOPHARM, V29, P387, DOI 10.1097/JCP.0b013e3181aba5a5; Vernino S, 1998, NEUROLOGY, V50, P1806, DOI 10.1212/WNL.50.6.1806; Vernino S, 2008, ANN NY ACAD SCI, V1132, P124, DOI 10.1196/annals.1405.011; VIETS HR, 1953, JAMA-J AM MED ASSOC, V153, P1273; VOLLMECKE TA, 1985, CHEM SENSES, V10, P413; WHITING PJ, 1987, J NEUROIMMUNOL, V16, P205, DOI 10.1016/0165-5728(87)90075-0	62	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45544	10.1371/journal.pone.0045544	http://dx.doi.org/10.1371/journal.pone.0045544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082113	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900008
J	Williamson, SJ; Allen, LZ; Lorenzi, HA; Fadrosh, DW; Brami, D; Thiagarajan, M; McCrow, JP; Tovchigrechko, A; Yooseph, S; Venter, JC				Williamson, Shannon J.; Allen, Lisa Zeigler; Lorenzi, Hernan A.; Fadrosh, Douglas W.; Brami, Daniel; Thiagarajan, Mathangi; McCrow, John P.; Tovchigrechko, Andrey; Yooseph, Shibu; Venter, J. Craig			Metagenomic Exploration of Viruses throughout the Indian Ocean	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; DNA PACKAGING MOTOR; PHOTOSYNTHESIS GENES; SAMPLING EXPEDITION; MARINE-ENVIRONMENT; MIMIVIRUS RELATIVES; VIRAL COMMUNITIES; HOST INTERACTIONS; GIANT VIRUSES; PHOTOSYSTEM-I	The characterization of global marine microbial taxonomic and functional diversity is a primary goal of the Global Ocean Sampling Expedition. As part of this study, 19 water samples were collected aboard the Sorcerer II sailing vessel from the southern Indian Ocean in an effort to more thoroughly understand the lifestyle strategies of the microbial inhabitants of this ultra-oligotrophic region. No investigations of whole virioplankton assemblages have been conducted on waters collected from the Indian Ocean or across multiple size fractions thus far. Therefore, the goals of this study were to examine the effect of size fractionation on viral consortia structure and function and understand the diversity and functional potential of the Indian Ocean virome. Five samples were selected for comprehensive metagenomic exploration; and sequencing was performed on the microbes captured on 3.0-, 0.8- and 0.1 mu m membrane filters as well as the viral fraction (<0.1 mu m). Phylogenetic approaches were also used to identify predicted proteins of viral origin in the larger fractions of data from all Indian Ocean samples, which were included in subsequent metagenomic analyses. Taxonomic profiling of viral sequences suggested that size fractionation of marine microbial communities enriches for specific groups of viruses within the different size classes and functional characterization further substantiated this observation. Functional analyses also revealed a relative enrichment for metabolic proteins of viral origin that potentially reflect the physiological condition of host cells in the Indian Ocean including those involved in nitrogen metabolism and oxidative phosphorylation. A novel classification method, MGTAXA, was used to assess virus-host relationships in the Indian Ocean by predicting the taxonomy of putative host genera, with Prochlorococcus, Acanthochlois and members of the SAR86 cluster comprising the most abundant predictions. This is the first study to holistically explore virioplankton dynamics across multiple size classes and provides unprecedented insight into virus diversity, metabolic potential and virus-host interactions.	[Williamson, Shannon J.; Allen, Lisa Zeigler; Fadrosh, Douglas W.; Brami, Daniel; McCrow, John P.; Yooseph, Shibu; Venter, J. Craig] J Craig Venter Inst, San Diego, CA USA; [Lorenzi, Hernan A.; Thiagarajan, Mathangi; Tovchigrechko, Andrey] J Craig Venter Inst, Rockville, MD USA; [Allen, Lisa Zeigler] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	J. Craig Venter Institute; J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography	Williamson, SJ (corresponding author), J Craig Venter Inst, San Diego, CA USA.	shannon.j.williamson@gmail.com		Yooseph, Shibu/0000-0001-5581-5002; McCrow, John/0000-0002-7014-5040; Lorenzi, Hernan/0000-0003-0910-7894	Office of Science (BER), U.S. Department of Energy [De-FC02-02ER63453]; Gordon and Betty Moore Foundation; National Science Foundation [0850256]; TeraGrid [DEB100001]; Direct For Biological Sciences [0850256] Funding Source: National Science Foundation	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); TeraGrid; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Office of Science (BER), U.S. Department of Energy, Cooperative Agreement No. De-FC02-02ER63453, the Gordon and Betty Moore Foundation, the National Science Foundation award 0850256 and TeraGrid allocation DEB100001 on the Texas Advanced Computing Center Ranger. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, BIOINFORMATICS, V25, P563, DOI 10.1093/bioinformatics/btp003; Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Alperovitch-Lavy A, 2011, ENVIRON MICROBIOL, V13, P24, DOI 10.1111/j.1462-2920.2010.02304.x; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Badger JH, 2005, INT J SYST EVOL MICR, V55, P1021, DOI 10.1099/ijs.0.63510-0; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Baumann S, 2007, VIROLOGY, V360, P209, DOI 10.1016/j.virol.2006.10.010; Beman JM, 2011, ISME J, V5, P1077, DOI 10.1038/ismej.2010.204; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Chan YW, 2007, FEMS MICROBIOL ECOL, V61, P65, DOI 10.1111/j.1574-6941.2007.00320.x; Chan YW, 2011, MOL BIOL EVOL, V28, P2269, DOI 10.1093/molbev/msr041; Claverie JM, 2009, J INVERTEBR PATHOL, V101, P172, DOI 10.1016/j.jip.2009.03.011; Clokie MRJ, 2006, J MAR BIOL ASSOC UK, V86, P499, DOI 10.1017/S0025315406013403; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; DeAngelis PL, 1997, SCIENCE, V278, P1800, DOI 10.1126/science.278.5344.1800; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Filee J, 2007, TRENDS GENET, V23, P10, DOI 10.1016/j.tig.2006.11.002; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Kuhl M, 2005, NATURE, V433, P820, DOI 10.1038/433820a; Landstein D, 1998, VIROLOGY, V250, P388, DOI 10.1006/viro.1998.9388; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lorenzi HA, 2011, STAND GENOMIC SCI, V4, P418, DOI 10.4056/sigs.1694706; Lucks JB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000001; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Massana R, 2007, ENVIRON MICROBIOL, V9, P2660, DOI 10.1111/j.1462-2920.2007.01378.x; McDaniel L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003263; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Monier A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-12; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Moreau H, 2010, J VIROL, V84, P12555, DOI 10.1128/JVI.01123-10; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pride DT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-8; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Robins H, 2005, J BACTERIOL, V187, P8370, DOI 10.1128/JB.187.24.8370-8374.2005; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2004, ENVIRON MICROBIOL, V6, P903, DOI 10.1111/j.1462-2920.2004.00676.x; Sandaa RA, 2008, RES MICROBIOL, V159, P374, DOI 10.1016/j.resmic.2008.04.013; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Sharon I, 2011, ISME J, V5, P1178, DOI 10.1038/ismej.2011.2; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; Steward GF, 2000, LIMNOL OCEANOGR, V45, P1697, DOI 10.4319/lo.2000.45.8.1697; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Tucker KP, 2011, ISME J, V5, P822, DOI 10.1038/ismej.2010.188; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Wilson WH, 2009, CURR TOP MICROBIOL, V328, P1; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016	82	87	88	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e42047	10.1371/journal.pone.0042047	http://dx.doi.org/10.1371/journal.pone.0042047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082107	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900002
J	Nakashima, K; Takeuchi, K; Chihara, K; Horiguchi, T; Sun, XD; Deng, L; Shoji, I; Hotta, H; Sada, K				Nakashima, Kenji; Takeuchi, Kenji; Chihara, Kazuyasu; Horiguchi, Tomoko; Sun, Xuedong; Deng, Lin; Shoji, Ikuo; Hotta, Hak; Sada, Kiyonao			HCV NS5A Protein Containing Potential Ligands for Both Src Homology 2 and 3 Domains Enhances Autophosphorylation of Src Family Kinase Fyn in B Cells	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INHERITED DISEASE CHERUBISM; TYROSINE KINASE; RBL-2H3 CELLS; REPLICATION; 3BP2; INHIBITION; INFECTION; TARGET; BINDS	Hepatitis C virus (HCV) infects B lymphocytes and induces mixed cryoglobulinemia and B cell non-Hodgkin's lymphoma. The molecular mechanism for the pathogenesis of HCV infection-mediated B cell disorders remains obscure. To identify the possible role for HCV nonstructural 5A (NS5A) protein in B cells, we generated the stable B cell lines expressing Myc-His tagged NS5A. Immunoprecipitation study in the presence or absence of pervanadate (PV) implied that NS5A was tyrosine phosphorylated by pervanadate (PV) treatment of the cells. Therefore we examined pull-down assay by using glutathione S-transferase (GST)-fusion proteins of various Src homology 2 (SH2) domains, which associates with phosphotyrosine within a specific amino acid sequence. The results showed that NS5A specifically bound to SH2 domain of Fyn from PV-treated B cells in addition to Src homology 3 (SH3) domain. Substitution of Arg(176) to Lys in the SH2 domain of Fyn abrogated this interaction. Deletion mutational analysis demonstrated that N-terminal region of NS5A was not required for the interaction with the SH2 domain of Fyn. Tyr(334) was identified as a tyrosine phosphorylation site in NS5A. Far-western analysis revealed that SH2 domain of Fyn directly bound to NS5A. Fyn and NS5A were colocalized in the lipid raft. These results suggest that NS5A directly binds to the SH2 domain of Fyn in a tyrosine phosphorylation-dependent manner. Lastly, we showed that the expression of NS5A in B cells increased phosphorylation of activation loop tyrosine in the kinase domain of Fyn. NS5A containing ligand for both SH2 and SH3 domains enhances an aberrant autophosphorylation and kinase activity of Fyn in B cells.	[Nakashima, Kenji; Takeuchi, Kenji; Chihara, Kazuyasu; Horiguchi, Tomoko; Sun, Xuedong; Sada, Kiyonao] Univ Fukui, Fac Med Sci, Sch Med, Div Genome Sci & Microbiol,Dept Pathol Sci, Eiheiji, Japan; [Takeuchi, Kenji; Chihara, Kazuyasu; Sada, Kiyonao] Univ Fukui, Org Life Sci Adv Programs, Eiheiji, Japan; [Deng, Lin; Shoji, Ikuo; Hotta, Hak] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Div Microbiol, Kobe, Hyogo 657, Japan	University of Fukui; University of Fukui; Kobe University	Sada, K (corresponding author), Univ Fukui, Fac Med Sci, Sch Med, Div Genome Sci & Microbiol,Dept Pathol Sci, Eiheiji, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015; Shoji, Ikuo/Y-7079-2019	Sada, Kiyonao/0000-0001-6124-3100; Shoji, Ikuo/0000-0002-0730-4379	University of Fukui; Takeda Science Foundation; Yakult Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports and Technology, Japan	University of Fukui; Takeda Science Foundation(Takeda Science Foundation (TSF)); Yakult Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by research funding from the University of Fukui, Takeda Science Foundation, Yakult Foundation, and the Grant-in-Aids from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Chihara K, 2011, GENES CELLS, V16, P1133, DOI 10.1111/j.1365-2443.2011.01557.x; Gisbert JP, 2003, GASTROENTEROLOGY, V125, P1723, DOI 10.1053/j.gastro.2003.09.025; Inubushi S, 2008, J GEN VIROL, V89, P1231, DOI 10.1099/vir.0.83510-0; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ito M, 2010, CLIN IMMUNOL, V135, P459, DOI 10.1016/j.clim.2010.02.002; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Maeno K, 2003, J BIOL CHEM, V278, P24912, DOI 10.1074/jbc.M301201200; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morsica G, 1999, BLOOD, V94, P1138; Nakashima K, 2011, MICROBIOL IMMUNOL, V55, P774, DOI 10.1111/j.1348-0421.2011.00382.x; Ogi K, 2011, GENES CELLS, V16, P951, DOI 10.1111/j.1365-2443.2011.01539.x; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Shelton H, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-24; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Supekova L, 2008, J BIOL CHEM, V283, P29, DOI 10.1074/jbc.M703988200; Suzuki T, 2007, J GASTROENTEROL, V42, P411, DOI 10.1007/s00535-007-2030-3	26	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46634	10.1371/journal.pone.0046634	http://dx.doi.org/10.1371/journal.pone.0046634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077515	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800011
J	Gazos-Lopes, F; Mesquita, RD; Silva-Cardoso, L; Senna, R; Silveira, AB; Jablonka, W; Cudischevitch, CO; Carneiro, AB; Machado, EA; Lima, LG; Monteiro, RQ; Nussenzveig, RH; Folly, E; Romeiro, A; Vanbeselaere, J; Mendonca-Previato, L; Previato, JO; Valenzuela, JG; Ribeiro, JMC; Atella, GC; Silva-Neto, MAC				Gazos-Lopes, Felipe; Mesquita, Rafael Dias; Silva-Cardoso, Livia; Senna, Raquel; Silveira, Alan Barbosa; Jablonka, Willy; Cudischevitch, Cecilia Oliveira; Carneiro, Alan Brito; Machado, Ednildo Alcantara; Lima, Luize G.; Monteiro, Robson Queiroz; Nussenzveig, Roberto Henrique; Folly, Evelize; Romeiro, Alexandre; Vanbeselaere, Jorick; Mendonca-Previato, Lucia; Previato, Jose Osvaldo; Valenzuela, Jesus G.; Ribeiro, Jose Marcos Chaves; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto			Glycoinositolphospholipids from Trypanosomatids Subvert Nitric Oxide Production in Rhodnius prolixus Salivary Glands	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BLOODSUCKING BUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; ANOPHELES-STEPHENSI; EPIMASTIGOTE FORMS; VECTOR SALIVA; RANGELI; CRUZI; SYNTHASE; INFECTION	Background: Rhodnius prolixus is a blood-sucking bug vector of Trypanosoma cruzi and T. rangeli. T. cruzi is transmitted by vector feces deposited close to the wound produced by insect mouthparts, whereas T. rangeli invades salivary glands and is inoculated into the host skin. Bug saliva contains a set of nitric oxide-binding proteins, called nitrophorins, which deliver NO to host vessels and ensure vasodilation and blood feeding. NO is generated by nitric oxide synthases (NOS) present in the epithelium of bug salivary glands. Thus, T. rangeli is in close contact with NO while in the salivary glands. Methodology/Principal Findings: Here we show by immunohistochemical, biochemical and molecular techniques that inositolphosphate-containing glycolipids from trypanosomatids downregulate NO synthesis in the salivary glands of R. prolixus. Injecting insects with T. rangeli-derived glycoinositolphospholipids (Tr GIPL) or T. cruzi-derived glycoinositolphospholipids (Tc GIPL) specifically decreased NO production. Salivary gland treatment with Tc GIPL blocks NO production without greatly affecting NOS mRNA levels. NOS protein is virtually absent from either Tr GIPL-or Tc GIPL-treated salivary glands. Evaluation of NO synthesis by using a fluorescent NO probe showed that T. rangeli-infected or Tc GIPL-treated glands do not show extensive labeling. The same effect is readily obtained by treatment of salivary glands with the classical protein tyrosine phosphatase (PTP) inhibitor, sodium orthovanadate (SO). This suggests that parasite GIPLs induce the inhibition of a salivary gland PTP. GIPLs specifically suppressed NO production and did not affect other anti-hemostatic properties of saliva, such as the anti-clotting and anti-platelet activities. Conclusions/Significance: Taken together, these data suggest that trypanosomatids have overcome NO generation using their surface GIPLs. Therefore, these molecules ensure parasite survival and may ultimately enhance parasite transmission.	[Gazos-Lopes, Felipe; Silva-Cardoso, Livia; Senna, Raquel; Silveira, Alan Barbosa; Jablonka, Willy; Cudischevitch, Cecilia Oliveira; Carneiro, Alan Brito; Lima, Luize G.; Monteiro, Robson Queiroz; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Mesquita, Rafael Dias] Inst Fed Educ Ciencia & Tecnol Rio de Janeiro, Rio De Janeiro, Brazil; [Machado, Ednildo Alcantara; Romeiro, Alexandre; Mendonca-Previato, Lucia; Previato, Jose Osvaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Nussenzveig, Roberto Henrique] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Folly, Evelize] Univ Fed Fluminense, Inst Biol, Predio Inst Biol, Dept Biol Celular & Mol, Rio De Janeiro, Brazil; [Vanbeselaere, Jorick] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Ribeiro, Jose Marcos Chaves] NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Gazos-Lopes, Felipe; Mesquita, Rafael Dias; Silva-Cardoso, Livia; Senna, Raquel; Silveira, Alan Barbosa; Jablonka, Willy; Cudischevitch, Cecilia Oliveira; Carneiro, Alan Brito; Folly, Evelize; Atella, Georgia Correa; Cardoso Silva-Neto, Mario Alberto] INCT EM, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ); Universidade Federal do Rio de Janeiro; University of Texas System; UTMD Anderson Cancer Center; Universidade Federal Fluminense; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Silva-Neto, MAC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	maneto@bioqmed.ufrj.br	Jablonka, Willy/D-2333-2017; Folly, Evelize/M-2409-2014; de Queiroz Monteiro, Robson/M-7097-2019; Machado, Ednildo A/G-9725-2013; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Folly das Chagas, Evelize/CAI-5848-2022; Atella, Georgia/AAK-7897-2020; Monteiro, Robson/GRX-0672-2022; Mesquita, Rafael Dias/AAH-4352-2022; Mesquita, Rafael Dias/AFP-3693-2022; Folly das Chagas, Evelize/CAF-9192-2022; Ribeiro, Jose/J-7011-2015	Folly, Evelize/0000-0001-6313-2447; Folly das Chagas, Evelize/0000-0001-6313-2447; Monteiro, Robson/0000-0002-5260-2332; Mesquita, Rafael Dias/0000-0002-2882-3362; Mesquita, Rafael Dias/0000-0002-2882-3362; Folly das Chagas, Evelize/0000-0001-6313-2447; Jablonka, Willy/0000-0001-5380-7797; Mendonca Previato, Lucia/0000-0003-3927-3244; Vanbeselaere, Jorick/0000-0002-1949-4835; G Lima, Luize/0000-0002-4167-6723; Previato, Jose Osvaldo/0000-0002-9233-9954; Ribeiro, Jose/0000-0002-9107-0818; Machado, Ednildo/0000-0002-4428-3829	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-Entomologia Molecular); International Foundation for Science (IFS-Sweden) [F/3619-1, F/2887-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000932, ZIAAI000810] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-Entomologia Molecular); International Foundation for Science (IFS-Sweden)(International Foundation for Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCT-Entomologia Molecular). This work was also supported by two grants provided by the International Foundation for Science (IFS-Sweden) to Dr. G. C. Atella (F/3619-1) and to Dr. M. A. C. Silva-Neto (F/2887-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Almeida IC, 2001, J LEUKOCYTE BIOL, V70, P467; Andersen JF, 2010, TOXICON, V56, P1120, DOI 10.1016/j.toxicon.2009.11.002; Anhe ACB, 2007, GENET MOL RES, V6, P197; Arrighi RBG, 2009, DEV COMP IMMUNOL, V33, P216, DOI 10.1016/j.dci.2008.08.009; Basseri HR, 2002, EXP PARASITOL, V100, P226, DOI 10.1016/S0014-4894(02)00026-7; Bian Z, 2001, J INFECT DIS, V183, P612, DOI 10.1086/318528; CARTER HE, 1967, J LIPID RES, V8, P391; CHAMPAGNE DE, 1995, J BIOL CHEM, V270, P8691, DOI 10.1074/jbc.270.15.8691; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dinglasan RR, 2005, INFECT IMMUN, V73, P7797, DOI 10.1128/IAI.73.12.7797-7807.2005; ELPHICK MR, 1993, BRAIN RES, V619, P344, DOI 10.1016/0006-8993(93)91632-3; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; Fiske CH, 1925, J BIOL CHEM, V66, P375; Folly E, 2003, BIOCHEM BIOPH RES CO, V310, P555, DOI 10.1016/j.bbrc.2003.09.038; GARCIA ES, 1994, EXP PARASITOL, V78, P287, DOI 10.1006/expr.1994.1030; Golodne DM, 2003, J BIOL CHEM, V278, P27766, DOI 10.1074/jbc.M212421200; Gomes SAO, 2008, ACTA TROP, V106, P137, DOI 10.1016/j.actatropica.2008.02.008; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; GULLIANI GL, 1976, AM J CLIN PATHOL, V65, P390; Hahn UK, 2001, J PARASITOL, V87, P778, DOI 10.1645/0022-3395(2001)087[0778:IONOIK]2.0.CO;2; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Heneberg P, 2009, CURR MED CHEM, V16, P706, DOI 10.2174/092986709787458407; Jablonka W, 2011, MEM I OSWALDO CRUZ, V106, P546, DOI 10.1590/S0074-02762011000500005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luder CGK, 2003, INT J PARASITOL, V33, P833, DOI 10.1016/S0020-7519(03)00092-4; Medeiros MM, 2007, J LEUKOCYTE BIOL, V82, P488, DOI 10.1189/jlb.0706478; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Mendonca-Previato L, 2005, CURR OPIN STRUC BIOL, V15, P499, DOI 10.1016/j.sbi.2005.08.011; Mesquita RD, 2008, INFECT IMMUN, V76, P5543, DOI 10.1128/IAI.00683-08; Milward AD, 2006, BBA-GEN SUBJECTS, V1760, P1411, DOI 10.1016/j.bbagen.2006.06.004; Montalibet J, 2005, METHODS, V35, P2, DOI 10.1016/j.ymeth.2004.07.002; Muller U, 1997, PROG NEUROBIOL, V51, P363, DOI 10.1016/S0301-0082(96)00067-6; Nogueira NFS, 2007, EXP PARASITOL, V116, P120, DOI 10.1016/j.exppara.2006.12.014; NUSSENZVEIG RH, 1995, J EXP BIOL, V198, P1093; OSBORN MJ, 1966, METHOD ENZYMOL, V8, P161; Patel B, 2006, J THROMB HAEMOST, V4, P2423, DOI 10.1111/j.1538-7836.2006.02160.x; Previato JO, 2004, ADV PARASIT, V56, P1, DOI 10.1016/S0065-308X(03)56001-8; PREVIATO JO, 1995, J BIOL CHEM, V270, P7241, DOI 10.1074/jbc.270.13.7241; PREVIATO JO, 1990, J BIOL CHEM, V265, P2518; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; REDMAN CA, 1995, BIOCHEM J, V311, P495, DOI 10.1042/bj3110495; RIBEIRO JMC, 1990, BRIT J PHARMACOL, V101, P932, DOI 10.1111/j.1476-5381.1990.tb14183.x; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; RIBEIRO JMC, 1993, FEBS LETT, V330, P165, DOI 10.1016/0014-5793(93)80265-V; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004; RIBEIRO JMC, 1989, EXP PARASITOL, V69, P104, DOI 10.1016/0014-4894(89)90177-X; Rozen S, 2000, Methods Mol Biol, V132, P365; Silveira AB, 2006, INSECT BIOCHEM MOLEC, V36, P200, DOI 10.1016/j.ibmb.2006.01.015; Stefano GB, 2002, BRAIN RES, V924, P82, DOI 10.1016/S0006-8993(01)03227-9; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Whitten MMA, 2007, INSECT BIOCHEM MOLEC, V37, P440, DOI 10.1016/j.ibmb.2007.02.001; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615; Yuda M, 1996, EUR J BIOCHEM, V242, P807, DOI 10.1111/j.1432-1033.1996.0807r.x	63	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47285	10.1371/journal.pone.0047285	http://dx.doi.org/10.1371/journal.pone.0047285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077586	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100087
J	Gresle, MM; Alexandrou, E; Wu, QZ; Egan, G; Jokubaitis, V; Ayers, M; Jonas, A; Doherty, W; Friedhuber, A; Shaw, G; Sendtner, M; Emery, B; Kilpatrick, T; Butzkueven, H				Gresle, Melissa M.; Alexandrou, Estella; Wu, Qizhu; Egan, Gary; Jokubaitis, Vilija; Ayers, Margaret; Jonas, Anna; Doherty, William; Friedhuber, Anna; Shaw, Gerry; Sendtner, Michael; Emery, Ben; Kilpatrick, Trevor; Butzkueven, Helmut			Leukemia Inhibitory Factor Protects Axons in Experimental Autoimmune Encephalomyelitis via an Oligodendrocyte-Independent Mechanism	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; MULTIPLE-SCLEROSIS; FACTOR PREVENTS; DEMYELINATION; SURVIVAL; NEURONS; DEGENERATION; MOTONEURONS; INJURY; CNTF	Leukemia inhibitory factor (LIF) and Ciliary Neurotrophic factor (CNTF) are members of the interleukin-6 family of cytokines, defined by use of the gp130 molecule as an obligate receptor. In the murine experimental autoimmune encephalomyelitis (EAE) model, antagonism of LIF and genetic deletion of CNTF worsen disease. The potential mechanism of action of these cytokines in EAE is complex, as gp130 is expressed by all neural cells, and could involve immuno-modulation, reduction of oligodendrocyte injury, neuronal protection, or a combination of these actions. In this study we aim to investigate whether the beneficial effects of CNTF/LIF signalling in EAE are associated with axonal protection; and whether this requires signalling through oligodendrocytes. We induced MOG(35-55) EAE in CNTF, LIF and double knockout mice. On a CNTF null background, LIF knockout was associated with increased EAE severity (EAE grade 2.1+/-0.14 vs 2.6+/-0.19; P<0.05). These mice also showed increased axonal damage relative to LIF heterozygous mice, as indicated by decreased optic nerve parallel diffusivity on MRI (1540+/-207 mu m(2)-/s vs 1310+/-175 mu m(2)-/s; P<0.05), and optic nerve (-12.5%) and spinal cord (-16%) axon densities; and increased serum neurofilament-H levels (2.5 fold increase). No differences in inflammatory cell numbers or peripheral auto-immune T-cell priming were evident. Oligodendrocyte-targeted gp130 knockout mice showed that disruption of CNTF/LIF signalling in these cells has no effect on acute EAE severity. These studies demonstrate that endogenous CNTF and LIF act centrally to protect axons from acute inflammatory destruction via an oligodendrocyte-independent mechanism.	[Gresle, Melissa M.; Butzkueven, Helmut] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic, Australia; [Gresle, Melissa M.; Alexandrou, Estella; Jokubaitis, Vilija; Jonas, Anna; Doherty, William; Emery, Ben; Kilpatrick, Trevor; Butzkueven, Helmut] Florey Neurosci Inst, Parkville, Vic, Australia; [Alexandrou, Estella; Emery, Ben; Kilpatrick, Trevor] Univ Melbourne, Dept Anat, Parkville, Vic 3052, Australia; [Wu, Qizhu; Egan, Gary] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Ayers, Margaret; Friedhuber, Anna] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Shaw, Gerry] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany	Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; University of Melbourne; State University System of Florida; University of Florida; University of Wurzburg	Gresle, MM (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne Brain Ctr, Parkville, Vic, Australia.	mgresle@unimelb.edu.au	Egan, Gary F./A-1381-2013; Jokubaitis, Vilija G./AAD-5949-2019; Sendtner, Michael/J-1542-2012; Emery, Ben/I-6223-2013; Sendtner, Michael/M-8137-2014; , Gerry/X-2377-2019	Jokubaitis, Vilija G./0000-0002-3942-4340; Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Egan, Gary/0000-0002-3186-4026; Kilpatrick, Trevor/0000-0003-3999-085X; gresle, melissa/0000-0003-0738-1136; Butzkueven, Helmut/0000-0003-3940-8727; Emery, Ben/0000-0002-9132-3045	National Multiple Sclerosis Society (United States of America) [RG3850A3/1]; National Health and Medical Research Council Australia [509088]; Melbourne Brain Centre at RMH [CRE fellowship]	National Multiple Sclerosis Society (United States of America); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Brain Centre at RMH [CRE fellowship]	This work was supported by the National Multiple Sclerosis Society (United States of America) [Project Grant RG3850A3/1 to HB and TK]; National Health and Medical Research Council Australia [Project Grant 509088 to HB and TK, and Career Development Award to HB]; Melbourne Brain Centre at RMH [CRE fellowship to MG]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Butzkueven H, 2006, GLIA, V53, P696, DOI 10.1002/glia.20321; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Cao W, 2011, IMMUNITY, V35, P273, DOI 10.1016/j.immuni.2011.06.011; CHEEMA SS, 1994, J NEUROSCI RES, V37, P213, DOI 10.1002/jnr.490370207; CHEEMA SS, 1994, NEUROREPORT, V5, P989, DOI 10.1097/00001756-199404000-00034; Compston A, 1996, Mult Scler, V1, P388; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, BRAIN, V130, P2566, DOI 10.1093/brain/awm206; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; Gresle MM, 2008, J NEUROSCI RES, V86, P3548, DOI 10.1002/jnr.21803; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Kerr BJ, 2005, GLIA, V51, P73, DOI 10.1002/glia.20177; Kuhlmann T, 2006, AM J PATHOL, V169, P584, DOI 10.2353/ajpath.2006.051086; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lee TI, 2009, NEUROCHEM RES, V34, P109, DOI 10.1007/s11064-008-9682-0; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Linker RA, 2008, J IMMUNOL, V180, P2204, DOI 10.4049/jimmunol.180.4.2204; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MAYER M, 1994, DEVELOPMENT, V120, P143; Menkhorst E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019665; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Soilu-Hanninen M, 2000, J NEUROSCI RES, V59, P712, DOI 10.1002/(SICI)1097-4547(20000315)59:6<712::AID-JNR3>3.3.CO;2-C; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029	35	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47379	10.1371/journal.pone.0047379	http://dx.doi.org/10.1371/journal.pone.0047379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077604	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100102
J	Heni, M; Ketterer, C; Wagner, R; Linder, K; Bohm, A; Herzberg-Schafer, SA; Machicao, F; Knoch, KP; Fritsche, A; Staiger, H; Haring, HU; Solimena, M				Heni, Martin; Ketterer, Caroline; Wagner, Robert; Linder, Katarzyna; Boehm, Anja; Herzberg-Schaefer, Silke A.; Machicao, Fausto; Knoch, Klaus-Peter; Fritsche, Andreas; Staiger, Harald; Haering, Hans-Ulrich; Solimena, Michele			Polymorphism rs11085226 in the Gene Encoding Polypyrimidine Tract-Binding Protein 1 Negatively Affects Glucose-Stimulated Insulin Secretion	PLOS ONE			English	Article							BETA-CELL DYSFUNCTION; PROINSULIN BIOSYNTHESIS; TRANSLATIONAL CONTROL; GRANULE PROTEINS; RNA; SENSITIVITY; TOLERANCE; ISLETS; RISK; PHOSPHORYLATION	Objective: Polypyrimidine tract-binding protein 1 (PTBP1) promotes stability and translation of mRNAs coding for insulin secretion granule proteins and thereby plays a role in beta-cells function. We studied whether common genetic variations within the PTBP1 locus influence insulin secretion, and/or proinsulin conversion. Methods: We genotyped 1,502 healthy German subjects for four tagging single nucleotide polymorphisms (SNPs) within the PTBP1 locus (rs351974, rs11085226, rs736926, and rs123698) covering 100% of genetic variation with an r(2)>= 0.8. The subjects were metabolically characterized by an oral glucose tolerance test with insulin, proinsulin, and C-peptide measurements. A subgroup of 320 subjects also underwent an IVGTT. Results: PTBP1 SNP rs11085226 was nominally associated with lower insulinogenic index and lower cleared insulin response in the OGTT (p <= 0.04). The other tested SNPs did not show any association with the analyzed OGTT-derived secretion parameters. In the IVGTT subgroup, SNP rs11085226 was accordingly associated with lower insulin levels within the first ten minutes following glucose injection (p = 0.0103). Furthermore, SNP rs351974 was associated with insulin levels in the IVGTT (p = 0.0108). Upon interrogation of MAGIC HOMA-B data, our rs11085226 result was replicated (MAGIC p = 0.018), but the rs351974 was not. Conclusions: We conclude that common genetic variation in PTBP1 influences glucose-stimulated insulin secretion. This underlines the importance of PTBP1 for beta cell function in vivo.	[Heni, Martin; Ketterer, Caroline; Wagner, Robert; Linder, Katarzyna; Boehm, Anja; Herzberg-Schaefer, Silke A.; Machicao, Fausto; Fritsche, Andreas; Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany; German Ctr Diabet Res DZD, Tubingen, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med Nutr & Prevent Med, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014; Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Wagner, Robert/B-3689-2012	Wagner, Robert/0000-0002-6120-0191; Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333; Moller, Anja/0000-0002-5344-8533	German Research Foundation [DFG FR1561/5-1]; Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); Federal Ministry of Education and Research [FKZ 01GI0803-04]; BMBF (German Federal Ministry of Education and Research) network of competence AKROBAT (Advance Knowledge for Restoration of Beta Cells and Diabetes) [01GI0810]; German Federal Ministry of Education and Research (BMBF)	German Research Foundation(German Research Foundation (DFG)); Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF (German Federal Ministry of Education and Research) network of competence AKROBAT (Advance Knowledge for Restoration of Beta Cells and Diabetes); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by a grant from the German Research Foundation to A.F. (DFG FR1561/5-1), by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI0803-04) (H.-U.H.), and by the BMBF (German Federal Ministry of Education and Research) network of competence AKROBAT (Advance Knowledge for Restoration of Beta Cells and Diabetes, 01GI0810) (M.S.). Furthermore, the study was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; Alarcon C, 2006, DIABETOLOGIA, V49, P2920, DOI 10.1007/s00125-006-0433-y; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehehalt F, 2010, ISLETS, V2, P30, DOI 10.4161/isl.2.1.10098; Fontana L, ATLAS GENETICS CYTOG; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goodge KA, 2000, SEMIN CELL DEV BIOL, V11, P235, DOI 10.1006/scdb.2000.0172; Grodsky G M, 1999, Diabetes Technol Ther, V1, P259, DOI 10.1089/152091599317161; GUEST PC, 1989, BIOCHEM J, V257, P431, DOI 10.1042/bj2570431; HALBAN PA, 1982, ENDOCRINOLOGY, V110, P1183, DOI 10.1210/endo-110-4-1183; Heni M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-86; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; JANG SK, 1990, GENE DEV, V4, P1560, DOI 10.1101/gad.4.9.1560; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Larsson H, 1999, J CLIN ENDOCR METAB, V84, P2068, DOI 10.1210/jc.84.6.2068; MARTIN SK, 1994, FEBS LETT, V356, P279, DOI 10.1016/0014-5793(94)01284-9; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1977, DIABETES, V26, P322, DOI 10.2337/diab.26.4.322; STEINER DF, 1992, DIABETOLOGIA, V35, pS41, DOI 10.1007/BF00586278; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Stumvoll M, 2001, J CLIN ENDOCR METAB, V86, P1235, DOI 10.1210/jc.86.3.1235; Suess C, 2009, MOL CELL PROTEOMICS, V8, P393, DOI 10.1074/mcp.M800157-MCP200; Tripathy D, 2003, DIABETES CARE, V26, P1395, DOI 10.2337/diacare.26.5.1395; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100	39	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46154	10.1371/journal.pone.0046154	http://dx.doi.org/10.1371/journal.pone.0046154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077502	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100025
J	Judelson, HS; Shrivastava, J; Manson, J				Judelson, Howard S.; Shrivastava, Jolly; Manson, Joseph			Decay of Genes Encoding the Oomycete Flagellar Proteome in the Downy Mildew Hyaloperonospora arabidopsidis	PLOS ONE			English	Article							PHYTOPHTHORA-INFESTANS REVEALS; INTRAFLAGELLAR TRANSPORT; CHLAMYDOMONAS-REINHARDTII; GENOME SEQUENCE; EVOLUTION; PROTEINS; LOCUS; IDENTIFICATION; GERMINATION; COMPONENTS	Zoospores are central to the life cycles of most of the eukaryotic microbes known as oomycetes, but some genera have lost the ability to form these flagellated cells. In the plant pathogen Phytophthora infestans, genes encoding 257 proteins associated with flagella were identified by comparative genomics. These included the main structural components of the axoneme and basal body, proteins involved in intraflagellar transport, regulatory proteins, enzymes for maintaining ATP levels, and others. Transcripts for over three-quarters of the genes were up-regulated during sporulation, and persisted to varying degrees in the pre-zoospore stage (sporangia) and motile zoospores. Nearly all of these genes had orthologs in other eukaryotes that form flagella or cilia, but not species that lack the organelle. Orthologs of 211 of the genes were also absent from a sister taxon to P. infestans that lost the ability to form flagella, the downy mildew Hyaloperonospora arabidopsidis. Many of the genes retained in H. arabidopsidis were also present in other non-flagellates, suggesting that they play roles both in flagella and other cellular processes. Remnants of the missing genes were often detected in the H. arabidopsidis genome. Degradation of the genes was associated with local compaction of the chromosome and a heightened propensity towards genome rearrangements, as such regions were less likely to share synteny with P. infestans.	[Judelson, Howard S.; Shrivastava, Jolly; Manson, Joseph] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			United States National Science Foundation; National Institute of Food and Agriculture of the United States Department of Agriculture	United States National Science Foundation(National Science Foundation (NSF)); National Institute of Food and Agriculture of the United States Department of Agriculture	This research was supported by grants to HSJ from the United States National Science Foundation, and the National Institute of Food and Agriculture of the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016725; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Charles M, 2009, MOL BIOL EVOL, V26, P1651, DOI 10.1093/molbev/msp076; CLARK MC, 1978, CAN J MICROBIOL, V24, P1032, DOI 10.1139/m78-171; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dick MW, 2001, STRAMINIPILOUS FUNGI; Eckhart L, 2006, MOL BIOL EVOL, V23, P2081, DOI 10.1093/molbev/msl077; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HEATH IB, 1974, MYCOLOGIA, V66, P354, DOI 10.2307/3758372; Hodges ME, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-185; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Hoyer-Fender S, 2010, SEMIN CELL DEV BIOL, V21, P142, DOI 10.1016/j.semcdb.2009.07.002; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Judelson HS, 2009, MOL GENET GENOMICS, V281, P193, DOI 10.1007/s00438-008-0407-5; Judelson HS, 1998, GENOME, V41, P605, DOI 10.1139/gen-41-4-605; Judelson HS, 2005, NAT REV MICROBIOL, V3, P47, DOI 10.1038/nrmicro1064; Judelson HS, 2002, MOL BIOL EVOL, V19, P1313, DOI 10.1093/oxfordjournals.molbev.a004192; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Keeling PJ, 2004, DEV CELL, V6, P614, DOI 10.1016/S1534-5807(04)00135-2; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; LeDizet M, 1998, AM J PHYSIOL-LUNG C, V275, pL1145, DOI 10.1152/ajplung.1998.275.6.L1145; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu YJJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-74; LUCK DJL, 1984, J CELL BIOL, V98, P789, DOI 10.1083/jcb.98.3.789; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Morris PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006133; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; OMOTO CK, 1981, NATURE, V290, P708, DOI 10.1038/290708a0; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; PENINGTON CJ, 1989, EXP MYCOL, V13, P158, DOI 10.1016/0147-5975(89)90021-2; Phirke P, 2011, DEV BIOL, V357, P235, DOI 10.1016/j.ydbio.2011.06.028; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Runge F, 2011, IMA FUNGUS, V2, P163, DOI 10.5598/imafungus.2011.02.02.07; Saeki M, 2006, BIOCHEM BIOPH RES CO, V342, P568, DOI 10.1016/j.bbrc.2006.02.009; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Strullu-Derrien C, 2011, P ROY SOC B-BIOL SCI, V278, P675, DOI 10.1098/rspb.2010.1603; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Wei M, 2010, CYTOSKELETON, V67, P71, DOI 10.1002/cm.20422; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; Yagi T, 2000, CELL STRUCT FUNCT, V25, P263, DOI 10.1247/csf.25.263; Yamagishi T, 2009, J PHYCOL, V45, P1110, DOI 10.1111/j.1529-8817.2009.00722.x; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811	68	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47624	10.1371/journal.pone.0047624	http://dx.doi.org/10.1371/journal.pone.0047624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077652	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100146
J	Kessler, M; Hertel, D; Jungkunst, HF; Kluge, J; Abrahamczyk, S; Bos, M; Buchori, D; Gerold, G; Gradstein, SR; Kohler, S; Leuschner, C; Moser, G; Pitopang, R; Saleh, S; Schulze, CH; Sporn, SG; Steffan-Dewenter, I; Tjitrosoedirdjo, SS; Tscharntke, T				Kessler, Michael; Hertel, Dietrich; Jungkunst, Hermann F.; Kluge, Juergen; Abrahamczyk, Stefan; Bos, Merijn; Buchori, Damayanti; Gerold, Gerhard; Gradstein, S. Robbert; Koehler, Stefan; Leuschner, Christoph; Moser, Gerald; Pitopang, Ramadhanil; Saleh, Shahabuddin; Schulze, Christian H.; Sporn, Simone G.; Steffan-Dewenter, Ingolf; Tjitrosoedirdjo, Sri S.; Tscharntke, Teja			Can Joint Carbon and Biodiversity Management in Tropical Agroforestry Landscapes Be Optimized?	PLOS ONE			English	Article							FOREST SOILS; STOCKS; DIVERSITY; DEFORESTATION; CONVERSION; STORAGE; ROOT	Managing ecosystems for carbon storage may also benefit biodiversity conservation, but such a potential 'win-win' scenario has not yet been assessed for tropical agroforestry landscapes. We measured above-and below-ground carbon stocks as well as the species richness of four groups of plants and eight of animals on 14 representative plots in Sulawesi, Indonesia, ranging from natural rainforest to cacao agroforests that have replaced former natural forest. The conversion of natural forests with carbon stocks of 227-362 Mg C ha(-1) to agroforests with 82-211 Mg C ha(-1) showed no relationships to overall biodiversity but led to a significant loss of forest-related species richness. We conclude that the conservation of the forest-related biodiversity, and to a lesser degree of carbon stocks, mainly depends on the preservation of natural forest habitats. In the three most carbon-rich agroforestry systems, carbon stocks were about 60% of those of natural forest, suggesting that 1.6 ha of optimally managed agroforest can contribute to the conservation of carbon stocks as much as 1 ha of natural forest. However, agroforestry systems had comparatively low biodiversity, and we found no evidence for a tight link between carbon storage and biodiversity. Yet, potential win-win agroforestry management solutions include combining high shade-tree quality which favours biodiversity with cacao-yield adapted shade levels.	[Hertel, Dietrich; Gerold, Gerhard] Univ Gottingen, Inst Geog, Gottingen, Germany; [Kessler, Michael; Kluge, Juergen; Abrahamczyk, Stefan] Univ Zurich, Zurich, Switzerland; [Jungkunst, Hermann F.] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Kluge, Juergen] Univ Marburg, Fac Geog, Marburg, Germany; [Abrahamczyk, Stefan] Univ Munich, Dept Biol, Munich, Germany; [Bos, Merijn] Louis Bolk Inst, La Driebergen, Netherlands; [Buchori, Damayanti] Bogor Agr Univ, Dept Plant Protect, Fac Agr, IPB, Bogor, Indonesia; [Gradstein, S. Robbert] Museum Natl Hist Nat, Dept Systemat & Evolut UMS 602, F-75231 Paris, France; [Koehler, Stefan] Univ Rostock, Fac Agr & Environm Sci, Rostock, Germany; [Moser, Gerald] Univ Giessen, Dept Plant Ecol, Giessen, Germany; [Pitopang, Ramadhanil] Tadulako Univ, Dept Biol, Fac Math & Nat Sci, Palu, Indonesia; [Saleh, Shahabuddin] Univ Tadulako, Dept Agrotechnol, Fac Agr, Palu, Indonesia; [Schulze, Christian H.] Univ Vienna, Dept Anim Biodivers, Fac Life Sci, Vienna, Austria; [Sporn, Simone G.] FEMS Cent Off, Cl Delft, Netherlands; [Steffan-Dewenter, Ingolf] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Bioctr, Wurzburg, Germany; [Tjitrosoedirdjo, Sri S.] Bogor Agr Univ, Dept Biol, Fac Math & Nat Sci, IPB, Bogor, Indonesia	University of Gottingen; University of Zurich; University of Koblenz & Landau; Philipps University Marburg; University of Munich; Bogor Agricultural University; Museum National d'Histoire Naturelle (MNHN); University of Rostock; Justus Liebig University Giessen; Universitas Tadulako; Universitas Tadulako; University of Vienna; University of Wurzburg; Bogor Agricultural University	Hertel, D (corresponding author), Univ Gottingen, Inst Geog, Gottingen, Germany.	Dietrich.Hertel@biologie.uni-goettingen.de	Buchori, Damayanti/L-5878-2017; Moser, Gerald/F-8085-2011; Kluge, Jurgen/D-6200-2011; Saleh, Shahabuddin/M-3553-2017; Abrahamczyk, Stefan/D-7316-2011; Tscharntke, Teja/N-5123-2014; Kessler, Michael/A-3605-2009	Buchori, Damayanti/0000-0002-2843-0737; Moser, Gerald/0000-0002-0030-2370; Kessler, Michael/0000-0003-4612-9937; Jungkunst, Hermann/0000-0002-9807-9401; PITOPANG, RAMADANIL/0000-0002-6449-9053; Steffan-Dewenter, Ingolf/0000-0003-1359-3944; Saleh, Shahabuddin/0000-0002-6683-5321; Sporn, Simone Goda/0000-0003-1424-528X	German Research Foundation (DFG) [SFB-552]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG), grant SFB-552 (Collaborative Research Centre 'Stability of Rainforest Margins in Indonesia'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATBC/GTO Marburg declaration, 2009, URG NEED MAX BIOD CO; Baritz R, 2010, FOREST ECOL MANAG, V260, P262, DOI 10.1016/j.foreco.2010.03.025; Bekessy SA, 2008, CONSERV BIOL, V22, P510, DOI 10.1111/j.1523-1739.2008.00943.x; Campbell BM, 2009, GLOBAL ENVIRON CHANG, V19, P397, DOI 10.1016/j.gloenvcha.2009.07.010; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Ebeling J, 2008, PHILOS T R SOC B, V363, P1917, DOI 10.1098/rstb.2007.0029; FAOstat, 2009, STAT DAT; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Ghazoul J, 2010, TRENDS ECOL EVOL, V25, P396, DOI 10.1016/j.tree.2010.03.005; Grainger A, 2009, CURR BIOL, V19, pR974, DOI 10.1016/j.cub.2009.10.001; Hardner JJ, 2000, MITIG ADAPT STRAT GL, V5, P60; Hertel D, 2009, FOREST ECOL MANAG, V258, P1904, DOI 10.1016/j.foreco.2009.07.019; Hertel D, 2009, SOIL BIOL BIOCHEM, V41, P481, DOI 10.1016/j.soilbio.2008.11.020; Houghton R.A., 2008, TRENDS COMPENDIUM DA; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Huston MA, 2003, J ENVIRON MANAGE, V67, P77, DOI 10.1016/S0301-4797(02)00190-1; IPCC, 2006, IPCC GUIDELINES NATL, V5; Kessler M, 2011, J APPL ECOL, V48, P330, DOI 10.1111/j.1365-2664.2010.01932.x; Kessler M, 2009, ECOL APPL, V19, P2142, DOI 10.1890/08-1074.1; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Matthews S, 2002, ECOL ECON, V40, P71, DOI 10.1016/S0921-8009(01)00269-5; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Perfecto I, 2007, ENVIRON SCI ENG, P227; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahayu S., 2005, ABOVEGROUND STOCK CA, P21; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Smiley GL, 2008, AGROFOREST SYST, V73, P219, DOI 10.1007/s10457-008-9144-3; Sodhi NS, 2010, CONSERVATION BIOLOGY FOR ALL, P1; Sodhi NS., 2007, TROPICAL CONSERVATIO; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Zomer RJ, 2009, 89 ICRAF WORLD AGR C	43	39	40	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47192	10.1371/journal.pone.0047192	http://dx.doi.org/10.1371/journal.pone.0047192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077569	Green Published, Green Accepted, gold			2022-12-25	WOS:000309995100074
J	Mayega, RW; Makumbi, F; Rutebemberwa, E; Peterson, S; Ostenson, CG; Tomson, G; Guwatudde, D				Mayega, Roy William; Makumbi, Fredrick; Rutebemberwa, Elizeus; Peterson, Stefan; Ostenson, Claes-Goran; Tomson, Goran; Guwatudde, David			Modifiable Socio-Behavioural Factors Associated with Overweight and Hypertension among Persons Aged 35 to 60 Years in Eastern Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DISEASE RISK-FACTORS; PHYSICAL-ACTIVITY; NONCOMMUNICABLE DISEASES; SOCIOECONOMIC-STATUS; INCOME COUNTRIES; OBESITY; POPULATION; PREVALENCE; WORLD	Background: Few studies have examined the behavioural correlates of non-communicable, chronic disease risk in low-income countries. The objective of this study was to identify socio-behavioural characteristics associated with being overweight or being hypertensive in a low-income setting, so as to highlight possible interventions and target groups. Methods: A population based survey was conducted in a Health and Demographic Surveillance Site (HDSS) in eastern Uganda. 1656 individuals aged 35 to 60 years had their Body Mass Index (BMI) and blood pressure (BP) assessed. Seven lifestyle factors were also assessed, using a validated questionnaire. Logistic regression was used to identify sociobehavioural factors associated with being overweight or being hypertensive. Results: Prevalence of overweight was found to be 18% (25.2% of women; 9.7% of men; p<0.001) while prevalence of obesity was 5.3% (8.3% of women; 2.2% of men). The prevalence of hypertension was 20.5%. Factors associated with being overweight included being female (OR 3.7; 95% CI 2.69-5.08), peri-urban residence (OR 2.5; 95% CI 1.46-3.01), higher socioeconomic status (OR 4.1; 95% CI 2.40-6.98), and increasing age (OR 1.8; 95% CI 1.12-2.79). Those who met the recommended minimum physical activity level, and those with moderate dietary diversity were less likely to be overweight (OR 0.5; 95% CI 0.35-0.65 and OR 0.7; 95% CI 0.49-3.01). Factors associated with being hypertensive included peri-urban residence (OR 2.4; 95% CI 1.60-3.66), increasing age (OR 4.5; 95% CI 2.94-6.96) and being over-weight (OR 2.8; 95% CI 1.98-3.98). Overweight persons in rural areas were significantly more likely to be hypertensive than those in peri-urban areas (p = 0.013). Conclusions: Being overweight in low-income settings is associated with sex, physical activity and dietary diversity and being hypertensive is associated with being overweight; these factors are modifiable. There is need for context-specific health education addressing disparities in lifestyles at community levels in rural Africa.	[Mayega, Roy William; Peterson, Stefan; Tomson, Goran] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Mayega, Roy William; Makumbi, Fredrick; Guwatudde, David] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Rutebemberwa, Elizeus; Peterson, Stefan] Makerere Univ, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Kampala, Uganda; [Ostenson, Claes-Goran] Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Ostenson, Claes-Goran] Karolinska Inst, Surg Endocrine & Diabet Unit, Stockholm, Sweden; [Peterson, Stefan] Uppsala Univ, Int Maternal & Child Hlth Unit, Uppsala, Sweden; [Tomson, Goran] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Div Med Management Ctr MMC, Stockholm, Sweden; [Rutebemberwa, Elizeus] Iganga Mayuge Hlth & Demog Surveillance Site, Iganga, Uganda	Karolinska Institutet; Makerere University; Makerere University; Karolinska Institutet; Karolinska Institutet; Uppsala University; Karolinska Institutet	Mayega, RW (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden.	wromay2000@yahoo.co.uk		Tomson, Goran/0000-0001-9222-3604; Rutebemberwa, Elizeus/0000-0001-8363-7928	Swedish International Development Agency; Swedish International Development Agency (SIDA)	Swedish International Development Agency; Swedish International Development Agency (SIDA)	This work was supported by the Swedish International Development Agency. The Management of Iganga-Mayuge HDSS, and the Diabetes Research Group at Karolinska Institutet, especially Agneta Hilding and Anna-Karin Eriksson, are duly acknowledged for their technical input, as is Pauline Binder, of the Women and Child Health Department, Uppsala University, Sweden, for the language audit. The Family Health and Wealth Project provided the anthropometry equipment.; This work was funded by the Swedish International Development Agency (SIDA) through a joint training and capacity building program between Makerere University in Uganda and Karolinska Institutet in Sweden. The grant covered the costs of field work, including training of research assistants, data collection and entry (http://www.sida.se/English/Countries-and-regions/Africa/Uganda/Our-work-in-Uganda/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Cooper RS, 1998, BMJ-BRIT MED J, V316, P614, DOI 10.1136/bmj.316.7131.614; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Deurenberg P, 2001, BRIT J NUTR, V85, P135, DOI 10.1079/BJN2000273; Echouffo-Tcheugui JB, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-44; Eriksson AK, 2008, DIABETIC MED, V25, P834, DOI 10.1111/j.1464-5491.2008.02463.x; Fezeu L, 2006, INT J EPIDEMIOL, V35, P105, DOI 10.1093/ije/dyi214; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hilding A, 2006, DIABETOLOGIA, V49, P2589, DOI 10.1007/s00125-006-0402-5; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; HOSMER DW, 2000, WILEY PS TX, P1; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Lasky D, 2002, NUTRITION, V18, P417, DOI 10.1016/S0899-9007(01)00726-2; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Maher D, 2011, INT J EPIDEMIOL, V40, P160, DOI 10.1093/ije/dyq156; Maletnlema TN, 2002, PUBLIC HEALTH NUTR, V5, P163, DOI 10.1079/PHN2001289; Mazengo MC, 1997, ACTA TROP, V68, P313, DOI 10.1016/S0001-706X(97)00113-7; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Najdi A, 2011, PREV MED, V52, P355, DOI 10.1016/j.ypmed.2011.03.009; Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/09595230500170266; Njelekela MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-30; Oladapo OO, 2010, CARDIOVASC J AFR, V21, P26; Oyeyemi AL, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-156; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; PPaBN Shanthi Mendis, 2011, WHO COLLABORATION WO; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P231; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Seedat Y K, 2007, Cardiovasc J Afr, V18, P316; Sodjinou R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-84; Swindale A., 2005, MEASURING HOUSEHOLD; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Turyatemba J., 2011, IGANGA MAYUGE DSS HE; Calverton M, 2007, UGANDA DEMOGRAPHIC H, P19; Unwin N, 2006, ANN TROP MED PARASIT, V100, P455, DOI 10.1179/136485906X97453; Unwin N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-272; Ustun B, 1998, DRUG ALCOHOL DEPEN, V50, P185; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; WHO, 2011, GLOB STAT REP NONC D; WHO, 2011, STEPS MAN STEPS INST; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2000, INT GUID MON ALC CON; World Health Organization, 1995, PHYS STAT US INT ANT	53	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47632	10.1371/journal.pone.0047632	http://dx.doi.org/10.1371/journal.pone.0047632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077653	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100147
J	Montagna, M; Sassera, D; Griggio, F; Epis, S; Bandi, C; Gissi, C				Montagna, Matteo; Sassera, Davide; Griggio, Francesca; Epis, Sara; Bandi, Claudio; Gissi, Carmela			Tick-Box for 3 '-End Formation of Mitochondrial Transcripts in Ixodida, Basal Chelicerates and Drosophila	PLOS ONE			English	Article							CANDIDATUS-MIDICHLORIA-MITOCHONDRII; RNA PUNCTUATION MODEL; DNA-BINDING PROTEIN; TERMINATION FACTOR; GENE ARRANGEMENT; RIBOSOMAL-RNA; PARALLEL EVOLUTION; SEQUENCE ALIGNMENT; IXODES-RICINUS; WEB SERVER	According to the tRNA punctuation model, the mitochondrial genome (mtDNA) of mammals and arthropods is transcribed as large polycistronic precursors that are maturated by endonucleolytic cleavage at tRNA borders and RNA polyadenylation. Starting from the newly sequenced mtDNA of Ixodes ricinus and using a combination of mitogenomics and transcriptional analyses, we found that in all currently-sequenced tick lineages (Prostriata, Metastriata and Argasidae) the 3'-end of the polyadenylated nad1 and rrnL transcripts does not follow the tRNA punctuation model and is located upstream of a degenerate 17-bp DNA motif. A slightly different motif is also present downstream the 3'-end of nad1 transcripts in the primitive chelicerate Limulus polyphemus and in Drosophila species, indicating the ancient origin and the evolutionary conservation of this motif in arthropods. The transcriptional analyses suggest that this motif directs the 3'-end formation of the nad1/rrnL mature RNAs, likely working as a transcription termination signal or a processing signal of precursor transcripts. Moreover, as most regulatory elements, this motif is characterized by a taxon-specific evolution. Although this signal is not exclusive of ticks, making a play on words it has been named "Tick-Box", since it is a check mark that has to be verified for the 3'-end formation of some mt transcripts, and its consensus sequence has been here carefully characterized in ticks. Indeed, in the whole mtDNA of all ticks, the Tick-Box is always present downstream of nad1 and rrnL, mainly in non-coding regions (NCRs) and occasionally within trnL(CUN). However, some metastriates present a third Tick-Box at an intriguing site - inside the small NCR located at one end of a 3.4 kb translocated region, the other end of which exhibits the nad1 Tick-Box - hinting that this motif could have been involved in metastriate gene order rearrangements.	[Griggio, Francesca; Gissi, Carmela] Univ Milan, Dipartimento Biosci, Milan, Italy; [Montagna, Matteo; Sassera, Davide; Epis, Sara; Bandi, Claudio] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	University of Milan; University of Milan	Gissi, C (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	carmela.gissi@unimi.it	Bandi, Claudio/J-7835-2018; EPIS, SARA/B-7708-2017; Montagna, Matteo/AAF-8281-2021	Bandi, Claudio/0000-0002-0181-4618; EPIS, SARA/0000-0001-8807-4802; Montagna, Matteo/0000-0003-4465-7146; Sassera, Davide/0000-0003-0442-5252; Gissi, Carmela/0000-0002-2269-079X	Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR); European Cooperation in Science and Technology [FA0701]; Universita degli Studi di Milano	Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Universita degli Studi di Milano	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy (MIUR: PRIN-2009 to CB and PRIN-2009 to CG); European Cooperation in Science and Technology (Cost Action FA0701 to CB) and Universita degli Studi di Milano (PUR project to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2007, MOL BIOL EVOL, V24, P1; Adachi J, 1996, J MOL EVOL, V42, P459; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENKEL BF, 1988, NUCLEIC ACIDS RES, V16, P9880, DOI 10.1093/nar/16.20.9880; BERTHIER F, 1986, NUCLEIC ACIDS RES, V14, P4519, DOI 10.1093/nar/14.11.4519; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Black WC, 1998, MOL BIOL EVOL, V15, P1772, DOI 10.1093/oxfordjournals.molbev.a025903; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Campbell NJH, 1999, MOL BIOL EVOL, V16, P732, DOI 10.1093/oxfordjournals.molbev.a026158; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Choi EH, 2007, DNA SEQUENCE, V18, P459, DOI 10.1080/10425170701289883; CHRISTIANSON TW, 1988, MOL CELL BIOL, V8, P4502, DOI 10.1128/MCB.8.10.4502; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Drummond AJ, 2010, GENEIOUS V5 5 7 CREA; Dunlop JA, 2009, EXP APPL ACAROL, V48, P183, DOI 10.1007/s10493-009-9247-1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fernandez-Silva P, 2001, NUCLEIC ACIDS RES, V29, P4736, DOI 10.1093/nar/29.22.4736; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Friedrich M, 1997, SYST BIOL, V46, P674, DOI 10.2307/2413500; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gissi C, 2003, GENOME RES, V13, P2203, DOI 10.1101/gr.1227803; Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Horak IG, 2002, EXP APPL ACAROL, V28, P27, DOI 10.1023/A:1025381712339; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Jones M, 2007, MOL PHYLOGENET EVOL, V43, P583, DOI 10.1016/j.ympev.2006.11.017; Keirans JE, 1999, ACAROLOGY, P344; Klimov PB, 2011, J HERED, V102, P283, DOI 10.1093/jhered/esr005; Klimov PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-598; Klompen JSH, 2000, CLADISTICS, V16, P79, DOI 10.1111/j.1096-0031.2000.tb00349.x; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Krzeminski Wieslaw, 2003, Acta Zoologica Cracoviensia, V46, P153; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Lupi R, 2010, MITOCHONDRION, V10, P192, DOI 10.1016/j.mito.2010.01.004; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Mans BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023675; Masta SE, 2000, MOL BIOL EVOL, V17, P1091, DOI 10.1093/oxfordjournals.molbev.a026390; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Masta SE, 2010, GENE, V449, P9, DOI 10.1016/j.gene.2009.09.009; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Montooth KL, 2009, J MOL EVOL, V69, P94, DOI 10.1007/s00239-009-9255-0; MUNDERLOH UG, 1994, J PARASITOL, V80, P533, DOI 10.2307/3283188; Murrell A, 2003, SYST PARASITOL, V56, P169, DOI 10.1023/B:SYPA.0000003802.36517.a0; Najm NA, 2012, PARASITOL RES, V110, P437, DOI 10.1007/s00436-011-2509-y; Nava S, 2009, FRONT BIOSCI-LANDMRK, V14, P2857, DOI 10.2741/3418; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Park SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-343; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Polosa PL, 1999, NUCLEIC ACIDS RES, V27, P1890, DOI 10.1093/nar/27.8.1890; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; ROBERTI M, 1991, NUCLEIC ACIDS RES, V19, P6249, DOI 10.1093/nar/19.22.6249; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Sassera D, 2006, INT J SYST EVOL MICR, V56, P2535, DOI 10.1099/ijs.0.64386-0; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shao R, 2004, INSECT MOL BIOL, V13, P219, DOI 10.1111/j.0962-1075.2004.00447.x; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shao RF, 2005, J MOL EVOL, V60, P764, DOI 10.1007/s00239-004-0226-1; Shao RF, 2005, MOL BIOL EVOL, V22, P620, DOI 10.1093/molbev/msi047; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Sonenshine D.E., 1993, ECOLOGY NIDICOLOUS T, V2; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; VALVERDE JR, 1994, P NATL ACAD SCI USA, V91, P5368, DOI 10.1073/pnas.91.12.5368; VANETTEN RA, 1983, J BIOL CHEM, V258, P104; Xu G, 2003, J PARASITOL, V89, P452, DOI 10.1645/0022-3395(2003)089[0452:MPAITT]2.0.CO;2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	80	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47538	10.1371/journal.pone.0047538	http://dx.doi.org/10.1371/journal.pone.0047538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077630	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100126
J	Peng, FW; Yao, HH; Akturk, HK; Buch, S				Peng, Fuwang; Yao, Honghong; Akturk, Halis Kaan; Buch, Shilpa			Platelet-Derived Growth Factor CC-Mediated Neuroprotection against HIV Tat Involves TRPC-Mediated Inactivation of GSK 3beta	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTECTS HUMAN NEURONS; CELL-SURVIVAL; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; REGULATORY PROTEIN; INDUCED APOPTOSIS; PI3K PATHWAY	Platelet-derived growth factor-CC (PDGF-CC) is the third member of the PDGF family, and has been implicated both in embryogenesis and development of the CNS. The biological function of this isoform however, remains largely unexplored in the context of HIV-associated dementia (HAD). In the present study, we demonstrate that exposure of human neuroblastoma cells SH-SY5Y to HIV transactivator protein Tat resulted in decreased intrinsic expression of PDGF-CC as evidenced by RT-PCR and western blot assays. Reciprocally, pretreatment of SH-SY5Y cells with PDGF-CC abrogated Tat-mediated neurotoxicity by mitigating apoptosis and neurite & MAP-2 loss. Using pharmacological and loss of function approaches we identified the role of phosphatidylinositol 3-kinase (PI3K)/Akt signaling in PDGF-CC-mediated neuroprotection. We report herein a novel role about the involvement of transient receptor potential canonical (TRPC) channel 1 in modulation of calcium transients in PDGF-CC-mediated neuroprotection. Furthermore we also demonstrated PDGF-CC-mediated inactivation of the downstream mediator - glycogen synthase kinase 3 beta (GSK3 beta) evidenced by its phosphorylation at Ser-9. This was further validated by gain and loss of function studies using cells transfected with either the wild type or mutant GSK3 beta constructs. Intriguingly, pretreatment of cells with either the PI3K inhibitor or TRPC blocker resulted in failure of PDGF-CC to inactivate GSK3 beta, thereby suggesting the intersection of PI3K and TRPC signaling at GSK3 beta. Taken together our findings lead to the suggestion that PDGF-CC could be developed as a therapeutic target to reverse Tat-mediated neurotoxicity with implications for HAD.	[Peng, Fuwang; Yao, Honghong; Buch, Shilpa] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Akturk, Halis Kaan] Creighton Med Ctr, Dept Med, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Creighton University	Buch, S (corresponding author), Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	sbuch@unmc.edu	Akturk, Halis Kaan/I-5179-2019	Akturk, Halis Kaan/0000-0003-4518-5179; Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant MH-068212 from the National Institutes of Health (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 1996, MOL MED, V2, P417, DOI 10.1007/BF03401901; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Alzheimer C, 2002, ADV EXP MED BIOL, V513, P335; Apati A, 2003, J BIOL CHEM, V278, P9235, DOI 10.1074/jbc.M205528200; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Arrazola MS, 2009, J CELL PHYSIOL, V221, P658, DOI 10.1002/jcp.21902; Bachis A, 2005, ANN NY ACAD SCI, V1053, P247, DOI 10.1196/annals.1344.022; Bell JE, 1998, REV NEUROL-FRANCE, V154, P816; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen ZW, 2000, J VIROL, V74, P6501, DOI 10.1128/JVI.74.14.6501-6510.2000; Chung WH, 2006, JARO-J ASSOC RES OTO, V7, P373, DOI 10.1007/s10162-006-0050-y; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Colafrancesco V, 2011, ARCH ITAL BIOL, V149, P183, DOI 10.4449/aib.v149i2.1376; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Cui W, 2011, BRAIN RES, V1394, P14, DOI 10.1016/j.brainres.2011.02.006; De Smedt H, 2011, CELL CALCIUM, V50, P207, DOI 10.1016/j.ceca.2011.06.004; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; Facci L, 2003, NEUROREPORT, V14, P1467, DOI 10.1097/00001756-200308060-00012; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; HELDIN CH, 1990, J CELL SCI, V96, P193; Hof PR, 1998, EXP NEUROL, V153, P234, DOI 10.1006/exnr.1998.6881; Hollman AM, 2005, BIOTECHNOL PROGR, V21, P451, DOI 10.1021/bp049804z; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Korade Z, 2011, NEURON, V71, P955, DOI 10.1016/j.neuron.2011.09.002; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Kucharzewska P, 2009, BIOCHEM BIOPH RES CO, V380, P413, DOI 10.1016/j.bbrc.2009.01.097; Kumar A, 1999, FEBS LETT, V462, P140, DOI 10.1016/S0014-5793(99)01487-8; Kuribara M, 2010, GEN COMP ENDOCR, V169, P123, DOI 10.1016/j.ygcen.2010.08.010; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; Liot G, 2004, EXP NEUROL, V187, P38, DOI 10.1016/j.expneurol.2004.01.002; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lu M, 2010, J MOL ENDOCRINOL, V44, P285, DOI 10.1677/JME-09-0138; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mattson MP, 2004, ANN NY ACAD SCI, V1012, P37, DOI 10.1196/annals.1306.004; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McGary EC, 2002, CLIN CANCER RES, V8, P3584; McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326; Nath A, 1999, SEMIN NEUROL, V19, P113, DOI 10.1055/s-2008-1040830; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Pei Y, DEVELOPMENT, V139, P1724; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Pietz K, 1996, NEUROSCI LETT, V204, P101, DOI 10.1016/0304-3940(96)12326-0; Rappaport J, 1999, J LEUKOCYTE BIOL, V65, P458, DOI 10.1002/jlb.65.4.458; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Sanders VJ, 2000, J NEUROSCI RES, V59, P671, DOI 10.1002/(SICI)1097-4547(20000301)59:5<671::AID-JNR10>3.0.CO;2-B; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Sossin WS, 2007, NAT NEUROSCI, V10, P537, DOI 10.1038/nn0507-537; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Subramaniam S, 2005, J NEUROSCI, V25, P2838, DOI 10.1523/JNEUROSCI.5060-04.2005; Tagami M, 1997, LAB INVEST, V76, P613; Tang ZS, 2010, J EXP MED, V207, P867, DOI 10.1084/jem.20091704; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; Vermijlen D, J EXP MED, V207, P807; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wang L, 2010, APOPTOSIS, V15, P1470, DOI 10.1007/s10495-010-0547-z; Wiley CA, 1996, AIDS, V10, P843, DOI 10.1097/00002030-199607000-00007; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Xu Y, 2004, P NATL ACAD SCI USA, V101, P7070, DOI 10.1073/pnas.0304859101; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zauli G, 2000, J BIOL CHEM, V275, P4159, DOI 10.1074/jbc.275.6.4159; Zhang SXL, 2003, FASEB J, V17, P1709, DOI 10.1096/fj.02-1111fje; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	95	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47572	10.1371/journal.pone.0047572	http://dx.doi.org/10.1371/journal.pone.0047572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077641	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100136
J	Szinte, M; Cavanagh, P				Szinte, Martin; Cavanagh, Patrick			Apparent Motion from Outside the Visual Field, Retinotopic Cortices May Register Extra-Retinal Positions	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; PSYCHOPHYSICS TOOLBOX; SUPERIOR COLLICULUS; SPACE CONSTANCY; PARIETAL CORTEX; FRONTAL-CORTEX; REPRESENTATION; MONKEYS; MAINTENANCE; STABILITY	Observers made a saccade between two fixation markers while a probe was flashed sequentially at two locations on a side screen. The first probe was presented in the far periphery just within the observer's visual field. This target was extinguished and the observers made a large saccade away from the probe, which would have left it far outside the visual field if it had still been present. The second probe was then presented, displaced from the first in the same direction as the eye movement and by about the same distance as the saccade step. Because both eyes and probes shifted by similar amounts, there was little or no shift between the first and second probe positions on the retina. Nevertheless, subjects reported seeing motion corresponding to the spatial displacement not the retinal displacement. When the second probe was presented, the effective location of the first probe lay outside the visual field demonstrating that apparent motion can be seen from a location outside the visual field to a second location inside the visual field. Recent physiological results suggest that target locations are "remapped" on retinotopic representations to correct for the effects of eye movements. Our results suggest that the representations on which this remapping occurs include locations that fall beyond the limits of the retina.	[Szinte, Martin; Cavanagh, Patrick] Univ Paris 05, Lab Psychol Percept, Paris, France; [Szinte, Martin; Cavanagh, Patrick] Ctr Natl Rech Sci, UMR 8158, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Szinte, M (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	martin.szinte@gmail.com			Chaire d'Excellence Grant; French Ministere de l'Enseignement Superieur et de la Recherche Grant	Chaire d'Excellence Grant; French Ministere de l'Enseignement Superieur et de la Recherche Grant	This research was supported by a Chaire d'Excellence Grant to PC and a French Ministere de l'Enseignement Superieur et de la Recherche Grant to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; CAELLI T, 1979, PERCEPTION, V8, P59, DOI 10.1068/p080059; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Colby CL, 1992, SCIENCE, V255, P90; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; Deubel H, 2010, VISION RES, V50, P249, DOI 10.1016/j.visres.2009.09.020; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; Fracasso A, 2010, J VISION, V10, DOI 10.1167/10.13.14; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Harrington D., 1981, VISUAL FIELDS TXB AT, V5th; Koch Carmen, 2007, P193, DOI 10.1016/B978-008044980-7/50011-2; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; ROCK I, 1962, AM J PSYCHOL, V75, P193, DOI 10.2307/1419603; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Szinte M, 2011, J VISION, V11, DOI 10.1167/11.2.4; Tark KJ, 2009, NAT NEUROSCI, V12, P1463, DOI 10.1038/nn.2406; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	35	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47386	10.1371/journal.pone.0047386	http://dx.doi.org/10.1371/journal.pone.0047386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077606	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100104
J	van Houte, S; Ros, VID; Mastenbroek, TG; Vendrig, NJ; Hoover, K; Spitzen, J; van Oers, MM				van Houte, Stineke; Ros, Vera I. D.; Mastenbroek, Tom G.; Vendrig, Nadia J.; Hoover, Kelli; Spitzen, Jeroen; van Oers, Monique M.			Protein Tyrosine Phosphatase-Induced Hyperactivity Is a Conserved Strategy of a Subset of BaculoViruses to Manipulate Lepidopteran Host Behavior	PLOS ONE			English	Article							SPODOPTERA-EXIGUA LARVAE; FEEDING-BEHAVIOR; VIRUS; GENES; SEQUENCE; IMPACT; ALIGNMENTS; SILKWORM; REVEALS; COMPLEX	Many parasites manipulate host behavior to increase the probability of transmission. To date, direct evidence for parasitic genes underlying such behavioral manipulations is scarce. Here we show that the baculovirus Autographa californica nuclear polyhedrovirus (AcMNPV) induces hyperactive behavior in Spodoptera exigua larvae at three days after infection. Furthermore, we identify the viral protein tyrosine phosphatase (ptp) gene as a key player in the induction of hyperactivity in larvae, and show that mutating the catalytic site of the encoded phosphatase enzyme prevents this induced behavior. Phylogenetic inference points at a lepidopteran origin of the ptp gene and shows that this gene is well-conserved in a group of related baculoviruses. Our study suggests that ptp-induced behavioral manipulation is an evolutionarily conserved strategy of this group of baculoviruses to enhance virus transmission, and represents an example of the extended phenotype concept. Overall, these data provide a firm base for a deeper understanding of the mechanisms behind baculovirus-induced insect behavior.	[van Houte, Stineke; Ros, Vera I. D.; Mastenbroek, Tom G.; van Oers, Monique M.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Hoover, Kelli] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hoover, Kelli] Penn State Univ, Ctr Chem Ecol, University Pk, PA 16802 USA; [Spitzen, Jeroen] Wageningen Univ, Entomol Lab, Wageningen, Netherlands	Wageningen University & Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wageningen University & Research	van Oers, MM (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	monique.vanoers@wur.nl	Spitzen, Jeroen/B-3098-2012; vendrig, nadia/B-6816-2013	Spitzen, Jeroen/0000-0003-0455-7511; Mastenbroek, Tom/0000-0002-2620-6395; Ros, Vera/0000-0002-4831-7299; van Houte, Stineke/0000-0001-7047-1308	Royal Dutch Academy of Sciences [08-PSA-BD-01]; Netherlands Organization for Scientific Research [ALW2PJ/11051]; C.T. de Wit Graduate School for Production Ecology and Resource Conservation	Royal Dutch Academy of Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); C.T. de Wit Graduate School for Production Ecology and Resource Conservation	SVH and VIDR were both supported by the Program Strategic Alliances of the Royal Dutch Academy of Sciences (project 08-PSA-BD-01). MVO was supported by a MEERVOUD grant from the Netherlands Organization for Scientific Research (project ALW2PJ/11051). KH was supported by a visiting scientist grant from the C.T. de Wit Graduate School for Production Ecology and Resource Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Beckage N.E., 1997, PARASITES PATHOGENS; Bennett KE, 2008, J MED ENTOMOL, V45, P921, DOI 10.1603/0022-2585(2008)45[921:BBOVSV]2.0.CO;2; Biernat MA, 2012, J BIOL RHYTHM, V27, P3, DOI 10.1177/0748730411429665; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; COMBES C, 1991, AM NAT, V138, P866, DOI 10.1086/285257; Dawkins R., 1982, pi; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Goulson D, 1997, OECOLOGIA, V109, P219, DOI 10.1007/s004420050076; Groner A., 1986, BIOL BACULOVIRUSES, V1, P177; Gross CH, 1998, J VIROL, V72, P7057, DOI 10.1128/JVI.72.9.7057-7063.1998; Guarino LA, 1998, J VIROL, V72, P7985, DOI 10.1128/JVI.72.10.7985-7991.1998; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Herniou EA, 2007, CURR DRUG TARGETS, V8, P1043, DOI 10.2174/138945007782151306; Hofmann O., 1891, INSEKTENTOTENDE PILZ; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Kamita SG, 2005, P NATL ACAD SCI USA, V102, P2584, DOI 10.1073/pnas.0409457102; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katsuma S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002644; KIM D, 1993, VIROLOGY, V195, P587, DOI 10.1006/viro.1993.1410; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Lefevre T, 2008, INFECT GENET EVOL, V8, P504, DOI 10.1016/j.meegid.2007.05.008; Lefevre T, 2009, ADV PARASIT, V68, P45, DOI 10.1016/S0065-308X(08)00603-9; LI YH, 1995, J VIROL, V69, P4533, DOI 10.1128/JVI.69.7.4533-4537.1995; LI YH, 1995, J GEN VIROL, V76, P2941, DOI 10.1099/0022-1317-76-12-2941; Li Y, 2008, J VIROL, V82, P5573, DOI 10.1128/JVI.00058-08; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; MOORE J, 1995, BIOSCIENCE, V45, P89, DOI 10.2307/1312610; Moore J., 2002, PARASITES BEHAV ANIM; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Peng K, 2010, J VIROL, V84, P9497, DOI 10.1128/JVI.00812-10; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; SHENG ZQ, 1993, J BIOL CHEM, V268, P4728; Shimada T, 1999, RIKEN REV, V22, P68; SMITH GE, 1979, J VIROL, V30, P828, DOI 10.1128/JVI.30.3.828-838.1979; SMITS PH, 1987, ENTOMOL EXP APPL, V43, P73, DOI 10.1007/BF00350378; SMITS PH, 1986, ENVIRON ENTOMOL, V15, P1189, DOI 10.1093/ee/15.6.1189; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Takagi T, 1998, P NATL ACAD SCI USA, V95, P9808, DOI 10.1073/pnas.95.17.9808; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; van Oers MM, 1999, INSECT MOL BIOL, V8, P531, DOI 10.1046/j.1365-2583.1999.00148.x; Vasconcelos SD, 1996, BIOL CONTROL, V7, P299, DOI 10.1006/bcon.1996.0098; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620	55	51	52	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46933	10.1371/journal.pone.0046933	http://dx.doi.org/10.1371/journal.pone.0046933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077534	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100047
J	Lofdahl, HE; Du, J; Nasman, A; Andersson, E; Rubio, CA; Lu, YX; Ramqvist, T; Dalianis, T; Lagergren, J; Dahlstrand, H				Lofdahl, Hedvig E.; Du, Juan; Nasman, Anders; Andersson, Emilia; Rubio, Carlos A.; Lu, Yunxia; Ramqvist, Torbjorn; Dalianis, Tina; Lagergren, Jesper; Dahlstrand, Hanna			Prevalence of Human Papillomavirus (HPV) in Oesophageal Squamous Cell Carcinoma in Relation to Anatomical Site of the Tumour	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; CANCER; SURVIVAL; HEAD; CLASSIFICATION; AMPLIFICATION; DNA	Background: The prevalence and role of human papillomavirus (HPV) in the aetiology of oesophageal squamous cell carcinoma is uncertain. Based on the presence of HPV in the oral cavity and its causal association with squamous cell carcinoma of the oropharynx, we hypothesised that HPV is more strongly associated with proximal than distal oesophageal squamous cell carcinoma. Methods: A population-based study comparing HPV infection in relation to tumour site in patients diagnosed with oesophageal squamous cell carcinomas in the Stockholm County in 1999-2006. Multiplex polymerase chain reaction genotyping (PCR) with Luminex was conducted on pre-treatment endoscopic biopsies to identify type specify HPV. Carcinogenic activity of HPV was assessed by p16(INK4a) expression. Multivariable logistic regression was used to calculate odds ratios and 95% confidence intervals. Results: Among 204 patients, 20 (10%) had tumours harbouring HPV DNA, almost all (90%) of HPV high-risk type, mainly HPV16. Tumours containing HPV were not overrepresented in the upper compared to the middle or lower third of the oesophagus (odds ratio 0.6, 95% confidence interval 0.2-1.9). P16(INK4a) expression was similarly common (24% and 16%) in the HPV-positive and HPV-negative groups. Conclusion: This study found a limited presence of HPV in oesophageal squamous cell carcinoma of uncertain oncogenic relevance and did not demonstrate that HPV was more strongly associated with proximal than distal tumours.	[Lofdahl, Hedvig E.; Lu, Yunxia; Lagergren, Jesper; Dahlstrand, Hanna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Du, Juan; Nasman, Anders; Andersson, Emilia; Rubio, Carlos A.; Ramqvist, Torbjorn; Dalianis, Tina; Dahlstrand, Hanna] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Karolinska Institutet; Karolinska Institutet; University of London; King's College London	Lofdahl, HE (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	hedvig.lofdahl@ki.se		Dalianis, Tina/0000-0001-7022-2424; Du, Juan/0000-0001-7649-9571; Nasman, Anders/0000-0003-4602-4297; Lu, Yunxia/0000-0002-1201-7729; Lagergren, Jesper/0000-0002-5143-5448	Swedish Cancer foundation	Swedish Cancer foundation	The study was funded by the Swedish Cancer foundation, a residential non-profitable organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Antonsson A, 2010, CANCER EPIDEM BIOMAR, V19, P2080, DOI 10.1158/1055-9965.EPI-10-0033; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bellizzi AM, 2009, AM J SURG PATHOL, V33, P1608, DOI 10.1097/PAS.0b013e3181b46fd4; Bognar G, 2008, HEPATO-GASTROENTEROL, V55, P93; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BOSCH FX, 1992, INT J CANCER, V52, P171, DOI 10.1002/ijc.2910520202; De Villiers EM, 2004, INT J CANCER, V109, P253, DOI 10.1002/ijc.11685; Dreilich M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-94; Ferlay J, 2010, INT J CANC; Ghosh SK, 2006, AM J PHYSIOL-GASTR L, V290, pG568, DOI 10.1152/ajpgi.00280.2005; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Klint A, 2010, ACTA ONCOL, V49, P578, DOI 10.3109/02841861003739330; Koshiol J, 2010, INT J CANCER, V127, P93, DOI 10.1002/ijc.25023; Lindblad M, 2006, ANN SURG, V243, P479, DOI 10.1097/01.sla.0000205825.34452.43; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Mendelsohn AH, 2010, LARYNGOSCOPE, V120, P1788, DOI 10.1002/lary.21044; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ragin CCR, 2006, BRIT J CANCER, V95, P1432, DOI 10.1038/sj.bjc.6603394; Ramqvist T, 2011, SCAND J INFECT DIS, V43, P115, DOI 10.3109/00365548.2010.526957; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; SYRJANEN KJ, 1982, ARCH GESCHWULSTFORSC, V52, P283; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721; Tornesello ML, 2009, J CLIN VIROL, V45, P28, DOI 10.1016/j.jcv.2009.02.004; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	28	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46538	10.1371/journal.pone.0046538	http://dx.doi.org/10.1371/journal.pone.0046538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077513	gold, Green Published, Green Submitted			2022-12-25	WOS:000309809500016
J	Keller, SS; Schoene-Bake, JC; Gerdes, JS; Weber, B; Deppe, M				Keller, Simon S.; Schoene-Bake, Jan-Christoph; Gerdes, Jan S.; Weber, Bernd; Deppe, Michael			Concomitant Fractional Anisotropy and Volumetric Abnormalities in Temporal Lobe Epilepsy: Cross-Sectional Evidence for Progressive Neurologic Injury	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; VOXEL-BASED MORPHOMETRY; HIPPOCAMPAL SCLEROSIS; WHITE-MATTER; FEBRILE SEIZURES; PARAHIPPOCAMPAL REGION; AUTOMATED SEGMENTATION; DIFFUSION ANISOTROPY; HUNTINGTONS-DISEASE; THALAMIC DIFFUSION	Background: In patients with temporal lobe epilepsy and associated hippocampal sclerosis (TLEhs) there are brain abnormalities extending beyond the presumed epileptogenic zone as revealed separately in conventional magnetic resonance imaging (MRI) and MR diffusion tensor imaging (DTI) studies. However, little is known about the relation between macroscopic atrophy (revealed by volumetric MRI) and microstructural degeneration (inferred by DTI). Methodology/Principal Findings: For 62 patients with unilateral TLEhs and 68 healthy controls, we determined volumes and mean fractional anisotropy (FA) of ipsilateral and contralateral brain structures from T1-weighted and DTI data, respectively. We report significant volume atrophy and FA alterations of temporal lobe, subcortical and callosal regions, which were more diffuse and bilateral in patients with left TLEhs relative to right TLEhs. We observed significant relationships between volume loss and mean FA, particularly of the thalamus and putamen bilaterally. When corrected for age, duration of epilepsy was significantly correlated with FA loss of an anatomically plausible route - including ipsilateral parahippocampal gyrus and temporal lobe white matter, the thalamus bilaterally, and posterior regions of the corpus callosum that contain temporal lobe fibres - that may be suggestive of progressive brain degeneration in response to recurrent seizures. Conclusions/Significance: Chronic TLEhs is associated with interrelated DTI-derived and volume-derived brain degenerative abnormalities that are influenced by the duration of the disorder and the side of seizure onset. This work confirms previously contradictory findings by employing multi-modal imaging techniques in parallel in a large sample of patients.	[Keller, Simon S.; Gerdes, Jan S.; Deppe, Michael] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Keller, Simon S.] Kings Coll London, Inst Psychiat, Dept Clin Neurosci, London WC2R 2LS, England; [Schoene-Bake, Jan-Christoph; Weber, Bernd] Univ Bonn, Dept Epileptol, Bonn, Germany; [Schoene-Bake, Jan-Christoph; Weber, Bernd] Life & Brain Res Ctr, Dept NeuroCognit Imaging, Bonn, Germany	University of Munster; University of London; King's College London; University of Bonn; University of Bonn	Deppe, M (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	deppe@uni-muenster.de	Weber, Bernd/H-5244-2012; Deppe, Michael/C-5780-2017	Weber, Bernd/0000-0002-7811-9605; Deppe, Michael/0000-0002-8372-9678; Keller, Simon/0000-0001-5247-9795	Transregional Collaborative Research Centre [SFB/TR 3]; Deutsche Forschungsgemeinschaft (DFG)	Transregional Collaborative Research Centre; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Transregional Collaborative Research Centre SFB/TR 3 (Project A8) of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi ME, 2009, AM J NEURORADIOL, V30, P1740, DOI 10.3174/ajnr.A1650; Aikia M, 2001, EPILEPSY BEHAV, V2, P20, DOI 10.1006/ebeh.2000.0140; Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Assaf BA, 2003, AM J NEURORADIOL, V24, P1857; Awasthi R, 2010, AM J NEURORADIOL, V31, P442, DOI 10.3174/ajnr.A1849; Baker GA, 2011, EPILEPSIA, V52, P1084, DOI 10.1111/j.1528-1167.2011.03043.x; Barr WB, 1997, J NEUROL NEUROSUR PS, V63, P461, DOI 10.1136/jnnp.63.4.461; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bernasconi N, 2004, NEUROIMAGE, V23, P717, DOI 10.1016/j.neuroimage.2004.06.015; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Bernasconi N, 2000, ANN NY ACAD SCI, V911, P495; Bernhardt BC, 2009, NEUROLOGY, V72, P1747, DOI 10.1212/01.wnl.0000345969.57574.f5; Bonilha L, 2007, J NEUROL NEUROSUR PS, V78, P286, DOI 10.1136/jnnp.2006.103994; Bonilha L, 2011, ACTA NEUROL SCAND; Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038; Cendes F, 2005, CURR OPIN NEUROL, V18, P173, DOI 10.1097/01.wco.0000162860.49842.90; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; CORBALLIS MC, 1978, BEHAV BRAIN SCI, V1, P261, DOI 10.1017/S0140525X00074471; DeCarli C, 1998, ANN NEUROL, V43, P41, DOI 10.1002/ana.410430110; Deppe M, 2008, NEUROLOGY, V71, P1981, DOI 10.1212/01.wnl.0000336969.98241.17; Deppe M, 2007, INVEST RADIOL, V42, P338, DOI 10.1097/01.rli.0000261935.41188.39; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; DODRILL CB, 1992, EPILEPSIA, V33, P327, DOI 10.1111/j.1528-1157.1992.tb02323.x; Douaud G, 2009, NEUROIMAGE, V46, P958, DOI 10.1016/j.neuroimage.2009.03.044; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Dreifuss S, 2001, NEUROLOGY, V57, P1636, DOI 10.1212/WNL.57.9.1636; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fluegel D, 2006, EPILEPSIA, V47, P941, DOI 10.1111/j.1528-1167.2006.00527.x; Focke NK, 2008, NEUROIMAGE, V40, P728, DOI 10.1016/j.neuroimage.2007.12.031; Fuerst D, 2003, ANN NEUROL, V53, P413, DOI 10.1002/ana.10509; Fuerst D, 2001, NEUROLOGY, V57, P184, DOI 10.1212/WNL.57.2.184; Gerdes JS, 2012, SEIZURE; Gong G, 2008, EPILEPSY RES, V80, P184, DOI 10.1016/j.eplepsyres.2008.04.002; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Hennessy MJ, 1999, NEUROLOGY, V53, P1276, DOI 10.1212/WNL.53.6.1276; Henry TR, 2011, RADIOLOGY, V261, P199, DOI 10.1148/radiol.11101651; Hermann BP, 2002, PROG BRAIN RES, V135, P429; Holmes MD, 1998, EPILEPSIA, V39, P1189, DOI 10.1111/j.1528-1157.1998.tb01310.x; Holtkamp M, 2004, J NEUROL, V251, P458, DOI 10.1007/s00415-004-0356-9; Janszky J, 2003, NEUROLOGY, V60, P1209, DOI 10.1212/01.WNL.0000052823.29467.A0; Jokeit H, 1999, J NEUROL NEUROSUR PS, V67, P44, DOI 10.1136/jnnp.67.1.44; Jutila L, 2001, AM J NEURORADIOL, V22, P1490; Keller SS, 2011, EPILEPSIA, V52, P1715, DOI 10.1111/j.1528-1167.2011.03117.x; Keller SS, 2008, EPILEPSIA, V49, P741, DOI 10.1111/j.1528-1167.2007.01485.x; Keller SS, 2002, J NEUROL NEUROSUR PS, V73, P648, DOI 10.1136/jnnp.73.6.648; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Keller SS, 2012, J NEUROIMAG IN PRESS; Keller SS, 2012, NEUROINFORM IN PRESS; Keller SS, 2011, J NEUROIMAGING; Keller SS, 2011, EPILEPSIA IN PRESS; Kemmotsu N, 2011, EPILEPSIA; Kent GP, 2006, EPILEPSY BEHAV, V9, P469, DOI 10.1016/j.yebeh.2006.07.005; Kim CH, 2010, EPILEPSY RES, V90, P21, DOI 10.1016/j.eplepsyres.2010.03.002; Kimiwada T, 2006, EPILEPSIA, V47, P167, DOI 10.1111/j.1528-1167.2006.00383.x; Kloppel S, 2008, BRAIN, V131, P196, DOI 10.1093/brain/awm275; KUKS JBM, 1993, LANCET, V342, P1391; Lee JW, 1998, EPILEPSIA, V39, P727, DOI 10.1111/j.1528-1157.1998.tb01158.x; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Liu RSN, 2005, EPILEPSIA, V46, P1482, DOI 10.1111/j.1528-1167.2005.51603.x; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; Ma XY, 2004, MAGN RESON MED, V51, P423, DOI 10.1002/mrm.10703; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; Meng L, 2010, MAGN RESON IMAGING, V28, P1290, DOI 10.1016/j.mri.2010.03.046; Mohammadi S, 2012, PLOS ONE IN PRESS; Moran NF, 2001, BRAIN, V124, P167, DOI 10.1093/brain/124.1.167; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mullaart RA, 1995, PEDIATR NEUROL, V13, P319, DOI 10.1016/0887-8994(95)00193-X; Natsume J, 2003, NEUROLOGY, V60, P1296, DOI 10.1212/01.WNL.0000058764.34968.C2; Oyegbile TO, 2004, NEUROLOGY, V62, P1736, DOI 10.1212/01.WNL.0000125186.04867.34; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Pfefferbaum A, 2010, NEUROBIOL AGING, V31, P482, DOI 10.1016/j.neurobiolaging.2008.04.013; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Salmenpera TM, 2006, EPILEPSY RES, V71, P102, DOI 10.1016/j.eplepsyres.2006.05.020; Schmidt MH, 2011, EPILEPSIA, V52, P49, DOI 10.1111/j.1528-1167.2011.03154.x; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Tudesco IDS, 2010, EPILEPSY BEHAV, V18, P223, DOI 10.1016/j.yebeh.2010.04.021; Theodore WH, 2002, PROG BRAIN RES, V135, P305; Thivard L, 2005, NEUROIMAGE, V28, P682, DOI 10.1016/j.neuroimage.2005.06.045; Tinuper P, 1996, EPILEPSIA, V37, P162, DOI 10.1111/j.1528-1157.1996.tb00007.x; Van Paesschen W, 1998, EPILEPSIA, V39, P633; Yang TH, 2012, EPILEPSY RES, V99, P267, DOI 10.1016/j.eplepsyres.2011.12.006	85	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46791	10.1371/journal.pone.0046791	http://dx.doi.org/10.1371/journal.pone.0046791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071638	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700031
J	Tattersall, J; Rao, GV; Runac, J; Hackstadt, T; Grieshaber, SS; Grieshaber, NA				Tattersall, Jeremiah; Rao, Geeta Vittal; Runac, Justin; Hackstadt, Ted; Grieshaber, Scott S.; Grieshaber, Nicole A.			Translation Inhibition of the Developmental Cycle Protein HctA by the Small RNA IhtA Is Conserved across Chlamydia	PLOS ONE			English	Article							HISTONE-LIKE PROTEIN; TRACHOMATIS; HC1; DNA; EXPRESSION; TRANSCRIPTION; PURIFICATION; INFECTIONS; REPRESSION; PREDICTION	The developmental cycle of the obligate intracellular pathogen Chlamydia trachomatis serovar L2 is controlled in part by the small non-coding RNA (sRNA), IhtA. All Chlamydia alternate in a regulated fashion between the infectious elementary body (EB) and the replicative reticulate body (RB) which asynchronously re-differentiates back to the terminal EB form at the end of the cycle. The histone like protein HctA is central to RB:EB differentiation late in the cycle as it binds to and occludes the genome, thereby repressing transcription and translation. The sRNA IhtA is a critical component of this regulatory loop as it represses translation of hctA until late in infection at which point IhtA transcription decreases, allowing HctA expression to occur and RB to EB differentiation to proceed. It has been reported that IhtA is expressed during infection by the human pathogens C. trachomatis serovars L2, D and L2b and C. pneumoniae. We show in this work that IhtA is also expressed by the animal pathogens C. caviae and C. muridarum. Expression of HctA in E. coli is lethal and co-expression of IhtA relieves this phenotype. To determine if regulation of HctA by IhtA is a conserved mechanism across pathogenic chlamydial species, we cloned hctA and ihtA from C. trachomatis serovar D, C. muridarum, C. caviae and C. pneumoniae and assayed for rescue of growth repression in E. coli co-expression studies. In each case, co-expression of ihtA with the cognate hctA resulted in relief of growth repression. In addition, expression of each chlamydial species IhtA rescued the lethal phenotype of C. trachomatis serovar L2 HctA expression. As biolayer interferometry studies indicate that IhtA interacts directly with hctA message for all species tested, we predict that conserved sequences of IhtA are necessary for function and/or binding.	[Tattersall, Jeremiah; Rao, Geeta Vittal; Runac, Justin; Grieshaber, Scott S.; Grieshaber, Nicole A.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Hackstadt, Ted] NIAID, Host Parasite Interact Sect, Intracellular Parasites Lab, NIH,Rocky Mt Labs, Hamilton, MT USA	State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Grieshaber, NA (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	ngriesha@ufl.edu		Hackstadt, Ted/0000-0003-1367-5528	National Institutes of Health grant [AI079193]; University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079193, ZIAAI000567] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Open-Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant AI079193 to NAG. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Altuvia S, 2004, J BACTERIOL, V186, P6679, DOI 10.1128/JB.186.20.6679-6680.2004; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; BARRY CE, 1992, SCIENCE, V256, P377, DOI 10.1126/science.256.5055.377; BARRY CE, 1993, MOL MICROBIOL, V9, P273, DOI 10.1111/j.1365-2958.1993.tb01689.x; BRICKMAN TJ, 1993, J BACTERIOL, V175, P4274, DOI 10.1128/JB.175.14.4274-4281.1993; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; FAHR MJ, 1995, J BACTERIOL, V177, P4252, DOI 10.1128/jb.177.15.4252-4260.1995; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Grieshaber NA, 2004, P NATL ACAD SCI USA, V101, P7451, DOI 10.1073/pnas.0400754101; Grieshaber NA, 2006, J BACTERIOL, V188, P5289, DOI 10.1128/JB.00526-06; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; HACKSTADT T, 1991, P NATL ACAD SCI USA, V88, P3937, DOI 10.1073/pnas.88.9.3937; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Ouellette SP, 2006, MOL MICROBIOL, V62, P1387, DOI 10.1111/j.1365-2958.2006.05465.x; Pedersen LB, 1996, J BACTERIOL, V178, P994, DOI 10.1128/jb.178.4.994-1002.1996; Pedersen LB, 1996, MOL MICROBIOL, V20, P295, DOI 10.1111/j.1365-2958.1996.tb02618.x; PEDERSEN LB, 1994, MOL MICROBIOL, V11, P1085, DOI 10.1111/j.1365-2958.1994.tb00385.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wolf K, 2000, INFECT IMMUN, V68, P2379, DOI 10.1128/IAI.68.4.2379-2385.2000; World Health Organization, 2001, GLOB PREV INC SEL CU; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	37	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47439	10.1371/journal.pone.0047439	http://dx.doi.org/10.1371/journal.pone.0047439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071807	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700080
J	Chen, R; Chung, SH				Chen, Rong; Chung, Shin-Ho			Structural Basis of the Selective Block of Kv1.2 by Maurotoxin from Computer Simulations	PLOS ONE			English	Article							MOLECULAR DYNAMIC SIMULATIONS; POTASSIUM CHANNEL KV1.3; SEA-ANEMONE TOXIN; SCORPION TOXIN; BROWNIAN DYNAMICS; ION-CHANNEL; K+ CHANNELS; AUTOIMMUNE-DISEASES; DOCKING; BINDING	The 34-residue polypeptide maurotoxin (MTx) isolated from scorpion venoms selectively inhibits the current of the voltage-gated potassium channel Kv1.2 by occluding the ion conduction pathway. Here using molecular dynamics simulation as a docking method, the binding modes of MTx to three closely related channels (Kv1.1, Kv1.2 and Kv1.3) are examined. We show that MTx forms more favorable electrostatic interactions with the outer vestibule of Kv1.2 compared to Kv1.1 and Kv1.3, consistent with the selectivity of MTx for Kv1.2 over Kv1.1 and Kv1.3 observed experimentally. One salt bridge in the bound complex of MTx-Kv1.2 forms and breaks in a simulation period of 20 ns, suggesting the dynamic nature of toxin-channel interactions. The toxin selectivity likely arises from the differences in the shape of the channel outer vestibule, giving rise to distinct orientations of MTx on block. Potential of mean force calculations show that MTx blocks Kv1.1, Kv1.2 and Kv1.3 with an IC50 value of 6 mu M, 0.6 nM and 18 mu M, respectively.	[Chen, Rong; Chung, Shin-Ho] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Chen, R (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	rong.chen@anu.edu.au; shin-ho.chung@anu.edu.au	Chung, Shin-Ho/A-5057-2010		National Health and Medical Research Council of Australia; Australian Commonwealth Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Commonwealth Government(Australian Government)	This work was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was undertaken on the NCI National Facility in Canberra, Australia, which is supported by the Australian Commonwealth Government.	Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; Avdonin V, 2000, BIOPHYS J, V79, P776, DOI 10.1016/S0006-3495(00)76335-1; Blanc E, 1997, PROTEINS, V29, P321, DOI 10.1002/(SICI)1097-0134(199711)29:3&lt;321::AID-PROT6&gt;3.0.CO;2-D; Carlier E, 2000, J PEPT RES, V55, P419, DOI 10.1034/j.1399-3011.2000.00715.x; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chen PC, 2012, TOXINS, V4, P110, DOI 10.3390/toxins4020110; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2012, BIOCHEMISTRY-US, V51, P1976, DOI 10.1021/bi201811j; Chen R, 2011, BIOPHYS J, V101, P2652, DOI 10.1016/j.bpj.2011.10.029; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cui M, 2001, BIOPHYS J, V80, P1659, DOI 10.1016/S0006-3495(01)76138-3; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Fajloun Z, 2011, J PEPT SCI, V17, P200, DOI 10.1002/psc.1313; Fu W, 2002, BIOPHYS J, V83, P2370, DOI 10.1016/S0006-3495(02)75251-X; Gordon D, 2012, J PHYS CHEM B, V116, P1933, DOI 10.1021/jp210105f; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Hansson T, 1998, J COMPUT AID MOL DES, V12, P27, DOI 10.1023/A:1007930623000; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Jin L, 2011, J MOL RECOGNIT, V24, P101, DOI 10.1002/jmr.1031; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Khabiri M, 2011, J PHYS CHEM B, V115, P11490, DOI 10.1021/jp2061909; Kharrat R, 1996, EUR J BIOCHEM, V242, P491, DOI 10.1111/j.1432-1033.1996.0491r.x; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Lecomte C, 2000, J PEPT RES, V55, P246, DOI 10.1034/j.1399-3011.2000.00170.x; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Visan V, 2004, MOL PHARMACOL, V66, P1103, DOI 10.1124/mol.104.002774; Visan V, 2004, TOXICON, V43, P973, DOI 10.1016/j.toxicon.2003.12.011; Yi H, 2008, PROTEINS, V70, P844, DOI 10.1002/prot.21706; Yi H, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11; Yu KQ, 2004, BIOPHYS J, V86, P3542, DOI 10.1529/biophysj.103.039461; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	50	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47253	10.1371/journal.pone.0047253	http://dx.doi.org/10.1371/journal.pone.0047253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071772	gold, Green Published			2022-12-25	WOS:000312385200096
J	Chung, SD; Lai, TY; Chien, CT; Yu, HJ				Chung, Shue Dong; Lai, Ting Yu; Chien, Chiang Ting; Yu, Hong Jen			Activating Nrf-2 Signaling Depresses Unilateral Ureteral Obstruction-Evoked Mitochondrial Stress-Related Autophagy, Apoptosis and Pyroptosis in Kidney	PLOS ONE			English	Article							INDUCED DIABETIC-NEPHROPATHY; CONTROLS CELLULAR APOPTOSIS; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; TUBULOINTERSTITIAL FIBROSIS; DEFENSE PATHWAY; RENAL INJURY; BCL-XL; RAT; ISCHEMIA/REPERFUSION	Exacerbated oxidative stress and inflammation may induce three types of programmed cell death, autophagy, apoptosis and pyroptosis in unilateral ureteral obstruction (UUO) kidney. Sulforaphane activating NF-E2-related nuclear factor erythroid-2 (Nrf-2) signaling may ameliorate UUO-induced renal damage. UUO was induced in the left kidney of female Wistar rats. The level of renal blood flow, cortical and medullary oxygen tension and reactive oxygen species (ROS) was evaluated. Fibrosis, ED-1 (macrophage/monocyte) infiltration, oxidative stress, autophagy, apoptosis and pyroptosis were evaluated by immunohistochemistry and Western blot in UUO kidneys. Effects of sulforaphane, an Nrf-2 activator, on Nrf-2- and mitochondrial stress-related proteins and renal injury were examined. UUO decreased renal blood flow and oxygen tension and increased renal ROS, 3-nitrotyrosine stain, ED-1 infiltration and fibrosis. Enhanced renal tubular Beclin-1 expression started at 4 h UUO and further enhanced at 3d UUO, whereas increased Atg-5-Atg12 and LC3-II expression were found at 3d UUO. Increased renal Bax/Bcl-2 ratio, caspase 3 and PARP fragments, apoptosis formation associated with increased caspase 1 and IL-1 beta expression for pyroptosis formation were started from 3d UUO. UUO reduced nuclear Nrf-2 translocation, increased cytosolic and inhibitory Nrf-2 expression, increased cytosolic Bax translocation to mitochondrial and enhanced mitochondrial Cytochrome c release into cytosol of the UUO kidneys. Sulforaphane significantly increased nuclear Nrf-2 translocation and decreased mitochondrial Bax translocation and Cytochrome c release into cytosol resulting in decreased renal injury. In conclusion, sulforaphane via activating Nrf-2 signaling preserved mitochondrial function and suppressed UUO-induced renal oxidative stress, inflammation, fibrosis, autophagy, apoptosis and pyroptosis.	[Lai, Ting Yu; Chien, Chiang Ting] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Lai, Ting Yu; Chien, Chiang Ting] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chung, Shue Dong] Far E Memory Hosp, Dept Urol, New Taipei City, Taiwan; [Chung, Shue Dong] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chung, Shue Dong; Yu, Hong Jen] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan Normal University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chien, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan.	ctchien@ntnu.edu.tw; yhj5251@ntu.edu.tw	lai, ting/HGD-7592-2022	YU, HONG-JENG/0000-0003-3287-5736	National Science Council of the Republic of China [NSC 94-3114-P002-002, NSC94-3114-P002-002-Y(8)]; Far-East Memorial Hospital	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Far-East Memorial Hospital	This work was supported in part by the National Science Council of the Republic of China (NSC 94-3114-P002-002, and NSC94-3114-P002-002-Y(8)) and research funding from the Far-East Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Chien CT, 2007, TRANSPLANTATION, V84, P1183, DOI 10.1097/01.tp.0000287334.38933.e3; Chien CT, 2005, AM J TRANSPLANT, V5, P1194, DOI 10.1111/j.1600-6143.2005.00826.x; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fiala JLA, 2011, TOXICOL SCI, V121, P57, DOI 10.1093/toxsci/kfr026; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Ha JH, 2012, CELL BIOL TOXICOL, V28, P19, DOI 10.1007/s10565-011-9202-x; Haugen E, 1999, BLOOD PURIFICAT, V17, P58, DOI 10.1159/000014377; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Isaka Y, 2009, TRANSPL P, V41, P52, DOI 10.1016/j.transproceed.2008.10.026; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Mazzei LJ, 2012, AM J NEPHROL, V35, P103, DOI 10.1159/000334935; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kathiria AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031231; KIVIRIKKO KI, 1963, ACTA PHYSIOL SCAND, V57, P462; Lee SY, 2004, TRANSPLANTATION, V78, P1756, DOI 10.1097/01.TP.0000144332.44435.AB; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu M, 2009, KIDNEY INT, V76, P277, DOI 10.1038/ki.2009.157; Mao L, 2012, J TRAUMA ACUTE CARE, V72, P189, DOI 10.1097/TA.0b013e31821bf541; Metcalfe PD, 2008, AM J PHYSIOL-ENDOC M, V294, pE435, DOI 10.1152/ajpendo.00704.2006; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Niture SK, 2011, J BIOL CHEM, V286, P44542, DOI 10.1074/jbc.M111.275073; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Pi JB, 2007, FREE RADICAL BIO MED, V42, P1797, DOI 10.1016/j.freeradbiomed.2007.03.001; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Qian HR, 2011, EUR J PHARM SCI, V43, P125, DOI 10.1016/j.ejps.2011.04.002; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Tosi MER, 2011, CELL STRESS CHAPERON, V16, P57, DOI 10.1007/s12192-010-0221-y; Sakai T, 1997, J UROLOGY, V158, P2316, DOI 10.1016/S0022-5347(01)68242-9; Stepkowski TM, 2011, FREE RADICAL BIO MED, V50, P1186, DOI 10.1016/j.freeradbiomed.2011.01.033; Whitehouse T, 2006, AM J PHYSIOL-RENAL, V291, pF647, DOI 10.1152/ajprenal.00475.2005; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Yeh CH, 2011, NEUROUROL URODYNAM, V30, P472, DOI 10.1002/nau.20855; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	44	101	106	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47299	10.1371/journal.pone.0047299	http://dx.doi.org/10.1371/journal.pone.0047299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071780	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200102
J	Joosen, IA; Schiphof, F; Versteylen, MO; Laufer, EM; Winkens, MH; Nelemans, PJ; Kooman, JP; Hofstra, L; Wildberger, JE; Leiner, T				Joosen, Ivo A.; Schiphof, Frank; Versteylen, Mathijs O.; Laufer, Eduard M.; Winkens, Mark H.; Nelemans, Patricia J.; Kooman, Jeroen P.; Hofstra, Leonard; Wildberger, Joachim E.; Leiner, Tim			Relation between Mild to Moderate Chronic Kidney Disease and Coronary Artery Disease Determined with Coronary CT Angiography	PLOS ONE			English	Article							RISK; CALCIFICATION; DYSFUNCTION; CALCIUM; ASSOCIATION; PREVALENCE; OUTCOMES	Background: Both end-stage and milder stages of chronic kidney disease (CKD) are associated with an increased risk of adverse cardiovascular events. Several studies found an association between decreasing renal function and increasing coronary artery calcification, but it remains unclear if this association is independent from traditional cardiovascular risk factors. Therefore, the aim of this study was to investigate whether mild to moderate CKD is independently associated with coronary plaque burden beyond traditional cardiovascular risk factors. Methods: A total of 2,038 patients with symptoms of chest discomfort suspected for coronary artery disease underwent coronary CT-angiography. We assessed traditional risk factors, coronary calcium score and coronary plaque characteristics (morphology and degree of luminal stenosis). Patients were subdivided in three groups, based on their estimated glomerular filtration rate (eGFR) Normal renal function (eGFR >= 90 mL/min/1.73 m(2)); mild CKD (eGFR 60-89 mL/min/1.73 m(2)); and moderate CKD (eGFR 30-59 mL/min/1.73 m(2)). Results: Coronary calcium score increased significantly with decreasing renal function (P < 0.001). Coronary plaque prevalence was higher in patients with mild CKD (OR 1.83, 95%CI 1.52-2.21) and moderate CKD (OR 2.46, 95%CI 1.69-3.59), compared to patients with normal renal function (both P < 0.001). Coronary plaques with >70% luminal stenosis were found significantly more often in patients with mild CKD (OR 1.67 (95%CI 1.16-2.40) and moderate CKD (OR2.36, 95%CI 1.35-4.13), compared to patients with normal renal function (both P < 0.01). After adjustment for traditional cardiovascular risk factors, the association between renal function and the presence of any coronary plaque as well as the association between renal function and the presence of coronary plaques with >70% luminal stenosis becomes weaker and were no longer statistically significant. Conclusion: Although decreasing renal function is associated with increasing extent and severity of coronary artery disease, mild to moderately CKD is not independently associated with coronary plaque burden after adjustment for traditional cardiovascular risk factors.	[Joosen, Ivo A.; Versteylen, Mathijs O.; Laufer, Eduard M.; Winkens, Mark H.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands; [Schiphof, Frank; Wildberger, Joachim E.; Leiner, Tim] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Radiol, Maastricht, Netherlands; [Nelemans, Patricia J.] Maastricht Univ, Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [Kooman, Jeroen P.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Hofstra, Leonard] Cardiol Ctr Netherlands, Utrecht, Netherlands; [Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center	Joosen, IA (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands.	ivo.joosen@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Austen W G, 1975, Circulation, V51, P5; Becker BN, 1997, J AM SOC NEPHROL, V8, P475; Borissoff JI, 2012, JACC CARDIO IN PRESS; Bostom AG, 1999, CIRCULATION, V99, P2361, DOI 10.1161/01.CIR.99.18.2361; Budoff MJ, 2011, AM J KIDNEY DIS, V58, P519, DOI 10.1053/j.ajkd.2011.04.024; Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160; Cho I, 2010, ATHEROSCLEROSIS, V208, P406, DOI 10.1016/j.atherosclerosis.2009.08.040; Clase CM, 2011, ANN INTERN MED, V154, P310, DOI 10.7326/0003-4819-154-5-201103010-00005; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Flowers N. T., 2008, Morbidity and Mortality Weekly Report, V57, P309; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Fox CS, 2004, KIDNEY INT, V66, P2017, DOI 10.1111/j.1523-1755.2004.00973.x; Gavin JR, 1999, DIABETES CARE, V22, pS5; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Ix JH, 2008, J AM SOC NEPHROL, V19, P579, DOI 10.1681/ASN.2007070765; Kasiske BL, 1998, AM J KIDNEY DIS, V32, pS142, DOI 10.1053/ajkd.1998.v32.pm9820472; Kono K, 2011, THER APHER DIAL, V15, P44, DOI 10.1111/j.1744-9987.2010.00855.x; Kramer H, 2005, J AM SOC NEPHROL, V16, P507, DOI 10.1681/ASN.2004070610; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luft FC, 2000, BASIC RES CARDIOL, V95, P72; McCullough Peter A, 2002, Rev Cardiovasc Med, V3, P71; Morita H, 2012, INT J CARDIOL, V158, P272, DOI 10.1016/j.ijcard.2011.02.052; Ogita M, 2009, J CARDIOL, V54, P59, DOI 10.1016/j.jjcc.2009.03.008; Parikh NI, 2008, AM J CARDIOL, V102, P440, DOI 10.1016/j.amjcard.2008.04.007; RABELINK TJ, 1994, KIDNEY INT, V46, P287, DOI 10.1038/ki.1994.274; Raff Gilbert L, 2009, J Cardiovasc Comput Tomogr, V3, P122, DOI 10.1016/j.jcct.2009.01.001; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roy SK, 2011, VASC HEALTH RISK MAN, V7, P719, DOI 10.2147/VHRM.S24536; Venkatesan J, 1997, SEMIN NEPHROL, V17, P257	34	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47267	10.1371/journal.pone.0047267	http://dx.doi.org/10.1371/journal.pone.0047267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071773	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200097
J	Pena-Diaz, P; Pelosi, L; Ebikeme, C; Colasante, C; Gao, F; Bringaud, F; Voncken, F				Pena-Diaz, Priscila; Pelosi, Ludovic; Ebikeme, Charles; Colasante, Claudia; Gao, Fei; Bringaud, Frederic; Voncken, Frank			Functional Characterization of TbMCP5, a Conserved and Essential ADP/ATP Carrier Present in the Mitochondrion of the Human Pathogen Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE LEVEL PHOSPHORYLATION; SUCCINATE COA-TRANSFERASE; BLOOD-STREAM; INDUCIBLE EXPRESSION; ENERGY-METABOLISM; PROTEIN; PROLINE; ACETATE; GENE; TRANSPORT	Trypanosoma brucei is a kinetoplastid parasite of medical and veterinary importance. Its digenetic life cycle alternates between the bloodstream form in the mammalian host and the procyclic form (PCF) in the bloodsucking insect vector, the tsetse fly. PCF trypanosomes rely in the glucose-depleted environment of the insect vector primarily on the mitochondrial oxidative phosphorylation of proline for their cellular ATP provision. We previously identified two T. brucei mitochondrial carrier family proteins, TbMCP5 and TbMCP15, with significant sequence similarity to functionally characterized ADP/ATP carriers from other eukaryotes. Comprehensive sequence analysis confirmed that TbMCP5 contains canonical ADP/ATP carrier sequence features, whereas they are not conserved in TbMCP15. Heterologous expression in the ANC-deficient yeast strain JL1 Delta 2 Delta 3u(-) revealed that only TbMCP5 was able to restore its growth on the non-fermentable carbon source lactate. Transport studies in yeast mitochondria showed that TbMCP5 has biochemical properties and ADP/ATP exchange kinetics similar to those of Anc2p, the prototypical ADP/ATP carrier of S. cerevisiae. Immunofluorescence microscopy and Western blot analysis confirmed that TbMCP5 is exclusively mitochondrial and is differentially expressed with 4.5-fold more TbMCP5 in the procyclic form of the parasite. Silencing of TbMCP5 expression in PCF T. brucei revealed that this ADP/ATP carrier is essential for parasite growth, particularly when depending on proline for energy generation. Moreover, ADP/ATP exchange in isolated T. brucei mitochondria was eliminated upon TbMCP5 depletion. These results confirmed that TbMCP5 functions as the main ADP/ATP carrier in the trypanosome mitochondrion. The important role of TbMCP5 in the T. brucei energy metabolism is further discussed.	[Pena-Diaz, Priscila; Gao, Fei; Voncken, Frank] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Pena-Diaz, Priscila; Gao, Fei; Voncken, Frank] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Pelosi, Ludovic] Univ Grenoble 1, Lab Biol Grande Echelle, iRTSV CEA Grenoble, Equipe Dynam Organelles & Plasticite Cellulaire, F-38054 Grenoble 9, France; [Ebikeme, Charles; Bringaud, Frederic] Univ Bordeaux Segalen, Ctr Resonance Magnet Syst Biol, CNRS UMR 5536, F-33076 Bordeaux, France; [Colasante, Claudia] Univ Giessen, Inst Anat & Zellbiol 2, D-35385 Giessen, Germany	University of Hull; University of Hull; University of York - UK; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Justus Liebig University Giessen	Voncken, F (corresponding author), Univ Hull, Dept Biol Sci, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.	F.Voncken@hull.ac.uk	Colasante, Claudia/AAO-1230-2021; Pelosi, Ludovic/M-6406-2014; Pelosi, Ludovic/AAB-9832-2020; Peña-Diaz, Priscila/AAI-1209-2020; Pena-Diaz, Priscila/G-9503-2014	Pelosi, Ludovic/0000-0002-4198-5681; Peña-Diaz, Priscila/0000-0002-9428-6737; Ebikeme, Charles/0000-0002-9989-6489; Voncken, Frank/0000-0002-2929-276X; Colasante, Claudia/0000-0002-5760-4919	BBSRC [BB/G00448X/1]; University Joseph Fourier; CNRS [ANR-MIME2007, ANR-BLANC-2010]; Commissariat a l'Energie Atomique et aux Energies Alternatives (programme Signalisation et Transport Membranaire); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine; Agence Nationale de la Recherche (ANR) programs; Biotechnology and Biological Sciences Research Council [BB/G00448X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University Joseph Fourier; CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique et aux Energies Alternatives (programme Signalisation et Transport Membranaire); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche (ANR) programs(French National Research Agency (ANR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC Grant BB/G00448X/1 (to F. V.); by grants from the University Joseph Fourier, CNRS, and the Commissariat a l'Energie Atomique et aux Energies Alternatives (programme Signalisation et Transport Membranaire) (to L. P.); and by grants METABOTRYP of the ANR-MIME2007 call and ACETOTRYP of the ANR-BLANC-2010 call from CNRS, the Universite Bordeaux Segalen, the Conseil Regional d'Aquitaine, and the Agence Nationale de la Recherche (ANR) programs (to F. B.).	ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626; Allemann N, 2000, MOL BIOCHEM PARASIT, V111, P87, DOI 10.1016/S0166-6851(00)00303-0; Babot M, 2012, J BIOL CHEM, V287, P10368, DOI 10.1074/jbc.M111.320697; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bellofatto Vivian, 2008, V442, P83, DOI 10.1007/978-1-59745-191-8_7; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; BLOCK MR, 1982, BIOCHEMISTRY-US, V21, P5451, DOI 10.1021/bi00265a011; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BOULAY F, 1983, ANAL BIOCHEM, V128, P323, DOI 10.1016/0003-2697(83)90382-2; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; Bringaud F, 1995, MOL BIOCHEM PARASIT, V74, P119, DOI 10.1016/0166-6851(95)02486-7; Bringaud F, 2010, PARASITOLOGY, V137, P1315, DOI 10.1017/S0031182009991843; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; Brown SV, 2006, EUKARYOT CELL, V5, P45, DOI 10.1128/EC.5.1.45-53.2006; BRUN R, 1979, ACTA TROP, V36, P289; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Clayton CE, 1999, PARASITOL TODAY, V15, P372, DOI 10.1016/S0169-4758(99)01498-2; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; Clemencon B, 2011, J BIOL CHEM, V286, P36119, DOI 10.1074/jbc.M111.277376; Colasante C, 2006, EUKARYOT CELL, V5, P1194, DOI 10.1128/EC.00096-06; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dassa EP, 2005, PROTEIN EXPRES PURIF, V40, P358, DOI 10.1016/j.pep.2004.12.019; DAUM G, 1982, J BIOL CHEM, V257, P3028; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Gualdron-Lopez M, 2012, INT J PARASITOL, V42, P1, DOI 10.1016/j.ijpara.2011.10.007; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Millerioux Y, 2012, J BIOL CHEM, V287, P17186, DOI 10.1074/jbc.M112.355404; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Roux P, 1996, ANAL BIOCHEM, V234, P31, DOI 10.1006/abio.1996.0046; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider Andre, 2007, Methods Mol Biol, V372, P379, DOI 10.1007/978-1-59745-365-3_27; Trezeguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; van Wilpe S, 1999, EUR J BIOCHEM, V264, P825, DOI 10.1046/j.1432-1327.1999.00673.x; Vassella E, 1997, MOL BIOCHEM PARASIT, V90, P381, DOI 10.1016/S0166-6851(97)00171-0; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	58	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41861	41874		10.1074/jbc.M112.404699	http://dx.doi.org/10.1074/jbc.M112.404699			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074217	Green Published, hybrid			2022-12-25	WOS:000312103000027
J	Du, YR; Liu, B; Guo, F; Xu, GF; Ding, YQ; Liu, Y; Sun, X; Xu, GL				Du, Yarui; Liu, Bo; Guo, Fan; Xu, Guifang; Ding, Yuqiang; Liu, Yong; Sun, Xin; Xu, Guoliang			The Essential Role of Mbd5 in the Regulation of Somatic Growth and Glucose Homeostasis in Mice	PLOS ONE			English	Article							CPG-BINDING DOMAIN; DNA METHYLATION; FACTOR I; HORMONE; INSULIN; GENE; PROTEINS; RECEPTOR; COMPLEX; TRANSCRIPTION	Methyl-CpG binding domain protein 5 (MBD5) belongs to the MBD family proteins, which play central roles in transcriptional regulation and development. The significance of MBD5 function is highlighted by recent studies implicating it as a candidate gene involved in human 2q23.1 microdeletion syndrome. To investigate the physiological role of Mbd5, we generated knockout mice. The Mbd5-deficient mice showed growth retardation, wasting and pre-weaning lethality. The observed growth retardation was associated with the impairment of GH/IGF-1 axis in Mbd5-null pups. Conditional knockout of Mbd5 in the brain resulted in the similar phenotypes as whole body deletion, indicating that Mbd5 functions in the nervous system to regulate postnatal growth. Moreover, the mutant mice also displayed enhanced glucose tolerance and elevated insulin sensitivity as a result of increased insulin signaling, ultimately resulting in disturbed glucose homeostasis and hypoglycemia. These results indicate Mbd5 as an essential factor for mouse postnatal growth and maintenance of glucose homeostasis.	[Du, Yarui; Liu, Bo; Guo, Fan; Xu, Guifang; Xu, Guoliang] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ding, Yuqiang] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China; [Liu, Yong] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sun, Xin] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison	Xu, GL (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	glxu@sibs.ac.cn	Guo, Fan/J-1857-2019; Guo, Fan/AAX-4952-2021; Liu, Bo/AAU-9183-2020	Guo, Fan/0000-0002-0165-073X; Ding, Yu-Qiang/0000-0003-1202-4635	Ministry of Science and Technology China [2007CB947503, 2009CB941101]; National Science Foundation of China [30730059, 31028012, 31000641]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology China (2007CB947503 and 2009CB941101), and National Science Foundation of China (30730059 to G. X., 31028012 to X. S. and 31000641 to Y.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Chung BHY, 2011, AM J MED GENET A, V155A, P424, DOI 10.1002/ajmg.a.33821; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fan GP, 2005, CELL RES, V15, P255, DOI 10.1038/sj.cr.7290294; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Grosso S, 2008, EPILEPSY RES, V79, P63, DOI 10.1016/j.eplepsyres.2007.12.011; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jaillard S, 2009, J MED GENET, V46, P847, DOI 10.1136/jmg.2008.058156; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; KAUFMAN HE, 1954, SCIENCE, V120, P723, DOI 10.1126/science.120.3122.723; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liu JL, 1999, ENDOCRINOLOGY, V140, P5178, DOI 10.1210/en.140.11.5178; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; Ooi GT, 1997, MOL ENDOCRINOL, V11, P997, DOI 10.1210/me.11.7.997; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van Bon BWM, 2010, EUR J HUM GENET, V18, P163, DOI 10.1038/ejhg.2009.152; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Walenkamp MJE, 2007, EUR J ENDOCRINOL, V156, P155, DOI 10.1530/eje.1.02327; Williams SR, 2010, EUR J HUM GENET, V18, P436, DOI 10.1038/ejhg.2009.199; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	38	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47358	10.1371/journal.pone.0047358	http://dx.doi.org/10.1371/journal.pone.0047358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077600	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100099
J	Incalzi, RA; Pennazza, G; Scarlata, S; Santonico, M; Petriaggi, M; Chiurco, D; Pedone, C; D'Amico, A				Incalzi, Raffaele Antonelli; Pennazza, Giorgio; Scarlata, Simone; Santonico, Marco; Petriaggi, Massimo; Chiurco, Domenica; Pedone, Claudio; D'Amico, Arnaldo			Reproducibility and Respiratory Function Correlates of Exhaled Breath Fingerprint in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							ELECTRONIC NOSE; LUNG-CANCER; CARBON-MONOXIDE; 6-MINUTE WALK; COPD PATIENTS; NITRIC-OXIDE; STANDARDIZATION; ASTHMA; SCALE; DISCRIMINATION	Background: The electronic nose (e nose) provides distinctive breath fingerprints for selected respiratory diseases. Both reproducibility and respiratory function correlates of breath fingerprint are poorly known. Objectives: To measure reproducibility of breath fingerprints and to assess their correlates among respiratory function indexes in elderly healthy and COPD subjects. Method: 25 subjects (5 COPD patients for each GOLD stage and 5 healthy controls) over 65 years underwent e-nose study through a seven sensor system and respiratory function tests at times 0, 7, and 15 days. Reproducibility of the e nose pattern was computed. The correlation between volatile organic compound (VOC) pattern and respiratory function/clinical parameters was assessed by the Spearman's rho. Measurements and Main Results: VOC patterns were highly reproducible within healthy and GOLD 4 COPD subjects, less among GOLD 1-3 patients. VOC patterns significantly correlated with expiratory flows (Spearman's rho ranging from 0.36 for MEF25% and sensor Co-Buti-TPP, to 0.81 for FEV1% and sensor Cu-Buti-TPP p<0.001)), but not with residual volume and total lung capacity. Conclusions: VOC patterns strictly correlated with expiratory flows. Thus, e nose might conveniently be used to assess COPD severity and, likely, to study phenotypic variability. However, the suboptimal reproducibility within GOLD 1-3 patients should stimulate further research to identify more reproducible breath print patterns.	[Incalzi, Raffaele Antonelli; Scarlata, Simone; Chiurco, Domenica; Pedone, Claudio] Campus Biomed Univ, Unit Resp Pathophysiol, Chair Geriatr, Rome, Italy; [Incalzi, Raffaele Antonelli] San Raffaele Cittadella Carita Fdn, Taranto, Italy; [Pennazza, Giorgio; Santonico, Marco; Petriaggi, Massimo] Campus Biomed Univ, Unit Elect Sensor Syst, CIR, Rome, Italy; [Santonico, Marco; D'Amico, Arnaldo] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University of Rome Tor Vergata	Scarlata, S (corresponding author), Campus Biomed Univ, Unit Resp Pathophysiol, Chair Geriatr, Rome, Italy.	s.scarlata@unicampus.it	Pedone, Claudio/F-9488-2010; Scarlata, Simone/G-6490-2010; Santonico, Marco/K-4465-2016	Pedone, Claudio/0000-0003-1847-9032; Scarlata, Simone/0000-0002-2704-2708; Santonico, Marco/0000-0002-3755-6198; Pennazza, Giorgio/0000-0003-4843-9445				Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Bastin A J, 2010, Chron Respir Dis, V7, P91, DOI 10.1177/1479972310364587; Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094, DOI 10.1164/ajrccm.161.4.9810093; Bellia V, 2007, CHEST, V132, P1175, DOI 10.1378/chest.06-2824; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bon JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006865; Boshier PR, 2010, J AM SOC MASS SPECTR, V21, P1070, DOI 10.1016/j.jasms.2010.02.008; Burgel PR, 2011, EUR RESPIR REV, V20, P7, DOI 10.1183/09059180.10010610; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Choi PP, 2004, CAN MED ASSOC J, V170, P1409, DOI 10.1503/cmaj.1030713; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'Amico A, 2010, LUNG CANCER, V68, P170, DOI 10.1016/j.lungcan.2009.11.003; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Di Natale C, 2007, SENSOR ACTUAT B-CHEM, V121, P238, DOI 10.1016/j.snb.2006.09.038; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Fens N, 2009, AM J RESP CRIT CARE, V180, P1076, DOI 10.1164/rccm.200906-0939OC; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Isajevs S, 2011, RESPIRATION, V81, P362, DOI 10.1159/000322560; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Magna G, 2012, LECT NOTES ELECT ENG, P127; Mangan D., 1994, Journal of the American Geriatrics Society, V42, pSA73; MARTIN TR, 1988, J APPL PHYSIOL, V65, P822, DOI 10.1152/jappl.1988.65.2.822; Massart D.L., 1988, CHEMOMETRICS TXB DAT, V2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montuschi P, 2010, CHEST, V137, P790, DOI 10.1378/chest.09-1836; *NIH, 2001, NIH PUBL, V2701; Paredi P, 2000, AM J RESP CRIT CARE, V162, P369, DOI 10.1164/ajrccm.162.2.9909025; Parr David G, 2011, Proc Am Thorac Soc, V8, P338, DOI 10.1513/pats.201101-014RM; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pennazza G, 2011, AIP CONF PROC, V1362, P155, DOI 10.1063/1.3626340; Pennazza G, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/1/017009; Santonico M, 2012, LUNG CANCER, V77, P46, DOI 10.1016/j.lungcan.2011.12.010; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; van Beurden WJC, 2002, RESPIRATION, V69, P211, DOI 10.1159/000063622; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Williamson PA, 2011, LUNG, V189, P121, DOI 10.1007/s00408-010-9275-y; WILSON RC, 1989, CLIN SCI, V76, P277, DOI 10.1042/cs0760277; Zavorsky GS, 2004, CHEST, V125, P1019, DOI 10.1378/chest.125.3.1019; 1983, B EUR PHYSIOPATHO S5, V19, P1	44	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45396	10.1371/journal.pone.0045396	http://dx.doi.org/10.1371/journal.pone.0045396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077492	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100017
J	Lambertsen, KL; Gramsbergen, JB; Sivasaravanaparan, M; Ditzel, N; Sevelsted-Moller, LM; Olivan-Viguera, A; Rabjerg, M; Wulff, H; Kohler, R				Lambertsen, Kate Lykke; Gramsbergen, Jan Bert; Sivasaravanaparan, Mithula; Ditzel, Nicholas; Sevelsted-Moller, Linda Maria; Olivan-Viguera, Aida; Rabjerg, Maj; Wulff, Heike; Kohler, Ralf			Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels	PLOS ONE			English	Article							CA2+-ACTIVATED K+-CHANNEL; ACTIVATED POTASSIUM CHANNELS; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; INTERMEDIATE-CONDUCTANCE; BLOOD-PRESSURE; DEFICIENT MICE; BRAIN; DOPAMINE; SK3	Background: The calmodulin/calcium-activated K+ channel KCa3.1 is expressed in red and white blood cells, epithelia and endothelia, and possibly central and peripheral neurons. However, our knowledge about its contribution to neurological functions and behavior is incomplete. Here, we investigated whether genetic deficiency or pharmacological activation of KCa3.1 change behavior and cerebral monoamine levels in mice. Methodology/Principal Findings: In the open field test, KCa3.1-deficiency increased horizontal activity, as KCa3.1(-/-) mice travelled longer distances (approximate to 145% of KCa3.1(+/+)) and at higher speed (approximate to 1.5-fold of KCa3.1(+/+)). Working memory in the Y-maze was reduced by KCa3.1-deficiency. Motor coordination on the rotarod and neuromuscular functions were unchanged. In KCa3.1(-/-) mice, HPLC analysis revealed that turn-over rates of serotonin were reduced in frontal cortex, striatum and brain stem, while noradrenalin turn-over rates were increased in the frontal cortex. Dopamine turn-over rates were unaltered. Plasma catecholamine and corticosterone levels were unaltered. Intraperitoneal injections of 10 mg/kg of the KCa3.1/KCa2-activator SKA-31 reduced rearing and turning behavior in KCa3.1(+/+) but not in KCa3.1(-/-) mice, while 30 mg/kg SKA-31 caused strong sedation in 50% of the animals of either genotypes. KCa3.1(-/-) mice were hyperactive (approximate to+60%) in their home cage and SKA-31-administration reduced nocturnal physical activity in KCa3.1(+/+) but not in KCa3.1(-/-) mice. Conclusions/Significance: KCa3.1-deficiency causes locomotor hyperactivity and altered monoamine levels in selected brain regions, suggesting a so far unknown functional link of KCa3.1 channels to behavior and monoaminergic neurotransmission in mice. The tranquilizing effects of low-dose SKA-31 raise the possibility to use KCa3.1/KCa2 channels as novel pharmacological targets for the treatment of neuropsychiatric hyperactivity disorders.	[Sevelsted-Moller, Linda Maria; Rabjerg, Maj; Kohler, Ralf] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Lambertsen, Kate Lykke; Gramsbergen, Jan Bert; Sivasaravanaparan, Mithula] Univ So Demark, Dept Neurobiol Res, Odense, Denmark; [Ditzel, Nicholas] Odense Univ Hosp, KMEB, DK-5000 Odense, Denmark; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Olivan-Viguera, Aida; Kohler, Ralf] Aragon Inst Hlth Sci I CS & ARAID, Zaragoza, Spain	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of California System; University of California Davis	Kohler, R (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	rkohler.iacs@aragon.es	Oliván-Viguera, Aida/I-4260-2015; Lambertsen, Kate L. Lykke/I-8676-2014; wulff, Heike/Z-2056-2019; Oliván-Viguera, Aida/ABG-4048-2020	Oliván-Viguera, Aida/0000-0001-5348-924X; Lambertsen, Kate L. Lykke/0000-0001-9276-4902; Oliván-Viguera, Aida/0000-0001-5348-924X; Rabjerg, Maj/0000-0002-6266-7906; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [KO1899/10/11]; Danish Parkinson Society; Lundbeckfonden; Carlsbergfondet; National Institutes of Health [R21 NS072585]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072585] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Parkinson Society; Lundbeckfonden(Lundbeckfonden); Carlsbergfondet(Carlsberg Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants of the Deutsche Forschungsgemeinschaft (KO1899/10/11 to RK), the Danish Parkinson Society (to JBG), Lundbeckfonden (to KLL and to RK), Carlsbergfondet (to KLL), and the National Institutes of Health (R21 NS072585 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Boettger MK, 2002, BRAIN, V125, P252, DOI 10.1093/brain/awf026; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Chen YJ, 2011, J CEREBR BLOOD F MET, V31, P2363, DOI 10.1038/jcbfm.2011.101; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Fan Xueliang, 2012, Curr Top Behav Neurosci, V9, P273, DOI 10.1007/7854_2011_121; Gramsbergen JB, 2002, BRAIN RES, V935, P47, DOI 10.1016/S0006-8993(02)02451-4; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jacobsen JPR, 2009, NEUROSCIENCE, V163, P73, DOI 10.1016/j.neuroscience.2009.05.062; Jacobsen JPR, 2008, GENES BRAIN BEHAV, V7, P836, DOI 10.1111/j.1601-183X.2008.00416.x; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kohler R, 2000, CIRC RES, V87, P496; Kohler R, 2010, PFLUG ARCH EUR J PHY, V459, P969, DOI 10.1007/s00424-010-0819-z; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Lambertsen KL, 2001, BRAIN RES PROTOC, V7, P175, DOI 10.1016/S1385-299X(01)00062-9; Liang Z, 2011, J PHYSL; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; Neylon CB, 2004, J NEUROCHEM, V90, P1414, DOI 10.1111/j.1471-4159.2004.02593.x; Oades RD, 2002, BEHAV BRAIN RES, V130, P97, DOI 10.1016/S0166-4328(01)00440-5; Russell VA, 2002, BEHAV BRAIN RES, V130, P191, DOI 10.1016/S0166-4328(01)00425-9; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Santiago RM, 2010, PROG NEURO-PSYCHOPH, V34, P1104, DOI 10.1016/j.pnpbp.2010.06.004; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Shakkottai VG, 2011, J NEUROSCI, V31, P13002, DOI 10.1523/JNEUROSCI.2789-11.2011; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Si H, 2006, CIRC RES, V99, P537, DOI 10.1161/01.RES.0000238377.08219.0c; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Toyama K, 2008, J CLIN INVEST; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; VANRENTERGHEM C, 1995, J NEUROCHEM, V65, P1274; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11	45	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47744	10.1371/journal.pone.0047744	http://dx.doi.org/10.1371/journal.pone.0047744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077667	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100159
J	Maddaluno, M; Grassia, G; Di Lauro, MV; Parisi, A; Maione, F; Cicala, C; De Filippis, D; Iuvone, T; Guglielmotti, A; Maffia, P; Mascolo, N; Ialenti, A				Maddaluno, Marcella; Grassia, Gianluca; Di Lauro, Maria Vittoria; Parisi, Antonio; Maione, Francesco; Cicala, Carla; De Filippis, Daniele; Iuvone, Teresa; Guglielmotti, Angelo; Maffia, Pasquale; Mascolo, Nicola; Ialenti, Armando			Bindarit Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation, Migration and Phenotypic Switching	PLOS ONE			English	Article							ANTIINFLAMMATORY AGENT BINDARIT; MONOCYTE CHEMOTACTIC PROTEINS; NEOINTIMAL FORMATION; VASCULAR INJURY; MOLECULAR-MECHANISMS; HYPERLIPIDEMIC MICE; MCP-1 SYNTHESIS; PROTECTS MICE; DIFFERENTIATION; EXPRESSION	Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial. However, the mechanisms underlying the efficacy of bindarit in controlling neointimal formation/restenosis have not been fully elucidated. Therefore, we investigated the effect of bindarit on human coronary smooth muscle cells activation, drawing attention to the phenotypic modulation process, focusing on contractile proteins expression as well as proliferation and migration. The expression of contractile proteins was evaluated by western blot analysis on cultured human coronary smooth muscle cells stimulated with TNF-alpha (30 ng/mL) or fetal bovine serum (5%). Bindarit (100-300 mM) reduced the embryonic form of smooth muscle myosin heavy chain while increased smooth muscle alpha-actin and calponin in both TNF-alpha- and fetal bovine serum-stimulated cells. These effects were associated with the inhibition of human coronary smooth muscle cell proliferation/migration and both MCP-1 and MCP-3 production. The effect of bindarit on smooth muscle cells phenotypic switching was confirmed in vivo in the rat balloon angioplasty model. Bindarit (200 mg/Kg/day) significantly reduced the expression of the embryonic form of smooth muscle myosin heavy chain, and increased smooth muscle alpha-actin and calponin in the rat carodid arteries subjected to endothelial denudation. Our results demonstrate that bindarit induces the differentiated state of human coronary smooth muscle cells, suggesting a novel underlying mechanisms by which this drug inhibits neointimal formation.	[Maddaluno, Marcella; Grassia, Gianluca; Di Lauro, Maria Vittoria; Parisi, Antonio; Maione, Francesco; Cicala, Carla; De Filippis, Daniele; Iuvone, Teresa; Maffia, Pasquale; Mascolo, Nicola; Ialenti, Armando] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Guglielmotti, Angelo] ACRAF, Angelini, Rome, Italy; [Maffia, Pasquale] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Naples Federico II; University of Glasgow	Mascolo, N (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	nicoladomenicocferd.mascolo@unina.it; ialenti@unina.it	Grassia, Gianluca/H-7677-2019; cicala, carla/AAK-3831-2020	Grassia, Gianluca/0000-0001-7846-5594; cicala, carla/0000-0002-8977-8251	Angelini [004FA11072, 004FA10204]	Angelini	A.I. received the project grants (004FA11072; 004FA10204) from Angelini for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors discussed with the funders the study design and decision to publish.	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Bhatia M, 2005, AM J PHYSIOL-GASTR L, V288, pG1259, DOI 10.1152/ajpgi.00435.2004; Bhatia M, 2008, INFLAMM RES, V57, P464, DOI 10.1007/s00011-008-7210-y; Charey DJ, 1991, ANNU REV PHYSIOL, V53, P161; Colombo A, 2012, J AM COLL CARDIOL, V59, pE11, DOI 10.1016/S0735-1097(12)60012-6; Denger S, 1999, ATHEROSCLEROSIS, V144, P15, DOI 10.1016/S0021-9150(99)00033-7; Grassia G, 2010, ARTERIOSCL THROM VAS, V30, P2458, DOI 10.1161/ATVBAHA.110.215467; Grassia G, 2009, CARDIOVASC RES, V84, P485, DOI 10.1093/cvr/cvp238; Ialenti A, 2011, ARTERIOSCL THROM VAS, V31, P2448, DOI 10.1161/ATVBAHA.111.230078; Indolfi C, 2000, J AM COLL CARDIOL, V35, P214, DOI 10.1016/S0735-1097(99)00526-4; Maddaluno M, 2011, ATHEROSCLEROSIS, V217, P113, DOI 10.1016/j.atherosclerosis.2011.04.002; Maffia P, 2006, CIRCULATION, V114, P430, DOI 10.1161/CIRCULATIONAHA.105.602714; Martin KA, 2007, J BIOL CHEM, V282, P36112, DOI 10.1074/jbc.M703914200; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Mirolo M, 2008, EUR CYTOKINE NETW, V19, P119, DOI 10.1684/ecn.2008.0133; Mora E, 2012, CELL CYCLE, V11, P159, DOI 10.4161/cc.11.1.18559; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parenti A, 2004, AM J PHYSIOL-HEART C, V286, pH1978, DOI 10.1152/ajpheart.00414.2003; Perico N, 2008, NAT REV DRUG DISCOV, V7, P936, DOI 10.1038/nrd2685; Regan CP, 2000, J CLIN INVEST, V106, P1139, DOI 10.1172/JCI10522; Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; Wada H, 2008, BIOCHEM BIOPH RES CO, V374, P731, DOI 10.1016/j.bbrc.2008.07.098	27	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47464	10.1371/journal.pone.0047464	http://dx.doi.org/10.1371/journal.pone.0047464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077623	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000309995100119
J	Pinto, P; Salgado, CG; Santos, N; Alencar, DO; Santos, S; Hutz, MH; Ribeiro-dos-Santos, A				Pinto, Pablo; Salgado, Claudio Guedes; Santos, Ney; Alencar, Dayse O.; Santos, Sidney; Hutz, Mara H.; Ribeiro-dos-Santos, Andrea			Polymorphisms in the CYP2E1 and GSTM1 Genes as Possible Protection Factors for Leprosy Patients	PLOS ONE			English	Article							ANTILEPROSY DRUGS; COMMON USE; POPULATION; GLUTATHIONE-S-TRANSFERASE-M1; SUSCEPTIBILITY	Background: The CYP2E1 and GSTM1 genes encode metabolic enzymes that have key functions in drug modification and elimination. Methodology/Principal Findings: We investigated the possible effects of CYP2E1 and GSTM1 polymorphisms in 71 leprosy patients and in 110 individuals from the general population. The GSTM1*0 null allele and INDEL CYP2E1*1D mutant genotypes were analyzed by conventional PCR, while CYP2E1 SNPs (1053C>T, 1293G>C and 7632T>A) were determined by RT-PCR. In leprosy patients, the GSTM1*0 and CYP2E1*5 alleles and the combined alleles GSTM1*0/CYP2E1*6 and GSTM1*0/CYP2E1*5 were significantly related to a baciloscopic index (BI) (BI<3), while the CYP2E1*6 allele was related to a better clinical evolution in the leprosy spectrum. Conclusions/Significance: Therefore, GSTM1*0, CYP2E1*5 and CYP2E1*6 may be possible protection factors for leprosy patients.	[Pinto, Pablo; Santos, Ney; Alencar, Dayse O.; Santos, Sidney; Ribeiro-dos-Santos, Andrea] Fed Univ Para, Inst Ciencias Biol, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Salgado, Claudio Guedes] Fed Univ Para, Inst Ciencias Biol, Lab Dermatoimunol, BR-66059 Belem, Para, Brazil; [Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, Rio Grande Do Sol, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Rio Grande do Sul	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil.	akely@ufpa.br	Salgado, Claudio G/C-5206-2014; Santos, Ândrea Ribeiro dos/B-6061-2013; Salgado, Claudio G/K-8931-2012; Pinto, Pablo/T-6154-2019; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Hutz, Mara H/I-4070-2012	Salgado, Claudio G/0000-0003-3961-7764; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Salgado, Claudio G/0000-0003-3961-7764; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Santos, Ney Pereira Carneiro dos/0000-0001-8087-7037; Hutz, Mara/0000-0002-9146-1229	FINEP (Financiadora de Estudos e Projetos), CNPq/Casadinho (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior); PROPES/UFPA (Universidade Federal do Para), FADESP (Fundacao de Amparo a Pesquisa)	FINEP (Financiadora de Estudos e Projetos), CNPq/Casadinho (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PROPES/UFPA (Universidade Federal do Para), FADESP (Fundacao de Amparo a Pesquisa)	This study was supported by FINEP (Financiadora de Estudos e Projetos), CNPq/Casadinho (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) and PROPES/UFPA (Universidade Federal do Para), FADESP (Fundacao de Amparo a Pesquisa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Cho HR, 2011, INT J IMMUNOGENET, V38, P145, DOI 10.1111/j.1744-313X.2010.00987.x; Crawford CL, 2010, CLIN INFECT DIS, V51, P476, DOI 10.1086/655155; Douglas JG, 1999, CLIN PHARMACOKINET, V37, P127; Etienne D, 2000, LEPROSY REV, V73, pS35; Goulart Isabela Maria Bernades, 2002, Rev. Soc. Bras. Med. Trop., V35, P453, DOI 10.1590/S0037-86822002000500005; Hardman JG, 2004, GOODMAN GILMAN BASES; Hasler Julia A., 1999, Molecular Aspects of Medicine, V20, P1, DOI 10.1016/S0098-2997(99)00005-9; JOPLING WH, 1983, LEPROSY REV, V54, P261; JOPLING WH, 1985, LEPROSY REV, V56, P61; Kaur MR, 2006, J DERMATOL TREAT, V17, P211, DOI 10.1080/09546630600830588; Kayaalti Z, 2010, ALCOHOL, V1, P9; Konwar R, 2010, ASIAN PAC J CANCER P, V11, P1067; Li L, 2011, LEUKEMIA RES, V35, P762, DOI 10.1016/j.leukres.2010.12.001; Long J, 1999, MULTIPLE LOCUS HAPLO; Moreira Adriana Souza, 2006, Arq. Bras. Oftalmol., V69, P865, DOI 10.1590/S0004-27492006000600015; Moreira MBR, 2002, GUIA CONTROLE HANSEN; MORRISON NE, 1976, INT J LEPROSY, V44, P133; Moyer AM, 2007, CLIN CANCER RES, V13, P7207, DOI 10.1158/1078-0432.CCR-07-0635; Opromolla Diltor Vladmir Araujo, 1997, Medicina (Ribeirao Preto), V30, P345; PFALTZGRAFF RE, 1985, LEPROSY, P134; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rivera RC, 2010, J BACTERIOL, V192, P3268; Rivers EC, 2008, CURR MED CHEM, V15, P1956, DOI 10.2174/092986708785132906; Sambrook J., 2002, MOL CLONING LAB MANU; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Souza Cacilda Silva, 1997, Medicina (Ribeirao Preto), V30, P325; Stretch R, 1999, Nurs Times, V95, P46; TSUTSUMI M, 1994, GASTROENTEROLOGY, V107, P1430, DOI 10.1016/0016-5085(94)90546-0; UEMATSU F, 1994, PHARMACOGENETICS, V4, P58, DOI 10.1097/00008571-199404000-00002; Vaishali BN, 2011, ASIATIC J BIOTECH RE, V2, P547; Wang SM, 2009, J HUM GENET, V54, P372, DOI 10.1038/jhg.2009.41; WIDERSTEN M, 1991, BIOCHEM J, V276, P519, DOI 10.1042/bj2760519; Yamada S, 2009, PHARMACOGENOMICS, V10, P1433, DOI [10.2217/pgs.09.66, 10.2217/PGS.09.66]; Yang BM, 2001, ALCOHOL, V23, P91, DOI 10.1016/S0741-8329(00)00135-X; Yano T, 2011, J BIOL CHEM, V286, P10276, DOI 10.1074/jbc.M110.200501	36	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47498	10.1371/journal.pone.0047498	http://dx.doi.org/10.1371/journal.pone.0047498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077626	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100122
J	Tanenhaus, AK; Zhang, JB; Yin, JCP				Tanenhaus, Anne K.; Zhang, Jiabin; Yin, Jerry C. P.			In Vivo Circadian Oscillation of dCREB2 and NF-kappa B Activity in the Drosophila Nervous System	PLOS ONE			English	Article							GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; MUSHROOM BODIES; LIFE-SPAN; CLOCK; SLEEP; LIGHT; CREB; TRANSCRIPTION; CAMP	cAMP response element-binding protein (CREB) and nuclear factor kappa-B (NF-kappa B) are two ubiquitous transcription factors involved in a wide number of cellular processes, including the circadian system. Many previous studies on these factors use cellular assays that provide limited information on circadian activity or anatomical specificity. The ability to study transcription factors in defined tissue within intact animals will help to bridge the gap between cellular and in vivo data. We have used the GAL4-UAS and FLP-FRT systems to gain spatial control over reporter gene expression. Using a luciferase-based reporter, we show in vivo that Drosophila dCREB2-and NF-kappa B-mediated transcription oscillates in neuronal cells, glia, and in the mushroom body, a higher-order brain center in flies. This oscillation is under circadian control, cycling with a 24-hour rhythm, under both light-dark and dark-dark conditions. In light-light conditions, dCREB2 and NF-kappa B reporter flies exhibit a suppression of rhythmic activity. Furthermore, neuronal cycling of dCREB2 and NF-kappa B activity are modulated in period mutant flies, indicating these oscillations are controlled through the central clock. This study shows for the first time region-specific circadian oscillation of dCREB2/NF-kappa B activity in the Drosophila nervous system.	[Yin, Jerry C. P.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Yin, Jerry C. P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Tanenhaus, Anne K.; Zhang, Jiabin] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Yin, JCP (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jcyin@wisc.edu			United States National Institutes of Health (NIH) [NIH NS063245]; High Q Foundation; AHAF (American Health Assistance Foundation); Neuroscience Training Program University of Wisconsin, Madison; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063245] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); High Q Foundation; AHAF (American Health Assistance Foundation)(BrightFocus Foundation); Neuroscience Training Program University of Wisconsin, Madison; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the United States National Institutes of Health (NIH) NIH NS063245, High Q Foundation (http://chdifoundation.org), AHAF (American Health Assistance Foundation) (www.ahaf.org), and the Neuroscience Training Program University of Wisconsin, Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Asai M, 2001, CURR BIOL, V11, P1524, DOI 10.1016/S0960-9822(01)00445-6; Atkinson SE, 2011, J BIOL RHYTHM, V26, P210, DOI 10.1177/0748730411402810; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Cecon E, 2010, CHRONOBIOL INT, V27, P52, DOI 10.3109/07420521003661615; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cuzzocrea S, 2002, BRIT J PHARMACOL, V135, P496, DOI 10.1038/sj.bjp.0704463; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Horiuchi J, 2004, J BIOL CHEM, V279, P12117, DOI 10.1074/jbc.M212839200; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; Kuo TH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-17; Lee B, 2010, J BIOL RHYTHM, V25, P410, DOI 10.1177/0748730410381229; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Liu SF, 1999, MOL PHARMACOL, V55, P658; Marpegan L, 2004, NEUROSCI LETT, V358, P9, DOI 10.1016/j.neulet.2003.12.112; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Moskalev A, 2011, AGING-US, V3, P391, DOI 10.18632/aging.100314; Ng FS, 2011, CURR BIOL, V21, P625, DOI 10.1016/j.cub.2011.03.027; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reid KJ, 2011, PROG BRAIN RES, V190, P3, DOI 10.1016/B978-0-444-53817-8.00001-3; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Si XN, 2005, J VIROL, V79, P8014, DOI 10.1128/JVI.79.13.8014-8023.2005; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Virlos L, 2003, SHOCK, V20, P544, DOI 10.1097/01.shk.0000093543.78705.aa; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zineldeen DH, 2010, CURR DRUG METAB, V11, P266	73	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45130	10.1371/journal.pone.0045130	http://dx.doi.org/10.1371/journal.pone.0045130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077489	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100014
J	Manda, P; Ozkan, S; Wang, H; McCarthy, F; Bridges, SM				Manda, Prashanti; Ozkan, Seval; Wang, Hui; McCarthy, Fiona; Bridges, Susan M.			Cross-Ontology Multi-level Association Rule Mining in the Gene Ontology	PLOS ONE			English	Article							EXPRESSION	The Gene Ontology (GO) has become the internationally accepted standard for representing function, process, and location aspects of gene products. The wealth of GO annotation data provides a valuable source of implicit knowledge of relationships among these aspects. We describe a new method for association rule mining to discover implicit co-occurrence relationships across the GO sub-ontologies at multiple levels of abstraction. Prior work on association rule mining in the GO has concentrated on mining knowledge at a single level of abstraction and/or between terms from the same sub-ontology. We have developed a bottom-up generalization procedure called Cross-Ontology Data Mining-Level by Level (COLL) that takes into account the structure and semantics of the GO, generates generalized transactions from annotation data and mines interesting multi-level cross-ontology association rules. We applied our method on publicly available chicken and mouse GO annotation datasets and mined 5368 and 3959 multi-level cross ontology rules from the two datasets respectively. We show that our approach discovers more and higher quality association rules from the GO as evaluated by biologists in comparison to previously published methods. Biologically interesting rules discovered by our method reveal unknown and surprising knowledge about co-occurring GO terms.	[Manda, Prashanti; Bridges, Susan M.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Ozkan, Seval] Mississippi State Univ, Dept Plant & Soil Sci, Mississippi State, MS 39762 USA; [Ozkan, Seval; Wang, Hui] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [McCarthy, Fiona] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Manda, P (corresponding author), Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA.	manda.prashanti@gmail.com		Manda, Prashanti/0000-0002-7162-7770	National Science Foundation [EPS 0903787, EPS 1006883]; U.S. Department of Agriculture [2007-35205-17941]	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the National Science Foundation under awards number EPS 0903787 and EPS 1006883 and by the U.S. Department of Agriculture under award 2007-35205-17941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Agrawal R, 1994, P 20 INT C VLDB; Alterovitz G, 2007, INFORM THEORETIC FRA, P16; Alterovitz G, 2007, NUCLEIC ACIDS RES, V35, pD322, DOI 10.1093/nar/gkl799; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Borgelt C, 2002, 15 C COMP STAT COMPS; Burgun A., 2004, P WORKSH FORM ARCH G, P28; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-54; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Davis MJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-498; Guangrong L, 2010, MINING BIOMEDICAL KN, P283; Han JW, 1999, IEEE T KNOWL DATA EN, V11, P798, DOI 10.1109/69.806937; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hoehndorf R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010996; Jiawei Han, 1995, Proceedings of the 1995 ACM CIKM International Conference on Information and Knowledge Management, P19; Liu B., 1999, P 5 ACM SIGKDD INT C, P337, DOI DOI 10.1145/312129.312274; Maryann Dorn ZJ ZJ, 2005, EMPIRICAL STUDY QUAL; McCarthy FM, 2011, NUCLEIC ACIDS RES, V39, pD497, DOI 10.1093/nar/gkq1115; Mungall CJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r2; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Tseng VS, 2009, INFORM SYST FRONT, V11, P433, DOI 10.1007/s10796-009-9156-1; van Hemert J, 2007, LECT NOTES COMPUT SC, V4414, P66	28	25	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47411	10.1371/journal.pone.0047411	http://dx.doi.org/10.1371/journal.pone.0047411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071802	Green Submitted, Green Published, gold			2022-12-25	WOS:000309809500046
J	Knee, W; Beaulieu, F; Skevington, JH; Kelso, S; Cognato, AI; Forbes, MR				Knee, Wayne; Beaulieu, Frederic; Skevington, Jeffrey H.; Kelso, Scott; Cognato, Anthony I.; Forbes, Mark R.			Species Boundaries and Host Range of Tortoise Mites (Uropodoidea) Phoretic on Bark Beetles (Scolytinae), Using Morphometric and Molecular Markers	PLOS ONE			English	Article							SOUTHERN PINE-BEETLE; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL-DNA; CENTRAL LOUISIANA; ACARI; CURCULIONIDAE; COLEOPTERA; DIVERSITY; DIVERGENCE; MORPHOLOGY	Understanding the ecology and evolutionary history of symbionts and their hosts requires accurate taxonomic knowledge, including clear species boundaries and phylogenies. Tortoise mites (Mesostigmata: Uropodoidea) are among the most diverse arthropod associates of bark beetles (Curculionidae: Scolytinae), but their taxonomy and host associations are largely unstudied. We tested the hypotheses that (1) morphologically defined species are supported by molecular data, and that (2) bark beetle uropodoids with a broad host range comprise cryptic species. To do so, we assessed the species boundaries of uropodoid mites collected from 51 host species, across 11 countries and 103 sites, using morphometric data as well as partial cytochrome oxidase I (COI) and nuclear large subunit ribosomal DNA (28S). Overall, morphologically defined species were confirmed by molecular datasets, with a few exceptions. Twenty-nine of the 36 uropodoid species (Trichouropoda, Nenteria and Uroobovella) collected in this study had narrow host ranges, while seven species had putative broad host ranges. In all but one species, U. orri, our data supported the existence of these host generalists, which contrasts with the typical finding that widespread generalists are actually complexes of cryptic specialists.	[Knee, Wayne; Forbes, Mark R.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Knee, Wayne; Beaulieu, Frederic; Skevington, Jeffrey H.; Kelso, Scott] Agr & Agri Food Canada, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Cognato, Anthony I.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Carleton University; Agriculture & Agri Food Canada; Michigan State University	Knee, W (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	wknee@connect.carleton.ca	Forbes, Mark R/B-3575-2013	Forbes, Mark/0000-0002-2288-3209	NSERC Discovery Grant; USDA-FS EDRR program [07-DG-11420004-182]; US-NSF [DEB-0328920]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); USDA-FS EDRR program; US-NSF(National Science Foundation (NSF))	This study was funded by an NSERC Discovery Grant to MRF, and in part by the USDA-FS EDRR program (# 07-DG-11420004-182) and by US-NSF (DEB-0328920) to AIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Zarazaga MA, 2009, ZOOTAXA, P1; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; ATHIASBINCHE F, 1989, ADV ECOL RES, V19, P303; Belbin L, 2003, PATN SOFTWARE EXTRAC; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bloszyk Jerzy, 2003, Biological Letters, V40, P15; Bright Jr D. E., 1976, CANADA DEP AGR PUBLI; Cardoza YJ, 2008, ENVIRON ENTOMOL, V37, P956, DOI 10.1603/0046-225X(2008)37[956:MSAFMN]2.0.CO;2; Cognato AI, 2007, CLADISTICS, V23, P539, DOI 10.1111/j.1096-0031.2007.00159.x; Dietrich M, 2012, J BIOGEOGR, V39, P545, DOI 10.1111/j.1365-2699.2011.02620.x; Dowling APG, 2010, INT J ACAROL, V36, P299, DOI 10.1080/01647951003604569; Evans G. O., 1965, Bulletin of the British Museum (Natural History) Zoology, V13, P247; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Gibson JF, 2010, MOL PHYLOGENET EVOL, V56, P1126, DOI 10.1016/j.ympev.2010.05.005; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hirschmann W., 1988, Acarologie (Nuremberg), V35, P1; Hirschmann W., 1985, Acarologie (Nuremberg), V32, P1; Hirschmann W., 1987, Acarologie (Nuremberg), V34, P1; Hirschmann W., 1986, Acarologie (Nuremberg), V33, P1; HIRSCHMANN W, 1989, ACAROLOGIA, V30, P3; Hirschmann W, 1972, ACAROLOGIE, V17; Hirschmann W, 1978, ACAROLOGIE, V24, P1; Hirschmann W, 1961, ACAROLOGIE, V4; Hofstetter R. W., 2008, INFORM IMAGES MITES; Hofstetter RW, 2009, ENTOMOL NEWS, V120, P397, DOI 10.3157/021.120.0408; Holynski RB, 2010, ARTHROPOD SYST PHYLO, V68, P143; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jordal B, 2008, ZOOL SCR, V37, P43, DOI 10.1111/j.1463-6409.2007.00306.x; Jordal BH, 2011, MOL PHYLOGENET EVOL, V59, P708, DOI 10.1016/j.ympev.2011.03.016; Kawazoe K, 2008, MOL PHYLOGENET EVOL, V49, P503, DOI 10.1016/j.ympev.2008.07.024; KETHLEY J B, 1975, Miscellaneous Publications of the Entomological Society of America, V9, P231; Kinn D. N., 1989, KEY PHORETIC MITES C, V357, P1; KINN DN, 1987, CAN J FOREST RES, V17, P187, DOI 10.1139/x87-032; KINN DN, 1982, FLA ENTOMOL, V65, P185, DOI 10.2307/3494161; KINN DN, 1978, CAN ENTOMOL, V110, P249, DOI 10.4039/Ent110249-3; Knee W, 2012, CAN ENTOMOL IN PRESS; Knee W, 2012, MOL PHYLOGENET EVOL, V65, P276, DOI 10.1016/j.ympev.2012.06.013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEVIEUX J, 1989, J APPL ENTOMOL, V108, P1, DOI 10.1111/j.1439-0418.1989.tb00425.x; Maddison WP, 2017, MESQUITE MODULAR SYS; Martin P, 2010, AQUAT SCI, V72, P347, DOI 10.1007/s00027-010-0135-x; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; MOSER JC, 1975, ANN ENTOMOL SOC AM, V68, P1113, DOI 10.1093/aesa/68.6.1113; MOSER JC, 1984, Z ANGEW ENTOMOL, V97, P437; MOSER JC, 1971, CAN ENTOMOL, V103, P1775, DOI 10.4039/Ent1031775-12; Nylander JAA, 2004, MRMODETEST V2 PROGRA; Park JK, 2000, MOL PHYLOGENET EVOL, V14, P75, DOI 10.1006/mpev.1999.0691; Paterson AM, 2001, INT J PARASITOL, V31, P1012, DOI 10.1016/S0020-7519(01)00199-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Schaffer S, 2010, MOL PHYLOGENET EVOL, V55, P677, DOI 10.1016/j.ympev.2009.11.025; Skoracka A, 2010, B ENTOMOL RES, V100, P263, DOI 10.1017/S0007485309990216; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Wisnewski J., 1992, Acarologie (Nuremberg), V39, P100; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P1	62	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47243	10.1371/journal.pone.0047243	http://dx.doi.org/10.1371/journal.pone.0047243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071768	gold, Green Submitted, Green Published			2022-12-25	WOS:000309807700070
J	Merola, I; Prato-Previde, E; Marshall-Pescini, S				Merola, Isabella; Prato-Previde, Emanuela; Marshall-Pescini, Sarah			Dogs' Social Referencing towards Owners and Strangers	PLOS ONE			English	Article							CANIS-FAMILIARIS; PET DOGS; INFANT RESPONSES; JOINT ATTENTION; BEHAVIOR; HUMANS; CHIMPANZEES; LOOKING; COGNITION; MOTHERS	Social referencing is a process whereby an individual uses the emotional information provided by an informant about a novel object/stimulus to guide his/her own future behaviour towards it. In this study adult dogs were tested in a social referencing paradigm involving a potentially scary object with either their owner or a stranger acting as the informant and delivering either a positive or negative emotional message. The aim was to evaluate the influence of the informant's identity on the dogs' referential looking behaviour and behavioural regulation when the message was delivered using only vocal and facial emotional expressions. Results show that most dogs looked referentially at the informant, regardless of his/her identity. Furthermore, when the owner acted as the informant dogs that received a positive emotional message changed their behaviour, looking at him/her more often and spending more time approaching the object and close to it; conversely, dogs that were given a negative message took longer to approach the object and to interact with it. Fewer differences in the dog's behaviour emerged when the informant was the stranger, suggesting that the dog-informant relationship may influence the dog's behavioural regulation. Results are discussed in relation to studies on human-dog communication, attachment, mood modification and joint attention.	[Merola, Isabella; Prato-Previde, Emanuela; Marshall-Pescini, Sarah] Univ Milan, Dept Biomed Sci & Technol, Psychol Sect, I-20133 Milan, Italy	University of Milan	Merola, I (corresponding author), Univ Milan, Dept Biomed Sci & Technol, Psychol Sect, I-20133 Milan, Italy.	isabella.merola@unimi.it		Marshall-Pescini, Sarah/0000-0002-5944-4701	University of Milan	University of Milan	This work was supported by a doctoral grant to Isabella Merola and a postdoctoral grant to Sarah Marshall-Pescini both from the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMRAS LA, 1991, INFANT BEHAV DEV, V14, P27, DOI 10.1016/0163-6383(91)90052-T; CARPENTER M, 1995, SOC DEV, V4, P217, DOI 10.1111/j.1467-9507.1995.tb00063.x; Carpenter M, AGENCY JOIN IN PRESS; de Rosnay M, 2006, BEHAV RES THER, V44, P1165, DOI 10.1016/j.brat.2005.09.003; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Deputte BL., 2011, J VET BEHAV, V6, P78, DOI [10.1016/j.jveb.2010.09.013, DOI 10.1016/J.JVEB.2010.09.013]; Elgier AM, 2009, BEHAV PROCESS, V81, P44, DOI 10.1016/j.beproc.2008.12.023; FEINMAN S, 1982, MERRILL PALMER QUART, V28, P445; Fukuzawa M, 2005, J COMP PSYCHOL, V119, P117, DOI 10.1037/0735-7036.119.1.117; Gaunet F, 2008, ANIM COGN, V11, P475, DOI 10.1007/s10071-008-0138-3; Gaunet F, 2010, ANIM COGN, V13, P311, DOI 10.1007/s10071-009-0279-z; GUNNAR MR, 1984, CHILD DEV, V55, P1231, DOI 10.2307/1129992; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; HORNIK R, 1987, CHILD DEV, V58, P937, DOI 10.2307/1130534; Itakura S., 1995, J HUM EVOL, V51, P44; Kaminski J, 2012, DEVELOPMENTAL SCI, V15, P222, DOI 10.1111/j.1467-7687.2011.01120.x; Kaminski J, 2011, ANIM BEHAV, V82, P651, DOI 10.1016/j.anbehav.2011.06.015; Kim G, 2010, INFANT BEHAV DEV, V33, P189, DOI 10.1016/j.infbeh.2009.12.009; Klinnert M. D, 1983, EMOTIONS EARLY DEV, P57; KLINNERT MD, 1986, DEV PSYCHOL, V22, P427, DOI 10.1037/0012-1649.22.4.427; Leavens DA, 2009, J CONSCIOUSNESS STUD, V16, P240; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2009, BEHAV PROCESS, V81, P416, DOI 10.1016/j.beproc.2009.03.015; Merola I, 2012, ANIM COGN, V15, P175, DOI 10.1007/s10071-011-0443-0; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Mongillo P, 2010, ANIM BEHAV, V80, P1057, DOI 10.1016/j.anbehav.2010.09.014; Morimoto Y, 2012, ANIM COGN, V15, P341, DOI 10.1007/s10071-011-0458-6; Mumme DL, 1996, CHILD DEV, V67, P3219, DOI 10.1111/j.1467-8624.1996.tb01910.x; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Roberts SGB, 2008, J COMP PSYCHOL, V122, P94, DOI 10.1037/0735-7036.122.1.94; ROSEN WD, 1992, DEV PSYCHOL, V28, P1172, DOI 10.1037/0012-1649.28.6.1172; Ruffman T, 2011, J VET BEHAV, V6, P97, DOI DOI 10.1016/J.JVEB.2010.08.009; Russell CL, 1997, J COMP PSYCHOL, V111, P185, DOI 10.1037/0735-7036.111.2.185; Scheider L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021676; Stenberg G, 2003, INFANT CHILD DEV, V12, P399, DOI 10.1002/icd.321; Stenberg G, 1997, INFANT BEHAV DEV, V20, P209, DOI 10.1016/S0163-6383(97)90023-0; Stenberg G, 2011, INFANCY, P1; Stenberg G, 2007, INFANCY, V11, P111, DOI 10.1111/j.1532-7078.2007.tb00218.x; Tomonaga M, 2004, JPN PSYCHOL RES, V46, P227, DOI 10.1111/j.1468-5584.2004.00254.x; Topal J, 1997, ANTHROZOOS, V10, P214, DOI 10.2752/089279397787000987; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Viranyi Z, 2006, ANIM COGN, V9, P13, DOI 10.1007/s10071-005-0257-z; Waish A, 2010, INFANT BEHAV DEV, V33, P79; WALDEN TA, 1988, CHILD DEV, V59, P1230, DOI 10.2307/1130486; Walden TA, 2005, INT J BEHAV DEV, V29, P356, DOI 10.1080/01650250500166824; ZARBATANY L, 1985, INFANT BEHAV DEV, V8, P25, DOI 10.1016/S0163-6383(85)80014-X	52	94	95	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47653	10.1371/journal.pone.0047653	http://dx.doi.org/10.1371/journal.pone.0047653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071828	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700096
J	Battad, JM; Traore, DAK; Byres, E; Rossjohn, J; Devenish, RJ; Olsen, S; Wilce, MCJ; Prescott, M				Battad, Jion M.; Traore, Daouda A. K.; Byres, Emma; Rossjohn, Jamie; Devenish, Rodney J.; Olsen, Seth; Wilce, Matthew C. J.; Prescott, Mark			A Green Fluorescent Protein Containing a QFG Tri-Peptide Chromophore: Optical Properties and X-Ray Crystal Structure	PLOS ONE			English	Article							STRUCTURE VALIDATION; COLOR TRANSITION; GFP; CHROMOPROTEIN; POCILLOPORIN; ANTHOZOA; MODELS; BLUE	Rtms5 is an deep blue weakly fluorescent GFP-like protein (lambda(max)(Abs), 592 nm; lambda(max)(Em), 630nm; Phi(F), 0.004) that contains a (66)Gln-Tyr-Gly chromophore tripeptide sequence. We investigated the optical properties and structure of two variants, Rtms5(Y67F) and Rtms5(Y67F/H146S) in which the tyrosine at position 67 was substituted by a phenylalanine. Compared to the parent proteins the optical spectra for these new variants were significantly blue-shifted. Rtms5(Y67F) spectra were characterised by two absorbing species (lambda(max)(Abs), 440 nm and 513 nm) and green fluorescence emission (lambda(max)(Ex), 440 nm; lambda(max)(Em), 508 nm; Phi(F), 0.11), whilst Rtms5(Y67F/H146S) spectra were characterised by a single absorbing species (lambda(max)(Abs), 440 nm) and a relatively high fluorescence quantum yield (Phi(F), 0.75; lambda(max)(Ex), 440 nm; lambda(max)(Em), 508 nm). The fluorescence emissions of each variant were remarkably stable over a wide range of pH (3-11). These are the first GFP-like proteins with green emissions (500-520 nm) that do not have a tyrosine at position 67. The X-ray crystal structure of each protein was determined to 2.2 angstrom resolution and showed that the benzylidine ring of the chromophore, similar to the 4-hydroxybenzylidine ring of the Rtms5 parent, is non-coplanar and in the trans conformation. The results of chemical quantum calculations together with the structural data suggested that the 513 nm absorbing species in Rtms5(Y67F) results from an unusual form of the chromophore protonated at the acylimine oxygen. These are the first X-ray crystal structures for fluorescent proteins with a functional chromophore containing a phenylalanine at position 67.	[Traore, Daouda A. K.; Byres, Emma; Rossjohn, Jamie; Wilce, Matthew C. J.] Monash Univ, Struct Biol Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic, Australia; [Olsen, Seth] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	Monash University; University of Queensland	Wilce, MCJ (corresponding author), Monash Univ, Struct Biol Unit, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic, Australia.	Matthew.Wilce@monash.edu; Mark.Prescott@monash.edu	Olsen, Seth/A-6157-2010; Traore, Daouda/B-5242-2013; Rossjohn, Jamie/F-9032-2013	Traore, Daouda/0000-0003-1001-4716; Rossjohn, Jamie/0000-0002-2020-7522	Australian Research Council [DP110101580]; National Computational Merit Allocation Scheme [m03]	Australian Research Council(Australian Research Council); National Computational Merit Allocation Scheme	The work was in part supported by an Australian Research Council Discovery Grant (DP110101580). Computations were carried out at the National Computational Infrastructure National Facility, Canberra, using resources provided under the National Computational Merit Allocation Scheme (project m03). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Barondeau DP, 2007, J AM CHEM SOC, V129, P3118, DOI 10.1021/ja063983u; Battad JM, 2007, J MOL BIOL, V368, P998, DOI 10.1016/j.jmb.2007.02.007; Celani P, 2000, J CHEM PHYS, V112, P5546, DOI 10.1063/1.481132; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chica RA, 2010, P NATL ACAD SCI USA, V107, P20257, DOI 10.1073/pnas.1013910107; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; El Azhary A, 1998, J CHEM PHYS, V108, P5185, DOI 10.1063/1.475955; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finley J, 1998, CHEM PHYS LETT, V288, P299, DOI 10.1016/S0009-2614(98)00252-8; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lackowicz JR., 2006, PRINCIPLES FLUORESCE, V3, DOI 10.1007/978-0-387-46312-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olsen S, 2006, CHEM PHYS LETT, V420, P507, DOI 10.1016/j.cplett.2006.01.021; Olsen S, 2007, J AM CHEM SOC, V129, P2054, DOI 10.1021/ja066430s; Olsen S, 2006, CHEM PHYS LETT, V426, P159, DOI 10.1016/j.cplett.2006.05.020; Olsen S, 2012, CHEM PHYS LETT, V532, P106, DOI 10.1016/j.cplett.2012.02.047; Olsen S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3563801; Olsen S, 2010, CHEM PHYS LETT, V492, P150, DOI 10.1016/j.cplett.2010.04.024; Olsen S, 2010, J CHEM THEORY COMPUT, V6, P1089, DOI 10.1021/ct100001b; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakhomov AA, 2006, BIOCHEMISTRY-US, V45, P7256, DOI 10.1021/bi060207q; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pettikiriarachchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041028; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shu XK, 2009, PROTEIN SCI, V18, P460, DOI 10.1002/pro.66; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Turcic K, 2006, BIOCHEM BIOPH RES CO, V340, P1139, DOI 10.1016/j.bbrc.2005.12.118; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Werner HJ, 2012, WIRES COMPUT MOL SCI, V2, P242, DOI 10.1002/wcms.82; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Wilmann PG, 2006, PHOTOCHEM PHOTOBIOL, V82, P359, DOI 10.1562/2005-05-02-RA-509; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	53	6	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47331	10.1371/journal.pone.0047331	http://dx.doi.org/10.1371/journal.pone.0047331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071789	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200107
J	Gilbert, RE; Zhang, Y; Williams, SJ; Zammit, SC; Stapleton, DI; Cox, AJ; Krum, H; Langham, R; Kelly, DJ				Gilbert, Richard E.; Zhang, Yuan; Williams, Spencer J.; Zammit, Steven C.; Stapleton, David I.; Cox, Alison J.; Krum, Henry; Langham, Robyn; Kelly, Darren J.			A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ADVANCED DIABETIC NEPHROPATHY; RENIN-ANGIOTENSIN SYSTEM; SMOOTH-MUSCLE-CELLS; RENAL-DISEASE; MATRIX DEPOSITION; IMAGE-ANALYSIS; PROGRESSION; TRANILAST; FIBROSIS	Background and Purpose: Locally-active growth factors have been implicated in the pathogenesis of many diseases in which organ fibrosis is a characteristic feature. In the setting of chronic kidney disease (CKD), two such pro-fibrotic factors, transforming growth factor-beta (TGF-beta) and platelet-derived growth factor (PDGF) have emerged as lead potential targets for intervention. Given the incomplete organ protection afforded by blocking the actions of TGF-beta or PDGF individually, we sought to determine whether an agent that inhibited the actions of both may have broader effects in ameliorating the key structural and functional abnormalities of CKD. Experimental Approach: Accordingly, we studied the effects of a recently described, small molecule anti-fibrotic drug, 3-methoxy-4-propargyloxycinnamoyl anthranilate (FT011, Fibrotech Therapeutics, Australia), which should have these effects. Key Results: In the in vitro setting, FT011 inhibited both TGF-beta 1 and PDGF-BB induced collagen production as well as PDGF-BB-mediated mesangial proliferation. Consistent with these in vitro actions, when studied in a robust model of non-diabetic kidney disease, the 5/6 nephrectomised rat, FT011 attenuated the decline in GFR, proteinuria and glomerulosclerosis (p<0.05 for all). Similarly, in the streptozotocin-diabetic Ren-2 rat, a model of advanced diabetic nephropathy, FT011 reduced albuminuria, glomerulosclerosis and tubulointerstitial fibrosis. Conclusions and Implications: Together these studies suggest that broadly antagonising growth factor actions, including those of TGF-beta 1 and PDGF-BB, has the potential to protect the kidney from progressive injury in both the diabetic and nondiabetic settings. Citation: Gilbert RE, Zhang Y, Williams SJ, Zammit SC, Stapleton DI, et al. (2012) A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat. PLoS ONE 7(10): e47160. doi: 10.1371/journal.pone.0047160	[Gilbert, Richard E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Zhang, Yuan; Cox, Alison J.; Langham, Robyn; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Williams, Spencer J.; Zammit, Steven C.] Univ Melbourne, Sch Chem, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Stapleton, David I.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Krum, Henry] Monash Univ, Sch Publ Hlth, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Kelly, Darren J.] Fibrotech Therapeut Pty Ltd, Melbourne, Vic, Australia	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Monash University	Gilbert, RE (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	richard.gilbert@utoronto.ca; dkelly@medstv.unimelb.edu.au	Williams, Spencer/C-3545-2009	Williams, Spencer/0000-0001-6341-4364; Kelly, Darren/0000-0003-4850-3929	NHMRC Program [546272, 334008]; Fibrotech Therapeutics Pty Ltd; Canada Research Chair Program	NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Fibrotech Therapeutics Pty Ltd; Canada Research Chair Program(Canada Research Chairs)	Darren J. Kelly is a National Health and Medical Research Council of Australia (NHMRC) Senior Fellow. Richard E. Gilbert is the Canada Research Chair in Diabetes Complications. This work was supported thanks in part to NHMRC Program Grants (#546272 and #334008), Fibrotech Therapeutics Pty Ltd and the Canada Research Chair Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADER R, 1980, PATHOL RES PRACT, V167, P204, DOI 10.1016/S0344-0338(80)80051-3; Bidani AK, 2000, KIDNEY INT, V57, P1651, DOI 10.1046/j.1523-1755.2000.00009.x; Bitzer M, 1998, KIDNEY BLOOD PRESS R, V21, P1, DOI 10.1159/000025837; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORDER WA, 1994, CONTRIB NEPHROL, V107, P140; Cho ME, 2007, CLIN J AM SOC NEPHRO, V2, P906, DOI 10.2215/CJN.01050207; Decleves AE, NAT REV NEPHROL, V6, P371; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; FLOEGE J, 1995, MINER ELECTROL METAB, V21, P271; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; Giachelli CM, 1998, AM J PATHOL, V152, P353; Gilbert RE, 1998, DIABETES, V47, P414, DOI 10.2337/diabetes.47.3.414; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hawthorne T, 2008, INT J CLIN PHARM TH, V46, P236; KAISSLING B, 1994, KIDNEY INT, V45, P709, DOI 10.1038/ki.1994.95; KAKIZAKI Y, 1991, CLIN EXP IMMUNOL, V85, P157; Kelly DJ, 2009, NEPHROL DIAL TRANSPL, V24, P1782, DOI 10.1093/ndt/gfn729; Kelly DJ, 2004, J AM SOC NEPHROL, V15, P2619, DOI 10.1097/01.ASN.0000139066.77892.04; Kelly DJ, 2002, NEPHROL DIAL TRANSPL, V17, P985, DOI 10.1093/ndt/17.6.985; Lassila M, 2005, J AM SOC NEPHROL, V16, P363, DOI 10.1681/ASN.2004050392; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Malyankar UM, 1997, KIDNEY INT, V51, P1766, DOI 10.1038/ki.1997.243; Martin J, 2005, CARDIOVASC RES, V65, P694, DOI 10.1016/j.cardiores.2004.10.041; Mifsud Sally, 2003, Nephron, V95, pp83, DOI 10.1159/000074845; Miyazawa K, 1995, ATHEROSCLEROSIS, V118, P213, DOI 10.1016/0021-9150(95)05607-6; Nakagawa T, 1999, AM J PATHOL, V155, P1689, DOI 10.1016/S0002-9440(10)65484-3; NIKOLICPATERSON DJ, 1994, KIDNEY INT, V45, pS79; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; RamachandraRao SP, 2009, J AM SOC NEPHROL, V20, P1765, DOI 10.1681/ASN.2008090931; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SABADINI E, 1988, AM J KIDNEY DIS, V12, P307, DOI 10.1016/S0272-6386(88)80225-7; Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285; Schena FP, 1997, KIDNEY INT, V52, P1439, DOI 10.1038/ki.1997.475; Sharma K, 2009, WORLD C NEPHR MIL, pSa775; Shikata K, 2001, CONTRIB NEPHROL, V134, P46; SHINKAI Y, 1987, BRIT J EXP PATHOL, V68, P847; Soma J, 2002, NEPHRON, V92, P693, DOI 10.1159/000064071; Soma J, 2006, NEPHROL DIAL TRANSPL; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; Takakuta K, 2010, EUR J PHARMACOL, V629, P118, DOI 10.1016/j.ejphar.2009.12.011; Wada T, 2000, KIDNEY INT, V58, P1492, DOI 10.1046/j.1523-1755.2000.00311.x; Watanabe S, 2000, BRIT J PHARMACOL, V130, P307, DOI 10.1038/sj.bjp.0703285; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zammit SC, 2009, BIOORG MED CHEM LETT, V19, P7003, DOI 10.1016/j.bmcl.2009.09.120; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	51	32	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47160	10.1371/journal.pone.0047160	http://dx.doi.org/10.1371/journal.pone.0047160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071743	Green Published, gold			2022-12-25	WOS:000312385200087
J	Keller, J; Brink, S; Busse, B; Schilling, AF; Schinke, T; Amling, M; Lange, T				Keller, Johannes; Brink, Silja; Busse, Bjoern; Schilling, Arndt F.; Schinke, Thorsten; Amling, Michael; Lange, Tobias			Divergent Resorbability and Effects on Osteoclast Formation of Commonly Used Bone Substitutes in a Human In Vitro-Assay	PLOS ONE			English	Article							SINUS FLOOR AUGMENTATION; RESORPTION PITS; BIOMATERIALS; DEFECTS; DISEASE	Bioactive bone substitute materials are a valuable alternative to autologous bone transplantations in the repair of skeletal defects. However, clinical studies have reported varying success rates for many commonly used biomaterials. While osteoblasts have traditionally been regarded as key players mediating osseointegration, increasing evidence suggests that bone-resorbing osteoclasts are of crucial importance for the longevity of applied biomaterials. As no standardized data on the resorbability of biomaterials exists, we applied an in vitro-assay to compare ten commonly used bone substitutes. Human peripheral blood mononuclear cells (PBMCs) were differentiated into osteoclasts in the co-presence of dentin chips and biomaterials or dentin alone (control) for a period of 28 days. Osteoclast maturation was monitored on day 0 and 14 by light microscopy, and material-dependent changes in extracellular pH were assessed twice weekly. Mature osteoclasts were quantified using TRAP stainings on day 28 and their resorptive activity was determined on dentin (toluidin blue staining) and biomaterials (scanning electron microscopy, SEM). The analyzed biomaterials caused specific changes in the pH, which were correlated with osteoclast multinuclearity (r = 0.942; p = 0.034) and activity on biomaterials (r = 0.594; p = 0.041). Perossal led to a significant reduction of pH, nuclei per osteoclast and dentin resorption, whereas Tutogen bovine and Tutobone human strikingly increased all three parameters. Furthermore, natural biomaterials were resorbed more rapidly than synthetic biomaterials leading to differential relative resorption coefficients, which indicate whether bone substitutes lead to a balanced resorption or preferential resorption of either the biomaterial or the surrounding bone. Taken together, this study for the first time compares the effects of widely used biomaterials on osteoclast formation and resorbability in an unbiased approach that may now aid in improving the preclinical evaluation of bone substitute materials.	[Keller, Johannes; Brink, Silja; Busse, Bjoern; Schilling, Arndt F.; Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Lange, Tobias] Univ Med Ctr Hamburg Eppendorf, Dept Anat & Expt Morphol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Keller, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany.	j.keller@uke.de	Busse, Björn/O-8462-2016; Lange, Tobias/K-8689-2015; Busse, Björn/AAC-4033-2020	Busse, Björn/0000-0002-3099-8073; Busse, Björn/0000-0002-3099-8073; Keller, Johannes/0000-0002-8925-7288				Bauer TW, 2007, SKELETAL RADIOL, V36, P1105, DOI 10.1007/s00256-007-0377-4; David JP, 2010, CURR DIR AUTOIMMUN, V11, P135, DOI 10.1159/000289202; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267; Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056; Gallo J, 2008, PHYSIOL RES, V57, P339, DOI 10.33549/physiolres.931140; Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308; Hillmeier J, 2003, OPERAT ORTHOP TRAUMA, V15, P343; Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017; Horvai AE, 2011, SEMIN DIAGN PATHOL, V28, P13, DOI 10.1053/j.semdp.2011.02.004; Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026; Knop C, 2006, ARCH ORTHOP TRAUM SU, V126, P204, DOI 10.1007/s00402-006-0107-8; KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009; Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039; Lange T, 2009, BIOMATERIALS, V30, P5312, DOI 10.1016/j.biomaterials.2009.06.023; Linhart W, 2003, UNFALLCHIRURG, V106, P618, DOI 10.1007/s00113-003-0628-3; Meyer S, 2008, ARCH ORTHOP TRAUM SU, V128, P539, DOI 10.1007/s00402-007-0402-z; Ooms EM, 2003, BIOMATERIALS, V24, P989, DOI 10.1016/S0142-9612(02)00438-6; Parikka V, 2001, ENDOCRINOLOGY, V142, P5371, DOI 10.1210/en.142.12.5371; PIPER K, 1992, ANAT EMBRYOL, V186, P291; REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L; Rueger JM, 1998, ORTHOPADE, V27, P72, DOI 10.1007/PL00003481; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079; Schnettler R, 2009, J BIOMED MATER RES B, V90B, P75, DOI 10.1002/jbm.b.31255; Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012; SHIBUTANI T, 1993, J BONE MINER RES, V8, P331; Shin Hong-In, 2005, Implant Dent, V14, P328; Soysa Niroshani Surangika, 2009, Journal of Medical and Dental Sciences, V56, P107; Spies CKG, 2009, ARCH ORTHOP TRAUM SU, V129, P979, DOI 10.1007/s00402-008-0705-8; TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017; Tudor C, 2008, ORAL SURG ORAL MED O, V105, P430, DOI 10.1016/j.tripleo.2007.07.037; von Stechow D, 2009, EUR SURG RES, V43, P298, DOI 10.1159/000233525; Winkler T, 2010, INT J ARTIF ORGANS, V33, P198, DOI 10.1177/039139881003300404; Yamada Y, 2007, MAT SCI ENG C-BIO S, V27, P762, DOI 10.1016/j.msec.2006.08.006; Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432	36	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46757	10.1371/journal.pone.0046757	http://dx.doi.org/10.1371/journal.pone.0046757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071629	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200042
J	Hung, WC; Takano, T; Higuchi, W; Iwao, Y; Khokhlova, O; Teng, LJ; Yamamoto, T				Hung, Wei-Chun; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Khokhlova, Olga; Teng, Lee-Jene; Yamamoto, Tatsuo			Comparative Genomics of Community-Acquired ST59 Methicillin-Resistant Staphylococcus aureus in Taiwan: Novel Mobile Resistance Structures with IS 1216V	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ANTIMICROBIAL RESISTANCE; MRSA STRAINS; SEQUENCE; CASSETTE; EMERGENCE; PLASMID; USA300; CLONE; IDENTIFICATION	Methicillin-resistant Staphylococcus aureus (MRSA) with ST59/SCCmecV and Panton-Valentine leukocidin gene is a major community-acquired MRSA (CA-MRSA) lineage in Taiwan and has been multidrug-resistant since its initial isolation. In this study, we studied the acquisition mechanism of multidrug resistance in an ST59 CA-MRSA strain (PM1) by comparative genomics. PM1's non-beta-lactam resistance was encoded by two unique genetic traits. One was a 21,832-bp composite mobile element structure (MESPM1), which was flanked by direct repeats of enterococcal IS1216V and was inserted into the chromosomal sasK gene; the target sequence (att) was 8 bp long and was duplicated at both ends of MESPM1. MESPM1 consisted of two regions: the 5'-end side 12.4-kb region carrying Tn551 (with ermB) and Tn5405-like (with aph[3']-IIIa and aadE), similar to an Enterococcus faecalis plasmid, and the 3'-end side 6,587-bp region (MEScat) that carries cat and is flanked by inverted repeats of IS1216V. MEScat possessed att duplication at both ends and additional two copies of IS1216V inside. MESPM1 represents the first enterococcal IS1216V-mediated composite transposon emerged in MRSA. IS1216V-mediated deletion likely occurred in IS1216V-rich MESPM1, resulting in distinct resistance patterns in PM1-derivative strains. Another structure was a 6,025-bp tet-carrying element (MEStet) on a 25,961-bp novel mosaic penicillinase plasmid (pPM1); MEStet was flanked by direct repeats of IS431, but with no target sequence repeats. Moreover, the PM1 genome was deficient in a copy of the restriction and modification genes (hsdM and hsdS), which might have contributed to the acquisition of enterococcal multidrug resistance.	[Hung, Wei-Chun; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Khokhlova, Olga; Yamamoto, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Bacteriol, Niigata, Japan; [Teng, Lee-Jene] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan	Niigata University; National Taiwan University	Yamamoto, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Bacteriol, Niigata, Japan.	tatsuoy@med.niigata-u.ac.jp	Khokhlova, Olga/J-3119-2017	Khokhlova, Olga/0000-0002-2829-5117; TENG, LEE-JENE/0000-0003-0104-741X				Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; Clinical and Laboratory Standards Institute, 2011, M100S21 CLIN LAB SCI; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Corvaglia AR, 2010, P NATL ACAD SCI USA, V107, P11954, DOI 10.1073/pnas.1000489107; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Gomez JAL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016720; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Heaton MP, 1996, GENE, V171, P9, DOI 10.1016/0378-1119(96)00022-4; HIGUCHI W, 2010, J INFECT CHEMOTHER, V16, P144, DOI DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ho PL, 2007, DIAGN MICR INFEC DIS, V57, P145, DOI 10.1016/j.diagmicrobio.2006.08.003; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Huang TW, 2012, J BACTERIOL, V194, P1256, DOI 10.1128/JB.06666-11; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kawaguchiya M, 2011, MICROB DRUG RESIST, V17, P241, DOI 10.1089/mdr.2010.0136; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; SCHWARZ S, 1991, ANTIMICROB AGENTS CH, V35, P1551, DOI 10.1128/AAC.35.8.1551; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Sletvold H, 2010, J ANTIMICROB CHEMOTH, V65, P1894, DOI 10.1093/jac/dkq219; Sung JML, 2007, ANTIMICROB AGENTS CH, V51, P2189, DOI 10.1128/AAC.01442-06; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Werner G, 2003, MICROB DRUG RESIST, V9, pS9; Yamamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029187; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhang M, 2011, FEMS MICROBIOL LETT, V323, P20, DOI 10.1111/j.1574-6968.2011.02355.x	45	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46987	10.1371/journal.pone.0046987	http://dx.doi.org/10.1371/journal.pone.0046987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071689	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300074
J	Sorbye, SW; Kilvaer, TK; Valkov, A; Donnem, T; Smeland, E; Al-Shibli, K; Bremnes, RM; Busund, LT				Sorbye, Sveinung W.; Kilvaer, Thomas K.; Valkov, Andrej; Donnem, Tom; Smeland, Eivind; Al-Shibli, Khalid; Bremnes, Roy M.; Busund, Lill-Tove			Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; POOR-PROGNOSIS; PROTEIN P62; EXPRESSION; P27(KIP1); DEGRADATION; CANCER; GRADE; IMMUNOREACTIVITY; OVEREXPRESSION	Purpose: The purpose of this study is to clarify the prognostic significance of expression of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas (STS). Optimised treatment of STS requires better identification of high risk patients who will benefit from adjuvant therapy. The prognostic significance of Jab1, p16, p21, p62, Ki67 and Skp2 in STS has not been sufficiently investigated. Experimental Design: Tissue microarrays from 193 STS patients were constructed from duplicate cores of viable and representative neoplastic tumor areas. Immunohistochemistry was used to evaluate the expression of Jab1, p16, p21, p62, Ki67 and Skp2. Results: In univariate analyses, high tumor expression of Ki67 (P = 0.007) and Skp2 (P = 0.050) correlated with shorter disease-specific survival (DSS). In subgroup analysis, a correlation between Skp2 and DSS was seen in patients with malignancy grade 1 or 2 (P = 0.027), tumor size > 5 cm (P = 0.018), no radiotherapy given (P = 0.029) and no chemotherapy given (P = 0.017). No such relationship was apparent for Jab1, p16, p21 and p62; but p62 showed a positive correlation to malignancy grade (P = 0.019). Ki67 was strongly positively correlated to malignancy grade (P = 0.001). In multivariate analyses, Skp2 was an independent negative prognostic factor for DSS in women (P = 0.009) and in patients without administered chemotherapy or radiotherapy (P = 0.026). Conclusions: Increased expression of Skp2 in patients with soft tissue sarcomas is an independent negative prognostic factor for disease-specific survival in women and in patients not administered chemotherapy or radiotherapy. Besides, further studies are warranted to explore if adjuvant chemotherapy or radiotherapy improve the poor prognosis of STS with high Skp2 expression.	[Sorbye, Sveinung W.; Valkov, Andrej; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Sorbye, Sveinung W.; Kilvaer, Thomas K.; Valkov, Andrej; Al-Shibli, Khalid; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Kilvaer, Thomas K.; Donnem, Tom; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992	Northern Norway Regional Health Authority (Helse Nord RHF)	Northern Norway Regional Health Authority (Helse Nord RHF)	The work was supported by the Northern Norway Regional Health Authority (Helse Nord RHF, http://www.helse-nord. no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2009, ENDOCR J, V56, P707, DOI 10.1507/endocrj.K08E-372; Alamanda VK, 2012, J SURG ONCOL, V105, P662, DOI 10.1002/jso.23021; Lopez-Guerrero JA, 2011, INT J CANCER, V128, P1139, DOI 10.1002/ijc.25424; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Bodner-Adler B, 2005, GYNECOL ONCOL, V96, P62, DOI 10.1016/j.ygyno.2004.09.026; BROWN DC, 1990, HISTOPATHOLOGY, V17, P489, DOI 10.1111/j.1365-2559.1990.tb00788.x; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; D'Angelo E, 2011, GYNECOL ONCOL, V121, P328, DOI 10.1016/j.ygyno.2011.01.022; Davidovich S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2122; Di Vizio D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-134; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Endo M, 2011, CLIN CANCER RES, V17, P3771, DOI 10.1158/1078-0432.CCR-10-2393; Esteva FJ, 2003, CLIN CANCER RES, V9, P5652; Goto A, 2004, PATHOL INT, V54, P675, DOI 10.1111/j.1440-1827.2004.01679.x; Grobmyer SR, 2004, ANN ONCOL, V15, P1667, DOI 10.1093/annonc/mdh431; Hakverdi S, 2011, EUR J GYNAECOL ONCOL, V32, P513; Huang HY, 2008, ANN SURG ONCOL, V15, P2239, DOI 10.1245/s10434-008-9968-0; Huang HY, 2006, CLIN CANCER RES, V12, P487, DOI 10.1158/1078-0432.CCR-05-1497; Inoue D, 2012, CANCER SCI, V103, P760, DOI 10.1111/j.1349-7006.2012.02216.x; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Karim RZ, 2010, HISTOPATHOLOGY, V56, P868, DOI 10.1111/j.1365-2559.2010.03562.x; Kiatisevi Piya, 2006, Journal of the Medical Association of Thailand, V89, P334; Kim YT, 1998, GYNECOL ONCOL, V71, P38, DOI 10.1006/gyno.1998.5134; Kitamura H, 2006, HISTOPATHOLOGY, V48, P157, DOI 10.1111/j.1365-2559.2005.02313.x; Koea JB, 2003, ANN SURG ONCOL, V10, P432, DOI 10.1245/ASO.2003.05.014; Korbonits M, 2002, J CLIN ENDOCR METAB, V87, P2635, DOI 10.1210/jc.87.6.2635; Leiser AL, 2006, GYNECOL ONCOL, V101, P86, DOI 10.1016/j.ygyno.2005.09.055; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; Maitra A, 2001, AID IJC1006 3 0 CO; MATSUMOTO K, 1993, INT J COLORECTAL DIS, V8, P103, DOI 10.1007/BF00299337; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P669, DOI 10.1002/cncr.21264; MORI T, 1994, CANCER RES, V54, P3396; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Naini S, 2008, CANCER RES, V68, P9583, DOI 10.1158/0008-5472.CAN-07-6178; Nishijo K, 2009, CANCER RES, V69, P2902, DOI 10.1158/0008-5472.CAN-08-3723; Nocito A, 2001, INT J CANCER, V94, P1, DOI 10.1002/ijc.1385; Oliveira AM, 2003, J CLIN ONCOL, V21, P722, DOI 10.1200/JCO.2003.05.112; RANEY RB, 1983, CANCER-AM CANCER SOC, V52, P44, DOI 10.1002/1097-0142(19830701)52:1<44::AID-CNCR2820520110>3.0.CO;2-V; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rolland P, 2007, ENDOCR-RELAT CANCER, V14, P73, DOI 10.1677/erc.1.01312; Sabah M, 2007, APPL IMMUNOHISTO M M, V15, P64, DOI 10.1097/01.pai.0000201809.43554.ed; Shim BY, 2010, CANCER RES TREAT, V42, P144, DOI 10.4143/crt.2010.42.3.144; Thway K, 2012, AM J SURG PATHOL, V36, P462, DOI 10.1097/PAS.0b013e3182417330; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsuchida R, 2002, JPN J CANCER RES, V93, P1000, DOI 10.1111/j.1349-7006.2002.tb02476.x; Umanskaya K, 2007, MOL CELL BIOL, V27, P7615, DOI 10.1128/MCB.01239-07; Valkov A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-200; Valkov A, 2011, INT J ONCOL, V38, P1031, DOI 10.3892/ijo.2011.920; Van de Putte G, 2003, GYNECOL ONCOL, V89, P140, DOI 10.1016/S0090-8258(03)00010-6; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319; Wang J, 2011, BLOOD, V118, P5429, DOI 10.1182/blood-2010-10-312785; Wang ZW, 2012, FRONT ONCOL, V1, DOI [10.3389/fonc.2011.00057, 10.3389/fonc.2012.00201]; Wang ZW, 2012, BBA-REV CANCER, V1825, P11, DOI 10.1016/j.bbcan.2011.09.002; YANG RS, 1995, CANCER-AM CANCER SOC, V76, P1398, DOI 10.1002/1097-0142(19951015)76:8<1398::AID-CNCR2820760815>3.0.CO;2-B; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zagars GK, 2003, INT J RADIAT ONCOL, V57, P739, DOI 10.1016/S0360-3016(03)00714-4	64	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47068	10.1371/journal.pone.0047068	http://dx.doi.org/10.1371/journal.pone.0047068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071715	Green Submitted, gold, Green Published			2022-12-25	WOS:000309827300081
J	Stavik, B; Skretting, G; Olstad, OK; Sletten, M; Vigeland, MD; Sandset, PM; Iversen, N				Stavik, Benedicte; Skretting, Grethe; Olstad, Ole Kristoffer; Sletten, Marit; Vigeland, Magnus Dehli; Sandset, Per Morten; Iversen, Nina			TFPI Alpha and Beta Regulate mRNAs and microRNAs Involved in Cancer Biology and in the Immune System in Breast Cancer Cells	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; GROWTH-FACTOR RECEPTOR; EGF RECEPTOR; TUMOR-GROWTH; EXPRESSION; APOPTOSIS; TISSUE; GENE; TARGET; OVEREXPRESSION	Emerging evidence indicate a new role of TFPI in cancer biology. We recently reported that both isoforms of TFPI induced apoptosis and inhibited proliferation of cancer cells. The signaling pathway(s) mediating the effects of TFPI is, however, presently still unclear. Our goal was to further investigate the cellular processes affected by TFPI and to get insight into the molecular mechanisms involved in the effects of TFPI, using a global gene expression study approach. TFPI alpha or TFPI beta cDNA were transfected into SK-BR-3 breast cancer cells for stable overexpression. Global mRNA and microRNA (miRNA) expressions were measured and functional annotation of the differentially expressed genes and miRNAs according to gene ontology terms was conducted. Selected results were validated using qRT-PCR and Western blot. A total of 242 and 801 mRNA transcripts and 120 and 46 miRNAs were differentially expressed in cells overexpressing TFPI alpha or TFPI beta, respectively. Overexpression of either isoform significantly affected the expression of genes involved in cell development (apoptosis, cell movement, migration, invasion, colony formation, growth, and adhesion) and immune response. Network analyses revealed biological interactions between these genes and implied that several of the genes may be involved in both processes. The expression profiles also correlated significantly with clinical phenotype and outcome. Functional cluster analyses indicated altered activity of the epidermal growth factor receptor, small GTPases, and the NF-kappa B and JAK/STAT cascades when TFPI was overexpressed, and increased activity of the transcription factors NF-kappa B and Elk-1 and phospho-Akt levels was observed. Integrated mRNA-miRNA analyses showed that 19% and 32% of the differentially expressed genes in cells overexpressing TFPI alpha or TFPI beta, respectively, may have been regulated by miRNAs. Overexpression of TFPI in breast cancer cells affected the expression of mRNAs and miRNAs involved in processes facilitating cancer cell growth and immunologic response, possibly by signal transduction involving the EGFR pathway.	[Stavik, Benedicte; Sletten, Marit; Vigeland, Magnus Dehli; Iversen, Nina] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Stavik, Benedicte; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Oslo, Norway; [Skretting, Grethe; Sandset, Per Morten] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Haematol, N-0027 Oslo, Norway; [Skretting, Grethe; Sandset, Per Morten] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Olstad, Ole Kristoffer] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo	Stavik, B (corresponding author), Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.	nina.iversen@medisin.uio.no	Sandset, Per Morten/J-8141-2019; Stavik, Benedicte/U-3406-2017	Sandset, Per Morten/0000-0001-5556-8099; Stavik, Benedicte/0000-0003-3341-9847; Vigeland, Magnus Dehli/0000-0002-9134-4962	South-Eastern Norway Regional Health Authority, Hamar, Norway; S.G. Sonneland foundation; J.H.Jr. Andresen foundation; Eckbo foundation	South-Eastern Norway Regional Health Authority, Hamar, Norway; S.G. Sonneland foundation; J.H.Jr. Andresen foundation; Eckbo foundation	This work was funded by research grants from the South-Eastern Norway Regional Health Authority, Hamar, Norway (www.helse-sorost.no/), and S.G. Sonneland, Eckbo and J.H.Jr. Andresen foundations. (www.unifor.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhosravi A, 2002, THROMB HAEMOSTASIS, V87, P930; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Casalini P, 2001, J BIOL CHEM, V276, P12449, DOI 10.1074/jbc.M009732200; Collison A, 2009, CLIN EXP PHARMACOL P, V36, P1049, DOI 10.1111/j.1440-1681.2009.05258.x; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Danielsen AJ, 2002, GROWTH FACTORS, V20, P1, DOI 10.1080/08977190290022185; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; HARRIS RA, 1995, BRIT J CANCER, V72, P386, DOI 10.1038/bjc.1995.343; Hembrough TA, 2003, CANCER RES, V63, P2997; Hognason T, 2001, FEBS LETT, V491, P9, DOI 10.1016/S0014-5793(01)02166-4; Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kurer MA, 2007, MOL BIOL REP, V34, P221, DOI 10.1007/s11033-006-9036-4; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Masri S, 2010, BREAST CANCER RES TR, V124, P89, DOI 10.1007/s10549-009-0716-3; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Provencal M, 2008, THROMB HAEMOSTASIS, V99, P576, DOI 10.1160/TH07-10-0623; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi M, 2009, CANCER TREAT REV, V35, P328, DOI 10.1016/j.ctrv.2008.12.002; Shirotani-Ikejima H, 2002, BIOCHEM BIOPH RES CO, V299, P847, DOI 10.1016/S0006-291X(02)02759-6; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Sierko E, 2010, THROMB HAEMOSTASIS, V103, P198, DOI 10.1160/TH09-06-0416; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2010, MOL CARCINOGEN, V49, P951, DOI 10.1002/mc.20679; Tikhomirov O, 2004, J BIOL CHEM, V279, P12988, DOI 10.1074/jbc.M311655200; Uray IP, 2011, RECENT RESULTS CANC, V188, P147, DOI 10.1007/978-3-642-10858-7_13; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang ZQ, 2008, J CELL PHYSIOL, V216, P551, DOI 10.1002/jcp.21429; Wu ZS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-542; WUN TC, 1988, J BIOL CHEM, V263, P6001; Zhang J, 2003, CIRCULATION, V108, P623, DOI 10.1161/01.CIR.0000078642.45127.7B; Zhao XR, 2006, CELL BIOL INT, V30, P653, DOI 10.1016/j.cellbi.2006.04.004	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47184	10.1371/journal.pone.0047184	http://dx.doi.org/10.1371/journal.pone.0047184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071754	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300088
J	Ahmed, AH; Hamada, M; Shinada, T; Ohfune, Y; Weerasinghe, L; Garner, PP; Oswald, RE				Ahmed, H. Ahmed; Hamada, Makoto; Shinada, Tetsuro; Ohfune, Yasufumi; Weerasinghe, Laksiri; Garner, Philip P.; Oswald, Robert E.			The Structure of (-)-Kaitocephalin Bound to the Ligand Binding Domain of the (S)-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA)/Glutamate Receptor, GluA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; PARTIAL AGONISTS; AMPA RECEPTORS; ION CHANNELS; TERMINAL DOMAIN; MECHANISMS; ANTAGONISM; ACTIVATION	Glutamate receptors mediate the majority of excitatory synaptic transmission in the central nervous system, and excessive stimulation of these receptors is involved in a variety of neurological disorders and neuronal damage from stroke. The development of new subtype-specific antagonists would be of considerable therapeutic interest. Natural products can provide important new lead compounds for drug discovery. The only natural product known to inhibit glutamate receptors competitively is (-)-kaitocephalin, which was isolated from the fungus Eupenicillium shearii and found to protect CNS neurons from excitotoxicity. Previous work has shown that it is a potent antagonist of some subtypes of glutamate receptors (AMPA and NMDA, but not kainate). The structure of kaitocephalin bound to the ligand binding domain of the AMPA receptor subtype, GluA2, is reported here. The structure suggests how kaitocephalin can be used as a scaffold to develop more selective and high affinity antagonists for glutamate receptors.	[Ahmed, H. Ahmed; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Hamada, Makoto; Shinada, Tetsuro; Ohfune, Yasufumi] Osaka City Univ, Grad Sch Sci, Osaka 5588585, Japan; [Weerasinghe, Laksiri; Garner, Philip P.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Cornell University; Osaka Metropolitan University; Washington State University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu	; Weerasinghe, Laksiri/H-4185-2018	Garner, Philip/0000-0002-6503-9550; Weerasinghe, Laksiri/0000-0003-1255-1101	National Institutes of Health [R01-GM068935]; National Science Foundation; National Institutes of Health/NIGMS under National Science Foundation [DMR-0936384]; National Institutes of Health through the NIGMS [GM103485]; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) [19201045, 23102009]; Yamada Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935, P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/NIGMS under National Science Foundation; National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, National Institutes of Health Grant R01-GM068935 (to R. E. O.). This work is based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the National Institutes of Health/NIGMS under National Science Foundation award DMR-0936384, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by National Institutes of Health Award GM103485 through the NIGMS.; Supported by the Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) Grants-in-aid for Scientific Research 19201045 and 23102009 and the Yamada Science Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Case D. A., 2012, AMBER 12; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Hamada M, 2009, ORG LETT, V11, P4664, DOI 10.1021/ol9019343; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Hogner A, 2003, J MED CHEM, V46, P214, DOI 10.1021/jm020989v; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Kasper C, 2006, J MOL BIOL, V357, P1184, DOI 10.1016/j.jmb.2006.01.024; Kawasaki M, 2005, ORG LETT, V7, P4165, DOI 10.1021/ol0515154; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Limon A, 2010, ACS CHEM NEUROSCI, V1, P175, DOI 10.1021/cn900037c; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Nelson JK, 2009, ANGEW CHEM INT EDIT, V48, P3087, DOI 10.1002/anie.200805426; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ShinYa K, 1997, TETRAHEDRON LETT, V38, P7079, DOI 10.1016/S0040-4039(97)01653-5; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Steenland HW, 2008, EUR J NEUROSCI, V27, P1166, DOI 10.1111/j.1460-9568.2008.06078.x; Takahashi K, 2012, ORG LETT, V14, P1644, DOI 10.1021/ol300431n; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Ueda M, 2012, CHEM LETT, V41, P658, DOI 10.1246/cl.2012.658; Vaswani RG, 2008, J ORG CHEM, V73, P1661, DOI 10.1021/jo702329z; Vaswani RG, 2009, BIOORG MED CHEM LETT, V19, P132, DOI 10.1016/j.bmcl.2008.11.004; Watanabe H, 2002, TETRAHEDRON LETT, V43, P861, DOI 10.1016/S0040-4039(01)02255-9; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Yu SY, 2011, TETRAHEDRON, V67, P1673, DOI 10.1016/j.tet.2010.12.068	42	12	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41007	41013		10.1074/jbc.M112.416362	http://dx.doi.org/10.1074/jbc.M112.416362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076153	Green Published, hybrid			2022-12-25	WOS:000311887600018
J	Lankadeva, YR; Singh, RR; Hilliard, LM; Moritz, KM; Denton, KM				Lankadeva, Yugeesh R.; Singh, Reetu R.; Hilliard, Lucinda M.; Moritz, Karen M.; Denton, Kate M.			Blunted Sodium Excretion in Response to a Saline Load in 5 Year Old Female Sheep Following Fetal Uninephrectomy	PLOS ONE			English	Article							REDUCED NEPHRON ENDOWMENT; RENAL FUNCTIONAL RESERVE; ANGIOTENSIN-II; BLOOD-PRESSURE; AGING KIDNEY; HYPERTENSION; GROWTH; NATRIURESIS; INFUSION; DISEASE	Previously, we have shown that fetal uninephrectomy (uni-x) causes hypertension in female sheep by 2 years of age. Whilst the hypertension was not exacerbated by 5 years of age, these uni-x sheep had greater reductions in renal blood flow (RBF). To further explore these early indications of a decline in renal function, we investigated the renal response to a saline load (25 ml/kg/40 min) in 5-year old female uni-x and sham sheep. Basal mean arterial pressure was similar to 15 mmHg greater (P-Group<0.001), and sodium excretion (similar to 50%), glomerular filtration rate (similar to 30%, GFR) and RBF (similar to 40%) were all significantly lower (P-Group<0.01) in uni-x compared to sham animals. In response to saline loading, sodium excretion increased significantly in both groups (P-Time<0.001), however this response was blunted in uni-x sheep (P-GroupxTime<0.01). This was accompanied with an attenuated increase in GFR and fractional sodium excretion (both P-GroupxTime<0.05), and reduced activation of the renin-angiotensin system (both P<0.05), as compared to the sham group. The reduction in sodium excretion was associated with up-regulations in the renal gene expression of NHE3 and Na+/K+ ATPase alpha and beta subunits in the kidney cortex of the uni-x compared to the sham animals (P<0.05). Notably, neither group completely excreted the saline load within the recovery period, but the uni-x retained a higher percentage of the total volume (uni-x: 48+/-7%; sham: 22+/-9%, P<0.05). In conclusion, a reduced ability to efficiently regulate extracellular fluid homeostasis is evident in female sheep at 5 years of age, which was exacerbated in animals born with a congenital nephron deficit. Whilst there was no overt exacerbation of hypertension and renal insufficiency with age in the uni-x sheep, these animals may be more vulnerable to secondary renal insults.	[Lankadeva, Yugeesh R.; Hilliard, Lucinda M.; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Singh, Reetu R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	Monash University; Monash University; University of Queensland	Denton, KM (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	kate.denton@monash.edu	Denton, Kate/AAG-2423-2019; Lankadeva, Yugeesh/R-9253-2019; Moritz, Karen/G-2508-2015	Lankadeva, Yugeesh/0000-0002-3589-9111; Moritz, Karen/0000-0002-8085-0034; Krause, Lucinda/0000-0002-8634-6568; Denton, Kate/0000-0002-5929-4387	National Heart Foundation [G 05M 2110]; Monash University Research Fund; Faculty Scholarship, Monash University; Department of Physiology; Australian Postgraduate Award; Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC); NHMRC	National Heart Foundation(National Heart Foundation of Australia); Monash University Research Fund(Monash University); Faculty Scholarship, Monash University; Department of Physiology; Australian Postgraduate Award(Australian Government); Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a National Heart Foundation Grant (G 05M 2110) and Monash University Research Fund. YL was supported by a Faculty Scholarship, Monash University; Department of Physiology, RS was supported by an Australian Postgraduate Award and Monash University, Faculty of Medicine, Nursing and Health Sciences Bridging Post-Doctoral Fellowship. KM was supported by a National Health and Medical Research Council (NHMRC) Career Development Award and by an NHMRC Senior Research Fellowship and KD was supported by an NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Alwasel SH, 2012, PEDIATR NEPHROL, V27, P285, DOI 10.1007/s00467-011-1976-9; Baylis C, 1998, J AM SOC NEPHROL, V9, P699; Baylis C, 2009, NAT REV NEPHROL, V5, P384, DOI 10.1038/nrneph.2009.90; BHISITKUL DM, 1991, J PEDIATR-US, V118, P698, DOI 10.1016/S0022-3476(05)80029-0; Bie P, 2004, ACTA PHYSIOL SCAND, V181, P495, DOI 10.1111/j.1365-201X.2004.01323.x; Bie P, 2000, AM J PHYSIOL-REG I, V278, pR1, DOI 10.1152/ajpregu.2000.278.1.R1; Bubb KJ, 2007, J PHYSIOL-LONDON, V578, P871, DOI 10.1113/jphysiol.2006.121160; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; EARLEY LE, 1966, ANN NY ACAD SCI, V139, P312, DOI 10.1111/j.1749-6632.1966.tb41206.x; Epstein M, 1996, J AM SOC NEPHROL, V7, P1106; FLISER D, 1993, J AM SOC NEPHROL, V3, P1371; Gallo LA, 2012, HYPERTENSION, V60, P206, DOI 10.1161/HYPERTENSIONAHA.112.195578; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Girardi ACC, 2002, AM J PHYSIOL-RENAL, V283, pF1296, DOI 10.1152/ajprenal.00010.2002; Granger JP, 2002, CURR HYPERTENS REP, V4, P152, DOI 10.1007/s11906-002-0040-3; Granger JP, 1998, ADV PHYSIOL EDUC, V20, pS157, DOI 10.1152/advances.1998.275.6.S157; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; HAYSLETT JP, 1979, PHYSIOL REV, V59, P137, DOI 10.1152/physrev.1979.59.1.137; Hoang K, 2003, KIDNEY INT, V64, P1417, DOI 10.1046/j.1523-1755.2003.00207.x; HOLLENBERG NK, 1986, AM J MED, V81, P412, DOI 10.1016/0002-9343(86)90291-3; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; KASISKE BL, 1987, KIDNEY INT, V31, P1153, DOI 10.1038/ki.1987.122; Kett MM, 2011, AM J PHYSIOL-REG I, V300, pR791, DOI 10.1152/ajpregu.00791.2010; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Moritz KM, 1999, CLIN EXP PHARMACOL P, V26, P857, DOI 10.1046/j.1440-1681.1999.03155.x; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Moritz KM, 1999, PEDIATR NEPHROL, V13, P171, DOI 10.1007/s004670050587; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Ojeda NB, 2008, HYPERTENSION, V52, P44, DOI 10.1161/HYPERTENSIONAHA.107.092890; Ojeda NB, 2011, AM J PHYSIOL-REG I, V301, pR1199, DOI 10.1152/ajpregu.00219.2011; Ojeda NB, 2010, AM J PHYSIOL-REG I, V298, pR1421, DOI 10.1152/ajpregu.00096.2010; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1093, DOI 10.1681/ASN.2009070759; POLLOCK CA, 1992, PFLUG ARCH EUR J PHY, V420, P159, DOI 10.1007/BF00374985; RABINOWE SL, 1987, HYPERTENSION, V10, P404, DOI 10.1161/01.HYP.10.4.404; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; RYDSTEDT LL, 1986, HYPERTENSION, V8, P217, DOI 10.1161/01.HYP.8.3.217; Sandgaard NCF, 2000, AM J PHYSIOL-REG I, V278, pR11, DOI 10.1152/ajpregu.2000.278.1.R11; Schnermann J, 2003, J AM SOC NEPHROL, V14, P1681, DOI 10.1097/01.ASN.0000069221.69551.30; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Singh RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042400; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2010, CLIN SCI, V118, P669, DOI 10.1042/CS20090479; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Singh RR, 2011, AM J PHYSL RENAL PHY; TUCK ML, 1976, CIRC RES, V39, P711, DOI 10.1161/01.RES.39.5.711; Vehaskari VM, 2005, J AM SOC NEPHROL, V16, P2545, DOI 10.1681/ASN.2005030300; Yanes LL, 2011, AM J HYPERTENS, V24, P740, DOI 10.1038/ajh.2011.71	54	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47528	10.1371/journal.pone.0047528	http://dx.doi.org/10.1371/journal.pone.0047528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077628	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100124
J	Sabri, F; Marchetta, JG; Sinden-Redding, M; Habenicht, JJ; Chung, TP; Melton, CN; Hatch, CJ; Lirette, RL				Sabri, Firouzeh; Marchetta, Jeffrey G.; Sinden-Redding, M.; Habenicht, James J.; Thien Phung Chung; Melton, Charles N.; Hatch, Chris J.; Lirette, Robert L.			Effect of Surface Plasma Treatments on the Adhesion of Mars JSC 1 Simulant Dust to RTV 655, RTV 615, and Sylgard 184	PLOS ONE			English	Article							ATR FT-IR; SILICONE-RUBBER	Background: Dust accumulation on surfaces of critical instruments has been a major concern during lunar and Mars missions. Operation of instruments such as solar panels, chromatic calibration targets, as well as Extra Vehicular Activity (EVA) suits has been severely compromised in the past as a result of dust accumulation and adhesion. Wind storms with wind speeds of up to 70 mph have not been effective in removing significant amounts of the deposited dust. This is indeed an indication of the strength of the adhesion force(s) involved between the dust particles and the surface(s) that they have adhered to. Complications associated with dust accumulation are more severe for non-conducting surfaces and have been the focus of this work. Methodology: Argon plasma treatment was investigated as a mechanism for lowering dust accumulation on non-conducting polymeric surfaces. Polymers chosen for this study include a popular variety of silicones routinely used for space and terrestrial applications namely RTV 655, RTV 615, and Sylgard 184. Surface properties including wettability, surface potential, and surface charge density were compared before and after plasma treatment and under different storage conditions. Effect of ultraviolet radiation on RTV 655 was also investigated and compared with the effect of Ar plasma treatment. Conclusion/Significance: Gravimetric measurements proved Ar plasma treatment to be an effective method for eliminating dust adhesion to all three polymers after short periods of exposure. No physical damage was detected on any of the polymer surfaces after Ar plasma treatment. The surface potential of all three polymers remained zero up to three months post plasma exposure. Ultraviolet radiation however was not effective in reducing surface and caused damage and significant discoloration to RTV 655. Therefore, Ar plasma treatment can be an effective and non-destructive method for treating insulating polymeric surfaces in order to eliminate dust adhesion and accumulation.	[Sabri, Firouzeh; Sinden-Redding, M.; Habenicht, James J.; Thien Phung Chung; Melton, Charles N.; Hatch, Chris J.; Lirette, Robert L.] Univ Memphis, Dept Phys, Memphis, TN 38152 USA; [Marchetta, Jeffrey G.] Univ Memphis, Dept Mech Engn, Memphis, TN 38152 USA	University of Memphis; University of Memphis	Sabri, F (corresponding author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.	fsabri@memphis.edu		Lirette, Robert/0000-0003-1787-1059	APS Hildred Blewett Award; TN Space Grant Consortium	APS Hildred Blewett Award; TN Space Grant Consortium	The first author is the recipient of the 2008 APS Hildred Blewett Award and would like to acknowledge the agency for financial support. Financial support was also provided in part by the TN Space Grant Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELBAUM J, 1995, J PROPUL POWER, V11, P554, DOI 10.2514/3.23877; Chen D, 2010, J ACOUST SOC AM, V127, P45, DOI 10.1121/1.3268507; Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.2002.8594; EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030; FAKES DW, 1988, SURF INTERFACE ANAL, V13, P233, DOI 10.1002/sia.740130411; Farrell WM, 1999, J GEOPHYS RES-PLANET, V104, P3795, DOI 10.1029/98JE02821; Farrell WM, 2000, ACTA ASTRONAUT, V46, P25, DOI 10.1016/S0094-5765(99)00182-4; Feneberg P, 1976, US Patent, Patent No. 3959105; GABOURY SR, 1991, POLYM COMMUN, V32, P390; Gaier JR, 1992, 105232 NASA; Gunnlaugsson HP, 2000, PLANET SPACE SCI, V48, P1491, DOI 10.1016/S0032-0633(00)00097-0; HALL JR, 1969, J APPL POLYM SCI, V13, P2085, DOI 10.1002/app.1969.070131006; Hillborg H, 2000, POLYMER, V41, P6851, DOI 10.1016/S0032-3861(00)00039-2; HOLLAHAN JR, 1970, J APPL POLYM SCI, V14, P2499, DOI 10.1002/app.1970.070141006; Hviid SF, 1997, SCIENCE, V278, P1768, DOI 10.1126/science.278.5344.1768; Kim J, 1999, IEEE T DIELECT EL IN, V6, P695, DOI 10.1109/94.798126; KUZNETSOV AY, 1995, J APPL POLYM SCI, V57, P201, DOI 10.1002/app.1995.070570208; Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038; Lai JY, 1996, J ADHES SCI TECHNOL, V10, P231, DOI 10.1163/156856196X00364; Landis G, 2000, JBIS-J BRIT INTERPLA, V53, P117; Landis GA, 1996, ACTA ASTRONAUT, V38, P885, DOI 10.1016/S0094-5765(96)00088-4; Landis GA, 1997, IECEC-97 - PROCEEDINGS OF THE THIRTY-SECOND INTERSOCIETY ENERGY CONVERSION ENGINEERING CONFERENCE, VOLS 1-4, P764, DOI 10.1109/IECEC.1997.659288; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; Llovera P, 2004, IEEE T DIELECT EL IN, V11, P1049, DOI 10.1109/TDEI.2004.1387828; Llovera P, 2009, J ELECTROSTAT, V67, P457, DOI 10.1016/j.elstat.2009.01.004; Maheshwari N, 2010, APPL SURF SCI, V257, P451, DOI 10.1016/j.apsusc.2010.07.010; MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P; Noll W, 1968, CHEM TECHNOLOGY SILI; Noras MA, 2002, 3001 TRCK; OWEN MJ, 1994, J ADHES SCI TECHNOL, V8, P1063, DOI 10.1163/156856194X00942; Perko HA, 2002, THESIS COLORADO STAT; Rohr T, 2005, P 8 POL ADV TECHN IN; Rohr T, 2005, POL MAT SPAC ENV P 8; Sabri F, 2008, ADV SPACE RES, V41, P118, DOI 10.1016/j.asr.2007.06.074; STEWART MT, 1988, ABSTR PAP AM CHEM S, V196, P71; Stubbs TJ, 2005, IMP DUST LUN EXPL C, P239; TRIOLO PM, 1983, J BIOMED MATER RES, V17, P129, DOI 10.1002/jbm.820170111; URBAN MW, 1990, J APPL POLYM SCI, V39, P265, DOI 10.1002/app.1990.070390206; Wilson A., 2007, HI BOOK SERIES	39	10	10	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45719	10.1371/journal.pone.0045719	http://dx.doi.org/10.1371/journal.pone.0045719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077496	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100020
J	Zobor, D; Kohl, S; Wissinger, B; Zrenner, E; Jagle, H				Zobor, Ditta; Kohl, Susanne; Wissinger, Bernd; Zrenner, Eberhart; Jaegle, Herbert			Rod and Cone Function in Patients with KCNV2 Retinopathy	PLOS ONE			English	Article							SUPERNORMAL SCOTOPIC ERG; RETINAL DEGENERATION; POTASSIUM CHANNEL; RETINITIS-PIGMENTOSA; B-WAVES; DYSTROPHY; ELECTRORETINOGRAM; MUTATIONS; DYSFUNCTION; SUBUNIT	Background: To investigate rod and cone function and disease mechanisms in patients with KCNV2 retinopathy. Methodology/Principal Findings: Psychophysical examinations as well as detailed electrophysiological examinations with Ganzfeld and multifocal electroretinogram (ERG) were performed to study response dynamics. Additionally, fundus photography, autofluorescence imaging and spectral domain OCTs were carried out for morphological characterization. Molecular genetic analysis revealed compound heterozygosity in five patients and homozygosity for the KCNV2 gene in one patient. The mutations resulted in complete absence of Kv8.2 subunits in three patients (no protein group, NOP), while the other three patients expressed mutant Kv8.2 subunits resulting in altered Kv2.1/Kv8.2 heteromeric or residual Kv2.1 homomeric potassium channel function (altered protein group, ALP). Although more advanced morphological changes were visible in the NOP group, a clear functional difference between the two groups could not be observed. All patients showed characteristic dynamics of the b-wave intensity-response function, however, scotopic b-wave response amplitudes were within normal limits. We also observed severely reduced oscillatory potentials. Conclusions/Significance: A specific genotype-phenotype correlation in retinal function could not be demonstrated. KCNV2 mutations cause a unique form of retinal disorder illustrating the importance of K+-channels for the resting potential, activation and deactivation of photoreceptors, while phototransduction remains unchanged. The reduced oscillatory potentials further suggest an altered function of the inner retina. Besides the characteristically steep amplitude-versus-intensity relationship, flicker responses at intermediate frequencies (5-15 Hz) are significantly reduced and shifted in phase.	[Zobor, Ditta; Kohl, Susanne; Wissinger, Bernd] Univ Tubingen, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany; [Jaegle, Herbert] Univ Regensburg, Dept Ophthalmol, Regensburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg	Zobor, D (corresponding author), Univ Tubingen, Inst Ophthalm Res, Mol Genet Lab, Tubingen, Germany.	ditta.zobor@med.uni-tuebingen.de	Jägle, Herbert/GPP-2945-2022	Kohl, Susanne/0000-0002-6438-6331	German Research Foundation; Pro Retina Society; Kerstan & Tistou Foundation	German Research Foundation(German Research Foundation (DFG)); Pro Retina Society; Kerstan & Tistou Foundation	This study was supported in part by the German Research Foundation, Pro Retina Society and the Kerstan & Tistou Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1984, BRIT J OPHTHALMOL, V68, P69, DOI 10.1136/bjo.68.2.69; BARNES S, 1994, NEUROSCIENCE, V58, P447, DOI 10.1016/0306-4522(94)90072-8; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Ben Salah S, 2008, AM J OPHTHALMOL, V145, P1099, DOI 10.1016/j.ajo.2008.02.004; Czirjak G, 2007, J NEUROPHYSIOL, V98, P1213, DOI 10.1152/jn.00493.2007; EVANS LS, 1993, DOC OPHTHALMOL, V84, P19, DOI 10.1007/BF01203279; FOERSTER MH, 1990, GRAEF ARCH CLIN EXP, V228, P116, DOI 10.1007/BF02764303; Friedburg C, 2011, INVEST OPHTH VIS SCI, V52, P8621, DOI 10.1167/iovs.11-8187; GOURAS P, 1983, ARCH OPHTHALMOL-CHIC, V101, P718, DOI 10.1001/archopht.1983.01040010718003; Heckenlively JR, 2008, PRINCIPLE PRACTICE C; Hood DC, 1996, VISION RES, V36, P889, DOI 10.1016/0042-6989(95)00174-3; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Hood DC, 2008, DOC OPHTHALMOL, V116, P1, DOI 10.1007/s10633-007-9089-2; KATO M, 1993, DOC OPHTHALMOL, V84, P71, DOI 10.1007/BF01203284; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Michaelides M, 2005, BRIT J OPHTHALMOL, V89, P332, DOI 10.1136/bjo.2004.050567; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; NATHANS J, 1989, SCI AM, V260, P42, DOI 10.1038/scientificamerican0289-42; Pinilla I, 2005, EXP EYE RES, V80, P51, DOI 10.1016/j.exer.2004.08.012; Robson AG, 2010, RETINA-J RET VIT DIS, V30, P51, DOI 10.1097/IAE.0b013e3181bfe24e; ROSENBERG T, 1993, ACTA OPHTHALMOL, V71, P246; SANDBERG MA, 1990, INVEST OPHTH VIS SCI, V31, P2283; Schatz A, 2012, DOC OPHTHALMOL, V124, P27, DOI 10.1007/s10633-011-9302-1; Sergouniotis PI, 2012, BRIT J OPHTHALMOL, V96, P213, DOI 10.1136/bjo.2011.203638; Sharpe LT, 1998, J NEUROSCI, V18, P10053; Tanimoto N, 2005, DOC OPHTHALMOL, V110, P219, DOI 10.1007/s10633-005-7861-8; Thiagalingam S, 2007, OPHTHALMIC GENET, V28, P135, DOI 10.1080/13816810701503681; Thompson DA, 2011, J PHYSIOL-LONDON, V589, P1681, DOI 10.1113/jphysiol.2010.198531; Wissinger B, 2008, INVEST OPHTH VIS SCI, V49, P751, DOI 10.1167/iovs.07-0471; Wissinger B, 2011, HUM MUTAT, V32, P1398, DOI 10.1002/humu.21580; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; YAGASAKI K, 1986, DOC OPHTHALMOL, V63, P73, DOI 10.1007/BF00153014	33	23	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46762	10.1371/journal.pone.0046762	http://dx.doi.org/10.1371/journal.pone.0046762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077521	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100038
J	Loha, E; Lunde, TM; Lindtjorn, B				Loha, Eskindir; Lunde, Torleif Markussen; Lindtjorn, Bernt			Effect of Bednets and Indoor Residual Spraying on Spatio-Temporal Clustering of Malaria in a Village in South Ethiopia: A Longitudinal Study	PLOS ONE			English	Article							SPATIAL-ANALYSIS; LEVEL; TRANSMISSION; INFECTION; DISEASE	Background: Understanding the spatio-temporal pattern of malaria transmission where prevention and control measures are in place will help to fine-tune strategies. The objective of this study was to assess the effect of mass distribution of bednets and indoor residual spraying (IRS) with insecticides on the spatio-temporal clustering of malaria in one malaria endemic village in south Ethiopia. Methods: A longitudinal study was conducted from April 2009 to April 2011. The average population was 6631 in 1346 locations. We used active and passive searches for malaria cases for 101 weeks. SatScan v9.1.1 was used to identify statistically significant retrospective space-time clusters. A discrete Poisson based model was applied with the aim of identifying areas with high rates. PASW Statistics 18 was used to build generalized Poisson loglinear model. Results: The total number of both types of malaria episodes was 622, giving 45.1 episodes per 1000 persons per year; among these, episodes of Plasmodium falciparum and vivax infection numbered 316 (22.9 per 1000 per year) and 306 (22.2 per 1000 per year), respectively. IRS with Dichlorodiphenyltrichloroethane (DDT) and later with Deltamethrin and free mass distribution of insecticide-treated nets (ITNs) were carried out during the study period. There was space-time clustering of malaria episodes at a household level. The spatio-temporal clustering of malaria was not influenced by free mass distribution of ITNs; however, the time-span of the spatio-temporal clustering of malaria cases ended after IRS with Deltamethrin. The presence of clusters on the south-east edge of the village was consistent with the finding of an increasing risk of acquiring malaria infection for individuals who lived closer to the identified vector breeding site. Conclusion: The risk of getting malaria infection varied significantly within one village. Free mass distribution of ITNs did not influence the spatio-temporal clustering of malaria, but IRS might have eliminated malaria clustering.	[Loha, Eskindir] Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Loha, Eskindir; Lunde, Torleif Markussen; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Lunde, Torleif Markussen] Univ Bergen, Inst Geophys, Bergen, Norway	Hawassa University; University of Bergen; University of Bergen	Loha, E (corresponding author), Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia.	eskindir_loha@yahoo.com	loha, eskindir/AAN-4925-2020; Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984; Shumbullo, Eskindir Loha/0000-0003-0003-2734; Lunde, Torleif Markussen/0000-0002-5047-9668	Centre for International Health, University of Bergen, Norway	Centre for International Health, University of Bergen, Norway	This research project was funded by Centre for International Health, University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO TECHN REP SER; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; FMoH, 2008, ETH NAT MAL IND SURV; Frossling J, 2008, GEOSPATIAL HEALTH, V3, P39; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Ghebreyesus T. A., 2003, Ethiopian Journal of Health Development, V17, P1; Gregorio DI, 2006, INT J HLTH GEOGRAPHI, V5; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kulldorff M., 2021, SATSCANTM USER GUIDE; Lengeler C, 2009, COCHRANE DATABASE SY, V2004; Loha E, 2012, AM J TROP MED HYG, V87, P450, DOI 10.4269/ajtmh.2012.12-0155; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; Perez AM, 2005, PREV VET MED, V71, P197, DOI 10.1016/j.prevetmed.2005.07.005; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RHB, 2011, SNNP REG HLTH BUR PL; Ricketts TC, 2003, ANNU REV PUBL HEALTH, V24, P1, DOI 10.1146/annurev.publhealth.24.100901.140924; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Rushton G, 2003, ANNU REV PUBL HEALTH, V24, P43, DOI 10.1146/annurev.publhealth.24.012902.140843; Sadler RC, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-34; Wangdi K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-89; Wen L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-88; Wheeler DC, 2011, ENV HLTH, V10; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5; Zhou GF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020318	28	28	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47354	10.1371/journal.pone.0047354	http://dx.doi.org/10.1371/journal.pone.0047354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077598	Green Published, gold			2022-12-25	WOS:000309809500044
J	Zhang, S; Li, CZ; Yan, H; Qiu, W; Chen, YG; Wang, PH; Weng, SP; He, JG				Zhang, Shuang; Li, Chao-Zheng; Yan, Hui; Qiu, Wei; Chen, Yong-Gui; Wang, Pei-Hui; Weng, Shao-Ping; He, Jian-Guo			Identification and Function of Myeloid Differentiation Factor 88 (MyD88) in Litopenaeus vannamei	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; ANTIMICROBIAL PEPTIDE; MOLECULAR CHARACTERIZATION; SHRIMP; INFECTION; CLONING; CDNA; GENE; RECOGNITION	Myeloid differentiation factor 88 (MyD88) is a universal and essential signaling protein in Toll-like receptor/interleukin-1 receptor-induced activation of nuclear factor-kappa B. In this study, two MyD88 protein variants (LvMyD88 and LvMyD88-1) were identified in Litopenaeus vannamei. The LvMyD88 cDNA is 1,848 bp in length and contains an open reading frame (ORF) of 1,428 bp, whereas the LvMyD88-1 cDNA is 1,719 bp in length and has an ORF of 1,299 bp. Both variants encode proteins with death and Toll/interleukin-1 receptor domains and share 91% sequence identity. In healthy L. vannamei, the LvMyD88 genes were highly expressed in hemocytes but at a low level in the hepatopancreas. The LvMyD88s expression was induced in hemocytes after challenge with lipopolysaccharide, CpG-ODN2006, Vibrio parahaemolyticus, Staphyloccocus aureus, and white spot syndrome virus, but not by poly I: C. Overexpression of LvMyD88 and LvMyD88-1 in Drosophila Schneider 2 cells led to activation of antimicrobial peptide genes and wsv069 (ie1), wsv303, and wsv371. These results suggested that LvMyD88 may play a role in antibacterial and antiviral response in L. vannamei. To our knowledge, this is the first report on MyD88 in shrimp and a variant of MyD88 gene in invertebrates.	[Zhang, Shuang; Li, Chao-Zheng; Yan, Hui; Qiu, Wei; Wang, Pei-Hui; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yong-Gui; He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	He, JG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	Chaozheng, Li/E-4632-2016; Wang, Pei-Hui/F-7682-2014	Wang, Pei-Hui/0000-0001-6853-2423; Li, Chaozheng/0000-0001-7639-7831	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation of Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; Open Project of the State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation of Science and Technology Bureau of Guangdong Province [2011A 020102002, 2009A 020102002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; Foundation of Administration of Ocean and Fisheries of Guangdong Province; Open Project of the State Key Laboratory of Biocontrol; Foundation of Science and Technology Bureau of Guangdong Province	This research was supported by the National Natural Science Foundation of China under Grant No. U1131002, the National High Technology Research and Development Program of China (973 Program) 2012CB114401, the China Agriculture Research System, the Special Fund for Agro-scientific Research in the Public Interest 201103034, the Foundation of Administration of Ocean and Fisheries of Guangdong Province A201101B02, the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04) and the Foundation of Science and Technology Bureau of Guangdong Province (2011A 020102002 and 2009A 020102002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; Bachere E, 2000, AQUACULTURE, V191, P3, DOI 10.1016/S0044-8486(00)00413-0; Bonnert TP, 1997, FEBS LETT, V402, P81, DOI 10.1016/S0014-5793(96)01506-2; Chang YS, 2004, J GEN VIROL, V85, P2963, DOI 10.1099/vir.0.80132-0; Fan ZH, 2008, INFECT IMMUN, V76, P664, DOI 10.1128/IAI.00948-07; Hardiman G, 1996, ONCOGENE, V13, P2467; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kongchum P, 2011, FISH SHELLFISH IMMUN, V30, P361, DOI 10.1016/j.fsi.2010.11.012; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li XL, 2011, FISH SHELLFISH IMMUN, V30, P33, DOI 10.1016/j.fsi.2010.09.003; Lightner DV, 2007, DEV BIOLOGICALS, V129, P137; Lightner DV, 2006, DEV BIOLOGICALS, V126, P117; Lin YR, 2011, J VIROL, V85, P3517, DOI 10.1128/JVI.01973-10; LORD KA, 1990, ONCOGENE, V5, P1095; McTaggart SJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-63; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prothmann C, 2000, MECH DEVELOP, V97, P85, DOI 10.1016/S0925-4773(00)00447-0; Qiu LM, 2007, FISH SHELLFISH IMMUN, V23, P614, DOI 10.1016/j.fsi.2007.01.012; Rebl A, 2009, VET IMMUNOL IMMUNOP, V131, P122, DOI 10.1016/j.vetimm.2009.03.006; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Skjaeveland I, 2009, DEV COMP IMMUNOL, V33, P1011, DOI 10.1016/j.dci.2009.04.007; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takano T, 2006, DEV COMP IMMUNOL, V30, P807, DOI 10.1016/j.dci.2005.11.003; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tohno M, 2007, CELL MOL IMMUNOL, V4, P369; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Wang XW, 2006, P NATL ACAD SCI USA, V103, P4204, DOI 10.1073/pnas.0507044103; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Whang I, 2011, MOL BIOL REP, V38, P3911, DOI 10.1007/s11033-010-0507-2; WHEATON S, 2007, DNA SEQ, V0018, P00480; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yang LS, 2007, MOL IMMUNOL, V44, P1999, DOI 10.1016/j.molimm.2006.09.021; Yao CL, 2009, FISH SHELLFISH IMMUN, V26, P249, DOI 10.1016/j.fsi.2008.10.014	53	64	68	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47038	10.1371/journal.pone.0047038	http://dx.doi.org/10.1371/journal.pone.0047038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071706	gold, Green Submitted, Green Published			2022-12-25	WOS:000309809500031
J	Demachi-Okamura, A; Torikai, H; Akatsuka, Y; Miyoshi, H; Yoshimori, T; Kuzushima, K				Demachi-Okamura, Ayako; Torikai, Hiroki; Akatsuka, Yoshiki; Miyoshi, Hiroyuki; Yoshimori, Tamotsu; Kuzushima, Kiyotaka			Autophagy Creates a CTL Epitope That Mimics Tumor-Associated Antigens	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I MOLECULES; ADAPTIVE IMMUNITY; CROSS-PRESENTATION; CELL; CANCER; IDENTIFICATION; DEGRADATION; LYMPHOCYTES; PEPTIDE	The detailed mechanisms responsible for processing tumor-associated antigens and presenting them to CTLs remain to be fully elucidated. In this study, we demonstrate a unique CTL epitope generated from the ubiquitous protein puromycin-sensitive aminopeptidase, which is presented via HLA-A24 on leukemic and pancreatic cancer cells but not on normal fibroblasts or EBV-transformed B lymphoblastoid cells. The generation of this epitope requires proteasomal digestion and transportation from the endoplasmic reticulum to the Golgi apparatus and is sensitive to chloroquine-induced inhibition of acidification inside the endosome/lysosome. Epitope liberation depends on constitutively active autophagy, as confirmed with immunocytochemistry for the autophagosome marker LC3 as well as RNA interference targeting two different autophagy-related genes. Therefore, ubiquitously expressed proteins may be sources of specific tumor-associated antigens when processed through a unique mechanism involving autophagy.	[Demachi-Okamura, Ayako; Akatsuka, Yoshiki; Kuzushima, Kiyotaka] Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 464, Japan; [Torikai, Hiroki] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Akatsuka, Yoshiki] Fujita Hlth Univ, Dept Hematol & Oncol, Toyoake, Aichi, Japan; [Miyoshi, Hiroyuki] RIKEN, BioResource Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki, Japan; [Kuzushima, Kiyotaka] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4648601, Japan; [Yoshimori, Tamotsu] Osaka Univ, Grad Sch Med, Dept Genet, Osaka, Japan	Aichi Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Fujita Health University; RIKEN; Nagoya University; Osaka University	Demachi-Okamura, A (corresponding author), Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 464, Japan.	ademachi@aichi-cc.jp; kkuzushi@aichi-cc.jp	Yoshimori, Tamotsu/K-9626-2014; Miyoshi, Hiroyuki/G-9808-2013	Yoshimori, Tamotsu/0000-0001-9787-3788; akatsuka, yoshiki/0000-0003-3623-2826	Ministry of Health, Labor and Welfare, Japan [29]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23701079]; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work is supported by the Third Team Comprehensive Control Research for Cancer (no. 29) from the Ministry of Health, Labor and Welfare, Japan, by Grants-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 23701079), and Hayashi Memorial Foundation for Female Natural Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdin N, 1998, J IMMUNOL, V161, P3271; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IGUCHI H, 1994, ONCOL REP, V1, P1223; Ito H, 2005, INT J ONCOL, V26, P1401; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kondo E, 2004, BLOOD, V103, P630, DOI 10.1182/blood-2003-03-0824; KUBO RT, 1994, J IMMUNOL, V152, P3913; Kuzushima K, 2001, BLOOD, V98, P1872, DOI 10.1182/blood.V98.6.1872; Kuzushima K, 1999, BLOOD, V94, P3094, DOI 10.1182/blood.V94.9.3094.421k14_3094_3100; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang XH, 2001, CANCER RES, V61, P3443; Lizee G, 2005, TRENDS IMMUNOL, V26, P141, DOI 10.1016/j.it.2005.01.005; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nagata N, 2005, CLIN CANCER RES, V11, P5265, DOI 10.1158/1078-0432.CCR-04-2542; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; ROBBINS PF, 1995, J IMMUNOL, V154, P5944; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; Susan PP, 2001, J CELL PHYSIOL, V187, P48, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1050>3.0.CO;2-I; Tajima K, 2004, TISSUE ANTIGENS, V64, P650, DOI 10.1111/j.1399-0039.2004.00329.x; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; Torikai H, 2006, BRIT J HAEMATOL, V134, P406, DOI 10.1111/j.1365-2141.2006.06205.x; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	48	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47126	10.1371/journal.pone.0047126	http://dx.doi.org/10.1371/journal.pone.0047126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071732	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700057
J	Laurence, A; Houdelier, C; Petton, C; Calandreau, L; Arnould, C; Favreau-Peigne, A; Leterrier, C; Boissy, A; Richard-Yris, MA; Lumineau, S				Laurence, Agathe; Houdelier, Cecilia; Petton, Christophe; Calandreau, Ludovic; Arnould, Cecile; Favreau-Peigne, Angelique; Leterrier, Christine; Boissy, Alain; Richard-Yris, Marie-Annick; Lumineau, Sophie			Japanese Quail's Genetic Background Modulates Effects of Chronic Stress on Emotional Reactivity but Not Spatial Learning	PLOS ONE			English	Article							SOCIAL REINSTATEMENT BEHAVIOR; CHRONIC PSYCHOLOGICAL STRESS; TONIC IMMOBILITY; SEXUAL-BEHAVIOR; DOMESTIC QUAIL; MEMORY; CORTICOSTERONE; FEAR; LONG; SELECTION	Chronic stress is known to enhance mammals' emotional reactivity and alters several of their cognitive functions, especially spatial learning. Few studies have investigated such effects in birds. We investigated the impact of a two-week stress on Japanese quail's emotional reactivity and spatial learning. Quail is an avian model widely used in laboratory studies and for extrapolation of data to other poultry species. As sensitivity to chronic stress can be modulated by intrinsic factors, we tested juvenile female Japanese quail from three lines, two of them divergently selected on tonic immobility duration, an indicator of general fearfulness. The different emotional reactivity levels of quail belonging to these lines can be revealed by a large variety of tests. Half of the birds were submitted to repeated unpredictable aversive events for two weeks, whereas the other half were left undisturbed. After this procedure, two tests (open field and emergence tests) evaluated the emotional reactivity of treated and control quails. They were then trained in a T-maze for seven days and their spatial learning was tested. The chronic stress protocol had an impact on resting, preening and foraging in the home cage. As predicted, the emotional reactivity of treated quails, especially those selected for long tonic immobility duration, was higher. Our spatial learning data showed that the treatment enhanced acquisition but not memorization. However, intrinsic fearfulness did not seem to interact with the treatment in this test. According to an inverted U-shaped relationship between stress and cognition, chronic stress can improve the adaptability of birds to a stressful environment. We discussed the mechanisms possibly implied in the increase of emotional reactivity and spatial abilities.	[Laurence, Agathe; Houdelier, Cecilia; Petton, Christophe; Richard-Yris, Marie-Annick; Lumineau, Sophie] Univ Rennes 1, Ethos UMR 6552, CNRS, Rennes, France; [Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] Univ Tours, UMR Physiol Reprod & Comportements 85, INRA, CNRS, Nouzilly, France; [Boissy, Alain] INRA, Unite Rech Herbivores, F-63122 St Genes Champanelle, France; [Favreau-Peigne, Angelique] INRA, Modelisat Syst Appl Ruminants UMR791, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours; INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Laurence, A (corresponding author), Univ Rennes 1, Ethos UMR 6552, CNRS, Rennes, France.	agathe.laurence@univ-rennes1.fr	Leterrier, Christine/AAY-7201-2020	Favreau-Peigne, Angelique/0000-0002-6707-7825; Lumineau, Sophie/0000-0002-2076-9947	French National Research Agency (ANR)	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR), project Emofarm http://www.agence-nationale-recherche.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; AMMASSARITEULE M, 1993, BEHAV GENET, V23, P405, DOI 10.1007/BF01067443; Archer J., 1976, P231; Awerman JL, 2010, COMP BIOCHEM PHYS A, V156, P136, DOI 10.1016/j.cbpa.2010.01.010; Benetti F, 2009, INT J DEV NEUROSCI, V27, P59, DOI 10.1016/j.ijdevneu.2008.09.200; Bertin A, 2005, THESIS RENNES 1 U FR; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P289, DOI 10.1016/0168-1591(84)90121-7; BLOKHUIS HJ, 1983, WORLD POULTRY SCI J, V39, P33, DOI 10.1079/WPS19830003; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Bouissou MF, 1996, HORM BEHAV, V30, P93, DOI 10.1006/hbeh.1996.0013; Bowman RE, 2001, BRAIN RES, V904, P279, DOI 10.1016/S0006-8993(01)02474-X; Broom DM, 1997, DOMESTIC ANIMAL BEHA; Burns M, 1998, PSYCHOBIOLOGY, V26, P249; Cahill L, 1996, CURR OPIN NEUROBIOL, V6, P237, DOI 10.1016/S0959-4388(96)80078-X; Calandreau L, 2011, BEHAV BRAIN RES, V225, P505, DOI 10.1016/j.bbr.2011.08.010; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CASTANON N, 1994, PSYCHONEUROENDOCRINO, V19, P257, DOI 10.1016/0306-4530(94)90065-5; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; Dalm S, 2009, BEHAV BRAIN RES, V196, P84, DOI 10.1016/j.bbr.2008.07.035; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Dickens MJ, 2009, P R SOC B, V276, P2051, DOI 10.1098/rspb.2008.1778; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; DUNCAN IJH, 1972, ANIM BEHAV, V20, P444, DOI 10.1016/S0003-3472(72)80007-1; DUNCAN IJH, 1991, J ANIM SCI, V69, P5017, DOI 10.2527/1991.69125017x; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Gaikwad S, 2011, BEHAV PROCESS, V87, P224, DOI 10.1016/j.beproc.2011.04.004; Gibbs ME, 2000, NEUROSCIENCE, V95, P913; GINSBURG HJ, 1974, ANIM BEHAV, V22, P745, DOI 10.1016/S0003-3472(74)80027-8; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hawkins P, 2001, LAB ANIM-UK, V35, pS1; Hazard D, 2008, HORM BEHAV, V54, P645, DOI 10.1016/j.yhbeh.2008.07.002; Houdelier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014604; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; Janitzky K, 2011, BEHAV BRAIN RES, V219, P142, DOI 10.1016/j.bbr.2010.12.032; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Johnston ANB, 1998, BEHAV NEUROSCI, V112, P929, DOI 10.1037/0735-7044.112.4.929; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1994, PHYSIOL BEHAV, V56, P529, DOI 10.1016/0031-9384(94)90297-6; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; LAUNAY F, 1991, BEHAV PROCESS, V24, P95, DOI 10.1016/0376-6357(91)90002-H; Lehmann J, 1999, PHARMACOL BIOCHEM BE, V64, P705, DOI 10.1016/S0091-3057(99)00150-1; Lindqvist C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000364; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Mayer U, 2012, J PHYSL PAR IN PRESS; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Mills AD, 2000, APPL ANIM BEHAV SCI, V69, P125, DOI 10.1016/S0168-1591(00)00126-X; MISSLIN R, 1986, BEHAV PROCESS, V12, P45, DOI 10.1016/0376-6357(86)90069-0; MOORE FL, 1984, HORM BEHAV, V18, P400, DOI 10.1016/0018-506X(84)90026-6; MURPHY LB, 1978, ANIM BEHAV, V26, P422, DOI 10.1016/0003-3472(78)90059-3; Nazar FN, 2011, STRESS, V14, P166, DOI 10.3109/10253890.2010.523093; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pardon MC, 2000, J PSYCHIATR NEUROSCI, V25, P167; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Radley JJ, 2005, AGEING RES REV, V4, P271, DOI 10.1016/j.arr.2005.03.004; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; Rich EL, 2005, AM J PHYSIOL-REG I, V288, pR1628, DOI 10.1152/ajpregu.00484.2004; Rushen J, 2000, BIOLOGY OF ANIMAL STRESS, P23, DOI 10.1079/9780851993591.0023; Saint-Dizier H, 2008, APPL ANIM BEHAV SCI, V112, P297, DOI 10.1016/j.applanim.2007.09.005; Sandi C, 1997, EUR J NEUROSCI, V9, P637, DOI 10.1111/j.1460-9568.1997.tb01412.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Spencer KA, 2007, HORM BEHAV, V51, P273, DOI 10.1016/j.yhbeh.2006.11.001; Spencer KA, 2009, ENDOCRINOLOGY, V150, P1931, DOI 10.1210/en.2008-1471; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Valance D, 2007, PHYSIOL BEHAV, V90, P165, DOI 10.1016/j.physbeh.2006.09.022; Vedhara K, 2000, PSYCHONEUROENDOCRINO, V25, P535, DOI 10.1016/S0306-4530(00)00008-1; Von Frijtag JC, 2000, BEHAV BRAIN RES, V117, P137, DOI 10.1016/S0166-4328(00)00300-4; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WOODARD AE, 1969, POULTRY SCI, V48, P118, DOI 10.3382/ps.0480118	84	16	16	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47475	10.1371/journal.pone.0047475	http://dx.doi.org/10.1371/journal.pone.0047475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071811	Green Submitted, gold, Green Published			2022-12-25	WOS:000309807700083
J	Pragman, AA; Kim, HB; Reilly, CS; Wendt, C; Isaacson, RE				Pragman, Alexa A.; Kim, Hyeun Bum; Reilly, Cavan S.; Wendt, Christine; Isaacson, Richard E.			The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SP NOV.; RIBOSOMAL-RNA; GEN. NOV.; EXACERBATIONS; ABSCESS; SAMPLES; HEALTH	Chronic obstructive pulmonary disease ( COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction. Bacterial infection of the lower respiratory tract contributes to approximately 50% of COPD exacerbations. Even during periods of stable lung function, the lung harbors a community of bacteria, termed the microbiome. The role of the lung microbiome in the pathogenesis of COPD remains unknown. The COPD lung microbiome, like the healthy lung microbiome, appears to reflect microaspiration of oral microflora. Here we describe the COPD lung microbiome of 22 patients with Moderate or Severe COPD compared to 10 healthy control patients. The composition of the lung microbiomes was determined using 454 pyrosequencing of 16S rDNA found in bronchoalveolar lavage fluid. Sequences were analyzed using mothur, Ribosomal Database Project, Fast UniFrac, and Metastats. Our results showed a significant increase in microbial diversity with the development of COPD. The main phyla in all samples were Actinobacteria, Firmicutes, and Proteobacteria. Principal coordinate analyses demonstrated separation of control and COPD samples, but samples did not cluster based on disease severity. However, samples did cluster based on the use of inhaled corticosteroids and inhaled bronchodilators. Metastats analyses demonstrated an increased abundance of several oral bacteria in COPD samples.	[Kim, Hyeun Bum; Isaacson, Richard E.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Pragman, Alexa A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Wendt, Christine] VA Med Ctr, Dept Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Isaacson, RE (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	isaac015@umn.edu	Pragman, Alexa/AAI-3715-2021	Pragman, Alexa/0000-0001-8152-3951	National Institutes of Health from National Institutes of Allergy and Infectious Diseases [T32-AI55433]; National Heart, Lung and Blood Institute [NO10HR-96140]; DIVISION OF LUNG DISEASES [N01HR096140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055433] Funding Source: NIH RePORTER	National Institutes of Health from National Institutes of Allergy and Infectious Diseases; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant T32-AI55433 from the National Institutes of Allergy and Infectious Diseases and the FORTE study from the National Heart, Lung and Blood Institute, contract NO10HR-96140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Masalma M, 2009, INT J SYST EVOL MICR, V59, P2232, DOI 10.1099/ijs.0.007823-0; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Behl D, 2008, J HOSP MED, V3, P81, DOI 10.1002/jhm.251; Bisgaard H, 2007, NEW ENGL J MED, V127; Blaser MJ, 2010, P NATL ACAD SCI USA, V107, P6125, DOI 10.1073/pnas.1002112107; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Couzin-Frankel J, 2010, SCIENCE, V330, P1168, DOI 10.1126/science.330.6008.1168; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Godara N, 2011, LUNG INDIA, V28, P272, DOI 10.4103/0970-2113.85689; Gold PM, 2009, RESP CARE, V54, P1040; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hirschmann JV, 2000, CHEST, V118, P193, DOI 10.1378/chest.118.1.193; Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189, DOI 10.1099/00207713-50-6-2189; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hsiao WWL, 2012, BMC GENOMICS; Huang YJ, 2011, EXPERT REV RESP MED, V5, P809, DOI [10.1586/ERS.11.76, 10.1586/ers.11.76]; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jumas-Bilak E, 2007, INT J SYST EVOL MICR, V57, P2743, DOI 10.1099/ijs.0.65213-0; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Lemieszek M, 2011, ANN AGR ENV MED, V18, P159; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Robertson D, 2009, J MED MICROBIOL, V58, P155, DOI 10.1099/jmm.0.003517-0; Romeo L, 2009, INT J OCCUP ENV HEAL, V15, P249; Roth MD, 2006, CHEST, V130, P1334, DOI 10.1378/chest.130.5.1334; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Steinberg JP., 2010, PRINCIPLES PRACTICE, P3015; Sze MA, 2012, AM J RESP CRIT CARE; Teles FRF, 2011, MOL ORAL MICROBIOL, V26, P127, DOI 10.1111/j.2041-1014.2010.00603.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang QB, 2010, J ENDODONT, V36, P218, DOI 10.1016/j.joen.2009.11.001; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	40	270	287	9	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47305	10.1371/journal.pone.0047305	http://dx.doi.org/10.1371/journal.pone.0047305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071781	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700073
J	Hiblot, J; Gotthard, G; Chabriere, E; Elias, M				Hiblot, Julien; Gotthard, Guillaume; Chabriere, Eric; Elias, Mikael			Structural and Enzymatic characterization of the lactonase SisLac from Sulfolobus islandicus	PLOS ONE			English	Article							QUORUM-QUENCHING LACTONASE; RAY DIFFRACTION ANALYSIS; THERMOSTABLE PHOSPHOTRIESTERASE; 3-DIMENSIONAL STRUCTURE; DIRECTED EVOLUTION; VIRULENCE; CRYSTALLIZATION; SOLFATARICUS; PROMISCUITY; GEOBACILLUS	Background: A new member of the Phosphotriesterase-Like Lactonases (PLL) family from the hyperthermophilic archeon Sulfolobus islandicus (SisLac) has been characterized. SisLac is a native lactonase that exhibits a high promiscuous phosphotriesterase activity. SisLac thus represents a promising target for engineering studies, exhibiting both detoxification and bacterial quorum quenching abilities, including human pathogens such as Pseudomonas aeruginosa. Methodology/Principal Findings: Here, we describe the substrate specificity of SisLac, providing extensive kinetic studies performed with various phosphotriesters, esters, N-acyl-homoserine lactones (AHLs) and other lactones as substrates. Moreover, we solved the X-ray structure of SisLac and structural comparisons with the closely related SsoPox structure highlighted differences in the surface salt bridge network and the dimerization interface. SisLac and SsoPox being close homologues (91% sequence identity), we undertook a mutational study to decipher these structural differences and their putative consequences on the stability and the catalytic properties of these proteins. Conclusions/Significance: We show that SisLac is a very proficient lactonase against aroma lactones and AHLs as substrates. Hence, data herein emphasize the potential role of SisLac as quorum quenching agent in Sulfolobus. Moreover, despite the very high sequence homology with SsoPox, we highlight key epistatic substitutions that influence the enzyme stability and activity.	[Hiblot, Julien; Gotthard, Guillaume; Chabriere, Eric] Univ Mediterranee, Fac Med & Pharm, CNRS IRD, URMITE UMR 6236,IFR48, Marseille, France; [Elias, Mikael] Weizmann Inst Sci, IL-76100 Rehovot, Israel	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Weizmann Institute of Science	Chabriere, E (corresponding author), Univ Mediterranee, Fac Med & Pharm, CNRS IRD, URMITE UMR 6236,IFR48, Marseille, France.	Eric.chabriere@univmed.fr; Mikael.elias@weizmann.ac.il	Elias, Mikael/AAH-9385-2021; Elias, Mikael/C-8484-2011; Hiblot, Julien/AAA-4452-2020	Elias, Mikael/0000-0003-0406-7539; Elias, Mikael/0000-0003-0406-7539; Hiblot, Julien/0000-0002-7883-8079	Direction Generale de l'armement (D.G.A.), France [REI. 2009 34 0045]; Vaincre La Mucoviscidose, France; D.G.A.; IEF Marie Curie program [252836]	Direction Generale de l'armement (D.G.A.), France; Vaincre La Mucoviscidose, France; D.G.A.; IEF Marie Curie program	This work was granted by Direction Generale de l'armement (D.G.A.), France (REI. 2009 34 0045) and Vaincre La Mucoviscidose, France. J.H. and G.G. are PhD students granted by D.G.A. M.E. is a fellow supported by the IEF Marie Curie program (grant No. 252836). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY; Amara N, 2011, CHEM REV, V111, P195, DOI 10.1021/cr100101c; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; Auernik KS, 2008, CURR OPIN BIOTECH, V19, P445, DOI 10.1016/j.copbio.2008.08.001; Ben-David M, 2012, J MOL BIOL, V418, P181, DOI 10.1016/j.jmb.2012.02.042; Chow JY, 2010, J BIOL CHEM, V285, P40911, DOI 10.1074/jbc.M110.177139; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Del Vecchio P, 2009, EXTREMOPHILES, V13, P461, DOI 10.1007/s00792-009-0231-9; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Dickschat JS, 2010, NAT PROD REP, V27, P343, DOI 10.1039/b804469b; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Draganov DI, 2010, CHEM-BIOL INTERACT, V187, P370, DOI 10.1016/j.cbi.2010.01.039; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; DUMAS DP, 1990, J BIOL CHEM, V265, P21498; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Elias M, 2007, ACTA CRYSTALLOGR F, V63, P553, DOI 10.1107/S1744309107023512; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gotthard G, 2011, ACTA CRYSTALLOGR F, V67, P354, DOI 10.1107/S1744309110053819; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; Hawwa R, 2009, J MOL BIOL, V393, P36, DOI 10.1016/j.jmb.2009.06.083; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Jackson CJ, 2006, BIOCHEM J, V397, P501, DOI 10.1042/BJ20060276; Jones MB, 2010, VIRULENCE, V1, P72, DOI 10.4161/viru.1.2.10752; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Koerdt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014104; Ma F, 2009, APPL MICROBIOL BIOT, V83, P135, DOI 10.1007/s00253-009-1890-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMullan G, 2004, BIOCHEM SOC T, V32, P214, DOI 10.1042/BST0320214; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Merone L, 2010, BIORESOURCE TECHNOL, V101, P9204, DOI 10.1016/j.biortech.2010.06.102; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; NG FS, 2010, APPL ENV MICROBIOL; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OMBURO GA, 1992, J BIOL CHEM, V267, P13278; Paggi RA, 2003, FEMS MICROBIOL LETT, V221, P49, DOI 10.1016/S0378-1097(03)00174-5; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Popat R, 2008, BRIT MED BULL, V87, P63, DOI 10.1093/bmb/ldn030; Porzio E, 2007, BIOCHIMIE, V89, P625, DOI 10.1016/j.biochi.2007.01.007; Raushel FM, 2002, CURR OPIN MICROBIOL, V5, P288, DOI 10.1016/S1369-5274(02)00314-4; Reimmann C, 2002, MICROBIOL-SGM, V148, P923, DOI 10.1099/00221287-148-4-923; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Reynolds DJ, BIOINFORMATICS UNPUB; Rochu D, 2004, BIOCHEM J, V380, P627, DOI 10.1042/BJ20031861; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vanhooke JL, 1996, BIOCHEMISTRY-US, V35, P6020, DOI 10.1021/bi960325l; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; Zhang G, 2012, ISME J; ZWART P, 2005, CCP4 NEWSLETTER  WIN	61	52	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47028	10.1371/journal.pone.0047028	http://dx.doi.org/10.1371/journal.pone.0047028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071703	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200070
J	Sawicki, M; Jeanson, E; Celiz, V; Clement, C; Jacquard, C; Vaillant-Gaveau, N				Sawicki, Melodie; Jeanson, Etienne; Celiz, Vanessa; Clement, Christophe; Jacquard, Cedric; Vaillant-Gaveau, Nathalie			Adaptation of Grapevine Flowers to Cold Involves Different Mechanisms Depending on Stress Intensity	PLOS ONE			English	Article							VITIS-VINIFERA L.; CHLOROPHYLL FLUORESCENCE; GAS-EXCHANGE; PHOTOSYNTHETIC PERFORMANCE; CARBOHYDRATE CONTENT; NIGHT TEMPERATURES; STARCH RESERVES; PLASMA-MEMBRANE; WATER-STRESS; FRUIT-SET	Grapevine flower development and fruit set are influenced by cold nights in the vineyard. To investigate the impact of cold stress on carbon metabolism in the inflorescence, we exposed the inflorescences of fruiting cuttings to chilling and freezing temperatures overnight and measured fluctuations in photosynthesis and sugar content. Whatever the temperature, after the stress treatment photosynthesis was modified in the inflorescence, but the nature of the alteration depended on the intensity of the cold stress. At 4 degrees C, photosynthesis in the inflorescence was impaired through non-stomatal limitations, whereas at 0 degrees C it was affected through stomatal limitations. A freezing night (-3 degrees C) severely deregulated photosynthesis in the inflorescence, acting primarily on photosystem II. Cold nights also induced accumulation of sugars. Soluble carbohydrates increased in inflorescences exposed to -3 degrees C, 0 degrees C and 4 degrees C, but starch accumulated only in inflorescences of plants treated at 0 and -3 degrees C. These results suggest that inflorescences are able to cope with cold temperatures by adapting their carbohydrate metabolism using mechanisms that are differentially induced according to stress intensity. Citation: Sawicki M, Jeanson E, Celiz V, Clement C, Jacquard C, et al. (2012) Adaptation of Grapevine Flowers to Cold Involves Different Mechanisms Depending on Stress Intensity. PLoS ONE 7(10): e46976. doi:10.1371/journal.pone.0046976	[Sawicki, Melodie; Jeanson, Etienne; Celiz, Vanessa; Clement, Christophe; Jacquard, Cedric; Vaillant-Gaveau, Nathalie] Univ Reims, Lab Stress Def & Reprod Plantes, Unite Rech Vignes & Vins Champagne EA 4707, UFR Sci Exactes & Nat, Reims, France	Universite de Reims Champagne-Ardenne	Vaillant-Gaveau, N (corresponding author), Univ Reims, Lab Stress Def & Reprod Plantes, Unite Rech Vignes & Vins Champagne EA 4707, UFR Sci Exactes & Nat, Reims, France.	nathalie.vaillant-gaveau@univ-reims.fr	GAVEAU, Nathalie/K-3030-2012; /AGD-9438-2022	Jacquard, Cedric/0000-0003-4284-6082	Champagne-Ardenne Region Council	Champagne-Ardenne Region Council(Region Grand-Est)	The authors thank the Champagne-Ardenne Region Council for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2000, J EXP BOT, V51, P1893, DOI 10.1093/jexbot/51.352.1893; Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Balibrea ME, 1997, J PLANT PHYSIOL, V151, P221, DOI 10.1016/S0176-1617(97)80156-3; BALO B, 1991, PHOTOSYNTHETICA, V25, P227; Barka EA, 1996, CAN J BOT, V74, P492, DOI 10.1139/b96-060; BAUER H, 1985, PHYSIOL PLANTARUM, V64, P449, DOI 10.1111/j.1399-3054.1985.tb08521.x; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bertamini M, 2007, BIOL PLANTARUM, V51, P381, DOI 10.1007/s10535-007-0080-2; Bertamini M, 2005, PHOTOSYNTHETICA, V43, P551, DOI 10.1007/s11099-005-0087-x; Bertamini M, 2006, ENVIRON EXP BOT, V57, P25, DOI 10.1016/j.envexpbot.2005.04.002; BUTTROSE MS, 1973, AM J ENOL VITICULT, V24, P14; CANDOLFIVASCONCELOS MC, 1990, VITIS, V29, P199; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Clement C, 1996, AM J BOT, V83, P459, DOI 10.2307/2446215; Ebadi A., 1995, Australian Journal of Grape and Wine Research, V1, P3, DOI 10.1111/j.1755-0238.1995.tb00071.x; Ebadi A., 1995, Australian Journal of Grape and Wine Research, V1, P11, DOI 10.1111/j.1755-0238.1995.tb00072.x; EWART A, 1977, AM J ENOL VITICULT, V28, P88; Fernandez O, 2012, PLANTA, V236, P355, DOI 10.1007/s00425-012-1611-4; Fernandez O, 2012, MOL PLANT MICROBE IN, V25, P496, DOI 10.1094/MPMI-09-11-0245; Flexas J, 1999, PLANT PHYSIOL, V121, P675, DOI 10.1104/pp.121.2.675; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Garstka M, 2007, PLANTA, V226, P1165, DOI 10.1007/s00425-007-0562-7; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; HALLGREN JE, 1990, STRESS RESPONSES PLA, P265; Hamman RA, 1996, AM J ENOL VITICULT, V47, P31; HAVAUX M, 1991, ENVIRON EXP BOT, V31, P23, DOI 10.1016/0098-8472(91)90004-8; Hendrickson L, 2004, PLANT CELL ENVIRON, V27, P795, DOI 10.1111/j.1365-3040.2004.01184.x; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Jean D, 2001, PHYSIOL PLANTARUM, V112, P379, DOI 10.1034/j.1399-3054.2001.1120311.x; JOLY RJ, 1991, TREE PHYSIOL, V9, P415, DOI 10.1093/treephys/9.3.415; Kaur G, 2011, SCI HORTIC-AMSTERDAM, V128, P174, DOI 10.1016/j.scienta.2011.01.037; Kerepesi I, 2000, CROP SCI, V40, P482, DOI 10.2135/cropsci2000.402482x; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Lebon G, 2008, J EXP BOT, V59, P2565, DOI 10.1093/jxb/ern135; Lebon G, 2005, ANN BOT-LONDON, V95, P943, DOI 10.1093/aob/mci108; Lebon G, 2004, SEX PLANT REPROD, V17, P71, DOI 10.1007/s00497-004-0217-9; Luo HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023033; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; MARTIN B, 1985, PHOTOSYNTH RES, V6, P121, DOI 10.1007/BF00032787; Matsuda O, 2005, J BIOL CHEM, V280, P3597, DOI 10.1074/jbc.M407226200; Matteucci M, 2011, J EXP BOT, V62, P3403, DOI 10.1093/jxb/err013; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Moutinho-Pereira JM, 2004, PHOTOSYNTHETICA, V42, P81, DOI 10.1023/B:PHOT.0000040573.09614.1d; Mullins MG., 1992, BIOL GRAPEVINE BIOL; NIIMI Y, 1978, J JPN SOC HORTIC SCI, V47, P301, DOI 10.2503/jjshs.47.301; OSMOND CB, 1995, J EXP BOT, V46, P1351, DOI 10.1093/jxb/46.special_issue.1351; Palliotti A, 2001, AM J ENOL VITICULT, V52, P317; Pelah D, 1997, PHYSIOL PLANTARUM, V99, P153, DOI 10.1034/j.1399-3054.1997.990121.x; Petit AN, 2008, J AGR FOOD CHEM, V56, P6761, DOI 10.1021/jf800919u; Petit AN, 2009, J EXP BOT, V60, P1155, DOI 10.1093/jxb/ern361; Petrie PR, 2005, AUST J GRAPE WINE R, V11, P59, DOI 10.1111/j.1755-0238.2005.tb00279.x; Poni S, 2009, AGR ECOSYST ENVIRON, V129, P97, DOI 10.1016/j.agee.2008.07.009; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Ruelland E, 2010, ENVIRON EXP BOT, V69, P225, DOI 10.1016/j.envexpbot.2010.05.011; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Saini HS, 1997, SEX PLANT REPROD, V10, P67, DOI 10.1007/s004970050069; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; STEPONKUS PL, 1989, J BIOENERG BIOMEMBR, V21, P21, DOI 10.1007/BF00762210; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Theocharis A, 2012, PLANTA, V235, P1091, DOI 10.1007/s00425-012-1641-y; Uemura M, 2003, PLANT PHYSIOL, V131, P1800, DOI 10.1104/pp.102.013227; Uemura M, 1999, J PLANT RES, V112, P245, DOI 10.1007/PL00013882; Vaillant-Gaveau N, 2011, J EXP BOT, V62, P4183, DOI 10.1093/jxb/err121; Van Heerden PDR, 2004, PLANT PHYSIOL BIOCH, V42, P117, DOI 10.1016/j.plaphy.2003.11.007; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VEMMOS SN, 1994, ANN BOT-LONDON, V73, P385, DOI 10.1006/anbo.1994.1048; Vogg G, 1998, PLANTA, V204, P201, DOI 10.1007/s004250050247; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Warren CR, 2008, J EXP BOT, V59, P1475, DOI 10.1093/jxb/erm245; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Yang TB, 2010, J BIOL CHEM, V285, P7119, DOI 10.1074/jbc.M109.035659; Yu DJ, 2009, BIOL PLANTARUM, V53, P133, DOI 10.1007/s10535-009-0019-x; Zapata C, 2004, FUNCT PLANT BIOL, V31, P1127, DOI 10.1071/FP04028; Zapata C, 2004, J PLANT PHYSIOL, V161, P1031, DOI 10.1016/j.jplph.2003.11.009	79	15	17	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46976	10.1371/journal.pone.0046976	http://dx.doi.org/10.1371/journal.pone.0046976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071684	gold, Green Published, Green Submitted			2022-12-25	WOS:000312385200060
J	Ciccarone, F; Klinger, FG; Catizone, A; Calabrese, R; Zampieri, M; Bacalini, MG; De Felici, M; Caiafa, P				Ciccarone, Fabio; Klinger, Francesca Gioia; Catizone, Angela; Calabrese, Roberta; Zampieri, Michele; Bacalini, Maria Giulia; De Felici, Massimo; Caiafa, Paola			Poly(ADP-ribosyl)ation Acts in the DNA Demethylation of Mouse Primordial Germ Cells Also with DNA Damage-Independent Roles	PLOS ONE			English	Article							BASE EXCISION-REPAIR; GENOMIC METHYLATION PATTERNS; CPG ISLAND METHYLATION; DE-NOVO METHYLATION; ADP-RIBOSE POLYMERS; METHYLTRANSFERASE EXPRESSION; PREIMPLANTATION DEVELOPMENT; ACTIVATES PARP-1; MAMMALIAN-CELLS; DNMT1	Poly(ADP-ribosyl)ation regulates chromatin structure and transcription driving epigenetic events. In particular, Parp1 is able to directly influence DNA methylation patterns controlling transcription and activity of Dnmt1. Here, we show that ADPribose polymer levels and Parp1 expression are noticeably high in mouse primordial germ cells (PGCs) when the bulk of DNA demethylation occurs during germline epigenetic reprogramming in the embryo. Notably, Parp1 activity is stimulated in PGCs even before its participation in the DNA damage response associated with active DNA demethylation. We demonstrate that PARP inhibition impairs both genome-wide and locus-specific DNA methylation erasure in PGCs. Moreover, we evidence that impairment of PARP activity causes a significant reduction of expression of the gene coding for Tet1 hydroxylases involved in active DNA demethylation. Taken together these results demonstrate new and adjuvant roles of poly(ADP-ribosyl)ation during germline DNA demethylation and suggest its possible more general involvement in genome reprogramming.	[Ciccarone, Fabio; Calabrese, Roberta; Zampieri, Michele; Bacalini, Maria Giulia; Caiafa, Paola] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Ciccarone, Fabio; Calabrese, Roberta; Zampieri, Michele; Bacalini, Maria Giulia; Caiafa, Paola] Fdn Cenci Bolognetti, Inst Pasteur, Rome, Italy; [Klinger, Francesca Gioia; De Felici, Massimo] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; [Catizone, Angela] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; University of Rome Tor Vergata; Sapienza University Rome	Caiafa, P (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy.	caiafa@bce.uniroma1.it	Klinger, Francesca Gioia/AAO-5349-2021; Zampieri, Michele/AGF-5460-2022; Bacalini, Maria Giulia/K-4931-2016; De Felici, Massimo/J-4845-2018; Zampieri, Michele/F-7099-2013; CICCARONE, FABIO/K-4225-2016; Ciccarone, Fabio/AAR-9128-2021	Klinger, Francesca Gioia/0000-0001-6744-0850; Zampieri, Michele/0000-0002-6799-2492; Bacalini, Maria Giulia/0000-0003-1618-2673; Zampieri, Michele/0000-0002-6799-2492; Ciccarone, Fabio/0000-0002-2425-2240; catizone, angela/0000-0002-7836-9495; De Felici, Massimo/0000-0001-8479-8264	Ministero della Salute; International FIRB [RBIN06E9Z8_003]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy	Ministero della Salute(Ministry of Health, Italy); International FIRB; Ministero dell'Istruzione, dell'Universita e della Ricerca, Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from Ministero della Salute (PC), from International FIRB 2006 (RBIN06E9Z8_003) and from Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, PC, MDF), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; Bacalini MG, 2011, DNA REPAIR, V10, P380, DOI 10.1016/j.dnarep.2011.01.002; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Branco MR, 2008, GENE DEV, V22, P1567, DOI 10.1101/gad.1690508; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Caiafa P, 2009, FASEB J, V23, P672, DOI 10.1096/fj.08-123265; Chevanne M, 2010, J CELL PHYSIOL, V222, P401, DOI 10.1002/jcp.21964; Chou WC, 2008, EMBO J, V27, P3140, DOI 10.1038/emboj.2008.229; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; De Felici M, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/425863; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guastafierro T, 2008, J BIOL CHEM, V283, P21873, DOI 10.1074/jbc.M801170200; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2012, TRENDS GENETICS TIG; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kurimoto K, 2008, CELL CYCLE, V7, P3514, DOI 10.4161/cc.7.22.6979; Kutuzov MM, 2011, BIOCHEMISTRY-MOSCOW+, V76, P147, DOI 10.1134/S0006297911010147; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lee GE, 2010, J BIOL CHEM, V285, P37630, DOI 10.1074/jbc.M110.148536; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Loseva O, 2010, J BIOL CHEM, V285, P8054, DOI 10.1074/jbc.M109.077834; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Maatouk DM, 2003, DEV BIOL, V258, P201, DOI 10.1016/S0012-1606(03)00110-6; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Masaoka A, 2012, J BIOL CHEM; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; Morita-Fujimura Y, 2009, DEV GROWTH DIFFER, V51, P567, DOI 10.1111/j.1440-169X.2009.01119.x; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Nocchi L, 2011, J BIOL CHEM, V286, P19478, DOI 10.1074/jbc.M110.217331; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; PESCE M, 1995, DEV BIOL, V170, P722, DOI 10.1006/dbio.1995.1250; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Reale A, 2005, ONCOGENE, V24, P13, DOI 10.1038/sj.onc.1208005; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005; Zampieri M, 2012, BIOCHEM J, V441, P645, DOI 10.1042/BJ20111417; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717	80	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46927	10.1371/journal.pone.0046927	http://dx.doi.org/10.1371/journal.pone.0046927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071665	Green Published, gold			2022-12-25	WOS:000309827300070
J	Eaves, DL; Turgeon, M; Vogt, S				Eaves, Daniel L.; Turgeon, Martine; Vogt, Stefan			Automatic Imitation in Rhythmical Actions: Kinematic Fidelity and the Effects of Compatibility, Delay, and Visual Monitoring	PLOS ONE			English	Article							HAND ACTIONS; MOVEMENT EXECUTION; ACTION-PERCEPTION; COORDINATION; INTERFERENCE; POSTURES; MOTION; SUFFICIENT; DYNAMICS; OBJECT	We demonstrate that observation of everyday rhythmical actions biases subsequent motor execution of the same and of different actions, using a paradigm where the observed actions were irrelevant for action execution. The cycle time of the distractor actions was subtly manipulated across trials, and the cycle time of motor responses served as the main dependent measure. Although distractor frequencies reliably biased response cycle times, this imitation bias was only a small fraction of the modulations in distractor speed, as well as of the modulations produced when participants intentionally imitated the observed rhythms. Importantly, this bias was not only present for compatible actions, but was also found, though numerically reduced, when distractor and executed actions were different (e.g., tooth brushing vs. window wiping), or when the dominant plane of movement was different (horizontal vs. vertical). In addition, these effects were equally pronounced for execution at 0, 4, and 8 s after action observation, a finding that contrasts with the more short-lived effects reported in earlier studies. The imitation bias was also unaffected when vision of the hand was occluded during execution, indicating that this effect most likely resulted from visuomotor interactions during distractor observation, rather than from visual monitoring and guidance during execution. Finally, when the distractor was incompatible in both dimensions (action type and plane) the imitation bias was not reduced further, in an additive way, relative to the single-incompatible conditions. This points to a mechanism whereby the observed action's impact on motor processing is generally reduced whenever this is not useful for motor planning. We interpret these findings in the framework of biased competition, where intended and distractor actions can be represented as competing and quasi-encapsulated sensorimotor streams.	[Eaves, Daniel L.] Univ Teesside, Sport & Exercise Sci Sect, Middlesbrough, Cleveland, England; [Eaves, Daniel L.; Turgeon, Martine; Vogt, Stefan] Univ Lancaster, Dept Psychol, Ctr Res Human Dev & Learning, Lancaster LA1 4YF, England	University of Teesside; Lancaster University	Eaves, DL (corresponding author), Univ Teesside, Sport & Exercise Sci Sect, Middlesbrough, Cleveland, England.	d.eaves@tees.ac.uk; mturgeon@stfx.ca; s.vogt@lancaster.ac.uk		Eaves, Daniel/0000-0003-2436-7694; Vogt, Stefan Reinhold/0000-0003-4627-3410				Bates LA, 2010, WIRES COGN SCI, V1, P685, DOI 10.1002/wcs.77; Bisio A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013506; Bouquet CA, 2007, J SPORT SCI, V25, P519, DOI 10.1080/02640410600946803; Bove M, 2009, BRAIN RES BULL, V80, P122, DOI 10.1016/j.brainresbull.2009.04.008; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Campione GC, 2011, BEHAV BRAIN RES, V225, P201, DOI 10.1016/j.bbr.2011.07.025; Castiello U, 2002, ATTENTION PERFORM, V19, P315; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; DiDio C, NEUROIMAGE IN PRESS; Eaves DL, 2011, PRESENCE-TELEOP VIRT, V20, P62, DOI 10.1162/pres_a_00035; Edwards MG, 2003, BRAIN COGNITION, V53, P495, DOI 10.1016/S0278-2626(03)00210-0; Gianelli C, 2008, BRAIN RES, V1218, P166, DOI 10.1016/j.brainres.2008.04.046; Gowen E, 2010, BRAIN COGNITION, V74, P288, DOI 10.1016/j.bandc.2010.08.010; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Griffiths D, 2009, Q J EXP PSYCHOL, V62, P2450, DOI 10.1080/17470210903103059; Hardwick RM, 2011, Q J EXP PSYCHOL, V64, P1082, DOI 10.1080/17470218.2010.538068; Hecht H, 2001, PSYCHOL RES-PSYCH FO, V65, P3, DOI 10.1007/s004260000043; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Higuchi S, 2009, HUM BRAIN MAPP C SAN; Hove MJ, 2010, J EXP PSYCHOL HUMAN, V36, P1525, DOI 10.1037/a0019059; Jax SA, 2009, NEUROPSYCHOLOGIA, V47, P1573, DOI 10.1016/j.neuropsychologia.2008.05.019; Kelso J.A.S., 1995, DYNAMIC PATTERNS; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Meulenbroek RGJ, 2007, EXP BRAIN RES, V180, P333, DOI 10.1007/s00221-007-0861-z; Miall RC, 2006, NEUROPSYCHOLOGIA, V44, P966, DOI 10.1016/j.neuropsychologia.2005.09.006; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Noy L, 2009, BRAIN COGNITION, V69, P360, DOI 10.1016/j.bandc.2008.08.030; Obhi SS, 2010, EXP BRAIN RES, V203, P427, DOI 10.1007/s00221-010-2253-z; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Richardson MJ, 2009, NEUROSCI LETT, V449, P117, DOI 10.1016/j.neulet.2008.10.092; Rizzolatti G., 2002, IMITATIVE MIND DEV E, V6, P247, DOI DOI 10.1017/CB09780511489969.015; Ronchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021070; Salama IM, 2011, Q J EXP PSYCHOL, V64, P833, DOI 10.1080/17470218.2011.572172; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Vogt S, 1996, COGNITIVE BRAIN RES, V3, P79, DOI 10.1016/0926-6410(95)00032-1; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Vogt S, 2001, UNINTENTIONAL UNPUB; Vogt S, 2007, J SPORT SCI, V25, P497, DOI 10.1080/02640410600946779; Vogt S, 2007, NEUROIMAGE, V37, P1371, DOI 10.1016/j.neuroimage.2007.07.005; Wild KS, 2010, EXP BRAIN RES, V204, P353, DOI 10.1007/s00221-009-2034-8; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Zentgraf K, 2011, VISION RES, V51, P827, DOI 10.1016/j.visres.2011.01.007	53	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46728	10.1371/journal.pone.0046728	http://dx.doi.org/10.1371/journal.pone.0046728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020QD	23071623	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000309827300055
J	Sherrard-Smith, E; Chadwick, E; Cable, J				Sherrard-Smith, Ellie; Chadwick, Elizabeth; Cable, Joanne			Abiotic and Biotic Factors Associated with Tick Population Dynamics on a Mammalian Host: Ixodes hexagonus Infesting Otters, Lutra lutra	PLOS ONE			English	Article							CLIMATE-CHANGE; LYME-DISEASE; VECTOR-BORNE; ECOLOGY; ENGLAND; RICINUS; SURVEILLANCE; TERRESTRIAL; PARASITES; IMPACT	The Eurasian otter, Lutra lutra, hosts several parasites with zoonotic potential. As this semiaquatic mammal has large ranges across terrestrial, freshwater and marine habitats, it has the capacity for wide dispersion of pathogens. Despite this, parasites of otters have received relatively little attention. Here, we examine their ectoparasite load and assess whether this is influenced by abiotic or biotic variables. Climatic phenomena such as the North Atlantic Oscillation (NAO) affect weather conditions in northern Europe. Consequently parasite distributions, particularly species with life stages exposed to the external environment, can be affected. We assessed the extent to which inter-annual variations in large-scale weather patterns (specifically the NAO and Central England (CE) temperatures) and host characteristics influenced tick prevalence and intensity. Ectoparasites consisted of a single species, the nidiculous tick Ixodes hexagonus (prevalence = 24.3%; mean intensity = 7.2; range = 1-122; on n = 820 otter hosts). The prevalence, but not intensity of infestation, was associated with high CE temperatures, while both prevalence and intensity were associated with positive phases of the NAO. Such associations indicate that I. hexagonus are most abundant when weather conditions are warmer and wetter. Ticks were more prevalent on juvenile than sub-adult or adult otters, which probably reflects the length of time the hosts spend in the holt where these ticks quest. High tick number was associated with poor host condition, so either poor condition hosts are more susceptible to ticks, or tick infestations negatively impact on host condition. Otters are clearly an important and common host for I. hexagonus, which has implications for vector-borne diseases. This work is the first to consider the impacts of long-term weather patterns on I. hexagonus and uses wild-animal cadavers to illustrate the importance of abiotic and biotic pressures impacting parasitic populations.	[Sherrard-Smith, Ellie; Chadwick, Elizabeth; Cable, Joanne] Cardiff Univ, Cardiff, S Glam, Wales	Cardiff University	Sherrard-Smith, E (corresponding author), Cardiff Univ, Cardiff, S Glam, Wales.	sherrardsmithe@cardiff.ac.uk	Chadwick, Elizabeth/G-1793-2010; Cable, Joanne/A-4360-2010	Chadwick, Elizabeth/0000-0002-6662-6343; Cable, Joanne/0000-0002-8510-7055; Sherrard-Smith, Ellie/0000-0001-8317-7992	Natural Environment Research Council Studentship (NERC) [NER/0329013]; Somerset Otter Group; Advanced NERC Fellowship [NER/J/S/2002/00706]	Natural Environment Research Council Studentship (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Somerset Otter Group; Advanced NERC Fellowship	Ellie Sherrard-Smith was supported by a Natural Environment Research Council Studentship (NERC),(NER/0329013) with Case Partner, James Williams and the Somerset Otter Group. Joanne Cable was funded by an Advanced NERC Fellowship (NER/J/S/2002/00706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, SYM ZOOL SOC; ARTHUR DR, 1953, PARASITOLOGY, V43, P227, DOI 10.1017/S003118200001859X; Black WC, 1998, MOL BIOL EVOL, V15, P1772, DOI 10.1093/oxfordjournals.molbev.a025903; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Cattadori IM, 2005, NATURE, V433, P737, DOI 10.1038/nature03276; Chadwick EA, 2011, ENVIRON SCI TECHNOL, V45, P1911, DOI 10.1021/es1034602; GERN L, 1991, MED VET ENTOMOL, V5, P431, DOI 10.1111/j.1365-2915.1991.tb00571.x; GRAY JS, 1992, J MED ENTOMOL, V29, P915, DOI 10.1093/jmedent/29.6.915; Green J., 1984, Lutra, V27, P85; Hancock PA, 2011, INT J PARASITOL, V41, P513, DOI 10.1016/j.ijpara.2010.12.012; HARRIS S, 1978, J ZOOL, V186, P83, DOI 10.1111/j.1469-7998.1978.tb03358.x; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hawlena H, 2006, OECOLOGIA, V148, P30, DOI 10.1007/s00442-005-0345-4; Hillyard P., 1996, TICKS N W EUROPE, P178; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Hubalek Z, 2003, MED VET ENTOMOL, V17, P46, DOI 10.1046/j.1365-2915.2003.00408.x; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kelly T.C., 2001, Irish Naturalists' Journal, V26, P363; Kerr GD, 2006, PARASITOL RES, V99, P214, DOI 10.1007/s00436-005-0110-y; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Kruuk H., 2006, OTTERS ECOLOGY BEHAV, DOI DOI 10.1093/ACPROF:OSO/9780198565871.001.0001; Kutz SJ, 2004, INTEGR COMP BIOL, V44, P109, DOI 10.1093/icb/44.2.109; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lopez-Moreno JI, 2008, J CLIMATE, V21, P1220, DOI 10.1175/2007JCLI1739.1; MACLEOD J., 1939, Empire Journal of Experimental Agriculture, V7, P97; MacLoed J, 1934, PARASITOLOGY, V26, P189; Mangal TD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001438; Medlock JM, 2008, J MED ENTOMOL, V45, P314, DOI 10.1603/0022-2585(2008)45[314:IOEAED]2.0.CO;2; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Moller AP, 2010, GLOBAL CHANGE BIOL, V16, P1158, DOI 10.1111/j.1365-2486.2009.02035.x; Nelder MP, 2005, VET PARASITOL, V129, P313, DOI 10.1016/j.vetpar.2004.02.029; Nusser SM, 2008, J WILDLIFE MANAGE, V72, P52, DOI 10.2193/2007-317; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2000, MED VET ENTOMOL, V14, P332, DOI 10.1046/j.1365-2915.2000.00244.x; Page RJC, 1996, MED VET ENTOMOL, V10, P359, DOI 10.1111/j.1365-2915.1996.tb00757.x; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Perry M, 2005, INT J CLIMATOL, V25, P1023, DOI 10.1002/joc.1160; Pfaffle M, 2011, EXP APPL ACAROL, V54, P151, DOI 10.1007/s10493-011-9432-x; Pfaffle M, 2010, THESIS KARLSRUHE I T; R Core Team, 2021, R LANG ENV STAT COMP; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Ripley B.D., 1988, STAT INFERENCE SPATI; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Sherrard-Smith E, 2009, PARASITOLOGY, V136, P1015, DOI 10.1017/S0031182009006362; Smith FD, 2011, MED VET ENTOMOL, V25, P377, DOI 10.1111/j.1365-2915.2011.00954.x; Snow KR, 1979, IDENTIFICATION LARVA; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Visbeck, 2003, GEOPHYS MONOGR SER, V134, P1, DOI [DOI 10.1029/134GM01, 10.1029/134GM01]	54	13	13	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47131	10.1371/journal.pone.0047131	http://dx.doi.org/10.1371/journal.pone.0047131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071736	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000309827300084
J	Nkurunungi, G; Lutangira, JE; Lule, SA; Akurut, H; Kizindo, R; Fitchett, JR; Kizito, D; Sebina, I; Muhangi, L; Webb, EL; Cose, S; Elliott, AM				Nkurunungi, Gyaviira; Lutangira, Jimreeves E.; Lule, Swaib A.; Akurut, Hellen; Kizindo, Robert; Fitchett, Joseph R.; Kizito, Dennison; Sebina, Ismail; Muhangi, Lawrence; Webb, Emily L.; Cose, Stephen; Elliott, Alison M.			Determining Mycobacterium tuberculosis Infection among BCG-Immunised Ugandan Children by T-SPOT.TB and Tuberculin Skin Testing	PLOS ONE			English	Article							HEALTH-CARE WORKERS; CALMETTE-GUERIN VACCINATION; ENZYME-LINKED IMMUNOSPOT; GAMMA RELEASE ASSAY; LATENT; DIAGNOSIS; RESPONSES; DISEASE; REPRODUCIBILITY; METAANALYSIS	Background: Children with latent tuberculosis infection (LTBI) represent a huge reservoir for future disease. We wished to determine Mycobacterium tuberculosis (M.tb) infection prevalence among BCG-immunised five-year-old children in Entebbe, Uganda, but there are limited data on the performance of immunoassays for diagnosis of tuberculosis infection in children in endemic settings. We therefore evaluated agreement between a commercial interferon gamma release assay (T-SPOT.TB) and the tuberculin skin test (TST; 2 units RT-23 tuberculin; positive defined as diameter >= 10 mm), along with the reproducibility of T-SPOT. TB on short-term follow-up, in this population. Methodology/Principal Findings: We recruited 907 children of which 56 were household contacts of TB patients. They were tested with T-SPOT. TB at age five years and then re-examined with T-SPOT. TB (n = 405) and TST (n = 319) approximately three weeks later. The principal outcome measures were T-SPOT. TB and TST positivity. At five years, 88 (9.7%) children tested positive by T-SPOT. TB. More than half of those that were T-SPOT. TB positive at five years were negative at follow-up, whereas 96% of baseline negatives were consistently negative. We observed somewhat better agreement between initial and follow-up T-SPOT. TB results among household TB contacts (kappa = 0.77) than among non-contacts (kappa = 0.39). Agreement between T-SPOT. TB and TST was weak (kappa = 0.28 and kappa = 0.40 for T-SPOT. TB at 5 years and follow-up, respectively). Of 28 children who were positive on both T-SPOT. TB tests, 14 (50%) had a negative TST. Analysis of spot counts showed high levels of instability in responses between baseline and follow-up, indicating variability in circulating numbers of T cells specific for certain M.tb antigens. Conclusions/Significance: We found that T-SPOT. TB positives are unstable over a three-week follow-up interval, and that TST compares poorly with T-SPOT. TB, making the categorisation of children as TB-infected or TB-uninfected difficult. Existing tools for the diagnosis of TB infection are unsatisfactory in determining infection among children in this setting.	[Nkurunungi, Gyaviira; Lutangira, Jimreeves E.; Lule, Swaib A.; Akurut, Hellen; Kizindo, Robert; Kizito, Dennison; Sebina, Ismail; Muhangi, Lawrence; Cose, Stephen; Elliott, Alison M.] MRC, Coinfect Studies Programme, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda; [Fitchett, Joseph R.; Cose, Stephen; Elliott, Alison M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Nkurunungi, G (corresponding author), MRC, Coinfect Studies Programme, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda.	gyaviira.nkurunungi@mrcuganda.org	Cose, Stephen/H-4851-2019; Nkurunungi, Gyaviira/L-6558-2019	Cose, Stephen/0000-0002-5156-037X; Sebina, Ismail/0000-0003-3232-3472; Lule, Swaib/0000-0002-6271-2033; Webb, Emily/0000-0002-4019-7456; Elliott, Alison/0000-0003-2818-9549; Nkurunungi, Gyaviira/0000-0003-4062-9105	Wellcome Trust [064693, 079110, 086801]; UK Medical Research Council; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by Wellcome Trust (www.wellcome.ac.uk) grant numbers 064693, 079110 and 086801. E. Webb was supported in part by the UK Medical Research Council (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2012, VACCINE, V30, P2083, DOI 10.1016/j.vaccine.2012.01.053; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Barnes PF, 2001, AM J RESP CRIT CARE, V163, P807, DOI 10.1164/ajrccm.163.4.ed0201c; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Chee CBE, 2001, AM J RESP CRIT CARE, V164, P958, DOI 10.1164/ajrccm.164.6.2101093; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Codecasa L, 2006, J CLIN MICROBIOL, V44, P1944, DOI 10.1128/JCM.02265-05; Cruz AT, 2011, PEDIATRICS, V127, pE31, DOI 10.1542/peds.2010-1725; Detjen AK, 2009, CLIN VACCINE IMMUNOL, V16, P1170, DOI 10.1128/CVI.00168-09; Doberne D, 2011, J CLIN MICROBIOL, V49, P3061, DOI 10.1128/JCM.01136-11; Elliott AM, 2007, CLIN TRIALS, V4, P42, DOI 10.1177/1740774506075248; Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; FINE PEM, 1994, LANCET, V344, P1245, DOI 10.1016/S0140-6736(94)90748-X; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Kakkar F, 2010, CAN J INFECT DIS MED, V21, pE111, DOI 10.1155/2010/129616; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lucas M, 2010, THORAX, V65, P442, DOI 10.1136/thx.2009.127555; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; MIGLIORI GB, 1994, EUR RESPIR J, V7, P946; Mutsvangwa J, 2010, THORAX, V65, P315, DOI 10.1136/thx.2009.124891; National Tuberculosis and Leprosy Program, 2005, UG NAT PROGR SURV RE; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; Sauzullo I, 2011, TUBERCULOSIS, V91, P322, DOI 10.1016/j.tube.2011.05.004; Shams H, 2005, AM J RESP CRIT CARE, V172, P1161, DOI 10.1164/rccm.200505-748OC; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Stott H, 1973, Tubercle, V54, P1; Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434; Uganda MoH, 2006, NAT POL GUID TB HIV; Uganda MoH, 2010, MAN NAT TUB LEPR PRO; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2011, US TUB INT GAMM REL	50	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47340	10.1371/journal.pone.0047340	http://dx.doi.org/10.1371/journal.pone.0047340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077594	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000309995100094
J	Song, ES; Melikishvili, M; Fried, MG; Juliano, MA; Juliano, L; Rodgers, DW; Hersh, LB				Song, Eun Suk; Melikishvili, Manana; Fried, Michael G.; Juliano, Maria A.; Juliano, Luiz; Rodgers, David W.; Hersh, Louis B.			Cysteine 904 Is Required for Maximal Insulin Degrading Enzyme Activity and Polyanion Activation	PLOS ONE			English	Article							MOLECULAR-BASIS; SUBSTRATE; RECOGNITION	Cysteine residues in insulin degrading enzyme have been reported as non-critical for its activity. We found that converting the twelve cysteine residues in rat insulin degrading enzyme (IDE) to serines resulted in a cysteine-free form of the enzyme with reduced activity and decreased activation by polyanions. Mutation of each cysteine residue individually revealed cysteine 904 as the key residue required for maximal activity and polyanion activation, although other cysteines affect polyanion binding to a lesser extent. Based on the structure of IDE, Asn 575 was identified as a potential hydrogen bond partner for Cys904 and mutation of this residue also reduced activity and decreased polyanion activation. The oligomerization state of IDE did not correlate with its activity, with the dimer being the predominant form in all the samples examined. These data suggest that there are several conformational states of the dimer that affect activity and polyanion activation.	[Song, Eun Suk; Melikishvili, Manana; Fried, Michael G.; Rodgers, David W.; Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Song, Eun Suk; Melikishvili, Manana; Fried, Michael G.; Rodgers, David W.; Hersh, Louis B.] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA; [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, Sao Paulo, Brazil	University of Kentucky; University of Kentucky; Universidade Federal de Sao Paulo (UNIFESP)	Hersh, LB (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	lhersh@uky.edu	Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013	Juliano, Luiz/0000-0002-5589-2822; Fried, Michael/0000-0002-5393-2640	United States National Institutes of Health [DA02243, AG19323, NS38041, DK54289]; Fundacao de Amparo Pesquisa do Estado de Sao Paulo FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS038041, R01NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by United States National Institutes of Health grants DA02243 (to L. B. H), AG19323 (to L. B. H), NS38041 (to D. W. R), DK54289 (to M. G. F), Fundacao de Amparo Pesquisa do Estado de Sao Paulo FAPESP (to L.J and M.A.J), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (to L.J and M.A.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Csuhai E, 1999, ANAL BIOCHEM, V269, P149, DOI 10.1006/abio.1999.4033; Dam J, 2004, METHOD ENZYMOL, V384, P185; Guo Q, 2010, J MOL BIOL, V395, P430, DOI 10.1016/j.jmb.2009.10.072; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011327; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Manolopoulou M, 2009, J BIOL CHEM, V284, P14177, DOI 10.1074/jbc.M900068200; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Noinaj N, 2012, J BIOL CHEM, V287, P48, DOI 10.1074/jbc.M111.264614; Noinaj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020864; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Ralat LA, 2011, J BIOL CHEM, V286, P4670, DOI 10.1074/jbc.M110.173252; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200	21	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46790	10.1371/journal.pone.0046790	http://dx.doi.org/10.1371/journal.pone.0046790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077523	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100040
J	Ahlen, G; Strindelius, L; Johansson, T; Nilsson, A; Chatzissavidou, N; Sjoblom, M; Rova, U; Holgersson, J				Ahlen, Gustaf; Strindelius, Lena; Johansson, Tomas; Nilsson, Anki; Chatzissavidou, Nathalie; Sjoblom, Magnus; Rova, Ulrika; Holgersson, Jan			Mannosylated Mucin-Type Immunoglobulin Fusion Proteins Enhance Antigen-Specific Antibody and T Lymphocyte Responses	PLOS ONE			English	Article							MHC CLASS-I; MANNOSE RECEPTOR; DENDRITIC CELLS; IMMUNE-RESPONSES; O-GLYCAN; DC-SIGN; RECOGNITION; LECTIN; IMMUNOGENICITY; MANNAN	Targeting antigens to antigen-presenting cells (APC) improve their immunogenicity and capacity to induce Th1 responses and cytotoxic T lymphocytes (CTL). We have generated a mucin-type immunoglobulin fusion protein (PSGL-1/mIgG(2b)), which upon expression in the yeast Pichia pastoris became multivalently substituted with O-linked oligomannose structures and bound the macrophage mannose receptor (MMR) and dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) with high affinity in vitro. Here, its effects on the humoral and cellular anti-ovalbumin (OVA) responses in C57BL/6 mice are presented. OVA antibody class and subclass responses were determined by ELISA, the generation of anti-OVA CTLs was assessed in Cr-51 release assays using in vitro-stimulated immune spleen cells from the different groups of mice as effector cells and OVA peptide-fed RMA-S cells as targets, and evaluation of the type of Th cell response was done by IFN-gamma, IL-2, IL-4 and IL-5 ELISpot assays. Immunizations with the OVA - mannosylated PSGL-1/mIgG(2b) conjugate, especially when combined with the AbISCO (R)-100 adjuvant, lead to faster, stronger and broader (with regard to IgG subclass) OVA IgG responses, a stronger OVA-specific CTL response and stronger Th1 and Th2 responses than if OVA was used alone or together with AbISCO (R)-100. Also non-covalent mixing of mannosylated PSGL-1/mIgG(2b), OVA and AbISCO (R)-100 lead to relatively stronger humoral and cellular responses. The O-glycan oligomannoses were necessary because PSGL-1/mIgG(2b) with mono- and disialyl core 1 structures did not have this effect. Mannosylated mucin-type fusion proteins can be used as versatile APC-targeting molecules for vaccines and as such enhance both humoral and cellular immune responses.	[Ahlen, Gustaf; Strindelius, Lena; Johansson, Tomas; Nilsson, Anki; Chatzissavidou, Nathalie] Recopharma AB, Stockholm, Sweden; [Sjoblom, Magnus; Rova, Ulrika] Lulea Univ Technol, S-95187 Lulea, Sweden; [Holgersson, Jan] Sahlgrens Acad, Gothenburg, Sweden	Lulea University of Technology; University of Gothenburg	Ahlen, G (corresponding author), Recopharma AB, Stockholm, Sweden.	gustaf.ahlen@ki.se	Ahlén, Gustaf/GLN-2986-2022	Ahlen, Gustaf/0000-0002-2681-6433	Recopharma AB; Swedish Research Council/Medicine [K2011-65X-3031-01-6]; County Council of Stockholm; County Council of Vastra Gotaland; Research Council of Norrbotten, Innovationsbron and Langmanska foretagarfonden; Recopharma through a research grant	Recopharma AB; Swedish Research Council/Medicine(Swedish Research Council); County Council of Stockholm(Stockholm County Council); County Council of Vastra Gotaland; Research Council of Norrbotten, Innovationsbron and Langmanska foretagarfonden; Recopharma through a research grant	This work was mainly financed by Recopharma AB. Further support was given by the Swedish Research Council/Medicine (K2011-65X-3031-01-6) and the County Councils of Stockholm and Vastra Gotaland (ALF) to JH, and the Research Council of Norrbotten, Innovationsbron and Langmanska foretagarfonden to UR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JH is acting CEO, board member and shareholder of Recopharma AB. At the time of the study, GA, LS, TJ, AN, and NC were employees of Recopharma. MS has been partly funded by Recopharma through a research grant to LTU. The technology described in the manuscript has been patent-sought by Recopharma, "Production of Human Glycosylated Proteins in Yeast and Methods of Use Thereof'' (United States application number 11/626156. Filing date 23-Jan-2007.) (WO application number PCT/IB2007/004164. Filing date 23-Jan-2007.) This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Apostolopoulos V., 2001, Current Molecular Medicine (Hilversum), V1, P469, DOI 10.2174/1566524013363645; Apostolopoulos V, 1996, VACCINE, V14, P930, DOI 10.1016/0264-410X(95)00258-3; APOSTOLOPOULOS V, 1995, P NATL ACAD SCI USA, V92, P10128, DOI 10.1073/pnas.92.22.10128; Apostolopoulos V, 2000, VACCINE, V18, P3174, DOI 10.1016/S0264-410X(00)00090-6; Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1714, DOI 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bovin NV, 1998, GLYCOCONJUGATE J, V15, P431, DOI 10.1023/A:1006963717646; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Davis WC, 2002, ANN NY ACAD SCI, V969, P119, DOI 10.1111/j.1749-6632.2002.tb04362.x; Dennehy KM, 2007, J LEUKOCYTE BIOL, V82, P253, DOI 10.1189/jlb.1206753; Duewell P, 2011, J IMMUNOL, V187, P55, DOI 10.4049/jimmunol.1004114; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Epstein SL, 1998, J IMMUNOL, V160, P322; Espuelas S, 2008, BIOCONJUGATE CHEM, V19, P2385, DOI 10.1021/bc8002524; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gustafsson A, 2006, EXPERT OPIN DRUG DIS, V1, P161, DOI 10.1517/17460441.1.2.161; Gustafsson A, 2011, GLYCOBIOLOGY, V21, P1071, DOI 10.1093/glycob/cwr046; Haicheur N, 2000, J IMMUNOL, V165, P3301, DOI 10.4049/jimmunol.165.6.3301; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Irache JM, 2008, EXPERT OPIN DRUG DEL, V5, P703, DOI 10.1517/17425247.5.6.703 ; Keler T, 2004, EXPERT OPIN BIOL TH, V4, P1953, DOI 10.1517/14712598.4.12.1953; Kiessling LL, 1996, CHEM BIOL, V3, P71, DOI 10.1016/S1074-5521(96)90280-X; Lam JS, 2005, J IMMUNOL, V175, P7496, DOI 10.4049/jimmunol.175.11.7496; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; LEE YC, 1995, ACCOUNTS CHEM RES, V28, P321, DOI 10.1021/ar00056a001; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Luong M, 2007, VACCINE, V25, P4340, DOI 10.1016/j.vaccine.2007.03.027; MAAHEIMO H, 1995, EUR J BIOCHEM, V234, P616, DOI 10.1111/j.1432-1033.1995.616_b.x; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Morein B, 2004, ADV DRUG DELIVER REV, V56, P1367, DOI 10.1016/j.addr.2004.02.004; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2010, MED MYCOL, V48, P897, DOI 10.3109/13693781003621575; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Roy R, 1996, CURR OPIN STRUC BIOL, V6, P692, DOI 10.1016/S0959-440X(96)80037-6; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sheng KC, 2008, J IMMUNOL, V181, P2455, DOI 10.4049/jimmunol.181.4.2455; Sheng KC, 2008, EUR J IMMUNOL, V38, P424, DOI 10.1002/eji.200737578; Sjolander A, 2001, VACCINE, V19, P2661, DOI 10.1016/S0264-410X(00)00497-7; Smith RE, 1999, J IMMUNOL, V162, P5536; STAHL PD, 1992, CURR OPIN IMMUNOL, V4, P49, DOI 10.1016/0952-7915(92)90123-V; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; Taylor M E, 2001, Results Probl Cell Differ, V33, P105; Trimble RB, 2004, GLYCOBIOLOGY, V14, P265, DOI 10.1093/glycob/cwh036; Uccini S, 1997, AM J PATHOL, V150, P929; Villacres MC, 1998, CELL IMMUNOL, V185, P30, DOI 10.1006/cimm.1998.1278; White K, 2006, PHARM RES, V23, P1473, DOI 10.1007/s11095-006-0272-z; Windon RG, 2000, VACCINE, V19, P572, DOI 10.1016/S0264-410X(00)00148-1; Woolard SN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/141657	63	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46959	10.1371/journal.pone.0046959	http://dx.doi.org/10.1371/journal.pone.0046959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071675	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500025
J	Steiner, L; Hopp, L; Wirth, H; Galle, J; Binder, H; Prohaska, SJ; Rohlf, T				Steiner, Lydia; Hopp, Lydia; Wirth, Henry; Galle, Joerg; Binder, Hans; Prohaska, Sonja J.; Rohlf, Thimo			A Global Genome Segmentation Method for Exploration of Epigenetic Patterns	PLOS ONE			English	Article							SELF-ORGANIZING MAPS; HISTONE MODIFICATIONS; GENE-EXPRESSION; CHROMATIN-STATE; STEM-CELLS; CHIP-SEQ; METHYLATIONS; LANDSCAPE; DISCOVERY; DNA	Current genome-wide ChIP-seq experiments on different epigenetic marks aim at unraveling the interplay between their regulation mechanisms. Published evaluation tools, however, allow testing for predefined hypotheses only. Here, we present a novel method for annotation-independent exploration of epigenetic data and their inter-correlation with other genome-wide features. Our method is based on a combinatorial genome segmentation solely using information on combinations of epigenetic marks. It does not require prior knowledge about the data (e.g. gene positions), but allows integrating the data in a straightforward manner. Thereby, it combines compression, clustering and visualization of the data in a single tool. Our method provides intuitive maps of epigenetic patterns across multiple levels of organization, e. g. of the co-occurrence of different epigenetic marks in different cell types. Thus, it facilitates the formulation of new hypotheses on the principles of epigenetic regulation. We apply our method to histone modification data on trimethylation of histone H3 at lysine 4, 9 and 27 in multi-potent and lineage-primed mouse cells, analyzing their combinatorial modification pattern as well as differentiation-related changes of single modifications. We demonstrate that our method is capable of reproducing recent findings of gene centered approaches, e. g. correlations between CpG-density and the analyzed histone modifications. Moreover, combining the clustered epigenetic data with information on the expression status of associated genes we classify differences in epigenetic status of e. g. house-keeping genes versus differentiation-related genes. Visualizing the distribution of modification states on the chromosomes, we discover strong patterns for chromosome X. For example, exclusively H3K9me3 marked segments are enriched, while poised and active states are rare. Hence, our method also provides new insights into chromosome-specific epigenetic patterns, opening up new questions how "epigenetic computation" is distributed over the genome in space and time.	[Steiner, Lydia; Hopp, Lydia; Wirth, Henry; Galle, Joerg; Binder, Hans; Prohaska, Sonja J.; Rohlf, Thimo] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Steiner, Lydia; Prohaska, Sonja J.] Univ Leipzig, Inst Comp Sci, Leipzig, Germany; [Hopp, Lydia; Wirth, Henry] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Rohlf, Thimo] Max Planck Inst Math Sci, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Max Planck Society	Rohlf, T (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.	rohlf@izbi.uni-leipzig.de	; Binder, Hans/U-5519-2018	Loeffler-Wirth, Henry/0000-0001-8239-440X; Muller, Lydia/0000-0001-9544-121X; Binder, Hans/0000-0002-2242-4678	BMBF grant MAGE [50500541]; Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment (LIFE Center, University of Leipzig); European Union; European Regional Development Fund (ERDF); European Social Fund (ESF); Free State of Saxony within the framework of its excellence initiative	BMBF grant MAGE; Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment (LIFE Center, University of Leipzig); European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); European Social Fund (ESF)(European Social Fund (ESF)); Free State of Saxony within the framework of its excellence initiative	LS and TR are supported by the BMBF grant MAGE (grant number 50500541). LH and HW are funded by the Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment (LIFE Center, University of Leipzig). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF), the European Social Fund (ESF), and by means of the Free State of Saxony within the framework of its excellence initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; ERWIN E, 1992, BIOL CYBERN, V67, P35, DOI 10.1007/BF00201800; Fasold M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-207; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Park SJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S50; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rohlf T, 2012, EPIGENOMICS-UK, V4, P205, DOI [10.2217/epi.11.117, 10.2217/EPI.11.117]; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Statham AL, 2010, BIOINFORMATICS, V26, P1662, DOI 10.1093/bioinformatics/btq247; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 1999, Intelligent Data Analysis, V3, P111, DOI 10.1016/S1088-467X(99)00013-X; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306	40	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46811	10.1371/journal.pone.0046811	http://dx.doi.org/10.1371/journal.pone.0046811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077526	Green Submitted, gold, Green Published			2022-12-25	WOS:000309809500020
J	Wilson, RA; Fernandez, J; Quispe, CF; Gradnigo, J; Seng, AY; Moriyama, E; Wright, JD				Wilson, Richard A.; Fernandez, Jessie; Quispe, Cristian F.; Gradnigo, Julien; Seng, Anya; Moriyama, Etsuko; Wright, Janet D.			Towards Defining Nutrient Conditions Encountered by the Rice Blast Fungus during Host Infection	PLOS ONE			English	Article							PLANT INFECTION; NITROGEN STARVATION; MAGNAPORTHE-GRISEA; GENE-EXPRESSION; BIOSYNTHESIS; METABOLISM; SEQUENCE; PROTEIN	Fungal diseases cause enormous crop losses, but defining the nutrient conditions encountered by the pathogen remains elusive. Here, we generated a mutant strain of the devastating rice pathogen Magnaporthe oryzae impaired for de novo methionine biosynthesis. The resulting methionine-requiring strain grew strongly on synthetic minimal media supplemented with methionine, aspartate or complex mixtures of partially digested proteins, but could not establish disease in rice leaves. Live-cell-imaging showed the mutant could produce normal appressoria and enter host cells but failed to develop, indicating the availability or accessibility of aspartate and methionine is limited in the plant. This is the first report to demonstrate the utility of combining biochemical genetics, plate growth tests and live-cell-imaging to indicate what nutrients might not be readily available to the fungal pathogen in rice host cells.	[Wilson, Richard A.; Fernandez, Jessie; Quispe, Cristian F.; Seng, Anya; Wright, Janet D.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Gradnigo, Julien; Moriyama, Etsuko] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Moriyama, Etsuko] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wilson, RA (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	rwilson10@unl.edu	Fernandez, Jessie/AAR-3477-2021	Fernandez, Jessie/0000-0002-0897-2707; Quispe, Cristian F./0000-0001-8909-3650	National Science Foundation (NSF) [IOS-1145347]; Department of Plant Pathology, University of Nebraska-Lincoln; UNL UCARE scholarship; Division Of Integrative Organismal Systems [1145347] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Plant Pathology, University of Nebraska-Lincoln; UNL UCARE scholarship; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	RAW is supported by National Science Foundation (NSF) IOS-1145347. JF and CFQ were supported by Graduate Student Assistantships from the Department of Plant Pathology, University of Nebraska-Lincoln. AS was supported by a UNL UCARE scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bolton MD, 2008, PHYSIOL MOL PLANT P, V72, P104, DOI 10.1016/j.pmpp.2008.07.001; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Divon HH, 2007, FEMS MICROBIOL LETT, V266, P65, DOI 10.1111/j.1574-6968.2006.00504.x; Dodds PN, 2010, SCIENCE, V330, P1486, DOI 10.1126/science.1200245; Donofrio NM, 2006, FUNGAL GENET BIOL, V43, P605, DOI 10.1016/j.fgb.2006.03.005; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Franceschetti M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002441; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; KARST F, 1977, MOL GEN GENET, V154, P269, DOI 10.1007/BF00571282; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lo SCC, 2002, EUKARYOT CELL, V1, P311, DOI 10.1128/EC.1.2.311-314.2002; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; Oh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042868; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Perkins D., 2001, NEUROSPORA COMPENDIU; Roberts CJ, 1995, NUCLEIC ACIDS RES, V23, P4818, DOI 10.1093/nar/23.23.4818; Saitoh H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002711; Sienko M, 1999, CURR GENET, V35, P638, DOI 10.1007/s002940050463; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Solomon PS, 2003, MOL PLANT PATHOL, V4, P203, DOI 10.1046/j.1364-3703.2003.00161.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talbot NJ, 1997, PHYSIOL MOL PLANT P, V50, P179, DOI 10.1006/pmpp.1997.0081; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032	31	40	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47392	10.1371/journal.pone.0047392	http://dx.doi.org/10.1371/journal.pone.0047392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071797	Green Published, gold			2022-12-25	WOS:000312385200113
J	Huang, KW; Chen, HH; Yang, HC; Horng, HE; Liao, SH; Yang, SY; Chieh, JJ; Wang, LM				Huang, Kai-Wen; Chen, Hsin-Hsien; Yang, Hong-Chang; Horng, Herng-Er; Liao, Shu-Hsien; Yang, Shieh Yueh; Chieh, Jen-Jie; Wang, Li-Ming			Discriminating Hepatocellular Carcinoma in Rats Using a High-T-c SQUID Detected Nuclear Resonance Spectrometer in a Magnetic Shielding Box	PLOS ONE			English	Article							GENE	In this study, we report the spin-lattice relaxation rate of hepatocellular carcinoma (HCC) and normal liver tissue in rats using a high-T-c superconducting quantum interference device (SQUID) based nuclear magnetic resonance (NMR) spectrometer. The resonance spectrometer used for discriminating liver tumors in rats via the difference in longitudinal relaxation time in low magnetic fields was set up in a compact and portable magnetic shielding box. The frequency-domain NMR signals of HCC tissues and normal liver tissues were analyzed to study their respective longitudinal relaxation rate T-1(-1). The T-1(-1) of liver tissues for ten normal rats and ten cancerous rats were investigated respectively. The averaged T-1(-1) value of normal liver tissue was (6.41 +/- 0.66) s(-1), and the averaged T-1(-1) value of cancerous tissue was (3.38 +/- 0.15) s(-1). The ratio of T-1(-1) for normal liver tissues and cancerous liver tissues of the rats investigated is estimated to be 1.9. Since this significant statistical difference, the T-1(-1) value can be used to distinguish the HCC tissues from normal liver tissues. This method of examining liver and tumor tissues has the advantages of being convenient, easy to operate, and stable.	[Yang, Hong-Chang] Kun Shan Univ, Dept Electroopt Engn, Tainan, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ Hosp, Angiogenesis Ctr, Taipei, Taiwan; [Huang, Kai-Wen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chen, Hsin-Hsien; Horng, Herng-Er; Liao, Shu-Hsien; Yang, Shieh Yueh; Chieh, Jen-Jie] Natl Taiwan Normal Univ, Inst Electroopt Sci & Technol, Taipei, Taiwan; [Yang, Shieh Yueh] MagQu Co Ltd, Sindian Strict, New Taipei City, Taiwan; [Wang, Li-Ming] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan; [Wang, Li-Ming] Natl Taiwan Univ, Grad Inst Appl Phys, Taipei 10764, Taiwan	Kun Shan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan Normal University; National Taiwan University; National Taiwan University	Yang, HC (corresponding author), Kun Shan Univ, Dept Electroopt Engn, Tainan, Taiwan.	hcyang@phys.ntu.edu.tw; phyfv001@ntnu.edu.tw		Liao, Shu-Hsien/0000-0002-5794-7583; HUANG, KAI-WEN/0000-0001-6375-8714; Chieh, Jen-Jie/0000-0002-7144-2637	National Science Council of Taiwan [NSC99-2112-M002-017-MY3, NSC 100-2120-M-002-015, NSC101-2120-M168-001]; Department of Health [DOH100-TD-N-111-008, DOH101-TD-N-111-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health	This work was supported by the National Science Council of Taiwan under grant number NSC99-2112-M002-017-MY3, NSC 100-2120-M-002-015, NSC101-2120-M168-001, and the Department of Health under grant number DOH100-TD-N-111-008, DOH101-TD-N-111-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HH, 2011, J APPL PHYS, V110, DOI 10.1063/1.3656984; Chen HH, 2011, IEEE T APPL SUPERCON, V21, P505, DOI 10.1109/TASC.2010.2084057; Chen MJ, 2011, J APPL PHYS, V110; Clarke J, 2007, ANNU REV BIOMED ENG, V9, P389, DOI 10.1146/annurev.bioeng.9.060906.152010; Huang KW, 2008, MOL THER, V16, P1681, DOI 10.1038/mt.2008.160; KIRICUTA IC, 1975, CANCER RES, V35, P1164; Liao SH, 2009, SUPERCOND SCI TECHNO, V22, P45008; Liao SH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3530124; Liao SH, 2007, J APPL PHYS, V102, DOI 10.1063/1.2767193; McDermott R, 2002, SCIENCE, V295, P2247, DOI 10.1126/science.1069280; Montesano R, 1997, JNCI-J NATL CANCER I, V89, P1844, DOI 10.1093/jnci/89.24.1844; Murakami T, 2011, ONCOLOGY-BASEL, V81, P86, DOI 10.1159/000333267; Qiu LQ, 2009, J MAGN RESON, V196, P101, DOI 10.1016/j.jmr.2008.09.009; Yang HC, 2008, APPL PHYS LETT, V92; Yang HC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2216904; Zotev VS, 2007, SUPERCOND SCI TECH, V20, pS367, DOI 10.1088/0953-2048/20/11/S13	16	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47057	10.1371/journal.pone.0047057	http://dx.doi.org/10.1371/journal.pone.0047057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071710	gold, Green Submitted, Green Published			2022-12-25	WOS:000309827300080
J	Leger, D; Beck, F; Richard, JB; Godeau, E				Leger, Damien; Beck, Francois; Richard, Jean-Baptiste; Godeau, Emmanuelle			Total Sleep Time Severely Drops during Adolescence	PLOS ONE			English	Article							CARDIOMETABOLIC RISK; DURATION; MEMORY; MARKERS; INFLAMMATION; METAANALYSIS; DEPRIVATION; PREVALENCE; CHILDHOOD; COGNITION	Restricted sleep duration among young adults and adolescents has been shown to increase the risk of morbidities such as obesity, diabetes or accidents. However there are few epidemiological studies on normal total sleep time (TST) in representative groups of teen-agers which allow to get normative data. Purpose: To explore perceived total sleep time on schooldays (TSTS) and non schooldays (TSTN) and the prevalence of sleep initiating insomnia among a nationally representative sample of teenagers. Methods: Data from 9,251 children aged 11 to 15 years-old, 50.7% of which were boys, as part of the cross-national study 2011 HBSC were analyzed. Self-completion questionnaires were administered in classrooms. An estimate of TSTS and TSTN (week-ends and vacations) was calculated based on specifically designed sleep habits report. Sleep deprivation was estimated by a TSTN - TSTS difference >2 hours. Sleep initiating nsomnia was assessed according to International classification of sleep disorders (ICSD 2). Children who reported sleeping 7 hours or less per night were considered as short sleepers. Results: A serious drop of TST was observed between 11 yo and 15 yo, both during the schooldays (9 hours 26 minutes vs. 7 h 55 min.; p < 0.001) and at a lesser extent during week-ends (10 h 17 min. vs. 9 h 44 min.; p < 0.001). Sleep deprivation concerned 16.0% of chidren aged of 11 yo vs. 40.5% of those of 15 yo (p < 0.001). Too short sleep was reported by 2.6% of the 11 yo vs. 24.6% of the 15 yo (p < 0.001). Conclusion: Despite the obvious need for sleep in adolescence, TST drastically decreases with age among children from 11 to 15 yo which creates significant sleep debt increasing with age.	[Leger, Damien] Univ Paris 05, Hotel Dieu, APHP, Ctr Sommeil & Vigilance, Paris, France; [Beck, Francois; Richard, Jean-Baptiste] Univ Paris 05, Cermes 3, CNRS UMR 821,Inserm EHESS U988, INPES,Direct Affaires Sci,Equipe Cesames,Ctr Rech, St Denis, France; [Godeau, Emmanuelle] Univ Toulouse 3, UMR INSERM Toulouse 3 1027, F-31062 Toulouse, France; [Godeau, Emmanuelle] Serv Med Rectorat, Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Leger, D (corresponding author), Univ Paris 05, Hotel Dieu, APHP, Ctr Sommeil & Vigilance, Paris, France.	damien.leger@htd.aphp.fr		Beck, Francois/0000-0002-4880-1638; Richard, Jean-Baptiste/0000-0002-4193-9159	INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education); INSERM; WHO (Worl Health Organisation)	INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); WHO (Worl Health Organisation)	This study was supported by INPES (Institut National de Prevention et d'education pour la Sante) (French national Institute of prevention and health education) and INSERM. Internationally, it was supported by the WHO (Worl Health Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Balkin TJ, 2008, CHEST, V134, P653, DOI 10.1378/chest.08-1064; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Carskadon MA, 2011, PEDIATR CLIN N AM, V58, P637, DOI 10.1016/j.pcl.2011.03.003; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Currie C, 2009, INT J PUBLIC HEALTH, V54, P131, DOI 10.1007/s00038-009-5404-x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Faraut B, 2011, BRAIN BEHAV IMMUN, V25, P16, DOI 10.1016/j.bbi.2010.08.001; Fitzgerald CT, 2011, J CLIN SLEEP MED, V7, P351, DOI 10.5664/JCSM.1188; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Gujar N, 2011, CEREB CORTEX, V21, P115, DOI 10.1093/cercor/bhq064; Harel-Fisch Y, 2011, J ADOLESCENCE, V34, P639, DOI 10.1016/j.adolescence.2010.09.008; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Huang YS, 2010, SLEEP MED, V11, P1035, DOI 10.1016/j.sleep.2010.04.009; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kim SJ, 2011, ARCH PEDIAT ADOL MED, V165, P806, DOI 10.1001/archpediatrics.2011.128; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Laberge L, 2011, J ADOLESCENT HEALTH, V48, P289, DOI 10.1016/j.jadohealth.2010.07.003; Leger D, 2011, SLEEP MED, V12, P454, DOI 10.1016/j.sleep.2010.12.012; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Martinez-Gomez D, 2011, SLEEP MED, V12, P997, DOI 10.1016/j.sleep.2011.05.009; Mindell JA, 2011, SLEEP MED, V12, P203, DOI 10.1016/j.sleep.2011.01.003; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; National Institutes of health, INF SLEEP; National Sleep Foundation, 2010, SLEEP TEENS BIOL BEH; National Sleep Foundation (NSF), 2006, SLEEP AM POLL NAT SU; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Owens JA, 2012, PEDIATRICS, V129, P987, DOI 10.1542/peds.2012-0755A; Philip P, 2006, SLEEP MED REV, V10, P347, DOI 10.1016/j.smrv.2006.04.002; Regestein Q, 2010, PSYCHIAT RES, V176, P34, DOI 10.1016/j.psychres.2008.11.006; Roberts C, 2009, INT J PUBLIC HEALTH, V54, P140, DOI 10.1007/s00038-009-5405-9; Roberts RE, 2011, BEHAV SLEEP MED, V9, P18, DOI 10.1080/15402002.2011.533991; Schreck KA, 2011, J SLEEP RES, V10, P1365; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Short MA, 2011, SLEEP, V34, P797, DOI 10.5665/SLEEP.1052; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Thorleifsdottir B, 2002, J PSYCHOSOM RES, V53, P529, DOI 10.1016/S0022-3999(02)00444-0; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Touchette E, 2009, SLEEP MED REV, V13, P355, DOI 10.1016/j.smrv.2008.12.001; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wells JCK, 2008, INT J OBESITY, V32, P1042, DOI 10.1038/ijo.2008.37; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolson AR, 1998, CHILD DEV, V69, P875; World Health organisation, 2005, WHO TECHN M SLEEP HL	49	86	89	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45204	10.1371/journal.pone.0045204	http://dx.doi.org/10.1371/journal.pone.0045204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082111	Green Published, gold			2022-12-25	WOS:000311146900006
J	Li, HJ; Liu, X; Zhang, GF				Li, Hongjun; Liu, Xiao; Zhang, Guofan			Consensus Microsatellite-Based Linkage Map for the Hermaphroditic Bay Scallop (Argopecten irradians) and Its Application in Size-Related QTL Analysis	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; QUANTITATIVE TRAIT LOCI; CHLAMYS-FARRERI JONES; SALMO-SALAR REVEALS; SHELL-COLOR; ZHIKONG SCALLOP; EASTERN OYSTER; EUCALYPTUS-GRANDIS; PSEUDO-TESTCROSS; GENETIC-MAP	Bay scallop (Argopecten irradians) is one of the most economically important aquaculture species in China. In this study, we constructed a consensus microsatellite-based genetic linkage map with a mapping panel containing two hybrid backcross-like families involving two subspecies of bay scallop, A. i. irradians and A. i. concentricus. One hundred sixty-one microsatellite and one phenotypic (shell color) markers were mapped to 16 linkage groups (LGs), which corresponds to the haploid chromosome number of bay scallop. The sex-specific map was 779.2 cM and 781.6 cM long in female and male, respectively, whereas the sex-averaged map spanned 849.3 cM. The average resolution of integrated map was 5.9 cM/locus and the estimated coverage was 81.3%. The proportion of distorted markers occurred more in the hybrid parents, suggesting that the segregation distortion was possibly resulted from heterospecific interaction between genomes of two subspecies of bay scallop. The overall female-to-male recombination rate was 1.13:1 across all linked markers in common to both parents, and considerable differences in recombination also existed among different parents in both families. Four size-related traits, including shell length (SL), shell height (SH), shell width (SW) and total weight (TW) were measured for quantitative trait loci (QTL) analysis. Three significant and six suggestive QTL were detected on five LGs. Among the three significant QTL, two (qSW-10 and qTW-10, controlling SW and TW, respectively) were mapped on the same region near marker AiAD121 on LG10 and explained 20.5% and 27.7% of the phenotypic variance, while the third (qSH-7, controlling SH) was located on LG7 and accounted for 15.8% of the phenotypic variance. Six suggestive QTL were detected on four different LGs. The linkage map and size-related QTL obtained in this study may facilitate marker-assisted selection (MAS) in bay scallop.	[Li, Hongjun; Liu, Xiao; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Liu, X (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	liuxiao@qdio.ac.cn			National High-Technology RD Plan [2012AA10A412]; National Natural Science Foundation of China [30371117, 30671622]; Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences [KF201006]	National High-Technology RD Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by grants from National High-Technology R&D Plan (2012AA10A412 to XL), National Natural Science Foundation of China (30371117 to XL; 30671622 to GZ), and Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences (KF201006 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMKEWICZ L, 1988, J HERED, V79, P14, DOI 10.1093/oxfordjournals.jhered.a110436; [Anonymous], 2004, MAPQTL VERSION 5 0 S; Baranski M, 2006, ANIM GENET, V37, P563, DOI 10.1111/j.1365-2052.2006.01531.x; BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; CHAKRAVARTI A, 1991, GENETICS, V128, P175; COLE TJ, 1975, NATURE, V257, P794, DOI 10.1038/257794a0; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; ELEK JA, 1990, AM MALACOL BULL, V7, P117; Fishman L, 2001, GENETICS, V159, P1701; GRATTAPAGLIA D, 1995, THEOR APPL GENET, V90, P933, DOI 10.1007/BF00222906; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Guo XM, 2009, REV AQUACULT, V1, P251, DOI 10.1111/j.1753-5131.2009.01014.x; Guo XM, 1999, J SHELLFISH RES, V18, P19; Guyomard R, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-15; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; INNES DJ, 1977, J HERED, V68, P203, DOI 10.1093/oxfordjournals.jhered.a108814; Lallias D, 2007, ANIM GENET, V38, P560, DOI 10.1111/j.1365-2052.2007.01647.x; Lallias D, 2007, ANIM GENET, V38, P340, DOI 10.1111/j.1365-2052.2007.01611.x; Lallias D, 2009, MAR BIOTECHNOL, V11, P570, DOI 10.1007/s10126-008-9173-y; Launey S, 2001, GENETICS, V159, P255; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Li H, 2011, MARINE BIOTECHNOLOGY, V14, P1; Li H.S., 2009, THESIS CHINESE ACAD; Li HJ, 2011, MOL BIOL REP, V38, P769, DOI 10.1007/s11033-010-0165-4; Li Hong-jun, 2009, Marine Sciences (Beijing), V33, P4; Li HJ, 2007, MOL ECOL NOTES, V7, P422, DOI 10.1111/j.1471-8286.2006.01606.x; Li L, 2005, AQUACULTURE, V245, P63, DOI 10.1016/j.aquaculture.2004.12.015; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Li Y., 2000, HEIBEI FISHERY, V2, P29; Lien S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-615; LINDAHL KF, 1991, TRENDS GENET, V7, P273, DOI 10.1016/0168-9525(91)90306-B; Liu B.-H., 1998, STAT GENOMICS LINKAG; Liu X, 2009, J SHELLFISH RES, V28, P419, DOI 10.2983/035.028.0226; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Mackay TFC, 1996, BIOESSAYS, V18, P113, DOI 10.1002/bies.950180207; Massault C, 2008, AQUACULTURE, V285, P23, DOI 10.1016/j.aquaculture.2008.06.040; McGoldrick DJ, 2000, J SHELLFISH RES, V19, P779; Melchinger AE, 1998, GENETICS, V149, P383; MITTON JB, 1977, CHESAPEAKE SCI, V18, P387, DOI 10.2307/1350595; Moen T, 2004, ANIM GENET, V35, P81, DOI 10.1111/j.1365-2052.2004.01097.x; NEWKIRK GF, 1980, J EXP MAR BIOL ECOL, V47, P89, DOI 10.1016/0022-0981(80)90140-9; Qin YJ, 2007, AQUACULTURE, V272, P281, DOI 10.1016/j.aquaculture.2007.07.214; Qin YJ, 2007, MAR BIOTECHNOL, V9, P66, DOI 10.1007/s10126-006-6076-7; Reece KS, 2004, J HERED, V95, P346, DOI 10.1093/jhered/esh058; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rieseberg LH, 2000, PLANT MOL BIOL, V42, P205, DOI 10.1023/A:1006340407546; Roberts S, 2005, MOL ECOL NOTES, V5, P567, DOI 10.1111/j.1471-8286.2005.00996.x; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Sauvage C, 2010, ANIM GENET, V41, P390, DOI 10.1111/j.1365-2052.2009.02018.x; Shaw PW, 1999, MOL ECOL, V8, P407, DOI 10.1046/j.1365-294X.1999.00588.x; Shi YH, 2009, AQUAC RES, V41, P35, DOI 10.1111/j.1365-2109.2009.02299.x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waller T.R., 1969, J PALEONTOL, V3, P1; Wang CM, 2008, ANIM GENET, V39, P34, DOI 10.1111/j.1365-2052.2007.01672.x; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang L, 2005, THESIS CHINESE ACAD; Wang LL, 2007, AQUACULTURE, V271, P252, DOI 10.1016/j.aquaculture.2007.06.020; Wang LL, 2007, AQUAC RES, V38, P409, DOI 10.1111/j.1365-2109.2007.01683.x; Wang LL, 2005, AQUAC RES, V36, P643, DOI 10.1111/j.1365-2109.2005.01268.x; Wang YP, 2004, BIOL BULL-US, V207, P247, DOI 10.2307/1543213; WEBER JL, 1989, AM J HUM GENET, V44, P388; Woram RA, 2004, GENOME, V47, P304, DOI [10.1139/G03-127, 10.1139/g03-127]; Wu R., 2007, STAT GENETICS QUANTI; Xu Fei, 2008, Journal of Fisheries of China, V32, P876; [喻达辉 YU Dahui], 2007, [中国水产科学, Journal of Fishery Sciences of China], V14, P361; Yu ZN, 2006, AQUACULTURE, V254, P160, DOI 10.1016/j.aquaculture.2005.10.016; Yu ZN, 2003, BIOL BULL-US, V204, P327, DOI 10.2307/1543603; Zhan A, 2009, ANIM GENET, V40, P821, DOI 10.1111/j.1365-2052.2009.01920.x; Zhan AB, 2005, FISHERIES SCI, V71, P1341, DOI 10.1111/j.1444-2906.2005.01100.x; Zhan AB, 2006, J MOLLUS STUD, V72, P436, DOI 10.1093/mollus/eyl018; Zhang F., 2000, ENG SCI, V2, P30; Zhang Fusui, 1994, Oceanologia et Limnologia Sinica, V25, P372; Zheng HP, 2004, J EXP MAR BIOL ECOL, V313, P213, DOI 10.1016/j.jembe.2004.04.015	77	25	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46926	10.1371/journal.pone.0046926	http://dx.doi.org/10.1371/journal.pone.0046926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077533	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800017
J	Liu, HL; Hallen, MA; Endow, SA				Liu, Hong-Lei; Hallen, Mark A.; Endow, Sharyn A.			Altered Nucleotide-Microtubule Coupling and Increased Mechanical Output by a Kinesin Mutant	PLOS ONE			English	Article							MEIOTIC SPINDLE; CRYSTAL-STRUCTURE; STRUCTURAL MODEL; MOTOR PROTEIN; NCD; BINDING; CONFORMATIONS; PURIFICATION; ACTIVATION; DYNAMICS	Kinesin motors hydrolyze ATP to produce force and do work in the cell - how the motors do this is not fully understood, but is thought to depend on the coupling of ATP hydrolysis to microtubule binding by the motor. Transmittal of conformational changes from the microtubule-to the nucleotide-binding site has been proposed to involve the central beta-sheet, which could undergo large structural changes important for force production. We show here that mutation of an invariant residue in loop L7 of the central beta-sheet of the Drosophila kinesin-14 Ncd motor alters both nucleotide and microtubule binding, although the mutated residue is not present in either site. Mutants show weak-ADP/tight-microtubule binding, instead of tight-ADP/weak-microtubule binding like wild type - they hydrolyze ATP faster than wild type, move faster in motility assays, and assemble long spindles with greatly elongated poles, which are also produced by simulations of assembly with tighter microtubule binding and faster sliding. The mutated residue acts like a mechanochemical coupling element - it transmits changes between the microtubule-binding and active sites, and can switch the state of the motor, increasing mechanical output by the motor. One possibility, based on our findings, is that movements by the residue and the loop that contains it could bend or distort the central beta-sheet, mediating free energy changes that lead to force production.	[Liu, Hong-Lei; Endow, Sharyn A.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Hallen, Mark A.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Hallen, Mark A.; Endow, Sharyn A.] Duke Univ, Med Ctr, Program Struct Biol & Biophys, Durham, NC USA	Duke University; Duke University; Duke University	Endow, SA (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	sharyn.endow@duke.edu		Endow, Sharyn A./0000-0002-0907-8889; Liu, Hong-Lei/0000-0003-3858-0373	National Institutes of Health [GM046225]; March of Dimes Birth Defects Foundation [1-FY07-443]; National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Birth Defects Foundation(March of Dimes); National Defense Science and Engineering; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant #GM046225 from the National Institutes of Health (http://www.nih.gov/) and grant #1-FY07-443 from the March of Dimes Birth Defects Foundation (http://www.marchofdimes.com/)to S. A. E., and a National Defense Science and Engineering Graduate Fellowship Award (http://ndseg.asee.org/) to M. A. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Endow SA, 1997, J CELL BIOL, V137, P1321, DOI 10.1083/jcb.137.6.1321; Endow SA, 1996, J CELL SCI, V109, P2429; Grant BJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001207; Hallen MA, 2011, BIOPHYS CHEM, V154, P56, DOI 10.1016/j.bpc.2011.01.001; Hallen MA, 2009, BIOPHYS J, V97, P2191, DOI 10.1016/j.bpj.2009.08.008; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Higuchi H, 2004, EMBO J, V23, P2993, DOI 10.1038/sj.emboj.7600306; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Howard J., 2001, MECH MOTOR PROTEINS; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Liang ZY, 2009, CURR BIOL, V19, P163, DOI 10.1016/j.cub.2008.12.017; Liu HL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00236; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasband W., 2006, IMAGEJ; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; Song H, 1997, BIOTECHNIQUES, V22, P82, DOI 10.2144/97221bm18; Song H, 1997, P NATL ACAD SCI USA, V94, P322, DOI 10.1073/pnas.94.1.322; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; YAMAMOTO AH, 1989, EMBO J, V8, P3543, DOI 10.1002/j.1460-2075.1989.tb08526.x; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531; Zou JW, 2008, J CELL BIOL, V180, P459, DOI 10.1083/jcb.200711031	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47148	10.1371/journal.pone.0047148	http://dx.doi.org/10.1371/journal.pone.0047148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077560	gold, Green Submitted, Green Published			2022-12-25	WOS:000310135800028
J	Aoyagi, K; Ohara-Imaizumi, M; Nishiwaki, C; Nakamichi, Y; Ueki, K; Kadowaki, T; Nagamatsu, S				Aoyagi, Kyota; Ohara-Imaizumi, Mica; Nishiwaki, Chiyono; Nakamichi, Yoko; Ueki, Kohjiro; Kadowaki, Takashi; Nagamatsu, Shinya			Acute Inhibition of PI3K-PDK1-Akt Pathway Potentiates Insulin Secretion through Upregulation of Newcomer Granule Fusions in Pancreatic beta-Cells	PLOS ONE			English	Article							SMALL G-PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; MICE LACKING; KINASE; ACTIVATION; 1ST-PHASE; AKT; PHOSPHORYLATES; TRANSLOCATION	In glucose-induced insulin secretion from pancreatic beta-cells, a population of insulin granules fuses with the plasma membrane without the typical docking process (newcomer granule fusions), however, its mechanism is unclear. In this study, we investigated the PI3K signaling pathways involved in the upregulation of newcomer granule fusions. Acute treatment with the class IA-selective PI3K inhibitors, PIK-75 and PI-103, enhanced the glucose-induced insulin secretion. Total internal reflection fluorescent microscopy revealed that the PI3K inhibitors increased the fusion events from newcomer granules. We developed a new system for transfection into pancreatic islets and demonstrated the usefulness of this system in order for evaluating the effect of transfected genes on the glucose-induced secretion in primary cultured pancreatic islets. Using this transfection system together with a series of constitutive active mutants, we showed that the PI3K-3-phosphoinositide dependent kinase-1 (PDK1)-Akt pathway mediated the potentiation of insulin secretion. The Akt inhibitor also enhanced the glucose-induced insulin secretion in parallel with the upregulation of newcomer granule fusions, probably via increased motility of intracellular insulin granules. These data suggest that the PI3K-PDK1-Akt pathway plays a significant role in newcomer granule fusions, probably through an alteration of the dynamics of the intracellular insulin granules.	[Aoyagi, Kyota; Ohara-Imaizumi, Mica; Nishiwaki, Chiyono; Nakamichi, Yoko; Nagamatsu, Shinya] Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Tokyo, Japan	Kyorin University; University of Tokyo	Nagamatsu, S (corresponding author), Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan.	shinya@ks.kyorin-u.ac.jp			Japan Society for Promotion of Science [B-20390260, 23113724, 20570189]; Research Foundation for Opto-Science and Technology; Novo Nordisk Pharma; Kyorin University School of Medicine Collaboration Project	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Foundation for Opto-Science and Technology; Novo Nordisk Pharma(Novo Nordisk); Kyorin University School of Medicine Collaboration Project	This research was supported by grants from the Grants-in-Aid for Scientific Research (KAKENHI), Japan Society for Promotion of Science B-20390260, 23113724, 20570189), Research Foundation for Opto-Science and Technology, Novo Nordisk Pharma, and Kyorin University School of Medicine Collaboration Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Aoyagi K, 2010, BIOCHEM J, V432, P375, DOI 10.1042/BJ20100864; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Dominguez V, 2011, J BIOL CHEM, V286, P4216, DOI 10.1074/jbc.M110.200295; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; El-Kholy W, 2003, FASEB J, V17, P720, DOI 10.1096/fj.02-0802fje; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; Galandrini R, 2005, BLOOD, V106, P577, DOI 10.1182/blood-2004-10-4100; HAGIWARA S, 1995, BIOCHEM BIOPH RES CO, V214, P51, DOI 10.1006/bbrc.1995.2255; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Itakura M, 2005, J NEUROCHEM, V94, P502, DOI 10.1111/j.1471-4159.2005.03242.x; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Komuro R, 1996, GENES CELLS, V1, P943, DOI 10.1046/j.1365-2443.1996.760276.x; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leibiger B, 2010, FASEB J, V24, P1824, DOI 10.1096/fj.09-148072; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Nunoi K, 2000, BIOCHEM BIOPH RES CO, V270, P798, DOI 10.1006/bbrc.2000.2514; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P41271, DOI 10.1074/jbc.C400360200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Ohara-Imaizumi M, 2009, BIOCHEM BIOPH RES CO, V385, P291, DOI 10.1016/j.bbrc.2009.04.155; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yamada E, 2005, J CELL BIOL, V168, P921, DOI 10.1083/jcb.200408182; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zawalich WS, 2000, ENDOCRINOLOGY, V141, P3287, DOI 10.1210/en.141.9.3287	51	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47381	10.1371/journal.pone.0047381	http://dx.doi.org/10.1371/journal.pone.0047381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077605	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100103
J	Munzbergova, Z				Muenzbergova, Zuzana			Seed Density Significantly Affects Species Richness and Composition in Experimental Plant Communities	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; GRASSLAND PRODUCTIVITY; LEVEL CONSEQUENCES; DISPERSAL LIMITATION; COMPETITION; DIVERSITY; COLONIZATION; FACILITATION; DISTURBANCE; HERBIVORY	Studies on the importance of seed arrival for community richness and composition have not considered the number of seeds arriving and its effect on species richness and composition of natural communities is thus unknown. A series of experimental dry grassland communities were established. All communities were composed of the same 44 species in exactly the same proportions on two substrates using three different seed densities. The results showed that seed density had an effect on species richness only at the beginning of the experiment. In contrast, the effects on species composition persisted across the entire study period. The results do not support the prediction that due to higher competition for light in nutrient-rich soil, species richness will be the highest in the treatment with the lowest seed density. However, the prevalence of small plants in the lowest seed density supported the expectation that low seed density guarantees low competition under high soil nutrients. In the nutrient-poor soil, species richness was the highest at the medium seed density, indicating that species richness reflects the balance between competition and limitations caused by the availability of propagules or their ability to establish themselves. This medium seed density treatment also contained the smallest plants. The results demonstrate that future seed addition experiments need to consider the amount of seed added so that it reflects the amount of seed that is naturally found in the field. Differences in seed density, mimicking different intensity of the seed rain may also explain differences in the composition of natural communities that cannot be attributed to habitat conditions. The results also have important implications for studies regarding the consequences of habitat fragmentation suggesting that increasing fragmentation may change species compositions not only due to different dispersal abilities but also due to differential response of plants to overall seed density.	[Muenzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague 2, Czech Republic; [Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Munzbergova, Z (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague 2, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013	Münzbergová, Zuzana/0000-0002-4026-6220	Czech Science Foundation [P505/10/0593]; Czech Academy of Sciences via the Institute of Botany, Academy of Sciences [RVO 67985939]; Ministry of Education of the Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences via the Institute of Botany, Academy of Sciences; Ministry of Education of the Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague	The study was supported by the Czech Science Foundation (P505/10/0593) (www.gacr.cz), and partly by the Czech Academy of Sciences (RVO 67985939) (www.cas.cz) via the Institute of Botany, Academy of Sciences, and by Ministry of Education (www.msmt.cz) of the Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONSER SP, 1995, ECOLOGY, V76, P2176, DOI 10.2307/1941691; Brewer JS, 2011, J ECOL, V99, P1219, DOI 10.1111/j.1365-2745.2011.01846.x; Brown RL, 2003, OIKOS, V102, P15, DOI 10.1034/j.1600-0706.2003.12191.x; Bustamante-Sanchez MA, 2011, J ECOL, V99, P288, DOI 10.1111/j.1365-2745.2010.01737.x; Cadotte MW, 2006, AM NAT, V168, P704, DOI 10.1086/508296; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chylova T, 2008, PRESLIA, V80, P183; Connell J. H., 1990, Perspectives on plant competition., P9; Corcket E, 2003, ACTA OECOL, V24, P139, DOI 10.1016/S1146-609X(03)00064-X; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Dickson TL, 2008, J ECOL, V96, P937, DOI 10.1111/j.1365-2745.2008.01420.x; Ehrlen J, 2000, ECOLOGY, V81, P1667, DOI 10.1890/0012-9658(2000)081[1667:DLAPOI]2.0.CO;2; Eskelinen A, 2005, OIKOS, V110, P360, DOI 10.1111/j.0030-1299.2005.13579.x; Foster BL, 2004, J ECOL, V92, P435, DOI 10.1111/j.0022-0477.2004.00882.x; Foster BL, 2001, ECOL LETT, V4, P530, DOI 10.1046/j.1461-0248.2001.00266.x; Foster BL, 2003, J ECOL, V91, P999, DOI 10.1046/j.1365-2745.2003.00830.x; Foster BL, 2011, J ECOL, V99, P473, DOI 10.1111/j.1365-2745.2010.01769.x; Fraser LH, 2008, OIKOS, V117, P1057, DOI [10.1111/j.0030-1299.2008.16251.x, 10.1111/j.2008.0030-1299.16251.x]; Goldberg DE, 1998, J ECOL, V86, P983, DOI 10.1046/j.1365-2745.1998.00319.x; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; GOLDBERG DE, 1995, FOLIA GEOBOT PHYTOTX, V30, P231, DOI 10.1007/BF02812101; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; Grime J. P., 1979, Plant strategies and vegetation processes.; Grime J. P., 2001, PLANT STRATEGIES VEG; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Harper J. L., 1977, Population biology of plants.; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Howard TG, 2001, J ECOL, V89, P110, DOI 10.1046/j.1365-2745.2001.00533.x; Hubbell Stephen P., 2001, V32, pi; Keddy P., 2001, COMPETITION; Keddy P. A., 1990, Perspectives on plant competition., P265; Keddy Paul A., 1994, Journal of Ecology, V82, P635, DOI 10.2307/2261270; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Korner C, 2008, NEW PHYTOL, V177, P698, DOI 10.1111/j.1469-8137.2007.02287.x; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; LEVINS R, 1971, P NATL ACAD SCI USA, V68, P1246, DOI 10.1073/pnas.68.6.1246; Lindborg R, 2007, J ECOL, V95, P555, DOI 10.1111/j.1365-2745.2007.01232.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; MacDougall AS, 2007, ECOLOGY, V88, P1105, DOI 10.1890/06-1836; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Munzbergova Z, 2002, J VEG SCI, V13, P227, DOI 10.1658/1100-9233(2002)013[0227:ATAKSI]2.0.CO;2; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Oksanen J, 1996, J ECOL, V84, P293, DOI 10.2307/2261364; Olsson PA, 2009, APPL VEG SCI, V12, P350, DOI 10.1111/j.1654-109X.2009.01029.x; Piessens K, 2005, BIOL CONSERV, V122, P61, DOI 10.1016/j.biocon.2004.05.023; Polley HW, 2006, OIKOS, V113, P287, DOI 10.1111/j.2006.0030-1299.14267.x; Rajaniemi TK, 2009, J VEG SCI, V20, P836, DOI 10.1111/j.1654-1103.2009.01086.x; S-Plus, 2000, PROF ED WIND REL 2; Safford HD, 2001, OIKOS, V95, P282, DOI 10.1034/j.1600-0706.2001.950210.x; Silletti AM, 2004, CAN J BOT, V82, P450, DOI [10.1139/B04-016, 10.1139/b04-016]; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; Suding KN, 2003, ECOLOGY, V84, P1; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Terborgh J, 2011, J ECOL, V99, P935, DOI 10.1111/j.1365-2745.2011.01836.x; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Tremlova K, 2007, ECOLOGY, V88, P965, DOI 10.1890/06-0924; Vandvik V, 2005, FOLIA GEOBOT, V40, P45, DOI 10.1007/BF02803043; Vandvik V, 2006, AM NAT, V168, P157, DOI 10.1086/505759; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wardle DA, 2001, OIKOS, V95, P161, DOI 10.1034/j.1600-0706.2001.950119.x; Warren J, 2009, THEOR ECOL-NETH, V2, P119, DOI 10.1007/s12080-008-0035-z; Williamson G. B., 1990, Perspectives on plant competition., P143; Zhang QG, 2007, OIKOS, V116, P1748, DOI [10.1111/j.2007.0030-1299.15988.x, 10.1111/j.0030-1299.2007.15988.x]; Zobel M, 2006, J VEG SCI, V17, P543, DOI 10.1111/j.1654-1103.2006.tb02477.x	71	12	12	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46704	10.1371/journal.pone.0046704	http://dx.doi.org/10.1371/journal.pone.0046704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077519	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100036
J	Lv, J; Qi, JJ; Shi, QX; Shen, D; Zhang, SP; Shao, GJ; Li, H; Sun, ZY; Weng, YQ; Shang, Y; Gu, XF; Li, XX; Zhu, XG; Zhang, JZ; van Treuren, R; van Dooijeweert, W; Zhang, ZH; Huang, SW				Lv, Jing; Qi, Jianjian; Shi, Qiuxiang; Shen, Di; Zhang, Shengping; Shao, Guangjin; Li, Hang; Sun, Zhanyong; Weng, Yiqun; Shang, Yi; Gu, Xingfang; Li, Xixiang; Zhu, Xiaoguo; Zhang, Jinzhe; van Treuren, Robbert; van Dooijeweert, Willem; Zhang, Zhonghua; Huang, Sanwen			Genetic Diversity and Population Structure of Cucumber (Cucumis sativus L.)	PLOS ONE			English	Article							GENOME	Knowing the extent and structure of genetic variation in germplasm collections is essential for the conservation and utilization of biodiversity in cultivated plants. Cucumber is the fourth most important vegetable crop worldwide and is a model system for other Cucurbitaceae, a family that also includes melon, watermelon, pumpkin and squash. Previous isozyme studies revealed a low genetic diversity in cucumber, but detailed insights into the crop's genetic structure and diversity are largely missing. We have fingerprinted 3,342 accessions from the Chinese, Dutch and U. S. cucumber collections with 23 highly polymorphic Simple Sequence Repeat (SSR) markers evenly distributed in the genome. The data reveal three distinct populations, largely corresponding to three geographic regions. Population 1 corresponds to germplasm from China, except for the unique semi-wild landraces found in Xishuangbanna in Southwest China and East Asia; population 2 to Europe, America, and Central and West Asia; and population 3 to India and Xishuangbanna. Admixtures were also detected, reflecting hybridization and migration events between the populations. The genetic background of the Indian germplasm is heterogeneous, indicating that the Indian cucumbers maintain a large proportion of the genetic diversity and that only a small fraction was introduced to other parts of the world. Subsequently, we defined a core collection consisting of 115 accessions and capturing over 77% of the SSR alleles. Insight into the genetic structure of cucumber will help developing appropriate conservation strategies and provides a basis for population-level genome sequencing in cucumber.	[Lv, Jing; Qi, Jianjian; Shi, Qiuxiang; Shen, Di; Zhang, Shengping; Shao, Guangjin; Shang, Yi; Gu, Xingfang; Li, Xixiang; Zhu, Xiaoguo; Zhang, Jinzhe; Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Opening Lab Genet Improvement Agr Crops, Sino Dutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100193, Peoples R China; [Li, Hang] Middlebury Coll, Middlebury, VT 05753 USA; [Li, Hang] Renmin Univ China, High Sch, Beijing, Peoples R China; [Sun, Zhanyong] EW Seed Int Ltd, Nanning, Guangxi, Peoples R China; [Weng, Yiqun] Univ Wisconsin, Dept Hort, Vegetable Crops Res Unit, USDA,ARS, Madison, WI 53706 USA; [van Treuren, Robbert; van Dooijeweert, Willem] Univ Wageningen & Res Ctr, Ctr Genet Resources, Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Renmin University of China; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Wageningen University & Research	Huang, SW (corresponding author), Chinese Acad Agr Sci, Opening Lab Genet Improvement Agr Crops, Sino Dutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100193, Peoples R China.	huangsanwen@caas.net.cn	Huang, Sanwen/ABE-9053-2020	Huang, Sanwen/0000-0002-8547-5309; zhang, zhonghua/0000-0002-1034-227X	National Program on Key Basic Research Projects in China (The 973 Program) [2012CB113900]; National High Tech Research Development Program in China (The 863 Program) [2010AA10A108]; Chinese Ministry of Finance [1251610601001]; National Natural Science Foundation of China [31071797]; Chinese Academy of Agricultural Sciences	National Program on Key Basic Research Projects in China (The 973 Program)(National Basic Research Program of China); National High Tech Research Development Program in China (The 863 Program)(National High Technology Research and Development Program of China); Chinese Ministry of Finance; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Agricultural Sciences	This study is supported by National Program on Key Basic Research Projects in China (The 973 Program: 2012CB113900), National High Tech Research Development Program in China (The 863 Program: 2010AA10A108), Chinese Ministry of Finance (1251610601001), The National Natural Science Foundation of China (31071797) and Chinese Academy of Agricultural Sciences (seed grant to Sanwen Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Dabholkar A.R., 2006, GEN PLANT BREEDING; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Han YH, 2009, P NATL ACAD SCI USA, V106, P14937, DOI 10.1073/pnas.0904833106; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Li Shizhen, COMPENDIUM MAT MED 3, V28, P14; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Meglic V, 1996, GENET RESOUR CROP EV, V43, P547, DOI 10.1007/BF00138831; Meglic V, 1996, GENET RESOUR CROP EV, V43, P533, DOI 10.1007/BF00138830; Pritchard JK, 2000, GENETICS, V155, P945; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; Robinson RW., 1997, CUCURBITS; Sebastian P, 2010, P NATL ACAD SCI USA, V107, P14269, DOI 10.1073/pnas.1005338107; SLATKIN M, 1985, EVOLUTION, V39, P53, DOI 10.2307/2408516; Staub JE, 1999, GENET RESOUR CROP EV, V46, P297, DOI 10.1023/A:1008663225896; Staub JE, 1997, GENET RESOUR CROP EV, V44, P315, DOI 10.1023/A:1008639103328; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatlioglu T., 2012, GENETIC IMPROVEMENT, P197; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Zhou HF, 2003, THEOR APPL GENET, V107, P332, DOI 10.1007/s00122-003-1251-y	28	74	80	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46919	10.1371/journal.pone.0046919	http://dx.doi.org/10.1371/journal.pone.0046919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071663	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500022
J	Singh, DK; Laremore, TN; Smith, PB; Maximova, SN; McNellis, TW				Singh, Dharmendra K.; Laremore, Tatiana N.; Smith, Philip B.; Maximova, Siela N.; McNellis, Timothy W.			Knockdown of FIBRILLIN4 Gene Expression in Apple Decreases Plastoglobule Plastoquinone Content	PLOS ONE			English	Article							LIPOCALIN PROTEIN FAMILY; PLASTID ULTRASTRUCTURE; LIPOPROTEIN PARTICLES; ARABIDOPSIS-THALIANA; QUINONE DISTRIBUTION; THYLAKOID MEMBRANES; MASS-SPECTROMETRY; PHOTOSYSTEM-II; CHLOROPLASTS; STRESS	Fibrillin4 (FBN4) is a protein component of plastoglobules, which are antioxidant-rich sub-compartments attached to the chloroplast thylakoid membranes. FBN4 is required for normal plant biotic and abiotic stress resistance, including bacterial pathogens, herbicide, high light intensity, and ozone; FBN4 is also required for the accumulation of osmiophilic material inside plastoglobules. In this study, the contribution of FBN4 to plastoglobule lipid composition was examined using cultivated apple trees in which FBN4 gene expression was knocked down using RNA interference. Chloroplasts and plastoglobules were isolated from leaves of wild-type and fbn4 knock-down trees. Total lipids were extracted from chloroplasts and plastoglobules separately, and analyzed using liquid chromatography-mass spectrometry (LC-MS). Three lipids were consistently present at lower levels in the plastoglobules from fbn4 knock-down apple leaves compared to the wild-type as determined by LC-MS multiple ion monitoring. One of these species had a molecular mass and fragmentation pattern that identified it as plastoquinone, a known major component of plastoglobules. The plastoquinone level in fbn4 knock-down plastoglobules was less than 10% of that in wild-type plastoglobules. In contrast, plastoquinone was present at similar levels in the lipid extracts of whole chloroplasts from leaves of wild-type and fbn4 knock-down trees. These results suggest that the partitioning of plastoquinone between the plastoglobules and the rest of the chloroplast is disrupted in fbn4 knock-down leaves. These results indicate that FBN4 is required for high-level accumulation of plastoquinone and some other lipids in the plastoglobule. The dramatic decrease in plastoquinone content in fbn4 knock-down plastoglobules is consistent with the decreased plastoglobule osmiophilicity previously described for fbn4 knock-down plastoglobules. Failure to accumulate the antioxidant plastoquinone in the fbn4 knock-down plastoglobules might contribute to the increased stress sensitivity of fbn4 knock-down trees.	[Singh, Dharmendra K.; McNellis, Timothy W.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Singh, Dharmendra K.] Penn State Univ, Intercoll Grad Degree Program Plant Biol, University Pk, PA 16802 USA; [Laremore, Tatiana N.; Smith, Philip B.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Maximova, Siela N.] Penn State Univ, Dept Hort, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	McNellis, TW (corresponding author), Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA.	twm4@psu.edu	; Singh, Dharmendra Kumar/I-4882-2014	Laremore, Tatiana/0000-0002-1036-8963; Singh, Dharmendra Kumar/0000-0002-6494-1710	United States National Science Foundation Plant Genome Research Program [DBI0420394]	United States National Science Foundation Plant Genome Research Program	This research was supported by a grant from the United States National Science Foundation Plant Genome Research Program (Award Number DBI0420394) to TWM, SNM, Robert M. Crassweller, and James W. Travis. Funder URL: www.nsf.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Bailey JL, 1963, BIOCHIM BIOPHYS ACTA, V78, P163; BARR R, 1967, AM J BOT, V54, P365, DOI 10.2307/2440765; BISHOP NI, 1971, ANNU REV BIOCHEM, V40, P197, DOI 10.1146/annurev.bi.40.070171.001213; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Breemen RBV, 1998, J CHROMATOGR A, V794, P245; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; DERUERE J, 1994, PLANT CELL, V6, P119, DOI 10.1105/tpc.6.1.119; DURET S, 1986, ENVIRON RES, V39, P96, DOI 10.1016/S0013-9351(86)80011-1; Eymery F, 1999, PLANT PHYSIOL BIOCH, V37, P305, DOI 10.1016/S0981-9428(99)80029-1; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; GREENWOOD AD, 1963, BIOCHIM BIOPHYS ACTA, V78, P148, DOI 10.1016/0006-3002(63)91620-2; Havaux M, 2005, PLANT CELL, V17, P3451, DOI 10.1105/tpc.105.037036; Hiltbrunner A, 2001, J CELL BIOL, V154, P309, DOI 10.1083/jcb.200104022; Hundal T, 1995, ARCH BIOCHEM BIOPHYS, V324, P117, DOI 10.1006/abbi.1995.9920; Jones AME, 2006, PROTEOMICS, V6, P4155, DOI 10.1002/pmic.200500172; Kessler F, 2007, ADV BIOCHEM ENG BIOT, V107, P153, DOI 10.1007/10_2007_054; Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3; Kruk J, 2008, BBA-BIOENERGETICS, V1777, P154, DOI 10.1016/j.bbabio.2007.10.008; Lohmann A, 2006, J BIOL CHEM, V281, P40461, DOI 10.1074/jbc.M609412200; OKAMOTO T, 1985, J CHROMATOGR, V342, P35, DOI 10.1016/S0378-4347(00)84487-4; Panou-Filotheou H, 2001, ANN BOT-LONDON, V88, P207, DOI 10.1006/anbo.2001.1441; Pshibytko NL, 2003, RUSS J PLANT PHYSL+, V50, P44, DOI 10.1023/A:1021932317144; Rey P, 2000, PLANT J, V21, P483, DOI 10.1046/j.1365-313x.2000.00699.x; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Simkin AJ, 2007, PHYTOCHEMISTRY, V68, P1545, DOI 10.1016/j.phytochem.2007.03.014; Singh DK, 2011, TRENDS PLANT SCI, V16, P432, DOI 10.1016/j.tplants.2011.03.014; Singh DK, 2010, PLANT PHYSIOL, V154, P1281, DOI 10.1104/pp.110.164095; SOLL J, 1980, ARCH BIOCHEM BIOPHYS, V204, P544, DOI 10.1016/0003-9861(80)90066-1; STEINMULLER D, 1985, PLANTA, V163, P201, DOI 10.1007/BF00393507; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Teshima K, 2005, ANAL BIOCHEM, V338, P12, DOI 10.1016/j.ab.2004.12.007; TEVINI M, 1985, PLANTA, V163, P91, DOI 10.1007/BF00395902; VALENTINE RC, 1958, NATURE, V181, P832, DOI 10.1038/181832b0; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083	39	21	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47547	10.1371/journal.pone.0047547	http://dx.doi.org/10.1371/journal.pone.0047547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077632	gold, Green Published, Green Submitted			2022-12-25	WOS:000309809500052
J	Wu, ZF; Sun, LH; Wang, HJ; Yao, JS; Jiang, CL; Xu, WH; Yang, ZX				Wu, Zhifeng; Sun, Lihua; Wang, Hongjun; Yao, Jianshe; Jiang, Chuanlu; Xu, Wenhui; Yang, Zhengxiang			MiR-328 Expression Is Decreased in High-Grade Gliomas and Is Associated with Worse Survival in Primary Glioblastoma	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; BREAST-CANCER; STEM-CELLS; MICRORNAS; RADIOTHERAPY; CONCOMITANT; TUMORS; ASTROCYTOMA; PROGRESSION	MicroRNAs, a group of small endogenous, noncoding RNAs, are aberrantly expressed in many human cancers and can act as oncogene or anti-oncogene. Recent evidence suggests that some miRNAs have prognostic value for tumors. MiR-328 is known as a tumor suppressor; however, its relationship with the clinicopathological features of glioblastoma (GBM) and its prognostic value has yet not been investigated. We found that expression of miR-328 was significantly decreased both in anaplastic and GBM cohorts and that low miR-328 expression also conferred poor survival in primary GBM (PGBM) patients. MiR-328 might, therefore, serve as an independent prognostic marker. Furthermore, expression profiles of miR-328-associated mRNAs were established via microarrays for 60 GBM samples. The ontology of the miR-328-associated genes was then analyzed, which identified gene sets tightly related to cell mitosis. In addition, ectopic expression of miR-328 inhibited U87 cell proliferation and induced U87 cell cycle arrest. In conclusion, this is the first report showing that miR-328 is associated with patient's survival time and that miR-328 might serve as an independent prognostic biomarker for GBM.	[Wu, Zhifeng; Sun, Lihua; Yao, Jianshe; Yang, Zhengxiang] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Neurosurg, Wuxi, Peoples R China; [Wang, Hongjun; Jiang, Chuanlu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [Xu, Wenhui] Jiangsu Univ, Affiliated Yixin Peoples Hosp, Dept Neurosurg, Yixin, Peoples R China	Nanjing Medical University; Harbin Medical University; Jiangsu University	Yang, ZX (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Neurosurg, Wuxi, Peoples R China.	neuro_slh@126.com; wuxiyangz@126.com	wu, zhi/GXH-3041-2022		Jiangsu Province's Science Development Foundation [Z201012]	Jiangsu Province's Science Development Foundation	This work is supported by Jiangsu Province's Science Development Foundation (project number Z201012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Calligaris D, 2010, CELL MOL LIFE SCI, V67, P1089, DOI 10.1007/s00018-009-0245-6; Chen L, 2012, ACTA GASTRO-ENT BELG, V75, P22; Corsini LR, 2012, EXPERT OPIN THER TAR, V16, pS103, DOI 10.1517/14728222.2011.650632; Donson AM, 2007, PEDIATR BLOOD CANCER, V48, P403, DOI 10.1002/pbc.20803; Fridman E, 2010, J MOL DIAGN, V12, P687, DOI 10.2353/jmoldx.2010.090187; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Li WQ, 2010, MED SCI MONITOR, V16, pHY27; Liu XQ, 2007, BIOCHEM BIOPH RES CO, V353, P960, DOI 10.1016/j.bbrc.2006.12.142; Luo XJ, 2011, EUR J PHARMACOL, V670, P427, DOI 10.1016/j.ejphar.2011.08.026; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Okumus NO, 2012, ANN SAUDI MED, V32, P250, DOI 10.5144/0256-4947.2012.250; Pichler M, 2012, BR J CANC; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Takahashi S, 2012, J NEURO-ONCOL, V106, P519, DOI 10.1007/s11060-011-0706-2; Tin AS, 2012, ANTI-CANCER DRUG, V23, P370, DOI 10.1097/CAD.0b013e32834f6ea8; Wang ZX, 2011, J SURG ONCOL, V104, P847, DOI 10.1002/jso.22008; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	33	45	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47270	10.1371/journal.pone.0047270	http://dx.doi.org/10.1371/journal.pone.0047270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077581	gold, Green Published, Green Submitted			2022-12-25	WOS:000309809500040
J	Dubrovin, EV; Popova, AV; Kraevskiy, SV; Ignatov, SG; Ignatyuk, TE; Yaminsky, IV; Volozhantsev, NV				Dubrovin, Evgeniy V.; Popova, Anastasia V.; Kraevskiy, Sergey V.; Ignatov, Sergei G.; Ignatyuk, Tatyana E.; Yaminsky, Igor V.; Volozhantsev, Nikolay V.			Atomic Force Microscopy Analysis of the Acinetobacter baumannii Bacteriophage AP22 Lytic Cycle	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; BIOFILM FORMATION; ESCHERICHIA-COLI; PHAGE; MONOLAYERS; SURFACES; SURVIVAL; ADHESION; DNA	Background: Acinetobacter baumannii is known for its ability to develop resistance to the major groups of antibiotics, form biofilms, and survive for long periods in hospital environments. The prevalence of infections caused by multidrug-resistant A. baumannii is a significant problem for the modern health care system, and application of lytic bacteriophages for controlling this pathogen may become a solution. Methodology/Principal Findings: In this study, using atomic force microscopy (AFM) and microbiological assessment we have investigated A. baumannii bacteriophage AP22, which has been recently described. AFM has revealed the morphology of bacteriophage AP22, adsorbed on the surfaces of mica, graphite and host bacterial cells. Besides, morphological changes of bacteriophage AP22-infected A. baumannii cells were characterized at different stages of the lytic cycle, from phage adsorption to the cell lysis. The phage latent period, estimated from AFM was in good agreement with that obtained by microbiological methods (40 min). Bacteriophage AP22, whose head diameter is 62 +/- 1 nm and tail length is 88 +/- 9 nm, was shown to disperse A. baumannii aggregates and adsorb to the bacterial surface right from the first minute of their mutual incubation at 37 degrees C. Conclusions/Significance: High rate of bacteriophage AP22 specific adsorption and its ability to disperse bacterial aggregates make this phage very promising for biomedical antimicrobial applications. Complementing microbiological results with AFM data, we demonstrate an effective approach, which allows not only comparing independently obtained characteristics of the lytic cycle but also visualizing the infection process.	[Dubrovin, Evgeniy V.; Yaminsky, Igor V.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Dubrovin, Evgeniy V.; Yaminsky, Igor V.] Adv Technol Ctr, Moscow, Russia; [Popova, Anastasia V.; Ignatov, Sergei G.; Volozhantsev, Nikolay V.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Russia; [Kraevskiy, Sergey V.; Ignatyuk, Tatyana E.] Alikhanov Inst Theoret & Expt Phys, Moscow, Russia	Lomonosov Moscow State University; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics	Dubrovin, EV (corresponding author), Moscow MV Lomonosov State Univ, Moscow, Russia.	dubrovin@genebee.msu.ru	Volozhantsev, Nikolay V./Q-5579-2016; Dubrovin, Evgeniy/B-3478-2008; Popova, Anastasia V/M-4608-2014; Kraevsky, Sergey/V-4593-2018; Sergei, Ignatov G/S-4012-2017; Yaminsky, Igor/H-7857-2013	Volozhantsev, Nikolay V./0000-0003-4667-1451; Dubrovin, Evgeniy/0000-0001-8883-5966; Popova, Anastasia V/0000-0003-0065-6459; Kraevsky, Sergey/0000-0001-8062-6668; Sergei, Ignatov G/0000-0003-1755-6614; Yaminsky, Igor/0000-0001-8731-3947	Moscow State University for young scientists	Moscow State University for young scientists	ED has the scholarship of Moscow State University for young scientists. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Archer MJ, 2009, SENSORS-BASEL, V9, P6298, DOI 10.3390/s90806298; Bolshakova AV, 2004, BIOTECHNOL PROGR, V20, P1615, DOI 10.1021/bp049742c; Braga PC, 2002, J ANTIMICROB CHEMOTH, V50, P457, DOI 10.1093/jac/dkf180; Britt DW, 1998, THIN SOLID FILMS, V327, P824, DOI 10.1016/S0040-6090(98)00770-6; Chen YY, 2009, LANGMUIR, V25, P4607, DOI 10.1021/la8036346; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Oliveira AC, 2010, REV ESC ENFERM USP, V44, P1112; Dubrovin EV, 2004, COLLOID J+, V66, P673, DOI 10.1007/s10595-005-0048-x; Dubrovin EV, 2008, LANGMUIR, V24, P13068, DOI 10.1021/la8022612; Dubrovin EV, 2007, NANOMED-NANOTECHNOL, V3, P128, DOI 10.1016/j.nano.2007.01.005; Dubrovin Evgeniy V, 2012, Open Microbiol J, V6, P22, DOI 10.2174/1874285801206010022; Dupres V, 2010, TRENDS MICROBIOL, V18, P397, DOI 10.1016/j.tim.2010.06.004; Eaton P, 2008, ULTRAMICROSCOPY, V108, P1128, DOI 10.1016/j.ultramic.2008.04.015; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Evilevitch A, 2011, J MOL BIOL, V405, P18, DOI 10.1016/j.jmb.2010.10.039; Fang JY, 1997, J PHYS CHEM B, V101, P8692, DOI 10.1021/jp971057j; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Ivanovska I, 2007, P NATL ACAD SCI USA, V104, P9603, DOI 10.1073/pnas.0703166104; Jeon DY, 2011, J APPL PHYS, V109, DOI 10.1063/1.3549113; Lee CN, 2011, APPL ENVIRON MICROB, V77, P6755, DOI 10.1128/AEM.05116-11; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007; LYUBCHENKO YL, 1993, NUCLEIC ACIDS RES, V21, P1117, DOI 10.1093/nar/21.5.1117; Malfatti F, 2010, ISME J, V4, P427, DOI 10.1038/ismej.2009.116; Marti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026030; Matsko N, 2001, J ELECTRON MICROSC, V50, P417, DOI 10.1093/jmicro/50.5.417; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Ploss M, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045002; Popova AV, 2012, FEMS MICROBIOL LETT, V332, P40, DOI 10.1111/j.1574-6968.2012.02573.x; Ryan EM, 2011, J PHARM PHARMACOL, V63, P1253, DOI 10.1111/j.2042-7158.2011.01324.x; Soon RL, 2009, ANTIMICROB AGENTS CH, V53, P4979, DOI 10.1128/AAC.00497-09; Sutherland IW, 2004, FEMS MICROBIOL LETT, V232, P1, DOI 10.1016/S0378-1097(04)00041-2; Teschke O, 2005, MICROSC RES TECHNIQ, V67, P312, DOI 10.1002/jemt.20203; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Towner KJ, 2009, J HOSP INFECT, V73, P355, DOI 10.1016/j.jhin.2009.03.032; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Webster CA, 1998, EUR J CLIN MICROBIOL, V17, P171, DOI 10.1007/BF01691113; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; Yang HJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-131	41	24	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47348	10.1371/journal.pone.0047348	http://dx.doi.org/10.1371/journal.pone.0047348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071792	Green Submitted, gold, Green Published			2022-12-25	WOS:000309807700076
J	Gu, W; Xu, WG; Ding, T; Guo, XJ				Gu, Wen; Xu, Weiguo; Ding, Tao; Guo, Xuejun			Fringe Controls Naive CD4(+)T Cells Differentiation through Modulating Notch Signaling in Asthmatic Rat Models	PLOS ONE			English	Article							T-CELLS; PROTEIN O-FUCOSYL-TRANSFERASE-1; LYMPHOCYTE DEVELOPMENT; LINEAGE COMMITMENT; GATA3 EXPRESSION; IN-VIVO; LIGANDS; GLYCOSYLATION; POLARIZATION; INFLAMMATION	The ability of Notch signaling to regulate T helper cell development and differentiation has been widely accepted. Fringe, O-fucose-beta 1,3-N-acetylglucosaminyltransferases modulate Notch receptor expression and promote the Notch signaling pathway through receptor-ligand binding. In this study, we assayed the expression levels of three Fringe homologs in naive CD4(+)T cells in asthmatic rats. We found that Radical Fringe (Rfng) was highly expressed, whereas both Lunatic Fringe (Lfng) and Manic Fringe (Mfng) were expressed at low levels. Down-regulation of Rfng using siRNA, and overexpression of Lfng or Mfng enhanced Th1 subset lineages and diminished Th2 subset lineages. Notch signaling was more activated in asthmatic naive CD4(+)T cells than in control cells, and Lfng, but not Mfng or Rfng, partly inhibited Notch signaling in asthmatic naive CD4(+)T lymphocytes. Lfng overexpression resulted in significantly decreased Th2 cytokine production in asthma, which was the same effect as the GSI (gamma-secretase inhibitor) treatment alone, but had an increased effect on Th1 cytokines than GSI treatment. Collectively, these data identify the essential role of Fringe modulating naive CD4(+)T cells differentiation through Notch signaling. Lfng regulated Th2 cells differentiation via a Notch-dependent manner and Th1 cells differentiation via a Notch-independent manner. Fringe could be a therapeutic strategy for the management and prevention of allergic asthma.	[Gu, Wen; Xu, Weiguo; Ding, Tao; Guo, Xuejun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Resp Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Guo, XJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Resp Med, Shanghai 200030, Peoples R China.	guoxj1964@yahoo.cn	Gu, Wen/M-2161-2015	Gu, Wen/0000-0003-1414-0605	National Natural Science Foundation of China [30971302]; Research and Innovation Project of Shanghai Education Committee [09ZZ114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Project of Shanghai Education Committee	This work was supported by the National Natural Science Foundation of China (No. 30971302)(www.nsfc.gov.cn). The study was also supported by the Research and Innovation Project of Shanghai Education Committee (No. 09ZZ114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2010, EUR J IMMUNOL, V40, P2608, DOI 10.1002/eji.200940006; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BUSSE WW, 1995, AM J RESP CRIT CARE, V152, P388, DOI 10.1164/ajrccm.152.1.7599853; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Corry DB, 2002, NAT REV DRUG DISCOV, V1, P55, DOI 10.1038/nrd702; Elias JA, 2000, AM J RESP CRIT CARE, V161, pS168, DOI 10.1164/ajrccm.161.supplement_2.a1q4-4; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; GAVETT SH, 1994, AM J RESP CELL MOL, V10, P587, DOI 10.1165/ajrcmb.10.6.8003337; Glimcher Laurie H., 2001, Journal of Clinical Investigation, V108, pS25; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; Hozumi K, 2008, EUR J IMMUNOL, V38, P977, DOI 10.1002/eji.200737688; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Kang JH, 2009, AM J RESP CRIT CARE, V179, P875, DOI 10.1164/rccm.200806-893OC; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mazzarella G, 2000, ALLERGY, V55, P6, DOI 10.1034/j.1398-9995.2000.00511.x; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Robey EA, 2004, CURR OPIN IMMUNOL, V16, P360, DOI 10.1016/j.coi.2004.03.009; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Sun J, 2008, J IMMUNOL, V180, P1655, DOI 10.4049/jimmunol.180.3.1655; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tsukumo S, 2004, J IMMUNOL, V173, P7109, DOI 10.4049/jimmunol.173.12.7109; Tsukumo SI, 2006, J IMMUNOL, V177, P8365, DOI 10.4049/jimmunol.177.12.8365; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Visan I, 2010, J IMMUNOL, V185, P4609, DOI 10.4049/jimmunol.1002008; Xu KL, 2010, AM J PHYSIOL-LUNG C, V298, pL45, DOI 10.1152/ajplung.90550.2008; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	42	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47288	10.1371/journal.pone.0047288	http://dx.doi.org/10.1371/journal.pone.0047288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071776	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200099
J	Kneissl, S; Abel, T; Rasbach, A; Brynza, J; Schneider-Schaulies, J; Buchholz, CJ				Kneissl, Sabrina; Abel, Tobias; Rasbach, Anke; Brynza, Julia; Schneider-Schaulies, Juergen; Buchholz, Christian J.			Measles Virus Glycoprotein-Based Lentiviral Targeting Vectors That Avoid Neutralizing Antibodies	PLOS ONE			English	Article							GENE DELIVERY; HEMAGGLUTININ; CELLS; NEUROVIRULENCE; ENCEPHALITIS; TRANSDUCTION; DOMAIN; VIVO	Lentiviral vectors (LVs) are potent gene transfer vehicles frequently applied in research and recently also in clinical trials. Retargeting LV entry to cell types of interest is a key issue to improve gene transfer safety and efficacy. Recently, we have developed a targeting method for LVs by incorporating engineered measles virus (MV) glycoproteins, the hemagglutinin (H), responsible for receptor recognition, and the fusion protein into their envelope. The H protein displays a single-chain antibody (scFv) specific for the target receptor and is ablated for recognition of the MV receptors CD46 and SLAM by point mutations in its ectodomain. A potential hindrance to systemic administration in humans is pre-existing MV-specific immunity due to vaccination or natural infection. We compared transduction of targeting vectors and non-targeting vectors pseudotyped with MV glycoproteins unmodified in their ectodomains (MV-LV) in presence of alpha-MV antibody-positive human plasma. At plasma dilution 1: 160 MV-LV was almost completely neutralized, whereas targeting vectors showed relative transduction efficiencies from 60% to 90%. Furthermore, at plasma dilution 1: 80 an at least 4-times higher multiplicity of infection (MOI) of MV-LV had to be applied to obtain similar transduction efficiencies as with targeting vectors. Also when the vectors were normalized to their p24 values, targeting vectors showed partial protection against alpha-MV antibodies in human plasma. Furthermore, the monoclonal neutralizing antibody K71 with a putative epitope close to the receptor binding sites of H, did not neutralize the targeting vectors, but did neutralize MV-LV. The observed escape from neutralization may be due to the point mutations in the H ectodomain that might have destroyed antibody binding sites. Furthermore, scFv mediated cell entry via the target receptor may proceed in presence of a-MV antibodies interfering with entry via the natural MV receptors. These results are promising for in vivo applications of targeting vectors in humans.	[Kneissl, Sabrina; Abel, Tobias; Rasbach, Anke; Brynza, Julia; Buchholz, Christian J.] Paul Ehrlich Inst, D-6070 Langen, Germany; [Schneider-Schaulies, Juergen] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany	Paul Ehrlich Institute; University of Wurzburg	Kneissl, S (corresponding author), Paul Ehrlich Inst, D-6070 Langen, Germany.	Sabrina.Kneissl@pei.de; Christian.Buchholz@pei.de		Buchholz, Christian/0000-0002-9837-7345; Schneider-Schaulies, Jurgen/0000-0001-7713-5518	European Community; LOEWE Center; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4- 518/17.004]	European Community(European Commission); LOEWE Center; Hessisches Ministerium fur Wissenschaft und Kunst	This work was supported by grants from the 7th European Community program project Persisting Transgenesis (Persist) to CJB and the LOEWE Center for Cell and Gene Therapy Frankfurt funded by Hessisches Ministerium fur Wissenschaft und Kunst (III L 4- 518/17.004 (2010)) to CJB and SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anliker B, 2010, NAT METHODS, V7, P929, DOI 10.1038/nmeth.1514; Buchholz CJ, 2009, TRENDS BIOTECHNOL, V27, P259, DOI 10.1016/j.tibtech.2009.02.002; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; de Swart RL, 2005, J VIROL, V79, P11547, DOI 10.1128/JVI.79.17.11547-11551.2005; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Enkirch T, 2013, GENE THER, V20, P16, DOI 10.1038/gt.2011.209; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Fournier P, 1997, J GEN VIROL, V78, P1295, DOI 10.1099/0022-1317-78-6-1295; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Frecha C, 2008, BLOOD, V112, P4843, DOI 10.1182/blood-2008-05-155945; Funke S, 2009, GENE THER, V16, P700, DOI 10.1038/gt.2009.11; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Levy C, 2012, MOL THER, V20, P1699, DOI 10.1038/mt.2012.96; LIEBERT UG, 1994, J VIROL, V68, P1486, DOI 10.1128/JVI.68.3.1486-1493.1994; Moeller K, 2001, J VIROL, V75, P7612, DOI 10.1128/JVI.75.16.7612-7620.2001; Munch RC, 2011, MOL THER, V19, P686, DOI 10.1038/mt.2010.298; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	25	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46667	10.1371/journal.pone.0046667	http://dx.doi.org/10.1371/journal.pone.0046667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071609	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200040
J	Starmann, J; Falth, M; Spindelbock, W; Lanz, KL; Lackner, C; Zatloukal, K; Trauner, M; Sultmann, H				Starmann, Julia; Faelth, Maria; Spindelboeck, Walter; Lanz, Katja-Lauren; Lackner, Carolin; Zatloukal, Kurt; Trauner, Michael; Sueltmann, Holger			Gene Expression Profiling Unravels Cancer-Related Hepatic Molecular Signatures in Steatohepatitis but Not in Steatosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; HYALINE BODIES; IN-VITRO; IDENTIFICATION; LIPOTOXICITY; PATHOGENESIS; AKR1B10; SMOKERS	Background: Pathogenesis and factors for determining progression of alcoholic and non-alcoholic steatosis to steatohepatitis with risk of further progression to liver cirrhosis and cancer are poorly understood. In the present study, we aimed to identify potential molecular signatures for discrimination of steatohepatitis from steatosis. Methodology and Results: Global microarray gene expression analysis was applied to unravel differentially expressed genes between steatohepatitis compared to steatosis and control samples. For functional annotation as well as the identification of disease-relevant biological processes of the differentially expressed genes the gene ontology (GO) database was used. Selected candidate genes (n = 46) were validated in 87 human liver samples from two sample cohorts by quantitative real-time PCR (qRT-PCR). The GO analysis revealed that genes down-regulated in steatohepatitis were mainly involved in metabolic processes. Genes up-regulated in steatohepatitis samples were associated with cancer progression and proliferation. In surgical liver resection samples, 39 genes and in percutaneous liver biopsies, 30 genes were significantly up-regulated in steatohepatitis. Furthermore, immunohistochemical investigation of human liver tissue revealed a significant increase of AKR1B10 protein expression in steatohepatitis. Conclusions: The development of steatohepatitis is characterized by distinct molecular changes. The most striking examples in this respect were KRT23 and AKR1B10, which we found to be highly differentially expressed in steatohepatitis compared to steatosis and normal liver. We propose that KRT23 and AKR1B10 may serve as future potential biomarkers for steatohepatitis as well as markers for progression to HCC.	[Starmann, Julia; Faelth, Maria; Sueltmann, Holger] German Canc Res Ctr, Unit Canc Genome Res, D-6900 Heidelberg, Germany; [Starmann, Julia; Faelth, Maria; Sueltmann, Holger] Natl Ctr Tumor Dis, Heidelberg, Germany; [Faelth, Maria] Cellzome GlaxoSmithKline, Heidelberg, Germany; [Spindelboeck, Walter; Lanz, Katja-Lauren; Trauner, Michael] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, Lab Expt & Mol Hepatol, Graz, Austria; [Lackner, Carolin; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Trauner, Michael] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; GlaxoSmithKline; Cellzome GmbH; Medical University of Graz; Medical University of Graz; Medical University of Vienna	Sultmann, H (corresponding author), German Canc Res Ctr, Unit Canc Genome Res, D-6900 Heidelberg, Germany.	h.sueltmann@dkfz.de	Sültmann, Holger/E-4534-2013	Sültmann, Holger/0000-0002-5257-8600; Trauner, Michael/0000-0002-1275-6425	Austria Wirtschaftsservice GmbH; Austrian Nationalstiftung	Austria Wirtschaftsservice GmbH; Austrian Nationalstiftung	This work was supported by the funding of the Austria Wirtschaftsservice GmbH (AWS) and the Austrian Nationalstiftung through the framework of the IMGuS research program (Institute for Medical and Genome Research and Systems Biology, Vienna). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Birkenkamp-Demtroder K, 2007, MOL ONCOL, V1, P181, DOI 10.1016/j.molonc.2007.05.005; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2006, MACSWEENS PATHOLOGY, P367; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cossrow N, 2004, J CLIN ENDOCR METAB, V89, P2590, DOI 10.1210/jc.2004-0339; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Hashimoto E, 2009, J GASTROENTEROL, V44, P89, DOI 10.1007/s00535-008-2262-x; Heringlake S, 2010, J HEPATOL, V52, P220, DOI 10.1016/j.jhep.2009.11.005; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; Machado M, 2006, J HEPATOL, V45, P600, DOI 10.1016/j.jhep.2006.06.013; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Penning TM, 2005, CLIN CANCER RES, V11, P1687, DOI 10.1158/1078-0432.CCR-05-0071; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Scuric Z, 1998, HEPATOLOGY, V27, P943, DOI 10.1002/hep.510270408; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stepanova M, 2010, OBES SURG, V20, P640, DOI 10.1007/s11695-010-0078-2; Stumptner C, 1999, AM J PATHOL, V154, P1701, DOI 10.1016/S0002-9440(10)65426-0; Stumptner C, 2007, HEPATOLOGY, V46, P851, DOI 10.1002/hep.21744; Syn WK, 2009, SEMIN LIVER DIS, V29, P200, DOI 10.1055/s-0029-1214375; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yip WW, 2006, SEMIN DIAGN PATHOL, V23, P149, DOI 10.1053/j.semdp.2006.11.002; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Younossi ZM, 2005, LIVER INT, V25, P760, DOI 10.1111/j.1478-3231.2005.01117.x	39	77	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46584	10.1371/journal.pone.0046584	http://dx.doi.org/10.1371/journal.pone.0046584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071592	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200033
J	Sterling, J; Fu, LZ; Matsuura, K; Shi, YB				Sterling, Job; Fu, Liezhen; Matsuura, Kazuo; Shi, Yun-Bo			Cytological and Morphological Analyses Reveal Distinct Features of Intestinal Development during Xenopus tropicalis Metamorphosis	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; RETINOIC ACID RECEPTORS; MOUSE SMALL-INTESTINE; AMPHIBIAN METAMORPHOSIS; STEM-CELLS; GENE-EXPRESSION; POSTEMBRYONIC DEVELOPMENT; FROG METAMORPHOSIS; CONNECTIVE-TISSUE; BINDING PROTEIN	Background: The formation and/or maturation of adult organs in vertebrates often takes place during postembryonic development, a period around birth in mammals when thyroid hormone (T3) levels are high. The T3-dependent anuran metamorphosis serves as a model to study postembryonic development. Studies on the remodeling of the intestine during Xenopus (X.) laevis metamorphosis have shown that the development of the adult intestine involves de novo formation of adult stem cells in a process controlled by T3. On the other hand, X. tropicalis, highly related to X. laevis, offers a number of advantages for studying developmental mechanisms, especially at genome-wide level, over X. laevis, largely due to its shorter life cycle and sequenced genome. To establish X. tropicalis intestinal metamorphosis as a model for adult organogenesis, we analyzed the morphological and cytological changes in X. tropicalis intestine during metamorphosis. Methodology/Principal Findings: We observed that in X. tropicalis, the premetamorphic intestine was made of mainly a monolayer of larval epithelial cells surrounded by little connective tissue except in the single epithelial fold, the typhlosole. During metamorphosis, the larval epithelium degenerates and adult epithelium develops to form a multi-folded structure with elaborate connective tissue and muscles. Interestingly, typhlosole, which is likely critical for adult epithelial development, is present along the entire length of the small intestine in premetamorphic tadpoles, in contrast to X. laevis, where it is present only in the anterior 1/3. T3-treatment induces intestinal remodeling, including the shortening of the intestine and the typhlosole, just like in X. laevis. Conclusions/Significance: Our observations indicate that the intestine undergoes similar metamorphic changes in X. laevis and X. tropicalis, making it possible to use the large amount of information available on X. laevis intestinal metamorphosis and the genome sequence information and genetic advantages of X. tropicalis to dissect the pathways governing adult intestinal development.	[Sterling, Job; Fu, Liezhen; Matsuura, Kazuo; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, PCRM, NIH, Bethesda, MD USA.	Shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639	National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001901] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P51, DOI 10.1007/BF02932850; Amano T, 1998, Wound Repair Regen, V6, P302, DOI 10.1046/j.1524-475X.1998.60406.x; Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Amaya E, 1998, TRENDS GENET, V14, P253, DOI 10.1016/S0168-9525(98)01506-6; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Damjanovski S, 1999, CELL RES, V9, P91, DOI 10.1038/sj.cr.7290009; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2005, J BIOL CHEM, V280, P27856, DOI 10.1074/jbc.M413275200; Fujimoto K, 2012, ENDOCRINOLOGY; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Hasebe T, 2011, STEM CELLS, V29, P154, DOI 10.1002/stem.560; Heimeier RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r55; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; ISHIZUYAOKA A, 1987, ANAT ANZEIGER, V164, P81; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; ISHIZUYAOKA A, 1992, ROUX ARCH DEV BIOL, V201, P322, DOI 10.1007/BF00592113; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MARSHALL JA, 1978, J ANAT, V126, P133; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; Matsuura K, 2012, ENDOCRINOLOGY, V153, P961, DOI 10.1210/en.2011-1736; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Puzianowska-Kuznicka M, 1997, MOL CELL BIOL, V17, P4738, DOI 10.1128/MCB.17.8.4738; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2001, PROG NUCLEIC ACID RE, V65, P53; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; SHI YB, 1993, J BIOL CHEM, V268, P20312; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-1; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Toner P G, 1971, DIGESTIVE SYSETM ULT; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557	47	25	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47407	10.1371/journal.pone.0047407	http://dx.doi.org/10.1371/journal.pone.0047407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071801	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200117
J	Wang, YM; Landheer, S; van Gilst, WH; van Amerongen, A; Hammes, HP; Henning, RH; Deelman, LE; Buikema, H				Wang, Yumei; Landheer, Sjoerd; van Gilst, Wiek H.; van Amerongen, Aart; Hammes, Hans-Peter; Henning, Robert H.; Deelman, Leo E.; Buikema, Hendrik			Attenuation of Renovascular Damage in Zucker Diabetic Fatty Rat by NWT-03, an Egg Protein Hydrolysate with ACE- and DPP4-Inhibitory Activity	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; ANGIOTENSIN-II; METABOLIC SYNDROME; GENE-EXPRESSION; UP-REGULATION; INHIBITORS; CYCLOOXYGENASE-2; KIDNEY; NEPHROPATHY; DYSFUNCTION	Background: Dipeptidyl peptidase 4 (DPP4) and angiotensin-converting enzyme (ACE) are important target enzymes in glycemic control and renovascular protection. Here, we studied the effect of NWT-03, an egg protein hydrolysate with DPP4- and ACE-inhibitory activity, on renovascular damage in Zucker diabetic fatty (ZDF) rats. Comparisons were made to rats treated with vildagliptin (VIL), included as a positive control for the effect of DPP4 inhibition. Methods: ZDF rats received NWT-03 (1 g/kg/day) or VIL (3 mg/kg/day) from 10 to 25 weeks of age. Metabolic and renal functions were assessed; the kidney was removed for histological analysis of glomerulosclerosis and expression of pro-inflammatory/fibrotic markers (RT-PCR and Western blotting); and the aorta was removed for studies of endothelium-dependent relaxation (EDR). Findings: Hyperinsulinemic ZDF rats typically developed signs of type-2 diabetes and renovascular damage, as evidenced by albuminuria, glomerulosclerosis, and impaired EDR. Neither NWT-03 nor VIL improved metabolic parameters; for VIL, this was despite a 5-fold increase in glucagon-like peptide (GLP)-1 levels. NWT-03 and VIL both reduced renal interleukin (Il)-1 beta/Il-13 mRNA expression and glomerulosclerosis. However, only NWT-03 additionally decreased renal tumor necrosis factor (TNF)-alpha mRNA and P22(phox) protein expression, reduced albuminuria, and restored aortic EDR. Indomethacin added to the organ bath instantly improved aortic EDR, indicating a role for cyclooxygenase (COX)-derived contractile prostanoids in opposing relaxation in ZDF rats. This indomethacin effect was reduced by NWT-03, but not by VIL, and coincided with decreased renal COX-1/2 protein expression. Conclusion and Interpretation: Long-term supplementation with the egg protein hydrolysate NWT-03 attenuated renovascular damage in this preclinical rat model of type 2 diabetes. A comparison to the DPP4-inhibitor VIL suggests that the effects of NWT-03 were related to both ACE-and DPP4-inhibitory properties. The development of protein hydrolysates with a multiple-targeting strategy may be of benefit to functional food formulations.	[Landheer, Sjoerd; Henning, Robert H.; Deelman, Leo E.; Buikema, Hendrik] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Wang, Yumei; Hammes, Hans-Peter] Heidelberg Univ, Univ Hosp Mannheim, Endocrinol Sect, Med Dept 5, D-6800 Mannheim, Germany; [van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van Amerongen, Aart] Univ Wageningen & Res Ctr, Wageningen, Netherlands	University of Groningen; Ruprecht Karls University Heidelberg; University of Groningen; Wageningen University & Research	Buikema, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands.	j.h.buikema@umcg.nl	Deelman, Leo/A-9140-2018; Henning, Robert H/AAY-5222-2020; van Gilst, Wiek/R-1806-2019; Hammes, Hans-Peter/S-3719-2019	Deelman, Leo/0000-0003-1798-8353; van Gilst, Wiek/0000-0003-2968-8585; Henning, Robert/0000-0002-5135-4621	Stichting Food & Nutrition Delta,; Dutch Ministry of Economic Affairs; Newtricious BV, Oirlo, The Netherlands	Stichting Food & Nutrition Delta,; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Newtricious BV, Oirlo, The Netherlands(Netherlands Government)	This study was supported by Stichting Food & Nutrition Delta and Dutch Ministry of Economic Affairs, and Newtricious BV, Oirlo, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Aytac Ugur, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P11, DOI 10.2174/1568008043340035; Basile Jan, 2009, South Med J, V102, pS1, DOI 10.1097/SMJ.0b013e3181ba0d8a; Buikema H, 2000, BRIT J PHARMACOL, V130, P1999, DOI 10.1038/sj.bjp.0703498; Burkey BF, 2005, J PHARMACOL EXP THER, V315, P688, DOI 10.1124/jpet.105.087064; Chander PN, 2004, J AM SOC NEPHROL, V15, P2391, DOI 10.1097/01.ASN.0000135971.88164.2C; Combettes MMJ, 2006, CURR OPIN PHARMACOL, V6, P598, DOI 10.1016/j.coph.2006.08.003; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Da Ros Roberto, 2004, Current Vascular Pharmacology, V2, P335; DEFRONZO RA, 1989, METABOLISM, V38, P387, DOI 10.1016/0026-0495(89)90129-7; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Enseleit F, 2001, J CARDIOVASC PHARM, V37, pS21, DOI 10.1097/00005344-200109011-00004; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Gschwend S, 2002, KIDNEY INT, V62, P181, DOI 10.1046/j.1523-1755.2002.00431.x; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hao CM, 2007, SEMIN NEPHROL, V27, P338, DOI 10.1016/j.semnephrol.2007.02.008; Harris RC, 2008, CURR OPIN NEPHROL HY, V17, P64, DOI 10.1097/MNH.0b013e3282f1bb7d; Hartmann R, 2007, CURR OPIN BIOTECH, V18, P163, DOI 10.1016/j.copbio.2007.01.013; Jaimes EA, 2005, KIDNEY INT, V68, P2143, DOI 10.1111/j.1523-1755.2005.00670.x; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Klahr S, 1998, AM J KIDNEY DIS, V31, P171, DOI 10.1053/ajkd.1998.v31.pm9428470; Komers R, 2005, KIDNEY INT, V67, P2151, DOI 10.1111/j.1523-1755.2005.00320.x; Mizuno M, 2002, HYPERTENS RES, V25, P271, DOI 10.1291/hypres.25.271; Moore KB, 2008, AM J THER, V15, P484, DOI 10.1097/MJT.0b013e3180ed42dc; Oltman CL, 2008, VASC PHARMACOL, V48, P47, DOI 10.1016/j.vph.2007.11.005; Pala L, 2003, BIOCHEM BIOPH RES CO, V310, P28, DOI 10.1016/j.bbrc.2003.08.111; Palalau AI, 2009, POSTGRAD MED, V121, P70, DOI 10.3810/pgm.2009.11.2079; Retailleau K, 2010, HYPERTENSION, V55, P339, DOI 10.1161/HYPERTENSIONAHA.109.140236; Rizvi AA, 2009, AM J MED SCI, V338, P310, DOI 10.1097/MAJ.0b013e3181a4158c; Rook M, 2005, NEPHROL DIAL TRANSPL, V20, P59, DOI 10.1093/ndt/gfh579; Sandovici M, 2008, KIDNEY INT, V73, P1364, DOI 10.1038/ki.2008.18; Sandovici M, 2004, NITRIC OXIDE-BIOL CH, V11, P194, DOI 10.1016/j.niox.2004.08.002; Schafer S, 2003, CARDIOVASC RES, V60, P447, DOI 10.1016/S0008-6363(03)00544-3; Smit-van Oosten A, 2005, J PATHOL, V194, P122; Sudre B, 2002, DIABETES, V51, P1461, DOI 10.2337/diabetes.51.5.1461; Suzaki Y, 2007, INT J BIOL SCI, V3, P40; Thomas L, 2009, J PHARMACOL EXP THER, V328, P556, DOI 10.1124/jpet.108.143966; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Vercruysse L, 2009, PEPTIDES, V30, P575, DOI 10.1016/j.peptides.2008.06.027; Vermeirssen V, 2004, BIOCHIMIE, V86, P231, DOI 10.1016/j.biochi.2004.01.003; Xu ZG, 2005, CIRCULATION, V111, P1962, DOI 10.1161/01.CIR.0000161831.07637.63	41	32	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46781	10.1371/journal.pone.0046781	http://dx.doi.org/10.1371/journal.pone.0046781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071636	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200045
J	Carroll, IM; Ringel-Kulka, T; Siddle, JP; Klaenhammer, TR; Ringel, Y				Carroll, Ian M.; Ringel-Kulka, Tamar; Siddle, Jennica P.; Klaenhammer, Todd R.; Ringel, Yehuda			Characterization of the Fecal Microbiota Using High-Throughput Sequencing Reveals a Stable Microbial Community during Storage	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; INTESTINAL MICROBIOTA; DIVERSITY; SAMPLES; BACTERIA; UNIFRAC	The handling and treatment of biological samples is critical when characterizing the composition of the intestinal microbiota between different ecological niches or diseases. Specifically, exposure of fecal samples to room temperature or long term storage in deep freezing conditions may alter the composition of the microbiota. Thus, we stored fecal samples at room temperature and monitored the stability of the microbiota over twenty four hours. We also investigated the stability of the microbiota in fecal samples during a six month storage period at -80 degrees C. As the stability of the fecal microbiota may be affected by intestinal disease, we analyzed two healthy controls and two patients with irritable bowel syndrome (IBS). We used high-throughput pyrosequencing of the 16S rRNA gene to characterize the microbiota in fecal samples stored at room temperature or -80 degrees C at six and seven time points, respectively. The composition of microbial communities in IBS patients and healthy controls were determined and compared using the Quantitative Insights Into Microbial Ecology (QIIME) pipeline. The composition of the microbiota in fecal samples stored for different lengths of time at room temperature or -80 degrees C clustered strongly based on the host each sample originated from. Our data demonstrates that fecal samples exposed to room or deep freezing temperatures for up to twenty four hours and six months, respectively, exhibit a microbial composition and diversity that shares more identity with its host of origin than any other sample.	[Carroll, Ian M.; Siddle, Jennica P.; Ringel, Yehuda] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA; [Ringel-Kulka, Tamar] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Klaenhammer, Todd R.] N Carolina State Univ, Dept Food Sci, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Ringel, Y (corresponding author), Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA.	ringel@med.unc.edu	Core, UNC Microbiome/AAB-3304-2022		National Center for Research Resources [UL1RR025747]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK092330] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Award Number UL1RR025747 from the National Center for Research Resources awarded to IC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Carroll IM, 2011, AM J PHYSIOL-GASTR L, V301, pG799, DOI 10.1152/ajpgi.00154.2011; Carroll IM, 2010, PROBIOTICS: A CLINICAL GUIDE, P55; Carroll IM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-19; Carroll IM, 2010, GASTROENTEROLOGY, V138, pS624; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Nelson A, 2010, LETT APPL MICROBIOL, V51, P272, DOI 10.1111/j.1472-765X.2010.02891.x; O'Carroll JM, 1999, AM J VET RES, V60, P359; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ringel Yehuda, 2009, Gastrointest Endosc Clin N Am, V19, P141, DOI 10.1016/j.giec.2008.12.004; Rochelle P, 1994, FEMS MICROBIOL ECOL, V15, P40; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	29	138	150	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46953	10.1371/journal.pone.0046953	http://dx.doi.org/10.1371/journal.pone.0046953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071673	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300072
J	Furlan, A; Roux, B; Lamballe, F; Conti, F; Issaly, N; Daian, F; Guillemot, JF; Richelme, S; Contensin, M; Bosch, J; Passarella, D; Piccolo, O; Dono, R; Maina, F				Furlan, Alessandro; Roux, Benjamin; Lamballe, Fabienne; Conti, Filippo; Issaly, Nathalie; Daian, Fabrice; Guillemot, Jean-Francois; Richelme, Sylvie; Contensin, Magali; Bosch, Joan; Passarella, Daniele; Piccolo, Oreste; Dono, Rosanna; Maina, Flavio			Combined Drug Action of 2-Phenylimidazo[2,1-b]Benzothiazole Derivatives on Cancer Cells According to Their Oncogenic Molecular Signatures	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; MET RECEPTOR; C-MET; TARGETED THERAPIES; IN-VIVO; CORE PATHWAYS; LUNG-CANCER; TUMOR-CELLS; INHIBITORS	The development of targeted molecular therapies has provided remarkable advances into the treatment of human cancers. However, in most tumors the selective pressure triggered by anticancer agents encourages cancer cells to acquire resistance mechanisms. The generation of new rationally designed targeting agents acting on the oncogenic path(s) at multiple levels is a promising approach for molecular therapies. 2-phenylimidazo[2,1-b]benzothiazole derivatives have been highlighted for their properties of targeting oncogenic Met receptor tyrosine kinase (RTK) signaling. In this study, we evaluated the mechanism of action of one of the most active imidazo[2,1-b]benzothiazol-2-ylphenyl moiety-based agents, Triflorcas, on a panel of cancer cells with distinct features. We show that Triflorcas impairs in vitro and in vivo tumorigenesis of cancer cells carrying Met mutations. Moreover, Triflorcas hampers survival and anchorage-independent growth of cancer cells characterized by "RTK swapping" by interfering with PDGFR beta phosphorylation. A restrained effect of Triflorcas on metabolic genes correlates with the absence of major side effects in vivo. Mechanistically, in addition to targeting Met, Triflorcas alters phosphorylation levels of the PI3K-Akt pathway, mediating oncogenic dependency to Met, in addition to Retinoblastoma and nucleophosmin/B23, resulting in altered cell cycle progression and mitotic failure. Our findings show how the unusual binding plasticity of the Met active site towards structurally different inhibitors can be exploited to generate drugs able to target Met oncogenic dependency at distinct levels. Moreover, the disease-oriented NCI Anticancer Drug Screen revealed that Triflorcas elicits a unique profile of growth inhibitory-responses on cancer cell lines, indicating a novel mechanism of drug action. The anti-tumor activity elicited by 2-phenylimidazo[2,1-b]benzothiazole derivatives through combined inhibition of distinct effectors in cancer cells reveal them to be promising anticancer agents for further investigation.	[Furlan, Alessandro; Roux, Benjamin; Lamballe, Fabienne; Conti, Filippo; Issaly, Nathalie; Daian, Fabrice; Guillemot, Jean-Francois; Richelme, Sylvie; Contensin, Magali; Dono, Rosanna; Maina, Flavio] Aix Marseille Univ, IBDML, CNRS UMR 7288, Marseille, France; [Bosch, Joan] Univ Barcelona, Fac Pharm, Organ Chem Lab, E-08028 Barcelona, Spain; [Bosch, Joan] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Passarella, Daniele] Univ Milan, Dipartimento Chim Organ & Ind, Milan, Italy; [Piccolo, Oreste] Studio Consulenza Sci, Sirtori, LC, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Barcelona; University of Barcelona; University of Milan	Maina, F (corresponding author), Aix Marseille Univ, IBDML, CNRS UMR 7288, Marseille, France.	flavio.maina@univ-amu.fr	Lamballe, Fabienne/P-4293-2017; FURLAN, Alessandro/O-3803-2019; Lamballe, Fabienne/GLT-0820-2022; Passarella, Daniele/L-3495-2013; Maina, Flavio/J-9962-2019; Bosch, Joan/B-1495-2013; DONO, ROSANNA/I-7821-2016	FURLAN, Alessandro/0000-0001-6502-8416; Lamballe, Fabienne/0000-0001-7631-942X; Passarella, Daniele/0000-0001-6180-9581; Maina, Flavio/0000-0001-6100-4695; Bosch, Joan/0000-0001-5974-1733; 	INCa (Institut National du Cancer); ARC (Association pour la recherche contre le cancer); FRM (Fondation pour la recherche medicale); FdF (Fondation de France); Fondation Bettencourt-Schueller; Marie Curie Host Fellowship for the Transfer of Knowledge [MTKD-CT-2004-509804]; Protisvalor; Valorpaca; Oseo; INCa; Italian Association of Cancer Research (ARC)	INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); ARC (Association pour la recherche contre le cancer)(Fondation ARC pour la Recherche sur le Cancer); FRM (Fondation pour la recherche medicale)(Fondation pour la Recherche Medicale); FdF (Fondation de France); Fondation Bettencourt-Schueller; Marie Curie Host Fellowship for the Transfer of Knowledge; Protisvalor; Valorpaca; Oseo; INCa(Institut National du Cancer (INCA) France); Italian Association of Cancer Research (ARC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by funds from the INCa (Institut National du Cancer), ARC (Association pour la recherche contre le cancer), FRM (Fondation pour la recherche medicale), FdF (Fondation de France), Fondation Bettencourt-Schueller, Marie Curie Host Fellowship for the Transfer of Knowledge (MTKD-CT-2004-509804), Protisvalor, Valorpaca, and Oseo to FM. This research has been developed within the CM0602 COST Action "Inhibitors of Angiogenesis: design, synthesis and biological exploitation". AF was supported by the INCa and ARC; NI by Valorpaca, FC by the Italian Association of Cancer Research (ARC) and by Oseo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2007, NAT MED, V13, P675, DOI 10.1038/nm0607-675; Asses Y, 2009, CHEM BIOL DRUG DES, V74, P560, DOI 10.1111/j.1747-0285.2009.00895.x; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bradshaw TD, 2002, MOL CANCER THER, V1, P239; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chua MS, 2000, CANCER RES, V60, P5196; Clague MJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002422; Colombo F, 2012, BIOORG MED CHEM LETT, V22, P4693, DOI 10.1016/j.bmcl.2012.05.078; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Cui JJ, 2007, EXPERT OPIN THER PAT, V17, P1035, DOI 10.1517/13543776.17.9.1035; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Furlan A, 2011, CELL DEATH DIFFER, V18, P1608, DOI 10.1038/cdd.2011.23; Furlan A, 2012, J HEPATOL, DOI [10.1016/j.jhep.2012.07.044, DOI 10.1016/J.JHEP.2012.07.044(2012)]; Furlan A, 2012, EUR J MED CHEM, V47, P239, DOI 10.1016/j.ejmech.2011.10.051; Genestine M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.11; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hose CD, 2003, MOL CANCER THER, V2, P1265; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; Lamballe F, 2011, J NEUROSCI, V31, P11144, DOI 10.1523/JNEUROSCI.2198-11.2011; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Maina F, 1999, NAT NEUROSCI, V2, P213, DOI 10.1038/6310; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Moumen A, 2007, DEVELOPMENT, V134, P1443, DOI 10.1242/dev.02820; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Mukherjee A, 2006, INT J ONCOL, V29, P1287; Patane S, 2008, BIOCHEM BIOPH RES CO, V375, P184, DOI 10.1016/j.bbrc.2008.07.159; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tanizaki J, 2011, J THORAC ONCOL, V6, P1624, DOI 10.1097/JTO.0b013e31822591e9; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Zwick E, 2002, TRENDS MOL MED, V8, P17, DOI 10.1016/S1471-4914(01)02217-1	52	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46738	10.1371/journal.pone.0046738	http://dx.doi.org/10.1371/journal.pone.0046738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071625	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300057
J	Ishihara, T; Mitsuhara, I; Takahashi, H; Nakaho, K				Ishihara, Takeaki; Mitsuhara, Ichiro; Takahashi, Hideki; Nakaho, Kazuhiro			Transcriptome Analysis of Quantitative Resistance-Specific Response upon Ralstonia solanacearum Infection in Tomato	PLOS ONE			English	Article							BACTERIAL WILT RESISTANCE; PATHOGENESIS-RELATED PROTEINS; FOR-GENE RESISTANCE; ARABIDOPSIS-THALIANA; RHAMNOGALACTURONAN-I; BASAL RESISTANCE; SALICYLIC-ACID; DEFENSE; PLANTS; IDENTIFICATION	Bacterial wilt, caused by the soil-borne bacterium Ralstonia solanacearum, is a lethal disease of tomato, but the molecular mechanisms of the host resistance responses to R. solanacearum remain unclear. In this study, we report the first work describing the transcriptome of cultivar resistance and susceptible tomato cultivar after inoculation with R. solanacearum. To elucidate the characteristics of resistance early in the interaction, we analyzed microarrays for resistant cultivar LS-89 and susceptible cultivar Ponderosa 1 day after stem inoculation. No change in gene expression was detected for Ponderosa, but expression levels of over 140 genes, including pathogenesis-related, hormone signaling and lignin biosynthesis genes, increased in LS-89. Expression of beta-1,3-glucanase genes increased substantially. In an immunohistochemical study, glucanase in LS-89 accumulated in the xylem and pith tissues surrounding xylem vessels filled with R. solanacearum. The expression of these genes also increased in four other resistant cultivars, but changed little in four susceptible cultivars in response to R. solanacearum, suggesting that similar reactions occur in other cultivars. These gene expression profiles will serve as fundamental information to elucidate the molecular mechanisms in the resistance response to R. solanacearum in tomato.	[Ishihara, Takeaki; Nakaho, Kazuhiro] Natl Agr & Food Res Org, Natl Agr Res Ctr, Div Plant Protect, Tsukuba, Ibaraki, Japan; [Mitsuhara, Ichiro] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki, Japan; [Takahashi, Hideki] Tohoku Univ, Grad Sch Agr Sci, Dept Life Sci, Sendai, Miyagi 980, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Agrobiological Sciences - Japan; Tohoku University	Nakaho, K (corresponding author), Natl Agr & Food Res Org, Natl Agr Res Ctr, Div Plant Protect, Tsukuba, Ibaraki, Japan.	nakaho@affrc.go.jp		Mitsuhara, Ichiro/0000-0001-8750-5017	Ministry of Agriculture, Forestry and Fisheries, Japan [21009]	Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by research and development projects for application in promoting new policy of Agriculture Forestry and Fisheries from the Ministry of Agriculture, Forestry and Fisheries, Japan (21009) (URL of funder's website: http://www.s.affrc.go.jp/docs/e/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz A, 2009, PEPTIDES, V30, P1600, DOI 10.1016/j.peptides.2009.06.005; Atamian HS, 2012, PLANTA, V235, P299, DOI 10.1007/s00425-011-1509-6; BENHAMOU N, 1989, PLANT CELL, V1, P1209; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; CHELLEMI DO, 1994, J AM SOC HORTIC SCI, V119, P325, DOI 10.21273/JASHS.119.2.325; Chen YY, 2009, PHYSIOL PLANTARUM, V136, P324, DOI 10.1111/j.1399-3054.2009.01226.x; d'Ursel CM, 1999, ANN PHYTOPATHOL SOC, V65, P361; Dahal D, 2010, PLANT MOL BIOL, V73, P643, DOI 10.1007/s11103-010-9646-z; Dahal D, 2009, PLANT PHYSIOL BIOCH, V47, P838, DOI 10.1016/j.plaphy.2009.05.001; DANESH D, 1994, MOL PLANT MICROBE IN, V7, P464, DOI 10.1094/MPMI-7-0464; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Diogo RVC, 2007, PHYSIOL MOL PLANT P, V70, P120, DOI 10.1016/j.pmpp.2007.07.008; DOMINGO C, 1994, PLANT MOL BIOL, V24, P725, DOI 10.1007/BF00029854; Gadea J, 1996, MOL PLANT MICROBE IN, V9, P409, DOI 10.1094/MPMI-9-0409; Ghareeb H, 2011, PHYSIOL MOL PLANT P, V75, P83, DOI 10.1016/j.pmpp.2010.11.004; GRIMAULT V, 1993, PLANT PATHOL, V42, P589, DOI 10.1111/j.1365-3059.1993.tb01539.x; GRIMAULT V, 1994, PHYSIOL MOL PLANT P, V44, P105, DOI 10.1016/S0885-5765(05)80105-5; Hanson PM, 1998, PLANT DIS, V82, P74, DOI 10.1094/PDIS.1998.82.1.74; Harikrishna K, 1996, PLANT MOL BIOL, V30, P899, DOI 10.1007/BF00020802; Hasegawa M, 2010, MOL PLANT MICROBE IN, V23, P1000, DOI 10.1094/MPMI-23-8-1000; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; He P, 2001, MOL PLANT MICROBE IN, V14, P1453, DOI 10.1094/MPMI.2001.14.12.1453; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Hikichi Yasufumi, 1999, Annals of the Phytopathological Society of Japan, V65, P597; Ho FI, 2009, BOT STUD, V50, P413; Ho GD, 1999, PHYTOPATHOLOGY, V89, P673, DOI 10.1094/PHYTO.1999.89.8.673; Hu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002589; Ishihara T, 2004, PLANT CELL PHYSIOL, V45, P470, DOI 10.1093/pcp/pch057; JOOSTEN MHAJ, 1990, PLANT PHYSIOL, V94, P585, DOI 10.1104/pp.94.2.585; JOOSTEN MHAJ, 1989, PLANT PHYSIOL, V89, P945, DOI 10.1104/pp.89.3.945; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lahaye T, 2004, TRENDS PLANT SCI, V9, P1, DOI 10.1016/j.tplants.2003.11.002; Lebeau A, 2011, PHYTOPATHOLOGY, V101, P154, DOI 10.1094/PHYTO-02-10-0048; Lee JM, 1998, J JPN SOC HORTIC SCI, V67, P1098, DOI 10.2503/jjshs.67.1098; Lin YM, 2008, MOL PLANT MICROBE IN, V21, P1261, DOI 10.1094/MPMI-21-9-1261; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Lopez-Martin MC, 2008, PLANT PHYSIOL, V147, P562, DOI 10.1104/pp.108.117408; Nakaho K, 2000, J PHYTOPATHOL, V148, P181, DOI 10.1046/j.1439-0434.2000.00476.x; Nakaho K, 2009, J PHYTOPATHOL, V157, P228, DOI 10.1111/j.1439-0434.2008.01467.x; Nakaho Kazuhiro, 1997, Annals of the Phytopathological Society of Japan, V63, P341, DOI 10.3186/jjphytopath.63.341; Nakaho Kazuhiro, 2004, Journal of General Plant Pathology, V70, P115, DOI 10.1007/s10327-003-0097-0; Nakaho Kazuhiro, 1997, Annals of the Phytopathological Society of Japan, V63, P83, DOI 10.3186/jjphytopath.63.83; Newman MA, 2001, MOL PLANT MICROBE IN, V14, P785, DOI 10.1094/MPMI.2001.14.6.785; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; PAYNE G, 1990, PLANT MOL BIOL, V15, P797, DOI 10.1007/BF00039420; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Saile E, 1997, PHYTOPATHOLOGY, V87, P1264, DOI 10.1094/PHYTO.1997.87.12.1264; Schaarschmidt S, 2007, PLANT J, V51, P390, DOI 10.1111/j.1365-313X.2007.03150.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thoquet P, 1996, MOL PLANT MICROBE IN, V9, P826, DOI 10.1094/MPMI-9-0826; Thoquet P, 1996, MOL PLANT MICROBE IN, V9, P837, DOI 10.1094/MPMI-9-0837; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; von Roepenack-Lahaye E, 2003, J BIOL CHEM, V278, P43373, DOI 10.1074/jbc.M305084200; Wang SH, 2008, PLANT J, V55, P89, DOI 10.1111/j.1365-313X.2008.03489.x; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wydra K, 2007, PHYSIOL MOL PLANT P, V70, P13, DOI 10.1016/j.pmpp.2007.05.006; Wydra K, 2006, PHYSIOL MOL PLANT P, V68, P41, DOI 10.1016/j.pmpp.2006.06.001; Zacares L, 2007, MOL PLANT MICROBE IN, V20, P1439, DOI 10.1094/MPMI-20-11-1439; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3	66	63	66	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46763	10.1371/journal.pone.0046763	http://dx.doi.org/10.1371/journal.pone.0046763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071630	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300060
J	De Saedeleer, CJ; Copetti, T; Porporato, PE; Verrax, J; Feron, O; Sonveaux, P				De Saedeleer, Christophe J.; Copetti, Tamara; Porporato, Paolo E.; Verrax, Julien; Feron, Olivier; Sonveaux, Pierre			Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; TRANSPORTER MCT4; LACTIC-ACID; TCA CYCLE; HYPOXIA; METABOLISM; INHIBITION; ANGIOGENESIS; HIF-1-ALPHA	Cancer can be envisioned as a metabolic disease driven by pressure selection and intercellular cooperativeness. Together with anaerobic glycolysis, the Warburg effect, formally corresponding to uncoupling glycolysis from oxidative phosphorylation, directly participates in cancer aggressiveness, supporting both tumor progression and dissemination. The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key contributor to glycolysis. It stimulates the expression of glycolytic transporters and enzymes supporting high rate of glycolysis. In this study, we addressed the reverse possibility of a metabolic control of HIF-1 in tumor cells. We report that lactate, the end-product of glycolysis, inhibits prolylhydroxylase 2 activity and activates HIF-1 in normoxic oxidative tumor cells but not in Warburg-phenotype tumor cells which also expressed lower basal levels of HIF-1 alpha. These data were confirmed using genotypically matched oxidative and mitochondria-depleted glycolytic tumor cells as well as several different wild-type human tumor cell lines of either metabolic phenotype. Lactate activates HIF-1 and triggers tumor angiogenesis and tumor growth in vivo, an activity that we found to be under the specific upstream control of the lactate transporter monocarboxylate transporter 1 (MCT1) expressed in tumor cells. Because MCT1 also gates lactate-fueled tumor cell respiration and mediates pro-angiogenic lactate signaling in endothelial cells, MCT1 inhibition is confirmed as an attractive anticancer strategy in which a single drug may target multiple tumor-promoting pathways.	[De Saedeleer, Christophe J.; Copetti, Tamara; Porporato, Paolo E.; Verrax, Julien; Feron, Olivier; Sonveaux, Pierre] UCL, IREC, Brussels, Belgium	Universite Catholique Louvain	Sonveaux, P (corresponding author), UCL, IREC, Brussels, Belgium.	pierre.sonveaux@uclouvain.be	Porporato, Paolo E./A-9932-2018; FERON, Olivier/AAM-6395-2020	Porporato, Paolo E./0000-0001-8519-1552; FERON, Olivier/0000-0001-5360-0286; Sonveaux, Pierre/0000-0001-6484-8834	European Research Council [243188 TUMETABO]; Fonds National de la Recherche Scientifique (F.R.S.-FNRS); Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute Francaise de Belgique [ARC 09/14-020]; NEOANGIO research program from the Region Wallonne de Belgique; Fondation Belge contre le Cancer [200-2008]; Fonds Speciaux de la Recherche (FSR) of the Universite catholique de Louvain (UCL); J. Maisin Foundation; St. Luc Foundation	European Research Council(European Research Council (ERC)European Commission); Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute Francaise de Belgique(Fonds de la Recherche Scientifique - FNRS); NEOANGIO research program from the Region Wallonne de Belgique; Fondation Belge contre le Cancer; Fonds Speciaux de la Recherche (FSR) of the Universite catholique de Louvain (UCL); J. Maisin Foundation; St. Luc Foundation	This work was supported by grants from the European Research Council (FP7/2007-2013 European Research Council Independent Researcher Starting Grant No. 243188 TUMETABO to P. Sonveaux), the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), the Fonds de la Recherche Scientifique Medicale (FRSM), an Action de Recherche Concertee from the Communaute Francaise de Belgique (ARC 09/14-020 to O. Feron. and P. Sonveaux), the NEOANGIO research program from the Region Wallonne de Belgique (to O. Feron), the Fondation Belge contre le Cancer (200-2008 to O. Feron and P. Sonveaux), the Fonds Speciaux de la Recherche (FSR) of the Universite catholique de Louvain (UCL), and the J. Maisin and St. Luc Foundations (to O. Feron). O. Feron is an Honorary Research Director, P. Sonveaux is a Research Associate, and J. Verrax is a Postdoctoral Researcher of the F.R.S.-FNRS. C. J. De Saedeleer is a Televie Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bouzin C, 2007, J IMMUNOL, V178, P1505, DOI 10.4049/jimmunol.178.3.1505; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Finch NA, 2009, PROTEIN J, V28, P362, DOI 10.1007/s10930-009-9202-3; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Martinez-Outschoorn UE, 2011, INT J BIOCHEM CELL B, V43, P1045, DOI 10.1016/j.biocel.2011.01.023; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Pollard PJ, 2003, ANN MED, V35, P632, DOI 10.1080/07853890310018458; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; RIDEOUT D, 1994, INT J CANCER, V57, P247, DOI 10.1002/ijc.2910570220; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Sonveaux P, 2003, CANCER RES, V63, P1012; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; STRAGAND JJ, 1981, CANCER RES, V41, P3364; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; WU R, 1959, J BIOL CHEM, V234, P1036	58	156	159	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46571	10.1371/journal.pone.0046571	http://dx.doi.org/10.1371/journal.pone.0046571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082126	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900021
J	Hawkes, C; Webster, J				Hawkes, Corinna; Webster, Jacqui			National Approaches to Monitoring Population Salt Intake: A Trade-Off between Accuracy and Practicality?	PLOS ONE			English	Article							URINARY SODIUM-EXCRETION; HYPERTENSION; REDUCTION; SAMPLE	Aims: There is strong evidence that diets high in salt are bad for health and that salt reduction strategies are cost effective. However, whilst it is clear that most people are eating too much salt, obtaining an accurate assessment of population salt intake is not straightforward, particularly in resource poor settings. The objective of this study is to identify what approaches governments are taking to monitoring salt intake, with the ultimate goal of identifying what actions are needed to address challenges to monitoring salt intake, especially in low and middle-income countries. Methods and Results: A written survey was issued to governments to establish the details of their monitoring methods. Of the 30 countries that reported conducting formal government salt monitoring activities, 73% were high income countries. Less than half of the 30 countries, used the most accurate assessment of salt through 24 hour urine, and only two of these were developing countries. The remainder mainly relied on estimates through dietary surveys. Conclusions: The study identified a strong need to establish more practical ways of assessing salt intake as well as technical support and advice to ensure that low and middle income countries can implement salt monitoring activities effectively.	[Hawkes, Corinna] World Canc Res Fund Int, London, England; [Webster, Jacqui] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney	Hawkes, C (corresponding author), World Canc Res Fund Int, London, England.	c.hawkes@wcrf.org		Webster, Jacqui/0000-0003-3513-3340	Health Canada; National Health and Medical Council Partnership Project; World Health Organisation	Health Canada; National Health and Medical Council Partnership Project; World Health Organisation(World Health Organization)	Corinna Hawkes received funding from Health Canada to conduct the survey reported in this study. Jacqui Webster was supported in her research on salt reduction throughout the period of this study by a National Health and Medical Council Partnership Project. She also received funding from the World Health Organisation to facilitate the development of salt reduction strategies in Pacific Islands and Mongolia and was commissioned by Health Canada to draft a Framework for Monitoring and Evaluation of Salt Reduction Strategies for WHO Member States. The funders were a member of a group that advised on the study. They therefore provided comments on the study design. They also participated by responding to the questionnaire. They played no role in data collection other than responding to the questionnaire. They played a role in the analysis by providing comments on drafts of the report. As recipients of the questionnaire, they also provided comments on the final manuscript (as did all recipients). The funders also provided the authors with permission to publish the manuscript in an academic journal.	Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BIBBINSDOMINGO K, 2010, NEW ENGL J MED; Boorman J., 2008, SALT INTAKE PROCESSE; Cappuccio FP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4995; Charlton KE, 2007, POLICY BRIEF; Choudhury S, 2010, CIRCULATION, V122, pE352; EU Platform on Diet Physical Activity and Health, 2009, NAT SALT IN IMPL EU; Ferrante D, 2011, REV PANAM SALUD PUBL, V29, P69, DOI 10.1590/S1020-49892011000200001; Harrington J, 2008, PSYCHOL REPORTS, V6; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Luft FC RL, 1979, HYPERTENSION, P261; Mann SJ, 2010, AM J HYPERTENS, V23, P743, DOI 10.1038/ajh.2010.57; Margerison C., 2006, ASIA PAC J CLIN NUTR, V15, pS37; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; National Centre for Social Research/Medical Research Council, 2008, ASS DIET SOD LEV AD; National Institute for Food and Nutrition Science, 2010, IMPL HUNG SALT RED P; New Zealand Ministry of Health, 2011, FOC NUTR KEY FIND 20; Ortega RM, 2011, BRIT J NUTR, V105, P787, DOI 10.1017/S000711451000423X; Penney S., 2009, DROPPING SALT PRACTI; Powles J, 2003, GAC SANIT S2, V17, P163; Radhika G, 2007, J Assoc Physicians India, V55, P405; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; Ribic CH, 2010, PUBLIC HEALTH NUTR, V13, P1803, DOI 10.1017/S136898001000025X; Sarno F, 2009, REV SAUDE PUBL, V43, P219, DOI 10.1590/S0034-89102009005000002; Singapore Ministry of Health, 1998, SING NAT NUTR SURV; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Van den Hooven C, 2007, 24 UURS URINE EXCRET; Webster J, 2011, J HYPERTENSION; WHO, 2011, GLOB STAT REP NONC D; WHO/PAHO Regional Expert Group for Cardiovascular Disease Prevention through Population-wide Dietary Salt Reduction (Sub-group for research and surveillance), 2010, PROT POP LEV SOD DET; Windhauser MM, 1999, J AM DIET ASSOC, V99, pS76, DOI 10.1016/S0002-8223(99)00420-4; World Action on Salt & Health, 2011, WASH INTR; World Bank, 2012, COUNTR CLASS INC; World Health Organisation and the Government of Canada, 2011, P TECHN M JOIN UNPUB	37	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46727	10.1371/journal.pone.0046727	http://dx.doi.org/10.1371/journal.pone.0046727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082128	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000311146900023
J	Bhalla, D; Chea, K; Hun, C; Vannareth, M; Huc, P; Chan, SL; Sebbag, R; Gerard, D; Dumas, M; Oum, S; Druet-Cabanac, M; Preux, PM				Bhalla, Devender; Chea, Kimly; Hun, Chamroeun; Vannareth, Mey; Huc, Pierre; Chan, Samleng; Sebbag, Robert; Gerard, Daniel; Dumas, Michel; Oum, Sophal; Druet-Cabanac, Michel; Preux, Pierre-Marie			Population-Based Study of Epilepsy in Cambodia Associated Factors, Measures of Impact, Stigma, Quality of Life, Knowledge-Attitude-Practice, and Treatment Gap	PLOS ONE			English	Article							CONVULSIVE EPILEPSY; SEIZURES; PEOPLE; PREVALENCE; CHILDREN; ETIOLOGY; RISK; EPIDEMIOLOGY; DISTRICT; ADULTS	Purpose: Identify epilepsy-associated factors and calculate measures of impact, stigma, quality of life (QOL), knowledge-attitude-practice (KAP) and treatment gap in Prey Veng, Cambodia. Methods: This first Cambodian population-based case-control study had 96 epileptologist-confirmed epilepsy cases and 192 randomly selected matched healthy controls. Standard questionnaires, which have been used in similar settings, were used for collecting data on various parameters. Univariate and multivariate regression was done to determine odds ratios. Jacoby stigma, 31-item QOL, KAP etc were determined and so were the factors associated with them using STATA software. Treatment gap was measured using direct method. Key findings: Multivariate analyses yielded family history of epilepsy, difficult or long delivery, other problems beside seizures (mainly mental retardation, hyperthermia), and eventful pregnancy of the subject's mother as factors associated with epilepsy. There was high frequency of seizure precipitants esp. those related to sleep. Population attributable risk (%) was: family history (15.0), eventful pregnancy of subject's mother (14.5), long/difficult birth (6.5), and other problem beside seizures (20.0). Mean stigma (1.9 +/- 1.1, on a scale of 3) was mainly related to treatment efficacy. Mean QOL (5.0 +/- 1.4 on a scale of 10) was mainly related to treatment regularity. Cause or risk factor could be determined in 56% of cases. Treatment gap was 65.8%. Significance: Factors in pre- and perinatal period were found to be most crucial for epilepsy risk in Cambodia which inturn provides major prevention opportunities. A global action plan for treatment, stigma reduction and improvement of QOL should be set-up in this country.	[Bhalla, Devender; Huc, Pierre; Dumas, Michel; Druet-Cabanac, Michel; Preux, Pierre-Marie] INSERM, U1094, Limoges, France; [Bhalla, Devender; Huc, Pierre; Dumas, Michel; Druet-Cabanac, Michel; Preux, Pierre-Marie] Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, GEIST, Limoges, France; [Bhalla, Devender; Huc, Pierre; Dumas, Michel; Druet-Cabanac, Michel; Preux, Pierre-Marie] CHU Limoges, Limoges, France; [Chea, Kimly; Hun, Chamroeun; Vannareth, Mey; Chan, Samleng; Oum, Sophal] Univ Hlth Sci, Phnom Penh, Cambodia; [Hun, Chamroeun; Chan, Samleng] Calmette Hosp, Dept Neurol, Phnom Penh, Cambodia; [Sebbag, Robert; Gerard, Daniel] Sanofi, Dept Access Med, Gentilly, France; [Bhalla, Devender; Hun, Chamroeun; Chan, Samleng] Cambodian Soc Neurol, Phnom Penh, Cambodia	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Limoges; CHU Limoges; Sanofi-Aventis; Sanofi France	Preux, PM (corresponding author), INSERM, U1094, Limoges, France.	preux@unilim.fr	Preux, Pierre-Marie/N-3538-2019; PREUX, Pierre-Marie/B-8393-2014	Preux, Pierre-Marie/0000-0002-2171-2977; PREUX, Pierre-Marie/0000-0002-2171-2977; Druet-Cabanac, Michel/0000-0001-5711-3346	Sanofi (Department of Access to Medicines) France; University of Health Sciences, Cambodia; department of access to medicines, Sanofi, Gentilly, France	Sanofi (Department of Access to Medicines) France; University of Health Sciences, Cambodia; department of access to medicines, Sanofi, Gentilly, France	This project was supported by Sanofi (Department of Access to Medicines) France and the University of Health Sciences, Cambodia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Corresponding author, Prof. Pierre-Marie Preux is the Plos One editorial board member. Drs Robert Sebbag and Daniel Gerard are employees of Sanofi France and the authors have received financial support from the department of access to medicines, Sanofi, Gentilly, France, there are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AIRD RB, 1983, EPILEPSIA, V24, P567, DOI 10.1111/j.1528-1157.1983.tb03421.x; Akinsulore A, 2010, AFR J PSYCHIATRY, V13, P351; Anderson V E, 1985, Prog Med Genet, V6, P9; Anderson V E, 1986, Adv Neurol, V44, P59; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1993, EPILEPSIA, V34, P592; Baker G, 2007, EPILEPSY PROF, V6, P31; Baker GA, 2000, EPILEPSIA, V41, P98, DOI 10.1111/j.1528-1157.2000.tb01512.x; Baker GA, 2002, EPILEPSY BEHAV, V3, pS26; Cramer JA, 1998, EPILEPSIA, V39, P81, DOI 10.1111/j.1528-1157.1998.tb01278.x; Cruz I, 1989, P ANN SCI M WFN RES; D'Amelio M, 2001, EPILEPSY DEV DISABIL, P3; Dalrymple J, 2000, BRIT MED J, V320, P94, DOI 10.1136/bmj.320.7227.94; Dodrill CB, 2002, PROG BRAIN RES, V135, P399; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Eidhin MN., 2001, IRISH J PSYCHOL, V22, P213; Guekht AB, 2007, SEIZURE-EUR J EPILEP, V16, P128, DOI 10.1016/j.seizure.2006.10.011; Hackett RJ, 1997, ACTA PAEDIATR, V86, P1257, DOI 10.1111/j.1651-2227.1997.tb14857.x; Heo K, 2012, SEIZURE-EUR J EPILEP, V21, P188, DOI 10.1016/j.seizure.2011.12.005; Herranz J L, 2007, Rev Neurol, V44 Suppl 3, pS43; Hiyoshi T, 2000, EPILEPSIA, V41, P31, DOI 10.1111/j.1528-1157.2000.tb02217.x; Jackson MJ, 2005, J NEUROL NEUROSUR PS, V76, pI45, DOI 10.1136/jnnp.2004.060467; Jacoby A, 2008, EPILEPSY BEHAV, V12, P286, DOI 10.1016/j.yebeh.2007.10.006; JACOBY A, 1994, SOC SCI MED, V38, P269, DOI 10.1016/0277-9536(94)90396-4; Jacoby A, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01391.x; JILEKAALL LM, 1965, ACTA PSYCHIAT SCAND, V41, P57; Kamgno J, 2003, EPILEPSIA, V44, P956, DOI 10.1046/j.1528-1157.2003.59302.x; Kuruba R, 2009, EPILEPSY BEHAV, V14, P65, DOI 10.1016/j.yebeh.2008.08.020; Lilienfeld AM, 1955, AM J PUBLIC HEALTH N, V45, P637, DOI 10.2105/AJPH.45.5_Pt_1.637; LILIENFELD AM, 1954, JAMA-J AM MED ASSOC, V155, P719, DOI 10.1001/jama.1954.03690260011004; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; Moore PM, 2002, SEIZURE-EUR J EPILEP, V11, P224, DOI 10.1053/seiz.2001.0668; MOSHE SL, 1981, BRAIN RES, V211, P190, DOI 10.1016/0006-8993(81)90082-2; Mrabet H, 2004, EPILEPSIA, V45, P838, DOI 10.1111/j.0013-9580.2004.56903.x; Nakken KO, 2005, EPILEPSY BEHAV, V6, P85, DOI 10.1016/j.yebeh.2004.11.003; Nubukpo P, 2003, Med Trop (Mars), V63, P143; Nyame P K, 1997, West Afr J Med, V16, P139; Ottman R, 1996, ANN NEUROL, V39, P442, DOI 10.1002/ana.410390406; Park SP, 2008, J CLIN NEUROL, V4, P99, DOI 10.3988/jcn.2008.4.3.99; Picot MC, 2004, EPILEPTIC DISORD, V6, P275; Piperidou C, 2008, QUAL LIFE RES, V17, P987, DOI 10.1007/s11136-008-9375-9; Preux PM, 2011, EPILEPSIA, V52, P1382, DOI 10.1111/j.1528-1167.2011.03102.x; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Rafael F, 2010, EPILEPSIA, V51, P1061, DOI 10.1111/j.1528-1167.2009.02511.x; RWIZA HT, 1993, EPILEPSIA, V34, P1017, DOI 10.1111/j.1528-1157.1993.tb02127.x; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; San Luis AM, 1996, NEUROL J SE ASIA, V1, P72; Santosh D, 2007, EPILEPSIA, V48, P1007, DOI 10.1111/j.1528-1167.2007.01040.x; Sidenvall R, 2001, EPILEPSIA, V42, P1261, DOI 10.1046/j.1528-1157.2001.15600.x; Smeets VMJ, 2007, EPILEPSY BEHAV, V10, P354, DOI 10.1016/j.yebeh.2007.02.006; Sun YL, 2011, PAEDIATR PERINAT EP, V25, P53, DOI 10.1111/j.1365-3016.2010.01143.x; Tran DS, 2007, EPILEPSY BEHAV, V10, P565, DOI 10.1016/j.yebeh.2007.02.018; Troster H., 1998, PSYCHOL HEALTH MED, V3, P149; Ullal GR, 1996, SEIZURE, V5, P221, DOI 10.1016/S1059-1311(96)80040-9; Varley J, 2010, SEIZURE-EUR J EPILEP, V19, P47, DOI 10.1016/j.seizure.2009.11.002; Weiss Mitchell G, 2006, Psychol Health Med, V11, P277; Wolfe WR, 2008, AM J PUBLIC HEALTH, V98, P1865, DOI 10.2105/AJPH.2007.122044; Youssef FF, 2009, EPILEPSY BEHAV, V15, P160, DOI 10.1016/j.yebeh.2009.01.027; Zhao YH, 2008, EPILEPSY BEHAV, V12, P373, DOI 10.1016/j.yebeh.2007.10.012	60	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46296	10.1371/journal.pone.0046296	http://dx.doi.org/10.1371/journal.pone.0046296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077505	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100027
J	Chen, J; Wang, W; Zhang, T; Ji, JJ; Qian, QR; Lu, LG; Fu, HL; Jin, WL; Cui, DX				Chen, Jun; Wang, Wei; Zhang, Tao; Ji, Jiajia; Qian, Qirong; Lu, Lungeng; Fu, Hualin; Jin, Weilin; Cui, Daxiang			Differential Expression of Phospholipase C Epsilon 1 Is Associated with Chronic Atrophic Gastritis and Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CRUCIAL ROLE; PLC-EPSILON; INFLAMMATION; CARCINOMA; GENE	Background: Chronic inflammation plays a causal role in gastric tumor initiation. The identification of predictive biomarkers from gastric inflammation to tumorigenesis will help us to distinguish gastric cancer from atrophic gastritis and establish the diagnosis of early-stage gastric cancer. Phospholipase C epsilon 1 (PLC epsilon 1) is reported to play a vital role in inflammation and tumorigenesis. This study was aimed to investigate the clinical significance of PLC epsilon 1 in the initiation and progression of gastric cancer. Methodology/Principal Findings: Firstly, the mRNA and protein expression of PLC epsilon 1 were analyzed by reverse transcription-PCR and Western blotting in normal gastric mucous epithelial cell line GES-1 and gastric cancer cell lines AGS, SGC7901, and MGC803. The results showed both mRNA and protein levels of PLC epsilon 1 were up-regulated in gastric cancer cells compared with normal gastric mucous epithelial cells. Secondly, this result was confirmed by immunohistochemical detection in a tissue microarray including 74 paired gastric cancer and adjacent normal tissues. Thirdly, an independence immunohistochemical analysis of 799 chronic atrophic gastritis tissue specimens demonstrated that PLC epsilon 1 expression in atrophic gastritis tissues were down-regulated since PLC epsilon 1 expression was negative in 524 (65.6%) atrophic gastritis. In addition, matched clinical tissues from atrophic severe gastritis and gastric cancer patients were used to further confirm the previous results by analyzing mRNA and protein levels expression of PLC epsilon 1 in clinical samples. Conclusions/Significances: Our results suggested that PLC epsilon 1 protein may be a potential biomarker to distinguish gastric cancer from inflammation lesion, and could have great potential in applications such as diagnosis and pre-warning of early-stage gastric cancer.	[Chen, Jun; Ji, Jiajia; Fu, Hualin; Jin, Weilin; Cui, Daxiang] Shanghai Jiao Tong Univ, Inst Micro Nano Sci & Technol, Key Lab Thin Film & Microfabricat Technol, Dept Bionano Sci & Engn,Dept Educ, Shanghai 200030, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Tao] Fujian Acad Med Sci, Dept Immunol, Fuzhou, Peoples R China; [Qian, Qirong] Second Mil Med Univ, Changzheng Hosp, Dept Surg, Shanghai, Peoples R China; [Lu, Lungeng] Shanghai Jiao Tong Univ, Inst Digest Dis, Affiliated Hosp 1, Shanghai 200030, Peoples R China; [Jin, Weilin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Sun Yat Sen University; Sun Yat Sen University; Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Cui, DX (corresponding author), Shanghai Jiao Tong Univ, Inst Micro Nano Sci & Technol, Key Lab Thin Film & Microfabricat Technol, Dept Bionano Sci & Engn,Dept Educ, Shanghai 200030, Peoples R China.	dxcui@sjtu.edu.cn	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405	National Key Basic Research Program of China (973 Project) [2010CB933900]; New Century Excellent Talent of Ministry of Education of China [NCET-08-0350]; Special Infection Diseases Key Project of China [2009ZX10004-311]; National Natural Science Foundation of China [31170961, 31100717]; Shanghai Science and Technology Fund [12ZR1415800]; Shanghai Jiao Tong University Innovation Fund For Postgraduates [Z-340-007]	National Key Basic Research Program of China (973 Project)(National Basic Research Program of China); New Century Excellent Talent of Ministry of Education of China; Special Infection Diseases Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Fund; Shanghai Jiao Tong University Innovation Fund For Postgraduates	This work was supported by National Key Basic Research Program of China (973 Project) (2010CB933900), New Century Excellent Talent of Ministry of Education of China (NCET-08-0350), Special Infection Diseases Key Project of China (2009ZX10004-311), National Natural Science Foundation of China (31170961 and 31100717), Shanghai Science and Technology Fund (12ZR1415800) and Shanghai Jiao Tong University Innovation Fund For Postgraduates (Z-340-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Boyer O, 2010, J MED GENET, V47, P445, DOI 10.1136/jmg.2009.076166; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Chen L, 2011, BIOSENS BIOELECTRON, V26, P3246, DOI 10.1016/j.bios.2010.12.034; Cheng HL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.014; Cui DX, 2005, WORLD J GASTROENTERO, V11, P1273, DOI 10.3748/wjg.v11.i9.1273; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; He M, 2011, ADV FUNCT MATER, V21, P4470, DOI 10.1002/adfm.201101040; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu LZ, 2010, J IMMUNOL, V184, P993, DOI 10.4049/jimmunol.0901816; Huang P, 2011, BIOMATERIALS, V32, P3447, DOI 10.1016/j.biomaterials.2011.01.032; Humans IWGotEoCRt, 1994, SCHIST LIV FLUK HEL; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Inoue M, 2000, CANCER LETT, V161, P105, DOI 10.1016/S0304-3835(00)00603-0; Kong YF, 2010, SMALL, V6, P2367, DOI 10.1002/smll.201001050; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Li ZM, 2010, MOL PHARMACEUT, V7, P94, DOI 10.1021/mp9001415; Ou LP, 2010, CANCER GENET CYTOGEN, V200, P110, DOI 10.1016/j.cancergencyto.2010.01.021; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Qian YB, 2006, CANCER, V107, P1562, DOI 10.1002/cncr.22206; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Takenaka N, 2011, EUR J IMMUNOL, V41, P202, DOI 10.1002/eji.201040675; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	32	19	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47563	10.1371/journal.pone.0047563	http://dx.doi.org/10.1371/journal.pone.0047563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077637	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100132
J	Meissen, JK; Yuen, BTK; Kind, T; Riggs, JW; Barupal, DK; Knoepfler, PS; Fiehn, O				Meissen, John K.; Yuen, Benjamin T. K.; Kind, Tobias; Riggs, John W.; Barupal, Dinesh K.; Knoepfler, Paul S.; Fiehn, Oliver			Induced Pluripotent Stem Cells Show Metabolomic Differences to Embryonic Stem Cells in Polyunsaturated Phosphatidylcholines and Primary Metabolism	PLOS ONE			English	Article							COPY NUMBER; FIBROBLASTS; INDUCTION; MICE	Induced pluripotent stem cells are different from embryonic stem cells as shown by epigenetic and genomics analyses. Depending on cell types and culture conditions, such genetic alterations can lead to different metabolic phenotypes which may impact replication rates, membrane properties and cell differentiation. We here applied a comprehensive metabolomics strategy incorporating nanoelectrospray ion trap mass spectrometry (MS), gas chromatography-time of flight MS, and hydrophilic interaction-and reversed phase-liquid chromatography-quadrupole time-of-flight MS to examine the metabolome of induced pluripotent stem cells (iPSCs) compared to parental fibroblasts as well as to reference embryonic stem cells (ESCs). With over 250 identified metabolites and a range of structurally unknown compounds, quantitative and statistical metabolome data were mapped onto a metabolite networks describing the metabolic state of iPSCs relative to other cell types. Overall iPSCs exhibited a striking shift metabolically away from parental fibroblasts and toward ESCs, suggestive of near complete metabolic reprogramming. Differences between pluripotent cell types were not observed in carbohydrate or hydroxyl acid metabolism, pentose phosphate pathway metabolites, or free fatty acids. However, significant differences between iPSCs and ESCs were evident in phosphatidylcholine and phosphatidylethanolamine lipid structures, essential and non-essential amino acids, and metabolites involved in polyamine biosynthesis. Together our findings demonstrate that during cellular reprogramming, the metabolome of fibroblasts is also reprogrammed to take on an ESC-like profile, but there are select unique differences apparent in iPSCs. The identified metabolomics signatures of iPSCs and ESCs may have important implications for functional regulation of maintenance and induction of pluripotency.	[Meissen, John K.; Kind, Tobias; Barupal, Dinesh K.; Knoepfler, Paul S.; Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Yuen, Benjamin T. K.; Riggs, John W.; Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	knoepfler@ucdavis.edu; ofiehn@ucdavis.edu	Kind, Tobias/A-7553-2010; Barupal, Dinesh K/A-9341-2010	Kind, Tobias/0000-0002-1908-4916; barupal, dinesh/0000-0002-9954-8628; Knoepfler, Paul/0000-0001-5444-334X	California Institute for Regenerative Medicine [RN2-00922]; National Institutes of Health [1R01GM100782, R01 DK078328]; National Science Foundation [MCB-1139644]; Direct For Biological Sciences [1139644] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was financially supported by California Institute for Regenerative Medicine grant RN2-00922 and National Institutes of Health grant 1R01GM100782 (both to PSK and National Institutes of Health grant R01 DK078328 and National Science Foundation grant MCB-1139644 (both to OF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Avila MA, 2004, INT J BIOCHEM CELL B, V36, P2125, DOI 10.1016/j.biocel.2003.11.016; Barupal DK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-99; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Cantz T, 2010, ADV BIOCHEM ENG BIOT, V123, P107, DOI 10.1007/10_2010_74; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Jurchott K, 2011, BIOSYSTEMS, V105, P130, DOI 10.1016/j.biosystems.2011.05.005; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lei ZT, 2011, J BIOL CHEM, V286, P25435, DOI 10.1074/jbc.R111.238691; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Moriwaki Y, 1999, HISTOL HISTOPATHOL, V14, P1321, DOI 10.14670/HH-14.1321; Munoz J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.84; Panopoulos AD, 2011, CELL RES, DOI [10.1038/cr.2011.1177, DOI 10.1038/CR.2011.1177]; PEGG AE, 1985, BIOCHEM BIOPH RES CO, V133, P82, DOI 10.1016/0006-291X(85)91844-3; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Quinlan AR, 2011, CELL STEM CELL, V9, P366, DOI 10.1016/j.stem.2011.07.018; Riggs JW, 2012, STEM CELLS IN PRESS; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; WARBURG O, 1956, SCIENCE, V124, P269; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	48	54	55	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46770	10.1371/journal.pone.0046770	http://dx.doi.org/10.1371/journal.pone.0046770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077522	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100039
J	Ren, YD; Ding, F; Suo, SQGW; Bu, RE; Zarlenga, DS; Ren, XF				Ren, Yudong; Ding, Fan; Suo, Siqingaowa; Bu, Ri-e; Zarlenga, Dante S.; Ren, Xiaofeng			Incidence Rates and Deaths of Tuberculosis in HIV-Negative Patients in the United States and Germany as Analyzed by New Predictive Model for Infection	PLOS ONE			English	Article							MDR TUBERCULOSIS; PROGRAMS	Incidence and mortality due to tuberculosis (TB) have been decreasing worldwide. Given that TB is a cosmopolitan disease, proper surveillance and evaluation are critical for controlling dissemination. Herein, mathematical modeling was performed in order to: 1) demonstrate a correlation between the incidence of TB in HIV-free patients in the US and Germany, and their corresponding mortality rates; 2) show the utility of the newly developed D-R algorithm for analyzing and predicting the incidence of TB in both countries; and 3) inform us on population death rates due to TB in HIV-negative patients. Using data published by the World Health Organization between 1990 and 2009, the relationship between incidence and mortality that could not be ascribed to HIV infection was evaluated. Using linear, quadratic and cubic curves, we found that a cubic function provided the best fit with the data in both the US (Y = 2.3588+2.2459X+61.1639X(2)-60.104X(3)) and Germany (Y = 1.9271+9.4967X+18.3824X(2)-10.350X(3)) where the correlation coefficient (R) between incidence and mortality was 0.995 and 0.993, respectively. Second, we demonstrated that fitted curves using the D-R model were equal to or better than those generated using the GM(1,1) algorithm as exemplified in the relative values for Sum of Squares of Error, Relative Standard Error, Mean Absolute Deviation, Average Relative Error, and Mean Absolute Percentage Error. Finally, future trends using both the D-R and the classic GM(1,1) models predicted a continued decline in infection and mortality rates of TB in HIV-negative patients rates extending to 2015 assuming no changes to diagnosis or treatment regimens are enacted.	[Ren, Yudong; Suo, Siqingaowa; Ren, Xiaofeng] NE Agr Univ, Coll Vet Med, Harbin, Peoples R China; [Ren, Yudong; Bu, Ri-e; Ren, Xiaofeng] Inner Mongolia Univ Nationalities, Sch Life Sci, Tongliao, Inner Mongolia, Peoples R China; [Ding, Fan] Chinese Armed Police Forest Force Command, Dept Hlth, Beijing, Peoples R China; [Zarlenga, Dante S.] ARS, Anim Parasit Dis Lab, Beltsville, MD USA	Northeast Agricultural University - China; Inner Mongolia University for Nationalities	Ren, XF (corresponding author), NE Agr Univ, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn			National Natural Science Foundation of China [31270187]; Program for New Century Excellent Talents in Heilongjiang Provincial University [1155-NCET-005]; Program for New Century Excellent Talents in University of Ministry of Education of P.R. China [NCET-10-0144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); Program for New Century Excellent Talents in University of Ministry of Education of P.R. China(Program for New Century Excellent Talents in University (NCET))	National Natural Science Foundation of China (31270187) to Y.R.; the Program for New Century Excellent Talents in Heilongjiang Provincial University (1155-NCET-005) and Program for New Century Excellent Talents in University of Ministry of Education of P.R. China (NCET-10-0144) to X.R. are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-3; [Anonymous], 2011, GLOB TUB CONTR; Ding F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027295; Ding F, 2011, INFECT GENET EVOL, V11, P222, DOI 10.1016/j.meegid.2010.09.015; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; Lieberman R, 2009, P SOC PHOTO-OPT INST, V7260; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; PAN H, 2005, TIME SERIES ANAL; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; Teo SSS, 2009, EUR RESPIR J, V34, P176, DOI 10.1183/09031936.00031808; World Health Organization, GLOB HLTH OBS GHO; XIONG HJ, 2005, GREY CONTROL	14	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e42055	10.1371/journal.pone.0042055	http://dx.doi.org/10.1371/journal.pone.0042055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077479	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100007
J	Yang, JX; Chen, B; Pan, YY; Han, J; Chen, F; Hu, SJ				Yang, Jin-Xiu; Chen, Bin; Pan, Yan-Yun; Han, Jie; Chen, Fei; Hu, Shen-Jiang			Zoledronate Attenuates Angiogenic Effects of Angiotensin II-Stimulated Endothelial Progenitor Cells via RhoA and MAPK Signaling	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; ACID; INHIBITION; PATHWAY; GROWTH; RAS; SYSTEM; ROCK	Background: New vessel formation plays a pivotal role in the pathogenesis of neovascular-related diseases. Endothelial progenitor cells (EPCs) were found to contribute to neovascular-related diseases and interference with EPC neovascularization may be a novel target for these diseases. Zoledronate (Zol) was reported to exhibit anti-angiogenic effect. Basing on these evidences, we proposed that Zol may affect EPC function to exert novel anti-angiogenic effect. In this study, we therefore investigated the effects of Zol on multiple aspects of EPC function and explored the underlying mechanisms involved. Methodology/Principal Findings: EPCs were cultured from bone marrow derived mononuclear cells. The potential effects of Zol on Angiotensin II (Ang II)-stimulated EPC proliferation, migration, adhesion, in vitro tube formation were investigated. The results showed that Ang II (1 mu M) enhanced EPC migration, adhesion, in vitro tube formation but had no effect on cell proliferation. Zol (75 and 100 mM) inhibited proliferation of EPCs and 50 mu M geranylgeranyol (GGOH) could reverse the decrease of EPC proliferation. We found for the first time that Zol (50-100 mu M) dose dependently attenuated migration, adhesion, and in vitro tube formation of EPCs stimulated by Ang II. GGOH could reverse the attenuation of EPC function induced by Zol. However, Zol did not induce EPC apoptosis. In addition, the underlying mechanisms were determined. The results revealed that Zol markedly down-regulated active RhoA stimulated by Ang II and inhibited the phosphorylation of Erk1/2 and JNK. Moreover, RhoA silencing resulted in a notable inhibition of EPC in vitro tube formation, suggesting that RhoA suppression played a pivotal role in Zol antiangiogenic effect. Conclusions/Significance: These findings suggested that Zol attenuated the promotion of EPC function stimulated by Ang II and exhibited novel antiangiogenic effect via RhoA and MAPK signaling. Thus, Zol may be served as a novel therapeutic agent for neovascular-related diseases treatment.	[Yang, Jin-Xiu; Chen, Bin; Pan, Yan-Yun; Han, Jie; Chen, Fei; Hu, Shen-Jiang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, SJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China.	s0hu0001@hotmail.com			National Natural Science Foundation of China [NSFC 81170242, 30470715, 30870939]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research project has been supported by the National Natural Science Foundation of China (NSFC 81170242, 30470715 and 30870939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bifulco M, 2005, LIFE SCI, V77, P1740, DOI 10.1016/j.lfs.2005.05.017; Bleiziffer O, 2011, J CELL MOL MED, V15, P2452, DOI 10.1111/j.1582-4934.2010.01247.x; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x; Crick DC, 1997, BIOCHEM BIOPH RES CO, V237, P483, DOI 10.1006/bbrc.1997.7145; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fournier PG, 2010, NEOPLASIA, V12, P571, DOI 10.1593/neo.10282; Gozzetti A, 2008, CALCIFIED TISSUE INT, V82, P258, DOI 10.1007/s00223-008-9123-8; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Ichiki T, 2004, ARTERIOSCL THROM VAS, V24, P622, DOI 10.1161/01.ATV.0000125707.94116.a4; Ino K, 2011, CURR CANCER DRUG TAR, V11, P405, DOI 10.2174/156800911795538057; Kahler CM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-50; Kawada K, 2005, JPN J CLIN ONCOL, V35, P28, DOI 10.1093/jjco/hyi005; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Kwon YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033618; Lau ST, 2011, CURR CANCER DRUG TAR, V11, P412; Li CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032380; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Mazzolai L, 2004, HYPERTENSION, V44, P277, DOI 10.1161/01.HYP.0000140269.55873.7b; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nogawa M, 2005, ONCOL RES, V15, P1; Potter DD, 1998, CIRCULATION, V98, P800, DOI 10.1161/01.CIR.98.8.800; Raikkonen J, 2010, BIOCHEM PHARMACOL, V79, P777, DOI 10.1016/j.bcp.2009.10.003; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Routhier A, 2010, ONCOL REP, V23, P861, DOI 10.3892/or_00000708; Rumpold H, 2004, J CELL MOL MED, V8, P509, DOI 10.1111/j.1582-4934.2004.tb00475.x; Sata M, 2006, ARTERIOSCL THROM VAS, V26, P1008, DOI 10.1161/01.ATV.0000206123.94140.f3; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sueishi K, 1997, ANN NY ACAD SCI, V811, P311, DOI 10.1111/j.1749-6632.1997.tb52011.x; Wilson SH, 2002, CIRCULATION, V105, P415, DOI 10.1161/hc0402.104119; Wood J, 2002, J PHARMACOL EXP THER, V302, P1055, DOI 10.1124/jpet.102.035295; Yamada J, 2009, J SURG RES, V151, P115, DOI 10.1016/j.jss.2008.01.031; Ye Y, 2009, FEBS LETT, V583, P2997, DOI 10.1016/j.febslet.2009.08.034; Yuasa T, 2007, CURR MED CHEM, V14, P2126	46	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46511	10.1371/journal.pone.0046511	http://dx.doi.org/10.1371/journal.pone.0046511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071580	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700021
J	Myhrvold, CL; Stone, HA; Bou-Zeid, E				Myhrvold, Conor L.; Stone, Howard A.; Bou-Zeid, Elie			What Is the Use of Elephant Hair?	PLOS ONE			English	Article							HEAT-TRANSFER; FORCED-CONVECTION; AFRICAN ELEPHANT; ASIAN ELEPHANTS; TEMPERATURE; EXCHANGE	The idea that low surface densities of hairs could be a heat loss mechanism is understood in engineering and has been postulated in some thermal studies of animals. However, its biological implications, both for thermoregulation as well as for the evolution of epidermal structures, have not yet been noted. Since early epidermal structures are poorly preserved in the fossil record, we study modern elephants to infer not only the heat transfer effect of present-day sparse hair, but also its potential evolutionary origins. Here we use a combination of theoretical and empirical approaches, and a range of hair densities determined from photographs, to test whether sparse hairs increase convective heat loss from elephant skin, thus serving an intentional evolutionary purpose. Our conclusion is that elephants are covered with hair that significantly enhances their thermoregulation ability by over 5% under all scenarios considered, and by up to 23% at low wind speeds where their thermoregulation needs are greatest. The broader biological significance of this finding suggests that maintaining a low-density hair cover can be evolutionary purposeful and beneficial, which is consistent with the fact that elephants have the greatest need for heat loss of any modern terrestrial animal because of their high body-volume to skin-surface ratio. Elephant hair is the first documented example in nature where increasing heat transfer due to a low hair density covering may be a desirable effect, and therefore raises the possibility of such a covering for similarly sized animals in the past. This elephant example dispels the widely-held assumption that in modern endotherms body hair functions exclusively as an insulator and could therefore be a first step to resolving the prior paradox of why hair was able to evolve in a world much warmer than our own.	[Myhrvold, Conor L.; Bou-Zeid, Elie] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Princeton University; Princeton University	Bou-Zeid, E (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	ebouzeid@princeton.edu	Bou-Zeid, Elie/A-9796-2008	Bou-Zeid, Elie/0000-0002-6137-8109				BEJAN A, 1990, J HEAT TRANS-T ASME, V112, P662, DOI 10.1115/1.2910438; Bejan A., 1993, HEAT TRANSF; BENEDICT FRANCIS G., 1938, JOUR MAMMAL, V19, P175, DOI 10.2307/1374612; Brutsaert W., 2013, EVAPORATION ATMOSPHE; BUSS IO, 1971, J MAMMAL, V52, P21, DOI 10.2307/1378428; CHURCHILL SW, 1977, J HEAT TRANS-T ASME, V99, P300, DOI 10.1115/1.3450685; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; FOWLER AJ, 1995, INT J HEAT MASS TRAN, V38, P767, DOI 10.1016/0017-9310(94)00210-M; HILEY P, 1975, NAT HIST, V84, P34; Holmes KR, APPENDIX A THERMAL C; Incropera F.P., 2007, FUNDAMENTALS HEAT MA; Kinahan AA, 2007, PHYSIOL BEHAV, V92, P560, DOI 10.1016/j.physbeh.2007.05.001; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; LANGMAN VA, 1995, J EXP BIOL, V198, P629; LAURSEN L, 1978, Mammalian Species, V92, P1; LEWIS DA, 1977, PLANT PHYSIOL, V60, P609, DOI 10.1104/pp.60.4.609; LILLYWHITE HB, 1987, J ZOOL, V211, P727; McKellar RC, 2011, SCIENCE, V333, P1619, DOI 10.1126/science.1203344; NOBEL PS, 1978, ECOLOGY, V59, P986, DOI 10.2307/1938550; PHILLIPS PK, 1992, COMP BIOCHEM PHYS A, V101, P693, DOI 10.1016/0300-9629(92)90345-Q; Pope S., 2000, TURBULENT FLOWS, DOI [10.1017/cbo9780511840531.004, DOI 10.1017/CBO9780511840531]; Rees PA, 2002, J THERM BIOL, V27, P353, DOI 10.1016/S0306-4565(01)00100-0; Sikes S.K, 1971, NATURAL HIST AFRICAN; van Leeuwenhoek A, 1712, PHILOS T ROY SOC LON, V27, P518; Weissenbock NM, 2012, J COMP PHYSIOL B, V182, P311, DOI 10.1007/s00360-011-0609-8; WILLIAMS TM, 1990, J ZOOL, V222, P235, DOI 10.1111/j.1469-7998.1990.tb05674.x; WOLPERT A, 1962, PLANT PHYSIOL, V37, P113, DOI 10.1104/pp.37.2.113; WRIGHT PG, 1984, S AFR J ZOOL, V19, P266; WRIGHT PG, 1984, S AFR J ZOOL, V19, P270; YAGLOM AM, 1974, J FLUID MECH, V62, P601, DOI 10.1017/S0022112074000838	31	16	16	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47018	10.1371/journal.pone.0047018	http://dx.doi.org/10.1371/journal.pone.0047018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071700	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200068
J	Okroj, M; Holmquist, E; King, BC; Blom, AM				Okroj, Marcin; Holmquist, Emelie; King, Ben C.; Blom, Anna M.			Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; PROTEIN ALPHA-CHAIN; 2 ACTIVE-SITES; C4B-BINDING PROTEIN; FACTOR-H; ALTERNATIVE PATHWAY; CLASSICAL PATHWAY; FACTOR DAF; SYSTEM; ACTIVATION	C3 and C5 convertases are central stages of the complement cascade since they converge the different initiation pathways, augment complement activation by an amplification loop and lead to a common terminal pathway resulting in the formation of the membrane attack complex. Several complement inhibitors attenuate convertase formation and/or accelerate dissociation of convertase complexes. Functional assays used to study these processes are often performed using purified complement components, from which enzymatic complexes are reconstituted on the surface of erythrocytes or artificial matrices. This strategy enables identification of individual interactions between convertase components and putative regulators but carries an inherent risk of detecting non-physiological interactions that would not occur in a milieu of whole serum. Here we describe a novel, alternative method based on C3 or C5-depleted sera, which support activation of the complement cascade up to the desired stages of convertases. This approach allows fast and simple assessment of the influence of putative regulators on convertase formation and stability. As an example of practical utility of the assay, we performed studies on thioredoxin-1 in order to clarify the mechanism of its influence on complement convertases.	[Okroj, Marcin; Holmquist, Emelie; King, Ben C.; Blom, Anna M.] Lund Univ, Dept Lab Med, Wallenberg Lab, Malmo, Sweden	Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; King, Benjamin/0000-0001-6776-8741	Cancerfonden; Swedish Research Council grants [K2012-66X-14928-09-5, K201080X-21514-01-4]; National Board of Health and Welfare; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Thelma Zoega; Foundation of Tore Nilsson; Foundation of King Gustav V's 80th anniversary; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; Ska ne University Hospital	Cancerfonden(Swedish Cancer Society); Swedish Research Council grants; National Board of Health and Welfare; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Thelma Zoega; Foundation of Tore Nilsson; Foundation of King Gustav V's 80th anniversary; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; Ska ne University Hospital	This work was supported by the Cancerfonden (http://www.cancerfonden.se/), Swedish Research Council grants K2012-66X-14928-09-5 and K201080X-21514-01-4 (http://vr.se), the National Board of Health and Welfare (http://www.socialstyrelsen.se/english) and the Foundations of Osterlund (http://www. alfredosterlundsstiftelse.se), Greta and Johan Kock (http://www.kockskastiftelsen.se), Thelma Zoega, Tore Nilsson (http://www.torenilsonsstiftelse.nu), King Gustav V's 80th anniversary, Knut and Alice Wallenberg (http://www.wallenberg.com/kaw) and Inga-Britt and Arne Lundberg (http://www.lundbergsstiftelsen.se), as well as grant from the Ska ne University Hospital.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arason GJ, 2010, SCAND J IMMUNOL, V71, P317, DOI 10.1111/j.1365-3083.2010.02386.x; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; FORSGREN A, 1974, INFECT IMMUN, V10, P402, DOI 10.1128/IAI.10.2.402-404.1974; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Hardig Y, 1997, BIOCHEM J, V323, P469; Harris CL, 2007, J IMMUNOL, V178, P352, DOI 10.4049/jimmunol.178.1.352; Homann C, 1997, GUT, V40, P544, DOI 10.1136/gut.40.4.544; Hourcade DE, 2002, J BIOL CHEM, V277, P1107, DOI 10.1074/jbc.M109322200; Inomata Y, 2008, INVEST OPHTH VIS SCI, V49, P5118, DOI 10.1167/iovs.07-1659; Jokiranta TS, 1996, FEBS LETT, V393, P297; King BC, 2012, J IMMUNOL, V188, P4103, DOI 10.4049/jimmunol.1101295; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Krych-Goldberg M, 2005, J IMMUNOL, V175, P4528, DOI 10.4049/jimmunol.175.7.4528; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Ma Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032099; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MULLEREBERHARD HJ, 1967, J EXP MED, V125, P359, DOI 10.1084/jem.125.2.359; NAGASAWA S, 1985, J BIOCHEM-TOKYO, V97, P493, DOI 10.1093/oxfordjournals.jbchem.a135083; Nangaku Masaomi, 2007, Clin Exp Nephrol, V11, P107, DOI 10.1007/s10157-007-0466-7; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Okroj M, 2009, J BIOL CHEM, V284, P505, DOI 10.1074/jbc.M806669200; Pangburn MK, 2009, J IMMUNOL, V182, P1061, DOI 10.4049/jimmunol.182.2.1061; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ruiz-Irastorza G, 2010, LANCET, V376, P1498, DOI 10.1016/S0140-6736(10)60709-X; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Skattum L, 1997, J INTERN MED, V242, P455, DOI 10.1111/j.1365-2796.1997.tb00018.x; Soglio DBD, 2008, HUM PATHOL, V39, P1103, DOI 10.1016/j.humpath.2007.12.014; Volankis JE, 1998, HUMAN COMPLEMENT SYS; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Watford WT, 2001, J IMMUNOL, V167, P6593, DOI 10.4049/jimmunol.167.11.6593; Wright AF, 2011, NAT GENET, V43, P1176, DOI 10.1038/ng.1012; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	40	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47245	10.1371/journal.pone.0047245	http://dx.doi.org/10.1371/journal.pone.0047245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071769	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200095
J	Trouet, V; Mukelabai, M; Verheyden, A; Beeckman, H				Trouet, Valerie; Mukelabai, Mukufute; Verheyden, Anouk; Beeckman, Hans			Cambial Growth Season of Brevi-Deciduous Brachystegia spiciformis Trees from South Central Africa Restricted to Less than Four Months	PLOS ONE			English	Article							INITIATIVE SAFARI 2000; ANNUAL RING FORMATION; TROPICAL DRY FOREST; WOOD FORMATION; CARBON ALLOCATION; LEAF PHENOLOGY; MIOMBO WOODLAND; GROWING-SEASON; CLIMATE-CHANGE; WATER STATUS	We investigate cambial growth periodicity in Brachystegia spiciformis, a dominant tree species in the seasonally dry miombo woodland of southern Africa. To better understand how the brevi-deciduous (experiencing a short, drought-induced leaf fall period) leaf phenology of this species can be linked to a distinct period of cambial activity, we applied a bi-weekly pinning to six trees in western Zambia over the course of one year. Our results show that the onset and end of cambial growth was synchronous between trees, but was not concurrent with the onset and end of the rainy season. The relatively short (three to four months maximum) cambial growth season corresponded to the core of the rainy season, when 75% of the annual precipitation fell, and to the period when the trees were at full photosynthetic capacity. Tree-ring studies of this species have found a significant relationship between annual tree growth and precipitation, but we did not observe such a correlation at intra-annual resolution in this study. Furthermore, a substantial rainfall event occurring after the end of the cambial growth season did not induce xylem initiation or false ring formation. Low sample replication should be taken into account when interpreting the results of this study, but our findings can be used to refine the carbon allocation component of process-based terrestrial ecosystem models and can thus contribute to a more detailed estimation of the role of the miombo woodland in the terrestrial carbon cycle. Furthermore, we provide a physiological foundation for the use of Brachystegia spiciformis tree-ring records in paleoclimate research.	[Trouet, Valerie] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Mukelabai, Mukufute] Zambia Meteorol Serv, Mongu, Zambia; [Verheyden, Anouk] Union Coll, Dept Geol, Schenectady, NY 12308 USA; [Beeckman, Hans] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium	University of Arizona; Union College; Royal Museum for Central Africa	Trouet, V (corresponding author), Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA.	trouet@ltrr.arizona.edu	Beeckman, Hans/I-7653-2019; Trouet, Valerie/AAE-4888-2021	Beeckman, Hans/0000-0001-8954-6277; Trouet, Valerie/0000-0002-2683-8704	Institute for the Promotion of Innovation by Science and Technology in Flanders	Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was supported by a grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora VK, 2005, GLOBAL CHANGE BIOL, V11, P39, DOI 10.1111/j.1365-2486.2004.00890.x; Baker TR, 2002, FOREST ECOL MANAG, V171, P261, DOI 10.1016/S0378-1127(01)00787-3; BOALER SB, 1966, J ECOL, V54, P465, DOI 10.2307/2257962; BORCHERT R, 1994, TREES-STRUCT FUNCT, V8, P115, DOI 10.1007/BF00196635; Borchert R, 1999, IAWA J, V20, P239, DOI 10.1163/22941932-90000687; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; Campbell B., 1996, MIOMBO TRANSITION WO; Cardoso FCG, 2012, PLANT SOIL, V354, P269, DOI 10.1007/s11104-011-1063-9; Chidumayo EN., 1993, RESPONSES MIOMBO HAR; CHOINSKI JS, 1993, TREE PHYSIOL, V13, P17, DOI 10.1093/treephys/13.1.17; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; D'Arrigo R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025465; Deslauriers A, 2003, CAN J FOREST RES, V33, P190, DOI 10.1139/X02-178; Deslauriers A, 2008, TREE PHYSIOL, V28, P863, DOI 10.1093/treephys/28.6.863; Die A, 2012, ANN BOT-LONDON, V110, P861, DOI 10.1093/aob/mcs145; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Epron D, 2012, TREE PHYSIOL, V32, P639, DOI 10.1093/treephys/tps055; ERNST WHO, 1988, FOREST ECOL MANAG, V25, P195, DOI 10.1016/0378-1127(88)90087-4; Franklin O, 2012, TREE PHYSIOL, V32, P648, DOI 10.1093/treephys/tpr138; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Frost P.G.H., 2000, VEGETATION STRUCTURE; Goward SN, 1995, J BIOGEOGR, V22, P549, DOI 10.2307/2845953; Gruber A, 2010, TREE PHYSIOL, V30, P490, DOI 10.1093/treephys/tpq003; GRUNDY IM, 1995, FOREST ECOL MANAG, V72, P109, DOI 10.1016/0378-1127(94)03467-B; Hayden B, 2010, J TROP ECOL, V26, P237, DOI 10.1017/S0266467409990563; Huemmrich KF, 2005, INT J REMOTE SENS, V26, P4381, DOI 10.1080/01431160500113393; Iqbal M., 1994, GROWTH PATTERNS VASC, P211; JACOBY GC, 1989, IAWA BULL, V10, P99, DOI 10.1163/22941932-90000478; Krepkowski J, 2011, TREES-STRUCT FUNCT, V25, P59, DOI 10.1007/s00468-010-0460-7; Landsberg J, 2003, CAN J FOREST RES, V33, P385, DOI 10.1139/X02-129; LAWTON RM, 1978, J ECOL, V66, P175, DOI 10.2307/2259187; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Makinen H, 2008, EUR J FOREST RES, V127, P235, DOI 10.1007/s10342-007-0199-x; Malaisse F., 1975, Tropical ecological systems., P137; Malaisse FP, 1974, PHENOLOGY SEASONALIT, P269, DOI DOI 10.1007/978-3-642-51863-8_23; Marcati CR, 2008, TREES-STRUCT FUNCT, V22, P3, DOI 10.1007/s00468-007-0173-8; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Moser L, 2010, TREE PHYSIOL, V30, P225, DOI 10.1093/treephys/tpp108; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Oladi R, 2011, TREES-STRUCT FUNCT, V25, P425, DOI 10.1007/s00468-010-0517-7; Otter LB, 2002, S AFR J SCI, V98, P131; Pearce RB, 1996, NEW PHYTOL, V132, P203, DOI 10.1111/j.1469-8137.1996.tb01842.x; Prislan P, 2011, IAWA J, V32, P443, DOI 10.1163/22941932-90000070; Privette JL, 2002, REMOTE SENS ENVIRON, V83, P232, DOI 10.1016/S0034-4257(02)00075-5; Rathgeber CBK, 2011, ANN BOT-LONDON, V108, P429, DOI 10.1093/aob/mcr168; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Rossi S, 2006, IAWA J, V27, P89, DOI 10.1163/22941932-90000139; Rossi S, 2008, GLOBAL ECOL BIOGEOGR, V17, P696, DOI 10.1111/j.1466-8238.2008.00417.x; Rossi S, 2007, OECOLOGIA, V152, P1, DOI 10.1007/s00442-006-0625-7; Rossi S, 2011, ARCT ANTARCT ALP RES, V43, P457, DOI 10.1657/1938-4246-43.3.457; Rossi S, 2011, GLOBAL CHANGE BIOL, V17, P614, DOI 10.1111/j.1365-2486.2010.02191.x; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Rutishauser T, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000382; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Scheiter S, 2009, GLOBAL CHANGE BIOL, V15, P2224, DOI 10.1111/j.1365-2486.2008.01838.x; Schmitt U, 2000, J APPL BOT-ANGEW BOT, V74, P10; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Schongart J, 2004, GLOBAL CHANGE BIOL, V10, P683, DOI 10.1111/j.1529-8817.2003.00754.x; Schoonenberg T, 2003, CAN J FOREST RES, V33, P330, DOI 10.1139/X02-172; Seo Jeong-Wook, 2007, Dendrochronologia, V25, P79, DOI 10.1016/j.dendro.2007.04.001; Singh KP, 2005, CURR SCI INDIA, V89, P964; Stahl C, 2010, J TROP ECOL, V26, P393, DOI 10.1017/S0266467410000155; Swap RJ, 2002, S AFR J SCI, V98, P125; Swidrak I, 2011, TREE PHYSIOL, V31, P483, DOI 10.1093/treephys/tpr034; Tarhule A., 2002, TREE-RING RES, V58, P31; Therrell MD, 2006, CLIM DYNAM, V26, P677, DOI 10.1007/s00382-005-0108-2; TRAPNELL CG, 1959, J ECOL, V47, P129, DOI 10.2307/2257252; Trouet V, 2006, BIOTROPICA, V38, P375, DOI 10.1111/j.1744-7429.2006.00155.x; Trouet V, 2001, IAWA J, V22, P385, DOI 10.1163/22941932-90000384; Trouet V, 2010, DENDROCHRONOLOGIA, V28, P161, DOI 10.1016/j.dendro.2009.10.002; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Volland-Voigt F, 2011, TREES-STRUCT FUNCT, V25, P39, DOI 10.1007/s00468-010-0461-6; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.2307/3060925; WELLES JM, 1991, AGRON J, V83, P818, DOI 10.2134/agronj1991.00021962008300050009x; Williams RJ, 1997, ECOLOGY, V78, P2542, DOI 10.1890/0012-9658(1997)078[2542:LPOWSI]2.0.CO;2; WOLTER KE, 1968, FOREST SCI, V14, P102; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; Zweifel R, 2000, TREES-STRUCT FUNCT, V15, P50, DOI 10.1007/s004680000072	81	43	43	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47364	10.1371/journal.pone.0047364	http://dx.doi.org/10.1371/journal.pone.0047364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071794	Green Published, gold			2022-12-25	WOS:000312385200111
J	Wang, CR; Xu, MJ; Fu, JH; Nisbet, AJ; Chang, QC; Zhou, DH; Huang, SY; Zou, FC; Zhu, XQ				Wang, Chun-Ren; Xu, Min-Jun; Fu, Jing-Hua; Nisbet, Alasdair J.; Chang, Qiao-Cheng; Zhou, Dong-Hui; Huang, Si-Yang; Zou, Feng-Cai; Zhu, Xing-Quan			Characterization of MicroRNAs from Orientobilharzia turkestanicum, a Neglected Blood Fluke of Human and Animal Health Significance	PLOS ONE			English	Article							MAJOR EGG ANTIGEN; CERCARIAL-DERMATITIS; GENE-EXPRESSION; SWIMMERS ITCH; IDENTIFICATION; SCHISTOSOMES; CLONING; PCR	The neglected blood flukes Orientobilharzia spp. belonging to the Platyhelminthes, infect animals in a number of countries of the world, and cause cercarial dermatitis in humans, as well as significant diseases and even death in economically-important animals. MicroRNAs (miRNAs) are now considered to be a key mechanism of gene regulation. Herein, we investigated the global miRNA expression profile of adult O. turkestanicum using next-generation sequencing technology and real-time quantitative PCR, to gain further information on the role of these molecules in host invasion and the parasitic lifestyle of this species. A total of 13.48 million high quality reads were obtained out of 13.78 million raw sequencing reads, with 828 expressed miRNAs identified. Phylogenetic analysis showed that the miRNAs of O. turkestanicum were still rapidly evolving and there was a "directed mutation" pattern compared with that of other species. Target mRNAs were successfully predicted to 518 miRNAs. These targets included energy metabolism, transcription initiation factors, signal transduction, growth factor receptors. miRNAs targeting egg proteins, including major egg antigen p40, and heat shock proteins were also found. Enrichment analysis indicated enrichment for mRNAs involved in catalytic, binding, transcription regulators and translation regulators. The present study represented the first large-scale characterization of O. turkestanicum miRNAs, which provides novel resources for better understanding the complex biology of this zoonotic parasite, which, in turn, has implications for the effective control of the disease it causes.	[Wang, Chun-Ren; Xu, Min-Jun; Fu, Jing-Hua; Zhou, Dong-Hui; Huang, Si-Yang; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Wang, Chun-Ren; Chang, Qiao-Cheng; Zhu, Xing-Quan] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Heilongjiang Pr, Peoples R China; [Fu, Jing-Hua] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Nisbet, Alasdair J.] Moredun Res Inst, Div Parasitol, Pentlands Sci Pk, Midlothian, Scotland; [Zou, Feng-Cai; Zhu, Xing-Quan] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan Province, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Heilongjiang Bayi Agricultural University; South China Agricultural University; Moredun Research Institute; Yunnan Agricultural University	Xu, MJ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	mjxu@yahoo.cn; xingquanzhu1@hotmail.com	Chang, Qiao-Cheng/GPF-6176-2022; ZOU, Fengcai/ABE-4598-2021	ZOU, Fengcai/0000-0002-9613-3734; Nisbet, Alasdair/0000-0002-4965-5396	State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVEB2009KFKT004, SKLVEB2011KFKT004, SKLVEB2011KFKT011, SKLVEB2010KFKT009, SKLVEB2009KFKT008, SKLVEB2011KFKT010]; Program for Outstanding Scientists in Agricultural Research; Heilongjiang Provincial Education Department [11551311]; Yunnan Provincial Program for Introducing High-level Scientists [2009CI125]	State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences; Program for Outstanding Scientists in Agricultural Research; Heilongjiang Provincial Education Department; Yunnan Provincial Program for Introducing High-level Scientists	This work was supported by grants from the Open Funds of the State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant Nos. SKLVEB2009KFKT004, SKLVEB2011KFKT004, SKLVEB2011KFKT011, SKLVEB2010KFKT009, SKLVEB2009KFKT008 and SKLVEB2011KFKT010), the Program for Outstanding Scientists in Agricultural Research, the Scientific Research Fund of Heilongjiang Provincial Education Department (Grant No. 11551311) and the Yunnan Provincial Program for Introducing High-level Scientists (Grant No. 2009CI125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouel-Nour MF, 2006, MEM I OSWALDO CRUZ, V101, P365, DOI 10.1590/S0074-02762006000400004; Agrawal M.C., 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/250868; ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; Brant SV, 2009, J HELMINTHOL, V83, P191, DOI 10.1017/S0022149X09308020; Brant SV, 2010, EMERG INFECT DIS, V16, P1357, DOI 10.3201/eid1609.091664; Bulantova J, 2011, MICRON, V42, P47, DOI 10.1016/j.micron.2010.08.003; Catelli M. G., 1999, Journal de la Societe de Biologie, V193, P361; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; deGentile L, 1996, B WORLD HEALTH ORGAN, V74, P159; Fraser SJ, 2009, CLIN EXP DERMATOL, V34, P344, DOI 10.1111/j.1365-2230.2008.02903.x; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Horweg C, 2006, WIEN KLIN WOCHENSCHR, V118, P77, DOI 10.1007/s00508-006-0674-2; Horak P, 2002, ADV PARASIT, V52, P155, DOI 10.1016/S0065-308X(02)52012-1; Kolarova L, 1999, J HELMINTHOL, V73, P215, DOI 10.1017/S0022149X99000335; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee JS, 2007, PARASITOL RES, V100, P677, DOI 10.1007/s00436-006-0324-7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2008, PARASITOL RES, V102, P939, DOI 10.1007/s00436-007-0857-4; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu GL, 2002, CHIN PUBLIC HLTH, V18, P73; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mai ZM, 1999, MOL CELL BIOL, V19, P2198; Monnig HO, 1950, VET HELMINTHOLOGY EN; Morley NJ, 2009, CLIN EXP DERMATOL, V34, pe443, DOI 10.1111/j.1365-2230.2009.03481.x; Roy N, 2012, BBA-MOL CELL RES, V1823, P707, DOI 10.1016/j.bbamcr.2011.12.003; SAHBA GH, 1979, AM J TROP MED HYG, V28, P912, DOI 10.4269/ajtmh.1979.28.912; Schets FM, 2008, J WATER HEALTH, V6, P187, DOI 10.2166/wh.2008.028; Smith RE, 2008, EXP PARASITOL, V118, P536, DOI 10.1016/j.exppara.2007.11.012; Soleng A, 2011, J HELMINTHOL, V85, P345, DOI 10.1017/S0022149X10000672; Verbrugge LM, 2004, AM J PUBLIC HEALTH, V94, P738, DOI 10.2105/AJPH.94.5.738; Wang C, 2002, PROGR VET MED, V23, P91; Wang CR, 2009, ACTA TROP, V109, P171, DOI 10.1016/j.actatropica.2008.11.009; Wang CR, 2009, EXP PARASITOL, V121, P193, DOI 10.1016/j.exppara.2008.10.012; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Xu MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-521; Xue XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004034	39	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47001	10.1371/journal.pone.0047001	http://dx.doi.org/10.1371/journal.pone.0047001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071694	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200065
J	Kwee, SA; Hernandez, B; Chan, O; Wong, LA				Kwee, Sandi A.; Hernandez, Brenda; Chan, Owen; Wong, Linda			Choline Kinase Alpha and Hexokinase-2 Protein Expression in Hepatocellular Carcinoma: Association with Survival	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MAMMARY EPITHELIAL-CELLS; CANCER-CELLS; MALIGNANT-TRANSFORMATION; PHOSPHOLIPID-METABOLISM; GLUCOSE-METABOLISM; PANCREATIC-CANCER; BREAST-CARCINOMA; FDG-PET; TUMOR	Purpose: Hexokinase-2 (HK2) and more recently choline kinase alpha (CKA) expression has been correlated with clinical outcomes in several major cancers. This study examines the protein expression of HK2 and CKA in hepatocellular carcinoma (HCC) in association with patient survival and other clinicopathologic parameters. Methods: Immunohistochemical analysis for HK2 and CKA expression was performed on a tissue microarray of 157 HCC tumor samples. Results were analyzed in relation to clinicopathologic data from Surveillance, Epidemiology, and End-Results Program registries. Mortality rates were assessed by Kaplan-Meier estimates and compared using log-rank tests. Predictors of overall survival were assessed using proportional hazards regression. RESULTS: Immunohistochemical expression of HK2 and CKA was detected in 71 (45%) and 55 (35%) tumor samples, respectively. Differences in tumor HK2 expression were associated with tumor grade (p = 0.008) and cancer stage (p = 0.001), while CKA expression differed significantly only across cancer stage (p = 0.048). Increased mortality was associated with tumor HK2 expression (p = 0.003) as well as CKA expression (p = 0.03) with hazard ratios of 1.86 (95% confidence interval (CI) 1.23-2.83) and 1.59 (95% CI 1.04-2.41), respectively. Similar effects on overall survival were noted in a subset analysis of early stage (I and II) HCC. Tumor HK2 expression, but not CKA expression, remained a significant predictor of survival in multivariable analyses. Conclusion: HK2 and CKA expression may have biologic and prognostic significance in HCC, with tumor HK2 expression being a potential independent predictor of survival.	[Kwee, Sandi A.] Queens Med Ctr, Honolulu, HI USA; [Kwee, Sandi A.; Hernandez, Brenda; Chan, Owen; Wong, Linda] Univ Hawaii Manoa, Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Wong, Linda] Univ Hawaii Manoa, John A Burns Sch Med, Dept Surg, Honolulu, HI 96822 USA	The Queen's Medical Center; Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Kwee, SA (corresponding author), Queens Med Ctr, Honolulu, HI USA.	skwee@queens.org		Kwee, Sandi/0000-0002-4624-8787	United States National Institutes of Health - National Cancer Institute [R01CA161209-02, R25RR019321-05S1, P30CA071789-12S9]; NATIONAL CANCER INSTITUTE [R01CA161209, P30CA071789] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR019321] Funding Source: NIH RePORTER	United States National Institutes of Health - National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by United States National Institutes of Health - National Cancer Institute grants R01CA161209-02, R25RR019321-05S1 and P30CA071789-12S9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Anderson WF, 2009, BREAST CANCER RES TR, V113, P189, DOI 10.1007/s10549-008-9918-3; Bhakoo KK, 1996, CANCER RES, V56, P4630; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Contractor K, 2011, CLIN CANCER RES, V17, P7673, DOI 10.1158/1078-0432.CCR-11-2048; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Goodman MT, 2005, HUM PATHOL, V36, P812, DOI 10.1016/j.humpath.2005.03.010; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Hatano E, 2006, WORLD J SURG, V30, P1736, DOI 10.1007/s00268-005-0791-5; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Janardhan S, 2006, CURR MED CHEM, V13, P1169, DOI 10.2174/092986706776360923; JIMENEZ B, 1995, J CELL BIOCHEM, V57, P141, DOI 10.1002/jcb.240570114; Kitamura K, 2012, ANN SURG ONCOL, V19, P156, DOI 10.1245/s10434-011-1990-y; Kitamura K, 2011, J HEPATOL, V55, P846, DOI 10.1016/j.jhep.2011.01.038; Kornberg A, 2012, LIVER TRANSPLANT, V18, P53, DOI 10.1002/lt.22416; Lyshchik A, 2007, CANCER INVEST, V25, P154, DOI 10.1080/07357900701208931; Mamede M, 2005, NEOPLASIA, V7, P369, DOI 10.1593/neo.04577; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Nimmagadda S, 2009, NEOPLASIA, V11, P477, DOI 10.1593/neo.81430; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Ren JS, 2012, INT J CANC; Salem N, 2009, Q J NUCL MED MOL IM, V53, P144; Seo S, 2007, CLIN CANCER RES, V13, P427, DOI 10.1158/1078-0432.CCR-06-1357; SMITH TAD, 1993, NMR BIOMED, V6, P318, DOI 10.1002/nbm.1940060506; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Talbot JN, 2010, J NUCL MED, V51, P1699, DOI 10.2967/jnumed.110.075507; Teefey SA, 2003, RADIOLOGY, V226, P533, DOI 10.1148/radiol.2262011980; Tohma T, 2005, HEPATO-GASTROENTEROL, V52, P486; TORIZUKA T, 1994, J NUCL MED, V35, P1965; TORIZUKA T, 1995, J NUCL MED, V36, P1811; Trojan J, 1999, AM J GASTROENTEROL, V94, P3314, DOI 10.1111/j.1572-0241.1999.01544.x; Wudel LJ, 2003, AM SURGEON, V69, P117; Yasuda S, 2004, J HEPATOL, V40, P117, DOI 10.1016/S0168-8278(03)00503-8; Zhao SJ, 2005, J NUCL MED, V46, P675	47	78	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46591	10.1371/journal.pone.0046591	http://dx.doi.org/10.1371/journal.pone.0046591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071593	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300038
J	Ramos-Murguialday, A; Schurholz, M; Caggiano, V; Wildgruber, M; Caria, A; Hammer, EM; Halder, S; Birbaumer, N				Ramos-Murguialday, Ander; Schuerolz, Markus; Caggiano, Vittorio; Wildgruber, Moritz; Caria, Andrea; Hammer, Eva Maria; Halder, Sebastian; Birbaumer, Niels			Proprioceptive Feedback and Brain Computer Interface (BCI) Based Neuroprostheses	PLOS ONE			English	Article							STROKE REHABILITATION; MOTOR IMAGERY; RECOVERY; THERAPY	Brain computer interface (BCI) technology has been proposed for motor neurorehabilitation, motor replacement and assistive technologies. It is an open question whether proprioceptive feedback affects the regulation of brain oscillations and therefore BCI control. We developed a BCI coupled on-line with a robotic hand exoskeleton for flexing and extending the fingers. 24 healthy participants performed five different tasks of closing and opening the hand: (1) motor imagery of the hand movement without any overt movement and without feedback, (2) motor imagery with movement as online feedback (participants see and feel their hand, with the exoskeleton moving according to their brain signals, (3) passive (the orthosis passively opens and closes the hand without imagery) and (4) active (overt) movement of the hand and rest. Performance was defined as the difference in power of the sensorimotor rhythm during motor task and rest and calculated offline for different tasks. Participants were divided in three groups depending on the feedback receiving during task 2 (the other tasks were the same for all participants). Group 1 (n = 9) received contingent positive feedback (participants' sensorimotor rhythm (SMR) desynchronization was directly linked to hand orthosis movements), group 2 (n = 8) contingent "negative" feedback (participants' sensorimotor rhythm synchronization was directly linked to hand orthosis movements) and group 3 (n = 7) sham feedback (no link between brain oscillations and orthosis movements). We observed that proprioceptive feedback (feeling and seeing hand movements) improved BCI performance significantly. Furthermore, in the contingent positive group only a significant motor learning effect was observed enhancing SMR desynchronization during motor imagery without feedback in time. Furthermore, we observed a significantly stronger SMR desynchronization in the contingent positive group compared to the other groups during active and passive movements. To summarize, we demonstrated that the use of contingent positive proprioceptive feedback BCI enhanced SMR desynchronization during motor tasks.	[Ramos-Murguialday, Ander; Schuerolz, Markus; Caria, Andrea; Hammer, Eva Maria; Halder, Sebastian; Birbaumer, Niels] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Ramos-Murguialday, Ander; Schuerolz, Markus; Caria, Andrea; Hammer, Eva Maria; Halder, Sebastian; Birbaumer, Niels] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Ramos-Murguialday, Ander] TECNALIA, Hlth Technol, San Sebastian, Spain; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venezia Lido, Italy; [Wildgruber, Moritz] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-8000 Munich, Germany; [Caggiano, Vittorio] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Technical University of Munich; Massachusetts Institute of Technology (MIT)	Ramos-Murguialday, A (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.	ander.ramos@med.uni-tuebingen.de	LUO, JINGJING/AAZ-6697-2021; Halder, Sebastian/G-3745-2012; Halder, Sebastian/J-6144-2019	LUO, JINGJING/0000-0002-3222-1276; Halder, Sebastian/0000-0003-1017-3696; Caggiano, Vittorio/0000-0002-2186-1550; Birbaumer, Niels/0000-0002-6786-5127; Caria, Andrea/0000-0003-2017-7084; Ramos-Murguialday, Dr. Ander/0000-0002-1549-4029	Deutsche Forschungsgemeinschaft (DFG); Werner Reichardt Center of Integrative Neuroscience (CIN), Bernstein [01GQ0761]; Bundes Ministerium fur Bildung und Forschung (BMBF) [16SV3783]; European Union [227632, HUMOUR 231724, WAY 288551]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Werner Reichardt Center of Integrative Neuroscience (CIN), Bernstein; Bundes Ministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), the Werner Reichardt Center of Integrative Neuroscience (CIN), Bernstein 01GQ0761, Bundes Ministerium fur Bildung und Forschung (BMBF) 16SV3783, European Union (European Research Council (ERC) 227632, Framework Program 7 Information and Communication Technologies (FP7-ICT) HUMOUR 231724 and (FP7-ICT) WAY 288551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2006, NATURE, V442, P125, DOI 10.1038/442125a; Alegre M, 2004, CLIN NEUROPHYSIOL, V115, P124, DOI 10.1016/S1388-2457(03)00311-0; Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Barbero A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-34; Birbaumer N, 2007, CURR BIOL, V17, pR1024, DOI 10.1016/j.cub.2007.10.004; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Bos R, 2002, IEEE T INSTRUM MEAS, V51, P1289, DOI 10.1109/TIM.2002.808031; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chatterjee A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-40; Cincotti Febo, 2007, Comput Intell Neurosci, P48937, DOI 10.1155/2007/48937; Daubechies I, 1996, P IEEE, V84, P510, DOI 10.1109/5.488696; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Dipietro L, 2005, IEEE T NEUR SYS REH, V13, P325, DOI 10.1109/TNSRE.2005.850423; Fukuda O, 1998, IEEE INT CONF ROBOT, P3492, DOI 10.1109/ROBOT.1998.680978; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Hinterberger T, 2004, EXP BRAIN RES, V154, P521, DOI 10.1007/s00221-003-1690-3; Hogan N, 2006, J REHABIL RES DEV, V43, P605, DOI 10.1682/JRRD.2005.06.0103; Hoshiyama M, 1997, EXP BRAIN RES, V115, P6, DOI 10.1007/PL00005685; Hu XL, 2009, NEUROREHAB NEURAL RE, V23, P837, DOI 10.1177/1545968309338191; Koralek AC, 2012, NATURE, V483, P331, DOI 10.1038/nature10845; Krebs HI, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-6; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Leeb R, 2006, PRESENCE-TELEOP VIRT, V15, P500, DOI 10.1162/pres.15.5.500; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Murguialday AR, 2011, CLIN NEUROPHYSIOL, V122, P925, DOI 10.1016/j.clinph.2010.08.019; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Ramos-Murguialday A, 2009, P NER 09; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Steel RGD aTJ, 1960, PRINCIPLES PROCEDURE, P187; Takahashi CD, 2008, BRAIN, V131, P425, DOI 10.1093/brain/awm311; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938	35	133	133	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47048	10.1371/journal.pone.0047048	http://dx.doi.org/10.1371/journal.pone.0047048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071707	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300079
J	Reddy, PA; Bhavanishankar, M; Bhagavatula, J; Harika, K; Mahla, RS; Shivaji, S				Reddy, Patlolla Anuradha; Bhavanishankar, Maradani; Bhagavatula, Jyotsna; Harika, Katakam; Mahla, Ranjeet Singh; Shivaji, Sisinthy			Improved Methods of Carnivore Faecal Sample Preservation, DNA Extraction and Quantification for Accurate Genotyping of Wild Tigers	PLOS ONE			English	Article							COLLECTION; SUCCESS; FECES	Background: Non-invasively collected samples allow a variety of genetic studies on endangered and elusive species. However due to low amplification success and high genotyping error rates fewer samples can be identified up to the individual level. Number of PCRs needed to obtain reliable genotypes also noticeably increase. Methods: We developed a quantitative PCR assay to measure and grade amplifiable nuclear DNA in feline faecal extracts. We determined DNA degradation in experimentally aged faecal samples and tested a suite of pre-PCR protocols to considerably improve DNA retrieval. Results: Average DNA concentrations of Grade I, II and III extracts were 982pg/mu l, 9.5pg/mu l and 0.4pg/mu l respectively. Nearly 10% of extracts had no amplifiable DNA. Microsatellite PCR success and allelic dropout rates were 92% and 1.5% in Grade I, 79% and 5% in Grade II, and 54% and 16% in Grade III respectively. Our results on experimentally aged faecal samples showed that ageing has a significant effect on quantity and quality of amplifiable DNA (p<0.001). Maximum DNA degradation occurs within 3 days of exposure to direct sunlight. DNA concentrations of Day 1 samples stored by ethanol and silica methods for a month varied significantly from fresh Day 1 extracts (p<0.1 and p<0.001). This difference was not significant when samples were preserved by two-step method (p>0.05). DNA concentrations of fresh tiger and leopard faecal extracts without addition of carrier RNA were 816.5pg/mu l (+/- 115.5) and 690.1pg/mu l (+/- 207.1), while concentrations with addition of carrier RNA were 49414.5pg/mu l (+/- 9370.6) and 20982.7pg/mu l (+/- 6835.8) respectively. Conclusions: Our results indicate that carnivore faecal samples should be collected as freshly as possible, are better preserved by two-step method and should be extracted with addition of carrier RNA. We recommend quantification of template DNA as this facilitates several downstream protocols.	[Reddy, Patlolla Anuradha; Bhavanishankar, Maradani; Bhagavatula, Jyotsna; Harika, Katakam; Mahla, Ranjeet Singh; Shivaji, Sisinthy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Shivaji, S (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	shivas@ccmb.res.in	Reddy, Anuradha/U-5864-2019; Mahla, Ranjeet/J-4691-2016; Mahla, Ranjeet/J-4691-2016	Mahla, Ranjeet/0000-0002-5525-8442; Mahla, Ranjeet/0000-0002-4351-9385	Department of Biotechnology, India; Central Zoo Authority, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Central Zoo Authority, India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of IndiaCentral Zoo Authority, Government of India)	This study was funded by the Department of Biotechnology, India and the Central Zoo Authority, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Bhagavatula J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-48; Broquet T, 2007, CONSERV GENET, V8, P249, DOI 10.1007/s10592-006-9146-5; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Kishore R, 2006, J FORENSIC SCI, V51, P1055, DOI 10.1111/j.1556-4029.2006.00204.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Mondol S, 2009, BIOL CONSERV, V142, P2350, DOI 10.1016/j.biocon.2009.05.014; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murphy MA, 2002, CONSERV GENET, V3, P435, DOI 10.1023/A:1020503330767; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Piggott MP, 2004, WILDLIFE RES, V31, P485, DOI 10.1071/WR03096; Reed JZ, 1997, MOL ECOL, V6, P225, DOI 10.1046/j.1365-294X.1997.00175.x; Roeder AD, 2004, MOL ECOL NOTES, V4, P761, DOI 10.1111/j.1471-8286.2004.00737.x; Santini A, 2007, MOL ECOL NOTES, V7, P955, DOI 10.1111/j.1471-8286.2007.01829.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wasser SK, 1997, MOL ECOL, V6, P1091, DOI 10.1046/j.1365-294X.1997.00281.x	18	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46732	10.1371/journal.pone.0046732	http://dx.doi.org/10.1371/journal.pone.0046732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071624	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300056
J	Younis, RH; Cao, W; Lin, RX; Xia, RH; Liu, ZQ; Edelman, MJ; Mei, YP; Mao, L; Ren, HN				Younis, Rania H.; Cao, Wei; Lin, Ruxian; Xia, Ronghui; Liu, Zhenqiu; Edelman, Martin J.; Mei, Yuping; Mao, Li; Ren, Hening			CDC25A(Q110del): A Novel Cell Division Cycle 25A Isoform Aberrantly Expressed in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DNA-DAMAGE; CDC25A PHOSPHATASE; DIFFERENTIAL EXPRESSION; ACTIVATING PHOSPHATASES; C-MYC; CHECKPOINT; PATHWAY; PHOSPHORYLATION; PROTEOLYSIS; CARCINOMA	Objective: Lung cancer remains number one cause of cancer related deaths worldwide. Cell cycle deregulation plays a major role in the pathogenesis of Non-Small Cell Lung Cancer (NSCLC). CDC25A represents a critical cell cycle regulator that enhances cell cycle progression. In this study we aimed to investigate the role of a novel CDC25A transcriptional variant, CDC25A(Q110del), on the regulation of the CDC25A protein, and its impact on prognosis of NSCLC patients. Methodology/Principal Findings: Here we report a novel CDC25A transcript variant with codon 110 (Glutamine) deletion, that we termed CDC25A(Q110del) in NSCLC cells. In 9 (75%) of the 12 NSCLC cell lines, CDC25A(Q110del) expression accounted for more than 20% of the CDC25A transcripts. Biological effects of CDC25A(Q110del) were investigated in H1299 and HEK-293F cells using UV radiation, flowcytometry, cyclohexamide treatment, and confocal microscopy. Compared to CDC25A(wt), CDC25A(Q110del) protein had longer half-life; cells expressing CDC25A(Q110del) were more resistant to UV irradiation and showed more mitotic activity. Taqman-PCR was used to quantify CDC25A(Q110del) expression levels in 88 primary NSCLC tumor/normal tissue pairs. In patients with NSCLC, Kaplan Meier curves showed tumors expressing higher levels of CDC25A(Q110del) relative to the adjacent lung tissues to have significantly inferior overall survival (P = .0018). Significance: Here we identified CDC25A(Q110del) as a novel transcriptional variant of CDC25A in NSCLC. The sequence-specific nature of the abnormality could be a prognostic indicator in NSCLC patients as well as a candidate target for future therapeutic strategies.	[Younis, Rania H.; Lin, Ruxian; Xia, Ronghui; Mei, Yuping; Mao, Li; Ren, Hening] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Cao, Wei] Jiao Tong Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shanghai 200030, Peoples R China; [Xia, Ronghui] Shanghai Jiao Tong Univ, Sch Med, People Hosp 9, Dept Oral Pathol,Key Lab Stomatol, Shanghai 200030, Peoples R China; [Liu, Zhenqiu] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Edelman, Martin J.] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ren, HN (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	Hren@umaryland.edu	Cao, Wei/ABE-1035-2021; Edelman, Martin/HGA-7272-2022; Mao, Li/C-7570-2011	Cao, Wei/0000-0003-2184-9380; Mao, Li/0000-0001-7263-3358; Edelman, Martin/0000-0002-3752-0726; Younis, Rania/0000-0001-5781-5460	NIH [R01 CA126818, R01 CA136635]; NATIONAL CANCER INSTITUTE [R01CA136635, R01CA126818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported in part by NIH grants R01 CA126818 and R01 CA136635. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albert H, 2011, CLIN CHEM LAB MED; Alvarez M, 2007, EXPERT REV ANTICANC, V7, P1423, DOI 10.1586/14737140.7.10.1423; Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Baldi A, 1997, CLIN CANCER RES, V3, P1691; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bhawal UK, 2007, VIRCHOWS ARCH, V450, P65, DOI 10.1007/s00428-006-0327-x; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Broggini M, 2000, ANTICANCER RES, V20, P4835; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Caputi M, 2005, J CELL PHYSIOL, V205, P319, DOI 10.1002/jcp.20424; Carbone DP, 2009, CANCER PREV RES, V2, P695, DOI 10.1158/1940-6207.CAPR-09-0142; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Demidova AR, 2009, J BIOL CHEM, V284, P4132, DOI 10.1074/jbc.M808118200; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fernandez-Vidal A, 2008, ANTI-CANCER AGENT ME, V8, P825, DOI 10.2174/187152008786847684; Fotedar R, 2004, CELL CYCLE, V3, P134; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Hernandez S, 1998, CANCER RES, V58, P1762; Hernandez S, 2001, LAB INVEST, V81, P465, DOI 10.1038/labinvest.3780254; Kallstrom H, 2005, EXP CELL RES, V303, P89, DOI 10.1016/j.yexcr.2004.09.012; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157; Khaled AR, 2005, J CELL BIOL, V169, P755, DOI 10.1083/jcb.200409099; Kim AW, 2012, J THORAC CARDIOV SUR, V143, P55, DOI 10.1016/j.jtcvs.2011.09.002; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Li N, 2012, J BIOL CHEM, V287, P17386, DOI 10.1074/jbc.M111.321158; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Mori S, 2004, CANCER-AM CANCER SOC, V100, P1673, DOI 10.1002/cncr.20164; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ray D, 2007, CELL CYCLE, V6, P3039, DOI 10.4161/cc.6.24.5104; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rother K, 2007, ONCOGENE, V26, P1949, DOI 10.1038/sj.onc.1209989; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; Shreeram S, 2008, MOL CELL BIOL, V28, P7442, DOI 10.1128/MCB.00138-08; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wegener S, 2000, EUR J CELL BIOL, V79, P810, DOI 10.1078/0171-9335-00115; Wu WG, 1998, CANCER RES, V58, P4082; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu XD, 2003, CLIN CANCER RES, V9, P1764; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	44	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46464	10.1371/journal.pone.0046464	http://dx.doi.org/10.1371/journal.pone.0046464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071577	Green Submitted, gold, Green Published			2022-12-25	WOS:000309827300032
J	Wong, EWP; Lee, WM; Cheng, CY				Wong, Elissa W. P.; Lee, Will M.; Cheng, C. Yan			Secreted Frizzled-related protein 1 (sFRP1) regulates spermatid adhesion in the testis via dephosphorylation of focal adhesion kinase and the nectin-3 adhesion protein complex	FASEB JOURNAL			English	Article						spermatogenesis; seminiferous epithelial cycle; apical ectoplasmic specialization	ANCHORING JUNCTION DYNAMICS; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; WNT ANTAGONIST; ECTOPLASMIC SPECIALIZATION; TUBULOBULBAR COMPLEXES; SIGNALING PATHWAY; BARRIER DYNAMICS; BREAST-CANCER; GERM-CELLS	Development of spermatozoa in adult mammalian testis during spermatogenesis involves extensive cell migration and differentiation. Spermatogonia that reside at the basal compartment of the seminiferous epithelium differentiate into more advanced germ cell types that migrate toward the apical compartment until elongated spermatids are released into the tubule lumen during spermiation. Apical ectoplasmic specialization (ES; a testis-specific anchoring junction) is the only cell junction that anchors and maintains the polarity of elongating/elongated spermatids (step 8-19 spermatids) in the epithelium. Little is known regarding the signaling pathways that trigger the disassembly of the apical ES at spermiation. Here, we show that secreted Frizzled-related protein 1 (sFRP1), a putative tumor suppressor gene that is frequently down-regulated in multiple carcinomas, is a crucial regulatory protein for spermiation. The expression of sFRP1 is tightly regulated in adult rat testis to control spermatid adhesion and sperm release at spermiation. Downregulation of sFRP1 during testicular development was found to coincide with the onset of the first wave of spermiation at approximately age 45 d postpartum, implying that sFRP1 might be correlated with elongated spermatid adhesion conferred by the apical ES before spermiation. Indeed, administration of sFRP1 recombinant protein to the testis in vivo delayed spermiation, which was accompanied by down-regulation of phosphorylated (p)-focal adhesion kinase (FAK)-Tyr(397) and retention of nectin-3 adhesion protein at the apical ES. To further investigate the functional relationship between p-FAK-Tyr(397) and localization of nectin-3, we overexpressed sFRP1 using lentiviral vectors in the Sertoli-germ cell coculture system. Consistent with the in vivo findings, overexpression of sFRP1 induced down-regulation of p-FAK-Tyr(397), leading to a decline in phosphorylation of nectin-3. In summary, this report highlights the critical role of sFRP1 in regulating spermiation via its effects on the FAK signaling and retention of nectin-3 adhesion complex at the apical ES.-Wong, E. W. P., Lee, W. M., Cheng, C. Y. Secreted Frizzled-related protein 1 (sFRP1) regulates spermatid adhesion in the testis via dephosphorylation of focal adhesion kinase and the nectin-3 adhesion protein complex. FASEB J. 27, 464-477 (2013). www.fasebj.org	[Wong, Elissa W. P.; Cheng, C. Yan] Rockefeller Univ, Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Population Council; Rockefeller University; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009	Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health (National Institute of Child Health and Human Development) [R01-HD-056034, U54-HD-029990]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Naama Kanarek for helpful discussion on the production of lentiviral vectors. The authors also appreciate the generous gifts of gag-pol and pMD.G plasmids from Prof. Yinon Ben-Neriah and Dr. Naama Kanarek (Hebrew University of Jerusalem, Jerusalem, Israel). This work was supported by grants from the U.S. National Institutes of Health (National Institute of Child Health and Human Development, R01-HD-056034 to C.Y.C; U54-HD-029990 Project 5 to C.Y.C.).	Amin N, 2012, FRONT BIOSCI-LANDMRK, V17, P784, DOI 10.2741/3957; Aravindan GR, 1996, J CELL PHYSIOL, V168, P123; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Beardsley A, 2006, J ENDOCRINOL, V190, P759, DOI 10.1677/joe.1.06867; Berndt T, 2007, ANNU REV PHYSIOL, V69, P341, DOI 10.1146/annurev.physiol.69.040705.141729; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; BROKELMANN J, 1963, Z ZELLFORSCH MIK ANA, V59, P820, DOI 10.1007/BF00362263; BROWN WJ, 1989, METHOD CELL BIOL, V31, P553; Cheng C Yan, 2011, Spermatogenesis, V1, P291; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; CHENG CY, 1989, J BIOL CHEM, V264, P21386; Cheng CY, 2005, CONTRACEPTION, V72, P251, DOI 10.1016/j.contraception.2005.03.008; Cheshenko N, 2005, J BIOL CHEM, V280, P31116, DOI 10.1074/jbc.M503518200; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Denison FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028306; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Froment P, 2007, J ENDOCRINOL, V194, P557, DOI 10.1677/JOE-07-0258; GALDIERI M, 1981, J ANDROL, V2, P249; Galen B, 2006, J VIROL, V80, P12209, DOI 10.1128/JVI.01503-06; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Han XZ, 2004, J BIOL CHEM, V279, P2832, DOI 10.1074/jbc.M308102200; Hoang B, 1996, J BIOL CHEM, V271, P26131, DOI 10.1074/jbc.271.42.26131; Ikawa M, 2002, P NATL ACAD SCI USA, V99, P7524, DOI 10.1073/pnas.072207299; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kele J, 2012, STEM CELLS, V30, P865, DOI 10.1002/stem.1049; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Plisov SY, 2001, DEVELOPMENT, V128, P1045; Polakis P, 2012, COLD SPRING HARB PER, V4; Pole JCM, 2006, ONCOGENE, V25, P5693, DOI 10.1038/sj.onc.1209570; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; RUSSELL L, 1976, ANAT REC, V185, P259, DOI 10.1002/ar.1091850302; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; Satoh W, 2008, GENESIS, V46, P92, DOI 10.1002/dvg.20369; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Vaid KS, 2007, J CELL PHYSIOL, V210, P644, DOI 10.1002/jcp.20855; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Xia WL, 2006, J BIOL CHEM, V281, P16799, DOI 10.1074/jbc.M601618200; Xia WL, 2005, DEV BIOL, V280, P321, DOI 10.1016/j.ydbio.2004.12.036; Young J'nelle S, 2012, Spermatogenesis, V2, P63; Young JS, 2009, BIOL REPROD, V80, P162, DOI 10.1095/biolreprod.108.070623; Young JS, 2009, BIOL REPROD, V80, P153, DOI 10.1095/biolreprod.108.070615; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	73	15	15	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					464	477		10.1096/fj.12-212514	http://dx.doi.org/10.1096/fj.12-212514			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23073828	Green Published			2022-12-25	WOS:000314358000007
J	Drago, A; Giegling, I; Schafer, M; Hartmann, AM; Moller, HJ; De Ronchi, D; Stassen, HH; Serretti, A; Rujescu, D				Drago, Antonio; Giegling, Ina; Schaefer, Martin; Hartmann, Annette M.; Moeller, Hans-Juergen; De Ronchi, Diana; Stassen, Hans H.; Serretti, Alessandro; Rujescu, Dan			No Association of a Set of Candidate Genes on Haloperidol Side Effects	PLOS ONE			English	Article							TARDIVE-DYSKINESIA; GENOMEWIDE ASSOCIATION; INDUCED AKATHISIA; RATING-SCALE; SCHIZOPHRENIA; POLYMORPHISMS; CYP3A4; EFFICACY; RECEPTOR; PHARMACOGENETICS	We previously investigated a sample of patients during an active phase of psychosis in the search for genetic predictors of haloperidol induced side effects. In the present work we extend the genetic association analysis to a wider panel of genetic variations, including 508 variations located in 96 genes. The original sample included 96 patients. An independent group of 357 patients from the CATIE study served as a replication sample. Outcomes in the investigation sample were the variation through time of: 1) the ESRS and UKU total scores 2) ESRS and UKU subscales (neurologic and psychic were included) related to tremors and 3) ESRS and UKU subscales that do not relate to tremors. Outcome in the replication sample was the presence vs absence of motoric side effects from baseline to visit 1 (similar to one month of treatment) as assessed by the AIMS scale test. Rs2242480 located in the CYP3A4 was associated with a different distribution of the UKU neurologic scores through time (permutated p = 0.047) along with a trend for a different haloperidol plasma levels (lower in CC subjects). This finding was not replicated in the CATIE sample. In conclusion, we did not find conclusive evidence for a major association between the investigated variations and haloperidol induced motoric side effects	[Drago, Antonio; De Ronchi, Diana; Serretti, Alessandro] Univ Bologna, Inst Psychiat, Bologna, Italy; [Giegling, Ina; Schaefer, Martin; Hartmann, Annette M.; Moeller, Hans-Juergen; Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Stassen, Hans H.] Psychiat Univ Hosp, Zurich, Switzerland	University of Bologna; University of Munich	Serretti, A (corresponding author), Univ Bologna, Inst Psychiat, Bologna, Italy.	alessandro.serretti@unibo.it	Hartmann, Annette/AAS-6331-2021; Serretti, Alessandro/G-3955-2017; Giegling, Ina/ABA-3677-2021; Rujescu, Dan/GRS-3875-2022; Drago, Antonio/O-5763-2018	Serretti, Alessandro/0000-0003-4363-3759; Drago, Antonio/0000-0002-2529-7256	National Institute of Mental Health [N01 MH900001, MH074027, MH52618, MH058693, MH56242]; Eli Lilly and Company; NIMH grant, Project Among African Americans to Explore Risks for Schizophrenia (PAART-NERS);  [1R01MH060881-01];  [MH060881-02];  [MH060881-03];  [MH060881-04];  [MH042191];  [MH063480];  [MH061622]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060879, R01MH067257, R10MH056242, R01MH059571, R01MH059586, R01MH042191, R01MH059588, R37MH042191, R01MH059566, R01MH060870, R01MH074027, R01MH061675, R01MH058693, R01MH061622, U01MH046289, R01MH056242, U01MH046318, R01MH060881, R01MH063480, U01MH046276, R01MH059587, R01MH059565] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Eli Lilly and Company(Eli Lilly); NIMH grant, Project Among African Americans to Explore Risks for Schizophrenia (PAART-NERS); ; ; ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	For replication, data and biomaterials were collected in three projects that participated in the National Institute of Mental Health (NIMH) Schizophrenia Genetics Initiative. From 1991-97, the Principal Investigators and Co-Investigators were: Harvard University, Boston, MA, U01 MH46318, Ming T. Tsuang, M. D., Ph.D., D.Sc., Stephen Faraone, Ph.D., and John Pepple, Ph.D.; Washington University, St. Louis, MO, U01 MH46276, C. Robert Cloninger, M. D., Theodore Reich, M. D., and Dragan Svrakic, M. D.; Columbia University, New York, NY U01 MH46289, Charles Kaufmann, M. D., Dolores Malaspina, M. D., and Jill Harkavy Friedman, Ph.D. The data from the Han Chinese Schizophrenia Linkage Other participants in the US were Stephen V. Faraone, Ph.D. (Co-Principal Investigator), Shao Zhu, M. D.(Project Coordinator) and Xingjia Cui, M. D. (Project Coordinator). The project leaders in Taiwan were Hai-Gwo Hwu, M. D. (Taiwan Principal Investigator, National Taiwan University Hospital), Wei J. Chen, M. D. Sci. D. (Taiwan Co-Principal Investigator). Other participants in Taiwan were: Chih-Min Liu, M. D., Shih-Kai Liu, M. D., Ming-Hsien Shieh, M. D., Tzung-Jeng Hwang, M. D., M. P. H., Ming-Ming Tsuang, M. D., Wen Chen OuYang, M. D., Ph.D., Chun-Ying Chen, M. D., Chwen-Cheng Chen, M. D., Ph.D., Jin-Jia Lin, M. D., Frank Huang-Chih Chou, M. D., Ph.D., Ching-Mo Chueh, M. D., Wei-Ming Liu, M. D., Chiao-Chicy Chen, M. D., Jia-Jiu Lo, M. D., Jia-Fu Lee, M. D., Ph.D. Seng Shen, M. D., Yung Feng, M. D., Shin-Pin Lin, M. D, Shi-Chin Guo, M. D, Ming-Cheng Kuo, M. D., Liang-Jen Chuo, M. D., Chih-Pin Lu, M. D., Deng-Yi Chen, M. D., Huan-Kwang Ferng, M. D., Nan-Ying Chiu, M. D., Wen-Kun Chen, M. D., Tien-Cheng Lee, M. D., Hsin-Pei Tang, M. D., Yih-Dar Lee, M. D., Wu-Shih Wang, M. D., For-Wey Long, M. D., Ph.D., Tiao-Lai Huang, M. D., Jung-Kwang Wen, M. D., Cheng-Sheng Chen, M. D., Wen-Hsiang Huang, M. D., Shu-Yu Yang, M. D., Mei-Hua Hall, Cheng-Hsing Chen, M. D. The project leaders in the People's Republic of China were Xiaogang Chen, M. D., Ph.D. (China Principal Investigator, Institute of Mental Heath, Xiang-ya Teaching Hospital, Central South University), and Xingqun Ni, M. D. (Original Principal Investigator, Sun Yat-sen University). Other participants in China were: Liwen Tan, M. D., Ph.D, Liang Zhou, M. D., Ph.D, Jiajun Shi, M. D., Ph.D, Xiaoling He, M. D., Ph.D, Xiogzhao Zhu, M. D., Ph.D, Lingjian Li, M. D., Ph.D, Ming Wang, M. D., Tiansheng Guo, M. D., Xiaqi Shen, M. D., Ph.D., Jinghua Yang, M. D. ENH/Northwestern University, Evanston, IL, MH059571, Pablo V. Gejman, M. D. (Collaboration Coordinator; PI), Alan R. Sanders, M. D.; Emory University School of Medicine, Atlanta, GA, MH59587, Farooq Amin, M. D. (PI); University of California, San Francisco, CA, MH60870, William Byerley, M. D. (PI); University of Iowa, Iowa, IA, MH59566, Raymond Crowe, M. D. (PI), Donald Black, M. D.; Washington University, St. Louis, MO, U01, MH060879, C. Robert Cloninger, M. D. (PI); University of Colorado, Denver, CO, MH059565, Robert Freedman, M. D. (PI), Ann Olincy, M. D.; University of Pennsylvania, Philadelphia, PA, MH061675, Douglas Levinson, M. D. (PI), Nancy Buccola, APRN, B. C., M.S.N., New Orleans, Louisiana; University of Queensland, Queensland, Australia, MH059588, Bryan Mowry, M. D. (PI); Mt. Sinai School of Medicine, New York, NY, MH059586, Jeremy Silverman, Ph.D. (PI). The principal investigators of the CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) trial were Jeffrey A. Lieberman, M. D., T. Scott Stroup, M. D., M. P. H., and Joseph P. McEvoy, M.; D. The CATIE trial was funded by a grant from the National Institute of Mental Health (N01 MH900001) along with MH074027 (PI PF Sullivan). Genotyping was funded by Eli Lilly and Company. Portuguese island families were contributed by Dr. Carlos Pato at the University of Southern California and his staff. This work was sponsored by NIMH grants MH52618 and MH058693. The principal investigators of the schizophrenia genetics study in Latino populations were Michael Escamilla, M. D., and Alvaro Jerez, M. D. This study was supported by grants 1R01MH060881-01, MH060881-02, MH060881-03, and MH060881-04. The principal investigators of the Neurobehavioral Family Study of Schizophrenia project were Raquel Gur, M. D., Ph.D., Vishwajit Nimgaonkar, Ph.D., and Laura Almasy, Ph.D. This study was supported by grants MH042191, MH063480, and MH061622. Data and biomaterials generated in Study 29 were collected by the Molecular Genetics of Schizophrenia, part 2 (MGS2), and funded by collaborative NIMH grants to Evanston Northwestern Healthcare/Northwestern University, Evanston, IL, MH59571, Pablo V. Gejman, M. D. (Collaboration Coordinator; PI), Alan R. Sanders, M. D.; Stanford University, Palo Alto, CA, MH61675, Douglas F. Levinson M. D. (PI); Louisiana State University, New Orleans, LA, MH67257, Nancy G. Buccola APRN, B. C., M.S.N. (PI); University of Queensland, Brisbane, Queensland, Australia, MH59588, Bryan J. Mowry, M. D. (PI); University of Colorado, Denver, CO, MH59565, Robert Freedman, M. D. (PI), Ann Olincy, M. D.; Emory University School of Medicine, Atlanta, GA, MH59587, Farooq Amin, M. D. (PI); University of Iowa, Iowa, IA, MH59566, Donald W. Black, M. D. (PI), Raymond R. Crowe, M. D.; Mount Sinai School of Medicine, New York, NY, MH59586, Jeremy M. Silverman, Ph.D. (PI); University of California, San Francisco, CA, MH60870, William F. Byerley, M. D. (PI); Washington University, St. Louis, MO, MH60879, C. Robert Cloninger, M. D. (PI). Study 22 was funded by a collaborative NIMH grant, Project Among African Americans to Explore Risks for Schizophrenia (PAART-NERS). Additional investigators who contributed to this study were Robert M. Savage (University of Alabama at Birmingham), Judith O'Jile (University of Mississippi), Trina Allen (Duke University), Monica E. Calkins and Ruben C. Gur (University of Pennsylvania), Muktar H. Aliyu, M. D., Dr. P. H. (Mayo Clinic, College of Medicine, Rochester, MN), and Paul D. Lyons, M. D., Ph.D. (University of Virginia, Department of Neurology, Charlottesville, VA). Data and biomaterials used in Study 23 were collected by the University of Pittsburgh and funded by an NIMH grant (Genetic Susceptibility in Schizophrenia, MH56242) to Dr. Vishwajit Nimgaonkar, M. D., Ph.D. Additional Prinicipal Investigators on this grant include Dr. Smita Deshpande, M. D., Dr. Ram Moanohar, Lohia Hospital, New Delhi, India; and Dr. Michael Owen, M. D., Ph.D., University of Wales College of Medicine, Cardiff, UK.	Aberg K, 2010, BIOL PSYCHIAT, V67, P279, DOI 10.1016/j.biopsych.2009.08.036; Alkelai A, 2009, PSYCHOPHARMACOLOGY, V206, P491, DOI 10.1007/s00213-009-1627-z; Arranz MJ, 2008, SCHIZOPHRENIA BULL, V34, P1130, DOI 10.1093/schbul/sbn114; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Chen CH, 2011, PHARMACOGENOMICS, V12, P1397, DOI [10.2217/pgs.11.103, 10.2217/PGS.11.103]; Dolzan V, 2008, PROG NEURO-PSYCHOPH, V32, P1562, DOI 10.1016/j.pnpbp.2008.05.022; Eichhammer P, 2000, AM J MED GENET, V96, P187, DOI 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8; Fang J, 2001, DRUG METAB DISPOS, V29, P1638; Galetin A, 2002, DRUG METAB DISPOS, V30, P1512, DOI 10.1124/dmd.30.12.1512; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Gharabawi GM, 2005, SCHIZOPHR RES, V77, P119, DOI 10.1016/j.schres.2005.03.008; Ghosh C, 2011, EPILEPSIA, V52, P562, DOI 10.1111/j.1528-1167.2010.02956.x; Giegling I, 2011, PHARMACOGENET GENOM, V21, P206, DOI 10.1097/FPC.0b013e32833efb18; Giegling I, 2011, PROG NEURO-PSYCHOPH, V35, P74, DOI 10.1016/j.pnpbp.2010.08.029; Giegling I, 2010, J PSYCHIATR RES, V44, P487, DOI 10.1016/j.jpsychires.2009.11.004; Guzey C, 2007, EUR J CLIN PHARMACOL, V63, P233, DOI 10.1007/s00228-006-0234-8; He BX, 2011, BASIC CLIN PHARMACOL, V108, P208, DOI 10.1111/j.1742-7843.2010.00657.x; Jaffe AB, 2003, J CLIN PSYCHIAT, V64, P3; Kaiser R, 2002, MOL PSYCHIATR, V7, P695, DOI 10.1038/sj.mp.4001054; Kalgutkar AS, 2003, DRUG METAB DISPOS, V31, P243, DOI 10.1124/dmd.31.3.243; Kastelic M, 2010, PROG NEURO-PSYCHOPH, V34, P387, DOI 10.1016/j.pnpbp.2010.01.005; Kasten M, 2011, PSYCHOPHARMACOLOGY, V214, P729, DOI 10.1007/s00213-010-2079-1; Lencz Todd, 2009, Dialogues Clin Neurosci, V11, P405; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; Marder SR, 1998, J CLIN PSYCHIAT, V59, P21; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11; Stroup TS, 2003, SCHIZOPHRENIA BULL, V29, P15, DOI 10.1093/oxfordjournals.schbul.a006986; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Yin M, 2009, J NEUROSCI, V29, P5170, DOI 10.1523/JNEUROSCI.5569-08.2009; Zai CC, 2007, MOL PSYCHIATR, V12, P794, DOI 10.1038/sj.mp.4002023; Zhang JP, 2011, EXPERT OPIN DRUG MET, V7, P9, DOI 10.1517/17425255.2011.532787	34	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e44853	10.1371/journal.pone.0044853	http://dx.doi.org/10.1371/journal.pone.0044853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077486	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000309995100012
J	Stanton, MA; Mann, J				Stanton, Margaret A.; Mann, Janet			Early Social Networks Predict Survival in Wild Bottlenose Dolphins	PLOS ONE			English	Article							TURSIOPS SP.; REPRODUCTIVE SUCCESS; SEX-DIFFERENCES; GROUP-SIZE; SHARK BAY; STRESS; BONDS; AGGRESSION; EXPERIENCE; EVOLUTION	A fundamental question concerning group-living species is what factors influence the evolution of sociality. Although several studies link adult social bonds to fitness, social patterns and relationships are often formed early in life and are also likely to have fitness consequences, particularly in species with lengthy developmental periods, extensive social learning, and early social bond-formation. In a longitudinal study of bottlenose dolphins (Tursiops sp.), calf social network structure, specifically the metric eigenvector centrality, predicted juvenile survival in males. Additionally, male calves that died post-weaning had stronger ties to juvenile males than surviving male calves, suggesting that juvenile males impose fitness costs on their younger counterparts. Our study indicates that selection is acting on social traits early in life and highlights the need to examine the costs and benefits of social bonds during formative life history stages.	[Stanton, Margaret A.; Mann, Janet] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Stanton, Margaret A.] Georgetown Univ, Dept Anthropol, Washington, DC USA; [Mann, Janet] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Georgetown University; Georgetown University; Georgetown University	Stanton, MA (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	mastanton@gwu.edu	Mann, Janet/L-2311-2019	Mann, Janet/0000-0003-0664-175X	Explorer's Club Washington Group; Georgetown University Center For the Environment; Georgetown University Graduate School of Arts and Sciences; NSF [0941487, 0918308, 0316800, 9753044]; ONR BAA [9-001, 10230702]; Georgetown University; Brach Foundation; Eppley Foundation for Research; National Geographic Society Committee for Research and Exploration	Explorer's Club Washington Group; Georgetown University Center For the Environment; Georgetown University Graduate School of Arts and Sciences; NSF(National Science Foundation (NSF)); ONR BAA(Office of Naval Research); Georgetown University; Brach Foundation; Eppley Foundation for Research; National Geographic Society Committee for Research and Exploration(National Geographic Society)	Funding was provided by The Explorer's Club Washington Group, Georgetown University Center For the Environment, Georgetown University Graduate School of Arts and Sciences, and grants to J.M., NSF (#s 0941487, 0918308, 0316800, 9753044), ONR BAA (#09-001 grant #10230702), Georgetown University, Brach Foundation, Eppley Foundation for Research, and the National Geographic Society Committee for Research and Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillargeon S, 2007, J STAT SOFTW, V19; Barocas A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022375; Bates D., 2011, IME4 LINEAR MIXED EF; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brent LJN, 2011, PHYSIOL BEHAV, V102, P76, DOI 10.1016/j.physbeh.2010.09.022; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Connor RC, 1998, TRENDS ECOL EVOL, V13, P228, DOI 10.1016/S0169-5347(98)01326-3; Connor RC, 2000, CETACEAN SOCIETIES, P91; Connor RC, 2001, P ROY SOC B-BIOL SCI, V268, P263, DOI 10.1098/rspb.2000.1357; Connor RC, 2011, BIOL LETTERS, V7, P623, DOI 10.1098/rsbl.2010.0852; Csardi N., 2006, INT J COMP SYST, V1695, P1; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Fay MP, 2010, J STAT SOFTW, V36, P1; Frere CH, 2010, P NATL ACAD SCI USA, V107, P19949, DOI 10.1073/pnas.1007997107; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gibson QA, 2008, ANIM BEHAV, V76, P389, DOI 10.1016/j.anbehav.2008.01.022; Harvey P.H., 1987, P181; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Krause J, 2002, LIVING GROUPS; Krutzen M, 2004, MOL ECOL, V13, P1975, DOI 10.1111/j.1365-294X.2004.02192.x; Lea AJ, 2010, P NATL ACAD SCI USA, V107, P21587, DOI 10.1073/pnas.1009882107; Lehmann J, 2009, P ROY SOC B-BIOL SCI, V276, P4417, DOI 10.1098/rspb.2009.1409; LEIGH SR, 2007, PRIMATES PERSPECTIVE, P396; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann Janet, 2006, P107; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Quinn GP, 2003, EXPT DESIGN DATA ANA; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Stanton MA, 2011, ANIM BEHAV, V82, P405, DOI 10.1016/j.anbehav.2011.05.026; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; Tsai Y, 2012, MAR MAMMAL SCI, DOI [10.1111/j.1748-7692.2011.00559, DOI 10.1111/J.1748-7692.2011.00559]; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; van den Berg CL, 1999, DEV PSYCHOBIOL, V34, P129, DOI 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.3.CO;2-C; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Wasserman S., 1994, SOCIAL NETWORK ANAL; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014	50	138	139	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47508	10.1371/journal.pone.0047508	http://dx.doi.org/10.1371/journal.pone.0047508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077627	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100123
J	Sikorski, C; Luppa, M; Brahler, E; Konig, HH; Riedel-Heller, SG				Sikorski, Claudia; Luppa, Melanie; Braehler, Elmar; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Obese Children, Adults and Senior Citizens in the Eyes of the General Public: Results of a Representative Study on Stigma and Causation of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT DISCRIMINATION; SOCIAL DISTANCE; ATTITUDES; PEOPLE; OVERWEIGHT; DEPRESSION; PREJUDICE; IMPACT; MODEL	Obese individuals are blamed for their excess weight based on causal attribution to the individual. It is unclear whether obese individuals of different age groups and gender are faced with the same amount of stigmatization. This information is important in order to identify groups of individuals at risk for higher stigmatization and discrimination. A telephone interview was conducted in a representative sample of 3,003 participants. Experimental manipulation was realized by vignettes describing obese and normal-weight children, adults and senior citizens. Stigmatizing attitudes were measured by semantic differential. Causal attribution was assessed. Internal factors were rated with highest agreement rates as a cause for the vignette's obesity. Lack of activity behavior and eating too much are the most supported causes. Importance of causes differed for the different vignettes. For the child, external causes were considered more important. The overweight vignette was rated consistently more negatively. Higher educational attainment and personal obesity were associated with lower stigmatizing attitudes. The vignette of the obese child was rated more negatively compared to that of an adult or senior citizen. Obesity is seen as a controllable condition, but for children external factors are seen as well. Despite this finding, they are faced with higher stigmatizing attitudes in the general public, contradicting attribution theory assumptions. Internal and external attribution were found to be inter-correlated. Obese children are the population most at risk for being confronted with stigmatization, making them a target point in stigma-reduction campaigns.	[Sikorski, Claudia] Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Sikorski, Claudia; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Koenig, Hans-Helmut] Hamburg Eppendorf Univ, Med Ctr, Dept Med Sociol & Hlth Econ, Hamburg, Germany	Leipzig University; Leipzig University; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Sikorski, C (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany.	Claudia.Sikorski@medizin.uni-leipzig.de	Braehler, Elmar/C-6535-2009; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021; König, Hans-Helmut/P-1211-2018	Braehler, Elmar/0000-0002-2648-2728; König, Hans-Helmut/0000-0001-5711-6862	Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1988, INT J PSYCHOL, V23, P137, DOI 10.1080/00207598808247757; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Angermeyer MC, 2004, SCHIZOPHR RES, V69, P175, DOI 10.1016/S0920-9964(03)00186-5; Bacardi-Gascon M, 2007, CHILD PSYCHIAT HUM D, V38, P99, DOI 10.1007/s10578-006-0045-2; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Behr D, 2008, ROUND 4 ESS TRANSLAT; Benecke A, 2003, OVERWEIGHT OBESITY; Corrigan P, 2003, J HEALTH SOC BEHAV, V44, P162, DOI 10.2307/1519806; Corrigan PW, 2008, J PSYCHOSOC NURS MEN, V46, P42, DOI 10.3928/02793695-20080101-04; Corrigan PW, 2001, PSYCHIAT SERV, V52, P953, DOI 10.1176/appi.ps.52.7.953; CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; German Society of Nutrition (DGE), 2008, NUTR REP; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gordon-Larsen P, 2001, OBES RES, V9, P112, DOI 10.1038/oby.2001.14; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; Hebl MR, 2008, OBESITY, V16, pS46, DOI 10.1038/oby.2008.458; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Holub SC, 2011, J APPL DEV PSYCHOL, V32, P118, DOI 10.1016/j.appdev.2011.02.006; International association for the study of obesity, 2011, OB PREV WORLDW GERM; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Lewis RJ, 1997, OBES RES, V5, P297, DOI 10.1002/j.1550-8528.1997.tb00555.x; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; McClure KJ, 2011, J HEALTH COMMUN, V16, P359, DOI 10.1080/10810730.2010.535108; Oliver JE, 2005, J HEALTH POLIT POLIC, V30, P923, DOI 10.1215/03616878-30-5-923; Phelan JC, 2008, SOC SCI MED, V67, P358, DOI 10.1016/j.socscimed.2008.03.022; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Puhl RM, 2011, J SCHOOL HEALTH, V81, P696, DOI 10.1111/j.1746-1561.2011.00646.x; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2005, HEALTH PSYCHOL, V24, P517, DOI 10.1037/0278-6133.24.5.517; Rand CSW, 2000, INT J EAT DISORDER, V28, P90, DOI 10.1002/(SICI)1098-108X(200007)28:1<90::AID-EAT11>3.0.CO;2-P; Ruggs EN, 2010, OBESITY FACTS, V3, P60, DOI 10.1159/000273208; Schenk L, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P853, DOI 10.1007/s00103-006-0018-4; Schlesinger M, 2005, J HEALTH POLIT POLIC, V30, P785, DOI 10.1215/03616878-30-5-785; Schomerus G, 2009, PSYCHOL MED, V39, P1855, DOI 10.1017/S0033291709005832; Schomerus G, 2010, PSYCHIAT PRAX, V37, P111, DOI 10.1055/s-0029-1223438; Seo DC, 2006, J NATL MED ASSOC, V98, P1300; Sikorski C, 2012, SCAND J PUBLIC HEALT, V40, P271, DOI 10.1177/1403494812443604; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; StataCorp, 2019, STATA STAT SOFTWARE; Taylor P., 2006, AM SEE WEIGHT PROBLE; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Visscher TLS, 2006, OBESITY, V14, P2054, DOI 10.1038/oby.2006.240; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Zwaanswijk M, 2011, PSYCHO-ONCOLOGY, V20, P269, DOI 10.1002/pon.1721	51	61	61	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46924	10.1371/journal.pone.0046924	http://dx.doi.org/10.1371/journal.pone.0046924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	020LH	23071664	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500023
J	Aoi, MC; Hu, K; Lo, MT; Selim, M; Olufsen, MS; Novak, V				Aoi, Mikio C.; Hu, Kun; Lo, Men-Tzung; Selim, Magdy; Olufsen, Mette S.; Novak, Vera			Impaired Cerebral Autoregulation Is Associated with Brain Atrophy and Worse Functional Status in Chronic Ischemic Stroke	PLOS ONE			English	Article							PATHOLOGICAL SYMPATHETIC ACTIVATION; EMPIRICAL MODE DECOMPOSITION; SPONTANEOUS BLOOD-PRESSURE; AUTONOMIC NEURAL-CONTROL; NONLINEAR ASSESSMENT; FLOW VELOCITY; HYPERINTENSITIES; HYPERTENSION; COUNTERPOINT; REACTIVITY	Dynamic cerebral autoregulation (dCA) is impaired following stroke. However, the relationship between dCA, brain atrophy, and functional outcomes following stroke remains unclear. In this study, we aimed to determine whether impairment of dCA is associated with atrophy in specific regions or globally, thereby affecting daily functions in stroke patients. We performed a retrospective analysis of 33 subjects with chronic infarctions in the middle cerebral artery territory, and 109 age-matched non-stroke subjects. dCA was assessed via the phase relationship between arterial blood pressure and cerebral blood flow velocity. Brain tissue volumes were quantified from MRI. Functional status was assessed by gait speed, instrumental activities of daily living (IADL), modified Rankin Scale, and NIH Stroke Score. Compared to the non-stroke group, stroke subjects showed degraded dCA bilaterally, and showed gray matter atrophy in the frontal, parietal and temporal lobes ipsilateral to infarct. In stroke subjects, better dCA was associated with less temporal lobe gray matter atrophy on the infracted side (p = 0.029), faster gait speed (p = 0.018) and lower IADL score (p<0.002). Our results indicate that better dynamic cerebral perfusion regulation is associated with less atrophy and better long-term functional status in older adults with chronic ischemic infarctions.	[Novak, Vera] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02215 USA; [Aoi, Mikio C.; Olufsen, Mette S.] N Carolina State Univ, Dept Math, Biomath Program, Raleigh, NC 27695 USA; [Hu, Kun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med, Boston, MA 02215 USA; [Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarker & Translat Med, Res Ctr Adapt Data Anal, Chungli 32054, Taiwan; [Selim, Magdy] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; North Carolina State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Central University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Novak, V (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gerontol, Boston, MA 02215 USA.	vnovak@bidmc.harvard.edu	huang, yuting/T-4341-2019; Hu, Kun/AAJ-1897-2020; Olufsen, Mette/AAL-7966-2020; Hu, Kun/GVS-8580-2022; Olufsen, Mette/AAY-9760-2020	Olufsen, Mette/0000-0003-2694-0044; Olufsen, Mette/0000-0003-2694-0044; Hu, Kun/0000-0003-0350-3132; Aoi, Mikio/0000-0002-7052-880X	National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH - NINDS) [R01-NS045745, RO1 NS057127]; National Institutes of Health National Institute of Neurological Disorders and Stroke - The Small Business Technology Transfer (NIH - NINDS - STTR) [1R41NS053128-01A2]; National Institutes of Health - National Institute of Aging (NIH-NIA) [1R01-AG0287601A2, 1P30AG028717-01A2, OAIC1P30AG028717-01A2]; American Diabetes Association [1-06-CR-25]; National Science Foundation/Division of Mathematical Sciences [0616597]; Kirschstein-National Research Service Award [5 T32 AG023480 - 05]; Center for Quantitative Sciences in Biology at North Carolina State University; National Institutes of Health - The National Heart, Lung, and Blood Institute (NIH - NHLBI) [K99HL102241, NIH- R00HL102241, NIH- P30AG028717]; KL2 Medical Research Investigator Training grant of Harvard Catalyst [5 KL2 RR025757-02]; Harvard Clinical and Translational Science Center [UL1 RR 025758]; National Center for Research Resources; Clinical Research Center [MO1-RR01302]; National Science Council (NSC) (Taiwan, ROC) [100-2221-E-008-008-MY2, 100-2911-I-008-001]; Beth Israel Deaconess Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025757, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102241, R00HL102241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS053128, R01NS057127, R01NS045745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028717, T32AG023480] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH - NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health National Institute of Neurological Disorders and Stroke - The Small Business Technology Transfer (NIH - NINDS - STTR); National Institutes of Health - National Institute of Aging (NIH-NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Diabetes Association(American Diabetes Association); National Science Foundation/Division of Mathematical Sciences(National Science Foundation (NSF)); Kirschstein-National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Quantitative Sciences in Biology at North Carolina State University; National Institutes of Health - The National Heart, Lung, and Blood Institute (NIH - NHLBI); KL2 Medical Research Investigator Training grant of Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Research Center; National Science Council (NSC) (Taiwan, ROC); Beth Israel Deaconess Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by The National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH - NINDS) (www.ninds.nih.gov/) (R01-NS045745), The National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH - NINDS), The National Institutes of Health National Institute of Neurological Disorders and Stroke - The Small Business Technology Transfer (NIH - NINDS - STTR) (1R41NS053128-01A2), The National Institutes of Health - National Institute of Aging (NIH-NIA) (1R01-AG0287601A2), (1P30AG028717-01A2), American Diabetes Association (1-06-CR-25), and The National Institutes of Health - National Institute of Aging (NIH-NIA) (OAIC1P30AG028717-01A2). MCA and MSO were supported in part by the National Science Foundation/Division of Mathematical Sciences-0616597 and Kirschstein-National Research Service Award 5 T32 AG023480 - 05 grants. MCA also received support from the Center for Quantitative Sciences in Biology at North Carolina State University. KH was supported by The National Institutes of Health - The National Heart, Lung, and Blood Institute (NIH - NHLBI) K99HL102241, NIH-R00HL102241, P30AG028717, and the KL2 Medical Research Investigator Training grant (5 KL2 RR025757-02) of Harvard Catalyst, The Harvard Clinical and Translational Science Center (Award # UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). MS receives grant support from the The National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH/NINDS) (RO1 NS057127). VN and KH were also supported by Grant Number UL1 RR025758-Harvard Clinical and Translational Science Center, from the National Center for Research Resources and a Beth Israel Deaconess Medical Center, Clinical Research Center Grant (MO1-RR01302). MTL was supported by National Science Council (NSC) (Taiwan, ROC) grants 100-2221-E-008-008-MY2 and 100-2911-I-008-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alvarez FJ, 2004, J CEREBR BLOOD F MET, V24, P1267, DOI 10.1097/01.WCB.0000139370.93203.4A; Benarroch EE., 1997, CENTRAL AUTONOMIC NE; Benjamini Y, 2001, ANN STAT, V29, P1165; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Hajjar I, 2010, AM J HYPERTENS, V23, P17, DOI 10.1038/ajh.2009.187; Hanes DS, 2007, AM J GERIATR CARDIOL, V16, P175, DOI 10.1111/j.1076-7460.2007.07109.x; Hu K, 2012, PLOS COMPUT IN PRESS; Hu K, 2008, CARDIOVASC ENG, V8, P60, DOI 10.1007/s10558-007-9045-5; Hu K, 2008, PHYSICA A, V387, P2279, DOI 10.1016/j.physa.2007.11.052; Hu K, 2009, J NEUROTRAUM, V26, P227, DOI 10.1089/neu.2008.0643; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Ito T, 2002, STROKE, V33, P2297, DOI 10.1161/01.STR.0000027274.03779.F3; Klein R, 1996, ARCH INTERN MED, V156, P622, DOI 10.1001/archinte.156.6.622; Kraemer M, 2004, J NEUROIMAGING, V14, P265, DOI 10.1177/1051228404264950; Kumai Y, 2008, EXP NEUROL, V210, P441, DOI 10.1016/j.expneurol.2007.11.028; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee SH, 2010, J NEUROL NEUROSUR PS, V81, P1316, DOI 10.1136/jnnp.2009.197335; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; MAEDA H, 1993, STROKE, V24, P670, DOI 10.1161/01.STR.24.5.670; Muller M, 2012, ANN NEUROLO IN PRESS; Muslumanoglu L, 2004, ARCH PHYS MED REHAB, V85, P470, DOI 10.1016/j.apmr.2003.03.009; New DI, 2003, AM J PHYSIOL-HEART C, V284, pH1212, DOI 10.1152/ajpheart.00644.2002; Novak V, 2006, DIABETES CARE, V29, P1529, DOI 10.2337/dc06-0261; Novak V, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-39; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Novak V, 2010, STROKE, V41, P61, DOI 10.1161/STROKEAHA.109.565556; Ogoh S, 2008, STROKE, V39, P1979, DOI 10.1161/STROKEAHA.107.510008; Omboni S, 1996, CLIN AUTON RES, V6, P171, DOI 10.1007/BF02281905; Papademetriou V, 2004, J AM COLL CARDIOL, V44, P1175, DOI 10.1016/j.jacc.2004.06.034; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Pohjasvaara T, 2000, ARCH NEUROL-CHICAGO, V57, P1295, DOI 10.1001/archneur.57.9.1295; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reinhard M, 2008, CEREBROVASC DIS, V26, P147, DOI 10.1159/000139662; SANDER D, 1995, CEREBROVASC DIS, V5, P381, DOI 10.1159/000107888; Sander D, 2001, NEUROLOGY, V57, P833, DOI 10.1212/WNL.57.5.833; Sare GM, 2008, J HYPERTENS, V26, P1058, DOI 10.1097/HJH.0b013e3282fbd240; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; SIMONSON DC, 1988, DIABETES CARE, V11, P821, DOI 10.2337/diacare.11.10.821; Stebbins GT, 2008, STROKE, V39, P785, DOI 10.1161/STROKEAHA.107.507392; Strandgaard S, 2008, J APPL PHYSIOL, V105, P1366, DOI 10.1152/japplphysiol.90597.2008a; Takada J, 2006, HYPERTENS RES, V29, P621, DOI 10.1291/hypres.29.621; Theil H., 1950, INDAGATIONES MATH, V12, P173; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; TURNER RC, 1993, J HYPERTENS, V11, P309; van Lieshout JJ, 2008, J APPL PHYSIOL, V105, P1364, DOI 10.1152/japplphysiol.90597.2008; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zhao P, 2009, NEUROLOGY, V72, P643, DOI 10.1212/01.wnl.0000342473.65373.80	59	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46794	10.1371/journal.pone.0046794	http://dx.doi.org/10.1371/journal.pone.0046794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071639	Green Published, gold			2022-12-25	WOS:000309807700032
J	Price, OF; Williamson, GJ; Henderson, SB; Johnston, F; Bowman, DMJS				Price, Owen F.; Williamson, Grant J.; Henderson, Sarah B.; Johnston, Fay; Bowman, David M. J. S.			The Relationship between Particulate Pollution Levels in Australian Cities, Meteorology, and Landscape Fire Activity Detected from MODIS Hotspots	PLOS ONE			English	Article							SMOKE FORECASTING SYSTEM; AIR-POLLUTION; BUSHFIRE SMOKE; EUCALYPT FORESTS; MORTALITY; SYDNEY; VERIFICATION; PARTICLES; QUALITY; EVENTS	Smoke from bushfires is an emerging issue for fire managers because of increasing evidence for its public health effects. Development of forecasting models to predict future pollution levels based on the relationship between bushfire activity and current pollution levels would be a useful management tool. As a first step, we use daily thermal anomalies detected by the MODIS Active Fire Product (referred to as "hotspots"), pollution concentrations, and meteorological data for the years 2002 to 2008, to examine the statistical relationship between fire activity in the landscapes and pollution levels around Perth and Sydney, two large Australian cities. Resultant models were statistically significant, but differed in their goodness of fit and the distance at which the strength of the relationship was strongest. For Sydney, a univariate model for hotspot activity within 100 km explained 24% of variation in pollution levels, and the best model including atmospheric variables explained 56% of variation. For Perth, the best radius was 400 km, explaining only 7% of variation, while the model including atmospheric variables explained 31% of the variation. Pollution was higher when the atmosphere was more stable and in the presence of on-shore winds, whereas there was no effect of wind blowing from the fires toward the pollution monitors. Our analysis shows there is a good prospect for developing region-specific forecasting tools combining hotspot fire activity with meteorological data.	[Price, Owen F.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Williamson, Grant J.; Johnston, Fay; Bowman, David M. J. S.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Henderson, Sarah B.] British Columbia Ctr Dis Control, Environm Hlth Serv, Vancouver, BC, Canada; [Johnston, Fay] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	University of Wollongong; University of Tasmania; University of Tasmania; Menzies Institute for Medical Research	Price, OF (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	oprice@uow.edu.au	Williamson, Grant/J-7514-2014; Bowman, David M.J.S./A-2930-2011; Price, Owen F/H-4033-2012	Williamson, Grant/0000-0002-3469-7550; Bowman, David M.J.S./0000-0001-8075-124X; Price, Owen F/0000-0001-5327-568X; Johnston, Fay Helena/0000-0002-5150-8678	ARC (Australian Research Council) [LP0882048]; Rural Fire Service of NSW; Tasmanian Environment Fund Grant	ARC (Australian Research Council)(Australian Research Council); Rural Fire Service of NSW; Tasmanian Environment Fund Grant	This work was supported by the ARC (Australian Research Council) Linkage Grant LP0882048 (www.arc.gov.au), the Rural Fire Service of NSW, and a grant from the Tasmanian Environment Fund Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiridis V, 2010, ATMOS CHEM PHYS, V10, P11567, DOI 10.5194/acp-10-11567-2010; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Bradstock RA, 1998, J ENVIRON MANAGE, V52, P259, DOI 10.1006/jema.1997.0177; Bradstock RA, J ENV MANAG IN PRESS; Danielsen PH, 2009, MUTAT RES-GEN TOX EN, V674, P116, DOI 10.1016/j.mrgentox.2008.10.014; De Vos AJBM, 2009, ARCH ENVIRON CON TOX, V56, P380, DOI 10.1007/s00244-008-9209-3; Dennekamp M, 2011, RESPIROLOGY, V16, P198, DOI 10.1111/j.1440-1843.2010.01868.x; Donovan GH, 2007, FRONT ECOL ENVIRON, V5, P73, DOI 10.1890/1540-9295(2007)5[73:BCWYWF]2.0.CO;2; Esplin B., 2003, REPORT INQUIRY 2002; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Henderson SB, 2010, INT J WILDLAND FIRE, V19, P844, DOI 10.1071/WF09027; Henderson SB, 2008, ATMOS ENVIRON, V42, P8524, DOI 10.1016/j.atmosenv.2008.05.008; Ichoku C, 2005, IEEE T GEOSCI REMOTE, V43, P2636, DOI 10.1109/TGRS.2005.857328; Jalava PI, 2006, TOXICOL APPL PHARM, V215, P341, DOI 10.1016/j.taap.2006.03.007; Jayachandran S, 2009, J HUM RESOUR, V44, P916, DOI 10.3368/jhr.44.4.916; Johnston F, 2010, AIR QUALITY CLIMATE, V44, P17; Johnston F, 2011, ENVIRON RES, V111, P811, DOI 10.1016/j.envres.2011.05.007; Johnston FH, 2011, J AIR WASTE MANAGE, V61, P390, DOI 10.3155/1047-3289.61.4.390; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P244, DOI 10.1016/S0034-4257(02)00076-7; Keith D.A., 2004, OCEAN SHORES DESERT; Larkin NK, 2009, INT J WILDLAND FIRE, V18, P906, DOI 10.1071/WF07086; Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004; Mills G.A., 2010, ATMOSPHERIC STABILIT; Minnich RA, 1997, INT J WILDLAND FIRE, V7, P221, DOI 10.1071/WF9970221; Morgan G, 2010, EPIDEMIOLOGY, V21, P47, DOI 10.1097/EDE.0b013e3181c15d5a; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; NEHPC, 2009, REV NAT ENV PROT AMB; NEHPC, 2003, NEPC NAT ENV PROT ME; O'Neill SM, 2009, DEV ENVIRONM SCI, V8, P499, DOI 10.1016/S1474-8177(08)00022-3; Penman TD, 2007, FOREST ECOL MANAG, V252, P24, DOI 10.1016/j.foreco.2007.06.004; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Price F, 2011, INT J WILDLAND FIRE, V20, P142, DOI 10.1071/WF10016; Rolph GD, 2009, WEATHER FORECAST, V24, P361, DOI 10.1175/2008WAF2222165.1; Sapkota A, 2005, ENVIRON SCI TECHNOL, V39, P24, DOI 10.1021/es035311z; Sastry N, 2002, DEMOGRAPHY, V39, P1, DOI 10.1353/dem.2002.0009; Snider G, 2006, J FOREST, V104, P431; Stein AF, 2009, WEATHER FORECAST, V24, P379, DOI 10.1175/2008WAF2222166.1; Stoneman GL, 2007, BIOL CONSERV, V137, P558, DOI 10.1016/j.biocon.2007.03.008; Teague B., 2010, 2009 VICTORIAN BUSHF; Water NDoECCa, 2010, AIR EM INV GREAT MET; Williamson GJ, INT J WILDL IN PRESS; Wise EK, 2008, INT J WILDLAND FIRE, V17, P214, DOI 10.1071/WF06111; Wooster M.J., 2005, J GEOPHYS RES, V110; 2002, REPORT INQUIRY 2001	44	28	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47327	10.1371/journal.pone.0047327	http://dx.doi.org/10.1371/journal.pone.0047327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071788	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700075
J	Suescun-Bolivar, LP; Iglesias-Prieto, R; Thome, PE				Suescun-Bolivar, Luis P.; Iglesias-Prieto, Roberto; Thome, Patricia E.			Induction of Glycerol Synthesis and Release in Cultured Symbiodinium	PLOS ONE			English	Article							CORAL PLESIASTREA-VERSIPORA; SYMBIOTIC ALGAE; MARINE COELENTERATES; PHOTOSYNTHETIC PRODUCTS; SCLERACTINIAN CORAL; OSMOTIC-STRESS; REEF CORALS; ZOOXANTHELLAE; DINOFLAGELLATE; OSMOREGULATION	Background:Symbiotic dinoflagellates transfer a substantial amount of their photosynthetic products to their animal hosts. This amount has been estimated to represent up to 90% of the photosynthetically fixed carbon and can satisfy in some instances the full respiratory requirements of the host. Although in several cnidarian-dinoflagellate symbioses glycerol is the primary photosynthetic product translocated to the host, the mechanism for its production and release has not been demonstrated conclusively. Principal Findings: Using Symbiodinium cells in culture we were able to reproduce the synthesis and release of glycerol in vitro by employing an inductor for glycerol synthesis, osmotic up-shocks. Photosynthetic parameters and fluorescence analysis of photosystem II showed that the inductive conditions did not have a negative effect on photosynthetic performance, suggesting that the capacity for carbon fixation by the cells was not compromised. The demand for glycerol production required to attain osmotic balance increased the expression of ribulose 1,5-bisphosphate and of glycerol 3-phosphate dehydrogenase, possibly competing with the flux of fixed carbon necessary for protein synthesis. In longer exposures of cultured Symbiodinium cells to high osmolarity, the response was analogous to photoacclimation, reducing the excitation pressure over photosystem II, suggesting that Symbiodinium cells perceived the stress as an increase in light. The induced synthesis of glycerol resulted in a reduction of growth rates. Conclusions: Our results favor a hypothetical mechanism of a signaling event involving a pressure sensor that may induce the flux of carbon (glycerol) from the symbiotic algae to the animal host, and strongly suggest that carbon limitation may be a key factor modulating the population of symbionts within the host.	[Suescun-Bolivar, Luis P.; Iglesias-Prieto, Roberto; Thome, Patricia E.] Univ Nacl Autonoma Mexico, Unidad Acad Sistemas Arrecifales Puerto Morelos, Inst Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Thome, PE (corresponding author), Univ Nacl Autonoma Mexico, Unidad Acad Sistemas Arrecifales Puerto Morelos, Inst Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico.	thome@cmarl.unam.mx	Ortíz, Patricia Elena e Thomé/G-8615-2011; Bolivar, Luis Parmenio Suescun/AAG-4176-2020	Ortíz, Patricia Elena e Thomé/0000-0002-1369-3884; Bolivar, Luis Parmenio Suescun/0000-0003-0707-403X	Cannon Foundation; Consejo Nacional de Ciencia y Tecnologia, Mexico	Cannon Foundation; Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially financed by a grant from the Cannon Foundation to RI-P. LPS-B was a recipient of a M.Sc. fellowship from the Consejo Nacional de Ciencia y Tecnologia, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1984, PLANT PHYSIOL, V74, P1010, DOI 10.1104/pp.74.4.1010; AHMAD I, 1986, PLANT PHYSIOL, V82, P406, DOI 10.1104/pp.82.2.406; Ault AD, 2002, EUKARYOT CELL, V1, P174, DOI 10.1128/EC.1.2.174-180.2002; AVRON M, 1986, TRENDS BIOCHEM SCI, V11, P5, DOI 10.1016/0968-0004(86)90218-5; BATTEY JF, 1987, MAR BIOL, V95, P37, DOI 10.1007/BF00447483; BLANK RJ, 1987, MAR BIOL, V94, P143, DOI 10.1007/BF00392906; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; CHITLARU E, 1991, PLANT PHYSIOL, V96, P50, DOI 10.1104/pp.96.1.50; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Cook CB, 2001, HYDROBIOLOGIA, V461, P71, DOI 10.1023/A:1012785725378; DAVIES PS, 1984, CORAL REEFS, V2, P181; Davy SK, 2001, COMP BIOCHEM PHYS A, V129, P487, DOI 10.1016/S1095-6433(01)00285-9; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; GATES RD, 1995, P NATL ACAD SCI USA, V92, P7430, DOI 10.1073/pnas.92.16.7430; Goyal A, 2007, PLANT PHYSIOL BIOCH, V45, P696, DOI 10.1016/j.plaphy.2007.05.008; Grant AJ, 2006, COMP BIOCHEM PHYS A, V144, P458, DOI 10.1016/j.cbpa.2006.04.012; Grant AJ, 2003, COMP BIOCHEM PHYS A, V135, P337, DOI 10.1016/S1095-6433(03)00081-3; Grant AJ, 1997, MAR BIOL, V128, P665, DOI 10.1007/s002270050133; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hagedorn M, 2010, PHYSIOL BIOCHEM ZOOL, V83, P157, DOI 10.1086/648484; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; HUSIC HD, 1986, PLANT PHYSIOL, V82, P594, DOI 10.1104/pp.82.2.594; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; KREMER BP, 1980, BRIT PHYCOL J, V15, P399, DOI 10.1080/00071618000650401; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Loram JE, 2007, MOL ECOL, V16, P4849, DOI 10.1111/j.1365-294X.2007.03491.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; MUSCATINE L, 1972, MAR BIOL, V13, P298, DOI 10.1007/BF00348077; MUSCATINE L, 1992, ENVIR SCI R, V43, P257; MUSCATINE L, 1958, P NATL ACAD SCI USA, V44, P1259, DOI 10.1073/pnas.44.12.1259; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Narang SS, 2008, J BIOL CHEM, V283, P1962, DOI 10.1074/jbc.M706877200; REES TAV, 1991, P ROY SOC B-BIOL SCI, V243, P227, DOI 10.1098/rspb.1991.0036; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Reynaud-Vaganay S, 2001, PALAEOGEOGR PALAEOCL, V175, P393, DOI 10.1016/S0031-0182(01)00382-0; Ritchie RJ, 1997, AUST J PLANT PHYSIOL, V24, P283, DOI 10.1071/PP96106; Rodriguez-Roman A, 2005, MAR BIOL, V146, P1063, DOI 10.1007/s00227-004-1529-x; Rosic NN, 2010, J APPL PHYCOL, V22, P139, DOI 10.1007/s10811-009-9433-x; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; Saito H, 2001, CHEM REV, V101, P2497, DOI 10.1021/cr000243+; Sayeed WMH, 2009, BBA-BIOMEMBRANES, V1788, P1108, DOI 10.1016/j.bbamem.2009.01.010; Schaller G Eric, 2008, Arabidopsis Book, V6, pe0112, DOI 10.1199/tab.0112; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; SUTTON DC, 1990, BIOL BULL, V178, P175, DOI 10.2307/1541975; Takishita K, 2003, PROTIST, V154, P443, DOI 10.1078/143446103322454176; TRENCH RK, 1971, PROC R SOC SER B-BIO, V177, P237, DOI 10.1098/rspb.1971.0025; TRENCH RK, 1971, PROC R SOC SER B-BIO, V177, P251, DOI 10.1098/rspb.1971.0026; TRENCH RK, 1971, PROC R SOC SER B-BIO, V177, P225, DOI 10.1098/rspb.1971.0024; TRENCH RK, 1974, HELGOLAND WISS MEER, V26, P174, DOI 10.1007/BF01611382; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Withers KJT, 1998, COMP BIOCHEM PHYS A, V120, P599, DOI 10.1016/S1095-6433(98)10070-3; Yancey PH, 2010, PHYSIOL BIOCHEM ZOOL, V83, P167, DOI 10.1086/644625; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	63	23	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47182	10.1371/journal.pone.0047182	http://dx.doi.org/10.1371/journal.pone.0047182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071753	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700064
J	Conlan, S; Kong, HH; Segre, JA				Conlan, Sean; Kong, Heidi H.; Segre, Julia A.			Species-Level Analysis of DNA Sequence Data from the NIH Human Microbiome Project	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; NASAL COLONIZATION; UNITED-STATES; CARRIAGE; IDENTIFICATION; PREVALENCE	Background: Outbreaks of antibiotic-resistant bacterial infections emphasize the importance of surveillance of potentially pathogenic bacteria. Genomic sequencing of clinical microbiological specimens expands our capacity to study cultivable, fastidious and uncultivable members of the bacterial community. Herein, we compared the primary data collected by the NIH's Human Microbiome Project (HMP) with published epidemiological surveillance data of Staphylococcus aureus. Methods: The HMP's initial dataset contained microbial survey data from five body regions (skin, nares, oral cavity, gut and vagina) of 242 healthy volunteers. A significant component of the HMP dataset was deep sequencing of the 16S ribosomal RNA gene, which contains variable regions enabling taxonomic classification. Since species-level identification is essential in clinical microbiology, we built a reference database and used phylogenetic placement followed by most recent common ancestor classification to look at the species distribution for Staphylococcus, Klebsiella and Enterococcus. Main Results: We show that selecting the accurate region of the 16S rRNA gene to sequence is analogous to carefully selecting culture conditions to distinguish closely related bacterial species. Analysis of the HMP data showed that Staphylococcus aureus was present in the nares of 36% of healthy volunteers, consistent with culture-based epidemiological data. Klebsiella pneumoniae and Enterococcus faecalis were found less frequently, but across many habitats. Conclusions: This work demonstrates that large 16S rRNA survey studies can be used to support epidemiological goals in the context of an increasing awareness that microbes flourish and compete within a larger bacterial community. This study demonstrates how genomic techniques and information could be critically important to trace microbial evolution and implement hospital infection control.	[Conlan, Sean; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Kong, Heidi H.] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Segre, JA (corresponding author), NHGRI, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA.	jsegre@nhgri.nih.gov	Conlan, Sean/B-4401-2008; Kong, Heidi H/L-4856-2018	Conlan, Sean/0000-0001-6848-3465; Kong, Heidi H/0000-0003-4424-064X	National Human Genome Research Institute; Center for Cancer Research, National Cancer Institute; NIH [UH3-AR057504]; NATIONAL CANCER INSTITUTE [ZIABC010938] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Human Genome Research Institute and Center for Cancer Research, National Cancer Institute Intramural Research Programs and NIH Common Fund Human Microbiome Project grant UH3-AR057504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, COMPREHENSI IN PRESS; Arumugam M, 2011, NATURE, V474, DOI 10.1038/nature10187; Clemente JC, 2010, BIOCOMPUT-PAC SYM, P3; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hollander R, 2001, J HOSP INFECT, V48, P207, DOI 10.1053/jhin.2001.0997; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jonasson J, 2002, APMIS, V110, P263, DOI 10.1034/j.1600-0463.2002.100309.x; Kader AA, 2007, INFECT CONT HOSP EP, V28, P1114, DOI 10.1086/519865; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Matsen FA, 2011, ARXIV11095423; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Monstein HJ, 2001, FEMS MICROBIOL LETT, V199, P103, DOI 10.1111/j.1574-6968.2001.tb10658.x; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Soergel DAW, 2012, ISME J; WEGNER DL, 1992, JAMA-J AM MED ASSOC, V267, P695, DOI 10.1001/jama.267.5.695; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	28	110	115	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47075	10.1371/journal.pone.0047075	http://dx.doi.org/10.1371/journal.pone.0047075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071716	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200076
J	Huang, Y; Das, AK; Yang, QY; Zhu, MJ; Du, M				Huang, Yan; Das, Arun Kr; Yang, Qi-Yuan; Zhu, Mei-Jun; Du, Min			Zfp423 Promotes Adipogenic Differentiation of Bovine Stromal Vascular Cells	PLOS ONE			English	Article							AFFECT FEEDLOT PERFORMANCE; WEANED SIMMENTAL STEERS; AFFECTING CARCASS VALUE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; AFRICAN ANCESTRY; TARGETED CATTLE; MARBLING SCORE	Intramuscular fat or marbling is critical for the palatability of beef. In mice, very recent studies show that adipocytes and fibroblasts share a common pool of progenitor cells, with Zinc finger protein 423 (Zfp423) as a key initiator of adipogenic differentiation. To evaluate the role of Zfp423 in intramuscular adipogenesis and marbling in beef cattle, we sampled beef muscle for separation of stromal vascular cells. These cells were immortalized with pCI neo-hEST2 and individual clones were selected by G418. A total of 288 clones (3 x 96 well plates) were isolated and induced to adipogenesis. The presence of adipocytes was assessed by Oil-Red-O staining. Three clones with high and low adipogenic potential respectively were selected for further analyses. In addition, fibro/adipogenic progenitor cells were selected using a surface marker, platelet derived growth factor receptor (PDGFR) alpha. The expression of Zfp423 was much higher (307.4 +/- 61.9%, P < 0.05) in high adipogenic cells, while transforming growth factor (TGF)-beta was higher (156.1 +/- 48.7%, P < 0.05) in low adipogenic cells. Following adipogenic differentiation, the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer binding protein alpha (C/EBP alpha) were much higher (239.4 +/- 84.1% and 310.7 +/- 138.4%, respectively, P < 0.05) in high adipogenic cells. Over-expression of Zfp423 in stromal vascular cells and cloned low adipogenic cells dramatically increased their adipogenic differentiation, accompanied with the inhibition of TGF-beta expression. Zfp423 knockdown by shRNA in high adipogenic cells largely prevented their adipogenic differentiation. The differential regulation of Zfp423 and TGF-beta between low and high adipogenic cells is associated with the DNA methylation in their promoters. In conclusion, data show that Zfp423 is a critical regulator of adipogenesis in stromal vascular cells of bovine muscle, and Zfp423 may provide a molecular target for enhancing intramuscular adipogenesis and marbling in beef cattle.	[Huang, Yan; Das, Arun Kr; Yang, Qi-Yuan; Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Huang, Yan; Das, Arun Kr; Yang, Qi-Yuan; Zhu, Mei-Jun] Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Laramie, WY 82071 USA; [Zhu, Mei-Jun] Univ Wyoming, Sch Food Sci, Laramie, WY 82071 USA	Washington State University; University of Wyoming; University of Wyoming	Du, M (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	min.du@wsu.edu	Huang, Yan/C-8202-2014; Zhu, Mei-Jun/A-4248-2013; Das, Arun K/H-3867-2011; Du, Min/H-4311-2011	Huang, Yan/0000-0001-9464-6889; Das, Arun K/0000-0003-4215-6436; Du, Min/0000-0002-7232-072X	National Institutes of Health [R01HD067449]; National Institute of Food and Agriculture from the U.S. Department of Agriculture [2008-35206-18826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Food and Agriculture from the U.S. Department of Agriculture; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant R01HD067449 and National Institute of Food and Agriculture Grant 2008-35206-18826 from the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Du M, 2012, J ANIMAL SC IN PRESS; Dudziec E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032750; FOIDART M, 1981, ARCH NEUROL-CHICAGO, V38, P152, DOI 10.1001/archneur.1981.00510030046006; Garcia LG, 2008, J ANIM SCI, V86, P3533, DOI 10.2527/jas.2007-0782; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hausman GJ, 2004, J ANIM SCI, V82, P429; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1254, DOI 10.1152/ajpendo.00015.2010; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kennedy L, 2008, MATRIX BIOL, V27, P274, DOI 10.1016/j.matbio.2008.01.004; Kim JY, 2007, PHYSIOL GENOMICS, V31, P328, DOI 10.1152/physiolgenomics.00206.2006; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; McKenna DR, 2002, J ANIM SCI, V80, P1212; Miljkovic I, 2011, METAB SYNDR RELAT D, V9, P319, DOI 10.1089/met.2010.0133; Miljkovic I, 2009, J CLIN ENDOCR METAB, V94, P2735, DOI 10.1210/jc.2008-2541; Palacios VG, 2001, PROSTAG LEUKOTR ESS, V65, P215, DOI 10.1054/plef.2001.0314; Platter WJ, 2005, J ANIM SCI, V83, P890; Pyatt NA, 2005, J ANIM SCI, V83, P2926; Pyatt NA, 2005, J ANIM SCI, V83, P2918; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salvadori C, 2005, MUSCLE NERVE, V31, P192, DOI 10.1002/mus.20252; Seyoum B, 2011, BIOCHEM BIOPH RES CO, V410, P13, DOI 10.1016/j.bbrc.2011.05.073; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tu AW, 2007, J BIOL CHEM, V282, P21187, DOI 10.1074/jbc.M700085200; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wertz AE, 2002, J ANIM SCI, V80, P28; Wertz E, 2001, J ANIM SCI, V79, P1660; Wood JD, 1999, P NUTR SOC, V58, P363, DOI 10.1017/S0029665199000488; Yan X, 2012, INT J OBESI IN PRESS; Zhao JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199372	40	50	56	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47496	10.1371/journal.pone.0047496	http://dx.doi.org/10.1371/journal.pone.0047496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071815	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200120
J	Peterfreund, GL; Vandivier, LE; Sinha, R; Marozsan, AJ; Olson, WC; Zhu, J; Bushman, FD				Peterfreund, Gregory L.; Vandivier, Lee E.; Sinha, Rohini; Marozsan, Andre J.; Olson, William C.; Zhu, Jun; Bushman, Frederic D.			Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; MONOCLONAL-ANTIBODIES; TOXIN-A; INFECTION; HOST; COLONIZATION; HAMSTER; PERTURBATION; COMMUNITIES; DYNAMICS	Antibiotic disruption of the intestinal microbiota may cause susceptibility to pathogens that is resolved by progressive bacterial outgrowth and colonization. Succession is central to ecological theory but not widely documented in studies of the vertebrate microbiome. Here, we study succession in the hamster gut after treatment with antibiotics and exposure to Clostridium difficile. C. difficile infection is typically lethal in hamsters, but protection can be conferred with neutralizing antibodies against the A and B toxins. We compare treatment with neutralizing monoclonal antibodies (mAb) to treatment with vancomycin, which prolongs the lives of animals but ultimately fails to protect them from death. We carried out longitudinal deep sequencing analysis and found distinctive waves of succession associated with each form of treatment. Clindamycin sensitization prior to infection was associated with the temporary suppression of the previously dominant Bacteroidales and the fungus Saccinobaculus in favor of Proteobacteria. In mAb-treated animals, C. difficile proliferated before joining Proteobacteria in giving way to re-expanding Bacteroidales and the fungus Wickerhamomyces. However, the Bacteroidales lineages returning by day 7 were different from those that were present initially, and they persisted for the duration of the experiment. Animals treated with vancomycin showed a different set of late-stage lineages that were dominated by Proteobacteria as well as increased disparity between the tissue-associated and luminal cecal communities. The control animals showed no change in their gut microbiota. These data thus suggest different patterns of ecological succession following antibiotic treatment and C. difficile infection. Citation: Peterfreund GL, Vandivier LE, Sinha R, Marozsan AJ, Olson WC, et al. (2012) Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile. PLoS ONE 7(10): e46966. doi:10.1371/journal.pone.0046966	[Peterfreund, Gregory L.; Sinha, Rohini; Zhu, Jun; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vandivier, Lee E.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Marozsan, Andre J.; Olson, William C.] Progen Pharmaceut, Tarrytown, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Bushman, FD (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu	Zhu, Jun/A-1324-2007	Bushman, Frederic/0000-0003-4740-4056	Penn Genome Frontiers Institute; NIH [R01 AI 094424, T32 GM007170, T32 AI055400]; Progenics Pharmaceuticals, Inc.;  [UH2DK083981]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094424, T32AI055400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER	Penn Genome Frontiers Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Progenics Pharmaceuticals, Inc.; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Project UH2DK083981, the Penn Genome Frontiers Institute, and This work was supported by Project UH2DK083981, the Penn Genome Frontiers Institute, and NIH grant R01 AI 094424. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, National Institutes of Health, or Pennsylvania Department of Health. G. P. was supported by in part by NIH Grants T32 GM007170 and T32 AI055400. This study was supported by Progenics Pharmaceuticals, Inc., which has a proprietary commercial interest in the antibodies used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. grant R01 AI 094424. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources, National Institutes of Health, or Pennsylvania Department of Health. G. P. was supported by in part by NIH Grants T32 GM007170 and T32 AI055400. This study was supported by Progenics Pharmaceuticals, Inc., which has a proprietary commercial interest in the antibodies used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER JH, 1989, ISRAEL J MED SCI, V25, P206; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; ARMSTRONG TG, 1950, LANCET, V259, P10; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; BORRIELLO SP, 1990, ANN MED, V22, P61, DOI 10.3109/07853899009147244; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Burkholder PR, 1942, P NATL ACAD SCI USA, V28, P285, DOI 10.1073/pnas.28.7.285; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carman RJ, 2009, ANAEROBE, V15, P244, DOI 10.1016/j.anaerobe.2009.09.009; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Douce G, 2010, METHODS MOL BIOL, V646, P215, DOI 10.1007/978-1-60327-365-7_14; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Garner CD, 2009, INFECT IMMUN, V77, P2691, DOI 10.1128/IAI.01570-08; Goulding D, 2009, INFECT IMMUN, V77, P5478, DOI 10.1128/IAI.00551-09; Hill DA, 2009, MUCOSAL IMMUNOLOGY; Hoffmann C, 2009, INFECT IMMUNITY; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Kamboj M, 2011, CLIN INFECT DIS, V53, P1003, DOI 10.1093/cid/cir643; Kelly CP, 2011, J MED MICROBIOL, V60, P1070, DOI 10.1099/jmm.0.030015-0; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Leander BS, 2004, J EUKARYOT MICROBIOL, V51, P291, DOI 10.1111/j.1550-7408.2004.tb00569.x; Liu Z, 2008, P NATL ACAD SCI USA, V105, P9769, DOI 10.1073/pnas.0802241105; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lucado J., 2012, HEALTHCARE COST UTIL; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Marozsan AJ, 2012, J INFECT DIS; MIRELMAN D, 1987, MICROBIOL REV, V51, P272, DOI 10.1128/MMBR.51.2.272-284.1987; Na X, 2011, J CLIN GASTROENTEROL, V45, pS154, DOI 10.1097/MCG.0b013e31822ec787; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Spizek J, 2004, ADV APPL MICROBIOL, V56, P121; Steele J, 2012, J INFECT DIS, V205, P384, DOI 10.1093/infdis/jir748; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1986, J INFECT DIS, V153, P547, DOI 10.1093/infdis/153.3.547; WILSON KH, 1983, J INFECT DIS, V147, P733, DOI 10.1093/infdis/147.4.733; WILSON KH, 1985, J INFECT DIS, V151, P355, DOI 10.1093/infdis/151.2.355; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065	49	59	62	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46966	10.1371/journal.pone.0046966	http://dx.doi.org/10.1371/journal.pone.0046966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071679	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200056
J	Rossi, D; Pianta, S; Magatti, M; Sedlmayr, P; Parolini, O				Rossi, Daniele; Pianta, Stefano; Magatti, Marta; Sedlmayr, Peter; Parolini, Ornella			Characterization of the Conditioned Medium from Amniotic Membrane Cells: Prostaglandins as Key Effectors of Its Immunomodulatory Activity	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-MARROW; STROMAL CELLS; T-CELLS; PERIPHERAL-BLOOD; DENDRITIC CELLS; ADIPOSE-TISSUE; INHIBIT; DIFFERENTIATION; PLACENTA	We previously demonstrated that cells isolated from the mesenchymal region of the human amniotic membrane (human amniotic mesenchymal tissue cells, hAMTC) possess immunoregulatory roles, such as inhibition of lymphocyte proliferation and cytokine production, and suppression of generation and maturation of monocyte-derived dendritic cells, as reported for MSC from other sources. The precise factors and mechanisms responsible for the immunoregulatory roles of hAMTC remain unknown. In this study, we aimed to identify the soluble factors released by hAMTC and responsible for the anti-proliferative effect on lymphocytes, and the mechanisms underlying their actions, in vitro. Conditioned medium (CM) was prepared under routine culture conditions from hAMTC (CM-hAMTC) and also from fragments of the whole human amniotic membrane (CM-hAM). We analyzed the thermostability, chemical nature, and the molecular weight of the factors likely responsible for the anti-proliferative effects. We also evaluated the participation of cytokines known to be involved in the immunomodulatory actions of MSC from other sources, and attempted to block different synthetic pathways. We demonstrate that the inhibitory factors are temperature-stable, have a small molecular weight, and are likely of a nonproteinaceous nature. Only inhibition of cyclooxygenase pathway partially reverted the anti-proliferative effect, suggesting prostaglandins as key effector molecules. Factors previously documented to take part in the inhibitory effects of MSCs from other sources (HGF, TGF-beta, NO and IDO) were not involved. Furthermore, we prove for the first time that the anti-proliferative effect is intrinsic to the amniotic membrane and cells derived thereof, since it is manifested in the absence of stimulating culture conditions, as opposed to MSC derived from the bone marrow, which possess an anti-proliferative ability only when cultured in the presence of activating stimuli. Finally, we show that the amniotic membrane could be an interesting source of soluble factors, without referring to extensive cell preparation.	[Rossi, Daniele; Pianta, Stefano; Magatti, Marta; Parolini, Ornella] Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy; [Rossi, Daniele] Univ Milan, Doctoral Sch Mol Med, Milan, Italy; [Sedlmayr, Peter] Med Univ Graz, Ctr Mol Med, Inst Cell Biol Histol & Embryol, Graz, Austria	University of Milan; Medical University of Graz	Parolini, O (corresponding author), Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy.	ornella.parolini@tin.it	PAROLINI, ORNELLA/C-7946-2013; PAROLINI, ORNELLA/ABI-7862-2020	PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430; Pianta, Stefano/0000-0002-1758-1791; Magatti, Marta/0000-0001-7883-4679	Fondazione della Comunita Bresciana ONLUS (Fondo per una Scienza Etica); Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR [FIRB RBNE06JBCW_002]; Fondazione Cariplo [211-0495]; Fondazione Poliambulanza	Fondazione della Comunita Bresciana ONLUS (Fondo per una Scienza Etica); Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); Fondazione Poliambulanza	This study was supported in part by Fondazione della Comunita Bresciana ONLUS (Fondo per una Scienza Etica), Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR (FIRB RBNE06JBCW_002), Fondazione Cariplo (grant no 211-0495), and Fondazione Poliambulanza. These funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930; Cargnoni A, 2009, CELL TRANSPLANT, V18, P1147, DOI 10.3727/096368909X12483162196764; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Chang CJ, 2006, STEM CELLS, V24, P2466, DOI 10.1634/stemcells.2006-0071; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Deuse T, 2011, CELL TRANSPLANT, V20, P655, DOI 10.3727/096368910X536473; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Eggenhofer E, 2011, TRANSPL IMMUNOL, V25, P141, DOI 10.1016/j.trim.2011.06.002; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Hegyi B, 2012, BIOCHEM BIOPH RES CO, V419, P215, DOI 10.1016/j.bbrc.2012.01.150; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kang JW, 2012, J VET SCI, V13, P23, DOI 10.4142/jvs.2012.13.1.23; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Kronsteiner B, 2011, STEM CELLS DEV, V20, P2115, DOI 10.1089/scd.2011.0031; La Rocca G, 2009, HISTOCHEM CELL BIOL, V131, P267, DOI 10.1007/s00418-008-0519-3; Liang L, 2011, CELL TRANSPLANT, V20, P1395, DOI 10.3727/096368910X557245; Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491; Magatti M, 2012, J CELL MOL MED, V16, P2208, DOI 10.1111/j.1582-4934.2012.01531.x; Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pira GL, 2006, HUM IMMUNOL, V67, P976, DOI 10.1016/j.humimm.2006.08.298; Popp FC, 2008, TRANSPL IMMUNOL, V20, P55, DOI 10.1016/j.trim.2008.08.004; Prichard HL, 2008, STEM CELLS, V26, P2691, DOI 10.1634/stemcells.2008-0140; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Sant'Anna LB, 2011, CELL TRANSPLANT, V20, P441, DOI 10.3727/096368910X522252; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sato K, 2010, J CLIN EXP HEMATOP, V50, P79, DOI 10.3960/jslrt.50.79; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Soncini M, 2007, J TISSUE ENG REGEN M, V1, P296, DOI 10.1002/term.40; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Tolar J, 2011, HUM GENE THER, V22, P257, DOI 10.1089/hum.2011.1104; Villaron EM, 2004, HAEMATOLOGICA, V89, P1421; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	52	106	106	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46956	10.1371/journal.pone.0046956	http://dx.doi.org/10.1371/journal.pone.0046956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071674	gold, Green Published			2022-12-25	WOS:000312385200054
J	Zhao, YG; Zhao, HY; Miao, L; Wang, L; Sun, F; Zhang, H				Zhao, Yan G.; Zhao, Hongyu; Miao, Lin; Wang, Li; Sun, Fei; Zhang, Hong			The p53-induced Gene Ei24 Is an Essential Component of the Basal Autophagy Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; BREAST-CANCER; CELLS; APOPTOSIS; P62; MEMBRANE; PROTEIN; P53; MYELINATION; SUPPRESSION	Ei24 is a DNA damage response gene involved in growth suppression and apoptosis. The physiological function of Ei24, however, is poorly understood. Here we generated conditional knock-out mice of Ei24 and demonstrated that EI24 is an essential component of the basal autophagy pathway. Mice with neural-specific Ei24 deficiency develop age-dependent neurological abnormalities caused by massive axon degeneration and extensive neuron loss in brain and spinal cord. Notably, ablation of Ei24 leads to vacuolated oligodendroglial cells and demyelination of axons. Liver- specific depletion of Ei24 causes severe hepatomegaly with hepatocyte hypertrophy. Ei24 deficiency impairs autophagic flux, leading to accumulation of LC3, p62 aggregates, and ubiquitin-positive inclusions. Our study indicates that Ei24 is an essential autophagy gene and plays an important role in clearance of aggregate-prone proteins in neurons and hepatocytes.	[Zhao, Yan G.; Zhao, Hongyu; Wang, Li; Sun, Fei; Zhang, Hong] Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China; [Zhao, Yan G.; Zhao, Hongyu; Miao, Lin; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing	Zhang, H (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Biomacromol, Beijing 100101, Peoples R China.	hongzhang@sun5.ibp.ac.cn	Sun, Fei/C-4190-2015; Sun, Fei/AAR-3186-2020	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Zhao, Yan/0000-0002-4588-6752	National Basic Research Program of China [2011CB910100, 2010CB835201]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2011CB910100, 2010CB835201) (to H. Z.).	Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ichimura Y, 2011, EXP ANIM TOKYO, V60, P329, DOI 10.1538/expanim.60.329; Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lehar SM, 1996, ONCOGENE, V12, P1181; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mork CN, 2007, FEBS LETT, V581, P5440, DOI 10.1016/j.febslet.2007.10.046; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377	30	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42053	42063		10.1074/jbc.M112.415968	http://dx.doi.org/10.1074/jbc.M112.415968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074225	Green Published, hybrid			2022-12-25	WOS:000312103000044
J	Crosby, HA; Rank, KC; Rayment, I; Escalante-Semerena, JC				Crosby, Heidi A.; Rank, Katherine C.; Rayment, Ivan; Escalante-Semerena, Jorge C.			Structural Insights into the Substrate Specificity of the Rhodopseudomonas palustris Protein Acetyltransferase RpPat IDENTIFICATION OF A LOOP CRITICAL FOR RECOGNITION BY RpPat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; X-RAY-DIFFRACTION; COENZYME-A; REDUCTIVE METHYLATION; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; LYSINE RESIDUES; RNASE R; CRYSTALLIZATION; SYNTHASE	Lysine acetylation is a post-translational modification that is important for the regulation of metabolism in both prokaryotes and eukaryotes. In bacteria, the best studied protein acetyltransferase is Pat. In the purple photosynthetic bacterium Rhodopseudomonas palustris, at least 10 AMP-forming acyl-CoA synthetase enzymes are acetylated by the Pat homologue RpPat. All bona fide RpPat substrates contain the conserved motif PX(4)GK. Here, we show that the presence of such a motif is necessary but not sufficient for recognition by RpPat. RpPat failed to acetylate the methylmalonyl-CoA synthetase of this bacterium (hereafter RpMatB) in vivo and in vitro, despite the homology of RpMatB to known RpPat substrates. We used RpMatB to identify structural determinants that are recognized by RpPat. To do this, we constructed a series of RpMatB chimeras that became substrates of RpPat. In such chimeras, a short region (11-25 residues) of RpMatB located > 20 residues N-terminal to the acetylation site was replaced with the corresponding sequences from other AMP-forming acyl-CoA synthetases that were known RpPat substrates. Strikingly, the enzymatic activity of RpMatB chimeras was regulated by acetylation both in vitro and in vivo. Crystal structures of two of these chimeras showed that the major difference between them and wild-type RpMatB was within a loop region similar to 23 angstrom from the acetylation site. On the basis of these results, we suggest that RpPat likely interacts with a relatively large surface of its substrates, in addition to the PX(4)GK motif, and that RpPat probably has relatively narrow substrate specificity.	[Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Rank, Katherine C.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, 527 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	jcescala@uga.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Crosby, Heidi/0000-0002-0360-0779	National Institutes of Health [R01 GM62203, R01 GM83987]; National Institutes of Health Biotechnology Training Grant from USPHS [T32-GM08349]; National Institutes of Health Molecular Biosciences Training Grant from USPHS [T32-GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, T32GM008349, R01GM083987, R01GM062203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biotechnology Training Grant from USPHS; National Institutes of Health Molecular Biosciences Training Grant from USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM62203 (to J. C. E.-S.) and R01 GM83987 (to I. R.).; Supported by National Institutes of Health Biotechnology Training Grant T32-GM08349 from USPHS.; Supported by National Institutes of Health Molecular Biosciences Training Grant T32-GM07215 from USPHS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; D'Arcy A, 1999, ACTA CRYSTALLOGR D, V55, P1623, DOI 10.1107/S0907444999008136; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kobayashi M, 1999, ACTA CRYSTALLOGR D, V55, P931, DOI 10.1107/S0907444999002115; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurinov IV, 2003, BIOCHEM PHARMACOL, V65, P1709, DOI 10.1016/S0006-2952(03)00144-8; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCELROY HE, 1992, J CRYST GROWTH, V122, P265, DOI 10.1016/0022-0248(92)90255-H; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore D. D, 2002, CURRENT PROTOCOLS MO, P201; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; Schubot FD, 2004, ACTA CRYSTALLOGR D, V60, P1981, DOI [10.1107/S0907444904023005, 10.1107/S090744490402.1005]; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Starai VJ, 2005, J BIOL CHEM, V280, P26200, DOI 10.1074/jbc.M504863200; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687	60	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41392	41404		10.1074/jbc.M112.417360	http://dx.doi.org/10.1074/jbc.M112.417360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076154	Green Published, hybrid			2022-12-25	WOS:000311887600052
J	You, CJ; Dai, XX; Yuan, BF; Wang, YS				You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Yinsheng			Effects of 6-Thioguanine and S-6-Methylthioguanine on Transcription in Vitro and in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; DNA MISMATCH REPAIR; MUTAGENESIS CAUSES; CROSS-LINKING; CANCER; INHIBITION; OXIDATION; MECHANISM; THERAPY	Thiopurine drugs are extensively used as chemotherapeutic agents in clinical practice, even though there is concern about the risk of therapy-related cancers. It has been previously suggested that the cytotoxicity of thiopurine drugs involves their metabolic activation, the resultant generation of 6-thioguanine ((S)G) and S-6-methylthioguanine (S(6)mG) in DNA, and the futile mismatch repair triggered by replication-induced SG: T and S(6)mG: T mispairs. Disruption of transcription is known to be one of the major consequences of DNA damage induced by many antiviral and antitumor agents; however, it remains undefined how SG and S(6)mG compromise the efficiency and fidelity of transcription. Using our recently developed competitive transcription and adduct bypass assay, herein we examined the impact of SG and S(6)mG on transcription in vitro and in human cells. Our results revealed that, when situated on the transcribed strand, S(6)mG exhibited both inhibitory and mutagenic effects during transcription mediated by single-subunit T7 RNA polymerase or multisubunit human RNA polymerase II in vitro and in human cells. Moreover, we found that the impact of S(6)mG on transcriptional efficiency and fidelity is modulated by the transcription-coupled nucleotide excision repair capacity. In contrast, (S)G did not considerably compromise the efficiency or fidelity of transcription, and it was a poor substrate for NER. We propose that S(6)mG might contribute, at least in part, to thiopurine-mediated cytotoxicity through inhibition of transcription and to potential therapy-related carcinogenesis via transcriptional mutagenesis.	[You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659; You, Changjun/0000-0003-4301-2098; Dai, Xiaoxia/0000-0002-3514-5061	National Institutes of Health [R01 DK082779]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK082779.	Ang WH, 2010, J AM CHEM SOC, V132, P7429, DOI 10.1021/ja101495v; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Bregeon D, 2011, NAT REV CANCER, V11, P218, DOI 10.1038/nrc3006; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Brem R, 2012, CANCER RES, V72, P4787, DOI 10.1158/0008-5472.CAN-12-1278; Brem R, 2009, NUCLEIC ACIDS RES, V37, P1951, DOI 10.1093/nar/gkp070; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Chifotides HT, 2004, INORG CHEM, V43, P1175, DOI 10.1021/ic034438m; Chouchana L, 2012, ALIMENT PHARM THER, V35, P15, DOI 10.1111/j.1365-2036.2011.04905.x; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Derheimer FA, 2005, EUR J CANCER, V41, P2569, DOI 10.1016/j.ejca.2005.08.012; Dimitri A, 2008, NUCLEIC ACIDS RES, V36, P6459, DOI 10.1093/nar/gkn657; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Glaab WE, 1998, CARCINOGENESIS, V19, P1931, DOI 10.1093/carcin/19.11.1931; GRIFFIN S, 1994, BIOCHEMISTRY-US, V33, P4787, DOI 10.1021/bi00182a006; Gu CN, 2007, NUCLEIC ACIDS RES, V35, P3693, DOI 10.1093/nar/gkm247; Gueranger Q, 2011, NUCLEIC ACIDS RES, V39, P5057, DOI 10.1093/nar/gkr112; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; HAWN MT, 1995, CANCER RES, V55, P3721; Karran P, 2008, NAT REV CANCER, V8, P24, DOI 10.1038/nrc2292; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Koumenis C, 1997, MOL CELL BIOL, V17, P7306, DOI 10.1128/MCB.17.12.7306; Krynetski EY, 2001, MOL PHARMACOL, V59, P367, DOI 10.1124/mol.59.2.367; Kuraoka I, 2006, METHOD ENZYMOL, V408, P214, DOI 10.1016/S0076-6879(06)08013-X; Lam LT, 2001, GENOME BIOL, V2; LENNARD L, 1985, BRIT J DERMATOL, V113, P723, DOI 10.1111/j.1365-2133.1985.tb02408.x; LEPAGE GA, 1963, CANCER RES, V23, P1202; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; O'Donovan P, 2005, SCIENCE, V309, P1871, DOI 10.1126/science.1114233; Penn I, 2000, DRUG SAFETY, V23, P101, DOI 10.2165/00002018-200023020-00002; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; Ren XL, 2010, NUCLEIC ACIDS RES, V38, P1832, DOI 10.1093/nar/gkp1165; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stellrecht Christine M, 2011, Cancers (Basel), V3, P4170, DOI 10.3390/cancers3044170; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Todd RC, 2009, METALLOMICS, V1, P280, DOI 10.1039/b907567d; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang HX, 2010, ANAL CHEM, V82, P5797, DOI 10.1021/ac1008628; WARREN DJ, 1995, CANCER RES, V55, P1670; Waters TR, 1997, BIOCHEMISTRY-US, V36, P2501, DOI 10.1021/bi9621573; Yan T, 2003, CLIN CANCER RES, V9, P2327; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Yuan BF, 2008, J BIOL CHEM, V283, P23665, DOI 10.1074/jbc.M804047200; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Yuan BF, 2011, CANCER RES, V71, P1904, DOI 10.1158/0008-5472.CAN-10-3430; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Zhu GY, 2012, CANCER RES, V72, P790, DOI 10.1158/0008-5472.CAN-11-3151	55	22	22	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40915	40923		10.1074/jbc.M112.418681	http://dx.doi.org/10.1074/jbc.M112.418681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076150	Green Published, hybrid			2022-12-25	WOS:000311887600011
J	Mustafa, F; Al Amri, D; Al Ali, F; Al Sari, N; Al Suwaidi, S; Jayanth, P; Philips, PS; Rizvi, TA				Mustafa, Farah; Al Amri, Dhuha; Al Ali, Farah; Al Sari, Noor; Al Suwaidi, Sarah; Jayanth, Preethi; Philips, Pretty S.; Rizvi, Tahir A.			Sequences within Both the 5 ' UTR and Gag Are Required for Optimal In Vivo Packaging and Propagation of Mouse Mammary Tumor Virus (MMTV) Genomic RNA	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REM-RESPONSIVE ELEMENT; LEADER RNA; TRANSLATIONAL CONTROL; RETROVIRUS PARTICLES; TRANSPORT ELEMENT; CELLULAR RNAS; TYPE-1; HIV-1; ENCAPSIDATION	Background: This study mapped regions of genomic RNA (gRNA) important for packaging and propagation of mouse mammary tumor virus (MMTV). MMTV is a type B betaretrovirus which preassembles intracellularly, a phenomenon distinct from retroviruses that assemble the progeny virion at cell surface just before budding such as the type C human and feline immunodeficiency viruses (HIV and FIV). Studies of FIV and Mason-Pfizer monkey virus (MPMV), a type D betaretrovirus with similar intracellular virion assembly processes as MMTV, have shown that the 5' untranslated region (5' UTR) and 5' end of gag constitute important packaging determinants for gRNA. Methodology: Three series of MMTV transfer vectors containing incremental amounts of gag or 5' UTR sequences, or incremental amounts of 5' UTR in the presence of 400 nucleotides (nt) of gag were constructed to delineate the extent of 5' sequences that may be involved in MMTV gRNA packaging. Real time PCR measured the packaging efficiency of these vector RNAs into MMTV particles generated by co-transfection of MMTV Gag/Pol, vesicular stomatitis virus envelope glycoprotein (VSV-G Env), and individual transfer vectors into human 293T cells. Transfer vector RNA propagation was monitored by measuring transduction of target HeLaT4 cells following infection with viral particles containing a hygromycin resistance gene expression cassette on the packaged RNA. Principal Findings: MMTV requires the entire 5' UTR and a minimum of similar to 120 nucleotide (nt) at the 5' end of gag for not only efficient gRNA packaging but also propagation of MMTV-based transfer vector RNAs. Vector RNAs without the entire 5' UTR were defective for both efficient packaging and propagation into target cells. Conclusions/Significance: These results reveal that the 5' end of MMTV genome is critical for both gRNA packaging and propagation, unlike the recently delineated FIV and MPMV packaging determinants that have been shown to be of bipartite nature.	[Mustafa, Farah] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates	United Arab Emirates University	Mustafa, F (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	fmustafa@uaeu.ac.ae	Mustafa, Farah/AAI-9415-2021	Mustafa, Farah/0000-0002-1081-3756; Rizvi, Tahir A/0000-0002-2572-1678	Research Affairs at the United Arab Emirates University [02-03-8-11/06]; Terry Fox Fund for Cancer Research [2009-06]	Research Affairs at the United Arab Emirates University; Terry Fox Fund for Cancer Research	This work was supported by a grant from the Research Affairs at the United Arab Emirates University under contract #02-03-8-11/06 to FM and Terry Fox Fund for Cancer Research grant #2009-06 to TAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dhaheri NS, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-66; Al Shamsi IR, 2011, VIRUS RES, V155, P352, DOI 10.1016/j.virusres.2010.09.018; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; BERKOWITZ RD, 1995, VIROLOGY, V212, P718, DOI 10.1006/viro.1995.1530; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Browning MT, 2003, VIRUS RES, V93, P199, DOI 10.1016/S0168-1702(03)00098-4; Browning MT, 2003, J GEN VIROL, V84, P621, DOI 10.1099/vir.0.18886-0; Browning MT, 2001, J VIROL, V75, P5129, DOI 10.1128/JVI.75.11.5129-5140.2001; BUETTI E, 1983, EMBO J, V2, P1423, DOI 10.1002/j.1460-2075.1983.tb01601.x; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Coffin JM, 1996, FIELDS VIROLOGY, P1767; Cullen BR, 2005, NATURE, V433, P26, DOI 10.1038/433026a; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; Gallego J, 2003, J BIOL CHEM, V278, P40385, DOI 10.1074/jbc.M301041200; Ghazawi A, 2006, MICROBES INFECT, V8, P767, DOI 10.1016/j.micinf.2005.09.015; Giles KE, 2004, RNA, V10, P299, DOI 10.1261/rna.2150604; Greatorex J, 2002, J MOL BIOL, V322, P543, DOI 10.1016/S0022-2836(02)00776-3; Greatorex Jane, 2004, Retrovirology, V1, P22, DOI 10.1186/1742-4690-1-22; Greatorex JS, 2006, J GEN VIROL, V87, P3039, DOI 10.1099/vir.0.81658-0; Guan YJ, 2001, J VIROL, V75, P2776, DOI 10.1128/JVI.75.6.2776-2785.2001; Guan YJ, 2000, J VIROL, V74, P8854, DOI 10.1128/JVI.74.19.8854-8860.2000; GUNZBURG WH, 1986, VIROLOGY, V155, P236, DOI 10.1016/0042-6822(86)90183-2; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; Heng X, 2012, J MOL BIOL, V417, P224, DOI 10.1016/j.jmb.2012.01.033; Hohenadl C, 2012, J GEN VIROL, V93, P308, DOI 10.1099/vir.0.035196-0; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; Jaballah SA, 2010, J MOL BIOL, V401, P996, DOI 10.1016/j.jmb.2010.06.043; Johnson SF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001007; Kaye JF, 1998, J VIROL, V72, P5877, DOI 10.1128/JVI.72.7.5877-5885.1998; Kenyon JC, 2011, NUCLEIC ACIDS RES, V39, P6692, DOI 10.1093/nar/gkr252; Kenyon JC, 2008, RNA, V14, P2597, DOI 10.1261/rna.1284908; Klein R, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/683505; Lanchy JM, 2003, RNA, V9, P1007, DOI 10.1261/rna.5590603; Lever AML, 2007, ADV PHARMACOL, V55, P1, DOI 10.1016/S1054-3589(07)55001-5; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; Mallona I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-404; McBride MS, 1997, J VIROL, V71, P2050, DOI 10.1128/JVI.71.3.2050-2058.1997; Mertz JA, 2005, J VIROL, V79, P14737, DOI 10.1128/JVI.79.23.14737-14747.2005; Mertz JA, 2009, J BIOL CHEM, V284, P25642, DOI 10.1074/jbc.M109.012476; Mertz JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-10; Miyazaki Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00264; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Motomura K, 2008, J VIROL, V82, P1923, DOI 10.1128/JVI.01937-07; Mullner M, 2008, NUCLEIC ACIDS RES, V36, P6284, DOI 10.1093/nar/gkn608; Muriaux D, 2002, J VIROL, V76, P11405, DOI 10.1128/JVI.76.22.11405-11413.2002; Muriaux D, 2001, P NATL ACAD SCI USA, V98, P5246, DOI 10.1073/pnas.091000398; Mustafa F, 2005, J VIROL, V79, P13817, DOI 10.1128/JVI.79.21.13817-13821.2005; Mustafa F, 2005, MICROBES INFECT, V7, P233, DOI 10.1016/j.micinf.2004.10.015; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306; OTT DE, 1995, AIDS RES HUM RETROV, V11, P1003, DOI 10.1089/aid.1995.11.1003; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Patel J, 2003, J VIROL, V77, P6284, DOI 10.1128/JVI.77.11.6284-6292.2003; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Rizvi TA, 1996, VIROLOGY, V222, P457, DOI 10.1006/viro.1996.0444; RIZVI TA, 1993, J VIROL, V67, P2681, DOI 10.1128/JVI.67.5.2681-2688.1993; Rizvi TA, 2010, J MOL BIOL, V403, P103, DOI 10.1016/j.jmb.2010.08.019; Rizvi TA, 2009, VIROLOGY, V385, P464, DOI 10.1016/j.virol.2008.12.027; Rulli SJ, 2007, J VIROL, V81, P6623, DOI 10.1128/JVI.02833-06; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; SALMONS B, 1989, BIOCHEM BIOPH RES CO, V159, P1191, DOI 10.1016/0006-291X(89)92236-5; Schmidt RD, 2003, VIROLOGY, V309, P166, DOI 10.1016/S0042-6822(02)00101-0; SHACKLEFORD GM, 1988, P NATL ACAD SCI USA, V85, P9655, DOI 10.1073/pnas.85.24.9655; Simpson SB, 1997, J VIROL, V71, P9150, DOI 10.1128/JVI.71.12.9150-9156.1997; Strappe PM, 2003, J GEN VIROL, V84, P2423, DOI 10.1099/vir.0.19185-0; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Whitney JB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-96; Yin PD, 1997, J VIROL, V71, P6237, DOI 10.1128/JVI.71.8.6237-6242.1997	74	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47088	10.1371/journal.pone.0047088	http://dx.doi.org/10.1371/journal.pone.0047088			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077548	gold, Green Published			2022-12-25	WOS:000310135800021
J	Sundararaj, S; Singh, D; Saxena, AK; Vashisht, K; Sijwali, PS; Dixit, R; Pandey, KC				Sundararaj, Srinivasan; Singh, Deepak; Saxena, Ajay K.; Vashisht, Kapil; Sijwali, Puran S.; Dixit, Rajnikant; Pandey, Kailash C.			The Ionic and Hydrophobic Interactions Are Required for the Auto Activation of Cysteine Proteases of Plasmodium falciparum	PLOS ONE			English	Article							HUMAN PROCATHEPSIN-B; CATHEPSIN-B; PROTEIN STRUCTURES; MALARIA PARASITES; STRUCTURAL BASIS; INHIBITION; HEMOGLOBIN; PROPEPTIDE; BIOSYNTHESIS; ZYMOGEN	The Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3 are major hemoglobinases and potential antimalarial drug targets. Our previous studies demonstrated that these enzymes are equipped with specific domains for specific functions. Structural and functional analysis of falcipains showed that they have unique domains including a refolding domain and a hemoglobin binding domain. As with many proteases, falcipain-2 and falcipain-3 are synthesized as inactive zymogens. However, it is not known how these enzymes get activated for hemoglobin hydrolysis. In this study, we are presenting the first evidence that salt bridges and hydrophobic interactions are required for the auto activation of cysteine proteases of P. falciparum. To investigate the mechanism of activation of these enzymes, we expressed the wild type protein as well as different mutants in E. coli. Refolding was assessed by circular dichroism. Both CD and trans activation data showed that the wild type enzymes and mutants are rich in secondary structures with similar folds. Our study revealed that prodomain-mature domain of falcipain-2 and falcipain-3 interacts via salt bridges and hydrophobic interactions. We mutated specific residues of falcipain-2 and falcipain-3, and evaluated their ability to undergo auto processing. Mutagenesis result showed that two salt bridges (Arg(185)-Glu(221), Glu(210)-Lys(403)) in falcipain-2, and one salt bridge (Arg(202)-Glu(238)) in falcipain-3, play crucial roles in the activation of these enzymes. Further study revealed that hydrophobic interactions present both in falcipain-2 (Phe(214), Trp(449) Trp(453)) and falcipain-3 (Phe(231) Trp(457) Trp(461)) also play important roles in the activation of these enzymes. Our results revealed the interactions involved in auto processing of two major hemoglobinases of malaria parasite.	[Sundararaj, Srinivasan; Singh, Deepak; Vashisht, Kapil; Dixit, Rajnikant; Pandey, Kailash C.] Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India; [Saxena, Ajay K.] Jawaharlal Nehru Univ, Sch Life Sci, Struct Biol Lab, New Delhi 110067, India; [Sijwali, Puran S.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Pandey, KC (corresponding author), Indian Council Med Res, Natl Inst Malaria Res, Host Parasite Interact Biol Grp, New Delhi, India.	kailashcp@mrcindia.org	Dixit, Rajnikant/D-2566-2009; vashisht, kapil/ABB-3966-2020; Sundararaj, Srinivasan/AAF-6809-2019	Dixit, Rajnikant/0000-0002-3536-8329; sundararaj, Srinivasan/0000-0002-9112-2454	Department of Biotechnology, Government of India; Ramalingaswami Fellowship	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ramalingaswami Fellowship	Work in the laboratory is supported by Department of Biotechnology, Government of India. KCP is a recipient of a Ramalingaswami Fellowship. The authors thank NIMR for extramural funds for setting a new laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Dahl EL, 2005, MOL BIOCHEM PARASIT, V139, P205, DOI 10.1016/j.molbiopara.2004.11.009; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FOX T, 1992, BIOCHEMISTRY-US, V31, P12571, DOI 10.1021/bi00165a005; Groves MR, 1998, PROTEINS, V32, P504, DOI 10.1002/(SICI)1097-0134(19980901)32:4<504::AID-PROT8>3.0.CO;2-F; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; KOMINAMI E, 1988, FEBS LETT, V231, P225, DOI 10.1016/0014-5793(88)80736-1; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V262, P159, DOI 10.1016/0003-9861(88)90178-6; Pandey KC, 2006, PLOS PATHOG, V2, P1031, DOI 10.1371/journal.ppat.0020117; Pandey KC, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/345195; Pandey KC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005694; Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102; Pandey KC, 2004, J BIOL CHEM, V279, P3484, DOI 10.1074/jbc.M310536200; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200; Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; WHO, 2008, WHO WORLD MAL REP; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47227	10.1371/journal.pone.0047227	http://dx.doi.org/10.1371/journal.pone.0047227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077573	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800033
J	Chopra, A; Patel, A; Shieh, AC; Janmey, PA; Kresh, JY				Chopra, Anant; Patel, Akash; Shieh, Adrian C.; Janmey, Paul A.; Kresh, J. Yasha			alpha-Catenin Localization and Sarcomere Self-Organization on N-Cadherin Adhesive Patterns Are Myocyte Contractility Driven	PLOS ONE			English	Article							CELL-CELL ADHESION; CARDIAC MYOCYTES; TRACTIONAL FORCES; COMPLEX; ACTIN; SHAPE; EXTENSION; DYNAMICS; CONTACTS; TENSION	The N-cadherin (N-cad) complex plays a crucial role in cardiac cell structure and function. Cadherins are adhesion proteins linking adjacent cardiac cells and, like integrin adhesions, are sensitive to force transmission. Forces through these adhesions are capable of eliciting structural and functional changes in myocytes. Compared to integrins, the mechanisms of force transduction through cadherins are less explored. alpha-catenin is a major component of the cadherin-catenin complex, thought to provide a link to the cell actin cytoskeleton. Using N-cad micropatterned substrates in an adhesion constrainment model, the results from this study show that alpha-catenin localizes to regions of highest internal stress in myocytes. This localization suggests that alpha-catenin acts as an adaptor protein associated with the cadherin mechanosensory apparatus, which is distinct from mechanosensing through integrins. Myosin inhibition in cells bound by integrins to fibronectin-coated patterns disrupts myofibiril organization, whereas on N-cad coated patterns, myosin inhibition leads to better organized myofibrils. This result indicates that the two adhesion systems provide independent mechanisms for regulating myocyte structural organization.	[Janmey, Paul A.; Kresh, J. Yasha] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA; [Chopra, Anant; Patel, Akash; Kresh, J. Yasha] Drexel Univ, Coll Med, Dept Cardiothorac Surg, Philadelphia, PA 19104 USA; [Chopra, Anant; Shieh, Adrian C.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Drexel University; Drexel University	Janmey, PA (corresponding author), Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.	janmey@mail.med.upenn.edu; jkresh@drexelmed.edu		Shieh, Adrian/0000-0001-9569-361X	National Institute of Health from the National Institute of General Medical Sciences [GM083272]; Joseph Di Palma Heart Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083272] Funding Source: NIH RePORTER	National Institute of Health from the National Institute of General Medical Sciences; Joseph Di Palma Heart Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by Grants from the National Institute of Health GM083272, from the National Institute of General Medical Sciences and the Joseph Di Palma Heart Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1994, J CELL SCI, V107, P3655; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Borghi N, 2010, P NATL ACAD SCI USA, V107, P13324, DOI 10.1073/pnas.1002662107; Bray MA, 2008, CELL MOTIL CYTOSKEL, V65, P641, DOI 10.1002/cm.20290; Chandran PL, 2009, CELL MOL BIOENG, V2, P13, DOI 10.1007/s12195-009-0044-z; Chopra A, 2011, AM J PHYSIOL-HEART C, V300, pH1252, DOI 10.1152/ajpheart.00515.2010; Deshpande VS, 2006, P NATL ACAD SCI USA, V103, P14015, DOI 10.1073/pnas.0605837103; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; GONCHAROVA EJ, 1992, DEVELOPMENT, V114, P173; Grosberg A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001088; IMANAKAYOSHIDA K, 1993, CELL MOTIL CYTOSKEL, V26, P301, DOI 10.1002/cm.970260405; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Koslov ER, 1997, J BIOL CHEM, V272, P27301, DOI 10.1074/jbc.272.43.27301; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1; Li J, 2006, CLIN MED RES, V4, P42, DOI 10.3121/cmr.4.1.42; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; SINCLAIR GB, 1984, INT J MECH SCI, V26, P477, DOI 10.1016/0020-7403(84)90002-X; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Tseng QZ, 2011, LAB CHIP, V11, P2231, DOI 10.1039/c0lc00641f; Uda Y, 2011, BIOCHEM BIOPH RES CO, V415, P396, DOI 10.1016/j.bbrc.2011.10.080; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zemljic-Harpf A, 2009, J INVEST MED, V57, P849, DOI 10.2310/JIM.0b013e3181c5e074	36	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47592	10.1371/journal.pone.0047592	http://dx.doi.org/10.1371/journal.pone.0047592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077648	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100143
J	Gwak, HS; Kim, TH; Jo, GH; Kim, YJ; Kwak, HJ; Kim, JH; Yin, J; Yoo, H; Lee, SH; Park, JB				Gwak, Ho-Shin; Kim, Tae Hoon; Jo, Guk Heui; Kim, Youn-Jae; Kwak, Hee-Jin; Kim, Jong Heon; Yin, Jinlong; Yoo, Heon; Lee, Seung Hoon; Park, Jong Bae			Silencing of MicroRNA-21 Confers Radio-Sensitivity through Inhibition of the PI3K/AKT Pathway and Enhancing Autophagy in Malignant Glioma Cell Lines	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA CELLS; RADIATION-INDUCED APOPTOSIS; TUMOR-SUPPRESSOR PDCD4; IONIZING-RADIATION; DNA-DAMAGE; IN-VIVO; POSTMITOTIC APOPTOSIS; PREMITOTIC APOPTOSIS; SIGNALING PATHWAYS; GENE RESPONSES	Radiation is a core part of therapy for malignant glioma and is often provided following debulking surgery. However, resistance to radiation occurs in most patients, and the underlying molecular mechanisms of radio-resistance are not fully understood. Here, we demonstrated that microRNA 21 (miR-21), a well-known onco-microRNA in malignant glioma, is one of the major players in radio-resistance. Radio-resistance in different malignant glioma cell lines measured by cytotoxic cell survival assay was closely associated with miR-21 expression level. Blocking miR-21 with anti-miR-21 resulted in radio-sensitization of U373 and U87 cells, whereas overexpression of miR-21 lead to a decrease in radio-sensitivity of LN18 and LN428 cells. Anti-miR-21 sustained gamma-H2AX DNA foci formation, which is an indicator of double-strand DNA damage, up to 24 hours and suppressed phospho-Akt (ser473) expression after exposure to c-irradiation. In a cell cycle analysis, a significant increase in the G(2)/M phase transition by anti-miR-21 was observed at 48 hours after irradiation. Interestingly, our results showed that anti-miR-21 increased factors associated with autophagosome formation and autophagy activity, which was measured by acid vesicular organelles, LC3 protein expression, and the percentage of GFP-LC3 positive cells. Furthermore, augmented autophagy by anti-miR-21 resulted in an increase in the apoptotic population after irradiation. Our results show that miR-21 is a pivotal molecule for circumventing radiation-induced cell death in malignant glioma cells through the regulation of autophagy and provide a novel phenomenon for the acquisition of radio-resistance.	[Gwak, Ho-Shin; Kim, Tae Hoon; Jo, Guk Heui; Kim, Youn-Jae; Kwak, Hee-Jin; Yin, Jinlong; Yoo, Heon; Lee, Seung Hoon; Park, Jong Bae] Natl Canc Ctr, Res Inst & Hosp, Specif Organs Canc Branch, Goyang, South Korea; [Kim, Jong Heon] Natl Canc Ctr, Res Inst & Hosp, Canc Cell & Mol Biol Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Park, JB (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Specif Organs Canc Branch, Goyang, South Korea.	jbp@ncc.re.kr			National Cancer Center Grant of South Korea [1010171, 1010172, 1110110, 1210043-1, 1210320-1, 1210042-1]; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0089971]; Korea Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea [A110878]; National Research Foundation Grant of South Korea [2012-0008362]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [1230920-1]	National Cancer Center Grant of South Korea; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation Grant of South Korea(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Jong Bae Park was supported by the National Cancer Center Grant (1010171 and 1010172) of South Korea; Ho-Shin Gwak was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2009-0089971); Jinlong Yin was supported by a grant of the Korea Health Technology R&D project, Ministry of Health & Welfare, Republic of Korea (A110878); Jong Heon Kim was supported by the National Cancer Center Grant (1110110) and the National Research Foundation Grant (2012-0008362) of South Korea; Youn-Jae Kim was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (1230920-1); Heon Yoo was supported by the National Cancer Center Grant (1210043-1) of South Korea; Seung Hoon Lee was supported by the National Cancer Center Grant (1210320-1 and 1210042-1) of South Korea. EJB(SEPT23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, no additional external funding was received for this study.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Azzam EI, 2003, CANCER RES, V63, P7128; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; Grana TM, 2002, CANCER RES, V62, P4142; Gupta AK, 2001, CANCER RES, V61, P4278; Gupta AK, 2002, CLIN CANCER RES, V8, P885; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Ito H, 2005, INT J ONCOL, V26, P1401; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Khodarev NN, 2001, P NATL ACAD SCI USA, V98, P12665, DOI 10.1073/pnas.211443698; Koul D, 2010, NEURO-ONCOLOGY, V12, P559, DOI 10.1093/neuonc/nop058; Kumaraswamy S, 2008, CANCER RES, V68, P3819, DOI 10.1158/0008-5472.CAN-08-0016; Kwak HJ, 2011, ONCOGENE; Lee CM, 2006, CLIN CANCER RES, V12, P250, DOI 10.1158/1078-0432.CCR-05-1084; Li B, 2004, ONCOGENE, V23, P4594, DOI 10.1038/sj.onc.1207602; Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Luo S, 2007, CELL DEATH DIFFER, V14, P1247, DOI 10.1038/sj.cdd.4402149; Martin LM, 2010, CANC TREAT REV; Nelson DA, 2004, GENE DEV, V18, P1223, DOI 10.1101/gad.1212404; Ning SC, 1999, RADIAT RES, V151, P659, DOI 10.2307/3580204; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Otomo T, 2004, J RADIAT RES, V45, P53, DOI 10.1269/jrr.45.53; Paglin S, 2001, CANCER RES, V61, P439; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Ren Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-27; Rhee CH, 1999, ONCOGENE, V18, P2711, DOI 10.1038/sj.onc.1202623; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosenzweig KE, 1997, CLIN CANCER RES, V3, P1149; Shinomiya N, 2000, INT J RADIAT ONCOL, V47, P767, DOI 10.1016/S0360-3016(99)00517-9; Shinomiya N, 2001, J CELL MOL MED, V5, P240, DOI 10.1111/j.1582-4934.2001.tb00158.x; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yao KC, 2003, J NEUROSURG, V98, P378, DOI 10.3171/jns.2003.98.2.0378; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang Chun-zhi, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P634, DOI [10.3760/cma.j.issn.1003-9406.2009.06.007, 10.3760/cma.j.issn.1003-9406.2009.06.006]; Zhou X, LAB INVEST, V90, P144; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	60	117	132	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47449	10.1371/journal.pone.0047449	http://dx.doi.org/10.1371/journal.pone.0047449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077620	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100116
J	Katzov-Eckert, H; Botosso, VF; Neto, EA; Zanotto, PMDA				Katzov-Eckert, Hagit; Botosso, Viviane F.; Neto, Eurico Arruda; de Andrade Zanotto, Paolo Marinho		VGND Consortium	Phylodynamics and Dispersal of HRSV Entails Its Permanence in the General Population in between Yearly Outbreaks in Children	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; RIO-DE-JANEIRO; GENETIC-VARIABILITY; SUBGROUP-A; MOLECULAR EPIDEMIOLOGY; G-PROTEIN; G-GLYCOPROTEIN; ANTIGENIC CHARACTERIZATION; TRANSMISSION DYNAMICS; PHYLOGENETIC ANALYSIS	Background: Human respiratory syncytial virus (HRSV) is one of the major etiologic agents of respiratory tract infections among children worldwide. Methodology/Principal Findings: Here through a comprehensive analysis of the two major HRSV groups A and B (n = 1983) which comprise of several genotypes, we present a complex pattern of population dynamics of HRSV over a time period of 50 years (1956-2006). Circulation pattern of HRSV revealed a series of expansions and fluctuations of co-circulating lineages with a predominance of HRSVA. Positively selected amino acid substitutions of the G glycoprotein occurred upon population growth of GB3 with a 60-nucleotide insertion (GB3 Insert), while other genotypes acquired substitutions upon both population growth and decrease, thus possibly reflecting a role for immune selected epitopes in linkage to the traced substitution sites that may have important relevance for vaccine design. Analysis evidenced the co-circulation and predominance of distinct HRSV genotypes in Brazil and suggested a year-round presence of the virus. In Brazil, GA2 and GA5 were the main culprits of HRSV outbreaks until recently, when the GB3 Insert became highly prevalent. Using Bayesian methods, we determined the dispersal patterns of genotypes through several inferred migratory routes. Conclusions/Significance: Genotypes spread across continents and between neighboring areas. Crucially, genotypes also remained at any given region for extended periods, independent of seasonal outbreaks possibly maintained by re-infecting the general population.	[Katzov-Eckert, Hagit; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Biomed Sci Inst ICB 2, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil; [Neto, Eurico Arruda] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cell Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Zanotto, PMDA (corresponding author), Univ Sao Paulo, Biomed Sci Inst ICB 2, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.	pzanotto@usp.br	Arruda, Eurico/E-4101-2012; Botosso, Viviane/I-5591-2014; Moraes, Claudia/K-4708-2016; Campos, Angélica Cristine Almeida/Z-6089-2019; de Freitas Oliveira, Carmem Aparecida/A-8969-2015; Oliveira, Danielle BL/H-8030-2015; Schvartsman, Claudio/M-8706-2015; de A. Zanotto, Paolo M./B-9286-2019; Proenca-Modena, Jose Luiz/C-8231-2014; Passos, Saulo/C-5166-2012	Botosso, Viviane/0000-0002-7876-3687; Moraes, Claudia/0000-0001-6782-4790; Campos, Angélica Cristine Almeida/0000-0003-0425-7498; de Freitas Oliveira, Carmem Aparecida/0000-0002-3392-7617; Oliveira, Danielle BL/0000-0002-3452-1336; Schvartsman, Claudio/0000-0001-5695-9331; de A. Zanotto, Paolo M./0000-0002-8167-0625; Proenca-Modena, Jose Luiz/0000-0002-4996-3153; Passos, Saulo/0000-0002-0908-2677; Durigon, Edison/0000-0003-4898-6553; Oliveira, Danielle/0000-0002-0534-0886; vieira, sandra/0000-0001-5100-8713; /0000-0002-9608-5736	FAPESP [Nu 00/4205-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work is part of the Viral Genetic Diversity Program (VGDN), funded by FAPESP under project Nu 00/4205-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AS, 2009, J CLIN VIROL, V45, P358, DOI 10.1016/j.jcv.2009.05.013; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Arbiza J, 2005, MEM I OSWALDO CRUZ, V100, P221, DOI 10.1590/S0074-02762005000300001; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Breugelmans JG, 2004, EMERG INFECT DIS, V10, P1502, DOI 10.3201/eid1008.040093; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Calegari Tatiany, 2005, Braz J Infect Dis, V9, P156, DOI 10.1590/S1413-86702005000200006; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; CANE PA, 1992, VIRUS RES, V25, P15, DOI 10.1016/0168-1702(92)90096-R; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; CANE PA, 1991, J GEN VIROL, V72, P349, DOI 10.1099/0022-1317-72-2-349; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Cardoso AM, 2010, CAD SAUDE PUBLICA, V26, P1270, DOI 10.1590/S0102-311X2010000700001; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Collins PL, 2007, FIELDS VIROLOGY, P1601; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fauquet C.M., 1999, 8 INT COMM TAX VIR, P1730, DOI 10.1006/rwvi.1999.0277; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Frabasile S, 2003, J MED VIROL, V71, P305, DOI 10.1002/jmv.10484; GARCIA O, 1994, J VIROL, V68, P5448; GARCIABARRENO B, 1990, EMBO J, V9, P4181, DOI 10.1002/j.1460-2075.1990.tb07642.x; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; Gillespie JH, 2000, GENETICS, V155, P909; Girard MP, 2005, VACCINE, V23, P5708, DOI 10.1016/j.vaccine.2005.07.046; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gushulak B, 2007, J TRAVEL MED, V14, P205, DOI 10.1111/j.1708-8305.2007.00128.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Kamasaki H, 2001, ARCH VIROL, V146, P457, DOI 10.1007/s007050170155; Li HY, 2004, J VIROL, V78, P10582, DOI 10.1128/JVI.78.19.10582-10587.2004; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; Matheson JW, 2006, J MED VIROL, V78, P1354, DOI 10.1002/jmv.20702; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; Meyerson NR, 2011, TRENDS MICROBIOL, V19, P286, DOI 10.1016/j.tim.2011.03.006; Michalski A, 2008, NZ EU APPROACHES SOC; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Moura FEA, 2004, J MED VIROL, V74, P156, DOI 10.1002/jmv.20159; Moura PO, 2007, J MED VIROL, V79, P174, DOI 10.1002/jmv.20778; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; NASCIMENTO JP, 1991, REV I MED TROP, V33, P287, DOI 10.1590/S0036-46651991000400008; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Oliveira DBL, 2009, J MED VIROL, V81, P915, DOI 10.1002/jmv.21436; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Ostlund MR, 2008, J MED VIROL, V80, P159, DOI 10.1002/jmv.21066; Page R.D.M., 1998, MOL EVOLUTION PHYLOG; Parveen S, 2006, J MED VIROL, V78, P659, DOI 10.1002/jmv.20590; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Raboni SM, 2003, TRANSPLANTATION, V76, P142, DOI 10.1097/01.TP.0000072012.26176.58; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Seki K, 2001, J MED VIROL, V64, P374, DOI 10.1002/jmv.1061; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SIQUEIRA MM, 1991, J CLIN MICROBIOL, V29, P557, DOI 10.1128/JCM.29.3.557-559.1991; Sole R, 2000, SIGNS LIFE COMPLEXIT; Spann KM, 2003, J VIROL, V77, P11201, DOI 10.1128/JVI.77.20.11201-11211.2003; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; TAYLOR CE, 1989, LANCET, V1, P777; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Vieira Sandra E., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P125, DOI 10.1590/S0036-46652001000300002; Weber A, 2001, MATH BIOSCI, V172, P95, DOI 10.1016/S0025-5564(01)00066-9; WERTZ GW, 1985, P NATL ACAD SCI USA, V82, P4075, DOI 10.1073/pnas.82.12.4075; White LJ, 2007, MATH BIOSCI, V209, P222, DOI 10.1016/j.mbs.2006.08.018; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zheng HQ, 1999, VIRUS RES, V59, P89, DOI 10.1016/S0168-1702(98)00132-4; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	91	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e41953	10.1371/journal.pone.0041953	http://dx.doi.org/10.1371/journal.pone.0041953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077477	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100005
J	Kraus, L; Trautewig, B; Klempnauer, J; Lieke, T				Kraus, Lilli; Trautewig, Britta; Klempnauer, Juergen; Lieke, Thorsten			Naive Rat NK Cells Control the Onset of T Cell Response	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ALLOGRAFT-REJECTION; 2 COMPLEMENTARY; SUBSETS; PROLIFERATION; ACTIVATION; EXPRESSION; RECEPTORS; MODEL; RESPONSIVENESS	NK cell function in the rat is only defined in a rudimentary way due to missing tools for clear NK cell identification. The present study introduces the congenic LEW.BH-NKC rat strain which allows distinct detection of rat NK cells using commercial antibodies. LEW.BH-NKC rats were exposed in vivo to the porcine B cell line L23 by subcutaneous transfer of L23 cell suspension. We used Luciferase transgeneic L23 cells to follow the course of rejection by living imaging. L23 cells were rejected within five days after placement under the skin thus the rejection is mediated by innate immune responses in the first place. Indeed we found increased percentages of NK cells in the blood, spleen and in draining lymph nodes using flow cytometry methods. Surprisingly, we found as a consequence a decrease in proliferative T cell response in the draining lymph nodes. We identified NK cells as mediators of this regulation by in vitro performed mixed lymphocyte reactions. The remarkable feature was the naive state of NK cells exhibiting the regulative capacity. Furthermore, the regulation was not exclusively mediated by IL-10 as it has been reported before for influence of T cell response by activated NK cells but predominantly by TGF-beta. Interestingly, after initiation of the adaptive immune response, NK cells failed to take influence on the proliferation of T cells. We conclude that naive NK cells build up a threshold of activation impulse that T cells have to overcome.	[Lieke, Thorsten] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, D-3000 Hannover, Germany; [Kraus, Lilli; Trautewig, Britta; Klempnauer, Juergen] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, Transplant Lab, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School	Lieke, T (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, ReMediES, D-3000 Hannover, Germany.	lieke.thorsten@mh-hannover.de			Association of Friends of General Surgery for Conveyance of Science and Teaching (FULAC)	Association of Friends of General Surgery for Conveyance of Science and Teaching (FULAC)	This study was funded by the Association of Friends of General Surgery for Conveyance of Science and Teaching (FULAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas K, 2003, J IMMUNOL, V171, P5396, DOI 10.4049/jimmunol.171.10.5396; Bonenfant C, 2003, XENOTRANSPLANTATION, V10, P107, DOI 10.1034/j.1399-3089.2003.01062.x; Candinas D, 1996, TRANSPLANTATION, V62, P1920, DOI 10.1097/00007890-199612270-00042; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Deniz G, 2008, J IMMUNOL, V180, P850, DOI 10.4049/jimmunol.180.2.850; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Fort MM, 1998, J IMMUNOL, V161, P3256; Frey M, 1998, J IMMUNOL, V161, P400; FRITZ FJ, 1990, IMMUNOLOGY, V71, P508; Hao L, 2006, P NATL ACAD SCI USA, V103, P3192, DOI 10.1073/pnas.0511280103; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Horwitz DA, 1999, MICROBES INFECT, V1, P1305, DOI 10.1016/S1286-4579(99)00253-1; KAEFFER B, 1990, INT J CANCER, V46, P481, DOI 10.1002/ijc.2910460326; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kveberg L, J LEUKOC BIOL; Kveberg L, 2006, J IMMUNOL, V176, P4133, DOI 10.4049/jimmunol.176.7.4133; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Li J, 2003, INT IMMUNOL, V15, P411, DOI 10.1093/intimm/dxg046; Lieke T, 2008, CLIN EXP IMMUNOL, V153, P221, DOI 10.1111/j.1365-2249.2008.03687.x; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; Maynard CL, 2008, IMMUNOL REV, V226, P219, DOI 10.1111/j.1600-065X.2008.00711.x; Naper C, 2005, J IMMUNOL, V174, P2702, DOI 10.4049/jimmunol.174.5.2702; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Nylen S, 2003, CLIN EXP IMMUNOL, V131, P457, DOI 10.1046/j.1365-2249.2003.02096.x; Ogura Y, 2001, TRANSPLANTATION, V71, P1827, DOI 10.1097/00007890-200106270-00020; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; PETRANYI GG, 1974, LANCET, V1, P736; Shegarfi H, 2009, SCAND J IMMUNOL, V70, P238, DOI 10.1111/j.1365-3083.2009.02292.x; Steiniger B, 2001, IMMUNOL REV, V184, P38, DOI 10.1034/j.1600-065x.2001.1840104.x; Takahashi K, 2004, BRAIN, V127, P1917, DOI 10.1093/brain/awh219; Voigt S, 2007, IMMUNITY, V26, P617, DOI 10.1016/j.immuni.2007.03.013; Zenhaeusern G, 2009, AM J TRANSPLANT, V9, P2624, DOI 10.1111/j.1600-6143.2009.02808.x	36	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47074	10.1371/journal.pone.0047074	http://dx.doi.org/10.1371/journal.pone.0047074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077546	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100057
J	Lubkowska, A; Dolegowska, B; Szygula, Z				Lubkowska, Anna; Dolegowska, Barbara; Szygula, Zbigniew			Whole-Body Cryostimulation - Potential Beneficial Treatment for Improving Antioxidant Capacity in Healthy Men - Significance of the Number of Sessions	PLOS ONE			English	Article							OXIDATIVE STRESS; URIC-ACID; SERUM-ALBUMIN; COLD-EXPOSURE; IN-VIVO; ERYTHROCYTES; CRYOTHERAPY; ENZYMES; VASOCONSTRICTION; F2-ISOPROSTANES	It is claimed that WBC (whole-body cryotherapy) enhances the resistance of the human body, also thanks to the beneficial effect on the antioxidant system. Accordingly, this research aimed to evaluate the effect of a series of whole-body cryostimulations on the level of non-enzymatic antioxidants and the activity of antioxidant enzymes in healthy men. The study was carried out on 30 young and healthy men aged 27.8 +/- 6.1 years with average body mass index and peak oxygen consumption (46.34 +/- 6.15 ml kg(-1).min(-1)). The participants were daily exposed for 3 minutes to cryogenic temperatures (-130 degrees C). Blood samples were obtained in the morning before cryostimulation, again 30 min after exposure and the following day in the morning, during the 1st, 10th and 20th session. Analysis concerned changes in plasma concentrations of total protein, albumin, glucose, uric acid and ceruloplasmin, and the most important components of the antioxidant system in red blood cells: superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, reduced and oxidized glutathione. To assess the oxidative stress level the 8-isoprostane concentration in plasma was measured. The obtained results indicate that cryogenic temperatures in repeated daily treatments result in changes in the peroxidant and antioxidant status. These changes seem to depend on the number of cryostimulations. After 20 daily treatments there was an increase in SOD, SOD: CAT ratio, a decrease in the concentration of reduced and oxidized glutathione and in the activity of GPx. It could be possible that differences in the activity of GSSG-R after 20 treatments depended on the body mass index of participants.	[Lubkowska, Anna] Pomeranian Med Univ, Fac Hlth Sci, Szczecin, Poland; [Lubkowska, Anna] Szczecin Univ, Fac Biol, Dept Physiol, Szczecin, Poland; [Dolegowska, Barbara] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland; [Szygula, Zbigniew] Univ Sch Phys Educ, Inst Human Physiol, Krakow, Poland	Pomeranian Medical University; University of Szczecin; Pomeranian Medical University	Lubkowska, A (corresponding author), Pomeranian Med Univ, Fac Hlth Sci, Szczecin, Poland.	annalubkowska@gmail.com	Lubkowska, Anna/A-4623-2015; Dolegowska, Barbara/O-4851-2014	Lubkowska, Anna/0000-0002-5378-5409; Dolegowska, Barbara/0000-0003-3138-1013; Szygula, Zbigniew/0000-0002-6685-6579	Ministry of Science and Higher Education [NN404 027235]; National Science Centre [N N404 312940]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	This paper was supported by the Ministry of Science and Higher Education, Grant No: NN404 027235 and National Science Centre No: N N404 312940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 1997, CLIN CHEM, V43, P562; Bailey SR, 2005, AM J PHYSIOL-HEART C, V289, pH243, DOI 10.1152/ajpheart.01305.2004; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; Bartosz G, 2003, WARSZAWA PWN; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Belik J, 2010, FREE RADICAL BIO MED, V48, P177, DOI 10.1016/j.freeradbiomed.2009.10.043; Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S; Comporti M, 2008, FREE RADICAL BIO MED, V44, P247, DOI 10.1016/j.freeradbiomed.2007.10.004; Djousse L, 2003, STROKE, V34, P53, DOI 10.1161/01.STR.0000048675.97975.84; Dugue B, 2005, SCAND J CLIN LAB INV, V65, P395, DOI 10.1080/00365510510025728; Dugue B, 2000, CLIN PHYSIOL, V20, P114; Edwards CJ, 1996, COMP HAEMATOL INT, V6, P24, DOI 10.1007/BF00368098; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; FLAVAHAN NA, 1991, NEWS PHYSIOL SCI, V6, P251; Ganta CK, 2006, AM J PHYSIOL-REG I, V291, pR558, DOI 10.1152/ajpregu.00846.2005; Giurgea N, 2005, MED SCI MONITOR, V11, pRA48; GOPAUL NK, 1994, BIOCHEM BIOPH RES CO, V200, P338, DOI 10.1006/bbrc.1994.1453; Hausswirth C, 2010, SCI SPORT, V25, P121, DOI 10.1016/j.scispo.2009.12.001; Jacobs I, 1994, Exerc Sport Sci Rev, V22, P221; Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Korac B, 2003, J THERM BIOL, V28, P245, DOI 10.1016/S0306-4565(02)00070-0; Kumar A, 2005, FASEB J, V19, P443, DOI 10.1096/fj.03-1364fje; Lubkowska A, 2009, SCAND J CLIN LAB INV, V69, P387, DOI 10.1080/00365510802699246; Lubkowska A, 2011, 2 POL C BIOCH CELL B; Lubkowska A, 2011, SCAND J CLIN LAB INV, V71, P419, DOI 10.3109/00365513.2011.580859; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; Lubkowska A, 2010, CRYOBIOLOGY, V61, P22, DOI 10.1016/j.cryobiol.2010.03.010; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Lubkowska A, 2008, J THERM BIOL, V33, P464, DOI 10.1016/j.jtherbio.2008.08.003; Luszczewski Adam, 2007, Reumatologia (Warsaw), V45, P284; Miller E, 2012, EUR J APPL PHYSIOL, V112, P1645, DOI 10.1007/s00421-011-2122-x; Miller E, 2010, J THERM BIOL, V35, P406, DOI 10.1016/j.jtherbio.2010.08.006; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nourooz-Zadeh J, 1998, BIOCHEM BIOPH RES CO, V242, P338, DOI 10.1006/bbrc.1997.7883; Prohaska JR, 2008, AM J CLIN NUTR, V88, p826S, DOI 10.1093/ajcn/88.3.826S; Rizvi SI, 2007, MOL BIOTECHNOL, V37, P58, DOI 10.1007/s12033-007-0048-7; Roberts LJ, 2006, FREE RADIC BIOL MED, V28, P505; Siems W, 1992, Arctic Med Res, V51, P3; SIEMS WG, 1994, FREE RADICAL BIO MED, V16, P299, DOI 10.1016/0891-5849(94)90030-2; Siems WG, 1999, QJM-INT J MED, V92, P193, DOI 10.1093/qjmed/92.4.193; Squadrito GL, 2000, ARCH BIOCHEM BIOPHYS, V376, P333, DOI 10.1006/abbi.2000.1721; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; Suzuki T, 2007, NITRIC OXIDE-BIOL CH, V16, P266, DOI 10.1016/j.niox.2006.10.008; Swenson C, 1996, SCAND J MED SCI SPOR, V6, P193, DOI 10.1111/j.1600-0838.1996.tb00090.x; Teixeira CE, 2004, CIRC RES, V94, P1273, DOI 10.1161/01.RES.0000131755.49084.04; Thompson-Torgerson CS, 2007, AM J PHYSIOL-HEART C, V292, pH1700, DOI 10.1152/ajpheart.01078.2006; Wozniak A, 2007, EUR J APPL PHYSIOL, V100, P137, DOI 10.1007/s00421-007-0404-0	51	48	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46352	10.1371/journal.pone.0046352	http://dx.doi.org/10.1371/journal.pone.0046352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077506	Green Published, gold			2022-12-25	WOS:000309995100028
J	Miyazaki, A; Ishii, K; Yamashita, S; Nejigane, S; Matsukawa, S; Ito, Y; Onuma, Y; Asashima, M; Michiue, T				Miyazaki, Aya; Ishii, Kentaro; Yamashita, Satoshi; Nejigane, Susumu; Matsukawa, Shinya; Ito, Yuzuru; Onuma, Yasuko; Asashima, Makoto; Michiue, Tatsuo			mNanog Possesses Dorsal Mesoderm-Inducing Ability by Modulating Both BMP and Activin/Nodal Signaling in Xenopus Ectodermal Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMEOBOX GENE; MAINTAINS PLURIPOTENCY; SPEMANNS ORGANIZER; ENDODERM FORMATION; NANOG; INDUCTION; EXPRESSION; PATHWAY; EMBRYOGENESIS	Background: In Xenopus early embryogenesis, various genes are involved with mesoderm formation. In particular, dorsal mesoderm contains the organizer region and induces neural tissues through the inhibition of bone morphogenetic protein (BMP) signaling. In our initial study to identify novel genes necessary for maintaining the undifferentiated state, we unexpectedly revealed mesoderm-inducing activity for mNanog in Xenopus. Methodology/Principal Findings: The present series of experiments investigated the effect of mNanog gene expression on Xenopus embryo. Ectopic expression of mNanog induced dorsal mesoderm gene activity, secondary axis formation, and weakly upregulated Activin/nodal signaling. The injection of mNanog also effectively inhibited the target genes of BMP signaling, while Xvent2 injection downregulated the dorsal mesoderm gene expression induced by mNanog injection. Conclusions/Significance: These results suggested that mNanog expression induces dorsal mesoderm by regulating both Activin/nodal signaling and BMP signaling in Xenopus. This finding highlights the possibly novel function for mNanog in stimulating the endogenous gene network in Xenopus mesoderm formation.	[Miyazaki, Aya; Ishii, Kentaro; Yamashita, Satoshi; Nejigane, Susumu; Matsukawa, Shinya; Asashima, Makoto; Michiue, Tatsuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Tokyo, Japan; [Ito, Yuzuru; Onuma, Yasuko; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Michiue, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Tokyo, Japan.	tmichiue@bio.c.u-tokyo.ac.jp	Asashima, Makoto/O-8389-2018; Ito, Yuzuru/M-1085-2018; Onuma, Yasuko/L-7083-2018	Asashima, Makoto/0000-0002-0012-026X; Ito, Yuzuru/0000-0001-7923-865X; Onuma, Yasuko/0000-0002-9330-194X	Management Expenses Grants from University of Tokyo and Ministry of Education, Culture, Sports, Science and Technology	Management Expenses Grants from University of Tokyo and Ministry of Education, Culture, Sports, Science and Technology	This study is supported by Management Expenses Grants from University of Tokyo and Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASASHIMA M, 1990, NATURWISSENSCHAFTEN, V77, P389, DOI 10.1007/BF01135742; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Carnac G, 1996, DEVELOPMENT, V122, P3055; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; GRAINGER RM, 1989, P NATL ACAD SCI USA, V86, P1900, DOI 10.1073/pnas.86.6.1900; Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812; GURDON JB, 1985, CELL, V41, P913, DOI 10.1016/S0092-8674(85)80072-6; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Henry GL, 1998, SCIENCE, V281, P91, DOI 10.1126/science.281.5373.91; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; JONES CM, 1995, DEVELOPMENT, V121, P3651; Joseph EM, 1997, DEV BIOL, V184, P367, DOI 10.1006/dbio.1997.8510; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morris SA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001004; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Onuma Y, 2005, DEV DYNAM, V234, P900, DOI 10.1002/dvdy.20574; Osada SI, 1999, DEVELOPMENT, V126, P3229; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scerbo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036855; Schuff M, 2012, STEM CELLS DEV, V21, P1225, DOI 10.1089/scd.2011.0285; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Veenstra GJC, 1998, CELL DEATH DIFFER, V5, P774, DOI 10.1038/sj.cdd.4400416; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wylie C, 1996, DEVELOPMENT, V122, P2987; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	42	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46630	10.1371/journal.pone.0046630	http://dx.doi.org/10.1371/journal.pone.0046630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071603	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700024
J	Shalom, L; Samuels, S; Zur, N; Shlizerman, L; Zemach, H; Weissberg, M; Ophir, R; Blumwald, E; Sadka, A				Shalom, Liron; Samuels, Sivan; Zur, Naftali; Shlizerman, Lyudmila; Zemach, Hanita; Weissberg, Mira; Ophir, Ron; Blumwald, Eduardo; Sadka, Avi			Alternate Bearing in Citrus: Changes in the Expression of Flowering Control Genes and in Global Gene Expression in ON- versus OFF-Crop Trees	PLOS ONE			English	Article							WASHINGTON NAVEL ORANGE; LOCUS-T-LIKE; SHOOT DEVELOPMENT; GIBBERELLIC-ACID; FRUIT-SET; CARBOHYDRATE-LEVELS; VEGETATIVE GROWTH; BIENNIAL-BEARING; ABSCISIC-ACID; RETURN BLOOM	Alternate bearing (AB) is the process in fruit trees by which cycles of heavy yield (ON crop) one year are followed by a light yield (OFF crop) the next. Heavy yield usually reduces flowering intensity the following year. Despite its agricultural importance, how the developing crop influences the following year's return bloom and yield is not fully understood. It might be assumed that an 'AB signal' is generated in the fruit, or in another organ that senses fruit presence, and moves into the bud to determine its fate-flowering or vegetative growth. The bud then responds to fruit presence by altering regulatory and metabolic pathways. Determining these pathways, and when they are altered, might indicate the nature of this putative AB signal. We studied bud morphology, the expression of flowering control genes, and global gene expression in ON- and OFF-crop buds. In May, shortly after flowering and fruit set, OFF-crop buds were already significantly longer than ON-crop buds. The number of differentially expressed genes was higher in May than at the other tested time points. Processes differentially expressed between ON- and OFF-crop trees included key metabolic and regulatory pathways, such as photosynthesis and secondary metabolism. The expression of genes of trehalose metabolism and flavonoid metabolism was validated by nCounter technology, and the latter was confirmed by metabolomic analysis. Among genes induced in OFF-crop trees was one homologous to SQUAMOSA PROMOTER BINDING-LIKE (SPL), which controls juvenile-to-adult and annual phase transitions, regulated by miR156. The expression pattern of SPL-like, miR156 and other flowering control genes suggested that fruit load affects bud fate, and therefore development and metabolism, a relatively long time before the flowering induction period. Results shed light on some of the metabolic and regulatory processes that are altered in ON and OFF buds.	[Shalom, Liron; Samuels, Sivan; Zur, Naftali; Shlizerman, Lyudmila; Zemach, Hanita; Weissberg, Mira; Ophir, Ron; Sadka, Avi] Agr Res Org, Volcani Ctr, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel; [Blumwald, Eduardo] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; University of California System; University of California Davis	Sadka, A (corresponding author), Agr Res Org, Volcani Ctr, Dept Fruit Tree Sci, IL-50250 Bet Dagan, Israel.	vhasadka@volcani.agri.gov.il	Blumwald, Eduardo/Y-2751-2019	Ophir, Ron/0000-0002-7951-6661	Chief Scientist of the Ministry of Agriculture and Rural Development [203-705]	Chief Scientist of the Ministry of Agriculture and Rural Development	This work was supported by fund number 203-705 of the Chief Scientist of the Ministry of Agriculture and Rural Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGUELLES T, 1977, J HORTIC SCI, V52, P199, DOI 10.1080/00221589.1977.11514748; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; BAIN JOAN M., 1958, AUSTRALIAN JOUR BOT, V6, P1, DOI 10.1071/BT9580001; BOWER JP, 1990, ACTA HORTIC, V275, P425, DOI 10.17660/ActaHortic.1990.275.52; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chao CCT, 2011, SCI HORTIC-AMSTERDAM, V130, P743, DOI 10.1016/j.scienta.2011.08.036; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Davenport T. L., 1990, Horticultural Reviews, V12, P349, DOI 10.1002/9781118060858.ch8; Duarte AMM, 2006, J AM SOC HORTIC SCI, V131, P586, DOI 10.21273/JASHS.131.5.586; Endo T, 2005, TRANSGENIC RES, V14, P703, DOI 10.1007/s11248-005-6632-3; Erner Y, 1993, REGULATION FLOWERING; Fornara F, 2009, CELL, V138, P625, DOI 10.1016/j.cell.2009.08.011; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; GARCIALUIS A, 1995, J HORTIC SCI, V70, P817; GARCIALUIS A, 1995, J AM SOC HORTIC SCI, V120, P222, DOI 10.21273/JASHS.120.2.222; GARCIALUIS A, 1988, ISRAEL J BOT, V37, P189; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GOLDSCHMIDT EE, 1982, J AM SOC HORTIC SCI, V107, P206; GOLDSCHMIDT EE, 1985, SCI HORTIC-AMSTERDAM, V26, P159, DOI 10.1016/0304-4238(85)90008-1; Goldschmidt EE, 1999, HORTSCIENCE, V34, P1020, DOI 10.21273/HORTSCI.34.6.1020; Goldschmidt EE, 1997, ACTA HORTIC, P201, DOI 10.17660/ActaHortic.1998.463.23; Grace SC, 2000, PHILOS T R SOC B, V355, P1499, DOI 10.1098/rstb.2000.0710; GUARDIOLA JL, 1982, PHYSIOL PLANTARUM, V55, P136, DOI 10.1111/j.1399-3054.1982.tb02276.x; Guitton B, 2012, J EXP BOT, V63, P131, DOI 10.1093/jxb/err261; Hanke M.V., 2007, GENES GENOMES GENOMI, VVolume 1, P1, DOI DOI 10.1007/S00425-017-2740-6; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; HILGEMAN RH, 1967, P AM SOC HORTIC SCI, V90, P110; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JONES WW, 1970, J AM SOC HORTIC SCI, V95, P380; JONES WW, 1976, PLANT PHYSIOL, V58, P681, DOI 10.1104/pp.58.5.681; JONES WW, 1974, HILGARDIA, V42, P441, DOI 10.3733/hilg.v42n12p441; Koshita Y, 1999, SCI HORTIC-AMSTERDAM, V79, P185, DOI 10.1016/S0304-4238(98)00209-X; Kotoda N, 2010, PLANT CELL PHYSIOL, V51, P561, DOI 10.1093/pcp/pcq021; KRAJEWSKI AJ, 1995, J HORTIC SCI BIOTECH, V70, P357, DOI 10.1080/14620316.1995.11515306; Li CY, 2003, ANN BOT-LONDON, V92, P137, DOI 10.1093/aob/mcg108; Li CY, 2003, PLANTA, V217, P11, DOI 10.1007/s00425-002-0963-6; LORD EM, 1987, BOT GAZ, V148, P17, DOI 10.1086/337623; LORD EM, 1985, BOT GAZ, V146, P320, DOI 10.1086/337531; Martinez-Fuentes A, 2010, J SCI FOOD AGR, V90, P1936, DOI 10.1002/jsfa.4038; Monerri C, 2011, SCI HORTIC-AMSTERDAM, V129, P71, DOI 10.1016/j.scienta.2011.03.009; Monselise S. P., 1984, Horticultural Reviews, V4, P128, DOI 10.1002/9781118060773.ch5; Monselise S.P., 1981, P INT SOC CITRICULTU, P239; Monselise S. P., 2019, CRC HDB FLOWERING, P275, DOI [10.1201/9781351072540, 10.1201/9781351072540-38, DOI 10.1201/9781351072540-38]; Munoz-Fambuena N, 2012, J PLANT GROWTH REGUL; Munoz-Fambuena N, 2011, ANN BOT-LONDON, V108, P511, DOI 10.1093/aob/mcr164; Nakagawa M, 2012, SCI HORTIC-AMSTERDAM, V139, P108, DOI 10.1016/j.scienta.2012.03.005; Nishikawa F, 2007, J EXP BOT, V58, P3915, DOI 10.1093/jxb/erm246; Okuda H, 1996, J JPN SOC HORTIC SCI, V65, P15, DOI 10.2503/jjshs.65.15; Okuda H, 2000, J HORTIC SCI BIOTECH, V75, P355, DOI 10.1080/14620316.2000.11511250; Pena L, 2001, NAT BIOTECHNOL, V19, P263, DOI 10.1038/85719; Pillitteri LJ, 2004, J AM SOC HORTIC SCI, V129, P846, DOI 10.21273/JASHS.129.6.0846; Pillitteri LJ, 2004, PLANT PHYSIOL, V135, P1540, DOI 10.1104/pp.103.036178; Ramon M, 2007, TRENDS PLANT SCI, V12, P185, DOI 10.1016/j.tplants.2007.03.007; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Samach A, 2012, ANN BOT IN PRESS; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Talon M, 1997, ACTA HORTIC, P209, DOI 10.17660/ActaHortic.1998.463.24; Tan FC, 2007, PHYSIOL PLANTARUM, V131, P481, DOI 10.1111/j.1399-3054.2007.00971.x; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Verreynne JS, 2009, J AM SOC HORTIC SCI, V134, P299, DOI 10.21273/JASHS.134.3.299; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yahata D, 1995, J JPN SOC HORTIC SCI, V64, P527, DOI 10.2503/jjshs.64.527	69	75	82	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46930	10.1371/journal.pone.0046930	http://dx.doi.org/10.1371/journal.pone.0046930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071667	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700042
J	Proestling, K; Hebar, A; Pruckner, N; Marton, E; Vinatzer, U; Schreiber, M				Proestling, Katharina; Hebar, Alexandra; Pruckner, Nina; Marton, Erika; Vinatzer, Ursula; Schreiber, Martin			The Pro Allele of the p53 Codon 72 Polymorphism Is Associated with Decreased Intratumoral Expression of BAX and p21, and Increased Breast Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RING-FINGER DOMAIN; MDM2 SNP309; GENE-MUTATIONS; TP53 R72P; SUSCEPTIBILITY; VARIANTS; PROTEIN; HDM2; IMMUNOHISTOCHEMISTRY	Background: The TP53 Arg72Pro polymorphism encodes two p53 variants with different biochemical properties. Here we investigated the impact of this polymorphism on the expression of key p53 target genes in a panel of human breast carcinomas, breast cancer risk, and age at onset. Methodology/Principal Findings: The Arg72Pro polymorphism was genotyped in 270 breast cancer patients and 221 control subjects. In addition, the Arg72Pro genotype of 116 breast tumors was determined, and correlated with intratumoral mRNA expression of TP53 and its key target genes MDM2, p21, BAX, and PERP, as quantified by qRT-PCR. We found a significantly increased breast cancer risk associated with the Pro-allele (per-allele odds ratio, 1.46; 95% confidence interval, 1.08-1.99), and a significantly later mean age at breast cancer onset for Pro/Pro patients (63.2 +/- 18 years) compared to Arg/Arg patients (58.2 +/- 15 years). The frequency of somatic TP53 inactivation was 25.4% in Arg/Arg, 20.9% in Arg/Pro, and 16.7% in Pro/Pro patients, which may reflect a higher selective pressure to mutate the Arg-allele. The median mRNA levels of p21 and BAX in the tumors of Pro-allele carriers were significantly reduced to 55.7% and 76.9% compared to Arg/Arg patients, whereas p53, MDM2 and PERP expression were hardly altered. Conclusions/Significance: The p53(72Arg) variant appears to be a more potent in vivo transcription factor and tumor suppressor in human breast cancer than the p53(72Pro) variant. The Arg72Pro genotype has no significant effects in patients with TP53 mutated tumors, in which p53 is non-functional.	[Proestling, Katharina; Hebar, Alexandra; Pruckner, Nina; Marton, Erika; Vinatzer, Ursula; Schreiber, Martin] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria	Medical University of Vienna	Schreiber, M (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	martin.schreiber@meduniwien.ac.at	Martin, Schreiber/F-2175-2013	Martin, Schreiber/0000-0003-1102-7789; Proestling, Katharina/0000-0002-0217-486X	Oesterreichische Nationalbank (Anniversary Fund) [12994]	Oesterreichische Nationalbank (Anniversary Fund)	Supported by funds of the Oesterreichische Nationalbank (Anniversary Fund, project number: 12994; http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardi LD, 2000, GENE DEV, V14, P704; Baynes C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1669; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Buyru N, 2003, ONCOL REP, V10, P711; De Vecchi G, 2008, CANCER DETECT PREV, V32, P140, DOI 10.1016/j.cdp.2008.06.003; Dumble M, 2004, ANN NY ACAD SCI, V1019, P171, DOI 10.1196/annals.1297.027; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Dusek RL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3171; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan Z, 1997, CLIN CANCER RES, V3, P1943; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; HARPER JW, 1993, CELL, V75, P805; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hu Z, 2010, BREAST CANCER RES TR, V120, P705, DOI 10.1007/s10549-009-0488-9; Huang Xin-En, 2003, Breast Cancer, V10, P307, DOI 10.1007/BF02967650; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Langerod A, 2002, CANCER EPIDEM BIOMAR, V11, P1684; Ma YL, 2011, BREAST CANCER RES TR, V125, P201, DOI 10.1007/s10549-010-0920-1; Norberg T, 1998, INT J CANCER, V79, P376, DOI 10.1002/(SICI)1097-0215(19980821)79:4<376::AID-IJC12>3.3.CO;2-S; Norberg T, 2001, CANCER RES, V61, P8317; Ohayon T, 2005, BRIT J CANCER, V92, P1144, DOI 10.1038/sj.bjc.6602451; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Olivier Magali, 2004, IARC Sci Publ, P247; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pietsch EC, 2006, ONCOGENE, V25, P1602, DOI 10.1038/sj.onc.1209367; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; R Development Core Team, 2009, R FDN STAT COMP; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Schmidt MK, 2007, CANCER RES, V67, P9584, DOI 10.1158/0008-5472.CAN-07-0738; Schmidt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2460; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Sjalander A, 1996, CARCINOGENESIS, V17, P1313, DOI 10.1093/carcin/17.6.1313; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Su L, 2003, LUNG CANCER-J IASLC, V40, P259, DOI 10.1016/S0169-5002(03)00081-3; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xi B, 2011, BREAST CANCER RES TR, V130, P561, DOI [10.1007/s10549-011-1583-2, 10.1007/s10549-011-1602-3, 10.1007/s10549-011-1615-y]; Xu Y, 2005, CLIN CANCER RES, V11, P7328, DOI 10.1158/1078-0432.CCR-05-0507; Zhang ZZ, 2010, BREAST CANCER RES TR, V120, P509, DOI 10.1007/s10549-009-0480-4	53	37	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47325	10.1371/journal.pone.0047325	http://dx.doi.org/10.1371/journal.pone.0047325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071787	gold, Green Published			2022-12-25	WOS:000312385200106
J	Rendl, LM; Bieman, MA; Vari, HK; Smibert, CA				Rendl, Laura M.; Bieman, Melissa A.; Vari, Heli K.; Smibert, Craig A.			The eIF4E-Binding Protein Eap1p Functions in Vts1p-Mediated Transcript Decay	PLOS ONE			English	Article							NANOS MESSENGER-RNA; YEAST SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; SAM DOMAIN; DEPENDENT TRANSLATION; DEADENYLASE COMPLEX; DROSOPHILA EMBRYO; BINDING PROTEIN; SMAUG; EIF4E	Sequence-specific RNA binding proteins can induce the degradation of mRNAs through their ability to recruit proteins that trigger transcript destabilization. For example, Vts1p, the S. cerevisiae member of the Smaug family of RNA binding proteins, is thought to induce transcript decay by recruiting the Ccr4p-Pop2p-Not deadenylase complex to target mRNAs. The resulting deadenylation triggers transcript decapping followed by 5'-to-3' exonucleolytic decay. Here we show that the eIF4E-binding protein, Eap1p, is required for efficient degradation of Vts1p target transcripts and that this role involves the ability of Eap1p to interact with eIF4E. Eap1p does not stimulate deadenylation of Vts1p target transcripts but is instead involved in decapping. Eap1p interacts with Vts1p and mediates an indirect interaction between Vts1p and eIF4E. Taken together these data suggest a model whereby the interaction of Vts1p with Eap1p at target mRNAs stimulates decapping.	[Rendl, Laura M.; Bieman, Melissa A.; Vari, Heli K.; Smibert, Craig A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Smibert, Craig A.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University of Toronto	Smibert, CA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	c.smibert@utoronto.ca			Canadian Cancer Society	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by an operating grant from the Canadian Cancer Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Aviv T, 2006, NAT STRUCT MOL BIOL, V13, P168, DOI 10.1038/nsmb1053; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Brachmann CB, 1998, YEAST, V14, P115; Briand JF, 2001, MOL CELL BIOL, V21, P189, DOI 10.1128/MCB.21.1.189-195.2001; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Cridge AG, 2010, NUCLEIC ACIDS RES, V38, P8039, DOI 10.1093/nar/gkq686; Crucs S, 2000, MOL CELL, V5, P457, DOI 10.1016/S1097-2765(00)80440-2; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Green JB, 2003, MOL CELL, V11, P1537, DOI 10.1016/S1097-2765(03)00178-3; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Ibrahimo S, 2006, YEAST, V23, P1075, DOI 10.1002/yea.1415; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Matsuo R, 2005, FEBS LETT, V579, P2433, DOI 10.1016/j.febslet.2005.03.043; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Rendl LM, 2008, RNA, V14, P1328, DOI 10.1261/rna.955508; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Semotok JL, 2008, MOL CELL BIOL, V28, P6757, DOI 10.1128/MCB.00037-08; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Smibert CA, 1996, GENE DEV, V10, P2600, DOI 10.1101/gad.10.20.2600; Vilela C, 2000, EMBO J, V19, P4372, DOI 10.1093/emboj/19.16.4372; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47121	10.1371/journal.pone.0047121	http://dx.doi.org/10.1371/journal.pone.0047121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071728	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200081
J	Sorli, SC; Colie, S; Albinet, V; Dubrac, A; Touriol, C; Guilbaud, N; Bedia, C; Fabrias, G; Casas, J; Segui, B; Levade, T; Andrieu-Abadie, N				Sorli, Sonia-Caroline; Colie, Sandra; Albinet, Virginie; Dubrac, Alexandre; Touriol, Christian; Guilbaud, Nicolas; Bedia, Carmen; Fabrias, Gemma; Casas, Josefina; Segui, Bruno; Levade, Thierry; Andrieu-Abadie, Nathalie			The nonlysosomal beta-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells	FASEB JOURNAL			English	Article						glycosylceramidase; unfolded protein response; cancer cell death; glucosylceramide	KLOTHO-RELATED PROTEIN; GLUCOSYLCERAMIDE SYNTHASE; ER STRESS; GAUCHER-DISEASE; DRUG-RESISTANCE; CERAMIDE; CANCER; SPHINGOLIPIDS; GLYCOSPHINGOLIPIDS; METABOLISM	Glycosphingolipids, which are abundant at the surface of melanoma cells, play crucial roles in tumor progression. We investigated whether a newly described glycosphingolipid hydrolase, encoded by the GBA2 gene, can modulate human melanoma cell growth and death. GBA2 expression was quantified on melanoma cells by RT-qPCR. The antiproliferative effects of GBA2 were assessed in tumor cells expressing inducible GBA2 and in established melanoma xenografts. As a control an inducible catalytically inactive GBA2 mutant was generated. Sphingolipid levels were monitored by mass spectrometry; unfolded protein response (UPR) and apoptosis were assessed by Western blot and flow cytometry analyses, respectively. We report that GBA2 is down-regulated in melanoma; inducible expression of GBA2 affects endogenous sphingolipid metabolism by promoting glucosylceramide degradation (decrease by 78%) and ceramide generation; this is followed by a UPR that causes apoptosis, subsequent decreased anchorage-independent cell growth, and reduced in vivo tumor growth (by 40%); and all these events are abrogated when expressing a catalytically inactive GBA2. This study documents for the first time the antitumor activity of GBA2 and provides evidence for the role of nonlysosomal glucosylceramide breakdown as a source of bioactive ceramide and a mechanistic link between glycolipid catabolism and the UPR/death response of melanoma cells.-Sorli, S.-C., Colie, S., Albinet, V., Dubrac, A., Touriol, C., Guilbaud, N., Bedia, C., Fabrias, G., Casas, J., Segui, B., Levade, T., Andrieu-Abadie, N. The nonlysosomal beta-glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells. FASEB J. 27, 489-498 (2013). www.fasebj.org	[Sorli, Sonia-Caroline; Colie, Sandra; Albinet, Virginie; Dubrac, Alexandre; Touriol, Christian; Segui, Bruno; Levade, Thierry; Andrieu-Abadie, Nathalie] Ctr Rech Cancerol Toulouse, Unite Mixte Rech UMR 1037, INSERM, Toulouse, France; [Sorli, Sonia-Caroline; Colie, Sandra; Albinet, Virginie; Dubrac, Alexandre; Touriol, Christian; Segui, Bruno; Levade, Thierry; Andrieu-Abadie, Nathalie] Univ Toulouse 3, F-31062 Toulouse, France; [Guilbaud, Nicolas] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France; [Bedia, Carmen; Fabrias, Gemma; Casas, Josefina] CSIC, IQAC, Dept Biomed Chem, Barcelona, Spain; [Levade, Thierry] Ctr Hosp Univ Toulouse, Lab Biochim Metab, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); CHU de Toulouse	Andrieu-Abadie, N (corresponding author), CHU Rangueil, Ctr Rech Cancerol Toulouse, UMR1037, INSERM, BP84225, F-31432 Toulouse 4, France.	thierry.levade@inserm.fr; andrieu@inserm.fr	Ségui, Bruno/O-8957-2014; Dubrac, Alexandre/AAQ-9515-2021; TOURIOL, Christian/O-8949-2014; Levade, Thierry/O-8948-2014; Andrieu-Abadie, Nathalie/N-6793-2013; Bedia, Carmen/D-3827-2013; Bedia, Carmen/H-9185-2015; Casas, Josefina/L-7934-2014	Ségui, Bruno/0000-0002-6119-1889; Dubrac, Alexandre/0000-0002-3829-2577; TOURIOL, Christian/0000-0003-1219-4693; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Bedia, Carmen/0000-0003-4584-5843; Fabrias, Gemma/0000-0001-7162-3772	Institut National de la Sante et de la Recherche Medicale (INSERM); Paul Sabatier University; Pierre-Fabre Dermo-Cosmetique; Centre Europeen de Recherche sur la Peau (Toulouse, France); Generalitat de Catalunya [2009SGR-1072]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Paul Sabatier University; Pierre-Fabre Dermo-Cosmetique; Centre Europeen de Recherche sur la Peau (Toulouse, France); Generalitat de Catalunya(Generalitat de Catalunya)	The authors thank N. Therville, S. Carpentier, and the staff of the animal facilities and the Plateforme d'Experimentation Fonctionnelle (S. Le Gonidec, A. Desquesnes, and A. Estival) for technical assistance. This project was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Paul Sabatier University, Pierre-Fabre Dermo-Cosmetique, Centre Europeen de Recherche sur la Peau (Toulouse, France), and Generalitat de Catalunya (grant 2009SGR-1072). The authors declare no conflicts of interest.	Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; Beutler E., 2001, METABOLIC MOL BASES, VIII, P3635; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Cobucci-Ponzano B, 2010, J BIOL CHEM, V285, P20691, DOI 10.1074/jbc.M109.086470; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Deng W, 2002, GLYCOBIOLOGY, V12, P145, DOI 10.1093/glycob/12.3.145; Deng W, 2000, J NATL CANCER I, V92, P912, DOI 10.1093/jnci/92.11.912; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gouaze V, 2005, CANCER RES, V65, P3861, DOI 10.1158/0008-5472.CAN-04-2329; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; KOBAYASHI T, 1981, J BIOL CHEM, V256, P7768; Kuphal S, 2009, J PATHOL, V219, P400, DOI 10.1002/path.2617; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Landgren O, 2007, ARCH INTERN MED, V167, P1189, DOI 10.1001/archinte.167.11.1189; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; PORTOUKALIAN J, 1979, EUR J BIOCHEM, V94, P19, DOI 10.1111/j.1432-1033.1979.tb12866.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Salma Y, 2009, BIOCHEM PHARMACOL, V78, P477, DOI 10.1016/j.bcp.2009.05.002; Sauane M, 2010, J CELL PHYSIOL, V222, P546, DOI 10.1002/jcp.21969; Segui B, 2006, BBA-BIOMEMBRANES, V1758, P2104, DOI 10.1016/j.bbamem.2006.05.024; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Sietsma H, 2000, CLIN CANCER RES, V6, P942; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Taddei TH, 2009, AM J HEMATOL, V84, P208, DOI 10.1002/ajh.21362; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Weiss M, 2003, CANCER RES, V63, P3654; Yahata K, 2000, J MOL MED, V78, P389, DOI 10.1007/s001090000131; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	45	31	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2013	27	2					489	498		10.1096/fj.12-215152	http://dx.doi.org/10.1096/fj.12-215152			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23073830				2022-12-25	WOS:000314358000009
J	Henke, N; Albrecht, P; Pfeiffer, A; Toutzaris, D; Zanger, K; Methner, A				Henke, Nadine; Albrecht, Philipp; Pfeiffer, Annika; Toutzaris, Diamandis; Zanger, Klaus; Methner, Axel			Stromal Interaction Molecule 1 (STIM1) Is Involved in the Regulation of Mitochondrial Shape and Bioenergetics and Plays a Role in Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ CHANNELS; ENDOPLASMIC-RETICULUM; CALCIUM-ENTRY; STORE; ORAI1; SUBSTRATE; DEPLETION; RELEASE; SERCA; KEAP1	Calcium ions are involved in a plethora of cellular functions including cell death and mitochondrial energy metabolism. Store-operated Ca2+ entry over the plasma membrane is activated by depletion of intracellular Ca2+ stores and is mediated by the sensor STIM1 and the channel ORAI1. We compared cell death susceptibility to oxidative stress in STIM1 knock-out and ORAI1 knockdown mouse embryonic fibroblasts and in knockout cells with reconstituted wild type and dominant active STIM1. We show that STIM1 and ORAI1 deficiency renders cells more susceptible to oxidative stress, which can be rescued by STIM1 and ORAI1 overexpression. STIM1 knock-out mitochondria are tubular, have a higher Ca2+ concentration, and are metabolically more active, resulting in constitutive oxidative stress causing increased nuclear translocation of the antioxidant transcription factor NRF2 triggered by increased phosphorylation of the translation initiation factor eIF2 alpha and the protein kinase-like endoplasmic reticulum kinase PERK. This leads to increased transcription of antioxidant genes and a high basal glutathione in STIM1 knock-out cells, which is, however, more rapidly expended upon additional stress, resulting in increased release and nuclear translocation of apoptosis-inducing factor with subsequent cell death. Our data suggest that store-operated Ca2+ entry and STIM1 are involved in the regulation of mitochondrial shape and bioenergetics and play a role in oxidative stress.	[Methner, Axel] Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Focus Program Translat Neurosci, Rhine Main Neurosci Network,Dept Neurol, D-55131 Mainz, Germany; [Henke, Nadine; Albrecht, Philipp; Pfeiffer, Annika; Toutzaris, Diamandis; Methner, Axel] Univ Dusseldorf, Fac Med, Dept Neurol, D-40225 Dusseldorf, Germany; [Zanger, Klaus] Univ Dusseldorf, Fac Med, Ctr Anat & Brain Res, D-40225 Dusseldorf, Germany	Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Methner, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Focus Program Translat Neurosci, Rhine Main Neurosci Network,Dept Neurol, Langenbeckstr 1, D-55131 Mainz, Germany.	axel.methner@gmail.com		Nickel, Nadine/0000-0002-0609-0735; Methner, Axel/0000-0002-8774-0057	Deutsche Forschungsgemeinschaft Grant [ME1922/9-1]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant ME1922/9-1 (to A. M.).	Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chiu WT, 2008, MOL BIOL CELL, V19, P2220, DOI 10.1091/mbc.E07-11-1170; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Frieden M, 2005, J BIOL CHEM, V280, P43198, DOI 10.1074/jbc.M510279200; Grohm J, 2010, BRAIN BEHAV IMMUN, V24, P831, DOI 10.1016/j.bbi.2009.11.015; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu HL, 2011, EXP MOL PATHOL, V91, P753, DOI 10.1016/j.yexmp.2011.09.005; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prins D, 2011, EMBO REP, V12, P1182, DOI 10.1038/embor.2011.173; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabbioni S, 1997, CANCER RES, V57, P4493; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003	37	51	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42042	42052		10.1074/jbc.M112.417212	http://dx.doi.org/10.1074/jbc.M112.417212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076152	hybrid, Green Published			2022-12-25	WOS:000312103000043
J	Kim, JJ; Khalid, O; Vo, S; Sun, HH; Wong, DTW; Kim, Y				Kim, Jeffrey J.; Khalid, Omar; Vo, Sheynie; Sun, Ho-hyun; Wong, David T. W.; Kim, Yong			A Novel Regulatory Factor Recruits the Nucleosome Remodeling Complex to Wingless Integrated (Wnt) Signaling Gene Promoters in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; INTRAGENIC DNA METHYLATION; BETA-CATENIN; CHROMATIN-STRUCTURE; DIFFERENTIATION; NURD; PLURIPOTENCY; TRANSCRIPTION; EXPRESSION; THERAPY	The nucleosome remodeling and deacetylation (NuRD) complex is required for modulating the transcription of essential pluripotency genes in ESC self-renewal. MBD3 is considered a key player in the formation of a functional NuRD complex. The recruitment of MBD3 to methylated promoters may require other prerequisite factors. We show that cyclin-dependent kinase 2-associated protein 1 (CDK2AP1), an essential gene for early embryonic development, plays a role in pluripotency of ESC by engaging MBD3 to the promoter region of Wnt signaling genes. The occupancy of MBD3 on several promoters of Wnt genes was significantly lost in the absence of CDK2AP1, resulting in hyperactivation of Wnt. We propose that the transcriptional modulation of the Wnt pathway mediated by NuRD requires the presence of essential auxiliary components such as CDK2AP1, which may aid the association of the complex with specific focal regions of the target promoters.	[Kim, Jeffrey J.; Khalid, Omar; Vo, Sheynie; Sun, Ho-hyun; Kim, Yong] Univ Calif Los Angeles, Lab Stem Cell & Canc Epigenet Res, Los Angeles, CA 90095 USA; [Kim, Jeffrey J.; Khalid, Omar; Wong, David T. W.; Kim, Yong] Univ Calif Los Angeles, Sch Dent, Dent Res Inst, Los Angeles, CA 90095 USA; [Wong, David T. W.; Kim, Yong] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Lab Stem Cell & Canc Epigenet Res, 10833 Le Conte Ave,73-035 CHS, Los Angeles, CA 90095 USA.	thadyk@ucla.edu		Sun, Ho-Hyun/0000-0002-7963-4633	California Institute of Regenerative Medicine [RB2-01562]; National Institutes of Health, NIDCR [R01DE014857, F30DE020003, T32DE07269]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F30DE020003, R01DE014857] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a California Institute of Regenerative Medicine grant (Basic Biology Award II, RB2-01562) (to Y. K.) and National Institutes of Health, NIDCR Grants R01DE014857 (to D. T. W. W.), F30DE020003 (to J. J. K.), and T32DE07269 (to O. K.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; Collins CA, 2011, DEVELOPMENT, V138, P5189, DOI 10.1242/dev.064592; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Latos PA, 2012, BIOL OPEN, V1, P341, DOI 10.1242/bio.2012513; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maniatis T., 1982, MOL CLONING LABORATO, pA840 A851; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Reddy BA, 2010, MOL CELL BIOL, V30, P5234, DOI 10.1128/MCB.00266-10; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Sambrook J, 2006, CSH PROTOC, V1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schroeder IS, 2012, CURR DIABETES REP, V12, P490, DOI 10.1007/s11892-012-0292-5; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	57	12	13	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41103	41117		10.1074/jbc.M112.416545	http://dx.doi.org/10.1074/jbc.M112.416545			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23074223	Green Published, hybrid			2022-12-25	WOS:000311887600027
J	Beguer-Pon, M; Benchetrit, J; Castonguay, M; Aarestrup, K; Campana, SE; Stokesbury, MJW; Dodson, JJ				Beguer-Pon, Melanie; Benchetrit, Jose; Castonguay, Martin; Aarestrup, Kim; Campana, Steven E.; Stokesbury, Michael J. W.; Dodson, Julian J.			Shark Predation on Migrating Adult American Eels (Anguilla rostrata) in the Gulf of St. Lawrence	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; EUROPEAN SILVER EEL; LATE FRESH-WATER; PATTERNS; TEMPERATURE; RECRUITMENT; PORBEAGLE; SURVIVAL; BEHAVIOR; MAKO	In an attempt to document the migratory pathways and the environmental conditions encountered by American eels during their oceanic migration to the Sargasso Sea, we tagged eight silver eels with miniature satellite pop-up tags during their migration from the St. Lawrence River in Quebec, Canada. Surprisingly, of the seven tags that successfully transmitted archived data, six were ingested by warm-gutted predators, as observed by a sudden increase in water temperature. Gut temperatures were in the range of 20 to 25 degrees C-too cold for marine mammals but within the range of endothermic fish. In order to identify the eel predators, we compared their vertical migratory behavior with those of satellite-tagged porbeagle shark and bluefin tuna, the only endothermic fishes occurring non-marginally in the Gulf of St. Lawrence. We accurately distinguished between tuna and shark by using the behavioral criteria generated by comparing the diving behavior of these two species with those of our unknown predators. Depth profile characteristics of most eel predators more closely resembled those of sharks than those of tuna. During the first days following tagging, all eels remained in surface waters and did not exhibit diel vertical migrations. Three eels were eaten at this time. Two eels exhibited inverse diel vertical migrations (at surface during the day) during several days prior to predation. Four eels were eaten during daytime, whereas the two night-predation events occurred at full moon. Although tagging itself may contribute to increasing the eel's susceptibility to predation, we discuss evidence suggesting that predation of silver-stage American eels by porbeagle sharks may represent a significant source of mortality inside the Gulf of St. Lawrence and raises the possibility that eels may represent a reliable, predictable food resource for porbeagle sharks.	[Beguer-Pon, Melanie; Benchetrit, Jose; Dodson, Julian J.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Castonguay, Martin] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Aarestrup, Kim] Tech Univ Denmark, Natl Inst Aquat Resource, Silkeborg, Denmark; [Campana, Steven E.] Canadian Shark Res Lab Bedford, Inst Oceanog, Dartmouth, NS, Canada; [Stokesbury, Michael J. W.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada	Laval University; Fisheries & Oceans Canada; Technical University of Denmark; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Acadia University	Beguer-Pon, M (corresponding author), Univ Laval, Dept Biol, Pavillon Vachon, Quebec City, PQ G1K 7P4, Canada.	melanie.beguer.1@ulaval.ca	Campana, Steven/L-7918-2019; Aarestrup, Kim/AAK-9155-2021	Campana, Steven/0000-0002-7453-3761; Aarestrup, Kim/0000-0001-8521-6270	Natural Science and Engineering Research Council of Canada; Canadian Foundation for Innovation	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	Funding for this project was provided to Julian J. Dodson and Martin Castonguay as part of the Ocean Tracking Strategic Network funded by the Natural Science and Engineering Research Council of Canada and the Canadian Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2008, FISHERIES MANAG ECOL, V15, P435, DOI 10.1111/j.1365-2400.2008.00639.x; Aarestrup K, 2010, AQUAT BIOL, V9, P263, DOI 10.3354/ab00260; Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Burgerhout E, 2011, NATURWISSENSCHAFTEN, V98, P631, DOI 10.1007/s00114-011-0805-0; Campana SE, 2010, CAN J FISH AQUAT SCI, V67, P769, DOI 10.1139/F10-020; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8; CASTONGUAY M, 1994, CAN J FISH AQUAT SCI, V51, P479, DOI 10.1139/f94-050; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; Chase BC, 2002, FISH B-NOAA, V100, P168; Daverat F, 2006, MAR ECOL PROG SER, V307, P247, DOI 10.3354/meps307247; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Friedland KD, 2007, ICES J MAR SCI, V64, P519, DOI 10.1093/icesjms/fsm022; Gilbert D, 1997, CAN J FISH AQUAT SCI, V54, P57, DOI 10.1139/cjfas-54-S1-57; Goldman KJ, 2004, ENVIRON BIOL FISH, V71, P403, DOI 10.1007/s10641-004-6588-9; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Hulbert LB, 2005, J FISH BIOL, V67, P490, DOI 10.1111/j.0022-1112.2005.00757.x; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Jellyman D, 2010, MAR ECOL PROG SER, V404, P241, DOI 10.3354/meps08468; Joyce WN, 2002, ICES J MAR SCI, V59, P1263, DOI 10.1006/jmsc.2002.1286; Kerstetter DW, 2004, FISH B-NOAA, V102, P750; Manabe R, 2011, MAR ECOL PROG SER, V437, P229, DOI 10.3354/meps09266; Methling C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020797; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Nagasawa Kazuya, 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P419; Pleizier NK, J FISH BIOL IN PRESS; Polovina JJ, 2008, MAR BIOL, V153, P257, DOI 10.1007/s00227-007-0801-2; Rencher AC, 2002, METHODS MULTIVARIATE; Schmidt J., 1925, Annual Report Smithsonian Institution, V1924, P279; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; Sepulveda CA, 2004, MAR BIOL, V145, P191, DOI 10.1007/s00227-004-1356-0; Stokesbury MJW, 2011, BIOL CONSERV, V144, P2684, DOI 10.1016/j.biocon.2011.07.029; Tesch F-W., 2003, EEL; Therriault J.-C., 1991, CAN SPEC PUBL FISH A; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Velez-Espino LA, 2010, REV FISH BIOL FISHER, V20, P163, DOI 10.1007/s11160-009-9127-0; Westerberg H, 2011, MIGRATION BEHAV STOC; Westerberg H, 2007, ICES J MAR SCI, V64, P1457, DOI 10.1093/icesjms/fsm079; Williams R, 2010, MAR ECOL PROG SER, V414, P249, DOI 10.3354/meps08718	40	65	66	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46830	10.1371/journal.pone.0046830	http://dx.doi.org/10.1371/journal.pone.0046830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082131	Green Published, gold			2022-12-25	WOS:000311146900026
J	Li, HM; Chen, D; Zhang, J				Li, Huimin; Chen, Dan; Zhang, Jing			Analysis of Intron Sequence Features Associated with Transcriptional Regulation in Human Genes	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN GENES; HUMAN GENOME; CPG ISLANDS; ENHANCER; IDENTIFICATION; METHYLATION; EXPRESSION; PROMOTER; ELEMENTS; PATTERNS	Although some preliminary work has revealed the potential transcriptional regulatory function of the introns in eukaryotes, additional evidences are needed to support this conjecture. In this study, we perform systemic analyses of the sequence characteristics of human introns. The results show that the first introns are generally longer and C, G and their dinucleotide compositions are over-represented relative to other introns, which are consistent with the previous findings. In addition, some new phenomena concerned with transcriptional regulation are found: i) the first introns are enriched in CpG islands; and ii) the percentages of the first introns containing TATA, CAAT and GC boxes are relatively higher than other position introns. The similar features of introns are observed in tissue-specific genes. The results further support that the first introns of human genes are likely to be involved in transcriptional regulation, and give an insight into the transcriptional regulatory regions of genes.	[Chen, Dan; Zhang, Jing] Yunnan Univ, Sch Math & Stat, Kunming, Peoples R China; [Li, Huimin; Chen, Dan] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Li, Huimin] Yunnan Univ Nationalities, Sch Math & Comp Sci, Kunming, Peoples R China	Yunnan University; Yunnan University; Yunnan Minzu University	Zhang, J (corresponding author), Yunnan Univ, Sch Math & Stat, Kunming, Peoples R China.	zhangjing@ynu.edu.cn			Science Foundation of Yunnan Province [2007A023M]; National Natural Science Foundation of China [11261066]	Science Foundation of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the Science Foundation of Yunnan Province (2007A023M) and a grant from the National Natural Science Foundation of China (11261066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Chen CF, 2002, P NATL ACAD SCI USA, V99, P2930, DOI 10.1073/pnas.052692099; Choi J, 2006, DEV BIOL, V296, P537, DOI 10.1016/j.ydbio.2006.04.470; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; Ge BS, 2003, J IMMUNOL, V171, P4210, DOI 10.4049/jimmunol.171.8.4210; Haverty PM, 2002, NUCLEIC ACIDS RES, V30, P214, DOI 10.1093/nar/30.1.214; Hu HY, 2007, GENOMICS, V90, P421, DOI 10.1016/j.ygeno.2007.07.003; Hu J, 2010, COMPUT BIOL CHEM, V34, P106, DOI 10.1016/j.compbiolchem.2010.03.008; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Kalari Krishna R., 2006, In Silico Biology, V6, P237; Klamut HJ, 1996, HUM MOL GENET, V5, P1599, DOI 10.1093/hmg/5.10.1599; Lamond AI, 1999, NATURE, V397, P655, DOI 10.1038/17697; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; [李慧敏 Li Huimin], 2010, [云南大学学报. 自然科学版, Journal of Yunnan University. Natural Science], V32, P338; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Makalowski W, 2000, GENE, V259, P61, DOI 10.1016/S0378-1119(00)00436-4; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Wilson MA, 2002, J CELL BIOCHEM, V85, P601, DOI 10.1002/jcb.10168; Ying S, 2010, J INVEST DERMATOL, V130, P2543, DOI 10.1038/jid.2010.179; Zhang J, 2003, COMPUT BIOL CHEM, V27, P497, DOI 10.1016/j.compbiolchem.2003.09.005	34	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46784	10.1371/journal.pone.0046784	http://dx.doi.org/10.1371/journal.pone.0046784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082130	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900025
J	Williams, TM; Loman, NJ; Ebruke, C; Musher, DM; Adegbola, RA; Pallen, MJ; Weinstock, GM; Antonio, M				Williams, Tiffany M.; Loman, Nicholas J.; Ebruke, Chinelo; Musher, Daniel M.; Adegbola, Richard A.; Pallen, Mark J.; Weinstock, George M.; Antonio, Martin			Genome Analysis of a Highly Virulent Serotype 1 Strain of Streptococcus pneumoniae from West Africa	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; MULTIPLE SEQUENCE ALIGNMENT; MOLECULAR EPIDEMIOLOGY; MOSAIC CHROMOSOMES; BINDING-PROTEINS; IDENTIFICATION; GENES; CHILDREN; MENINGITIS; DIVERSITY	Streptococcus pneumoniae is a leading cause of pneumonia, meningitis, and bacteremia, estimated to cause 2 million deaths annually. The majority of pneumococcal mortality occurs in developing countries, with serotype 1 a leading cause in these areas. To begin to better understand the larger impact that serotype 1 strains have in developing countries, we characterized virulence and genetic content of PNI0373, a serotype 1 strain from a diseased patient in The Gambia. PNI0373 and another African serotype 1 strain showed high virulence in a mouse intraperitoneal challenge model, with 20% survival at a dose of 1 cfu. The PNI0373 genome sequence was similar in structure to other pneumococci, with the exception of a 100 kb inversion. PNI0373 showed only15 lineage specific CDS when compared to the pan-genome of pneumococcus. However analysis of non-core orthologs of pneumococcal genomes, showed serotype 1 strains to be closely related. Three regions were found to be serotype 1 associated and likely products of horizontal gene transfer. A detailed inventory of known virulence factors showed that some functions associated with colonization were absent, consistent with the observation that carriage of this highly virulent serotype is unusual. The African serotype 1 strains thus appear to be closely related to each other and different from other pneumococci despite similar genetic content.	[Williams, Tiffany M.; Weinstock, George M.] Washington Univ, Genome Inst, St Louis, MO 63130 USA; [Loman, Nicholas J.; Pallen, Mark J.] Univ Birmingham, Ctr Syst Biol, Birmingham, W Midlands, England; [Ebruke, Chinelo; Adegbola, Richard A.; Antonio, Martin] MRC Labs, Bacterial Dis Programme, Banjul, Gambia; [Musher, Daniel M.] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX USA	Washington University (WUSTL); University of Birmingham; MRC Laboratory Molecular Biology; Baylor College of Medicine	Weinstock, GM (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63130 USA.	gweinsto@genome.wustl.edu	Weinstock, George M/C-6314-2013; Loman, Nicholas/Z-1573-2019	Weinstock, George M/0000-0002-2997-4592; Loman, Nicholas/0000-0002-9843-8988; Pallen, Mark/0000-0003-1807-3657	NIH-NHGRI [U54HG003079, U54HG004968]; Medical Research Council, UK; MRC [MC_U190074190, MC_U190081991] Funding Source: UKRI; Medical Research Council [MC_U190081991, MC_U190074190] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG003079] Funding Source: NIH RePORTER	NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research was supported by grants from NIH-NHGRI U54HG003079 and U54HG004968. We also thank The Medical Research Council, UK for funding in The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; BORODOVSKY M, 1993, BIOSYSTEMS, V30, P161, DOI 10.1016/0303-2647(93)90068-N; Bridy-Pappas AE, 2005, PHARMACOTHERAPY, V25, P1193, DOI 10.1592/phco.2005.25.9.1193; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brueggemann AB, 2003, J CLIN MICROBIOL, V41, P4966, DOI 10.1128/JCM.41.11.4966-4970.2003; Chiavolini D, 2008, CLIN MICROBIOL REV, V21, P666, DOI 10.1128/CMR.00012-08; Chou AC, 2008, J MED MICROBIOL, V57, P839, DOI 10.1099/jmm.0.47612-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Gonzalez BE, 2004, J CLIN MICROBIOL, V42, P2810, DOI 10.1128/JCM.42.6.2810-2812.2004; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Holliman RE, 2007, T ROY SOC TROP MED H, V101, P405, DOI 10.1016/j.trstmh.2006.08.014; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hsieh Yu-Chia, 2008, Chang Gung Med J, V31, P117; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Klugman Keith P., 2008, P317; KLUGMAN KP, 1988, J INFECT DIS, V158, P956, DOI 10.1093/infdis/158.5.956; KOSTYUKOVA NN, 1995, FEMS IMMUNOL MED MIC, V10, P133, DOI 10.1111/j.1574-695X.1995.tb00022.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lopez R, 2004, INT MICROBIOL, V7, P163; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mehiri-Zghal E, 2010, DIAGN MICR INFEC DIS, V66, P225, DOI 10.1016/j.diagmicrobio.2009.05.008; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Mulholland K, 1999, VACCINE, V17, pS79, DOI 10.1016/S0264-410X(99)00112-7; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Organization WH, 1999, PNEUM VACC, P177; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Ramdani-Bouguessa N, 2003, ANTIMICROB AGENTS CH, V47, P824, DOI 10.1128/AAC.47.2.824-826.2003; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940; YOTHER J, 1982, INFECT IMMUN, V36, P184, DOI 10.1128/IAI.36.1.184-188.1982; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	75	27	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e26742	10.1371/journal.pone.0026742	http://dx.doi.org/10.1371/journal.pone.0026742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082106	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900001
J	Ma, YB; Xu, YX; Yestrepsky, BD; Sorenson, RJ; Chen, M; Larsen, SD; Sun, HM				Ma, Yibao; Xu, Yuanxi; Yestrepsky, Bryan D.; Sorenson, Roderick J.; Chen, Meng; Larsen, Scott D.; Sun, Hongmin			Novel Inhibitors of Staphylococcus aureus Virulence Gene Expression and Biofilm Formation	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS; PROTEIN-A; ANTIMICROBIAL PEPTIDES; ANTIBIOTIC DEVELOPMENT; PUBLIC-HEALTH; REGULATOR AGR; ALPHA-TOXIN; INFECTIONS; EPIDERMIDIS; MICROORGANISMS	Staphylococcus aureus is a major human pathogen and one of the more prominent pathogens causing biofilm related infections in clinic. Antibiotic resistance in S. aureus such as methicillin resistance is approaching an epidemic level. Antibiotic resistance is widespread among major human pathogens and poses a serious problem for public health. Conventional antibiotics are either bacteriostatic or bacteriocidal, leading to strong selection for antibiotic resistant pathogens. An alternative approach of inhibiting pathogen virulence without inhibiting bacterial growth may minimize the selection pressure for resistance. In previous studies, we identified a chemical series of low molecular weight compounds capable of inhibiting group A streptococcus virulence following this alternative anti-microbial approach. In the current study, we demonstrated that two analogs of this class of novel anti-virulence compounds also inhibited virulence gene expression of S. aureus and exhibited an inhibitory effect on S. aureus biofilm formation. This class of anti-virulence compounds could be a starting point for development of novel anti-microbial agents against S. aureus.	[Yestrepsky, Bryan D.; Sorenson, Roderick J.; Larsen, Scott D.] Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, Ann Arbor, MI 48109 USA; [Ma, Yibao; Xu, Yuanxi; Sun, Hongmin] Univ Missouri, Dept Internal Med, Columbia, MO USA; [Chen, Meng] Nanova Inc, Columbia, MO USA	University of Michigan System; University of Michigan; University of Missouri System; University of Missouri Columbia	Larsen, SD (corresponding author), Univ Michigan, Coll Pharm, Vahlteich Med Chem Core, 428 Church St, Ann Arbor, MI 48109 USA.	sdlarsen@umich.edu; sunh@health.missouri.edu	Ma, Yibao/H-3849-2016	Ma, Yibao/0000-0002-3270-8893	National Institutes of Health (NIH) [P01HL573461, T32 GM007767]; University of Michigan Life Sciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Life Sciences Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant P01HL573461 (HS), University of Michigan Life Sciences Institute Innovation Partnership grant (HS and SDL), and NIH Pharmacological Sciences Training Program Grant T32 GM007767 (BDY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, FEMS IMMUNOL MED MIC, V58, P147, DOI 10.1111/j.1574-695X.2009.00601.x; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Bax R, 2000, INT J ANTIMICROB AG, V16, P51, DOI 10.1016/S0924-8579(00)00189-8; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Boles B.R., 2011, TRENDS MICROBIOL; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2001, METHOD ENZYMOL, V336, P239, DOI 10.1016/S0076-6879(01)36593-X; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Deighton MA, 2001, METHOD ENZYMOL, V336, P177, DOI 10.1016/S0076-6879(01)36589-8; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McGillivray SM, 2012, ANTIMICROB AGENTS CH, V56, P1854, DOI 10.1128/AAC.05131-11; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; NOVICK RP, 1965, J BACTERIOL, V90, P467, DOI 10.1128/JB.90.2.467-480.1965; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2004, FRONT BIOSCI-LANDMRK, V9, P841, DOI 10.2741/1295; Otto M, 2009, MED RES REV, P1; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Rasko DA, 2009, CURR PROTOC MICROBIO; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; REGASSA LB, 1992, INFECT IMMUN, V60, P3381, DOI 10.1128/IAI.60.8.3381-3388.1992; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Shaw LN, 2005, J BACTERIOL, V187, P1751, DOI 10.1128/JB.187.5.1751-1762.2005; Smagur J, 2009, BIOL CHEM, V390, P361, DOI 10.1515/BC.2009.042; Sun H, 2011, J THROMB HAEMOST, V9, P189, DOI 10.1111/j.1538-7836.2011.04316.x; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084; Waldor MK, 2006, NEW ENGL J MED, V354, P296, DOI 10.1056/NEJMcibr054591; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2012, BIOTECHNOL BIOENG, V109, P336, DOI 10.1002/bit.23342; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Zhang LQ, 2010, PROTEIN EXPRES PURIF, V69, P204, DOI 10.1016/j.pep.2009.09.007	74	57	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47255	10.1371/journal.pone.0047255	http://dx.doi.org/10.1371/journal.pone.0047255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077578	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100081
J	Martinez, EE; Anderson, PD; Logan, M; Abdulkadir, SA				Martinez, Erin E.; Anderson, Philip D.; Logan, Monica; Abdulkadir, Sarki A.			Antioxidant Treatment Promotes Prostate Epithelial Proliferation in Nkx3.1 Mutant Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; VITAMIN-E; N-ACETYLCYSTEINE; TARGET GENES; TRAMP MICE; CANCER; EXPRESSION; PREVENTION; CELL; SELENIUM	Discordant results in preclinical and clinical trials have raised questions over the effectiveness of antioxidants in prostate cancer chemoprevention. Results from the large-scale Selenium and Vitamin E Cancer Prevention Trial (SELECT) showed that antioxidants failed to prevent, and in some cases promoted, prostate cancer formation in men without a history of the disease. One possible explanation for these alarming results is the notion that the effects of antioxidant treatment on the prostate are modified by specific, intrinsic genetic risk factors, causing some men to respond negatively to antioxidant treatment. Loss of expression of the homeobox transcription factor NKX3.1 in the prostate is frequently associated with human prostate cancer. Nkx3.1 mutant mice display prostatic hyperplasia and dysplasia and are used as a model of the early stages of prostate cancer initiation. While the mechanisms by which Nkx3.1 loss promotes prostate tumorigenicity are not completely understood, published data have suggested that elevated reactive oxygen species (ROS) associated with Nkx3.1 loss may be a causative factor. Here we have tested this hypothesis by treating Nkx3.1 mutant mice with the antioxidant N-acetylcysteine (NAC) for 13 weeks post-weaning. Surprisingly, while NAC treatment decreased ROS levels in Nkx3.1 mutant mouse prostates, it failed to reduce prostatic epithelial hyperplasia/dysplasia. Rather, NAC treatment increased epithelial cell proliferation and promoted the expression of a pro-proliferative gene signature. These results show that ROS do not promote proliferation in the Nkx3.1-null prostate, but instead inhibit proliferation, suggesting that antioxidant treatment may encourage prostate epithelial cell proliferation early in prostate tumorigenesis. Our findings provide new insight that may help explain the increased prostate cancer risk observed with vitamin E treatment in the SELECT trial and emphasize the need for preclinical studies using accurate models of cancer.	[Martinez, Erin E.; Anderson, Philip D.; Abdulkadir, Sarki A.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Logan, Monica] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Abdulkadir, Sarki A.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Meharry Medical College; Vanderbilt University	Abdulkadir, SA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	sarki.abdulkadir@vanderbilt.edu			National Cancer Institute (NCI) [R01 CA094858]; Vanderbilt Ingram Cancer Center [P30 CA068485]; Department of Defense [W81XWH-11-1-0230]; National Heart, Lung, and Blood Institute [2T32H007735-17]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA094858] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt Ingram Cancer Center; Department of Defense(United States Department of Defense); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA094858 from the National Cancer Institute (NCI) to SAA and Vanderbilt Ingram Cancer Center Support Grant P30 CA068485. PDA was supported by Department of Defense Postdoctoral Fellowship Award W81XWH-11-1-0230. ML was supported by 2T32H007735-17 from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2005, ANN NY ACAD SCI, V1059, P33, DOI 10.1196/annals.1339.018; Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Abe M, 2011, BJU INT, V107, P126, DOI 10.1111/j.1464-410X.2010.09344.x; Adhami VM, 2003, J NUTR, V133, p2417S, DOI 10.1093/jn/133.7.2417S; Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; Akamatsu S, 2010, HUM MOL GENET, V19, P4265, DOI 10.1093/hmg/ddq350; Anderson PD, 2012, J CLIN INVEST, V122, P1907, DOI 10.1172/JCI58540; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Barve A, 2009, INT J CANCER, V124, P1693, DOI 10.1002/ijc.24106; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bowen C, 2000, CANCER RES, V60, P6111; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Bowen C, 2010, CANCER RES, V70, P3089, DOI 10.1158/0008-5472.CAN-09-3138; Chaudhuri L, 2010, FREE RADICAL BIO MED, V49, P40, DOI 10.1016/j.freeradbiomed.2010.03.012; Chen CY, 2008, J NAT PROD, V71, P933, DOI 10.1021/np070620e; Chen H, 2002, CANCER RES, V62, P338; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Fleshner NE, 1998, CANCER METAST REV, V17, P325, DOI 10.1023/A:1006118628183; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Khan N, 2012, BUTEIN INDUCES APOPT; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kim J, 2012, ONCOGENE, V31, P322, DOI 10.1038/onc.2011.236; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kim MJ, 2002, CANCER RES, V62, P2999; Kim Tae Hyong, 2005, Angiogenesis, V8, P307; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Klein EA, 2009, J NATL CANCER I, V101, P283, DOI 10.1093/jnci/djp009; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li HJ, 2005, CANCER RES, V65, P2498, DOI 10.1158/0008-5472.CAN-04-3535; Li M, 2009, ANAT REC, V292, P1107, DOI 10.1002/ar.20925; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; McCormick DL, 2010, CANCER PREV RES, V3, P381, DOI 10.1158/1940-6207.CAPR-09-0176; McNeil C, 2011, J NATL CANCER I, V103, P1731, DOI 10.1093/jnci/djr504; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mikhak B, 2008, CARCINOGENESIS, V29, P2335, DOI 10.1093/carcin/bgn212; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muhlbradt E, 2009, CANCER RES, V69, P2615, DOI 10.1158/0008-5472.CAN-08-3022; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nyska A, 2003, TOXICOL PATHOL, V31, P39, DOI 10.1080/01926230390173833; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Ozten-Kandas Nur, 2011, J Carcinog, V10, P27, DOI 10.4103/1477-3163.90438; Pan JS, 2009, WORLD J GASTROENTERO, V15, P1702, DOI 10.3748/wjg.15.1702; Pathak SK, 2005, EUR J CANCER, V41, P61, DOI 10.1016/j.ejca.2004.09.028; Quick SK, 2008, CANCER EPIDEM BIOMAR, V17, P1082, DOI 10.1158/1055-9965.EPI-07-2755; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Ruscica M, 2007, PEPTIDES, V28, P426, DOI 10.1016/j.peptides.2006.08.045; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Shiota M, 2012, J UROLOGY, V187, P707, DOI 10.1016/j.juro.2011.09.147; Singh Rajendra K, 2010, J Cancer Sci Ther, V2, P89; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam NNC, 2006, PROSTATE, V66, P57, DOI 10.1002/pros.20313; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Thapa D, 2012, BIOCHEM PHARMACOL, V83, P1319, DOI 10.1016/j.bcp.2011.12.027; Venkateswaran V, 2004, CANCER RES, V64, P5891, DOI 10.1158/0008-5472.CAN-04-0690; Vindrieux D, 2009, ENDOCR-RELAT CANCER, V16, P663, DOI 10.1677/ERC-09-0109; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Zhang HY, 2008, CANCER RES, V68, P8770, DOI 10.1158/0008-5472.CAN-08-1912; Zhang JJ, 2010, UROLOGY, V75, P779, DOI 10.1016/j.urology.2009.08.063	74	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46792	10.1371/journal.pone.0046792	http://dx.doi.org/10.1371/journal.pone.0046792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077524	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100041
J	Nair, R; Ngangan, AV; Kemp, ML; McDevitt, TC				Nair, Rekha; Ngangan, Alyssa V.; Kemp, Melissa L.; McDevitt, Todd C.			Gene Expression Signatures of Extracellular Matrix and Growth Factors during Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							SUSPENSION-CULTURE; MOUSE EMBRYOS; BODIES; MICROARRAY; PROFILES; SYSTEMS; MODEL; LINES; BMP4	Pluripotent stem cells are uniquely capable of differentiating into somatic cell derivatives of all three germ lineages, therefore holding tremendous promise for developmental biology studies and regenerative medicine therapies. Although temporal patterns of phenotypic gene expression have been relatively well characterized during the course of differentiation, coincident patterns of endogenous extracellular matrix (ECM) and growth factor expression that accompany pluripotent stem cell differentiation remain much less well-defined. Thus, the objective of this study was to examine the global dynamic profiles of ECM and growth factor genes associated with early stages of pluripotent mouse embryonic stem cell (ESC) differentiation. Gene expression analysis of ECM and growth factors by ESCs differentiating as embryoid bodies for up to 14 days was assessed using PCR arrays (172 unique genes total), and the results were examined using a variety of data mining methods. As expected, decreases in the expression of genes regulating pluripotent stem cell fate preceded subsequent increases in morphogen expression associated with differentiation. Pathway analysis generated solely from ECM and growth factor gene expression highlighted morphogenic cell processes within the embryoid bodies, such as cell growth, migration, and intercellular signaling, that are required for primitive tissue and organ developmental events. In addition, systems analysis of ECM and growth factor gene expression alone identified intracellular molecules and signaling pathways involved in the progression of pluripotent stem cell differentiation that were not contained within the array data set. Overall, these studies represent a novel framework to dissect the complex, dynamic nature of the extracellular biochemical milieu of stem cell microenvironments that regulate pluripotent cell fate decisions and morphogenesis.	[Nair, Rekha; Ngangan, Alyssa V.; Kemp, Melissa L.; McDevitt, Todd C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Nair, Rekha; Ngangan, Alyssa V.; Kemp, Melissa L.; McDevitt, Todd C.] Emory Univ, Atlanta, GA 30322 USA; [Kemp, Melissa L.; McDevitt, Todd C.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology	McDevitt, TC (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	todd.mcdevitt@bme.gatech.edu		Kemp, Melissa/0000-0003-3781-8802	National Institutes of Health (NIH) [EB007316, T32 GM008433]; Georgia Tech/Emory Center for Regenerative Medicine (GTEC) [NSF EEC-9731463]; Emergent Behaviors of Integrated Cellular Systems Science and Technology Center (EBICS) [NSF STC-0939511]; National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008433] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Tech/Emory Center for Regenerative Medicine (GTEC); Emergent Behaviors of Integrated Cellular Systems Science and Technology Center (EBICS); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funding from the National Institutes of Health (NIH) (EB007316), the Georgia Tech/Emory Center for Regenerative Medicine (GTEC, NSF EEC-9731463) and the Emergent Behaviors of Integrated Cellular Systems Science and Technology Center (EBICS, NSF STC-0939511). RN was supported by a National Science Foundation Graduate Research Fellowship and AN was supported by NIH training grant T32 GM008433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya B, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-22; Boyd NL, 2007, EXP BIOL MED, V232, P833; Carpenedo RL, 2007, STEM CELLS, V25, P2224, DOI 10.1634/stemcells.2006-0523; Chen SS, 2007, STEM CELLS, V25, P553, DOI 10.1634/stemcells.2006-0419; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Grinnell KL, 2007, CELL PROLIFERAT, V40, P685, DOI 10.1111/j.1365-2184.2007.00464.x; Gunji W, 2004, BIOCHEM BIOPH RES CO, V325, P265, DOI 10.1016/j.bbrc.2004.10.025; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; Hopfl G, 2004, METH MOL B, V254, P79; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kelly DL, 2000, MOL REPROD DEV, V56, P113, DOI 10.1002/(SICI)1098-2795(200006)56:2&lt;113::AID-MRD1&gt;3.0.CO;2-Q; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Michelini M, 2006, CELL PROLIFERAT, V39, P217, DOI 10.1111/j.1365-2184.2006.00381.x; Nair R, 2008, J BIOMED MAT RES A; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Nourse MB, ARTERIOSCLER THROMB, V30, P80; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren JQ, 2011, CYTOTHERAPY, V13, P661, DOI 10.3109/14653249.2010.548379; Sargent CY, 2009, TISSUE ENG PT A, V15, P331, DOI 10.1089/ten.tea.2008.0145; Sargent CY, BIOTECHNOL BIOENG, V105, P611; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Shukla S, J HISTOCHEM CYTOCHEM, V58, P345; Singla DK, 2007, AM J PHYSIOL-HEART C, V293, pH1590, DOI 10.1152/ajpheart.00431.2007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5	35	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e42580	10.1371/journal.pone.0042580	http://dx.doi.org/10.1371/journal.pone.0042580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077480	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100008
J	Wada, A; Kono, M; Kawauchi, S; Takagi, Y; Morikawa, T; Funakoshi, K				Wada, Atsushi; Kono, Mari; Kawauchi, Sawako; Takagi, Yuri; Morikawa, Takashi; Funakoshi, Kunihiro			Rapid Discrimination of Gram-Positive and Gram-Negative Bacteria in Liquid Samples by Using NaOH-Sodium Dodecyl Sulfate Solution and Flow Cytometry	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; SYSMEX UF-1000I; DIAGNOSIS	Background: For precise diagnosis of urinary tract infections (UTI), and selection of the appropriate prescriptions for their treatment, we explored a simple and rapid method of discriminating gram-positive and gram-negative bacteria in liquid samples. Methodology/Principal Findings: We employed the NaOH-sodium dodecyl sulfate (SDS) solution conventionally used for plasmid extraction from Escherichia coli and the automated urine particle analyzer UF-1000i (Sysmex Corporation) for our novel method. The NaOH-SDS solution was used to determine differences in the cell wall structures between gram-positive and gram-negative bacteria, since the tolerance to such chemicals reflects the thickness and structural differences of bacterial cell walls. The UF-1000i instrument was used as a quantitative bacterial counter. We found that gram-negative bacteria, including E. coli, in liquid culture could easily be lysed by direct addition of equal volumes of NaOH-SDS solution. In contrast, Enterococcus faecalis, which is a gram-positive bacterium, could not be completely lysed by the solution. We then optimized the reaction time of the NaOH-SDS treatment at room temperature by using 3 gram-positive and 4 gram-negative bacterial strains and determined that the optimum reaction time was 5 min. Finally, in order to evaluate the generalizability of this method, we treated 8 gram-positive strains and 8 gram-negative strains, or 4 gram-positive and 4 gram-negative strains incubated in voluntary urine from healthy volunteers in the same way and demonstrated that all the gram-positive bacteria were discriminated quantitatively from gram negative bacteria using this method. Conclusions/Significance: Using our new method, we could easily discriminate gram-positive and gram-negative bacteria in liquid culture media within 10 min. This simple and rapid method may be useful for determining the treatment course of patients with UTIs, especially for those without a prior history of UTIs. The method may be easily applied in order to obtain additional information for clinical prescriptions from bacteriuria.	[Wada, Atsushi; Kono, Mari; Kawauchi, Sawako; Takagi, Yuri; Morikawa, Takashi; Funakoshi, Kunihiro] Sysmex Corp, Sci Affairs, Cell Anal Ctr, Nishi Ku, Kobe, Hyogo, Japan	Sysmex Corporation	Wada, A (corresponding author), Sysmex Corp, Sci Affairs, Cell Anal Ctr, Nishi Ku, Kobe, Hyogo, Japan.	Wada.Atsushi@sysmex.co.jp						BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brook I, 2004, INT J UROL, V11, P133, DOI 10.1111/j.1442-2042.2003.00756.x; De Rosa R, 2010, CLIN CHIM ACTA, V411, P1137, DOI 10.1016/j.cca.2010.03.027; Grabe M, 2011, GUIDELINES UROLOGICA; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hauss O, 2008, SYSMEX J INT, V18, P38; HOVELIUS B, 1984, REV INFECT DIS, V6, P328; Hu XZ, 2010, LABMEDICINE, V41, P349, DOI 10.1309/LM9P7LK3HASEOSKD; Imirzalioglu C, 2008, ANDROLOGIA, V40, P66, DOI 10.1111/j.1439-0272.2007.00830.x; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; Jiang T, 2011, SCAND J CLIN LAB INV, V71, P30, DOI 10.3109/00365513.2010.535011; Kadkhoda K, 2011, DIAGN MICR INFEC DIS, V69, P130, DOI 10.1016/j.diagmicrobio.2010.09.013; Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005; Lehmann LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017146; Manoni F, 2010, CLIN CHEM LAB MED, V48, P1107, DOI 10.1515/CCLM.2010.233; Manoni F, 2009, DIAGN MICR INFEC DIS, V65, P103, DOI 10.1016/j.diagmicrobio.2009.06.003; Mohan R, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026846, 10.1371/journal.pone.0026432]; Nagy E, 2009, CLIN MICROBIOL INFEC, V15, P796, DOI 10.1111/j.1469-0691.2009.02788.x; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; Nanos NE, 2008, CLIN CHIM ACTA, V392, P30, DOI 10.1016/j.cca.2008.02.020; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Okada H, 2007, SYSMEX J INT, V17, P95; Okada H, 2006, J CLIN MICROBIOL, V44, P3596, DOI 10.1128/JCM.02543-05; Palmqvist E, 2008, SCAND J CLIN LAB INV, V68, P312, DOI 10.1080/00365510701759703; Pieretti B, 2010, J CLIN MICROBIOL, V48, P3990, DOI 10.1128/JCM.00975-10; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Saadeh SA, 2011, PEDIATR NEPHROL, V26, P1967, DOI 10.1007/s00467-011-1801-5; Saito Takashi, 2005, Journal of Infection and Chemotherapy, V11, P220, DOI 10.1007/s10156-005-0399-6; Sambrook J., 2001, MOL CLONING LAB MANU; SCHWARZ S, 1989, J GEN MICROBIOL, V135, P3329; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Tanji Y, 2004, J BIOTECHNOL, V114, P11, DOI 10.1016/j.jbiotec.2004.05.011; van der Zwet WC, 2010, CLIN CHEM LAB MED, V48, P1765, DOI 10.1515/CCLM.2010.342; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; VOSKUIL MI, 1993, APPL ENVIRON MICROB, V59, P1138, DOI 10.1128/AEM.59.4.1138-1142.1993; Wang J, 2010, AM J CLIN PATHOL, V133, P577, DOI 10.1309/AJCP1GT2JXOCQBCZ; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1	38	29	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47093	10.1371/journal.pone.0047093	http://dx.doi.org/10.1371/journal.pone.0047093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077549	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100059
J	Delagrave, S; Hernandez, H; Zhou, CH; Hamberger, JF; Mundle, ST; Catalan, J; Baloglu, S; Anderson, SF; DiNapoli, JM; Londono-Hayes, P; Parrington, M; Almond, J; Kleanthous, H				Delagrave, Simon; Hernandez, Hector; Zhou, Changhong; Hamberger, John F.; Mundle, Sophia T.; Catalan, John; Baloglu, Simge; Anderson, Stephen F.; DiNapoli, Joshua M.; Londono-Hayes, Patricia; Parrington, Mark; Almond, Jeffrey; Kleanthous, Harry			Immunogenicity and Efficacy of Intramuscular Replication-Defective and Subunit Vaccines against Herpes Simplex Virus Type 2 in the Mouse Genital Model	PLOS ONE			English	Article							GUINEA-PIGS; DELETION MUTANT; HSV-2 DNA; PHASE-I; GLYCOPROTEIN; PROTECTION; IMMUNIZATION; INFECTION; RESPONSES; ADJUVANT	Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwide, causing a range of symptoms that result in significant healthcare costs and human suffering. ACAM529 is a replication-defective vaccine candidate prepared by growing the previously described dl5-29 on a cell line appropriate for GMP manufacturing. This vaccine, when administered subcutaneously, was previously shown to protect mice from a lethal vaginal HSV-2 challenge and to afford better protection than adjuvanted glycoprotein D (gD) in guinea pigs. Here we show that ACAM529 given via the intramuscular route affords significantly greater immunogenicity and protection in comparison with subcutaneous administration in the mouse vaginal HSV-2 challenge model. Further, we describe a side-by-side comparison of intramuscular ACAM529 with a gD vaccine across a range of challenge virus doses. While differences in protection against death are not significant, ACAM529 protects significantly better against mucosal infection, reducing peak challenge virus shedding at the highest challenge dose by over 500-fold versus 5-fold for gD. Over 27% (11/40) of ACAM529-immunized animals were protected from viral shedding while 2.5% (1/40) were protected by the gD vaccine. Similarly, 35% (7/20) of mice vaccinated with ACAM529 were protected from infection of their dorsal root ganglia while none of the gD-vaccinated mice were protected. These results indicate that measuring infection of the vaginal mucosa and of dorsal root ganglia over a range of challenge doses is more sensitive than evaluating survival at a single challenge dose as a means of directly comparing vaccine efficacy in the mouse vaginal challenge model. The data also support further investigation of ACAM529 for prophylaxis in human subjects.	[Delagrave, Simon; Hernandez, Hector; Zhou, Changhong; Hamberger, John F.; Mundle, Sophia T.; Catalan, John; Baloglu, Simge; Anderson, Stephen F.; DiNapoli, Joshua M.; Londono-Hayes, Patricia; Parrington, Mark; Almond, Jeffrey; Kleanthous, Harry] Sanofi Pasteur, Discovery N Amer, Cambridge, MA USA	Sanofi-Aventis	Delagrave, S (corresponding author), Sanofi Pasteur, Discovery N Amer, Cambridge, MA USA.	simon.delagrave@sanofipasteur.com						Akhrameyeva NV, 2011, J VIROL, V85, P5036, DOI 10.1128/JVI.02548-10; Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein DI, 2005, CLIN INFECT DIS, V40, P1271, DOI 10.1086/429240; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Brockman MA, 2006, J VIROL, V80, P7111, DOI 10.1128/JVI.01421-05; Byers AM, 2009, BIOLOGICALS, V37, P148, DOI 10.1016/j.biologicals.2009.02.018; Cattamanchi A, 2008, CLIN VACCINE IMMUNOL, V15, P1638, DOI 10.1128/CVI.00167-08; Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; de Bruyn G, 2006, VACCINE, V24, P914, DOI 10.1016/j.vaccine.2005.08.088; Fisman DN, 2002, SEX TRANSM DIS, V29, P608, DOI 10.1097/00007435-200210000-00008; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Khodai T, 2011, CLIN VACCINE IMMUNOL, V18, P1702, DOI 10.1128/CVI.05071-11; Knuf M, 2010, EUR J PEDIATR, V169, P925, DOI 10.1007/s00431-010-1142-6; Koelle DM, 2008, CLIN VACCINE IMMUNOL, V15, P773, DOI 10.1128/CVI.00020-08; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Milligan GN, 1998, J IMMUNOL, V160, P6093; Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011; Morrison LA, 1997, VIROLOGY, V239, P315, DOI 10.1006/viro.1997.8884; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Schiffer Joshua T, 2009, Curr Infect Dis Rep, V11, P457, DOI 10.1007/s11908-009-0066-7; Siegrist CA, 2008, VACCINES; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Tengvall S, 2006, J VIROL, V80, P5283, DOI 10.1128/JVI.02013-05; Tirabassi RS, 2011, VACCINE, V29, P1090, DOI 10.1016/j.vaccine.2010.11.076	33	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46714	10.1371/journal.pone.0046714	http://dx.doi.org/10.1371/journal.pone.0046714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071620	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700026
J	Okun, E; Barak, B; Saada-Madar, R; Rothman, SM; Griffioen, KJ; Roberts, N; Castro, K; Mughal, MR; Pita, MA; Stranahan, AM; Arumugam, TV; Mattson, MP				Okun, Eitan; Barak, Boaz; Saada-Madar, Ravit; Rothman, Sarah M.; Griffioen, Kathleen J.; Roberts, Nicholas; Castro, Kamilah; Mughal, Mohamed R.; Pita, Mario A.; Stranahan, Alexis M.; Arumugam, Thiruma V.; Mattson, Mark P.			Evidence for a Developmental Role for TLR4 in Learning and Memory	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; ADULT HIPPOCAMPAL NEUROGENESIS; AMYGDALA; HMGB1	Toll-like receptors (TLRs) play essential roles in innate immunity and increasing evidence indicates that these receptors are expressed in neurons, astrocytes and microglia in the brain where they mediate responses to infection, stress and injury. Very little is known about the roles of TLRs in cognition. To test the hypothesis that TLR4 has a role in hippocampus-dependent spatial learning and memory, we used mice deficient for TLR4 and mice receiving chronic TLR4 antagonist infusion to the lateral ventricles in the brain. We found that developmental TLR4 deficiency enhances spatial reference memory acquisition and memory retention, impairs contextual fear-learning and enhances motor functions, traits that were correlated with CREB up-regulation in the hippocampus. TLR4 antagonist infusion into the cerebral ventricles of adult mice did not affect cognitive behavior, but instead affected anxiety responses. Our findings indicate a developmental role for TLR4 in shaping spatial reference memory, and fear learning and memory. Moreover, we show that central TLR4 inhibition using a TLR4 antagonist has no discernible physiological role in regulating spatial and contextual hippocampus-dependent cognitive behavior.	[Okun, Eitan; Saada-Madar, Ravit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel; [Barak, Boaz] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Barak, Boaz] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rothman, Sarah M.; Griffioen, Kathleen J.; Roberts, Nicholas; Castro, Kamilah; Mughal, Mohamed R.; Pita, Mario A.; Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA; [Stranahan, Alexis M.] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA; [Arumugam, Thiruma V.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Bar Ilan University; Tel Aviv University; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Georgia; Augusta University; University of Queensland; Johns Hopkins University	Okun, E (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel.	eitan.okun@biu.ac.il	Stranahan, Alexis/AAF-3559-2020; okun, eitan/K-1314-2016; okun, eitan/AAC-9571-2019; Arumugam, Thiruma Valavan/B-4898-2011; Arumugam, Thiruma/AAG-6958-2019	okun, eitan/0000-0001-8474-1487; okun, eitan/0000-0001-8474-1487; Arumugam, Thiruma/0000-0002-3377-0939; Madar, Ravit/0000-0002-2025-8178; Castro, Kamilah/0000-0002-0176-0998; Barak, Boaz/0000-0001-9724-4578	Intramural Research Program of the National Institute on Aging; Gonda Multidisciplinary Center for Brain Research; Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University; NATIONAL INSTITUTE ON AGING [ZIAAG000317, ZIAAG000332, ZIAAG000312] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Gonda Multidisciplinary Center for Brain Research; Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the Intramural Research Program of the National Institute on Aging and in part by the Gonda Multidisciplinary Center for Brain Research and the Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Hauss-Wegrzyniak B, 2000, NEUROREPORT, V11, P1759, DOI 10.1097/00001756-200006050-00032; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008; Liu CC, 2011, NEUROSCIENCE, V189, P359, DOI 10.1016/j.neuroscience.2011.05.067; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-21; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; MORRIS RGM, 1982, TRENDS NEUROSCI, V5, P3, DOI 10.1016/0166-2236(82)90003-0; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rico JLR, 2010, BEHAV BRAIN RES, V215, P102, DOI 10.1016/j.bbr.2010.07.001; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104	23	91	92	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47522	10.1371/journal.pone.0047522	http://dx.doi.org/10.1371/journal.pone.0047522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071817	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700087
J	Akamatsu, S; Takahashi, A; Takata, R; Kubo, M; Inoue, T; Morizono, T; Tsunoda, T; Kamatani, N; Haiman, CA; Wan, P; Chen, GK; Le Marchand, L; Kolonel, LN; Henderson, BE; Fujioka, T; Habuchi, T; Nakamura, Y; Ogawa, O; Nakagawa, H				Akamatsu, Shusuke; Takahashi, Atsushi; Takata, Ryo; Kubo, Michiaki; Inoue, Takahiro; Morizono, Takashi; Tsunoda, Tatsuhiko; Kamatani, Naoyuki; Haiman, Christopher A.; Wan, Peggy; Chen, Gary K.; Le Marchand, Loic; Kolonel, Laurence N.; Henderson, Brian E.; Fujioka, Tomoaki; Habuchi, Tomonori; Nakamura, Yusuke; Ogawa, Osamu; Nakagawa, Hidewaki			Reproducibility, Performance, and Clinical Utility of a Genetic Risk Prediction Model for Prostate Cancer in Japanese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MULTIPLE LOCI; VARIANTS; ANTIGEN; REPLICATION; POPULATION; 8Q24; IDENTIFICATION; EPIDEMIOLOGY	Prostate specific antigen (PSA) is widely used as a diagnostic biomarker for prostate cancer (PC). However, due to its low predictive performance, many patients without PC suffer from the harms of unnecessary prostate needle biopsies. The present study aims to evaluate the reproducibility and performance of a genetic risk prediction model in Japanese and estimate its utility as a diagnostic biomarker in a clinical scenario. We created a logistic regression model incorporating 16 SNPs that were significantly associated with PC in a genome-wide association study of Japanese population using 689 cases and 749 male controls. The model was validated by two independent sets of Japanese samples comprising 3,294 cases and 6,281 male controls. The areas under curve (AUC) of the model were 0.679, 0.655, and 0.661 for the samples used to create the model and those used for validation. The AUCs were not significantly altered in samples with PSA 1-10 ng/ml. 24.2% and 9.7% of the patients had odds ratio <0.5 (low risk) or >2 (high risk) in the model. Assuming the overall positive rate of prostate needle biopsies to be 20%, the positive biopsy rates were 10.7% and 42.4% for the low and high genetic risk groups respectively. Our genetic risk prediction model for PC was highly reproducible, and its predictive performance was not influenced by PSA. The model could have a potential to affect clinical decision when it is applied to patients with gray-zone PSA, which should be confirmed in future clinical studies.	[Akamatsu, Shusuke; Takata, Ryo; Nakagawa, Hidewaki] RIKEN, Ctr Genom Med, Lab Biomarker Dev, Tokyo, Japan; [Akamatsu, Shusuke; Inoue, Takahiro; Ogawa, Osamu] Kyoto Univ, Dept Urol, Grad Sch Med, Kyoto, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki; Fujioka, Tomoaki] RIKEN, Ctr Genom Med, Lab Stat Anal, Tokyo, Japan; [Takata, Ryo] Iwate Med Univ, Dept Urol, Morioka, Iwate 020, Japan; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Morizono, Takashi; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Haiman, Christopher A.; Wan, Peggy; Chen, Gary K.; Henderson, Brian E.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic; Kolonel, Laurence N.] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Habuchi, Tomonori] Akita Univ, Sch Med, Dept Urol, Akita 010, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan	RIKEN; Kyoto University; RIKEN; Iwate Medical University; RIKEN; RIKEN; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Akita University; University of Tokyo	Nakagawa, H (corresponding author), RIKEN, Ctr Genom Med, Lab Biomarker Dev, Tokyo, Japan.	hidewaki@ims.u-tokyo.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kubo, Michiaki/N-7947-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; 	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government; Japan Society for the Promotion of Science [22390306]; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Japanese Foundation for Prostate Research; United States National Institute of Health [HG004726, CA148537, CA54281, CA63464]; Grants-in-Aid for Scientific Research [22390306, 23659752] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R37CA054281, R01CA063464, R01CA054281, U01CA063464, U19CA148537] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Foundation for Prostate Research; United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government, and was supported in part by Research grant # 22390306 (H. Nakagawa) from the Japan Society for the Promotion of Science, by the Princess Takamatsu Cancer Research Fund (H. Nakagawa), by Takeda Science Foundation (H. Nakagawa), and by The Japanese Foundation for Prostate Research (S. Akamatsu). The Multiethnic Cohort (MEC) was supported by United States National Institute of Health grants HG004726, CA148537, CA54281, and CA63464. S. Akamatsu is a Japan Society for the Promotion of Science Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Antoniou AC, 2010, CANCER RES, V70, P9742, DOI 10.1158/0008-5472.CAN-10-1907; Auprich M, 2012, BJU INT, V109, P1627, DOI 10.1111/j.1464-410X.2011.10584.x; Batra J, 2011, AM J EPIDEMIOL, V174, P1391, DOI 10.1093/aje/kwr271; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Catalona WJ, 2011, CANCER RES, V71, P3442, DOI 10.1158/0008-5472.CAN-11-0314; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Ekwueme Donatus U, 2007, Prev Chronic Dis, V4, pA100; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Ito K, 1997, Int J Urol, V4, P474, DOI 10.1111/j.1442-2042.1997.tb00288.x; Ito K, 2002, CANCER-AM CANCER SOC, V95, P2112, DOI 10.1002/cncr.10941; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kawakami S, 2008, INT J UROL, V15, P1055, DOI 10.1111/j.1442-2042.2008.02183.x; Klein RJ, 2012, EUR UROL, V61, P471, DOI 10.1016/j.eururo.2011.10.047; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lindstrom S, 2012, CANCER EPIDEM BIOMAR, V21, P212, DOI 10.1158/1055-9965.EPI-11-0870-T; LITTRUP PJ, 1994, J UROLOGY, V152, P1873, DOI 10.1016/S0022-5347(17)32405-9; Loeb S, 2007, CANCER LETT, V249, P30, DOI 10.1016/j.canlet.2006.12.022; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P435, DOI [10.1093/jjco/hyp047, 10.1093/jjco/hyp077]; Nakagawa H, 2012, CANCER SCI, V103, P607, DOI 10.1111/j.1349-7006.2011.02193.x; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; PIENTA KJ, 1993, ANN INTERN MED, V118, P793, DOI 10.7326/0003-4819-118-10-199305150-00007; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Strope SA, 2010, NAT REV UROL, V7, P487, DOI 10.1038/nrurol.2010.120; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Vickers AJ, 2009, J CLIN ONCOL, V27, P398, DOI 10.1200/JCO.2008.18.1685; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zheng J, 2012, PROSTATE, V72, P577, DOI 10.1002/pros.21462; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2009, CLIN CANCER RES, V15, P1105, DOI 10.1158/1078-0432.CCR-08-1743	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46454	10.1371/journal.pone.0046454	http://dx.doi.org/10.1371/journal.pone.0046454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071574	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200026
J	Skariah, S; Mordue, DG				Skariah, Sini; Mordue, Dana G.			Identification of Toxoplasma gondii Genes Responsive to the Host Immune Response during In Vivo Infection	PLOS ONE			English	Article							NITRIC-OXIDE; MICROARRAY; NORMALIZATION; TRANSCRIPTOME; RESISTANCE; SUMMARIES; ANTIGENS; SURFACE; STAGE; TIME	Toxoplasma gondii is an obligate intracellular protozoa parasite that causes the disease toxoplasmosis. It resides within host cells in a parasitophorous vacuole distinct from the host cell endocytic system. T. gondii was used as a model to investigate how obligate intracellular parasites alter their gene expression in response to the host immune response during infection compared to growth in host cells in vitro. While bacterial pathogens clearly alter gene expression to adapt to the host environment during infection, the degree to which the external environment affects gene expression by obligate intracellular pathogens sequestered within host cells is less clear. The global transcriptome of T. gondii was analyzed in vivo in the presence and absence of the IFN-gamma-dependent host innate immune response. The parasites' in vivo transcriptome was also compared to its transcriptome in vitro in fibroblast cells. Our results indicate that the parasite transcriptome is significantly altered during in vivo infection in the presence, but not absence, of IFN-gamma-dependent immunity compared with fibroblasts infected in vitro. Many of the parasite genes increased in vivo appear to be common to an early general stress response by the parasite; surprisingly putative oocyst stage specific genes were also disproportionately increased during infection.	[Skariah, Sini; Mordue, Dana G.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	New York Medical College	Mordue, DG (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	Dana_Mordue@nymc.edu	skariah, sini/AAF-5014-2020	Skariah, Sini/0000-0002-9125-1889	National Institutes of Health [AI072028]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI072028 (to DGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-603; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botella H, 2011, CELL HOST MICROBE, V10, P248, DOI 10.1016/j.chom.2011.08.006; Buchholz KR, 2011, EUKARYOT CELL, V10, P1637, DOI 10.1128/EC.05182-11; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; Ferreira-da-Silva MD, 2009, INT J MED MICROBIOL, V299, P381, DOI 10.1016/j.ijmm.2008.10.002; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029998; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Gaji RY, 2011, MOL MICROBIOL, V79, P192, DOI 10.1111/j.1365-2958.2010.07441.x; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kirkman LA, 2001, INFECT IMMUN, V69, P148, DOI 10.1128/IAI.69.1.148-153.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Manger ID, 1998, INFECT IMMUN, V66, P2237, DOI 10.1128/IAI.66.5.2237-2244.1998; Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412; Mordue DG, 1997, J IMMUNOL, V159, P4452; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; OdbergFerragut C, 1996, MOL BIOCHEM PARASIT, V82, P237, DOI 10.1016/0166-6851(96)02740-5; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santi-Rocca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031777; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017241	37	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46621	10.1371/journal.pone.0046621	http://dx.doi.org/10.1371/journal.pone.0046621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071600	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200036
J	Wu, G; Zhu, J; He, FH; Wang, WW; Hu, SN; Yu, J				Wu, Gang; Zhu, Jiang; He, Fuhong; Wang, Weiwei; Hu, Songnian; Yu, Jun			Gene and Genome Parameters of Mammalian Liver Circadian Genes (LCGs)	PLOS ONE			English	Article							EXPRESSION; CLOCK; MOUSE; ORGANIZATION; RHYTHMS; TRANSCRIPTION; COMPONENTS; DROSOPHILA; DYNAMICS; PATTERN	The mammalian circadian system controls various physiology processes and behavior responses by regulating thousands of circadian genes with rhythmic expressions. In this study, we redefined circadian-regulated genes based on published results in the mouse liver and compared them with other gene groups defined relative to circadian regulations, especially the non-circadian-regulated genes expressed in liver at multiple molecular levels from gene position to protein expression based on integrative analyses of different datasets from the literature. Based on the intra-tissue analysis, the liver circadian genes or LCGs show unique features when compared to other gene groups. First, LCGs in general have less neighboring genes and larger in both genomic and 3' UTR lengths but shorter in CDS (coding sequence) lengths. Second, LCGs have higher mRNA and protein abundance, higher temporal expression variations, and shorter mRNA half-life. Third, more than 60% of LCGs form major co-expression clusters centered in four temporal windows: dawn, day, dusk, and night. In addition, larger and smaller LCGs are found mainly expressed in the day and night temporal windows, respectively, and we believe that LCGs are well-partitioned into the gene expression regulatory network that takes advantage of gene size, expression constraint, and chromosomal architecture. Based on inter-tissue analysis, more than half of LCGs are ubiquitously expressed in multiple tissues but only show rhythmical expression in one or limited number of tissues. LCGs show at least three-fold lower expression variations across the temporal windows than those among different tissues, and this observation suggests that temporal expression variations regulated by the circadian system is relatively subtle as compared with the tissue expression variations formed during development. Taken together, we suggest that the circadian system selects gene parameters in a cost effective way to improve tissue-specific functions by adapting temporal variations from the environment over evolutionary time scales.	[Wu, Gang; Zhu, Jiang; He, Fuhong; Wang, Weiwei; Hu, Songnian; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wu, Gang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Zhu, Jiang] Harvard Univ, Sch Med, Boston, MA USA; [Zhu, Jiang] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [He, Fuhong] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Wang, Weiwei] Univ Alberta, Dept Med, Edmonton, AB, Canada	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Alberta	Yu, J (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn	He, Fuhong/HHZ-2474-2022; Wu, Gang/AAC-8206-2022; He, Fuhong/T-4887-2019; Hu, Songnian/C-6509-2013	Wu, Gang/0000-0002-4526-2034; He, Fuhong/0000-0002-3176-8309; Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [2011CB944100, 2011CB944101, 90919024]; Ministry of Science and Technology [2009FY120100]; Ministry of Science and Technology of the People's Republic of China [2012AA020409]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work is supported by grants from the National Basic Research Program (973 Program; 2011CB944100 and 2011CB944101), National Natural Science Foundation of China (90919024), from the Special Foundation Work Program, the Ministry of Science and Technology (2009FY120100), from National Programs for High Technology Research and Development (863 Program), the Ministry of Science and Technology of the People's Republic of China (2012AA020409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Enright AJ, 2004, GENOME BIOL, V5; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harrisingh MC, 2008, SCIENCE, V320, P879, DOI 10.1126/science.1158619; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kojima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011264; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lempiainen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018216; Lin WH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-32; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Ptitsyn AA, 2011, ANN MED, V43, P1, DOI 10.3109/07853890.2010.538078; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-55; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	66	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46961	10.1371/journal.pone.0046961	http://dx.doi.org/10.1371/journal.pone.0046961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071677	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200055
J	Soukup, ST; Spanier, B; Grunz, G; Bunzel, D; Daniel, H; Kulling, SE				Soukup, Sebastian T.; Spanier, Britta; Gruenz, Gregor; Bunzel, Diana; Daniel, Hannelore; Kulling, Sabine E.			Formation of Phosphoglycosides in Caenorhabditis elegans: A Novel Biotransformation Pathway	PLOS ONE			English	Article							LIFE-SPAN; PHYTOESTROGENS GENISTEIN; DAIDZEIN; BIOAVAILABILITY; THERMOTOLERANCE; GLYCOSIDES; GENETICS; STRESS	Background: Caenorhabditis elegans (C. elegans) has become a widely used model to explore the effect of food constituents as well as on life-span extension. The results imply that besides essential nutrients several flavonoids are able to impact the aging process. What is less investigated is the bioavailability and biotransformation of these compounds in C. elegans. In the present study, we focused on the soy isoflavone genistein and its metabolism in the nematode as a basis for assessing whether this model system mimics the mammalian condition. Principal Findings: C. elegans was exposed to 100 mM genistein for 48 hours. The worm homogenate was extracted and analyzed by liquid chromatography (LC). 11 metabolites of genistein were detected and characterized using LC electrospray ionization mass spectrometry. All genistein metabolites formed by C. elegans were found to be sugar conjugates, primarily genistein-O-glucosides. The dominant metabolite was identified as genistein-7-O-phosphoglucoside. Further interesting metabolites include two genistein-di-O-glycosides, a genistein-O-disaccharide as well as a genistein-O-phosphodisaccharide. Conclusions/Significance: Our study provides evidence for a novel biotransformation pathway in C. elegans leading to conjugative metabolites which are not known for mammals. The metabolism of genistein in mammals and in C. elegans differs widely which may greatly impact the bioactivity. These differences need to be appropriately taken into consideration when C. elegans is used as a model to assess possible health or aging effects.	[Soukup, Sebastian T.; Bunzel, Diana; Kulling, Sabine E.] Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Fed Res Inst Nutr & Food, Karlsruhe, Germany; [Spanier, Britta; Gruenz, Gregor; Daniel, Hannelore] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, Dept Biochem, Freising Weihenstephan, Germany	Technical University of Munich	Kulling, SE (corresponding author), Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Fed Res Inst Nutr & Food, Karlsruhe, Germany.	sabine.kulling@mri.bund.de	Daniel, Hannelore/B-8982-2009	Kulling, Sabine E./0000-0002-9956-2702	Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Germany	Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Germany	The work was supported by the Max Rubner-Institute, Federal Research Institute of Nutrition and Food, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Ablajan K, 2011, J MASS SPECTROM, V46, P77, DOI 10.1002/jms.1867; BRENNER S, 1974, GENETICS, V77, P71; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Fischer M, 2012, MOL NUTR FOOD RES, V56, P957, DOI 10.1002/mnfr.201200006; Gruber J, 2007, ANN NY ACAD SCI, V1100, P530, DOI 10.1196/annals.1395.059; Grunz G, 2012, MECH AGEING DEV, V133, P1, DOI 10.1016/j.mad.2011.11.005; Hosoda K, 2011, DRUG METAB DISPOS, V39, P1762, DOI 10.1124/dmd.111.038281; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Ko JH, 2006, FEMS MICROBIOL LETT, V258, P263, DOI 10.1111/j.1574-6968.2006.00226.x; Laing ST, 2010, BIOCHEM J, V432, P505, DOI 10.1042/BJ20101346; Mathew S, 2012, PROCESS BIOCHEM, V47, P528, DOI 10.1016/j.procbio.2011.11.012; Mortensen A, 2009, MOL NUTR FOOD RES, V53, pS266, DOI 10.1002/mnfr.200800478; Pugazhendhi D, 2008, J ENDOCRINOL, V197, P503, DOI 10.1677/JOE-07-0384; Shimoda K, 2010, NUTRIENTS, V2, P171, DOI 10.3390/nu2020171; Surco-Laos F, 2011, FOOD FUNCT, V2, P445, DOI 10.1039/c1fo10049a; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wong CK, 1997, BIOCHEM BIOPH RES CO, V233, P579, DOI 10.1006/bbrc.1997.6502; Wood W B, 1988, Dev Biol (N Y 1985), V5, P57; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yuan B, 2012, J AGR FOOD CHEM, V60, P1428, DOI 10.1021/jf204421c; Zhang Y, 1999, J NUTR, V129, P399, DOI 10.1093/jn/129.2.399	24	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46914	10.1371/journal.pone.0046914	http://dx.doi.org/10.1371/journal.pone.0046914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082135	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900030
J	Valenzuela, R; Espinosa, A; Gonzalez-Manan, D; D'Espessailles, A; Fernandez, V; Videla, LA; Tapia, G				Valenzuela, Rodrigo; Espinosa, Alejandra; Gonzalez-Manan, Daniel; D'Espessailles, Amanda; Fernandez, Virginia; Videla, Luis A.; Tapia, Gladys			N-3 Long-Chain Polyunsaturated Fatty Acid Supplementation Significantly Reduces Liver Oxidative Stress in High Fat Induced Steatosis	PLOS ONE			English	Article							INSULIN-RESISTANCE; EICOSAPENTAENOIC ACID; DESATURASE ACTIVITY; METABOLIC SYNDROME; HEPATIC STEATOSIS; ADIPOSE-TISSUE; DISEASE; OMEGA-3-FATTY-ACIDS; RATIO; INFLAMMATION	Omega-3 (n-3) long-chain polyunsaturated fatty acids (n-3 LCPUFA) are associated with several physiological functions, suggesting that their administration may prevent non transmissible chronic diseases. Therefore, we investigate whether dietary n-3 LCPUFA supplementation triggers an antioxidant response preventing liver steatosis in mice fed a high fat diet (HFD) in relation to n-3 LCPUFA levels. Male C57BL/6J mice received (a) control diet (10% fat, 20% protein, 70% carbohydrate), (b) control diet plus n-3 LCPUFA (108 mg/kg/day eicosapentaenoic acid plus 92 mg/kg/day docosahexaenoic acid), (c) HFD (60% fat, 20% protein, 20% carbohydrate), or (d) HFD plus n-3 LCPUFA for 12 weeks. Parameters of liver steatosis, glutathione status, protein carbonylation, and fatty acid analysis were determined, concomitantly with insulin resistance and serum tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, and IL-6 levels. HFD significantly increased total fat and triacylglyceride contents with macrovesicular steatosis, concomitantly with higher fasting serum glucose and insulin levels, HOMA, and serum TNF-alpha, IL-1 beta, and IL-6. Reduced and total liver glutathione contents were diminished by HFD, with higher GSSG/GSH ratio and protein carbonylation, n-3 LCPUFA depletion and elevated n-6/n-3 ratio over control values. These changes were either reduced or normalized to control values in animals subjected to HFD and n-3 LCPUFA, with significant increased hepatic total n-3 LCPUFA content and reduced n-6/n-3 ratio being observed after n-3 LCPUFA supplementation alone. So, repletion of liver n-3 LCPUFA levels by n-3 LCPUFA dietary supplementation in HFD obese mice reduces hepatic lipid content, with concomitant antioxidant and anti-inflammatory responses favouring insulin sensitivity.	[Gonzalez-Manan, Daniel; D'Espessailles, Amanda; Fernandez, Virginia; Videla, Luis A.; Tapia, Gladys] Univ Chile, Fac Med, Mol & Clin Pharmacol Program, Inst Biomed Sci, Santiago 7, Chile; [Valenzuela, Rodrigo] Univ Chile, Fac Med, Sch Nutr & Dietet, Santiago 7, Chile; [Espinosa, Alejandra] Univ Chile, Fac Med, Sch Med Technol, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Tapia, G (corresponding author), Univ Chile, Fac Med, Mol & Clin Pharmacol Program, Inst Biomed Sci, Santiago 7, Chile.	gtapia@med.uchile.cl			FONDECYT (National Fund for Scientific and Technological Development) [1110043]	FONDECYT (National Fund for Scientific and Technological Development)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by grant 1110043 from FONDECYT (National Fund for Scientific and Technological Development) to G. T., Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Allard JP, 2008, J HEPATOL, V48, P300, DOI 10.1016/j.jhep.2007.09.009; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Araya J, 2010, OBESITY, V18, P1460, DOI 10.1038/oby.2009.379; Aronis A, 2005, FREE RADICAL BIO MED, V38, P1221, DOI 10.1016/j.freeradbiomed.2005.01.015; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenner RR, 2003, PROSTAG LEUKOTR ESS, V68, P151, DOI 10.1016/S0952-3278(02)00265-X; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; DEMOZ A, 1992, LIPIDS, V27, P968, DOI 10.1007/BF02535573; Elizondo A, 2008, BIOL RES, V41, P59, DOI [10.4067/S0716-97602008000100008, /S0716-97602008000100008]; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hatzitolios Apostolos, 2004, Indian J Gastroenterol, V23, P131; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MORRISON WR, 1964, J LIPID RES, V5, P600; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P545, DOI 10.1016/j.numecd.2007.08.002; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shapiro H, 2011, CLIN NUTR, V30, P6, DOI 10.1016/j.clnu.2010.06.001; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spadaro L, 2008, DIGEST LIVER DIS, V40, P194, DOI 10.1016/j.dld.2007.10.003; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Warensjo E, 2008, AM J CLIN NUTR, V88, P203, DOI 10.1093/ajcn/88.1.203; Zhou YE, 2009, BRIT J NUTR, V102, P888, DOI 10.1017/S0007114509301609; Zhu FS, 2008, WORLD J GASTROENTERO, V14, P6395, DOI 10.3748/wjg.14.6395; Zuniga J, 2010, FREE RADICAL RES, V44, P854, DOI 10.3109/10715762.2010.485995	44	90	90	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46400	10.1371/journal.pone.0046400	http://dx.doi.org/10.1371/journal.pone.0046400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082120	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900015
J	Rippe, RCA; Meulman, JJ; Eilers, PHC				Rippe, Ralph C. A.; Meulman, Jacqueline J.; Eilers, Paul H. C.			Reliable Single Chip Genotyping with Semi-Parametric Log-Concave Mixtures	PLOS ONE			English	Article							SNP; ALGORITHM; NORMALIZATION	The common approach to SNP genotyping is to use (model-based) clustering per individual SNP, on a set of arrays. Genotyping all SNPs on a single array is much more attractive, in terms of flexibility, stability and applicability, when developing new chips. A new semi-parametric method, named SCALA, is proposed. It is based on a mixture model using semi-parametric log-concave densities. Instead of using the raw data, the mixture is fitted on a two-dimensional histogram, thereby making computation time almost independent of the number of SNPs. Furthermore, the algorithm is effective in low-MAF situations. Comparisons between SCALA and CRLMM on HapMap genotypes show very reliable calling of single arrays. Some heterozygous genotypes from HapMap are called homozygous by SCALA and to lesser extent by CRLMM too. Furthermore, HapMap's NoCalls (NN) could be genotyped by SCALA, mostly with high probability. The software is available as R scripts from the website www.math.leidenuniv.nl/similar to rrippe.	[Rippe, Ralph C. A.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Meulman, Jacqueline J.] Leiden Univ, Inst Math, NL-2300 RA Leiden, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Rippe, RCA (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	R.C.A.Rippe@lumc.nl						Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Currie ID, 2006, J R STAT SOC B, V68, P259, DOI 10.1111/j.1467-9868.2006.00543.x; Eilers P, 2007, P 23 INT WORKSH STAT; Eilers PHC, 2007, COMPUT STAT DATA AN, V51, P5444, DOI 10.1016/j.csda.2006.08.027; Eilers PHC, 2004, BIOINFORMATICS, V20, P623, DOI 10.1093/bioinformatics/btg454; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giannoulatou E, 2008, BIOINFORMATICS, V24, P2209, DOI 10.1093/bioinformatics/btn386; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rippe R, 2010, P 25 INT WORKSH STAT; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Tabangin Meredith E, 2009, BMC Proc, V3 Suppl 7, pS41, DOI 10.1186/1753-6561-3-S7-S41; Wright MH, 2010, BIOINFORMATICS, V26, P2952, DOI 10.1093/bioinformatics/btq533; Xiao YY, 2007, BIOINFORMATICS, V23, P1459, DOI 10.1093/bioinformatics/btm131	17	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46267	10.1371/journal.pone.0046267	http://dx.doi.org/10.1371/journal.pone.0046267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077503	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800006
J	Leddon, SA; Sant, AJ				Leddon, Scott A.; Sant, Andrea J.			The Peptide Specificity of the Endogenous T Follicular Helper Cell Repertoire Generated after Protein Immunization	PLOS ONE			English	Article							MHC-CLASS-II; RESTRICTED ANTIGEN PRESENTATION; GERMINAL CENTER B; INFLUENZA-VIRUS; PRESENTING CELLS; KINETIC STABILITY; DENDRITIC CELLS; FLOW-CYTOMETRY; BALB/C MICE; RESPONSES	T follicular helper (Tfh) cells potentiate high-affinity, class-switched antibody responses, the predominant correlate of protection from vaccines. Despite intense interest in understanding both the generation and effector functions of this lineage, little is known about the epitope specificity of Tfh cells generated during polyclonal responses. To date, studies of peptide-specific Tfh cells have relied on either the transfer of TcR transgenic cells or use of peptide:MHC class II tetramers and antibodies to stain TcR and follow limited peptide specificities. In order to comprehensively evaluate polyclonal responses generated from the natural endogenous TcR repertoire, we developed a sorting strategy to separate Tfh cells from non-Tfh cells and found that their epitope-specific responses could be tracked with cytokine-specific ELISPOT assays. The immunodominance hierarchies of Tfh and non-Tfh cells generated in response to immunization with several unrelated protein antigens were remarkably similar. Additionally, increasing the kinetic stability of peptide-MHC class II complexes enhanced the priming of both Tfh and conventional CD4 T cells. These findings may provide us with a strategy to rationally and selectively modulate epitope-specific Tfh responses. By understanding the parameters that control epitope-specific priming, vaccines may be tailored to enhance or focus Tfh responses to facilitate optimal B cell responses.	[Leddon, Scott A.; Sant, Andrea J.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Sant, AJ (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	andrea_sant@urmc.rochester.edu			National Institutes of Health [HHSN27220201200005C, HHSN266200700008C, R01AI51542, 5T32AI007285]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007285, R01AI051542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants HHSN27220201200005C, HHSN266200700008C and R01AI51542, and 5T32AI007285 from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADORINI L, 1988, P NATL ACAD SCI USA, V85, P5181, DOI 10.1073/pnas.85.14.5181; Alam S, 2011, J VIROL, V85, P13310, DOI 10.1128/JVI.05728-11; Arnold CN, 2007, EUR J IMMUNOL, V37, P100, DOI 10.1002/eji.200636486; Bozzacco L, 2011, J PROTEOME RES, V10, P5016, DOI 10.1021/pr200503g; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chaves FA, 2012, J IMMUNOL; Chen XJ, 2008, ARCH IMMUNOL THER EX, V56, P77, DOI 10.1007/s00005-008-0014-5; Chen XJ, 2004, IMMUNOL RES, V29, P19, DOI 10.1385/IR:29:1-3:019; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2011, CURR OPIN IMMUNOL, V23, P111, DOI 10.1016/j.coi.2010.10.007; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Fazilleau N, 2007, CURR OPIN IMMUNOL, V19, P259, DOI 10.1016/j.coi.2007.04.003; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gapin L, 1998, J IMMUNOL, V160, P1555; Gatto D, 2010, J ALLERGY CLIN IMMUN, V126, P898, DOI 10.1016/j.jaci.2010.09.007; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; GERHARD W, 1991, J VIROL, V65, P364, DOI 10.1128/JVI.65.1.364-372.1991; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Hardtke S, 2005, BLOOD, V106, P1924, DOI 10.1182/blood-2004-11-4494; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Karlsson AC, 2003, J IMMUNOL METHODS, V283, P141, DOI 10.1016/j.jim.2003.09.001; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Leddon SA, 2010, CURR OPIN ORGAN TRAN, V15, P505, DOI 10.1097/MOT.0b013e32833bfc5c; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Lennon-Dumenil AM, 2002, CURR OPIN IMMUNOL, V14, P15, DOI 10.1016/S0952-7915(01)00293-X; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Marelli-Berg FM, 2010, IMMUNOLOGY, V130, P158, DOI 10.1111/j.1365-2567.2010.03278.x; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; McLachlan James B, 2007, Proc Am Thorac Soc, V4, P439, DOI 10.1513/pats.200606-137MS; Menges PR, 2008, J IMMUNOL, V180, P1619, DOI 10.4049/jimmunol.180.3.1619; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nayak JL, 2010, VIRAL IMMUNOL, V23, P169, DOI 10.1089/vim.2009.0099; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Ploquin MJY, 2011, J IMMUNOL, V187, P3321, DOI 10.4049/jimmunol.1101006; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Richards KA, 2011, IMMUNOLOGY, V133, P246, DOI 10.1111/j.1365-2567.2011.03435.x; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Tassignon J, 2005, J IMMUNOL METHODS, V305, P188, DOI 10.1016/j.jim.2005.07.014; Tobery TW, 2006, AIDS RES HUM RETROV, V22, P1081, DOI 10.1089/aid.2006.22.1081; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; WATTS C, 1993, J EXP MED, V178, P1459, DOI 10.1084/jem.178.4.1459; Weaver JM, 2009, P NATL ACAD SCI USA, V106, P8647, DOI 10.1073/pnas.0811584106; Yang M, 2009, BIOCHEM BIOPH RES CO, V378, P203, DOI 10.1016/j.bbrc.2008.11.037; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	73	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46952	10.1371/journal.pone.0046952	http://dx.doi.org/10.1371/journal.pone.0046952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077537	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100049
J	Rosenfield, SM; Bowden, ET; Cohen-Missner, S; Gibby, KA; Ory, V; Henke, RT; Riegel, AT; Wellstein, A				Rosenfield, Sonia M.; Bowden, Emma T.; Cohen-Missner, Shani; Gibby, Krissa A.; Ory, Virginie; Henke, Ralf T.; Riegel, Anna T.; Wellstein, Anton			Pleiotrophin (PTN) Expression and Function and in the Mouse Mammary Gland and Mammary Epithelial Cells	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; GROWTH-FACTOR PLEIOTROPHIN; RECEPTOR TYROSINE KINASE; HUMAN BREAST-CANCER; 3-DIMENSIONAL CULTURE MODELS; ACTIVATED PROTEIN-KINASE; HEMATOPOIETIC STEM-CELLS; MOLECULE HB-GAM; MESSENGER-RNA; BRANCHING MORPHOGENESIS	Expression of the heparin-binding growth factor, pleiotrophin (PTN) in the mammary gland has been reported but its function during mammary gland development is not known. We examined the expression of PTN and its receptor ALK (Anaplastic Lymphoma Kinase) at various stages of mouse mammary gland development and found that their expression in epithelial cells is regulated in parallel during pregnancy. A 30-fold downregulation of PTN mRNA expression was observed during mid-pregnancy when the mammary gland undergoes lobular-alveolar differentiation. After weaning of pups, PTN expression was restored although baseline expression of PTN was reduced significantly in mammary glands of mice that had undergone multiple pregnancies. We found PTN expressed in epithelial cells of the mammary gland and thus used a monoclonal anti-PTN blocking antibody to elucidate its function in cultured mammary epithelial cells (MECs) as well as during gland development. Real-time impedance monitoring of MECs growth, migration and invasion during anti-PTN blocking antibody treatment showed that MECs motility and invasion but not proliferation depend on the activity of endogenous PTN. Increased number of mammospheres with laminin deposition after anti-PTN blocking antibody treatment of MECs in 3D culture and expression of progenitor markers suggest that the endogenously expressed PTN inhibits the expansion and differentiation of epithelial progenitor cells by disrupting cell-matrix adhesion. In vivo, PTN activity was found to inhibit ductal outgrowth and branching via the inhibition of phospho ERK1/2 signaling in the mammary epithelial cells. We conclude that PTN delays the maturation of the mammary gland by maintaining mammary epithelial cells in a progenitor phenotype and by inhibiting their differentiation during mammary gland development.	[Rosenfield, Sonia M.; Cohen-Missner, Shani; Gibby, Krissa A.; Ory, Virginie; Henke, Ralf T.; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20057 USA; [Bowden, Emma T.] MedImmune, Gaithersburg, MD USA	Georgetown University; AstraZeneca; Medimmune	Wellstein, A (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20057 USA.	wellstea@georgetown.edu		Wellstein, Anton/0000-0002-0570-4950	NCI/NIH [RO1 CA101811]; Pharmaceutical Manufacturers Association; Department of Defense Breast Cancer Research Program [BC083308]; NATIONAL CANCER INSTITUTE [R01CA101811, T32CA009686, P50CA058185] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pharmaceutical Manufacturers Association; Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants awarded to AW from the NCI/NIH (RO1 CA101811); to Shani Cohen-Missner from the Pharmaceutical Manufacturers Association (Fellowship); to Sonia M. Rosenfield from the Department of Defense Breast Cancer Research Program (Predoctoral Grant: BC083308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Bachelard-Cascales E, 2010, STEM CELLS, V28, P1081, DOI 10.1002/stem.435; Ball SM, 1998, ANAT REC, V250, P459, DOI 10.1002/(SICI)1097-0185(199804)250:4<459::AID-AR9>3.0.CO;2-S; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; CAPETANAKI Y, 1990, ONCOGENE, V5, P645; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; CHAUHAN AK, 1993, P NATL ACAD SCI USA, V90, P679, DOI 10.1073/pnas.90.2.679; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; CZUBAYKO F, 1994, J BIOL CHEM, V269, P21358; Czubayko F, 1997, GENE THER, V4, P943, DOI 10.1038/sj.gt.3300483; CZUBAYKO F, 1995, BREAST CANCER RES TR, V36, P157, DOI 10.1007/BF00666037; Czubayko F, 1996, P NATL ACAD SCI USA, V93, P14753, DOI 10.1073/pnas.93.25.14753; D'Cruz CM, 2002, MOL ENDOCRINOL, V16, P2034, DOI 10.1210/me.2002-0073; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; FANG WJ, 1992, J BIOL CHEM, V267, P25889; GARLAND HO, 1987, J ENDOCRINOL, V113, P435, DOI 10.1677/joe.0.1130435; Henke RT, 2006, METHODS, V38, P253, DOI 10.1016/j.ymeth.2005.11.013; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hienola A, 2004, MOL CELL NEUROSCI, V26, P75, DOI 10.1016/j.mcn.2004.01.018; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113; Istvanffy R, 2011, BLOOD, V118, P2712, DOI 10.1182/blood-2010-05-287235; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jung CG, 2004, FASEB J, V18, P1237, DOI 10.1096/fj.03-0927fje; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; LaRocca J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024432; Ledoux D, 1997, J HISTOCHEM CYTOCHEM, V45, P1239, DOI 10.1177/002215549704500907; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li G, 2005, CALCIFIED TISSUE INT, V76, P299, DOI 10.1007/s00223-004-0145-6; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; Marzan CV, 2011, DEV BIOL, V349, P125, DOI 10.1016/j.ydbio.2010.10.018; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; MILNER PG, 1992, BIOCHEMISTRY-US, V31, P12023, DOI 10.1021/bi00163a009; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mou L, INVEST OPHTHALMOL VI, V51, P396; O'Brien J, 2010, J MAMMARY GLAND BIOL, V15, P353, DOI 10.1007/s10911-010-9185-x; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Orr B, 2011, PROSTATE, V71, P305, DOI 10.1002/pros.21244; Pavlov I, 2002, MOL CELL NEUROSCI, V20, P330, DOI 10.1006/mcne.2002.1104; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V362, P5, DOI 10.1016/j.bbrc.2007.06.050; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V358, P399, DOI 10.1016/j.bbrc.2007.04.137; Petersen W, 2004, ARCH ORTHOP TRAUM SU, V124, P603, DOI 10.1007/s00402-003-0582-0; Pufe T, 2003, OSTEOARTHR CARTILAGE, V11, P260, DOI 10.1016/S1063-4584(02)00385-0; Pufe T, 2003, ARTHRITIS RHEUM, V48, P660, DOI 10.1002/art.10839; RIEGEL AT, 1994, BREAST CANCER RES TR, V31, P309; ROSNER B, 1994, AM J EPIDEMIOL, V139, P819, DOI 10.1093/oxfordjournals.aje.a117079; RUSSO IH, 1978, J NATL CANCER I, V61, P1439; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Sakural H, 2001, DEVELOPMENT, V128, P3283; Schulte AM, 1997, TUMOUR ANGIOGENESIS, P273; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SINGER PA, 1986, J BIOL CHEM, V261, P538; Souttou B, 1997, J BIOL CHEM, V272, P19588, DOI 10.1074/jbc.272.31.19588; Stingl J, 2006, NATURE, P1; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Stylianou DC, 2009, ONCOGENE, V28, P3296, DOI 10.1038/onc.2009.184; Szabat E, 1996, DEV BIOL, V178, P77, DOI 10.1006/dbio.1996.0199; Tassi E, 2011, AM J PATHOL, V179, P2220, DOI 10.1016/j.ajpath.2011.07.043; THORDARSON G, 1995, CARCINOGENESIS, V16, P2847, DOI 10.1093/carcin/16.11.2847; Tiede BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008035; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Tso JY, 2011, US Patent, P1, Patent No. 7888485; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; Weber D, 2000, CANCER RES, V60, P5284; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; WELLSTEIN A, 2010, SCI WEBINAR SERIES A; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Weng TT, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-80; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Yanagisawa H, 2010, NEUROSCI RES, V66, P111, DOI 10.1016/j.neures.2009.10.002; Yang JH, 1999, CARCINOGENESIS, V20, P623, DOI 10.1093/carcin/20.4.623; Yang XB, 2003, J BONE MINER RES, V18, P47, DOI 10.1359/jbmr.2003.18.1.47; Zhang N, 1997, J BIOL CHEM, V272, P16733, DOI 10.1074/jbc.272.27.16733	87	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47876	10.1371/journal.pone.0047876	http://dx.doi.org/10.1371/journal.pone.0047876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077670	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100162
J	Valentim, FL; Neven, F; Boyen, P; van Dijk, ADJ				Valentim, Felipe Leal; Neven, Frank; Boyen, Peter; van Dijk, Aalt D. J.			Interactome-Wide Prediction of Protein-Protein Binding Sites Reveals Effects of Protein Sequence Variation in Arabidopsis thaliana	PLOS ONE			English	Article							HOT-SPOTS; CONSERVATION; TOPLESS; MOTIFS; ROLES; INTERFACES; RESPONSES; ORTHOLOG; COMPLEX; AUX/IAA	The specificity of protein-protein interactions is encoded in those parts of the sequence that compose the binding interface. Therefore, understanding how changes in protein sequence influence interaction specificity, and possibly the phenotype, requires knowing the location of binding sites in those sequences. However, large-scale detection of protein interfaces remains a challenge. Here, we present a sequence-and interactome-based approach to mine interaction motifs from the recently published Arabidopsis thaliana interactome. The resultant proteome-wide predictions are available via www.ab.wur.nl/sliderbio and set the stage for further investigations of protein-protein binding sites. To assess our method, we first show that, by using a priori information calculated from protein sequences, such as evolutionary conservation and residue surface accessibility, we improve the performance of interface prediction compared to using only interactome data. Next, we present evidence for the functional importance of the predicted sites, which are under stronger selective pressure than the rest of protein sequence. We also observe a tendency for compensatory mutations in the binding sites of interacting proteins. Subsequently, we interrogated the interactome data to formulate testable hypotheses for the molecular mechanisms underlying effects of protein sequence mutations. Examples include proteins relevant for various developmental processes. Finally, we observed, by analysing pairs of paralogs, a correlation between functional divergence and sequence divergence in interaction sites. This analysis suggests that large-scale prediction of binding sites can cast light on evolutionary processes that shape protein-protein interaction networks.	[Valentim, Felipe Leal; van Dijk, Aalt D. J.] Plant Res Int, Biosci, Wageningen, Netherlands; [Neven, Frank; Boyen, Peter] Hasselt Univ, Hasselt, Belgium; [Neven, Frank; Boyen, Peter] Transnat Univ Limburg, Hasselt, Belgium	Hasselt University; Hasselt University	van Dijk, ADJ (corresponding author), Plant Res Int, Biosci, Wageningen, Netherlands.	aaltjan.vandijk@wur.nl	VALENTIM, Felipe LEAL/T-7105-2019; Neven, Frank/AAR-7385-2020	NEVEN, Frank/0000-0002-7143-1903; van Dijk, Aalt-Jan/0000-0002-8872-5123; LEAL VALENTIM, Felipeoe/0000-0002-9740-2940	Netherlands Organisation for Scientific Research (NWO) VENI grant [863.08.027]; SYSFLO Marie Curie Initial Training Network; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Netherlands Organisation for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); SYSFLO Marie Curie Initial Training Network; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by an Netherlands Organisation for Scientific Research (NWO) VENI grant (863.08.027) to ADJvD, the SYSFLO Marie Curie Initial Training Network (FLV), and a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Boyen P, 2011, IEEE ACM T COMPUT BI, V8, P1344, DOI 10.1109/TCBB.2011.17; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cheng NH, 2003, J BIOL CHEM, V278, P6503, DOI 10.1074/jbc.M210883200; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Fleury D, 2007, PLANT CELL, V19, P417, DOI 10.1105/tpc.106.041319; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Hanada K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000781; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Leung KC, 2004, PLANT MOL BIOL, V55, P297, DOI 10.1007/s11103-004-0642-z; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Morsy M, 2008, TRENDS PLANT SCI, V13, P183, DOI 10.1016/j.tplants.2008.01.006; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Poole Rebecca L., 2007, V406, P179; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Sun MGF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-235; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tian Q, 1999, DEVELOPMENT, V126, P711; Valdar WSJ, 2001, PROTEINS, V42, P108; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P26, DOI 10.1093/bioinformatics/btm539; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; Van Leene J, 2011, TRENDS PLANT SCI, V16, P141, DOI 10.1016/j.tplants.2010.12.004; Villanneva JM, 1999, GENE DEV, V13, P3160, DOI 10.1101/gad.13.23.3160; Wang CM, 2012, PLANT PHYSIOL, V158, P1523, DOI 10.1104/pp.111.192203; Yu JT, 2010, BIOINFORMATICS, V26, P2610, DOI 10.1093/bioinformatics/btq483; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhao DZ, 2003, PLANT PHYSIOL, V133, P203, DOI 10.1104/pp.103.024703	61	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47022	10.1371/journal.pone.0047022	http://dx.doi.org/10.1371/journal.pone.0047022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077539	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100051
J	Ylilauri, M; Pentikainen, OT				Ylilauri, Mikko; Pentikainen, Olli T.			Structural Mechanism of N-Methyl-D-Aspartate Receptor Type 1 Partial Agonism	PLOS ONE			English	Article							LIGAND-BINDING CORE; SITE PARTIAL AGONIST; NMDA RECEPTORS; MOLECULAR-DYNAMICS; GLUTAMATE-RECEPTOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURES; SYNAPTIC PLASTICITY; SUBUNIT; DOMAIN	N-methyl-D-aspartate (NMDA) receptors belong to a family of ionotropic glutamate receptors that contribute to the signal transmission in the central nervous system. NMDA receptors are heterotetramers that usually consist of two GluN1 and GluN2 monomers. The extracellular ligand-binding domain (LBD) of a monomer is comprised of discontinuous segments that form the functional domains D1 and D2. While the binding of a full agonist glycine to LBD of GluN1 is linked to cleft closure and subsequent ion-channel opening, partial agonists are known to activate the receptor only sub-maximally. Although the crystal structures of the LBD of related GluA2 receptor explain the mechanism for the partial agonism, structures of GluN1-LBD cannot distinguish the difference between full and partial agonists. It is, however, probable that the partial agonists of GluN1 alter the structure of the LBD in order to result in a different pharmacological response than seen with full agonists. In this study, we used molecular dynamics simulations to reveal an intermediate closure-stage for GluN1, which is unseen in crystal structures. According to our calculations, this intermediate closure is not a transient stage but an energetically stable conformation. Our results demonstrate that the partial agonist cannot exert firm GluN1-LBD closure, especially if there is even a small force that disrupts the LBD closure. Accordingly, this result suggests the importance of forces from the ion channel for the relationship between pharmacological response and the structure of the LBD of members of this receptor family.	[Pentikainen, Olli T.] Univ Jyvaskyla, Computat Biosci Lab, Dept Biol & Environm Sci, Jyvaskyla, Finland; Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Pentikainen, OT (corresponding author), Univ Jyvaskyla, Computat Biosci Lab, Dept Biol & Environm Sci, Jyvaskyla, Finland.	olli.t.pentikainen@jyu.fi	Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016	National Doctoral Programme in Informational and Structural Biology	National Doctoral Programme in Informational and Structural Biology	This study was funded by the National Doctoral Programme in Informational and Structural Biology (M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frydenvang K, 2009, J BIOL CHEM, V284, P14219, DOI 10.1074/jbc.M808547200; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kaye SL, 2006, J BIOL CHEM, V281, P12736, DOI 10.1074/jbc.M512728200; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lash-Van Wyhe LL, 2010, NEUROPHARMACOLOGY, V58, P640, DOI 10.1016/j.neuropharm.2009.11.013; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lisman JE, 2001, CURR BIOL, V11, pR788, DOI 10.1016/S0960-9822(01)00472-9; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moretti L, 2004, J STRUCT BIOL, V145, P205, DOI 10.1016/j.jsb.2003.10.016; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Moskal JR, 2011, NEUROSCI BIOBEHAV R, V35, P1982, DOI 10.1016/j.neubiorev.2011.06.006; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Paoletti P, 2011, EUR J NEUROSCI, V33, P1351, DOI 10.1111/j.1460-9568.2011.07628.x; Pentikainen U, 2006, ORG BIOMOL CHEM, V4, P1058, DOI 10.1039/b515111b; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Postila PA, 2011, J CHEM INF MODEL, V51, P1037, DOI 10.1021/ci2000055; Postila PA, 2010, NEUROPHARMACOLOGY, V58, P515, DOI 10.1016/j.neuropharm.2009.08.019; Priestley T, 1998, BRIT J PHARMACOL, V124, P1767, DOI 10.1038/sj.bjp.0702010; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Talukder I, 2011, J GEN PHYSIOL, V138, P179, DOI 10.1085/jgp.201110623; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Urwyler S, 2009, J MED CHEM, V52, P5093, DOI 10.1021/jm900363q; Vijayan R, 2010, PHYS CHEM CHEM PHYS, V12, P14057, DOI 10.1039/c004336b; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Wood PL, 2008, NEUROREPORT, V19, P1059, DOI 10.1097/WNR.0b013e32830435c9	53	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47604	10.1371/journal.pone.0047604	http://dx.doi.org/10.1371/journal.pone.0047604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077649	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100144
J	Gotte, G; Helmy, AM; Ercole, C; Spadaccini, R; Laurents, DV; Donadelli, M; Picone, D				Gotte, Giovanni; Helmy, Alexander Mahmoud; Ercole, Carmine; Spadaccini, Roberta; Laurents, Douglas V.; Donadelli, Massimo; Picone, Delia			Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities	PLOS ONE			English	Article							BULL SEMEN RIBONUCLEASES; AMYLOID-LIKE FIBRILS; HUMAN CYSTATIN-C; CRYSTAL-STRUCTURE; DIMERIC STRUCTURE; ANTITUMOR ACTION; PROTEIN; OLIGOMERIZATION; DISSOCIATION; AGGREGATION	Bovine seminal (BS) RNase, the unique natively dimeric member of the RNase super-family, represents a special case not only for its additional biological actions but also for the singular features of 3D domain swapping. The native enzyme is indeed a mixture of two isoforms: M = M, a dimer held together by two inter-subunit disulfide bonds, and MxM, 70% of the total, which, besides the two mentioned disulfides, is additionally stabilized by the swapping of its N-termini. When lyophilized from 40% acetic acid, BS-RNase oligomerizes as the super-family proto-type RNase A does. In this paper, we induced BS-RNase self-association and analyzed the multimers by size-exclusion chromatography, cross-linking, electrophoresis, mutagenesis, dynamic light scattering, molecular modelling. Finally, we evaluated their enzymatic and cytotoxic activities. Several BS-RNase domain-swapped oligomers were detected, including two tetramers, one exchanging only the N-termini, the other being either N- or C-swapped. The C-swapping event, confirmed by results on a BS-K113N mutant, has been firstly seen in BS-RNase here, and probably stabilizes also multimers larger than tetramers. Interestingly, all BS-RNase oligomers are more enzymatically active than the native dimer and, above all, they display a cytotoxic activity that definitely increases with the molecular weight of the multimers. This latter feature, to date unknown for BS-RNase, suggests again that the self-association of RNases strongly modulates their biological and potentially therapeutic properties.	[Gotte, Giovanni; Helmy, Alexander Mahmoud; Donadelli, Massimo] Univ Verona, Sez Chim Biol, Dipartimento Sci Vita & Riprod, I-37100 Verona, Italy; [Ercole, Carmine; Picone, Delia] Univ Naples Federico II, Dipartimento Sci Chim, Naples, Italy; [Spadaccini, Roberta] Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy; [Laurents, Douglas V.] Inst Quim Fis Rocasolano CSIC, Madrid, Spain	University of Verona; University of Naples Federico II; University of Sannio; Consejo Superior de Investigaciones Cientificas (CSIC)	Gotte, G (corresponding author), Univ Verona, Sez Chim Biol, Dipartimento Sci Vita & Riprod, I-37100 Verona, Italy.	giovanni.gotte@univr.it	Donadelli, Massimo/AAC-2003-2022; Laurents, Douglas V/E-7527-2015; Picone, Delia/L-2480-2015	Laurents, Douglas V/0000-0002-4187-165X; Picone, Delia/0000-0002-7582-2581; Donadelli, Massimo/0000-0001-9224-9230; Gotte, Giovanni/0000-0003-3179-7158; SPADACCINI, Roberta/0000-0002-2262-1065	Italian Ministero Istruzione Universita e Ricerca (MIUR) [Gottex60%-08, FR-GOTTEG-09]; University of Verona, Italy; Spanish Ministerio de Ciencia e Innovacion (MICINN) [CTQ2010-21567-C02-02]	Italian Ministero Istruzione Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Verona, Italy; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by the grants "Gottex60%-08'' and "FR-GOTTEG-09'', funded by the Italian Ministero Istruzione Universita e Ricerca (MIUR), and by the University of Verona, Italy. "CTQ2010-21567-C02-02'' from the Spanish Ministerio de Ciencia e Innovacion (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADINOLFI BS, 1995, BIOCHEM BIOPH RES CO, V213, P525, DOI 10.1006/bbrc.1995.2163; Adinolfi S, 1996, FEBS LETT, V398, P326, DOI 10.1016/S0014-5793(96)01034-4; Avitabile F, 2003, BIOCHEMISTRY-US, V42, P8704, DOI 10.1021/bi0342517; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Berisio R, 2003, FEBS LETT, V554, P105, DOI 10.1016/S0014-5793(03)01114-1; CAFARO V, 1995, FEBS LETT, V359, P31, DOI 10.1016/0014-5793(94)01450-F; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Ciglic MI, 1998, BIOCHEMISTRY-US, V37, P4008, DOI 10.1021/bi972203e; Cozza G, 2008, BIOPOLYMERS, V89, P26, DOI 10.1002/bip.20833; CRESTFIELD AM, 1962, ARCH BIOCHEM BIOPHYS, P217; D'Alessio G., 1997, RIBONUCLEASES STRUCT, P383; DALESSIO G, 1975, BIOCHEMISTRY-US, V14, P1116, DOI 10.1021/bi00677a004; DALESSIO G, 1972, EUR J BIOCHEM, V26, P153, DOI 10.1111/j.1432-1033.1972.tb01751.x; DALESSIO G, 1972, FEBS LETT, V27, P285, DOI 10.1016/0014-5793(72)80642-2; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIDONATO A, 1973, BIOCHEM BIOPH RES CO, V55, P919, DOI 10.1016/0006-291X(73)91231-X; DIDONATO A, 1981, BIOCHEMISTRY-US, V20, P7232, DOI 10.1021/bi00528a028; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Ercole C, 2003, EUR J BIOCHEM, V270, P4729, DOI 10.1046/j.1432-1033.2003.03872.x; Ercole C, 2007, BIOCHEMISTRY-US, V46, P2227, DOI 10.1021/bi0613630; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Geiger R, 2011, J BIOL CHEM, V286, P5813, DOI 10.1074/jbc.M110.171694; Goldenberg DP, 1989, ANAL PROTEIN CONFORM; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gotte G, 2006, BBA-PROTEINS PROTEOM, V1764, P44, DOI 10.1016/j.bbapap.2005.10.011; Gotte G, 2004, J BIOL CHEM, V279, P36670, DOI 10.1074/jbc.M404780200; Gotte G, 2003, J BIOL CHEM, V278, P10763, DOI 10.1074/jbc.M213146200; Gotte G, 2003, J BIOL CHEM, V278, P46241, DOI 10.1074/jbc.M308470200; Gotte G, 2008, BBA-PROTEINS PROTEOM, V1784, P638, DOI 10.1016/j.bbapap.2007.12.013; Gotte G, 2006, BIOCHEMISTRY-US, V45, P10795, DOI 10.1021/bi060933t; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; KIM JS, 1995, J BIOL CHEM, V270, P10525, DOI 10.1074/jbc.270.18.10525; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; KUNITZ M, 1946, J BIOL CHEM, V164, P563; Libonati M, 2004, BIOCHEM J, V380, P311, DOI 10.1042/BJ20031922; LIBONATI M, 1969, Italian Journal of Biochemistry (English Edition), V18, P407; LIN SH, 1984, BIOCHEMISTRY-US, V23, P5504, DOI 10.1021/bi00318a019; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2002, PROTEIN SCI, V11, P371, DOI 10.1110/ps.36602; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Lopez-Alonso JP, 2009, ARCH BIOCHEM BIOPHYS, V489, P41, DOI 10.1016/j.abb.2009.07.013; Lopez-Alonso JP, 2006, J BIOL CHEM, V281, P9400, DOI 10.1074/jbc.M510491200; Matousek J, 2003, J BIOL CHEM, V278, P23817, DOI 10.1074/jbc.M302711200; MATOUSEK J, 1973, EXPERIENTIA, V29, P858, DOI 10.1007/BF01946329; MAZZARELLA L, 1995, P NATL ACAD SCI USA, V92, P3799, DOI 10.1073/pnas.92.9.3799; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Montioli R, 2012, INT J BIOCHEM CELL B, V44, P536, DOI 10.1016/j.biocel.2011.12.007; Nenci A, 2001, PROTEIN SCI, V10, P2017, DOI 10.1110/ps.14101; Oppici E, 2012, MOL GENET METAB, V105, P132, DOI 10.1016/j.ymgme.2011.09.033; Lopez-Alonso JP, 2010, J AM CHEM SOC, V132, P1621, DOI 10.1021/ja9081638; PICCOLI R, 1992, P NATL ACAD SCI USA, V89, P1870, DOI 10.1073/pnas.89.5.1870; Picone D, 2005, J BIOL CHEM, V280, P13771, DOI 10.1074/jbc.M413157200; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; SUZUKI H, 1987, BIOL CHEM H-S, V368, P1305, DOI 10.1515/bchm3.1987.368.2.1305; TAMBURRINI M, 1989, J PROTEIN CHEM, V8, P719, DOI 10.1007/BF01024897; Teng PK, 2012, PROTEIN SCI, V21, P26, DOI 10.1002/pro.754; Torrent M, 2010, BIOMACROMOLECULES, V11, P1983, DOI 10.1021/bm100334u; VESCIA S, 1980, CANCER RES, V40, P3740; Viola M, 2005, INT J ONCOL, V27, P1071; Vottariello F, 2011, BIOCHIMIE, V93, P1846, DOI 10.1016/j.biochi.2011.07.005; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; WANG D, 1977, BIOCHEMISTRY-US, V16, P2937, DOI 10.1021/bi00632a021	73	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46804	10.1371/journal.pone.0046804	http://dx.doi.org/10.1371/journal.pone.0046804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071641	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700033
J	Quigg, A; Kotabova, E; Jaresova, J; Kana, R; Setlik, J; Sediva, B; Komarek, O; Prasil, O				Quigg, Antonietta; Kotabova, Eva; Jaresova, Jana; Kana, Radek; Setlik, Jiri; Sediva, Barbora; Komarek, Ondrej; Prasil, Ondrej			Photosynthesis in Chromera velia Represents a Simple System with High Efficiency	PLOS ONE			English	Article							SHADE-ADAPTED COLONIES; CHLOROPHYLL FLUORESCENCE; EVOLUTIONARY INHERITANCE; ELEMENTAL STOICHIOMETRY; SYMBIOTIC CORAL; COMMON ORIGIN; LIFE-CYCLE; DINOFLAGELLATE; LIGHT; PHOTOPROTECTION	Chromera velia (Alveolata) is a close relative to apicomplexan parasites with a functional photosynthetic plastid. Even though C. velia has a primitive complement of pigments (lacks chlorophyll c) and uses an ancient type II form of RuBISCO, we found that its photosynthesis is very efficient with the ability to acclimate to a wide range of irradiances. C. velia maintain similar maximal photosynthetic rates when grown under continual light-limited (low light) or light-saturated (high light) conditions. This flexible acclimation to continuous light is provided by an increase of the chlorophyll content and photosystem II connectivity under light limited conditions and by an increase in the content of protective carotenoids together with stimulation of effective non-photochemical quenching under high light. C. velia is able to significantly increase photosynthetic rates when grown under a light-dark cycle with sinusoidal changes in light intensity. Photosynthetic activities were nonlinearly related to light intensity, with maximum performance measured at midmorning. C. velia efficiently acclimates to changing irradiance by stimulation of photorespiration and non-photochemical quenching, thus avoiding any measurable photoinhibition. We suggest that the very high CO2 assimilation rates under sinusoidal light regime are allowed by activation of the oxygen consuming process (possibly chlororespiration) that maintains high efficiency of RuBISCO (type II). Despite the overall simplicity of the C. velia photosynthetic system, it operates with great efficiency.	[Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Kotabova, Eva; Jaresova, Jana; Kana, Radek; Setlik, Jiri; Sediva, Barbora; Komarek, Ondrej; Prasil, Ondrej] Acad Sci Czech Republ, Inst Microbiol, Trebon, Czech Republic; [Kotabova, Eva; Jaresova, Jana; Kana, Radek; Prasil, Ondrej] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Quigg, A (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	quigga@tamug.edu	Komárek, Ondřej/AAA-9707-2020; Kotabova, Eva/E-4560-2011; Kaňa, Radek/A-6434-2009; Komarek, Ondrej/J-9203-2014; Prasil, Ondrej/H-2454-2014	Kotabova, Eva/0000-0003-1092-3020; Kaňa, Radek/0000-0001-5768-6902; Komarek, Ondrej/0000-0002-3855-3335; Prasil, Ondrej/0000-0002-0012-4359	Grant Agency of the Czech Academy of Sciences [GAAV IAA601410907]; Grant Agency of the Czech Republic [GACR P501/12/G055]; Texas A&M Universities International programs office; Czech Academy of Sciences [RVO 61388971]	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Texas A&M Universities International programs office; Czech Academy of Sciences(Czech Academy of Sciences)	This research has been supported by the Grant Agency of the Czech Academy of Sciences, grant GAAV IAA601410907 and by Grant Agency of the Czech Republic, grant GACR P501/12/G055. International Research Travel Awards from Texas A&M Universities International programs office to A. Q. supported several visits to the Institute of Microbiology in Trebon., Czech Republic were the work was conducted. The Institute of Microbiology is funded by the Czech Academy of Sciences (contract RVO 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Beardall J, 2003, ADV PHOTO RESPIRAT, V14, P157; Botte CY, 2011, J BIOL CHEM, V286, P29893, DOI 10.1074/jbc.M111.254979; BURRIS JE, 1981, MAR BIOL, V65, P215, DOI 10.1007/BF00397114; Butler NB, 1982, CARBON DIOXIDE EQUIL; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P912, DOI 10.1016/j.bbabio.2010.12.004; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T, 2004, SYST ASSOC SPEC VOL, P75; CHANG SS, 1983, MAR BIOL, V76, P219, DOI 10.1007/BF00393021; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Falkowski P.G., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P2830; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; FALKOWSKI PG, 1985, LIMNOL OCEANOGR, V30, P311, DOI 10.4319/lo.1985.30.2.0311; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Gorbunov MY, 2000, LIMNOL OCEANOGR, V45, P242, DOI 10.4319/lo.2000.45.1.0242; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Guo JT, 2010, J EUKARYOT MICROBIOL, V57, P444, DOI 10.1111/j.1550-7408.2010.00495.x; Havelkova-Dousova H, 2004, PHOTOSYNTHETICA, V42, P273, DOI 10.1023/B:PHOT.0000040600.04502.32; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN, P37; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Kana R, 2002, PHOTOSYNTH RES, V72, P271, DOI 10.1023/A:1019894720789; Kana R, 2012, BIOCH BIOPH IN PRESS; Kana R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029700; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Kotabova E, 2011, FEBS LETT, V585, P1941, DOI 10.1016/j.febslet.2011.05.015; Leblond JD, 2012, J EUKARYOT MICROBIOL, V59, P191, DOI 10.1111/j.1550-7408.2012.00611.x; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Levy O, 2004, MAR ECOL PROG SER, V268, P105, DOI 10.3354/meps268105; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; McFadden GI, 1997, PLANT SYST EVOL, P261; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; Nassoury N, 2001, PLANT CELL, V13, P923; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; Obornik M, 2011, PROTIST, V162, P115, DOI 10.1016/j.protis.2010.02.004; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Pan H, 2012, PHOTOSYNTH RES, V111, P19, DOI 10.1007/s11120-011-9710-9; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peltier G, 2010, PHOTOSYNTH RES, V106, P19, DOI 10.1007/s11120-010-9575-3; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; QUIGG A, 2003, PLANT CELL ENVIRON, V26, P1; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; Ralph PJ, 2002, MAR BIOL, V141, P639, DOI 10.1007/s00227-002-0866-x; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Schnepf E, 1999, GRANA, V38, P81, DOI 10.1080/00173139908559217; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Sutak R, 2010, PLANT PHYSIOL, V154, P991, DOI 10.1104/pp.110.159947; Warner ME, 2010, DEVEL APPL PHYCOL, V4, P209, DOI 10.1007/978-90-481-9268-7_10; Weatherby K, 2011, PROTIST, V162, P142, DOI 10.1016/j.protis.2010.02.003; Whitney SM, 1998, AUST J PLANT PHYSIOL, V25, P131, DOI 10.1071/PP97131; Yellowlees D, 2003, ADV PHOTO RESPIRAT, V14, P437; Zhang ZD, 2000, J MOL EVOL, V51, P26, DOI 10.1007/s002390010064	70	36	36	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47036	10.1371/journal.pone.0047036	http://dx.doi.org/10.1371/journal.pone.0047036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071705	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200071
J	Skolimowska, KH; Rangaka, MX; Meintjes, G; Pepper, DJ; Seldon, R; Matthews, K; Wilkinson, RJ; Wilkinson, KA				Skolimowska, Keira H.; Rangaka, Molebogeng X.; Meintjes, Graeme; Pepper, Dominique J.; Seldon, Ronnett; Matthews, Kerryn; Wilkinson, Robert J.; Wilkinson, Katalin A.			Altered Ratio of IFN-gamma/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV-Tuberculosis Immune Reconstitution Inflammatory Syndrome	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; T-CELLS; ACTIVE TUBERCULOSIS; IL-10; PREVALENCE; PULMONARY; COHORT; BLOOD	We have described a clinical relationship between HIV-Tuberculosis Immune Reconstitution Inflammatory Syndrome (TBIRIS) and anti-tubercular drug resistance. Here we studied the immune response of TB-IRIS patients from whom a drug-resistant (n = 11) or drug-susceptible (n = 25) Mycobacterium tuberculosis (MTB) strain was isolated after presenting with TBIRIS. ELISpot analysis and multiplex cytokine analysis of the supernatant collected from peripheral blood mononuclear cells stimulated overnight with the heat-killed H37Rv MTB laboratory strain was used. Although there was no statistical difference in IFN-gamma ELISpot responses between the two groups, the results point towards higher bacterial load in the drug-resistant patients, possibly due to failed therapy. The ratio between secreted IFN-gamma/IL-10 and IL-2/IL-10 was significantly lower in TB-IRIS patients in whom the cause of TB was a drug-resistant strain compared to those with a fully sensitive strain (p = 0.02). Since host immune responses are dependent on the bacterial load, we hypothesise that the impaired cytokine balance is likely to be caused by the poorly controlled bacterial growth in these patients.	[Skolimowska, Keira H.; Rangaka, Molebogeng X.; Meintjes, Graeme; Seldon, Ronnett; Matthews, Kerryn; Wilkinson, Robert J.; Wilkinson, Katalin A.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa; [Wilkinson, Robert J.; Wilkinson, Katalin A.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Skolimowska, Keira H.; Meintjes, Graeme; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Meintjes, Graeme; Pepper, Dominique J.; Wilkinson, Robert J.] GF Jooste Hosp, Infect Dis Unit, Cape Town, South Africa	University of Cape Town; MRC National Institute for Medical Research; Imperial College London	Wilkinson, KA (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa.	katalin.wilkinson@uct.ac.za	Wilkinson, Katalin/AAQ-7713-2021; Rangaka, Molebogeng/E-4116-2015; Wilkinson, Katalin/AAF-6805-2020	Wilkinson, Katalin/0000-0002-9796-2040; Meintjes, Graeme/0000-0003-1196-4414; Matthews, Kerryn/0000-0003-2695-5895; RANGAKA, Molebogeng/0000-0001-9594-188X; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [081667, 084323, 088316, 084670]; European-Developing Countries Clinical Trial Partnership (EDCTP) [060613]; Medical Research Council, UK; United States Agency for International Development and President's Emergency Plan for AIDS Relief (PEPFAR) via the Perinatal HIV Research Unit; Fogarty International Center South African TB/AIDS Training Award [NIH/FIC 1U2RTW007373-01A1, U2RTW007370 ICORTA]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European-Developing Countries Clinical Trial Partnership (EDCTP); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States Agency for International Development and President's Emergency Plan for AIDS Relief (PEPFAR) via the Perinatal HIV Research Unit(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center South African TB/AIDS Training Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Wellcome Trust (081667, 084323, 088316, 084670) and European-Developing Countries Clinical Trial Partnership (EDCTP) (060613). KAW is supported by the Medical Research Council, UK. DJP was supported by funding from the United States Agency for International Development and President's Emergency Plan for AIDS Relief (PEPFAR) via the Perinatal HIV Research Unit. GM and DJP were also funded in part through a Fogarty International Center South African TB/AIDS Training Award (NIH/FIC 1U2RTW007373-01A1, U2RTW007370 ICORTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; de Araujo JA, 2008, TUBERCULOSIS, V88, P474, DOI 10.1016/j.tube.2008.06.002; Eum SY, 2008, RESPIRATION, V76, P331, DOI 10.1159/000113932; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Geffner L, 2009, INFECT IMMUN, V77, P5025, DOI 10.1128/IAI.00224-09; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Haddow LJ, 2010, AIDS, V24, P103, DOI 10.1097/QAD.0b013e32832ec1f4; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, BRIT MED J, V333, P559, DOI 10.1136/bmj.38971.587222.AB; Meintjes G, 2009, CLIN INFECT DIS, V48, P667, DOI 10.1086/596764; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2010, CLIN INFECT DIS, V51, P830, DOI 10.1086/656283; Meintjes G, 2008, AM J RESP CRIT CARE, V178, P1083, DOI 10.1164/rccm.200806-858OC; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Newton SM, 2006, P NATL ACAD SCI US; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Remoli ME, 2011, IMMUNOL CELL BIOL, V89, P437, DOI 10.1038/icb.2010.106; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Tadokera R, 2011, EUR RESPIR J, V37, P1248, DOI 10.1183/09031936.00091010; Wu YE, 2010, INT J INFECT DIS, V14, pE815, DOI 10.1016/j.ijid.2010.04.005	28	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46481	10.1371/journal.pone.0046481	http://dx.doi.org/10.1371/journal.pone.0046481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071578	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200028
J	Tsetskhladze, ZR; Canfield, VA; Ang, KC; Wentzel, SM; Reid, KP; Berg, AS; Johnson, SL; Kawakami, K; Cheng, KC				Tsetskhladze, Zurab R.; Canfield, Victor A.; Ang, Khai C.; Wentzel, Steven M.; Reid, Katherine P.; Berg, Arthur S.; Johnson, Stephen L.; Kawakami, Koichi; Cheng, Keith C.			Functional Assessment of Human Coding Mutations Affecting Skin Pigmentation Using Zebrafish	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OCULOCUTANEOUS ALBINISM TYPE-4; HAIR COLOR; MATP GENE; MUTAGENESIS; ASSOCIATION; EVOLUTION; SLC24A5; POPULATION; EXPRESSION	A major challenge in personalized medicine is the lack of a standard way to define the functional significance of the numerous nonsynonymous, single nucleotide coding variants that are present in each human individual. To begin to address this problem, we have used pigmentation as a model polygenic trait, three common human polymorphisms thought to influence pigmentation, and the zebrafish as a model system. The approach is based on the rescue of embryonic zebrafish mutant phenotypes by "humanized" zebrafish orthologous mRNA. Two hypomorphic polymorphisms, L374F in SLC45A2, and A111T in SLC24A5, have been linked to lighter skin color in Europeans. The phenotypic effect of a second coding polymorphism in SLC45A2, E272K, is unclear. None of these polymorphisms had been tested in the context of a model organism. We have confirmed that zebrafish albino fish are mutant in slc45a2; wild-type slc45a2 mRNA rescued the albino mutant phenotype. Introduction of the L374F polymorphism into albino or the A111T polymorphism into slc24a5 (golden) abolished mRNA rescue of the respective mutant phenotypes, consistent with their known contributions to European skin color. In contrast, the E272K polymorphism had no effect on phenotypic rescue. The experimental conclusion that E272K is unlikely to affect pigmentation is consistent with a lack of correlation between this polymorphism and quantitatively measured skin color in 59 East Asian humans. A survey of mutations causing human oculocutaneous albinism yielded 257 missense mutations, 82% of which are theoretically testable in zebrafish. The developed approach may be extended to other model systems and may potentially contribute to our understanding the functional relationships between DNA sequence variation, human biology, and disease.	[Tsetskhladze, Zurab R.; Ang, Khai C.; Wentzel, Steven M.; Reid, Katherine P.; Cheng, Keith C.] Penn State Hershey Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA; [Canfield, Victor A.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA USA; [Berg, Arthur S.] Penn State Hershey Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Johnson, Stephen L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kawakami, Koichi] Grad Univ Adv Studies Sokendai, Div Mol & Dev Biol, Natl Inst Genet, Dept Genet, Mishima, Shizuoka, Japan; [Tsetskhladze, Zurab R.; Ang, Khai C.; Wentzel, Steven M.; Reid, Katherine P.; Cheng, Keith C.] Penn State Hershey Coll Med, Dept Pathol, Div Expt Pathol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Washington University (WUSTL); Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Tsetskhladze, ZR (corresponding author), Penn State Hershey Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA.	zut555@gmail.com; kcheng76@gmail.com	Ang, Khai C./N-7956-2019; Kawakami, Koichi/AAF-1380-2019	Ang, Khai C./0000-0001-7695-9953; Berg, Arthur/0000-0002-4097-7348; Cheng, Keith/0000-0002-5350-5825	National Institutes of Health [R01AR052535]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health through grant R01AR052535 to KCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaluf S, 2002, PIGM CELL RES, V15, P119, DOI 10.1034/j.1600-0749.2002.1o072.x; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Fullerton A, 1996, CONTACT DERMATITIS, V35, P1, DOI 10.1111/j.1600-0536.1996.tb02258.x; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Hyodo-Taguchi Y, 1997, MECH DEVELOP, V68, P27, DOI 10.1016/S0925-4773(97)00128-7; Inagaki K, 2004, AM J HUM GENET, V74, P466, DOI 10.1086/382195; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Leong IUS, 2011, BIRTH DEFECTS RES C, V93, P249, DOI 10.1002/bdrc.20213; Long QM, 1997, DEVELOPMENT, V124, P4105; Mohideen MAPK, 2003, DEV DYNAM, V228, P414, DOI 10.1002/dvdy.10407; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Ohashi A, 1996, MELANOMA RES, V6, P25, DOI 10.1097/00008390-199602000-00004; Patten SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031650; Pretorius PR, 2011, HUM MOL GENET, V20, P1625, DOI 10.1093/hmg/ddr039; Rawls JF, 2003, GENETICS, V163, P997; Rundshagen U, 2004, HUM MUTAT, V23, P106, DOI 10.1002/humu.10311; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; STREISINGER G, 1986, GENETICS, V112, P311; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Sturm RA, 2006, TRENDS GENET, V22, P464, DOI 10.1016/j.tig.2006.06.010; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thisse B, 2004, ZFIN DIRECT DATA SUB; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	44	43	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47398	10.1371/journal.pone.0047398	http://dx.doi.org/10.1371/journal.pone.0047398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071798	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200114
J	Balwani, S; Chaudhuri, R; Nandi, D; Jaisankar, P; Agrawal, A; Ghosh, B				Balwani, Sakshi; Chaudhuri, Rituparna; Nandi, Debkumar; Jaisankar, Parasuraman; Agrawal, Anurag; Ghosh, Balaram			Regulation of NF-kappa B Activation through a Novel PI-3K-Independent and PKA/Akt-Dependent Pathway in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; GENE-EXPRESSION; TNF-ALPHA; AKT; PHOSPHORYLATION; ADHESION; TRANSCRIPTION; SUPPRESSION; INHIBITION	The transcription factor NF-kappa B regulates numerous inflammatory diseases, and proteins involved in the NF-kappa B-activating signaling pathway are important therapeutic targets. In human umbilical vein endothelial cells (HUVECs), TNF-alpha-induced I kappa B alpha degradation and p65/RelA phosphorylation regulate NF-kappa B activation. These are mediated by IKKs (I kappa B kinases) viz. IKK alpha, beta and gamma which receive activating signals from upstream kinases such as Akt. Akt is known to be positively regulated by PI-3K (phosphoinositide-3-kinase) and differentially regulated via Protein kinase A (PKA) in various cell types. However, the involvement of PKA/Akt cross talk in regulating NF-kappa B in HUVECs has not been explored yet. Here, we examined the involvement of PKA/Akt cross-talk in HUVECs using a novel compound, 2-methyl-pyran-4-one-3-O-beta-D-2',3',4',6'-tetra-Oacetyl glucopyranoside (MPTAG). We observed that MPTAG does not directly inhibit IKK-beta but prevents TNF-alpha-induced activation of IKK-beta by blocking its association with Akt and thereby inhibits NF-kappa B activation. Interestingly, our results also revealed that inhibitory effect of MPTAG on Akt and NF-kappa B activation was unaffected by wortmannin, and was completely abolished by H-89 treatment in these cells. Thus, MPTAG-mediated inhibition of TNF-alpha-induced Akt activation was independent of PI-3K and dependent on PKA. Most importantly, MPTAG restores the otherwise repressed activity of PKA and inhibits the TNF-alpha-induced Akt phosphorylation at both Thr308 and Ser473 residues. Thus, we demonstrate for the first time the involvement of PKA/Akt cross talk in NF-kappa B activation in HUVECs. Also, MPTAG could be useful as a lead molecule for developing potent therapeutic molecules for diseases where NF-kappa B activation plays a key role.	[Balwani, Sakshi; Chaudhuri, Rituparna; Agrawal, Anurag; Ghosh, Balaram] CSIR Inst Genom & Integrat Biol, Immunogenet Mol Lab, Delhi, India; [Nandi, Debkumar; Jaisankar, Parasuraman] CSIR Indian Inst Chem Biol, Dept Med Chem, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ghosh, B (corresponding author), CSIR Inst Genom & Integrat Biol, Immunogenet Mol Lab, Delhi, India.	bghosh@igib.res.in	Chaudhuri, Rituparna/GWU-5111-2022; Ghosh, Balaram/G-1248-2010; Jaisankar, Parasuraman/C-1553-2009; Agrawal, Anurag/GZL-5821-2022	Jaisankar, Parasuraman/0000-0003-0583-4920; Agrawal, Anurag/0000-0002-0340-5252	Network Project of Council of Scientific and Industrial Research (CSIR), Government of India [NWP 0033]; CSIR	Network Project of Council of Scientific and Industrial Research (CSIR), Government of India; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The work was funded by the Network Project (NWP 0033) of the Council of Scientific and Industrial Research (CSIR), Government of India. SB and DB acknowledge CSIR for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert D, 1999, J BIOL CHEM, V274, P22176, DOI 10.1074/jbc.274.32.22176; Attar RM, 1997, SEMIN CANCER BIOL, V8, P93, DOI 10.1006/scbi.1997.0060; Baek YS, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-18; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Balwani S, 2011, BIOCHIMIE, V93, P921, DOI 10.1016/j.biochi.2011.01.010; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Breccia M, 2010, EXPERT OPIN THER TAR, V14, P1157, DOI 10.1517/14728222.2010.522570; Burow ME, 2000, BIOCHEM BIOPH RES CO, V271, P342, DOI 10.1006/bbrc.2000.2626; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Flood PM, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/216298; Forti FL, 2000, ENDOCR RES, V26, P911, DOI 10.3109/07435800009048616; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Kang JS, 2006, MOL PHARMACOL, V69, P941, DOI 10.1124/mol.105.017442; Kermarrec N, 2005, CRIT CARE MED, V33, P1359, DOI 10.1097/01.CCM.0000166359.47577.57; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Krohn K, 2007, ARKIVOC, P46, DOI 10.3998/ark.5550190.0008.505; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Madan B, 2000, MOL PHARMACOL, V58, P526, DOI 10.1124/mol.58.3.526; Mayo MW, 2002, J BIOL CHEM, V277, P11116, DOI 10.1074/jbc.M108670200; Meng FY, 2003, BBA-GENE STRUCT EXPR, V1630, P35, DOI 10.1016/j.bbaexp.2003.09.001; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Ozes ON, 1999, NATURE, V401, P82; Radomska-Lesniewska DM, 2006, J PHYSIOL PHARMACOL, V57, P325; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Saito Y, 2010, AM J PHYSIOL-RENAL, V298, pF1436, DOI 10.1152/ajprenal.00512.2009; Sakai A, 1996, LIFE SCI, V58, P2377, DOI 10.1016/0024-3205(96)00241-X; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Strnad J, 2007, TRENDS PHARMACOL SCI, V28, P142, DOI 10.1016/j.tips.2007.01.005; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Vogel AI, 1989, VOGELS TXB PRACTICAL, P674; Wang L, 2001, J BIOL CHEM, V276, P37242, DOI 10.1074/jbc.M105089200; WEBER C, 1995, CIRCULATION, V91, P1914, DOI 10.1161/01.CIR.91.7.1914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhu L, 2001, FEBS LETT, V508, P369, DOI 10.1016/S0014-5793(01)03084-8	46	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46528	10.1371/journal.pone.0046528	http://dx.doi.org/10.1371/journal.pone.0046528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071583	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300034
J	Lorenzi, S; Forloni, M; Cifaldi, L; Antonucci, C; Citti, A; Boldrini, R; Pezzullo, M; Castellano, A; Russo, V; van der Bruggen, P; Giacomini, P; Locatelli, F; Fruci, D				Lorenzi, Silvia; Forloni, Matteo; Cifaldi, Loredana; Antonucci, Chiara; Citti, Arianna; Boldrini, Renata; Pezzullo, Marco; Castellano, Aurora; Russo, Vincenzo; van der Bruggen, Pierre; Giacomini, Patrizio; Locatelli, Franco; Fruci, Doriana			IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM AMINOPEPTIDASES; BETA-2-MICROGLOBULIN GENE-EXPRESSION; HISTOCOMPATIBILITY CLASS-I; HIGH-RISK NEUROBLASTOMA; KAPPA-B; MULTIPLE DEFECTS; INTERFERON-GAMMA; MELANOMA-CELLS; HEAVY-CHAINS; MAGE-3	Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remarkable low expression of Major Histocompatibility Complex class I (MHC-I) and Antigen Processing Machinery (APM) molecules, including Endoplasmic Reticulum (ER) Aminopeptidases, and poorly presents tumor antigens to Cytotoxic T Lymphocytes (CTL). We have previously shown that this is due to low expression of the transcription factor NF-kB p65. Herein, we show that not only NF-kB p65, but also the Interferon Regulatory Factor 1 (IRF1) and certain APM components are low in a subset of NB cell lines with aggressive features. Whereas single transfection with either IRF1, or NF-kB p65 is ineffective, co-transfection results in strong synergy and substantial reversion of the MHC-I/APM-low phenotype in all NB cell lines tested. Accordingly, linked immunohistochemistry expression patterns between nuclear IRF1 and p65 on the one hand, and MHC-I on the other hand, were observed in vivo. Absence and presence of the three molecules neatly segregated between high-grade and low-grade NB, respectively. Finally, APM reconstitution by double IRF1/p65 transfection rendered a NB cell line susceptible to killing by anti MAGE-A3 CTLs, lytic efficiency comparable to those seen upon IFN-gamma treatment. This is the first demonstration that a complex immune escape phenotype can be rescued by reconstitution of a limited number of master regulatory genes. These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.	[Lorenzi, Silvia; Forloni, Matteo; Cifaldi, Loredana; Antonucci, Chiara; Pezzullo, Marco; Castellano, Aurora; Locatelli, Franco; Fruci, Doriana] IRCCS, Bambino Gesu Childrens Hosp, Paediat Haematol Oncol Dept, Rome, Italy; [Citti, Arianna; Boldrini, Renata] IRCCS, Bambino Gesu Childrens Hosp, Dept Pathol, Rome, Italy; [Russo, Vincenzo] Ist Sci San Raffaele, Canc Gene Therapy Unit, I-20132 Milan, Italy; [van der Bruggen, Pierre] Regina Elena Inst Canc Res, Lab Immunol CRS, Rome, Italy; [Giacomini, Patrizio] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium; [Giacomini, Patrizio] Ludwig Inst Canc Res, Brussels, Belgium; [Locatelli, Franco] Univ Pavia, I-27100 Pavia, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Universite Catholique Louvain; Ludwig Institute for Cancer Research; University of Pavia	Fruci, D (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Paediat Haematol Oncol Dept, Rome, Italy.	fruci@opbg.net	Fruci, Doriana/AAA-8218-2019; castellano, aurora/AAA-6535-2020; Giacomini, Patrizio/K-5217-2016; Pezzullo, Marco/AAI-2404-2019; Cifaldi, Loredana/AAI-1972-2019; Russo, Vincenzo/K-5650-2016	Fruci, Doriana/0000-0003-3388-7296; castellano, aurora/0000-0002-2316-4927; Giacomini, Patrizio/0000-0001-6109-1709; Russo, Vincenzo/0000-0003-1592-5041; Cifaldi, Loredana/0000-0001-5014-430X; Forloni, Matteo/0000-0003-4858-8491	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy);  [5 x 1000 AIRC]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); 	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) to D. F. and P. G. and the special grant 5 x 1000 AIRC to F. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Cheung IY, 1997, CLIN CANCER RES, V3, P821; Cifaldi L, 2011, CANCER RES, V71, P1597, DOI 10.1158/0008-5472.CAN-10-3326; Corrias MV, 1996, INT J CANCER, V69, P403, DOI 10.1002/(SICI)1097-0215(19961021)69:5<403::AID-IJC9>3.0.CO;2-9; Corrias MV, 2001, TISSUE ANTIGENS, V57, P110, DOI 10.1034/j.1399-0039.2001.057002110.x; Coughlin CM, 2006, J CLIN ONCOL, V24, P5725, DOI 10.1200/JCO.2005.05.3314; Doody GM, 2007, J IMMUNOL, V179, P7614, DOI 10.4049/jimmunol.179.11.7614; Drew PD, 1995, J INTERF CYTOK RES, V15, P1037, DOI 10.1089/jir.1995.15.1037; DREW PD, 1993, J IMMUNOL, V150, P3300; Drew PD, 1995, J NEUROIMMUNOL, V63, P157, DOI 10.1016/0165-5728(95)00140-9; FELTNER DE, 1989, J IMMUNOL, V143, P4292; Fontana R, 2009, BLOOD, V113, P1651, DOI 10.1182/blood-2008-07-168666; Forloni M, 2010, CANCER RES, V70, P916, DOI 10.1158/0008-5472.CAN-09-2582; Fruci D, 2006, J IMMUNOL, V176, P4869, DOI 10.4049/jimmunol.176.8.4869; Fruci D, 2008, J CELL PHYSIOL, V216, P742, DOI 10.1002/jcp.21454; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Giorda E, 2003, CANCER RES, V63, P4119; Gobin SJP, 2003, BLOOD, V101, P3058, DOI 10.1182/blood-2002-09-2924; Gobin SJP, 1998, J IMMUNOL, V161, P2276; Gobin SJP, 1999, J IMMUNOL, V163, P1428; Grau E, 2009, J CANCER RES CLIN, V135, P523, DOI 10.1007/s00432-008-0484-1; Himoudi N, 2008, CANCER IMMUNOL IMMUN, V57, P693, DOI 10.1007/s00262-007-0409-x; Jacobs JFM, 2007, INT J CANCER, V120, P67, DOI 10.1002/ijc.22118; Lesinski GB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-142; Lode HN, 2004, ANN NY ACAD SCI, V1028, P113, DOI 10.1196/annals.1322.012; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Martayan A, 1999, BRIT J CANCER, V80, P639, DOI 10.1038/sj.bjc.6690405; MATTHAY KK, 1995, EUR J CANCER, V31A, P572, DOI 10.1016/0959-8049(95)00015-B; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Moschonas A, 2008, MOL CELL BIOL, V28, P6208, DOI 10.1128/MCB.00611-08; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Prigione I, 2004, ANN NY ACAD SCI, V1028, P69, DOI 10.1196/annals.1322.008; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; RIMOLDI D, 1993, INT J CANCER, V54, P527, DOI 10.1002/ijc.2910540329; Rodolfo M, 2003, CANCER RES, V63, P6948; Russo V, 2000, P NATL ACAD SCI USA, V97, P2185, DOI 10.1073/pnas.040540197; Santhekadur PK, 2012, J BIOL CHEM, V287, P3425, DOI 10.1074/jbc.M111.298976; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Sigalotti L, 2008, J CELL PHYSIOL, V215, P287, DOI 10.1002/jcp.21380; Soling A, 1999, ANTICANCER RES, V19, P2205; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tanioka T, 2005, FEBS J, V272, P916, DOI 10.1111/j.1742-4658.2004.04521.x; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Wolfl M, 2005, CANCER IMMUNOL IMMUN, V54, P400, DOI 10.1007/s00262-004-0603-z; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	53	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46928	10.1371/journal.pone.0046928	http://dx.doi.org/10.1371/journal.pone.0046928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071666	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300071
J	Novielli, NM; Al-Khazraji, BK; Medeiros, PJ; Goldman, D; Jackson, DN				Novielli, Nicole M.; Al-Khazraji, Baraa K.; Medeiros, Philip J.; Goldman, Daniel; Jackson, Dwayne N.			Pre-Diabetes Augments Neuropeptide Y-1- and alpha(1)-Receptor Control of Basal Hindlimb Vascular Tone in Young ZDF Rats	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SYMPATHETIC NERVOUS-SYSTEM; TYPE-2 DIABETES-MELLITUS; SPRAGUE-DAWLEY RATS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; BLOOD-PRESSURE; SMOOTH-MUSCLE; HYPERTENSION; EXPRESSION	Background: Peripheral vascular disease in pre-diabetes may involve altered sympathetically-mediated vascular control. Thus, we investigated if pre-diabetes modifies baseline sympathetic Y-1-receptor (Y1R) and alpha(1)-receptor (alpha R-1) control of hindlimb blood flow (Q(fem)) and vascular conductance (VC). Methods: Q(fem) and VC were measured in pre-diabetic ZDF rats (PD) and lean controls (CTRL) under infusion of BIBP3226 (Y1R antagonist), prazosin (alpha R-1 antagonist) and BIBP3226+prazosin. Neuropeptide Y (NPY) concentration and Y1R and alpha R-1 expression were determined from hindlimb skeletal muscle samples. Results: Baseline Q(fem) and VC were similar between groups. Independent infusions of BIBP3226 and prazosin led to increases in Q(fem) and VC in CTRL and PD, where responses were greater in PD (p<0.05). The percent change in VC following both drugs was also greater in PD compared to CTRL (p<0.05). As well, Q(fem) and VC responses to combined blockade (BIBP3226+prazosin) were greater in PD compared to CTRL (p<0.05). Interestingly, an absence of synergistic effects was observed within groups, as the sum of the VC responses to independent drug infusions was similar to responses following combined blockade. Finally, white and red vastus skeletal muscle NPY concentration, Y1R expression and alpha R-1 expression were greater in PD compared to CTRL. Conclusions: For the first time, we report heightened baseline Y1R and alpha R-1 sympathetic control of Q(fem) and VC in prediabetic ZDF rats. In support, our data suggest that augmented sympathetic ligand and receptor expression in pre-diabetes may contribute to vascular dysregulation.	[Novielli, Nicole M.; Al-Khazraji, Baraa K.; Medeiros, Philip J.; Goldman, Daniel; Jackson, Dwayne N.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Goldman, Daniel; Jackson, Dwayne N.] Univ Western Ontario, Biomed Engn Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Jackson, DN (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	dwayne.jackson@schulich.uwo.ca	Al-Khazraji, Baraa/AAI-6118-2021; Goldman, Daniel/CAF-8020-2022; Jackson, Dwayne N/E-4153-2015; Al-Khazraji, Baraa/S-1994-2016	Al-Khazraji, Baraa/0000-0003-1075-4183; Jackson, Dwayne N/0000-0002-0751-1415; Al-Khazraji, Baraa/0000-0003-1075-4183; Goldman, Daniel/0000-0002-8707-5536	National Institutes of Health [R33 HL089094]; Natural Sciences and Engineering Research Council [R4218A03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding source: National Institutes of Health, R33 HL089094 and Natural Sciences and Engineering Research Council, R4218A03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EA, 1992, HYPERTENSION, V19, P621, DOI 10.1161/01.HYP.19.6.621; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; ARMSTRONG RB, 1984, AM J PHYSIOL, V246, pH59, DOI 10.1152/ajpheart.1984.246.1.H59; BARTFAI T, 1988, ANNU REV PHARMACOL, V28, P285, DOI 10.1146/annurev.pa.28.040188.001441; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YL, 1996, J APPL PHYSIOL, V81, P349, DOI 10.1152/jappl.1996.81.1.349; Crawford SO, 2010, INT J EPIDEMIOL; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dvorakova MC, 2008, NEUROSCIENCE, V151, P1016, DOI 10.1016/j.neuroscience.2007.07.069; EISENHOFER G, 1989, CLIN SCI, V76, P171, DOI 10.1042/cs0760171; Ekelund U, 1997, BRIT J PHARMACOL, V120, P387, DOI 10.1038/sj.bjp.0700908; Ellis CG, 2010, AM J PHYSIOL-HEART C, V298, pH1661, DOI 10.1152/ajpheart.01239.2009; EPSTEIN M, 1992, HYPERTENSION, V19, P403, DOI 10.1161/01.HYP.19.5.403; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Faeh D, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-32; Franco-Cereceda A, 1998, EUR J PHARMACOL, V349, P1, DOI 10.1016/S0014-2999(98)00242-8; Frisbee JC, 2004, J APPL PHYSIOL, V97, P764, DOI 10.1152/japplphysiol.01216.2003; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Hu ZW, 1996, J CLIN INVEST, V98, P1826, DOI 10.1172/JCI118983; Huggett RJ, 2006, DIABETOLOGIA, V49, P2741, DOI 10.1007/s00125-006-0399-9; Huggett RJ, 2003, CIRCULATION, V108, P3097, DOI 10.1161/01.CIR.0000103123.66264.FE; Jackson DN, 2005, J PHYSIOL-LONDON, V568, P573, DOI 10.1113/jphysiol.2005.092700; Jackson DN, 2005, J PHYSIOL-LONDON, V562, P285, DOI 10.1113/jphysiol.2004.076141; Jackson DN, 2004, AM J PHYSIOL-REG I, V287, pR228, DOI 10.1152/ajpregu.00723.2003; Jackson DN, 2010, AM J PHYSL REGUL INT; Kim SH, 2008, DIABETES CARE, V31, P1433, DOI 10.2337/dc08-0045; Kim SH, 2008, DIABETES CARE, V31, P347, DOI 10.2337/dc07-1574; LAUGHLIN MH, 1983, AM J PHYSIOL, V244, pH814, DOI 10.1152/ajpheart.1983.244.6.H814; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; Lesniewski LA, 2008, AM J PHYSIOL-HEART C, V294, pH1840, DOI 10.1152/ajpheart.00692.2007; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; LUNDBERG JM, 1994, ADV SEC MESS PHOSPH, V29, P223; Lundberg JM, 1996, PHARMACOL REV, V48, P113; Malmstrom R E, 1997, Acta Physiol Scand Suppl, V636, P1; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; MARTIN WH, 1990, AM J PHYSIOL, V259, pH1402, DOI 10.1152/ajpheart.1990.259.5.H1402; Matyal R, 2011, EUR J PHARMACOL, V665, P19, DOI 10.1016/j.ejphar.2011.04.039; MUNTZEL MS, 1995, CLIN EXP HYPERTENS, V17, P39, DOI 10.3109/10641969509087053; Okon EB, 2003, J VASC RES, V40, P520, DOI 10.1159/000075238; Scherrer U, 1997, CIRCULATION, V96, P4104; SOMA LR, 1983, ANN NY ACAD SCI, V406, P32, DOI 10.1111/j.1749-6632.1983.tb53483.x; TERJUNG RL, 1988, MED SCI SPORT EXER, V20, pS124, DOI 10.1249/00005768-198810001-00006; Zukowska-Grojec Z, 1993, BIOL NEUROPEPTIDE Y, P315; ZUKOWSKAGROJEC Z, 1988, LIFE SCI, V42, P1615, DOI 10.1016/0024-3205(88)90440-7; ZukowskaGrojec Z, 1995, ANN NY ACAD SCI, V771, P219, DOI 10.1111/j.1749-6632.1995.tb44683.x	46	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46659	10.1371/journal.pone.0046659	http://dx.doi.org/10.1371/journal.pone.0046659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071607	gold, Green Submitted, Green Published			2022-12-25	WOS:000309827300044
J	Yang, C; Huang, TW; Wen, SY; Chang, CY; Tsai, SF; Wu, WF; Chang, CH				Yang, Chi; Huang, Tzu-Wen; Wen, Shiau-Yi; Chang, Chun-Yang; Tsai, Shih-Feng; Wu, Whei-Fen; Chang, Chuan-Hsiung			Genome-Wide PhoB Binding and Gene Expression Profiles Reveal the Hierarchical Gene Regulatory Network of Phosphate Starvation in Escherichia coli	PLOS ONE			English	Article							TRANSCRIPTIONAL ANALYSIS; CHROMOSOMAL GENES; SURVIVAL; REGULON; EXOPOLYSACCHARIDE; NORMALIZATION; METHYLGLYOXAL; HOMEOSTASIS; METABOLISM; STIMULON	The phosphate starvation response in bacteria has been studied extensively for the past few decades and the phosphate-limiting signal is known to be mediated via the PhoBR two-component system. However, the global DNA binding profile of the response regulator PhoB and the PhoB downstream responses are currently unclear. In this study, chromatin immunoprecipitation for PhoB was combined with high-density tiling array (ChIP-chip) as well as gene expression microarray to reveal the first global down-stream responses of the responding regulator, PhoB in E. coli. Based on our ChIP-chip experimental data, forty-three binding sites were identified throughout the genome and the known PhoB binding pattern was updated by identifying the conserved pattern from these sites. From the gene expression microarray data analysis, 287 differentially expressed genes were identified in the presence of PhoB activity. By comparing the results obtained from our ChIP-chip and microarray experiments, we were also able to identify genes that were directly or indirectly affected through PhoB regulation. Nineteen out of these 287 differentially expressed genes were identified as the genes directly regulated by PhoB. Seven of the 19 directly regulated genes (including phoB) are transcriptional regulators. These transcriptional regulators then further pass the signal of phosphate starvation down to the remaining differentially expressed genes. Our results unveiled the genome-wide binding profile of PhoB and the downstream responses under phosphate starvation. We also present the hierarchical structure of the phosphate sensing regulatory network. The data suggest that PhoB plays protective roles in membrane integrity and oxidative stress reduction during phosphate starvation.	[Yang, Chi; Wen, Shiau-Yi; Chang, Chuan-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Huang, Tzu-Wen; Tsai, Shih-Feng] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli, Taiwan; [Chang, Chun-Yang; Wu, Whei-Fen] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Taiwan University	Yang, C (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Ctr Syst & Synthet Biol, Taipei 112, Taiwan.	cchang@ym.edu.tw	Wu, Whei-Fen/AAS-6031-2021; Tsai, Shih-Feng/E-3997-2010	Yang, Chi/0000-0002-1676-5185; WU, WHI-FIN/0000-0002-9526-6287	National Science Council, Taiwan [NSC 100-2319-B-010-002]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by a grant from the National Science Council, Taiwan (NSC 100-2319-B-010-002), and the Aim for the Top University Plan grant from the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2005, J BACTERIOL, V187, P8063, DOI 10.1128/JB.187.23.8063-8080.2005; APHA A, 1995, STANDARD METHODS EXA, V19th; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baek JH, 2007, J MICROBIOL BIOTECHN, V17, P244; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bishop RE, 2005, J ENDOTOXIN RES, V11, P174, DOI 10.1179/096805105X35242; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Gerard F, 1999, MICROBIOL-UK, V145, P1547, DOI 10.1099/13500872-145-7-1547; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; HE Y, 1993, EUR J BIOCHEM, V217, P89, DOI 10.1111/j.1432-1033.1993.tb18222.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishige T, 2003, J BACTERIOL, V185, P4519, DOI 10.1128/JB.185.15.4519-4529.2003; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Kuan Pei Fen, 2008, Pac Symp Biocomput, P515; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamarche MG, 2010, CURR MICROBIOL, V60, P356, DOI 10.1007/s00284-009-9549-x; Lee SM, 2004, J FOOD PROTECT, V67, P252, DOI 10.4315/0362-028X-67.2.252; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mao Y, 2006, LETT APPL MICROBIOL, V42, P642, DOI 10.1111/j.1472-765X.2006.01875.x; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; Moreau PL, 2004, J BACTERIOL, V186, P7364, DOI 10.1128/JB.186.21.7364-7368.2004; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; VanBogelen RA, 1996, J BACTERIOL, V178, P4344, DOI 10.1128/jb.178.15.4344-4366.1996; von Kruger WMA, 2006, PROTEOMICS, V6, P1495, DOI 10.1002/pmic.200500238; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16	44	25	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47314	10.1371/journal.pone.0047314	http://dx.doi.org/10.1371/journal.pone.0047314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071782	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300090
J	Sanz, AB; Sanchez-Nino, MD; Carrasco, S; Manzarbeitia, F; Ruiz-Andres, O; Selgas, R; Ruiz-Ortega, M; Gonzalez-Enguita, C; Egido, J; Ortiz, A				Belen Sanz, Ana; Dolores Sanchez-Nino, Maria; Carrasco, Susana; Manzarbeitia, Felix; Ruiz-Andres, Olga; Selgas, Rafael; Ruiz-Ortega, Marta; Gonzalez-Enguita, Carmen; Egido, Jesus; Ortiz, Alberto			Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; B PATHWAY ACTIVATION; TUBULAR EPITHELIUM; WEAK INDUCER; FAS LIGAND; RECEPTOR; FN14; TRAIL; DEATH; EXPRESSION	Tumor necrosis factor-like weak inducer of apoptosis (TWEAK, TNFSF12) is a member of the tumor necrosis factor superfamily. TWEAK activates the Fn14 receptor, and may regulate cell death, survival and proliferation in tumor cells. However, there is little information on the function and regulation of this system in prostate cancer. Fn14 expression and TWEAK actions were studied in two human prostate cancer cell lines, the androgen-independent PC-3 cell line and androgen-sensitive LNCaP cells. Additionally, the expression of Fn14 was analyzed in human biopsies of prostate cancer. Fn14 expression is increased in histological sections of human prostate adenocarcinoma. Both prostate cancer cell lines express constitutively Fn14, but, the androgen-independent cell line PC-3 showed higher levels of Fn14 that the LNCaP cells. Fn14 expression was up-regulated in PC-3 human prostate cancer cells in presence of inflammatory cytokines (TNF alpha/IFN gamma) as well as in presence of bovine fetal serum. TWEAK induced apoptotic cell death in PC-3 cells, but not in LNCaP cells. Moreover, in PC-3 cells, co-stimulation with TNF alpha/IFN gamma/TWEAK induced a higher rate of apoptosis. However, TWEAK or TWEAK/TNF alpha/IFN gamma did not induce apoptosis in presence of bovine fetal serum. TWEAK induced cell death through activation of the Fn14 receptor. Apoptosis was associated with activation of caspase-3, release of mitochondrial cytochrome C and an increased Bax/BclxL ratio. TWEAK/Fn14 pathway activation promotes apoptosis in androgen-independent PC-3 cells under certain culture conditions. Further characterization of the therapeutic target potential of TWEAK/Fn14 for human prostate cancer is warranted.	[Carrasco, Susana; Manzarbeitia, Felix; Ruiz-Andres, Olga; Ruiz-Ortega, Marta; Gonzalez-Enguita, Carmen; Egido, Jesus; Ortiz, Alberto] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Madrid, Spain; [Carrasco, Susana; Ruiz-Andres, Olga; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] Fdn Renal Inigo Alvarez Toledo, Madrid, Spain; [Belen Sanz, Ana; Dolores Sanchez-Nino, Maria; Selgas, Rafael] IdiPAZ, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz	Ortiz, A (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Madrid, Spain.	aortiz@fjd.es	Sanz, Ana Belen/C-9489-2013; Gonzalez Enguita, Carmen/GWQ-3941-2022; Ortega, Marta Ruiz/AAN-2136-2020; ortiz, alberto/Y-7582-2018; Ruiz-Ortega, Marta/D-3584-2012; Sanchez-Niño, Maria Dolores/B-7350-2019; Gonzalez Enguita, Maria Del Carmen/N-7830-2018; ruiz-ortega, marta/D-3584-2012	Sanz, Ana Belen/0000-0002-0255-5689; Ortega, Marta Ruiz/0000-0002-1495-6535; ortiz, alberto/0000-0002-9805-9523; Ruiz-Ortega, Marta/0000-0002-1495-6535; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Carrasco Navarro, Susana/0000-0003-3746-0580; Gonzalez Enguita, Maria Del Carmen/0000-0002-5881-6614; ruiz-ortega, marta/0000-0002-1403-2690	Fondo de Investigacion Sanitaria (FIS) [PS09/00447]; Instituto de Salud Carlos III-Redes Tematicas de Investigacion Cooperativa en Salud(ISCIII-RETIC) [REDinREN/RD06/0016]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Instituto de Salud Carlos III-Redes Tematicas de Investigacion Cooperativa en Salud(ISCIII-RETIC)	Grant support from Fondo de Investigacion Sanitaria (FIS) PS09/00447, Instituto de Salud Carlos III-Redes Tematicas de Investigacion Cooperativa en Salud(ISCIII-RETIC)REDinREN/RD06/0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; Alonso V, 2009, LIFE SCI, V85, P421, DOI 10.1016/j.lfs.2009.07.005; Sanz AB, 2011, KIDNEY INT, V80, P708, DOI 10.1038/ki.2011.180; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Bucur O, 2006, FRONT BIOSCI-LANDMRK, V11, P1549, DOI 10.2741/1903; Carrero JJ, 2009, CLIN J AM SOC NEPHRO, V4, P110, DOI 10.2215/CJN.02790608; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Cornforth AN, 2008, ONCOGENE, V27, P4422, DOI 10.1038/onc.2008.80; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Dai L, 2009, CANCER LETT, V283, P159, DOI 10.1016/j.canlet.2009.03.036; Dionne S, 2010, ANTICANCER RES, V30, P157; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Festuccia C, 2008, INT J ONCOL, V33, P381, DOI 10.3892/ijo_00000019; Guseva NV, 2004, J CELL BIOCHEM, V91, P70, DOI 10.1002/jcb.10707; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Hwang C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-26; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Kaduka Y, 2005, BIOCHEM BIOPH RES CO, V331, P384, DOI 10.1016/j.bbrc.2005.03.176; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Kim HS, 2010, PROSTATE, V70, P1540, DOI 10.1002/pros.21189; Kralisch S, 2008, ATHEROSCLEROSIS, V199, P440, DOI 10.1016/j.atherosclerosis.2007.10.022; Lorz C, 2000, J AM SOC NEPHROL, V11, P1266, DOI 10.1681/ASN.V1171266; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Martin-Ventura JL, 2011, ATHEROSCLEROSIS, V214, P486, DOI 10.1016/j.atherosclerosis.2010.11.009; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; Michaelson JS, 2009, RESULTS PROBL CELL D, V49, P145, DOI 10.1007/400_2008_18; Michaelson JS, 2012, CANC BIOL THER, V13, P20564; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Molano A, 2009, IMMUNOL LETT, V125, P119, DOI 10.1016/j.imlet.2009.06.010; Moreno JA, 2009, ATHEROSCLEROSIS, V207, P103, DOI 10.1016/j.atherosclerosis.2009.04.033; Munoz-Garcia B, 2006, STROKE, V37, P2044, DOI 10.1161/01.STR.0000230648.00027.00; Nakayama M, 2003, BIOCHEM BIOPH RES CO, V306, P819, DOI 10.1016/S0006-291X(03)01051-9; Nastiuk KL, 2008, CANCER BIOL THER, V7, P1171, DOI 10.4161/cbt.7.8.6712; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360; O'Kane HF, 2006, J UROLOGY, V175, P432, DOI 10.1016/S0022-5347(05)00160-6; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; Perez-Martinez FC, 2007, J CLIN PATHOL, V60, P290, DOI 10.1136/jcp.2006.037853; Rodriguez-Berriguete G, 2012, PROSTATE, V72, P40, DOI 10.1002/pros.21404; Royuela M, 2008, HISTOL HISTOPATHOL, V23, P1279, DOI 10.14670/HH-23.1279; Sanz AB, 2009, J CELL MOL MED, V13, P3329, DOI 10.1111/j.1582-4934.2009.00766.x; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Snyder CF, 2010, PROSTATE CANCER P D, V13, P58, DOI 10.1038/pcan.2009.39; Tenniswood M, 2004, CANCER BIOL THER, V3, P769, DOI 10.4161/cbt.3.8.1028; Tiller G, 2009, ENDOCRINOLOGY, V150, P5373, DOI 10.1210/en.2009-0488; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang DF, 2010, CANCER LETT, V294, P91, DOI 10.1016/j.canlet.2010.01.027; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xia Li-Ping, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P575	61	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47440	10.1371/journal.pone.0047440	http://dx.doi.org/10.1371/journal.pone.0047440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077618	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100114
J	Burai, R; Ramesh, C; Nayak, TK; Dennis, MK; Bryant, BK; Prossnitz, ER; Arterburn, JB				Burai, Ritwik; Ramesh, Chinnasamy; Nayak, Tapan K.; Dennis, Megan K.; Bryant, Bj K.; Prossnitz, Eric R.; Arterburn, Jeffrey B.			Synthesis and Characterization of Tricarbonyl-Re/Tc(I) Chelate Probes Targeting the G Protein-Coupled Estrogen Receptor GPER/GPR30	PLOS ONE			English	Article							BREAST-CANCER; GPR30; BIOMOLECULES; ANTAGONIST; COMPLEXES; CLICK; GPER	The discovery of the G protein-coupled estrogen receptor GPER (also GPR30) and the resulting development of selective chemical probes have revealed new aspects of estrogen receptor biology. The potential clinical relevance of this receptor has been suggested from numerous studies that have identified GPER expression in breast, endometrial, ovarian and other cancers. Thus GPER can be considered a candidate biomarker and target for non-invasive imaging and therapy. We have designed and synthesized a series of organometallic tricarbonyl-rhenium complexes conjugated to a GPER-selective small molecule derived from tetrahydro-3H-cyclopenta[c] quinoline. The activity and selectivity of these chelates in GPER-mediated signaling pathways were evaluated. These results demonstrate that GPER targeting characteristics depend strongly on the structure of the chelate and linkage. Ethanone conjugates functioned as agonists, a 1,2,3-triazole spacer yielded an antagonist, and derivatives with increased steric volume exhibited decreased activities. Promising GPER selectivity was observed, as none of the complexes interacted with the nuclear estrogen receptors. Radiolabeling with technetium-99m in aqueous media was efficient and gave radioligands with high radiochemical yields and purity. These chelates have favorable physicochemical properties, show excellent stability in biologically relevant media, exhibit receptor specificity and are promising candidates for continuing development as diagnostic imaging agents targeting GPER expression in cancer.	[Burai, Ritwik; Ramesh, Chinnasamy; Bryant, Bj K.; Arterburn, Jeffrey B.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; [Nayak, Tapan K.; Dennis, Megan K.; Prossnitz, Eric R.] Univ New Mexico, Dept Cell Biol & Physiol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Prossnitz, Eric R.; Arterburn, Jeffrey B.] Univ New Mexico, Hlth Sci Ctr, Ctr Canc, Albuquerque, NM 87131 USA	New Mexico State University; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Arterburn, JB (corresponding author), New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.	jarterbu@nmsu.edu	Prossnitz, Eric/I-4599-2019; Prossnitz, Eric R./B-4543-2008	Prossnitz, Eric/0000-0001-9190-8302; Nayak, Tapan/0000-0002-3706-6092; Dennis, Megan/0000-0002-8986-5021	United States National Institutes of Health [R01 CA127731, CA118743, CA116662, P20-GM103451]; New Mexico Cowboys for Cancer Research Foundation; Oxnard Foundation; Stranahan Foundation; NATIONAL CANCER INSTITUTE [R01CA118743, R01CA127731, R01CA116662] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Mexico Cowboys for Cancer Research Foundation; Oxnard Foundation; Stranahan Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financed by United States National Institutes of Health grants R01 CA127731 (ERP, JBA), CA118743 (ERP), CA116662 (ERP) and P20-GM103451 (JBA); the New Mexico Cowboys for Cancer Research Foundation (JBA, ERP); Oxnard Foundation (ERP); and the Stranahan Foundation (ERP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto R, 2001, J AM CHEM SOC, V123, P3135, DOI 10.1021/ja003932b; Alonso DA, 2002, J ORG CHEM, V67, P5588, DOI 10.1021/jo025619t; Arias-Pulido H, 2010, BREAST CANCER RES TR, V123, P51, DOI 10.1007/s10549-009-0631-7; Bartholoma M, 2009, CHEM COMMUN, P493, DOI 10.1039/b814903h; Bartholoma MD, 2010, CHEM REV, V110, P2903, DOI 10.1021/cr1000755; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Burai R, 2010, ORG BIOMOL CHEM, V8, P2252, DOI 10.1039/c001307b; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Le Bras G, 2006, TETRAHEDRON LETT, V47, P5497, DOI 10.1016/j.tetlet.2006.05.155; Mindt TL, 2006, J AM CHEM SOC, V128, P15096, DOI 10.1021/ja066779f; Nayak TK, 2008, J NUCL MED, V49, P978, DOI 10.2967/jnumed.107.048546; Nayak TK, 2010, ACS CHEM BIOL, V5, P681, DOI 10.1021/cb1000636; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Ramesh C, 2006, J AM CHEM SOC, V128, P14476, DOI 10.1021/ja066360p; Ramesh C, 2010, J MED CHEM, V53, P1004, DOI 10.1021/jm9011802; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Struthers H, 2008, CHEM-EUR J, V14, P6173, DOI 10.1002/chem.200702024; Tzanopoulou S, 2010, J MED CHEM, V53, P4633, DOI 10.1021/jm1001293; Zhu W, 2004, CHEM COMMUN, P888, DOI 10.1039/b400878b	30	17	19	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46861	10.1371/journal.pone.0046861	http://dx.doi.org/10.1371/journal.pone.0046861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077529	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100045
J	Carter, MA; Dubois, L; Tremblay, MS; Taljaard, M; Jones, BL				Carter, Megan A.; Dubois, Lise; Tremblay, Mark S.; Taljaard, Monica; Jones, Bobby L.			Trajectories of Childhood Weight Gain: The Relative Importance of Local Environment versus Individual Social and Early Life Factors	PLOS ONE			English	Article							BODY-MASS INDEX; DEVELOPMENTAL TRAJECTORIES; PHYSICAL-ACTIVITY; SAS PROCEDURE; OVERWEIGHT; CHILDREN; OBESITY; URBAN; PREVALENCE; HEALTH	Objective: To determine the association between local environmental factors with child weight status in a longitudinal study, using a semi-parametric, group-based method, while also considering social and early life factors. Methods: Standardized, directly measured BMI from 4-10 y of age, and group-based trajectory modeling (PROC TRAJ) were used to estimate developmental trajectories of weight change in a Quebec birth cohort (n = 1,566). Associations between the weight trajectories and living location, social cohesion, disorder, and material and social deprivation were estimated after controlling for social and early life factors. Results: Four weight trajectory groups were estimated: low-increasing (9.7%); low-medium, accelerating (36.2%); medium-high, increasing (43.0%); and high-stable (11.1%). In the low-increasing and medium-high trajectory groups, living in a semi-urban area was inversely related to weight, while living in a rural area was positively related to weight in the high-stable group. Disorder was inversely related to weight in the low-increasing group only. Other important risk factors for high-stable weight included obesity status of the mother, smoking during pregnancy, and overeating behaviors. Conclusions: In this study, associations between local environment factors and weight differed by trajectory group. Early life factors appear to play a more consistent role in weight status. Further work is needed to determine the influence of place on child weight.	[Carter, Megan A.; Dubois, Lise] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada; [Dubois, Lise; Tremblay, Mark S.; Taljaard, Monica] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Tremblay, Mark S.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Taljaard, Monica] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Jones, Bobby L.] Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, Behav Genet Res Program, Pittsburgh, PA 15213 USA	University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Carter, MA (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada.	carter.megan@gmail.com	Tremblay, Mark/ABI-5477-2020; Tremblay, Mark/AAF-2981-2019	Taljaard, Monica/0000-0002-3978-8961	Canadian Institutes for Health Research (CIHR Canada Graduate Scholarship); ministere de la Sante et des Services sociaux du Quebec (MSSS); ministere de la Famille et des Aines (MFA); Lucie and Andre Chagnon Foundation; Institut de la statistique du Quebec; Quebec Ministry of Health and Social Services	Canadian Institutes for Health Research (CIHR Canada Graduate Scholarship)(Canadian Institutes of Health Research (CIHR)); ministere de la Sante et des Services sociaux du Quebec (MSSS); ministere de la Famille et des Aines (MFA); Lucie and Andre Chagnon Foundation; Institut de la statistique du Quebec(Institut National de la Sante et de la Recherche Medicale (Inserm)); Quebec Ministry of Health and Social Services	This work was supported by grants from the Canadian Institutes for Health Research (CIHR Canada Graduate Scholarship) and funders of the QLSCD (ministere de la Sante et des Services sociaux du Quebec (MSSS), ministere de la Famille et des Aines (MFA), Lucie and Andre Chagnon Foundation, and Institut de la statistique du Quebec). The QLSCD was primarily funded by the Quebec Ministry of Health and Social Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard P, 2007, SOC SCI MED, V65, P1839, DOI 10.1016/j.socscimed.2007.05.037; Bruner M, 2008, INT J PEDIATR OBES, V3, P205, DOI 10.1080/17477160802158477; Burdette AM, 2012, J ADOLESCENT HEALTH, V50, P30, DOI 10.1016/j.jadohealth.2011.03.009; Carter MA, 2010, HEALTH PLACE, V16, P616, DOI 10.1016/j.healthplace.2009.12.012; Cohen DA, 2006, SOC SCI MED, V62, P769, DOI 10.1016/j.socscimed.2005.06.033; Curtis LJ, 2004, SOC SCI MED, V58, P1917, DOI 10.1016/j.socscimed.2003.08.007; Desrosiers H., 2009, EXCESS WEIGHT CHILDR; DESROSIERS H, 2000, FAMILY CHILD CARE NE; Dubois L, 2007, INT J EPIDEMIOL, V36, P132, DOI 10.1093/ije/dyl281; Franzini L, 2009, AM J PUBLIC HEALTH, V99, P271, DOI 10.2105/AJPH.2007.128702; Grafova IB, 2008, PREV MED, V47, P304, DOI 10.1016/j.ypmed.2008.04.012; Hejazi S, 2011, GLOBAL PERSPECTIVES ON CHILDHOOD OBESITY: CURRENT STATUS, CONSEQUENCES AND PREVENTION, P21, DOI 10.1016/B978-0-12-374995-6.10003-9; Institut de la statistique du Quebec, 2009, VAR DER ELDEQ 1998 A; Institut de la statistique du Quebec, 2001, CONC DEF OP ASP 5 MO; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; KUCZMARSKI RJ, 2002, VITAL HLTH STAT, P11; Lebel A, 2009, CAN J PUBLIC HEALTH, V100, P18, DOI 10.1007/BF03405486; Lewis RD, 2006, J SCHOOL HEALTH, V76, P126, DOI 10.1111/j.1746-1561.2006.00080.x; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; Liu JH, 2008, J RURAL HEALTH, V24, P407, DOI 10.1111/j.1748-0361.2008.00188.x; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Mendelson R., 2003, REV CENSUS METROPOLI; Must A, 2006, INT J OBESITY, V30, P590, DOI 10.1038/sj.ijo.0803300; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nonnemaker JM, 2009, OBESITY, V17, P1274, DOI 10.1038/oby.2009.5; Ogden CL, 2010, CHANGES TERMINOLOGY; Ogden Cynthia L, 2004, Md Med, V5, P19; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oliver LN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-16; Pampalon R, 2000, Chronic Dis Can, V21, P104; Pampalon R, 2009, CHRONIC DIS CAN, V29, P178; Pampalon R., 2004, INDICE DEFAVORISATIO; Pampalon R, 2004, DEV SYSTEME EVALUATI; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Sandercock GRH, 2011, PEDIATR INT, V53, P718, DOI 10.1111/j.1442-200X.2011.03354.x; Shields M, 2005, MEASURED OBESITY OVE; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Slater SJ, 2010, J ADOLESCENT HEALTH, V47, P496, DOI 10.1016/j.jadohealth.2010.03.017; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Turcotte M., 2008, CAN SOC TRENDS, V11, P20; Veitch J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-31; Ventura AK, 2009, OBESITY, V17, P2067, DOI 10.1038/oby.2009.123; Verger P, 2007, REV EPIDEMIOL SANTE, V55, P347, DOI 10.1016/j.respe.2007.06.003; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Williams PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027657	52	48	47	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47065	10.1371/journal.pone.0047065	http://dx.doi.org/10.1371/journal.pone.0047065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077545	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000309995100056
J	Huang, CC; Chan, WL; Luo, JC; Chen, YC; Chen, TJ; Chung, CM; Huang, PH; Lin, SJ; Chen, JW; Leu, HB				Huang, Chin-Chou; Chan, Wan-Leong; Luo, Jiing-Chyuan; Chen, Yu-Chun; Chen, Tzeng-Ji; Chung, Chia-Min; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang			Gastroesophageal Reflux Disease and Atrial Fibrillation: A Nationwide Population-Based Study	PLOS ONE			English	Article							CATHETER ABLATION; RISK; EPIDEMIOLOGY; ESOPHAGITIS; MANAGEMENT; LOCUS	Objectives: Precise mechanisms of atrial fibrillation (AF) are uncertain, but their association with esophageal disorders has been recently proposed. The association between gastroesophageal reflux disease (GERD), the most common gastroesophageal disorder, and AF remains undetermined. We therefore aimed to investigate the association between GERD and later development of AF. Methods and Results: Patients with GERD were identified from the 1,000,000-person cohort dataset sampled from the Taiwan National Health Insurance database. The study cohort comprised 29,688 newly diagnosed adult GERD patients; 29,597 randomly selected age-, gender-, comobidity-matched subjects comprised the comparison cohort. Cox proportional hazard regressions were performed as a means of comparing the AF-free survival rate for the two cohorts. During a maximum three years of follow-up, a total of 351 patients experienced AF, including 184 (0.62%) patients in the GERD cohort and 167 (0.56%) in the control group. The log-rank test showed that patients with GERD had significantly higher incidence of AF than those without GERD (p = 0.024). After Cox proportional hazard regression model analysis, GERD was independently associated with the increased risk of AF (hazard ratio, 1.31; 95% confidence interval, 1.06-1.61, p = 0.013). Conclusion: GERD was independently associated with an increased risk of future AF in a nationwide population-based cohort.	[Huang, Chin-Chou; Chan, Wan-Leong; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Huang, Chin-Chou; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chan, Wan-Leong; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Luo, Jiing-Chyuan] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Huang, Chin-Chou; Huang, Po-Hsun; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Chin-Chou; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Huang, Po-Hsun; Lin, Shing-Jong; Leu, Hsin-Bang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Luo, Jiing-Chyuan] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Yu-Chun] Natl Yang Ming Univ Hosp, Dept Med Res & Educ, Yi Lan, Taiwan; [Chung, Chia-Min] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Leu, HB (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan.	hbleu@vghtpe.gov.tw	Chen, YuChun/L-1052-2019; Chen, Yu Chun/K-6635-2019; Chen, Yu-Chun/B-1227-2012; Chen, TJ/AAH-8430-2021	Chen, YuChun/0000-0002-4124-1949; Chen, Yu-Chun/0000-0002-4124-1949; 	Taipei Veterans General Hospital, Taipei, Taiwan [V99B1-011, V99C1-125, V100B-013]; Yen Tjing Ling Medical Foundation, Taipei, Taiwan [CI-97-13, CI-98-16]; National Science Council [NSC 100-2314-B-075-055]; UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council [NSC-99-2911-I-009-101-A2]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Yen Tjing Ling Medical Foundation, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-engineering from the National Science Council	The present study was partly supported by research grants from the V99B1-011, V99C1-125, and V100B-013 from Taipei Veterans General Hospital, Taipei, Taiwan; CI-97-13 and CI-98-16 from the Yen Tjing Ling Medical Foundation, Taipei, Taiwan; NSC 100-2314-B-075-055 and UST-UCSD International Center of Excellence in Advanced Bio-engineering NSC-99-2911-I-009-101-A2 from the National Science Council. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Bunch TJ, 2008, AM J CARDIOL, V102, P1207, DOI 10.1016/j.amjcard.2008.06.048; Bureau of National Health Insurance, 2002, 2001 NAT HLTH INS AN; Chang CS, 1997, AM J GASTROENTEROL, V92, P668; Chauhan A, 1996, J AM COLL CARDIOL, V27, P1621, DOI 10.1016/0735-1097(96)00041-1; Chen KY, 2009, AM J MED SCI, V338, P453, DOI 10.1097/MAJ.0b013e3181b51fbd; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; DODDS WJ, 1982, NEW ENGL J MED, V307, P1547, DOI 10.1056/NEJM198212163072503; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; Fock KM, 2008, J GASTROEN HEPATOL, V23, P8, DOI 10.1111/j.1440-1746.2007.05249.x; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gerson L, 2006, J CLIN GASTROENTEROL, V40, P828, DOI 10.1097/01.mcg.0000225571.42890.a5; Gillinov AM, 2004, ANN THORAC SURG, V78, P1836, DOI 10.1016/S0003-4975(03)01434-6; Goh KL, 2004, J GASTROEN HEPATOL, V19, pS22, DOI 10.1111/j.1440-1746.2004.03591.x; Gordon J, 2002, EUR J CARDIO-THORAC, V21, P587, DOI 10.1016/S1010-7940(01)01172-1; Ho KY, 2006, J GASTROEN HEPATOL, V21, P1362, DOI 10.1111/j.1440-1746.2006.04341.x; Hoorn EJ, 2010, AM J KIDNEY DIS, V56, P112, DOI 10.1053/j.ajkd.2009.11.019; Hou YL, 2007, J AM COLL CARDIOL, V50, P61, DOI 10.1016/j.jacc.2007.02.066; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Huang CC, 2010, AM J CARDIOL, V105, P1705, DOI 10.1016/j.amjcard.2010.01.348; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Kanoupakis EM, 2000, AM J CARDIOL, V86, P954, DOI 10.1016/S0002-9149(00)01129-2; Kollarik M, 2009, PULM PHARMACOL THER, V22, P130, DOI 10.1016/j.pupt.2008.12.017; Kunz JS, 2009, CLIN CARDIOL, V32, P584, DOI 10.1002/clc.20660; Lee CH, 2007, AM J MED, V120, pe1; Lee YC, 2006, J GASTROEN HEPATOL, V21, P798, DOI 10.1111/j.1440-1746.2005.04034.x; Lin LJ, 2008, CLIN THER, V30, P1726, DOI 10.1016/j.clinthera.2008.09.010; Maixent JM, 1998, J CARDIOVASC ELECTR, V9, P612, DOI 10.1111/j.1540-8167.1998.tb00942.x; Marcus GM, 2010, J INNOVATIONS CARD R, V1, P85, DOI 10.19102/icrm.2010.011206; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nishida K, 2011, CIRCULATION, V123, P137, DOI 10.1161/CIRCULATIONAHA.110.972778; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; Rieder F, 2007, GASTROENTEROLOGY, V132, P154, DOI 10.1053/j.gastro.2006.10.009; Schauerte P, 2000, CIRCULATION, V102, P2774, DOI 10.1161/01.CIR.102.22.2774; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; SPECHLER SJ, 1992, DIGESTION, V51, P24, DOI 10.1159/000200911; Stollberger C, 2003, J GASTROENTEROL, V38, P1109, DOI 10.1007/s00535-003-1216-6; Tsao HM, 2005, CHEST, V128, P2581, DOI 10.1378/chest.128.4.2581; Weigl M, 2003, SOUTH MED J, V96, P1128, DOI 10.1097/01.SMJ.0000084294.77504.4B	41	27	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47575	10.1371/journal.pone.0047575	http://dx.doi.org/10.1371/journal.pone.0047575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077642	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100137
J	Le Marchand, SJ; Piston, DW				Le Marchand, Sylvain J.; Piston, David W.			Glucose Decouples Intracellular Ca2+ Activity from Glucagon Secretion in Mouse Pancreatic Islet Alpha-Cells	PLOS ONE			English	Article							BETA-CELLS; ELECTRICAL-ACTIVITY; ELECTROPHYSIOLOGICAL CHARACTERIZATION; INSULIN-SECRETION; CALCIUM-CHANNELS; RODENT ISLETS; INTACT ISLETS; K+ CHANNELS; DELTA-CELLS; RELEASE	The mechanisms of glucagon secretion and its suppression by glucose are presently unknown. This study investigates the relationship between intracellular calcium levels ([Ca2+](i)) and hormone secretion under low and high glucose conditions. We examined the effects of modulating ion channel activities on [Ca2+](i) and hormone secretion from ex vivo mouse pancreatic islets. Glucagon-secreting alpha-cells were unambiguously identified by cell specific expression of fluorescent proteins. We found that activation of L-type voltage-gated calcium channels is critical for alpha-cell calcium oscillations and glucagon secretion at low glucose levels. Calcium channel activation depends on K-ATP channel activity but not on tetrodotoxin-sensitive Na+ channels. The use of glucagon secretagogues reveals a positive correlation between alpha-cell [Ca2+](i) and secretion at low glucose levels. Glucose elevation suppresses glucagon secretion even after treatment with secretagogues. Importantly, this inhibition is not mediated by K-ATP channel activity or reduction in alpha-cell [Ca2+](i). Our results demonstrate that glucose uncouples the positive relationship between [Ca2+](i) and secretory activity. We conclude that glucose suppression of glucagon secretion is not mediated by inactivation of calcium channels, but instead, it requires a calcium-independent inhibitory pathway.	[Le Marchand, Sylvain J.; Piston, David W.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Piston, DW (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	dave.piston@vanderbilt.edu			National Institutes of Health [DK53434, GM72048, RR25649]; Vanderbilt Diabetes Center [DK20593]; Vanderbilt Ingram Cancer Center [CA68485]; Vanderbilt Digestive Disease Research Center [DK58404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053434, P30DK058404, P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM072048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes Center; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK53434, GM72048, and RR25649. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Equipment and technical assistance were provided by the Vanderbilt Islet Procurement and Analysis, and Hormone Assay cores (supported by the Vanderbilt Diabetes Center (DK20593), the Vanderbilt Ingram Cancer Center (CA68485), and the Vanderbilt Digestive Disease Research Center (DK58404)).	Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Berts A, 1997, ENDOCRINE, V6, P79, DOI 10.1007/BF02738806; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; FALKE LC, 1989, FEBS LETT, V251, P167, DOI 10.1016/0014-5793(89)81448-6; Fox JEM, 2006, ENDOCRINOLOGY, V147, P4655, DOI 10.1210/en.2006-0424; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GERICH JE, 1974, J CLIN INVEST, V54, P833, DOI 10.1172/JCI107823; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gromada J, 2004, DIABETES, V53, pS181, DOI 10.2337/diabetes.53.suppl_3.S181; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; HAHN HJ, 1977, BIOCHIM BIOPHYS ACTA, V499, P362, DOI 10.1016/0304-4165(77)90067-8; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hoy M, 2000, J PHYSIOL-LONDON, V527, P109, DOI 10.1111/j.1469-7793.2000.00109.x; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; KASAI H, 1987, Neuroscience Research, V4, P228, DOI 10.1016/0168-0102(87)90014-9; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; LECLERCQMEYER V, 1976, DIABETOLOGIA, V12, P531, DOI 10.1007/BF01219520; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Leung YM, 2005, ENDOCRINOLOGY, V146, P4766, DOI 10.1210/en.2005-0803; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; PAGLIARA AS, 1975, J CLIN INVEST, V55, P244, DOI 10.1172/JCI107928; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quoix N, 2009, DIABETES, V58, P412, DOI 10.2337/db07-1298; RANDRIAMAMPITA C, 1991, CELL CALCIUM, V12, P313, DOI 10.1016/0143-4160(91)90005-Y; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Shiota C, 2005, AM J PHYSIOL-ENDOC M, V289, pE570, DOI 10.1152/ajpendo.00102.2005; Singh V, 2007, J CLIN ENDOCR METAB, V92, P673, DOI 10.1210/jc.2006-1578; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Smith PA, 1997, J PHYSIOL-LONDON, V499, P625, DOI 10.1113/jphysiol.1997.sp021955; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vignali S, 2006, J PHYSIOL-LONDON, V572, P691, DOI 10.1113/jphysiol.2005.102368; Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358; Zawalich WS, 2008, METABOLISM, V57, P30, DOI 10.1016/j.metabol.2007.07.020	44	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47084	10.1371/journal.pone.0047084	http://dx.doi.org/10.1371/journal.pone.0047084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077547	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100058
J	Kohnen, A; Richter, I; Brandl, R				Kohnen, Annette; Richter, Iris; Brandl, Roland			No Concordant Phylogeographies of the Rose Gall Wasp Diplolepis rosae (Hymenoptera, Cynipidae) and Two Associated Parasitoids across Europe	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION ROUTES; POPULATION-GENETICS; MITOCHONDRIAL-DNA; ANDRICUS-KOLLARI; HISTORY; COALESCENT; DIVERSITY; PATTERNS; SUPPORT; SUCCESS	According to the Host-tracking Hypothesis, species of higher trophic levels with a close relationship to their hosts, such as parasites or parasitoids, are expected to show spatio-temporal phylogeographic patterns similar to those of their host. Alternatively, with ecological sorting, a subset of the local species pools might shift to a related host species, thereby disengaging common phylogeographic patterns. Here, we compare the phylogeographic structures of the cynipid rose gall wasp Diplolepis rosae across Europe and of two of its most common parasitoids, the wasps Orthopelma mediator and Glyphomerus stigma, by analysing the sequences of two gene fragments (COI and ITS 2). The phylogeographic structures of the three species associated with roses were incongruent. D. rosae had the lowest genetic diversity with one major clade, O. mediator showed the classical phylogeographic structure for Europe with one eastern and one western clade, and G. stigma had the highest diversity but no geographical structuring. This discordance of geographical patterns may be explained by 1) the dispersal propensity of adult parasitoids or 2) the parasitoids having the ability to switch to another host, while the primary host becomes rare or is even not available. Furthermore there was no indication that phylogenetic patterns were affected by Wolbachia infections. Our results document that communities of closely interacting species may be the result of idiosyncratic biogeographic histories.	[Kohnen, Annette; Richter, Iris; Brandl, Roland] Univ Marburg, Dept Anim Ecol, Marburg, Germany	Philipps University Marburg	Kohnen, A (corresponding author), Univ Marburg, Dept Anim Ecol, Marburg, Germany.	annettekohnen@gmx.de			Deutsche Forschungsgemeinschaft (DFG) [SPP 1127]; FAZIT-Stiftung Gemeinnutzige Verlagsgesellschaft mbH, Germany	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FAZIT-Stiftung Gemeinnutzige Verlagsgesellschaft mbH, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/index.jsp) within the Priority Programme SPP 1127 (Adaptive Radiation - Origin of Biological Diversity) and by the FAZIT-Stiftung Gemeinnutzige Verlagsgesellschaft mbH, Germany (http://www.fazit-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Blair K. G., 1944, Proceedings and Transactions South London Entomological and Natural History Society, V1943, P55; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BRANDL R, 1992, P ROY SOC B-BIOL SCI, V249, P13, DOI 10.1098/rspb.1992.0077; Brandle M, 2005, BIOL J LINN SOC, V84, P775, DOI 10.1111/j.1095-8312.2005.00464.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Crandall ED, 2008, MOL ECOL, V17, P5276, DOI 10.1111/j.1365-294X.2008.03995.x; Dawson MN, 2002, MOL ECOL, V11, P1065, DOI 10.1046/j.1365-294X.2002.01503.x; Dingler H, 1907, MITTEILUNGEN NATURWI, V6, P1; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Funk DJ, 2000, P ROY SOC B-BIOL SCI, V267, P2517, DOI 10.1098/rspb.2000.1314; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Johannesen J, 2003, ENTOMOL EXP APPL, V108, P149, DOI 10.1046/j.1570-7458.2003.00077.x; JUKES T H, 1969, P21; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Kohnen A, 2011, BIOL J LINN SOC, V102, P369, DOI 10.1111/j.1095-8312.2010.01582.x; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; Liljeblad J, 1998, SYST ENTOMOL, V23, P229, DOI 10.1046/j.1365-3113.1998.00053.x; Lohse K, 2010, EVOLUTION, V64, P2664, DOI 10.1111/j.1558-5646.2010.01024.x; Lunt DH, 1998, HEREDITY, V80, P633, DOI 10.1046/j.1365-2540.1998.00311.x; Nicholls JA, 2010, MOL ECOL, V19, P592, DOI 10.1111/j.1365-294X.2009.04499.x; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Plantard O, 1998, P ROY SOC B-BIOL SCI, V265, P1075, DOI 10.1098/rspb.1998.0401; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2003, TRACER VERSION 1 5; Randolph S, 2005, NATURAL HIST ROSE BE; Redfern M, 1992, PLANT GALLS; Ritz CM, 2005, J HERED, V96, P4, DOI 10.1093/jhered/esi011; Rokas A, 2002, MOL PHYLOGENET EVOL, V22, P206, DOI 10.1006/mpev.2001.1032; Rokas A, 2003, MOL ECOL, V12, P2153, DOI 10.1046/j.1365-294X.2003.01894.x; Rokas A, 2001, HEREDITY, V87, P294, DOI 10.1046/j.1365-2540.2001.00872.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santucci F, 1998, MOL ECOL, V7, P1163, DOI 10.1046/j.1365-294x.1998.00436.x; Schilthuizen M, 1998, HEREDITY, V81, P270, DOI 10.1046/j.1365-2540.1998.00385.x; Schilthuizen M, 1997, P ROY SOC B-BIOL SCI, V264, P361, DOI 10.1098/rspb.1997.0052; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoonhoven L.M., 1998, INSECT PLANT BIOL PH; SCHRODER D., 1967, Technical Bulletin. Commonwealth Institute of Biological Control, P93; Stauffer C, 1999, MOL ECOL, V8, P763, DOI 10.1046/j.1365-294X.1999.00626.x; STILLE B, 1985, ENTOMOL GEN, V10, P87; STILLE B, 1984, OECOLOGIA, V63, P364, DOI 10.1007/BF00390666; STILLE B, 1985, GENETICA, V67, P145, DOI 10.1007/BF02424421; Stone G, 2001, MOL ECOL, V10, P761, DOI 10.1046/j.1365-294x.2001.01211.x; Stone GN, 2007, MOL ECOL, V16, P2768, DOI 10.1111/j.1365-294X.2007.03348.x; Stone GN, 2012, CURR BIOL, V22, P532, DOI 10.1016/j.cub.2012.01.059; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Strong DR, 1984, INSECTS PLANTS COMMO; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Wagener B, 2006, BIOL CONTROL, V37, P131, DOI 10.1016/j.biocontrol.2006.01.004; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wissemann V, 2002, J APPL BOT-ANGEW BOT, V76, P176	66	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47156	10.1371/journal.pone.0047156	http://dx.doi.org/10.1371/journal.pone.0047156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071742	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700061
J	Ma, HX; Yuan, H; Yuan, ZY; Yu, CJ; Wang, RX; Jiang, Y; Hu, ZB; Shen, HB; Chen, N				Ma, Hongxia; Yuan, Hua; Yuan, Zhiyao; Yu, Chenjie; Wang, Ruixia; Jiang, Yue; Hu, Zhibin; Shen, Hongbing; Chen, Ning			Genetic Variations in Key MicroRNA Processing Genes and Risk of Head and Neck Cancer: A Case-Control Study in Chinese Population	PLOS ONE			English	Article							CELL-PROLIFERATION; DOWN-REGULATION; BLADDER-CANCER; DICER; EXPRESSION; RESISTANCE; PROGNOSIS; CARCINOMA	MicroRNAs (miRNAs) have been reported to play a key role in oncogenesis. Genetic variations in miRNA processing genes and miRNA binding sites may affect the biogenesis of miRNA and the miRNA-mRNA interactions, hence promoting tumorigenesis. In the present study, we hypothesized that potentially functional polymorphisms in miRNA processing genes may contribute to head and neck cancer (HNC) susceptibility. To test this hypothesis, we genotyped three SNPs at miRNA binding sites of miRNA processing genes (rs1057035 in 3'UTR of DICER, rs3803012 in 3'UTR of RAN and rs10773771 in 3'UTR of HIWI) with a case-control study including 397 HNC cases and 900 controls matched by age and sex in Chinese. Although none of three SNPs was significantly associated with overall risk of HNC, rs1057035 in 39UTR of DICER was associated with a significantly decreased risk of oral cancer (TC/CC vs. TT: adjusted OR = 0.65, 95% CI = 0.46-0.92). Furthermore, luciferase activity assay showed that rs1057035 variant C allele led to significantly lower expression levels as compared to the T allele, which may be due to the relatively high inhibition of hsa-miR-574-3p on DICER mRNA. These findings indicated that rs1057035 located at 39UTR of DICER may contribute to the risk of oral cancer by affecting the binding of miRNAs to DICER. Large-scale and well-designed studies are warranted to validate our findings.	[Yuan, Hua; Yuan, Zhiyao; Wang, Ruixia; Chen, Ning] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Ma, Hongxia; Jiang, Yue; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, MOE Key Lab Modern Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Ma, Hongxia; Yuan, Hua; Jiang, Yue; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Yu, Chenjie] Nanjing Univ, Dept Otorhinolaryngol, Affiliated Drum Tower Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University	Chen, N (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	ningchen09@gmail.com		Chen, Ning/0000-0003-4785-5076	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Natural Science Foundation [BK2011764]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported in part by Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Jiangsu Natural Science Foundation (BK2011764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BLOT WJ, 1988, CANCER RES, V48, P3282; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Clague J, 2010, MOL CARCINOGEN, V49, P183, DOI 10.1002/mc.20588; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Guo X, 2012, J CANC RES CLIN ONCO; Han L, 2010, INT J ONCOL, V37, P299, DOI 10.3892/ijo_00000678; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; He W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-426; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Izumiya M, 2011, CANCER SCI, V102, P1615, DOI 10.1111/j.1349-7006.2011.02007.x; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Selever J, 2011, CLIN CANCER RES, V17, P6510, DOI 10.1158/1078-0432.CCR-11-1403; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wu BH, 2011, ORAL ONCOL, V47, P314, DOI 10.1016/j.oraloncology.2011.03.019; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yuan H, 2012, MOL MED REP, V5, P420, DOI 10.3892/mmr.2011.668	29	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47544	10.1371/journal.pone.0047544	http://dx.doi.org/10.1371/journal.pone.0047544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071822	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700092
J	Viladomiu, M; Hontecillas, R; Pedragosa, M; Carbo, A; Hoops, S; Michalak, P; Michalak, K; Guerrant, RL; Roche, JK; Warren, CA; Bassaganya-Riera, J				Viladomiu, Monica; Hontecillas, Raquel; Pedragosa, Mireia; Carbo, Adria; Hoops, Stefan; Michalak, Pawel; Michalak, Katarzyna; Guerrant, Richard L.; Roche, James K.; Warren, Cirle A.; Bassaganya-Riera, Josep			Modeling the Role of Peroxisome Proliferator-Activated Receptor gamma and MicroRNA-146 in Mucosal Immune Responses to Clostridium difficile	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CONJUGATED LINOLEIC-ACID; PPAR-GAMMA; INCREASED SPORULATION; RISK-FACTOR; COLITIS; INFECTION; GENE; EXPRESSION; DIARRHEA	Clostridium difficile is an anaerobic bacterium that has re-emerged as a facultative pathogen and can cause nosocomial diarrhea, colitis or even death. Peroxisome proliferator-activated receptor (PPAR) gamma has been implicated in the prevention of inflammation in autoimmune and infectious diseases; however, its role in the immunoregulatory mechanisms modulating host responses to C. difficile and its toxins remains largely unknown. To characterize the role of PPAR gamma in C. difficile-associated disease (CDAD), immunity and gut pathology, we used a mouse model of C. difficile infection in wild-type and T cell-specific PPAR gamma null mice. The loss of PPAR gamma in T cells increased disease activity and colonic inflammatory lesions following C. difficile infection. Colonic expression of IL-17 was upregulated and IL-10 downregulated in colons of T cell-specific PPAR gamma null mice. Also, both the loss of PPAR gamma in T cells and C. difficile infection favored Th17 responses in spleen and colonic lamina propria of mice with CDAD. MicroRNA (miRNA)-sequencing analysis and RT-PCR validation indicated that miR-146b was significantly overexpressed and nuclear receptor co-activator 4 (NCOA4) suppressed in colons of C. difficile-infected mice. We next developed a computational model that predicts the upregulation of miR-146b, downregulation of the PPAR gamma co-activator NCOA4, and PPAR gamma, leading to upregulation of IL-17. Oral treatment of C. difficile-infected mice with the PPAR gamma agonist pioglitazone ameliorated colitis and suppressed pro-inflammatory gene expression. In conclusion, our data indicates that miRNA-146b and PPAR gamma activation may be implicated in the regulation of Th17 responses and colitis in C. difficile-infected mice.	[Viladomiu, Monica; Hontecillas, Raquel; Pedragosa, Mireia; Carbo, Adria; Hoops, Stefan; Bassaganya-Riera, Josep] Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Viladomiu, Monica; Hontecillas, Raquel; Pedragosa, Mireia; Carbo, Adria; Hoops, Stefan; Guerrant, Richard L.; Roche, James K.; Warren, Cirle A.; Bassaganya-Riera, Josep] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA USA; [Guerrant, Richard L.; Roche, James K.; Warren, Cirle A.] Univ Virginia, Div Infect Dis & Int Hlth, Ctr Global Hlth, Charlottesville, VA USA; [Michalak, Pawel; Michalak, Katarzyna] Virginia Tech, Med Informat & Syst Div, Virginia Bioinformat Inst, Blacksburg, VA USA; [Michalak, Pawel] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Virginia; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Viladomiu, Monica/GNM-6447-2022		National Institutes of Health [5R01AT004308]; NIAID [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health 5R01AT004308 to JB-R, NIAID Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Artzi S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-39; Barbut F, 2011, CURR OPIN INFECT DIS, V24, P370, DOI 10.1097/QCO.0b013e32834748e5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2012, CLIN NUTR; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Blondeau JM, 2009, J ANTIMICROB CHEMOTH, V63, P238, DOI 10.1093/jac/dkn477; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guri AJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-60; Hassan T, 2012, EXPERT REV ANTI-INFE, V10, P359, DOI [10.1586/ERI.11.175, 10.1586/eri.11.175]; Hontecillas R, 2011, MUCOSAL IMMUNOL, V4, P304, DOI 10.1038/mi.2010.75; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Khanna S, 2010, EXPERT REV GASTROENT, V4, P409, DOI 10.1586/EGH.10.48; Kim JW, 2010, WORLD J GASTROENTERO, V16, P3573, DOI 10.3748/wjg.v16.i28.3573; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kuehn BM, 2011, JAMA-J AM MED ASSOC, V306, P1849, DOI 10.1001/jama.2011.1569; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lim PL, 2008, EMERG INFECT DIS, V14, P1487, DOI 10.3201/eid1409.070043; Mcfarland LV, 2005, J MED MICROBIOL, V54, P101, DOI 10.1099/jmm.0.45753-0; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Mohapatra SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010215; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Oertli M, 2011, J IMMUNOL, V187, P3578, DOI 10.4049/jimmunol.1101772; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Pawlowski SW, 2009, J HOSP INFECT, V73, P185, DOI 10.1016/j.jhin.2009.05.013; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vaishnavi C, 2010, INDIAN J MED RES, V131, P487; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447	53	25	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47525	10.1371/journal.pone.0047525	http://dx.doi.org/10.1371/journal.pone.0047525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071818	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700088
J	Escribano-Avila, G; Sanz-Perez, V; Pias, B; Virgos, E; Escudero, A; Valladares, F				Escribano-Avila, Gema; Sanz-Perez, Virginia; Pias, Beatriz; Virgos, Emilio; Escudero, Adrian; Valladares, Fernando			Colonization of Abandoned Land by Juniperus thurifera Is Mediated by the Interaction of a Diverse Dispersal Assemblage and Environmental Heterogeneity	PLOS ONE			English	Article							MARTEN MARTES-FOINA; FOX VULPES-VULPES; SEED DISPERSAL; FOREST FRAGMENTATION; PATTERNS; BIRDS; FRUIT; CARNIVORES; FRUGIVORES; MAMMALS	Land abandonment is one of the most powerful global change drivers in developed countries where recent rural exodus has been the norm. Abandonment of traditional land use practices has permitted the colonization of these areas by shrub and tree species. For fleshy fruited species the colonization of new areas is determined by the dispersal assemblage composition and abundance. In this study we showed how the relative contribution to the dispersal process by each animal species is modulated by the environmental heterogeneity and ecosystem structure. This complex interaction caused differential patterns on the seed dispersal in both, landscape patches in which the process of colonization is acting nowadays and mature woodlands of Juniperus thurifera, a relict tree distributed in the western Mediterranean Basin. Thrushes (Turdus spp) and carnivores (red fox and stone marten) dispersed a high amount of seeds while rabbits and sheeps only a tiny fraction. Thrushes dispersed a significant amount of seeds in new colonization areas, however they were limited by the presence of high perches with big crop size. While carnivores dispersed seeds to all studied habitats, even in those patches where no trees of J. thurifera were present, turning out to be critical for primary colonization. The presence of Pinus and Quercus was related to a reduced consumption of J. thurifera seeds while the presence of fleshy fruited shrubs was related with higher content of J. thurifera seeds in dispersers' faeces. Therefore environmental heterogeneity and ecosystem structure had a great influence on dispersers feeding behaviour, and should be considered in order to accurately describe the role of seed dispersal in ecological process, such as regeneration and colonization. J. thurifera expansion is not seed limited thanks to its diverse dispersal community, hence the conservation of all dispersers in an ecosystem enhance ecosystems services and resilience.	[Escribano-Avila, Gema; Virgos, Emilio; Escudero, Adrian; Valladares, Fernando] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain; [Sanz-Perez, Virginia] Univ Castilla La Mancha, Fac Ciencias Ambientales, Toledo, Spain; [Pias, Beatriz] Univ Complutense Madrid, Dept Biol Vegetal 1, Madrid, Spain; [Valladares, Fernando] CSIC, Museo Nacl Ciencias Nat, Madrid, Spain	Universidad Rey Juan Carlos; Universidad de Castilla-La Mancha; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Escribano-Avila, G (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain.	gema.escribano@urjc.es	Valladares, Fernando/K-9406-2014; Escudero, Adrián/H-5046-2015; Pías, Beatriz/ABF-9948-2020	Valladares, Fernando/0000-0002-5374-4682; Escudero, Adrián/0000-0002-1427-5465; Pías, Beatriz/0000-0002-1136-8914; Escribano-Avila, Gema/0000-0003-1362-8924	Spanish Ministry for Education; Spanish Ministry for Innovation and Science [CGL2010-16388/BOS]; Consolider Montes [CSD2008_00040]; VULGLO [CGL2010-22180-C03-03]; CALCOFIS [CGL2009-13013]; Community of Madrid [CM-S2009/AMB-1783]	Spanish Ministry for Education(Spanish Government); Spanish Ministry for Innovation and Science(Spanish Government); Consolider Montes; VULGLO; CALCOFIS; Community of Madrid(Comunidad de Madrid)	Gema Escribano-Avila was supported by a FPU-MEC doctoral grant from the Spanish Ministry for Education (http://www.educacion.gob.es/portada.html). Funding was provided by the Spanish Ministry for Innovation and Science (http://www.idi.mineco.gob.es/) with the grants CGL2010-16388/BOS, Consolider Montes (CSD2008_00040), VULGLO (CGL2010-22180-C03-03) and CALCOFIS (CGL2009-13013), and by the Community of Madrid grant (http://www.madrimasd.org/) REMEDINAL 2 (CM-S2009/AMB-1783). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 1994, RESTOR ECOL, V2, P219, DOI [10.1111/j.1526-100X.1994.tb00054.x, DOI 10.1111/J.1526-100X.1994.TB00054.X]; Alcantara JM, 2003, J EVOLUTION BIOL, V16, P1168, DOI 10.1046/j.1420-9101.2003.00618.x; Barlow J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033373; Barrientos R, 2006, ACTA OECOL, V30, P107, DOI 10.1016/j.actao.2006.02.006; Bates D, 2012, LME4 LINEAR MIXED EF; Blanco-Castro E., 2005, BOSQUES IBERICOS INT; Breitbach N, 2010, OECOLOGIA, V162, P965, DOI 10.1007/s00442-009-1547-y; CALISTI M, 1990, REV ECOL-TERRE VIE, V45, P309; Calvino-Cancela M, 2009, ECOLOGY, V90, P3503, DOI 10.1890/08-1629.1; Camacho J., 1989, Donana Acta Vertebrata, V16, P239; Carlo T. A., 2007, Seed dispersal: theory and its application in a changing world, P369, DOI 10.1079/9781845931650.0369; DEBUSSCHE M, 1982, VEGETATIO, V48, P255; Deckers B, 2005, ECOGRAPHY, V28, P99, DOI 10.1111/j.0906-7590.2005.04054.x; DeSoto L, 2010, APPL VEG SCI, V13, P15, DOI 10.1111/j.1654-109X.2009.01045.x; DIAZ M, 1993, Z SAUGETIERKD, V58, P302; Duncan RS, 2006, NEW FOREST, V31, P131, DOI 10.1007/s11056-004-5395-7; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Garcia D, 2001, J ECOL, V89, P639, DOI 10.1046/j.1365-2745.2001.00577.x; Garcia D, 2004, ECOGRAPHY, V27, P187, DOI 10.1111/j.0906-7590.2004.03751.x; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Gimeno TE, 2012, EUR J FOREST RES, V131, P977, DOI 10.1007/s10342-011-0569-2; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Heras J, 1994, ALBASIT, V34, P161; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HERRERA CM, 1989, OIKOS, V55, P250, DOI 10.2307/3565429; HERRERA CM, 1984, OECOLOGIA, V63, P386, DOI 10.1007/BF00390670; Holbrook KM, 2002, ECOGRAPHY, V25, P745, DOI 10.1034/j.1600-0587.2002.250610.x; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; JORDANO P, 1993, VEGETATIO, V108, P85; Kerr JT, 2000, CONSERV BIOL, V14, P1726, DOI [10.1046/j.1523-1739.2000.99275.x, 10.1111/j.1523-1739.2000.99275.x]; Lavorel S, 1998, GLOBAL ECOL BIOGEOGR, V7, P157, DOI 10.2307/2997371; LIVINGSTON RB, 1972, ECOLOGY, V53, P1141, DOI 10.2307/1935427; Lopez-Bao JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014569; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martinez I, 2008, ECOSCIENCE, V15, P189, DOI 10.2980/15-2-3096; Matias L, 2010, RESTOR ECOL, V18, P619, DOI 10.1111/j.1526-100X.2008.00475.x; McConkey K, 2012, BIOL CONSERV, DOI [10.1016/j.biocon.2011.09.018, DOI 10.1016/J.BIO-CON.2011.09.018]; Mottet A, 2006, AGR ECOSYST ENVIRON, V114, P296, DOI 10.1016/j.agee.2005.11.017; Munoz Reinoso Jose Carlos, 1993, Donana Acta Vertebrata, V20, P49; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Olano JM, 2008, FOREST ECOL MANAG, V255, P506, DOI 10.1016/j.foreco.2007.09.015; Padial JM, 2002, MAMM BIOL, V67, P137, DOI 10.1078/1616-5047-00021; Pandolfi M, 1996, Z SAUGETIERKD, V61, P215; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Rosalino LM, 2010, ANN ZOOL FENN, V47, P195, DOI 10.5735/086.047.0304; Russo SE, 2003, OECOLOGIA, V136, P80, DOI 10.1007/s00442-003-1239-y; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SANTOS T, 1994, BIOL CONSERV, V70, P129, DOI 10.1016/0006-3207(94)90280-1; Santos T, 1999, ECOGRAPHY, V22, P193, DOI 10.1111/j.1600-0587.1999.tb00468.x; Sarkar D., 2019, NLME LINEAR NONLINEA; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Tasser E, 2007, AGR ECOSYST ENVIRON, V118, P115, DOI 10.1016/j.agee.2006.05.004; Traveset A, 2002, CAB INT 2002 SEED DI, P339; Vasconcelos HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007762; Virgos E, 1999, MAMMAL REV, V29, P117, DOI 10.1046/j.1365-2907.1999.00041.x; Virgos E, 2002, BIODIVERS CONSERV, V11, P1063, DOI 10.1023/A:1015856703786; Weir JES, 2007, LANDSCAPE ECOL, V22, P131, DOI 10.1007/s10980-006-9002-5; Westhoek HJ, 2006, AGR ECOSYST ENVIRON, V114, P7, DOI 10.1016/j.agee.2005.11.005	60	29	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46993	10.1371/journal.pone.0046993	http://dx.doi.org/10.1371/journal.pone.0046993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071692	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200063
J	Somasagara, RR; Hegde, M; Chiruvella, KK; Musini, A; Choudhary, B; Raghavan, SC				Somasagara, Ranganatha R.; Hegde, Mahesh; Chiruvella, Kishore K.; Musini, Anjaneyulu; Choudhary, Bibha; Raghavan, Sathees C.			Extracts of Strawberry Fruits Induce Intrinsic Pathway of Apoptosis in Breast Cancer Cells and Inhibits Tumor Progression in Mice	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; LEUKEMIC-CELLS; PROTEIN; PREVENTION; VEGETABLES; P73; P53; PROLIFERATION; POLYPHENOLS; ACTIVATION	Background: The consumption of berry fruits, including strawberries, has been suggested to have beneficial effects against oxidative stress mediated diseases. Berries contain multiple phenolic compounds and secondary metabolites that contribute to their biological properties. Methodology/Principal Findings: Current study investigates the anticancer activity of the methanolic extract of strawberry (MESB) fruits in leukaemia (CEM) and breast cancer (T47D) cell lines ex vivo, and its cancer therapeutic and chemopreventive potential in mice models. Results of MTT, trypan blue and LDH assays suggested that MESB can induce cytotoxicity in cancer cells, irrespective of origin, in a concentration-and time-dependent manner. Treatment of mice bearing breast adenocarcinoma with MESB blocked the proliferation of tumor cells in a time-dependent manner and resulted in extended life span. Histological and immunohistochemical studies suggest that MESB treatment affected tumor cell proliferation by activating apoptosis and did not result in any side effects. Finally, we show that MESB can induce intrinsic pathway of apoptosis by activating p73 in breast cancer cells, when tumor suppressor gene p53 is mutated. Conclusions/Significance: The present study reveals that strawberry fruits possess both cancer preventive and therapeutic values and we discuss the mechanism by which it is achieved.	[Somasagara, Ranganatha R.; Hegde, Mahesh; Chiruvella, Kishore K.; Musini, Anjaneyulu; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Choudhary, Bibha] IBAB, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	chiruvella, kishore k/I-2074-2014; Chiruvella, Kishore Kumar/AEU-8773-2022; Chiruvella, Kishore Kumar/AAH-3131-2022; Hegde, MahesH/ABE-2057-2020	chiruvella, kishore k/0000-0002-4997-5875; Chiruvella, Kishore Kumar/0000-0002-4997-5875; Hegde, MahesH/0000-0002-7853-6281	Indian Institute of Science, Bangalore, India; UGC Khothari postdoctoral fellowship programme, India	Indian Institute of Science, Bangalore, India; UGC Khothari postdoctoral fellowship programme, India	This study was supported by start-up grants from Indian Institute of Science, Bangalore, India for SCR. RSR is supported by UGC Khothari postdoctoral fellowship programme, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIA MAM, 1966, CANCER RES, V26, P1787; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boivin D, 2007, ANTICANCER RES, V27, P937; Chiruvella KK, 2012, J MOL BIOL, V417, P197, DOI 10.1016/j.jmb.2012.01.029; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1118::AID-JSFA570&gt;3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9]; Conney AH, 2003, CANCER RES, V63, P7005; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; GERDES J, 1984, J IMMUNOL, V133, P1710; Hannum SM, 2004, CRIT REV FOOD SCI, V44, P1, DOI 10.1080/10408690490263756; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kavitha CV, 2009, BIOCHEM PHARMACOL, V77, P348, DOI 10.1016/j.bcp.2008.10.018; Kumagai H, 2004, CARCINOGENESIS, V25, P723, DOI 10.1093/carcin/bgh067; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Meyers KJ, 2003, J AGR FOOD CHEM, V51, P6887, DOI 10.1021/jf034506n; Noaman E, 2008, CANCER LETT, V268, P348, DOI 10.1016/j.canlet.2008.04.012; Olsson ME, 2004, J AGR FOOD CHEM, V52, P2490, DOI 10.1021/jf030461e; Pink JJ, 1996, BRIT J CANCER, V74, P1227, DOI 10.1038/bjc.1996.521; Rijken PJ, 1999, CARCINOGENESIS, V20, P2267, DOI 10.1093/carcin/20.12.2267; Seeram NP, 2006, J AGR FOOD CHEM, V54, P9329, DOI 10.1021/jf061750g; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Sharif T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032526; Sharif T, 2010, EUR J CANCER, V46, P983, DOI 10.1016/j.ejca.2009.12.029; Sharma S, 2012, MOL CARCINOG; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; VOJTESEK B, 1993, J CELL SCI, V105, P607; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Wang H, 1996, J AGR FOOD CHEM, V44, P701, DOI 10.1021/jf950579y; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Wang SY, 2000, J AGR FOOD CHEM, V48, P5677, DOI 10.1021/jf000766i; Weaver J, 2009, INT J ONCOL, V34, P777, DOI 10.3892/ijo_00000203; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	40	76	77	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47021	10.1371/journal.pone.0047021	http://dx.doi.org/10.1371/journal.pone.0047021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071702	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000312385200069
J	Di Paola, A; Valentini, R; Paparella, F				Di Paola, Arianna; Valentini, Riccardo; Paparella, Francesco			Climate Change Threatens Coexistence within Communities of Mediterranean Forested Wetlands	PLOS ONE			English	Article							CARBON-DIOXIDE; OAK WOODLANDS; WATER-VAPOR; BIODIVERSITY; COMPETITION; PLANTS; VARIABILITY; ECOSYSTEMS; SUMMER; GROWTH	The Mediterranean region is one of the hot spots of climate change. This study aims at understanding what are the conditions sustaining tree diversity in Mediterranean wet forests under future scenarios of altered hydrological regimes. The core of the work is a quantitative, dynamic model describing the coexistence of different Mediterranean tree species, typical of arid or semi-arid wetlands. Two kind of species, i.e. Hygrophilous (drought sensitive, flood resistant) and Non-hygrophilous (drought resistant, flood sensitive), are broadly defined according to the distinct adaptive strategies of trees against water stress of summer drought and winter flooding. We argue that at intermediate levels of water supply the dual role of water (resource and stress) results in the coexistence of the two kind of species. A bifurcation analysis allows us to assess the effects of climate change on the coexistence of the two species in order to highlight the impacts of predicted climate scenarios on tree diversity. Specifically, the model has been applied to Mediterranean coastal swamp forests of Central Italy located at Castelporziano Estate and Circeo National Park. Our results show that there are distinct rainfall thresholds beyond which stable coexistence becomes impossible. Regional climatic projections show that the lower rainfall threshold may be approached or crossed during the XXI century, calling for an urgent adaptation and mitigation response to prevent biodiversity losses.	[Di Paola, Arianna; Valentini, Riccardo] Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, Viterbo, Italy; [Di Paola, Arianna; Valentini, Riccardo] Euromediterranean Ctr Climate Change, Div Impacts Agr Forest & Nat Ecosyst, Viterbo, Italy; [Paparella, Francesco] Univ Salento, Dept Math & Phys Ennio De Giorgi, Lecce, Italy	Tuscia University; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); University of Salento	Di Paola, A (corresponding author), Univ Tuscia, Dept Innovat Biol Agrofood & Forest Syst, Viterbo, Italy.	a.dipaola@unitus.it	Di Paola, Arianna/GZK-3564-2022; Di Paola, Arianna/M-4304-2017; DI PAOLA, Arianna/N-4891-2019; Valentini, Riccardo/D-1226-2010	DI PAOLA, Arianna/0000-0001-9050-4787; Valentini, Riccardo/0000-0002-6756-5634; Paparella, Francesco/0000-0003-1526-970X	CIRCE Project [036931]; CIRCE [036961]; CARBOEXTREME UE [226701]	CIRCE Project(European Commission); CIRCE(European Commission); CARBOEXTREME UE	Funding provided by CIRCE Project grant number 036931. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge Dario Papale and Goffredo Filibeck (University of Tuscia) for many constructive suggestions. The research leading to these results has been supported by the CIRCE and CARBOEXTREME UE projects (respectively under g.a. n 036961 and n 226701).	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Antunez I, 2001, OECOLOGIA, V128, P172, DOI 10.1007/s004420100645; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Baldocchi DD, 2007, ADV WATER RESOUR, V30, P2113, DOI 10.1016/j.advwatres.2006.06.013; Baldocchi DD, 2010, ECOL APPL, V20, P1583, DOI 10.1890/08-2047.1; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Bernetti G., 1995, SELVICOLTURA SPECIAL; Blasi C, 1998, FLORA VEGETAZIONE PA; Callaway R. M., 2007, POSITIVE INTERACTION; Cammarano M, 2011, J THEOR BIOL, V285, P46, DOI 10.1016/j.jtbi.2011.06.031; Castellani C, 1970, ANN I SPERIMENTALE A, VI; CHABOT BF, 1982, ANNU REV ECOL SYST, V13, P229, DOI 10.1146/annurev.es.13.110182.001305; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Dislich C, 2010, ECOL MODEL, V221, P2227, DOI 10.1016/j.ecolmodel.2010.06.011; DONOVAN LA, 1991, OECOLOGIA, V86, P594, DOI 10.1007/BF00318327; Fitoka E., 2008, EKBY NOA MEDWET PUBL; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Giordano A, 1999, PEDOLOGIA; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Glendinning P, 1994, STABILITY INSTABILIT; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Holstein G., 1984, CALIFORNIA RIPARIAN; Huston M. A., 1994, BIOL DIVERSITY; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; INFC, 2005, MIN POL AGR AL FOR I; Kazda M, 2000, TREE PHYSIOL, V20, P1029; Kozlowski TT, 1997, TREE PHYSL MONOGRAPH, V1; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Levin SA, 2006, FRAGILE DOMINION COM; Luterbacher J, 2006, DEV EARTH ENV SCI, V4, P27; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Manes F, 1997, ATMOS ENVIRON, V31, P1352; Munkemuller T, 2009, J THEOR BIOL, V259, P109, DOI 10.1016/j.jtbi.2009.03.010; Pezzotta M, 1998, FLORA VEGETAZIONE PA, P23; Rambal S., 2001, TERRESTRIAL GLOBAL P; Reichstein M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003430; Rodriguez-Gonzalez PM, 2010, FOREST ECOL MANAG, V259, P2015, DOI 10.1016/j.foreco.2010.02.012; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schulze ED, 2002, PLANT ECOLOGY; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Skinner J, 1995, CONSERVATION MEDITER; Stanisci A, 1998, FLORA VEGETAZIONE PA; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D., 1982, Monographs in Population Biology, pi; Tognetti R, 1998, PLANT CELL ENVIRON, V21, P613, DOI 10.1046/j.1365-3040.1998.00301.x; Tyree MT, 1996, ANN SCI FOREST, V53, P173, DOI 10.1051/forest:19960201; Ulbrich U, 2006, DEV EARTH ENV SCI, V4, P399; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; VANCE RR, 1984, ECOLOGY, V65, P1349, DOI 10.2307/1939115; Vitale M, 2003, ECOL MODEL, V166, P123, DOI 10.1016/S0304-3800(03)00129-7; Walker B, 2004, ECOL SOC, V9; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; Xiao S, 2009, OIKOS, V118, P1343, DOI 10.1111/j.1600-0706.2009.17588.x; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Zavala M.A., 2005, INVEST AGRAR-SIST R, V14, P482	59	5	5	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e44727	10.1371/journal.pone.0044727	http://dx.doi.org/10.1371/journal.pone.0044727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23077484	gold, Green Submitted, Green Published			2022-12-25	WOS:000309831500007
J	Dupuy, V; Manso-Silvan, L; Barbe, V; Thebault, P; Dordet-Frisoni, E; Citti, C; Poumarat, F; Blanchard, A; Breton, M; Sirand-Pugnet, P; Thiaucourt, F				Dupuy, Virginie; Manso-Silvan, Lucia; Barbe, Valerie; Thebault, Patricia; Dordet-Frisoni, Emilie; Citti, Christine; Poumarat, Francois; Blanchard, Alain; Breton, Marc; Sirand-Pugnet, Pascal; Thiaucourt, Francois			Evolutionary History of Contagious Bovine Pleuropneumonia Using Next Generation Sequencing of Mycoplasma mycoides Subsp mycoides "Small Colony''	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IDENTIFICATION; PERFORMANCE; HIGHLIGHTS; ALGORITHMS; PROTEIN	Mycoplasma mycoides subsp. mycoides "Small Colony'' (MmmSC) is responsible for contagious bovine pleuropneumonia (CBPP) in bovidae, a notifiable disease to the World Organization for Animal Health (OIE). Although its origin is not documented, the disease was known in Europe in 1773. It reached nearly world-wide distribution in the 19th century through the cattle trade and was eradicated from most continents by stamping-out policies. During the 20th century it persisted in Africa, and it reappeared sporadically in Southern Europe. Yet, classical epidemiology studies failed to explain the re-occurrence of the disease in Europe in the 1990s. The objectives of this study were to obtain a precise phylogeny of this pathogen, reconstruct its evolutionary history, estimate the date of its emergence, and determine the origin of the most recent European outbreaks. A large-scale genomic approach based on next-generation sequencing technologies was applied to construct a robust phylogeny of this extremely monomorphic pathogen by using 20 representative strains of various geographical origins. Sixty two polymorphic genes of the MmmSC core genome were selected, representing 83601 bp in total and resulting in 139 SNPs within the 20 strains. A robust phylogeny was obtained that identified a lineage specific to European strains; African strains were scattered in various branches. Bayesian analysis allowed dating the most recent common ancestor for MmmSC around 1700. The strains circulating in Sub-Saharan Africa today, however, were shown to descend from a strain that existed around 1810. MmmSC emerged recently, about 300 years ago, and was most probably exported from Europe to other continents, including Africa, during the 19th century. Its diversity is now greater in Africa, where CBPP is enzootic, than in Europe, where outbreaks occurred sporadically until 1999 and where CBPP may now be considered eradicated unless MmmSC remains undetected.	[Dupuy, Virginie; Manso-Silvan, Lucia; Thiaucourt, Francois] Ctr Int Rech Agron Dev, UMR CMAEE, Montpellier, France; [Barbe, Valerie] CEA DSV IG Genoscope, Evry, France; [Thebault, Patricia] Univ Bordeaux, Ctr Bioinformat & Genom Fonct, CBiB, Bordeaux, France; [Dordet-Frisoni, Emilie; Citti, Christine] INRA, Ecole Vet Toulouse, UMR 1225, Toulouse, France; [Dordet-Frisoni, Emilie; Citti, Christine] Univ Toulouse, INP, ENVT, UMR1225,IHAP, Toulouse, France; [Poumarat, Francois] Agence Natl Secur Sanit, Lab Lyon, UMR Mycoplasmoses Ruminants, Lyon, France; [Blanchard, Alain; Breton, Marc; Sirand-Pugnet, Pascal] Univ Bordeaux, UMR1332, Villenave Dornon, France; [Blanchard, Alain; Breton, Marc; Sirand-Pugnet, Pascal] INRA, UMR1332, Villenave Dornon, France	CIRAD; Universite de Montpellier; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon; VetAgro Sup; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Dupuy, V (corresponding author), Ctr Int Rech Agron Dev, UMR CMAEE, Montpellier, France.	francois.thiaucourt@cirad.fr	Frisoni, Emilie Dordet/AAT-2275-2020; Thébault, Patricia/AAD-1105-2020; Blanchard, Alain/C-6130-2009; Blanchard, Alain/I-3916-2019	Thébault, Patricia/0000-0003-2276-4573; Blanchard, Alain/0000-0003-4223-5185; Blanchard, Alain/0000-0003-4223-5185; Manso-Silvan, Lucia/0000-0002-5539-3804; Dordet Frisoni, Emilie/0000-0002-6315-5670; SIRAND-PUGNET, Pascal/0000-0003-2613-0762; Citti, Christine/0000-0003-4754-6003	EVOLMYCO project from the "Agence Nationale pour la Recherche" [ANR-07-GMGE-001]	EVOLMYCO project from the "Agence Nationale pour la Recherche"(French National Research Agency (ANR))	This study was performed within the EVOLMYCO project (ANR-07-GMGE-001) from the "Agence Nationale pour la Recherche.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cottew, 1987, REV SCI TECH OIE, V6, P625; Curasson G, 1942, PERIPNEUMONIE BOVINE, P276; de Rochebrune AT, 1880, CR HEBD ACAD SCI, V91, P304; de Rochebrune AT, 1885, C R ACAD SCI HEBD D, V100, P658; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Enright MC, 2011, SCIENCE, V331, P407, DOI 10.1126/science.1201690; Estienne Charles, 1564, AGR MAISON RUSTIQUE; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fischer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036150; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Frangeul L, 2004, BIOINFORMATICS, V20, P790, DOI 10.1093/bioinformatics/btg490; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray RR, 2011, MOL BIOL EVOL, V28, P1593, DOI 10.1093/molbev/msq319; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haller B de, 1773, MEMOIRE CONTAGION PA; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hutyra F, 1949, SPECIAL PATHOLOGY TH, P455; Huzard JB, 1798, MEMOIRE PERIPNEUMONI; Kamashev D, 2011, BIOCHEMISTRY-US, V50, P8692, DOI 10.1021/bi2009097; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; LEE DH, 1987, EPIDEMIOL INFECT, V98, P361, DOI 10.1017/S0950268800062129; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; McAuliffe L, 2007, FEMS MICROBIOL LETT, V276, P181, DOI 10.1111/j.1574-6968.2007.00936.x; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; NEWTON LG, 1992, AUST VET J, V69, P306, DOI 10.1111/j.1751-0813.1992.tb09912.x; Peires J. B., 1989, DEAD WILL ARISE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Regalla J, 1996, REV SCI TECH OIE, V15, P1309, DOI 10.20506/rst.15.4.979; Roeder PL, 2011, PREV VET MED, V102, P98, DOI 10.1016/j.prevetmed.2011.04.004; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Scheuchzer JJ, 1732, FLIEGENDER ZUNGEN KR; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Thiaucourt F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-114; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Vilei EM, 2000, MICROBIOL-UK, V146, P477, DOI 10.1099/00221287-146-2-477; Willems L, 1852, RECL MED VET PRATIQU, V3, P401; Yaya A, 2008, VET RES, V39	45	20	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46821	10.1371/journal.pone.0046821	http://dx.doi.org/10.1371/journal.pone.0046821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23071648	Green Published, gold, Green Submitted			2022-12-25	WOS:000309831500084
J	Umeshappa, CS; Nanjundappa, RH; Xie, YF; Freywald, A; Deng, YL; Ma, H; Xiang, J				Umeshappa, Channakeshava Sokke; Nanjundappa, Roopa Hebbandi; Xie, Yufeng; Freywald, Andrew; Deng, Yulin; Ma, Hong; Xiang, Jim			CD154 and IL-2 Signaling of CD4(+) T Cells Play a Critical Role in Multiple Phases of CD8(+) CTL Responses Following Adenovirus Vaccination	PLOS ONE			English	Article							AD5-VECTORED HIV-1 VACCINE; MEDIATED-IMMUNITY; CD40 LIGAND; CLASS-I; PROTECTIVE IMMUNITY; RECALL RESPONSES; DENDRITIC CELLS; VIRUS-INFECTION; GENE-TRANSFER; UP-REGULATION	Adenoviral (AdV) vectors represent most commonly utilized viral vaccines in clinical studies. While the role of CD8(+) cytotoxic T lymphocyte (CTL) responses in mediating AdV-induced protection is well understood, the involvement of CD4(+) T cell-provided signals in the development of functional CD8(+) CTL responses remain unclear. To explore CD4(+) T helper signals required for AdVova-stimulated CTL responses, we established an adoptive transfer system by transferring CD4(+) T cells derived from various knock out and transgenic mice into wild-type and/or CD4-deficient animals, followed by immunizing with recombinant ovalbumin(OVA)-expressing AdVova vector. Without CD4(+) T help, both primary and memory CTL responses were greatly reduced in this model, and were associated with increased PD-1 expression. The provision of OVA-specific CD4(+) T help in CD4(+) T cell-deficient mice restored AdVova-induced primary CTL responses, and supported survival and recall responses of AdVova-stimulated memory CTLs. These effects were specifically mediated by CD4(+) T cell-produced IL-2 and CD154 signals. Adoptive transfer of "helped" or "unhelped" effector and memory CTLs into naive CD4(+) T cell-deficient or -sufficient mice also revealed an additional role for polyclonal CD4(+) T cell environment in the survival of AdVova-stimulated CTLs, partially explaining the extension of CTL contraction phase. Finally, during recall responses, CD4(+) T cell environment, particularly involving memory CD4(+) T cells, greatly enhanced expansion of memory CTLs. Collectively, our data strongly suggest a critical role for CD4(+) T help in multiple phases of AdV-stimulated CTL responses, and could partially explain certain failures in AdV-based immunization trials targeting malignant tumors and chronic diseases that are often associated with compromised CD4(+) T cell population and function.	[Umeshappa, Channakeshava Sokke; Nanjundappa, Roopa Hebbandi; Xie, Yufeng; Xiang, Jim] Univ Saskatchewan, Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada; [Umeshappa, Channakeshava Sokke; Freywald, Andrew; Xiang, Jim] Univ Saskatchewan, Dept Oncol, Saskatoon, SK, Canada; [Umeshappa, Channakeshava Sokke; Freywald, Andrew; Xiang, Jim] Univ Saskatchewan, Dept Pathol, Saskatoon, SK, Canada; [Deng, Yulin; Ma, Hong; Xiang, Jim] Beijing Inst Technol, Beijing 100081, Peoples R China	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Beijing Institute of Technology	Xiang, J (corresponding author), Univ Saskatchewan, Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK, Canada.	jim.xiang@saskcancer.ca			Canadian Institute of Health Research (CIHR) [MOP 79415]; Beijing Natural Science Foundation [5121002]; University of Saskatchewan	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); University of Saskatchewan	This study was supported by research grants from Canadian Institute of Health Research CIHR) (MOP 79415) (http://www.cihr-irsc.gc.ca/e/193.html) and Beijing Natural Science Foundation (5121002). CSU was supported by Dean's and Vanier Canada Graduate Scholarships from the University of Saskatchewan and the CIHR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen SO, 2000, J IMMUNOL, V164, P3689, DOI 10.4049/jimmunol.164.7.3689; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Bassett JD, 2011, BLOOD, V117, P1146, DOI 10.1182/blood-2010-03-272336; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chen Y, 2011, CANCER GENE THER, V18, P489, DOI 10.1038/cgt.2011.18; Cohen Jon, 2005, Science, V309, P1003, DOI 10.1126/science.309.5737.1003; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; de Herve MGD, 2008, J IMMUNOL, V181, P5974, DOI 10.4049/jimmunol.181.9.5974; de Herve MGD, 2010, J IMMUNOL, V185, P1028, DOI 10.4049/jimmunol.0904209; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Herzog R, 2009, GENE THERAPY IMMUNOL; Holst PJ, 2007, J GEN VIROL, V88, P1708, DOI 10.1099/vir.0.82727-0; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Holst PJ, 2011, J IMMUNOL, V186, P3997, DOI 10.4049/jimmunol.1001251; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; KAHN M, 1991, J IMMUNOL, V146, P3235; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kish DD, 2007, J LEUKOCYTE BIOL, V82, P85, DOI 10.1189/jlb.0207089; Krawczyk CM, 2007, INFECT IMMUN, V75, P3556, DOI 10.1128/IAI.00086-07; Kushwah R, 2007, CELL MOL IMMUNOL, V4, P81; Kushwah R, 2008, J IMMUNOL, V180, P4098, DOI 10.4049/jimmunol.180.6.4098; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721; Martin B, 2003, P NATL ACAD SCI USA, V100, P6021, DOI 10.1073/pnas.1037754100; Mu JY, 2010, J GENE MED, V12, P693, DOI 10.1002/jgm.1487; Novy P, 2007, J IMMUNOL, V179, P8243, DOI 10.4049/jimmunol.179.12.8243; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Phares TW, 2012, J VIROL, V86, P2416, DOI 10.1128/JVI.06797-11; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Rapetti L, 2008, J IMMUNOL, V181, P299, DOI 10.4049/jimmunol.181.1.299; Ryu SJ, 2009, BLOOD, V113, P4273, DOI 10.1182/blood-2008-09-181263; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Shi MQ, 2006, J LEUKOCYTE BIOL, V80, P1354, DOI 10.1189/jlb.0506321; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Thomsen AR, 1998, J IMMUNOL, V161, P4583; Umeshappa CS, 2011, IMMUNOL CELL BIOL, V89, P578, DOI 10.1038/icb.2011.28; Umeshappa CS, 2009, J IMMUNOL, V182, P193, DOI 10.4049/jimmunol.182.1.193; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wiesel M, 2010, J IMMUNOL, V185, P5188, DOI 10.4049/jimmunol.1001990; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; Yang TC, 2006, J IMMUNOL, V176, P200, DOI 10.4049/jimmunol.176.1.200; Yang TC, 2007, MOL THER, V15, P997, DOI 10.1038/sj.mt.6300130; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015	66	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47004	10.1371/journal.pone.0047004	http://dx.doi.org/10.1371/journal.pone.0047004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071696	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300077
J	Sharma, B; Joshi, S; Sassano, A; Majchrzak, B; Kaur, S; Aggarwal, P; Nabet, B; Bulic, M; Stein, BL; McMahon, B; Baker, DP; Fukunaga, R; Altman, JK; Licht, JD; Fish, EN; Platanias, LC				Sharma, Bhumika; Joshi, Sonali; Sassano, Antonella; Majchrzak, Beata; Kaur, Surinder; Aggarwal, Priya; Nabet, Behnam; Bulic, Marinka; Stein, Brady L.; McMahon, Brandon; Baker, Darren P.; Fukunaga, Rikiro; Altman, Jessica K.; Licht, Jonathan D.; Fish, Eleanor N.; Platanias, Leonidas C.			Sprouty Proteins Are Negative Regulators of Interferon (IFN) Signaling and IFN-inducible Biological Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE PATHWAY; CELLS RESPOND; I INTERFERONS; MAP KINASE; ACTIVATION; GROWTH; PHOSPHORYLATION; GENES; ANTAGONIST; GENERATION	Interferons (IFNs) have important antiviral and antineoplastic properties, but the precise mechanisms required for generation of these responses remain to be defined. We provide evidence that during engagement of the Type I IFN receptor (IFNR), there is up-regulation of expression of Sprouty (Spry) proteins 1, 2, and 4. Our studies demonstrate that IFN-inducible up-regulation of Spry proteins is Mnk kinase-dependent and results in suppressive effects on the IFN-activated p38 MAP kinase (MAPK), the function of which is required for transcription of interferon-stimulated genes (ISGs). Our data establish that ISG15 mRNA expression and IFN-dependent antiviral responses are enhanced in Spry1,2,4 triple knock-out mouse embryonic fibroblasts, consistent with negative feedback regulatory roles for Spry proteins in IFN-mediated signaling. In other studies, we found that siRNA-mediated knockdown of Spry1, Spry2, or Spry4 promotes IFN-inducible antileukemic effects in vitro and results in enhanced suppressive effects on malignant hematopoietic progenitors from patients with polycythemia vera. Altogether, our findings demonstrate that Spry proteins are potent regulators of Type I IFN signaling and negatively control induction of Type I IFN-mediated biological responses.	[Sharma, Bhumika; Joshi, Sonali; Sassano, Antonella; Kaur, Surinder; Aggarwal, Priya; Nabet, Behnam; Bulic, Marinka; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Sharma, Bhumika; Joshi, Sonali; Sassano, Antonella; Kaur, Surinder; Aggarwal, Priya; Nabet, Behnam; Bulic, Marinka; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Licht, Jonathan D.; Platanias, Leonidas C.] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA; [Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Div Hematol Oncol, Dept Med, Chicago, IL 60612 USA; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M1, Canada; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Fukunaga, Rikiro] Osaka Univ Pharmaceut Sci, Biochem Lab, Osaka 5691094, Japan	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Biogen; Osaka University of Pharmaceutical Sciences	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Nabet, Behnam/AAZ-4987-2020; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Fukunaga, Rikiro/CAG-2891-2022	Nabet, Behnam/0000-0002-6738-4200; Licht, Jonathan/0000-0002-3942-1369; 	National Institutes of Health [CA155566, CA77816, CA161796]; Merit Review grant from the Department of Veterans Affairs; Lynn Sage Foundation; Canadian Institutes of Health Research Grant [285791]; NATIONAL CANCER INSTITUTE [R01CA155566, R01CA161796, R01CA077816, P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24590105] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review grant from the Department of Veterans Affairs(US Department of Veterans Affairs); Lynn Sage Foundation; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA155566, CA77816, and CA161796 (to L. C. P.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to L. C. P.); by the Lynn Sage Foundation (to J. D. L.); and by Canadian Institutes of Health Research Grant 285791 (to E. N. F.).	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Cheon H, 2011, J INTERF CYTOK RES, V31, P33, DOI 10.1089/jir.2010.0100; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Lasfar A, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/349575; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Li X, 2003, BIOCHEM SOC T, V31, P1445; Lu M, 2010, EXP HEMATOL, V38, P472, DOI 10.1016/j.exphem.2010.03.005; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Minowada G, 1999, DEVELOPMENT, V126, P4465; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Quintas-Cardama A, 2009, J CLIN ONCOL, V27, P5418, DOI 10.1200/JCO.2009.23.6075; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200	45	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42352	42360		10.1074/jbc.M112.400721	http://dx.doi.org/10.1074/jbc.M112.400721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074222	hybrid, Green Published			2022-12-25	WOS:000312103000070
J	Frosini, S; Lardicci, C; Balestri, E				Frosini, Silvia; Lardicci, Claudio; Balestri, Elena			Global Change and Response of Coastal Dune Plants to the Combined Effects of Increased Sand Accretion (Burial) and Nutrient Availability	PLOS ONE			English	Article							ATMOSPHERIC NITROGEN DEPOSITION; SALT SPRAY; SEA-LEVEL; GROWTH; PERSPECTIVE; ECOSYSTEMS; BIODIVERSITY; VEGETATION; RESOURCES; GRASSLAND	Coastal dune plants are subjected to natural multiple stresses and vulnerable to global change. Some changes associated with global change could interact in their effects on vegetation. As vegetation plays a fundamental role in building and stabilizing dune systems, effective coastal habitat management requires a better understanding of the combined effects of such changes on plant populations. A manipulative experiment was conducted along a Mediterranean dune system to examine the individual and combined effects of increased sediment accretion (burial) and nitrogen enrichment associated with predicted global change on the performance of young clones of Sporobolus virginicus, a widespread dune stabilizing species. Increased burial severity resulted in the production of taller but thinner shoots, while nutrient enrichment stimulated rhizome production. Nutrient enrichment increased total plant biomass up to moderate burial levels (50% of plant height), but it had not effect at the highest burial level (100% of plant height). The effects of such factors on total biomass, shoot biomass and branching were influenced by spatial variation in natural factors at the scale of hundreds of metres. These results indicate that the effects of burial and nutrient enrichment on plant performance were not independent. Their combined effects may not be predicted by knowing the individual effects, at least under the study conditions. Under global change scenarios, increased nutrient input could alleviate nutrient stress in S. virginicus, enhancing clonal expansion and productivity, but this benefit could be offset by increased sand accretion levels equal or exceeding 100% of plant height. Depletion of stored reserves for emerging from sand could increase plant vulnerability to other stresses in the long-term. The results emphasize the need to incorporate statistical designs for detecting non-independent effects of multiple changes and adequate spatial replication in future works to anticipate the impact of global change on dune ecosystem functioning.	[Frosini, Silvia; Lardicci, Claudio; Balestri, Elena] Univ Pisa, Dept Biol, Pisa, Italy	University of Pisa	Balestri, E (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	ebalestri@biologia.unipi.it	Balestri, Elena/AAV-5021-2021; lardicci, claudio/K-8698-2018	Balestri, Elena/0000-0002-4497-0418; LARDICCI, CLAUDIO/0000-0001-5356-7914	University of Pisa; Solvay Chimica Italia S.p.A. of Rosignano Solvay; Solvay Chimica Italia S.p.A.	University of Pisa; Solvay Chimica Italia S.p.A. of Rosignano Solvay; Solvay Chimica Italia S.p.A.	This work was a part of the Ph.D. thesis of S. Frosini supported by a fellowship from the University of Pisa. The study was partially funded by Solvay Chimica Italia S.p.A. of Rosignano Solvay (www.solvay.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CL receives grant/research support from Solvay Chimica Italia S.p.A. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors have nothing to disclose.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Bach CE, 1998, ECOL ENTOMOL, V23, P238, DOI 10.1046/j.1365-2311.1998.00133.x; Balestri E, 2004, MAR BIOL, V145, P61, DOI 10.1007/s00227-004-1301-2; Balestri E, 2012, ESTUAR COAST SHELF S, V99, P74, DOI 10.1016/j.ecss.2011.12.017; Bell HL, 2003, AM J BOT, V90, P1416, DOI 10.3732/ajb.90.10.1416; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; BREEN CM, 1977, HYDROBIOLOGIA, V54, P135, DOI 10.1007/BF00034987; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Brown JF, 1997, J ECOL, V85, P151, DOI 10.2307/2960647; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clayton WD., 1974, FLORA TROPICAL E AFR; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; D'Ulisse A., 1996, J COAST CONSERV, V2, P3, DOI [10.1007/BF02743032, DOI 10.1007/BF02743032]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Everard M, 2010, AQUAT CONSERV, V20, P476, DOI 10.1002/aqc.1114; Feagin RA, 2005, FRONT ECOL ENVIRON, V3, P359, DOI 10.2307/3868584; Flamini G, 2003, FLAVOUR FRAG J, V18, P460, DOI 10.1002/ffj.1253; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gilbert M, 2008, OECOLOGIA, V156, P169, DOI 10.1007/s00442-008-0968-3; Gilbert ME, 2008, PHYSIOL PLANTARUM, V134, P464, DOI 10.1111/j.1399-3054.2008.01153.x; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; Gormally CL, 2010, ESTUAR COAST, V33, P1237, DOI 10.1007/s12237-010-9269-2; Gornish ES, 2010, GLOBAL CHANGE BIOL, V16, P2668, DOI 10.1111/j.1365-2486.2009.02144.x; Gratani L, 2007, FITOSOCIOLOGIA, V44, P11; Greaver TL, 2010, GLOBAL CHANGE BIOL, V16, P1860, DOI 10.1111/j.1365-2486.2010.02168.x; Griffiths ME, 2006, PLANT ECOL, V186, P69, DOI 10.1007/s11258-006-9113-8; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gutierrez J.L., 2010, TRANSP OPT NETW ICTO, P1; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARRIS D, 1986, J ECOL, V74, P1057, DOI 10.2307/2260233; Hesp P. A., 2007, PLANT DISTURBANCE EC, P215; Houle G, 1997, AM J BOT, V84, P1729, DOI 10.2307/2446472; Jones MLM, 2004, PLANT BIOLOGY, V6, P598, DOI 10.1055/s-2004-821004; Kooijman AM, 1998, J ECOL, V86, P511, DOI 10.1046/j.1365-2745.1998.00273.x; Leithead HL, 1971, USDA HDB, V389; MARCUM KB, 1992, NEW PHYTOL, V120, P281, DOI 10.1111/j.1469-8137.1992.tb05665.x; Martinez ML, 2004, ECOL STU AN, V171, P3; MAUN M. A., 2009, BIOL COASTAL SAND DU, P197; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 2004, ECOL STU AN, V171, P119; MAUN MA, 1984, J ECOL, V72, P565, DOI 10.2307/2260067; Maun MA, 2009, BIOL COASTAL SAND DU; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; NAIDOO G, 1992, OECOLOGIA, V90, P445, DOI 10.1007/BF00317704; Owen NW, 2004, J VEG SCI, V15, P669, DOI 10.1111/j.1654-1103.2004.tb02309.x; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Plassmann K, 2009, SCI TOTAL ENVIRON, V407, P1391, DOI 10.1016/j.scitotenv.2008.10.012; Provoost S, 2011, J COAST CONSERV, V15, P207, DOI 10.1007/s11852-009-0068-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Remke E, 2009, ECOSYSTEMS, V12, P1173, DOI 10.1007/s10021-009-9282-0; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salman A.H.P.M., 1992, EUROPEAN COASTAL DUN, P439; Sandrini-Neto L., 2011, GAD R PACKAGE ANOVA; Scartazza A, 2007, CLIMA E CAMBIAMENTI, P245; Snedecor GW, 1980, STAT METHODS, V7th; Stallins JA, 2003, ANN ASSOC AM GEOGR, V93, P13, DOI 10.1111/1467-8306.93102; SYKES MT, 1990, ACTA BOT NEERL, V39, P171, DOI 10.1111/j.1438-8677.1990.tb01485.x; Titlyanova AA, 1999, J VEG SCI, V10, P307, DOI 10.2307/3237060; TROELSTRA SR, 1990, PLANT SOIL, V127, P1, DOI 10.1007/BF00010831; Tsoar H, 2005, PHYSICA A, V357, P50, DOI 10.1016/j.physa.2005.05.067; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Valverde T, 1997, J COASTAL RES, V13, P497; van den Berg LJL, 2005, ENVIRON POLLUT, V138, P77, DOI 10.1016/j.envpol.2005.02.024; Van Der Maarel Eddy, 1993, V2 PART A, P7; Van Der Meulen F, 2004, ECOL STU AN, V171, P259; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wilson JB, 1999, ECOL LETT, V2, P233; Zhang JH, 1996, ANN BOT-LONDON, V78, P591, DOI 10.1006/anbo.1996.0165	72	30	30	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47561	10.1371/journal.pone.0047561	http://dx.doi.org/10.1371/journal.pone.0047561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077636	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100131
J	Heinze, DM; Carmical, JR; Aronson, JF; Thangamani, S				Heinze, Dar M.; Carmical, J. Russ; Aronson, Judith F.; Thangamani, Saravanan			Early Immunologic Events at the Tick-Host Interface	PLOS ONE			English	Article							IXODES-SCAPULARIS; PROTEIN; MOUSE; TRANSMISSION; EXPRESSION; VIRUS; INFESTATIONS; INTERFERES; ATTACHMENT; INHIBITION	Ixodes species ticks are competent vectors of tick-borne viruses including tick-borne encephalitis and Powassan encephalitis. Tick saliva has been shown to facilitate and enhance viral infection. This likely occurs by saliva-mediated modulation of host responses into patterns favorable for viral infection and dissemination. Because of the rapid kinetics of tick-borne viral transmission, this modulation must occur as early as tick attachment and initiation of feeding. In this study, cutaneous bite-site lesions were analyzed using Affymetrix mouse genome 430A 2.0 arrays and histopathology at 1, 3, 6, and 12 hours after uninfected Ixodes scapularis nymphal tick attachment. At 1 and 3 hrs after attachment, the gene expression profile is markedly different than at later time points. Upregulated gene ontology term clusters enriched at 1 and 3 hrs were related to post-translational modification. At 6 and 12 hrs, cytoskeletal rearrangements, DNA replication/cell division, inflammation, and chemotaxis were prominent clusters. At 6 and 12 hrs, extracellular matrix, signaling, and DNA binding clusters were downregulated. Histopathological analysis shows minimal inflammation at 1 and 3 hrs but an appreciable neutrophil infiltrate at 6 and 12 hrs. In addition, putative hyperemia, localized necrosis, and increased ECM deposition were identified. Putting the gene expression and histopathology analysis together suggests early tick feeding is characterized by modulation of host responses in resident cells that merges into a nascent, neutrophil-driven immune response by 12 hrs post-attachment.	[Heinze, Dar M.; Aronson, Judith F.; Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Heinze, Dar M.; Aronson, Judith F.; Thangamani, Saravanan] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA; [Carmical, J. Russ] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thangamani, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	sathanga@utmb.edu	Thangamani, Saravanan/E-7371-2010	Thangamani, Saravanan/0000-0002-4269-5993	National Institute of Allergy and Infectious Diseases [T32AI007526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007526] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DH was supported by the National Institute of Allergy and Infectious Diseases award number T32AI007526. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev AN, 1996, EXP APPL ACAROL, V20, P713, DOI 10.1007/BF00051556; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Beaufays J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003987; BINNINGTON KC, 1978, INT J PARASITOL, V8, P97, DOI 10.1016/0020-7519(78)90004-8; Bouchard K., 2005, BIOL DIS VECTORS, V2, P705; Coulombe PA, 2004, EUR J CELL BIOL, V83, P735, DOI 10.1078/0171-9335-00443; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Hajnicka V, 2001, PARASITE IMMUNOL, V23, P483, DOI 10.1046/j.1365-3024.2001.00403.x; Heinze DM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-26; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue KI, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/101659; Jiang Y, 2010, LETT APPL MICROBIOL, V50, P468, DOI 10.1111/j.1472-765X.2010.02824.x; Jiang Y, 2009, ARCH VIROL, V154, P639, DOI 10.1007/s00705-009-0352-6; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; KAUFMAN WR, 1989, PARASITOL TODAY, V5, P47; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; MCSWAIN JL, 1982, J PARASITOL, V68, P100, DOI 10.2307/3281330; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Schoeler GB, 1999, EXP PARASITOL, V92, P239, DOI 10.1006/expr.1999.4426; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Skallova A, 2008, J IMMUNOL, V180, P6186, DOI 10.4049/jimmunol.180.9.6186; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Vancova I, 2010, PARASITE IMMUNOL, V32, P460, DOI 10.1111/j.1365-3024.2010.01203.x; Ward PP, 2008, AM J PATHOL, V172, P1019, DOI 10.2353/ajpath.2008.061145; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032	46	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47301	10.1371/journal.pone.0047301	http://dx.doi.org/10.1371/journal.pone.0047301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077588	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100089
J	Twig, G; Afek, A; Shamiss, A; Derazne, E; Tzur, D; Gordon, B; Tirosh, A				Twig, Gilad; Afek, Arnon; Shamiss, Ari; Derazne, Estela; Tzur, Dorit; Gordon, Barak; Tirosh, Amir			White Blood Cell Count and the Risk for Coronary Artery Disease in Young Adults	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEART-DISEASE; LEUKOCYTE COUNT; ATHEROSCLEROSIS RISK; TRIGLYCERIDE LEVELS; MEN; ASSOCIATION; PREDICTOR	Background: The association between white blood cell (WBC) count and coronary artery disease (CAD) is unknown in young adults. Our objective was to assess the association between WBC count and its changes over time with CAD incidence in the Metabolic, Life-style and Nutrition Assessment in Young adults (MELANY) study, a cohort of Israeli army personnel. Methods and Findings: 29,120 apparently healthy young men (mean age; 31.2 +/- 5.5 years) with a normal baseline WBC count (3,000-12,000 cells/mm(3)) were followed during a mean follow up of 7.5 +/- 3.8 years for incidence of CAD. Participants were screened every 3-5 years using a stress test, and CAD was confirmed by coronary angiography. In a multivariate model adjusted for age, body mass index (BMI), LDL- and HDL-cholesterol, blood pressure, family history of CAD, physical activity, diabetes, triglycerides and smoking status, WBC levels (divided to quintiles) above 6,900 cells/mm(3) (quintile 4) were associated with a 2.17-fold increase (95% CI = 1.18-3.97) in the risk for CAD as compared with men in quintile 1 (WBC <= 5,400 cells/mm(3)). When modeled as a continuous variable, a WBC increment of 1000 cells/mm(3) was associated with a 17.4% increase in CAD risk (HR 1.174; 95% CI = 1.067-1.290, p = 0.001). A decrease in the WBC level (within the normal range) during the follow-up period was associated with increased physical activity and decreased triglyceride levels as well as with reduced incidence of CAD. Conclusions: WBC count is an independent risk factor for CAD in young adults at values well within the normal range. WBC count may assist in detecting subgroups of young men at either low or high risk for progression to CAD.	[Twig, Gilad] Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel; [Twig, Gilad; Tirosh, Amir] Chaim Sheba Med Ctr, Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Tel Hashomer, Israel; [Twig, Gilad; Derazne, Estela; Tzur, Dorit; Gordon, Barak] Chaim Sheba Med Ctr, Israel Def Forces Med Corps, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamiss, Ari] Chaim Sheba Med Ctr, Chaim Sheba Med Ctr Management, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamiss, Ari; Derazne, Estela; Gordon, Barak] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Tirosh, Amir] Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health	Twig, G (corresponding author), Chaim Sheba Med Ctr, Dept Med B, IL-52621 Tel Hashomer, Israel.	Gilad.Twig@gmail.com; Atirosh@partners.org	Gordon, Barak/L-6139-2018; Twig, Gilad/C-4373-2018	Gordon, Barak/0000-0002-5283-722X; Twig, Gilad/0000-0003-2829-3645; Tirosh, Amir/0000-0003-2210-5906	Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	GT and AT were supported by a grant from the Pinchas Borenstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel, and by the Israel Defense Forces Medical Corps. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara A, 1993, REV PORT CARDIOL, V12, P899; Amaro A, 1993, Rev Port Cardiol, V12, P913; Aronow HD, 2003, J AM COLL CARDIOL, V41, p17A; Asadollahi K, 2010, QJM-INT J MED, V103, P285, DOI 10.1093/qjmed/hcp182; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Jee SH, 2005, AM J EPIDEMIOL, V162, P1062, DOI 10.1093/aje/kwi326; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Mizuno Y, 2011, J ATHEROSCLER THROMB, V18, P351, DOI 10.5551/jat.7591; Navas-Nacher EL, 2001, ANN INTERN MED, V134, P433, DOI 10.7326/0003-4819-134-6-200103200-00007; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59, DOI 10.1093/oxfordjournals.aje.a116421; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; Shankar A, 2007, ATHEROSCLEROSIS, V192, P177, DOI 10.1016/j.atherosclerosis.2006.04.029; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Takeda Y, 2003, JPN HEART J, V44, P201, DOI 10.1536/jhj.44.201; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499, DOI 10.1161/01.ATV.16.4.499; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002	30	46	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47183	10.1371/journal.pone.0047183	http://dx.doi.org/10.1371/journal.pone.0047183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077568	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500036
J	Belhacene, N; Gamas, P; Goncalves, D; Jacquin, M; Beneteau, M; Jacquel, A; Colosetti, P; Ricci, JE; Wakkach, A; Auberger, P; Marchetti, S				Belhacene, Nathalie; Gamas, Parvati; Goncalves, Diogo; Jacquin, Marie; Beneteau, Marie; Jacquel, Arnaud; Colosetti, Pascal; Ricci, Jean-Ehrland; Wakkach, Abdellilah; Auberger, Patrick; Marchetti, Sandrine			Severe Thymic Atrophy in a Mouse Model of Skin Inflammation Accounts for Impaired TNFR1 Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SRC FAMILY KINASES; T-CELLS; LYMPHOTOXIN; APOPTOSIS; MICE; LYN; TRANSGENES; PSORIASIS; LIGHT	Transgenic mice expressing the caspase-cleaved form of the tyrosine kinase Lyn (Lyn Delta N) develop a TNF alpha- dependent skin disease that accurately recapitulates human psoriasis. Participation of lymphocytes in this disease was confirmed by backcrossing Lyn Delta N mice on a Rag-1 deficient background. The present study was therefore conducted to analyze whether modification of lymphocyte homeostasis does occur and participate in the phenotype of Lyn Delta N mice. We show here that LynDN mice consistently exhibit thymic atrophy that correlates with both a net decrease in the CD4+/CD8+ Double Positive (DP) and an increase in Single Positive (SP) thymocyte sub-populations, but also display an increase of splenic mature B cell. Interestingly, a normal immune phenotype was rescued in a TNFR1 deficient background. Finally, none of these immune alterations was detected in newborn mice before the onset of inflammation. Therefore, we conclude that chronic inflammation can induce thymic atrophy and perturb spleen homeostasis in Lyn Delta N mice through the increased production of TNF alpha, LT beta and TNFR1 signaling.	[Belhacene, Nathalie; Gamas, Parvati; Goncalves, Diogo; Jacquel, Arnaud; Colosetti, Pascal; Auberger, Patrick; Marchetti, Sandrine] Fac Med Nice, INSERM, Team Cell Death Differentiat Inflammat & Canc, Ctr Mediterraneen Med Mol,UMR 1065, F-06034 Nice, France; [Jacquin, Marie; Beneteau, Marie; Ricci, Jean-Ehrland] Fac Med Nice, INSERM, Team Metab Control Cell Deaths, Ctr Mediterraneen Med Mol,UMR 1065, F-06034 Nice, France; [Wakkach, Abdellilah] CNRS, FRE 3472, LP2M, F-06034 Nice, France; [Belhacene, Nathalie; Gamas, Parvati; Goncalves, Diogo; Jacquin, Marie; Beneteau, Marie; Jacquel, Arnaud; Colosetti, Pascal; Ricci, Jean-Ehrland; Wakkach, Abdellilah; Auberger, Patrick; Marchetti, Sandrine] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Belhacene, Nathalie; Gamas, Parvati; Goncalves, Diogo; Jacquel, Arnaud; Colosetti, Pascal; Auberger, Patrick; Marchetti, Sandrine] Equipe Labellisee Ligue Natl Canc 2011 2013, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Marchetti, S (corresponding author), Fac Med Nice, INSERM, Team Cell Death Differentiat Inflammat & Canc, Ctr Mediterraneen Med Mol,UMR 1065, U210, F-06034 Nice, France.	marchett@unice.fr	RICCI, Jean Ehrland/AAS-4379-2020; Jacquel, Arnaud/O-1928-2017; Marchetti, Sandrine/P-6479-2016; Colosetti, Pascal/ABH-4585-2020; AUBERGER, Patrick/G-1491-2013; WAKKACH, Abdelilah/J-6584-2016; Ricci, Jean Ehrland/I-7117-2016; Jacquel, Arnaud/AAJ-4760-2021	RICCI, Jean Ehrland/0000-0003-1585-8117; Jacquel, Arnaud/0000-0001-5062-8048; Marchetti, Sandrine/0000-0001-8326-5730; AUBERGER, Patrick/0000-0002-2481-8275; WAKKACH, Abdelilah/0000-0002-6658-8009; Ricci, Jean Ehrland/0000-0003-1585-8117; Jacquel, Arnaud/0000-0001-5062-8048	Inserm; la Ligue Nationale contre le Cancer (Equipe Labelisee); la Fondation de France and la Fondation pour la Recherche Medicale [DMP20101120387]; Fondation pour la Recherche Medicale; Ligne Nationale Contre le Cancer; ANR grant [ANR-09-JCJC-0003]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Ligue Nationale contre le Cancer (Equipe Labelisee); la Fondation de France and la Fondation pour la Recherche Medicale; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligne Nationale Contre le Cancer; ANR grant(French National Research Agency (ANR))	This work was supported by Inserm, la Ligue Nationale contre le Cancer (Equipe Labelisee 2011-2013), la Fondation de France and la Fondation pour la Recherche Medicale (DMP20101120387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJ, MB and DG are recipients of fellowships from the Fondation pour la Recherche Medicale. AJ is recipient of fellowship of the Ligne Nationale Contre le Cancer. JER's team is supported by an ANR grant (ANR-09-JCJC-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 1998, J EXP MED, V188, P745, DOI 10.1084/jem.188.4.745; Baseta JG, 2000, J IMMUNOL, V165, P5621, DOI 10.4049/jimmunol.165.10.5621; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Ettinger R, 1998, INT IMMUNOL, V10, P727, DOI 10.1093/intimm/10.6.727; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Heikenwalder M, 2008, AM J PATHOL, V172, P1555, DOI 10.2353/ajpath.2008.070572; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Liepinsh DJ, 2009, EUR J IMMUNOL, V39, P2906, DOI 10.1002/eji.200839191; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Luciano F, 2003, FASEB J, V17, P711, DOI 10.1096/fj.02-0716fje; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Marchetti S, 2009, EMBO J, V28, P2449, DOI 10.1038/emboj.2009.183; McCarthy DA, 2006, IMMUNOL RES, V35, P41, DOI 10.1385/IR:35:1:41; PROBERT L, 1993, J IMMUNOL, V151, P1894; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang J, 2001, J IMMUNOL, V167, P5099, DOI 10.4049/jimmunol.167.9.5099; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47321	10.1371/journal.pone.0047321	http://dx.doi.org/10.1371/journal.pone.0047321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071785	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700074
J	Bjarnason, A; Thorleifsdottir, G; Love, A; Gudnason, JF; Asgeirsson, H; Hallgrimsson, KL; Kristjansdottir, BS; Haraldsson, G; Baldursson, O; Kristinsson, KG; Gottfredsson, M				Bjarnason, Agnar; Thorleifsdottir, Gudlaug; Love, Arthur; Gudnason, Janus F.; Asgeirsson, Hilmir; Hallgrimsson, Kristinn L.; Kristjansdottir, Berglind S.; Haraldsson, Gunnsteinn; Baldursson, Olafur; Kristinsson, Karl G.; Gottfredsson, Magnus			Severity of Influenza A 2009 (H1N1) Pneumonia Is Underestimated by Routine Prediction Rules. Results from a Prospective, Population-Based Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PANDEMIC INFLUENZA; UNITED-STATES; HOSPITALIZED-PATIENTS; VIRUS; GUIDELINES; MANAGEMENT; AUSTRALIA; INFECTION; DEATH	Background: Characteristics of patients with community-acquired pneumonia (CAP) due to pandemic influenza A 2009 (H1N1) have been inadequately compared to CAP caused by other respiratory pathogens. The performance of prediction rules for CAP during an epidemic with a new infectious agent are unknown. Methods: Prospective, population-based study from November 2008-November 2009, in centers representing 70% of hospital beds in Iceland. Patients admitted with CAP underwent evaluation and etiologic testing, including polymerase chain reaction (PCR) for influenza. Data on influenza-like illness in the community and overall hospital admissions were collected. Clinical and laboratory data, including pneumonia severity index (PSI) and CURB-65 of patients with CAP due to H1N1 were compared to those caused by other agents. Results: Of 338 consecutive and eligible patients 313 (93%) were enrolled. During the pandemic peak, influenza A 2009 (H1N1) patients constituted 38% of admissions due to CAP. These patients were younger, more dyspnoeic and more frequently reported hemoptysis. They had significantly lower severity scores than other patients with CAP (1.23 vs. 1.61, P = .02 for CURB-65, 2.05 vs. 2.87 for PSI, P < .001) and were more likely to require intensive care admission (41% vs. 5%, P < .001) and receive mechanical ventilation (14% vs. 2%, P = .01). Bacterial co-infection was detected in 23% of influenza A 2009 (H1N1) patients with CAP. Conclusions: Clinical characteristics of CAP caused by influenza A 2009 (H1N1) differ markedly from CAP caused by other etiologic agents. Commonly used CAP prediction rules often failed to predict admissions to intensive care or need for assisted ventilation in CAP caused by the influenza A 2009 (H1N1) virus, underscoring the importance of clinical acumen under these circumstances.	[Bjarnason, Agnar; Thorleifsdottir, Gudlaug; Love, Arthur; Kristjansdottir, Berglind S.; Kristinsson, Karl G.; Gottfredsson, Magnus] Univ Iceland, Fac Med, Reykjavik, Iceland; [Bjarnason, Agnar; Asgeirsson, Hilmir; Hallgrimsson, Kristinn L.; Baldursson, Olafur; Gottfredsson, Magnus] Landspitali Univ Hosp, Dept Med, Reykjavik, Iceland; [Thorleifsdottir, Gudlaug; Love, Arthur] Landspitali Univ Hosp, Dept Virol, Reykjavik, Iceland; [Gudnason, Janus F.] Landspitali Univ Hosp, Dept Emergency Med, Reykjavik, Iceland; [Haraldsson, Gunnsteinn; Kristinsson, Karl G.] Landspitali Univ Hosp, Dept Clin Microbiol, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital	Gottfredsson, M (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	magnusgo@landspitali.is	Asgeirsson, Hilmir/AAY-5583-2021; Gottfredsson, Magnus/AAD-9086-2020; Haraldsson, Gunnsteinn/A-6227-2014	Asgeirsson, Hilmir/0000-0003-3869-8021; Haraldsson, Gunnsteinn/0000-0002-9897-0384; Kristjansdottir, Berglind/0000-0002-0020-3786; Bjarnason, Agnar/0000-0002-2892-3304; Gottfredsson, Magnus/0000-0003-2465-0422	Icelandic Center for Research, Rannis [100436021]; Landspitali University Hospital Science Fund	Icelandic Center for Research, Rannis; Landspitali University Hospital Science Fund	This work was supported by grants from the Icelandic Center for Research, Rannis [grant number 100436021]; and the Landspitali University Hospital Science Fund. URL: http://rannis.is/english/home/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CDC PROT REALT RTPCR; Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Champunot R, 2010, JPN J INFECT DIS, V63, P251; Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; Chien YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029219; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hedlund J, 2005, SCAND J INFECT DIS, V37, P791, DOI 10.1080/00365540500264050; Jain S, 2012, CLIN INFECT DIS, V54, P1221, DOI 10.1093/cid/cis197; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koon K, 2010, EMERG INFECT DIS, V16, P1976, DOI 10.3201/eid1612.091697; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Mulrennan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012849; MURRAY PR, 1975, MAYO CLIN PROC, V50, P339; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Sala H, 2011, J EMERG MED, V41, P435, DOI 10.1016/j.jemermed.2010.05.093; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Sigmundsdottir G, 2010, EUROSURVEILLANCE, V15, P17; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; The WHO Collaborating Centre for Influenza, 2007, CDC REALT RTPCR RTPC; Welti M, 2003, DIAGN MICR INFEC DIS, V45, P85, DOI 10.1016/S0732-8893(02)00484-4	37	22	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46816	10.1371/journal.pone.0046816	http://dx.doi.org/10.1371/journal.pone.0046816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071646	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700035
J	Zhou, Q; Mao, YQ; Jiang, WD; Chen, YR; Huang, RY; Zhou, XB; Wang, YF; Shi, Z; Wang, ZS; Huang, RP				Zhou, Qi; Mao, Ying-Qing; Jiang, Wei-Dong; Chen, Yun-Ru; Huang, Ren-Yu; Zhou, Xiang-Bing; Wang, Ya-Feng; Shi, Zhi; Wang, Zhong-Sheng; Huang, Ruo-Pan			Development of IGF Signaling Antibody Arrays for the Identification of Hepatocellular Carcinoma Biomarkers	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-2; IMMUNOSORBENT-ASSAY ELISA; GROWTH-FACTOR AXIS; II MESSENGER-RNA; HUMAN HEPATOMA; EXPRESSION; CANCER; TUMORS; RECEPTORS; SYSTEM	Purpose: Our objective was to develop a system to simultaneously and quantitatively measure the expression levels of the insulin-like growth factor (IGF) family proteins in numerous samples and to apply this approach to profile the IGF family proteins levels in cancer and adjacent tissues from patients with hepatocellular carcinoma (HCC). Experimental Design: Antibodies against ten IGF family proteins (IGF-1, IGF-1R, IGF-2, IGF-2R, IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-6, and Insulin) were immobilized on the surface of a glass slide in an array format to create an IGF signaling antibody array. Tissue lysates prepared from patient's liver cancer tissues and adjacent tissues were then applied to the arrays. The proteins captured by antibodies on the arrays were then incubated with a cocktail of biotinylated detection antibodies and visualized with a fluorescence detection system. By comparison with standard protein amount, the exact protein concentrations in the samples can be determined. The expression levels of the ten IGF family proteins in 25 pairs of HCC and adjacent tissues were quantitatively measured using this novel antibody array technology. The differential expression levels between cancer tissues and adjacent tissues were statistically analyzed. Results: A novel IGF signaling antibody array was developed which allows the researcher to simultaneously detect ten proteins involved in IGF signal pathway with high sensitivity and specificity. Using this approach, we found that the levels of IGF-2R and IGFBP-2 in HCC tissues were higher than those in adjacent tissues. Conclusion: Our IGF signaling antibody array which can detect the expression of ten IGF family members with high sensitivity and specificity will undoubtedly prove a powerful tool for drug and biomarker discovery.	[Mao, Ying-Qing; Jiang, Wei-Dong; Chen, Yun-Ru; Huang, Ren-Yu; Shi, Zhi; Wang, Zhong-Sheng; Huang, Ruo-Pan] RayBiotech Inc, Guangzhou, Guangdong, Peoples R China; [Zhou, Qi; Zhou, Xiang-Bing; Wang, Ya-Feng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Mao, Ying-Qing; Jiang, Wei-Dong; Huang, Ruo-Pan] RayBiotech Inc, Norcross, GA USA; [Shi, Zhi; Huang, Ruo-Pan] S China Biochip Res Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Huang, RP (corresponding author), RayBiotech Inc, Guangzhou, Guangdong, Peoples R China.	rhuang@raybiotech.com			project for Guangzhou economic development district [2009L-P180, 2010Q?P450]; Guangzhou leading talent entrepreneurial venture [LCY201111]; Guangdong innovative research and development team [201001s0104659419]	project for Guangzhou economic development district; Guangzhou leading talent entrepreneurial venture; Guangdong innovative research and development team	The authors would like to express our thanks for the support of the leading scientist project for Guangzhou economic development district (2009L-P180), Guangzhou leading talent entrepreneurial venture (LCY201111), Guangdong innovative research and development team (201001s0104659419) and research grants from the Guangzhou economic development district (2010Q?P450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z; Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; CARIANI E, 1988, CANCER RES, V48, P6844; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chaves J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0b013e32834258a1; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; ENGVALL E, 1977, MED BIOL, V55, P193; Gong YW, 2000, MOL CELL BIOCHEM, V207, P101, DOI 10.1023/A:1007010818094; Hoeflich A, 2001, CANCER RES, V61, P8601; Huang RP, 2003, FRONT BIOSCI-LANDMRK, V8, pD559, DOI 10.2741/1017; Huang RP, 2003, COMB CHEM HIGH T SCR, V6, P769; Huang RP, 2001, CLIN CHEM LAB MED, V39, P209, DOI 10.1515/CCLM.2001.032; Huang Ruo-Pan, 2004, Methods Mol Biol, V264, P215; Iakova P, 2011, SEMIN CANCER BIOL, V21, P28, DOI 10.1016/j.semcancer.2010.09.001; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; Lin Y, 2003, PROTEOMICS, V3, P1750, DOI 10.1002/pmic.200300530; MULLER HL, 1994, J CLIN ENDOCR METAB, V79, P428, DOI 10.1210/jc.79.2.428; Ng IO, 1998, J GASTROEN HEPATOL, V13, P152, DOI 10.1111/j.1440-1746.1998.tb00630.x; Osipo C, 2001, EXP CELL RES, V264, P388, DOI 10.1006/excr.2000.5121; Pavelic K, 2002, MOL MED, V8, P771, DOI 10.1007/BF03402082; Ranke MB, 2003, HORM RES, V60, P174, DOI 10.1159/000073229; Reen D J, 1994, Methods Mol Biol, V32, P461; Ricort JM, 2004, GROWTH HORM IGF RES, V14, P277, DOI 10.1016/j.ghir.2004.02.002; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; Ruan WJ, 2010, ACTA DIABETOL, V47, P5, DOI 10.1007/s00592-009-0142-3; Scharf JG, 1998, CARCINOGENESIS, V19, P2121, DOI 10.1093/carcin/19.12.2121; SU TS, 1989, CANCER RES, V49, P1773; Sztefko K, 2009, ADV MED SCI-POLAND, V54, P51, DOI 10.2478/v10039-009-0017-4; Tognon CE, 2012, EXPERT OPIN THER TAR, V16, P33, DOI 10.1517/14728222.2011.638626; Uchida K, 1997, MOL CARCINOGEN, V18, P193, DOI 10.1002/(SICI)1098-2744(199704)18:4<193::AID-MC2>3.3.CO;2-2; Wu J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-30; YANG DY, 1991, CARCINOGENESIS, V12, P1893, DOI 10.1093/carcin/12.10.1893	38	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46851	10.1371/journal.pone.0046851	http://dx.doi.org/10.1371/journal.pone.0046851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071652	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700037
J	Gan, ZH; Zhang, T; Liu, YC; Wu, DC				Gan, Zhenhai; Zhang, Ting; Liu, Yongchun; Wu, Daocheng			Temperature-Triggered Enzyme Immobilization and Release Based on Cross-Linked Gelatin Nanoparticles	PLOS ONE			English	Article							REVERSIBLE IMMOBILIZATION; SENSITIVE HYDROGELS; GLUCOAMYLASE; PH; STABILIZATION; ALGINATE; GEL; ADSORPTION; FIBERS; SILICA	A glucoamylase-immobilized system based on cross-linked gelatin nanoparticles (CLGNs) was prepared by coacervation method. This system exhibited characteristics of temperature-triggered phase transition, which could be used for enzyme immobilization and release. Their morphology and size distribution were examined by transmission electron microscopy and dynamic light scattering particle size analyzer. Their temperature-triggered glucoamylase immobilization and release features were also further investigated under different temperatures. Results showed that the CLGNs were regularly spherical with diameters of 155 +/- 5 nm. The loading efficiencies of glucoamylase immobilized by entrapment and adsorption methods were 59.9% and 24.7%, respectively. The immobilized enzyme was released when the system temperature was above 40 degrees C and performed high activity similar to free enzyme due to the optimum temperature range for glucoamylase. On the other hand, there was no enzyme release that could be found when the system temperature was below 40 degrees C. The efficiency of temperature-triggered release was as high as 99.3% for adsorption method, while the release of enzyme from the entrapment method was not detected. These results indicate that CLGNs are promising matrix for temperature-triggered glucoamylase immobilization and release by adsorption immobilization method. Citation: Gan Z, Zhang T, Liu Y, Wu D (2012) Temperature-Triggered Enzyme Immobilization and Release Based on Cross-Linked Gelatin Nanoparticles. PLoS ONE 7(10): e47154. doi: 10.1371/journal.pone.0047154	[Gan, Zhenhai; Liu, Yongchun; Wu, Daocheng] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Educ Minist, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Zhang, Ting] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Ctr Sci Res, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Wu, DC (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Educ Minist, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China.	wudaocheng@mail.xjtu.edu.cn	Wu, Daocheng/H-5661-2017	Wu, Daocheng/0000-0002-6183-539X	National Basic Research Program 973 of China [2010CB732603]; National Nature Science Foundation of China [20905060, 30970712]; grants of Shaanxi province science and technology and innovation project [2011KTCL03-07]; Open Research Fund of State Key Laboratory of Precision Spectroscopy, East China Normal University	National Basic Research Program 973 of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); grants of Shaanxi province science and technology and innovation project; Open Research Fund of State Key Laboratory of Precision Spectroscopy, East China Normal University	This study was supported in part by National Basic Research Program 973 of China (No. 2010CB732603); the National Nature Science Foundation of China (No. 20905060 and 30970712); and the grants of Shaanxi province science and technology and innovation project (Nos. 2011KTCL03-07). The authors are also thankful for the support in part by the Open Research Fund of State Key Laboratory of Precision Spectroscopy, East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanomi Y, 2011, MOLECULES, V16, P6041, DOI 10.3390/molecules16076041; Bai YX, 2009, APPL MICROBIOL BIOT, V83, P457, DOI 10.1007/s00253-009-1864-4; Bayramoglu G, 2009, PROCESS BIOCHEM, V44, P880, DOI 10.1016/j.procbio.2009.04.011; BEAUCHAMP RO, 1992, CRIT REV TOXICOL, V22, P143, DOI 10.3109/10408449209145322; Gai LL, 2009, APPL BIOCHEM BIOTECH, V158, P747, DOI 10.1007/s12010-008-8373-2; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; Gaur R, 2005, WORLD J MICROB BIOT, V21, P1123, DOI 10.1007/s11274-005-0080-3; Ge J, 2009, BIOCHEM ENG J, V44, P53, DOI 10.1016/j.bej.2009.01.002; Goswami S, 2010, J MACROMOL SCI A, V47, P119, DOI 10.1080/10601320903458556; Jun SH, 2012, CHEM MATER, V24, P924, DOI 10.1021/cm202125q; Kaetsu I, 2000, RADIAT PHYS CHEM, V57, P465, DOI 10.1016/S0969-806X(99)00416-8; Kommareddy S, 2007, NANOMED-NANOTECHNOL, V3, P32, DOI 10.1016/j.nano.2006.11.005; Kovalenko GA, 2008, CARBOHYD RES, V343, P1202, DOI 10.1016/j.carres.2008.02.006; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Krajewska B, 2009, J MOL CATAL B-ENZYM, V59, P22, DOI 10.1016/j.molcatb.2009.01.004; Laveille P, 2010, NEW J CHEM, V34, P2153, DOI 10.1039/c0nj00161a; Mahkam M, 2010, INT J MOL SCI, V11, P1546, DOI 10.3390/ijms11041546; Mao JS, 2006, ADV MATER, V18, P2289, DOI 10.1002/adma.200600040; Milasinovic N, 2010, REACT FUNCT POLYM, V70, P807, DOI 10.1016/j.reactfunctpolym.2010.07.017; Mondal K, 2006, BBA-PROTEINS PROTEOM, V1764, P1080, DOI 10.1016/j.bbapap.2006.04.008; Montiel C, 2007, J MOL CATAL B-ENZYM, V48, P90, DOI 10.1016/j.molcatb.2007.06.012; Naganagouda K, 2006, PROCESS BIOCHEM, V41, P1903, DOI 10.1016/j.procbio.2006.03.040; Pereira-Lachataignerais J, 2006, CHEM PHYS LIPIDS, V140, P88, DOI 10.1016/j.chemphyslip.2006.01.008; Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4; Sakata S, 2007, RADIAT PHYS CHEM, V76, P733, DOI 10.1016/j.radphyschem.2004.12.010; Saleem M, 2005, PROCESS BIOCHEM, V40, P849, DOI 10.1016/j.procbio.2004.02.026; Saraogi GK, 2010, INT J PHARMACEUT, V385, P143, DOI 10.1016/j.ijpharm.2009.10.004; Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008; Shakya AK, 2010, PROG POLYM SCI, V35, P459, DOI 10.1016/j.progpolymsci.2010.01.003; Sheelu G, 2008, J AM OIL CHEM SOC, V85, P739, DOI 10.1007/s11746-008-1261-7; Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082; Singh AN, 2011, J AGR FOOD CHEM, V59, P6256, DOI 10.1021/jf200472x; Solomatin SV, 2003, LANGMUIR, V19, P8069, DOI 10.1021/la030015l; Tanriseven A, 2001, PROCESS BIOCHEM, V36, P1081, DOI 10.1016/S0032-9592(01)00146-7; Tanriseven A, 2008, BIOCHEM ENG J, V39, P430, DOI 10.1016/j.bej.2007.10.011; Tarannum N, 2010, J APPL POLYM SCI, V118, P2821, DOI 10.1002/app.32393; Tardioli PW, 2011, PROCESS BIOCHEM, V46, P409, DOI 10.1016/j.procbio.2010.08.011; Torres-Salas P, 2011, ADV MATER, V23, P5275, DOI 10.1002/adma.201101821; Wang B, 2006, REACT FUNCT POLYM, V66, P509, DOI 10.1016/j.reactfunctpolym.2005.10.003; Wang F, 2007, J MOL CATAL B-ENZYM, V48, P1, DOI 10.1016/j.molcatb.2007.05.003; Wang MF, 2010, BIOCHEM ENG J, V52, P168, DOI 10.1016/j.bej.2010.08.003; Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461; Wu DC, 2008, J PHARM PHARM SCI, V11, P32, DOI 10.18433/J3988J; Yates MZ, 1997, MACROMOLECULES, V30, P5060, DOI 10.1021/ma961694s; Zhang BH, 2012, APPL MICROBIOL BIOT, V93, P61, DOI 10.1007/s00253-011-3672-x	45	26	27	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47154	10.1371/journal.pone.0047154	http://dx.doi.org/10.1371/journal.pone.0047154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071741	gold, Green Published, Green Submitted			2022-12-25	WOS:000312385200086
J	Cardenas, PA; Cooper, PJ; Cox, MJ; Chico, M; Arias, C; Moffatt, MF; Cookson, WO				Cardenas, Paul Andres; Cooper, Philip J.; Cox, Michael J.; Chico, Martha; Arias, Carlos; Moffatt, Miriam F.; Cookson, William Osmond			Upper Airways Microbiota in Antibiotic-Naive Wheezing and Healthy Infants from the Tropics of Rural Ecuador	PLOS ONE			English	Article							ASTHMA; DIVERSITY; MICROORGANISMS; COLONIZATION; PREVALENCE; RESPONSES; SOFTWARE; BACTERIA; INNATE; TOOL	Background: Observations that the airway microbiome is disturbed in asthma may be confounded by the widespread use of antibiotics and inhaled steroids. We have therefore examined the oropharyngeal microbiome in early onset wheezing infants from a rural area of tropical Ecuador where antibiotic usage is minimal and glucocorticoid usage is absent. Materials and Methods: We performed pyrosequencing of amplicons of the polymorphic bacterial 16S rRNA gene from oropharyngeal samples from 24 infants with non-infectious early onset wheezing and 24 healthy controls (average age 10.2 months). We analyzed microbial community structure and differences between cases and controls by QIIME software. Results: We obtained 76,627 high quality sequences classified into 182 operational taxonomic units (OTUs). Firmicutes was the most common and diverse phylum (71.22% of sequences) with Streptococcus being the most common genus (49.72%). Known pathogens were found significantly more often in cases of infantile wheeze compared to controls, exemplified by Haemophilus spp. (OR = 2.12, 95% Confidence Interval (CI) 1.82-2.47; P = 5.46x10(-23)) and Staphylococcus spp. (OR = 124.1, 95%CI 59.0-261.2; P = 1.87x10(-241)). Other OTUs were less common in cases than controls, notably Veillonella spp. (OR = 0.59, 95%CI = 0.56-0.62; P = 8.06x10(-86)). Discussion: The airway microbiota appeared to contain many more Streptococci than found in Western Europe and the USA. Comparisons between healthy and wheezing infants revealed a significant difference in several bacterial phylotypes that were not confounded by antibiotics or use of inhaled steroids. The increased prevalence of pathogens such as Haemophilus and Staphylococcus spp. in cases may contribute to wheezing illnesses in this age group.	[Cardenas, Paul Andres; Cox, Michael J.; Moffatt, Miriam F.; Cookson, William Osmond] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Cardenas, Paul Andres; Cooper, Philip J.; Chico, Martha; Arias, Carlos] Fdn Ecuatoriana Invest Salud FEPIS, Quininde, Esmeraldas Prov, Ecuador; [Cardenas, Paul Andres] Univ San Francisco Quito, Inst Microbiol, Quito, Ecuador; [Cooper, Philip J.] Univ San Francisco Quito, Colegio Ciencias Salud, Quito, Ecuador; [Cooper, Philip J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Imperial College London; Liverpool School of Tropical Medicine; University of Liverpool	Cookson, WO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	w.cookson@imperial.ac.uk	Cookson, William/HHC-1790-2022	Cardenas, Paul/0000-0001-9626-4489; Cox, Michael/0000-0002-4002-1506	Wellcome Trust [088862/Z/09/Z]; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The cohort and collection of samples in Ecuador was supported by the Wellcome Trust (grant number, 088862/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Charlson ES, AM J RESP CRIT CARE; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cooper PJ, 2009, ALLERGY, V64, P5, DOI 10.1111/j.1398-9995.2008.01902.x; CROWE CC, 1973, J INFECT DIS, V128, P527, DOI 10.1093/infdis/128.4.527; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Edgar RC, 2010, BIOINFORMATICS; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Herbst T, 2011, AM J RESP CRIT CARE; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Just J, 2010, J ASTHMA, V47, P412, DOI 10.3109/02770900903584035; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Mallol J, 2010, THORAX, V65, P1004, DOI 10.1136/thx.2009.115188; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mason KL, 2009, CELL MICROBIOL, V11, P1297, DOI 10.1111/j.1462-5822.2009.01347.x; Nembrini C, 2011, THORAX; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2012, BIOINFORMATICS; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Sacchi CT, 2005, J CLIN MICROBIOL, V43, P3734, DOI 10.1128/JCM.43.8.3734-3742.2005; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tano K, 2003, ACTA OTO-LARYNGOL, V123, P724, DOI 10.1080/00016480310000403; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wechsler ME, 2009, MAYO CLIN PROC, V84, P707, DOI 10.1016/S0025-6196(11)60521-1; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	46	70	73	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46803	10.1371/journal.pone.0046803	http://dx.doi.org/10.1371/journal.pone.0046803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071640	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309827300061
J	Grasemann, H; Shehnaz, D; Enomoto, M; Leadley, M; Belik, J; Ratjen, F				Grasemann, Hartmut; Shehnaz, Darakhshanda; Enomoto, Masahiro; Leadley, Michael; Belik, Jaques; Ratjen, Felix			L-Ornithine Derived Polyamines in Cystic Fibrosis Airways	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE; L-ARGININE; HYDROGEN-PEROXIDE; GUINEA-PIG; IN-VITRO; SPERMINE; METABOLISM; ARGINASE; EPITHELIUM	Increased arginase activity contributes to airway nitric oxide ( NO) deficiency in cystic fibrosis (CF). Whether down-stream products of arginase activity contribute to CF lung disease is currently unknown. The objective of this study was to test whether L-ornithine derived polyamines are present in CF airways and contribute to airway pathophysiology. Polyamine concentrations were measured in sputum of patients with CF and in healthy controls, using liquid chromatography-tandem mass spectrometry. The effect of spermine on airway smooth muscle mechanical properties was assessed in bronchial segments of murine airways, using a wire myograph. Sputum polyamine concentrations in stable CF patients were similar to healthy controls for putrescine and spermidine but significantly higher for spermine. Pulmonary exacerbations were associated with an increase in sputum and spermine levels. Treatment for pulmonary exacerbations resulted in decreases in arginase activity, L-ornithine and spermine concentrations in sputum. The changes in sputum spermine with treatment correlated significantly with changes in L-ornithine but not with sputum inflammatory markers. Incubation of mouse bronchi with spermine resulted in an increase in acetylcholine-induced force and significantly reduced nitric oxide-induced bronchial relaxation. The polyamine spermine is increased in CF airways. Spermine contributes to airways obstruction by reducing the NO-mediated smooth muscle relaxation.	[Grasemann, Hartmut; Ratjen, Felix] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada; [Grasemann, Hartmut; Shehnaz, Darakhshanda; Enomoto, Masahiro; Leadley, Michael; Belik, Jaques; Ratjen, Felix] Univ Toronto, Hosp Sick Children, SickKids Res Inst, Program Physiol & Expt Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Grasemann, H (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada.	hartmut.grasemann@sickkids.ca		Ratjen, Felix/0000-0003-4057-6592	Cystic Fibrosis Canada; Lynn and Arnold Irwin Family Foundation; Canadian Foundation for Innovation (CFI)	Cystic Fibrosis Canada; Lynn and Arnold Irwin Family Foundation; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	The study was supported by Cystic Fibrosis Canada and the Lynn and Arnold Irwin Family Foundation (www.cysticfibrosis.ca). Mass spectrometry analyses were performed at the Analytical Facility For Bioactive Molecules (AFBM) of the Centre for the Study of Complex Childhood Diseases (CSCCD) at the Hospital for Sick Children, Toronto, Ontario. The CSCCD was supported by the Canadian Foundation for Innovation (CFI) (www.innovation.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleh S, 2010, J PEDIATR-US, V157, P1006, DOI 10.1016/j.jpeds.2010.06.001; Belik J, 2007, AM J PHYSIOL-LUNG C, V292, pL699, DOI 10.1152/ajplung.00108.2006; Blachier F, 1997, NITRIC OXIDE-BIOL CH, V1, P268, DOI 10.1006/niox.1997.0127; BUEB JL, 1992, BIOCHEM J, V282, P545, DOI 10.1042/bj2820545; Byun JA, 2008, BIOMED CHROMATOGR, V22, P73, DOI 10.1002/bmc.898; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; Chen H, 2007, AM J PHYSIOL-LUNG C, V293, pL883, DOI 10.1152/ajplung.00093.2007; CHIDECKEL EW, 1985, EUR J PHARMACOL, V116, P187, DOI 10.1016/0014-2999(85)90203-1; COHEN LF, 1976, BLOOD, V48, P469; Dut R, 2008, ALLERGY, V63, P1605, DOI 10.1111/j.1398-9995.2008.01766.x; Grasemann H, 2005, AM J RESP CRIT CARE, V172, P1523, DOI 10.1164/rccm.200502-253OC; Grasemann H, 2011, EUROPEAN RESP J S55, V38, p365s; Grasemann H, 2006, RESP RES, V7, P1, DOI 10.1186/1465-9921-7-87; Grasemann H, 2006, AM J RESP CRIT CARE, V174, P208, DOI 10.1164/rccm.200509-1439OC; Grasemann H, 2012, CURR PHARM DESIGN, V18, P726, DOI 10.2174/138161212799315911; Grasemann H, 2011, AM J RESP CRIT CARE, V183, P1363, DOI 10.1164/rccm.201012-1995OC; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hoet PHM, 2000, AM J PHYSIOL-LUNG C, V278, pL417, DOI 10.1152/ajplung.2000.278.3.L417; HU JG, 1994, NEUROSCI LETT, V175, P41, DOI 10.1016/0304-3940(94)91073-1; Kelley TJ, 1998, J CLIN INVEST, V102, P1200, DOI 10.1172/JCI2357; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Maarsingh H, 2008, N-S ARCH PHARMACOL, V378, P171, DOI 10.1007/s00210-008-0286-7; RABE KF, 1995, AM J PHYSIOL-LUNG C, V269, pL332, DOI 10.1152/ajplung.1995.269.3.L332; Rackef K., 2010, OPEN NITRIC OXIDE J, V2, P9, DOI [DOI 10.2174/1875042701002020009, 10.2174/1875042701002020009]; RENNERT OM, 1976, TEX REP BIOL MED, V34, P187; RHODEN KJ, 1989, BRIT J PHARMACOL, V98, P325, DOI 10.1111/j.1476-5381.1989.tb16898.x; RUSSELL DH, 1979, PEDIATR RES, V13, P1137, DOI 10.1203/00006450-197910000-00011; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; SWARD K, 1995, AM J PHYSIOL-CELL PH, V269, pC563, DOI 10.1152/ajpcell.1995.269.3.C563; Tessler R, 2008, PEDIATR RES, V64, P24, DOI 10.1203/PDR.0b013e31817289c2; Wang YL, 2001, BIOCHEM J, V359, P387, DOI 10.1042/0264-6021:3590387; WARD JK, 1993, J CLIN INVEST, V92, P736, DOI 10.1172/JCI116644; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	35	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46618	10.1371/journal.pone.0046618	http://dx.doi.org/10.1371/journal.pone.0046618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071598	gold, Green Submitted, Green Published			2022-12-25	WOS:000309827300040
J	Ray, A; Amato, AA; Bradshaw, EM; Felice, KJ; DiCapua, DB; Goldstein, JM; Lundberg, IE; Nowak, RJ; Ploegh, HL; Spooner, E; Wu, Q; Willis, SN; O'Connor, KC				Ray, Arundhati; Amato, Anthony A.; Bradshaw, Elizabeth M.; Felice, Kevin J.; DiCapua, Daniel B.; Goldstein, Jonathan M.; Lundberg, Ingrid E.; Nowak, Richard J.; Ploegh, Hidde L.; Spooner, Eric; Wu, Qian; Willis, Simon N.; O'Connor, Kevin C.			Autoantibodies Produced at the Site of Tissue Damage Provide Evidence of Humoral Autoimmunity in Inclusion Body Myositis	PLOS ONE			English	Article							INFLAMMATORY MYOPATHIES; MULTIPLE-SCLEROSIS; PLASMA-CELLS; MUSCLE; ANTIBODIES; PATHOGENESIS; CYTOSKELETAL; POLYMYOSITIS; FILAMENTS; SUBSETS	Inclusion body myositis (IBM) belongs to a group of muscle diseases known as the inflammatory myopathies. The presence of antibody-secreting plasma cells in IBM muscle implicates the humoral immune response in this disease. However, whether the humoral immune response actively contributes to IBM pathology has not been established. We sought to investigate whether the humoral immune response in IBM both in the periphery and at the site of tissue damage was directed towards self-antigens. Peripheral autoantibodies present in IBM serum but not control serum recognized self-antigens in both muscle tissue and human-derived cell lines. To study the humoral immune response at the site of tissue damage in IBM patients, we isolated single plasma cells directly from IBM-derived muscle tissue sections and from these cells, reconstructed a series of recombinant immunoglobulins (rIgG). These rIgG, each representing a single muscle-associated plasma cell, were examined for reactivity to self-antigens. Both, flow cytometry and immunoblotting revealed that these rIgG recognized antigens expressed by cell lines and in muscle tissue homogenates. Using a mass spectrometry-based approach, Desmin, a major intermediate filament protein, expressed abundantly in muscle tissue, was identified as the target of one IBM muscle-derived rIgG. Collectively, these data support the view that IBM includes a humoral immune response in both the periphery and at the site of tissue damage that is directed towards self-antigens.	[Ray, Arundhati; Willis, Simon N.; O'Connor, Kevin C.] Yale Univ, Sch Med, Dept Neurol, Human & Translat Immunol Program, New Haven, CT 06510 USA; [Amato, Anthony A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Amato, Anthony A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Bradshaw, Elizabeth M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Felice, Kevin J.] Hosp Special Care, Neuromuscular Program, New Britain, CT USA; [Felice, Kevin J.] Univ Connecticut, Sch Med, Dept Neurol, Farmington, CT USA; [DiCapua, Daniel B.; Goldstein, Jonathan M.; Nowak, Richard J.] Yale Univ, Sch Med, Dept Neurol, Div Neuromuscular Med, New Haven, CT 06510 USA; [Lundberg, Ingrid E.] Karolinska Inst, Rheumatol Unit, Dept Med, Karolinska Univ Hosp Solna, Stockholm, Sweden; [Ploegh, Hidde L.; Spooner, Eric] MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA USA; [Wu, Qian] Univ Connecticut, Ctr Hlth, Dept Pathol & Lab Med, Farmington, CT USA	Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Connecticut; Yale University; Karolinska Institutet; Karolinska University Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Connecticut	O'Connor, KC (corresponding author), Yale Univ, Sch Med, Dept Neurol, Human & Translat Immunol Program, New Haven, CT 06510 USA.	kevin.oconnor@yale.edu		Lundberg, Ingrid/0000-0002-6068-9212	National Institute of Arthritis and Muscoloskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH) [1R03AR061529]; NIH [F32AI065100]; National Health and Medical Research Council of Australia; Swedish Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI065100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061529] Funding Source: NIH RePORTER	National Institute of Arthritis and Muscoloskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by grant 1R03AR061529 to KCO from National Institute of Arthritis and Muscoloskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAMS or NIH. Support was also provided by a gift from Professor Martin Shubik to KCO and to the Department of Neurology at Yale School of Medicine. EMB was supported by NIH under Ruth L. Kirschstein National Research Service Award (F32AI065100). SNW is supported by a National Health and Medical Research Council of Australia, CJ Martin Biomedical Research Fellowship and IEL by a grant from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya K, 2000, BRAIN, V123, P2030, DOI 10.1093/brain/123.10.2030; Askanas V, 2007, CURR OPIN RHEUMATOL, V19, P550, DOI 10.1097/BOR.0b013e3282efdc7c; Bender A, 1998, J NEUROIMMUNOL, V84, P86, DOI 10.1016/S0165-5728(97)00246-4; Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547; Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116; Dalakas MC, 1996, CURR OPIN NEUROL, V9, P235, DOI 10.1097/00019052-199606000-00015; Dalakas MC, 2006, NEUROLOGY, V66, pS33, DOI 10.1212/01.wnl.0000192129.65677.87; Dalakas MC, 1997, ANN NEUROL, V41, P100, DOI 10.1002/ana.410410116; Dimitri D, 2006, BRAIN, V129, P986, DOI 10.1093/brain/awl020; Duskin A, 2010, IMMUNOL REV, V233, P112, DOI 10.1111/j.0105-2896.2009.00856.x; Fyhr IM, 1998, J NEUROIMMUNOL, V91, P129, DOI 10.1016/S0165-5728(98)00163-5; Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20; Greenberg Steven A, 2010, Curr Rheumatol Rep, V12, P221, DOI 10.1007/s11926-010-0102-5; Gunawardena H, 2008, CURR OPIN RHEUMATOL, V20, P675, DOI 10.1097/BOR.0b013e328313bff4; Hohlfeld R, 2007, NEUROLOGY, V69, P1966, DOI 10.1212/01.wnl.0000279589.06059.37; Hohlfeld R, 2011, BRAIN, V134, P3141, DOI 10.1093/brain/awr258; Koffman BM, 1998, MUSCLE NERVE, V21, P115, DOI 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.3.CO;2-G; Krystufkova O, 2009, ANN RHEUM DIS, V68, P836, DOI 10.1136/ard.2008.091405; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Mahler EAM, 2011, RHEUMATOLOGY, V50, P2206, DOI 10.1093/rheumatology/ker088; Menge T, 2002, IMMUNOBIOLOGY, V205, P1, DOI 10.1078/0171-2985-00107; Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0; O'Connor KC, 2007, NAT MED, V13, P211, DOI 10.1038/nm1488; Owens GP, 2009, ANN NEUROL, V65, P639, DOI 10.1002/ana.21641; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Salajegheh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020266; Salajegheh M, 2010, MUSCLE NERVE, V42, P576, DOI 10.1002/mus.21739; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Selva-O'Callaghan A, 2003, RHEUMATOLOGY, V42, P1016, DOI 10.1093/rheumatology/keg253; SENECAL JL, 1988, ARTHRITIS RHEUM, V31, P864, DOI 10.1002/art.1780310707; VARON D, 1990, CLIN IMMUNOL IMMUNOP, V54, P454, DOI 10.1016/0090-1229(90)90058-X; Wang XW, 2000, J IMMUNOL METHODS, V244, P217, DOI 10.1016/S0022-1759(00)00260-X; Willis SN, 2009, J IMMUNOL, V182, P3310, DOI 10.4049/jimmunol.0803424; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46709	10.1371/journal.pone.0046709	http://dx.doi.org/10.1371/journal.pone.0046709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071619	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300053
J	Schneider, K; Breuer, C; Kawamura, A; Jikumaru, Y; Hanada, A; Fujioka, S; Ichikawa, T; Kondou, Y; Matsui, M; Kamiya, Y; Yamaguchi, S; Sugimoto, K				Schneider, Katja; Breuer, Christian; Kawamura, Ayako; Jikumaru, Yusuke; Hanada, Atsushi; Fujioka, Shozo; Ichikawa, Takanari; Kondou, Youichi; Matsui, Minami; Kamiya, Yuji; Yamaguchi, Shinjiro; Sugimoto, Keiko			Arabidopsis PIZZA Has the Capacity to Acylate Brassinosteroids	PLOS ONE			English	Article							FULL-LENGTH CDNA; CELL-SUSPENSION CULTURES; FOX HUNTING SYSTEM; GENE; BIOSYNTHESIS; MUTANT; CYTOCHROME-P450; IDENTIFICATION; BRASSINOLIDE; METABOLISM	Brassinosteroids (BRs) affect a wide range of developmental processes in plants and compromised production or signalling of BRs causes severe growth defects. To identify new regulators of plant organ growth, we searched the Arabidopsis FOX (Full-length cDNA Over-eXpressor gene) collection for mutants with altered organ size and isolated two overexpression lines that display typical BR deficient dwarf phenotypes. The phenotype of these lines, caused by an overexpression of a putative acyltransferase gene PIZZA (PIZ), was partly rescued by supplying exogenous brassinolide (BL) and castasterone (CS), indicating that endogenous BR levels are rate-limiting for the growth of PIZ overexpression lines. Our transcript analysis further showed that PIZ overexpression leads to an elevated expression of genes involved in BR biosynthesis and a reduced expression of BR inactivating hydroxylases, a transcriptional response typical to low BR levels. Taking the advantage of relatively high endogenous BR accumulation in a mild bri1-301 background, we found that overexpression of PIZ results in moderately reduced levels of BL and CS and a strong reduction of typhasterol (TY) and 6-deoxocastasterone (6-deoxoCS), suggesting a role of PIZ in BR metabolism. We tested a set of potential substrates in vitro for heterologously expressed PIZ and confirmed its acyltransferase activity with BL, CS and TY. The PIZ gene is expressed in various tissues but as reported for other genes involved in BR metabolism, the loss-of-function mutants did not display obvious growth phenotypes under standard growth conditions. Together, our data suggest that PIZ can modify BRs by acylation and that these properties might help modulating endogenous BR levels in Arabidopsis.	[Schneider, Katja; Breuer, Christian; Kawamura, Ayako; Jikumaru, Yusuke; Hanada, Atsushi; Ichikawa, Takanari; Kondou, Youichi; Matsui, Minami; Kamiya, Yuji; Yamaguchi, Shinjiro; Sugimoto, Keiko] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Fujioka, Shozo] RIKEN Adv Sci Inst, Wako, Saitama, Japan	RIKEN; RIKEN	Sugimoto, K (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan.	sugimoto@psc.riken.jp	Kamiya, Yuji/F-9420-2010; Breuer, Christian/A-8977-2011; Sugimoto, Keiko/B-3368-2010; Matsui, Minami/A-5235-2016	Kamiya, Yuji/0000-0003-4415-520X; Sugimoto, Keiko/0000-0002-9209-8230; Matsui, Minami/0000-0001-5162-2668; Schneider, Katja/0000-0002-1226-6047	Japan Society for the Promotion of Science [2008511]; Ministry of Education, Culture, Sports and Technology of Japan [22119010]; RIKEN; Grants-in-Aid for Scientific Research [22119010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Japan Society for the Promotion of Science (Grant Number 2008511, http://www.jsps.go.jp/english/index.html); and the Ministry of Education, Culture, Sports and Technology of Japan (Grant Number 22119010, http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Michael Neff for bas1 and sob7 lines, Guang Wu for the bri1-301 line, Tadao Asami for GA<INF>4</INF>, and Suguru Takatsuto for deuterium-labelled internal standards. We are grateful to Kanae Niinuma for her help with the microarray analysis and members of the Sugimoto Lab for discussion. KSch and CB were recipients of the JSPS postdoctoral fellowship and RIKEN postdoctoral fellowship, respectively.	Albinsky D, 2010, MOL PLANT, V3, P125, DOI 10.1093/mp/ssp069; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Anastasiou E, 2007, CURR OPIN PLANT BIOL, V10, P63, DOI 10.1016/j.pbi.2006.11.002; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bajguz A, 2007, PLANT PHYSIOL BIOCH, V45, P95, DOI 10.1016/j.plaphy.2007.01.002; Bancos S, 2002, PLANT PHYSIOL, V130, P504, DOI 10.1104/pp.005439; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Breuer C, 2009, PLANT CELL, V21, P2307, DOI 10.1105/tpc.109.068387; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Friedrichsen DM, 2002, GENETICS, V162, P1445; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Fujita M, 2007, BIOCHEM BIOPH RES CO, V364, P250, DOI 10.1016/j.bbrc.2007.09.124; GASPARINI F, 1979, J BIOL CHEM, V254, P6650; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Gonzalez N., 2012, TRENDS PLANT SCI; Gou JY, 2009, P NATL ACAD SCI USA, V106, P18855, DOI 10.1073/pnas.0905555106; Guo ZX, 2010, PLANT CELL, V22, P1161, DOI 10.1105/tpc.109.069203; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hochberg RB, 1998, ENDOCR REV, V19, P331, DOI 10.1210/er.19.3.331; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; Ingram GC, 2006, CURR OPIN PLANT BIOL, V9, P12, DOI 10.1016/j.pbi.2005.11.007; Kanji SS, 1999, J CLIN ENDOCR METAB, V84, P2481, DOI 10.1210/jc.84.7.2481; Kim GT, 1999, P NATL ACAD SCI USA, V96, P9433, DOI 10.1073/pnas.96.16.9433; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim GT, 1998, GENE DEV, V12, P2381, DOI 10.1101/gad.12.15.2381; Kim TW, 2005, PLANT CELL, V17, P2397, DOI 10.1105/tpc.105.033738; Kolbe A, 1996, PHYTOCHEMISTRY, V41, P163, DOI 10.1016/0031-9422(95)00546-3; KOLBE A, 1995, PHYTOCHEMISTRY, V38, P633, DOI 10.1016/0031-9422(94)00742-C; Komaki S, 2012, PLANT CELL PHYSIOL, V53, P953, DOI 10.1093/pcp/pcs070; Kondou Y, 2011, METHODS MOL BIOL, V729, P183, DOI 10.1007/978-1-61779-065-2_12; Kondou Y, 2009, PLANT J, V57, P883, DOI 10.1111/j.1365-313X.2008.03733.x; Kwon M, 2005, J PLANT BIOL, V48, P1, DOI 10.1007/BF03030559; Li Y, 2002, PLANT PHYSIOL, V128, P854, DOI 10.1104/pp.010658; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Molina I, 2009, PLANT PHYSIOL, V151, P1317, DOI 10.1104/pp.109.144907; Ndamukong I, 2009, PLANT J, V58, P541, DOI 10.1111/j.1365-313X.2009.03798.x; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Nemhauser JL, 2004, J EXP BOT, V55, P265, DOI 10.1093/jxb/erh024; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Roh H, 2012, PLANT PHYSIOL, V159, P696, DOI 10.1104/pp.112.197202; Rouleau M, 1999, J BIOL CHEM, V274, P20925, DOI 10.1074/jbc.274.30.20925; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; SCHMIDT J, 1991, PHYTOCHEMISTRY, V30, P364, DOI 10.1016/0031-9422(91)84159-P; Serra O, 2010, PLANT J, V62, P277, DOI 10.1111/j.1365-313X.2010.04144.x; Shimada Y, 2003, PLANT PHYSIOL, V131, P287, DOI 10.1104/pp.013029; Soeno K, 2000, J PESTIC SCI, V25, P117; St-Pierre B, 1998, PLANT J, V14, P703, DOI 10.1046/j.1365-313x.1998.00174.x; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Takahashi N, 2005, PLANT J, V42, P13, DOI 10.1111/j.1365-313X.2005.02357.x; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Thornton LE, 2010, PLANT MOL BIOL; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; Xu WH, 2008, CELL RES, V18, P472, DOI 10.1038/cr.2008.36; Yoshimitsu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023851; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	71	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46805	10.1371/journal.pone.0046805	http://dx.doi.org/10.1371/journal.pone.0046805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071642	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300062
J	Ginkel, C; Hartmann, D; vom Dorp, K; Zlomuzica, A; Farwanah, H; Eckhardt, M; Sandhoff, R; Degen, J; Rabionet, M; Dere, E; Dormann, P; Sandhoff, K; Willecke, K				Ginkel, Christina; Hartmann, Dieter; vom Dorp, Katharina; Zlomuzica, Armin; Farwanah, Hany; Eckhardt, Matthias; Sandhoff, Roger; Degen, Joachim; Rabionet, Mariona; Dere, Ekrem; Doermann, Peter; Sandhoff, Konrad; Willecke, Klaus			Ablation of Neuronal Ceramide Synthase 1 in Mice Decreases Ganglioside Levels and Expression of Myelin-associated Glycoprotein in Oligodendrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(DIHYDRO)CERAMIDE SYNTHASE; SUBSTRATE-SPECIFICITY; COMPLEX GANGLIOSIDES; METABOLIC-PATHWAYS; MOUSE; SPHINGOLIPIDS; DEFICIENT; DISEASE; MOTOR; ROLES	Ceramide synthase 1 (CerS1) catalyzes the synthesis of C18 ceramide and is mainly expressed in the brain. Custom-made antibodies to a peptide from the C-terminal region of the mouse CerS1 protein yielded specific immunosignals in neurons but no other cell types of wild type brain, but the CerS1 protein was not detected in CerS1-deficient mouse brains. To elucidate the biological function of CerS1-derived sphingolipids in the brain, we generated CerS1-deficient mice by introducing a targeted mutation into the coding region of the cers1 gene. General deficiency of CerS1 in mice caused a foliation defect, progressive shrinkage, and neuronal apoptosis in the cerebellum. Mass spectrometric analyses revealed up to 60% decreased levels of ganglio-sides in cerebellum and forebrain. Expression of myelin-associated glycoprotein was also decreased by about 60% in cerebellum and forebrain, suggesting that interaction and stabilization of oligodendrocytic myelin-associated glycoprotein by neuronal gangliosides is due to the C18 acyl membrane anchor of CerS1-derived precursor ceramides. A behavioral analysis of CerS1-deficient mice yielded functional deficits including impaired exploration of novel objects, locomotion, and motor coordination. Our results reveal an essential function of CerS1-derived ceramide in the regulation of cerebellar development and neurodevelopmentally regulated behavior.	[Ginkel, Christina; Farwanah, Hany; Degen, Joachim; Sandhoff, Konrad; Willecke, Klaus] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Hartmann, Dieter] Univ Bonn, Inst Anat, Div Neuroanat, D-53115 Bonn, Germany; [vom Dorp, Katharina; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53115 Bonn, Germany; [Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Zlomuzica, Armin] Ruhr Univ Bochum, Dept Clin Psychol & Psychotherapy, D-44780 Bochum, Germany; [Sandhoff, Roger; Rabionet, Mariona] German Canc Res Ctr, Lipid Pathobiochem Grp Cellular & Mol Pathol, D-69120 Heidelberg, Germany; [Dere, Ekrem] Univ Paris 06, Unite Format & Rech Sci Vie, F-75005 Paris, France	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Ruhr University Bochum; Helmholtz Association; German Cancer Research Center (DKFZ); UDICE-French Research Universities; Sorbonne Universite	Willecke, K (corresponding author), Univ Bonn, Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	k.willecke@uni-bonn.de	Dere, Ekrem/F-3879-2018; Dere, Ekrem/Y-3872-2019	Dere, Ekrem/0000-0001-7823-7778; 	German Research Foundation through Collaborative Research Center Grant [SFB645, B2, B8, B5];  [DE1149/5-1]	German Research Foundation through Collaborative Research Center Grant; 	This work was supported by the German Research Foundation through Collaborative Research Center Grant SFB645, project B2 (to K. W.), project B8 (to P. D.), and project B5 (to M. E.), and through Grant DE1149/5-1 (to E. D.).	Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Bevins RA, 2005, NEUROSCI BIOBEHAV R, V29, P707, DOI 10.1016/j.neubiorev.2005.03.013; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; Blatter K, 2006, EXP BRAIN RES, V168, P541, DOI 10.1007/s00221-005-0114-y; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dere E, 2003, EUR J NEUROSCI, V18, P629, DOI 10.1046/j.1460-9568.2003.02784.x; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kim YS, 2010, CEREBELLUM, V9, P310, DOI 10.1007/s12311-010-0163-z; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Maxeiner S, 2005, J NEUROSCI, V25, P566, DOI 10.1523/JNEUROSCI.3232-04.2005; Mencarelli C., 2012, CELL MOL LI IN PRESS; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; MERRILL AH, 1983, BIOCHIM BIOPHYS ACTA, V754, P284, DOI 10.1016/0005-2760(83)90144-3; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; MOMOI T, 1976, BIOCHIM BIOPHYS ACTA, V441, P488; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; NAGY A, 2003, MANIPULATING MOUSE E, P476; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Russell D. W, 2001, MOL CLONING LAB MANU, P34; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Sandhoff R, 2010, FEBS LETT, V584, P1907, DOI 10.1016/j.febslet.2009.12.032; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26; Sun J, 2004, GLYCOBIOLOGY, V14, P851, DOI 10.1093/glycob/cwh107; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang BH, 2007, DNA SEQUENCE, V18, P92, DOI 10.1080/10425170601060947; Watanabe S, 2010, GLIA, V58, P1197, DOI 10.1002/glia.20999; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zheng-Fischhofer Q, 2007, EUR J CELL BIOL, V86, P683, DOI 10.1016/j.ejcb.2007.01.005; Zlomuzica A, 2008, EUR J NEUROSCI, V27, P1461, DOI 10.1111/j.1460-9568.2008.06115.x; Zlomuzica A, 2012, DEV NEUROSCI-BASEL, V34, P277, DOI 10.1159/000339305	59	87	90	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41888	41902		10.1074/jbc.M112.413500	http://dx.doi.org/10.1074/jbc.M112.413500			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074226	Green Published, hybrid			2022-12-25	WOS:000312103000029
J	Luo, H; Guo, P; Zhou, QQ				Luo, Han; Guo, Ping; Zhou, Qiquan			Role of TLR4/NF-kappa B in Damage to Intestinal Mucosa Barrier Function and Bacterial Translocation in Rats Exposed to Hypoxia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; TUMOR-NECROSIS-FACTOR; TIGHT JUNCTIONS; GUT FLORA; KAPPA-B; COLITIS; DISEASE; INJURY; INFLAMMATION; ENVIRONMENT	The role of Toll-like receptor 4 (TLR4)/nuclear factor-kappa-B (NF-kappa B) in intestinal mucosal barrier damage and bacterial translocation under hypoxic exposure is unclear. Here, we investigated their role using an acute hypobaric hypoxia model. Adult Sprague-Dawley rats were divided into control (C), hypoxia (H), hypoxia+NF-kappa B inhibitor pyrrolidinedithiocarbamic acid (PDTC) (100 mg. kg) (HP), hypoxia+0.5 mg/kg lipopolysaccharide (HPL), and hypoxia+PDTC+LPS (HPL) group. Except control group, other four groups were placed in a hypobaric chamber set at 7000 m. Samples were collected at 72 h after pressure reduction. Damage in ultrastructure of the intestinal tract was examined by transmission electron microscopy and bacterial translocation was detected by cultivation. Kinetic turbidimetric assay was used to measure the serum LPS. ELISA was performed to detect TNF-alpha and IL-6 serum concentrations. Fluorescent quantitative RT-PCR was used to measure TLR4 mRNA levels was measured using quantitative RT-PCR and protein of NF-kappa B p65 was measured by western blotting. Different degrees of intestinal mucosa damage were observed in groups H and HL. The damage was significantly alleviated after blockage of the TLR4/NF-kappa B signaling pathway. PDTC-treatment also reversed hyoxia- and LPS-induced bacterial translocation rate and increased serum levels of LPS, TNF-alpha, and IL-6. TLR4 mRNA levels and NF-kappa B p65 expression were consistent with the serum factor results. This study suggested that TLR4 and NF-kappa B expression increased in rat intestinal tissues after acute hypoxia exposure. PDTC-treatment reversed TLR4 and NF-kappa B upregulation and alleviated damage to the intestinal tract and bacterial translocation. Thus, the TLR4/NF-kappa B signaling pathway may be critical to the mechanism underlying hypoxia-induced damage to intestinal barrier function and bacterial translocation.	[Luo, Han; Guo, Ping; Zhou, Qiquan] Third Mil Med Univ, Dept High Altitude Dis, Coll High Altitude Mil Med, Chongqing, Peoples R China; [Luo, Han; Guo, Ping; Zhou, Qiquan] Minist Educ, Key Lab High Altitude Med, Chongqing, Peoples R China; [Luo, Han; Guo, Ping; Zhou, Qiquan] Key Lab High Altitude Med PLA, Chongqing, Peoples R China	Army Medical University	Zhou, QQ (corresponding author), Third Mil Med Univ, Dept High Altitude Dis, Coll High Altitude Mil Med, Chongqing, Peoples R China.	zhouqq9918@yahoo.com.cn			National Science and Technology Ministry [2009BAI85B03]; Chinese People's Liberation Army Eleventh Five-year Plan for Scientific and Technological Research [2008G093]	National Science and Technology Ministry; Chinese People's Liberation Army Eleventh Five-year Plan for Scientific and Technological Research	This work was funded by the National Science and Technology Ministry (Grant # 2009BAI85B03) and Chinese People's Liberation Army Eleventh Five-year Plan for Scientific and Technological Research (Grant # 2008G093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2006, WORLD J GASTROENTERO, V12, P1493, DOI 10.3748/wjg.v12.i10.1493; Bellot Pablo, 2008, Gastroenterol Hepatol, V31, P508; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Clarke TB, 2011, CELL HOST MICROBE, V9, P404, DOI 10.1016/j.chom.2011.04.012; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cui W., 2007, WORLD CHINESE J DIGE, V15, P1788; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; Farrell CP, 2012, J EPITHEL BIOL PHARM, V5, P13; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Gao JS, 2009, WORD J GASTROENTEROL, V17, P1540; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Igawa S, 2011, EXP DERMATOL, V20, P53, DOI 10.1111/j.1600-0625.2010.01170.x; Kelly Caleb J, 2012, J Epithel Biol Pharmacol, V5, P67, DOI 10.2174/1875044301205010067; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Noreen M, 2012, INFLAMM RES, V61, P177, DOI 10.1007/s00011-011-0427-1; Ohkawara T, 2005, CLIN EXP IMMUNOL, V141, P412, DOI 10.1111/j.1365-2249.2005.02877.x; Peterson CY, 2010, SURG INFECT, V11, P137, DOI 10.1089/sur.2009.053; Recavarren-Arce S, 2005, HISTOPATHOLOGY, V46, P374, DOI 10.1111/j.1365-2559.2005.02102.x; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shimizu K, 2006, J TRAUMA, V60, P126, DOI 10.1097/01.ta.0000197374.99755.fe; Soares AL, 2010, SHOCK, V34, P306, DOI 10.1097/SHK.0b013e3181cdc585; Spehlmann ME, 2009, CURR OPIN GASTROEN, V25, P92, DOI 10.1097/MOG.0b013e328324f857; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; VanDeventer SJH, 1997, GUT, V40, P443, DOI 10.1136/gut.40.4.443; Walser EM, 2006, CARDIOVASC INTER RAD, V29, P102, DOI 10.1007/s00270-004-0220-4; Wang ZT, 2004, WORLD J GASTROENTERO, V10, P1619, DOI 10.3748/wjg.v10.i11.1619; Wei LP, 2010, MICROVASC RES, V80, P158, DOI 10.1016/j.mvr.2010.01.003; [吴文明 WU Wen-ming], 2010, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V35, P592; Wullaert A, 2010, INT J MED MICROBIOL, V300, P49, DOI 10.1016/j.ijmm.2009.08.007; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Zhang FangXin, 2010, Zhongguo Weishengtaxixue Zazhi / Chinese Journal of Microecology, V22, P1; Zhou B., 2009, CHIN J GASTROENTEROL, V18, P751; Zhou QQ, 2011, WORLD J GASTROENTERO, V17, P1584, DOI 10.3748/wjg.v17.i12.1584	36	49	53	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46291	10.1371/journal.pone.0046291	http://dx.doi.org/10.1371/journal.pone.0046291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082119	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900014
J	Shan, L; Chen, YA; Davis, L; Han, G; Zhu, WW; Molina, AD; Arango, H; LaPolla, JP; Hoffman, MS; Sellers, T; Kirby, T; Nicosia, SV; Sutphen, R				Shan, Lian; Chen, Y. Ann; Davis, Lorelei; Han, Gang; Zhu, Weiwei; Molina, Ashley D.; Arango, Hector; LaPolla, James P.; Hoffman, Mitchell S.; Sellers, Thomas; Kirby, Tyler; Nicosia, Santo V.; Sutphen, Rebecca			Measurement of Phospholipids May Improve Diagnostic Accuracy in Ovarian Cancer	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LYSOPHOSPHATIDIC ACID; GYNECOLOGIC ONCOLOGIST; POTENTIAL BIOMARKER; GENE-EXPRESSION; PELVIC MASS; MANAGEMENT; CA125; CLASSIFICATION; SELECTION	Background: More than two-thirds of women who undergo surgery for suspected ovarian neoplasm do not have cancer. Our previous results suggest phospholipids as potential biomarkers of ovarian cancer. In this study, we measured the serum levels of multiple phospholipids among women undergoing surgery for suspected ovarian cancer to identify biomarkers that better predict whether an ovarian mass is malignant. Methodology/Principal Findings: We obtained serum samples preoperatively from women with suspected ovarian cancer enrolled through a prospective, population-based rapid ascertainment system. Samples were analyzed from all women in whom a diagnosis of epithelial ovarian cancer (EOC) was confirmed and from benign disease cases randomly selected from the remaining (non-EOC) samples. We measured biologically relevant phospholipids using liquid chromatography/electrospray ionization mass spectrometry. We applied a powerful statistical and machine learning approach, Hybrid huberized support vector machine (HH-SVM) to prioritize phospholipids to enter the biomarker models, and used cross-validation to obtain conservative estimates of classification error rates. Results: The HH-SVM model using the measurements of specific combinations of phospholipids supplements clinical CA125 measurement and improves diagnostic accuracy. Specifically, the measurement of phospholipids improved sensitivity (identification of cases with preoperative CA125 levels below 35) among two types of cases in which CA125 performance is historically poor - early stage cases and those of mucinous histology. Measurement of phospholipids improved the identification of early stage cases from 65% (based on CA125) to 82%, and mucinous cases from 44% to 88%. Conclusions/Significance: Levels of specific serum phospholipids differ between women with ovarian cancer and those with benign conditions. If validated by independent studies in the future, these biomarkers may serve as an adjunct at the time of clinical presentation, to distinguish between women with ovarian cancer and those with benign conditions with shared symptoms and features.	[Molina, Ashley D.; Sutphen, Rebecca] Univ S Florida, Epidemiol Ctr, Morsani Coll Med, Tampa, FL 33620 USA; [Shan, Lian; Davis, Lorelei] Frantz Biomarkers LLC, Mentor, OH USA; [Chen, Y. Ann; Han, Gang; Zhu, Weiwei; Sellers, Thomas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Arango, Hector] W Coast Gynecol Oncol, Clearwater, FL USA; [LaPolla, James P.] Womens Canc Associates, Gynecol Oncol, St Petersburg, FL USA; [Nicosia, Santo V.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Sutphen, R (corresponding author), Univ S Florida, Epidemiol Ctr, Morsani Coll Med, Tampa, FL 33620 USA.	Rebecca.Sutphen@epi.usf.edu		Han, Gang/0000-0002-5781-5169; Chen, yian/0000-0003-1468-3490	American Cancer Society [CRTG-00-196]; National Cancer Institute, Department of Defense [R01-CA106414, DAMD17-98-1-8659]; Celma Mastry Ovarian Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA106414, P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute, Department of Defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Department of Defense); Celma Mastry Ovarian Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the American Cancer Society (CRTG-00-196), the National Cancer Institute (R01-CA106414), Department of Defense DAMD17-98-1-8659 and the Celma Mastry Ovarian Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carney ME, 2002, GYNECOL ONCOL, V84, P36, DOI 10.1006/gyno.2001.6460; Carter Jori S, 2011, Female Patient (Parsippany), V36, P30; Christine M, 2012, EVOLUTION TRANSLATIO; CURTIN JP, 1994, GYNECOL ONCOL, V55, pS42, DOI 10.1006/gyno.1994.1340; Dorigo O, 2011, CANCER PREV RES, V4, P1356, DOI 10.1158/1940-6207.CAPR-11-0378; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Goode EL, 2010, NAT GENET; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heinzelmann-Schwarz VA, 2006, BRIT J CANCER, V94, P904, DOI 10.1038/sj.bjc.6603003; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; KILLACKEY MA, 1988, OBSTET GYNECOL, V71, P319; KOONINGS PP, 1989, OBSTET GYNECOL, V74, P921; Marchini S, 2008, CLIN CANCER RES, V14, P7850, DOI 10.1158/1078-0432.CCR-08-0523; MAYER AR, 1992, GYNECOL ONCOL, V47, P223, DOI 10.1016/0090-8258(92)90110-5; Meleh M, 2007, J CHROMATOGR B, V858, P287, DOI 10.1016/j.jchromb.2007.08.008; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Morrow CP, 1993, TUMORS OCARY CLASSIF; Murdoch WJ, 2004, EXP BIOL MED, V229, P546, DOI 10.1177/153537020422900613; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Pozlep B, 2007, EUR J GYNAECOL ONCOL, V28, P394; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sedlakova I, 2008, EUR J GYNAECOL ONCOL, V29, P511; Sedlakova I, 2006, Ceska Gynekol, V71, P312; Shan L, COMMUNICATION; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Skates SJ, 2011, CANCER PREV RES, V4, P1401, DOI 10.1158/1940-6207.CAPR-10-0402; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang L, 2008, BIOINFORMATICS, V24, P412, DOI 10.1093/bioinformatics/btm579; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yoon HR, 2003, J CHROMATOGR B, V788, P85, DOI 10.1016/S1570-0232(02)01031-0	39	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46846	10.1371/journal.pone.0046846	http://dx.doi.org/10.1371/journal.pone.0046846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082132	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900027
J	Yuan, HW; Wang, CX; Zhang, N; Bai, Y; Shi, YZ; Zhou, Y; Wang, YL; Zhang, T; Zhou, J; Yu, X; Sun, XY; Liu, ZR; Zhao, XQ; Wang, YJ				Yuan, Huai Wu; Wang, Chun Xue; Zhang, Ning; Bai, Ying; Shi, Yu Zhi; Zhou, Yong; Wang, Yi Long; Zhang, Tong; Zhou, Juan; Yu, Xin; Sun, Xin Yu; Liu, Zhao Rui; Zhao, Xing Quan; Wang, Yong Jun			Poststroke Depression and Risk of Recurrent Stroke at 1 Year in a Chinese Cohort Study	PLOS ONE			English	Article							MORTALITY; SYMPTOMS; ASSOCIATION; SCALE	Background: Studies show that poststroke depression (PSD) increases mortality risk at 1 year. However, whether PSD increases the risk of recurrent stroke at 1 year remains unclear. This study was to investigate whether PSD at 2 weeks following a stroke could increase risk of recurrent stroke at 1 year. Methods and Results: This was a multi-centered prospective cohort study. A total of 2306 patients with acute stroke were enrolled in our study. PSD was diagnosed according to the criteria set by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). The outcomes of recurrent stroke were followed up via face-to-face or phone interview. A total of 1713 patients had complete follow-up data, with 481 (28.1%) cases of PSD and 158 (9.2%) cases of cumulative recurrent stroke at 1 year. Multivariate logistic regression analysis showed a 49% increase of OR of recurrent stroke at 1 year in patients with PSD, compared to patients without PSD following a stroke (OR = 1.49, 95% CI: 1.03-2.15). There was no significant correlation between anti-depressant drugs and the risk of recurrent stroke at 1 year following a stroke (OR = 1.96, 95%: CI 0.95-4.04). Conclusions: Based on the DSM-IV diagnostic criteria, nearly 3 out of 10 hospitalized stroke patients in China were diagnosed with PSD at 2 weeks following a stroke. PSD is associated with a higher risk of recurrent stroke at 1 year. Our study did not find benefit of anti-depressant drugs in reducing such risk.	[Yuan, Huai Wu; Wang, Chun Xue; Zhang, Ning; Bai, Ying; Shi, Yu Zhi; Zhou, Yong; Wang, Yi Long; Zhang, Tong; Zhao, Xing Quan; Wang, Yong Jun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhou, Juan] Capital Med Univ, Beijing Daxing Dist Hosp, Dept Neurol, Beijing, Peoples R China; [Yu, Xin; Sun, Xin Yu; Liu, Zhao Rui] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China	Capital Medical University; Capital Medical University; Peking University	Yuan, HW (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	Yhw0202@hotmail.com; chunxue.sen@gmail.com	sun, xinyu/GXG-5674-2022; Zhang, Tong/HGC-1090-2022	Shi, YuZhi/0000-0002-4018-6984	Beijing Science and Technology Committee [7102050]; National Science Foundation [81071115]; Young Scientists Fund of the Beijing Health Bureau [2009-009]; National 11th Five-year Scientific and Technological Brainstorm Project [2006BA101A11]; Pfizer Pharmaceutical Company	Beijing Science and Technology Committee; National Science Foundation(National Science Foundation (NSF)); Young Scientists Fund of the Beijing Health Bureau; National 11th Five-year Scientific and Technological Brainstorm Project; Pfizer Pharmaceutical Company(Pfizer)	This study was funded jointly by the Beijing Science and Technology Committee (grant no. 7102050, www.bjkw.gov.cn), the National Science Foundation (grant no. 81071115, www.nsfc.gov.cn), the Young Scientists Fund of the Beijing Health Bureau (grant No. 2009-009, www.bjhb.gov.cn), and the National 11th Five-year Scientific and Technological Brainstorm Project (grant No. 2006BA101A11, www.most.gov.cn). This study was also supported by Pfizer Pharmaceutical Company (www.pfizer.com). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; Chen Z., 2008, 3 NATL SURVEY CAUSE, V1, P14; Elkind MSV, 2009, AM J MED, V122, P7, DOI 10.1016/j.amjmed.2009.02.005; Ellekjaer H, 1997, STROKE, V28, P2180, DOI 10.1161/01.STR.28.11.2180; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; House A, 2001, STROKE, V32, P696, DOI 10.1161/01.STR.32.3.696; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KUNITZ SC, 1984, STROKE, V15, P740, DOI 10.1161/01.STR.15.4.740; LIPSEY JR, 1984, LANCET, V1, P297; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Meng X, 2011, STROKE, V42, P3619, DOI 10.1161/STROKEAHA.111.624148; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Peters R, 2010, AGE AGEING, V39, P439, DOI 10.1093/ageing/afq042; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Ventetuolo CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030480; Wassertheil Smoller S, 2004, ARCH INTERN MED, V164, P289; Whooley MA, 1998, ARCH INTERN MED, V158, P2129, DOI 10.1001/archinte.158.19.2129; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711	23	49	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46906	10.1371/journal.pone.0046906	http://dx.doi.org/10.1371/journal.pone.0046906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082134	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900029
J	Tessadori, F; van Weerd, JH; Burkhard, SB; Verkerk, AO; de Pater, E; Boukens, BJ; Vink, A; Christoffels, VM; Bakkers, J				Tessadori, Federico; van Weerd, Jan Hendrik; Burkhard, Silja B.; Verkerk, Arie O.; de Pater, Emma; Boukens, Bastiaan J.; Vink, Aryan; Christoffels, Vincent M.; Bakkers, Jeroen			Identification and Functional Characterization of Cardiac Pacemaker Cells in Zebrafish	PLOS ONE			English	Article							DEVELOPING HUMAN HEART; SINOATRIAL NODE; CONDUCTION SYSTEM; MOLECULAR ANALYSIS; MESSENGER-RNA; VENOUS POLE; DIFFERENTIATION; TISSUES; MYOCARDIUM; EXPRESSION	In the mammalian heart a conduction system of nodes and conducting cells generates and transduces the electrical signals evoking myocardial contractions. Specialized pacemaker cells initiating and controlling cardiac contraction rhythmicity are localized in an anatomically identifiable structure of myocardial origin, the sinus node. We previously showed that in mammalian embryos sinus node cells originate from cardiac progenitors expressing the transcription factors T-box transcription factor 3 (Tbx3) and Islet-1 (Isl1). Although cardiac development and function are strikingly conserved amongst animal classes, in lower vertebrates neither structural nor molecular distinguishable components of a conduction system have been identified, questioning its evolutionary origin. Here we show that zebrafish embryos lacking the LIM/homeodomain-containing transcription factor Isl1 display heart rate defects related to pacemaker dysfunction. Moreover, 3D reconstructions of gene expression patterns in the embryonic and adult zebrafish heart led us to uncover a previously unidentified, Isl1-positive and Tbx2b-positive region in the myocardium at the junction of the sinus venosus and atrium. Through their long interconnecting cellular protrusions the identified Isl1-positive cells form a ring-shaped structure. In vivo labeling of the Isl1-positive cells by transgenic technology allowed their isolation and electrophysiological characterization, revealing their unique pacemaker activity. In conclusion we demonstrate that Isl1-expressing cells, organized as a ring-shaped structure around the venous pole, hold the pacemaker function in the adult zebrafish heart. We have thereby identified an evolutionary conserved, structural and molecular distinguishable component of the cardiac conduction system in a lower vertebrate.	[van Weerd, Jan Hendrik; Verkerk, Arie O.; Boukens, Bastiaan J.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Tessadori, Federico; Burkhard, Silja B.; de Pater, Emma; Bakkers, Jeroen] Univ Med Ctr Utrecht, Hubrecht Inst KNAW, Utrecht, Netherlands; [Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bakkers, Jeroen] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Christoffels, VM (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	V.M.Christoffels@amc.uva.nl; j.bakkers@hubrecht.eu	Bakkers, Jeroen/H-5551-2011; Vink, Aryan/E-3585-2010	Bakkers, Jeroen/0000-0002-9418-0422; Tessadori, Federico/0000-0001-9975-0546; de Pater, Emma/0000-0002-7195-6769; van Weerd, Jan Hendrik/0000-0001-7955-8477; Verkerk, Arie/0000-0003-2140-834X; Boukens, Bastiaan J/0000-0001-6449-145X	Royal Dutch Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research (NWO/ALW) [864.08.009]; European Commission [HEALTH-2007-B-223463]; Rembrandt Institute; NICHD	Royal Dutch Academy of Arts and Sciences (KNAW); Netherlands Organization for Scientific Research (NWO/ALW)(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Rembrandt Institute; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Work in J. Bakkers' laboratory was supported by the Royal Dutch Academy of Arts and Sciences (KNAW) and the Netherlands Organization for Scientific Research (NWO/ALW) grant 864.08.009. Work in V. Christoffels' laboratory was supported by the European Commission under the FP7 Integrated Project CardioGeNet (HEALTH-2007-B-223463) and by the Rembrandt Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank K. Kawakami for providing the galFF plasmid and the Tg(UAS:GFP) and Tg(UAS:RFP) fish. The Islet-1 homeobox monoclonal antibody 39.4D5 developed by Jessell, T.M./Brenner-Morton, S. was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ammirabile G, 2012, CARDIOVASC RES, V93, P291, DOI 10.1093/cvr/cvr314; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Bussmann J, 2011, DEVELOPMENT, V138, P4327, DOI 10.1242/dev.068080; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Dupays L, 2005, J MOL CELL CARDIOL, V38, P787, DOI 10.1016/j.yjmcc.2005.02.021; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Flack M, 1910, J PHYSIOL-LONDON, V41, P64; Frank DU, 2012, P NATL ACAD SCI USA, V109, pE154, DOI 10.1073/pnas.1115165109; Glukhov AV, 2010, AM J PHYSIOL-HEART C, V299, pH482, DOI 10.1152/ajpheart.00756.2009; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Keith A, 1907, J ANAT PHYSIOL, V41, P172; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Puskaric S, 2010, HUM MOL GENET, V19, P4625, DOI 10.1093/hmg/ddq393; Sanchez-Quintana D, 2005, HEART, V91, P189, DOI 10.1136/hrt.2003.031542; Shi WM, 1999, CIRC RES, V85, pE1; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2010, CIRCULATION, V122, P798, DOI 10.1161/CIRCULATIONAHA.110.953844; Solc David, 2007, Exp Clin Cardiol, V12, P113; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Verkerk AO, 2009, HEART RHYTHM, V6, P1485, DOI 10.1016/j.hrthm.2009.07.024; VIRAGH S, 1980, DEV BIOL, V80, P28, DOI 10.1016/0012-1606(80)90496-0; Weinberger F, 2012, CIRC RES; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026	46	123	123	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47644	10.1371/journal.pone.0047644	http://dx.doi.org/10.1371/journal.pone.0047644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077655	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800061
J	Coats, RO; Wann, JP				Coats, Rachel O.; Wann, John P.			Reaching a Better Understanding of the Control of Bimanual Movements in Older Adults	PLOS ONE			English	Article							VISUAL FEEDBACK-CONTROL; 2 HANDS; COORDINATION	The ability to interact skilfully with the environment is essential for independent living and therefore a critical factor for the aging population. Here we investigate the differences between young and older adults in a bimanual reaching task where the goal is to bring two objects together to the same location with a synchronous placement. Older (mean age 74) and young (mean age 20) adults were asked to pick up two spatially disparate objects, one in each hand, and bring them together to place them in one of three trays laid out in front of them from left to right. The results showed that the older adults were no more detrimentally affected than the young by asymmetric bimanual movements compared to symmetric ones, and both groups completed their movements in the same time. Nevertheless, compared to the young, the older adult group produced reaches characterised by higher peak velocities (although this effect was marginal), shorter hover times, and where the movement distance varied for each hand the scaling of the kinematic profile across the two limbs diverged from that found with younger participants. They then spent longer than the young in the final adjustment phase and during this phase they made more adjustments than the young, and as a result were more synchronous in terms of the final placement of the objects. It seems that the older adults produced reach movements that were designed to reach the vicinity of the tray quite rapidly, after which time they made discreet adjustments to their initial trajectories in order to exercise the precision necessary to place the objects in the tray. These findings are consistent with the idea that older adults have problems using online control (as they wait until they can fixate both objects before making adjustments).	[Coats, Rachel O.] Univ Leeds, Ctr Sport & Exercise Sci, Leeds LS2 9JT, W Yorkshire, England; [Wann, John P.] Royal Holloway Univ London, Dept Psychol, London, England	University of Leeds; University of London; Royal Holloway University London	Coats, RO (corresponding author), Univ Leeds, Ctr Sport & Exercise Sci, Leeds LS2 9JT, W Yorkshire, England.	r.o.a.coats@leeds.ac.uk	Coats, Rachel/AAH-6980-2019	Coats, Rachel/0000-0003-4415-408X	Economic and Social Research Council (ESRC)	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors would like the thank the Economic and Social Research Council (ESRC) http://www.esrc.ac.uk/for funding the first author's PhD for which this data was collected. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert AS, 2010, NEUROPSYCHOLOGIA, V48, P1165, DOI 10.1016/j.neuropsychologia.2009.11.013; Bingham GP, 2008, EXP BRAIN RES, V184, P283, DOI 10.1007/s00221-007-1107-9; Bruyn JL, 2009, Q J EXP PSYCHOL, V62, P1328, DOI 10.1080/17470210802483891; Coats RO, 2011, EXP BRAIN RES, V214, P139, DOI 10.1007/s00221-011-2813-x; Fling BW, 2012, CEREB CORTEX, V22, P2643, DOI 10.1093/cercor/bhr349; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Jackson G, 1999, DANCE MAG, V73, P90; KELSO JAS, 1979, J EXP PSYCHOL HUMAN, V5, P229, DOI 10.1037/0096-1523.5.2.229; MARTENIUK RG, 1984, Q J EXP PSYCHOL-A, V36, P335, DOI 10.1080/14640748408402163; Mason AH, 2009, HUM MOVEMENT SCI, V28, P48, DOI 10.1016/j.humov.2008.09.002; Miller KA, 2012, Q J EXP PSYCHOL; Riek S, 2003, EXP BRAIN RES, V153, P59, DOI 10.1007/s00221-003-1581-7; SEIDLER RD, 1995, QUEST, V47, P386, DOI 10.1080/00336297.1995.10484165; Seidler-Dobrin RD, 1998, EXP BRAIN RES, V119, P467, DOI 10.1007/s002210050362; Srinivasan D, 2010, EXP BRAIN RES, V203, P391, DOI 10.1007/s00221-010-2241-3; Stelmach G.E., 1988, J GERONTOL, V43, P18	18	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47222	10.1371/journal.pone.0047222	http://dx.doi.org/10.1371/journal.pone.0047222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077572	Green Published, gold			2022-12-25	WOS:000309995100077
J	Gong, YL; Wang, ZG; Liang, ZH; Duan, HX; Ouyang, LC; Yu, Q; Xu, Z; Shen, GX; Weng, XF; Wu, XW				Gong, Yeli; Wang, Zhigang; Liang, Zhihui; Duan, Hongxia; Ouyang, Lichen; Yu, Qian; Xu, Zhe; Shen, Guanxin; Weng, Xiufang; Wu, Xiongwen			Soluble MOG35-55/I-A(b) Dimers Ameliorate Experimental Autoimmune Encephalomyelitis by Reducing Encephalitogenic T Cells	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; PEPTIDE COMPLEXES; TCR; INDUCTION; ANTIGEN; RECOGNITION; ACTIVATION; TOLERANCE; THERAPY; BINDING	The MOG35-55 peptide-induced experimental autoimmune encephalomyelitis (EAE) model in C57BL/6 mice is a useful animal model to explore therapeutic approaches to T cell-mediated autoimmune diseases because the dominant T-cell epitope(s) have been defined. It is rational that antigen-specific immunosuppression can be induced by using MHC-peptide complexes as specific TCR ligand(s) that interact with autoreactive T cells in the absence of co-stimulation. In this study, a soluble divalent MOG35-55/I-A(b) fusion protein (MOG35-55/I-A(b) dimer) was constructed to specifically target the autoreactive CD4(+) T cells in the EAE mouse. Intraperitoneal administration of the MOG35-55/I-A(b) dimer significantly delayed and ameliorated EAE symptoms by reducing EAE-related inflammation in the mouse CNS and reducing encephalitogenic Th1 and Th17 cells in the peripheral lymphoid organs. We observed that dimer intervention at a concentration of 1.2 nM suppressed MOG35-55 peptide-specific 2D2 transgenic T cells (2D2 T cells) proliferation by over 90% after in vitro activation with MOG35-55 peptide. The mechanisms involved in this antigen-specific dimer-mediated suppression were found to be downregulated TCR-CD3 expression as well as upregulated expression of membrane-bound TGF-beta (mTGF-beta) and IL-10 suppressive cytokines by the autoreactive CD4(+) T cells. Collectively, our data demonstrates that soluble divalent MHC class II molecules can abrogate pathogenic T cells in EAE. Furthermore, our data suggests that this strategy may provide an efficient and clinically useful option to treat autoimmune diseases.	[Gong, Yeli; Wang, Zhigang; Liang, Zhihui; Duan, Hongxia; Ouyang, Lichen; Yu, Qian; Xu, Zhe; Shen, Guanxin; Weng, Xiufang; Wu, Xiongwen] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Weng, XF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China.	wengxiufang@hotmail.com; xiongwenwu@hotmail.com	Duan, Hongxia/GSE-5955-2022	Duan, Hongxia/0000-0003-3995-1228	National Natural Science Foundation of China [30801017, 30972697]; Chinese Department of Science and Technology [2007CB512900, 2008AA02Z113]; International Science and Technology Cooperation Program of China [2011DFA31030]; Deutsche Forschungsgemeinschaft [SFB/Transregio TRR60]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Department of Science and Technology; International Science and Technology Cooperation Program of China; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This publication was made possible by grants from the National Natural Science Foundation of China (No. 30801017, No. 30972697), the "973" and the "863" project of the Chinese Department of Science and Technology (2007CB512900, 2008AA02Z113), and the International Science and Technology Cooperation Program of China (2011DFA31030) and Deutsche Forschungsgemeinschaft (SFB/Transregio TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABASTADO JP, 1995, J EXP MED, V182, P439, DOI 10.1084/jem.182.2.439; Appel H, 2000, J BIOL CHEM, V275, P312, DOI 10.1074/jbc.275.1.312; Appleman LJ, 2003, IMMUNOL REV, V192, P161, DOI 10.1034/j.1600-065X.2003.00009.x; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; BARBER LD, 1993, ANNU REV CELL BIOL, V9, P163; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Burrows GG, 2001, J IMMUNOL, V167, P4386, DOI 10.4049/jimmunol.167.8.4386; Carey B, 2005, CLIN IMMUNOL, V116, P65, DOI 10.1016/j.clim.2005.02.013; Casares S, 2001, Int Rev Immunol, V20, P547, DOI 10.3109/08830180109045578; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Huan JY, 2004, J IMMUNOL, V172, P4556, DOI 10.4049/jimmunol.172.7.4556; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; MATSUMOTO Y, 1994, IMMUNOLOGY, V81, P1; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Offner H, 2011, J NEUROIMMUNOL, V231, P7, DOI 10.1016/j.jneuroim.2010.09.013; Preda I, 2005, EUR J IMMUNOL, V35, P2762, DOI 10.1002/eji.200526158; Rickert U, 2006, TRANSPLANTATION, V81, P1337, DOI 10.1097/01.tp.0000205770.07196.e6; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Shevach EM, 2004, ARTHRITIS RHEUM, V50, P2721, DOI 10.1002/art.20500; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sinha S, 2007, J NEUROSCI, V27, P12531, DOI 10.1523/JNEUROSCI.3599-07.2007; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Subramanian S, 2009, STROKE, V40, P2539, DOI 10.1161/STROKEAHA.108.543991; Wang CH, 2003, J IMMUNOL, V171, P1934, DOI 10.4049/jimmunol.171.4.1934; Wasserman HA, 2008, J IMMUNOL, V180, P7259, DOI 10.4049/jimmunol.180.11.7259; WEINSHENKER BG, 1991, NEUROLOGY, V41, P1047, DOI 10.1212/WNL.41.7.1047; Weng XF, 2007, TRANSPLANTATION, V84, P1298, DOI 10.1097/01.tp.0000288231.97880.bd; Wong WF, 2011, J BIOL CHEM, V286, P11110, DOI 10.1074/jbc.M110.166694; Zhang MH, 2009, TRANSPLANTATION, V87, P8, DOI 10.1097/TP.0b013e31818b6141	39	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47435	10.1371/journal.pone.0047435	http://dx.doi.org/10.1371/journal.pone.0047435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077616	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100112
J	Lee, JH; Hong, CS; Lee, S; Yang, JE; Park, YI; Lee, D; Hyeon, T; Jung, S; Paik, SR				Lee, Jung-Ho; Hong, Chul-Suk; Lee, Soonkoo; Yang, Jee-Eun; Park, Yong Il; Lee, Daekyun; Hyeon, Taeghwan; Jung, Seunho; Paik, Seung R.			Radiating Amyloid Fibril Formation on the Surface of Lipid Membranes through Unit-Assembly of Oligomeric Species of alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; ALZHEIMERS-DISEASE; PROTEIN AGGREGATION; FIBRILLIZATION; PATHOGENESIS; MECHANISM; LESIONS	Background: Lewy body in the substantia nigra is a cardinal pathological feature of Parkinson's disease. Despite enormous efforts, the cause-and-effect relationship between Lewy body formation and the disorder is yet to be explicitly unveiled. Methodology/Principal Findings: Here, we showed that radiating amyloid fibrils (RAFs) were instantly developed on the surface of synthetic lipid membranes from the beta-sheet free oligomeric species of alpha-synuclein through a unit-assembly process. The burgeoning RAFs were successfully matured by feeding them with additional oligomers, which led to concomitant dramatic shrinkage and disintegration of the membranes by pulling off lipid molecules to the extending fibrils. Mitochondria and lysosomes were demonstrated to be disrupted by the oligomeric alpha-synuclein via membrane-dependent fibril formation. Conclusion: The physical structure formation of amyloid fibrils, therefore, could be considered as detrimental to the cells by affecting membrane integrity of the intracellular organelles, which might be a molecular cause for the neuronal degeneration observed in Parkinson's disease.	[Lee, Jung-Ho; Hong, Chul-Suk; Lee, Soonkoo; Yang, Jee-Eun; Park, Yong Il; Lee, Daekyun; Hyeon, Taeghwan; Paik, Seung R.] Seoul Natl Univ, Coll Engn, Inst Chem Proc, Sch Chem & Biol Engn, Seoul, South Korea; [Jung, Seunho] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Konkuk University	Paik, SR (corresponding author), Seoul Natl Univ, Coll Engn, Inst Chem Proc, Sch Chem & Biol Engn, Seoul, South Korea.	srpaik@snu.ac.kr	Jung, Seunho/D-4555-2011; Park, Yong Il/AAI-1187-2019	Park, Yong Il/0000-0003-3167-4908	National Research Foundation of Korea (NRF); Korea government [Ministry of Education, Science, and Technology; MEST] [2012-0002064, 2012-013582]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government [Ministry of Education, Science, and Technology; MEST](Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government [Ministry of Education, Science, and Technology; MEST] (2012-0002064, 2012-013582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhak G, 2009, BMB REP, V42, P541, DOI 10.5483/BMBRep.2009.42.9.541; Bhak G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004177; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Lee D, 2011, ANGEW CHEM INT EDIT, V50, P1332, DOI 10.1002/anie.201004301; Lee JH, 2008, BIOPHYS J, V95, pL16, DOI 10.1529/biophysj.108.135186; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McNaught KSP, 2006, NEUROBIOL AGING, V27, P530, DOI 10.1016/j.neurobiolaging.2005.08.012; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; ROY S, 1969, J PATHOL, V99, P39, DOI 10.1002/path.1710990106; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576	26	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47580	10.1371/journal.pone.0047580	http://dx.doi.org/10.1371/journal.pone.0047580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077644	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100139
J	McDonald, AT; Bird, J; Kirkland, JI; Dodson, P				McDonald, Andrew T.; Bird, John; Kirkland, James I.; Dodson, Peter			Osteology of the Basal Hadrosauroid Eolambia caroljonesa (Dinosauria: Ornithopoda) from the Cedar Mountain Formation of Utah	PLOS ONE			English	Article							CRETACEOUS YIXIAN FORMATION; ORNITHISCHIA ORNITHOPODA; JINZHOUSAURUS-YANGI; IGUANODONTIA; PHYLOGENY	Background: Eolambia caroljonesa is known from copious remains from the lower Cenomanian Mussentuchit Member of the Cedar Mountain Formation in eastern Utah; however, the taxon has been only briefly described. Thus, we present herein a complete osteological description of Eolambia. Methodology/Principal Findings: The description of Eolambia presented here is based upon the holotype partial skeleton (CEUM 9758), paratype partial skull (CEUM 5212), and abundant disarticulated elements from two bonebeds that contain juvenile individuals. These remains allow the skeletal anatomy of Eolambia to be documented almost fully and a revised diagnosis to be proposed. Conclusions/Significance: The description provided here facilitates comparisons between Eolambia and other iguanodontians and allows Eolambia to be coded for additional characters in phylogenetic analyses. The close affinity between Eolambia and Probactrosaurus gobiensis from the Early Cretaceous of China supports previous hypotheses of faunal interchange between Asia and North America in the early Late Cretaceous.	[McDonald, Andrew T.; Dodson, Peter] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Bird, John] Coll Eastern Utah Prehistor Museum, Price, UT USA; [Kirkland, James I.] Utah Geol Survey, Salt Lake City, UT USA; [Dodson, Peter] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Utah System of Higher Education; Utah State University; Utah State University College of Eastern Utah; University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Jurassic Foundation; Evolving Earth Foundation; University of Pennsylvania Paleobiology Summer Stipend; Utah Friends of Paleontology	Jurassic Foundation; Evolving Earth Foundation; University of Pennsylvania Paleobiology Summer Stipend; Utah Friends of Paleontology	ATM's research was funded by grants from the Jurassic Foundation (http://jurassicfoundation.org/), Evolving Earth Foundation (http://www.evolvingearth.org/), University of Pennsylvania Paleobiology Summer Stipend (http://www.sas.upenn.edu/earth/), and Utah Friends of Paleontology (http://www.utahpaleo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez-Velasco AA, 2012, CAN J EARTH SCI, V49, P379, DOI 10.1139/E11-062; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; BRILL K, 2006, HORNS BEAKS CERATOPS, P49; CARPENTER K, 1995, J VERTEBR PALEONTOL, V15, P275, DOI 10.1080/02724634.1995.10011230; Carpenter K, 1999, UTAH GEOL SURV MISC, P243; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; CIFELLI RL, 1999, UTAH GEOLOGICAL SURV, V991, P219; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; DiCroce Tony, 2001, P183; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Forster C.A., 1990, Journal of Vertebrate Paleontology, V10, P273; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gilmore C. W., 1909, P US NATIONAL MUSEUM, V36, P197, DOI DOI 10.5479/SI.00963801.36-1666.197; Gilpen D., 2006, HORNS BEAKS CERATOPS, P79; Godefroit P, 2005, CR PALEVOL, V4, P697, DOI 10.1016/j.crpv.2005.07.004; Godefroit Pascal, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V68, P3; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Head JJ, 2001, J VERTEBR PALEONTOL, V21, P392, DOI 10.1671/0272-4634(2001)021[0392:AROTPP]2.0.CO;2; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P283; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Langston WJ., 1960, FTELDIANA GEOL MEM, V3, P319; Lu Junchang, 1997, P27; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2010, ZOOTAXA, P1; McDonald AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036745; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Paul GS, 2008, CRETACEOUS RES, V29, P192, DOI 10.1016/j.cretres.2007.04.009; Prieto-Marquez A, 2011, PALAEONTOLOGY, V54, P773, DOI 10.1111/j.1475-4983.2011.01053.x; Prieto-Marquez A, 2010, AM MUS NOVIT, P1, DOI 10.1206/3694.2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P503, DOI 10.1111/j.1096-3642.2010.00642.x; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1998, NEUES JB GEOLOGIE PA, V210, P41, DOI DOI 10.1127/NJGPA/210/1998/41; Sereno P. C, 2005, STEM ARCHOSAURIA VER; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Shibata M, 2011, ACTA GEOL SIN-ENGL, V85, P969, DOI 10.1111/j.1755-6724.2011.00230.x; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Taquet R, 1976, CHAPITRE, P57; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Weishampel D.B., 1989, Journal of Vertebrate Paleontology, V9, P56; WEISHAMPEL DB, 1993, PALAEONTOLOGY, V36, P361; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978; Xu Xing, 2000, Vertebrata Palasiatica, V38, P176; You HL, 2009, CAN J EARTH SCI, V46, P949, DOI 10.1139/E09-067; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148	69	47	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45712	10.1371/journal.pone.0045712	http://dx.doi.org/10.1371/journal.pone.0045712			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077495	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100019
J	Cayres-Vallinoto, IMV; Vallinoto, ACR; Azevedo, VN; Machado, LFA; Ishak, MDG; Ishak, R				Cayres-Vallinoto, Izaura M. V.; Vallinoto, Antonio C. R.; Azevedo, Vania N.; Almeida Machado, Luis Fernando; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo			Human JCV Infections as a Bio-Anthropological Marker of the Formation of Brazilian Amazonian Populations	PLOS ONE			English	Article							HUMAN POLYOMAVIRUS JC; VIRUS-DNA; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; NATIVE-AMERICANS; ASIAN GENOTYPES; URINE SAMPLES; CELL-LINE; BK VIRUS; PREVALENCE	JC polyomavirus (JCV) is a member of the Polyomaviridae family. It presents a tropism to kidney cells, and the infection occurs in a variety of human population groups of different ethnic background. The present study investigated the prevalence of JCV infection among human populations from the Brazilian Amazon region, and describes the molecular and phylogenetic features of the virus. Urine samples from two urban groups of Belem (healthy subjects), one Brazilian Afro-descendant "quilombo" from the Rio Trombetas region, and native Indians from the Wai-Wai, Urubu-Kaapor, Tembe, Assurini, Arara do Laranjal, Aukre, Parakana, Surui and Munduruku villages were investigated for the presence of the virus by amplifying VP1 (230 bp) and IG (610 bp) regions using a polymerase chain reaction. Nucleotide sequences (440 nucleotides, nt) from 48 samples were submitted to phylogenetic analysis. The results confirmed the occurrence of types A (subtype EU), B (subtypes Af-2, African and MY, Asiatic) and C (subtype Af-1) among healthy subjects; type B, subtypes Af-2 and MY, among the Afro-Brazilians; and type B, subtype MY, within the Surui Indians. An unexpected result was the detection of another polyomavirus, the BKV, among Afro-descendants. The present study shows, for the first time, the occurrence of JC and BK polyomaviruses infecting humans from the Brazilian Amazon region. The results show a large genetic variability of strains circulating in the region, infecting a large group of individuals. The presence of European, Asiatic and African subtypes associated to the ethnic origin of the population samples investigated herein, highlights the idea that JCV is a fairly good marker for studying the early migration of human populations, reflecting their early and late history. Furthermore, the identification of the specific mutations associated to the virus subtypes, suggests that these mutations have occurred after the entrance of the virus in the Amazon region of Brazil.	[Cayres-Vallinoto, Izaura M. V.; Vallinoto, Antonio C. R.; Azevedo, Vania N.; Almeida Machado, Luis Fernando; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo] Fed Univ Para, Virol Lab, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	Ishak, R (corresponding author), Fed Univ Para, Virol Lab, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	rishak@ufpa.br	Vallinoto, Antonio Carlos/B-4139-2014; Vallinoto, Antonio Carlos/AAL-9501-2020; Machado, Luiz Fernando Almeida/I-2246-2019	Vallinoto, Antonio Carlos/0000-0003-1135-6507; Vallinoto, Antonio Carlos/0000-0003-1135-6507; Machado, Luiz Fernando Almeida/0000-0002-4571-4715; Cayres Vallinoto, Izaura Maria V./0000-0003-1408-8384	Brazilian National Council for Scientific and Technological Development (CNPq)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present study was fully supported by a grant from the Brazilian National Council for Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini HT, 1997, P NATL ACAD SCI USA, V94, P14542, DOI 10.1073/pnas.94.26.14542; Agostini HT, 2001, J GEN VIROL, V82, P1221, DOI 10.1099/0022-1317-82-5-1221; Agostini HT, 1996, J CLIN MICROBIOL, V34, P159, DOI 10.1128/JCM.34.1.159-164.1996; Azzi A, 1999, J CLIN VIROL, V14, P79, DOI 10.1016/S1386-6532(99)00055-4; Behzad-Behbahani A, 2004, J CLIN VIROL, V29, P224, DOI 10.1016/S1386-6532(03)00155-0; Carvalho BM, 2005, THESIS U FEDERAL PAR; Chima SC, 1998, MEM I OSWALDO CRUZ, V93, P615, DOI 10.1590/S0074-02761998000500010; DOSSANTOS SEB, 1995, REV BRAS GENET, V18, P311; Engels EA, 2005, INT J CANCER, V117, P1013, DOI 10.1002/ijc.21277; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Gee GV, 2003, VIROLOGY, V314, P101, DOI 10.1016/S0042-6822(03)00389-1; Gu ZY, 2003, J MED VIROL, V70, P600, DOI 10.1002/jmv.10436; Hale AD, 2002, J VIROL METHODS, V104, P93, DOI 10.1016/S0166-0934(02)00036-8; Hatwell JN, 2000, J GEN VIROL, V81, P1191, DOI 10.1099/0022-1317-81-5-1191; Henmi C, 2005, BIOCHEM BIOPH RES CO, V327, P242, DOI 10.1016/j.bbrc.2004.11.158; Ikegaya H, 2005, AM J PHYS ANTHROPOL, V128, P185, DOI 10.1002/ajpa.20189; Ikegaya H, 2004, FORENSIC SCI INT, V139, P169, DOI 10.1016/j.forsciint.2003.10.019; Jeong BH, 2004, J MED VIROL, V72, P281, DOI 10.1002/jmv.10568; Kitamura T, 1997, J CLIN MICROBIOL, V35, P1255, DOI 10.1128/JCM.35.5.1255-1257.1997; Knowles WA, 2003, J VIROL METHODS, V109, P47, DOI 10.1016/S0166-0934(03)00043-0; KUNITAKE T, 1995, J CLIN MICROBIOL, V33, P1448, DOI 10.1128/JCM.33.6.1448-1451.1995; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; McNees AL, 2005, J CLIN VIROL, V34, P52, DOI 10.1016/j.jcv.2004.12.018; Miranda JJ, 2003, AM J PHYS ANTHROPOL, V120, P125, DOI 10.1002/ajpa.10155; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; PADGETT BL, 1973, J INFECT DIS, V127, P467, DOI 10.1093/infdis/127.4.467; Page RD, 2001, TREEVIEW 1 4 SOFTWAR; Pires EP, 2011, TRANSPL INFECT DIS, V13, P633, DOI 10.1111/j.1399-3062.2011.00614.x; RODRIGUES JD, 1999, THESIS U FEDERAL PAR; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Salles V., 1998, NEGRO SOB REGIME ESC; Stoner GL, 2000, MICROBES INFECT, V2, P1905, DOI 10.1016/S1286-4579(00)01339-3; Sugimoto C, 2002, J MOL EVOL, V55, P322, DOI 10.1007/s00239-001-2329-2; Sundsfjord A, 1999, J INFECT DIS, V180, P1, DOI 10.1086/314830; Suzuki M, 2002, J VIROL, V76, P10074, DOI 10.1128/JVI.76.19.10074-10078.2002; Takasaka T, 2006, AM J PHYS ANTHROPOL, V129, P465, DOI 10.1002/ajpa.20208; TOMINAGA T, 1992, VIROLOGY, V186, P736; Vallinoto ACR, 2002, HUM BIOL, V74, P633, DOI 10.1353/hub.2002.0059; Vallinoto IMVC, 2003, GENET MOL BIOL, V26, P235, DOI 10.1590/S1415-47572003000300003; Whiley DM, 2001, J CLIN MICROBIOL, V39, P4357, DOI 10.1128/JCM.39.12.4357-4361.2001; Whiley DM, 2004, J MED VIROL, V72, P467, DOI 10.1002/jmv.20005; Yogo Y, 2004, REV MED VIROL, V14, P179, DOI 10.1002/rmv.428; Zambrano A, 2002, PROSTATE, V53, P263, DOI 10.1002/pros.10157; Zheng HY, 2003, J MOL EVOL, V56, P18, DOI 10.1007/s00239-002-2376-3	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46523	10.1371/journal.pone.0046523	http://dx.doi.org/10.1371/journal.pone.0046523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071582	Green Submitted, gold, Green Published			2022-12-25	WOS:000309809500015
J	Chang, YJ; Hsieh, BT				Chang, Yuan-Jen; Hsieh, Bor-Tsung			Effect of Composition Interactions on the Dose Response of an N-Isopropylacrylamide Gel Dosimeter	PLOS ONE			English	Article							OPTICAL-CT APPARATUS; ACID-BASED GEL; COMPUTED-TOMOGRAPHY; POLYMER GELS; FT-RAMAN; DISTRIBUTIONS; SENSITIVITY; STABILITY; SCANNER; NMR	In this study, a two-level full factorial design was used to identify the effects of the interactions between compositions in an N-isopropylacrylamide (NIPAM) gel dosimeter involving the following variables: (A) gelatin, (B) NIPAM, (C) the crosslinker N, N'-methylene-bis-acrylamide (Bis), and (D) the antioxidant tetrakis (hydroxymethyl) phosphonium chloride (THPC). The dose range was from 0 Gy to 5 Gy. Optical computed tomography was used to scan the polymer gel dosimeter. Each component was set to two levels for all four variables, including (A) 4% and 6%, (B) 4% and 6%, (C) 2% and 4%, as well as (D) 5 and 15 mM. Response surface methodology and a central composite design were adopted for the quantitative investigation of the respective interaction effects on the dose response curve of the gel. The results showed that the contributions of the interaction effects, i.e., AB (6.22%), AC (8.38%), AD (7.74%), BC (9.44%), ABC (18.24%), BCD (12.66%), and ABCD (13.4%), were greater than those of the four main effects, accounting for over 76.08% of the total variability. These results also indicated that the NIPAM gel recipe with the highest sensitivity was at 40%C (mass fraction of Bis).	[Chang, Yuan-Jen] Cent Taiwan Univ Sci & Technol, Dept Management Informat Syst, Taichung, Taiwan; [Chang, Yuan-Jen] Cent Taiwan Univ Sci & Technol, Inst Biomed Engn & Mat Sci, Taichung, Taiwan; [Hsieh, Bor-Tsung] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan	Central Taiwan University Science & Technology; Central Taiwan University Science & Technology; Central Taiwan University Science & Technology	Chang, YJ (corresponding author), Cent Taiwan Univ Sci & Technol, Dept Management Informat Syst, Taichung, Taiwan.	ronchang@ctust.edu.tw			National Science Council of Taiwan [NSC 99-2632-B-166-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This research was funded by the National Science Council of Taiwan (NSC 99-2632-B-166-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock C, 2010, PHYS MED BIOL, V55, pR1, DOI 10.1088/0031-9155/55/5/R01; Brindha S, 2004, PHYS MED BIOL, V49, pN353, DOI 10.1088/0031-9155/49/20/N01; Chang YJ, 2011, NUCL INSTRUM METH A, V652, P783, DOI 10.1016/j.nima.2010.09.097; Chen DC, 2012, J MED BIOL IN PRESS; Conklin J, 2008, J PHYS C SER, V56, P211; De Deene Y, 2007, PHYS MED BIOL, V52, P2719, DOI 10.1088/0031-9155/52/10/006; De Deene Y, 2006, PHYS MED BIOL, V51, P653, DOI 10.1088/0031-9155/51/3/012; De Deene Y, 2002, PHYS MED BIOL, V47, P2459, DOI 10.1088/0031-9155/47/14/307; De Deene Y, 2002, PHYS MED BIOL, V47, P3441, DOI 10.1088/0031-9155/47/19/301; De Deene Y, 2000, PHYS MED BIOL, V45, P859, DOI 10.1088/0031-9155/45/4/304; Fong PM, 2001, PHYS MED BIOL, V46, P3105, DOI 10.1088/0031-9155/46/12/303; Gore JC, 1996, PHYS MED BIOL, V41, P2695, DOI 10.1088/0031-9155/41/12/009; Guo PY, 2006, MED PHYS, V33, P3962, DOI 10.1118/1.2349686; Hayashi S, 2010, RADIAT PHYS CHEM, V79, P803, DOI 10.1016/j.radphyschem.2010.01.014; Jirasek A, 2006, PHYS MED BIOL, V51, P1891, DOI 10.1088/0031-9155/51/7/018; Jirasek AI, 2001, PHYS MED BIOL, V46, P1949, DOI 10.1088/0031-9155/46/7/315; Koeva VI, 2008, MACROMOL SYMP, V261, P157, DOI 10.1002/masy.200850121; Krstajic N, 2007, PHYS MED BIOL, V52, P3693, DOI 10.1088/0031-9155/52/13/003; Krstajic N, 2007, PHYS MED BIOL, V52, pN257, DOI 10.1088/0031-9155/52/11/N01; Krstajic N, 2006, PHYS MED BIOL, V51, P2055, DOI 10.1088/0031-9155/51/8/007; Lepage M, 2001, J APPL POLYM SCI, V79, P1572, DOI 10.1002/1097-4628(20010228)79:9<1572::AID-APP50>3.0.CO;2-B; Massillon-JL G, 2010, APPL RADIAT ISOTOPES, V68, P144, DOI 10.1016/j.apradiso.2009.08.016; Montgomery DC, 2005, DESIGN ANAL EXPT, p[203, 405]; Oldham M, 2001, MED PHYS, V28, P1436, DOI 10.1118/1.1380430; Olding T, 2011, PHYS MED BIOL, V55, P2819; Olding T, 2010, PHYS MED BIOL, V55, P2819, DOI 10.1088/0031-9155/55/10/003; Pak F, 2012, 54 ANN M AAPM; Senden RJ, 2006, PHYS MED BIOL, V51, P3301, DOI 10.1088/0031-9155/51/14/001; Van Doorn T, 2005, PHYS ENG SCI MED, V28, P76; Wuu C. S., 2010, J PHYS C SER, V250, P1; Wuu CS, 2006, MED PHYS, V33, P1412, DOI 10.1118/1.2188820; Wuu CS, 2003, MED PHYS, V30, P132, DOI 10.1118/1.1533749; Xu Y, 2004, MED PHYS, V31, P3024, DOI 10.1118/1.1803674; Xu Y, 2003, MED PHYS, V30, P2257, DOI 10.1118/1.1593837; Xu Y, 2010, MED PHYS, V37, P861, DOI 10.1118/1.3298017	35	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e44905	10.1371/journal.pone.0044905	http://dx.doi.org/10.1371/journal.pone.0044905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077487	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500005
J	Sun, MY; Hua, W; Liu, J; Huang, SM; Wang, XF; Liu, GH; Wang, HZ				Sun, Meiyu; Hua, Wei; Liu, Jing; Huang, Shunmou; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong			Design of New Genome- and Gene-Sourced Primers and Identification of QTL for Seed Oil Content in a Specially High-Oil Brassica napus Cultivar	PLOS ONE			English	Article							SEQUENCE REPEATS SSRS; ATP-CITRATE LYASE; LINKAGE MAP; OILSEED RAPE; ARABIDOPSIS-THALIANA; L.; CONSTRUCTION; MICROSATELLITES; SEGREGATION; CANDIDATES	Rapeseed (Brassica napus L.) is one of most important oilseed crops in the world. There are now various rapeseed cultivars in nature that differ in their seed oil content because they vary in oil-content alleles and there are high-oil alleles among the high-oil rapeseed cultivars. For these experiments, we generated doubled haploid (DH) lines derived from the cross between the specially high-oil cultivar zy036 whose seed oil content is approximately 50% and the specially low-oil cultivar 51070 whose seed oil content is approximately 36%. First, to address the deficiency in polymorphic markers, we designed 5944 pairs of newly developed genome-sourced primers and 443 pairs of newly developed primers related to oil-content genes to complement the 2244 pairs of publicly available primers. Second, we constructed a new DH genetic linkage map using 527 molecular markers, consisting of 181 publicly available markers, 298 newly developed genome-sourced markers and 48 newly developed markers related to oil-content genes. The map contained 19 linkage groups, covering a total length of 2,265.54 cM with an average distance between markers of 4.30 cM. Third, we identified quantitative trait loci (QTL) for seed oil content using field data collected at three sites over 3 years, and found a total of 12 QTL. Of the 12 QTL associated with seed oil content identified, 9 were high-oil QTL which derived from the specially high-oil cultivar zy036. Two high-oil QTL on chromosomes A2 and C9 co-localized in two out of three trials. By QTL mapping for seed oil content, we found four candidate genes for seed oil content related to four gene markers: GSNP39, GSSR161, GIFLP106 and GIFLP046. This information will be useful for cloning functional genes correlated with seed oil content in the future.	[Sun, Meiyu; Hua, Wei; Liu, Jing; Huang, Shunmou; Wang, Xinfa; Liu, Guihua; Wang, Hanzhong] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wang, HZ (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China.	wanghz@oilcrops.cn			National Key Basic Research Program of China [2011CB109300]; National Transgenic Research Projects of China [2009ZX08009-018B]	National Key Basic Research Program of China(National Basic Research Program of China); National Transgenic Research Projects of China	This study was supported by the National Key Basic Research Program of China (2011CB109300) and the National Transgenic Research Projects of China (2009ZX08009-018B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; Chen XW, 2011, THEOR APPL GENET, V122, P1375, DOI 10.1007/s00122-011-1538-3; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cheung WY, 1997, THEOR APPL GENET, V94, P569, DOI 10.1007/s001220050453; Choi SR, 2007, THEOR APPL GENET, V115, P777, DOI 10.1007/s00122-007-0608-z; CHURCHILL GA, 1994, GENETICS, V138, P963; Coupe SA, 2006, J EXP BOT, V57, P329, DOI 10.1093/jxb/erj033; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Doerge RW, 1996, GENETICS, V142, P285; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; ECKE W, 1995, THEOR APPL GENET, V91, P972, DOI 10.1007/BF00223908; Fatland BL, 2005, PLANT CELL, V17, P182, DOI 10.1105/tpc.104.026211; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; GRODZICKER T, 1974, J VIROL, V13, P1237, DOI 10.1128/JVI.13.6.1237-1244.1974; Hu ZY, 2009, PLANT CELL REP, V28, P541, DOI 10.1007/s00299-008-0654-2; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; Kloosterman B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-158; KONISHI T, 1990, JPN J GENET, V65, P411, DOI 10.1266/jjg.65.411; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; KRESOVICH S, 1995, THEOR APPL GENET, V91, P206, DOI 10.1007/BF00220879; Lagercrantz U, 1998, GENETICS, V150, P1217; Li Chao, 2011, Acta Agronomica Sinica, V37, P249; Li RJ, 2006, PLANTA, V224, P952, DOI 10.1007/s00425-006-0266-4; Lidder P, 2005, PLANT PHYSIOL, V138, P2374, DOI 10.1104/pp.105.060368; Lin Y, 2006, PLANTA, V225, P153, DOI 10.1007/s00425-006-0337-6; Liu HJ, 2009, ARCH BIOCHEM BIOPHYS, V489, P34, DOI 10.1016/j.abb.2009.07.014; Lombard V, 2001, THEOR APPL GENET, V103, P491, DOI 10.1007/s001220100560; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Lowe AJ, 2002, MOL ECOL NOTES, V2, P7, DOI 10.1046/j.1471-8286.2002.00126.x; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Nesi N, 2008, CR BIOL, V331, P763, DOI 10.1016/j.crvi.2008.07.018; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkin IAP, 1995, GENOME, V38, P1122, DOI 10.1139/g95-149; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Si P, 2003, AUST J AGR RES, V54, P397, DOI 10.1071/AR01203; Slabaugh MB, 2003, PLANT BIOTECHNOL J, V1, P167, DOI 10.1046/j.1467-7652.2003.00016.x; Smooker AM, 2011, THEOR APPL GENET, V122, P1075, DOI 10.1007/s00122-010-1512-5; SzewcMcFadden AK, 1996, THEOR APPL GENET, V93, P534, DOI 10.1007/BF00417944; Tong J., 2009, ACAD AGR SCI; Uzunova MI, 1999, PLANT BREEDING, V118, P323, DOI 10.1046/j.1439-0523.1999.00371.x; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Wang H, 1999, P 10 INT RAP C CANB, P264; [王汉中 Wang Hanzhong], 2005, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V27, P74; Wang HanZhong, 2004, Chinese Journal of Oil Crop Sciences, V26, P1; Wang S., 2001, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Weselake RJ, 2009, BIOTECHNOL ADV, V27, P866, DOI 10.1016/j.biotechadv.2009.07.001; Westermeier P, 2009, THEOR APPL GENET, V119, P1301, DOI 10.1007/s00122-009-1135-x; Yan XY, 2009, EUPHYTICA, V170, P355, DOI 10.1007/s10681-009-0006-5; Yu JK, 2006, THEOR APPL GENET, V113, P1093, DOI 10.1007/s00122-006-0369-0; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhao JY, 2012, THEOR APPL GENET, V124, P407, DOI 10.1007/s00122-011-1716-3; 王汉中, 2004, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V26, P98	64	37	47	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47037	10.1371/journal.pone.0047037	http://dx.doi.org/10.1371/journal.pone.0047037			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077542	Green Submitted, Green Published, gold			2022-12-25	WOS:000309809500030
J	Alexandrov, AI; Polyanskaya, AB; Serpionov, GV; Ter-Avanesyan, MD; Kushnirov, VV				Alexandrov, Alexander I.; Polyanskaya, Alla B.; Serpionov, Genrikh V.; Ter-Avanesyan, Michael D.; Kushnirov, Vitaly V.			The Effects of Amino Acid Composition of Glutamine-Rich Domains on Amyloid Formation and Fragmentation	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PLUS CHAPERONE CLPB; PRION-LIKE FACTOR; PROTEIN DISAGGREGATION; SUBSTRATE-SPECIFICITY; DNAK CHAPERONE; CO-CHAPERONE; PSI+ PRION; PROPAGATION; HSP104	Fragmentation of amyloid polymers by the chaperone Hsp 104 allows them to propagate as prions in yeast. The factors which determine the frequency of fragmentation are unclear, though it is often presumed to depend on the physical strength of prion polymers. Proteins with long polyglutamine stretches represent a tractable model for revealing sequence elements required for polymer fragmentation in yeast, since they form poorly fragmented amyloids. Here we show that interspersion of polyglutamine stretches with various amino acid residues differentially affects the in vivo formation and fragmentation of the respective amyloids. Aromatic residues tyrosine, tryptophan and phenylalanine strongly stimulated polymer fragmentation, leading to the appearance of oligomers as small as dimers. Alanine, methionine, cysteine, serine, threonine and histidine also enhanced fragmentation, while charged residues, proline, glycine and leucine inhibited polymerization. Our data indicate that fragmentation frequency primarily depends on the recognition of fragmentation-promoting residues by Hsp 104 and/or its co-chaperones, rather than on the physical stability of polymers. This suggests that differential exposure of such residues to chaperones defines prion variant-specific differences in polymer fragmentation efficiency.	[Alexandrov, Alexander I.; Polyanskaya, Alla B.; Serpionov, Genrikh V.; Ter-Avanesyan, Michael D.; Kushnirov, Vitaly V.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Alexandrov, AI (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia.	alexvir@inbi.ras.ru	Vitaly, Kushnirov/AAU-6003-2021; Alexandrov, Alexander/C-9579-2019; Alexandrov, Alexander/N-7620-2013	Alexandrov, Alexander/0000-0001-7250-4740; Kushnirov, Vitaly/0000-0003-0316-0766	Ministry of Education and Science of the Russian Federation [11.519.11.2001]; Russian Foundation for Basic Research [11-04-00442]; Wellcome Trust Grant	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Wellcome Trust Grant(Wellcome Trust)	The work was supported by the Ministry of Education and Science of the Russian Federation (# 11.519.11.2001), the Russian Foundation for Basic Research (grant # 11-04-00442) and a Wellcome Trust Grant to VVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Goldsbury C, 2011, J STRUCT BIOL, V173, P1, DOI 10.1016/j.jsb.2010.09.018; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Herbert D., 1971, METHODS MICROBIOLO B, V5B, P244; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074	32	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46458	10.1371/journal.pone.0046458	http://dx.doi.org/10.1371/journal.pone.0046458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071575	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200027
J	Kulacki, KJ; Cardinale, BJ				Kulacki, Konrad J.; Cardinale, Bradley J.			Effects of Nano-Titanium Dioxide on Freshwater Algal Population Dynamics	PLOS ONE			English	Article							OXIDE NANOPARTICLES; TIO2 PARTICLES; NANOMATERIALS; TOXICITY; ECOTOXICITY; EUTROPHICATION; IMPACT; TESTS; ZNO	To make predictions about the possible effects of nanomaterials across environments and taxa, toxicity testing must incorporate not only a variety of organisms and endpoints, but also an understanding of the mechanisms that underlie nanoparticle toxicity. Here, we report the results of a laboratory experiment in which we examined how titanium dioxide nanoparticles impact the population dynamics and production of biomass across a range of freshwater algae. We exposed 10 of the most common species of North American freshwater pelagic algae (phytoplankton) to five increasing concentrations of n-TiO2 (ranging from controls to 300 mg n-TiO2 L-1). We then examined the effects of n-TiO2 on the population growth rates and biomass production of each algal species over a period of 25 days. On average, increasing concentrations of n-TiO2 had no significant effects on algal growth rates (p = 0.376), even though there was considerable species-specific variation in responses. In contrast, exposure to n-TiO2 tended to increase maximum biomass achieved by species in culture (p = 0.06). Results suggest that titanium dioxide nanoparticles could influence certain aspects of population growth of freshwater phytoplankton, though effects are unlikely at environmentally relevant concentrations.	[Kulacki, Konrad J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Kulacki, Konrad J.; Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	University of California System; University of California Santa Barbara; University of Michigan System; University of Michigan	Kulacki, KJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	kkulacki@umich.edu	Cardinale, Bradley J/I-7076-2013		National Science Foundation; Environmental Protection Agency [NSF-EF0830117]	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency)	This study was supported by grants from the National Science Foundation and Environmental Protection Agency under Cooperative Agreement # NSF-EF0830117. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or the Environmental Protection Agency. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2006, OCCUP MED-OXFORD, V56, P300, DOI 10.1093/occmed/kql051; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Bertilsson S, 1998, LIMNOL OCEANOGR, V43, P885, DOI 10.4319/lo.1998.43.5.0885; Carpenter SR, 1998, AUST J ECOL, V23, P68, DOI 10.1111/j.1442-9993.1998.tb00706.x; Cherchi C, 2010, ENVIRON SCI TECHNOL, V44, P8302, DOI 10.1021/es101658p; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; Degussa Corp, 1994, TIT DIOX P 25; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Hall S, 2009, NANOTOXICOLOGY, V3, P91, DOI 10.1080/17435390902788078; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Hendriks AJ, 2005, ENVIRON TOXICOL CHEM, V24, P2267, DOI 10.1897/05-122.1; Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; JORGENSEN EG, 1969, PHYSIOL PLANTARUM, V22, P1307; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim SC, 2005, MICROCHEM J, V80, P227, DOI 10.1016/j.microc.2004.07.008; Kreyling WG, 2006, J NANOPART RES, V8, P543, DOI 10.1007/s11051-005-9068-z; Lewis MA, 2003, FUNDAMENTALS AQUATIC, P135; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; Metzler DM, 2011, CHEM ENG J, V170, P538, DOI 10.1016/j.cej.2011.02.002; Mileyeva-Biebesheimer ON, 2010, ENVIRON ENG SCI, V27, P329, DOI 10.1089/ees.2009.0332; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Rejeski D, 2010, PROJECT EMERGING NAN; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; Scully NM, 2003, FEMS MICROBIOL ECOL, V46, P353, DOI 10.1016/S0168-6496(03)00198-3; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Som C, 2011, ENVIRON INT, V37, P1131, DOI 10.1016/j.envint.2011.02.013; STEELE JH, 1962, LIMNOL OCEANOGR, V7, P137, DOI 10.4319/lo.1962.7.2.0137; U. S. Environmental Protection Agency, 2010, 2007 NAT LAK ASS DAT; Velzeboer I, 2008, ENVIRON TOXICOL CHEM, V27, P1942, DOI 10.1897/07-509.1; Wang JX, 2008, CHEMOSPHERE, V73, P1121, DOI 10.1016/j.chemosphere.2008.07.040; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Watanabe M.M., 2005, ALGAL CULTURING TECH, P13; Wehr J. D., 2003, FRESHWATER ALGAE N A	38	40	41	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47130	10.1371/journal.pone.0047130	http://dx.doi.org/10.1371/journal.pone.0047130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071735	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200084
J	Nasi, T; Virtanen, J; Toppila, J; Salmi, T; Ilmoniemi, RJ				Nasi, Tiina; Virtanen, Jaakko; Toppila, Jussi; Salmi, Tapani; Ilmoniemi, Risto J.			Cyclic Alternating Pattern Is Associated with Cerebral Hemodynamic Variation: A Near-Infrared Spectroscopy Study of Sleep in Healthy Humans	PLOS ONE			English	Article							OPTICAL TOMOGRAPHY; BRAIN ACTIVATION; BLOOD-PRESSURE; NERVE ACTIVITY; REM-SLEEP; CAP; OSCILLATIONS; AROUSAL; RESPONSES; SENSITIVITY	The cyclic alternating pattern (CAP), that is, cyclic variation of brain activity within non-REM sleep stages, is related to sleep instability and preservation, as well as consolidation of learning. Unlike the well-known electrical activity of CAP, its cerebral hemodynamic counterpart has not been assessed in healthy subjects so far. We recorded scalp and cortical hemodynamics with near-infrared spectroscopy on the forehead and systemic hemodynamics (heart rate and amplitude of the photoplethysmograph) with a finger pulse oximeter during 23 nights in 11 subjects. Electrical CAP activity was recorded with a polysomnogram. CAP was related to changes in scalp, cortical, and systemic hemodynamic signals that resembled the ones seen in arousal. Due to their repetitive nature, CAP sequences manifested as low-and very-low-frequency oscillations in the hemodynamic signals. The subtype A3+B showed the strongest hemodynamic changes. A transient hypoxia occurred during CAP cycles, suggesting that an increased CAP rate, especially with the subtype A3+B, which may result from diseases or fragmented sleep, might have an adverse effect on the cerebral vasculature.	[Nasi, Tiina; Virtanen, Jaakko; Ilmoniemi, Risto J.] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland; [Nasi, Tiina; Virtanen, Jaakko; Ilmoniemi, Risto J.] Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Cent Hosp, Helsinki, Finland; [Toppila, Jussi; Salmi, Tapani] Univ Helsinki, HUS Med Imaging Ctr, Dept Clin Neurophysiol, Cent Hosp, Helsinki, Finland; [Toppila, Jussi; Salmi, Tapani] Univ Helsinki, Dept Neurol Sci, Helsinki, Finland	Aalto University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Nasi, T (corresponding author), Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	tiina.nasi@aalto.fi	Ilmoniemi, Risto/E-9704-2012; Näsi, Tiina/E-7314-2012	Ilmoniemi, Risto/0000-0002-3340-2618; Näsi, Tiina/0000-0002-5311-3530	Finnish Cultural Foundation; HUSLAB EVO [TLE82N0008]	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); HUSLAB EVO	The study was financially supported by the Finnish Cultural Foundation (http://www.skr.fi/) and by the HUSLAB EVO funding (TLE82N0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico D, 2010, SLEEP MED, V11, P791, DOI 10.1016/j.sleep.2010.02.009; Bangash MF, 2008, SLEEP, V31, P321, DOI 10.1093/sleep/31.3.321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2011, TRANSL RES, V158, P1, DOI 10.1016/j.trsl.2010.12.008; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Boas DA, 2001, NEUROIMAGE, V13, P76, DOI 10.1006/nimg.2000.0674; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Catcheside PG, 2001, SLEEP, V24, P895, DOI 10.1093/sleep/24.8.895; Chua ECP, 2010, ANN BIOMED ENG, V38, P945, DOI 10.1007/s10439-009-9882-z; Clare S, 1999, MAGNET RESON MED, V42, P1117, DOI 10.1002/(SICI)1522-2594(199912)42:6<1117::AID-MRM16>3.0.CO;2-J; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; DAVIES RJO, 1993, J APPL PHYSIOL, V74, P1123, DOI 10.1152/jappl.1993.74.3.1123; Dehghani H, 2009, APPL OPTICS, V48, pD137, DOI 10.1364/AO.48.00D137; Dresler M, 2011, CURR BIOL, V21, P1833, DOI 10.1016/j.cub.2011.09.029; Elwell CE, 1999, ADV EXP MED BIOL, V471, P57; Ferri R, 2008, NEUROSCI LETT, V432, P228, DOI 10.1016/j.neulet.2007.12.025; Firbank M, 1998, NEUROIMAGE, V8, P69, DOI 10.1006/nimg.1998.0348; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; HORNYAK M, 1991, BRAIN, V114, P1281, DOI 10.1093/brain/114.3.1281; HOSHI Y, 1994, BRAIN RES, V652, P257, DOI 10.1016/0006-8993(94)90235-6; Iber C., 2007, AASM MANUAL SCORING; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Koo BB, 2011, CIRCULATION, V124, P1223, DOI 10.1161/CIRCULATIONAHA.111.038968; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; MCCORMICK PW, 1992, J NEUROSURG, V76, P315, DOI 10.3171/jns.1992.76.2.0315; Nasi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025415; Nissila I, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1884193; NOLL G, 1994, ACTA PHYSIOL SCAND, V151, P319, DOI 10.1111/j.1748-1716.1994.tb09751.x; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Parrino L, 1996, J CLIN NEUROPHYSIOL, V13, P314, DOI 10.1097/00004691-199607000-00005; Parrino L, 1998, ELECTROEN CLIN NEURO, V107, P439, DOI 10.1016/S0013-4694(98)00108-4; Parrino L, 2012, SLEEP MED REV, V16, P27, DOI 10.1016/j.smrv.2011.02.003; Pizza F, 2009, CLIN NEUROPHYSIOL, V120, P1329, DOI 10.1016/j.clinph.2009.05.009; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Shelley KH, 2007, ANESTH ANALG, V105, pS31, DOI 10.1213/01.ane.0000269512.82836.c9; Tachtsidis I, 2004, PHYSIOL MEAS, V25, P437, DOI 10.1088/0967-3334/25/2/003; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tarvainen T, 2005, APPL OPTICS, V44, P1879, DOI 10.1364/AO.44.001879; Terzano MG, 2002, SLEEP MED, V3, P187, DOI 10.1016/S1389-9457(02)00003-5; Terzano MG, 2000, SLEEP MED REV, V4, P101, DOI 10.1053/smrv.1999.0083; TERZANO MG, 1992, SLEEP, V15, P64; Togo F, 2006, CLIN NEUROPHYSIOL, V117, P2597, DOI 10.1016/j.clinph.2006.07.314; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Virtanen J, 2012, SLEEP BREATH, V16, P309, DOI 10.1007/s11325-011-0526-9; Virtanen J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606576	50	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46899	10.1371/journal.pone.0046899	http://dx.doi.org/10.1371/journal.pone.0046899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071658	Green Published, Green Submitted			2022-12-25	WOS:000312385200049
J	Yang, HH; Huang, IT; Lin, CH; Chen, TY; Chen, LK				Yang, Hui-Hua; Huang, I-Tsong; Lin, Chin-Hui; Chen, Tren-Yi; Chen, Li-Kuang			New Genotypes of Orientia tsutsugamushi Isolated from Humans in Eastern Taiwan	PLOS ONE			English	Article							RICKETTSIA-TSUTSUGAMUSHI; SCRUB TYPHUS; PHYLOGENETIC ANALYSIS; SEQUENCE HOMOLOGIES; PROTEIN ANTIGEN; RECOMBINATION; IDENTIFICATION; GENE; CLASSIFICATION; VARIANTS	Scrub typhus, an acute febrile illness, is caused by the obligate intracellular bacterium Orientia tsutsugamushi. In our study, O. tsutsugamushi was rapidly detected and typed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analysis of the 56-kDa type-specific antigen (TSA) gene. To investigate the genotypes of clinical variants of O. tsutsugamushi, we collected 3223 blood samples from eastern Taiwanese patients with suspected scrub typhus from 2002 to 2008. In total, 505 samples were found to be positive for scrub typhus infection by PCR, and bacteria were isolated from 282 of them. Four prototype genotype strains (Karp, Kato, Kawasaki and Gilliam) and eleven different Taiwanese genotype isolates (Taiwan-A, -B, -C, -D, -E, -G, -H, -J, -N, -O and -P) were identified by RPLF analysis. Taiwan-H, the major genotype in eastern Taiwan, exhibited prevalence and isolation rates of 47.3% (239/505) and 42.6% (120/282), respectively. We also assessed the genetic relatedness of the 56-kDa TSA gene among eight Taiwan-H isolates, thirteen other Taiwanese isolates and 104 DNA sequences deposited in the GenBank database using MEGA version 5.0 and PHYLIP version 3.66. We found that the Taiwan-H isolates formed into a new cluster, which was designated the Taiwan Gilliam-variant (TG-v) cluster to distinguish it from the Japanese Gilliam-variant (JG-v) cluster. According to Simplot analysis, TG-v is a new recombinant strain among Gilliam, Ikeda and Kato. Moreover, the Gilliam-Kawasaki cluster had the highest percentage of RFLP cases and was the most frequently isolated type in eastern Taiwan (50.1%, 253/505; 44.0%, 124/282). These findings shed light on the genetic evolution of O. tsutsugamushi into different strains and may be useful in vaccine development and epidemic disease control in the future.	[Yang, Hui-Hua; Huang, I-Tsong; Chen, Li-Kuang] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Yang, Hui-Hua; Huang, I-Tsong; Lin, Chin-Hui; Chen, Li-Kuang] Buddhist Tzu Chi Gen Hosp, Contract Lab Viral & Rickettsial Infect, Hualien, Taiwan; [Yang, Hui-Hua; Chen, Li-Kuang] Buddhist Tzu Chi Gen Hosp, Emerging Infect Pathogen Res Lab, Hualien, Taiwan; [Huang, I-Tsong; Chen, Li-Kuang] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Hualien, Taiwan; [Chen, Tren-Yi] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Li-Kuang] Emergency Med Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Chung Shan Medical University; Buddhist Tzu Chi General Hospital	Chen, LK (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	likuangchen@gmail.com			Centers for Disease Control, R.O.C (Taiwan) [DOH 92-DC-1205, 94x007, DOH 91-DC-1085, 92-DC-1073, 93-DC-1022, CDC 94-RM-101, 95-RD-014]	Centers for Disease Control, R.O.C (Taiwan)	This work was supported by grants from the Centers for Disease Control, R.O.C (Taiwan) (DOH 92-DC-1205, 94x007, DOH 91-DC-1085, 92-DC-1073, 93-DC-1022, CDC 94-RM-101, 95-RD-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacksell SD, 2008, FEMS IMMUNOL MED MIC, V52, P335, DOI 10.1111/j.1574-695X.2007.00375.x; Brown CT, 2011, APPL ENVIRON MICROB, V77, P6867, DOI 10.1128/AEM.05272-11; Chen HL, 1995, J FORMOS MED ASS S2, V94, pS112; Chen Huei-Ling, 1999, Journal of Microbiology Immunology and Infection, V32, P68; Enatsu T, 1999, FEMS MICROBIOL LETT, V180, P163, DOI 10.1111/j.1574-6968.1999.tb08791.x; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Fournier PE, 2008, CLIN MICROBIOL INFEC, V14, P168, DOI 10.1111/j.1469-0691.2007.01889.x; FURUYA Y, 1993, J CLIN MICROBIOL, V31, P1637, DOI 10.1128/JCM.31.6.1637-1640.1993; GROVES MG, 1989, INFECT IMMUN, V57, P1476, DOI 10.1128/IAI.57.5.1476-1482.1989; KAWAMORI F, 1993, J VET MED SCI, V55, P749, DOI 10.1292/jvms.55.749; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu HY, 2010, AM J TROP MED HYG, V83, P658, DOI 10.4269/ajtmh.2010.09-0608; Lukashev AN, 2005, J GEN VIROL, V86, P2333, DOI 10.1099/vir.0.80974-0; Ni YS, 2005, AM J TROP MED HYG, V73, P936, DOI 10.4269/ajtmh.2005.73.936; OHASHI N, 1990, J CLIN MICROBIOL, V28, P2111, DOI 10.1128/JCM.28.9.2111-2113.1990; Ohashi N, 1996, MICROBIOL IMMUNOL, V40, P627, DOI 10.1111/j.1348-0421.1996.tb01120.x; OHASHI N, 1992, J BIOL CHEM, V267, P12728; OHASHI N, 1989, INFECT IMMUN, V57, P1427, DOI 10.1128/IAI.57.5.1427-1431.1989; Qiang Y, 2003, MICROBIOL IMMUNOL, V47, P577, DOI 10.1111/j.1348-0421.2003.tb03420.x; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; SHISHIDO A, 1969, J IMMUNOL, V103, P480; Sonthayanon P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000752; STOVER CK, 1990, INFECT IMMUN, V58, P2076, DOI 10.1128/IAI.58.7.2076-2084.1990; Sun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036577; Tamura A, 1997, FEMS MICROBIOL LETT, V150, P225, DOI 10.1016/S0378-1097(97)00119-5; TAMURA A, 1995, INT J SYST BACTERIOL, V45, P589, DOI 10.1099/00207713-45-3-589; Tamura A, 2001, MICROBIOL IMMUNOL, V45, P439, DOI 10.1111/j.1348-0421.2001.tb02643.x; TAMURA A, 1984, MICROBIOL IMMUNOL, V28, P873, DOI 10.1111/j.1348-0421.1984.tb00743.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WATT G, 1994, CLIN INFECT DIS, V18, P624, DOI 10.1093/clinids/18.4.624; Yu YF, 2005, AM J TROP MED HYG, V72, P458, DOI 10.4269/ajtmh.2005.72.458; Zoll J, 2009, J VIROL, V83, P3379, DOI 10.1128/JVI.02529-08	34	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46997	10.1371/journal.pone.0046997	http://dx.doi.org/10.1371/journal.pone.0046997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071693	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200064
J	Li, Z; Shen, JX; Wu, WKK; Wang, XJ; Liang, JQ; Qiu, GX; Liu, JM				Li, Zheng; Shen, Jianxiong; Wu, William Ka Kei; Wang, Xiaojuan; Liang, Jinqian; Qiu, Guixing; Liu, Jiaming			Vitamin A Deficiency Induces Congenital Spinal Deformities in Rats	PLOS ONE			English	Article							VERTEBRATE SEGMENTATION CLOCK; RETINOIC-ACID; BILATERAL SYMMETRY; GENE-EXPRESSION; SOMITOGENESIS; SCOLIOSIS; EMBRYO; DEFECTS; OSCILLATIONS; ANOMALIES	Most cases of congenital spinal deformities were sporadic and without strong evidence of heritability. The etiology of congenital spinal deformities is still elusive and assumed to be multi-factorial. The current study seeks to elucidate the effect of maternal vitamin A deficiency and the production of congenital spinal deformities in the offsping. Thirty two female rats were randomized into two groups: control group, which was fed a normal diet; vitamin A deficient group, which were given vitamin A-deficient diet from at least 2 weeks before mating till delivery. Three random neonatal rats from each group were killed the next day of parturition. Female rats were fed an AIN-93G diet sufficient in vitamin A to feed the rest of neonates for two weeks until euthanasia. Serum levels of vitamin A were assessed in the adult and filial rats. Anteroposterior (AP) spine radiographs were obtained at week 2 after delivery to evaluate the presence of the skeletal abnormalities especially of spinal deformities. Liver and vertebral body expression of retinaldehyde dehydrogenase (RALDHs) and RARs mRNA was assessed by reverse transcription-real time PCR. VAD neonates displayed many skeletal malformations in the cervical, thoracic, the pelvic and sacral and limbs regions. The incidence of congenital scoliosis was 13.79% (8/58) in the filial rats of vitamin A deficiency group and 0% in the control group. Furthermore, vitamin A deficiency negatively regulate the liver and verterbral body mRNA levels of RALDH1, RALDH2, RALDH3, RAR-alpha, RAR-beta and RAR-gamma. Vitamin A deficiency in pregnancy may induce congenital spinal deformities in the postnatal rats. The decreases of RALDHs and RARs mRNA expression induced by vitamin A deprivation suggest that vertebral birth defects may be caused by a defect in RA signaling pathway during somitogenesis.	[Li, Zheng; Shen, Jianxiong; Liang, Jinqian; Qiu, Guixing; Liu, Jiaming] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Orthopaed Surg, Beijing, Peoples R China; [Wu, William Ka Kei; Wang, Xiaojuan] Chinese Univ Hong Kong, LKS Inst Hlth Sci, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese University of Hong Kong	Shen, JX (corresponding author), Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Orthopaed Surg, Beijing, Peoples R China.	shenjianxiong@medmail.com.cn	Wu, William K.K./A-3277-2009; Shen, Jianxiong/AAH-6200-2019; wu, william/HII-5817-2022	Wu, William K.K./0000-0002-5662-5240; Qiu, Guixing/0000-0002-4597-9350				Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Vega VA, 2009, NUTRITION, V25, P828, DOI 10.1016/j.nut.2009.01.008; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Azevedo PS, 2010, CELL PHYSIOL BIOCHEM, V26, P395, DOI 10.1159/000320563; BANTZ EW, 1984, CLIN PEDIATR, V23, P352; Basu PS, 2002, SPINE, V27, P2255, DOI 10.1097/01.BRS.0000029425.58936.BA; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cui J, 2003, DEV BIOL, V260, P496, DOI 10.1016/S0012-1606(03)00257-4; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Eckalbar WL, 2012, DEV BIOL, V363, P308, DOI 10.1016/j.ydbio.2011.11.021; Farley FA, 2006, J PEDIATR ORTHOPED, V26, P341, DOI 10.1097/01.bpo.0000203011.58529.d8; Giampietro Philip F, 2003, Clin Med Res, V1, P125; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; GREVE C, 1987, J NUTR, V117, P189, DOI 10.1093/jn/117.1.189; Haider BA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006980.pub2; Hensinger RN, 2009, SPINE, V34, P1745, DOI 10.1097/BRS.0b013e3181abf69e; Kaiser ME, 2003, DEV BIOL, V257, P14, DOI 10.1016/S0012-1606(03)00044-7; Li N, 2010, J NUTR BIOCHEM, V21, P710, DOI 10.1016/j.jnutbio.2009.04.011; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Molotkov A, 2002, EUR J BIOCHEM, V269, P2607, DOI 10.1046/j.1432-1033.2002.02935.x; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Pickett EA, 2008, DEVELOPMENT, V135, P589, DOI 10.1242/dev.013763; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Pourquie O, 2000, CURR TOP DEV BIOL, V47, P81; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Rahab NG, 2009, J NUTR, V139, P696, DOI 10.3945/jn.108.102988; Robinson JF, 2012, TOXICOL SCI, V126, P242, DOI 10.1093/toxsci/kfr342; Romeih M, 2003, DEV DYNAM, V228, P697, DOI 10.1002/dvdy.10419; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; See AWM, 2008, DEV BIOL, V316, P171, DOI 10.1016/j.ydbio.2007.10.018; Shifley Emily T., 2007, Birth Defects Research, V81, P121, DOI 10.1002/bdrc.20090; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Suh SW, 2001, J PEDIATR ORTHOPED, V21, P525, DOI 10.1097/00004694-200107000-00021; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Tanumihardjo SA, 2002, J LIPID RES, V43, P350; TREDWELL SJ, 1982, SPINE, V7, P331, DOI 10.1097/00007632-198207000-00002; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; Wei H, 2009, J NUTR SCI VITAMINOL, V55, P208, DOI 10.3177/jnsv.55.208; Whatham A, 2008, OPHTHAL PHYSL OPT, V28, P1, DOI 10.1111/j.1475-1313.2007.00531.x; White JC, 1998, P NATL ACAD SCI USA, V95, P13459, DOI 10.1073/pnas.95.23.13459; WILLHITE CC, 1989, CRIT REV TOXICOL, V20, P113, DOI 10.3109/10408448909017906	46	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46565	10.1371/journal.pone.0046565	http://dx.doi.org/10.1371/journal.pone.0046565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071590	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300037
J	Arroyo, DS; Soria, JA; Gaviglio, EA; Garcia-Keller, C; Cancela, LM; Rodriguez-Galan, MC; Wang, JM; Iribarren, P				Arroyo, Daniela S.; Soria, Javier A.; Gaviglio, Emilia A.; Garcia-Keller, Constanza; Cancela, Liliana M.; Rodriguez-Galan, Maria C.; Wang, Ji Ming; Iribarren, Pablo			Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy	FASEB JOURNAL			English	Article						inflammation; peptidoglycan; CNS	ADAPTIVE IMMUNE-RESPONSES; POPULATION-CONTROL; DENDRITIC CELLS; ACTIVATION; APOPTOSIS; TLR2; BETA; INTERLEUKIN-4; PEPTIDOGLYCAN; NECROPTOSIS	Microglial cells are phagocytes in the central nervous system (CNS) and become activated in pathological conditions, resulting in microgliosis, manifested by increased cell numbers and inflammation in the affected regions. Thus, controlling microgliosis is important to prevent pathological damage to the brain. Here, we evaluated the contribution of Toll-like receptor 2 (TLR2) to microglial survival. We observed that activation of microglial cells with peptidoglycan (PGN) from Staphylococcus aureus and other TLR2 ligands results in cell activation followed by the induction of autophagy and autophagy-dependent cell death. In C57BL/6J mice, intracerebral injection of PGN increased the autophagy of microglial cells and reduced the microglial/macrophage cell number in brain parenchyma. Our results demonstrate a novel role of TLRs in the regulation of microglial cell activation and survival, which are important for the control of microgliosis and associated inflammatory responses in the CNS.-Arroyo, D. S., Soria, J. A., Gaviglio, E. A., Garcia-Keller, C., Cancela, L. M., Rodriguez-Galan, M. C., Wang, J. M., Iribarren, P. Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy. FASEB J. 27, 299-312 (2013). www.fasebj.org	[Arroyo, Daniela S.; Soria, Javier A.; Gaviglio, Emilia A.; Rodriguez-Galan, Maria C.; Iribarren, Pablo] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, CIBICI,CONICET, RA-5000 Cordoba, Argentina; [Garcia-Keller, Constanza; Cancela, Liliana M.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Farmacol, IFEC,CONICET, RA-5000 Cordoba, Argentina; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA	National University of Cordoba; National University of Cordoba; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Iribarren, P (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, CIBICI,CONICET, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	piribarr@fcq.unc.edu.ar			Fogarty International Center, U.S. National Institutes of Health (HIH) [1R01TW007621]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SECyT-UNC), Argentina; FOGARTY INTERNATIONAL CENTER [R01TW007621] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010015, ZIABC010725] Funding Source: NIH RePORTER	Fogarty International Center, U.S. National Institutes of Health (HIH); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SECyT-UNC), Argentina; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank biochemist Paula Icely for technical support and secretarial assistance. This work was supported by the Fogarty International Center, U.S. National Institutes of Health (HIH; grant 1R01TW007621); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; and Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SECyT-UNC), Argentina. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Fogarty International Center, NIH. The authors declare no conflicts of interest.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016/j.intimp.2011.05.006; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Boddeke EWGM, 1999, J NEUROIMMUNOL, V98, P176, DOI 10.1016/S0165-5728(99)00096-X; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davenport CM, 2010, J NEUROCHEM, V112, P552, DOI 10.1111/j.1471-4159.2009.06485.x; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Delavallee L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Iribarren P, 2002, ARCH IMMUNOL THER EX, V50, P187; Iribarren Pablo, 2002, BMC Immunol, V3, P6, DOI 10.1186/1471-2172-3-6; Jones LL, 1997, J NEUROCYTOL, V26, P755, DOI 10.1023/A:1018514415073; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneko YS, 2009, BRAIN RES, V1279, P9, DOI 10.1016/j.brainres.2009.05.008; Kielian T, 2005, GLIA, V49, P567, DOI 10.1002/glia.20144; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Lu BF, 2007, AUTOPHAGY, V3, P158, DOI 10.4161/auto.3637; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MANN SS, 1994, J BIOL CHEM, V269, P11492; Mayo L, 2007, CELL DEATH DIFFER, V14, P183, DOI 10.1038/sj.cdd.4401989; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Rabinovich GA, 1999, EUR J IMMUNOL, V29, P563, DOI 10.1002/(SICI)1521-4141(199902)29:02<563::AID-IMMU563>3.0.CO;2-A; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Soria JA, 2011, NEUROBIOL DIS, V43, P616, DOI 10.1016/j.nbd.2011.05.010; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Suk K, 2001, BRAIN RES, V900, P342, DOI 10.1016/S0006-8993(01)02326-5; Vidlak D, 2011, BRAIN BEHAV IMMUN, V25, P905, DOI 10.1016/j.bbi.2010.09.016; Wirenfeldt M, 2005, J NEUROSCI RES, V82, P507, DOI 10.1002/jnr.20659; Wirenfeldt M, 2007, AM J PATHOL, V171, P617, DOI 10.2353/ajpath.2007.061044; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	55	39	42	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					299	312		10.1096/fj.12-214312	http://dx.doi.org/10.1096/fj.12-214312			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23073832	Green Published			2022-12-25	WOS:000313103200028
J	Chen, CM; Bentham, J; Cosgrove, C; Braganca, J; Cuenda, A; Bamforth, SD; Schneider, JE; Watkins, H; Keavney, B; Davies, B; Bhattacharya, S				Chen, Chiann-mun; Bentham, Jamie; Cosgrove, Catherine; Braganca, Jose; Cuenda, Ana; Bamforth, Simon D.; Schneider, Juergen E.; Watkins, Hugh; Keavney, Bernard; Davies, Benjamin; Bhattacharya, Shoumo			Functional Significance of SRJ Domain Mutations in CITED2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MELANOCYTE-SPECIFIC GENE; TRANSCRIPTION FACTOR; CARDIAC-MALFORMATIONS; HEART DEVELOPMENT; BINDING-PROTEIN; MOUSE MODEL; ES CELLS; COACTIVATOR; ACTIVATION	CITED2 is a transcriptional co-activator with 3 conserved domains shared with other CITED family members and a unique Serine-Glycine Rich Junction (SRJ) that is highly conserved in placental mammals. Loss of Cited2 in mice results in cardiac and aortic arch malformations, adrenal agenesis, neural tube and placental defects, and partially penetrant defects in left-right patterning. By screening 1126 sporadic congenital heart disease (CHD) cases and 1227 controls, we identified 19 variants, including 5 unique non-synonymous sequence variations (N62S, R92G, T166N, G180-A187del and A187T) in patients. Many of the CHD-specific variants identified in this and previous studies cluster in the SRJ domain. Transient transfection experiments show that T166N mutation impairs TFAP2 co-activation function and ES cell proliferation. We find that CITED2 is phosphorylated by MAPK1 in vitro at T166, and that MAPK1 activation enhances the coactivation function of CITED2 but not of CITED2-T166N. In order to investigate the functional significance in vivo, we generated a T166N mutation of mouse Cited2. We also used PhiC31 integrase-mediated cassette exchange to generate a Cited2 knock-in allele replacing the mouse Cited2 coding sequence with human CITED2 and with a mutant form deleting the entire SRJ domain. Mouse embryos expressing only CITED2-T166N or CITED2-SRJ-deleted alleles surprisingly show no morphological abnormalities, and mice are viable and fertile. These results indicate that the SRJ domain is dispensable for these functions of CITED2 in mice and that mutations clustering in the SRJ region are unlikely to be the sole cause of the malformations observed in patients with sporadic CHD. Our results also suggest that coding sequence mutations observed in case-control studies need validation using in vivo models and that predictions based on structural conservation and in vitro functional assays, or even in vivo global loss of function models, may be insufficient.	[Chen, Chiann-mun; Bentham, Jamie; Cosgrove, Catherine; Braganca, Jose; Bamforth, Simon D.; Schneider, Juergen E.; Watkins, Hugh; Bhattacharya, Shoumo] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England; [Bamforth, Simon D.; Keavney, Bernard] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Cuenda, Ana] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Bhattacharya, S (corresponding author), Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford, England.	sbhattac@well.ox.ac.uk	Braganca, Jose/F-4410-2012; Bhattacharya, Shoumo/F-4127-2010; Davies, Ben/GYD-9163-2022; Bamforth, Simon David/I-1277-2019	Braganca, Jose/0000-0001-9566-400X; Bhattacharya, Shoumo/0000-0002-5571-0478; Davies, Ben/0000-0003-3405-507X; Bamforth, Simon David/0000-0002-5666-4485; Chen, Chiann-mun/0000-0002-7007-3649; Watkins, Hugh/0000-0002-5287-9016; Keavney, Bernard/0000-0001-9573-0812; Davies, Benjamin/0000-0003-3623-600X	Wellcome Trust [083228/Z/07/Z, 090532/Z/09/Z]; British Heart Foundation [CH/09/003, PG/07/045/22690]; British Heart Foundation [RG/10/17/28553, RG/08/012/25941, FS/11/50/29038] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by grants from the Wellcome Trust (083228/Z/07/Z to S. B. and 090532/Z/09/Z to the Wellcome Trust Centre for Human Genetics; www.wellcome.ac.uk), and grants from the British Heart Foundation (CH/09/003 and PG/07/045/22690; www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R, 2000, HEART, V11, P89; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Burn J., 2002, PRINCIPLES PRACTICE; Campbell David G, 2002, J Biomol Tech, V13, P119; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feijoo C, 2005, J CELL SCI, V118, P397, DOI 10.1242/jcs.01655; FERENCZ C, 1989, J AM COLL CARDIOL, V14, P756, DOI 10.1016/0735-1097(89)90122-8; Ferencz Charlotte, 1993, Cardiology Clinics, V11, P557; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; HOFFMAN JIE, 2002, PAEDIAT CARDIOLOGY, P111; Janknecht R, 1996, ONCOGENE, V12, P1961; Karel F., 2001, FUNCTIONAL ANATOMY V; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kuma Y, 2004, BIOCHEM J, V379, P133, DOI 10.1042/BJ20031559; Michell AC, 2010, DEV DYNAM, V239, P1988, DOI 10.1002/dvdy.22334; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Qayyum SR, 2001, ANAT RECORD, V264, P273, DOI 10.1002/ar.1162; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; RUNCIMAN SIC, 1995, ANAT RECORD, V243, P71, DOI 10.1002/ar.1092430109; Schneider JE, 2003, J MOL CELL CARDIOL, V35, P217, DOI 10.1016/S0022-2828(02)00291-2; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Yang Xiao-fei, 2010, Zhonghua Er Ke Za Zhi, V48, P293; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	59	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46256	10.1371/journal.pone.0046256	http://dx.doi.org/10.1371/journal.pone.0046256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082118	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900013
J	Hadi-Alijanvand, H; Proctor, EA; Goliaei, B; Dokholyan, NV; Moosavi-Movahedi, AA				Hadi-Alijanvand, Hamid; Proctor, Elizabeth A.; Goliaei, Bahram; Dokholyan, Nikolay V.; Moosavi-Movahedi, Ali A.			Thermal Unfolding Pathway of PHD2 Catalytic Domain in Three Different PHD2 Species: Computational Approaches	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; MOLECULAR-DYNAMICS SIMULATIONS; CELL CARCINOMA; AGGREGATION; PROTEINS; OVEREXPRESSION	Prolyl hydroxylase domain 2 containing protein (PHD2) is a key protein in regulation of angiogenesis and metastasis. In normoxic condition, PHD2 triggers the degradation of hypoxia-inducible factor 1 (HIF-1 alpha) that induces the expression of hypoxia response genes. Therefore the correct function of PHD2 would inhibit angiogenesis and consequent metastasis of tumor cells in normoxic condition. PHD2 mutations were reported in some common cancers. However, high levels of HIF-1 alpha protein were observed even in normoxic metastatic tumors with normal expression of wild type PHD2. PHD2 malfunctions due to protein misfolding may be the underlying reason of metastasis and invasion in such cases. In this study, we scrutinize the unfolding pathways of the PHD2 catalytic domain's possible species and demonstrate the properties of their unfolding states by computational approaches. Our study introduces the possibility of aggregation disaster for the prominent species of PHD2 during its partial unfolding. This may justify PHD2 inability to regulate HIF-1 alpha level in some normoxic tumor types.	[Hadi-Alijanvand, Hamid; Goliaei, Bahram; Moosavi-Movahedi, Ali A.] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Proctor, Elizabeth A.; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC USA; [Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Proctor, Elizabeth A.; Dokholyan, Nikolay V.; Moosavi-Movahedi, Ali A.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; Univ Tehran, Inst Biochem & Biophys, Ctr Excellence Biothermodynam, Tehran, Iran	University of Tehran; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Tehran	Moosavi-Movahedi, AA (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.	moosavi@ibb.ut.ac.ir	Hadi-Alijanvand, Hamid/AAE-3921-2020; Dokholyan, Nikolay/D-8081-2018; Moosavi-Movahedi, Ali A./K-7453-2013; Proctor, Elizabeth A./K-2350-2012	Hadi-Alijanvand, Hamid/0000-0001-8289-2214; Dokholyan, Nikolay/0000-0002-8225-4025; Proctor, Elizabeth A./0000-0002-7627-2198; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432				Adami C, 2004, PHYS LIFE REV, V1, P3, DOI 10.1016/j.plrev.2004.01.002; Astuti D, 2011, ENDOCR-RELAT CANCER, V18, P73, DOI 10.1677/ERC-10-0113; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; Bellesia G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3108461; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Chan DA, 2010, BRIT J CANCER, V103, P1, DOI 10.1038/sj.bjc.6605682; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Chong SH, 2011, J AM CHEM SOC, V133, P7075, DOI 10.1021/ja1116233; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Day R, 2003, ADV PROTEIN CHEM, V66, P373; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Kato H, 2006, INT J CANCER, V118, P1144, DOI 10.1002/ijc.21488; Lee K, 2008, MOL CANCER RES, V6, P829, DOI 10.1158/1541-7786.MCR-07-2113; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajan A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009890; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Toofanny RD, 2010, BIOPHYS J, V98, P2671, DOI 10.1016/j.bpj.2010.02.048; Zagrovic B, 2002, J MOL BIOL, V323, P153, DOI 10.1016/S0022-2836(02)00888-4; Zhong H, 1999, CANCER RES, V59, P5830	34	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47061	10.1371/journal.pone.0047061	http://dx.doi.org/10.1371/journal.pone.0047061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077544	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100055
J	Tsiper, MV; Sturgis, J; Avramova, LV; Parakh, S; Fatig, R; Juan-Garcia, A; Li, NY; Rajwa, B; Narayanan, P; Qualls, CW; Robinson, JP; Davisson, VJ				Tsiper, Maria V.; Sturgis, Jennifer; Avramova, Larisa V.; Parakh, Shilpa; Fatig, Raymond; Juan-Garcia, Ana; Li, Nianyu; Rajwa, Bartek; Narayanan, Padma; Qualls, C. W., Jr.; Robinson, J. Paul; Davisson, V. Jo			Differential Mitochondrial Toxicity Screening and Multi-Parametric Data Analysis	PLOS ONE			English	Article							CYTOTOXICITY; DYSFUNCTION; CANCER	Early evaluation of new drug entities for their potential to cause mitochondrial dysfunction is becoming an important task for drug development. Multi-parametric high-content screening (mp-HCS) of mitochondrial toxicity holds promise as a lead in-vitro strategy for drug testing and safety evaluations. In this study, we have developed a mp-HCS and multi-parametric data analysis scheme for assessing cell responses to induced mitochondrial perturbation. The mp-HCS measurements are shown to be robust enough to allow for quantitative comparison of biological systems with different metabolic pathways simulated by alteration of growth media. Substitution of medium glucose for galactose sensitized cells to drug action and revealed novel response parameters. Each compound was quantitatively characterized according to induced phenotypic changes of cell morphology and functionality measured by fluorescent biomarkers for mitochondrial activity, plasma membrane permeability, and nuclear morphology. Descriptors of drug effects were established by generation of a SCRIT (Specialized-Cell-Response-to-Induced-Toxicity) vector, consisting of normalized statistical measures of each parameter at each dose and growth condition. The dimensionality of SCRIT vectors depends on the number of parameters chosen, which in turn depends on the hypothesis being tested. Specifically, incorporation of three parameters of response into SCRIT vectors enabled clustering of 84 training compounds with known pharmacological and toxicological activities according to the degree of toxicity and mitochondrial involvement. Inclusion of 6 parameters enabled the resolution of more subtle differences between compounds within a common therapeutic class; scoring enabled a ranking of statins in direct agreement with clinical outcomes. Comparison of drug-induced changes required variations in glucose for separation of mitochondrial dysfunction from other types of cytotoxicity. These results also demonstrate that the number of drugs in a training set, the choice of parameters used in analysis, and statistical measures are fundamental for specific hypothesis testing and assessment of quantitative phenotypic differences.	[Fatig, Raymond; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Tsiper, Maria V.; Avramova, Larisa V.; Parakh, Shilpa; Rajwa, Bartek] Purdue Univ Discovery Pk, Bindley Biosci Ctr, W Lafayette, IN USA; [Sturgis, Jennifer; Juan-Garcia, Ana; Robinson, J. Paul] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Robinson, J. Paul] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Li, Nianyu; Narayanan, Padma; Qualls, C. W., Jr.] Amgen Inc, Comparat Biol & Safety Sci, Seattle, WA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Amgen	Davisson, VJ (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	davisson@purdue.edu	Robinson, Joseph P/K-8492-2012; Rajwa, Bartek/B-3169-2009; Robinson, Joseph/AAA-1001-2020; Juan-Garcia, Ana/K-7653-2019; Juan-Garcia, Ana/F-3403-2013	Rajwa, Bartek/0000-0001-7540-8236; Robinson, Joseph/0000-0001-8383-3240; Juan-Garcia, Ana/0000-0002-5988-0490; Juan-Garcia, Ana/0000-0002-5988-0490	Amgen Corporation; National Institutes of Health [RR021116, GM0513155]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021116] Funding Source: NIH RePORTER	Amgen Corporation(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was enabled in part by a grant from the Amgen Corporation to VJD and JPR under terms of collaborative agreement with expectations that the results be made available for public disclosure. The laser scanning cytometer and automation equipment were made possible by grants from National Institutes of Health RR021116 (JPR), and National Institutes of Health GM0513155 (VJD). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham VC, 2008, J BIOMOL SCREEN, V13, P527, DOI 10.1177/1087057108318428; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; de Denus S, 2004, PHARMACOTHERAPY, V24, P584, DOI 10.1592/phco.24.6.584.34738; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Dykens JA, 2008, TOXICOL SCI, V103, P335, DOI 10.1093/toxsci/kfn056; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Gohil VM, 2010, NATURE BIOTECHNOLOGY; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kubota T, 2004, BIOCHEM PHARMACOL, V67, P2175, DOI 10.1016/j.bcp.2004.02.037; Le SB, 2006, CELL DEATH DIFFER, V13, P151, DOI 10.1038/sj.cdd.4401732; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Mehta R., 2008, DRUG INDUCED MITOCHO, P71, DOI DOI 10.1002/9780470; Nadanaciva S, 2009, CURR PROTOC TOXICOL; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; O'Brien P.J., 2007, HIGH CONTENT ANAL SU, P293; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Popelova O, 2009, BRIT J CANCER, V101, P792, DOI 10.1038/sj.bjc.6605192; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Will Y, 2008, TOXICOL SCI, V106, P153, DOI 10.1093/toxsci/kfn157; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	28	32	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45226	10.1371/journal.pone.0045226	http://dx.doi.org/10.1371/journal.pone.0045226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077490	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100015
J	Yanagawa, A; Fujiwara-Tsujii, N; Akino, T; Yoshimura, T; Yanagawa, T; Shimizu, S				Yanagawa, Aya; Fujiwara-Tsujii, Nao; Akino, Toshiharu; Yoshimura, Tsuyoshi; Yanagawa, Takashi; Shimizu, Susumu			Odor Aversion and Pathogen-Removal Efficiency in Grooming Behavior of the Termite Coptotermes formosanus	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGI; BEAUVERIA-BASSIANA; ISOPTERA; VIRULENCE; SHIRAKI; RHINOTERMITIDAE; DEGRADATION; MECHANISMS; REPELLENCY	The results of biocontrol with entomopathogens in termites have been discouraging because of the strong social hygiene behavior for removing pathogens from termite colonies. However, the mechanism of pathogen detection is still unclear. For the successful application of biopesticides to termites in nature, it would be beneficial to identify substances that could disrupt the termite's ability to perceive pathogens. We hypothesized that termites can perceive pathogens and this ability plays an important role in effective hygiene behavior. In this study, pathogen-detection in the subterranean termite Coptotermes formosanus was investigated. We performed quantitative assays on conidia removal by grooming behavior using epifluoresence microscopy and Y-maze tests to examine the perception of fungal odor by termites. Three species each of high-and low-virulence entomopathogenic fungi were used in each test. The results demonstrated that termites removed conidia more effectively from a nestmate's cuticle if its odor elicited stronger aversion. Highly virulent pathogens showed higher attachment rates to termite surfaces and their odors were more strongly avoided than those of low-virulence isolates in the same species. Moreover, termites appeared to groom each other more persistently when they had more conidia on their bodies. In brief, insect perception of pathogen-related odor seems to play a role in the mechanism of their hygiene behavior.	[Yanagawa, Aya; Yoshimura, Tsuyoshi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Fujiwara-Tsujii, Nao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Akino, Toshiharu] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan; [Yanagawa, Takashi] Kurume Univ, Biostat Ctr, Kurume, Fukuoka 830, Japan; [Shimizu, Susumu] Kyushu Univ, Inst Biol Control, Fukuoka 812, Japan	Kyoto University; National Institute of Agrobiological Sciences - Japan; Kyoto Institute of Technology; Kurume University; Kyushu University	Yanagawa, A (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.	ayanagawa@rish.kyoto-u.ac.jp			Kyoto University; Grants-in-Aid for Scientific Research [24880019] Funding Source: KAKEN	Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Kyoto University: The corresponding author have been funded 'the start-up fundation' from the affiliation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucias D. G., 1996, Pflanzenschutz-Nachrichten Bayer (English ed.), V49, P103; BOUCIAS DG, 1988, APPL ENVIRON MICROB, V54, P1795, DOI 10.1128/AEM.54.7.1795-1805.1988; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Chouvenc T, 2010, J ECON ENTOMOL, V103, P1327, DOI 10.1603/EC09407; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Crespo R, 2000, MYCOLOGIA, V92, P528, DOI 10.2307/3761512; Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000031; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Dong CJ, 2007, MICROBIOL RES, V162, P53, DOI 10.1016/j.micres.2006.07.001; Ferron P, 1981, HDB MICROBIAL CONTRO, P465; FLOYD MA, 1976, J INSECT PHYSIOL, V22, P697, DOI 10.1016/0022-1910(76)90235-3; Gao Q, 2012, ACTA ETHOL, V15, P55, DOI 10.1007/s10211-011-0108-7; Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005; HUNG SY, 1992, J INVERTEBR PATHOL, V60, P152, DOI 10.1016/0022-2011(92)90089-M; Hussain A, 2010, BIOL CONTROL, V55, P166, DOI 10.1016/j.biocontrol.2010.08.009; Hussain A, 2010, J INVERTEBR PATHOL, V104, P166, DOI 10.1016/j.jip.2010.03.004; Jackson MA, 2010, BIOCONTROL, V55, P129, DOI 10.1007/s10526-009-9240-y; Lax AR, 2003, PEST MANAG SCI, V59, P788, DOI 10.1002/ps.721; LIN HC, 1992, J CHEM ECOL, V18, P1623, DOI 10.1007/BF00993234; Mburu DM, 2009, J INSECT PHYSIOL, V55, P774, DOI 10.1016/j.jinsphys.2009.04.015; Milner RJ, 1998, BIOL CONTROL, V11, P240, DOI 10.1006/bcon.1997.0574; Mulrooney JE, 2007, J ECON ENTOMOL, V100, P488, DOI 10.1603/0022-0493(2007)100[488:HROTAA]2.0.CO;2; Nishi O, 2010, P TRG 7 2010 PAC RIM; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Quesada-Moraga E, 2006, J APPL ENTOMOL, V130, P442, DOI 10.1111/j.1439-0418.2006.01079.x; Rath AC, 2000, BIOCONTROL SCI TECHN, V10, P563, DOI 10.1080/095831500750016370; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosengaus RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P546, DOI 10.1007/s002650100394; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; SAS Institute Inc, 1999, SAS 9 1 3 SERV PACK; Seger C, 2005, HELV CHIM ACTA, V88, P802, DOI 10.1002/hlca.200590057; Shimizu S, 2003, APPL ENTOMOL ZOOL, V38, P125, DOI 10.1303/aez.2003.125; Staples JA, 2000, SOCIOBIOLOGY, V36, P133; STLEGER RJ, 1986, J INVERTEBR PATHOL, V47, P167, DOI 10.1016/0022-2011(86)90043-1; Sun JZ, 2008, ENVIRON ENTOMOL, V37, P755, DOI 10.1603/0046-225X(2008)37[755:IOMAAT]2.0.CO;2; Sun JZ, 2002, J INVERTEBR PATHOL, V81, P78, DOI 10.1016/S0022-2011(02)00152-0; Talael-Hassanloui R, 2007, J INVERTEBR PATHOL, V94, P102, DOI 10.1016/j.jip.2006.09.009; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Verma M, 2009, INT BIODETER BIODEGR, V63, P959, DOI 10.1016/j.ibiod.2009.05.009; Yanagawa A., 2005, JPN J ENV ENTOMOL ZO, V16, P17, DOI DOI 10.11257/JJEEZ.16.17; Yanagawa A, 2008, J INVERTEBR PATHOL, V97, P165, DOI 10.1016/j.jip.2007.09.005; Yanagawa A, 2011, J INVERTEBR PATHOL, V108, P1, DOI 10.1016/j.jip.2011.06.001; Yanagawa A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14101; Yanagawa A, 2010, SOCIOBIOLOGY, V56, P255; Yanagawa A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0601; ZOBERI MH, 1995, MYCOLOGIA, V87, P354, DOI 10.2307/3760831	47	26	29	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47412	10.1371/journal.pone.0047412	http://dx.doi.org/10.1371/journal.pone.0047412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077609	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100107
J	Basu, M; Das, T; Ghosh, A; Majumder, S; Maji, AK; Kanjilal, SD; Mukhopadhyay, I; Roychowdhury, S; Banerjee, S; Sengupta, S				Basu, Madhumita; Das, Tania; Ghosh, Alip; Majumder, Subhadipa; Maji, Ardhendu Kumar; Kanjilal, Sumana Datta; Mukhopadhyay, Indranil; Roychowdhury, Susanta; Banerjee, Soma; Sengupta, Sanghamitra			Gene-Gene Interaction and Functional Impact of Polymorphisms on Innate Immune Genes in Controlling Plasmodium falciparum Blood Infection Level	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; RNA SECONDARY STRUCTURES; GENOME-WIDE ASSOCIATION; SEVERE MALARIAL ANEMIA; TUMOR-NECROSIS-FACTOR; REGULATORY VARIATION; MESSENGER-RNA; PROMOTER REGION; THERMODYNAMIC PARAMETERS; ENVIRONMENT INTERACTIONS	Genetic variations in toll-like receptors and cytokine genes of the innate immune pathways have been implicated in controlling parasite growth and the pathogenesis of Plasmodium falciparum mediated malaria. We previously published genetic association of TLR4 non-synonymous and TNF-alpha promoter polymorphisms with P. falciparum blood infection level and here we extend the study considerably by (i) investigating genetic dependence of parasite-load on interleukin-12B polymorphisms, (ii) reconstructing gene-gene interactions among candidate TLRs and cytokine loci, (iii) exploring genetic and functional impact of epistatic models and (iv) providing mechanistic insights into functionality of disease-associated regulatory polymorphisms. Our data revealed that carriage of AA (P = 0.0001) and AC (P = 0.01) genotypes of IL12B 3'UTR polymorphism was associated with a significant increase of mean log-parasitemia relative to rare homozygous genotype CC. Presence of IL12B+1188 polymorphism in five of six multifactor models reinforced its strong genetic impact on malaria phenotype. Elevation of genetic risk in two-component models compared to the corresponding single locus and reduction of IL12B (2.2 fold) and lymphotoxin-a (1.7 fold) expressions in patients'peripheral-blood-mononuclear-cells under TLR4Thr399Ile risk genotype background substantiated the role of Multifactor Dimensionality Reduction derived models. Marked reduction of promoter activity of TNF-a risk haplotype (C-C-G-G) compared to wild- type haplotype (T-C-G-G) with (84%) and without (78%) LPS stimulation and the loss of binding of transcription factors detected in-silico supported a causal role of TNF-1031. Significantly lower expression of IL12B+1188 AA (5 fold) and AC (9 fold) genotypes compared to CC and under-representation (P = 0.0048) of allele A in transcripts of patients' PBMCs suggested an Allele-Expression-Imbalance. Allele (A+1188C) dependent differential stability (2 fold) of IL12B-transcripts upon actinomycin-D treatment and observed structural modulation (P = 0.013) of RNA-ensemble were the plausible explanations for AEI. In conclusion, our data provides functional support to the hypothesis that de-regulated receptor-cytokine axis of innate immune pathway influences blood infection level in P. falciparum malaria.	[Basu, Madhumita; Majumder, Subhadipa; Sengupta, Sanghamitra] Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India; [Das, Tania; Roychowdhury, Susanta] Indian Inst Chem Biol, Canc & Cell Biol Div, Kolkata, W Bengal, India; [Ghosh, Alip; Banerjee, Soma] Postgrad Inst Med Educ & Res, Liver Res Ctr, Kolkata, W Bengal, India; [Maji, Ardhendu Kumar] Calcutta Sch Trop Med, Dept Protozool, Kolkata, W Bengal, India; [Kanjilal, Sumana Datta] Calcutta Natl Med Coll, Dept Pediat Med, Kolkata, W Bengal, India; [Mukhopadhyay, Indranil] Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India	University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Calcutta School of Tropical Medicine (CSTM); Indian Statistical Institute; Indian Statistical Institute Kolkata	Sengupta, S (corresponding author), Univ Calcutta, Dept Biochem, Kolkata, W Bengal, India.	sanghamitrasg@yahoo.com	Sengupta, Sanghamitra/AAW-4300-2021	Basu, Madhumita/0000-0002-0378-7780	Department of Science and Technology, New Delhi (SERC Fast Track Scheme) [SR/FTP/L-56/2005]; University Grants Commission (Major Research Project) [33-232/2007]; University Grants Commission-Special Assistance Programme-The Research Fellowship in Sciences for meritorious students (UGC-SAP-RFSMS) scheme; Council of Scientific and Industrial Research (CSIR)-Senior Research Fellowship [09/(0829)/2010-EMR-I]	Department of Science and Technology, New Delhi (SERC Fast Track Scheme); University Grants Commission (Major Research Project); University Grants Commission-Special Assistance Programme-The Research Fellowship in Sciences for meritorious students (UGC-SAP-RFSMS) scheme; Council of Scientific and Industrial Research (CSIR)-Senior Research Fellowship	This work was supported by the Department of Science and Technology, New Delhi (SERC Fast Track Scheme - SR/FTP/L-56/2005 dated 25.04.2006) and University Grants Commission (Major Research Project - F. No 33-232/2007(SR) dated 13.03.2008). MB is supported by a pre-doctoral fellowship from University Grants Commission-Special Assistance Programme-The Research Fellowship in Sciences for meritorious students (UGC-SAP-RFSMS) scheme, and Council of Scientific and Industrial Research (CSIR)-Senior Research Fellowship (Sanction no. 09/(0829)/2010-EMR-I dated 29.3.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 1999, B SOC PATHOL EXOT, V92, P256; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Asselbergs FW, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-39; Atkinson A, 2011, GENES IMMUN, V12, P481, DOI 10.1038/gene.2011.19; Barbier M, 2008, MICROBES INFECT, V10, P673, DOI 10.1016/j.micinf.2008.03.001; Basu M, 2010, INFECT GENET EVOL, V10, P686, DOI 10.1016/j.meegid.2010.03.008; Berg JM, 2002, BIOCHEMISTRY-US, V5th; BETTS L, 1994, J BIOL CHEM, V269, P26456; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Bindewald E, 2006, RNA, V12, P342, DOI 10.1261/rna.2164906; Blencowe B, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P545; Boutlis CS, 2003, INFECT IMMUN, V71, P6354, DOI 10.1128/IAI.71.11.6354-6357.2003; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Carter AM, 2002, THROMB HAEMOSTASIS, V87, P846, DOI 10.1055/s-0037-1613095; Cattaert T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010304; Chan IHS, 2008, ALLERGY, V63, P1031, DOI 10.1111/j.1398-9995.2008.01639.x; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Diakite M, 2009, HUM GENET, V125, P105, DOI 10.1007/s00439-008-0597-2; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2006, J MOL BIOL, V359, P554, DOI 10.1016/j.jmb.2006.01.056; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hall MA, 2000, GENES IMMUN, V1, P219, DOI 10.1038/sj.gene.6363661; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hill AVS, 1996, PARASITOLOGY, V112, pS75, DOI 10.1017/S003118200007668X; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Hill AVS, 1999, P ASSOC AM PHYSICIAN, V111, P272, DOI 10.1046/j.1525-1381.1999.99234.x; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Jais PH, 2005, GENET MED, V7, P83, DOI 10.1097/01.GIM.0000153665.55420.C3; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kaluza W, 2000, J INVEST DERMATOL, V114, P1180, DOI 10.1046/j.1523-1747.2000.00001.x; Keller CC, 2006, INFECT IMMUN, V74, P5249, DOI 10.1128/IAI.00843-06; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kiryu H, 2012, BIOINFORMATICS, V28, P1093, DOI 10.1093/bioinformatics/bts097; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Kwiatkowski D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P233; Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Mangino M, 2008, J MOL MED, V86, P99, DOI 10.1007/s00109-007-0264-4; Marquet S, 2008, HUM MOL GENET, V17, P2190, DOI 10.1093/hmg/ddn118; Martin JS, 2012, RNA, V18, P77, DOI 10.1261/rna.029900.111; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; May L, 2010, EUR J HUM GENET, V18, P490, DOI 10.1038/ejhg.2009.182; Mechanic L.E., 2011, GENET EPIDEMIOL; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Mei H, 2007, AM J HUM GENET, V81, P1251, DOI 10.1086/522307; Mei H, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S145; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Metcalf CJE, 2011, SCIENCE, V333, P984, DOI 10.1126/science.1204588; Miteva LD, 2012, RHEUMATOL INT, V32, P53, DOI 10.1007/s00296-010-1547-6; Mohan K, 1998, EXP HEMATOL, V26, P45; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Morahan G, 2002, GENES IMMUN, V3, P414, DOI 10.1038/sj.gene.6363909; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Navikas V, 1996, J NEUROSCI RES, V45, P322, DOI 10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B; Ndiaye R, 2005, TISSUE ANTIGENS, V65, P474, DOI 10.1111/j.1399-0039.2005.00388.x; Neuman RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009903; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; Ong'echa JM, 2008, CLIN IMMUNOL, V126, P211, DOI 10.1016/j.clim.2007.08.007; Ong'echa JM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-69; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Perkins DJ, 2000, J INFECT DIS, V182, P988, DOI 10.1086/315762; Phawong C, 2010, IMMUNOGENETICS, V62, P345, DOI 10.1007/s00251-010-0439-y; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Randall LM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-302; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schuetze N, 2005, INT IMMUNOL, V17, P649, DOI 10.1093/intimm/dxh247; Sikora M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024996; Sikora M, 2009, HUM MOL GENET, V18, P3136, DOI 10.1093/hmg/ddp240; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stevenson MM, 2001, MICROBES INFECT, V3, P49, DOI 10.1016/S1286-4579(00)01354-X; STEVENSON MM, 1993, CLIN EXP IMMUNOL, V92, P77, DOI 10.1111/j.1365-2249.1993.tb05951.x; TAYLORROBINSON AW, 1994, INFECT IMMUN, V62, P2490, DOI 10.1128/IAI.62.6.2490-2498.1994; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tripathi G, 2010, CELLULAR BIOCH SCI; Tso HW, 2004, J INFECT DIS, V190, P913, DOI 10.1086/422693; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; Waksman SA, 1940, P SOC EXP BIOL MED, V45, P609; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2006, GUID TREATM MAL; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhang L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-87; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; ZUKER M, 1989, METHOD ENZYMOL, V180, P262; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	132	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46441	10.1371/journal.pone.0046441	http://dx.doi.org/10.1371/journal.pone.0046441			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071570	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500013
J	Connorton, JM; Webster, RE; Cheng, NH; Pittman, JK				Connorton, James M.; Webster, Rachel E.; Cheng, Ninghui; Pittman, Jon K.			Knockout of Multiple Arabidopsis Cation/H+ Exchangers Suggests Isoform-Specific Roles in Metal Stress Response, Germination and Seed Mineral Nutrition	PLOS ONE			English	Article							ION HOMEOSTASIS; SALT TOLERANCE; MANGANESE TRANSPORT; CALCIUM SENSOR; PROTEIN-KINASE; H+-ATPASE; CAX1; EXPRESSION; MUTATIONS; PHOSPHATE	Cation/H+ exchangers encoded by CAX genes play an important role in the vacuolar accumulation of metals including Ca2+ and Mn2+. Arabidopsis thaliana CAX1 and CAX3 have been previously shown to differ phylogenetically from CAX2 but the physiological roles of these different transporters are still unclear. To examine the functions and the potential of redundancy between these three cation transporters, cax1/cax2 and cax2/cax3 double knockout mutants were generated and compared with wild type and cax single knockouts. These double mutants had equivalent metal stress responses to single cax mutants. Both cax1 and cax1/cax2 had increased tolerance to Mg stress, while cax2 and cax2/cax3 both had increased sensitivity to Mn stress. The cax1/cax2 and cax2/cax3 mutants did not exhibit the deleterious developmental phenotypes previously seen with the cax1/cax3 mutant. However, these new double mutants did show alterations in seed germination, specifically a delay in germination time. These alterations correlated with changes in nutrient content within the seeds of the mutants, particularly the cax1/cax2 mutant which had significantly higher seed content of Ca and Mn. This study indicates that the presence of these Arabidopsis CAX transporters is important for normal germination and infers a role for CAX proteins in metal homeostasis within the seed.	[Connorton, James M.; Webster, Rachel E.; Pittman, Jon K.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Cheng, Ninghui] Baylor Coll Med, Childrens Nutr Res Ctr, ARS, USDA, Houston, TX 77030 USA	University of Manchester; Baylor College of Medicine; United States Department of Agriculture (USDA)	Pittman, JK (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Jon.Pittman@manchester.ac.uk		Connorton, James/0000-0002-9379-5599; Pittman, Jon/0000-0001-7197-1494	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship grant [BB/B502152/1]; United States Department of Agriculture/Agricultural Research Service [6250-51000-055]; Biotechnology and Biological Sciences Research Council [BB/B502152/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United States Department of Agriculture/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship grant (BB/B502152/1) to J.K.P., a BBSRC PhD studentship for J.M.C., and funding from The United States Department of Agriculture/Agricultural Research Service under Cooperation Agreement 6250-51000-055 to N.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKLA BJ, 1995, PLANT PHYSIOL, V109, P549, DOI 10.1104/pp.109.2.549; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; BENNETT AB, 1983, J MEMBRANE BIOL, V71, P95, DOI 10.1007/BF01870678; BEWLEY J. D, 2013, SEEDS, V3, DOI [DOI 10.1007/978-1-4614-4693-4_1, 10.1017/S0960258513000287]; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Broadley MR, 2004, J EXP BOT, V55, P321, DOI 10.1093/jxb/erh002; Catala R, 2003, PLANT CELL, V15, P2940, DOI 10.1105/tpc.015248; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Conn SJ, 2011, PLANT CELL, V23, P240, DOI 10.1105/tpc.109.072769; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Edmond C, 2009, BIOCHEM J, V418, P145, DOI 10.1042/BJ20081814; Emery L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00001; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Karley AJ, 2009, CURR OPIN PLANT BIOL, V12, P291, DOI 10.1016/j.pbi.2009.04.013; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Koren'kov V, 2007, PLANTA, V225, P403, DOI 10.1007/s00425-006-0352-7; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu TY, 2011, PLANT PHYSIOL, V156, P1176, DOI 10.1104/pp.111.175257; Lovegrove A, 2000, TRENDS PLANT SCI, V5, P102, DOI 10.1016/S1360-1385(00)01571-5; Manohar M, 2011, PLANT BIOLOGY, V13, P561, DOI 10.1111/j.1438-8677.2011.00466.x; Manohar M, 2011, BIOCHEMISTRY-US, V50, P6189, DOI 10.1021/bi2003839; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mei H, 2009, NEW PHYTOL, V183, P95, DOI 10.1111/j.1469-8137.2009.02831.x; OHNISHI T, 1975, ANAL BIOCHEM, V69, P261, DOI 10.1016/0003-2697(75)90585-0; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Peiter E, 2011, CELL CALCIUM, V50, P120, DOI 10.1016/j.ceca.2011.02.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittman JK, 2004, PLANT MOL BIOL, V56, P959, DOI 10.1007/s11103-004-6446-3; Pittman JK, 2005, NEW PHYTOL, V167, P733, DOI 10.1111/j.1469-8137.2005.01453.x; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Puig S, 2009, CURR OPIN PLANT BIOL, V12, P299, DOI 10.1016/j.pbi.2009.04.008; Punshon T, 2012, PLANT PHYSIOL, V158, P352, DOI 10.1104/pp.111.184812; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Shigaki T, 2010, PLANT BIOLOGY, V12, P935, DOI 10.1111/j.1438-8677.2010.00368.x; WILLIAMS LE, 1990, PLANT PHYSIOL, V92, P747, DOI 10.1104/pp.92.3.747; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhao J, 2008, PLANTA, V227, P659, DOI 10.1007/s00425-007-0648-2; Zhao J, 2009, J BIOL CHEM, V284, P34075, DOI 10.1074/jbc.M109.070235; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	55	18	21	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47455	10.1371/journal.pone.0047455	http://dx.doi.org/10.1371/journal.pone.0047455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071810	Green Submitted, Green Published, gold			2022-12-25	WOS:000309809500050
J	You, FZ; Huo, KM; Wang, RL; Xu, DM; Deng, J; Wei, Y; Shi, FL; Liu, HY; Cheng, GM; Zhang, Z; Yang, P; Sun, T; Wang, XY; Jacobsson, B; Zhu, CL				You, Fengzhi; Huo, Kaiming; Wang, Ruili; Xu, Dongmei; Deng, Jie; Wei, Ying; Shi, Fenglian; Liu, Hongyang; Cheng, Guomei; Zhang, Zhan; Yang, Ping; Sun, Tao; Wang, Xiaoyang; Jacobsson, Bo; Zhu, Changlian			Maternal Mortality in Henan Province, China: Changes between 1996 and 2009	PLOS ONE			English	Article							COUNTRIES; DEATHS; HEALTH; DETERMINANTS; PREVENTABILITY; COVERAGE; OUTCOMES; SYSTEM; CHILD	Background: Maternal deaths occur mostly in developing countries and the majority of them are preventable. This study analyzes changes in maternal mortality and related causes in Henan Province, China, between 1996 and 2009, in an attempt to provide a reliable basis for introducing effective interventions to reduce the maternal mortality ratio (MMR), part of the fifth Millennium Development Goal. Methods and Findings: This population-based maternal mortality survey in Henan Province was carried out from 1996 to 2009. Basic information was obtained from the health care network for women and children and the vital statistics system, from specially trained monitoring personnel in 25 selected monitoring sites and by household survey in each case of maternal death. This data was subsequently reported to the Henan Provincial Maternal and Child Healthcare Hospital. The total MMR in Henan Province declined by 78.4%, from 80.1 per 100 000 live births in 1996 to 17.3 per 100 000 live births in 2009. The decline was more pronounced in rural than in urban areas. The most common causes of maternal death during this period were obstetric hemorrhage (43.8%), pregnancy-induced hypertension (15.8%), amniotic fluid embolism (13.9%) and heart disease (8.0%). The MMR was higher in rural areas with lower income, less education and poorer health care. Conclusion: There was a remarkable decrease in the MMR in Henan Province between 1996 and 2009 mainly in the rural areas and MMR due to direct obstetric causes such as obstetric hemorrhage. This study indicates that improving the health care network for women, training of obstetric staff at basic-level units, promoting maternal education, and increasing household income are important interventional strategies to reduce the MMR further.	[Huo, Kaiming; Wang, Xiaoyang; Zhu, Changlian] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Peoples R China; [You, Fengzhi; Xu, Dongmei; Deng, Jie; Wei, Ying; Shi, Fenglian; Liu, Hongyang; Cheng, Guomei; Zhang, Zhan; Yang, Ping] Zhengzhou Univ, Affiliated Hosp 3, Dept Womens Healthcare, Zhengzhou, Peoples R China; [You, Fengzhi; Xu, Dongmei; Deng, Jie; Wei, Ying; Shi, Fenglian; Yang, Ping] Henan Prov Womens & Childrens Hosp, Dept Womens Healthcare, Zhengzhou, Henan, Peoples R China; [Wang, Ruili] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Peoples R China; [Sun, Tao] Hlth Dept Henan Prov, Womens & Childrens Hlth Care Sect, Zhengzhou, Peoples R China; [Wang, Xiaoyang] Univ Gothenburg, Dept Physiol, Perinatal Ctr, Sahlgrenska Acad, Gothenburg, Sweden; [Jacobsson, Bo] Univ Gothenburg, Sahlgrenska Univ Hosp E, Dept Obstet & Gynecol, Perinatal Ctr, Gothenburg, Sweden; [Jacobsson, Bo] Norwegian Inst Publ Hlth, Oslo, Norway; [Zhu, Changlian] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Zhengzhou University; Zhengzhou University; Zhengzhou University; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Norwegian Institute of Public Health (NIPH); University of Gothenburg	Zhu, CL (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou, Peoples R China.	zhuc@zzu.edu.cn	Jacobsson, Bo/O-8007-2014; Zhu, Changlian/AAN-6205-2020	Jacobsson, Bo/0000-0001-5079-2374; Zhu, Changlian/0000-0002-5029-6730; Wang, Xiaoyang/0000-0001-9717-8160	Health Department of Henan Province; Chinese Ministry of Health	Health Department of Henan Province; Chinese Ministry of Health	This study was funded by the Health Department of Henan Province and the Chinese Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldawood A, 2011, ANN SAUDI MED, V31, P518, DOI 10.4103/0256-4947.84631; Anderson T, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c431; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; Bodker B, 2009, ACTA OBSTET GYN SCAN, V88, P556, DOI 10.1080/00016340902897992; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chen YY, 2012, J HEALTH ECON, V31, P1, DOI 10.1016/j.jhealeco.2011.11.001; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; Du Q, 2009, HEALTH CARE WOMEN IN, V30, P957, DOI 10.1080/07399330903052137; Feng XL, 2010, BJOG-INT J OBSTET GY, V117, P1527, DOI 10.1111/j.1471-0528.2010.02707.x; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kilpatrick SJ, 2002, OBSTET GYNECOL, V100, P321, DOI 10.1016/S0029-7844(02)02065-3; Li J, 2007, BJOG-INT J OBSTET GY, V114, P865, DOI 10.1111/j.1471-0528.2007.01362.x; Li XH, 2011, ACTA OBSTET GYN SCAN, V90, P586, DOI 10.1111/j.1600-0412.2011.01110.x; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037458; Liang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-243; Liang JA, 2010, INT J GYNECOL OBSTET, V110, P93, DOI 10.1016/j.ijgo.2010.03.013; Alvarez JL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-462; Ministry of Health of the People's Republic China, 2010, CHIN HLTH YB 2010; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; Organization wH, 1993, INT AL STAT CLASS DI, V2; Palmer A, 2009, LANCET, V373, P1987, DOI 10.1016/S0140-6736(09)60231-2; Qiu LQ, 2010, MIDWIFERY, V26, P544, DOI 10.1016/j.midw.2010.06.003; Qiu PY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-520; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Shen C, 1999, SOC SCI MED, V49, P197, DOI 10.1016/S0277-9536(99)00112-4; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012	32	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47153	10.1371/journal.pone.0047153	http://dx.doi.org/10.1371/journal.pone.0047153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071740	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500032
J	Andersson, DA; Gentry, C; Bevan, S				Andersson, David A.; Gentry, Clive; Bevan, Stuart			TRPA1 Has a Key Role in the Somatic Pro-Nociceptive Actions of Hydrogen Sulfide	PLOS ONE			English	Article							PRIMARY AFFERENT NEURONS; CALCIUM-CHANNELS; REFERRED HYPERALGESIA; SENSORY NEURONS; VISCERAL PAIN; COLD; ACTIVATION; RECEPTOR; INFLAMMATION; TRPM8	Hydrogen sulfide (H2S), which is produced endogenously from L-cysteine, is an irritant with pro-nociceptive actions. We have used measurements of intracellular calcium concentration, electrophysiology and behavioral measurements to show that the somatic pronociceptive actions of H2S require TRPA1. A H2S donor, NaHS, activated TRPA1 expressed in CHO cells and stimulated DRG neurons isolated from Trpa1(+/+) but not Trpa1(-/-) mice. TRPA1 activation by NaHS was pH dependent with increased activity at acidic pH. The midpoint of the relationship between NaHS EC50 values and external pH was pH 7.21, close to the expected dissociation constant for H2S (pK(a) 7.04). NaHS evoked single channel currents in inside-out and cell-attached membrane patches consistent with an intracellular site of action. In behavioral experiments, intraplantar administration of NaHS and L-cysteine evoked mechanical and cold hypersensitivities in Trpa1(+/+) but not in Trpa1(-/-) mice. The sensitizing effects of L-cysteine in wild-type mice were inhibited by a cystathionine beta-synthase inhibitor, D, L-propargylglycine (PAG), which inhibits H2S formation. Mechanical hypersensitivity evoked by intraplantar injections of LPS was prevented by PAG and the TRPA1 antagonist AP-18 and was absent in Trpa1(-/-) mice, indicating that H2S mediated stimulation of TRPA1 is necessary for the local pronociceptive effects of LPS. The pro-nociceptive effects of intraplantar NaHS were retained in Trpv1(-/-) mice ruling out TRPV1 as a molecular target. In behavioral studies, NaHS mediated sensitization was also inhibited by a T-type calcium channel inhibitor, mibefradil. In contrast to the effects of NaHS on somatic sensitivity, intracolonic NaHS administration evoked similar nociceptive effects in Trpa1(+/+) and Trpa1(-/-) mice, suggesting that the visceral pro-nociceptive effects of H2S are independent of TRPA1. In electrophysiological studies, the depolarizing actions of H2S on isolated DRG neurons were inhibited by AP-18, but not by mibefradil indicating that the primary excitatory effect of H2S on DRG neurons is TRPA1 mediated depolarization.	[Andersson, David A.; Gentry, Clive; Bevan, Stuart] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England	University of London; King's College London	Bevan, S (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	stuart.bevan@kcl.ac.uk	Bevan, Stuart/A-8821-2008; Andersson, David A/C-3435-2008	Andersson, David A/0000-0001-7451-8548; Bevan, Stuart John/0000-0002-8977-1797	King's College London/London Law Trust Medal Fellowship	King's College London/London Law Trust Medal Fellowship	DAA was supported by a King's College London/London Law Trust Medal Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; BEVAN S, 1995, J NEUROSCI, V15, P4918; Bhatia M, 2006, AM J PHYSIOL-LUNG C, V291, pL896, DOI 10.1152/ajplung.00053.2006; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Cunha TM, 2008, EUR J PHARMACOL, V590, P127, DOI 10.1016/j.ejphar.2008.05.048; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Dal-Secco D, 2008, J IMMUNOL, V181, P4287, DOI 10.4049/jimmunol.181.6.4287; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Distrutti E, 2006, J PHARMACOL EXP THER, V319, P447, DOI 10.1124/jpet.106.106435; Docherty RJ, 1997, BRIT J PHARMACOL, V121, P1461, DOI 10.1038/sj.bjp.0701272; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Harada N, 2002, J LAB CLIN MED, V139, P218, DOI 10.1067/mlc.2002.121856; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Holzer P, 2007, CURR OPIN PHARMACOL, V7, P563, DOI 10.1016/j.coph.2007.09.004; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Kimura H, 2010, ANTIOXID REDOX SIGNA; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Krueger D, 2010, NEUROGASTROENT MOTIL, V22, P1224, DOI 10.1111/j.1365-2982.2010.01571.x; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Matsunami M, 2009, GUT, V58, P751, DOI 10.1136/gut.2007.144543; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; Miyamoto R, 2011, NEUROSCI LETT, V499, P137, DOI 10.1016/j.neulet.2011.05.057; Mizutani A, 2009, ANESTHESIOLOGY, V110, P361, DOI 10.1097/ALN.0b013e3181942f3c; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nishimura S, 2009, GUT, V58, P762, DOI 10.1136/gut.2008.151910; Ogawa H, 2012, NEUROSCIENCE, V218, P335, DOI 10.1016/j.neuroscience.2012.05.044; Patacchini R, 2004, BRIT J PHARMACOL, V142, P31, DOI 10.1038/sj.bjp.0705764; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Todorovic SM, 2007, CHANNELS, V1, P238, DOI 10.4161/chan.4953; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; Tsubota-Matsunami M, 2012, J PHARMACOL SCI, V119, P293, DOI 10.1254/jphs.12086SC; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	59	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46917	10.1371/journal.pone.0046917	http://dx.doi.org/10.1371/journal.pone.0046917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071662	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700041
J	Shen, QY; Fuchs, T; Sahir, N; Luscher, B				Shen, Qiuying; Fuchs, Thomas; Sahir, Nadia; Luscher, Bernhard			GABAergic Control of Critical Developmental Periods for Anxiety- and Depression-Related Behavior in Mice	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEWLY GENERATED NEURONS; GABA(A) RECEPTORS; SEROTONIN(1A) RECEPTOR; VISUAL-CORTEX; GENE; MATURATION; MODEL; INNERVATION; DELETION	Vulnerability for anxiety and depressive disorders is thought to have origins in early life and is increasingly recognized to involve deficits in GABAergic neurotransmission. Mice that were rendered heterozygous for the gamma 2 subunit gene of GABA(A) receptors (GABA(A)Rs) show behavioral, cognitive, neuroendocrine and pharmacologic features expected of a mouse model of melancholic anxious depression, including reduced survival of adult-born hippocampal neurons. Here we embarked on elucidating the developmental substrate underlying this phenotype, focusing on the Elevated Plus Maze and Forced Swim Test as relevant behavioral paradigms. In a first series of experiments using hemizygous tamoxifen-induced genetic inactivation of a floxed gamma 2 genomic locus we show that reducing the gene dosage at postnatal days (P) 13/14 but not P27/28 results in altered behavior in both of these tests in adulthood, reminiscent of the anxious-depressive phenotype previously described for global heterozygous mice. However, in contrast to global heterozygous mice, the behavioral changes induced by gamma 2 subunit knockdown at P13/14 occurred without changes in adult hippocampal neurogenesis, indicating that altered neurogenesis is not an absolute prerequisite for anxiety-and depression-related behavior in this model. In a separate series of experiments using a pharmacological approach, acute but transient potentiation of GABA(A)Rs with diazepam uncovered distinct developmental vulnerabilities for altered behavior in the Elevated Plus Maze and Forced Swim Test, respectively. Specifically, diazepam given during P10-16 but not during later weeks resulted in increased anxiety-like behavior in adulthood, while diazepam administered during P29-35 but not earlier nor later resulted in increased immobility behavior in adulthood. We conclude that anxiety-like behavior in the Elevated Plus Maze and behavioral despair-like immobility in the Forced Swim Test are controlled by separate postnatal critical periods characterized by distinct developmental sensitivity to manipulation of GABAergic transmission via gamma 2 subunit-containing GABA(A)Rs.	[Shen, Qiuying; Fuchs, Thomas; Sahir, Nadia; Luscher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shen, Qiuying; Luscher, Bernhard] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Luscher, Bernhard] Penn State Univ, Dept Psychiat, Coll Med, Hershey, PA USA; [Shen, Qiuying; Fuchs, Thomas; Sahir, Nadia; Luscher, Bernhard] Penn State Univ, Ctr Mol Invest Neurol Disorders, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Luscher, B (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	BXL25@psu.edu	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906	National Institutes of Mental Health (NIMH) [MH60989, MH089111]; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089111, R01MH060989] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This publication was made possible by grants MH60989 and MH089111 to B. L. from the National Institutes of Mental Health (NIMH) and a grant from the Pennsylvania Department of Health using Tobacco Settlement Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman CJ, 2007, TRENDS NEUROSCI, V30, P382, DOI 10.1016/j.tins.2007.06.002; Allain AE, 2010, ANN NY ACAD SCI, V1198, P208, DOI 10.1111/j.1749-6632.2010.05433.x; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; [Anonymous], [No title captured]; Ansorge MS, 2007, CURR OPIN PHARMACOL, V7, P8, DOI 10.1016/j.coph.2006.11.006; Baho E, 2012, J NEUROSCI, V32, P911, DOI 10.1523/JNEUROSCI.4352-11.2012; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046; Briner A, 2010, ANESTHESIOLOGY, V112, P546, DOI 10.1097/ALN.0b013e3181cd7942; CARLSON GA, 1980, AM J PSYCHIAT, V137, P445; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; De Roo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007043; Deng W, 2010, NAT REV NEUROSCI; Depino AM, 2008, BRAIN RES, V1210, P189, DOI 10.1016/j.brainres.2008.03.006; Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Gamez W, 2007, J ANXIETY DISORD, V21, P526, DOI 10.1016/j.janxdis.2006.08.003; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Guilloux JP, 2011, MOL PSYCHIAT; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hanson ND, 2011, DEPRESSION ANTIDEPRE; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kessler RC, 2012, INT J METHODS PSYCHI; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; Koob GF, 2012, HAND CLINIC, V106, P137, DOI 10.1016/B978-0-444-52002-9.00009-7; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Leussis MP, 2008, SYNAPSE, V62, P22, DOI 10.1002/syn.20462; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Murphy JM, 2004, ACTA PSYCHIAT SCAND, V109, P355, DOI 10.1111/j.1600-0447.2003.00286.x; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Phillips NK, 2005, J ABNORM CHILD PSYCH, V33, P13, DOI 10.1007/s10802-005-0930-3; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Sernagor E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00011; Shen QY, 2010, BIOL PSYCHIAT, V68, P512, DOI 10.1016/j.biopsych.2010.04.024; Sibille E, 2000, J NEUROSCI, V20, P2758; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Vinkers CH, 2010, BIOL PSYCHIAT, V67, P309, DOI 10.1016/j.biopsych.2009.08.013; Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009; Vollmayr B, 2003, BIOL PSYCHIAT, V54, P1035, DOI 10.1016/S0006-3223(03)00527-4; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Webber Ann L, 2005, Clin Exp Optom, V88, P365; WEISSMAN MM, 1984, J AFFECT DISORDERS, V7, P179, DOI 10.1016/0165-0327(84)90039-9; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P932; Weissman MM, 2009, JAMA-J AM MED ASSOC, V302, P1167, DOI 10.1001/jama.2009.1329; Yoo JH, 2010, SYNAPSE, V64, P274, DOI 10.1002/syn.20726	78	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47441	10.1371/journal.pone.0047441	http://dx.doi.org/10.1371/journal.pone.0047441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071808	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700081
J	Jalali, S; Ramanathan, GK; Parthasarathy, PT; Aljubran, S; Galam, L; Yunus, A; Garcia, S; Cox, RR; Lockey, RF; Kolliputi, N				Jalali, Samuel; Ramanathan, Gurukumar K.; Parthasarathy, Prasanna Tamarapu; Aljubran, Salman; Galam, Lakshmi; Yunus, Asfiya; Garcia, Sara; Cox, Ruan R., Jr.; Lockey, Richard F.; Kolliputi, Narasaiah			Mir-206 Regulates Pulmonary Artery Smooth Muscle Cell Proliferation and Differentiation	PLOS ONE			English	Article							DOWN-REGULATION; HYPERTENSION; EXPRESSION; NOTCH; APOPTOSIS; PROMOTES; INHIBITION; MODULATION; INVASION; PATHWAY	Pulmonary Arterial Hypertension (PAH) is a progressive devastating disease characterized by excessive proliferation of the Pulmonary Arterial Smooth Muscle Cells (PASMCs). Studies suggest that PAH and cancers share an apoptosis-resistant state featuring excessive cell proliferation. MicroRNA-206 (miR-206) is known to regulate proliferation and is implicated in various types of cancers. However, the role of miR-206 in PAH has not been studied. In this study, it is hypothesized that miR-206 could play a role in the proliferation of PASMCs. In the present study, the expression patterns of miR-206 were investigated in normal and hypertensive mouse PASMCs. The effects of miR-206 in modulating cell proliferation, apoptosis and smooth muscle cell markers in human pulmonary artery smooth muscle cells (hPASMCs) were investigated in vitro. miR-206 expression in mouse PASMCs was correlated with an increase in right ventricular systolic pressure. Reduction of miR-206 levels in hPASMCs causes increased proliferation and reduced apoptosis and these effects were reversed by the overexpression of miR-206. miR-206 over expression also increased the levels of smooth muscle cell differentiation markers a-smooth muscle actin and calponin implicating its importance in the differentiation of SMCs. miR-206 overexpression down regulated Notch-3 expression, which is key a factor in PAH development. These results suggest that miR-206 is a potential regulator of proliferation, apoptosis and differentiation of PASMCs, and that it could be used as a novel treatment strategy in PAH.	[Jalali, Samuel; Ramanathan, Gurukumar K.; Parthasarathy, Prasanna Tamarapu; Aljubran, Salman; Galam, Lakshmi; Yunus, Asfiya; Garcia, Sara; Cox, Ruan R., Jr.; Lockey, Richard F.; Kolliputi, Narasaiah] Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Kolliputi, N (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33620 USA.	nkollipu@health.usf.edu	Kolliputi, Narasaiah/I-6050-2012	Kolliputi, Narasaiah/0000-0002-2654-1900	American Heart Association National Scientist Development Grant [09SDG2260957]; NIH [R01 HL105932]; Joy McCann Culverhouse Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105932] Funding Source: NIH RePORTER	American Heart Association National Scientist Development Grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joy McCann Culverhouse Endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association National Scientist Development Grant 09SDG2260957 and NIH R01 HL105932 to Narasaiah Kolliputi and the Joy McCann Culverhouse Endowment to the Division of Allergy and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Boniface S, 2011, Rev Mal Respir, V28, pe94, DOI 10.1016/j.rmr.2009.07.001; Bonnet S, 2007, PHARMACOL THERAPEUT, V115, P56, DOI 10.1016/j.pharmthera.2007.03.014; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chen XY, 2012, CANCER LETT, V314, P41, DOI 10.1016/j.canlet.2011.09.014; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Guo L, 2012, HYPERTENSION; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Joshi Sachindra R, 2011, Pulm Circ, V1, P357, DOI 10.4103/2045-8932.87301; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Thistlethwaite PA, 2010, ADV EXP MED BIOL, V661, P279, DOI 10.1007/978-1-60761-500-2_18; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Zhang TH, 2011, ANTICANCER RES, V31, P3859	35	86	104	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46808	10.1371/journal.pone.0046808	http://dx.doi.org/10.1371/journal.pone.0046808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071643	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200047
J	Kerschberger, B; Hilderbrand, K; Boulle, AM; Coetzee, D; Goemaere, E; De Azevedo, V; Van Cutsem, G				Kerschberger, Bernhard; Hilderbrand, Katherine; Boulle, Andrew M.; Coetzee, David; Goemaere, Eric; De Azevedo, Virginia; Van Cutsem, Gilles			The Effect of Complete Integration of HIV and TB Services on Time to Initiation of Antiretroviral Therapy: A Before-After Study	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; MORTALITY; PREVALENCE; INFECTION; SURVIVAL; EARLIER; ADULTS; CARE	Background: Studies have shown that early ART initiation in TB/HIV co-infected patients lowers mortality. One way to implement earlier ART commencement could be through integration of TB and HIV services, a more efficient model of care than separate, vertical programs. We present a model of full TB/HIV integration and estimate its effect on time to initiation of ART. Methodology/Principal Findings: We retrospectively reviewed TB registers and clinical notes of 209 TB/HIV co-infected adults with a CD4 count <250 cells/mu l and registered for TB treatment at one primary care clinic in a South African township between June 2008 and May 2009. Using Kaplan-Meier and Cox proportional hazard analysis, we compared time between initiation of TB treatment and ART for the periods before and after full, "one-stop shop" integration of TB and HIV services (in December 2009). Potential confounders were determined a priori through directed acyclic graphs. Robustness of assumptions was investigated by sensitivity analyses. The analysis included 188 patients (100 pre- and 88 post-integration), yielding 56 person-years of observation. Baseline characteristics of the two groups were similar. Median time to ART initiation decreased from 147 days (95% confidence interval [CI] 85-188) before integration of services to 75 days (95% CI 52-119) post-integration. In adjusted analyses, patients attending the clinic post-integration were 1.60 times (95% CI 1.11-2.29) more likely to have started ART relative to the pre-integration period. Sensitivity analyses supported these findings. Conclusions/Significance: Full TB/HIV care integration is feasible and led to a 60% increased chance of co-infected patients starting ART, while reducing time to ART initiation by an average of 72 days. Although these estimates should be confirmed through larger studies, they suggest that scale-up of full TB/HIV service integration in high TB/HIV prevalence settings may shorten time to ART initiation, which might reduce excess mortality and morbidity.	[Kerschberger, Bernhard; Hilderbrand, Katherine; Van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Hilderbrand, Katherine; Boulle, Andrew M.; Coetzee, David; Van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Goemaere, Eric] Med Sans Frontieres, S African Med Unit, Johannesburg, South Africa; [De Azevedo, Virginia] City Cape Town, Hlth Directorate, Khayelitsha, South Africa	University of Cape Town	Van Cutsem, G (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	gillesvancutsem@gmail.com	Boulle, Andrew/C-1413-2008; Van Cutsem, Gilles/ABB-1171-2021	Boulle, Andrew/0000-0002-7713-8062; Van Cutsem, Gilles/0000-0002-8972-4480; Kerschberger, Bernhard/0000-0003-0525-7262				Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; [Anonymous], 2010, HIV TB CARE PRIMARY; [Anonymous], 2008, INT J TUBERC LUNG DI, V12; [Anonymous], 2009, NAT TUB MAN GUID 200; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; BLANC FX, 2010, 18 INT AIDS C VIENN; Chilton D, 2008, THORAX, V63, P935, DOI 10.1136/thx.2008.104232; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Craig P, 2008, BMJ, V337; Fisher A., 2002, DESIGNING HIV AIDS I; Franke MF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001029; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Gasana M, 2008, INT J TUBERC LUNG D, V12, pS39; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Hernan MA, 2004, J EPIDEMIOL COMMUN H, V58, P265, DOI 10.1136/jech.2002.006361; Hirschhorn LR, 2006, HUMAN RESOURCES HLTH, V4; Huerga H, 2010, INT J TUBERC LUNG D, V14, P611; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-258; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Legido-Quigley H, 2010, GLOB S HLTH SYST RES; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Medecins Sans Frontieres, 2010, HIV TB CAR PRIM HLTH; Micek M, 2005, INTEGRATING TB HIV C; Miti S, 2003, INT J TUBERC LUNG D, V7, pS92; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Naidoo S., 2007, Southern African Journal of Epidemiology & Infection, V22, P45; Okot-Chono R, 2009, INT J TUBERC LUNG D, V13, P955; Pepper DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037634; Perumal R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-243; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Simon S, 2008, PALLIATIVE MED, V23; Smart T, 2010, INTEGRATING TB HIV S; South African Department of Health, 2004, S AFR NAT TUB CONTR; South African Department of Health, 2010, CLIN GUID MAN HIV AI; Tabarsi P, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-14; Tawfik L, 2006, IMPACT HIV AIDS HLTH; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; UNAIDS, 2010, GLOB REP UNAIDS REP; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; WHO, 2010, ANT THER HIV INF AD; WHO, 2006, WORLD HLTH REPORT 20; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organisation, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2010, GLOB TUB CONTR WHO R	53	42	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46988	10.1371/journal.pone.0046988	http://dx.doi.org/10.1371/journal.pone.0046988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071690	Green Published, Green Submitted, gold			2022-12-25	WOS:000309827300075
J	Muller, JR; Waldmann, TA; Kruhlak, MJ; Dubois, S				Mueller, Juergen R.; Waldmann, Thomas A.; Kruhlak, Michael J.; Dubois, Sigrid			Paracrine and Transpresentation Functions of IL-15 Are Mediated by Diverse Splice Versions of IL-15R alpha in Human Monocytes and Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ALPHA-CHAIN; NATURAL-KILLER; CUTTING EDGE; T-CELLS; EXPRESSION; INTERLEUKIN-15; GLYCOSYLATION; TRANS; NK; PROLIFERATION	Species-specific differences of post-translational modifications suggested the existence of human IL-15R alpha isoforms. We identified eight new isoforms that are predicted to modify the intracellular C termini of IL-15R alpha, and another N-terminal exon "Ex2A" that was consistently present in all but one of the C-terminal isoforms. Ex2A encodes a 49-amino acid domain that allowed the transfer of IL-15/IL-15R alpha complex to the cell surface but prevented its cleavage from cell membranes and its secretion thus facilitating the transpresentation of IL-15 as part of the immunological synapse. The Ex2A domain also affected the O-glycosylation of IL-15R alpha that explained the species-specific differences. The Ex2A domain appeared to be removed from major IL-15R alpha species during protein maturation, but both Ex2A and IL-15R alpha appeared on the surface of monocytic cells upon activation. The membrane-associated form of the only C-terminal isoform that lacked Ex2A (IC3) was retained inside the cell, but soluble IL-15/IL-15R alpha complexes were readily released from cells that expressed IL-15/IL-15R alpha-IC3 thus limiting this IL-15/IL-15R alpha isoform to act as a secreted molecule. These data suggest that splice versions of IL-15R alpha determine the range of IL-15 activities.	[Mueller, Juergen R.; Waldmann, Thomas A.; Dubois, Sigrid] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; [Kruhlak, Michael J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Dubois, S (corresponding author), NCI, Metab Branch, NIH, Bldg 10,Rm 4B47,10 Ctr Dr, Bethesda, MD 20892 USA.	duboiss@mail.nih.gov	Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Dubois, Sigrid/0000-0002-4543-5222	NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC004002, ZICBC010915] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the NCI, National Institutes of Health.	ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Baum LG, 2002, IMMUNITY, V16, P5, DOI 10.1016/S1074-7613(02)00265-0; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubois SP, 2005, P NATL ACAD SCI USA, V102, P8662, DOI 10.1073/pnas.0503360102; Freeze H H, 2001, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1502s03; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Koka R, 2004, J IMMUNOL, V173, P3594, DOI 10.4049/jimmunol.173.6.3594; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Mariner JM, 2001, J IMMUNOL, V166, P2602, DOI 10.4049/jimmunol.166.4.2602; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Yokoyama Wayne M, 2006, Curr Protoc Immunol, VChapter 2, DOI 10.1002/0471142735.im0205s74	35	16	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40328	40338		10.1074/jbc.M112.378612	http://dx.doi.org/10.1074/jbc.M112.378612			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23074221	Green Published, hybrid			2022-12-25	WOS:000311448800024
J	Chen, LH; Hu, W; Tan, SL; Wang, M; Ma, ZB; Zhou, SY; Deng, XM; Zhang, Y; Huang, C; Yang, GX; He, GY				Chen, Lihong; Hu, Wei; Tan, Shenglong; Wang, Min; Ma, Zhanbing; Zhou, Shiyi; Deng, Xiaomin; Zhang, Yang; Huang, Chao; Yang, Guangxiao; He, Guangyuan			Genome-Wide Identification and Analysis of MAPK and MAPKK Gene Families in Brachypodium distachyon	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; SALT STRESS; ENHANCES SENSITIVITY; ARABIDOPSIS; TRANSCRIPTION; EXPRESSION; ETHYLENE; PATHWAY; PLANTS; MPK4	MAPK cascades are universal signal transduction modules and play important roles in plant growth, development and in response to a variety of biotic and abiotic stresses. Although MAPKs and MAPKKs have been systematically investigated in several plant species including Arabidopsis, rice and poplar, no systematic analysis has been conducted in the emerging monocot model plant Brachypodium distachyon. In the present study, a total of 16 MAPK genes and 12 MAPKK genes were identified from B. distachyon. An analysis of the genomic evolution showed that both tandem and segment duplications contributed significantly to the expansion of MAPK and MAPKK families. Evolutionary relationships within subfamilies were supported by exon-intron organizations and the architectures of conserved protein motifs. Synteny analysis between B. distachyon and the other two plant species of rice and Arabidopsis showed that only one homolog of B. distachyon MAPKs was found in the corresponding syntenic blocks of Arabidopsis, while 13 homologs of B. distachyon MAPKs and MAPKKs were found in that of rice, which was consistent with the speciation process of the three species. In addition, several interactive protein pairs between the two families in B. distachyon were found through yeast two hybrid assay, whereas their orthologs of a pair in Arabidopsis and other plant species were not found to interact with each other. Finally, expression studies of closely related family members among B. distachyon, Arabidopsis and rice showed that even recently duplicated representatives may fulfill different functions and be involved in different signal pathways. Taken together, our data would provide a foundation for evolutionary and functional characterization of MAPK and MAPKK gene families in B. distachyon and other plant species to unravel their biological roles.	[Chen, Lihong; Hu, Wei; Wang, Min; Ma, Zhanbing; Zhou, Shiyi; Deng, Xiaomin; Zhang, Yang; Huang, Chao; Yang, Guangxiao; He, Guangyuan] HUST, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Wuhan, Peoples R China; [Tan, Shenglong] HUST, Sch Comp Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, GX (corresponding author), HUST, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Wuhan, Peoples R China.	ygx@mail.hust.edu.cn; hegy@mail.hust.edu.cn	tan, sheng/GSN-2599-2022		Key Projects of International Cooperation of Chinese Ministry of Science and Technology [2009DFB20290, 2009DFB30340]; National Project of Oceanic and Public welfare Industry of China [201005013]; Chinese State Council Special Major Programs [2009ZX08016-001A]	Key Projects of International Cooperation of Chinese Ministry of Science and Technology; National Project of Oceanic and Public welfare Industry of China; Chinese State Council Special Major Programs	This study was financially supported by the Key Projects of International Cooperation of Chinese Ministry of Science and Technology (2009DFB20290 and 2009DFB30340, http://www.cistc.gov.cn/englishversion/), National Project of Oceanic and Public welfare Industry of China (201005013, http://www.most.gov.cn/eng/programmes1/) and the Chinese State Council Special Major Programs (2009ZX08016-001A, http://www.most.gov.cn/eng/programmes1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Beck M, 2011, NEW PHYTOL, V189, P1069, DOI 10.1111/j.1469-8137.2010.03565.x; Beck M, 2010, PLANT CELL, V22, P755, DOI 10.1105/tpc.109.071746; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Boudsocq M, 2005, PLANT PHYSIOL, V138, P1185, DOI 10.1104/pp.105.061275; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Gudesblat GE, 2007, NEW PHYTOL, V173, P713, DOI 10.1111/j.1469-8137.2006.01953.x; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jang CS, 2006, PLANT PHYSIOL, V142, P1148, DOI 10.1104/pp.106.082891; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kong FL, 2012, GENE, V499, P108, DOI 10.1016/j.gene.2012.01.048; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; Lee SK, 2011, J BIOSCIENCES, V36, P139, DOI 10.1007/s12038-011-9002-8; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Ohme-Takagi M, 2000, PLANT CELL PHYSIOL, V41, P1187, DOI 10.1093/pcp/pcd057; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wilson C, 1997, PLANT CELL, V9, P2093, DOI 10.1105/tpc.9.11.2093; Wise RA, 2007, CHEST, V132, P1191, DOI 10.1378/chest.07-0455; Xu J, 2008, J BIOL CHEM, V283, P26996, DOI 10.1074/jbc.M801392200; Yoo SD, 2008, PLANT SIGNAL BEHAV, V3, P848, DOI 10.4161/psb.3.10.5995; Zeng QN, 2011, PLANT J, V67, P895, DOI 10.1111/j.1365-313X.2011.04642.x; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032153; Zhou CJ, 2009, PLANT PHYSIOL, V150, P167, DOI 10.1104/pp.108.133439	55	47	60	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46744	10.1371/journal.pone.0046744	http://dx.doi.org/10.1371/journal.pone.0046744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082129	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900024
J	Ngo, S; Chiang, V; Ho, E; Le, L; Guo, ZF				Ngo, Sam; Chiang, Vicky; Ho, Elaine; Le, Linh; Guo, Zhefeng			Prion Domain of Yeast Ure2 Protein Adopts a Completely Disordered Structure: A Solid-Support EPR Study	PLOS ONE			English	Article							REVEALS CONFORMATIONAL EQUILIBRIA; LABELED SIDE-CHAINS; RESIDUAL STRUCTURE; SPIN; MOTION; STATE; FIBRILS; CORE; CONSERVATION; DIMENSIONS	Amyloid fibril formation is associated with a range of neurodegenerative diseases in humans, including Alzheimer's, Parkinson's, and prion diseases. In yeast, amyloid underlies several non-Mendelian phenotypes referred to as yeast prions. Mechanism of amyloid formation is critical for a complete understanding of the yeast prion phenomenon and human amyloid-related diseases. Ure2 protein is the basis of yeast prion [URE3]. The Ure2p prion domain is largely disordered. Residual structures, if any, in the disordered region may play an important role in the aggregation process. Studies of Ure2p prion domain are complicated by its high aggregation propensity, which results in a mixture of monomer and aggregates in solution. Previously we have developed a solid-support electron paramagnetic resonance (EPR) approach to address this problem and have identified a structured state for the Alzheimer's amyloid-beta monomer. Here we use solid-support EPR to study the structure of Ure2p prion domain. EPR spectra of Ure2p prion domain with spin labels at every fifth residue from position 10 to position 75 show similar residue mobility profile for denaturing and native buffers after accounting for the effect of solution viscosity. These results suggest that Ure2p prion domain adopts a completely disordered structure in the native buffer. A completely disordered Ure2p prion domain implies that the amyloid formation of Ure2p, and likely other Q/N-rich yeast prion proteins, is primarily driven by inter-molecular interactions.	[Ngo, Sam; Chiang, Vicky; Ho, Elaine; Le, Linh; Guo, Zhefeng] Univ Calif Los Angeles, Inst Mol Biol, Brain Res Inst, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Brain Res Inst, Dept Neurol, Los Angeles, CA 90024 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013	Guo, Zhefeng/0000-0003-1992-7255	Larry L. Hillblom Foundation [2008-A-005-SUP]	Larry L. Hillblom Foundation	Funding was provided by the Larry L. Hillblom Foundation (Grant 2008-A-005-SUP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Bond CJ, 1997, P NATL ACAD SCI USA, V94, P13409, DOI 10.1073/pnas.94.25.13409; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fei L, 2010, PRION, V4, P9, DOI 10.4161/pri.4.1.10670; Fei L, 2009, J BIOL CHEM, V284, P11134, DOI 10.1074/jbc.M809673200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grigoryants VM, 2000, BIOPHYS J, V78, P2702, DOI 10.1016/S0006-3495(00)76814-7; Gu L, 2012, J BIOL CHEM, V287, P9081, DOI 10.1074/jbc.M111.292086; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Ngo S, 2011, J BIOL CHEM, V286, P29691, DOI 10.1074/jbc.M111.269092; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Schneider D. J., 1989, SPIN LABELING THEORY, P1; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wilchek M, 2003, J BIOCHEM BIOPH METH, V55, P67, DOI 10.1016/S0165-022X(02)00178-1	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47248	10.1371/journal.pone.0047248	http://dx.doi.org/10.1371/journal.pone.0047248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077577	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800035
J	Alvi, AHK; Sayyed, AH; Naeem, M; Ali, M				Alvi, Anwaar H. K.; Sayyed, Ali H.; Naeem, Muhammad; Ali, Muhammad			Field Evolved Resistance in Helicoverpa armigera (Lepidoptera: Noctuidae) to Bacillus thuringiensis Toxin Cry1Ac in Pakistan	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; CROSS-RESISTANCE; DIAMONDBACK MOTH; INHERITANCE; GENETICS; POPULATION; INDOXACARB; MECHANISM; COTTON; CROPS	Helicoverpa armigera (Hubner) is one of the most destructive pests of several field and vegetable crops, with indiscriminate use of insecticides contributing to multiple instances of resistance. In the present study we assessed whether H. armigera had developed resistance to Bt cotton and compared the results with several conventional insecticides. Furthermore, the genetics of resistance was also investigated to determine the inheritance to Cry1Ac resistance. To investigate the development of resistance to Bt cotton, and selected foliar insecticides, H. armigera populations were sampled in 2010 and 2011 in several cotton production regions in Pakistan. The resistance ratios (RR) for Cry1Ac, chlorpyrifos, profenofos, cypermethrin, spinosad, indoxacarb, abamectin and deltamethrin were 580-fold, 320-, 1110-, 1950-, 200-, 380, 690, and 40-fold, respectively, compared with the laboratory susceptible (Lab-PK) population. Selection of the field collected population with Cry1Ac in 2010 for five generations increased RR to 5440-fold. The selection also increased RR for deltamethrin, chlorpyrifos, profenofos, cypermethrin, spinosad, indoxacarb, abamectin to 125-folds, 650-, 2840-, 9830-, 370-, 3090-, 1330-fold. The estimated LC50s for reciprocal crosses were 105 mu g/ml (Cry1Ac-SEL female x Lab-PK male) and 81 g mu g/ml (Lab-PK female x 6Cry1Ac-SEL male) suggesting that the resistance to Cry1Ac was autosomal; the degree of dominance (D-LC) was 0.60 and 0.57 respectively. Mixing of enzyme inhibitors significantly decreased resistance to Cry1Ac suggesting that the resistance to Cry1Ac and other insecticides tested in the present study was primarily metabolic. Resistance to Cry1Ac was probably due to a single but unstable factor suggesting that crop rotation with non-Bt cotton or other crops could reduce the selection pressure for H. armigera and improve the sustainability of Bt cotton.	[Alvi, Anwaar H. K.; Sayyed, Ali H.; Ali, Muhammad] Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan; [Alvi, Anwaar H. K.; Naeem, Muhammad] PMAS Arid Agr Univ, Dept Entomol, Rawalpindi, Pakistan	Bahauddin Zakariya University; Arid Agriculture University	Sayyed, AH (corresponding author), Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan.	ali_sayyed@outlook.com	Naqvi, Sayyed Hussnain Ali/I-7283-2015		Higher Education Commission of Pakistan; IRSIP (International Research Support Initiative Program)	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); IRSIP (International Research Support Initiative Program)	These studies were part of PhD work by the first author, and sincere thanks are due to the Higher Education Commission of Pakistan for granting a PhD Merit Scholarship to carry out studies at PMAS Arid University, Rawalpindi/BZU, Multan Pakistan and an IRSIP (International Research Support Initiative Program) fellowship for studies at the University of Sussex, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; AHMAD M, 1995, J ECON ENTOMOL, V88, P771, DOI 10.1093/jee/88.4.771; Ahmad M, 2002, PEST MANAG SCI, V58, P203, DOI 10.1021/ps.440; Ahrnad M, 2007, PEST MANAG SCI, V63, P1002, DOI 10.1002/ps.1430; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Carriere Y, 2001, J ECON ENTOMOL, V94, P315, DOI 10.1603/0022-0493-94.2.315; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; FINNEY D J, 1971, P333; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Horowitz AR, 2003, ARCH INSECT BIOCHEM, V54, P177, DOI 10.1002/arch.10115; King ABS, 1994, INSECT PESTS COTTON, P445; LANDE R, 1981, GENETICS, V99, P541; LeOra S, 2003, POLO PLUS; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; Sayyed AH, 2000, APPL ENVIRON MICROB, V66, P1509, DOI 10.1128/AEM.66.4.1509-1516.2000; Sayyed AH, 2008, PEST MANAG SCI, V64, P813, DOI 10.1002/ps.1570; Sayyed AH, 2006, PEST MANAG SCI, V62, P1045, DOI 10.1002/ps.1270; Sayyed AH, 2008, J ECON ENTOMOL, V101, P1927, DOI 10.1603/0022-0493-101.6.1927; Shad SA, 2010, PEST MANAG SCI, V66, P839, DOI 10.1002/ps.1950; Sokal R. R., 1981, BIOMETRY; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	26	48	49	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47309	10.1371/journal.pone.0047309	http://dx.doi.org/10.1371/journal.pone.0047309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077589	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100090
J	Cheng, SQ; Fan, CG; Sinha, S; Bobik, TA				Cheng, Shouqiang; Fan, Chenguang; Sinha, Sharmistha; Bobik, Thomas A.			The PduQ Enzyme Is an Alcohol Dehydrogenase Used to Recycle NAD(+) Internally within the Pdu Microcompartment of Salmonella enterica	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; L-THREONINE KINASE; SHELL PROTEIN; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; COENZYME-A; TYPHIMURIUM; ORGANELLES; ETHANOLAMINE; GENES	Salmonella enterica uses a bacterial microcompartment (MCP) for coenzyme B-12-dependent 1,2-propanediol (1,2-PD) utilization (Pdu). The Pdu MCP consists of a protein shell that encapsulates enzymes and cofactors required for metabolizing 1,2-PD as a carbon and energy source. Here we show that the PduQ protein of S. enterica is an iron-dependent alcohol dehydrogenase used for 1,2-PD catabolism. PduQ is also demonstrated to be a new component of the Pdu MCP. In addition, a series of in vivo and in vitro studies show that a primary function of PduQ is to recycle NADH to NAD(+) internally within the Pdu MCP in order to supply propionaldehyde dehydrogenase (PduP) with its required cofactor (NAD(+)). Genetic tests determined that a pduQ deletion mutant grew slower than wild-type Salmonella on 1,2-PD and that this phenotype was not complemented by a non-MCP associated Adh2 from Zymomonas that catalyzes the same reaction. This suggests that PduQ has a MCP-specific function. We also found that a pduQ deletion mutant had no growth defect in a genetic background having a second mutation that prevents MCP formation which further supports a MCP-specific role for PduQ. Moreover, studies with purified Pdu MCPs demonstrated that the PduQ enzyme can convert NADH to NAD(+) to supply the PduP reaction in vitro. Cumulatively, these studies show that the PduQ enzyme is used to recycle NADH to NAD(+) internally within the Pdu MCP. To our knowledge, this is the first report of internal recycling as a mechanism for cofactor homeostasis within a bacterial MCP.	[Sinha, Sharmistha; Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Cheng, Shouqiang] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Fan, Chenguang] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA	Iowa State University; Northwestern University; Feinberg School of Medicine; Yale University	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	bobik@iastate.edu	Fan, Cheguang/O-9709-2016; Cheng, Shouqiang/K-6794-2013	Fan, Cheguang/0000-0003-0662-1185; Cheng, Shouqiang/0000-0001-6417-2635; Sinha, Sharmistha/0000-0003-2459-650X	National Institutes of Healt [AI081146]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081146] Funding Source: NIH RePORTER	National Institutes of Healt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Healt grant AI081146 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Cheng SQ, 2010, J BACTERIOL, V192, P5071, DOI 10.1128/JB.00575-10; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Corchero JL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-92; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Fan CG, 2009, J BIOL CHEM, V284, P20240, DOI 10.1074/jbc.M109.027425; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heithoff DM, 1999, J BACTERIOL, V181, P799, DOI 10.1128/JB.181.3.799-807.1999; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Johnson CLV, 2004, J BACTERIOL, V186, P7881, DOI 10.1128/JB.186.23.7881-7887.2004; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; KINOSHITA S, 1985, APPL MICROBIOL BIOT, V22, P249; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Moon JH, 2011, J MOL BIOL, V407, P413, DOI 10.1016/j.jmb.2011.01.045; Mori K, 1997, BIOSCI BIOTECH BIOCH, V61, P1729, DOI 10.1271/bbb.61.1729; Mori K, 1999, BIOCHEMISTRY-US, V38, P13170, DOI 10.1021/bi9911738; OBRADORS N, 1988, J BACTERIOL, V170, P2159, DOI 10.1128/jb.170.5.2159-2162.1988; Palacios S, 2003, J BACTERIOL, V185, P2802, DOI 10.1128/JB.185.9.2802-2810.2003; Papapostolou D, 2009, MOL BIOSYST, V5, P723, DOI 10.1039/b902440a; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014009; Penrod JT, 2006, J BACTERIOL, V188, P2865, DOI 10.1128/JB.188.8.2865-2874.2006; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; RONDON MR, 1995, J BACTERIOL, V177, P7119, DOI 10.1128/JB.177.24.7119-7124.1995; RONDON MR, 1995, J BACTERIOL, V177, P5434, DOI 10.1128/jb.177.19.5434-5439.1995; Sambrook J, 2001, MOL CLONING LAB MANU; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; SCHMIEGER H, 1971, MOL GEN GENET, V110, P378, DOI 10.1007/BF00438281; Sinha S, 2012, J BACTERIOL, V194, P1912, DOI 10.1128/JB.06529-11; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wang J, 1998, J AM CHEM SOC, V120, P5793, DOI 10.1021/ja9735970; Warren JW, 2000, PLASMID, V44, P138, DOI 10.1006/plas.2000.1477; Winter SE, 2011, GUT MICROBES, V2, P58, DOI 10.4161/gmic.2.1.14911; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006	64	54	56	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47144	10.1371/journal.pone.0047144	http://dx.doi.org/10.1371/journal.pone.0047144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077559	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100068
J	Parsons, LS; Wilkens, S				Parsons, Lee S.; Wilkens, Stephan			Probing Subunit-Subunit Interactions in the Yeast Vacuolar ATPase by Peptide Arrays	PLOS ONE			English	Article							N-TERMINAL DOMAIN; V-ATPASE; H+-ATPASE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; A(1)A(0)-ATP SYNTHASE; PERIPHERAL STATOR; CENTRAL STALK; COMPLEX; V-1	Background: Vacuolar (H+)-ATPase (V-ATPase; V1Vo-ATPase) is a large multisubunit enzyme complex found in the endomembrane system of all eukaryotic cells where its proton pumping action serves to acidify subcellular organelles. In the plasma membrane of certain specialized tissues, V-ATPase functions to pump protons from the cytoplasm into the extracellular space. The activity of the V-ATPase is regulated by a reversible dissociation mechanism that involves breaking and re-forming of protein-protein interactions in the V-1-ATPase - V-o-proton channel interface. The mechanism responsible for regulated V-ATPase dissociation is poorly understood, largely due to a lack of detailed knowledge of the molecular interactions that are responsible for the structural and functional link between the soluble ATPase and membrane bound proton channel domains. Methodology/Principal Findings: To gain insight into where some of the stator subunits of the V-ATPase associate with each other, we have developed peptide arrays from the primary sequences of V-ATPase subunits. By probing the peptide arrays with individually expressed V-ATPase subunits, we have identified several key interactions involving stator subunits E, G, C, H and the N-terminal domain of the membrane bound a subunit. Conclusions: The subunit-peptide interactions identified from the peptide arrays complement low resolution structural models of the eukaryotic vacuolar ATPase obtained from transmission electron microscopy. The subunit-subunit interaction data are discussed in context of our current model of reversible enzyme dissociation.	[Parsons, Lee S.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY USA.	wilkenss@upstate.edu		Parsons, Lee/0000-0002-3336-1975	National Institutes of Health, National Institute of General Medical Sciences [GM058600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, National Institute of General Medical Sciences grant GM058600 to SW. The funders (www.nigms.nih.gov) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper SL, 2010, J NEPHROL, V23, pS57; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Brown D, 1997, J EXP BIOL, V200, P257; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hildenbrand ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012588; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P18286; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kish-Trier E, 2009, FEBS LETT, V583, P3121, DOI 10.1016/j.febslet.2009.08.035; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rahman S, 2011, ANAL BIOCHEM, V418, P301, DOI 10.1016/j.ab.2011.07.009; Rigter Alan, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-6; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Saroussi S, 2009, J EXP BIOL, V212, P1604, DOI 10.1242/jeb.025866; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Tomashek JJ, 1997, J BIOL CHEM, V272, P16618, DOI 10.1074/jbc.272.26.16618; Toro EJ, 2012, CURR PROTEIN PEPT SC, V13, P180; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	70	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46960	10.1371/journal.pone.0046960	http://dx.doi.org/10.1371/journal.pone.0046960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071676	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500026
J	Wei, SO; Chu, PC; Chuang, HC; Hung, WC; Kulp, SK; Chen, CS				Wei, Shuo; Chu, Po-Chen; Chuang, Hsiao-Ching; Hung, Wen-Chun; Kulp, Samuel K.; Chen, Ching-Shih			Targeting the Oncogenic E3 Ligase Skp2 in Prostate and Breast Cancer Cells with a Novel Energy Restriction-Mimetic Agent	PLOS ONE			English	Article							PHOSPHORYLATION-DEPENDENT PROTEOLYSIS; ANAPHASE-PROMOTING COMPLEX; UBIQUITIN LIGASE; BETA-TRCP; COP9 SIGNALOSOME; DEGRADATION; PROTEIN; SCFSKP2; DESTRUCTION; CYCLE	Substantial evidence supports the oncogenic role of the E3 ubiquitin ligase S-phase kinase-associated protein 2 (Skp2) in many types of cancers through its ability to target a broad range of signaling effectors for ubiquitination. Thus, this oncogenic E3 ligase represents an important target for cancer drug discovery. In this study, we report a novel mechanism by which CG-12, a novel energy restriction-mimetic agent (ERMA), down-regulates the expression of Skp2 in prostate cancer cells. Pursuant to our previous finding that upregulation of beta-transducin repeat-containing protein (beta-TrCP) expression represents a cellular response in cancer cells to ERMAs, including CG-12 and 2-deoxyglucose, we demonstrated that this beta-TrCP accumulation resulted from decreased Skp2 expression. Evidence indicates that Skp2 targets beta-TrCP for degradation via the cyclin-dependent kinase 2-facilitated recognition of the proline-directed phosphorylation motif (SP)-S-412. This Skp2 downregulation was attributable to Sirt1-dependent suppression of COP9 signalosome (Csn)5 expression in response to CG-12, leading to increased cullin 1 neddylation in the Skp1-cullin1-F-box protein complex and consequent Skp2 destabilization. Moreover, we determined that Skp2 and beta-TrCP are mutually regulated, providing a feedback mechanism that amplifies the suppressive effect of ERMAs on Skp2. Specifically, cellular accumulation of beta-TrCP reduced the expression of Sp1, a beta-TrCP substrate, which, in turn, reduced Skp2 gene expression. This Skp2-beta-TrCP-Sp1 feedback loop represents a novel crosstalk mechanism between these two important F-box proteins in cancer cells with aberrant Skp2 expression under energy restriction, which provides a proof-of-concept that the oncogenic Csn5/Skp2 signaling axis represents a "druggable'' target for this novel ERMA.	[Wei, Shuo; Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Chen, Ching-Shih] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan	University System of Ohio; Ohio State University; National Health Research Institutes - Taiwan; National Cheng Kung University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Hung, Wen-Chun/F-4846-2011		Public Health Service grant from the National Cancer Institute [CA112250]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	Public Health Service grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grant CA112250 from the National Cancer Institute to C.S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Huang YC, 2006, J CELL PHYSIOL, V209, P363, DOI 10.1002/jcp.20741; Jiang H, 2005, MOL CELL, V18, P699, DOI 10.1016/j.molcel.2005.05.011; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Wang HB, 2008, J CELL SCI, V121, P2578, DOI 10.1242/jcs.030742; Wang ZW, 2012, BBA-REV CANCER, V1825, P11, DOI 10.1016/j.bbcan.2011.09.002; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wei SO, 2010, J BIOL CHEM, V285, P9780, DOI 10.1074/jbc.M109.065466; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Yang J, 2008, J MED CHEM, V51, P2100, DOI 10.1021/jm701212m	42	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47298	10.1371/journal.pone.0047298	http://dx.doi.org/10.1371/journal.pone.0047298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071779	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500041
J	Bell, K; Funke, S; Pfeiffer, N; Grus, FH				Bell, Katharina; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.			Serum and Antibodies of Glaucoma Patients Lead to Changes in the Proteome, Especially Cell Regulatory Proteins, in Retinal Cells	PLOS ONE			English	Article							OCULAR HYPERTENSION TREATMENT; ALZHEIMERS-DISEASE; NEURONAL DEATH; NITRIC-OXIDE; SELDI-TOF; AUTOANTIBODIES; APOPTOSIS; LINE; PRESSURE; NEURODEGENERATION	Purpose: Previous studies show significantly specifically changed autoantibody reactions against retinal antigens in the serum of glaucoma and ocular hypertension (OHT) patients in comparison to healthy people. As pathogenesis of glaucoma still is unknown the aim of this study was to analyze if the serum and antibodies of glaucoma patients interact with neuroretinal cells. Methods: R28 cells were incubated with serum of patients suffering from primary open angle glaucoma (POAG), normal tension glaucoma (NTG) or OHT, POAG serum after antibody removal and serum from healthy people for 48 h under a normal or an elevated pressure of 15000 Pa (112 mmHg). RGC5 cells were additionally incubated with POAG antibodies under a normal pressure. Protein profiles of the R28 cells were measured with Seldi-Tof-MS, protein identification was performed with Maldi-TofTof-MS. Protein analysis of the RGC5 cells was performed with ESI-Orbitrap MS. Statistical analysis including multivariate statistics, variance component analysis as well as calculating Mahalanobis distances was performed. Results: Highly significant changes of the complex protein profiles after incubation with glaucoma and OHT serum in comparison to healthy serum were detected, showing specific changes in the cells (e.g. Protein at 9192 Da (p<0.001)). The variance component analysis showed an effect of the serum of 59% on the cells. The pressure had an effect of 11% on the cells. Antibody removal led to significantly changed cell reactions (p<0.03). Furthermore, the incubation with POAG serum and its antibodies led to pro-apoptotic changes of proteins in the cells. Conclusions: These studies show that the serum and the antibodies of glaucoma patients significantly change protein expressions involved in cell regulatory processes in neuroretinal cells. These could lead to a higher vulnerability of retinal cells towards stress factors such as an elevated IOP and eventually could lead to an increased apoptosis of the cells as in glaucoma.	[Bell, Katharina; Funke, Sebastian; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Ophthalmol, Mainz, Germany.	grus@eye-research.org	Bell, Katharina/T-5802-2019; Pfeiffer, Norbert/AAO-7586-2020		DOG (Deutsche Ophthalmologische Gesellschaft)	DOG (Deutsche Ophthalmologische Gesellschaft)	DOG (Deutsche Ophthalmologische Gesellschaft) funding for innovative scientific work; 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar A, 2000, J NEUROSCI RES, V60, P495, DOI 10.1002/(SICI)1097-4547(20000515)60:4<495::AID-JNR8>3.0.CO;2-S; Agar A, 2006, BRAIN RES, V1086, P191, DOI 10.1016/j.brainres.2006.02.061; Bacalini MG, 2011, EXP HEMATOL; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; D'Andrea MR, 2005, MED HYPOTHESES, V64, P458, DOI 10.1016/j.mehy.2004.08.024; Duce JA, 2006, J MOL BIOL, V361, P493, DOI 10.1016/j.jmb.2006.06.038; Gelinas W, 2005, GENE DEV, V19, P1263, DOI 10.1101/gad.1326205; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Grundke-Iqbal I, 2006, Bratisl Lek Listy, V107, P359; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Grus FH, 2004, MOL VIS, V10, P132; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Gutteridge Ian F, 2000, Clin Exp Optom, V83, P161; Huang FL, 2009, ELECTROPHORESIS, V30, P1168, DOI 10.1002/elps.200800548; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kremmer S, 2001, CLIN EXP IMMUNOL, V125, P211, DOI 10.1046/j.1365-2249.2001.01578.x; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kumarswamy R, 2009, MITOCHONDRION, V9, P1, DOI 10.1016/j.mito.2008.10.003; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Lee SM, 2011, J PERINAT MED, V39, P391, DOI [10.1515/JPM.2011.028, 10.1515/jpm.2011.028]; Li L, 2000, CLIN EXP IMMUNOL, V120, P261, DOI 10.1046/j.1365-2249.2000.01219.x; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lin Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034457; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maruyama I, 2000, INVEST OPHTH VIS SCI, V41, P1657; Morales M, 2007, EUR J PHARMACOL, V567, P145, DOI 10.1016/j.ejphar.2007.04.020; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Neufeld AH, 1999, SURV OPHTHALMOL, V43, pS129, DOI 10.1016/S0039-6257(99)00010-7; Ogawa O, 2003, ACTA NEUROPATHOL, V105, P524, DOI 10.1007/s00401-003-0684-3; Okisaka S, 1997, JPN J OPHTHALMOL, V41, P84, DOI 10.1016/S0021-5155(97)00013-0; Pang XM, 2011, GENE DEV, V25, P2278, DOI 10.1101/gad.171645.111; Pfeiffer N, 2005, OPHTHALMOLOGE, V102, P230, DOI 10.1007/s00347-004-1150-x; Poletaev AB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P600, DOI 10.1023/A:1015514732179; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Reichelt J, 2008, CURR EYE RES, V33, P253, DOI 10.1080/02713680701871157; Schwartz M, 2007, CAN J OPHTHALMOL, V42, P439, DOI 10.3129/i07-050; Seigel G M, 1996, Mol Vis, V2, P2; Seigel GM, 1997, IN VITRO CELL DEV-AN, V33, P499; Sommer A, 2010, ARCH OPHTHALMOL-CHIC, V128, P363, DOI 10.1001/archophthalmol.2010.13; Sukharev SA, 1997, CELL DEATH DIFFER, V4, P457, DOI 10.1038/sj.cdd.4400263; Sun W, 2002, NEUROREPORT, V13, P2421, DOI 10.1097/00001756-200212200-00009; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wax M B, 2000, Curr Opin Ophthalmol, V11, P145, DOI 10.1097/00055735-200004000-00014; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yoneda S, 2005, JPN J OPHTHALMOL, V49, P106, DOI 10.1007/s10384-004-0156-x; Yun HY, 1996, CRIT REV NEUROBIOL, V10, P291, DOI 10.1615/CritRevNeurobiol.v10.i3-4.20	55	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46910	10.1371/journal.pone.0046910	http://dx.doi.org/10.1371/journal.pone.0046910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071659	gold, Green Submitted, Green Published			2022-12-25	WOS:000309807700040
J	Almela, P; Navarro-Zaragoza, J; Garcia-Carmona, JA; Mora, L; Hidalgo, J; Milanes, MV; Laorden, ML				Almela, Pilar; Navarro-Zaragoza, Javier; Garcia-Carmona, Juan-Antonio; Mora, Lucia; Hidalgo, Juana; Milanes, Maria-Victoria; Laorden, Maria-Luisa			Role of Corticotropin-Releasing Factor (CRF) Receptor-1 on the Catecholaminergic Response to Morphine Withdrawal in the Nucleus Accumbens (NAc)	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; TYROSINE-HYDROXYLASE PHOSPHORYLATION; VENTRAL TEGMENTAL AREA; DOPAMINE RELEASE; IN-VIVO; NEURONAL-ACTIVITY; MESSENGER-RNAS; DRUG-ABUSE; STRESS; COCAINE	Stress induces the release of the peptide corticotropin-releasing factor (CRF) into the ventral tegmental area (VTA), and also increases dopamine (DA) levels in brain regions receiving dense VTA input. Since the role of stress in drug addiction is well established, the present study examined the possible involvement of CRF1 receptor in the interaction between morphine withdrawal and catecholaminergic pathways in the reward system. The effects of naloxone-precipitated morphine withdrawal on signs of withdrawal, hypothalamo-pituitary-adrenocortical (HPA) axis activity, dopamine (DA) and noradrenaline (NA) turnover in the nucleus accumbens (NAc) and activation of VTA dopaminergic neurons, were investigated in rats pretreated with vehicle or CP-154,526 (selective CRF1R antagonist). CP-154,526 attenuated the increases in body weight loss and suppressed some of withdrawal signs. Pretreatment with CRF1 receptor antagonist resulted in no significant modification of the increased NA turnover at NAc or plasma corticosterone levels that were seen during morphine withdrawal. However, blockade of CRF1 receptor significantly reduced morphine withdrawal-induced increases in plasma adrenocorticotropin (ACTH) levels, DA turnover and TH phosphorylation at Ser40 in the NAc. In addition, CP-154,526 reduced the number of TH containing neurons expressing c-Fos in the VTA after naloxone-precipitated morphine withdrawal. Altogether, these results support the idea that VTA dopaminergic neurons are activated in response to naloxone-precipitated morphine withdrawal and suggest that CRF1 receptors are involved in the activation of dopaminergic pathways which project to NAc.	[Almela, Pilar; Navarro-Zaragoza, Javier; Garcia-Carmona, Juan-Antonio; Mora, Lucia; Hidalgo, Juana; Milanes, Maria-Victoria; Laorden, Maria-Luisa] Univ Murcia, Fac Med, Dept Farmacol, Murcia, Spain	University of Murcia	Laorden, ML (corresponding author), Univ Murcia, Fac Med, Dept Farmacol, Murcia, Spain.	laorden@um.es	Milanés, M Victoria/K-6591-2017; García-Carmona, Juan-Antonio/AAA-8173-2021; HIDALGO, JUANA MARI/ABF-4553-2020; Milanés, M. Victoria/AGB-4075-2022	Milanés, M Victoria/0000-0002-0984-2218; HIDALGO, JUANA MARI/0000-0001-5149-1848; Milanés, M. Victoria/0000-0002-0984-2218; Garcia-Carmona, Juan Antonio/0000-0003-3938-7698; Navarro-Zaragoza, Javier/0000-0003-1653-8131	Ministerio de Ciencia e Innovacion [SAF2010-17907]; Red de Trastornos Adictivos (RTA) [RD06/0001/1006]; Fundacion Seneca [15405/PI/10]; Region de Murcia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos (RTA); Fundacion Seneca(Fundacion Seneca); Region de Murcia	This work was supported by Ministerio de Ciencia e Innovacion (SAF2010-17907), Red de Trastornos Adictivos (RTA; RD06/0001/1006) and Fundacion Seneca (15405/PI/10), Region de Murcia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Aston-Jone G, 2008, BIOL PSYCHIAT, V63, P1005, DOI 10.1016/j.biopsych.2008.03.016; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Budygin EA, 2012, NEUROSCIENCE, V201, P331, DOI 10.1016/j.neuroscience.2011.10.056; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; Deak T, 1999, ENDOCRINOLOGY, V140, P79, DOI 10.1210/en.140.1.79; deFonseca FR, 1997, SCIENCE, V276, P2050, DOI 10.1126/science.276.5321.2050; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; DIANA M, 1995, J PHARMACOL EXP THER, V272, P781; DICHIARA G, 1992, TRENDS PHARMACOL SCI, V13, P185; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; Fuertes G, 2000, NEUROENDOCRINOLOGY, V71, P60, DOI 10.1159/000054521; Gallagher JP, 2008, EUR J PHARMACOL, V583, P215, DOI 10.1016/j.ejphar.2007.11.075; Garcia-Carmona JA, 2012, PSYCHOPHARMACOLOGY, V220, P379, DOI 10.1007/s00213-011-2478-y; Goeders NE, 2000, NEUROPSYCHOPHARMACOL, V23, P577, DOI 10.1016/S0893-133X(00)00148-2; GOLD LH, 1994, EUR J PHARMACOL, V253, P45, DOI 10.1016/0014-2999(94)90755-2; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2010, BRAIN RES, V1314, P3, DOI 10.1016/j.brainres.2009.11.008; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1999, BIOL PSYCHIAT, V46, P1167, DOI 10.1016/S0006-3223(99)00164-X; Korosi A, 2006, BRAIN RES, V1072, P46, DOI 10.1016/j.brainres.2005.12.034; Laorden ML, 2002, J NEUROCHEM, V83, P132, DOI 10.1046/j.1471-4159.2002.01123.x; Laorden ML, 2000, J PHARMACOL EXP THER, V293, P578; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Lu L, 2003, J NEUROCHEM, V84, P1378, DOI 10.1046/j.1471-4159.2003.01635.x; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Navarro-Zaragoza J, 2010, MOL PHARMACOL, V77, P864, DOI 10.1124/mol.109.062463; Nunez C, 2008, N-S ARCH PHARMACOL, V378, P407, DOI 10.1007/s00210-008-0304-9; Nunez C, 2007, ENDOCRINOLOGY, V148, P5780, DOI 10.1210/en.2007-0510; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; Papaleo F, 2007, NEURON, V53, P577, DOI 10.1016/j.neuron.2007.01.022; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Riegel AC, 2008, NEURON, V57, P559, DOI 10.1016/j.neuron.2007.12.029; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; ROSSETTI ZL, 1992, EUR J PHARMACOL, V221, P227, DOI 10.1016/0014-2999(92)90706-A; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Sauvage M, 2001, NEUROSCIENCE, V104, P643, DOI 10.1016/S0306-4522(01)00137-3; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Skelton KH, 2007, EUR J PHARMACOL, V571, P17, DOI 10.1016/j.ejphar.2007.05.041; Smith RJ, 2008, BRAIN STRUCT FUNCT, V213, P43, DOI 10.1007/s00429-008-0191-3; Stinus L, 2005, NEUROPSYCHOPHARMACOL, V30, P90, DOI 10.1038/sj.npp.1300487; Tidey JW, 1996, BRAIN RES, V721, P140, DOI 10.1016/0006-8993(96)00159-X; TILDERS FJH, 1985, FED PROC, V44, P155; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9; Zorrilla EP, 2004, EXPERT OPIN INV DRUG, V13, P799, DOI 10.1517/13543784.13.7.799; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	66	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47089	10.1371/journal.pone.0047089	http://dx.doi.org/10.1371/journal.pone.0047089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071721	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200078
J	Faivre, V; Lukaszewicz, AC; Alves, A; Charron, D; Payen, D; Haziot, A				Faivre, Valerie; Lukaszewicz, Anne Claire; Alves, Arnaud; Charron, Dominique; Payen, Didier; Haziot, Alain			Human Monocytes Differentiate into Dendritic Cells Subsets that Induce Anergic and Regulatory T Cells in Sepsis	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; SEPTIC PATIENTS; BONE-MARROW; TOLERANCE; INFECTION; IMMUNOSUPPRESSION; RECEPTOR; EPIDEMIOLOGY; SUPPRESSION; POPULATION	Background: Sepsis is a multifactorial pathology with high susceptibility to secondary infections. Innate and adaptive immunity are affected in sepsis, including monocyte deactivation. Methodology/Principal Findings: To better understand the effects of alterations in monocytes on the regulation of immune responses during sepsis, we analyzed their differentiation in dendritic cell (DC). Cells from septic patients differentiated overwhelmingly into CD1a-negative DC, a population that was only a minor subset in controls and that is so far poorly characterized. Analysis of T cell responses induced with purified CD1a-negative and CD1a+ DC indicated that (i) CD1a-negative DC from both healthy individuals and septic patients fail to induce T cell proliferation, (ii) TGF beta and IL-4 were strongly produced in mixed leukocyte reaction (MLR) with control CD1a-negative DC; reduced levels were produced with patients DC together with a slight induction of IFN gamma, (iii) compared to controls, CD1a+ DC derived from septic patients induced 3-fold more Foxp3+ T cells. Conclusion/Significance: Our results indicate a strong shift in DC populations derived from septic patients' monocytes with expanded cell subsets that induce either T cell anergy or proliferation of T cells with regulatory potential. Lower regulatory cytokines induction on a per cell basis by CD1a-negative dendritic cells from patients points however to a down regulation of immune suppressive abilities in these cells.	[Faivre, Valerie; Charron, Dominique; Haziot, Alain] INSERM UMRS 940, Paris, France; [Faivre, Valerie; Charron, Dominique; Haziot, Alain] Univ Paris Diderot, Inst Univ Hematol, UMRS 940, Paris, France; [Faivre, Valerie; Lukaszewicz, Anne Claire; Payen, Didier] Univ Paris Diderot, EA3509, Paris, France; [Faivre, Valerie; Lukaszewicz, Anne Claire; Payen, Didier] Hosp Lariboisiere, AP HP, Dept Anesthesiol & Intens Care, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Haziot, A (corresponding author), INSERM UMRS 940, Paris, France.	alain.haziot@univ-paris-diderot.fr	alves, arnaud/ABE-1469-2020; alves, arnaud/ABD-2113-2021; Lukaszewicz, Anne-Claire/GXG-4590-2022; Haziot, Alain/AAF-5507-2021	alves, arnaud/0000-0002-7242-0245; alves, arnaud/0000-0002-7280-8688; Haziot, Alain/0000-0002-4031-7446	Association pour la Recherche sur le Cancer [7639, 4286]; INSERM; Ministere de l'Education et de La Recherche; plan quadriennal Universite Paris 7 [EA322]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education et de La Recherche; plan quadriennal Universite Paris 7	This work was supported by the Association pour la Recherche sur le Cancer grants 7639 and 4286 (A.H.), plan quadriennal EA322 Universite Paris 7, Ministere de l'Education et de La Recherche (D.P.), and institutional funds from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; AYALA A, 1994, J SURG RES, V56, P579, DOI 10.1006/jsre.1994.1092; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Buckner JH, 2008, ANN NY ACAD SCI, V1143, P151, DOI 10.1196/annals.1443.014; Burchardi H, 2004, PHARMACOECONOMICS, V22, P793, DOI 10.2165/00019053-200422120-00003; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Cernadas M, 2009, CLIN EXP IMMUNOL, V155, P523, DOI 10.1111/j.1365-2249.2008.03853.x; Chandra R, 2008, J LEUKOCYTE BIOL, V83, P1541, DOI 10.1189/jlb.1207838; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Doyle JS, 2011, SEMIN RESP CRIT CARE, V32, P115, DOI 10.1055/s-0031-1275525; Esmon CT, 2004, CRIT CARE MED, V32, pS219, DOI 10.1097/01.CCM.0000127036.27343.48; Faivre V, 2007, CLIN EXP IMMUNOL, V147, P426, DOI 10.1111/j.1365-2249.2006.03287.x; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Gelin C, 2009, J LEUKOCYTE BIOL, V85, P215, DOI 10.1189/jlb.0308206; Grassi F, 1998, J LEUKOCYTE BIOL, V64, P484, DOI 10.1002/jlb.64.4.484; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KIEFER F, 1991, BLOOD, V78, P2577; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wang TS, 2008, J MOL MED, V86, P495, DOI 10.1007/s00109-007-0300-4; Xiao HY, 2006, INFECT IMMUN, V74, P5227, DOI 10.1128/IAI.01220-05; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Ylipalosaari P, 2006, CRIT CARE, V10, DOI 10.1186/cc4902	42	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47209	10.1371/journal.pone.0047209	http://dx.doi.org/10.1371/journal.pone.0047209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071758	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200092
J	Grigoryan, AV; Wang, H; Cardozo, TJ				Grigoryan, Arsen V.; Wang, Hong; Cardozo, Timothy J.			Can the Energy Gap in the Protein-Ligand Binding Energy Landscape Be Used as a Descriptor in Virtual Ligand Screening?	PLOS ONE			English	Article							DOCKING; FLEXIBILITY; RECEPTOR; CONFORMATIONS; RECOGNITION; MECHANISMS; POCKETOME; ENSEMBLES; PEPTIDES; MODES	The ranking of scores of individual chemicals within a large screening library is a crucial step in virtual screening (VS) for drug discovery. Previous studies showed that the quality of protein-ligand recognition can be improved using spectrum properties and the shape of the binding energy landscape. Here, we investigate whether the energy gap, defined as the difference between the lowest energy pose generated by a docking experiment and the average energy of all other generated poses and inferred to be a measure of the binding energy landscape sharpness, can improve the separation power between true binders and decoys with respect to the use of the best docking score. We performed retrospective single-and multiple-receptor conformation VS experiments in a diverse benchmark of 40 domains from 38 therapeutically relevant protein targets. Also, we tested the performance of the energy gap on 36 protein targets from the Directory of Useful Decoys (DUD). The results indicate that the energy gap outperforms the best docking score in its ability to discriminate between true binders and decoys, and true binders tend to have larger energy gaps than decoys. Furthermore, we used the energy gap as a descriptor to measure the height of the native binding phase and obtained a significant increase in the success rate of near native binding pose identification when the ligand binding conformations within the boundaries of the native binding phase were considered. The performance of the energy gap was also evaluated on an independent test case of VS-identified PKR-like ER-localized eIF2 alpha kinase (PERK) inhibitors. We found that the energy gap was superior to the best docking score in its ability to more highly rank active compounds from inactive ones. These results suggest that the energy gap of the protein-ligand binding energy landscape is a valuable descriptor for use in VS.	[Grigoryan, Arsen V.; Wang, Hong; Cardozo, Timothy J.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA	New York University	Grigoryan, AV (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10012 USA.	arsen.grigoryan@nyumc.org			NIH [OD004631, OD006536]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004631] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants OD004631 and OD006536 to TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R, 2001, CURR OPIN CHEM BIOL, V5, P375, DOI 10.1016/S1367-5931(00)00217-9; ABAGYAN RA, 1993, FEBS LETT, V325, P17, DOI 10.1016/0014-5793(93)81406-P; Abagyan RA, 1999, J COMPUT PHYS, V151, P402, DOI 10.1006/jcph.1999.6233; Abagyan R, 2009, METHODS MOL BIOL, V575, P249, DOI 10.1007/978-1-60761-274-2_11; Abramowitz M, 1972, HDB MATH FUNCTIONAL; Barril X, 2005, J MED CHEM, V48, P4432, DOI 10.1021/jm048972v; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bottegoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018845; Chen YW, 2008, ARCH BIOCHEM BIOPHYS, V469, P4, DOI 10.1016/j.abb.2007.05.014; Damm KL, 2007, J AM CHEM SOC, V129, P8225, DOI 10.1021/ja0709728; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Dokholyan NV, 2000, J MOL BIOL, V296, P1183, DOI 10.1006/jmbi.1999.3534; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Good AC, 2008, J COMPUT AID MOL DES, V22, P169, DOI 10.1007/s10822-007-9167-2; Gorelik B, 2008, PROTEINS, V71, P1373, DOI 10.1002/prot.21847; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Janin J, 1996, PROTEINS, V25, P438, DOI 10.1002/(SICI)1097-0134(199608)25:4<438::AID-PROT4>3.3.CO;2-1; Kallblad P, 2004, J MED CHEM, V47, P3334, DOI 10.1021/jm0498147; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Kokh DB, 2011, WIRES COMPUT MOL SCI, V1, P298, DOI 10.1002/wcms.29; Kufareva I, 2012, NUCLEIC ACIDS RES, V40, pD535, DOI 10.1093/nar/gkr825; McCammon JA, 2005, BBA-PROTEINS PROTEOM, V1754, P221, DOI 10.1016/j.bbapap.2005.07.041; McCammon JA, 1998, CURR OPIN STRUC BIOL, V8, P245, DOI 10.1016/S0959-440X(98)80046-8; Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; Muller-Dethlefs K, 2000, CHEM REV, V100, P143, DOI 10.1021/cr9900331; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Papoian GA, 2003, BIOPOLYMERS, V68, P333, DOI 10.1002/bip.10286; Potoyan DA, 2011, J AM CHEM SOC, V133, P7405, DOI 10.1021/ja1111964; Rejto PA, 1996, P NATL ACAD SCI USA, V93, P8945, DOI 10.1073/pnas.93.17.8945; Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943; Rueda M, 2009, J CHEM INF MODEL, V49, P716, DOI 10.1021/ci8003732; Ruvinsky AM, 2005, J COMPUT CHEM, V26, P1089, DOI 10.1002/jcc.20246; Schug A, 2010, CURR OPIN PHARMACOL, V10, P709, DOI 10.1016/j.coph.2010.09.012; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teodoro ML, 2003, CURR PHARM DESIGN, V9, P1635, DOI 10.2174/1381612033454595; Totrov M. M., 1999, P 3 ANN INT C COMP M, P312, DOI DOI 10.1145/299432.299509; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tovchigrechko A, 2001, PROTEIN SCI, V10, P1572, DOI 10.1110/ps.8701; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Tsai CJ, 1998, FOLD DES, V3, pR71, DOI 10.1016/S1359-0278(98)00032-7; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Verkhivker GM, 1999, J MOL RECOGNIT, V12, P371, DOI 10.1002/(SICI)1099-1352(199911/12)12:6<371::AID-JMR479>3.0.CO;2-O; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Wang H, 2010, CHEM BIOL DRUG DES, V76, P480, DOI 10.1111/j.1747-0285.2010.01048.x; Wang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188101; Wang J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.198101; Wei DG, 2010, J CHEM INF MODEL, V50, P1855, DOI 10.1021/ci900463u; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zhuravlev PI, 2010, CURR OPIN STRUC BIOL, V20, P16, DOI 10.1016/j.sbi.2009.12.010; Zhuravlev PI, 2009, J PHYS CHEM B, V113, P8800, DOI 10.1021/jp810659u	61	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46532	10.1371/journal.pone.0046532	http://dx.doi.org/10.1371/journal.pone.0046532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071584	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200030
J	Yao, YT; Wang, L; Zhang, H; Wang, HB; Zhao, XP; Zhang, YD; Zhang, LL; Fan, XQ; Qian, GX; Hu, JF; Ge, SF				Yao, Yuting; Wang, Li; Zhang, He; Wang, Haibo; Zhao, Xiaoping; Zhang, Yidan; Zhang, Leilei; Fan, Xianqun; Qian, Guanxiang; Hu, Ji-Fan; Ge, Shengfang			A Novel Anticancer Therapy That Simultaneously Targets Aberrant p53 and Notch Activities in Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; GROWTH-FACTOR II; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; ADENOVIRUS; EXPRESSION; ONYX-015; ACTIVATION; INHIBITION; RECEPTOR	Notch signaling pathway plays an important role in tumorigenesis by maintaining the activity of self-renewal of cancer stem cells, and therefore, it is hypothesized that interference of Notch signaling may inhibit tumor formation and progression. H101 is a recombinant oncolytic adenovirus that is cytolytic in cells lacking intact p53, but it is unable to eradicate caner stem cells. In this study, we tested a new strategy of tumor gene therapy by combining a Notch1-siRNA with H101 oncolytic adenovirus. In HeLa-S3 tumor cells, the combined therapy blocked the Notch pathway and induced apoptosis in tumors that are p53-inactive. In nude mice bearing xenograft tumors derived from HeLa-S3 cells, the combination of H101/Notch1-siRNA therapies inhibited tumor growth. Moreover, Notch1-siRNA increased Hexon gene expression at both the transcriptional and the translational levels, and promoted H101 replication in tumors, thereby enhancing the oncolytic activity of H101. These data demonstrate the feasibility to combine H101 p53-targted oncolysis and anti-Notch siRNA activities as a novel anti-cancer therapy.	[Yao, Yuting; Wang, Li; Wang, Haibo; Zhao, Xiaoping; Zhang, Yidan; Zhang, Leilei; Fan, Xianqun; Qian, Guanxiang; Ge, Shengfang] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Shanghai 200030, Peoples R China; [Yao, Yuting; Zhang, He; Wang, Haibo; Zhao, Xiaoping; Zhang, Yidan; Zhang, Leilei; Fan, Xianqun; Ge, Shengfang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Zhang, He; Hu, Ji-Fan] Stanford Univ, Sch Med, VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qian, GX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Shanghai 200030, Peoples R China.	qiangx@shsmu.edu.cn; jifan@stanford.edu; geshengfang@sjtu.edu.cn	Hu, Jifan/Q-3003-2019; WANG, LI/K-2495-2014	WANG, LI/0000-0002-3784-8828	National Key Program for Basic Research of China [2010CB529902]; National Natural Science Foundation of China [10979034, 81001008]; Science and Technology Commission of Shanghai [10JC1409100]; Shanghai Leading Academic Discipline Project [S30205]; National Institutes of Health [1R43 CA103553-01]; Department of Defense [W81XWH-04-1-0597]; NATIONAL CANCER INSTITUTE [R43CA103553] Funding Source: NIH RePORTER	National Key Program for Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by The National Key Program for Basic Research of China (2010CB529902), The National Natural Science Foundation of China (10979034 and 81001008) to G. Q.; The Science and Technology Commission of Shanghai (10JC1409100), The Shanghai Leading Academic Discipline Project (S30205) to S. G.; National Institutes of Health grant (1R43 CA103553-01) and Department of Defense Grant (W81XWH-04-1-0597) to J.F.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bolos V, 2009, CLIN TRANSL ONCOL, V11, P11, DOI 10.1007/s12094-009-0305-2; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Carette JE, 2007, VIROLOGY, V361, P56, DOI 10.1016/j.virol.2006.11.011; Chen HL, 2006, EMBO J, V25, P5329, DOI 10.1038/sj.emboj.7601399; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Dix BR, 2000, CANCER RES, V60, P2666; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Garber K, 2007, J NATL CANCER I, V99, P1284, DOI 10.1093/jnci/djm148; Hu JF, 1996, J BIOL CHEM, V271, P18253, DOI 10.1074/jbc.271.30.18253; Hu JF, 1997, J BIOL CHEM, V272, P20715, DOI 10.1074/jbc.272.33.20715; Jia RB, 2011, MOL MED REP, V4, P163, DOI 10.3892/mmr.2010.397; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kakarala M, 2007, CANCER J, V13, P271, DOI 10.1097/PPO.0b013e318156da4e; Kasuya H, 2007, CURR CANCER DRUG TAR, V7, P123, DOI 10.2174/156800907780058826; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; LIANG XH, 1995, J CELL BIOCHEM, V57, P509, DOI 10.1002/jcb.240570316; LUNA RMD, 1995, NATURE, V378, P203; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Parks AL, 2000, DEVELOPMENT, V127, P1373; Post Leonard E, 2002, Curr Opin Investig Drugs, V3, P1768; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ries S, 2002, BRIT J CANCER, V86, P5, DOI 10.1038/sj.bjc.6600006; Roth JA, 1999, ONCOLOGY-NY, V13, P148; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Wang H, 2011, INT J CANCER, V2011, P2613; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Wiman KG, 2006, CELL DEATH DIFFER, V13, P921, DOI 10.1038/sj.cdd.4401921; Xiaolin Huang LW, 2012, PLOS ONE, V7; Yu H, 2007, INT J GYNECOL CANCER, V17, P511, DOI 10.1111/j.1525-1438.2007.00813.x; Yu L, 2007, ANTICANCER RES, V27, P2311; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zhang H, 2009, MOL THER, V17, P57, DOI 10.1038/mt.2008.236; Zhang P, 2010, HUM GENE THER, V21, P27, DOI 10.1089/hum.2009.021	49	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46627	10.1371/journal.pone.0046627	http://dx.doi.org/10.1371/journal.pone.0046627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071601	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200037
J	Yarrow, JF; Beggs, LA; Conover, CF; McCoy, SC; Beck, DT; Borst, SE				Yarrow, Joshua F.; Beggs, Luke A.; Conover, Christine F.; McCoy, Sean C.; Beck, Darren T.; Borst, Stephen E.			Influence of Androgens on Circulating Adiponectin in Male and Female Rodents	PLOS ONE			English	Article							TESTOSTERONE REPLACEMENT; BODY-COMPOSITION; INSULIN SENSITIVITY; PLASMA ADIPONECTIN; METABOLIC SYNDROME; LIPID-METABOLISM; FAT DISTRIBUTION; GLYCEMIC CONTROL; OLDER MEN; STRENGTH	Several endocrine factors, including sex-steroid hormones are known to influence adiponectin secretion. Our purpose was to evaluate the influence of testosterone and of the synthetic non-aromatizable/non-5 alpha reducible androgen 17 beta-hydroxyestra-4,9,11-trien-3-one (trenbolone) on circulating adiponectin and adiponectin protein expression within visceral fat. Young male and female F344 rats underwent sham surgery (SHAM), gonadectomy (GX), or GX plus supraphysiologic testosterone-enanthate (TE) administration. Total circulating adiponectin was 39% higher in intact SHAM females than SHAM males (p < 0.05). GX increased total adiponectin by 29-34% in both sexes (p < 0.05), while TE reduced adiponectin to concentrations that were 46-53% below respective SHAMs (p <= 0.001) and ablated the difference in adiponectin between sexes. No differences in high molecular weight (HMW) adiponectin were observed between sexes or treatments. Adiponectin concentrations were highly and negatively associated with serum testosterone (males: r = -0.746 and females: r = -0.742, p <= 0.001); however, no association was present between adiponectin and estradiol. In separate experiments, trenbolone-enanthate (TREN) prevented the GX-induced increase in serum adiponectin (p <= 0.001) in young animals, with Low-dose TREN restoring adiponectin to the level of SHAMs and higher doses of TREN reducing adiponectin to below SHAM concentrations (p <= 0.001). Similarly, TREN reduced adiponectin protein expression within visceral fat (p, 0.05). In adult GX males, Low-dose TREN also reduced total adiponectin and visceral fat mass to a similar magnitude as TE, while increasing serum HMW adiponectin above SHAM and GX animals (p, 0.05). Serum adiponectin was positively associated with visceral fat mass in young (r = 0.596, p <= 0.001) and adult animals (r = 0.657, p <= 0.001). Our results indicate that androgens reduce circulating total adiponectin concentrations in a dose-dependent manner, while maintaining HMW adiponectin. This change is directionally similar to the androgen-induced lipolytic effects on visceral adiposity and equal in magnitude between TE and TREN, suggesting that neither the aromatization nor the 5 alpha reduction of androgens is required for this effect.	[Yarrow, Joshua F.; Beck, Darren T.; Borst, Stephen E.] Malcom Randall Vet Affairs Med Ctr, GRECC, Gainesville, FL USA; [Yarrow, Joshua F.; Beggs, Luke A.; Borst, Stephen E.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	Geriatric Research Education & Clinical Center; State University System of Florida; University of Florida	Yarrow, JF (corresponding author), Malcom Randall Vet Affairs Med Ctr, GRECC, Gainesville, FL USA.	jfyarrow@ufl.edu		BECK, DARREN/0000-0002-1674-9839	Veterans Department [CDA-2]; Veterans Department Merit Award; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Veterans Department; Veterans Department Merit Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Veterans Department CDA-2 to JFY and by a Veterans Department Merit Award to SEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bauer ERS, 2000, APMIS, V108, P838, DOI 10.1111/j.1600-0463.2000.tb00007.x; Belanger C, 2002, HORM METAB RES, V34, P737, DOI 10.1055/s-2002-38265; Berra M, 2006, ASIAN J ANDROL, V8, P725, DOI 10.1111/j.1745-7262.2006.00204.x; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P678, DOI 10.1210/jc.2004-1184; Bhasin S, 2003, J GERONTOL A-BIOL, V58, P1103; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Bolona ER, 2007, MAYO CLIN PROC, V82, P20, DOI 10.4065/82.1.20; Borst SE, 2006, LIFE SCI, V79, P411, DOI 10.1016/j.lfs.2006.01.035; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451, DOI 10.1093/gerona/60.11.1451; Christodoulakos GE, 2008, CLIMACTERIC, V11, P155, DOI 10.1080/13697130801954484; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Cornoldi A, 2010, INT J CARDIOL, V142, P50, DOI 10.1016/j.ijcard.2008.12.107; Corona G, 2011, BEST PRACT RES CL EN, V25, P337, DOI 10.1016/j.beem.2010.07.002; Frederiksen L, 2011, EUR J ENDOCRINOL; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; Hero M, 2006, EUR J ENDOCRINOL, V155, P453, DOI 10.1530/eje.1.02226; Heufelder AE, 2009, J ANDROL, V30, P726, DOI 10.2164/jandrol.108.007005; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jain P, 2000, J UROLOGY, V164, P371, DOI 10.1016/S0022-5347(05)67363-6; Kafkas S, 2011, J OBSTET GYNAECOL RE; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Kunnari A, 2008, METABOLISM, V57, P1509, DOI 10.1016/j.metabol.2008.06.004; Lakshman KM, 2010, J CLIN ENDOCR METAB, V95, P3955, DOI 10.1210/jc.2010-0102; Lanfranco F, 2004, CLIN ENDOCRINOL, V60, P500, DOI 10.1111/j.1365-2265.2004.02007.x; Lapauw B, 2009, EUR J ENDOCRINOL, V160, P397, DOI 10.1530/EJE-08-0881; Laughlin GA, 2007, INT J OBESITY, V31, P457, DOI 10.1038/sj.ijo.0803427; Le Guevel R, 2001, HUM REPROD, V16, P1030, DOI 10.1093/humrep/16.5.1030; Leung KC, 2009, METABOLISM, V58, P239, DOI 10.1016/j.metabol.2008.09.020; MacKenzie SM, 2008, CLIN ENDOCRINOL, V69, P848, DOI 10.1111/j.1365-2265.2008.03262.x; Matyskova R, 2010, HORM METAB RES, V42, P182, DOI 10.1055/s-0029-1243250; McCoy SC, 2012, BONE, V51, P667, DOI 10.1016/j.bone.2012.07.008; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Merki-Feld GS, 2011, METABOLISM, V60, P180, DOI 10.1016/j.metabol.2009.12.010; Motoshima H, 2002, J CLIN ENDOCR METAB, V87, P5662, DOI 10.1210/JC.2002-020635; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; Page ST, 2005, J ANDROL, V26, P85; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pfaehler A, 2011, TOXICOL LETT; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Storer TW, 2008, J AM GERIATR SOC, V56, DOI 10.1111/j.1532-5415.2008.01927.x; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029; Tan R S, 2004, Expert Opin Drug Saf, V3, P599, DOI 10.1517/14740338.3.6.599; Traish AM, 2009, J ANDROL, V30, P23, DOI 10.2164/jandrol.108.005751; Van LT, 2010, PROG BRAIN RES, V181, P177, DOI 10.1016/S0079-6123(08)81010-2; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yanase T, 2008, J STEROID BIOCHEM, V109, P254, DOI 10.1016/j.jsbmb.2008.03.017; Yarrow JF, 2011, MED SCI SPORTS EXERC; Yarrow JF, 2008, AM J PHYSIOL-ENDOC M, V295, pE1213, DOI 10.1152/ajpendo.90640.2008; Yarrow JF, 2011, AM J PHYSIOL-ENDOC M, V300, pE650, DOI 10.1152/ajpendo.00440.2010; Yarrow JF, 2010, STEROIDS, V75, P377, DOI 10.1016/j.steroids.2010.01.019	58	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47315	10.1371/journal.pone.0047315	http://dx.doi.org/10.1371/journal.pone.0047315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071783	gold, Green Submitted, Green Published			2022-12-25	WOS:000312385200103
J	Derbre, F; Ferrando, B; Gomez-Cabrera, MC; Sanchis-Gomar, F; Martinez-Bello, VE; Olaso-Gonzalez, G; Diaz, A; Gratas-Delamarche, A; Cerda, M; Vina, J				Derbre, Frederic; Ferrando, Beatriz; Carmen Gomez-Cabrera, Mari; Sanchis-Gomar, Fabian; Martinez-Bello, Vladimir E.; Olaso-Gonzalez, Gloria; Diaz, Ana; Gratas-Delamarche, Arlette; Cerda, Miguel; Vina, Jose			Inhibition of Xanthine Oxidase by Allopurinol Prevents Skeletal Muscle Atrophy: Role of p38 MAPKinase and E3 Ubiquitin Ligases	PLOS ONE			English	Article							OXIDATIVE STRESS; SOLEUS MUSCLE; CONTRACTILE DYSFUNCTION; CELLULAR ADAPTATIONS; ANTIOXIDANT CAPACITY; PROTEIN-TURNOVER; ACUTE EXERCISE; MAPK PATHWAY; URIC-ACID; VITAMIN-E	Alterations in muscle play an important role in common diseases and conditions. Reactive oxygen species (ROS) are generated during hindlimb unloading due, at least in part, to the activation of xanthine oxidase (XO). The major aim of this study was to determine the mechanism by which XO activation causes unloading-induced muscle atrophy in rats, and its possible prevention by allopurinol, a well-known inhibitor of this enzyme. For this purpose we studied one of the main redox sensitive signalling cascades involved in skeletal muscle atrophy i.e. p38 MAPKinase, and the expression of two well known muscle specific E3 ubiquitin ligases involved in proteolysis, the Muscle atrophy F-Box (MAFbx; also known as atrogin-1) and Muscle RING (Really Interesting New Gene) Finger-1 (MuRF-1). We found that hindlimb unloading induced a significant increase in XO activity and in the protein expression of the antioxidant enzymes CuZnSOD and Catalase in skeletal muscle. The most relevant new fact reported in this paper is that inhibition of XO with allopurinol, a drug widely used in clinical practice, prevents soleus muscle atrophy by similar to 20% after hindlimb unloading. This was associated with the inhibition of the p38 MAPK-MAFbx pathway. Our data suggest that XO was involved in the loss of muscle mass via the activation of the p38MAPK-MAFbx pathway in unloaded muscle atrophy. Thus, allopurinol may have clinical benefits to combat skeletal muscle atrophy in bedridden, astronauts, sarcopenic, and cachexic patients.	[Ferrando, Beatriz; Carmen Gomez-Cabrera, Mari; Sanchis-Gomar, Fabian; Martinez-Bello, Vladimir E.; Olaso-Gonzalez, Gloria; Gratas-Delamarche, Arlette; Vina, Jose] Univ Valencia, Dept Physiol, Fdn Invest Hosp Clin Univ INCLIVA, Valencia, Spain; [Derbre, Frederic] Univ Rennes 2, Lab Movement Sport & Hlth Sci, ENS Cachan, F-35043 Rennes, France; [Diaz, Ana] Univ Valencia, Fac Med, UCIM, Valencia, Spain; [Cerda, Miguel] Univ Valencia, Dept Pathol, Valencia, Spain	University of Valencia; Universite Rennes 2; University of Valencia; University of Valencia	Vina, J (corresponding author), Univ Valencia, Dept Physiol, Fdn Invest Hosp Clin Univ INCLIVA, Valencia, Spain.	jose.vina@uv.es	Gomez-Cabrera, Mari Carmen/O-3109-2019; Gomez-Cabrera, Maria Carmen/H-6911-2018; Sanchis-Gomar, Fabian/R-4045-2019; Ferrando, Beatriz/AAA-5010-2020; González, Gloria Olaso/H-4682-2014; Vina, Jose/AAB-3069-2021; Martinez-Bello, Vladimir/ABB-6447-2021; Derbre, Frederic/R-8776-2017	Gomez-Cabrera, Mari Carmen/0000-0003-4000-1684; Gomez-Cabrera, Maria Carmen/0000-0003-4000-1684; Sanchis-Gomar, Fabian/0000-0003-0424-4208; Ferrando, Beatriz/0000-0002-4285-0105; González, Gloria Olaso/0000-0002-3138-3513; Vina, Jose/0000-0001-9709-0089; Martinez-Bello, Vladimir/0000-0002-3408-9678; Derbre, Frederic/0000-0002-1531-6425	Spanish Ministry of Education and Science [SAF2010-19498]; Conselleria de Educacion de la Generalitat Valenciana [PROMETEO/2010/074]; Red Tematica de Investigacion Cooperativa en Envejecimiento y Fragilidad (RETICEF) [ISCIII2006-RED13-027]; EU [COSTB35]; Spanish Ministry of Innovation and Science [DPS2008- 06968]; European Union	Spanish Ministry of Education and Science(Spanish Government); Conselleria de Educacion de la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Red Tematica de Investigacion Cooperativa en Envejecimiento y Fragilidad (RETICEF); EU(European Commission); Spanish Ministry of Innovation and Science(Spanish Government); European Union(European Commission)	This work is supported by grants SAF2010-19498, from the Spanish Ministry of Education and Science; PROMETEO/2010/074 from the Conselleria de Educacion de la Generalitat Valenciana. ISCIII2006-RED13-027 from the "Red Tematica de Investigacion Cooperativa en Envejecimiento y Fragilidad (RETICEF)'', EU Funded COSTB35 and DPS2008- 06968 from Spanish Ministry of Innovation and Science. The studies have also been co-financed by FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Appell HJ, 1997, INT J SPORTS MED, V18, P157; Arbogast S, 2007, J APPL PHYSIOL, V102, P956, DOI 10.1152/japplphysiol.00538.2006; Barreiro E, 2005, AM J RESP CELL MOL, V32, P9, DOI 10.1165/rcmb.2004-0021OC; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Betters JL, 2004, AM J RESP CRIT CARE, V170, P1179, DOI 10.1164/rccm.200407-939OC; Childs TE, 2003, AM J PHYSIOL-CELL PH, V285, pC391, DOI 10.1152/ajpcell.00478.2002; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; COSTELLI P, 1993, J CLIN INVEST, V92, P2783, DOI 10.1172/JCI116897; Di Giovanni S, 2004, ANN NEUROL, V55, P195, DOI 10.1002/ana.10811; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Gomez-Cabrera MC, 2010, AM J PHYSIOL-REG I, V298, pR2, DOI 10.1152/ajpregu.00142.2009; Gomez-Cabrera MC, 2006, BRIT J NUTR, V96, pS31, DOI 10.1079/BJN20061696; Gomez-Cabrera MC, 2005, J PHYSIOL-LONDON, V567, P113, DOI 10.1113/jphysiol.2004.080564; Gomez-Cabrera MC, 2003, JAMA-J AM MED ASSOC, V289, P2503, DOI 10.1001/jama.289.19.2503-b; Haddad F, 2006, J APPL PHYSIOL, V100, P433, DOI 10.1152/japplphysiol.01203.2005; IBRAHIM B, 1978, HISTOCHEM J, V10, P615, DOI 10.1007/BF01003142; Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010; Ji LL, 2004, FASEB J, V18, P1499, DOI 10.1096/fj.04-1846com; Koesterer TJ, 2002, J APPL PHYSIOL, V93, P1959, DOI 10.1152/japplphysiol.00511.2002; Koistinen HA, 2003, DIABETOLOGIA, V46, P1324, DOI 10.1007/s00125-003-1196-3; KONDO H, 1993, AM J PHYSIOL, V265, pE839, DOI 10.1152/ajpendo.1993.265.6.E839; KONDO H, 1993, FEBS LETT, V326, P189, DOI 10.1016/0014-5793(93)81788-2; KONDO H, 1992, AM J PHYSIOL, V262, pE583, DOI 10.1152/ajpendo.1992.262.5.E583; Lack JA, 1997, BRIT J ANAESTH, V78, P601, DOI 10.1093/bja/78.5.601; Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Mador MJ, 2001, RESP RES, V2, P216; Matuszczak Y, 2004, AVIAT SPACE ENVIR MD, V75, P581; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MOORHOUSE PC, 1987, FEBS LETT, V213, P23, DOI 10.1016/0014-5793(87)81458-8; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Oishi Y, 2008, ACTA PHYSIOL, V192, P381, DOI 10.1111/j.1748-1716.2007.01747.x; Pellegrino MA, 2011, J PHYSIOL-LONDON, V589, P2147, DOI 10.1113/jphysiol.2010.203232; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Romagnali M, 2010, FREE RADICAL BIO MED, V49, P171, DOI 10.1016/j.freeradbiomed.2010.03.024; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Ryan MJ, 2011, FREE RADICAL BIO MED, V51, P38, DOI 10.1016/j.freeradbiomed.2011.04.002; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Servais S, 2007, FREE RADICAL BIO MED, V42, P627, DOI 10.1016/j.freeradbiomed.2006.12.001; Shavlakadze T, 2006, BIOESSAYS, V28, P994, DOI 10.1002/bies.20479; Shin HS, 2006, J PAIN SYMPTOM MANAG, V31, P493, DOI 10.1016/j.jpainsymman.2005.11.014; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475	55	85	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46668	10.1371/journal.pone.0046668	http://dx.doi.org/10.1371/journal.pone.0046668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071610	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300046
J	Gwak, J; Lee, JH; Chung, YH; Song, GY; Oh, S				Gwak, Jungsug; Lee, Jee-Hyun; Chung, Young-Hwa; Song, Gyu-Yong; Oh, Sangtaek			Small Molecule-Based Promotion of PKC alpha-Mediated beta-Catenin Degradation Suppresses the Proliferation of CRT-Positive Cancer Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; COLON-CANCER; WNT PATHWAY; IN-VITRO; KAPPA-B; PHOSPHORYLATION; COMPLEX; APC; TARGET; GROWTH	Aberrant accumulation of intracellular beta-catenin is a well recognized characteristic of several cancers, including prostate, colon, and liver cancers, and is a potential target for development of anticancer therapeutics. Here, we used cell-based small molecule screening to identify CGK062 as an inhibitor of Wnt/beta-catenin signaling. CGK062 promoted protein kinase C alpha (PKC alpha)-mediated phosphorylation of beta-catenin at Ser33/Ser37, marking it for proteasomal degradation. This reduced intracellular beta-catenin levels and consequently antagonized beta-catenin response transcription (CRT). Pharmacological inhibition or depletion of PKC alpha abrogated CGK062-mediated phosphorylation and degradation of beta-catenin. In addition, CGK062 repressed the expression of the genes encoding cyclin D1, c-myc, and axin-2, beta-catenin target genes, and thus inhibited the growth of CRT-positive cancer cells. Furthermore, treatment of nude mice bearing PC3 xenograft tumors with CGK062 at doses of 50 mg/kg and 100 mg/kg (i.p.) significantly suppressed tumor growth. Our findings suggest that CGK062 exerts its anticancer activity by promoting PKC alpha-mediated beta-catenin phosphorylation/degradation. Therefore, CGK062 has significant therapeutic potential for the treatment of CRT-positive cancers.	[Lee, Jee-Hyun; Song, Gyu-Yong] Chungnam Natl Univ, Coll Pharm, Taejon, South Korea; [Gwak, Jungsug; Oh, Sangtaek] Kookmin Univ, Dept Adv Fermentat Fus Sci & Technol, Seoul, South Korea; [Gwak, Jungsug; Oh, Sangtaek] Inje Univ, PharmacoGen Res Ctr, Pusan, South Korea; [Chung, Young-Hwa] Pusan Natl Univ, Dept Cognomechatron Engn, WCU, Pusan, South Korea	Chungnam National University; Kookmin University; Inje University; Pusan National University	Song, GY (corresponding author), Chungnam Natl Univ, Coll Pharm, Taejon, South Korea.	gysong@cnu.ac.kr; ohsa@kookmin.ac.kr		Song, Gyu Yong/0000-0001-6058-5790	National Reserch Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A2A2A01002941]	National Reserch Foundation of Korea (NRF); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through the National Reserch Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A2A2A01002941). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Barker N, 2000, BIOESSAYS, V22, P961; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cho M, 2005, FEBS LETT, V579, P4213, DOI 10.1016/j.febslet.2005.06.049; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Gwak J, 2006, J CELL SCI, V119, P4702, DOI 10.1242/jcs.03256; Gwak J, 2009, J CELL MOL MED, V13, P2171, DOI 10.1111/j.1582-4934.2009.00683.x; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kuhl M, 2004, FRONT BIOSCI-LANDMRK, V9, P967; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Park S, 2006, MOL PHARMACOL, V70, P960, DOI 10.1124/mol.106.024729; Roh H, 2001, CANCER RES, V61, P6563; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	33	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46697	10.1371/journal.pone.0046697	http://dx.doi.org/10.1371/journal.pone.0046697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071615	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300051
J	MacKay, KB; Lowenson, JD; Clarke, SG				MacKay, Kennen B.; Lowenson, Jonathan D.; Clarke, Steven G.			Wortmannin Reduces Insulin Signaling and Death in Seizure-Prone Pcmt1(-/-) Mice	PLOS ONE			English	Article							L-ISOASPARTYL METHYLTRANSFERASE; PROTEIN-REPAIR ENZYME; O-METHYLTRANSFERASE; MAMMALIAN TARGET; DEFICIENT MICE; KINASE-B; PHOSPHOINOSITIDE 3-KINASE; DAMAGED PROTEINS; ALTERED PROTEINS; RAPAMYCIN MTOR	L-isoaspartyl (D-aspartyl) O-methyltransferase deficient mice (Pcmt1(-/-)) accumulate isomerized aspartyl residues in intracellular proteins until their death due to seizures at approximately 45 days. Previous studies have shown that these mice have constitutively activated insulin signaling in their brains, and that these brains are 20-30% larger than those from age-matched wild-type animals. To determine whether insulin pathway activation and brain enlargement is responsible for the fatal seizures, we administered wortmannin, an inhibitor of the phosphoinositide 3-kinase that catalyzes an early step in the insulin pathway. Oral wortmannin reduced the average brain size in the Pcmt1(-/-) animals to within 6% of the wild-type DMSO administered controls, and nearly doubled the lifespan of Pcmt1(-/-) at 60% survival of the original population. Immunoblotting revealed significant decreases in phosphorylation of Akt, PDK1, and mTOR in Pcmt1(-/-) mice and Akt and PDK1 in wild-type animals upon treatment with wortmannin. These data suggest activation of the insulin pathway and its resulting brain enlargement contributes to the early death of Pcmt1(-/-) mice, but is not solely responsible for the early death observed in these animals.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	clarke@mbi.ucla.edu	Lowenson, Jonathan/AAN-6768-2020		National Institutes of Health [GM026020, GM007185]; Ellision Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellision Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants GM026020 and GM007185 (www.nih.gov) and by the Ellision Medical Foundation (www.elllisonfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; CARSON MJ, 1993, NEURON, V10, P729, DOI 10.1016/0896-6273(93)90173-O; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Corti A, 2011, J CELL SCI, V124, P515, DOI 10.1242/jcs.077172; Cournoyer P, 2009, NEUROPHARMACOLOGY, V56, P839, DOI 10.1016/j.neuropharm.2009.01.008; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; Farrar CE, 2005, J COMP NEUROL, V493, P524, DOI 10.1002/cne.20780; Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001; Furuchi T, 2007, YAKUGAKU ZASSHI, V127, P1927, DOI 10.1248/yakushi.127.1927; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; Gomez TA, 2007, AUTOPHAGY, V3, P357, DOI 10.4161/auto.4143; Gomez TA, 2008, MECH AGEING DEV, V129, P752, DOI 10.1016/j.mad.2008.09.019; GUNTHER R, 1989, FOOD CHEM TOXICOL, V27, P173, DOI 10.1016/0278-6915(89)90066-5; Haugabook SJ, 2001, FASEB J, V15, P16; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Jindal A, 2011, INDIAN J PHARM EDUC, V45, P333; Khare S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020850; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; Lanthier J, 2002, J NEUROCHEM, V83, P581, DOI 10.1046/j.1471-4159.2002.01150.x; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1933; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Padmore L, 1996, INT IMMUNOL, V8, P585, DOI 10.1093/intimm/8.4.585; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Rasul A, 2012, APOPTOSIS INT J PROG; Rattan SIS, 2008, BIOL CHEM, V389, P267, DOI 10.1515/BC.2008.030; Ryu J, 2011, ACTA PHARMACOL SIN, V32, P1165, DOI 10.1038/aps.2011.94; Sambri I, 2011, J BIOL CHEM, V286, P43690, DOI 10.1074/jbc.M111.290437; Shivakrupa R, 2003, CANCER RES, V63, P4412; Tokuda S, 2011, HUM MOL GENET, V20, P988, DOI 10.1093/hmg/ddq544; UI M, 1995, TRENDS BIOCHEM SCI, V20, P303, DOI 10.1016/S0968-0004(00)89056-8; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004	55	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46719	10.1371/journal.pone.0046719	http://dx.doi.org/10.1371/journal.pone.0046719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071621	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300054
J	Jimenez, E; Sefah, K; Lopez-Colon, D; Van Simaeys, D; Chen, HW; Tockman, MS; Tan, WH				Jimenez, Elizabeth; Sefah, Kwame; Lopez-Colon, Dalia; Van Simaeys, Dimitri; Chen, Hui William; Tockman, Melvyn S.; Tan, Weihong			Generation of Lung Adenocarcinoma DNA Aptamers for Cancer Studies	PLOS ONE			English	Article							CELL; PEGAPTANIB; PROBES	Lung cancer is the most lethal malignancy in the world, and each year thousands of people die from this disease. Early detection has proven to increase the 5-year survival for this cancer in general, independent of the origination site in the lung. To address this challenge, we have used cell-based SELEX (Systematic Evolution of Ligands by Exponential Enrichment) to select a panel of aptamers capable of distinguishing lung adenocarcinoma cells from normal lung epithelial cells. These aptamers bind at physiological and formalin-fixed conditions and display affinity for their targets with apparent K(d')s in the nanomolar range. Our findings suggest that the selected aptamers have the potential to be used in clinical settings, as well as to improve classification of nonsurgical specimens, another current challenge in lung cancer.	[Jimenez, Elizabeth; Sefah, Kwame; Lopez-Colon, Dalia; Van Simaeys, Dimitri; Tan, Weihong] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Chen, Hui William] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Tockman, Melvyn S.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Oncol Sci, Tampa, FL 33682 USA	State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Tan, WH (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Jimenez, Elizabeth/GQB-5576-2022; Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008	Jimenez, Elizabeth/0000-0001-7798-2194; Tan, Weihong/0000-0002-8066-1524; Van Simaeys, Dimitri/0000-0003-3457-761X	University of Florida Open-Access Publishing Fund; National Institutes of Health, Washington, DC [69953]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	University of Florida Open-Access Publishing Fund; National Institutes of Health, Washington, DC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund and by the National Institutes of Health grant #69953, Washington, DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American cancer Society, 2011, AM CANC SOC, V1, P1; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Chakravarthy U, 2006, OPHTHALMOLOGY, V113, P1508, DOI 10.1016/j.ophtha.2006.02.064; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FRAIRE AE, 1987, CANCER, V60, P370, DOI 10.1002/1097-0142(19870801)60:3<370::AID-CNCR2820600314>3.0.CO;2-W; Gold L, 2002, CHEM BIOL, V9, P1259, DOI 10.1016/S1074-5521(02)00286-7; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Huang YP, 2011, INT J CANCER, V128, P2261, DOI 10.1002/ijc.25569; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Parekh P, 2010, ANAL CHEM, V82, P8642, DOI 10.1021/ac101801j; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rerole AL, 2011, CANCER RES, V71, P484, DOI 10.1158/0008-5472.CAN-10-1443; ROGGLI VL, 1985, HUM PATHOL, V16, P569, DOI 10.1016/S0046-8177(85)80106-4; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Said N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp719; Sefah K, 2010, PLOS ONE, V12; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Stoltenburg R, 2005, ANAL BIOANAL CHEM, V383, P83, DOI 10.1007/s00216-005-3388-9; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Simaeys D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013770; Weiderpass E, 2010, J PREVENTIVE MED PUB, V6, P459; Zeng ZH, 2010, MODERN PATHOL, V23, P1553, DOI 10.1038/modpathol.2010.151; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	30	20	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46222	10.1371/journal.pone.0046222	http://dx.doi.org/10.1371/journal.pone.0046222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082117	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900012
J	VerCauteren, KC; Pilon, JL; Nash, PB; Phillips, GE; Fischer, JW				VerCauteren, Kurt C.; Pilon, John L.; Nash, Paul B.; Phillips, Gregory E.; Fischer, Justin W.			Prion Remains Infectious after Passage through Digestive System of American Crows (Corvus brachyrhynchos)	PLOS ONE			English	Article							SCRAPIE AGENT; MULE DEER; PROTEIN; ENCEPHALOPATHY; SHEEP; DISEASE; TRANSPORTATION; TRANSMISSION; INACTIVATION; DEGRADATION	Avian scavengers, such as American crows (Corvus brachyrhynchos), have potential to translocate infectious agents (prions) of transmissible spongiform encephalopathy (TSE) diseases including chronic wasting disease, scrapie, and bovine spongiform encephalopathy. We inoculated mice with fecal extracts obtained from 20 American crows that were force-fed material infected with RML-strain scrapie prions. These mice all evinced severe neurological dysfunction 196-231 d postinoculation ((x) over bar = 198; 95% CI: 210-216) and tested positive for prion disease. Our results suggest a large proportion of crows that consume prion-positive tissue are capable of passing infectious prions in their feces ((p) over cap = 1.0; 95% CI: 0.8-1.0). Therefore, this common, migratory North American scavenger could play a role in the geographic spread of TSE diseases.	[VerCauteren, Kurt C.; Pilon, John L.; Nash, Paul B.; Phillips, Gregory E.; Fischer, Justin W.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA)	VerCauteren, KC (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA.	kurt.c.vercauteren@aphis.usda.gov		Fischer, Justin/0000-0002-9472-8945	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	Funding was provided by U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS). A representative of VS served on a panel that provided input to the 5-year plan for the Chronic Wasting Disease Project of the National Wildlife Research Center, within which this project was conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; [Anonymous], 2006, SAS MIXED MODELS; Appel TR, 2006, J GEN VIROL, V87, P1385, DOI 10.1099/vir.0.81426-0; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Centers for Disease Control and Prevention, 2011, BSE BOV SPONG ENC MA; CHANDLER RL, 1961, LANCET, V1, P1378; Chronic Wasting Disease Alliance, 2011, CHRON WAST DIS N AM; COLLINGE J, 2006, BASIC NEUROCHEMISTRY, P791; Dagleish MP, 2010, J GEN VIROL, V91, P3116, DOI 10.1099/vir.0.025049-0; Duke G.E., 1986, P289; Evans H. E., 2004, HDB BIRD BIOL, P41; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; HUNTER GD, 1967, J COMP PATHOL, V77, P301, DOI 10.1016/0021-9975(67)90039-4; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jennelle CS, 2009, J WILDLIFE MANAGE, V73, P655, DOI 10.2193/2008-282; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Langeveld JPM, 2003, J INFECT DIS, V188, P1782, DOI 10.1086/379664; de Motes CM, 2008, VET MICROBIOL, V131, P205, DOI 10.1016/j.vetmic.2008.02.014; Martinsen TC, 2002, SCAND J GASTROENTERO, V37, P497, DOI 10.1080/00365520252903017; Matthews D, 2003, REV SCI TECH OIE, V22, P283, DOI 10.20506/rst.22.1.1393; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nicholson EM, 2007, LETT APPL MICROBIOL, V44, P631, DOI 10.1111/j.1472-765X.2007.02124.x; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; Post K, 1999, LANCET, V354, P1969, DOI 10.1016/S0140-6736(99)00469-9; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4; Ziswiler V., 1972, P343; [No title captured]	36	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45774	10.1371/journal.pone.0045774	http://dx.doi.org/10.1371/journal.pone.0045774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082115	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900010
J	Arpino, JAJ; Rizkallah, PJ; Jones, DD				Arpino, James A. J.; Rizkallah, Pierre J.; Jones, D. Dafydd			Crystal Structure of Enhanced Green Fluorescent Protein to 1.35 angstrom Resolution Reveals Alternative Conformations for Glu222	PLOS ONE			English	Article							AEQUOREA; MUTATIONS; STABILITY; MUTANTS; BIOLOGY; GFP	Enhanced Green Fluorescent Protein (EGFP) is one of the most widely used engineered variants of the original wild-type Green Fluorescent Protein. Here, we report the high resolution (1.35 angstrom) structure of EGFP crystallised in its untagged sequence form that reveals the combined impact of the F64L and S65T, that give rise to improved folding and spectral characteristics. The overall structure of EGFP is very similar to wt GFP, forming the classical beta-barrel fold with the chromophore containing helix running through the core of the structure. Replacement of Phe64 with Leu in EGFP results in subtle rearrangement of hydrophobic core packing close to the chromophore including the reduction in surface exposure of two hydrophobic residues. Replacement of Ser65 with Thr has a significant impact on the local hydrogen bond network in the vicinity of the chromophore. Detailed analysis of electron density reveals that several residues close to the chromophore occupy at least two distinct conformations. This includes Glu222 that defines the charged state on the chromophore, with the two conformations having slightly different effects on the hydrogen bond network surrounding the chromophore. Hence, the reported high-resolution structure of EGFP has provided a long overdue molecular description of one of the most important fluorescent protein variants currently in general use.	[Arpino, James A. J.; Jones, D. Dafydd] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Rizkallah, Pierre J.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Jones, DD (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	jonesdd@cf.ac.uk	Jones, Dafydd/A-4330-2010; Rizkallah, Pierre J/A-5367-2012	Rizkallah, Pierre J/0000-0002-9290-0369	BBSRC CASE; Merck KGaA; Merck KGaA through a BBBSRC; BBSRC [BB/E007384/1, BB/E001084/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001084/1, BB/E007384/1] Funding Source: researchfish	BBSRC CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Merck KGaA; Merck KGaA through a BBBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JAJA was supported by a BBSRC CASE studentship in collaboration with Merck KGaA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by a contribution from Merck KGaA through a BBBSRC sponsored CASE studentship. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Budisa N, 2004, BIOL CHEM, V385, P191, DOI 10.1515/BC.2004.038; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Royant A, 2011, J STRUCT BIOL, V174, P385, DOI 10.1016/j.jsb.2011.02.004; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shu X, 2007, BIOCHEMISTRY-US, V46, P12005, DOI 10.1021/bi7009037; Steiner T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001680; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	26	94	96	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47132	10.1371/journal.pone.0047132	http://dx.doi.org/10.1371/journal.pone.0047132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077555	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800025
J	Andersen, JC; Mills, NJ				Andersen, Jeremy C.; Mills, Nicholas J.			DNA Extraction from Museum Specimens of Parasitic Hymenoptera	PLOS ONE			English	Article							BUMBLE BEES BOMBUS; TRIOXYS-PALLIDUS; MULTIMODEL INFERENCE; BEHAVIORAL ECOLOGY; MODEL SELECTION; HIGH-ACCURACY; AMPLIFICATION; COLLECTIONS; HEMIPTERA; PRIMERS	At the same time that molecular researchers are improving techniques to extract DNA from museum specimens, this increased demand for access to museum specimens has created tension between the need to preserve specimens for maintaining collections and morphological research and the desire to conduct molecular analyses. To address these concerns, we examined the suitability of non-invasive DNA extraction techniques on three species of parasitic Hymenoptera (Braconidae), and test the effects of body size (parasitoid species), age (time since collection), and DNA concentration from each extract on the probability of amplifying meaningful fragments of two commonly used genetic loci. We found that age was a significant factor for determining the probability of success for sequencing both 28S and COI fragments. While the size of the braconid parasitoids significantly affected the total amount of extracted DNA, neither size nor DNA concentration were significant factors for the amplification of either gene region. We also tested several primer combinations of various lengths, but were unable to amplify fragments longer than similar to 150 base pairs. These short fragments of 28S and COI were however sufficient for species identification, and for the discovery of within species genetic variation.	[Andersen, Jeremy C.; Mills, Nicholas J.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Andersen, JC (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	jandersen@berkeley.edu		Andersen, Jeremy/0000-0002-9273-6490; Mills, Nicholas/0000-0001-8885-8674	Margaret C. Walker fund for Systematic Entomology; EPA STAR graduate fellowship	Margaret C. Walker fund for Systematic Entomology; EPA STAR graduate fellowship(United States Environmental Protection Agency)	This project was funded with support from the Margaret C. Walker fund for Systematic Entomology, and from an EPA STAR graduate fellowship for JCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2009, STAT METHODS SOCIAL, P441; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Bluemel JK, 2011, MOL ECOL RESOUR, V11, P770, DOI 10.1111/j.1755-0998.2011.03008.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Deyrup MA, 1975, B U WASHINGTON; Dolphin K, 2001, BIOL J LINN SOC, V73, P279, DOI [10.1111/j.1095-8312.2001.tb01363.x, 10.1006/bijl.2001.0537]; Drummond A, 2011, GENEIOUS V 5 5 4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fredslund J, 2005, NUCLEIC ACIDS RES, V33, pW516, DOI 10.1093/nar/gki425; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoddle MS, 2008, CONTROL PESTS WEEDS; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Lis JA, 2011, ZOOTAXA, P18, DOI 10.11646/zootaxa.2748.1.2; Lozier JD, 2009, MOL ECOL, V18, P1875, DOI 10.1111/j.1365-294X.2009.04160.x; Maddison DR, 2005, MACCLADE; Mandrioli M, 2008, MUS MANAGE CURATOR, V23, P193, DOI 10.1080/09647770802012375; Martin MJ, 1995, J MOL EVOL, V41, P1128, DOI 10.1007/BF00173194; Mazerolle MJ, 2012, AICCMODAVG MODEL SEL; MESSING RH, 1989, ENTOMOPHAGA, V34, P153, DOI 10.1007/BF02372664; Mills N, 2000, PARASITOID POPULATION BIOLOGY, P217; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Nagy Zoltan T., 2010, Entomologica Romanica, V15, P11; Noyes John S., 1994, Norwegian Journal of Agricultural Sciences Supplement, V16, P59; R Core Team, 2021, R LANG ENV STAT COMP; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Rowley DL, 2007, MOL ECOL NOTES, V7, P915, DOI 10.1111/j.1471-8286.2007.01905.x; SCOTT DW, 1974, PAN-PAC ENTOMOL, V50, P204; Shenefelt Roy D., 1943, RES STUD STATE COLL WASHINGTON, V11, P51; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Smith CI, 2001, NATURE, V410, P771, DOI 10.1038/35071177; Stigenberg Julia, 2011, Zootaxa, V3084, P1; Strange JP, 2009, APIDOLOGIE, V40, P134, DOI 10.1051/apido/2008070; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tagliavia M, 2011, ANAL LETT, V44, P1058, DOI 10.1080/00032719.2010.506939; THIREAU JC, 1990, CAN J ZOOL, V68, P1000, DOI 10.1139/z90-144; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Ugelvig LV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-201; VANDENBOSCH R, 1962, J ECON ENTOMOL, V55, P857, DOI 10.1093/jee/55.6.857; VANDENBOSCH R, 1970, CALIF AGR, V24, P8; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1	47	24	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45549	10.1371/journal.pone.0045549	http://dx.doi.org/10.1371/journal.pone.0045549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077493	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100018
J	Bashir, T; Cloninger, C; Artinian, N; Anderson, L; Bernath, A; Holmes, B; Benavides-Serrato, A; Sabha, N; Nishimura, RN; Guha, A; Gera, J				Bashir, Tariq; Cloninger, Cheri; Artinian, Nicholas; Anderson, Lauren; Bernath, Andrew; Holmes, Brent; Benavides-Serrato, Angelica; Sabha, Nesrin; Nishimura, Robert N.; Guha, Abhijit; Gera, Joseph			Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; CELLULAR COMPOSITION; PTEN LOSS; MTOR; PATHWAY; EXPRESSION; COMPLEX; CANCER	Background: Hyperactivation of the mTORC2 signaling pathway has been shown to contribute to the oncogenic properties of gliomas. Moreover, overexpression of the mTORC2 regulatory subunit Rictor has been associated with increased proliferation and invasive character of these tumor cells. Methodology/Principal Findings: To determine whether Rictor overexpression was sufficient to induce glioma formation in mice, we inserted a Cre-lox-regulated human Rictor transgene into the murine ROSA26 locus. This floxed Rictor strain was crossed with mice expressing the Cre recombinase driven from the glial fibrillary acidic protein (GFAP) promoter whose expression is limited to the glial cell compartment. Double transgenic GFAP-Cre/Rictor(loxP/loxP) mice developed multifocal infiltrating glioma containing elevated mTORC2 activity and typically involved the subventricular zone (SVZ) and lateral ventricle. Analysis of Rictor-dependent signaling in these tumors demonstrated that in addition to elevated mTORC2 activity, an mTORC2-independent marker of cortical actin network function, was also elevated. Upon histological examination of the neoplasms, many displayed oligodendroglioma-like phenotypes and expressed markers associated with oligodendroglial lineage tumors. To determine whether upstream oncogenic EGFRvIII signaling would alter tumor phenotypes observed in the GFAP-Cre/Rictor(loxP/loxP) mice, transgenic GFAP-EGFRvIII; GFAP-Cre/Rictor(loxP/loxP) mice were generated. These mice developed mixed astrocytic-oligodendroglial tumors, however glioma formation was accelerated and correlated with increased mTORC2 activity. Additionally, the subventricular zone within the GFAP-Cre/Rictor(loxP/loxP) mouse brain was markedly expanded, and a further proliferation within this compartment of the brain was observed in transgenic GFAP-EGFRvIII; GFAP-Cre/Rictor(loxP/loxP) mice. Conclusion/Significance: These data collectively establish Rictor as a novel oncoprotein and support the role of dysregulated Rictor expression in gliomagenesis via mTOR-dependent and mTOR-independent mechanisms. Furthermore, oncogenic EGFRvIII signaling appears to potentiate the in vivo proliferative capacity of GFAP-Cre/Rictor(loxP/loxP) gliomas.	[Bashir, Tariq; Cloninger, Cheri; Artinian, Nicholas; Anderson, Lauren; Bernath, Andrew; Holmes, Brent; Benavides-Serrato, Angelica; Nishimura, Robert N.; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA USA; [Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Nishimura, Robert N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sabha, Nesrin; Guha, Abhijit] Univ Toronto, Hosp Sick Children, Res Inst, Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Gera, Joseph] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gera, J (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA USA.	jgera@mednet.ucla.edu		Gera, Joseph/0000-0002-2908-6894; Holmes, Brent/0000-0002-2768-2991	National Institutes of Health [R01CA109312]; Veterans Administration; NATIONAL CANCER INSTITUTE [R01CA168700, R01CA109312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by National Institutes of Health grant R01CA109312 and funds from the Veterans Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel TW, 2009, MOL CANCER RES, V7, P645, DOI 10.1158/1541-7786.MCR-08-0477; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bromberg JEC, 2009, ONCOLOGIST, V14, P155, DOI 10.1634/theoncologist.2008-0248; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Dasgupta B, 2005, CANCER RES, V65, P2755, DOI 10.1158/0008-5472.CAN-04-4058; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Ding H, 2003, CANCER RES, V63, P1106; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fortin D, 1999, NEUROSURGERY, V45, P1279, DOI 10.1097/00006123-199912000-00001; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao DM, 2010, MOL CELL, V39, P797, DOI 10.1016/j.molcel.2010.08.016; Gibault L, 2012, MODERN PATHOL, V25, P197, DOI 10.1038/modpathol.2011.163; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; HURTT MR, 1992, J NEUROPATH EXP NEUR, V51, P84, DOI 10.1097/00005072-199201000-00010; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; JAROS E, 1992, BRIT J CANCER, V66, P373, DOI 10.1038/bjc.1992.273; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Martin J, 2008, BIOCHEM BIOPH RES CO, V372, P578, DOI 10.1016/j.bbrc.2008.05.086; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Morri LGT, 2011, P NATL ACAD SCI USA, V108, P19024, DOI 10.1073/pnas.1111963108; Nagy A., 2003, MANIPULATING MOUSE E; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Sabatini D.M., 2012, COLD SPRING HARB PER, V4; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SCHLEGEL J, 1994, J NEURO-ONCOL, V22, P201, DOI 10.1007/BF01052920; Setoguchi T, 2004, J CELL BIOL, V166, P963, DOI 10.1083/jcb.200404104; Shannon P, 2005, AM J PATHOL, V167, P859, DOI 10.1016/S0002-9440(10)62057-3; Shinojima N, 2003, CANCER RES, V63, P6962; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	57	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47741	10.1371/journal.pone.0047741	http://dx.doi.org/10.1371/journal.pone.0047741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077666	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100158
J	Chaturvedi, P; Khanna, R; Parnaik, VK				Chaturvedi, Pankaj; Khanna, Richa; Parnaik, Veena K.			Ubiquitin ligase RNF123 Mediates Degradation of Heterochromatin Protein 1 alpha and beta in Lamin A/C Knock-Down Cells	PLOS ONE			English	Article							A-TYPE LAMINS; HUTCHINSON-GILFORD-PROGERIA; CHROMATIN ORGANIZATION; NUCLEAR LAMINS; PROTEASOMAL DEGRADATION; RETINOBLASTOMA PROTEIN; REGULATES PROTEOLYSIS; HIGH-MOBILITY; LAMINOPATHIES; EXPRESSION	Background: The nuclear lamina is a key determinant of nuclear architecture, integrity and functionality in metazoan nuclei. Mutations in the human lamin A gene lead to highly debilitating genetic diseases termed as laminopathies. Expression of lamin A mutations or reduction in levels of endogenous A-type lamins leads to nuclear defects such as abnormal nuclear morphology and disorganization of heterochromatin. This is accompanied by increased proteasomal degradation of certain nuclear proteins such as emerin, nesprin-1 alpha, retinoblastoma protein and heterochromatin protein 1 (HP1). However, the pathways of proteasomal degradation have not been well characterized. Methodology/Principal Findings: To investigate the mechanisms underlying the degradation of HP1 proteins upon lamin misexpression, we analyzed the effects of shRNA-mediated knock-down of lamins A and C in HeLa cells. Cells with reduced levels of expression of lamins A and C exhibited proteasomal degradation of HP1 alpha and HP1 beta but not HP1 gamma. Since specific ubiquitin ligases are upregulated in lamin A/C knock-down cells, further studies were carried out with one of these ligases, RNF123, which has a putative HP1-binding motif. Ectopic expression of GFP-tagged RNF123 directly resulted in degradation of HP1 alpha and HP1 beta. Mutational analysis showed that the canonical HP1-binding pentapeptide motif PXVXL in the N-terminus of RNF123 was required for binding to HP1 proteins and targeting them for degradation. The role of endogenous RNF123 in the degradation of HP1 isoforms was confirmed by RNF123 RNAi experiments. Furthermore, FRAP analysis suggested that HP1 beta was displaced from chromatin in laminopathic cells. Conclusions/Significance: Our data support a role for RNF123 ubiquitin ligase in the degradation of HP1 alpha and HP1 beta upon lamin A/C knock-down. Hence lamin misexpression can cause degradation of mislocalized proteins involved in key nuclear processes by induction of specific components of the ubiquitin-proteasome system.	[Chaturvedi, Pankaj; Khanna, Richa; Parnaik, Veena K.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Parnaik, VK (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	veenap@ccmb.res.in	Chaturvedi, Pankaj/ABC-4658-2020	Chaturvedi, Pankaj/0000-0001-7596-2165; Khanna, Richa/0000-0001-8513-3029	Department of Science and Technology, India; Council of Scientific and Industrial Research; University Grants Commission, India	Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India)	VKP is a recipient of the JC Bose national fellowship from the Department of Science and Technology, India. PC and RK were supported by pre-doctoral fellowships from the Council of Scientific and Industrial Research and University Grants Commission, India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chaturvedi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010620; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gurudatta BV, 2010, J GENET, V89, P37, DOI 10.1007/s12041-010-0009-y; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Lu BY, 2000, GENETICS, V155, P699; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mariappan I, 2005, MOL BIOL CELL, V16, P1948, DOI 10.1091/mbc.E04-02-0154; Muchir A, 2006, BIOCHEM BIOPH RES CO, V351, P1011, DOI 10.1016/j.bbrc.2006.10.147; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nitta RT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000963; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Parnaik VK, 2011, J BIOSCIENCES, V36, P471, DOI 10.1007/s12038-011-9085-2; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tripathi K, 2008, J BIOSCIENCES, V33, P345, DOI 10.1007/s12038-008-0054-3; Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806	37	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47558	10.1371/journal.pone.0047558	http://dx.doi.org/10.1371/journal.pone.0047558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077635	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100130
J	Edin, S; Wikberg, ML; Dahlin, AM; Rutegard, J; Oberg, A; Oldenborg, PA; Palmqvist, R				Edin, Sofia; Wikberg, Maria L.; Dahlin, Anna M.; Rutegard, Jorgen; Oberg, Ake; Oldenborg, Per-Arne; Palmqvist, Richard			The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; CELL LUNG-CANCER; ISLAND METHYLATOR PHENOTYPE; HUMAN PROSTATE-CANCER; REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; INFILTRATING MACROPHAGES; COLON-CANCER; ENDOMETRIAL CANCER; PATIENT SURVIVAL	High macrophage infiltration has been correlated to improved survival in colorectal cancer (CRC). Tumor associated macrophages (TAMs) play complex roles in tumorigenesis since they are believed to hold both tumor preventing (M1 macrophages) and tumor promoting (M2 macrophages) activities. Here we have applied an immunohistochemical approach to determine the degree of infiltrating macrophages with a M1 or M2 phenotype in clinical specimens of CRC in relation to prognosis, both in CRC in general but also in subgroups of CRC defined by microsatellite instability (MSI) screening status and the CpG island methylator phenotype (CIMP). A total of 485 consecutive CRC specimens were stained for nitric oxide synthase 2 (NOS2) (also denoted iNOS) as a marker for the M1 macrophage phenotype and the scavenger receptor CD163 as a marker for the M2 macrophage phenotype. The average infiltration of NOS2 and CD163 expressing macrophages along the invasive tumor front was semi-quantitatively evaluated using a four-graded scale. Two subtypes of macrophages, displaying M1 (NOS2(+)) or M2 (CD163(+)) phenotypes, were recognized. We observed a significant correlation between the amount of NOS2(+) and CD163(+) cells (P<0.0001). A strong inverse correlation to tumor stage was found for both NOS2 (P<0.0001) and CD163 (P<0.0001) infiltration. Furthermore, patients harbouring tumors highly infiltrated by NOS2+ cells had a significantly better prognosis than those infiltrated by few NOS2+ cells, and this was found to be independent of MSI screening status and CIMP status. No significant difference was found on cancer-specific survival in groups of CRC with different NOS2/CD163 ratios. In conclusion, an increased infiltration of macrophages with a M1 phenotype at the tumor front is accompanied by a concomitant increase in macrophages with a M2 phenotype, and in a stage dependent manner correlated to a better prognosis in patients with CRC.	[Edin, Sofia; Wikberg, Maria L.; Dahlin, Anna M.; Palmqvist, Richard] Umea Univ, Dept Med Biosci, Umea, Sweden; [Rutegard, Jorgen; Oberg, Ake] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Oldenborg, Per-Arne] Umea Univ, Dept Integrat Med Biol Histol & Cell Biol, Umea, Sweden	Umea University; Umea University; Umea University	Edin, S (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	sofia.edin@medbio.umu.se		Dahlin, Anna/0000-0002-6754-2571	Swedish Cancer Society [CAN 2011/839]; Swedish Research Council [B03488901]; County Council of Vasterbotten, Sweden [VLL-132981]; Cancer Research Foundation in Northern Sweden [AMP 09-619]; Tore Nilsons Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten, Sweden; Cancer Research Foundation in Northern Sweden; Tore Nilsons Foundation	This study was supported by grants from the Swedish Cancer Society (grant no. CAN 2011/839, Palmqvist; www.cancerfonden.se), Swedish Research Council (grant no. B03488901, Palmqvist; www.vr.se), Cutting-Edge Research Grant from the County Council of Vasterbotten, Sweden (grant no. VLL-132981, Palmqvist), Cancer Research Foundation in Northern Sweden (grant no. AMP 09-619, Edin; www.cancerforskningsfonden.se), and Tore Nilsons Foundation (Edin, www.torenilsonsstiftelse.nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Banerjea Ayan, 2005, World J Surg Oncol, V3, P26, DOI 10.1186/1477-7819-3-26; Bauer K, 2011, FAM CANCER, V10, P557, DOI 10.1007/s10689-011-9449-7; Bronkhorst IHG, 2011, INVEST OPHTH VIS SCI, V52, P643, DOI 10.1167/iovs.10-5979; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Chai CY, 2008, J CLIN PATHOL, V61, P658, DOI 10.1136/jcp.2007.050666; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Dai FQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-220; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Haas M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-65; Hamada I, 2002, ANTICANCER RES, V22, P4281; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Hashimoto I, 2000, ANTICANCER RES, V20, P4853; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Hawkins N, 2002, GASTROENTEROLOGY, V122, P1376, DOI 10.1053/gast.2002.32997; Jensen TO, 2009, J CLIN ONCOL, V27, P3330, DOI 10.1200/JCO.2008.19.9919; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Kloor M, 2010, INT J CANCER, V127, P1001, DOI 10.1002/ijc.25283; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Lackner C, 2004, VIRCHOWS ARCH, V445, P160, DOI 10.1007/s00428-004-1051-z; Leek RD, 1996, CANCER RES, V56, P4625; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P1414; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Nagtegaal ID, 2002, J PATHOL, V197, P20, DOI 10.1002/path.1098; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122; Ohno S, 2004, ANTICANCER RES, V24, P3335; Ohno S, 2003, ANTICANCER RES, V23, P5015; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Salvesen HB, 1999, INT J CANCER, V84, P539; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shimura S, 2000, CANCER RES, V60, P5857; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tsutsui S, 2005, ONCOL REP, V14, P425; van Dongen M, 2010, INT J CANCER, V127, P899, DOI 10.1002/ijc.25113; Weber B, 2009, SEMIN IMMUNOPATHOL, V31, P171, DOI 10.1007/s00281-009-0156-5; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13	65	326	337	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47045	10.1371/journal.pone.0047045	http://dx.doi.org/10.1371/journal.pone.0047045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077543	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100054
J	Hossain, MK; Kamil, AA; Baten, MA; Mustafa, A				Hossain, Md. Kamrul; Kamil, Anton Abdulbasah; Baten, Md. Azizul; Mustafa, Adli			Stochastic Frontier Approach and Data Envelopment Analysis to Total Factor Productivity and Efficiency Measurement of Bangladeshi Rice	PLOS ONE			English	Article							GROWTH; DEA	The objective of this paper is to apply the Translog Stochastic Frontier production model (SFA) and Data Envelopment Analysis (DEA) to estimate efficiencies over time and the Total Factor Productivity (TFP) growth rate for Bangladeshi rice crops (Aus, Aman and Boro) throughout the most recent data available comprising the period 1989-2008. Results indicate that technical efficiency was observed as higher for Boro among the three types of rice, but the overall technical efficiency of rice production was found around 50%. Although positive changes exist in TFP for the sample analyzed, the average growth rate of TFP for rice production was estimated at almost the same levels for both Translog SFA with half normal distribution and DEA. Estimated TFP from SFA is forecasted with ARIMA (2, 0, 0) model. ARIMA (1, 0, 0) model is used to forecast TFP of Aman from DEA estimation.	[Hossain, Md. Kamrul; Kamil, Anton Abdulbasah] Univ Sains Malaysia, Sch Distance Educ, Math Sect, George Town, Malaysia; [Baten, Md. Azizul] Univ Utara Malaysia, Sch Quantitat Sci, Dept Decis Sci, Darul Aman, Kedah, Malaysia; [Mustafa, Adli] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia	Universiti Sains Malaysia; Universiti Utara Malaysia; Universiti Sains Malaysia	Hossain, MK (corresponding author), Univ Sains Malaysia, Sch Distance Educ, Math Sect, George Town, Malaysia.	kamrulstat@gmail.com	Hossain, Kamrul/AAE-3023-2021; Kamil, Anton Abdulbasah/A-9795-2011	Kamil, Anton Abdulbasah/0000-0001-5410-812X; Mustafa, Adli/0000-0003-0989-674X; Hossain, Md. Kamrul/0000-0002-1917-8701; Baten, Md. Azizul/0000-0001-9786-6369				Adachi K, 2010, AGR APPL EC ASS; Ahmed R, 2004, EC POLIT WKLY   0904; Alam Mohammad Jahangir, 2011, 85 ANN C AGR EC SOC; Alauddin M., 1991, Pakistan Development Review, V30, P173; Alene AD, 2010, AGR ECON-BLACKWELL, V41, P223, DOI 10.1111/j.1574-0862.2010.00450.x; Coelli T., 2003, Journal of International Development, V15, P321, DOI 10.1002/jid.975; FARE R, 1992, ECON J, V102, P158, DOI 10.2307/2234861; Headey D, 2010, AGR ECON-BLACKWELL, V41, P1, DOI 10.1111/j.1574-0862.2009.00420.x; HJALMARSSON L, 1992, SCAND J ECON, V94, pS193, DOI 10.2307/3440259; Hussain SS, 2011, BANGLADESH GRAIN FEE; Lan L. W., 2003, J CHINESE I TRANSPOR, V15, P49; Lin LC, 2005, PROC E ASIA SOC TRAN, V5, P592; Malmquist S, 1953, TRABAJOS ESTATISTICA, V4, P1209, DOI [DOI 10.1007/BF03006863, 10.1007/BF03006863]; Nin PA, 2008, IFPRI DISCUSSION PAP; Ondrich J, 2001, EUR J OPER RES, V129, P434, DOI 10.1016/S0377-2217(99)00429-4; Rahman S. M., 1999, THESIS; Selim S, 2010, ECON BULL, V30, P461; Shephard RW, 1970, THEORY COST PRODUCTI; Nguyen TT, 2012, AGR ECON-BLACKWELL, V43, P369, DOI 10.1111/j.1574-0862.2012.00589.x; Wadud A, 2000, APPL ECON, V32, P1665, DOI 10.1080/000368400421011; Wei Z, 2011, DEV ECON, V49, P1, DOI 10.1111/j.1746-1049.2010.00120.x	21	23	24	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46081	10.1371/journal.pone.0046081	http://dx.doi.org/10.1371/journal.pone.0046081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077500	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000309995100024
J	Li, LM; Zhu, DH; Huang, L; Zhang, J; Bian, Z; Chen, X; Liu, Y; Zhang, CY; Zen, K				Li, Limin; Zhu, Dihan; Huang, Lei; Zhang, Jing; Bian, Zhen; Chen, Xi; Liu, Yuan; Zhang, Chen-Yu; Zen, Ke			Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles	PLOS ONE			English	Article							BIOMARKERS; EXPRESSION; CANCER; SERUM; BIOGENESIS; MECHANISM; DIAGNOSIS; EXOSOMES; MIRNAS; RNAI	Cell-secreted miRNAs are highly stable and can serve as biomarkers for various diseases and signaling molecules in intercellular communication. The mechanism underlying the stability of circulating miRNAs, however, remains incompletely understood. Here we show that Argonaute 2 (Ago2) complexes and microvesicles (MVs) provide specific and non-specific protection for miRNA in cell-secreted MVs, respectively. First, the resistance of MV-encapsulated miRNAs to RNaseA was both depended on intact vesicular structure of MVs and protease-sensitive. Second, an immunoprecipitation assay using a probe complementary to human miR-16, a miRNA primarily located in the MVs and showed a strong, protease-sensitive resistance to RNaseA, identified Ago2 as a major miR-16-associated protein. Compared with protein-free miR-16, Ago2-associated miR-16 was resistant to RNaseA in a dose-and time-dependent fashion. Third, when the miR-16/Ago2 complex was disrupted by trypaflavine, the resistance of miR-16 to RNaseA was decreased. In contrast, when the association of miR-16 with the Ago2 complexes was increased during cell apoptosis, although the total amount of miR-16 and Ago2 remained unchanged, the resistance of miR-16 to RNaseA in the MVs was enhanced. A similar correlation between the increase of miR-223/Ago2 association and the resistance of miR-223 against RNaseA was observed during all trans retinoic acid (ATRA)induced cell differentiation of promyelocytic HL60 cells. In conclusion, the association of miRNAs with Ago2 complexes, an event that is linked to cell functional status, plays a critical role in stabilizing the circulating miRNAs in cell-secreted MVs.	[Li, Limin; Zhu, Dihan; Huang, Lei; Zhang, Jing; Bian, Zhen; Chen, Xi; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Bian, Zhen; Liu, Yuan] Georgia State Univ, Dept Biol, CMBP, Atlanta, GA USA	Nanjing University; University System of Georgia; Georgia State University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China (973 Program) [2012CB517603, 2011CB504803]; National Natural Science Foundation of China [30988003, 30225037, 30471991, 30570731]; Natural Science Foundation of Jiangsu Province [BK2011013]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Basic Research Program of China (973 Program, 2012CB517603 and 2011CB504803), National Natural Science Foundation of China (No. 30988003, 30225037, 30471991, 30570731), and the Natural Science Foundation of Jiangsu Province (No. BK2011013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Congleton J, 2011, EXP CELL RES, V317, P910, DOI 10.1016/j.yexcr.2010.12.003; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perez-Martinez M, 2010, J CELL SCI, V123, P1160, DOI 10.1242/jcs.064238; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang BH, 2006, J CELL PHYSIOL, V209, P266, DOI 10.1002/jcp.20713; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zubakov D, 2010, INT J LEGAL MED, V124, P217, DOI 10.1007/s00414-009-0402-3	37	142	150	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46957	10.1371/journal.pone.0046957	http://dx.doi.org/10.1371/journal.pone.0046957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077538	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100050
J	McGuire, M; Pinoges, L; Kanapathipillai, R; Munyenyembe, T; Huckabee, M; Makombe, S; Szumilin, E; Heinzelmann, A; Pujades-Rodriguez, M				McGuire, Megan; Pinoges, Loretxu; Kanapathipillai, Rupa; Munyenyembe, Tamika; Huckabee, Martha; Makombe, Simon; Szumilin, Elisabeth; Heinzelmann, Annette; Pujades-Rodriguez, Mar			Treatment Initiation, Program Attrition and Patient Treatment Outcomes Associated with Scale-Up and Decentralization of HIV Care in Rural Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL TREATMENT PROGRAMS; RAPID EXPANSION; ADULT PATIENTS; SOUTH-AFRICA; FOLLOW-UP; THERAPY; SUPPRESSION; EXPERIENCE; MORTALITY	Objective: To describe patient antiretroviral therapy (cART) outcomes associated with intensive decentralization of services in a rural HIV program in Malawi. Methods: Longitudinal analysis of data from HIV-infected patients starting cART between August 2001 and December 2008 and of a cross-sectional immunovirological assessment conducted 12 (62) months after therapy start. One-year mortality, lost to follow-up, and attrition (deaths and lost to follow-up) rates were estimated with exact Poisson 95% confidence intervals (CI) by type of care delivery and year of initiation. Association of virological suppression (<50 copies/mL) and immunological success (CD4 gain >= 100 cells/mu L), with type of care was investigated using multiple logistic regression. Results: During the study period, 4322 cART patients received centralized care and 11,090 decentralized care. At therapy start, patients treated in decentralized health facilities had higher median CD4 count levels (167 vs. 130 cell/mu L, P<0.0001) than other patients. Two years after cART start, program attrition was lower in decentralized than centralized facilities (9.9 per 100 person-years, 95% CI: 9.5-10.4 vs. 20.8 per 100 person-years, 95% CI: 19.7-22.0). One year after treatment start, differences in immunological success (adjusted OR = 1.23, 95% CI: 0.83-1.83), and viral suppression (adjusted OR = 0.80, 95% CI: 0.56-1.14) between patients followed at centralized and decentralized facilities were not statistically significant. Conclusions: In rural Malawi, 1- and 2-year program attrition was lower in decentralized than in centralized health facilities and no statistically significant differences in one-year immunovirological outcomes were observed between the two health care levels. Longer follow-up is needed to confirm these results.	[Pinoges, Loretxu; Pujades-Rodriguez, Mar] Epicentre, Dept Clin Res, Paris, France; [McGuire, Megan] Epicentre, Dept Clin Res, Nairobi, Kenya; [Kanapathipillai, Rupa; Munyenyembe, Tamika; Huckabee, Martha] Med Sans Frontieres, Chiradzulu, Malawi; [Kanapathipillai, Rupa] Monash Med Ctr, Melbourne, Vic, Australia; [Makombe, Simon] Minist Hlth, Clin HIV Unit, Lilongwe, Malawi; [Szumilin, Elisabeth; Heinzelmann, Annette] Med Sans Frontieres, Paris, France	Monash University; Doctors Without Borders	Pujades-Rodriguez, M (corresponding author), Epicentre, Dept Clin Res, Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018	Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez, Mar/0000-0002-1375-1028				Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; [Anonymous], 2008, EP FACT SHEET HIV AI; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Dou ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022707; Dube C, 2010, B WORLD HEALTH ORGAN, V88, P788, DOI 10.2471/BLT.09.063982; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Gimbel-Sherr Sarah O, 2007, Hum Resour Health, V5, P7, DOI 10.1186/1478-4491-5-7; Giordano TP, 2003, CLIN INFECT DIS, V37, P433, DOI 10.1086/376638; HIV Unit MoH, 2008, ART PUBL PRIV SECT M; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; McGuire M, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02504.x; Medecins Sans Frontieres M The Ministry of Health and Population CDM, 2012, PERSP PRACT ANT TREA; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ministry of Health, 2008, Q REP ANT TREATM PRO; Ministry of Health, 2005, TREATM AIDS 5 YEAR P; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Muula AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-208; Office of the President and Cabinet, 2008, MAL HIV AIDS MON EV; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS WHO, 2009, AIDS EP UPD 2008 UPD; UNDP Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, 2009, WORLD POP PROSP 2008; UNGASS, 2010, MAL HIV AIDS MON EV; Wellons MF, 2002, J AM GERIATR SOC, V50, P603, DOI 10.1046/j.1532-5415.2002.50152.x; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	43	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e38044	10.1371/journal.pone.0038044	http://dx.doi.org/10.1371/journal.pone.0038044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077473	Green Published, gold			2022-12-25	WOS:000309995100001
J	McKenney, ES; Sargent, M; Khan, H; Uh, E; Jackson, ER; San Jose, G; Couch, RD; Dowd, CS; van Hoek, ML				McKenney, Elizabeth S.; Sargent, Michelle; Khan, Hameed; Uh, Eugene; Jackson, Emily R.; San Jose, Geraldine; Couch, Robin D.; Dowd, Cynthia S.; van Hoek, Monique L.			Lipophilic Prodrugs of FR900098 Are Antimicrobial against Francisella novicida In Vivo and In Vitro and Show GlpT Independent Efficacy	PLOS ONE			English	Article							PHOSPHONIC ACID ANTIBIOTICS; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS; GLYCEROL-3-PHOSPHATE TRANSPORTER; MYCOBACTERIUM-TUBERCULOSIS; FOSMIDOMYCIN RESISTANCE; PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTIVITY; DRUG-RESISTANCE; ESTER PRODRUGS	Bacteria, plants, and algae produce isoprenoids through the methylerythritol phosphate (MEP) pathway, an attractive pathway for antimicrobial drug development as it is present in prokaryotes and some lower eukaryotes but absent from human cells. The first committed step of the MEP pathway is catalyzed by 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR/MEP synthase). MEP pathway genes have been identified in many biothreat agents, including Francisella, Brucella, Bacillus, Burkholderia, and Yersinia. The importance of the MEP pathway to Francisella is demonstrated by the fact that MEP pathway mutations are lethal. We have previously established that fosmidomycin inhibits purified MEP synthase (DXR) from F. tularensis LVS. FR900098, the acetyl derivative of fosmidomycin, was found to inhibit the activity of purified DXR from F. tularensis LVS (IC50 = 230 nM). Fosmidomycin and FR900098 are effective against purified DXR from Mycobacterium tuberculosis as well, but have no effect on whole cells because the compounds are too polar to penetrate the thick cell wall. Fosmidomycin requires the GlpT transporter to enter cells, and this is absent in some pathogens, including M. tuberculosis. In this study, we have identified the GlpT homologs in F. novicida and tested transposon insertion mutants of glpT. We showed that FR900098 also requires GlpT for full activity against F. novicida. Thus, we synthesized several FR900098 prodrugs that have lipophilic groups to facilitate their passage through the bacterial cell wall and bypass the requirement for the GlpT transporter. One compound, that we termed "compound 1", was found to have GlpT-independent antimicrobial activity. We tested the ability of this best performing prodrug to inhibit F. novicida intracellular infection of eukaryotic cell lines and the caterpillar Galleria mellonella as an in vivo infection model. As a lipophilic GlpT-independent DXR inhibitor, compound 1 has the potential to be a broad-spectrum antibiotic, and should be effective against most MEP-dependent organisms.	[McKenney, Elizabeth S.; van Hoek, Monique L.] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Sargent, Michelle; Khan, Hameed; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA; [Uh, Eugene; Jackson, Emily R.; San Jose, Geraldine; Dowd, Cynthia S.] George Washington Univ, Dept Chem, Washington, DC 20052 USA; [Couch, Robin D.; van Hoek, Monique L.] George Mason Univ, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA	George Mason University; George Mason University; George Washington University; George Mason University	van Hoek, ML (corresponding author), George Mason Univ, Sch Syst Biol, Manassas, VA USA.	mvanhoek@gmu.edu	van Hoek, Monique/E-1629-2011	van Hoek, Monique/0000-0003-1679-4899	Defense Threat Reduction Agency [HDTRA1-11-1-054]; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [RC1AI086453]; GWU Department of Chemistry; U.S. Army Medical Research and Materiel Command [W23RYX1291N601]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086453] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GWU Department of Chemistry; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MVH was supported by the Defense Threat Reduction Agency HDTRA1-11-1-054. CSD was funded by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) grant RC1AI086453 and the GWU Department of Chemistry. RDC was supported by U.S. Army Medical Research and Materiel Command W23RYX1291N601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-123; Andaloussi M, 2011, J MED CHEM, V54, P4964, DOI 10.1021/jm2000085; Aperis G, 2007, MICROBES INFECT, V9, P729, DOI 10.1016/j.micinf.2007.02.016; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; BIEGELEISEN JZ, 1960, J BACTERIOL, V79, P155, DOI 10.1128/JB.79.1.155-156.1960; Blazewska K, 2003, TETRAHEDRON, V59, P10249, DOI 10.1016/j.tet.2003.10.056; Borrmann S, 2004, J INFECT DIS, V190, P1534, DOI 10.1086/424603; Brown AC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-78; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dhiman RK, 2005, J BACTERIOL, V187, P8395, DOI 10.1128/JB.187.24.8395-8402.2005; Fokin AA, 2007, ORG LETT, V9, P4379, DOI 10.1021/ol702082k; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; Fujisaki S, 1996, GENE, V175, P83, DOI 10.1016/0378-1119(96)00128-X; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Haemers T, 2008, BIOORGAN MED CHEM, V16, P3361, DOI 10.1016/j.bmc.2007.12.001; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jawaid S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008288; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Koppisch AT, 2002, BIOCHEMISTRY-US, V41, P236, DOI 10.1021/bi0118207; Kurz T, 2007, ARCH PHARM, V340, P339, DOI 10.1002/ardp.200700013; Lemieux MJ, 2004, RES MICROBIOL, V155, P623, DOI 10.1016/j.resmic.2004.05.016; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Mackie Ryan S, 2012, Front Microbiol, V3, P226, DOI 10.3389/fmicb.2012.00226; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; OKUHARA M, 1980, J ANTIBIOT, V33, P24, DOI 10.7164/antibiotics.33.24; OKUHARA M, 1980, J ANTIBIOT, V33, P13, DOI 10.7164/antibiotics.33.13; OLSUFJEV NG, 1982, J HYG EPID MICROB IM, V26, P291; Ortmann R, 2005, ARCH PHARM, V338, P305, DOI 10.1002/ardp.200500976; Ortmann R, 2003, BIOORG MED CHEM LETT, V13, P2163, DOI 10.1016/S0960-894X(03)00354-8; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Sakamoto Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2030, DOI 10.1271/bbb.67.2030; Sangari FJ, 2010, P NATL ACAD SCI USA, V107, P14081, DOI 10.1073/pnas.1001962107; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Singh N, 2007, CURR PHARM DESIGN, V13, P1161, DOI 10.2174/138161207780618939; TSUCHIYA T, 1982, EUR J DRUG METAB PH, V7, P59, DOI 10.1007/BF03189544; Uh E, 2011, BIOORG MED CHEM LETT, V21, P6973, DOI 10.1016/j.bmcl.2011.09.123; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang BC, 2011, BIOCHEMISTRY-US, V50, P3570, DOI 10.1021/bi200113y; Zingle C, 2010, J ORG CHEM, V75, P3203, DOI 10.1021/jo9024732; ZWIERZAK A, 1984, SYNTHESIS-STUTTGART, P223	49	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e38167	10.1371/journal.pone.0038167	http://dx.doi.org/10.1371/journal.pone.0038167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077474	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100002
J	Shaukat, Z; Wong, HWS; Nicolson, S; Saint, RB; Gregory, SL				Shaukat, Zeeshan; Wong, Heidi W. S.; Nicolson, Shannon; Saint, Robert B.; Gregory, Stephen L.			A Screen for Selective Killing of Cells with Chromosomal Instability Induced by a Spindle Checkpoint Defect	PLOS ONE			English	Article							GENOMIC INSTABILITY; ASSEMBLY CHECKPOINT; TARGETING CANCER; DNA BREAKS; DROSOPHILA; ANEUPLOIDY; JNK; P53; MUTATIONS; MAD2	Background: The spindle assembly checkpoint is crucial for the maintenance of a stable chromosome number. Defects in the checkpoint lead to Chromosomal INstability (CIN), which is linked to the progression of tumors with poor clinical outcomes such as drug resistance and metastasis. As CIN is not found in normal cells, it offers a cancer-specific target for therapy, which may be particularly valuable because CIN is common in advanced tumours that are resistant to conventional therapy. Principal Findings: Here we identify genes that are required for the viability of cells with a CIN phenotype. We have used RNAi knockdown of the spindle assembly checkpoint to induce CIN in Drosophila and then screened the set of kinase and phosphatase genes by RNAi knockdown to identify those that induce apoptosis only in the CIN cells. Genes identified include those involved in JNK signaling pathways and mitotic cytoskeletal regulation. Conclusions/Significance: The screen demonstrates that it is feasible to selectively kill cells with CIN induced by spindle checkpoint defects. It has identified candidates that are currently being pursued as cancer therapy targets (e. g. Nek2: NIMA related kinase 2), confirming that the screen is able to identify promising drug targets of clinical significance. In addition, several other candidates were identified that have no previous connection with mitosis or apoptosis. Further screening and detailed characterization of the candidates could potentially lead to the therapies that specifically target advanced cancers that exhibit CIN.	[Shaukat, Zeeshan; Nicolson, Shannon; Gregory, Stephen L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Wong, Heidi W. S.; Saint, Robert B.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia	University of Adelaide; University of Melbourne	Gregory, SL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	stephen.gregory@adelaide.edu.au	Saint, Robert/A-4190-2008; Gregory, Stephen L/B-9918-2008	Saint, Robert/0000-0002-7989-6043; Gregory, Stephen L/0000-0002-0046-5815; Nicolson, Shannon/0000-0001-9580-3460	National Health and Medical Research Council [525477, 1027878]; University of Adelaide; University of Melbourne	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; University of Melbourne(University of Melbourne)	This work was funded in part by National Health and Medical Research Council grants 525477 and 1027878 (www.nhmrc.gov.au). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Bloomington and VDRC stock centers for provision of flies. We thank the University of Adelaide and University of Melbourne for providing facilities and student scholarships.	Aihara H, 2004, GENE DEV, V18, P877, DOI 10.1101/gad.1184604; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bogoyevitch MA, 2009, BIOCHIM BIOPHYS ACTA, V1804, P463; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Crasta K, 2012, NATURE; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Duensing A, 2010, ADV EXP MED BIOL, V676, P93; Fukasawa K, 1997, MOL CELL BIOL, V17, P506, DOI 10.1128/MCB.17.1.506; Furlong F, 2012, J PATHOL, V226, P746, DOI 10.1002/path.3035; Galimberti F, 2011, CLIN CANCER RES, V17, P1218, DOI 10.1158/1078-0432.CCR-10-1178; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kasiappan R, 2009, MOL CANCER RES, V7, P536, DOI 10.1158/1541-7786.MCR-08-0422; Kawajiri S, 2011, TRENDS PHARMACOL SCI, V32, P573, DOI 10.1016/j.tips.2011.06.001; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Lawlor KT, 2011, HUM MOL GENET, V20, P3757, DOI 10.1093/hmg/ddr292; Liu QD, 2010, EXP MOL PATHOL, V88, P225, DOI 10.1016/j.yexmp.2009.12.004; Liu RX, 2010, ENDOCRINE, V38, P38, DOI 10.1007/s12020-010-9324-6; Lunardi A, 2010, P NATL ACAD SCI USA, V107, P6322, DOI 10.1073/pnas.1002447107; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; MacDonald PE, 2011, DIABETOLOGIA, V54, P719, DOI 10.1007/s00125-011-2072-1; Mazzorana M, 2011, CURR CANCER DRUG TAR, V11, P600, DOI 10.2174/156800911795655949; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Menzel N, 2007, MECH DEVELOP, V124, P78, DOI 10.1016/j.mod.2006.09.007; MERTENS F, 1994, GENE CHROMOSOME CANC, V10, P221, DOI 10.1002/gcc.2870100402; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mitelman F, 1997, CANCER GENET CYTOGEN, V95, P1, DOI 10.1016/S0165-4608(96)00252-X; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Orr B, 2007, MOL BIOL CELL, V18, P850, DOI 10.1091/mbc.E06-07-0587; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pihan GA, 2001, CANCER RES, V61, P2212; Polaski S, 2006, GENETICS, V174, P719, DOI 10.1534/genetics.106.056564; Prencipe M, 2010, CELL CYCLE, V9, P2856, DOI 10.4161/cc.9.14.12362; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Roschke AV, 2005, CELL CYCLE, V4, P679, DOI 10.4161/cc.4.5.1687; Schlafli P, 2009, CELL MOL LIFE SCI, V66, P876, DOI 10.1007/s00018-009-8699-0; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sonn S, 2011, ZYGOTE, V19, P15, DOI 10.1017/S0967199410000183; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Stronach B, 2005, DEV DYNAM, V232, P575, DOI 10.1002/dvdy.20283; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang JY, 2009, MOL BIOL CELL, V20, P2381, DOI 10.1091/mbc.E08-12-1206	71	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47447	10.1371/journal.pone.0047447	http://dx.doi.org/10.1371/journal.pone.0047447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077619	gold, Green Submitted, Green Published			2022-12-25	WOS:000309995100115
J	Siemer, AB; Huang, KY; McDermott, AE				Siemer, Ansgar B.; Huang, Kuo-Ying; McDermott, Ann E.			Protein Linewidth and Solvent Dynamics in Frozen Solution NMR	PLOS ONE			English	Article							SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; GLASS-TRANSITION; CONFORMATIONAL DISTRIBUTIONS; ANTIFREEZE PROTEIN; METHYL-GROUP; T4 LYSOZYME; WATER; SPECTROSCOPY; HYDRATION	Solid-state NMR of proteins in frozen aqueous solution is a potentially powerful technique in structural biology, especially if it is combined with dynamic nuclear polarization signal enhancement strategies. One concern regarding NMR studies of frozen solution protein samples at low temperatures is that they may have poor linewidths, thus preventing high-resolution studies. To learn more about how the solvent shell composition and temperature affects the protein linewidth, we recorded H-1, H-2, and C-13 spectra of ubiquitin in frozen water and frozen glycerol-water solutions at different temperatures. We found that the C-13 protein linewidths generally increase with decreasing temperature. This line broadening was found to be inhomogeneous and independent of proton decoupling. In pure water, we observe an abrupt line broadening with the freezing of the bulk solvent, followed by continuous line broadening at lower temperatures. In frozen glycerol-water, we did not observe an abrupt line broadening and the NMR lines were generally narrower than for pure water at the same temperature. H-1 and H-2 measurements characterizing the dynamics of water that is in exchange with the protein showed that the C-13 line broadening is relatively independent from the arrest of isotropic water motions.	[Siemer, Ansgar B.; Huang, Kuo-Ying; McDermott, Ann E.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Siemer, AB (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	asiemer@usc.edu; aem5@columbia.edu		McDermott, Ann/0000-0002-9249-1649	National Science Foundation (NSF) [mcb 0316248]; National Institutes of Health (NIH) [r01 gm 88724]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088724] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) mcb 0316248 and National Institutes of Health (NIH) r01 gm 88724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Atilgan C, 2008, BIOPHYS J, V94, P79, DOI 10.1529/biophysj.107.116426; Bajaj VS, 2009, J AM CHEM SOC, V131, P118, DOI 10.1021/ja8045926; Barnes AB, 2008, APPL MAGN RESON, V34, P237, DOI 10.1007/s00723-008-0129-1; Bertini I, 2011, P NATL ACAD SCI USA, V108, P10396, DOI 10.1073/pnas.1103854108; BIELECKI A, 1995, J MAGN RESON SER A, V116, P215, DOI 10.1006/jmra.1995.0010; Doster W, 2005, BBA-PROTEINS PROTEOM, V1749, P173, DOI 10.1016/j.bbapap.2005.03.010; Doster W, 2010, BBA-PROTEINS PROTEOM, V1804, P3, DOI 10.1016/j.bbapap.2009.06.019; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840; Georgieva ER, 2012, J MAGN RESON, V216, P69, DOI 10.1016/j.jmr.2012.01.004; Goddard YA, 2009, J MAGN RESON, V199, P68, DOI 10.1016/j.jmr.2009.04.001; Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499; Havlin RH, 2005, P NATL ACAD SCI USA, V102, P3284, DOI 10.1073/pnas.0406130102; Havlin RH, 2007, BIOCHEMISTRY-US, V46, P3586, DOI 10.1021/bi0622928; Heugen U, 2006, P NATL ACAD SCI USA, V103, P12301, DOI 10.1073/pnas.0604897103; Hu KN, 2010, J AM CHEM SOC, V132, P24, DOI 10.1021/ja908471n; Jansson H, 2005, J PHYS CHEM B, V109, P24134, DOI 10.1021/jp052418v; KENNEDY SD, 1990, BIOPOLYMERS, V29, P1801, DOI 10.1002/bip.360291411; Krushelnitsky A, 2009, J PHYS CHEM B, V113, P10022, DOI 10.1021/jp900337x; Linden AH, 2011, J BIOMOL NMR, V51, P283, DOI 10.1007/s10858-011-9535-z; Long HW, 1998, J AM CHEM SOC, V120, P7039, DOI 10.1021/ja974277j; Maus DC, 1996, J AM CHEM SOC, V118, P5665, DOI 10.1021/ja960248h; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Ringe D, 2003, BIOPHYS CHEM, V105, P667, DOI 10.1016/S0301-4622(03)00096-6; Sharpe S, 2006, BIOCHEMISTRY-US, V45, P918, DOI 10.1021/bi051766k; Sharpe S, 2004, J AM CHEM SOC, V126, P4979, DOI 10.1021/ja0392162; Shinyashiki N, 2009, J PHYS CHEM B, V113, P14448, DOI 10.1021/jp905511w; Siemer AB, 2010, P NATL ACAD SCI USA, V107, P17580, DOI 10.1073/pnas.1009369107; Siemer AB, 2008, J AM CHEM SOC, V130, P17394, DOI 10.1021/ja8047893; Tompa K, 2009, BIOPHYS J, V96, P2789, DOI 10.1016/j.bpj.2008.11.038; Tournier AL, 2003, BIOPHYS J, V85, P1871, DOI 10.1016/S0006-3495(03)74614-1; Gonzalez JAT, 2011, J CHEM ENG DATA, V56, P1397, DOI 10.1021/je101164q; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Vogel M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.225701; Vugmeyster L, 2010, J AM CHEM SOC, V132, P4038, DOI 10.1021/ja909599k; Zech SG, 2005, J AM CHEM SOC, V127, P8618, DOI 10.1021/ja0503128	38	51	51	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47242	10.1371/journal.pone.0047242	http://dx.doi.org/10.1371/journal.pone.0047242			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077575	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100079
J	Smith, S; Witkowski, A; Moghul, A; Yoshinaga, Y; Nefedov, M; de Jong, P; Feng, DJ; Fong, LR; Tu, YP; Hu, Y; Young, SG; Pham, T; Cheung, C; Katzman, SM; Brand, MD; Quinlan, CL; Fens, M; Kuypers, F; Misquitta, S; Griffey, SM; Tran, S; Gharib, A; Knudsen, J; Hannibal-Bach, HK; Wang, G; Larkin, S; Thweatt, J; Pasta, S				Smith, Stuart; Witkowski, Andrzej; Moghul, Ayesha; Yoshinaga, Yuko; Nefedov, Michael; de Jong, Pieter; Feng, Dejiang; Fong, Loren; Tu, Yiping; Hu, Yan; Young, Stephen G.; Pham, Thomas; Cheung, Carling; Katzman, Shana M.; Brand, Martin D.; Quinlan, Casey L.; Fens, Marcel; Kuypers, Frans; Misquitta, Stephanie; Griffey, Stephen M.; Tran, Son; Gharib, Afshin; Knudsen, Jens; Hannibal-Bach, Hans Kristian; Wang, Grace; Larkin, Sandra; Thweatt, Jennifer; Pasta, Saloni			Compromised Mitochondrial Fatty Acid Synthesis in Transgenic Mice Results in Defective Protein Lipoylation and Energy Disequilibrium	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; BLOOD-CELLS; LIPOIC ACID; EXPRESSION; SYNTHASE; CLONING; PURIFICATION; ENZYME; DEATH	A mouse model with compromised mitochondrial fatty acid synthesis has been engineered in order to assess the role of this pathway in mitochondrial function and overall health. Reduction in the expression of mitochondrial malonyl CoA-acyl carrier protein transacylase, a key enzyme in the pathway encoded by the nuclear Mcat gene, was achieved to varying extents in all examined tissues employing tamoxifen-inducible Cre-lox technology. Although affected mice consumed more food than control animals, they failed to gain weight, were less physically active, suffered from loss of white adipose tissue, reduced muscle strength, kyphosis, alopecia, hypothermia and shortened lifespan. The Mcat-deficient phenotype is attributed primarily to reduced synthesis, in several tissues, of the octanoyl precursors required for the posttranslational lipoylation of pyruvate and alpha-ketoglutarate dehydrogenase complexes, resulting in diminished capacity of the citric acid cycle and disruption of energy metabolism. The presence of an alternative lipoylation pathway that utilizes exogenous free lipoate appears restricted to liver and alone is insufficient for preservation of normal energy metabolism. Thus, de novo synthesis of precursors for the protein lipoylation pathway plays a vital role in maintenance of mitochondrial function and overall vigor.	[Smith, Stuart; Witkowski, Andrzej; Moghul, Ayesha; Yoshinaga, Yuko; Nefedov, Michael; de Jong, Pieter; Feng, Dejiang; Pham, Thomas; Cheung, Carling; Fens, Marcel; Kuypers, Frans; Misquitta, Stephanie; Tran, Son; Gharib, Afshin; Wang, Grace; Larkin, Sandra; Thweatt, Jennifer; Pasta, Saloni] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Fong, Loren; Tu, Yiping; Hu, Yan; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Katzman, Shana M.; Brand, Martin D.; Quinlan, Casey L.] Buck Inst Res Aging, Novato, CA USA; [Griffey, Stephen M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Gharib, Afshin] Dominican Univ Calif, San Rafael, CA USA; [Knudsen, Jens; Hannibal-Bach, Hans Kristian] Odense Univ, Dept Biochem & Mol Biol, Odense, Denmark	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Los Angeles; Buck Institute for Research on Aging; University of California System; University of California Davis; University of Southern Denmark	Smith, S (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	ssmith@chori.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Witkowski, Andrzej/0000-0002-0442-4586; Quinlan, Casey/0000-0002-7808-8271; Young, Stephen/0000-0001-7270-3176	National Institutes of Health [GM069717, AG032118]; United Mitochondrial Disease Foundation; Netherlands Organisation for Scientific Research, The Hague, The Netherlands; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Netherlands Organisation for Scientific Research, The Hague, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant GM069717 and United Mitochondrial Disease Foundation (to SS) and National Institutes of Health Grant AG032118 (to MDB). MF is supported by the Netherlands Organisation for Scientific Research, The Hague, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0; BROWN GK, 1994, J MED GENET, V31, P875, DOI 10.1136/jmg.31.11.875; Brugnara C, 1998, INT J CLIN LAB RES, V28, P1, DOI 10.1007/s005990050011; Bunkoczi G, 2009, CHEM BIOL, V16, P667, DOI 10.1016/j.chembiol.2009.04.011; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chen ZJ, 2009, FASEB J, V23, P3682, DOI 10.1096/fj.09-133587; Crawley J. N., 2007, WHATS WRONG MY MOUSE; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Gharid A, 2011, NEURODEGENERATION TH, P63; Gurvitz A, 2008, APPL ENVIRON MICROB, V74, P5078, DOI 10.1128/AEM.00655-08; Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018; Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988; Jong MC, 1998, J CLIN INVEST, V101, P145, DOI 10.1172/JCI791; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI [10.2183/pjab.84.246, 10.2183/pjab/84.246]; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; Naviaux R, 1997, SPECTRUM MITOCHONDRI, P3; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Paul E, 2009, MAMM GENOME, V20, P92, DOI 10.1007/s00335-008-9168-z; Pliss L, 2004, J NEUROCHEM, V91, P1082, DOI 10.1111/j.1471-4159.2004.02790.x; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; SCHNEIDER H, 1980, P NATL ACAD SCI-BIOL, V77, P442, DOI 10.1073/pnas.77.1.442; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Sidhu S, 2008, AM J PHYSIOL-HEART C, V295, pH946, DOI 10.1152/ajpheart.00363.2008; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Tous M, 2004, METABOLISM, V53, P95, DOI 10.1016/j.metabol.2003.08.012; Treiber N, 2011, AGING CELL, V10, P239, DOI 10.1111/j.1474-9726.2010.00658.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; van Ampting MTJ, 2009, DIGEST DIS SCI, V54, P2588, DOI 10.1007/s10620-008-0685-0; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; Witkowski A, 2011, J BIOL CHEM, V286, P33729, DOI 10.1074/jbc.M111.291591; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yiou R, 2001, J ANAT, V199, P599, DOI 10.1046/j.1469-7580.2001.19950599.x; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	52	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47196	10.1371/journal.pone.0047196	http://dx.doi.org/10.1371/journal.pone.0047196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077570	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100075
J	Bourn, RL; De Biase, I; Pinto, RM; Sandi, C; Al-Mahdawi, S; Pook, MA; Bidichandani, SI				Bourn, Rebecka L.; De Biase, Irene; Pinto, Ricardo Mouro; Sandi, Chiranjeevi; Al-Mahdawi, Sahar; Pook, Mark A.; Bidichandani, Sanjay I.			Pms2 Suppresses Large Expansions of the (GAA.TTC)(n) Sequence in Neuronal Tissues	PLOS ONE			English	Article							GAA TRIPLET-REPEAT; DNA MISMATCH REPAIR; DOUBLE-STRAND BREAKS; KNOCK-IN MICE; FRIEDREICH ATAXIA; HUNTINGTON-DISEASE; SOMATIC INSTABILITY; TRINUCLEOTIDE REPEATS; MYOTONIC-DYSTROPHY; EPIGENETIC CHANGES	Expanded trinucleotide repeat sequences are the cause of several inherited neurodegenerative diseases. Disease pathogenesis is correlated with several features of somatic instability of these sequences, including further large expansions in postmitotic tissues. The presence of somatic expansions in postmitotic tissues is consistent with DNA repair being a major determinant of somatic instability. Indeed, proteins in the mismatch repair (MMR) pathway are required for instability of the expanded (CAG.CTG)(n) sequence, likely via recognition of intrastrand hairpins by MutS beta. It is not clear if or how MMR would affect instability of disease-causing expanded trinucleotide repeat sequences that adopt secondary structures other than hairpins, such as the triplex/R-loop forming (GAA.TTC)(n) sequence that causes Friedreich ataxia. We analyzed somatic instability in transgenic mice that carry an expanded (GAA.TTC)(n) sequence in the context of the human FXN locus and lack the individual MMR proteins Msh2, Msh6 or Pms2. The absence of Msh2 or Msh6 resulted in a dramatic reduction in somatic mutations, indicating that mammalian MMR promotes instability of the (GAA.TTC)(n) sequence via MutSa. The absence of Pms2 resulted in increased accumulation of large expansions in the nervous system (cerebellum, cerebrum, and dorsal root ganglia) but not in non-neuronal tissues (heart and kidney), without affecting the prevalence of contractions. Pms2 suppressed large expansions specifically in tissues showing MutS alpha-dependent somatic instability, suggesting that they may act on the same lesion or structure associated with the expanded (GAA.TTC)(n) sequence. We conclude that Pms2 specifically suppresses large expansions of a pathogenic trinucleotide repeat sequence in neuronal tissues, possibly acting independently of the canonical MMR pathway.	[Bourn, Rebecka L.; De Biase, Irene; Bidichandani, Sanjay I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Bidichandani, Sanjay I.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Pinto, Ricardo Mouro; Sandi, Chiranjeevi; Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Biosci Div, Uxbridge UB8 3PH, Middx, England	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Brunel University	Bidichandani, SI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	Sanjay-Bidichandani@ouhsc.edu	Pinto, Ricardo Mouro/AAD-1048-2021	Pinto, Ricardo Mouro/0000-0001-6744-2805; Bidichandani, Sanjay/0000-0001-6191-6475	National Ataxia Foundation; Ataxia UK; Wellcome Trust; National Institutes of Health (NIH/NINDS); Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047596] Funding Source: NIH RePORTER	National Ataxia Foundation; Ataxia UK; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	IDB was supported by a postdoctoral fellowship from the National Ataxia Foundation. RMP was supported by Ataxia UK. SA was supported by The Wellcome Trust. This research was made possible by grants from the National Institutes of Health (NIH/NINDS) and the Muscular Dystrophy Association to S.I.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; Goellner GM, 1997, AM J HUM GENET, V60, P879; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Gomes-Pereira Mario, 2004, V277, P61; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Hawk JD, 2005, P NATL ACAD SCI USA, V102, P8639, DOI 10.1073/pnas.0503415102; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jun SH, 2006, FEBS J, V273, P1609, DOI 10.1111/j.1742-4658.2006.05190.x; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; LeProust EM, 2000, J MOL BIOL, V302, P1063, DOI 10.1006/jmbi.2000.4073; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Mancuso M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011121; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Mariappan SVS, 1999, J MOL BIOL, V285, P2035, DOI 10.1006/jmbi.1998.2435; Merlo D, 2005, CELL DEATH DIFFER, V12, P307, DOI 10.1038/sj.cdd.4401572; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pearson CE, 1997, HUM MOL GENET, V6, P1117, DOI 10.1093/hmg/6.7.1117; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Pollard LM, 2008, NUCLEIC ACIDS RES, V36, P489, DOI 10.1093/nar/gkm1066; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Rindler PM, 2011, NUCLEIC ACIDS RES, V39, P526, DOI 10.1093/nar/gkq788; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Schrader CE, 2008, J IMMUNOL, V180, P664, DOI 10.4049/jimmunol.180.1.664-c; Shah SN, 2009, CANCER RES, V69, P1143, DOI 10.1158/0008-5472.CAN-08-3499; Sharma R, 2002, HUM MOL GENET, V11, P2175, DOI 10.1093/hmg/11.18.2175; Sharma R, 2004, ANN NEUROL, V56, P898, DOI 10.1002/ana.20333; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Siehler SY, 2009, DNA REPAIR, V8, P242, DOI 10.1016/j.dnarep.2008.10.011; SMITH GK, 1995, NUCLEIC ACIDS RES, V23, P4303; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; SU SS, 1988, J BIOL CHEM, V263, P6829; Suen IS, 1999, BBA-GENE STRUCT EXPR, V1444, P14, DOI 10.1016/S0167-4781(98)00267-X; Sureshkumar S, 2009, SCIENCE, V323, P1060, DOI 10.1126/science.1164014; Tian L, 2009, J BIOL CHEM, V284, P20452, DOI 10.1074/jbc.C109.014977; Tiner WJ, 2001, J MOL BIOL, V314, P353, DOI 10.1006/jmbi.2001.5174; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; VARLET I, 1990, P NATL ACAD SCI USA, V87, P7883, DOI 10.1073/pnas.87.20.7883; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850	72	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47085	10.1371/journal.pone.0047085	http://dx.doi.org/10.1371/journal.pone.0047085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071719	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700050
J	Koopman, JJE; van Bodegom, D; Jukema, JW; Westendorp, RGJ				Koopman, Jacob J. E.; van Bodegom, David; Jukema, J. Wouter; Westendorp, Rudi G. J.			Risk of Cardiovascular Disease in a Traditional African Population with a High Infectious Load: A Population-Based Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; EPIDEMIOLOGIC TRANSITION; DEVELOPMENTAL ORIGINS; GENETIC-VARIATION; GLOBAL BURDEN; INFLAMMATION; ATHEROSCLEROSIS; MALARIA; ASSOCIATION	Background: To test the inflammatory origin of cardiovascular disease, as opposed to its origin in western lifestyle. Population-based assessment of the prevalences of cardiovascular risk factors and cardiovascular disease in an inflammation-prone African population, including electrocardiography and ankle-arm index measurement. Comparison with known prevalences in American and European societies. Methodology/Principal Findings: Traditional population in rural Ghana, characterised by adverse environmental conditions and a high infectious load. Population-based sample of 924 individuals aged 50 years and older. Median values for cardiovascular risk factors, including waist circumference, BMI, blood pressure, and markers of glucose and lipid metabolism and inflammation. Prevalence of myocardial infarction detected by electrocardiography and prevalence of peripheral arterial disease detected by ankle-arm index. When compared to western societies, we found the Ghanaians to have more proinflammatory profiles and less cardiovascular risk factors, including obesity, dysglycaemia, dyslipidaemia, and hypertension. Prevalences of cardiovascular disease were also lower. Definite myocardial infarction was present in 1.2% (95%CI: 0.6 to 2.4%). Peripheral arterial disease was present in 2.8% (95%CI: 1.9 to 4.1%). Conclusions/Significance: Taken together, our data indicate that for the pathogenesis of cardiovascular disease inflammatory processes alone do not suffice and additional factors, probably lifestyle-related, are mandatory.	[Koopman, Jacob J. E.; van Bodegom, David; Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [van Bodegom, David] Leyden Acad Vital & Ageing, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Koopman, JJE (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	j.j.e.koopman@lumc.nl	Jukema, J. Wouter/ABD-6503-2021	Jukema, J. Wouter/0000-0002-3246-8359; van Bodegom, David/0000-0002-5691-8342	the Netherlands Foundation for the Advancements of Tropical Research [WOTRO 93-467]; the Netherlands Organization for Scientific Research [NOW 051-14-050]; European Union [FP6 036894]; Board of Leiden University Medical Center, and Stichting Dioraphte	the Netherlands Foundation for the Advancements of Tropical Research; the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Board of Leiden University Medical Center, and Stichting Dioraphte	This research has been supported by the Netherlands Foundation for the Advancements of Tropical Research (WOTRO 93-467), the Netherlands Organization for Scientific Research (NOW 051-14-050), the European Union funded Network of Excellence LifeSpan (FP6 036894), a grant of the Board of Leiden University Medical Center, and Stichting Dioraphte. The funders have had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GHANA POVERTY REDUCT, VI; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Boef AGC, 2012, GENES IMMUN, V13, P103, DOI 10.1038/gene.2011.57; Boef AGC, PARASITIC INFE UNPUB; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; De Bacquer D, 2000, HEART, V84, P625, DOI 10.1136/heart.84.6.625; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Ghana Health Service, 2005, UPP E REG HLTH ADM A; Ghana Living Standards Survey, 2008, REP 5 ROUND GLSS 5; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Imrie H, 2007, AM J TROP MED HYG, V76, P280, DOI 10.4269/ajtmh.2007.76.280; International Fund for Agricultural Development, 2006, 1757GH INT FUND AGR; Kung'u JK, 2009, AM J TROP MED HYG, V81, P1062, DOI 10.4269/ajtmh.2009.09-0091; Kuningas M, 2009, PLOS ONE, V4, pA174, DOI 10.1371/journal.pone.0007795; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MANN GV, 1962, J CHRON DIS, V15, P341, DOI 10.1016/0021-9681(62)90082-6; Marques-Vidal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021002; May Linda, 2009, Immun Ageing, V6, P7, DOI 10.1186/1742-4933-6-7; McDade TW, 2012, AM J HUM BIOL; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Meij JJ, 2009, T ROY SOC TROP MED H, V103, P173, DOI 10.1016/j.trstmh.2008.09.015; Meij JJ, 2009, J EVOLUTION BIOL, V22, P1014, DOI 10.1111/j.1420-9101.2009.01713.x; National Center for Health Statistics, NHANES 2003 2004; National Heart Lung and Blood Institute., 2004, NIH PUBL, V04-5230; National Heart Lung and Blood Institute Division of blood diseases and resources, 2002, NIH PUBL; NHANES III, NHANES 3 EX SURV 198; Nordestgaard BG, 2009, CURR OPIN LIPIDOL, V20, P393, DOI 10.1097/MOL.0b013e3283307bfe; Perez MV, 2012, HEART RHYTHM, V9, P558, DOI 10.1016/j.hrthm.2011.11.020; Prineas R., 1982, MINNESOTA CODE MANUA; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Reddy VK, 2008, ANN NONINVAS ELECTRO, V13, P341, DOI 10.1111/j.1542-474X.2008.00252.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Samols D., 2006, AM J MED, V119, p166., DOI [DOI 10.1016/J.AMJMED.2005.06.057, 10.1016/j.amjmed.2005.06.057]; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Stowe RP, 2010, J GERONTOL A-BIOL, V65, P429, DOI 10.1093/gerona/glp198; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; van Bodegom D, 2009, T ROY SOC TROP MED H, V103, P795, DOI 10.1016/j.trstmh.2008.12.003; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; VAUGHAN JP, 1977, T ROY SOC TROP MED H, V71, P226, DOI 10.1016/0035-9203(77)90013-X; Vitelli LL, 1998, AM J CARDIOL, V81, P453, DOI 10.1016/S0002-9149(97)00937-5; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; WATKINS LO, 1984, AM HEART J, V108, P850, DOI 10.1016/0002-8703(84)90681-1; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Welsh P, 2010, J CLIN ENDOCR METAB, V95, P93, DOI 10.1210/jc.2009-1064; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Woloshin S, 2005, NEW ENGL J MED, V352, P1611, DOI 10.1056/NEJM200504143521525; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	55	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46855	10.1371/journal.pone.0046855	http://dx.doi.org/10.1371/journal.pone.0046855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071653	Green Published, gold			2022-12-25	WOS:000309807700038
J	O'Callaghan, EK; Anderson, ST; Moynagh, PN; Coogan, AN				O'Callaghan, Emma K.; Anderson, Sean T.; Moynagh, Paul N.; Coogan, Andrew N.			Long-Lasting Effects of Sepsis on Circadian Rhythms in the Mouse	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; PHASE RESPONSE CURVES; SUPRACHIASMATIC NUCLEUS; LOCOMOTOR-ACTIVITY; BIOLOGICAL CLOCK; MICE; RECEPTOR; AGE; NEUROINFLAMMATION; ALTERS	Daily patterns of activity and physiology are termed circadian rhythms and are driven primarily by an endogenous biological timekeeping system, with the master clock located in the suprachiasmatic nucleus. Previous studies have indicated reciprocal relationships between the circadian and the immune systems, although to date there have been only limited explorations of the long-term modulation of the circadian system by immune challenge, and it is to this question that we addressed ourselves in the current study. Sepsis was induced by peripheral treatment with lipopolysaccharide (5 mg/kg) and circadian rhythms were monitored following recovery. The basic parameters of circadian rhythmicity (free-running period and rhythm amplitude, entrainment to a light/dark cycle) were unaltered in post-septic animals compared to controls. Animals previously treated with LPS showed accelerated re-entrainment to a 6 hour advance of the light/dark cycle, and showed larger phase advances induced by photic stimulation in the late night phase. Photic induction of the immediate early genes c-FOS, EGR-1 and ARC was not altered, and neither was phase-shifting in response to treatment with the 5-HT-1a/7 agonist 8-OH-DPAT. Circadian expression of the clock gene product PER2 was altered in the suprachiasmatic nucleus of post-septic animals, and PER1 and PER2 expression patterns were altered also in the hippocampus. Examination of the suprachiasmatic nucleus 3 months after treatment with LPS showed persistent upregulation of the microglial markers CD-11b and F4/80, but no changes in the expression of various neuropeptides, cytokines, and intracellular signallers. The effects of sepsis on circadian rhythms does not seem to be driven by cell death, as 24 hours after LPS treatment there was no evidence for apoptosis in the suprachiasmatic nucleus as judged by TUNEL and cleaved-caspase 3 staining. Overall these data provide novel insight into how septic shock exerts chronic effects on the mammalian circadian system.	[O'Callaghan, Emma K.; Anderson, Sean T.; Coogan, Andrew N.] Natl Univ Ireland Maynooth, Dept Psychol, Maynooth, Kildare, Ireland; [Moynagh, Paul N.] Natl Univ Ireland Maynooth, Inst Immunol, Maynooth, Kildare, Ireland	Maynooth University; Maynooth University	Coogan, AN (corresponding author), Natl Univ Ireland Maynooth, Dept Psychol, Maynooth, Kildare, Ireland.	andrew.coogan@nuim.ie		Moynagh, Paul/0000-0002-4139-3061; Anderson, Sean/0000-0003-1805-2485; Coogan, Andrew/0000-0003-1998-0240	Health Research Board of Ireland [HRA2009/177]	Health Research Board of Ireland	This study was supported by the Health Research Board of Ireland (HRA2009/177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beynon AL, 2010, CHRONOBIOL INT, V27, P1546, DOI 10.3109/07420528.2010.501927; Beynon AL, 2009, NEUROIMMUNOMODULAT, V16, P392, DOI 10.1159/000228914; Boggio VI, 2003, NEUROSIGNALS, V12, P89, DOI 10.1159/000071818; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cibois M, 2010, TRENDS CELL BIOL, V20, P533, DOI 10.1016/j.tcb.2010.06.004; Coogan AN, 2008, BRAIN RES, V1232, P104, DOI 10.1016/j.brainres.2008.07.087; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Deng XH, 2010, CHRONOBIOL INT, V27, P742, DOI 10.3109/07420521003681498; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Guenthner CJ, 2009, NEUROSCIENCE, V164, P832, DOI 10.1016/j.neuroscience.2009.08.022; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; Horikawa K, 2004, NEUROSCI LETT, V368, P130, DOI 10.1016/j.neulet.2004.06.072; Hut RA, 2011, BEHAV BRAIN RES, V221, P466, DOI 10.1016/j.bbr.2010.11.039; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kwak Y, 2008, J BIOL RHYTHM, V23, P150, DOI 10.1177/0748730407313355; Kyriacou CP, 2010, TRENDS COGN SCI, V14, P259, DOI 10.1016/j.tics.2010.03.007; Leone MJ, 2006, J NEUROSCI RES, V84, P1521, DOI 10.1002/jnr.21042; LeSauter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035938; Logan RW, 2012, J IMMUNOL, V188, P2583, DOI 10.4049/jimmunol.1102715; Lundkvist GBS, 2010, J BIOL RHYTHM, V25, P92, DOI 10.1177/0748730409360963; Lundkvist GB, 1999, BRAIN RES, V849, P231, DOI 10.1016/S0006-8993(99)02086-7; Lundkvist GB, 2002, NEUROBIOL DIS, V11, P20, DOI 10.1006/nbdi.2002.0536; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Motzkus D, 2002, J MOL NEUROSCI, V18, P105, DOI 10.1385/JMN:18:1-2:105; Murphy BA, 2007, BRAIN BEHAV IMMUN, V21, P467, DOI 10.1016/j.bbi.2006.11.002; Nava F, 2000, NEUROSCI LETT, V288, P228, DOI 10.1016/S0304-3940(00)01199-X; Nygard M, 2009, NEUROREPORT, V20, P213, DOI 10.1097/WNR.0b013e32831f1ca2; O'Keeffe SM, 2012, NEUROSCIENCE, V201, P219, DOI 10.1016/j.neuroscience.2011.11.002; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Palomba M, 2008, J BIOL RHYTHM, V23, P220, DOI 10.1177/0748730408316998; Palomba M, 2008, J NEUROIMMUNOL, V193, P24, DOI 10.1016/j.jneuroim.2007.09.002; Pantazopoulos H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020658; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; Plano SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037121; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; ROSENBERG RS, 1991, AM J PHYSIOL, V261, pR491, DOI 10.1152/ajpregu.1991.261.2.R491; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Sadki A, 2007, NEUROBIOL AGING, V28, P296, DOI 10.1016/j.neurobiolaging.2005.12.007; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Smith L, 2009, J NEUROENDOCRINOL, V21, P946, DOI 10.1111/j.1365-2826.2009.01914.x; Streck EL, 2008, NEUROCHEM RES, V33, P2171, DOI 10.1007/s11064-008-9671-3; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Taraborrelli C, 2011, BRAIN BEHAV IMMUN, V25, P434, DOI 10.1016/j.bbi.2010.11.001; Tong X, 2012, J BIOL CHEM; Vilaplana J, 1999, J NEUROSCI METH, V88, P181, DOI 10.1016/S0165-0270(99)00016-3; Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009; Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048; Wyse CA, 2010, BRAIN RES, V1337, P21, DOI 10.1016/j.brainres.2010.03.113; Yamamura Y, 2010, CHRONOBIOL INT, V27, P213, DOI 10.3109/07420521003769111; ZEE PC, 1992, AM J PHYSIOL, V263, pR1099, DOI 10.1152/ajpregu.1992.263.5.R1099	62	39	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47087	10.1371/journal.pone.0047087	http://dx.doi.org/10.1371/journal.pone.0047087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071720	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000309807700051
J	Zou, SM; Li, Q; Kong, LF				Zou, Shanmei; Li, Qi; Kong, Lingfeng			Monophyly, Distance and Character-Based Multigene Barcoding Reveal Extraordinary Cryptic Diversity in Nassarius: A Complex and Dangerous Community	PLOS ONE			English	Article							SPECIES IDENTIFICATION; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL-DNA; GASTROPODA; EXTRACTION; GENETICS; MOLLUSCA; SNAIL	Background: Correct identification and cryptic biodiversity revelation for marine organisms are pressing since the marine life is important in maintaining the balance of ecological system and is facing the problem of biodiversity crisis or food safety. DNA barcoding has been proved successful to provide resolution beyond the boundaries of morphological information. Nassarius, the common mudsnail, plays an important role in marine environment and has problem in food safety, but the classification of it is quite confused because of the complex morphological diversity. Methodology/Principal Findings: Here we report a comprehensive barcoding analysis of 22 Nassarius species. We integrated the mitochondrial and nuclear sequences and the morphological characters to determine 13 Nassarius species studied and reveal four cryptic species and one pair synonyms. Distance, monophyly, and character-based barcoding methods were employed. Conclusions/Significance: Such successful identification and unexpected cryptic discovery is significant for Nassarius in food safety and species conversation and remind us to pay more attention to the hidden cryptic biodiversity ignored in marine life. Distance, monophyly, and character-based barcoding methods are all very helpful in identification but the character-based method shows some advantages.	[Zou, Shanmei; Li, Qi; Kong, Lingfeng] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China	Ocean University of China	Li, Q (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	973 Program [2010CB126406]; National Marine Public Welfare Research Program [201205023]	973 Program(National Basic Research Program of China); National Marine Public Welfare Research Program	This study was supported by research grants from 973 Program (2010CB126406) and National Marine Public Welfare Research Program (201205023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster GFJ, 2000, J MOLLUS STUD, V66, P570, DOI 10.1093/mollus/66.4.570; Bargues MD, 1997, MOL BIOL EVOL, V14, P569, DOI 10.1093/oxfordjournals.molbev.a025794; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Boss K.J., 1982, P945; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CERNOHORSKY W O, 1972, Records of the Auckland Institute and Museum, V9, P125; Cernohorsky WO, 1984, B AUCKLAND I MUS, V14, P1; Chiu YW, 2002, ZOOL STUD, V41, P321; Cossmann M, 1901, ESSAIS PALEOCONCHOLO, V4, P293; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Haasl DM, 2000, J PALEONTOL, V74, P839, DOI 10.1666/0022-3360(2000)074<0839:PRANG>2.0.CO;2; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Knowles LL, 2007, SYST BIOL, V56, P887, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Li HT, 2010, CHIN J OCEANOL LIMN, V28, P565, DOI 10.1007/s00343-010-9031-4; Maddison WP, 2005, MACCLADE ANAL PHYLOG; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Palumbi Stephen R., 1996, P205; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Svavarsson J, 2001, MAR POLLUT BULL, V42, P370, DOI 10.1016/S0025-326X(00)00164-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teske PR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000614; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Moorsel CHM, 2000, MALACOLOGIA, V42, P203; Vogler AP, 2006, FRONT ECOL ENVIRON, V4, P270, DOI 10.1890/1540-9295(2006)004[0268:wdbaet]2.0.co;2; Wang W, 2007, J XIAMEN UNIV-NAT SC, V46, P171; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilke T, 2001, J ZOOL SYST EVOL RES, V39, P227, DOI 10.1046/j.1439-0469.2001.00171.x; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Xu J., 2007, CHIN J HLTH LAB TECH, P63; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Zhang Nong, 2009, Asian Journal of Ecotoxicology, V4, P289; Zou SM, 2012, MAR BIOTECHNOL, V14, P21, DOI 10.1007/s10126-011-9384-5; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	57	17	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47276	10.1371/journal.pone.0047276	http://dx.doi.org/10.1371/journal.pone.0047276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071774	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700072
J	Arriaga, G; Zhou, EP; Jarvis, ED				Arriaga, Gustavo; Zhou, Eric P.; Jarvis, Erich D.			Of Mice, Birds, and Men: The Mouse Ultrasonic Song System Has Some Features Similar to Humans and Song-Learning Birds	PLOS ONE			English	Article							LOWER BRAIN-STEM; NEURAL PATHWAYS; MOTOR NUCLEI; SPINAL-CORD; VOCALIZATIONS; PROJECTIONS; EVOLUTION; CIRCUITS; LANGUAGE; BEHAVIOR	Humans and song-learning birds communicate acoustically using learned vocalizations. The characteristic features of this social communication behavior include vocal control by forebrain motor areas, a direct cortical projection to brainstem vocal motor neurons, and dependence on auditory feedback to develop and maintain learned vocalizations. These features have so far not been found in closely related primate and avian species that do not learn vocalizations. Male mice produce courtship ultrasonic vocalizations with acoustic features similar to songs of song-learning birds. However, it is assumed that mice lack a forebrain system for vocal modification and that their ultrasonic vocalizations are innate. Here we investigated the mouse song system and discovered that it includes a motor cortex region active during singing, that projects directly to brainstem vocal motor neurons and is necessary for keeping song more stereotyped and on pitch. We also discovered that male mice depend on auditory feedback to maintain some ultrasonic song features, and that sub-strains with differences in their songs can match each other's pitch when cross-housed under competitive social conditions. We conclude that male mice have some limited vocal modification abilities with at least some neuroanatomical features thought to be unique to humans and song-learning birds. To explain our findings, we propose a continuum hypothesis of vocal learning.	[Arriaga, Gustavo; Zhou, Eric P.; Jarvis, Erich D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA; [Zhou, Eric P.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	Duke University; Howard Hughes Medical Institute; Tulane University	Arriaga, G (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.	arriaga@neuro.duke.edu; jarvis@neuro.duke.edu	Jarvis, Erich D/A-2319-2008; Zimmermann, Elke/D-2281-2015	Jarvis, Erich D/0000-0001-8931-5049; 	National Institutes of Health [DP1 OD000448]; HHMI; National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by a National Institutes of Health pioneer award DP1 OD000448 and HHMI investigator award to EDJ and an National Science Foundation predoctoral fellowship to GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN PG, 1981, BRAIN LANG, V13, P171, DOI 10.1016/0093-934X(81)90137-1; ARENDS JJA, 1982, J COMP NEUROL, V209, P313, DOI 10.1002/cne.902090309; Arriaga G, 2012, BRAIN LANG IN PRESS; Aston-Jones G, 2000, J NEUROSCI METH, V103, P51, DOI 10.1016/S0165-0270(00)00295-8; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Briefer EF, 2012, ANIM BEHAV, V83, P991, DOI 10.1016/j.anbehav.2012.01.020; Card J P, 2001, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0105s09; Chen C-C, 2012, JOVE J VIS EXP, DOI [10.3791/3764, DOI 10.3791/3764]; Coude G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026822; Deacon T. W., 2007, EVOLUTION NERVOUS SY, V4, P529; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Fitch WT, 2010, NEURON, V65, P795, DOI 10.1016/j.neuron.2010.03.011; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hage SR, 2006, EUR J NEUROSCI, V23, P3297, DOI 10.1111/j.1460-9568.2006.04835.x; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Heaton JT, 1999, J ACOUST SOC AM, V105, P2010, DOI 10.1121/1.426734; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; IWATSUBO T, 1990, NEUROLOGY, V40, P309, DOI 10.1212/WNL.40.2.309; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; KIRZINGER A, 1982, BRAIN RES, V233, P299, DOI 10.1016/0006-8993(82)91204-5; Konishi M., 1963, Z TIERPSYCHOL, V20, P349, DOI DOI 10.1111/J.1439-0310.1963.TB01156.X; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; KUYPERS HGJ, 1958, BRAIN, V81, P364, DOI 10.1093/brain/81.3.364; KUYPERS HGJM, 1958, J COMP NEUROL, V110, P221, DOI 10.1002/cne.901100205; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; Okanoya K, 2004, JPN PSYCHOL RES, V46, P207, DOI 10.1111/j.1468-5584.2004.00252.x; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Riede T, 2011, J NEUROPHYSIOL, V106, P2580, DOI 10.1152/jn.00478.2011; RUBSAMEN R, 1990, J COMP PHYSIOL A, V167, P771; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; SHIPLEY C, 1988, EXP BRAIN RES, V69, P431; Simoes CS, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00123; Simonyan K, 2003, BRAIN RES, V974, P43, DOI 10.1016/S0006-8993(03)02548-4; Simonyan K, 2011, NEUROSCIENTIST, V17, P197, DOI 10.1177/1073858410386727; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Snowdon CT, 1999, ETHOLOGY, V105, P893, DOI 10.1046/j.1439-0310.1999.00483.x; SUTTON D, 1974, BRAIN RES, V71, P61, DOI 10.1016/0006-8993(74)90191-7; Taglialatela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018852; Takahashi K, 2001, BRAIN RES, V894, P359, DOI 10.1016/S0006-8993(01)02123-0; Van Daele DJ, 2009, NEUROSCIENCE, V162, P501, DOI 10.1016/j.neuroscience.2009.05.005; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Willott JF, 2000, FUNCTIONAL NEUROBIOL, P605	57	174	174	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46610	10.1371/journal.pone.0046610	http://dx.doi.org/10.1371/journal.pone.0046610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071596	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200035
J	Jin, FY; Ji, HF; Jia, CS; Brockmeier, U; Hermann, DM; Metzen, E; Zhu, YQ; Chi, BR				Jin, Fengyan; Ji, Huifan; Jia, Chunshu; Brockmeier, Ulf; Hermann, Dirk M.; Metzen, Eric; Zhu, Yingqiao; Chi, Baorong			Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116	PLOS ONE			English	Article							RECOMBINANT HUMAN ENDOSTATIN; CANCER; OVEREXPRESSION; EXPRESSION; EFFICACY; THERAPY	Combination treatment with endostar, a novel modified endostatin, and cytotoxic chemotherapies showed a survival benefit in Chinese clinical trials. However, the exact mechanism for this synergism remains unclear. In this study, we report for the first time that the chemokine receptor CXCR4 and the hypoxia-inducible transcription factors (HIF)-1 alpha and HIF-2 alpha are involved in these synergistic antitumor effects in human colorectal cancer SW1116 cells in vitro when endostar treatment is combined with the cytotoxic drug oxaliplatin. Under normoxia, we demonstrate that endostar and oxaliplatin treatments synergize to inhibit SW1116 cell proliferation, Matrigel adhesion and invasion by reduction of CXCR4 expression. Consistently, these antitumor abilities of endostar and oxaliplatin were markedly reduced by silencing of CXCR4 in SW1116 cells. Under low oxygen conditions (hypoxia, 1% oxygen), enhanced proliferation of SW1116 cells exposed to oxaliplatin was observed due to the emergence of drug resistance. Strikingly, endostar overcame oxaliplatin-resistance, most likely as a consequence of reduced HIF-2 alpha and CXCR4 levels. CXCR4, is only dependent on HIF-2 alpha, which promotes more aggressive phenotype and more significant for oxaliplatin resistance in SW1116 cells. Our data not only provide clues to aid understanding of the mechanism of the synergism of endostar and chemotherapy under either normoxia or hypoxia, but also suggests a new strategy of combination endostar and chemotherapy treatments which might potentiate therapeutic efficacies and/or counteract chemotherapy resistance. Citation: Jin F, Ji H, Jia C, Brockmeier U, Hermann DM, et al. (2012) Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116. PLoS ONE 7(10): e47161. doi: 10.1371/journal.pone.0047161	[Jin, Fengyan; Ji, Huifan; Jia, Chunshu; Zhu, Yingqiao; Chi, Baorong] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China; [Jin, Fengyan] Jilin Prov Tumor Hosp, Changchun, Peoples R China; [Jin, Fengyan; Hermann, Dirk M.] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Brockmeier, Ulf; Metzen, Eric] Univ Duisburg Essen, Dept Physiol, Essen, Germany	Jilin University; University of Duisburg Essen; University of Duisburg Essen	Zhu, YQ (corresponding author), Jilin Univ, Hosp 1, Changchun 130023, Peoples R China.	zhuyingqiaoZYQ@163.com; chibr@jlu.edu.cn	Hermann, Dirk M/AAP-5538-2020; Jin, Fengyan/AAG-9931-2020; Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 	Science and Technology foundation of Jilin Province, China [200705438]	Science and Technology foundation of Jilin Province, China	This work was supported by the Science and Technology foundation of Jilin Province, China (200705438 to Fengyan Jin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, DRUG RESIST UPDATE, V8, P59, DOI 10.1016/j.drup.2005.03.001; Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dewhirst MW, 2007, RADIOTHER ONCOL, V83, P249, DOI 10.1016/j.radonc.2007.05.016; Egawa T, 2001, IMMUNITY, V15, P323, DOI 10.1016/S1074-7613(01)00185-6; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Hamilton S., 2000, PATHOLOGY GENETICS T, P105; Han BH, 2011, J THORAC ONCOL, V6, P1104, DOI 10.1097/JTO.0b013e3182166b6b; Hao J, 2008, CANCER GENE THER, V15, P449, DOI 10.1038/cgt.2008.4; Ingold B, 2009, HISTOPATHOLOGY, V55, P576, DOI 10.1111/j.1365-2559.2009.03426.x; Jia Y, 2011, EUR J GYNAECOL ONCOL, V32, P316; Kim J, 2005, J CLIN ONCOL, V23, P2744, DOI 10.1200/JCO.2005.07.078; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Kim YM, 2000, CANCER RES, V60, P5410; Kulke MH, 2006, J CLIN ONCOL, V24, P3555, DOI 10.1200/JCO.2006.05.6762; Liu FJ, 2008, CANCER SCI, V99, P2055, DOI 10.1111/j.1349-7006.2008.00905.x; Macpherson GR, 2003, MOL CANCER THER, V2, P845; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Ottaiano A, 2006, CLIN CANCER RES, V12, P2795, DOI 10.1158/1078-0432.CCR-05-2142; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; Perletti G, 2000, CANCER RES, V60, P1793; Rapisarda A, 2009, DRUG RESIST UPDATE, V12, P74, DOI 10.1016/j.drup.2009.03.002; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Wylie PG, 2007, CLIN LAB MED, V27, P193, DOI 10.1016/j.cll.2006.12.008; Yu Y, 2004, P NATL ACAD SCI USA, V101, P8005, DOI 10.1073/pnas.0402551101; Zhou JF, 2011, CHINESE MED J-PEKING, V124, P4299, DOI 10.3760/cma.j.issn.0366-6999.2011.24.031	34	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47161	10.1371/journal.pone.0047161	http://dx.doi.org/10.1371/journal.pone.0047161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071744	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200088
J	Lin, JF; Heuser, T; Song, KK; Fu, XF; Nicastro, D				Lin, Jianfeng; Heuser, Thomas; Song, Kangkang; Fu, Xiaofeng; Nicastro, Daniela			One of the Nine Doublet Microtubules of Eukaryotic Flagella Exhibits Unique and Partially Conserved Structures	PLOS ONE			English	Article							SEA-URCHIN SPERM; DYNEIN REGULATORY COMPLEX; CENTRAL-PAIR MICROTUBULES; CHLAMYDOMONAS-FLAGELLA; CRYOELECTRON TOMOGRAPHY; RADIAL SPOKES; I1 DYNEIN; MOLECULAR ARCHITECTURE; MICROSCOPE TOMOGRAPHY; CENTRAL APPARATUS	The axonemal core of motile cilia and flagella consists of nine doublet microtubules surrounding two central single microtubules. Attached to the doublets are thousands of dynein motors that produce sliding between neighboring doublets, which in turn causes flagellar bending. Although many structural features of the axoneme have been described, structures that are unique to specific doublets remain largely uncharacterized. These doublet-specific structures introduce asymmetry into the axoneme and are likely important for the spatial control of local microtubule sliding. Here, we used cryo-electron tomography and doublet-specific averaging to determine the 3D structures of individual doublets in the flagella of two evolutionarily distant organisms, the protist Chlamydomonas and the sea urchin Strongylocentrotus. We demonstrate that, in both organisms, one of the nine doublets exhibits unique structural features. Some of these features are highly conserved, such as the inter-doublet link i-SUB5-6, which connects this doublet to its neighbor with a periodicity of 96 nm. We also show that the previously described inter-doublet links attached to this doublet, the o-SUB5-6 in Strongylocentrotus and the proximal 1-2 bridge in Chlamydomonas, are likely not homologous features. The presence of inter-doublet links and reduction of dynein arms indicate that inter-doublet sliding of this unique doublet against its neighbor is limited, providing a rigid plane perpendicular to the flagellar bending plane. These doublet-specific features and the non-sliding nature of these connected doublets suggest a structural basis for the asymmetric distribution of dynein activity and inter-doublet sliding, resulting in quasi-planar waveforms typical of 9+2 cilia and flagella.	[Lin, Jianfeng; Heuser, Thomas; Song, Kangkang; Fu, Xiaofeng; Nicastro, Daniela] Brandeis Univ, Dept Biol, Rosenstiel Ctr, Waltham, MA 02254 USA	Brandeis University	Nicastro, D (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Ctr, Waltham, MA 02254 USA.	nicastro@brandeis.edu		Heuser, Thomas/0000-0001-7385-0178; Lin, Jianfeng/0000-0003-1215-0906; Lin, Jianfeng/0000-0001-5732-1209; Nicastro, Daniela/0000-0002-0122-7173	National Institutes of Health [GM083122]; W. M. Keck Foundation; National Science Foundation [DMR-MRSEC-0820492]; Pew Biomedical Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); Pew Biomedical Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM083122; http://www.nigms.nih.gov), from the W. M. Keck Foundation (http://www.wmkeck.org), the National Science Foundation (DMR-MRSEC-0820492 supporting TH; http://mrsec.org) and by a Pew Biomedical Scholars Award (to DN; http://www.pewtrusts.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B, 1959, J BIOPHYS BIOCHEM CY, V5, P269, DOI 10.1083/jcb.5.2.269; Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Barber CF, 2012, MOL BIOL CELL, V23, P111, DOI 10.1091/mbc.E11-08-0692; BOZKURT HH, 1993, CELL MOTIL CYTOSKEL, V24, P109; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Brokaw CJ, 2002, CELL MOTIL CYTOSKEL, V53, P103, DOI 10.1002/cm.10067; Bui KH, 2009, J CELL BIOL, V186, P437, DOI 10.1083/jcb.200903082; Bui KH, 2008, J CELL BIOL, V183, P923, DOI 10.1083/jcb.200808050; CHWANG AT, 1971, PROC R SOC SER B-BIO, V178, P327, DOI 10.1098/rspb.1971.0068; COSTELLO DP, 1973, BIOL BULL, V145, P279, DOI 10.2307/1540040; COSTELLO DP, 1973, BIOL BULL-US, V145, P292, DOI 10.2307/1540041; DEINER M, 1993, J CELL SCI, V104, P1251; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; Dymek EE, 2011, MOL BIOL CELL, V22, P2520, DOI 10.1091/mbc.E11-03-0271; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; GATTI JL, 1985, J BIOL CHEM, V260, P7599; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; GIBBONS BH, 1985, CELL MOTIL CYTOSKEL, V5, P333, DOI 10.1002/cm.970050406; GIBBONS IR, 1963, P NATL ACAD SCI USA, V50, P1002, DOI 10.1073/pnas.50.5.1002; GIBBONS IR, 1961, J BIOPHYS BIOCHEM CY, V11, P179, DOI 10.1083/jcb.11.1.179; GIBBONS IR, 1982, SYM SOC EXP BIOL, P225; GIBBONS IR, 1981, J CELL BIOL, V91, pS107, DOI 10.1083/jcb.91.3.107s; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Harris EH., 2009, CHLAMYDOMONAS SOURCE; Heuser T, 2012, P NATL ACAD SCI USA, V109, pE2067, DOI 10.1073/pnas.1120690109; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; HOOPS HJ, 1984, J CELL BIOL, V98, P818, DOI 10.1083/jcb.98.3.818; HOSOKAWA Y, 1987, J CELL BIOL, V105, P1297, DOI 10.1083/jcb.105.3.1297; HUANG B, 1979, J BIOL CHEM, V254, P3091; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; HYAMS JS, 1975, SCIENCE, V189, P891, DOI 10.1126/science.1098148; HYAMS JS, 1978, J CELL SCI, V33, P235; KAGAMI O, 1992, J CELL SCI, V103, P653; KAMIYA R, 1995, CELL MOTIL CYTOSKEL, V32, P98, DOI 10.1002/cm.970320205; KATO T, 1993, CELL STRUCT FUNCT, V18, P371, DOI 10.1247/csf.18.371; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lesich KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094953; Lin JF, 2012, CYTOSKELETON, V69, P88, DOI 10.1002/cm.21000; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Linck RW, 2007, CELL MOTIL CYTOSKEL, V64, P489, DOI 10.1002/cm.20202; Lindemann CB, 2005, BIOPHYS J, V89, P1165, DOI 10.1529/biophysj.105.060681; LINDEMANN CB, 1992, J CELL SCI, V102, P249; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Minoura I, 1999, CELL STRUCT FUNCT, V24, P27, DOI 10.1247/csf.24.27; Myster SH, 1997, MOL BIOL CELL, V8, P607, DOI 10.1091/mbc.8.4.607; Nakano I, 2003, J CELL SCI, V116, P1627, DOI 10.1242/jcs.00336; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nicastro D, 2009, METHOD CELL BIOL, V91, P1, DOI 10.1016/S0091-679X(08)91001-3; OGAWA K, 1977, P NATL ACAD SCI USA, V74, P5006, DOI 10.1073/pnas.74.11.5006; OGAWA K, 1982, J CELL BIOL, V92, P706, DOI 10.1083/jcb.92.3.706; OMOTO CK, 1981, NATURE, V290, P708, DOI 10.1038/290708a0; Omoto CK, 1999, MOL BIOL CELL, V10, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pigino G, 2012, J STRUCT BIOL, V178, P199, DOI 10.1016/j.jsb.2012.02.012; Pigino G, 2011, J CELL BIOL, V195, P673, DOI 10.1083/jcb.201106125; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; SATIR P, 1965, J CELL BIOL, V26, P805, DOI 10.1083/jcb.26.3.805; SHINGYOJI C, 1977, NATURE, V265, P269, DOI 10.1038/265269a0; Sineshchekov OA, 1999, TRENDS PLANT SCI, V4, P201, DOI 10.1016/S1360-1385(99)01409-0; Smith DJ, 2009, CELL MOTIL CYTOSKEL, V66, P220, DOI 10.1002/cm.20345; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Wargo MJ, 2004, J CELL SCI, V117, P2533, DOI 10.1242/jcs.01082; Wargo MJ, 2003, P NATL ACAD SCI USA, V100, P137, DOI 10.1073/pnas.0135800100; WARNER FD, 1976, J CELL SCI, V20, P101; Wirschell M, 2007, CELL MOTIL CYTOSKEL, V64, P569, DOI 10.1002/cm.20211; Wirschell M, 2009, MOL BIOL CELL, V20, P3044, DOI 10.1091/mbc.E09-04-0276; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; [No title captured]	78	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46494	10.1371/journal.pone.0046494	http://dx.doi.org/10.1371/journal.pone.0046494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071579	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200029
J	Teixeira, JJV; Crozatti, MTL; dos Santos, CA; Romano-Lieber, NS				Vieira Teixeira, Jorge Juarez; Lonardoni Crozatti, Marcia Terezinha; dos Santos, Carlos Aparecido; Romano-Lieber, Nicolina Silvana			Potential Drug-Drug Interactions in Prescriptions to Patients over 45 Years of Age in Primary Care, Southern Brazil	PLOS ONE			English	Article							MEDICAL PRESCRIPTIONS; RISK-FACTORS; ANTIDEPRESSANTS; POLYPHARMACY; POPULATION; ALERTS; UNITS	Background: Few cross-sectional studies involving adults and elderly patients with major DDIs have been conducted in the primary care setting. The study aimed to investigate the prevalence of potential drug-drug interactions (DDIs) in patients treated in primary care. Methodology/Principal Findings: A cross-sectional study involving patients aged 45 years or older was conducted at 25 Basic Health Units in the city of Maringa (southern Brazil) from May to December 2010. The data were collected from prescriptions at the pharmacy of the health unit at the time of the delivery of medication to the patient. After delivery, the researcher checked the electronic medical records of the patient. A total of 827 patients were investigated (mean age: 64.1; mean number of medications: 4.4). DDIs were identified in the Micromedex (R) database. The prevalence of potential DDIs and major DDIs was 63.0% and 12.1%, respectively. In both the univariate and multivariate analyses, the number of drugs prescribed was significantly associated with potential DDIs, with an increasing risk from three to five drugs (OR = 4.74; 95% CI: 2.90-7.73) to six or more drugs (OR = 23.03; 95% CI: 10.42-50.91). Forty drugs accounted for 122 pairs of major DDIs, the most frequent of which involved simvastatin (23.8%), captopril/enalapril (16.4%) and fluoxetine (16.4%). Conclusions/Significance: This is the first large-scale study on primary care carried out in Latin America. Based on the findings, the estimated prevalence of potential DDIs was high, whereas clinically significant DDIs occurred in a smaller proportion. Exposing patients to a greater number of prescription drugs, especially three or more, proved to be a significant predictor of DDIs. Prescribers should be more aware of potential DDIs. Future studies should assess potential DDIs in primary care over a longer period of time.	[Vieira Teixeira, Jorge Juarez] Univ Estadual Maringa, Ctr Ciencias Saude, Dept Anal Clin & Biomed, Maringa, Parana, Brazil; [Lonardoni Crozatti, Marcia Terezinha] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil; [dos Santos, Carlos Aparecido] Univ Estadual Maringa, Ctr Ciencias Exatas, Dept Estat, Maringa, Parana, Brazil; [Vieira Teixeira, Jorge Juarez; Romano-Lieber, Nicolina Silvana] Univ Sao Paulo, Fac Saude Publ, Dept Prat Saude Publ, Sao Paulo, Brazil	Universidade Estadual de Maringa; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Maringa; Universidade de Sao Paulo	Teixeira, JJV (corresponding author), Univ Estadual Maringa, Ctr Ciencias Saude, Dept Anal Clin & Biomed, Maringa, Parana, Brazil.	jjvteixeira@uem.br			Brazilian fostering agency Conselho Nacional de Pesquisa, (CNPq) [476374/2010-3]; Brazilian fostering agency Fundacao Araucaria (state of Parana) [093/2010]	Brazilian fostering agency Conselho Nacional de Pesquisa, (CNPq)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian fostering agency Fundacao Araucaria (state of Parana)	This study received financial and logistical support from the Brazilian fostering agencies Conselho Nacional de Pesquisa, (CNPq; Brasilia; process number 476374/2010-3) and Fundacao Araucaria (state of Parana; announcement 18/2009 - agreement 093/2010), which provided a scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca Jacob, 2004, J Am Pharm Assoc (2003), V44, P136, DOI 10.1331/154434504773062582; Astrand B, 2006, EUR J CLIN PHARMACOL, V62, P749, DOI 10.1007/s00228-006-0143-x; Avery AJ, 2002, BRIT J GEN PRACT, V52, pS17; Becker ML, 2005, DRUG SAFETY, V28, P371, DOI 10.2165/00002018-200528050-00001; Becquemont L, 2007, CLIN PHARMACOL THER, V81, P679, DOI 10.1038/sj.clpt.6100098; Bergk V, 2004, CLIN PHARMACOL THER, V76, P85, DOI 10.1016/j.clpt.2004.02.009; Bjerrum L, 2003, SCAND J PRIM HEALTH, V21, P153, DOI 10.1080/02813430310001806; Bjorkman IK, 2002, ANN PHARMACOTHER, V36, P1675, DOI 10.1345/aph.1A484; Bleich GW, 2009, SAO PAULO MED J, V127, P206, DOI 10.1590/S1516-31802009000400005; Brvar Miran, 2009, BMC Clin Pharmacol, V9, P8, DOI 10.1186/1472-6904-9-8; Chatsisvili A, 2010, PHARM WORLD SCI, V32, P187, DOI 10.1007/s11096-010-9365-1; Neto VC, 2010, BRAZ J PHARM SCI, V46, P795, DOI 10.1590/S1984-82502010000400022; Cruciol-Souza Joice Mara, 2006, Clinics, V61, P515, DOI 10.1590/S1807-59322006000600005; de Abajo FJ, 2006, BASIC CLIN PHARMACOL, V98, P304, DOI 10.1111/j.1742-7843.2006.pto_303.x; Doubova SV, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-147; Egger SS, 2003, EUR J CLIN PHARMACOL, V58, P773, DOI 10.1007/s00228-002-0557-z; Fokter N, 2010, WIEN KLIN WOCHENSCHR, V122, P81, DOI 10.1007/s00508-009-1251-2; Guedon-Moreau L, 2003, EUR J CLIN PHARMACOL, V59, P689, DOI 10.1007/s00228-003-0684-1; Halkin H, 2001, CLIN PHARMACOL THER, V69, P260, DOI 10.1067/mcp.2001.114228; Haueis P, 2011, CLIN PHARMACOL THER, V90, P588, DOI 10.1038/clpt.2011.150; Indermitte J, 2007, DRUG SAFETY, V30, P71, DOI 10.2165/00002018-200730010-00007; JANKEL CA, 1990, DICP ANN PHARMAC, V24, P982, DOI 10.1177/106002809002401014; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Kravitz RL, 2008, AM J MED, V121, P1, DOI 10.1016/j.amjmed.2008.09.007; Lapi F, 2010, PHARM WORLD SCI, V32, P200, DOI 10.1007/s11096-010-9370-4; Lin CF, 2011, DRUG AGING, V28, P219, DOI 10.2165/11586870-000000000-00000; Linnarsson Rolf, 1993, Scandinavian Journal of Primary Health Care, V11, P181, DOI 10.3109/02813439308994827; Lopez-Picazo JJ, 2010, EUR J GEN PRACT, V16, P92, DOI 10.3109/13814788.2010.481709; Magnus D, 2002, J CLIN PHARM THER, V27, P377, DOI 10.1046/j.1365-2710.2002.00434.x; Mallet L, 2007, LANCET, V370, P185, DOI 10.1016/S0140-6736(07)61092-7; Mannheimer B, 2006, EUR J CLIN PHARMACOL, V62, P1075, DOI 10.1007/s00228-006-0214-z; Miyasaka LS, 2003, REV SAUDE PUBL, V37, P212, DOI 10.1590/S0034-89102003000200008; Morera T, 2005, BASIC CLIN PHARMACOL, V96, P289, DOI 10.1111/j.1742-7843.2005.pto960403.x; Nobili A, 2009, J CLIN PHARM THER, V34, P377, DOI 10.1111/j.1365-2710.2009.01021.x; Oshima Y, 2011, INTERNAL MED, V50, P845, DOI 10.2169/internalmedicine.50.4484; Paige NM, 2009, MAYO CLIN PROC, V84, P180, DOI 10.1016/S0025-6196(11)60826-4; Passarelli MCG, 2005, DRUG AGING, V22, P767, DOI 10.2165/00002512-200522090-00005; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pivatto Junior F, 2009, REV AMRIGS, V53, P251; Putnam Wayne, 2006, Can Fam Physician, V52, P340; Schech S, 2007, PHARMACOEPIDEM DR S, V16, P352, DOI 10.1002/pds.1287; Schuler J, 2008, WIEN KLIN WOCHENSCHR, V120, P733, DOI 10.1007/s00508-008-1089-z; Secoli SR, 2010, DRUG AGING, V27, P759, DOI 10.2165/11538460-000000000-00000; Seymour RM, 1998, DRUG AGING, V12, P485, DOI 10.2165/00002512-199812060-00006; Silva N. M. O., 2010, Revista de Ciencias Farmaceuticas Basica e Aplicada, V31, P171; Smithburger PL, 2010, DRUG SAFETY, V33, P879, DOI 10.2165/11532340-000000000-00000; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Viktil KK, 2007, BRIT J CLIN PHARMACO, V63, P187, DOI 10.1111/j.1365-2125.2006.02744.x; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; Yang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016641; Zurakowski T, 2009, NURSE PRACT, V34, P36, DOI 10.1097/01.NPR.0000348320.38365.59	52	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47062	10.1371/journal.pone.0047062	http://dx.doi.org/10.1371/journal.pone.0047062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071711	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200073
J	Zhu, XG; Wang, YC; Pi, WH; Liu, H; Wickrema, A; Tuan, D				Zhu, Xingguo; Wang, Yongchao; Pi, Wenhu; Liu, Hui; Wickrema, Amittha; Tuan, Dorothy			NF-Y Recruits Both Transcription Activator and Repressor to Modulate Tissue- and Developmental Stage-Specific Expression of Human gamma-Globin Gene	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTORS; FETAL-HEMOGLOBIN; HEREDITARY PERSISTENCE; COUP-TFII; ENDOGENOUS RETROVIRUS; TRANSGENIC MICE; POINT MUTATION; BINDING FACTOR; PROMOTER; COMPLEX	The human embryonic, fetal and adult beta-like globin genes provide a paradigm for tissue- and developmental stage-specific gene regulation. The fetal gamma-globin gene is expressed in fetal erythroid cells but is repressed in adult erythroid cells. The molecular mechanism underlying this transcriptional switch during erythroid development is not completely understood. Here, we used a combination of in vitro and in vivo assays to dissect the molecular assemblies of the active and the repressed proximal gamma-globin promoter complexes in K562 human erythroleukemia cell line and primary human fetal and adult erythroid cells. We found that the proximal gamma-globin promoter complex is assembled by a developmentally regulated, general transcription activator NF-Y bound strongly at the tandem CCAAT motifs near the TATA box. NF-Y recruits to neighboring DNA motifs the developmentally regulated, erythroid transcription activator GATA-2 and general repressor BCL11A, which in turn recruit erythroid repressor GATA-1 and general repressor COUP-TFII to form respectively the NF-Y/GATA-2 transcription activator hub and the BCL11A/COUP-TFII/GATA-1 transcription repressor hub. Both the activator and the repressor hubs are present in both the active and the repressed gamma-globin promoter complexes in fetal and adult erythroid cells. Through changes in their levels and respective interactions with the co-activators and co-repressors during erythroid development, the activator and the repressor hubs modulate erythroid- and developmental stage-specific transcription of gamma-globin gene. Citation: Zhu X, Wang Y, Pi W, Liu H, Wickrema A, et al. (2012) NF-Y Recruits Both Transcription Activator and Repressor to Modulate Tissue- and Developmental Stage-Specific Expression of Human gamma-Globin Gene. PLoS ONE 7(10): e47175. doi: 10.1371/journal.pone.0047175	[Zhu, Xingguo; Wang, Yongchao; Pi, Wenhu; Tuan, Dorothy] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Zhu, Xingguo; Wang, Yongchao; Pi, Wenhu; Tuan, Dorothy] Georgia Hlth Sci Univ, Coll Grad Studies, Augusta, GA USA; [Liu, Hui; Wickrema, Amittha] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Chicago	Tuan, D (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA.	dtuanlo@georgiahealth.edu			National Institutes of Health [HL 89519, MD003383, CA98550]; Giving Tree Foundation; NATIONAL CANCER INSTITUTE [R01CA098550] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089519] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD003383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giving Tree Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health (HL 89519 and MD003383 to D.T., CA98550 to A.W.), and the Giving Tree Foundation to A.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerbajinai W, 2009, BLOOD, V114, P187, DOI 10.1182/blood-2008-07-170712; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; Blobel GA, 2002, J LEUKOCYTE BIOL, V71, P545; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Elefanty AG, 1996, EMBO J, V15, P319, DOI 10.1002/j.1460-2075.1996.tb00362.x; Filipe A, 1999, EMBO J, V18, P687, DOI 10.1093/emboj/18.3.687; Goodman RH, 2000, GENE DEV, V14, P1553; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Kabe Y, 2005, MOL CELL BIOL, V25, P512, DOI 10.1128/MCB.25.1.512-522.2005; Kang JA, 2008, J BIOL CHEM, V283, P6997, DOI 10.1074/jbc.M706712200; Kim BJ, 2009, DEV BIOL, V326, P378, DOI 10.1016/j.ydbio.2008.11.001; KIM CG, 1990, J BIOL CHEM, V265, P13362; Li QL, 2004, P NATL ACAD SCI USA, V101, P8096, DOI 10.1073/pnas.0402594101; Li QL, 2001, EMBO J, V20, P157, DOI 10.1093/emboj/20.1.157; Liberati C, 1998, J BIOL CHEM, V273, P16880, DOI 10.1074/jbc.273.27.16880; Liberati C, 2001, J BIOL CHEM, V276, P41700, DOI 10.1074/jbc.M102987200; Ling JH, 2002, J VIROL, V76, P2410, DOI 10.1128/JVI.76.5.2410-2423.2002; Liu LR, 2005, J BIOL CHEM, V280, P7452, DOI 10.1074/jbc.M411407200; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Ramchandran R, 2000, AM J HEMATOL, V65, P14, DOI 10.1002/1096-8652(200009)65:1<14::AID-AJH3>3.0.CO;2-F; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000; Zhu XG, 2007, NUCLEIC ACIDS RES, V35, P5532, DOI 10.1093/nar/gkm595	42	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47175	10.1371/journal.pone.0047175	http://dx.doi.org/10.1371/journal.pone.0047175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071749	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200089
J	Casanova, EA; Okoniewski, MJ; Cinelli, P				Casanova, Elisa A.; Okoniewski, Michal J.; Cinelli, Paolo			Cross-Species Genome Wide Expression Analysis during Pluripotent Cell Determination in Mouse and Rat Preimplantation Embryos	PLOS ONE			English	Article							KINASE RHO-KINASE; STEM-CELLS; SELF-RENEWAL; BETA-CATENIN; SIGNAL-TRANSDUCTION; MYOSIN PHOSPHATASE; SMOOTH-MUSCLE; STAT3; DIFFERENTIATION; ACTIVATION	The transition between morula and blastocyst stage during preimplantation development represents the first differentiation event of embryogenesis. Morula cells undergo the first cellular specialization and produce two well-defined populations of cells, the trophoblast and the inner cell mass (ICM). Embryonic stem cells (ESCs) with unlimited self-renewal capacity are believed to represent the in vitro counterpart of the ICM. Both mouse and rat ESCs can be derived from the ICM cells, but their in vitro stability differs. In this study we performed a microarray analysis in which we compared the transcriptome of mouse and rat morula, blastocyst, and ICM. This cross-species comparison represents a good model for understanding the differences in derivation and cultivation of ESCs observed in the two species. In order to identify alternative regulation of important molecular mechanisms the investigation of differential gene expression between the two species was extended at the level of signaling pathways, gene families, and single selected genes of interest. Some of the genes differentially expressed between the two species are already known to be important factors in the maintenance of pluripotency in ESCs, like for example Sox2 or Stat3, or play a role in reprogramming somatic cells to pluripotency like c-Myc, Klf4 and p53 and therefore represent interesting candidates to further analyze in vitro in the rat ESCs. This is the first study investigating the gene expression changes during the transition from morula to blastocyst in the rat preimplantation development. Our data show that in the pluripotent pool of cells of the rat and mouse preimplantation embryo substantial differential regulation of genes is present, which might explain the difficulties observed for the derivation and culture of rat ESCs using mouse conditions.	[Casanova, Elisa A.; Cinelli, Paolo] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Okoniewski, Michal J.] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Okoniewski, Michal J.] ETH, Zurich, Switzerland; [Cinelli, Paolo] Univ Zurich, Ctr Appl Biotechnol & Mol Med, Zurich, Switzerland; [Cinelli, Paolo] Univ Zurich Hosp, Div Trauma Surg, Clin Res Ctr, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Cinelli, P (corresponding author), Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.	paolo.cinelli@usz.ch		Cinelli, Paolo/0000-0002-0163-9055	Swiss National Science Foundation [31003A-118361]; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This work was supported by the Swiss National Science Foundation (Grant 31003A-118361) and the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asanoma K, 2011, DEV BIOL, V351, P110, DOI 10.1016/j.ydbio.2010.12.038; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Ciemerych MA, 2005, ONCOGENE, V24, P2877, DOI 10.1038/sj.onc.1208608; Cinelli P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-57; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1; Graf U, 2011, GENES-BASEL, V2, P280, DOI 10.3390/genes2010280; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitisin K., 2007, SCI STKE, V2007; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lemaitre JM, 1996, ADV CANCER RES, V70, P95, DOI 10.1016/S0065-230X(08)60873-8; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nagy A., 2003, MANIPULATING MOUSE E; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Ramos SD, 2001, J APPL PHYSIOL, V91, P667, DOI 10.1152/jappl.2001.91.2.667; SAVATIER P, 1994, ONCOGENE, V9, P809; Shatz M, 2008, INT J RADIAT BIOL, V84, P177, DOI 10.1080/09553000701745293; Shen Y, 2011, CELL RES, V21, P1143, DOI 10.1038/cr.2011.98; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Totsukawa G, 1999, J CELL BIOL, V144, P735, DOI 10.1083/jcb.144.4.735; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang YC, 2004, DEV DYNAM, V231, P72, DOI 10.1002/dvdy.20114; Wray J, 2011, NATURE CELL BIOL; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yang DH, 2009, DEV DYNAM, V238, P514, DOI 10.1002/dvdy.21856; Yi F, 2011, NATURE CELL BIOL; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	80	12	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47107	10.1371/journal.pone.0047107	http://dx.doi.org/10.1371/journal.pone.0047107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077551	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000309995100061
J	Chauhan, C; Behura, SK; Debruyn, B; Lovin, DD; Harker, BW; Gomez-Machorro, C; Mori, A; Romero-Severson, J; Severson, DW				Chauhan, Chitra; Behura, Susanta K.; Debruyn, Becky; Lovin, Diane D.; Harker, Brent W.; Gomez-Machorro, Consuelo; Mori, Akio; Romero-Severson, Jeanne; Severson, David W.			Comparative Expression Profiles of Midgut Genes in Dengue Virus Refractory and Susceptible Aedes aegypti across Critical Period for Virus Infection	PLOS ONE			English	Article							INNATE IMMUNITY; VECTOR COMPETENCE; RNA INTERFERENCE; MOSQUITO; PATHWAY; DROSOPHILA; GENETICS; PROGRAMS; DEFENSE; DISEASE	Background: Aedes aegypti is the primary mosquito vector for dengue virus (DENV) worldwide. Infectivity of dengue virus varies among natural populations of this mosquito. How A. aegypti responds to DENV infection relative to which genes and associated pathways contribute to its differential susceptibility as a vector is not well defined. Methods/Principal Findings: Here, we used custom cDNA microarrays to identify groups of genes that were differentially expressed in midgut tissues between susceptible and refractory strains in a highly time specific manner. While genes involved in protein processing in the endoplasmic reticulum, mRNA surveillance, and the proteasome were significantly up-regulated in the susceptible strain, several metabolic processes including glycolysis, glycan biosynthesis and Wnt pathway were active in the refractory strain. In addition, several key signaling genes were expressed as common responsive genes in both susceptible and refractory mosquitoes that may be necessary for signal transduction to trigger the appropriate host response to the viral infection. These are coordinately expressed in the form of tight gene networks and expression clusters that may be necessary to differentially contribute to the progression of dengue infection between the two strains. Conclusions: Our data show that highly correlated differential expression of responsive genes throughout the post infection period in A. aegypti midgut tissues is necessary for a coordinated transcriptional response of the mosquito genes to host or defend the viral infection.	[Chauhan, Chitra; Behura, Susanta K.; Debruyn, Becky; Lovin, Diane D.; Harker, Brent W.; Gomez-Machorro, Consuelo; Mori, Akio; Romero-Severson, Jeanne; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame	Severson, DW (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	severson.1@nd.edu	Romero-Severson, Jeanne/B-5259-2011	Romero-Severson, Jeanne/0000-0003-4112-7238; Severson, David/0000-0002-5798-3365; behura, Susanta/0000-0003-1057-2435	National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA [RO1-AI059342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059342] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by grant RO1-AI059342 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders EM, 2001, INT CONGR SER, V1219, P527, DOI 10.1016/S0531-5131(01)00386-7; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Behura SK, 2012, INFECT GENET EVOL, V12, P1413, DOI 10.1016/j.meegid.2012.04.027; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425; CHEN WJ, 1993, J MED ENTOMOL, V30, P524, DOI 10.1093/jmedent/30.3.524; Christophers, 1960, AEDES AEGYPTI L YELL; Clemons A., 2010, COLD SPRING HARBOR P, V2010; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Gil L, 2004, AM J TROP MED HYG, V71, P652, DOI 10.4269/ajtmh.2004.71.652; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Impoinvil DE, 2007, HEALTH POLICY, V83, P196, DOI 10.1016/j.healthpol.2007.01.009; KOURI GP, 1989, B WORLD HEALTH ORGAN, V67, P375; Levy F, 2004, MOL CELL PROTEOMICS, V3, P156, DOI 10.1074/mcp.M300114-MCP200; Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x; Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Molina-Cruz A, 2005, AM J TROP MED HYG, V72, P631, DOI 10.4269/ajtmh.2005.72.631; Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; Morlais I, 2001, GENETICS, V158, P1125; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schafer J, 2006, R NEWS, V6, P50; SCHLIESSMANN DJ, 1974, MOSQ NEWS, V34, P1; Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Steinert S, 2011, IMMUNOL REV, V240, P129, DOI 10.1111/j.1600-065X.2010.00985.x; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WHO, 1997, DENG HAEM FEV DIAGN; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098	51	46	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47350	10.1371/journal.pone.0047350	http://dx.doi.org/10.1371/journal.pone.0047350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077596	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100096
J	Cheng, MR; He, B; Wan, T; Zhu, WP; Han, J; Zha, BB; Chen, HX; Yang, FX; Li, Q; Wang, W; Xu, HZ; Ye, T				Cheng, Mingrong; He, Bing; Wan, Tao; Zhu, Weiping; Han, Jiang; Zha, Bingbing; Chen, Houxiang; Yang, Fengxiao; Li, Qing; Wang, Wei; Xu, Hongzhi; Ye, Tao			5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma via Activation of the p53 Pathway in the Orthotopic Transplant Mouse Model	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; GALACTOSYLATED CHITOSAN; CANCER-CELLS; GENE CARRIER; IN-VITRO; APOPTOSIS; ASIALOGLYCOPROTEIN; HYDROCHLORIDE; NANOCARRIERS; HEPATOCYTE	Biodegradable polymer nanoparticle drug delivery systems provide targeted drug delivery, improved pharmacokinetic and biodistribution, enhanced drug stability and fewer side effects. These drug delivery systems are widely used for delivering cytotoxic agents. In the present study, we synthesized GC/5-FU nanoparticles by combining galactosylated chitosan (GC) material with 5-FU, and tested its effect on liver cancer in vitro and in vivo. The in vitro anti-cancer effects of this sustained release system were both dose-and time-dependent, and demonstrated higher cytotoxicity against hepatic cancer cells than against other cell types. The distribution of GC/5-FU in vivo revealed the greatest accumulation in hepatic cancer tissues. GC/5-FU significantly inhibited tumor growth in an orthotropic liver cancer mouse model, resulting in a significant reduction in tumor weight and increased survival time in comparison to 5-FU alone. Flow cytometry and TUNEL assays in hepatic cancer cells showed that GC/5-FU was associated with higher rates of G0-G1 arrest and apoptosis than 5-FU. Analysis of apoptosis pathways indicated that GC/5-FU upregulates p53 expression at both protein and mRNA levels. This in turn lowers Bcl-2/Bax expression resulting in mitochondrial release of cytochrome C into the cytosol with subsequent caspase-3 activation. Upregulation of caspase-3 expression decreased poly ADP-ribose polymerase 1 (PARP-1) at mRNA and protein levels, further promoting apoptosis. These findings indicate that sustained release of GC/5-FU nanoparticles are more effective at targeting hepatic cancer cells than 5-FU monotherapy in the mouse orthotropic liver cancer mouse model.	[Cheng, Mingrong; He, Bing; Zhu, Weiping; Xu, Hongzhi; Ye, Tao] Fudan Univ, Dept Gen Surg, Shanghai Peoples Hosp 5, Shanghai 200433, Peoples R China; [Cheng, Mingrong; Han, Jiang; Wang, Wei] Shanghai Pudong New Area, Dept Gen Surg, Zhoupu Hosp, Shanghai, Peoples R China; [Wan, Tao; Chen, Houxiang; Yang, Fengxiao] Wuhan Univ Technol, Biomed Mat & Engn Ctr, Wuhan 430070, Peoples R China; [Zha, Bingbing] Fudan Univ, Dept Endocrine, Shanghai Peoples Hosp 5, Shanghai 200433, Peoples R China; [Li, Qing] Shanghai Fifth Peoples Hosp, Pujiang Hosp, Dept Gen Med, Shanghai, Peoples R China	Fudan University; Wuhan University of Technology; Fudan University	He, B (corresponding author), Fudan Univ, Dept Gen Surg, Shanghai Peoples Hosp 5, Shanghai 200433, Peoples R China.	2011cmr@sina.com; wantao@whut.edu.cn			Natural Science Foundation of Shanghai [09ZR1424700, 114119a4700]; Minhang District Natural Science Foundation of Shanghai [2009MHZ085]; Minhang District Public Health Bureau Foundation of Shanghai [2009MW28]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Minhang District Natural Science Foundation of Shanghai; Minhang District Public Health Bureau Foundation of Shanghai	This work was supported by the Natural Science Foundation of Shanghai (09ZR1424700 and 114119a4700); the Minhang District Natural Science Foundation of Shanghai (2009MHZ085); and the Minhang District Public Health Bureau Foundation of Shanghai (2009MW28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex SM, 2011, INT J PHARMACEUT, V410, P125, DOI 10.1016/j.ijpharm.2011.02.067; Alvarez-Lorenzo C, 2011, CURR DRUG TARGETS, V12, P1112, DOI 10.2174/138945011795906615; Arya G, 2011, NANOMED-NANOTECHNOL, V7, P859, DOI 10.1016/j.nano.2011.03.009; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Avraam K, 2011, EUR J GYNAECOL ONCOL, V32, P516; Bansal SS, 2011, CANCER PREV RES, V4, P1158, DOI 10.1158/1940-6207.CAPR-10-0006; Burke AR, 2012, BIOMATERIALS, V33, P2961, DOI 10.1016/j.biomaterials.2011.12.052; BURNS ER, 1983, CANCER LETT, V20, P235, DOI 10.1016/0304-3835(83)90054-X; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Chang CJ, 2007, HEPATOLOGY, V45, P746, DOI 10.1002/hep.21560; Cheng MR, 2011, J BIOMED MATER RES B, V99B, P70, DOI 10.1002/jbm.b.31873; Choi BH, 2008, CANCER LETT, V261, P37, DOI 10.1016/j.canlet.2007.11.014; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; De Souza R, 2010, DRUG DELIV, V17, P365, DOI 10.3109/10717541003762854; Ernsting MJ, 2012, BIOMATERIALS, V33, P1445, DOI 10.1016/j.biomaterials.2011.10.061; FALLON RJ, 1994, J BIOL CHEM, V269, P26626; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao SY, 2005, EUR J PHARM BIOPHARM, V60, P327, DOI 10.1016/j.ejpb.2005.02.011; Gould WR, 2006, J THROMB HAEMOST, V4, P834, DOI 10.1111/j.1538-7836.2006.01830.x; Gu XF, 2011, NANOSCALE RES LETT, V6, DOI [10.1186/1556-276X-6-199, 10.1186/1556-276X-6-555]; Guan M, 2012, NANOMEDICINE; Hirai T, 2001, CARDIOVASC INTER RAD, V24, P176, DOI 10.1007/s002700000389; Huang Z, 2007, HEPATOB PANCREAT DIS, V6, P312; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang H, 2011, J BIOSCI BIOENG, V111, P719, DOI 10.1016/j.jbiosc.2011.01.012; Khurana A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3140; Kim JH, 2008, J CONTROL RELEASE, V127, P41, DOI 10.1016/j.jconrel.2007.12.014; Kim TH, 2004, BIOMATERIALS, V25, P3783, DOI 10.1016/j.biomaterials.2003.10.063; Kodama Y, 2008, BIOL PHARM BULL, V31, P1049, DOI 10.1248/bpb.31.1049; Lee JS, 2012, INT J TOXICOL, V31, P70, DOI 10.1177/1091581811423845; Lee JB, 2012, INT J CANCER, V131, pE781, DOI 10.1002/ijc.27361; Li DC, 2009, J CONTROL RELEASE, V138, P103, DOI 10.1016/j.jconrel.2009.05.008; Li P, 2011, WORLD J GASTROENTERO, V17, P4563, DOI 10.3748/wjg.v17.i41.4563; Managit C, 2005, INT J PHARMACEUT, V301, P255, DOI 10.1016/j.ijpharm.2005.05.020; Marcucci F, 2004, DRUG DISCOV TODAY, V9, P219, DOI 10.1016/S1359-6446(03)02988-X; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Parikh N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-16; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Rojiani MV, 2010, INT J CLIN EXP PATHO, V3, P775; Ruppova K, 2000, NEOPLASMA, V47, P172; Saha RN, 2010, MOL MEMBR BIOL, V27, P215, DOI 10.3109/09687688.2010.510804; Sanpui P, 2011, ACS APPL MATER INTER, V3, P218, DOI 10.1021/am100840c; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Shi YP, 2011, ANTICANCER RES, V31, P3595; Singh G, 2008, AAPS PHARMSCITECH, V9, P791, DOI 10.1208/s12249-008-9111-3; SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001; Tataru G, 2012, J BIOMED MATER RES A, V100A, P1209, DOI 10.1002/jbm.a.34069; Dung TD, 2011, INT J MOL MED, V28, P927, DOI 10.3892/ijmm.2011.780; Wadher KJ, 2011, INDIAN J PHARM SCI, V73, P208; Wang SL, 2008, J DRUG TARGET, V16, P233, DOI [10.1080/10611860801902609, 10.1080/10611860801902609 ]; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; Wettergren Y, 2012, CANCER-AM CANCER SOC, V118, P2935, DOI 10.1002/cncr.26595; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Wilson B, 2012, INT J BIOL MACROMOL	54	54	60	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47115	10.1371/journal.pone.0047115	http://dx.doi.org/10.1371/journal.pone.0047115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077553	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100063
J	Kaneko, Y; Tajiri, N; Su, TP; Wang, Y; Borlongan, CV				Kaneko, Yuji; Tajiri, Naoki; Su, Tsung-Ping; Wang, Yun; Borlongan, Cesar V.			Combination Treatment of Hypothermia and Mesenchymal Stromal Cells Amplifies Neuroprotection in Primary Rat Neurons Exposed to Hypoxic-Ischemic-Like Injury In Vitro: Role of the Opioid System	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; BRAIN-INJURY; DELTA; STROKE; HIBERNATION; ENCEPHALOPATHY; NEUROGENESIS; DISORDERS; THERAPY	This study was designed to reveal the therapeutic regimen and mechanism of action underlying hypothermia treatment in combination with stem cell transplantation for ameliorating neonatal hypoxic-ischemic-like injury. Primary rat neurons were exposed to oxygen-glucose deprivation (OGD), which produced hypoxic-ischemic-like injury in vitro, then incubated at 25 degrees C (severe hypothermia), 34 degrees C (moderate hypothermia), and 37 degrees C (normothermia) with or without subsequent co-culture with mesenchymal stromal cells (MSCs). Combination treatment of moderate hypothermia and MSCs significantly improved cell survival and mitochondrial activity after OGD exposure. The exposure of delta opioid human embryonic kidney cells (HEK293) to moderate hypothermia attenuated OGD-mediated cell alterations, which were much more pronounced in HEK293 cells overexpressing the delta opioid receptor. Further, the addition of delta opioid peptide to 34 degrees C hypothermia and stem cell treatment in primary rat neurons showed synergistic neuroprotective effects against OGD which were significantly more robust than the dual combination of moderate hypothermia and MSCs, and were significantly reduced, but not completely abolished, by the opioid receptor antagonist naltrexone altogether implicating a ligand-receptor mechanism of neuroprotection. Further investigations into non-opioid therapeutic signaling pathways revealed growth factor mediation and anti-apoptotic function accompanying the observed therapeutic benefits. These results support combination therapy of hypothermia and stem cells for hypoxic-ischemic-like injury in vitro, which may have a direct impact on current clinical trials using stand-alone hypothermia or stem cells for treating neonatal encephalopathy.	[Kaneko, Yuji; Tajiri, Naoki; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA; [Su, Tsung-Ping; Wang, Yun] NIDA, NIH, Baltimore, MD USA	State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Tajiri, Naoki/K-1230-2012	Borlongan, Cesar/0000-0002-2966-9782; Tajiri, Naoki/0000-0003-2189-662X	National Institutes of Health; National Institute of Neurological Disorders and Stroke [1R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000549, ZIADA000206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); James and Esther King Foundation for Biomedical Research Program; SanBio Inc.; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	CVB is supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003080; Bell E, 2003, DIABETES, V52, P2731, DOI 10.2337/diabetes.52.11.2731; Bolling SF, 2001, J THORAC CARDIOV SUR, V122, P476, DOI 10.1067/mtc.2001.116203; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Borlongan CV, 2010, CELL TRANSPLANT, V19, P507, DOI 10.3727/096368909X480044; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Borlongan CV, 2005, BRAIN RES, V1048, P116, DOI 10.1016/j.brainres.2005.04.087; Borlongan CV, 2004, STROKE, V35, P2206, DOI 10.1161/01.STR.0000138954.25825.0b; Borlongan CV, 2004, FRONT BIOSCI-LANDMRK, V9, P3392, DOI 10.2741/1490; Borlongan CV, 2000, NEUROREPORT, V11, P923, DOI 10.1097/00001756-200004070-00005; Borlongan CV, 2001, CELL TRANSPLANT, V10, P53; Boutin H, 1999, STROKE, V30, P1271, DOI 10.1161/01.STR.30.6.1271; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; Fan XY, 2010, CURR NEUROPHARMACOL, V8, P324, DOI 10.2174/157015910793358150; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Glass HC, 2011, J PEDIATR-US, V159, P731, DOI 10.1016/j.jpeds.2011.07.015; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gunn AJ, 1998, EARLY HUM DEV, V53, P19, DOI 10.1016/S0378-3782(98)00033-4; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; Higgins RD, 2011, J PEDIATR-US, V159, P851, DOI 10.1016/j.jpeds.2011.08.004; Huang YC, 2009, STEM CELL REV REP, V5, P247, DOI 10.1007/s12015-009-9069-x; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Jatana M, 2006, PEDIATR RES, V59, P684, DOI 10.1203/01.pdr.0000215045.91122.44; Jenkins DD, 2009, J CHILD NEUROL, V24, P1212, DOI 10.1177/0883073809338412; Kevelaitis E, 1999, CIRCULATION, V99, P3079, DOI 10.1161/01.CIR.99.23.3079; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Massaro AN, 2011, J PEDIATR-US, V158, P678, DOI 10.1016/j.jpeds.2010.11.060; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Rodrigues MCO, 2012, NEUROSCI BIOBEHAV R, V36, P177, DOI 10.1016/j.neubiorev.2011.05.010; Ozawa K, 2008, J AUTOIMMUN, V30, P121, DOI 10.1016/j.jaut.2007.12.008; Pacini D, 2012, EUR J CARDIOTHORAC S; Persson AI, 2003, EUR J NEUROSCI, V17, P1159, DOI 10.1046/j.1460-9568.2003.02538.x; Rawls Scott M, 2011, Front Biosci (Schol Ed), V3, P822; Robertson NJ, 2008, LANCET, V372, P801, DOI 10.1016/S0140-6736(08)61329-X; Saller MM, 2012, BIOCHEM BIOPH RES CO, V423, P379, DOI 10.1016/j.bbrc.2012.05.134; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Schwartz CF, 1999, ANN THORAC SURG, V68, P2089, DOI 10.1016/S0003-4975(99)01165-0; Tam EWY, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002884; Tsai SY, 2010, SYNAPSE, V64, P267, DOI 10.1002/syn.20727; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	56	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47583	10.1371/journal.pone.0047583	http://dx.doi.org/10.1371/journal.pone.0047583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077646	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100141
J	Meng, S; Xu, JG; Xiong, YW; Ye, CY				Meng, Shuang; Xu, Jianguo; Xiong, Yanwen; Ye, Changyun			Rapid and Sensitive Detection of Plesiomonas shigelloides by Loop-Mediated Isothermal Amplification of the hugA Gene	PLOS ONE			English	Article							ESCHERICHIA-COLI; FRESH-WATER; BEEF; IRON	Plesiomonas shigelloides is one of the causative agents of human gastroenteritis, with increasing number of reports describing such infections in recent years. In this study, the hugA gene was chosen as the target to design loop-mediated isothermal amplification (LAMP) assays for the rapid, specific, and sensitive detection of P. shigelloides. The performance of the assay with reference plasmids and spiked human stools as samples was evaluated and compared with those of quantitative PCR (qPCR). No false-positive results were observed for the 32 non-P. shigelloides strains used to evaluate assay specificity. The limit of detection for P. shigelloides was approximately 20 copies per reaction in reference plasmids and 5x10(3) CFU per gram in spiked human stool, which were more sensitive than the results of qPCR. When applied in human stool samples spiked with 2 low levels of P. shigelloides, the LAMP assays achieved accurate detection after 6-h enrichment. In conclusion, the LAMP assay developed in this study is a valuable method for rapid, cost-effective, and simple detection of P. shigelloides in basic clinical and field laboratories in the rural areas of China.	[Meng, Shuang; Xu, Jianguo; Xiong, Yanwen; Ye, Changyun] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Ye, CY (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	yechangyun@icdc.cn			National Science and Technology Key Project on Major Infectious Diseases [2008ZX10004-001, 2009ZX10004-101, 2011ZX10004-001]	National Science and Technology Key Project on Major Infectious Diseases	This work was supported by the National Science and Technology Key Project on Major Infectious Diseases (2008ZX10004-001, 2009ZX10004-101, 2011ZX10004-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auxiliadora-Martins M, 2010, HEART LUNG, V39, P335, DOI 10.1016/j.hrtlng.2009.06.015; Chan SSW, 2003, EMERG MED J, V20, P335, DOI 10.1136/emj.20.4.335; Escobar JC, 2012, EMERG INFECT DIS, V18, P322, DOI 10.3201/eid1802.110562; Garrity GM, 2003, BERGEYS MANUAL SYSTE; Gonzalez-Rey C, 2000, FEMS IMMUNOL MED MIC, V29, P107, DOI 10.1016/S0928-8244(00)00194-2; Gu WM, 2006, INT J FOOD MICROBIOL, V111, P81, DOI 10.1016/j.ijfoodmicro.2006.05.005; Hara-Kudo Y, 2008, FOODBORNE PATHOG DIS, V5, P97, DOI 10.1089/fpd.2007.0031; Herrera FC, 2006, INT J FOOD MICROBIOL, V108, P233, DOI 10.1016/j.ijfoodmicro.2005.12.008; JANDA JM, 1993, J CLIN MICROBIOL, V31, P1206, DOI 10.1128/JCM.31.5.1206-1208.1993; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Krovacek K, 2000, COMP IMMUNOL MICROB, V23, P45, DOI 10.1016/S0147-9571(99)00058-2; Lee ACW, 1996, PEDIATR HEMAT ONCOL, V13, P265, DOI 10.3109/08880019609030826; Miller WA, 2006, MICROB ECOL, V52, P198, DOI 10.1007/s00248-006-9080-6; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ohtsuka K, 2010, FOODBORNE PATHOG DIS, V7, P1563, DOI 10.1089/fpd.2010.0585; Okada K, 2010, DIAGN MICR INFEC DIS, V66, P135, DOI 10.1016/j.diagmicrobio.2009.09.004; Oldham AL, 2008, CAN J MICROBIOL, V54, P97, DOI [10.1139/W07-122, 10.1139/w07-122]; Ozdemir O, 2010, J MICROBIOL IMMUNOL, V43, P344, DOI 10.1016/S1684-1182(10)60053-9; PAUL R, 1990, J CLIN MICROBIOL, V28, P1445, DOI 10.1128/JCM.28.6.1445-1446.1990; REINHARDT JF, 1985, JAMA-J AM MED ASSOC, V253, P3294, DOI 10.1001/jama.253.22.3294; Salerno A, 2010, FOLIA MICROBIOL, V55, P641, DOI 10.1007/s12223-010-0104-8; Santos JA, 1999, J FOOD PROTECT, V62, P1475, DOI 10.4315/0362-028X-62.12.1475; Schneider F, 2009, MED MALADIES INFECT, V39, P397, DOI 10.1016/j.medmal.2008.11.010; Villarreal DM, 2008, APPL ENVIRON MICROB, V74, P5854, DOI 10.1128/AEM.01291-08; Wouafo M, 2006, FOODBORNE PATHOG DIS, V3, P209, DOI 10.1089/fpd.2006.3.209	26	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e41978	10.1371/journal.pone.0041978	http://dx.doi.org/10.1371/journal.pone.0041978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077478	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100006
J	Pozzi, C; Wilk, K; Lee, JC; Gening, M; Nifantiev, N; Pier, GB				Pozzi, Clarissa; Wilk, Katarzyna; Lee, Jean C.; Gening, Marina; Nifantiev, Nikolay; Pier, Gerald B.			Opsonic and Protective Properties of Antibodies Raised to Conjugate Vaccines Targeting Six Staphylococcus aureus Antigens	PLOS ONE			English	Article							INFLUENZAE TYPE-B; CLUMPING FACTOR-B; FIBRINOGEN-BINDING; CAPSULAR POLYSACCHARIDES; OPSONOPHAGOCYTIC ASSAY; PASSIVE-IMMUNIZATION; NASAL COLONIZATION; ALPHA-HEMOLYSIN; INFECTION; IRON	Staphylococcus aureus is a major cause of nosocomial and community-acquired infections for which a vaccine is greatly desired. Antigens found on the S. aureus outer surface include the capsular polysaccharides (CP) of serotype 5 (CP5) or 8 (CP8) and/or a second antigen, a beta-(1 -> 6)-polymer of N-acetyl-D-glucosamine (PNAG). Antibodies specific for either CP or PNAG antigens have excellent in vitro opsonic killing activity (OPKA), but when mixed together have potent interference in OPKA and murine protection. To ascertain if this interference could be abrogated by using a synthetic non-acetylated oligosaccharide fragment of PNAG, 9GlcNH(2), in place of chemically partially deacetylated PNAG, three conjugate vaccines consisting of 9GlcNH(2) conjugated to a non-toxic mutant of alpha-hemolysin (Hla H35L), CP5 conjugated to clumping factor B (ClfB), or CP8 conjugated to iron-surface determinant B (IsdB) were used separately to immunize rabbits. Opsonic antibodies mediating killing of multiple S. aureus strains were elicited for all three vaccines and showed carbohydrate antigen-specific reductions in the tissue bacterial burdens in animal models of S. aureus skin abscesses, pneumonia, and nasal colonization. Carrier-protein specific immunity was also shown to be effective in reducing bacterial levels in infected lungs and in nasal colonization. However, use of synthetic 9GlcNH(2) to induce antibody to PNAG did not overcome the interference in OPKA engendered when these were combined with antibody to either CP5 or CP8. Whereas each individual vaccine showed efficacy, combining antisera to CP antigens and PNAG still abrogated individual OPKA activities, indicating difficulty in achieving a multi-valent vaccine targeting both the CP and PNAG antigens.	[Pozzi, Clarissa; Wilk, Katarzyna; Lee, Jean C.; Pier, Gerald B.] Harvard Univ, Sch Med, Channing Lab, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Gening, Marina; Nifantiev, Nikolay] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry	Pier, GB (corresponding author), Harvard Univ, Sch Med, Channing Lab, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA.	gpier@rics.bwh.harvard.edu	Nifantiev, Nikolay E/O-6579-2015; Pier, Gerald/AAO-2692-2021	Nifantiev, Nikolay E/0000-0002-0727-4050; Pier, Gerald/0000-0002-9112-2331; Lee, Jean/0000-0002-8094-5180	National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI46706, AI057159, U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI046706, R01AI046706, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases numbers AI46706 (GBP) and AI057159, a component of Award Number U54 AI057159. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; Cerca N, 2007, P NATL ACAD SCI USA, V104, P7528, DOI 10.1073/pnas.0700630104; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Dejonge M, 2007, J PEDIATR-US, V151, P260, DOI 10.1016/j.jpeds.2007.04.060; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Erickson DL, 2008, J BACTERIOL, V190, P8163, DOI 10.1128/JB.01181-08; Fowler VG, 2012, ECMID 2012 C; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; Gerber JS, 2009, CLIN INFECT DIS, V49, P65, DOI 10.1086/599348; Guide SV, 2003, J INFECT DIS, V187, P845, DOI 10.1086/368388; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Harro C, 2010, CLIN VACCINE IMMUNOL, V17, P1868, DOI 10.1128/CVI.00356-10; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; KAISER AB, 1992, J INFECT DIS, V166, P393, DOI 10.1093/infdis/166.2.393; Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kernodle DS, 2011, J INFECT DIS, V203, P1692, DOI 10.1093/infdis/jir141; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Kluytmans J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b364; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002; Martinez JE, 1999, CLIN DIAGN LAB IMMUN, V6, P581, DOI 10.1128/CDLI.6.4.581-586.1999; Matthysse AG, 2008, APPL ENVIRON MICROB, V74, P2384, DOI 10.1128/AEM.01854-07; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Miajlovic H, 2010, MICROBIOL-SGM, V156, P920, DOI 10.1099/mic.0.036673-0; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Romero-Steiner S, 2003, CLIN DIAGN LAB IMMUN, V10, P1019, DOI 10.1128/CDLI.10.6.1019-1024.2003; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Sau S, 1997, MICROBIOL-UK, V143, P2395, DOI 10.1099/00221287-143-7-2395; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Skurnik D, 2012, J INFECT DIS, V205, P1709, DOI 10.1093/infdis/jis254; Skurnik D, 2010, J CLIN INVEST, V120, P3220, DOI 10.1172/JCI42748; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; SMITH RL, 1979, ANAL BIOCHEM, V98, P478, DOI 10.1016/0003-2697(79)90170-2; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; Spellberg B, 2012, SEMIN IMMUNOPATHOL, V34, P335, DOI 10.1007/s00281-011-0293-5; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Swingler G, 2003, COCHRANE DB SYST REV; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Weisman LE, 2011, PEDIATRICS, V128, P271, DOI 10.1542/peds.2010-3081; Wolz C, 1996, INFECT IMMUN, V64, P3142, DOI 10.1128/IAI.64.8.3142-3147.1996	68	37	39	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46648	10.1371/journal.pone.0046648	http://dx.doi.org/10.1371/journal.pone.0046648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077517	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100035
J	Prusty, BK; Bohme, L; Bergmann, B; Siegl, C; Krause, E; Mehlitz, A; Rudel, T				Prusty, Bhupesh K.; Boehme, Linda; Bergmann, Birgit; Siegl, Christine; Krause, Eva; Mehlitz, Adrian; Rudel, Thomas			Imbalanced Oxidative Stress Causes Chlamydial Persistence during Non-Productive Human Herpes Virus Co-Infection	PLOS ONE			English	Article							IN-VITRO; TRACHOMATIS PERSISTENCE; GLUCOSE-METABOLISM; MIXED INFECTIONS; HUMAN-MONOCYTES; CELL-CULTURE; BLOOD; HUMAN-HERPESVIRUS-6; FAMILY; IDENTIFICATION	Both human herpes viruses and Chlamydia are highly prevalent in the human population and are detected together in different human disorders. Here, we demonstrate that co-infection with human herpes virus 6 (HHV6) interferes with the developmental cycle of C. trachomatis and induces persistence. Induction of chlamydial persistence by HHV6 is independent of productive virus infection, but requires the interaction and uptake of the virus by the host cell. On the other hand, viral uptake is strongly promoted under co-infection conditions. Host cell glutathione reductase activity was suppressed by HHV6 causing NADPH accumulation, decreased formation of reduced glutathione and increased oxidative stress. Prevention of oxidative stress restored infectivity of Chlamydia after HHV6-induced persistence. We show that co-infection with Herpes simplex virus 1 or human Cytomegalovirus also induces chlamydial persistence by a similar mechanism suggesting that Chlamydia -human herpes virus co-infections are evolutionary shaped interactions with a thus far unrecognized broad significance.	[Prusty, Bhupesh K.; Boehme, Linda; Bergmann, Birgit; Siegl, Christine; Mehlitz, Adrian; Rudel, Thomas] Univ Wurzburg, Bioctr, Chair Microbiol, Wurzburg, Germany; [Krause, Eva] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	University of Wurzburg; Heinrich Pette Institute	Rudel, T (corresponding author), Univ Wurzburg, Bioctr, Chair Microbiol, Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Prusty, Bhupesh/AAF-4843-2020	Prusty, Bhupesh/0000-0001-7051-4670	German Research Foundation (DFG); University of Wuerzburg; German Federal Ministry of Education and Research [0315834 A, 01GS08200]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This publication was funded by the German Research Foundation (DFG), the University of Wuerzburg in the funding programme Open Access Publishing, and German Federal Ministry of Education and Research, Grant 0315834 A and 01GS08200 to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beydemir S, 2002, J ENZYM INHIB MED CH, V17, P271, DOI 10.1080/1475636021000010941; Bohme L, 2010, CELL MICROBIOL, V12, P1340, DOI 10.1111/j.1462-5822.2010.01473.x; Boncompain G, 2010, INFECT IMMUN, V78, P80, DOI 10.1128/IAI.00725-09; Borel N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-201; Carter JD, 2011, ANN MED; Caruso A, 2003, J MED VIROL, V70, P451, DOI 10.1002/jmv.10416; Caselli E, 2002, J CLIN MICROBIOL, V40, P4131, DOI 10.1128/JCM.40.11.4131-4137.2002; Chen FH, 2010, CANCER LETT, V296, P96, DOI 10.1016/j.canlet.2010.04.004; Cirino F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-23; Dai DF, 2011, AUTOPHAGY, V7, P917, DOI 10.4161/auto.7.8.15813; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Deka S, 2007, CELL MICROBIOL, V9, P725, DOI 10.1111/j.1462-5822.2006.00823.x; Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kahane S, 2001, APPL ENVIRON MICROB, V67, P4789, DOI 10.1128/AEM.67.10.4789-4795.2001; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Kuipers JG, 1998, ARTHRITIS RHEUM, V41, P1894, DOI 10.1002/1529-0131(199810)41:10<1894::AID-ART24>3.0.CO;2-E; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Lazarev VN, 2010, FREE RADICAL BIO MED, V49, P1947, DOI 10.1016/j.freeradbiomed.2010.09.024; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luppi M, 1996, HAEMATOLOGICA, V81, P265; Lusso P, 2006, J CLIN VIROL, V37, pS4, DOI 10.1016/S1386-6532(06)70004-X; MANOR E, 1986, INFECT IMMUN, V54, P90, DOI 10.1128/IAI.54.1.90-95.1986; MATSUMOTO A, 1970, J BACTERIOL, V101, P278, DOI 10.1128/JB.101.1.278-285.1970; Mori Y, 2003, J VIROL, V77, P2452, DOI 10.1128/JVI.77.4.2452-2458.2003; Mukhopadhyay S, 2006, MOL CELL PROTEOMICS, V5, P2311, DOI 10.1074/mcp.M600214-MCP200; Nicolson GL, 2003, APMIS, V111, P557, DOI 10.1034/j.1600-0463.2003.1110504.x; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Paavonen J, 1988, Obstet Gynecol Surv, V43, P373, DOI 10.1097/00006254-198807000-00001; Prusty BK, 2008, VIROLOGY, V382, P37, DOI 10.1016/j.virol.2008.09.006; Rotola A, 1998, P NATL ACAD SCI USA, V95, P13911, DOI 10.1073/pnas.95.23.13911; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Sharma M, 2011, CELL MICROBIOL, V13, P1573, DOI 10.1111/j.1462-5822.2011.01642.x; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Stuedli A, 2005, VET MICROBIOL, V106, P209, DOI 10.1016/j.vetmic.2004.10.023; Torii S, 2011, CELL DEATH DIFFER, V18, P1711, DOI 10.1038/cdd.2011.47; Vanover J, 2010, MICROBIOLOGY, P1; Vanover J, 2008, MICROBIOL-SGM, V154, P971, DOI 10.1099/mic.0.2007/012161-0; Wang Y, 2006, PROTEIN SCI, V15, P122, DOI 10.1110/ps.051616206; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Wu CA, 1998, J GEN VIROL, V79, P1247, DOI 10.1099/0022-1317-79-5-1247; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yoshikawa T, 2002, J MED VIROL, V66, P497, DOI 10.1002/jmv.2172; Zhan P, 2011, EUR J CANCER, V47, P742, DOI 10.1016/j.ejca.2010.11.003	57	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47427	10.1371/journal.pone.0047427	http://dx.doi.org/10.1371/journal.pone.0047427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077614	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100110
J	Baik, J; Rosania, GR				Baik, Jason; Rosania, Gus R.			Macrophages Sequester Clofazimine in an Intracellular Liquid Crystal-Like Supramolecular Organization	PLOS ONE			English	Article							PHASE-TRANSITIONS; IN-VITRO; B663; SUPEROXIDE; DIHYDROPHENAZINES; MOLECULES; AUTOPHAGY; LAMPRENE; DRUGS; CELLS	Clofazimine is a poorly-soluble but orally-bioavailable small molecule drug that massively accumulates in macrophages when administered over prolonged periods of time. To determine whether crystal-like drug inclusions (CLDIs) that form in subcellular spaces correspond to pure clofazimine crystals, macrophages of clofazimine-fed mice were elicited with an intraperitoneal thioglycollate injection. Inside these cells, CLDIs appeared uniform in size and shape, but were sensitive to illumination. Once removed from cells, CLDIs were unstable. Unlike pure clofazimine crystals, isolated CLDIs placed in distilled water burst into small birefringent globules, which aggregated into larger clusters. Also unlike pure clofazimine crystals, CLDIs fragmented when heated, and disintegrated in alkaline media. In contrast to all other organelles, CLDIs were relatively resistant to sonication and trypsin digestion, which facilitated their biochemical isolation. The powder x-ray diffraction pattern obtained from isolated CLDIs was consistent with the diffraction pattern of liquid crystals and inconsistent with the expected molecular diffraction pattern of solid, three dimensional crystals. Observed with the transmission electron microscope (TEM), CLDIs were bounded by an atypical double-layered membrane, approximately 20 nanometers thick. CLDIs were polymorphic, but generally exhibited an internal multilayered organization, comprised of stacks of membranes 5 to 15 nanometers thick. Deep-etch, freeze-fracture electron microscopy of unfixed snap-frozen tissue samples confirmed this supramolecular organization. These results suggest that clofazimine accumulates in macrophages by forming a membrane-bound, multilayered, liquid crystal-like, semi-synthetic cytoplasmic structure.	[Baik, Jason; Rosania, Gus R.] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rosania, GR (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	grosania@umich.edu			National Institutes of Health [GM007767, RO1GM078200]; American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078200, T32GM007767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM007767 (to J.B.), and RO1GM078200 (to G.R.R.). The contents are sole responsibilities of authors, and do not represent the official views of the NIH. J.B. was also supported by American Foundation for Pharmaceutical Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APLIN RT, 1975, EXPERIENTIA, V31, P468, DOI 10.1007/BF02026384; Atkinson A J Jr, 1967, Int J Lepr Other Mycobact Dis, V35, P119; Baik J, 2011, MOL PHARMACEUT, V8, P1742, DOI 10.1021/mp200101b; BARRY VC, 1957, NATURE, V179, P1013, DOI 10.1038/1791013a0; CAFFREY M, 1990, BIOPHYS J, V58, P21, DOI 10.1016/S0006-3495(90)82350-X; Cholo MC, 2012, J ANTIMICROB CHEMOTH, V67, P290, DOI 10.1093/jac/dkr444; CONALTY M L, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P479; DELHANTY JD, 1974, BRIT J EXP PATHOL, V55, P13; Desikan K V, 1975, Lepr Rev, V46, P181; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Griffis LC, 2010, FOOD CHEM TOXICOL, V48, P363, DOI 10.1016/j.fct.2009.10.024; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Joseph JS, 2011, METHODS, V55, P342, DOI 10.1016/j.ymeth.2011.08.013; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Koynova R, 2002, CHEM PHYS LIPIDS, V115, P107, DOI 10.1016/S0009-3084(01)00200-6; KRAJEWSKA MM, 1993, J INFECT DIS, V167, P899, DOI 10.1093/infdis/167.4.899; LEIJH PCJ, 1984, INFECT IMMUN, V46, P448, DOI 10.1128/IAI.46.2.448-452.1984; Lu Y, 2011, ANTIMICROB AGENTS CH, V55, P5185, DOI 10.1128/AAC.00699-11; MANSFIELD RE, 1974, AM J TROP MED HYG, V23, P1116, DOI 10.4269/ajtmh.1974.23.1116; MASON GH, 1977, LEPROSY REV, V48, P175; MCDOUGALL AC, 1974, INT J LEPROSY, V42, P1; MCDOUGALL AC, 1980, BRIT J DERMATOL, V102, P227, DOI 10.1111/j.1365-2133.1980.tb05697.x; OConnor R, 1995, DRUG METAB REV, V27, P591, DOI 10.3109/03602539508994208; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Petri WAJ, 2006, GOODMAN GILMANS PHAR, P1218; Queiroz RHC, 2002, PHARMACOL RES, V46, P191, DOI 10.1016/S1043-6618(02)00086-5; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rappolt M, 2003, BIOPHYS J, V84, P3111, DOI 10.1016/S0006-3495(03)70036-8; RYCHLEWSKA U, 1985, J AM CHEM SOC, V107, P4768, DOI 10.1021/ja00302a027; SAHU A, 1991, INT J IMMUNOPHARMACO, V13, P419, DOI 10.1016/0192-0561(91)90012-V; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; SAVAGE JE, 1989, J ANTIMICROB CHEMOTH, V23, P691, DOI 10.1093/jac/23.5.691; Sukpanichnant S, 2000, AM J SURG PATHOL, V24, P129, DOI 10.1097/00000478-200001000-00016; VANRENSBURG CEJ, 1992, ANTIMICROB AGENTS CH, V36, P2729, DOI 10.1128/AAC.36.12.2729; VANRENSBURG CEJ, 1993, CANCER RES, V53, P318; Venkatesan K, 2007, ARZNEIMITTEL-FORSCH, V57, P472; WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zheng N, 2011, J PHARMACOL EXP THER, V336, P661, DOI 10.1124/jpet.110.175679; [No title captured]	42	62	64	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47494	10.1371/journal.pone.0047494	http://dx.doi.org/10.1371/journal.pone.0047494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071814	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700086
J	Bolognesi, R; Ramaseshadri, P; Anderson, J; Bachman, P; Clinton, W; Flannagan, R; Ilagan, O; Lawrence, C; Levine, S; Moar, W; Mueller, G; Tan, JG; Uffman, J; Wiggins, E; Heck, G; Segers, G				Bolognesi, Renata; Ramaseshadri, Parthasarathy; Anderson, Jerry; Bachman, Pamela; Clinton, William; Flannagan, Ronald; Ilagan, Oliver; Lawrence, Christina; Levine, Steven; Moar, William; Mueller, Geoffrey; Tan, Jianguo; Uffman, Joshua; Wiggins, Elizabeth; Heck, Gregory; Segers, Gerrit			Characterizing the Mechanism of Action of Double-Stranded RNA Activity against Western Corn Rootworm (Diabrotica virgifera virgifera LeConte)	PLOS ONE			English	Article							INTERFERENCE; GENE; COLEOPTERA; DROSOPHILA	RNA interference (RNAi) has previously been shown to be effective in western corn rootworm (WCR, Diabrotica virgifera virgifera LeConte) larvae via oral delivery of synthetic double-stranded RNA (dsRNA) in an artificial diet bioassay, as well as by ingestion of transgenic corn plant tissues engineered to express dsRNA. Although the RNAi machinery components appear to be conserved in Coleopteran insects, the key steps in this process have not been reported for WCR. Here we characterized the sequence of events that result in mortality after ingestion of a dsRNA designed against WCR larvae. We selected the Snf7 ortholog (DvSnf7) as the target mRNA, which encodes an essential protein involved in intracellular trafficking. Our results showed that dsRNAs greater than or equal to approximately 60 base-pairs (bp) are required for biological activity in artificial diet bioassays. Additionally, 240 bp dsRNAs containing a single 21 bp match to the target sequence were also efficacious, whereas 21 bp short interfering (si) RNAs matching the target sequence were not. This result was further investigated in WCR midgut tissues: uptake of 240 bp dsRNA was evident in WCR midgut cells while a 21 bp siRNA was not, supporting the size-activity relationship established in diet bioassays. DvSnf7 suppression was observed in a time-dependent manner with suppression at the mRNA level preceding suppression at the protein level when a 240 bp dsRNA was fed to WCR larvae. DvSnf7 suppression was shown to spread to tissues beyond the midgut within 24 h after dsRNA ingestion. These events (dsRNA uptake, target mRNA and protein suppression, systemic spreading, growth inhibition and eventual mortality) comprise the overall mechanism of action by which DvSnf7 dsRNA affects WCR via oral delivery and provides insights as to how targeted dsRNAs in general are active against insects.	[Bolognesi, Renata; Ramaseshadri, Parthasarathy; Anderson, Jerry; Clinton, William; Flannagan, Ronald; Ilagan, Oliver; Wiggins, Elizabeth; Heck, Gregory; Segers, Gerrit] Monsanto Co, Div Biotechnol, Chesterfield, MO USA; [Bachman, Pamela; Lawrence, Christina; Levine, Steven; Moar, William; Mueller, Geoffrey; Tan, Jianguo; Uffman, Joshua] Monsanto Co, Regulatory Div, St Louis, MO USA	Monsanto; Monsanto	Ramaseshadri, P (corresponding author), Monsanto Co, Div Biotechnol, Chesterfield, MO USA.	pprama1@monsanto.com						Alves AP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14122; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Auer C, 2009, TRENDS BIOTECHNOL, V27, P644, DOI 10.1016/j.tibtech.2009.08.005; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Behlke MA, 2006, BIOFORUM EUROPE, V6, P25; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Borgio J. F., 2010, Journal of Biopesticides, V3, P386; Brown SJ, 2009, EVOL DEV, V1, P11; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Coy MR, 2012, J APPL ENTOMOL, V136, P741, DOI 10.1111/j.1439-0418.2012.01713.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kim DW, 2011, MOL CELLS, V31, P585, DOI 10.1007/s10059-011-1045-z; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Kumar P., 2012, PLOS ONE, V7; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Ramaseshadri P, 2012, PLOS ONE IN PRESS; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Rocha JJE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019087; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Smagghe G., 2012, USE RNAI CONTROL INS, P177; Suazo A, 2009, INSECT MOL BIOL, V18, P727, DOI 10.1111/j.1365-2583.2009.00912.x; Sweeney NT, 2006, CURR BIOL, V16, P1006, DOI 10.1016/j.cub.2006.03.067; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Yamaguchi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025469; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	43	260	320	8	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47534	10.1371/journal.pone.0047534	http://dx.doi.org/10.1371/journal.pone.0047534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071820	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700090
J	Lo, SM; McElroy, KA; Francis, NJ				Lo, Stanley M.; McElroy, Kyle A.; Francis, Nicole J.			Chromatin Modification by PSC Occurs at One PSC per Nucleosome and Does Not Require the Acidic Patch of Histone H2A	PLOS ONE			English	Article							GROUP RESPONSE ELEMENTS; POLYCOMB GROUP PROTEINS; REPLICATION IN-VITRO; BITHORAX COMPLEX; DROSOPHILA-MELANOGASTER; NUCLEAR REORGANIZATION; EPIGENETIC REGULATION; RECOMBINANT HISTONES; SEX-COMBS; DNA	Chromatin architecture is regulated through both enzymatic and non-enzymatic activities. For example, the Polycomb Group (PcG) proteins maintain developmental gene silencing using an array of chromatin-based mechanisms. The essential Drosophila PcG protein, Posterior Sex Combs (PSC), compacts chromatin and inhibits chromatin remodeling and transcription through a non-enzymatic mechanism involving nucleosome bridging. Nucleosome bridging is achieved through a combination of nucleosome binding and self-interaction. Precisely how PSC interacts with chromatin to bridge nucleosomes is not known and is the subject of this work. We determine the stoichiometry of PSC-chromatin interactions in compact chromatin (in which nucleosomes are bridged) using Scanning Transmission Electron Microscopy (STEM). We find that full compaction occurs with one PSC per nucleosome. In addition to compacting chromatin, we show that PSC oligomerizes nucleosome arrays. PSC-mediated oligomerization of chromatin occurs at similar stoichiometry as compaction suggesting it may also involve nucleosome bridging. Interactions between the tail of histone H4 and the acidic patch of histone H2A are important for chromatin folding and oligomerization, and several chromatin proteins bind the histone H2A acidic patch. However, mutation of the acidic patch of histone H2A does not affect PSC's ability to inhibit chromatin remodeling or bridge nucleosomes. In fact, PSC does not require nucleosomes for bridging activity but can bridge naked DNA segments. PSC clusters nucleosomes on sparsely assembled templates, suggesting it interacts preferentially with nucleosomes over bare DNA. This may be due to the ability of PSC to bind free histones. Our data are consistent with a model in which each PSC binds a nucleosome and at least one other PSC to directly bridge nucleosomes and compact chromatin, but also suggest that naked DNA can be included in compacted structures. We discuss how our data highlight the diversity of mechanisms used to modify chromatin architecture.	[Lo, Stanley M.; McElroy, Kyle A.; Francis, Nicole J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Francis, NJ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	francis@mcb.harvard.edu		Lo, Stanley/0000-0003-3574-2197	National Institute of General Medical Sciences/National Institutes of Health [GM078456-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078456] Funding Source: NIH RePORTER	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from National Institute of General Medical Sciences/National Institutes of Health (GM078456-01) to NJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2009, BIOCHEMISTRY-US, V48, P276, DOI 10.1021/bi801705g; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, TRENDS GENET, V27, P454, DOI 10.1016/j.tig.2011.06.008; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Beh L. Y., 2012, PNAS, V109; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Butenko Y, 2011, BBA-GENE REGUL MECH, V1809, P395, DOI 10.1016/j.bbagrm.2011.05.013; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Comet I, 2011, P NATL ACAD SCI USA, V108, P2294, DOI 10.1073/pnas.1002059108; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emmons RB, 2009, GENETICS, V182, P999, DOI 10.1534/genetics.108.097360; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Fedorova E, 2008, CHROMOSOME RES, V16, P649, DOI 10.1007/s10577-008-1218-6; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Gutierrez L, 2012, DEVELOPMENT, V139, P117, DOI 10.1242/dev.074450; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kassis JA, 2002, ADV GENET, V46, P421; King IFG, 2005, MOL CELL BIOL, V25, P6578, DOI 10.1128/MCB.25.15.6578-6591.2005; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Lee KM, 2001, CURR PROTOC MOL BIOL; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li HB, 2011, MOL CELL BIOL, V31, P616, DOI 10.1128/MCB.00849-10; Li XH, 2010, GENE DEV, V24, P933, DOI 10.1101/gad.1901510; Lo SM, 2012, MOL CELL, V46, P784, DOI 10.1016/j.molcel.2012.05.038; Lo SM, 2010, BIOCHEMISTRY-US, V49, P9438, DOI 10.1021/bi100532a; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mahmoudi T, 2002, EMBO J, V21, P1775, DOI 10.1093/emboj/21.7.1775; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; McBryant SJ, 2008, MOL CELL BIOL, V28, P3563, DOI 10.1128/MCB.01389-07; McBryant SJ, 2009, J BIOL CHEM, V284, P16716, DOI 10.1074/jbc.M109.011288; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Mohd-Sarip A, 2012, SCIENCE, V336, P744, DOI 10.1126/science.1215927; Muller M, 1999, GENETICS, V153, P1333; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Sexton T., 2012, CELL; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; TERRANOVA R, 2008, DEV CELL; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Wall JS, 1998, METHOD CELL BIOL, V53, P139; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Woodcock CL, 1998, METHOD CELL BIOL, V53, P167; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Wyrick JJ, 2012, BBA-GENE REGUL MECH, V1819, P892, DOI 10.1016/j.bbagrm.2012.04.001; Yang JG, 2007, METHODS, V41, P291, DOI 10.1016/j.ymeth.2006.08.015; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	76	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47162	10.1371/journal.pone.0047162	http://dx.doi.org/10.1371/journal.pone.0047162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071745	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700062
J	Shin, YC; Shin, SY; Chun, JN; Cho, HS; Lim, JM; Kim, HG; So, I; Kwon, D; Jeon, JH				Shin, Young-Cheul; Shin, Soo-Yong; Chun, Jung Nyeo; Cho, Hyeon Sung; Lim, Jin Muk; Kim, Hong-Gee; So, Insuk; Kwon, Dongseop; Jeon, Ju-Hong			TRIP Database 2.0: A Manually Curated Information Hub for Accessing TRP Channel Interaction Network	PLOS ONE			English	Article							HUMAN-DISEASE; PROTEINS; FAMILY	Transient receptor potential (TRP) channels are a family of Ca2+-permeable cation channels that play a crucial role in biological and disease processes. To advance TRP channel research, we previously created the TRIP (TRansient receptor potential channel-Interacting Protein) Database, a manually curated database that compiles scattered information on TRP channel protein-protein interactions (PPIs). However, the database needs to be improved for information accessibility and data utilization. Here, we present the TRIP Database 2.0 (http://www.trpchannel.org) in which many helpful, user-friendly web interfaces have been developed to facilitate knowledge acquisition and inspire new approaches to studying TRP channel functions: 1) the PPI information found in the supplementary data of referred articles was curated; 2) the PPI summary matrix enables users to intuitively grasp overall PPI information; 3) the search capability has been expanded to retrieve information from 'PubMed' and 'PIE the search' (a specialized search engine for PPI-related articles); and 4) the PPI data are available as sif files for network visualization and analysis using 'Cytoscape'. Therefore, our TRIP Database 2.0 is an information hub that works toward advancing data-driven TRP channel research.	[Kwon, Dongseop] Myongji Univ, Dept Comp Engn, Gyeonggi Do, South Korea; [Shin, Young-Cheul; Chun, Jung Nyeo; So, Insuk; Jeon, Ju-Hong] Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul, South Korea; [Shin, Soo-Yong] Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Shin, Soo-Yong] Univ Ulsan, Coll Med, Seoul, South Korea; [Cho, Hyeon Sung] Seoul Natl Univ, Coll Med, Interdisciplinary Program Med Informat, Seoul, South Korea; [Chun, Jung Nyeo; So, Insuk; Jeon, Ju-Hong] Seoul Natl Univ, Inst Dermatol Sci, Seoul, South Korea; [Cho, Hyeon Sung] Elect & Telecommun Res Inst, IT Convergence Technol Res Lab, Taejon, South Korea; [Lim, Jin Muk; Kim, Hong-Gee] Seoul Natl Univ, Biomed Knowledge Engn Lab, Seoul, South Korea	Myongji University; Seoul National University (SNU); University of Ulsan; Asan Medical Center; University of Ulsan; Seoul National University (SNU); Seoul National University (SNU); Electronics & Telecommunications Research Institute - Korea (ETRI); Seoul National University (SNU)	Kwon, D (corresponding author), Myongji Univ, Dept Comp Engn, Gyeonggi Do, South Korea.	Dongseop@mju.ac.kr; jhjeon2@snu.ac.kr	So, Insuk/J-2762-2012; Jeon, Ju-Hong/D-5740-2012; Shin, Soo-Yong/K-3156-2012	Cho, HyeonSung/0000-0003-0029-6617; Jeon, Ju-Hong/0000-0002-5603-2955	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2008-2005948, 2011-0022437, 2010-0019472, 2012R1A1A2002804]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2008-2005948, 2011-0022437, 2010-0019472, and 2012R1A1A2002804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Desai BN, 2005, PFLUG ARCH EUR J PHY, V451, P11, DOI 10.1007/s00424-005-1429-z; Freichel M, 2007, BIOCHEM SOC T, V35, P120, DOI 10.1042/BST0350120; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Kim S, 2012, BIOINFORMATICS, V28, P597, DOI 10.1093/bioinformatics/btr702; Kiselyov K., 2007, V179, P559; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Shin YC, 2011, NUCLEIC ACIDS RES, V39, pD356, DOI 10.1093/nar/gkq814; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725	22	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47165	10.1371/journal.pone.0047165	http://dx.doi.org/10.1371/journal.pone.0047165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071747	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700063
J	Sun, YW; Connor, MG; Pennington, JM; Lawrenz, MB				Sun, Yanwen; Connor, Michael G.; Pennington, Jarrod M.; Lawrenz, Matthew B.			Development of Bioluminescent Bioreporters for In Vitro and In Vivo Tracking of Yersinia pestis	PLOS ONE			English	Article							PRIMARY PNEUMONIC PLAGUE; PLASMINOGEN-ACTIVATOR; BUBONIC PLAGUE; III SECRETION; EXPRESSION; INFECTION; PSEUDOTUBERCULOSIS; LUXCDABE; PROTEASE; ADHESIN	Yersinia pestis causes an acute infection known as the plague. Conventional techniques to enumerate Y. pestis can be labor intensive and do not lend themselves to high throughput assays. In contrast, bioluminescent bioreporters produce light that can be detected using plate readers or optical imaging platforms to monitor bacterial populations as a function of luminescence. Here, we describe the development of two Y. pestis chromosomal-based luxCDABE bioreporters, Lux(Pto/C) and Lux(PcysZK). These bioreporters use constitutive promoters to drive expression of luxCDABE that allow for sensitive detection of bacteria via bioluminescence in vitro. Importantly, both bioreporters demonstrate a direct correlation between bacterial numbers and bioluminescence, which allows for bioluminescence to be used to compare bacterial numbers. We demonstrate the use of these bioreporters to test antimicrobial inhibitors (Lux(Pto/C)) and monitor intracellular survival (Lux(Pto/C) and LuxPcysZK) in vitro. Furthermore, we show that Y. pestis infection of the mouse model can be monitored using whole animal optical imaging in real time. Using optical imaging, we observed Y. pestis dissemination and differentiated between virulence phenotypes in live animals via bioluminescence. Finally, we demonstrate that whole animal optical imaging can identify unexpected colonization patterns in mutant-infected animals.	[Sun, Yanwen; Connor, Michael G.; Pennington, Jarrod M.; Lawrenz, Matthew B.] Univ Louisville, Sch Med, Ctr Predict Med Biodefense & Emerging Infect Dis, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville	Lawrenz, MB (corresponding author), Univ Louisville, Sch Med, Ctr Predict Med Biodefense & Emerging Infect Dis, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	matt.lawrenz@louisville.edu	Connor, Michael/AAB-4671-2021	Connor, Michael/0000-0002-5413-2338; Lawrenz, Matthew/0000-0003-1505-5429	University of Louisville	University of Louisville	This work was supported by internal funding from the University of Louisville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bina XR, 2010, PLASMID, V64, P156, DOI 10.1016/j.plasmid.2010.07.001; Bland DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017352; Butler T, 1983, PLAGUE OTHER YERSINI; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Close D, 2012, SENSORS-BASEL, V12, P732, DOI 10.3390/s120100732; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Galen JE, 1999, INFECT IMMUN, V67, P6424; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lawrenz MB, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00119; Lawrenz MB, 2009, INFECT IMMUN, V77, P317, DOI 10.1128/IAI.01206-08; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; Nham T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034714; Pan NJ, 2009, ANTIMICROB AGENTS CH, V53, P385, DOI 10.1128/AAC.00670-08; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Strong PCR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-85; Thorslund SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016784; Trcek J, 2010, MICROBIOL-SGM, V156, P2734, DOI 10.1099/mic.0.038240-0; Trcek J, 2010, FEMS MICROBIOL LETT, V307, P201, DOI 10.1111/j.1574-6968.2010.01983.x; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; Warawa JM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00133; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154	33	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47123	10.1371/journal.pone.0047123	http://dx.doi.org/10.1371/journal.pone.0047123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071730	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700056
J	Su, YY; Luo, B; Jin, Y; Wu, SH; Lobarinas, E; Salvi, RJ; Chen, L				Su, Yan-Yan; Luo, Bin; Jin, Yan; Wu, Shu-Hui; Lobarinas, Edward; Salvi, Richard J.; Chen, Lin			Altered Neuronal Intrinsic Properties and Reduced Synaptic Transmission of the Rat's Medial Geniculate Body in Salicylate-Induced Tinnitus	PLOS ONE			English	Article							AUDITORY-CORTEX; INFERIOR COLLICULUS; SODIUM-SALICYLATE; REBOUND DEPOLARIZATION; POSTNATAL-DEVELOPMENT; BEHAVIORAL PARADIGM; GABA(B) RECEPTORS; PYRAMIDAL NEURONS; NEURAL ACTIVITY; LIMBIC SYSTEM	Sodium salicylate (NaSal), an aspirin metabolite, can cause tinnitus in animals and human subjects. To explore neural mechanisms underlying salicylate-induced tinnitus, we examined effects of NaSal on neural activities of the medial geniculate body (MGB), an auditory thalamic nucleus that provides the primary and immediate inputs to the auditory cortex, by using the whole-cell patch-clamp recording technique in MGB slices. Rats treated with NaSal (350 mg/kg) showed tinnitus-like behavior as revealed by the gap prepulse inhibition of acoustic startle (GPIAS) paradigm. NaSal (1.4 mM) decreased the membrane input resistance, hyperpolarized the resting membrane potential, suppressed current-evoked firing, changed the action potential, and depressed rebound depolarization in MGB neurons. NaSal also reduced the excitatory and inhibitory postsynaptic response in the MGB evoked by stimulating the brachium of the inferior colliculus. Our results demonstrate that NaSal alters neuronal intrinsic properties and reduces the synaptic transmission of the MGB, which may cause abnormal thalamic outputs to the auditory cortex and contribute to NaSal-induced tinnitus. Citation: Su Y-Y, Luo B, Jin Y, Wu S-H, Lobarinas E, et al. (2012) Altered Neuronal Intrinsic Properties and Reduced Synaptic Transmission of the Rat's Medial Geniculate Body in Salicylate-Induced Tinnitus. PLoS ONE 7(10): e46969. doi:10.1371/journal.pone.0046969	[Su, Yan-Yan; Luo, Bin; Jin, Yan; Chen, Lin] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China; [Su, Yan-Yan; Luo, Bin; Jin, Yan; Chen, Lin] Univ Sci & Technol China, Auditory Res Lab, Hefei 230026, Peoples R China; [Wu, Shu-Hui] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada; [Lobarinas, Edward; Salvi, Richard J.] SUNY Buffalo, Ctr Hearing & Deafness, Buffalo, NY 14260 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Carleton University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chen, L (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Peoples R China.	linchen@ustc.edu.cn	Chen, Lin/N-8327-2013	Chen, Lin/0000-0002-5847-2989	National Basic Research Program of China [2011CB504506]; National Natural Science Foundation of China [30730041, 30970977]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant 2011CB504506) and the National Natural Science Foundation of China (Grants 30730041 and 30970977). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett EL, 1999, J NEUROPHYSIOL, V81, P1999, DOI 10.1152/jn.1999.81.5.1999; Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.003; Basta D, 2008, HEARING RES, V240, P42, DOI 10.1016/j.heares.2008.02.005; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; CLERICI WJ, 1990, J COMP NEUROL, V297, P32, DOI 10.1002/cne.902970104; CLERICI WJ, 1990, J COMP NEUROL, V297, P14, DOI 10.1002/cne.902970103; Cong DN, 2011, SCI CHINA LIFE SCI, V54, P560, DOI 10.1007/s11427-011-4178-6; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; DAY RO, 1989, BRIT J CLIN PHARMACO, V28, P695, DOI 10.1111/j.1365-2125.1989.tb03562.x; DEER BC, 1982, J OTOLARYNGOL, V11, P260; Eggermont JJ, 1998, HEARING RES, V117, P149, DOI 10.1016/S0378-5955(98)00008-2; Eggermont JJ, 2008, AM J AUDIOL, V17, pS162, DOI 10.1044/1059-0889(2008/07-0025); Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gong N, 2008, NEUROPHARMACOLOGY, V54, P454, DOI 10.1016/j.neuropharm.2007.10.017; Guitton MJ, 2003, J NEUROSCI, V23, P3944; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Hsieh CY, 2002, JARO-J ASSOC RES OTO, V3, P479, DOI 10.1007/s10162-002-2052-8; HU B, 1995, J PHYSIOL-LONDON, V483, P167, DOI 10.1113/jphysiol.1995.sp020576; JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Jung HY, 1997, J NEUROSCI, V17, P6639; Kizawa K, 2010, NEUROSCIENCE, V165, P1323, DOI 10.1016/j.neuroscience.2009.11.048; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Liu XP, 2012, BRAIN RES IN PRESS; Liu YX, 2004, HEARING RES, V193, P68, DOI 10.1016/j.heares.2004.03.006; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Luo B, 2011, HEARING RES, V280, P157, DOI 10.1016/j.heares.2011.05.018; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; MONGAN E, 1973, JAMA-J AM MED ASSOC, V226, P142, DOI 10.1001/jama.226.2.142; Paul AK, 2009, NEUROIMAGE, V44, P312, DOI 10.1016/j.neuroimage.2008.09.024; Peruzzi D, 1997, J NEUROSCI, V17, P3766; Ralli M, 2010, OTOL NEUROTOL, V31, P823, DOI 10.1097/MAO.0b013e3181de4662; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; SILVERSTEIN H, 1967, ANN OTO RHINOL LARYN, V76, P118, DOI 10.1177/000348946707600109; Smith PH, 2006, J COMP NEUROL, V496, P314, DOI 10.1002/cne.20913; Su YY, 2009, HEARING RES, V253, P60, DOI 10.1016/j.heares.2009.03.007; Sun H, 2009, NEUROSCIENCE, V160, P198, DOI 10.1016/j.neuroscience.2009.02.011; Sun HY, 2008, BRAIN RES, V1226, P70, DOI 10.1016/j.brainres.2008.06.010; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Surges R, 2006, BIOCHEM BIOPH RES CO, V348, P1343, DOI 10.1016/j.bbrc.2006.07.193; Tennigkeit F, 1998, DEV BRAIN RES, V109, P255, DOI 10.1016/S0165-3806(98)00056-X; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang HT, 2006, HEARING RES, V215, P77, DOI 10.1016/j.heares.2006.03.004; Wei L, 2010, HEARING RES, V267, P54, DOI 10.1016/j.heares.2010.03.088; WINER JA, 1988, J COMP NEUROL, V278, P47, DOI 10.1002/cne.902780104; Winer JA, 1996, P NATL ACAD SCI USA, V93, P3083, DOI 10.1073/pnas.93.7.3083; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zhang X, 2011, NEUROSCIENCE, V172, P232, DOI 10.1016/j.neuroscience.2010.10.073	54	32	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46969	10.1371/journal.pone.0046969	http://dx.doi.org/10.1371/journal.pone.0046969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071681	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200058
J	Vaz, N; Silva, JDLE; Dias, JOM				Vaz, Nuno; Lencart e Silva, Joao D.; Dias, Joao Miguel			Salt Fluxes in a Complex River Mouth System of Portugal	PLOS ONE			English	Article							TIDAL CHANGES; AVEIRO; RIA; DISPERSION; LAGOON	Measurements of velocity and salinity near the mouth and head of the Espinheiro channel (Ria de Aveiro lagoon, Portugal) are used to study the local variation of physical water properties and to assess the balance, under steady conditions, between the seaward salt transport induced by river discharge and the landward dispersion induced by various mixing mechanisms. This assessment is made using data sampled during complete tidal cycles. Under the assumption that the estuarine tidal channel is laterally homogeneous and during moderate tidal periods (except for one survey), currents and salinity data were decomposed into various spatial and temporal means and their deviations. Near the channel's mouth, the main contributions to the salt transport are the terms due to freshwater discharge and the tidal correlation. Near the channel's head, this last term is less important than the density driven circulation, which is enhanced by the increase in freshwater discharge. The remaining terms, which are dependent on the deviations from the mean depth have a smaller role in the results of salt transport. The computed salt transport per unit width of a section perpendicular to the mean flow is in close agreement to the sum of the advective and dispersive terms (within or very close to 12%). An imbalance of the salt budget across the sections is observed for all the surveys. Considerations are made on how this approach can inform the management of hazardous contamination and how to use these results to best time the release of environmental flows during dry months.	[Vaz, Nuno; Lencart e Silva, Joao D.; Dias, Joao Miguel] Univ Aveiro, Dept Fis, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro	Vaz, N (corresponding author), Univ Aveiro, Dept Fis, CESAM, Campus Santiago, P-3800 Aveiro, Portugal.	nuno.vaz@ua.pt	Lencart e Silva, João D./B-3513-2011; Dias, João Miguel/F-3292-2010; Vaz, Nuno AF/F-5552-2010; Vaz, Nuno/GXH-8216-2022	Lencart e Silva, João D./0000-0001-8237-6981; Dias, João Miguel/0000-0002-7613-6241; Vaz, Nuno AF/0000-0002-8484-6948; 	Project BioChangeR [PTDC/AAC-AMB/121191/2010]; Project DyEPlume [PTDC/MAR/107939/2008]; FEDER; COMPETE programs; LAGOONS Project; EU [283157]; Ciencia Program; Portuguese Science Foundation	Project BioChangeR; Project DyEPlume; FEDER(European Commission); COMPETE programs; LAGOONS Project; EU(European Commission); Ciencia Program; Portuguese Science Foundation(Portuguese Foundation for Science and Technology)	This work was partially supported by Projects BioChangeR (PTDC/AAC-AMB/121191/2010) and DyEPlume (PTDC/MAR/107939/2008) funded by FEDER and COMPETE programs and LAGOONS Project funded by EU-FP7 grant agreement no 283157. The first author is supported by the Ciencia 2008 Program, financed by the Portuguese Science Foundation JLS is supported by the LAGOONS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo IB, 2008, CONT SHELF RES, V28, P1010, DOI 10.1016/j.csr.2008.02.001; Bergamo AL, 2000, THESIS U S PAULO S P; Borrego C, 1990, CASE STUDY IN PRESS; BOWDEN KF, 1963, AIR WATER POLLUT, V7, P343; de Miranda LB, 2005, OCEAN DYNAM, V55, P430, DOI 10.1007/s10236-005-0028-z; Dias JM, 1999, OCEANOL ACTA, V22, P473, DOI 10.1016/S0399-1784(00)87681-1; Dias JM, 2000, PHYS CHEM EARTH PT B, V25, P369, DOI 10.1016/S1464-1909(00)00028-9; DIAS JM, 2001, THESIS U AVEIRO AVEI; Dyer K.R., 1997, ESTUARIES PHYS INTRO, Vsecond; DYER KR, 1982, ESTUAR COAST SHELF S, V15, P443, DOI 10.1016/0272-7714(82)90053-1; Dyer KR, 1986, INTERMITTENCY ESTUAR; Dyer KR., 1974, ESTUAR COAST MAR SCI, V2, P273; FISCHER HB, 1976, ANNU REV FLUID MECH, V8, P107, DOI 10.1146/annurev.fl.08.010176.000543; Fischer HB., 1979, MIXING INLAND COASTA; HUNKINS K, 1981, J PHYS OCEANOGR, V11, P729, DOI 10.1175/1520-0485(1981)011<0729:SDITHE>2.0.CO;2; Jay DA, 1997, ESTUARIES, V20, P262, DOI 10.2307/1352342; KJERFVE B, 1975, ESTUAR COAST MAR SCI, V3, P311, DOI 10.1016/0302-3524(75)90031-6; Kjerfve Bjorn, 1986, PHYS SHALLOW ESTUARI, V280, P22, DOI [DOI 10.1029/LN016P0022, 10.1029/LN016p0022]; MANTOVANELLI A., 1999, THESIS U FEDERAL PAR; Miranda L. de, 1996, REV BRAS, V44, P123; Miranda LB, 2004, J COASTAL RES SI, P697; Moreira M. H., 1993, Netherlands Journal of Aquatic Ecology, V27, P465, DOI 10.1007/BF02334807; Picado A, 2010, CONT SHELF RES, V30, P1854, DOI 10.1016/j.csr.2010.08.012; Simpson JH, 1997, ESTUARIES, V20, P103, DOI 10.2307/1352724; UNESCO, 1985, IAPSO PUBL SCI, V32; UNESCO (United Nations Educational Scientific and Cultural Organization), 1985, UNESCO TECHN PAP MAR; Vaz N, 2008, J MARINE SYST, V70, P168, DOI 10.1016/j.jmarsys.2007.05.002; Vaz N, 2009, CONT SHELF RES, V29, P29, DOI 10.1016/j.csr.2007.12.005; Vicente C.M., 1985, JORNADAS RIA AVEIRO, VIII, P41	29	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47349	10.1371/journal.pone.0047349	http://dx.doi.org/10.1371/journal.pone.0047349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071793	Green Submitted, gold, Green Published			2022-12-25	WOS:000312385200110
J	Hao, CY; Wang, YQ; Hou, J; Feuillet, C; Balfourier, F; Zhang, XY				Hao, Chenyang; Wang, Yuquan; Hou, Jian; Feuillet, Catherine; Balfourier, Francois; Zhang, Xueyong			Association Mapping and Haplotype Analysis of a 3.1-Mb Genomic Region Involved in Fusarium Head Blight Resistance on Wheat Chromosome 3BS	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; MARKER-ASSISTED SELECTION; SPATIAL GENETIC-STRUCTURE; QUANTITATIVE TRAIT LOCUS; LINKAGE DISEQUILIBRIUM; SCAB RESISTANCE; SPRING WHEAT; MAJOR QTL; POPULATION; DIVERSITY	A previous study provided an in-depth understanding of molecular population genetics of European and Asian wheat gene pools using a sequenced 3.1-Mb contig (ctg954) on chromosome 3BS. This region is believed to carry the Fhb1 gene for response to Fusarium head blight. In this study, 266 wheat accessions were evaluated in three environments for Type II FHB response based on the single floret inoculation method. Hierarchical clustering (UPGMA) based on a Manhattan dissimilarity matrix divided the accessions into eight groups according to five FHB-related traits which have a high correlation between them; Group VIII comprised six accessions with FHB response levels similar to variety Sumai 3. Based on the compressed mixed linear model (MLM), association analysis between five FHB-related traits and 42 molecular markers along the 3.1-Mb region revealed 12 significant association signals at a threshold of P<0.05. The highest proportion of phenotypic variation (6.2%) in number of diseased spikelets (NDS) occurred at locus cfb6059, and the physical distance was about 2.9 Kb between umn10 and this marker. Haplotype block (HapB) analysis using a sliding window LD of 5 markers, detected six HapBs in the 3.1-Mb region at r(2)>0.1 and P<0.001 between random closely linked markers. F-tests among Haps with frequencies >0.05 within each HapB at r(2)>0.1 and P<0.001 showed significant differences between the Hap carried by FHB resistant resources, such as Sumai 3 and Wangshuibai, and susceptible genotypes in HapB3 and HapB6. These results suggest that Fhb1 is located within HapB6, with the possibility that another gene is located at or near HapB3. SSR markers and Haps detected in this study will be helpful in further understanding the genetic basis of FHB resistance, and provide useful information for marker-assisted selection of Fhb1 in wheat breeding.	[Feuillet, Catherine; Balfourier, Francois] INRA, UMR 1095, Clermont Ferrand, France; [Hao, Chenyang; Wang, Yuquan; Hou, Jian; Zhang, Xueyong] Chinese Acad Agr Sci, Key Lab Crop Gene Resources & Germplasm Enhanceme, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China	INRAE; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Balfourier, F (corresponding author), INRA, UMR 1095, Clermont Ferrand, France.	balfour@clermont.inra.fr; xueyongz@caas.net.cn			Chinese Ministry of Science and Technology [2010CB125900]; Chinese Agricultural Research System [CARS-3-1-2]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Agricultural Research System	This research is a joint program between the Chinese Academy of Agriculture Science (CAAS) and the French National Institute for Agronomical Research (INRA). It was financially supported by the Chinese Ministry of Science and Technology (2010CB125900) and the Chinese Agricultural Research System (CARS-3-1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BAI GH, 1994, PLANT DIS, V78, P760, DOI 10.1094/PD-78-0760; Bai GH, 1999, PHYTOPATHOLOGY, V89, P343, DOI 10.1094/PHYTO.1999.89.4.343; Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Bourdoncle W, 2003, EUPHYTICA, V131, P131, DOI 10.1023/A:1023056207513; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Dexter JE, 1997, CEREAL CHEM, V74, P519, DOI 10.1094/CCHEM.1997.74.5.519; Dexter JE, 1996, CEREAL CHEM, V73, P695; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garner C, 2003, GENET EPIDEMIOL, V24, P57, DOI 10.1002/gepi.10217; Gilbert J, 2000, CAN J PLANT PATHOL, V22, P1, DOI 10.1080/07060660009501155; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hao CY, 2010, THEOR APPL GENET, V121, P1209, DOI 10.1007/s00122-010-1382-x; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Koebner RMD, 2003, TRENDS BIOTECHNOL, V21, P59, DOI 10.1016/S0167-7799(02)00036-7; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Lin F, 2004, THEOR APPL GENET, V109, P1504, DOI 10.1007/s00122-004-1772-z; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Liu Sixin, 2006, Functional & Integrative Genomics, V6, P83, DOI 10.1007/s10142-005-0007-y; Liu SX, 2003, CROP SCI, V43, P760, DOI 10.2135/cropsci2003.0760; Loffler M, 2009, MOL BREEDING, V23, P473, DOI 10.1007/s11032-008-9250-y; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Ma ZQ, 2008, CEREAL RES COMMUN, V36, P245, DOI 10.1556/CRC.36.2008.Suppl.B.22; Malysheva-Otto LV, 2006, MOL BREEDING, V18, P143, DOI 10.1007/s11032-006-9023-4; McCartney CA, 2004, THEOR APPL GENET, V109, P261, DOI 10.1007/s00122-004-1640-x; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Miedaner T, 2011, MOL BREEDING, V28, P647, DOI 10.1007/s11032-010-9516-z; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pritchard JK, 2000, GENETICS, V155, P945; Pumphrey MO, 2007, CROP SCI, V47, P200, DOI 10.2135/cropsci2006.03.0206; ROHLF F, 2000, NTSYS NUMERICAL TAXO; Shen X, 2003, THEOR APPL GENET, V106, P1041, DOI 10.1007/s00122-002-1133-8; Snijders C. H. A., 1994, P37; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Steiner B, 2004, THEOR APPL GENET, V109, P215, DOI 10.1007/s00122-004-1620-1; Stracke S, 2007, GENETICS, V175, P805, DOI 10.1534/genetics.106.063800; Waldron BL, 1999, CROP SCI, V39, P805, DOI 10.2135/cropsci1999.0011183X003900030032x; Xue SL, 2011, THEOR APPL GENET, V123, P1055, DOI 10.1007/s00122-011-1647-z; Xue S, 2010, THEOR APPL GENET, V121, P147, DOI 10.1007/s00122-010-1298-5; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang ZP, 2005, GENOME, V48, P187, DOI [10.1139/G04-104, 10.1139/g04-104]; Yu JB, 2008, CROP SCI, V48, P1090, DOI 10.2135/cropsci2007.10.0554; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang JA, 2011, PLANTA, V234, P891, DOI 10.1007/s00425-011-1434-8; Zhang X, 2004, EUPHYTICA, V139, P59, DOI 10.1007/s10681-004-2298-9; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou WC, 2002, GENOME, V45, P719, DOI 10.1139/G02-034; Zwart RS, 2008, THEOR APPL GENET, V117, P813, DOI 10.1007/s00122-008-0822-3	64	23	26	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46444	10.1371/journal.pone.0046444	http://dx.doi.org/10.1371/journal.pone.0046444			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071572	gold, Green Published, Green Submitted			2022-12-25	WOS:000309827300029
J	Kopecky, V; Kohoutova, J; Lapkouski, M; Hofbauerova, K; Sovova, Z; Ettrichova, O; Gonzalez-Perez, S; Dulebo, A; Kaftan, D; Smatanova, IK; Revuelta, JL; Arellano, JB; Carey, J; Ettrich, R				Kopecky, Vladimir, Jr.; Kohoutova, Jaroslava; Lapkouski, Mikalai; Hofbauerova, Katerina; Sovova, Zofie; Ettrichova, Olga; Gonzalez-Perez, Sergio; Dulebo, Alexander; Kaftan, David; Smatanova, Ivana Kuta; Revuelta, Jose L.; Arellano, Juan B.; Carey, Jannette; Ettrich, Ruediger			Raman Spectroscopy Adds Complementary Detail to the High-Resolution X-Ray Crystal Structure of Photosynthetic PsbP from Spinacia oleracea	PLOS ONE			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYSTEM-II; SECONDARY-STRUCTURE; MOLECULAR-DYNAMICS; ASSISTED CRYSTALLOGRAPHY; PROTEIN-STRUCTURE; AMIDE-I; EFFICIENT; EVOLUTION; PEPTIDES	Raman microscopy permits structural analysis of protein crystals in situ in hanging drops, allowing for comparison with Raman measurements in solution. Nevertheless, the two methods sometimes reveal subtle differences in structure that are often ascribed to the water layer surrounding the protein. The novel method of drop-coating deposition Raman spectropscopy (DCDR) exploits an intermediate phase that, although nominally "dry,'' has been shown to preserve protein structural features present in solution. The potential of this new approach to bridge the structural gap between proteins in solution and in crystals is explored here with extrinsic protein PsbP of photosystem II from Spinacia oleracea. In the high-resolution (1.98 angstrom) x-ray crystal structure of PsbP reported here, several segments of the protein chain are present but unresolved. Analysis of the three kinds of Raman spectra of PsbP suggests that most of the subtle differences can indeed be attributed to the water envelope, which is shown here to have a similar Raman intensity in glassy and crystal states. Using molecular dynamics simulations cross-validated by Raman solution data, two unresolved segments of the PsbP crystal structure were modeled as loops, and the amino terminus was inferred to contain an additional beta segment. The complete PsbP structure was compared with that of the PsbP-like protein CyanoP, which plays a more peripheral role in photosystem II function. The comparison suggests possible interaction surfaces of PsbP with higher-plant photosystem II. This work provides the first complete structural picture of this key protein, and it represents the first systematic comparison of Raman data from solution, glassy, and crystalline states of a protein.	[Kohoutova, Jaroslava; Lapkouski, Mikalai; Sovova, Zofie; Ettrichova, Olga; Smatanova, Ivana Kuta; Ettrich, Ruediger] Acad Sci Czech Republ, Global Change Res Ctr, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic; [Kopecky, Vladimir, Jr.; Hofbauerova, Katerina] Charles Univ Prague, Inst Phys, Fac Math & Phys, Prague, Czech Republic; [Kohoutova, Jaroslava; Smatanova, Ivana Kuta] Univ S Bohemia, Fac Fisheries & Protect Waters, Nove Hrady, Czech Republic; [Hofbauerova, Katerina] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Sovova, Zofie; Dulebo, Alexander; Kaftan, David; Ettrich, Ruediger] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Gonzalez-Perez, Sergio; Arellano, Juan B.] Inst Recursos Nat & Agrobiol Salamanca IRNASA CSI, Dept Estres Abiot, Salamanca, Spain; [Revuelta, Jose L.] Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Carey, Jannette] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Charles University Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Princeton University	Ettrich, R (corresponding author), Acad Sci Czech Republ, Global Change Res Ctr, Inst Nanobiol & Struct Biol, Nove Hrady, Czech Republic.	ettrich@nh.cas.cz	Pérez, Sergio González/M-2831-2014; Kopecký, Vladimír/A-6965-2008; Revuelta, Jose Luis/ABG-1502-2020; Smatanova, Ivana Kuta/H-6516-2014; Arellano, Juan B./D-7174-2013; Revuelta, Jose L/C-2324-2012; Hofbauerova, Katerina/C-7626-2012; Kaftan, David/N-6799-2019; Ettrich, Rudi H/C-1463-2011; Kaftan, David/J-5790-2017	Pérez, Sergio González/0000-0001-7558-4109; Kopecký, Vladimír/0000-0002-7331-9018; Revuelta, Jose Luis/0000-0001-7838-5308; Smatanova, Ivana Kuta/0000-0002-1337-9481; Arellano, Juan B./0000-0001-8677-8697; Revuelta, Jose L/0000-0001-7838-5308; Hofbauerova, Katerina/0000-0001-7608-793X; Ettrich, Rudi H/0000-0001-8624-7706; Kaftan, David/0000-0003-0932-0986	Academy of Sciences of the Czech Republic [RVO: 61388971, AVOZ60870520]; Ministry of Education of the Czech Republic [MSM6007665808, ME09062, COST LD11011]; Czech Science Foundation [203/08/0114]; Grant Agency of the Academy of Sciences of Czech Republic [IAA608170901, KJB101120805]; Spanish Ministerio de Ciencia e Innovacion [BIO2008-00194, BF2007-68107-C02-02/BMC]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Academy of Sciences of Czech Republic(Grant Agency of the Czech Republic); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Support by the Academy of Sciences of the Czech Republic (RVO: 61388971, AVOZ60870520), the Ministry of Education of the Czech Republic (MSM6007665808, ME09062, COST LD11011), the Czech Science Foundation (grant 203/08/0114 to RE), and the Grant Agency of the Academy of Sciences of the Czech Republic (number IAA608170901 to DK and AD, number KJB101120805 to VK and KH) is gratefully acknowledged. JLR and JBA thank the Spanish Ministerio de Ciencia e Innovacion (reference numbers BIO2008-00194 and BF2007-68107-C02-02/BMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altose MD, 2001, P NATL ACAD SCI USA, V98, P3006, DOI 10.1073/pnas.061029598; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balsera M, 2005, J MOL BIOL, V350, P1051, DOI 10.1016/j.jmb.2005.05.044; Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERJOT M, 1987, J RAMAN SPECTROSC, V18, P289, DOI 10.1002/jrs.1250180411; Bumba L, 2003, PHOTOSYNTH RES, V77, P1, DOI 10.1023/A:1024927631196; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Carey PR, 2004, BIOCHEMISTRY-US, V43, P8885, DOI 10.1021/bi049138a; Carey PR, 1999, J BIOL CHEM, V274, P26625, DOI 10.1074/jbc.274.38.26625; Carpentier P, 2010, STRUCTURE, V18, P1410, DOI 10.1016/j.str.2010.09.010; De Las Rivas J, 2007, BBA-BIOENERGETICS, V1767, P575, DOI 10.1016/j.bbabio.2007.01.018; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ifuku K, 2005, PHOTOSYNTH RES, V84, P251, DOI 10.1007/s11120-004-7160-3; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Ifuku K, 2004, EMBO REP, V5, P362, DOI 10.1038/sj.embor.7400113; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Ifuku K, 2008, PHOTOSYNTH RES, V98, P427, DOI 10.1007/s11120-008-9359-1; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kapitan J, 2006, J AM CHEM SOC, V128, P13451, DOI 10.1021/ja062958l; Kohoutova J, 2009, ACTA CRYSTALLOGR F, V65, P111, DOI 10.1107/S1744309108040578; Kopecky V, 2004, SPECTROSC-INT J, V18, P323, DOI 10.1155/2004/747828; Kopecky V, 2006, VIB SPECTROSC, V42, P184, DOI 10.1016/j.vibspec.2006.04.019; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JNT CCP4 ESF EACBM N, V26; LI TS, 1992, BIOCHEMISTRY-US, V31, P6673, DOI 10.1021/bi00144a006; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McGeehan JE, 2011, BBA-PROTEINS PROTEOM, V1814, P750, DOI 10.1016/j.bbapap.2010.07.021; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; MIURA T, 1989, J RAMAN SPECTROSC, V20, P667, DOI 10.1002/jrs.1250201007; Miura T, 1995, Subcell Biochem, V24, P55; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nield J, 2002, J BIOL CHEM, V277, P15006, DOI 10.1074/jbc.M110549200; Ortiz C, 2006, ANAL BIOCHEM, V353, P157, DOI 10.1016/j.ab.2006.03.025; Overman SA, 1999, BIOCHEMISTRY-US, V38, P4018, DOI 10.1021/bi982901e; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Tensmeyer Lowell G., 1996, P69; THOMAS GA, 1989, BIOCHEMISTRY-US, V28, P2001, DOI 10.1021/bi00431a007; THOMAS GJ, 1987, BIOPOLYMERS, V26, P921, DOI 10.1002/bip.360260611; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tuma R, 2005, J RAMAN SPECTROSC, V36, P307, DOI 10.1002/jrs.1323; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WILLIAMS RW, 1986, METHOD ENZYMOL, V130, P311; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; YU NT, 1974, J AM CHEM SOC, V96, P4664, DOI 10.1021/ja00821a049; Zhang DM, 2003, ANAL CHEM, V75, P5703, DOI 10.1021/ac0345087; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	60	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46694	10.1371/journal.pone.0046694	http://dx.doi.org/10.1371/journal.pone.0046694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071614	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300050
J	Razafsky, D; Blecher, N; Markov, A; Stewart-Hutchinson, PJ; Hodzic, D				Razafsky, David; Blecher, Nathaniel; Markov, Alexander; Stewart-Hutchinson, P. J.; Hodzic, Didier			LINC Complexes Mediate the Positioning of Cone Photoreceptor Nuclei in Mouse Retina	PLOS ONE			English	Article							MEMBRANE PROTEIN; SUN PROTEINS; MIGRATION; ENVELOPE; LAMIN; ACTIN; KASH; EXPRESSION; MUTATIONS; NESPRINS	It has long been observed that many neuronal types position their nuclei within restricted cytoplasmic boundaries. A striking example is the apical localization of cone photoreceptors nuclei at the outer edge of the outer nuclear layer of mammalian retinas. Yet, little is known about how such nuclear spatial confinement is achieved and further maintained. Linkers of the Nucleoskeleton to the Cytoskeleton (LINC complexes) consist of evolutionary-conserved macromolecular assemblies that span the nuclear envelope to connect the nucleus with the peripheral cytoskeleton. Here, we applied a new transgenic strategy to disrupt LINC complexes either in cones or rods. In adult cones, we observed a drastic nuclear mislocalization on the basal side of the ONL that affected cone terminals overall architecture. We further provide evidence that this phenotype may stem from the inability of cone precursor nuclei to migrate towards the apical side of the outer nuclear layer during early postnatal retinal development. By contrast, disruption of LINC complexes within rod photoreceptors, whose nuclei are scattered across the outer nuclear layer, had no effect on the positioning of their nuclei thereby emphasizing differential requirements for LINC complexes by different neuronal types. We further show that Sun1, a component of LINC complexes, but not A-type lamins, which interact with LINC complexes at the nuclear envelope, participate in cone nuclei positioning. This study provides key mechanistic aspects underlying the well-known spatial confinement of cone nuclei as well as a new mouse model to evaluate the pathological relevance of nuclear mispositioning.	[Razafsky, David; Blecher, Nathaniel; Markov, Alexander; Hodzic, Didier] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Stewart-Hutchinson, P. J.] NYU, Sch Med, Dept Pathol, New York, NY USA	Washington University (WUSTL); New York University	Razafsky, D (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	hodzicd@vision.wustl.edu			National Institute of Health (NIH) [GM084204, T32 EY013360]; Research to Prevent Blindness, Inc.; NIH Vision Core [P30 EY002687]; NATIONAL EYE INSTITUTE [P30EY002687, R01EY022632, T32EY013360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084204] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH Vision Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are supported by the National Institute of Health (NIH) (GM084204), an NIH Training Grant (T32 EY013360 to DR) and by awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc. Unrestricted grant and the NIH Vision Core Grant P30 EY002687. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chiquet C, 2002, NEUROSCIENCE, V115, P1323, DOI 10.1016/S0306-4522(02)00327-5; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dupre N, 2007, ANN NEUROL, V62, P93, DOI 10.1002/ana.21143; Fan SS, 1997, DEVELOPMENT, V124, P1497; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; GARTNER S, 1981, BRIT J OPHTHALMOL, V65, P23, DOI 10.1136/bjo.65.1.23; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; Gros-Louis F, 2007, NAT GENET, V39, P80, DOI 10.1038/ng1927; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kolandaivelu S, 2011, J BIOL CHEM, V286, P33252, DOI 10.1074/jbc.M111.259101; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kozlov S, 2005, NOVART FDN SYMP, V264, P258; Kozlov Serguei, 2005, V264, P246, DOI 10.1002/0470093765.ch17; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; LAI YL, 1982, EXP EYE RES, V34, P219, DOI 10.1016/0014-4835(82)90056-2; Le YZ, 2006, MOL VIS, V12, P389; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Meyerzon M, 2009, DEVELOPMENT IN PRESS; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Moeller MJ, 2005, AM J PHYSIOL-RENAL, V289, pF481, DOI 10.1152/ajprenal.00332.2004; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Pow DV, 2007, EXP EYE RES, V84, P850, DOI 10.1016/j.exer.2007.01.005; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Rich KA, 1997, J COMP NEUROL, V388, P47; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Trifunovic D, 2010, J COMP NEUROL, V518, P3604, DOI 10.1002/cne.22416; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhou K, 2009, J CELL BIOL, V186, P229, DOI 10.1083/jcb.200902101; Zhou X, 2012, J CELL BIOL, V196, P203, DOI 10.1083/jcb.201108098; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	61	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47180	10.1371/journal.pone.0047180	http://dx.doi.org/10.1371/journal.pone.0047180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071752	Green Published, gold			2022-12-25	WOS:000309827300087
J	Botelho, HM; Leal, SS; Cardoso, I; Yanamandra, K; Morozova-Roche, LA; Fritz, G; Gomes, CM				Botelho, Hugo M.; Leal, Sonia S.; Cardoso, Isabel; Yanamandra, Kiran; Morozova-Roche, Ludmilla A.; Fritz, Guenter; Gomes, Claudio M.			S100A6 Amyloid Fibril Formation Is Calcium-modulated and Enhances Superoxide Dismutase-1 (SOD1) Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CELLULAR PRION PROTEIN; P-COMPONENT; MUTANT P53; A-BETA; ALZHEIMERS-DISEASE; BINDING-PROTEIN; METAL-IONS; MICE; RECEPTOR	S100A6 is a small EF-hand calcium- and zinc-binding protein involved in the regulation of cell proliferation and cytoskeletal dynamics. It is overexpressed in neurodegenerative disorders and a proposed marker for Amyotrophic Lateral Sclerosis (ALS). Following recent reports of amyloid formation by S100 proteins, we investigated the aggregation properties of S100A6. Computational analysis using aggregation predictors Waltz and Zyggregator revealed increased propensity within S100A6 helices HI and HIV. Subsequent analysis of Thioflavin-T binding kinetics under acidic conditions elicited a very fast process with no lag phase and extensive formation of aggregates and stacked fibrils as observed by electron microscopy. Ca2+ exerted an inhibitory effect on the aggregation kinetics, which could be reverted upon chelation. An FT-IR investigation of the early conformational changes occurring under these conditions showed that Ca2+ promotes anti-parallel beta-sheet conformations that repress fibrillation. At pH 7, Ca2+ rendered the fibril formation kinetics slower: time-resolved imaging showed that fibril formation is highly suppressed, with aggregates forming instead. In the absence of metals an extensive network of fibrils is formed. S100A6 oligomers, but not fibrils, were found to be cytotoxic, decreasing cell viability by up to 40%. This effect was not observed when the aggregates were formed in the presence of Ca2+. Interestingly, native S1006 seeds SOD1 aggregation, shortening its nucleation process. This suggests a cross-talk between these two proteins involved in ALS. Overall, these results put forward novel roles for S100 proteins, whose metalmodulated aggregation propensity may be a key aspect in their physiology and function.	[Botelho, Hugo M.; Leal, Sonia S.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Cardoso, Isabel] Inst Biol Mol & Celular, Mol Neurobiol Unit, P-4150180 Oporto, Portugal; [Cardoso, Isabel] Inst Politecn Porto, Escola Super Tecnol Saude Porto, P-4400330 Vila Nova De Gaia, Portugal; [Yanamandra, Kiran; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Fritz, Guenter] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany	Universidade Nova de Lisboa; Universidade do Porto; Polytechnic Institute of Porto; Umea University; University of Freiburg	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ 127, P-2780756 Oeiras, Portugal.	gomes@itqb.unl.pt	Morozova-Roche, Ludmilla/AAV-9983-2021; Cardoso, Isabel/K-3903-2013; Morozova-Roche, Ludmilla A./AAU-9044-2021; Yanamandra, Kiran/M-4037-2014; Gomes, Cláudio M./A-8152-2008; Fritz, Guenter/E-2933-2013; Leal, Sónia/F-1129-2015; Botelho, Hugo M/B-3092-2008	Morozova-Roche, Ludmilla/0000-0001-5886-2023; Cardoso, Isabel/0000-0003-2472-7055; Yanamandra, Kiran/0000-0002-4908-5848; Gomes, Cláudio M./0000-0003-4662-6933; Fritz, Guenter/0000-0002-4571-8812; Leal, Sónia/0000-0001-8445-0065; Botelho, Hugo M/0000-0002-4208-1086	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) [PTDC/QUI/70101, PTDC/EBB-BIO/117793/2010, PTDC/QUI-BIQ/117789/2010]; Swedish Medical Research Council; Kempe Foundation; Brain Foundation; Insamlingsstiftelsen Sweden; Deutsche Forschungsgemeinschaft (DFG) [FR 1488/3-2, FR 1488/5-2]; CRUP/DAAD collaborative grant [A-15/08];  [SFRH/BPD/47477/2008];  [SFRH/BD/31126/2006];  [PEst-OE/EQB/LA0004/2011]	Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal)(Portuguese Foundation for Science and Technology); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Kempe Foundation; Brain Foundation; Insamlingsstiftelsen Sweden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); CRUP/DAAD collaborative grant; ; ; 	This work was supported in part by the Fundacao para a Ciencia e Tecnologia (FCT/MCTES, Portugal) through research grants PTDC/QUI/70101, PTDC/EBB-BIO/117793/2010, and PTDC/QUI-BIQ/117789/2010 (to C. M. G.), doctoral and post-doctoral fellowships (SFRH/BPD/47477/2008 (to S. S. L.) and SFRH/BD/31126/2006 (to H. M. B.)), the strategic Grant PEst-OE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado), and by the Swedish Medical Research Council, Kempe Foundation, Brain Foundation, and Insamlingsstiftelsen Sweden (to L. M. R.). This work was also funded in part by Grants FR 1488/3-2 and FR 1488/5-2 from the Deutsche Forschungsgemeinschaft (DFG) (to G. F.) and a CRUP/DAAD collaborative grant A-15/08 (to C. M. G. and G. F.).	Ahl IM, 2004, PROTEIN EXPRES PURIF, V37, P311, DOI 10.1016/j.pep.2004.06.006; Amadoro G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.001; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Andreetto E, 2011, CHEMBIOCHEM, V12, P1313, DOI 10.1002/cbic.201100192; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Barbato C, 2005, NEUROBIOL DIS, V18, P399, DOI 10.1016/j.nbd.2004.10.011; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Berridge M.V., 1996, BIOCHEMICA, V4, P14, DOI DOI 10.1155/2013/420601; Bodin K, 2010, NATURE, V468, P93, DOI 10.1038/nature09494; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Botelho HM, 2012, METHODS MOL BIOL, V849, P373, DOI 10.1007/978-1-61779-551-0_25; Botelho HM, 2009, FEBS J, V276, P1776, DOI 10.1111/j.1742-4658.2009.06912.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Fritz G., 2004, HDB METALLOPROTEINS; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Hoyaux D, 2002, J NEUROPATH EXP NEUR, V61, P736, DOI 10.1093/jnen/61.8.736; Hoyaux D, 2000, BBA-MOL CELL RES, V1498, P264, DOI 10.1016/S0167-4889(00)00101-4; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inoue S, 1998, AMYLOID, V5, P99, DOI 10.3109/13506129808995287; Inoue S, 2005, AMYLOID, V12, P157, DOI 10.1080/13506120500232010; Inoue S, 1996, LAB INVEST, V74, P670; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leal SS, 2012, COORDIN CHEM REV, V256, P2253, DOI 10.1016/j.ccr.2012.04.004; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; MOSS J, 1994, HISTOPATHOLOGY, V24, P427, DOI 10.1111/j.1365-2559.1994.tb00551.x; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nicolls MR, 2004, CURR ALZHEIMER RES, V1, P47, DOI 10.2174/1567205043480555; Nielsen EH, 2000, SCAND J IMMUNOL, V52, P110; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otterbein LR, 2002, STRUCTURE, V10, P557, DOI 10.1016/S0969-2126(02)00740-2; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; Roltsch E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-78; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877; Shi J, 2002, J NUCL MED, V43, P1044; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Togashi S, 1997, LAB INVEST, V77, P525; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562; Zhang XA, 2010, PROG MOL BIOL TRANSL, V93, P309, DOI 10.1016/S1877-1173(10)93013-5; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	75	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42233	42242		10.1074/jbc.M112.396416	http://dx.doi.org/10.1074/jbc.M112.396416			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23076148	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000312103000059
J	Mao, DH; Chen, CY				Mao, Donghai; Chen, Caiyan			Colinearity and Similar Expression Pattern of Rice DREB1s Reveal Their Functional Conservation in the Cold-Responsive Pathway	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; FREEZING TOLERANCE; BOOTING STAGE; CBF GENES; NATURAL VARIATION; CANDIDATE GENE; HIGH-SALT; ARABIDOPSIS	The clustered genes C-repeat (CRT) binding factor (CBF)1/dehydration-responsive element binding protein (DREB)1B, CBF2/DREB1C, and CBF3/DREB1A play a central role in cold acclimation and facilitate plant resistance to freezing in Arabidopsis thaliana. Rice (Oryza sativa L.) is very sensitive to low temperatures; enhancing the cold stress tolerance of rice is a key challenge to increasing its yield. In this study, we demonstrate chilling acclimation, a phenomenon similar to Arabidopsis cold acclimation, in rice. To determine whether rice CBF/DREB1 genes participate in this cold-responsive pathway, all putative homologs of Arabidopsis DREB1 genes were filtered from the complete rice genome through a BLASTP search, followed by phylogenetic, colinearity and expression analysis. We thereby identified 10 rice genes as putative DREB1 homologs: nine of these were located in rice genomic regions with some colinearity to the Arabidopsis CBF1-CBF4 region. Expression profiling revealed that six of these genes (Os01g73770, Os02g45450, Os04g48350, Os06g03670, Os09g35010, and Os09g35030) were similarly expressed in response to chilling acclimation and cold stress and were co-expressed with genes involved in cold signalling, suggesting that these DREB1 homologs may be involved in the cold response in rice. The results presented here serve as a prelude towards understanding the function of rice homologs of DREB1 genes in cold-sensitive crops.	[Mao, Donghai; Chen, Caiyan] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Chen, CY (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Peoples R China.	cychen@isa.ac.cn	Chen, Caiyan/ABB-1458-2021; Mao, Donghai/AAB-7444-2020	Mao, Donghai/0000-0002-9850-149X	Chinese Academy of Sciences [KZCX2-YW-T07, KZCX2-YW-JC403]; National Natural Science Foundation of China [31101211]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Chinese Academy of Sciences (http://www.cas.cn. KZCX2-YW-T07, KZCX2-YW-JC403) and the National Natural Science Foundation of China (http://www.nsfc.gov.cn. 31101211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; Andaya VC, 2003, J EXP BOT, V54, P2579, DOI 10.1093/jxb/erg243; ANDERSON MD, 1994, PLANT PHYSIOL, V105, P331, DOI 10.1104/pp.105.1.331; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Francia E, 2007, THEOR APPL GENET, V115, P1083, DOI 10.1007/s00122-007-0634-x; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Han Longzhi, 2007, Journal of Genetics and Genomics, V34, P239, DOI 10.1016/S1673-8527(07)60025-3; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Ji SuLan, 2008, Acta Agronomica Sinica, V34, P551, DOI 10.3724/SP.J.1006.2008.00551; Ji ZJ, 2010, RICE SCI, V17, P282, DOI 10.1016/S1672-6308(09)60028-7; Jiang YH, 2012, PLANT J, V70, P398, DOI 10.1111/j.1365-313X.2011.04877.x; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Kuroki M, 2007, THEOR APPL GENET, V115, P593, DOI 10.1007/s00122-007-0589-y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levitt J., 1980, RESPONSES PLANTS ENV; Lin YH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-111; Liu FX, 2003, CHINESE SCI BULL, V48, P2068, DOI 10.1360/03wc0287; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; McKhann HI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-105; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Ohno S., 1970, P1; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Saito K, 2004, THEOR APPL GENET, V109, P515, DOI 10.1007/s00122-004-1667-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Vandepoele K, 2002, TRENDS GENET, V18, P606, DOI 10.1016/S0168-9525(02)02796-8; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang QY, 2008, PLANT MOL BIOL, V67, P589, DOI 10.1007/s11103-008-9340-6; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-284; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Xia RuiXiang, 2010, Scientia Agricultura Sinica, V43, P443; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhang Y, 2009, BMB REP, V42, P486, DOI 10.5483/BMBRep.2009.42.8.486; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x; Zhu HY, 2006, GENETICS, V172, P2491, DOI 10.1534/genetics.105.051185	58	63	73	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47275	10.1371/journal.pone.0047275	http://dx.doi.org/10.1371/journal.pone.0047275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077584	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800037
J	Balakrishnan, S; Vijayan, S; Nair, S; Subramoniapillai, J; Mrithyunjayan, S; Wilson, N; Satyanarayana, S; Dewan, PK; Kumar, AMV; Karthickeyan, D; Willis, M; Harries, AD; Nair, SA				Balakrishnan, Shibu; Vijayan, Shibu; Nair, Sanjeev; Subramoniapillai, Jayasankar; Mrithyunjayan, Sunilkumar; Wilson, Nevin; Satyanarayana, Srinath; Dewan, Puneet K.; Kumar, Ajay M. V.; Karthickeyan, Durai; Willis, Matthew; Harries, Anthony D.; Nair, Sreenivas Achuthan			High Diabetes Prevalence among Tuberculosis Cases in Kerala, India	PLOS ONE			English	Article							IMPACT; RISK	Background: While diabetes mellitus (DM) is a known risk factor for tuberculosis, the prevalence among TB patients in India is unknown. Routine screening of TB patients for DM may be an opportunity for its early diagnosis and improved management and might improve TB treatment outcomes. We conducted a cross-sectional survey of TB patients registered from June-July 2011 in the state of Kerala, India, to determine the prevalence of DM. Methodology/Principal Findings: A state-wide representative sample of TB patients in Kerala was interviewed and screened for DM using glycosylated hemoglobin (HbA1c); patients self-reporting a history of DM or those with HbA1c >= 6.5% were defined as diabetic. Among 552 TB patients screened, 243(44%) had DM - 128(23%) had previously known DM and 115(21%) were newly diagnosed - with higher prevalence among males and those aged >50years. The number needed to screen(NNS) to find one newly diagnosed case of DM was just four. Of 128 TB patients with previously known DM, 107(84%) had HbA1c >= 7% indicating poor glycemic control. Conclusions/Significance: Nearly half of TB patients in Kerala have DM, and approximately half of these patients were newly-diagnosed during this survey. Routine screening of TB patients for DM using HbA1c yielded a large number of DM cases and offered earlier management opportunities which may improve TB and DM outcomes. However, the most cost-effective ways of DM screening need to be established by futher operational research.	[Balakrishnan, Shibu; Dewan, Puneet K.; Kumar, Ajay M. V.; Karthickeyan, Durai; Nair, Sreenivas Achuthan] Off WHO Representat India, Dept TB, New Delhi, India; [Vijayan, Shibu; Wilson, Nevin; Satyanarayana, Srinath] SE Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Nair, Sanjeev] Govt Med Coll, Dept Resp Med, Thiruvananthapuram, Kerala, India; [Subramoniapillai, Jayasankar; Mrithyunjayan, Sunilkumar] Directorate Hlth Serv, Thiruvananthapuram, Kerala, India; [Willis, Matthew] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div TB Eliminat, Atlanta, GA USA; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Balakrishnan, S (corresponding author), Off WHO Representat India, Dept TB, New Delhi, India.	balakrishnans@rntcp.org	Nair, Sanjeev/AAD-4560-2019	Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797; Wilson, Nevin/0000-0002-0191-8855; Satyanarayana, Srinath/0000-0002-5420-2551	Central TB Division, Government of India	Central TB Division, Government of India(Ministry of Health and Family Welfare (MOHFW), Government of India)	Funding support of Indian Rupees 180000/- was provided only by the Central TB Division, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; [Anonymous], 2011, GLOB TUB CONTR 2011; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Balakrishnan S, 2011, INT J TUBERC LUNG D, pS348; Central TB Division, 2005, TECHN OP GUID TUB CO; Central TB Division, 2011, TB IND 2011; Directorate of Health Services Kerala state, 2011, NONC DIS; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Ezung T, 2002, J INDIAN MED ASSOC, V100, P378; Ezung Thungchanbemo, 2002, J Indian Med Assoc, V100, P378; Federation I. D, 2011, IDF DIAB ATL INT DIA; Goyal B N, 1978, J DIABETES ASS INDIA, V18, P191; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kishore B, 1973, J Assoc Physicians India, V21, P875; Kumar PR, 2010, J CLIN ENDOCR METAB, V95, P2832, DOI 10.1210/jc.2009-2433; Kumar Sunil, 2009, Indian J Tuberc, V56, P10; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Nanda C N, 1968, J Assoc Physicians India, V16, P741; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; PATEL J C, 1989, Indian Journal of Medical Sciences, V43, P177; Ramachandran A, 2010, JAPI S, P58; Ramachandran A, 2009, J DIABETES, V1, P18, DOI 10.1111/j.1753-0407.2008.00004.x; Raman Kutty V, 1999, Ethn Health, V4, P231; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Singh M., 1984, INDIAN J TUBERC, V31, P118; Sreenivas A, 2010, INT J TUBERCULOSI S2, pS87; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tripathy SR, 1984, IND J TUB, V31, P122; WHO, 2011, COLLABORATIVE FRAMEW; World Health Organization, 2011, US GLYC HAEM HBA1C D	32	102	102	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46502	10.1371/journal.pone.0046502	http://dx.doi.org/10.1371/journal.pone.0046502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077512	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100033
J	Dongol, S; Thompson, CN; Clare, S; Tran, VTN; Duy, PT; Karkey, A; Arjyal, A; Koirala, S; Khatri, NS; Maskey, P; Poudel, S; Jaiswal, VK; Vaidya, S; Dougan, G; Farrar, JJ; Dolecek, C; Basnyat, B; Baker, S				Dongol, Sabina; Thompson, Corinne N.; Clare, Simon; Tran Vu Thieu Nga; Pham Thanh Duy; Karkey, Abhilasha; Arjyal, Amit; Koirala, Samir; Khatri, Nely Shrestha; Maskey, Pukar; Poudel, Sanjay; Jaiswal, Vijay Kumar; Vaidya, Sujan; Dougan, Gordon; Farrar, Jeremy J.; Dolecek, Christiane; Basnyat, Buddha; Baker, Stephen			The Microbiological and Clinical Characteristics of Invasive Salmonella in Gallbladders from Cholecystectomy Patients in Kathmandu, Nepal	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; CARRIERS; BILIARY; FEVER; BLOOD; INFECTIONS; GALLSTONES; PARATYPHI; BACTERIA; BILE	Gallbladder carriage of invasive Salmonella is considered fundamental in sustaining typhoid fever transmission. Bile and tissue was obtained from 1,377 individuals undergoing cholecystectomy in Kathmandu to investigate the prevalence, characteristics and relevance of invasive Salmonella in the gallbladder in an endemic area. Twenty percent of bile samples contained a Gram-negative organism, with Salmonella Typhi and Salmonella Paratyphi A isolated from 24 and 22 individuals, respectively. Gallbladders that contained Salmonella were more likely to show evidence of acute inflammation with extensive neutrophil infiltrate than those without Salmonella, corresponding with higher neutrophil and lower lymphocyte counts in the blood of Salmonella positive individuals. Antimicrobial resistance in the invasive Salmonella isolates was limited, indicating that gallbladder colonization is unlikely to be driven by antimicrobial resistance. The overall role of invasive Salmonella carriage in the gallbladder is not understood; here we show that 3.5% of individuals undergoing cholecystectomy in this setting have a high concentration of antimicrobial sensitive, invasive Salmonella in their bile. We predict that such individuals will become increasingly important if current transmission mechanisms are disturbed; prospectively identifying these individuals is, therefore, paramount for rapid local and regional elimination.	[Thompson, Corinne N.; Tran Vu Thieu Nga; Pham Thanh Duy; Farrar, Jeremy J.; Dolecek, Christiane; Baker, Stephen] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dongol, Sabina; Karkey, Abhilasha; Arjyal, Amit; Koirala, Samir; Khatri, Nely Shrestha; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci, Kathmandu, Nepal; [Thompson, Corinne N.; Farrar, Jeremy J.; Dolecek, Christiane; Baker, Stephen] Univ Oxford, Ctr Trop Med, Oxford, England; [Clare, Simon; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Maskey, Pukar; Poudel, Sanjay; Jaiswal, Vijay Kumar; Vaidya, Sujan] Patan Hosp, Kathmandu, Nepal	University of Oxford; University of Oxford; University of Oxford; Wellcome Trust Sanger Institute	Baker, S (corresponding author), Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam.	sbaker@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Pham, Thanh Duy/AAX-3845-2020	Pham, Thanh Duy/0000-0001-7029-9210; SHRESTHA KHATRI, NELY/0000-0002-5399-4171; Baker, Stephen/0000-0003-1308-5755; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust of Great Britain; OAK Foundation through Oxford University, UK	Wellcome Trust of Great Britain(Wellcome Trust); OAK Foundation through Oxford University, UK	This work was supported by The Wellcome Trust of Great Britain. SB is funded by an OAK Foundation through Oxford University, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PERF STAND ANT SEN S; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Baker S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-45; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BENAVENTE L, 1984, T ROY SOC TROP MED H, V78, P404, DOI 10.1016/0035-9203(84)90134-2; Brooks J, 1996, CAN MED ASSOC J, V154, P915; Capoor MR, 2008, BRAZ J INFECT DIS, V12, P222, DOI 10.1590/S1413-86702008000300012; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Everest P, 2001, TRENDS MICROBIOL, V9, P316, DOI 10.1016/S0966-842X(01)02067-4; GILMAN RH, 1979, LANCET, V1, P795; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Karkey A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013988; Khatri NS, 2009, ANN INTERN MED, V150, P567, DOI 10.7326/0003-4819-150-8-200904210-00017; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Parry CM, 2010, ANTIMICROB AGENTS CH, V54, P5201, DOI 10.1128/AAC.00963-10; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; Ristori C, 1982, Bull Pan Am Health Organ, V16, P361; RYAN CA, 1989, REV INFECT DIS, V11, P1; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; SCHIOLER H, 1983, SCAND J INFECT DIS, V15, P17, DOI 10.3109/inf.1983.15.issue-1.04; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Vaishnavi C, 2005, JPN J INFECT DIS, V58, P363; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998	30	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47342	10.1371/journal.pone.0047342	http://dx.doi.org/10.1371/journal.pone.0047342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077595	Green Published, gold, Green Accepted			2022-12-25	WOS:000309995100095
J	Garcia-Bermudez, M; Lopez-Mejias, R; Gonzalez-Juanatey, C; Corrales, A; Robledo, G; Castaneda, S; Miranda-Filloy, JA; Blanco, R; Fernandez-Gutierrez, B; Balsa, A; Gonzalez-Alvaro, I; Gomez-Vaquero, C; Llorca, J; Martin, J; Gonzalez-Gay, MA				Garcia-Bermudez, Mercedes; Lopez-Mejias, Raquel; Gonzalez-Juanatey, Carlos; Corrales, Alfonso; Robledo, Gema; Castaneda, Santos; Miranda-Filloy, Jose A.; Blanco, Ricardo; Fernandez-Gutierrez, Benjamin; Balsa, Alejandro; Gonzalez-Alvaro, Isidoro; Gomez-Vaquero, Carmen; Llorca, Javier; Martin, Javier; Gonzalez-Gay, Miguel A.			Analysis of the Interferon Gamma (rs2430561,+874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTIMA-MEDIA THICKNESS; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROTIC DAMAGE; DISEASE; SUSCEPTIBILITY; INFLAMMATION; POLYMORPHISM; MECHANISMS; CONTRIBUTE	Objective: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular (CV) morbidity and mortality. Since interferon-gamma (IFN-gamma) has a direct effect on inflammation, in this study we assessed the potential association of the IFNG functional gene variant rs2430561 with CV disease in patients with RA. Methods: One thousand six hundred and thirty-five patients fulfilling the 1987 American College of Rheumatology classification criteria for RA were genotyped for the IFNG (rs2430561, +874T/A) gene polymorphism using TaqMan genotyping assay. Patients were stratified according to the presence of CV events or not. Logistic regression models to explain the presence of CV disease according to the IFNG rs2430561 allele distribution were performed. The potential influence of this variant in the development of subclinical atherosclerosis was also analyzed in a subgroup of patients with no history of CV events to determine carotid artery intima-media thickness (IMT) (n = 286) and presence of carotid plaques. Levels of the cytokine were determined in a subgroup of patients by ELISA. Results: Adjusted logistic regression model disclosed that presence of the minor allele A was not associated with increased risk of suffering CV events in RA patients. Besides, differences did not achieve statistical significance regarding carotid IMT and presence of carotid plaques in RA patients carrying IFNG rs2430561 variant allele. Levels of IFN-gamma were higher in patients who had suffered CV events compared to patients who did not. Conclusion: Our results do not support a role of IFNG rs2430561 (+874T/A) functional gene variant in the development of CV disease in RA patients.	[Lopez-Mejias, Raquel; Corrales, Alfonso; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain; [Garcia-Bermudez, Mercedes; Robledo, Gema; Martin, Javier] CSIC, IPBLN, Granada, Spain; [Gonzalez-Juanatey, Carlos] Hosp Xeral Calde, Div Cardiol, Lugo, Spain; [Castaneda, Santos; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, IIS Princesa, Dept Rheumatol, Madrid, Spain; [Miranda-Filloy, Jose A.] Hosp Xeral Calde, Dept Rheumatol, Lugo, Spain; [Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Balsa, Alejandro] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain; [Gomez-Vaquero, Carmen] Hosp Univ Bellvitge, IDIBELL, Dept Rheumatol, Barcelona, Spain; [Llorca, Javier] Univ Cantabria, Dept Epidemiol & Computat Biol, Sch Med, E-39005 Santander, Spain; [Llorca, Javier] IFIMAV, CIBERESP, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Clinico San Carlos; Hospital Universitario La Paz; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Gonzalez-Gay, MA (corresponding author), Hosp Univ Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain.	miguelaggay@hotmail.com	Martín, María/HDL-9512-2022; García-Bermúdez, Mercedes/E-7708-2013; González-Gay, Miguel A./B-2306-2008; Martin, Javier/B-8141-2008; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Balsa, Alejandro/ABF-6456-2020; Martín, Javier/AAV-5209-2021; blanco, ricardo/AAA-1248-2020; Llorca, Javier/F-7371-2011	García-Bermúdez, Mercedes/0000-0002-2643-5956; González-Gay, Miguel A./0000-0002-7924-7406; Martin, Javier/0000-0002-2202-0622; blanco, ricardo/0000-0003-2344-2285; Llorca, Javier/0000-0001-8569-861X; Fernandez-Gutierrez, Benjamin/0000-0002-6126-8786	Fondo de Investigaciones Sanitarias [PI06-0024, PS09/00748]; Instituto de Salud Carlos III (ISCIII), National Health System (Spain) [RD08/0075]; EuropeanIMI BTCure Program; Fundacion Espanola de Reumatologia	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III (ISCIII), National Health System (Spain); EuropeanIMI BTCure Program; Fundacion Espanola de Reumatologia	This work was supported by two grants from Fondo de Investigaciones Sanitarias PI06-0024 and PS09/00748 (Spanish National Health System; Ministry of Science and Innovation, Spain Government) and by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), National Health System (Spain) within the VI Programa Nacionalde I+D+i 2008-2011 (FEDER). This work was supported in part by grants from the EuropeanIMI BTCure Program. MGB is a beneficiary of a grant from Fundacion Espanola de Reumatologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos S, 2011, CYTOKINE, V54, P68, DOI 10.1016/j.cyto.2011.01.004; Amezcua-Guerra LM, 2008, J RHEUMATOL, V35, P2071; Aravena O, 2011, IMMUNOBIOLOGY, V216, P1256, DOI 10.1016/j.imbio.2011.07.006; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Bartoloni E, 2011, ARTHRIT CARE RES, V63, P178, DOI 10.1002/acr.20322; Carmona L, 2002, RHEUMATOLOGY, V41, P88, DOI 10.1093/rheumatology/41.1.88; Constantin A, 2001, LANCET, V358, P2051, DOI 10.1016/S0140-6736(01)07143-4; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dhawan SS, 2008, CURR ATHEROSCLER REP, V10, P128, DOI 10.1007/s11883-008-0019-x; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; Full LE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2631; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2008, SEMIN ARTHRITIS RHEU, V38, P67, DOI 10.1016/j.semarthrit.2008.02.001; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2003, AM J MED, V114, P647, DOI 10.1016/S0002-9343(03)00133-5; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Kerekes G, 2008, J RHEUMATOL, V35, P398; Khani-Hanjani A, 2000, LANCET, V356, P820, DOI 10.1016/S0140-6736(00)02657-X; Kim K, 2010, ANN RHEUM DIS, V69, P1247, DOI 10.1136/ard.2009.117572; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Lopez-Mejias R, 2012, ATHEROSCLEROSIS; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P1408, DOI 10.1002/art.22527; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Patel S, 2008, INT J BIOCHEM CELL B, V40, P576, DOI 10.1016/j.biocel.2007.11.017; Pokorny V, 2001, LANCET, V358, P122, DOI 10.1016/S0140-6736(01)05342-9; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rodriguez-Rodriguez L, 2011, ATHEROSCLEROSIS, V216, P125, DOI 10.1016/j.atherosclerosis.2010.10.052; Schroecksnadel Katharina, 2006, Current Vascular Pharmacology, V4, P205, DOI 10.2174/157016106777698379; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47166	10.1371/journal.pone.0047166	http://dx.doi.org/10.1371/journal.pone.0047166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077565	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100071
J	Juvet, SC; Han, M; Vanama, R; Joe, B; Kim, EY; Zhao, FLD; Jeon, C; Adeyi, O; Zhang, L				Juvet, Stephen C.; Han, Mei; Vanama, Ramesh; Joe, Betty; Kim, Edward Y.; Zhao, Fei Linda; Jeon, Caroline; Adeyi, Oyedele; Zhang, Li			Autocrine IFN gamma Controls the Regulatory Function of Lymphoproliferative Double Negative T Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; INTERFERON-GAMMA; DENDRITIC CELLS; SURFACE EXPRESSION; APOPTOTIC CELLS; HELPER-CELLS; FAS LIGAND; INHIBITION; ACTIVATION; PATHWAY	TCR alpha beta(+) CD4(-)CD8(-)NK(-) double negative T cells (DN T cells) can act as regulatory T cells to inhibit allograft rejection and autoimmunity. Their role in graft-versus-host disease and mechanisms of suppression remain elusive. In this study, we demonstrate that DN T cells can inhibit CD4(+) T cell-mediated GVHD in a semi-allogeneic model of bone marrow transplantation. Furthermore, we present evidence of a novel autocrine IFN gamma signaling pathway in Fas-deficient C57BL/6.lpr (B6.lpr) DN T cells. B6.lpr DN T cells lacking IFN gamma or its receptor were impaired in their ability to suppress syngeneic CD4(+) T cells responding to alloantigen stimulation both in vitro and in vivo. Autocrine IFN gamma signaling was required for sustained B6.lpr DN T cell IFN gamma secretion in vivo and for upregulation of surface Fas ligand expression during TCR stimulation. Fas ligand (FasL) expression by B6.lpr DN T cells permitted lysis of activated CD4(+) T cells and was required for suppression of GVHD. Collectively, our data indicate that DN T cells can inhibit GVHD and that IFN gamma plays a critical autocrine role in controlling the regulatory function of B6.lpr DN T cells.	[Juvet, Stephen C.; Zhang, Li] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Div Respirol, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Clinician Scientist Training Program, Toronto, ON, Canada; [Han, Mei; Vanama, Ramesh; Joe, Betty; Kim, Edward Y.; Adeyi, Oyedele; Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhao, Fei Linda; Jeon, Caroline; Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Juvet, Stephen C.; Han, Mei; Vanama, Ramesh; Joe, Betty; Kim, Edward Y.; Zhao, Fei Linda; Jeon, Caroline; Adeyi, Oyedele; Zhang, Li] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhang, L (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	lzhang@uhnres.utoronto.ca		Adeyi, Oyedele/0000-0003-4272-1095; Juvet, Stephen/0000-0002-7243-556X	Canadian Institutes of Health Research [14431]; Canadian Cancer Society [020516]; Terry Fox Foundation/National Cancer Institute of Canada [18014]; Department of Medicine, University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation/National Cancer Institute of Canada; Department of Medicine, University of Toronto(University of Toronto)	This work was supported by Canadian Institutes of Health Research (http://cihr-irsc.gc.ca/) Grant # 14431 and Canadian Cancer Society (http://www.cancer.ca/Research.aspx) Grant # 020516 to LZ. SCJ received salary support from a Terry Fox Foundation/National Cancer Institute of Canada (http://www.cancer.ca/Research.aspx) Clinical Research Fellowship # 18014 and the Clinician-Scientist Training Program, Department of Medicine, University of Toronto (http://www.deptmedicine.utoronto.ca/edustudies/CSTProgram.htm). LZ is the Maria H. Bacardi Chair in Transplantation at the University Health Network (www.uhn.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Blazar BR, 1997, TRANSPLANTATION, V64, P571, DOI 10.1097/00007890-199708270-00004; Boselli D, 2007, EUR J IMMUNOL, V37, P2196, DOI 10.1002/eji.200636541; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; Chen WH, 2003, J IMMUNOL, V170, P1846, DOI 10.4049/jimmunol.170.4.1846; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Ford MS, 2007, EUR J IMMUNOL, V37, P2234, DOI 10.1002/eji.200636991; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; GIESE T, 1994, J IMMUNOL, V152, P2000; Haas C, 1997, J IMMUNOL, V158, P5484; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hill M, 2011, AM J TRANSPLANT, V11, P2036, DOI 10.1111/j.1600-6143.2011.03651.x; Hillhouse EE, 2010, IMMUNOL CELL BIOL, V88, P771, DOI 10.1038/icb.2010.84; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Jung ID, 2007, FEBS LETT, V581, P1449, DOI 10.1016/j.febslet.2007.02.073; KELLEY VE, 1985, CLIN IMMUNOL IMMUNOP, V37, P220, DOI 10.1016/0090-1229(85)90153-9; Kim S, 2000, J IMMUNOL, V164, P2931, DOI 10.4049/jimmunol.164.6.2931; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; Li XJ, 2007, J IMMUNOL, V179, P939, DOI 10.4049/jimmunol.179.2.939; Ma L, 2005, EUR J IMMUNOL, V35, P3364, DOI 10.1002/eji.200535192; MATZINGER P, 1991, J IMMUNOL METHODS, V145, P185, DOI 10.1016/0022-1759(91)90325-A; McIver Z, 2008, BRIT J HAEMATOL, V141, P170, DOI 10.1111/j.1365-2141.2008.07021.x; MURRAY L, 1989, EUR J IMMUNOL, V19, P563, DOI 10.1002/eji.1830190325; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; SYKES M, 1995, BLOOD, V86, P2429, DOI 10.1182/blood.V86.6.2429.bloodjournal8662429; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; Wang ZJ, 2006, J CLIN INVEST, V116, P2434, DOI 10.1172/JCI25826; Wei B, 2010, AM J TRANSPLANT, V10, P69, DOI 10.1111/j.1600-6143.2009.02858.x; Yang YG, 1998, J CLIN INVEST, V102, P2126, DOI 10.1172/JCI4992; Young KJ, 2003, J IMMUNOL, V171, P134, DOI 10.4049/jimmunol.171.1.134; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhang D, 2007, BLOOD, V109, P4071, DOI 10.1182/blood-2006-10-050625; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	44	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47732	10.1371/journal.pone.0047732	http://dx.doi.org/10.1371/journal.pone.0047732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077665	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100157
J	Karimi, K; Kandiah, N; Chau, J; Bienenstock, J; Forsythe, P				Karimi, Khalil; Kandiah, Nalaayini; Chau, Jessie; Bienenstock, John; Forsythe, Paul			A Lactobacillus rhamnosus Strain Induces a Heme Oxygenase Dependent Increase in Foxp3+Regulatory T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; THERAPEUTIC TARGET; ORAL TOLERANCE; EXPRESSION; MATURATION; INDUCTION; COMMENSAL; DIFFERENTIATION; INTERLEUKIN-10; INFLAMMATION	We investigated the consequences of feeding with a Lactobacillus species on the immune environment in GALT, and the role of dendritic cells and heme oxygenase-1 in mediating these responses. Feeding with a specific strain of Lactobacillus rhamnosus induced a significant increase in CD4+CD25+Foxp3+ functional regulatory T cells in GALT. This increase was greatest in the mesenteric lymph nodes and associated with a marked decrease in TNF and IFN gamma production. Dendritic cell regulatory function and HO-1 expression was also increased. The increase in Foxp3+ T cells could be prevented by treatment with a heme oxygenase inhibitor. However, neither inhibition of heme oxygenase nor blockade of IL-10 and TGF beta prevented the inhibition of inflammatory cytokine production. In conclusion Lactobacillus feeding induced a tolerogenic environment in GALT. HO-1 was critical to the enhancement of Foxp3+ regulatory T cells while additional, as yet unknown, pathways were involved in the down-regulation of inflammatory cytokine production by T cells.	[Karimi, Khalil; Kandiah, Nalaayini; Chau, Jessie; Bienenstock, John; Forsythe, Paul] McMaster Univ, Brain Body Inst, Hamilton, ON, Canada; [Forsythe, Paul] McMaster Univ, Firestone Inst Resp Hlth, Hamilton, ON, Canada; [Karimi, Khalil; Chau, Jessie; Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Karimi, K (corresponding author), McMaster Univ, Brain Body Inst, Hamilton, ON, Canada.	karimik@mcmaster.ca; forsytp@mcmaster.ca	Karimi, Khalil/ABA-4735-2020	Karimi, Khalil/0000-0002-7245-5851	AllerGen NCE [09-B6]	AllerGen NCE	Funded in part by a grant from AllerGen NCE (http://www.allergen-nce.ca/index.html) Grant 09-B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Biburger M, 2010, J LEUKOCYTE BIOL, V87, P192, DOI 10.1189/jlb.0508280; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Commeren DL, 2003, IMMUNOLOGY, V110, P188, DOI 10.1046/j.1365-2567.2003.01730.x; Dubois B, 2005, CELL MOL LIFE SCI, V62, P1322, DOI 10.1007/s00018-005-5036-0; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Forsythe P, 2010, IMMUNOL INVEST, V39, P429, DOI 10.3109/08820131003667978; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Giris M, 2007, INT J COLORECTAL DIS, V22, P591, DOI 10.1007/s00384-006-0238-y; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI [10.1097/00130832-200302000-00003, 10.1097/01.all.0000053262.39029.a1]; Karimi K, 2008, MOL THER, V16, P411, DOI 10.1038/sj.mt.6300347; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Listopad J, 2007, EXP DERMATOL, V16, P661, DOI 10.1111/j.1600-0625.2007.00581.x; Lyons A, 2010, CLIN EXP ALLERGY, V40, P811, DOI 10.1111/j.1365-2222.2009.03437.x; Ma DL, 2004, INFECT IMMUN, V72, P5308, DOI 10.1128/IAI.72.9.5308-5314.2004; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2006, J EXP MED, V203, P497, DOI 10.1084/jem.20060227; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Moreau A, 2009, FASEB J, V23, P3070, DOI 10.1096/fj.08-128173; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; Naito Y, 2004, ALIMENT PHARM THERAP, V20, P177, DOI 10.1111/j.1365-2036.2004.01992.x; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Park DJ, 2010, AM J PATHOL, V176, P2831, DOI 10.2353/ajpath.2010.090845; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Raval CM, 2010, CURR DRUG TARGETS, V11, P1532; Reid G, 2005, CAN FAM PHYSICIAN, V51, P1487; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sun LA, 2011, J SURG RES, V166, pE187, DOI 10.1016/j.jss.2010.11.917; Trampuz A, 2006, J MED MICROBIOL, V55, P1271, DOI 10.1099/jmm.0.46488-0; Ueckert JE, 1997, LETT APPL MICROBIOL, V25, P295, DOI 10.1046/j.1472-765X.1997.00225.x; Vancanneyt M, 2006, APPL ENVIRON MICROB, V72, P5376, DOI 10.1128/AEM.00091-06; Vijayan V, 2010, WORLD J GASTROENTERO, V16, P3112, DOI 10.3748/wjg.v16.i25.3112; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wunder C, 2002, J PHYSIOL-LONDON, V540, P1013, DOI 10.1113/physiol.2001.015446; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116	61	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47556	10.1371/journal.pone.0047556	http://dx.doi.org/10.1371/journal.pone.0047556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077634	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100129
J	Preta, G; Fadeel, B				Preta, Giulio; Fadeel, Bengt			AIF and Scythe (Bat3) Regulate Phosphatidylserine Exposure and Macrophage Clearance of Cells Undergoing Fas (APO-1)-Mediated Apoptosis	PLOS ONE			English	Article							BASIC BIOLOGICAL PHENOMENON; WIDE-RANGING IMPLICATIONS; MEDIATED APOPTOSIS; LIPID RAFTS; AMINOPHOSPHOLIPID TRANSLOCASE; PHOSPHOLIPID SCRAMBLASE-1; AUTOIMMUNE-DISEASE; FLIP-FLOP; EXTERNALIZATION; CLEAVAGE	Phosphatidylserine (PS) exposure on the cell surface has been considered a characteristic feature of apoptosis and serves as a molecular cue for engulfment of dying cells by phagocytes. However, the mechanism of PS exposure is still not fully elucidated. Here we show that the cytosolic release from mitochondria of apoptosis-inducing factor (AIF) is required for PS exposure during death receptor-induced apoptosis and for efficient clearance of cell corpses by primary human macrophages. Fas-triggered PS exposure was significantly reduced upon siRNA-mediated silencing of AIF expression and by inhibition of the cytosolic translocation of AIF. In addition, AIF localizes to the plasma membrane upon Fas ligation and promotes activation of phospholipid scrambling activity. Finally, cytosolic stabilization of AIF through interaction with Scythe is shown to be involved in apoptotic PS exposure. Taken together, our results suggest an essential role for AIF and its binding partner Scythe in the pathway leading to apoptotic corpse clearance.	[Preta, Giulio; Fadeel, Bengt] Karolinska Inst, Div Mol Toxicol, Inst Environm Med, Stockholm, Sweden	Karolinska Institutet	Fadeel, B (corresponding author), Karolinska Inst, Div Mol Toxicol, Inst Environm Med, Stockholm, Sweden.	bengt.fadeel@ki.se	Preta, Giulio/N-7141-2016; Preta, Giulio/AAW-6182-2021	Preta, Giulio/0000-0002-8318-4698; 	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The authors received support from the Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo A, 2002, J BIOL CHEM, V277, P49965, DOI 10.1074/jbc.M204513200; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Borisenko GG, 2003, ARCH BIOCHEM BIOPHYS, V413, P41, DOI 10.1016/S0003-9861(03)00083-3; Bratton DL, 1997, J BIOL CHEM, V272, P26159, DOI 10.1074/jbc.272.42.26159; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Jitkaew S, 2009, J BIOL CHEM, V284, P27827, DOI 10.1074/jbc.M109.027912; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Marchetti P, 1996, J IMMUNOL, V157, P4830; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Norberg E, 2010, EMBO J, V29, P3869, DOI 10.1038/emboj.2010.253; Preta G, 2012, FEBS LETT, V586, P747, DOI 10.1016/j.febslet.2012.01.034; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun Y, 2005, BLOOD, V105, P4070, DOI 10.1182/blood-2004-10-4075; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Tyurina YY, 2007, J BIOL CHEM, V282, P8498, DOI 10.1074/jbc.M606950200; Uthaisang W, 2003, FEBS LETT, V545, P110, DOI 10.1016/S0014-5793(03)00508-8; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; Witasp Erika, 2008, Current Immunology Reviews, V4, P53, DOI 10.2174/157339508784325064; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Zhuang JG, 1998, J BIOL CHEM, V273, P15628, DOI 10.1074/jbc.273.25.15628	44	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47328	10.1371/journal.pone.0047328	http://dx.doi.org/10.1371/journal.pone.0047328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077592	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100092
J	Rueppell, O; Meier, S; Deutsch, R				Rueppell, Olav; Meier, Stephen; Deutsch, Roland			Multiple Mating But Not Recombination Causes Quantitative Increase in Offspring Genetic Diversity for Varying Genetic Architectures	PLOS ONE			English	Article							HONEY-BEE; APIS-MELLIFERA; SOCIAL EVOLUTION; SCIENTIFIC NOTE; LINKAGE MAP; COLONIES; POLYANDRY; FREQUENCY; QTL; SEX	Explaining the evolution of sex and recombination is particularly intriguing for some species of eusocial insects because they display exceptionally high mating frequencies and genomic recombination rates. Explanations for both phenomena are based on the notion that both increase colony genetic diversity, with demonstrated benefits for colony disease resistance and division of labor. However, the relative contributions of mating number and recombination rate to colony genetic diversity have never been simultaneously assessed. Our study simulates colonies, assuming different mating numbers, recombination rates, and genetic architectures, to assess their worker genotypic diversity. The number of loci has a strong negative effect on genotypic diversity when the allelic effects are inversely scaled to locus number. In contrast, dominance, epistasis, lethal effects, or limiting the allelic diversity at each locus does not significantly affect the model outcomes. Mating number increases colony genotypic variance and lowers variation among colonies with quickly diminishing returns. Genomic recombination rate does not affect intra-and inter-colonial genotypic variance, regardless of mating frequency and genetic architecture. Recombination slightly increases the genotypic range of colonies and more strongly the number of workers with unique allele combinations across all loci. Overall, our study contradicts the argument that the exceptionally high recombination rates cause a quantitative increase in offspring genotypic diversity across one generation. Alternative explanations for the evolution of high recombination rates in social insects are therefore needed. Short-term benefits are central to most explanations of the evolution of multiple mating and high recombination rates in social insects but our results also apply to other species.	[Rueppell, Olav] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA; [Meier, Stephen] Univ N Carolina, Dept Phys & Astron, Greensboro, NC 27412 USA; [Deutsch, Roland] Univ N Carolina, Dept Math & Stat, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro	Rueppell, O (corresponding author), Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA.	olav_rueppell@uncg.edu	Rueppell, Olav/G-2679-2010	Rueppell, Olav/0000-0001-5370-4229; Deutsch, Roland/0000-0002-5938-0330	UNCG; National Evolutionary Synthesis Center (NESCent); NSF [EF-0423641, 0926288, 0850465]; National Institutes of Health [R15GM102753]; United States Department of Agriculture [2010-65104-20533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102753] Funding Source: NIH RePORTER	UNCG; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by UNCG, the National Evolutionary Synthesis Center (NESCent), NSF #EF-0423641, two undergraduate training grants of the National Science Foundation (#0926288 and #0850465), and OR was additionally supported by a National Institutes of Health grant (R15GM102753) and the United States Department of Agriculture (2010-65104-20533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Becks L, 2011, J EVOLUTION BIOL, V24, P656, DOI 10.1111/j.1420-9101.2010.02199.x; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Bell G., 1982, MASTERPIECE NATURE E; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Boomsma Jacobus J., 2009, P3; Brown MJF, 2003, EVOLUTION, V57, P2067, DOI 10.1111/j.0014-3820.2003.tb00386.x; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Crozier RH, 2001, ANN ZOOL FENN, V38, P267; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; Gadau J, 2000, NATURWISSENSCHAFTEN, V87, P87, DOI 10.1007/s001140050016; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Gove R, 2009, INSECT SOC, V56, P319, DOI 10.1007/s00040-009-0028-y; Graham AM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-95; Haberl M, 1998, BEHAV ECOL SOCIOBIOL, V42, P247, DOI 10.1007/s002650050436; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; Hughes WOH, 2008, J EVOLUTION BIOL, V21, P1090, DOI 10.1111/j.1420-9101.2008.01532.x; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; HUNT GJ, 1995, GENETICS, V139, P1371; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kallenberg O., 1997, FDN MODERN PROBABILI; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Lohaus R, 2010, J HERED, V101, pS142, DOI 10.1093/jhered/esq013; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Mattila HR, 2008, P ROY SOC B-BIOL SCI, V275, P809, DOI 10.1098/rspb.2007.1620; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Meznar ER, 2010, J HERED, V101, pS118, DOI 10.1093/jhered/esq002; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Rueppell O, 2008, BIOL LETTERS, V4, P270, DOI 10.1098/rsbl.2008.0065; Rueppell O, 2009, BEHAV GENET, V39, P541, DOI 10.1007/s10519-009-9278-8; Ruppell O, 2003, MOL ECOL, V12, P795, DOI 10.1046/j.1365-294X.2003.01769.x; Ruppell O, 2004, J HERED, V95, P481, DOI 10.1093/jhered/esh072; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; SHERMAN PW, 1979, AM NAT, V113, P925, DOI 10.1086/283445; Sirvio A, 2006, J EVOLUTION BIOL, V19, P1475, DOI 10.1111/j.1420-9101.2006.01131.x; Sirvio A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-95; Sirvio A, 2011, EVOLUTION, V65, P869, DOI 10.1111/j.1558-5646.2010.01170.x; SMITH JM, 1976, J THEOR BIOL, V63, P245, DOI 10.1016/0022-5193(76)90033-3; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Song YX, 2011, J THEOR BIOL, V273, P55, DOI 10.1016/j.jtbi.2010.12.020; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Team RDC, 2005, R LANG ENV STAT COMP; TEMPLETON AR, 1979, AM NAT, V113, P937, DOI 10.1086/283446; Waibel M, 2006, P ROY SOC B-BIOL SCI, V273, P1815, DOI 10.1098/rspb.2006.3513; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wiernasz DC, 2008, MOL ECOL, V17, P1137, DOI 10.1111/j.1365-294X.2007.03646.x; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; ZHAO HY, 1995, GENETICS, V139, P1057	59	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47220	10.1371/journal.pone.0047220	http://dx.doi.org/10.1371/journal.pone.0047220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077571	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100076
J	Shiner, T; Seymour, B; Symmonds, M; Dayan, P; Bhatia, KP; Dolan, RJ				Shiner, Tamara; Seymour, Ben; Symmonds, Mkael; Dayan, Peter; Bhatia, Kailash P.; Dolan, Raymond J.			The Effect of Motivation on Movement: A Study of Bradykinesia in Parkinson's Disease	PLOS ONE			English	Article							DECISION-MAKING; STRIDE LENGTH; EXTERNAL CUES; REWARD; GAIT; VARIABILITY; DOPAMINE; REINFORCEMENT; POTENTIALS; NUCLEUS	Background: Bradykinesia is a cardinal feature of Parkinson's disease (PD). Despite its disabling impact, the precise cause of this symptom remains elusive. Recent thinking suggests that bradykinesia may be more than simply a manifestation of motor slowness, and may in part reflect a specific deficit in the operation of motivational vigour in the striatum. In this paper we test the hypothesis that movement time in PD can be modulated by the specific nature of the motivational salience of possible action-outcomes. Methodology/Principal Findings: We developed a novel movement time paradigm involving winnable rewards and avoidable painful electrical stimuli. The faster the subjects performed an action the more likely they were to win money (in appetitive blocks) or to avoid a painful shock (in aversive blocks). We compared PD patients when OFF dopaminergic medication with controls. Our key finding is that PD patients OFF dopaminergic medication move faster to avoid aversive outcomes (painful electric shocks) than to reap rewarding outcomes (winning money) and, unlike controls, do not speed up in the current trial having failed to win money in the previous one. We also demonstrate that sensitivity to distracting stimuli is valence specific. Conclusions/Significance: We suggest this pattern of results can be explained in terms of low dopamine levels in the Parkinsonian state leading to an insensitivity to appetitive outcomes, and thus an inability to modulate movement speed in the face of rewards. By comparison, sensitivity to aversive stimuli is relatively spared. Our findings point to a rarely described property of bradykinesia in PD, namely its selective regulation by everyday outcomes.	[Shiner, Tamara; Seymour, Ben; Symmonds, Mkael; Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Seymour, Ben] Univ Cambridge, Dept Clin Neurol, Cambridge, England; [Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London, England; [Bhatia, Kailash P.] UCL, Sobell Dept Motor Neurosci & Movement Disorders, London, England	University of London; University College London; University of Cambridge; University of London; University College London; University of London; University College London	Shiner, T (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	tamarashiner@gmail.com	Shiner, Tamara/AAT-7920-2020	Dayan, Peter/0000-0003-3476-1839; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X; Bhatia, Kailash/0000-0001-8185-286X	MRC; Wellcome Trust; GlaxoSmithKline; Orion Corporation; Ipsen; Merz Pharmaceuticals, LLC; MRC [G0700531] Funding Source: UKRI; Medical Research Council [G0700531] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Orion Corporation; Ipsen(Ipsen); Merz Pharmaceuticals, LLC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funders for this study are the MRC who support Tamara Shiner with a clinical research training fellowship grant and the Wellcome trust who support RD with a Wellcome Trust Programme Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interests: KP Bhatia received funding for travel from GlaxoSmithKline, Orion Corporation, Ipsen, and Merz Pharmaceuticals, LLC; serves on the editorial boards of Movement Disorders and Therapeutic Advances in Neurological Disorders; receives royalties from the publication of Oxford Specialist Handbook of Parkinson's Disease and Other Movement Disorders (Oxford University Press, 2008); received speaker honoraria from GlaxoSmithKline, Ipsen, Merz Pharmaceuticals, LLC, and Sun Pharmaceutical Industries Ltd.; personal compensation for scientific advisory board for GSK and Boehringer Ingelheim; received research support from Ipsen. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BERARDELLI A, 1986, J NEUROL NEUROSUR PS, V49, P1273, DOI 10.1136/jnnp.49.11.1273; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; Critchley M, 1929, BRAIN, V52, P23, DOI 10.1093/brain/52.1.23; Crofts HS, 2001, CEREB CORTEX, V11, P1015, DOI 10.1093/cercor/11.11.1015; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; Czernecki V, 2002, NEUROPSYCHOLOGIA, V40, P2257, DOI 10.1016/S0028-3932(02)00108-2; Edwards MJ, 2008, PARKINSONS DIS OTHER; Fahn S., 1987, UNIFIED PARKINSONS D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Graef S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00169; HALLETT M, 1980, BRAIN, V103, P301, DOI 10.1093/brain/103.2.301; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Monchi O, 2007, BRAIN, V130, P233, DOI 10.1093/brain/awl326; MONTGOMERY EB, 1990, NEUROLOGY, V40, P269, DOI 10.1212/WNL.40.2.269; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niva Y, 2007, ANN NY ACAD SCI, V1104, P357, DOI 10.1196/annals.1390.018; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Praamstra P, 1998, BRAIN, V121, P167, DOI 10.1093/brain/121.1.167; Rahman S, 2008, BEHAV NEUROL, V19, P127, DOI 10.1155/2008/456298; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; SHERIDAN MR, 1990, BRAIN, V113, P1149, DOI 10.1093/brain/113.4.1149; SHERIDAN MR, 1987, BRAIN, V110, P1247, DOI 10.1093/brain/110.5.1247; TEASDALE N, 1990, J NEUROL NEUROSUR PS, V53, P862, DOI 10.1136/jnnp.53.10.862; Uc EY, 2006, NEUROLOGY, V67, P1774, DOI 10.1212/01.wnl.0000245086.32787.61; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571	38	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47138	10.1371/journal.pone.0047138	http://dx.doi.org/10.1371/journal.pone.0047138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077557	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100066
J	Umbers, KDL; Osborne, L; Keogh, JS				Umbers, Kate D. L.; Osborne, Louise; Keogh, J. Scott			The Effects of Residency and Body Size on Contest Initiation and Outcome in the Territorial Dragon, Ctenophorus decresii	PLOS ONE			English	Article							AGONISTIC DISPLAYS; FIDDLER-CRAB; MALE COMBAT; LIZARD; EVOLUTION; AGGRESSION; SIGNALS; INFORMATION; COMPETITION; ENCOUNTERS	Empirical studies of the determinants of contests have been attempting to unravel the complexity of animal contest behaviour for decades. This complexity requires that experiments incorporate multiple determinants into studies to tease apart their relative effects. In this study we examined the complex contest behaviour of the tawny dragon (Ctenophorus decresii), a territorial agamid lizard, with the specific aim of defining the factors that determine contest outcome. We manipulated the relative size and residency status of lizards in contests to weight their importance in determining contest outcome. We found that size, residency and initiating a fight were all important in determining outcomes of fights. We also tested whether residency or size was important in predicting the status of lizard that initiated a fight. We found that residency was the most important factor in predicting fight initiation. We discuss the effects of size and residency status in context of previous studies on contests in tawny dragons and other animals. Our study provides manipulative behavioural data in support of the overriding effects of residency on initiation fights and winning them.	[Umbers, Kate D. L.; Osborne, Louise; Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Keogh, JS (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	scott.keogh@anu.edu.au	Keogh, Scott/C-8441-2009; Umbers, Kate/D-3566-2011	Keogh, Scott/0000-0002-1373-6186; Umbers, Kate/0000-0002-9375-4527	Australian Research Council; School of Botany and Zoology; ANU	Australian Research Council(Australian Research Council); School of Botany and Zoology; ANU(Australian National University)	This study was funded by the Australian Research Council (www.arc.gov.au), the School of Botany and Zoology, and ANU (www.anu.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 1996, ECOL ENTOMOL, V21, P309, DOI 10.1046/j.1365-2311.1996.00007.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CARYL PG, 1979, BEHAVIOUR, V68, P136, DOI 10.1163/156853979X00287; Cook JM, 2006, ANIM BEHAV, V71, P1095, DOI 10.1016/j.anbehav.2005.07.027; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; DECOURCY KR, 1994, ANIM BEHAV, V47, P251, DOI 10.1006/anbe.1994.1037; ENGLUND G, 1990, ANIM BEHAV, V39, P55, DOI 10.1016/S0003-3472(05)80725-0; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; FOX SF, 1992, ANIM BEHAV, V44, P780, DOI 10.1016/S0003-3472(05)80306-9; Gibbons J. R., 1977, COMP ECOLOGY BEHAV L; GIBBONS JRH, 1979, COPEIA, P29; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; Hardy ICW, 1998, TRENDS ECOL EVOL, V13, P385, DOI 10.1016/S0169-5347(98)01430-X; Hardy ICW, 2001, TRENDS ECOL EVOL, V16, P174, DOI 10.1016/S0169-5347(01)02119-X; Hoefler CD, 2002, J INSECT BEHAV, V15, P779, DOI 10.1023/A:1021123523307; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Huntingford F.A., 1987, ANIMAL CONFLICT; Huntingford FA, 1995, J EXP MAR BIOL ECOL, V193, P21, DOI 10.1016/0022-0981(95)00108-5; Jaroensutasinee M, 2002, CRUSTACEANA, V75, P1107, DOI 10.1163/156854002763270509; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; JENSSEN TA, 1977, AM ZOOL, V17, P203; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; LEIMAR O, 1991, EVOLUTION, V45, P862, DOI 10.1111/j.1558-5646.1991.tb04355.x; LIGON JD, 1990, ANIM BEHAV, V40, P367, DOI 10.1016/S0003-3472(05)80932-7; LINDSTROM K, 1992, BEHAV ECOL SOCIOBIOL, V30, P53; MCMANN S, 1993, ANIM BEHAV, V46, P657, DOI 10.1006/anbe.1993.1242; Nijman V, 2000, BEHAV PROCESS, V49, P77, DOI 10.1016/S0376-6357(00)00078-4; OLSSON M, 1992, ANIM BEHAV, V44, P386, DOI 10.1016/0003-3472(92)90046-C; Olsson M, 2000, BEHAV ECOL, V11, P587, DOI 10.1093/beheco/11.6.587; Osborne L, 2005, ACTA ETHOLOG, V8, P45, DOI 10.1007/s10211-005-0108-6; Osborne L, 2005, J ETHOL, V23, P189, DOI 10.1007/s10164-005-0151-9; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peters RA, 2003, AUSTRAL ECOL, V28, P499, DOI 10.1046/j.1442-9993.2003.01306.x; R Core Team, 2022, R LANG ENV STAT COMP; Radder RS, 2006, J ETHOL, V24, P275, DOI 10.1007/s10164-006-0192-8; RAND WM, 1976, Z TIERPSYCHOL, V40, P279; ROWLAND WJ, 1989, ANIM BEHAV, V37, P282, DOI 10.1016/0003-3472(89)90117-6; Sacchi R, 2009, AGGRESSIVE BEHAV, V35, P274, DOI 10.1002/ab.20305; SMITH IP, 1994, ANIM BEHAV, V47, P885, DOI 10.1006/anbe.1994.1120; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Stapley J, 2006, BIOL LETTERS, V2, P169, DOI 10.1098/rsbl.2005.0419; Stokkebo S, 2000, ANIM BEHAV, V59, P1111, DOI 10.1006/anbe.2000.1407; Stuart-Fox DM, 2003, ANIM BEHAV, V66, P541, DOI 10.1006/anbe.2003.2235; Wenseleers T, 2002, J INSECT BEHAV, V15, P85, DOI 10.1023/A:1014484229639; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; Whiting MJ, 1999, BEHAV ECOL SOCIOBIOL, V46, P210, DOI 10.1007/s002650050611	47	24	24	19	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47143	10.1371/journal.pone.0047143	http://dx.doi.org/10.1371/journal.pone.0047143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077558	Green Published, gold			2022-12-25	WOS:000309995100067
J	Wang, H; Yang, YP; Wang, GJ; Wang, SM; Yeap, BY; Sykes, M; Yang, YG				Wang, Hui; Yang, Yanping; Wang, Guanjun; Wang, Shumei; Yeap, Beow Yong; Sykes, Megan; Yang, Yong-Guang			Donor Bone Marrow-Derived T Cells Inhibit GVHD Induced by Donor Lymphocyte Infusion in Established Mixed Allogeneic Hematopoietic Chimeras	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; REFRACTORY HEMATOLOGIC MALIGNANCIES; REGULATORY-CELLS; TRANSPLANTATION; INDUCTION; THERAPY; SUPPRESSION; ENVIRONMENT; TOLERANCE; REJECTION	Delayed administration of donor lymphocyte infusion (DLI) to established mixed chimeras has been shown to achieve antitumor responses without graft-vs.-host disease (GVHD). Herein we show that de novo donor BM-derived T cells that are tolerant of the recipients are important in preventing GVHD in mixed chimeras receiving delayed DLI. Mixed chimeras lacking donor BM-derived T cells developed significantly more severe GVHD than those with donor BM-derived T cells after DLI, even though both groups had comparable levels of total T cells at the time of DLI. Post-DLI depletion of donor BM-derived T cells in mixed chimeras, as late as 20 days after DLI, also provoked severe GVHD. Although both CD4 and CD8 T cells contributed to the protection, the latter were significantly more effective, suggesting that inhibition of GVHD was not mainly mediated by CD4 regulatory T cells. The lack of donor BM-derived T cells was associated with markedly increased accumulation of DLI-derived alloreactive T cells in parenchymal GVHD target tissues. Thus, donor BM-derived T cells are an important factor in determining the risk of GVHD and therefore, offer a potential therapeutic target for preventing and ameliorating GVHD in the setting of delayed DLI in established mixed chimeras.	[Wang, Hui; Sykes, Megan; Yang, Yong-Guang] Columbia Univ Coll Phys & Surg, Columbia Ctr Translat Immunol, New York, NY 10032 USA; [Wang, Hui; Yang, Yanping; Wang, Shumei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA USA; [Yang, Yanping; Wang, Guanjun; Yang, Yong-Guang] Jilin Univ, Bethune Hosp 1, Changchun 130023, Jilin, Peoples R China; [Yeap, Beow Yong] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA	Columbia University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Jilin University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Yang, YG (corresponding author), Columbia Univ Coll Phys & Surg, Columbia Ctr Translat Immunol, 630 W 168th St, New York, NY 10032 USA.	yy2324@columbia.edu		Yang, Yong-Guang/0000-0003-4985-1247	NIH [PO1 CA111519, RC1 HL100117, R01 AI064569]; NATIONAL CANCER INSTITUTE [P01CA111519] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064569] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NIH (PO1 CA111519, RC1 HL100117 and R01 AI064569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Chakraverty R, 2008, J IMMUNOL, V181, P6820, DOI 10.4049/jimmunol.181.10.6820; Chakraverty R, 2006, J EXP MED, V203, P2021, DOI 10.1084/jem.20060376; Chen X, 2009, BLOOD, V114, P891, DOI 10.1182/blood-2009-01-197178; Dulude G, 1999, J EXP MED, V189, P1329, DOI 10.1084/jem.189.8.1329; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Gorski J, 2007, BLOOD, V109, P5502, DOI 10.1182/blood-2006-12-061713; Joetham A, 2011, J IMMUNOL, V186, P113, DOI 10.4049/jimmunol.1001663; Johnson BD, 1999, J IMMUNOL, V163, P6479; Johnson BD, 2002, BIOL BLOOD MARROW TR, V8, P525, DOI 10.1053/bbmt.2002.v8.pm12434947; Kapp JA, 2006, INT IMMUNOL, V18, P1549, DOI 10.1093/intimm/dxl088; Karlsson I, 2007, J VIROL, V81, P13444, DOI 10.1128/JVI.01466-07; Lu LR, 2006, IMMUNOL REV, V212, P51, DOI 10.1111/j.0105-2896.2006.00418.x; Mapara MY, 2002, BLOOD, V100, P1903, DOI 10.1182/blood-2002-01-0023; Miller JS, 2007, BLOOD, V110, P2761, DOI 10.1182/blood-2007-05-090340; Nakagawa T, 2010, INT IMMUNOL, V22, P129, DOI 10.1093/intimm/dxp119; Nguyen VH, 2008, BLOOD, V111, P945, DOI 10.1182/blood-2007-07-103895; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pelot M R, 1999, Biol Blood Marrow Transplant, V5, P133, DOI 10.1053/bbmt.1999.v5.pm10392959; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sho M, 2005, P NATL ACAD SCI USA, V102, P13230, DOI 10.1073/pnas.0505070102; Spitzer TR, 2000, BIOL BLOOD MARROW TR, V6, P309, DOI 10.1016/S1083-8791(00)70056-5; Spitzer TR, 2003, TRANSPLANTATION, V75, P1748, DOI 10.1097/01.TP.0000064211.23536.AD; Sugita S, 2007, EXP EYE RES, V85, P626, DOI 10.1016/j.exer.2007.07.015; Sykes M, 1999, LANCET, V353, P1755, DOI 10.1016/S0140-6736(98)11135-2; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; Wang H, 2009, BLOOD, V113, P3612, DOI 10.1182/blood-2008-07-168419; Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47120	10.1371/journal.pone.0047120	http://dx.doi.org/10.1371/journal.pone.0047120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077554	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100064
J	Del Ry, S; Cabiati, M; Lionetti, V; Aquaro, GD; Martino, A; Mattii, L; Morales, MA				Del Ry, Silvia; Cabiati, Manuela; Lionetti, Vincenzo; Aquaro, Giovanni D.; Martino, Alessandro; Mattii, Letizia; Morales, Maria-Aurora			Pacing-Induced Regional Differences in Adenosine Receptors mRNA Expression in a Swine Model of Dilated Cardiomyopathy	PLOS ONE			English	Article							VENTRICULAR PUMP FUNCTION; HEART-FAILURE; NPR-B; ACTIVATION; DESENSITIZATION; CONTRACTILITY; TRANSPORT; GENES	The adenosinergic system is essential in the mediation of intrinsic protection and myocardial resistance to insult; it may be considered a cardioprotective molecule and adenosine receptors (ARs) represent potential therapeutic targets in the setting of heart failure (HF). The aim of the study was to test whether differences exist between mRNA expression of ARs in the anterior left ventricle (LV) wall (pacing site: PS) compared to the infero septal wall (opposite region: OS) in an experimental model of dilated cardiomyopathy. Cardiac tissue was collected from LV PS and OS of adult male minipigs with pacing-induced HF (n = 10) and from a control group (C, n = 4). ARs and TNF-alpha mRNA expression was measured by Real Time-PCR and the results were normalized with the three most stably expressed genes (GAPDH, HPRT1, TBP). Immunohistochemistry analysis was also performed. After 3 weeks of pacing higher levels of expression for each analyzed AR were observed in PS except for A(1)R (A(1)R: C = 0.6 +/- 0.2, PS = 0.1 +/- 0.04, OS = 0.04 +/- 0.01, p<0.0001 C vs. PS and OS respectively; A(2A)R: C = 1.04 +/- 0.59, PS = 2.62 +/- 0.79, OS = 2.99 +/- 0.79; A(2B)R: C = 1.2 +/- 0.1, PS = 5.59 +/- 2.3, OS = 1.59 +/- 0.46; A(3)R: C = 0.76 +/- 0.18, PS = 8.40 +/- 3.38, OS = 4.40 +/- 0.83). Significant contractile impairment and myocardial hypoperfusion were observed at PS after three weeks of pacing as compared to OS. TNF-alpha mRNA expression resulted similar in PS (6.3 +/- 2.4) and in OS (5.9 +/- 2.7) although higher than in control group (3.4 +/- 1.5). ARs expression was mainly detected in cardiomyocytes. This study provided new information on ARs local changes in the setting of LV dysfunction and on the role of these receptors in relation to pacing-induced abnormalities of myocardial perfusion and contraction. These results suggest a possible therapeutic role of adenosine in patients with HF and dyssynchronous LV contraction.	[Del Ry, Silvia; Cabiati, Manuela; Morales, Maria-Aurora] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Lionetti, Vincenzo] Scuola Super Sant Anna, Lab Med Sci, Inst Life Sci, Pisa, Italy; [Aquaro, Giovanni D.] Fdn CNR Reg Toscana G Monasterio, MRI Lab, Pisa, Italy; [Martino, Alessandro] Univ Pisa, Dept Biol, Div Genet, Pisa, Italy; [Mattii, Letizia] Univ Pisa, Med Histol & Embryol Sect, Dept Human Morphol & Appl Biol, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; University of Pisa; University of Pisa	Del Ry, S (corresponding author), CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy.	delry@ifc.cnr.it	Lionetti, Vincenzo/AAN-1994-2020; Lionetti, Vincenzo/AAH-9503-2020; Del Ry, Silvia/C-1149-2015; aquaro, giovanni donato/AAB-8978-2019; mattii, letizia/K-3023-2019; Lionetti, Vincenzo/G-9528-2014; MATTII, LETIZIA/B-6123-2018; Cabiati, Manuela/K-1306-2014; Mattii, Letizia/AAZ-4735-2021	Lionetti, Vincenzo/0000-0002-0640-8651; Del Ry, Silvia/0000-0001-7163-245X; MATTII, LETIZIA/0000-0001-6835-7987; Cabiati, Manuela/0000-0002-0811-6257; aquaro, giovanni donato/0000-0003-0915-915X				Baker CM, 2002, PACE, V25, P1166, DOI 10.1046/j.1460-9592.2002.01166.x; Ciruela F, 1997, MOL PHARMACOL, V52, P788, DOI 10.1124/mol.52.5.788; Del Ry S, 2011, PEPTIDES, V32, P1713, DOI 10.1016/j.peptides.2011.06.014; Del Ry S, 2007, PEPTIDES, V28, P1390, DOI 10.1016/j.peptides.2007.05.003; Del Ry S, 2011, J CARDIOVASC PHARM, V58, P149, DOI 10.1097/FJC.0b013e31821dcc0b; Del Ry S, 2009, PEPTIDES, V30, P1710, DOI 10.1016/j.peptides.2009.06.013; Del Ry S, 2008, PEPTIDES, V29, P2208, DOI 10.1016/j.peptides.2008.09.005; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gemignani V, 2010, PACE, V33, P795, DOI 10.1111/j.1540-8159.2009.02684.x; Gorlach A, 2005, CIRC RES, V97, P1, DOI 10.1161/01.RES.0000174112.36064.77; GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Karsai D, 2006, J CARDIOVASC PHARM, V47, P103, DOI 10.1097/01.fjc.0000196239.51018.a0; KITAKAZE M, 1993, CARDIOVASC RES, V27, P18, DOI 10.1093/cvr/27.1.18; Klaasse EC, 2008, PURINERG SIGNAL, V4, P21, DOI 10.1007/s11302-007-9086-7; Lionetti V, 2007, AM J PHYSIOL-HEART C, V293, pH2747, DOI 10.1152/ajpheart.00592.2007; Lionetti Vincenzo, 2009, J Card Fail, V15, P920, DOI 10.1016/j.cardfail.2009.06.436; Martino A, 2011, J BIOTECHNOL, V153, P92, DOI 10.1016/j.jbiotec.2011.04.002; Monahan TS, 2000, AM J PHYSIOL-HEART C, V279, pH1472, DOI 10.1152/ajpheart.2000.279.4.H1472; Ojaimi C, 2007, PHYSIOL GENOMICS, V29, P76, DOI 10.1152/physiolgenomics.00159.2006; Prescimone T, 2011, PHARMACOL RES, V63, P207, DOI 10.1016/j.phrs.2010.09.006; Prinzen FW, 1999, J AM COLL CARDIOL, V33, P1735, DOI 10.1016/S0735-1097(99)00068-6; Prinzen FW, 2002, PACE, V25, P484, DOI 10.1046/j.1460-9592.2002.00484.x; Ralevic V, 1998, PHARMACOL REV, V50, P413; Robin E, 2011, J MOL CELL CARDIOL, V51, P945, DOI 10.1016/j.yjmcc.2011.08.023; Shryock JC, 1997, AM J CARDIOL, V79, P2, DOI 10.1016/S0002-9149(97)00256-7; Sweeney MO, 2008, CIRC-ARRHYTHMIA ELEC, V1, P127, DOI 10.1161/CIRCEP.108.777904; Talukder MAH, 2003, J CARDIOVASC PHARM, V41, P562, DOI 10.1097/00005344-200304000-00008	29	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47011	10.1371/journal.pone.0047011	http://dx.doi.org/10.1371/journal.pone.0047011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071699	gold, Green Published			2022-12-25	WOS:000309809500029
J	Melzer, N; Hicking, G; Gobel, K; Wiendl, H				Melzer, Nico; Hicking, Gordon; Goebel, Kerstin; Wiendl, Heinz			TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT STRIATAL NEURONS; ADP-RIBOSE; HYDROGEN-PEROXIDE; CALCIUM INFLUX; IMMUNE-SYSTEM; ACTIVATION; ACID; LTRPC2; LYMPHOCYTES	TRPM2, a highly Ca2+-permeable member of the transient receptor potential melastatin-related (TRPM) family of cation channels, is expressed in cells of the immune system. We demonstrate firstly that TRPM2 cation channels on T cells critically influence T cell proliferation and proinflammatory cytokine secretion following polyclonal T cell receptor stimulation. Consistently, trpm2-deficient mice exhibited an attenuated clincal phenotype of experimental autoimmune encephalomyelitis (EAE) with reduced inflammatory and demyelinating spinal cord lesions. Importantly, trmp2-deficient T cells were as susceptible as wildtype T cells to oxidative stress-induced cell death as it occurs in inflammatory CNS lesions. This supports the notion that the attenuated EAE phenotype is mainly due to reduced T cell effector functions but unaffected by potential modulation of T cell survival at the site of inflammation. Our findings suggest TRPM2 cation channels as a potential target for treating autoimmune CNS inflammation.	[Melzer, Nico; Hicking, Gordon; Goebel, Kerstin; Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany	University of Munster	Melzer, N (corresponding author), Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst &, Munster, Germany.	nico.melzer@ukmuenster.de	Wiendl, Heinz/AAX-6041-2021; Melzer, Nico/HGE-2991-2022	Melzer, Nico/0000-0002-2420-701X; Wiendl, Heinz/0000-0003-4310-3432	University of Munster (IMF) [ME121010]	University of Munster (IMF)	This study was supported by an intramural grant of the University of Munster (IMF - ME121010) to NM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari MR, 2009, J CELL MOL MED, V13, P3260, DOI 10.1111/j.1582-4934.2009.00737.x; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Hill K, 2006, NEUROPHARMACOLOGY, V50, P89, DOI 10.1016/j.neuropharm.2005.08.021; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Kaneko S, 2006, J PHARMACOL SCI, V101, P66, DOI 10.1254/jphs.FP0060128; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kraft R, 2006, BRIT J PHARMACOL, V148, P264, DOI 10.1038/sj.bjp.0706739; Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2006, MOL MED, V12, P334, DOI 10.2119/2006-00094.Malavasi; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Smith MA, 2003, J PHYSIOL-LONDON, V547, P417, DOI 10.1113/jphysiol.2002.034561; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	27	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47617	10.1371/journal.pone.0047617	http://dx.doi.org/10.1371/journal.pone.0047617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077651	gold, Green Submitted, Green Published			2022-12-25	WOS:000309809500053
J	Lorenzen, JM; Menne, J; Schmidt, BMW; Schmidt, M; Martino, F; Dietrich, R; Samiri, S; Worthmann, H; Heeren, M; Weissenborn, K; Haller, H; Schiffer, M; Kielstein, JT; Thum, T				Lorenzen, Johan M.; Menne, Jan; Schmidt, Bernhard M. W.; Schmidt, Mascha; Martino, Filippo; Dietrich, Robert; Samiri, Senguel; Worthmann, Hans; Heeren, Meike; Weissenborn, Karin; Haller, Hermann; Schiffer, Mario; Kielstein, Jan T.; Thum, Thomas			Circulating microRNAs in Patients with Shiga-Toxin-Producing E. coli O104:H4 Induced Hemolytic Uremic Syndrome	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; MYOCARDIAL-INFARCTION; ECULIZUMAB; DISEASE; MEDIATORS; MIR-210	Background: In early May 2011, an outbreak of hemorrhagic colitis associated with hemolytic-uremic syndrome (HUS) first developed in Northern Germany and spread to 15 other countries in Europe. The outbreak-strain O104:H4, which combined virulence factors of typical enteroaggregative and Shiga-Toxin-producing E. coli was associated with an unusual high rate of hemolytic uremic syndrome. Also an unexpected high rate of coma and seizures leading to mechanical ventilation and ICU treatment was observed. MicroRNAs are small ribonucleotides orchestrating gene expression. We tested whether circulating microRNAs in serum of HUS patients during the 2011 epidemics are altered in this patient cohort and related to clinical manifestations. Methodology/Principal Findings: We profiled microRNAs using RNA isolated from serum of patients and healthy age-matched controls. The results were validated in 38 patients at baseline, 29 patients during follow-up and 21 age-matched healthy controls by miRNA-specific quantitative RT-PCR. Circulating levels of miR-24, miR-126 were increased in HUS patients versus controls. There was no association between these microRNAs and renal function or the need for renal replacement therapy. In contrast, levels of miR-126 were associated with neurological symptoms at baseline and during follow-up. In addition, miR-126 (on admission) and miR-24 (on admission and during follow-up) were associated with platelet count. Conclusions/Significance: Circulating microRNAs are strongly altered in this patient cohort and associated with neurological symptoms as well as platelet count.	[Lorenzen, Johan M.; Schmidt, Mascha; Martino, Filippo; Dietrich, Robert; Samiri, Senguel; Thum, Thomas] IMTTS, Hannover, Germany; [Lorenzen, Johan M.; Menne, Jan; Schmidt, Bernhard M. W.; Dietrich, Robert; Samiri, Senguel; Haller, Hermann; Schiffer, Mario; Kielstein, Jan T.] Hannover Med Sch, Dept Med, Div Nephrol & Hypertens, Hannover, Germany; [Worthmann, Hans; Heeren, Meike; Weissenborn, Karin] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Thum, Thomas] IRCCS San Raffaele, Ctr Clin & Basic Res, Rome, Italy	Hannover Medical School; Hannover Medical School; Center Clinical & Basic Research; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Lorenzen, JM (corresponding author), IMTTS, Hannover, Germany.	J.M.Lorenzen@gmail.com; Thum.Thomas@mh-hannover.de	Kielstein, Jan T./I-2956-2019; Schiffer, Mario/U-7050-2019	Kielstein, Jan T./0000-0001-8110-9064; Schiffer, Mario/0000-0002-8414-1470; Lorenzen, Johan/0000-0002-9132-948X; Thum, Thomas/0000-0003-4360-1511	Deutsche Forschungsgemeinschaft [DFG LO 1736/1-1]; Integrated Research Center Transplantation (IFB-Tx ); German Federal Ministry of Education and Research [01EO0802]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Integrated Research Center Transplantation (IFB-Tx ); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors acknowledge the support of the Deutsche Forschungsgemeinschaft (DFG LO 1736/1-1 to JL and TT) and a grant of the Integrated Research Center Transplantation (IFB-Tx to TT) as well as a grant by the German Federal Ministry of Education and Research (01EO0802 to TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fiedler J, 2011, CIRCULATION, V124, P720, DOI 10.1161/CIRCULATIONAHA.111.039008; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gruppo RA, 2009, NEW ENGL J MED, V360, P544, DOI 10.1056/NEJMc0809959; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Karpman D, 2010, SEMIN THROMB HEMOST, V36, P575, DOI 10.1055/s-0030-1262879; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Lorenzen JM, 2011, AM J TRANSPLANT, V11, P2221, DOI 10.1111/j.1600-6143.2011.03679.x; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Thurman JM, 2009, CLIN J AM SOC NEPHRO, V4, P1920, DOI 10.2215/CJN.02730409; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	23	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47215	10.1371/journal.pone.0047215	http://dx.doi.org/10.1371/journal.pone.0047215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071762	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700066
J	Nowsheen, S; Cooper, T; Stanley, JA; Yang, ES				Nowsheen, Somaira; Cooper, Tiffiny; Stanley, Jennifer A.; Yang, Eddy S.			Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							FACTOR RECEPTOR EGFR; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; GROWTH; BRCA1; HEAD; CETUXIMAB; CARCINOMAS; EXPRESSION; PATHWAYS	Few therapeutic options exist for the highly aggressive triple negative breast cancers (TNBCs). In this study, we report that a contextual synthetic lethality can be achieved both in vitro and in vivo with combined EGFR and PARP inhibition with lapatinib and ABT-888, respectively. The mechanism involves a transient DNA double strand break repair deficit induced by lapatinib and subsequent activation of the intrinsic pathway of apoptosis. Further dissection of the mechanism reveals that EGFR and BRCA1 can be found in the same protein complex, which is reduced by lapatinib. Interestingly, lapatinib also increases cytosolic BRCA1 and EGFR, away from their nuclear DNA repair substrates. Taken together, these results reveal a novel regulation of homologous recombination repair involving EGFR and BRCA1 interaction and alteration of subcellular localization. Additionally, a contextual synthetic lethality may exist between combined EGFR and PARP inhibitors.	[Nowsheen, Somaira; Cooper, Tiffiny; Stanley, Jennifer A.; Yang, Eddy S.] Univ Alabama Birmingham, Sch Med, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL USA; [Yang, Eddy S.] Univ Alabama Birmingham, Sch Med, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Yang, Eddy S.] Univ Alabama Birmingham, Sch Med, Ctr Comprehens Canc, Dept Pharmacol & Toxicol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yang, ES (corresponding author), Univ Alabama Birmingham, Sch Med, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL USA.	eyang@uab.edu			UAB Specialized Programs of Research Excellence (SPORE) in breast cancer [5P50CA089019-10]; Translational Scholar Award from Sidney Kimmel Foundation; Breast Cancer Research Foundation of Alabama; State of Alabama Investment Pool for Action (IMPACT) Award from the University of Alabama at Birmingham School of Medicine; Comprehensive Cancer Center and Department of Radiation Oncology at the University of Alabama at Birmingham School of Medicine; NATIONAL CANCER INSTITUTE [P50CA089019] Funding Source: NIH RePORTER	UAB Specialized Programs of Research Excellence (SPORE) in breast cancer; Translational Scholar Award from Sidney Kimmel Foundation; Breast Cancer Research Foundation of Alabama; State of Alabama Investment Pool for Action (IMPACT) Award from the University of Alabama at Birmingham School of Medicine; Comprehensive Cancer Center and Department of Radiation Oncology at the University of Alabama at Birmingham School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a career development award from the UAB Specialized Programs of Research Excellence (SPORE) in breast cancer (5P50CA089019-10), a Translational Scholar Award from Sidney Kimmel Foundation, pilot funding from the Breast Cancer Research Foundation of Alabama, the State of Alabama Investment Pool for Action (IMPACT) Award from the University of Alabama at Birmingham School of Medicine, and developmental support from the Comprehensive Cancer Center and Department of Radiation Oncology at the University of Alabama at Birmingham School of Medicine (to ESY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2002, CANCER RES, V62, P7350; Anido J, 2003, CLIN CANCER RES, V9, P1274; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boyle F, 2012, J CLIN ONCOL, V30; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Dittmann K, 2005, RADIOTHER ONCOL, V76, P157, DOI 10.1016/j.radonc.2005.06.022; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Huang SM, 2000, CLIN CANCER RES, V6, P2166; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Jiang JH, 2011, CANCER RES, V71, P5546, DOI 10.1158/0008-5472.CAN-10-3423; Laulier C, 2011, CANCER RES, V71, P3590, DOI 10.1158/0008-5472.CAN-10-3119; Lehmann Bd Fau - Bauer JA, 2011, IDENTIFICATION HUMAN; Li LP, 2008, CANCER RES, V68, P9141, DOI 10.1158/0008-5472.CAN-08-1127; Liu D, 2011, MED ONCOL; Martin V, 2012, HISTOL HISTOPATHOL, V27, P785, DOI 10.14670/HH-27.785; Myllynen L, 2011, RADIOTHER ONCOL, V101, P147, DOI 10.1016/j.radonc.2011.05.046; Nakajima H, 2012, BREAST CANC; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nowsheen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024148; Nowsheen S, 2011, RADIOTHER ONCOL, V99, P331, DOI 10.1016/j.radonc.2011.05.084; Oliveras-Ferraros C, 2008, INT J ONCOL, V33, P1165, DOI 10.3892/ijo_00000106; Peddi PF, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/217185; Roberti MP, 2011, BREAST CANCER RES TR, V130, P465, DOI 10.1007/s10549-011-1360-2; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Voldborg BR, 1997, ANN ONCOL, V8, P1197, DOI 10.1023/A:1008209720526; Vranic S, 2011, ONCOL LETT, V2, P1131, DOI 10.3892/ol.2011.375; Wang H, 2010, CANCER RES, V70, P6258, DOI 10.1158/0008-5472.CAN-09-4713; Yang ES, 2010, FEBS J, V277, P3079, DOI 10.1111/j.1742-4658.2010.07734.x; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	37	85	91	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46614	10.1371/journal.pone.0046614	http://dx.doi.org/10.1371/journal.pone.0046614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071597	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700023
J	Tickle, PG; Nudds, RL; Codd, JR				Tickle, Peter G.; Nudds, Robert L.; Codd, Jonathan R.			Barnacle Geese Achieve Significant Energetic Savings by Changing Posture	PLOS ONE			English	Article							FOWL NUMIDA-MELEAGRIS; GUINEA-FOWL; RESTING METABOLISM; BRANTA-LEUCOPSIS; URIA-LOMVIA; BIRDS; EXPENDITURE; SHOREBIRDS; ALLOMETRY; MUSCLES	Here we report the resting metabolic rate in barnacle geese (Branta leucopsis) and provide evidence for the significant energetic effect of posture. Under laboratory conditions flow-through respirometry together with synchronous recording of behaviour enabled a calculation of how metabolic rate varies with posture. Our principal finding is that standing bipedally incurs a 25% increase in metabolic rate compared to birds sitting on the ground. In addition to the expected decrease in energy consumption of hindlimb postural muscles when sitting, we hypothesise that a change in breathing mechanics represents one potential mechanism for at least part of the observed difference in energetic cost. Due to the significant effect of posture, future studies of resting metabolic rates need to take into account and/or report differences in posture.	[Tickle, Peter G.; Nudds, Robert L.; Codd, Jonathan R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Codd, JR (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	jonathan.codd@manchester.ac.uk		Codd, Jonathan/0000-0003-0211-1786	BBRSC Biotechnology and Biological Sciences Research Council [G/01138/1]; BBSRC [BB/G011338/1, BB/I021116/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011338/1, BB/I021116/1] Funding Source: researchfish	BBRSC Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded through the BBRSC Biotechnology and Biological Sciences Research Council (G/01138/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT PM, 1987, J ZOOL, V213, P327, DOI 10.1111/j.1469-7998.1987.tb03708.x; Brody Samuel, 1945; Butler PJ, 1998, J AVIAN BIOL, V29, P536, DOI 10.2307/3677173; CALDER WA, 1967, AM J PHYSIOL, V213, P883, DOI 10.1152/ajplegacy.1967.213.4.883; Calder WA, 1975, AVIAN BIOL, P259; Claessens LPAM, 2009, J EXP ZOOL PART A, V311A, P586, DOI 10.1002/jez.501; Codd JR, 2005, J EXP BIOL, V208, P849, DOI 10.1242/jeb.01489; Deighton T, 1940, J AGR SCI, V30, P141, DOI 10.1017/S0021859600047845; Dietz MW, 1999, J EXP BIOL, V202, P2831; Ellerby DJ, 2005, J PHYSIOL-LONDON, V564, P631, DOI 10.1113/jphysiol.2005.082974; Ellerby DJ, 2003, PHYSIOL BIOCHEM ZOOL, V76, P695, DOI 10.1086/376430; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Gabrielsen Geir Wing, 1996, Canadian Wildlife Service Occasional Paper, V91, P49; HARTMAN FRANK A., 1961, SMITHSONIAN MISC COLL, V143, P1; Hawkins PAJ, 1997, J EXP BIOL, V200, P1757; HERREID CF, 1984, J INSECT PHYSIOL, V30, P395, DOI 10.1016/0022-1910(84)90097-0; JANES DN, 1995, PHYSIOL ZOOL, V68, P1029, DOI 10.1086/physzool.68.6.30163792; Lighton JRB, 2008, MEASURING METABOLIC, Vxiii; LUSTICK S, 1978, SCIENCE, V200, P81, DOI 10.1126/science.635577; Markley JS, 2010, COMP BIOCHEM PHYS A, V155, P146, DOI 10.1016/j.cbpa.2009.10.023; McFarland JC, 2008, J MORPHOL, V269, P967, DOI 10.1002/jmor.10636; McKechnie AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P502, DOI 10.1086/383511; MIDTGARD U, 1978, ORNIS SCAND, V9, P214, DOI 10.2307/3675884; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Nudds RL, 2010, COMP BIOCHEM PHYS A, V156, P318, DOI 10.1016/j.cbpa.2010.01.023; Portugal SJ, 2007, J EXP BIOL, V210, P1391, DOI 10.1242/jeb.004598; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Tickle PG, 2010, COMP BIOCHEM PHYS A, V156, P309, DOI 10.1016/j.cbpa.2010.01.022; VANKAMPEN M, 1976, J AGR SCI, V87, P85, DOI 10.1017/S0021859600026617; WALSBERG GE, 1995, J EXP BIOL, V198, P213; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057	31	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46950	10.1371/journal.pone.0046950	http://dx.doi.org/10.1371/journal.pone.0046950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071672	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200053
J	Vinnedge, LMP; Ho, SM; Wikenheiser-Brokamp, KA; Wells, SI				Vinnedge, Lisa M. Privette; Ho, Shuk-Mei; Wikenheiser-Brokamp, Kathryn A.; Wells, Susanne I.			The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; PROTEIN DEK; BINDING; DNA; 17-BETA-ESTRADIOL; PROTOONCOGENE; CHROMATIN; CELLS; CHEMORESISTANCE	Expression of estrogen and progesterone hormone receptors indicates a favorable prognosis due to the successful use of hormonal therapies such as tamoxifen and aromatase inhibitors. Unfortunately, 15-20% of patients will experience breast cancer recurrence despite continued use of tamoxifen. Drug resistance to hormonal therapies is of great clinical concern so it is imperative to identify novel molecular factors that contribute to tumorigenesis in hormone receptor positive cancers and/or mediate drug sensitivity. The hope is that targeted therapies, in combination with hormonal therapies, will improve survival and prevent recurrence. We have previously shown that the DEK oncogene, which is a chromatin remodeling protein, supports breast cancer cell proliferation, invasion and the maintenance of the breast cancer stem cell population. In this report, we demonstrate that DEK expression is associated with positive hormone receptor status in primary breast cancers and is up-regulated in vitro following exposure to the hormones estrogen, progesterone, and androgen. Chromatin immunoprecipitation experiments identify DEK as a novel estrogen receptor a (ER alpha) target gene whose expression promotes estrogen-induced proliferation. Finally, we report for the first time that DEK depletion enhances tamoxifen-induced cell death in ER+ breast cancer cell lines. Together, our data suggest that DEK promotes the pathogenesis of ER+ breast cancer and that the targeted inhibition of DEK may enhance the efficacy of conventional hormone therapies.	[Vinnedge, Lisa M. Privette; Wells, Susanne I.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA; [Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Wikenheiser-Brokamp, Kathryn A.] Cincinnati Veteran Affairs Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Wells, SI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH USA.	Susanne.Wells@cchmc.org	Vinnedge, Lisa Privette/H-5869-2019	Vinnedge, Lisa Privette/0000-0003-2087-4920; Migliaccio, Antimo/0000-0002-4197-2055	National Cancer Institute [F32CA139931, T32HL091805]; Public Health Service [CA116316]; NATIONAL CANCER INSTITUTE [R01CA116316, F32CA139931] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091805] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Kirschstein National Research Service Awards (NRSA), award numbers F32CA139931 and T32HL091805 from the National Cancer Institute, to LMPV; and Public Health Service grant CA116316 to SIW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2007, MOL CANCER RES, V5, P881, DOI 10.1158/1541-7786.MCR-07-0055; ACS (American Cancer Society), 2011, BREAST CANC FACTS FI; Ageberg M, 2006, HAEMATOL-HEMATOL J, V91, P268; Alexiadis V, 2000, GENE DEV, V14, P1308; American Cancer Society I, 2007, BREAST CANC FACTS FI, P2007; ANDREASSEN PR, 1994, J CELL BIOL, V127, P789, DOI 10.1083/jcb.127.3.789; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Brown SBF, 2009, BRIT J CANCER, V100, P807, DOI 10.1038/sj.bjc.6604934; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P1571, DOI 10.1093/nar/gkg247; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; Coser KR, 2003, P NATL ACAD SCI USA, V100, P13994, DOI 10.1073/pnas.2235866100; Evans AJ, 2004, AM J PATHOL, V164, P285, DOI 10.1016/S0002-9440(10)63118-5; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Kappes F, 2004, MOL CELL BIOL, V24, P6011, DOI 10.1128/MCB.24.13.6011-6020.2004; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Kavanaugh GM, NUCL ACIDS RES, V39, P7465; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kondoh N, 1999, CANCER RES, V59, P4990; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Liu SP, 2012, PATHOL INT, V62, P176, DOI 10.1111/j.1440-1827.2011.02775.x; Lu ZL, 2005, WORLD J GASTROENTERO, V11, P3850; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Mor-Vaknin N, ARTHRITIS RHEUM, V63, P556; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; PAPENDORP JT, 1985, J CELL PHYSIOL, V125, P591, DOI 10.1002/jcp.1041250331; PODHAJCER OL, 1988, CANCER, V61, P1807, DOI 10.1002/1097-0142(19880501)61:9<1807::AID-CNCR2820610914>3.0.CO;2-M; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riveiro-Falkenbach E, 2010, CLIN CANCER RES, V16, P2932, DOI 10.1158/1078-0432.CCR-09-2330; Sammons M, 2006, J BIOL CHEM, V281, P26802, DOI 10.1074/jbc.M600915200; Sawatsubashi S, GENES DEV, V24, P159; Schug J, 2003, CURRENT PROTOCOLS BI; Shibata T, 2010, ONCOGENE; Sitwala KV, 2002, ONCOGENE, V21, P8862, DOI 10.1038/sj.onc.1206041; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; VANDERBURG B, 1988, J CELL PHYSIOL, V134, P101, DOI 10.1002/jcp.1041340112; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Waldmann T, 2003, NUCLEIC ACIDS RES, V31, P7003, DOI 10.1093/nar/gkg864; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304	45	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46985	10.1371/journal.pone.0046985	http://dx.doi.org/10.1371/journal.pone.0046985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071688	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200062
J	Ahn, SW; Gang, GT; Tadi, S; Nedumaran, B; Kim, YD; Park, JH; Kweon, GR; Koo, SH; Lee, K; Ahn, RS; Yim, YH; Lee, CH; Harris, RA; Choi, HS				Ahn, Seung Won; Gang, Gil-Tae; Tadi, Surendar; Nedumaran, Balachandar; Kim, Yong Deuk; Park, Ji Hoon; Kweon, Gi Ryang; Koo, Seung-Hoi; Lee, Keesook; Ahn, Ryun-Sup; Yim, Yong-Hyeon; Lee, Chul-Ho; Harris, Robert A.; Choi, Hueng-Sik			Phosphoenolpyruvate Carboxykinase and Glucose-6-phosphatase Are Required for Steroidogenesis in Testicular Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; NUCLEAR RECEPTOR NUR77; HEPATIC GLUCONEOGENESIS; TUMOR-CELLS; RAT TESTIS; TRANSCRIPTIONAL COREPRESSOR; LUTEINIZING-HORMONE; GENE-EXPRESSION; CYCLIC-AMP; KINASE-A	Cyclic AMP (cAMP) induces steroidogenic enzyme gene expression and stimulates testosterone production in Leydig cells. Phosphoenolpyruvate carboxykinase (PEPCK) is expressed in Leydig cells, but its role has not been defined. In this study, we found that PEPCK and glucose-6-phosphatase (Glc-6-Pase) are increased significantly following cAMP treatment of mouse Leydig cells. Moreover, cAMP treatment increased recruitment of the cAMP-response element-binding transcription factor and decreased recruitment of the corepressor DAX-1 on the pepck promoter. Furthermore, cAMP induced an increase in ATP that correlated with a decrease in phospho-AMP- activated protein kinase (AMPK). In contrast, knockdown or inhibition of PEPCK decreased ATP and increased phospho-AMPK. Treatment with an AMPK activator or overexpression of the constitutively active form of AMPK inhibited cAMP-induced steroidogenic enzyme promoter activities and gene expression. Liver receptor homolog-1 (LRH-1) was involved in cAMP-induced steroidogenic enzyme gene expression but was inhibited by AMPK activation in Leydig cells. Additionally, inhibition or knockdown of PEPCK and Glc-6-Pase decreased cAMP-mediated induction of steroidogenic enzyme gene expression and steroidogenesis. Finally, pubertal mouse (8-week-old) testes and human chorionic gonadotropin-induced prepubertal mouse testes showed increased PEPCK and Glc-6-Pase gene expression. Taken together, these results suggest that induction of PEPCK and Glc-6-Pase by cAMP plays an important role in Leydig cell steroidogenesis.	[Ahn, Seung Won; Nedumaran, Balachandar; Kim, Yong Deuk; Lee, Keesook; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Ahn, Seung Won; Nedumaran, Balachandar; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Gang, Gil-Tae; Lee, Chul-Ho] Chungnam Natl Univ, Sch Med, Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Tadi, Surendar] Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 305806, South Korea; [Park, Ji Hoon; Kweon, Gi Ryang] Chungnam Natl Univ, Sch Med, Dept Biochem, Taejon 305806, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Ahn, Ryun-Sup] CHA Med Univ, Grad Sch Integrat Med, Seoul 135913, South Korea; [Yim, Yong-Hyeon] Korea Res Inst Stand & Sci, Taejon 305806, South Korea; [Harris, Robert A.] Indiana Univ Sch Med, Richard Roudebush Vet Affairs Med Ctr, World Class Univ Program, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju 501746, South Korea	Chonnam National University; Chonnam National University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Chungnam National University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Korea Research Institute of Standards & Science (KRISS); Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015; Nedumaran, Balachandar/V-9958-2019; Ahn, Ryun S./D-1218-2011	Koo, Seung-Hoi/0000-0001-8769-2879; 	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science, and Technology [2011-0018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea; Ministry of Education, Science, and Technology Grant [20100019512]	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science, and Technology; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea; Ministry of Education, Science, and Technology Grant	This work was supported by National Creative Research Initiatives Grant 2011-0018305 from the Korean Ministry of Education, Science, and Technology and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology Grant 20100019512.	Ahn SW, 2008, MOL CELLS, V26, P74; AMROLIA P, 1988, BIOCHEM J, V249, P925, DOI 10.1042/bj2490925; Arion WJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P279, DOI 10.1006/abbi.1997.0563; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Caron KM, 1997, MOL ENDOCRINOL, V11, P138, DOI 10.1210/me.11.2.138; Chakravarty K, 2001, J BIOL CHEM, V276, P34816, DOI 10.1074/jbc.M103310200; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chen Y, 2003, J ENDOCRINOL, V179, P63, DOI 10.1677/joe.0.1790063; Clark BJ, 2001, MOL CELL ENDOCRINOL, V173, P183, DOI 10.1016/S0303-7207(00)00410-X; Clem BF, 2005, ENDOCRINOLOGY, V146, P1348, DOI 10.1210/en.2004-0761; Doege H, 2000, J BIOL CHEM, V275, P16275, DOI 10.1074/jbc.275.21.16275; FREEMAN DA, 1992, J LIPID RES, V33, P1139; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Inoue Y, 2008, J CONTROL RELEASE, V126, P59, DOI 10.1016/j.jconrel.2007.10.022; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lalli E, 2010, EXPERT OPIN THER TAR, V14, P169, DOI 10.1517/14728220903531454; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; LEIDERMA.B, 1969, ENDOCRINOLOGY, V85, P607, DOI 10.1210/endo-85-3-607; LIANG T, 1976, J PROTOZOOL, V23, P473, DOI 10.1111/j.1550-7408.1976.tb03816.x; Lin XZ, 2001, MOL ENDOCRINOL, V15, P1264, DOI 10.1210/me.15.8.1264; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MOYLE WR, 1970, STEROIDS, V15, P681, DOI 10.1016/S0039-128X(70)80073-3; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; Nehar D, 1998, BIOL REPROD, V59, P1425, DOI 10.1095/biolreprod59.6.1425; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; ROMMERTS FF, 1973, FEBS LETT, V33, P114, DOI 10.1016/0014-5793(73)80172-3; ROMMERTS FFG, 1982, J REPROD FERTIL, V65, P289, DOI 10.1530/jrf.0.0650289; Sewer MB, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290163; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532; Stocco DM, 2001, MOL CELL ENDOCRINOL, V177, P55, DOI 10.1016/S0303-7207(01)00423-3; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; WICKS WD, 1972, BIOCHEM BIOPH RES CO, V48, P205, DOI 10.1016/0006-291X(72)90364-6; Yanez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543	46	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41875	41887		10.1074/jbc.M112.421552	http://dx.doi.org/10.1074/jbc.M112.421552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23074219	hybrid, Green Published			2022-12-25	WOS:000312103000028
J	Combes, A; Ndoye, I; Bance, C; Bruzaud, J; Djediat, C; Dupont, J; Nay, B; Prado, S				Combes, Audrey; Ndoye, Idrissa; Bance, Caroline; Bruzaud, Jerome; Djediat, Chakib; Dupont, Joelle; Nay, Bastien; Prado, Soizic			Chemical Communication between the Endophytic Fungus Paraconiothyrium Variabile and the Phytopathogen Fusarium oxysporum	PLOS ONE			English	Article							MASS-SPECTROMETRY; BIOSYNTHESIS; OXYLIPINS; TETRALONE; WOOD	Paraconiothyrium variabile, one of the specific endophytic fungi isolated from the host plant Cephalotaxus harringtonia, possesses the faculty to inhibit the growth of common phytopathogens, thus suggesting a role in its host protection. A strong antagonism between the endophyte P. variabile and Fusarium oxysporum was observed and studied using optic and electronic microscopies. A disorganization of the mycelium of F. oxysporum was thus noticed. Interestingly, the biological effect of the main secondary metabolites isolated from P. variabile against F. oxysporum did not account for this strong antagonism. However, a metabolomic approach of pure fungal strains and confrontation zones using the data analysis tool XCMS were analyzed and pointed out a competition-induced metabolite production by the endophyte in the presence of the phytopathogen. Subsequent MS/MS fragmentations permitted to identify one of the induced metabolites as 13-oxo-9,11-octadecadienoic acid and highlighted a negative modulation of the biosynthesis of beauvericin, one of the most potent mycotoxin of F. oxysporum, during the competition with the endophyte.	[Combes, Audrey; Ndoye, Idrissa; Bance, Caroline; Bruzaud, Jerome; Nay, Bastien; Prado, Soizic] Museum Natl Hist Nat, MCAM, MNHN CNRS, UMR 7245, F-75231 Paris, France; [Dupont, Joelle] Museum Natl Hist Nat, OSEB, MNHN CNRS, UMR 7205, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Prado, S (corresponding author), Museum Natl Hist Nat, MCAM, MNHN CNRS, UMR 7245, F-75231 Paris, France.	sprado@mnhn.fr	Nay, Bastien/E-7483-2011	Nay, Bastien/0000-0002-1209-1830; Audrey, combes/0000-0003-3318-7230	Fondation pour la Recherche sur la Biodiversite; Action Transversale du Museum "Biodiversite des microorganismes dans les ecosystemes actuels et passe's" from the Museum National d'Histoire Naturelle; Consortium National de Recherche en Ge'nomique; "service de systematique moleculaire" of the Museum National d'Histoire Naturelle [IFR 101]	Fondation pour la Recherche sur la Biodiversite; Action Transversale du Museum "Biodiversite des microorganismes dans les ecosystemes actuels et passe's" from the Museum National d'Histoire Naturelle; Consortium National de Recherche en Ge'nomique; "service de systematique moleculaire" of the Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS))	The French Ambassy at Dakar, Senegal and Cheikh Anta Diop University at Dakar are acknowledged providing a research fellowship to IN. This project was supported by the following grants: "Projets Innovants FRB 2009" from the Fondation pour la Recherche sur la Biodiversite (AAP-IN-2009-026), the Action Transversale du Museum "Biodiversite des microorganismes dans les ecosystemes actuels et passe's" from the Museum National d'Histoire Naturelle, by the "Consortium National de Recherche en Ge'nomique", and the "service de systematique moleculaire" of the Museum National d'Histoire Naturelle (IFR 101). It is part of the agreement no 2005/67 between the Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of life" directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript can be added to the manuscript.	Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; BALLIO A, 1966, TETRAHEDRON LETT, P3723; Bocar M, 2003, J NAT PROD, V66, P152, DOI 10.1021/np0203178; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; Dong JY, 2008, J NAT PROD, V71, P952, DOI 10.1021/np800034g; Dufour C, 2005, CHEM PHYS LIPIDS, V138, P60, DOI 10.1016/j.chemphyslip.2005.08.003; Estrada AER, 2011, FUNGAL GENET BIOL, V48, P874, DOI 10.1016/j.fgb.2011.06.006; Evanno L, 2008, PLANTA MED, V74, P870, DOI 10.1055/s-2008-1074546; Evidente A, 2011, EUR J ORG CHEM, V2011, P5564, DOI 10.1002/ejoc.201100941; Feng SB, 2007, J AGR FOOD CHEM, V55, P8589, DOI 10.1021/jf0716735; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Fujimoto H, 1998, CHEM PHARM BULL, V46, P423; Gimenez C, 2007, CURR ORG CHEM, V11, P707, DOI 10.2174/138527207780598765; Glauser G, 2009, J AGR FOOD CHEM, V57, P1127, DOI 10.1021/jf8033539; Heilmann-Clausen J, 2005, MICROB ECOL, V49, P399, DOI 10.1007/s00248-004-0240-2; IWASAKI S, 1973, TETRAHEDRON LETT, P3537; KNIGHT DW, 1977, TETRAHEDRON LETT, P4543; Kokubun T, 2003, PHYTOCHEMISTRY, V62, P779, DOI 10.1016/S0031-9422(02)00606-4; Langenfeld A, 2012, FUNGAL BIOL IN PRESS; Laurent D, 2002, TETRAHEDRON, V58, P9163, DOI 10.1016/S0040-4020(02)01222-X; Leao PN, 2010, P NATL ACAD SCI USA, V107, P11183, DOI 10.1073/pnas.0914343107; Liu L, 2010, EUR J ORG CHEM, V2010, P3302, DOI 10.1002/ejoc.201000284; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Morita M, 1996, CHEM PHARM BULL, V44, P1603, DOI 10.1248/cpb.44.1603; Oh DC, 2005, BIOORGAN MED CHEM, V13, P5267, DOI 10.1016/j.bmc.2005.05.068; Oh DC, 2007, J NAT PROD, V70, P515, DOI 10.1021/np060381f; Park HB, 2009, J NAT PROD, V72, P248, DOI 10.1021/np800606e; POWELL R G, 1970, Tetrahedron Letters, V11, P815, DOI 10.1016/S0040-4039(01)97839-6; Prado S, 2011, STUDIES NATURAL PROD; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Shiono Y, 2011, PHYTOCHEMISTRY, V72, P1400, DOI 10.1016/j.phytochem.2011.04.016; Singh SK, 2011, MICROB ECOL, V61, P729, DOI 10.1007/s00248-011-9818-7; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soliman SSM, 2011, J NAT PROD, V74, P2497, DOI 10.1021/np200303v; Song HH, 2009, FOOD ADDIT CONTAM A, V26, P518, DOI 10.1080/02652030802562904; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Wicklow DT, 2005, MYCOL RES, V109, P610, DOI 10.1017/S0953756205002820; Young CA, 2005, MOL GENET GENOMICS, V274, P13, DOI 10.1007/s00438-005-1130-0; Zhang CL, 2008, APPL MICROBIOL BIOT, V78, P833, DOI 10.1007/s00253-008-1371-z	44	61	64	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47313	10.1371/journal.pone.0047313	http://dx.doi.org/10.1371/journal.pone.0047313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077591	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100091
J	Hasselrot, K; Cheruiyot, J; Kimani, J; Ball, TB; Kaul, R; Hirbod, T				Hasselrot, Klara; Cheruiyot, Juliana; Kimani, Joshua; Ball, Terry B.; Kaul, Rupert; Hirbod, Taha			Feasibility and Safety of Cervical Biopsy Sampling for Mucosal Immune Studies in Female Sex Workers from Nairobi, Kenya	PLOS ONE			English	Article							HIV-1 INFECTION; TRANSMISSION; PROSTITUTES; EXPRESSION; RECEPTORS; TISSUE; WOMEN; RISK	Background: There is an urgent need to improve our understanding of the mucosal immuno-pathogenesis of HIV acquisition in the female genital tract, particularly in high-risk women such as female sex workers (FSWs). Cervical biopsy samples offer technical advantages over cytobrush sampling, but there are concerns that this might increase HIV acquisition, particularly if healing is slow and/or women do not abstain from sex during healing. Methodology/Principal Findings: Cervical biopsy samples and cervico-vaginal swabs for co-infection diagnostics, prostate specific antigen (PSA) and immune studies were collected from 59 women, including HIV seropositive and HIV-exposed seronegative (HESN) FSWs as well as lower risk women from Nairobi, Kenya. A clinical-demographic questionnaire was administered and women were instructed to avoid sexual intercourse, douching and the insertion of tampons for 14 days. All participants underwent a repeat exam to assess healing within the 14 days, and had HIV diagnostics at six months. Cervical sampling was well tolerated, and 82% of participants had healed macroscopically by 5 days. Both self-report and PSA screening suggested high levels of compliance with pre- and post-procedure abstinence. Delayed healing was associated with vulvovaginal candidiasis (VVC) and HESN status. At six-month follow up all low-risk and HESN participants remained HIV seronegative. Conclusion: Cervical biopsy sampling is a safe and well-tolerated method to obtain cervical biopsies in this context, particularly if participants with VVC are excluded. As healing could be delayed up to 11 days, it is important to support (both financially and with rigorous counseling) a period of post-procedure abstinence to minimize HIV risk.	[Hasselrot, Klara; Hirbod, Taha] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med,Unit Infect Dis, Stockholm, Sweden; [Cheruiyot, Juliana; Kimani, Joshua; Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Ball, Terry B.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Ball, Terry B.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, Terry B.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Kaul, Rupert; Hirbod, Taha] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Kaul, Rupert; Hirbod, Taha] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada	Karolinska Institutet; Karolinska University Hospital; University of Nairobi; University of Manitoba; University of Manitoba; Public Health Agency of Canada; University of Toronto; University of Toronto	Hirbod, T (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Med,Unit Infect Dis, Stockholm, Sweden.	taha.hirbod@ki.se		Kaul, Rupert/0000-0002-1586-4093	SIDA; Swedish Research Council; Eric and Edith Fernstrom Foundation; Canadian Institutes of Health Research; Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative	SIDA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Eric and Edith Fernstrom Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative(Bill & Melinda Gates Foundation)	This study was supported by grants from SIDA, the Swedish Research Council, Eric and Edith Fernstrom Foundation and the Canadian Institutes of Health Research and the Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Embree JE, 2000, AIDS, V14, P2535, DOI 10.1097/00002030-200011100-00016; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Hirbod T, 2009, JAIDS-J ACQ IMM DEF, V51, P239, DOI 10.1097/QAI.0b013e3181a74f89; Hobbs MM, 2010, CONTRACEPTION, V82, P291, DOI 10.1016/j.contraception.2010.02.022; Horton RE, 2010, J INFECT DIS, V202, pS377, DOI 10.1086/655971; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Kaul R, 2011, SEX TRANSM INFECT, V87, P125, DOI 10.1136/sti.2009.040931; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; Wendel SB, 2010, INT J ONCOL, V37, P1565, DOI 10.3892/ijo_00000810; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	17	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47570	10.1371/journal.pone.0047570	http://dx.doi.org/10.1371/journal.pone.0047570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077640	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100135
J	Jagdeo, JR; Adams, LE; Brody, NI; Siegel, DM				Jagdeo, Jared R.; Adams, Lauren E.; Brody, Neil I.; Siegel, Daniel M.			Transcranial Red and Near Infrared Light Transmission in a Cadaveric Model	PLOS ONE			English	Article							LASER THERAPY; IRRADIATION; RADIATION; STROKE; SAFETY	Background and Objective: Low level light therapy has garnered significant interest within the past decade. The exact molecular mechanisms of how red and near infrared light result in physiologic modulation are not fully understood. Heme moieties and copper within cells are red and near infrared light photoreceptors that induce the mitochondrial respiratory chain component cytochrome C oxidase, resulting in a cascade linked to cytoprotection and cellular metabolism. The copper centers in cytochrome C oxidase have a broad absorption range that peaks around 830 nm. Several in vitro and in vivo animal and human models exist that have demonstrated the benefits of red light and near infrared light for various conditions. Clinical applications for low level light therapy are varied. One study in particular demonstrated improved durable functional outcomes status post-stroke in patients treated with near infrared low level light therapy compared to sham treatment [1]. Despite previous data suggesting the beneficial effect in treating multiple conditions, including stroke, with low level light therapy, limited data exists that measures transmission in a human model. Study Design/Materials and Methods: To investigate this idea, we measured the transmission of near infrared light energy, using red light for purposes of comparison, through intact cadaver soft tissue, skull bones, and brain using a commercially available LED device at 830 nm and 633 nm. Results: Our results demonstrate that near infrared measurably penetrates soft tissue, bone and brain parenchyma in the formalin preserved cadaveric model, in comparison to negligible red light transmission in the same conditions. Conclusion: These findings indicate that near infrared light can penetrate formalin fixed soft tissue, bone and brain and implicate that benefits observed in clinical studies are potentially related to direct action of near infrared light on neural tissue.	[Jagdeo, Jared R.; Adams, Lauren E.; Brody, Neil I.; Siegel, Daniel M.] Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA; [Jagdeo, Jared R.] Sacramento Vet Affairs Med Ctr, Dermatol Serv, Mather, CA USA; [Jagdeo, Jared R.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Siegel, Daniel M.] Brooklyn Vet Affairs Med Ctr, Dermatol Serv, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Davis	Jagdeo, JR (corresponding author), Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA.	jrjagdeo@gmail.com						Bachelard HS, 1975, BRAIN WORK, P79; BEAUVOIT B, 1994, BIOPHYS J, V67, P2501, DOI 10.1016/S0006-3495(94)80740-4; Berrocal E, 2009, OPT EXPRESS, V17, P13792, DOI 10.1364/OE.17.013792; Chiappelli J, 2008, J ENVIRON HEALTH, V71, P24; Danno K, 2001, PHOTODERMATOL PHOTO, V17, P261, DOI 10.1034/j.1600-0781.2001.170603.x; GARN SM, 1954, AMA ARCH DERM SYPH, V70, P601, DOI 10.1001/archderm.1954.01540230051006; Giuliani A, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-8; Goldberg David J, 2006, J Drugs Dermatol, V5, P748; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hirsch R, 2007, DERMATOLOGY, P2145; James Byrnes, 2009, NATO SCI PEACE SECUR, P21; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Leonard DR, 2004, DIABETES CARE, V27, P168, DOI 10.2337/diacare.27.1.168; Levy M, 2004, PHYSIOLOGY, P265; Minatel DG, 2009, LASER SURG MED, V41, P433, DOI 10.1002/lsm.20789; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Pandian PS, 2009, MED BIOL ENG COMPUT, V47, P1197, DOI 10.1007/s11517-009-0531-3; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Samoilova K I, 2003, Tsitologiia, V45, P596; Samoilova KA, 2004, PHOTOCH PHOTOBIO SCI, V3, P96, DOI 10.1039/b305738k; Schubert V, 2001, PHOTODERMATOL PHOTO, V17, P32, DOI 10.1034/j.1600-0781.2001.017001032.x; Waiz Makram, 2006, J Cosmet Laser Ther, V8, P27, DOI 10.1080/14764170600607368; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Yamazaki M, 2003, INT J DERMATOL, V42, P738, DOI 10.1046/j.1365-4362.2003.01968.x; Yokoyama K, RHEUMATOID ARTHRITIS; Zhang R, 2009, J MOL CELL CARDIOL, V46, P4, DOI 10.1016/j.yjmcc.2008.09.707; Zhang YO, 2003, J INVEST DERMATOL, V120, P849, DOI 10.1046/j.1523-1747.2003.12133.x; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	32	91	96	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47460	10.1371/journal.pone.0047460	http://dx.doi.org/10.1371/journal.pone.0047460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077622	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100118
J	Ott, M; Litzenburger, UM; Sahm, F; Rauschenbach, KJ; Tudoran, R; Hartmann, C; Marquez, VE; von Deimling, A; Wick, W; Platten, M				Ott, Martina; Litzenburger, Ulrike M.; Sahm, Felix; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Hartmann, Christian; Marquez, Victor E.; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase	PLOS ONE			English	Article							POLYCOMB-REPRESSIVE COMPLEX-2; METHYLTRANSFERASE GENE EZH2; ACUTE-LEUKEMIA CELLS; GROUP PROTEIN EZH2; TYROSINE KINASE; BREAST-CANCER; TRANSCRIPTIONAL REPRESSION; COORDINATED REGULATION; THERAPEUTIC TARGET; PROLONGS SURVIVAL	Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of the Polycomb-repressive complex 2 (PRC2) that epigenetically silences gene transcription through histone H3 lysine trimethylation (H3K27me3). EZH2 has been implicated in stem cell maintenance and is overexpressed in hematological and solid malignancie's including malignant glioma. EZH2 is thought to promote tumor progression by silencing tumor suppressor genes. Hence pharmacological disruption of the PRC2 is an attractive therapeutic strategy for cancer treatment. Here we show that EZH2 is expressed in human glioma and correlates with malignancy. Silencing of EZH2 reduced glioma cell proliferation and invasiveness. While we did not observe induction of cell cycle-associated tumor suppressor genes by silencing or pharmacological inhibition of EZH2, microarray analyses demonstrated a strong transcriptional reduction of the AXL receptor kinase. Neither histone nor DNA methylation appeared to be involved in the positive regulation of AXL by EZH2. Silencing AXL mimicked the antiinvasive effects of EZH2 knockdown. Finally, AXL expression is found in human gliomas with high EZH2 expression. Collectively these data suggest that EZH2 drives glioma invasiveness via transcriptional control of AXL independent of histone or DNA methylation.	[Ott, Martina; Litzenburger, Ulrike M.; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany; [Sahm, Felix; Hartmann, Christian; von Deimling, Andreas] Univ Heidelberg Hosp, Inst Neuropathol, Heidelberg, Germany; [Ott, Martina; Litzenburger, Ulrike M.; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Platten, Michael] German Canc Res Ctr, Clin Cooperat Unit, D-6900 Heidelberg, Germany; [Ott, Martina; Litzenburger, Ulrike M.; Rauschenbach, Katharina J.; Tudoran, Ruxandra; Platten, Michael] German Canc Res Ctr, Helmholtz Grp Expt Neuroimmunol, D-6900 Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Dept Neurooncol, D-6900 Heidelberg, Germany; [Sahm, Felix; Hartmann, Christian; von Deimling, Andreas] German Canc Res Ctr, Dept Neuropathol, D-6900 Heidelberg, Germany; [Hartmann, Christian] Hannover Med Sch, Inst Pathol, Dept Neuropathol, D-3000 Hannover, Germany; [Marquez, Victor E.] NCI, Biol Chem Lab, Frederick, MD 21701 USA	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Platten, M (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany.	michael.platten@med.uni-heidelberg.de	Marquez, Victor/AAP-3549-2021; Wick, Wolfgang/AAA-2545-2020; Platten, Michael/F-2902-2013; Sahm, Felix/GQY-8202-2022; von Deimling, Andreas/F-7774-2013; Hartmann, Christian/D-1882-2010	Wick, Wolfgang/0000-0002-6171-634X; Platten, Michael/0000-0002-4746-887X; Sahm, Felix/0000-0001-5441-1962; von Deimling, Andreas/0000-0002-5863-540X; 	Helmholtz Association [VH-NG-306]; Hertie Foundation; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research	Helmholtz Association(Helmholtz Association); Hertie Foundation; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Helmholtz Association (VH-NG-306) to MP and the Hertie Foundation to WW and by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research to VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Avilla E, 2011, CANCER RES, V71, P1792, DOI 10.1158/0008-5472.CAN-10-2186; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bommi PV, 2010, CELL CYCLE, V9, P2663, DOI 10.4161/cc.9.13.12147; Breton CV, 2011, EPIGENETICS, V6; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Capper D, 2009, ACTA NEUROPATHOL; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; de Haan G, 2007, ANN NY ACAD SCI, V1106, P233, DOI 10.1196/annals.1392.008; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Fiskus W, 2009, CANCER BIOL THER, V8, P939, DOI 10.4161/cbt.8.10.8213; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee WP, 2002, ONCOGENE, V21, P329, DOI 10.1038/sj.onc.1205066; Lemke D, 2012, CLIN CANCER RES, V18, P105, DOI 10.1158/1078-0432.CCR-11-0880; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liu R, 2010, BLOOD, V116, P297, DOI 10.1182/blood-2009-12-257154; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Mudduluru G, 2008, BIOSCIENCE REP, V28, P161, DOI 10.1042/BSR20080046; Mudduluru G, 2011, BIOL CELL, V103, P21, DOI 10.1042/BC20100094; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Ou WB, 2011, ONCOGENE, V30, P1643, DOI 10.1038/onc.2010.555; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tsang DPF, 2011, J GASTROEN HEPATOL, V26, P19, DOI 10.1111/j.1440-1746.2010.06447.x; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wagener N, 2008, INT J CANCER, V123, P1545, DOI 10.1002/ijc.23683; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Ye X, 2010, ONCOGENE, V29, P5254, DOI 10.1038/onc.2010.268; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zheng SC, 2011, NEURO-ONCOLOGY, V13, P280, DOI 10.1093/neuonc/noq190	66	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47663	10.1371/journal.pone.0047663	http://dx.doi.org/10.1371/journal.pone.0047663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077658	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100151
J	Petersen, HI; Lindstrom, S				Petersen, Henrik I.; Lindstrom, Sofie			Synchronous Wildfire Activity Rise and Mire Deforestation at the Triassic-Jurassic Boundary	PLOS ONE			English	Article							ATLANTIC MAGMATIC PROVINCE; TRIASSIC/JURASSIC BOUNDARY; MASS-EXTINCTION; CHARCOAL; TERRESTRIAL; BORNHOLM; REFLECTANCE; TEMPERATURE; SUCCESSION; GREENLAND	The end-Triassic mass extinction event (similar to 201.4 million years ago) caused major faunal and floral turnovers in both the marine and terrestrial realms. The biotic changes have been attributed to extreme greenhouse warming across the Triassic-Jurassic (T-J) boundary caused by massive release of carbon dioxide and/or methane related to extensive volcanism in the Central Atlantic Magmatic Province (CAMP), resulting in a more humid climate with increased storminess and lightning activity. Lightning strikes are considered the primary source of wildfires, producing charcoal, microscopically recognized as inertinite macerals. The presence of polycyclic aromatic hydrocarbons (PAHs) of pyrolytic origin and allochthonous charcoal in siliciclastic T-J boundary strata has suggested widespread wildfire activity at the time. We have investigated largely autochthonous coal and coaly beds across the T-J boundary in Sweden and Denmark. These beds consist of predominantly organic material from the in situ vegetation in the mires, and as the coaly beds represent a substantial period of time they are excellent environmental archives. We document a remarkable increase in inertinite content in the coal and coaly beds across the T-J boundary. We show estimated burning temperatures derived from inertinite reflectance measurements coupled with palynological data and conclude that pre-boundary late Rhaetian mire wildfires included high-temperature crown fires, whereas latest Rhaetian-Sinemurian mire wildfires were more frequent but dominated by lower temperature surface fires. Our results suggest a major change in the mire ecosystems across the T-J boundary from forested, conifer dominated mires to mires with a predominantly herbaceous and shrubby vegetation. Contrary to the overall regional vegetation for which onset of recovery commenced in the early Hettangian, the sensitive mire ecosystem remained affected during the Hettangian and did not start to recover until around the Hettangian-Sinemurian boundary. Decreasing inertinite content through the Lower Jurassic suggests that fire activity gradually resumed to considerable lower levels.	[Petersen, Henrik I.] Geol Survey Denmark & Greenland GEUS, Dept Reservoir Geol, Copenhagen, Denmark; [Lindstrom, Sofie] Geol Survey Denmark & Greenland GEUS, Dept Stratig, Copenhagen, Denmark	Geological Survey Of Denmark & Greenland; Geological Survey Of Denmark & Greenland	Petersen, HI (corresponding author), Geol Survey Denmark & Greenland GEUS, Dept Reservoir Geol, Copenhagen, Denmark.	hip@geus.dk	Lindström, Sofie/G-5481-2018; Petersen, Henrik/ABB-4663-2020	Lindström, Sofie/0000-0001-8278-1055; Petersen, Henrik/0000-0001-6606-7062				Ahlberg A, 2003, SEDIMENT GEOL, V161, P15, DOI 10.1016/S0037-0738(02)00381-0; Ahlberg A, 2002, TERRA NOVA, V14, P241, DOI 10.1046/j.1365-3121.2002.00416.x; Ahlberg A, 1994, LUND PUBLICATIONS GE, V123; ARNDORFF L, 1993, PALAEOGEOGR PALAEOCL, V100, P235, DOI 10.1016/0031-0182(93)90056-O; BALME BE, 1995, REV PALAEOBOT PALYNO, V87, P85; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Berner RA, 2007, PALAEOGEOGR PALAEOCL, V244, P368, DOI 10.1016/j.palaeo.2006.06.039; Bojesen-Koefoed JA, 1997, INT J COAL GEOL, V34, P345, DOI 10.1016/S0166-5162(97)00030-X; Bonis NR, 2009, REV PALAEOBOT PALYNO, V156, P376, DOI 10.1016/j.revpalbo.2009.04.003; Bonis NR, 2010, J GEOL SOC LONDON, V167, P877, DOI 10.1144/0016-76492009-141; BUSH MB, 1995, AM NAT, V145, P594, DOI 10.1086/285757; Bush MB, 2001, GLOBAL ECOL BIOGEOGR, V10, P359, DOI 10.1046/j.1466-822X.2001.00247.x; Diesscl C.F.K, 1992, COAL BEARING DEPOSIT; Dybkjaer K, 1991, DANMARKS GEOLOGISK A, V30; Gravesen P, 1982, DANMARKS GEOLOGISK B, V7; GRY H, 1969, MEDDELELSER DANSK GE, V19, P69; Hallam A, 1999, EARTH-SCI REV, V48, P217, DOI 10.1016/S0012-8252(99)00055-0; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Int Comm Coal Organic Petrology, 2001, FUEL, V80, P459, DOI 10.1016/s0016-2361(00)00102-2; Jones T.P., 1997, MEDED NED INST TOEG, V58, P93; JONES TP, 1991, B SOC GEOL FR, V162, P193; Konijnenburg-Van Cittert JHAV, 2002, REV PALAEOBOT PALYNO, V119, P113; Kuerschner WM, 2007, PALAEOGEOGR PALAEOCL, V244, P257, DOI 10.1016/j.palaeo.2006.06.031; Larsen G, 1968, PALAEOGEOGR PALAEOCL, V106, P91; Lindstrom S, 2006, PALAEOGEOGR PALAEOCL, V241, P339, DOI 10.1016/j.palaeo.2006.04.006; Lindstrom S, 2002, REV PALAEOBOT PALYNO, V120, P247, DOI 10.1016/S0034-6667(02)00079-9; Lindstrom S, 2012, GEOLOGY, V40, P531, DOI 10.1130/G32928.1; Mander L, 2012, INT J PLANT SCI, V173, P429, DOI 10.1086/664715; Marynowski L, 2009, PALAIOS, V24, P785, DOI 10.2110/palo.2009.p09-044r; Marzoli A, 2004, GEOLOGY, V32, P973, DOI 10.1130/G20652.1; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2007, PALEOBIOLOGY, V33, P547, DOI 10.1666/06026.1; Moore P. D., 1987, GEOL SOC SPEC PUBL, V32, P7, DOI DOI 10.1144/GSL.SP.1987.032.01.02; Nichols GJ, 2000, PALAEOGEOGR PALAEOCL, V164, P43, DOI 10.1016/S0031-0182(00)00174-7; Nielsen L.H., 2003, JURASSIC DENMARK GRE, V1, P459, DOI [10.34194/geusb.v1.4681, DOI 10.34194/GEUSB.V1.4681]; Nielsen LH, 2010, PALAEOGEOGR PALAEOCL, V292, P103, DOI 10.1016/j.palaeo.2010.03.032; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Petersen HI, 2011, INT J COAL GEOL, V87, P2, DOI 10.1016/j.coal.2011.04.004; Petersen H. I., 2003, JURASSIC DENMARK GRE, V1; PETERSEN HI, 1993, INT J COAL GEOL, V22, P189, DOI 10.1016/0166-5162(93)90026-7; PETERSEN HI, 1995, INT J COAL GEOL, V27, P99, DOI 10.1016/0166-5162(94)00020-Z; Petersen HI, 1994, DANMARKS GEOLOGISK A, V55, P1; PIENKOWSKI G, 1991, SEDIMENTOLOGY, V38, P503, DOI 10.1111/j.1365-3091.1991.tb00364.x; Pott C, 2011, PALAEONTOLOGY, V54, P1025, DOI 10.1111/j.1475-4983.2011.01090.x; Poulsen NE, 2003, CONTRIBUTION SERIES, V31; Poulsen Niels E., 2003, Geological Survey of Denmark and Greenland Bulletin, V1, P115; Preto N, 2010, PALAEOGEOGR PALAEOCL, V290, P1, DOI 10.1016/j.palaeo.2010.03.015; Reeve N, 1999, Q J ROY METEOR SOC, V125, P893, DOI 10.1002/qj.49712555507; REIN G., 2009, INT REV CHEM ENG, V1, P3; Ruhl M, 2011, GEOLOGY, V39, P431, DOI 10.1130/G31680.1; Ruhl M, 2011, SCIENCE, V333, P430, DOI 10.1126/science.1204255; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Scott AC, 2005, GEOLOGY, V33, P589, DOI 10.1130/G21474.1; SCOTT AC, 1989, INT J COAL GEOL, V12, P443, DOI 10.1016/0166-5162(89)90061-X; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P281, DOI 10.1016/S0031-0182(00)00192-9; Scott AC, 1994, NATURE INFLUENCE FIR; Scott AC, 2007, INT J COAL GEOL, V70, P53, DOI 10.1016/j.coal.2006.02.009; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; Steinthorsdottir M, 2012, GEOLOGY, V40, P815, DOI 10.1130/G33334.1; Steinthorsdottir M, 2011, PALAEOGEOGR PALAEOCL, V308, P418, DOI 10.1016/j.palaeo.2011.05.050; SURLYK F, 1995, SEDIMENTOLOGY, V42, P323, DOI 10.1111/j.1365-3091.1995.tb02105.x; Sykorova I, 2005, INT J COAL GEOL, V62, P85, DOI 10.1016/j.coal.2004.06.006; Taylor G. H., 1998, ORGANIC PETROLOGY NE; Therkelsen J, 1992, THESIS U AARHUS; Troedsson G, 1951, LUNDS U ARSSKRIFT NY; van de Schootbrugge B, 2007, PALAEOGEOGR PALAEOCL, V244, P126, DOI 10.1016/j.palaeo.2006.06.026; van de Schootbrugge B, 2009, NAT GEOSCI, V2, P589, DOI 10.1038/NGEO577; VAUGHAN A, 1995, J SEDIMENT RES A, V65, P129; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035	69	59	68	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47236	10.1371/journal.pone.0047236	http://dx.doi.org/10.1371/journal.pone.0047236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077574	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100078
J	Franke, EI; Vanderbrink, BA; Hile, KL; Zhang, HJ; Cain, A; Matsui, F; Meldrum, KK				Franke, Ethan I.; Vanderbrink, Brian A.; Hile, Karen L.; Zhang, Hongji; Cain, Alexandra; Matsui, Futoshi; Meldrum, Kirstan K.			Renal IL-18 Production Is Macrophage Independent During Obstructive Injury	PLOS ONE			English	Article							GAMMA-INDUCING FACTOR; UP-REGULATION; INTERLEUKIN-18; KIDNEY; TGF-BETA-1; ACTIVATION; CYTOKINE; CELLS; MICE	Background: Interleukin 18 (IL-18) is a pro-inflammatory cytokine that mediates fibrotic renal injury during obstruction. Macrophages are a well-known source of IL-18; however, renal tubular epithelial cells are also a potential source of this cytokine. We hypothesized that IL-18 is predominantly a renal tubular cell product and is produced during renal obstruction independent of macrophage infiltration. Methods: To study this, male C57BL6 mice were subjected to unilateral ureteral obstruction (UUO) vs. sham operation in the presence or absence of macrophage depletion (liposomal clodronate (1 ml/100 g body weight i.v.)). The animals were sacrificed 1 week after surgery and renal cortical tissue harvested. Tissue levels of active IL-18 (ELISA), IL-18 receptor mRNA expression (real time PCR), and active caspase-1 expression (western blot) were measured. The cellular localization of IL-18 and IL-18R was assessed using dual labeling immunofluorescent staining (IFS). Results: Immunohistochemical staining of renal tissue sections confirmed macrophage depletion by liposomal clodronate. IL-18 production, IL-18R expression, and active caspase 1 expression were elevated in response to renal obstruction and did not decline to a significant degree in the presence of macrophage depletion. Obstruction-induced IL-18 and IL-18R production localized predominantly to tubular epithelial cells (TEC) during obstruction despite macrophage depletion. Conclusion: These results demonstrate that renal tubular epithelial cells are the primary source of IL-18 production during obstructive injury, and that tubular cell production of IL-18 occurs independent of macrophage infiltration.	[Meldrum, Kirstan K.] Univ Florida, Dept Urol, Gainesville, FL 32611 USA; [Franke, Ethan I.; Vanderbrink, Brian A.; Hile, Karen L.; Zhang, Hongji; Cain, Alexandra; Matsui, Futoshi] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN USA	State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington	Meldrum, KK (corresponding author), Univ Florida, Dept Urol, Gainesville, FL 32611 USA.	Kirstan.Meldrum@urology.ufl.edu			United States National Institutes of Health grant [DK08165]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081695, F32DK008165] Funding Source: NIH RePORTER	United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by United States National Institutes of Health grant DK08165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani-Hani AH, 2009, KIDNEY INT, V76, P500, DOI 10.1038/ki.2009.216; Daemen MARC, 1999, J IMMUNOL, V162, P5506; DIAMOND JR, 1994, AM J PHYSIOL, V266, pF926, DOI 10.1152/ajprenal.1994.266.6.F926; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Faust J, 2002, ARTHRITIS RHEUM-US, V46, P3083, DOI 10.1002/art.10563; Fortin CF, 2009, FASEB J, V23, P194, DOI 10.1096/fj.08-110213; Gauer S, 2007, KIDNEY INT, V72, P1081, DOI 10.1038/sj.ki.5002473; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; He ZB, 2009, AM J PHYSIOL-RENAL, V296, pF535, DOI 10.1152/ajprenal.90634.2008; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Leslie JA, 2008, J SURG RES, V145, P170, DOI 10.1016/j.jss.2007.03.037; Liang D, 2007, NEPHROLOGY, V12, P53, DOI 10.1111/j.1440-1797.2006.00737.x; Striz I, 2005, IMMUNOL LETT, V99, P30, DOI 10.1016/j.imlet.2005.01.010; VanderBrink BA, 2011, J UROLOGY, V186, P1502, DOI 10.1016/j.juro.2011.05.046; Zhang HJ, 2011, AM J PHYSIOL-RENAL, V301, pF171, DOI 10.1152/ajprenal.00339.2010	17	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47417	10.1371/journal.pone.0047417	http://dx.doi.org/10.1371/journal.pone.0047417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077611	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500048
J	Jiang, X; Neapolitan, RE				Jiang, Xia; Neapolitan, Richard E.			Mining Pure, Strict Epistatic Interactions from High-Dimensional Datasets: Ameliorating the Curse of Dimensionality	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-GENE; RISK; ALGORITHM; INFERENCE; REVEALS; ALLELES; MODELS; APOE	Background: The interaction between loci to affect phenotype is called epistasis. It is strict epistasis if no proper subset of the interacting loci exhibits a marginal effect. For many diseases, it is likely that unknown epistatic interactions affect disease susceptibility. A difficulty when mining epistatic interactions from high-dimensional datasets concerns the curse of dimensionality. There are too many combinations of SNPs to perform an exhaustive search. A method that could locate strict epistasis without an exhaustive search can be considered the brass ring of methods for analyzing high-dimensional datasets. Methodology/Findings: A SNP pattern is a Bayesian network representing SNP-disease relationships. The Bayesian score for a SNP pattern is the probability of the data given the pattern, and has been used to learn SNP patterns. We identified a bound for the score of a SNP pattern. The bound provides an upper limit on the Bayesian score of any pattern that could be obtained by expanding a given pattern. We felt that the bound might enable the data to say something about the promise of expanding a 1-SNP pattern even when there are no marginal effects. We tested the bound using simulated datasets and semi-synthetic high-dimensional datasets obtained from GWAS datasets. We found that the bound was able to dramatically reduce the search time for strict epistasis. Using an Alzheimer's dataset, we showed that it is possible to discover an interaction involving the APOE gene based on its score because of its large marginal effect, but that the bound is most effective at discovering interactions without marginal effects. Conclusions/Significance: We conclude that the bound appears to ameliorate the curse of dimensionality in high-dimensional datasets. This is a very consequential result and could be pivotal in our efforts to reveal the dark matter of genetic disease risk from high-dimensional datasets.	[Jiang, Xia] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Neapolitan, Richard E.] Northwestern Univ, Div Hlth & Biomed Informat, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine	Jiang, X (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	xij6@pitt.edu			National Library of Medicine at the United States National Institutes of Health [1K99LM010822-01]; NATIONAL LIBRARY OF MEDICINE [R00LM010822, K99LM010822] Funding Source: NIH RePORTER	National Library of Medicine at the United States National Institutes of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by [grant number 1K99LM010822-01] from the National Library of Medicine at the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armes JE, 1998, CANCER-AM CANCER SOC, V83, P2335, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.3.CO;2-E; Bateson W., 1909, MENDELS PRINCIPLES H; Briggs FBS, 2010, GENES IMMUN, V11, P199, DOI 10.1038/gene.2009.110; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Epstein MJ, 2008, P IEEE S COMP INT BI; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Fisher J, 2012, GAMETES FAST DIRECT; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han B, 2009, P IEEE INT C BIOINF; Heckerman D, 1995, MSRTR9409; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jiang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022075; Jiang X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-89; Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li J, 2011, BIOINFORMATICS, V27, pI222, DOI 10.1093/bioinformatics/btr227; Logsdon BA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-58; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Meng Yan, 2007, BMC Proc, V1 Suppl 1, pS56; Miller DJ, 2009, BIOINFORMATICS, V25, P2478, DOI 10.1093/bioinformatics/btp435; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Moore JH, 2007, P EVOBIO 2007; Nagel RL, 2005, CR BIOL, V328, P606, DOI 10.1016/j.crvi.2005.05.003; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Oh S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S9-S5; Perrier E, 2008, J MACH LEARN RES, V9, P2251; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Silander T, 2007, P 23 C ANN C UNC ART; Singh AP, 2005, CMUCALCD050106; Spinola M, 2001, AM J HUM GENET, V55, P27; Spirtes P., 2000, CAUSATION PREDICTION; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Verzilli CJ, 2006, AM J HUM GENET, V79, P100, DOI 10.1086/505313; Wan X, 2010, BIOINFORMATICS, V26, P30, DOI 10.1093/bioinformatics/btp622; Wongseree W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-294; Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zhang X, 2009, P 13 ANN INT C RES C; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46771	10.1371/journal.pone.0046771	http://dx.doi.org/10.1371/journal.pone.0046771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071633	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000309809500019
J	Barretti, DLM; Magalhaes, FD; Fernandes, T; do Carmo, EC; Rosa, KT; Irigoyen, MC; Negrao, CE; Oliveira, EM				Mendes Barretti, Diego Lopes; Magalhaes, Flavio de Castro; Fernandes, Tiago; do Carmo, Everton Crivoi; Rosa, Kaleizu Teodoro; Irigoyen, Maria Claudia; Negrao, Carlos Eduardo; Oliveira, Edilamar Menezes			Effects of Aerobic Exercise Training on Cardiac Renin-Angiotensin System in an Obese Zucker Rat Strain	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CONVERTING ENZYME-INHIBITION; BLOOD-PRESSURE; WEIGHT-LOSS; RECEPTOR; MYOCARDIUM; EXPRESSION; APOPTOSIS; INCREASE; PLASMA	Objective: Obesity and renin angiotensin system (RAS) hyperactivity are profoundly involved in cardiovascular diseases, however aerobic exercise training (EXT) can prevent obesity and cardiac RAS activation. The study hypothesis was to investigate whether obesity and its association with EXT alter the systemic and cardiac RAS components in an obese Zucker rat strain. Methods: The rats were divided into the following groups: Lean Zucker rats (LZR); lean Zucker rats plus EXT (LZR+EXT); obese Zucker rats (OZR) and obese Zucker rats plus EXT (OZR+EXT). EXT consisted of 10 weeks of 60-min swimming sessions, 5 days/week. At the end of the training protocol heart rate (HR), systolic blood pressure (SBP), cardiac hypertrophy (CH) and function, local and systemic components of RAS were evaluated. Also, systemic glucose, triglycerides, total cholesterol and its LDL and HDL fractions were measured. Results: The resting HR decreased (, 12%) for both LZR+EXT and OZR+EXT. However, only the LZR+EXT reached significance (p, 0.05), while a tendency was found for OZR versus OZR+EXT (p = 0.07). In addition, exercise reduced (57%) triglycerides and (61%) LDL in the OZR+EXT. The systemic angiotensin I-converting enzyme (ACE) activity did not differ regardless of obesity and EXT, however, the OZR and OZR+EXT showed (66%) and (42%), respectively, less angiotensin II (Ang II) plasma concentration when compared with LZR. Furthermore, the results showed that EXT in the OZR prevented increase in CH, cardiac ACE activity, Ang II and AT2 receptor caused by obesity. In addition, exercise augmented cardiac ACE2 in both training groups. Conclusion: Despite the unchanged ACE and lower systemic Ang II levels in obesity, the cardiac RAS was increased in OZR and EXT in obese Zucker rats reduced some of the cardiac RAS components and prevented obesity-related CH. These results show that EXT prevented the heart RAS hyperactivity and cardiac maladaptive morphological alterations in obese Zucker rats.	[Mendes Barretti, Diego Lopes; Magalhaes, Flavio de Castro; Fernandes, Tiago; do Carmo, Everton Crivoi; Negrao, Carlos Eduardo; Oliveira, Edilamar Menezes] Univ Sao Paulo, Lab Biochem & Mol Biol Exercise, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Rosa, Kaleizu Teodoro; Irigoyen, Maria Claudia; Negrao, Carlos Eduardo] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Oliveira, EM (corresponding author), Univ Sao Paulo, Lab Biochem & Mol Biol Exercise, Sch Phys Educ & Sport, Sao Paulo, Brazil.	edilamar@usp.br	Gothe, Neha/B-2781-2016; Oliveira, Edilamar M/AAG-1082-2019; Negrao, Carlos E/C-4281-2012; de Castro Magalhaes, Flavio/AAB-5540-2022; Magalhães, Flávio/AAE-9680-2020; Fernandes, Tiago/I-7891-2014; Carmo, Everton/F-7129-2012	Gothe, Neha/0000-0002-2736-757X; Oliveira, Edilamar M/0000-0002-7101-312X; de Castro Magalhaes, Flavio/0000-0002-1963-982X; Fernandes, Tiago/0000-0002-9057-3878; Carmo, Everton/0000-0003-1353-0206; Negrao, Carlos Eduardo/0000-0003-4652-1226	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [MCT/CNPq 485720/07-8)]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/52458-0, 07/56771-4]; CNPq, Brazil [307591/2009-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present investigation was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq 485720/07-8). D.L.M. Barretti and T. Fernandes were the recipients of fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, No. 07/52458-0 and 07/56771-4). E.M. Oliveira was awarded scholarships from CNPq (No. 307591/2009-3), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Adam A, 2010, NEUROPEPTIDES, V44, P69, DOI 10.1016/j.npep.2009.09.004; AlonsoGalicia M, 1996, HYPERTENSION, V28, P1047, DOI 10.1161/01.HYP.28.6.1047; Alves MF, 2005, BRAZ J MED BIOL RES, V38, P861, DOI 10.1590/S0100-879X2005000600007; Avelar E, 2007, HYPERTENSION, V49, P34, DOI 10.1161/01.HYP.0000251711.92482.14; Berggren JR, 2008, AM J PHYSIOL-ENDOC M, V294, pE726, DOI 10.1152/ajpendo.00354.2007; Boustany CM, 2004, AM J PHYSIOL-REG I, V287, pR943, DOI 10.1152/ajpregu.00265.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carroll JF, 2002, MED SCI SPORT EXER, V34, P596, DOI 10.1097/00005768-200204000-00006; Chappel MC, 2006, KIDNEY INT, V70, P7, DOI 10.1038/sj.ki.5000321; CRARY GS, 1995, J AM SOC NEPHROL, V6, P1295; Deitel M, 2003, OBES SURG, V13, P329, DOI 10.1381/096089203765887598; DESIMONE G, 1994, HYPERTENSION, V23, P600, DOI 10.1161/01.HYP.23.5.600; Dostal DE, 2000, REGUL PEPTIDES, V91, P1, DOI 10.1016/S0167-0115(99)00123-8; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Duarte J, 1999, EUR J PHARMACOL, V365, P225, DOI 10.1016/S0014-2999(98)00879-6; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Fernandes T, 2011, HYPERTENSION, V58, P182, DOI 10.1161/HYPERTENSIONAHA.110.168252; Filho AG, 2008, EXP PHYSIOL, V93, P589, DOI 10.1113/expphysiol.2007.014293; Galderisi M, 2008, J CARDIOVASC PHARM, V51, P523, DOI 10.1097/FJC.0b013e31817751a7; Gembardt F, 2008, FASEB J; Goldenberg I, 2001, J HYPERTENS, V19, P1681, DOI 10.1097/00004872-200109000-00022; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; HARKER CT, 1993, J AM SOC NEPHROL, V4, P1354; Howard BV, 2003, ENDOCRIN METAB CLIN, V32, P855, DOI 10.1016/S0889-8529(03)00073-2; Huang TH, 2008, DIABETES OBES METAB, V10, P574, DOI 10.1111/j.1463-1326.2007.00750.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; MATHE D, 1995, DIABETES METAB, V21, P106; Medeiros A, 2004, BRAZ J MED BIOL RES, V37, P1909, DOI 10.1590/S0100-879X2004001200018; Mosconi E, 2011, J LIPID RES, V52, P330, DOI 10.1194/jlr.M011825; Murphy NF, 2006, EUR HEART J, V27, P96, DOI 10.1093/eurheartj/ehi506; O'Rourke R A, 1984, Arch Inst Cardiol Mex, V54, P405; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; Pereira MG, 2009, EUR J APPL PHYSIOL, V105, P843, DOI 10.1007/s00421-008-0967-4; Peterson JM, 2008, J APPL PHYSL; SCHONFELD G, 1974, J LIPID RES, V15, P457; Siddiqui AH, 2009, HYPERTENSION, V53, P256, DOI 10.1161/HYPERTENSIONAHA.108.126086; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Stepp DW, 2007, AM J PHYSIOL-HEART C, V293, pH2537, DOI 10.1152/ajpheart.01081.2006; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Toblli JE, 2004, AM J HYPERTENS, V17, P172, DOI 10.1016/j.amjhyper.2003.10.006; Toblli JE, 2006, OBESITY, V14, P1586, DOI 10.1038/oby.2006.183; van der Merwe L, 2008, HUM GENET, V124, P57, DOI 10.1007/s00439-008-0524-6	43	41	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46114	10.1371/journal.pone.0046114	http://dx.doi.org/10.1371/journal.pone.0046114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077501	Green Submitted, gold, Green Published			2022-12-25	WOS:000309809500011
J	Wang, S; Cao, JL; Liu, X; Hu, HQ; Shi, J; Zhang, SZ; Keller, NP; Lu, L				Wang, Sha; Cao, Jinling; Liu, Xiao; Hu, Hongqin; Shi, Jie; Zhang, Shizhu; Keller, Nancy P.; Lu, Ling			Putative Calcium Channels CchA and MidA Play the Important Roles in Conidiation, Hyphal Polarity and Cell Wall Components in Aspergillus nidulans	PLOS ONE			English	Article							CYCLOSPORINE-A; MECHANOSENSITIVE CHANNEL; FILAMENTOUS FUNGUS; GROWTH; CALCINEURIN; COMPLEX; YEAST; GENE; LOCALIZATION; DEFECTS	Although the high affinity Ca2+ channel, Cch1, and its subunit Mid1 have been investigated and evaluated in yeast and some of filamentous fungi, little is known about the function of their homologs in the Aspergilli. Here, we have functionally characterized the yeast homologs, CchA and MidA, in Aspergillus nidulans using conditional and null deletion mutants. CchA and MidA not only have functional benefits of fast growth, which is consistent with Cch1 and Mid1 in yeast, but also have unique and complex roles in regulating conidiation, hyphal polarity and cell wall components in low-calcium environments. The defect of CchA or MidA resulted in a sharp reduction in the number of conidiospores, accompanied by abnormal metulae, and undeveloped-phialides at a higher density of inoculum. Most interestingly, these conidiation defects in mutants can, remarkably, be rescued either by extra-cellular Ca2+ in a calcineurin-dependent way or by osmotic stress in a calcineurin-independent way. Moreover, the fact that the phenotypic defects are not exacerbated by the presence of the double deletion, together with the Y2H assay, indicates that CchA and MidA may form a complex to function together. Our findings suggest that the high-affinity Ca2+ channel may represent a viable and completely unexplored avenue to reduce conidiation in the Aspergilli.	[Wang, Sha; Cao, Jinling; Liu, Xiao; Hu, Hongqin; Shi, Jie; Zhang, Shizhu; Lu, Ling] Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Microbiol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Keller, Nancy P.] UW Madison, Dept Plant Pathol, Dept Bacteriol, Madison, WI USA; [Keller, Nancy P.] UW Madison, Dept Med Microbiol & Immunol, Madison, WI USA	Nanjing Normal University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lu, L (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Microbiol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	linglu@njnu.edu.cn	Keller, Nancy P./ABC-5911-2021; zhang, shizhu/HDO-3599-2022; Lu, Ling/AGU-8326-2022	Lu, Ling/0000-0002-2891-7326; zhang, shizhu/0000-0002-0283-3714	National Natural Science Foundation of China [NSFC31070031, NSFC 31200057]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [11KJA180005]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Innovation Project for College Graduates of Jiangsu Province [CX10B_394Z]; Excellent Doctoral Dissertation Special Fund of Nanjing Normal University [2010BS0004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Innovation Project for College Graduates of Jiangsu Province; Excellent Doctoral Dissertation Special Fund of Nanjing Normal University	This work was financially supported by the National Natural Science Foundation of China (NSFC31070031) and Natural Science Foundation of the Jiangsu Higher Education Institutions of China (Grant No. 11KJA180005) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and the Research to LL, Innovation Project for College Graduates of Jiangsu Province (Grant No. CX10B_394Z) and Excellent Doctoral Dissertation Special Fund of Nanjing Normal University (Grant No. 2010BS0004) to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also financially supported by the National Natural Science Foundation of China (NSFC 31200057 to Z.S).	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Ambudkar IS, 2011, NEUROCHEM RES, V36, P1212, DOI 10.1007/s11064-011-0465-7; Bormann J, 2009, MICROBIOL-SGM, V155, P3922, DOI 10.1099/mic.0.030825-0; Brand A, 2009, MOL MICROBIOL, V71, P1155, DOI 10.1111/j.1365-2958.2008.06592.x; Brown SH, 2008, APPL ENVIRON MICROB, V74, P5674, DOI 10.1128/AEM.00565-08; Brown SH, 2009, MOL PLANT MICROBE IN, V22, P882, DOI 10.1094/MPMI-22-7-0882; Cavinder B, 2011, EUKARYOT CELL, V10, P832, DOI 10.1128/EC.00235-10; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Dagenais TRT, 2008, INFECT IMMUN, V76, P3214, DOI 10.1128/IAI.00009-08; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Denning DW, 2011, FUTURE MICROBIOL, V6, P1229, DOI [10.2217/FMB.11.118, 10.2217/fmb.11.118]; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Fujikawa T, 2009, MOL MICROBIOL, V73, P553, DOI 10.1111/j.1365-2958.2009.06786.x; Gao LN, 2011, CELL SIGNAL, V23, P1750, DOI 10.1016/j.cellsig.2011.06.009; Groppi S, 2011, CELL CALCIUM, V49, P376, DOI 10.1016/j.ceca.2011.03.006; Hallen HE, 2008, EUKARYOT CELL, V7, P415, DOI 10.1128/EC.00248-07; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Harris SD, 2009, FUNGAL GENET BIOL, V46, pS82, DOI 10.1016/j.fgb.2008.07.023; Herrero-Garcia E, 2011, FUNGAL BIOL-UK, V115, P393, DOI 10.1016/j.funbio.2011.02.005; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; Juvvadi PR, 2011, MOL MICROBIOL, V82, P1235, DOI 10.1111/j.1365-2958.2011.07886.x; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Klis F., 2007, BIOL FUNGAL CELL, P97; Kmetzsch Livia, 2011, Commun Integr Biol, V4, P186, DOI 10.4161/cib.4.2.14271; LEHMANN PF, 1975, INFECT IMMUN, V12, P987, DOI 10.1128/IAI.12.5.987-992.1975; Lew RR, 2008, EUKARYOT CELL, V7, P647, DOI 10.1128/EC.00411-07; Li SH, 2005, MOL BIOL CELL, V16, P3591, DOI 10.1091/mbc.E04-12-1071; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022421; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; MAY GS, 1989, J CELL BIOL, V109, P2267, DOI 10.1083/jcb.109.5.2267; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; Ouedraogo JP, 2011, J BIOL CHEM, V286, P13859, DOI 10.1074/jbc.M110.203588; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Penalva MA, 2005, FUNGAL GENET BIOL, V42, P963, DOI 10.1016/j.fgb.2005.09.004; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shi J, 2008, FUNGAL GENET BIOL, V45, P1570, DOI 10.1016/j.fgb.2008.08.011; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Stiber JA, 2011, CELL CALCIUM, V49, P341, DOI 10.1016/j.ceca.2010.11.012; Tada T, 2003, J BIOL CHEM, V278, P9647, DOI 10.1074/jbc.M206993200; Tasaka Y, 2000, BIOCHEM BIOPH RES CO, V269, P265, DOI 10.1006/bbrc.2000.2278; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; Wang G, 2006, PROTOPLASMA, V228, P159, DOI 10.1007/s00709-006-0181-3; Wang JJ, 2009, MICROBIOL-SGM, V155, P2714, DOI 10.1099/mic.0.029215-0; Wolfe DM, 2006, NEUROMOL MED, V8, P279, DOI 10.1385/NMM:8:3:279; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10; ZHOU XL, 1991, SCIENCE, V253, P1415, DOI 10.1126/science.1716786	61	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46564	10.1371/journal.pone.0046564	http://dx.doi.org/10.1371/journal.pone.0046564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071589	gold, Green Published, Green Submitted			2022-12-25	WOS:000309809500017
J	Yang, JR; Huang, YP; Chang, FY; Hsu, LC; Lin, YC; Huang, HY; Wu, FT; Wu, HS; Liu, MT				Yang, Ji-Rong; Huang, Yuan-Pin; Chang, Feng-Yee; Hsu, Li-Ching; Lin, Yu-Cheng; Huang, Hsiang-Yi; Wu, Fu-Ting; Wu, Ho-Sheng; Liu, Ming-Tsan			Phylogenetic and Evolutionary History of Influenza B Viruses, which Caused a Large Epidemic in 2011-2012, Taiwan	PLOS ONE			English	Article							COCIRCULATING LINEAGES; FREQUENT REASSORTMENT; MULTIPLE GENOTYPES; NS GENES; HEMAGGLUTININ; SEASON; EFFICACY; DELETION; VACCINE; PATTERN	The annual recurrence of the influenza epidemic is considered to be primarily associated with immune escape due to changes to the virus. In 2011-2012, the influenza B epidemic in Taiwan was unusually large, and influenza B was predominant for a long time. To investigate the genetic dynamics of influenza B viruses during the 2011-2012 epidemic, we analyzed the sequences of 4,386 influenza B viruses collected in Taiwan from 2004 to 2012. The data provided detailed insight into the flux patterns of multiple genotypes. We found that a re-emergent TW08-I virus, which was the major genotype and had co-circulated with the two others, TW08-II and TW08-III, from 2007 to 2009 in Taiwan, successively overtook TW08-II in March and then underwent a lineage switch in July 2011. This lineage switch was followed by the large epidemic in Taiwan. The whole-genome compositions and phylogenetic relationships of the representative viruses of various genotypes were compared to determine the viral evolutionary histories. We demonstrated that the large influenza B epidemic of 2011-2012 was caused by Yamagata lineage TW08-I viruses that were derived from TW04-II viruses in 2004-2005 through genetic drifts without detectable reassortments. The TW08-I viruses isolated in both 2011-2012 and 2007-2009 were antigenically similar, indicating that an influenza B virus have persisted for 5 years in antigenic stasis before causing a large epidemic. The results suggest that in addition to the emergence of new variants with mutations or reassortments, other factors, including the interference of multi-types or lineages of influenza viruses and the accumulation of susceptible hosts, can also affect the scale and time of an influenza B epidemic.	[Yang, Ji-Rong; Huang, Yuan-Pin; Chang, Feng-Yee; Hsu, Li-Ching; Lin, Yu-Cheng; Huang, Hsiang-Yi; Wu, Fu-Ting; Wu, Ho-Sheng; Liu, Ming-Tsan] Ctr Dis Control, Taipei, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University	Wu, HS (corresponding author), Ctr Dis Control, Taipei, Taiwan.	wuhs@cdc.gov.tw; mtliu@cdc.gov.tw			Centers for Disease Control, Department of Health, Taiwan [DOH100-DC-2019, DOH100-DC-2022, DOH101-DC-2015, DOH101-DC-2401]	Centers for Disease Control, Department of Health, Taiwan	This study was supported by grants from Centers for Disease Control, Department of Health, Taiwan (DOH100-DC-2019, DOH100-DC-2022, DOH101-DC-2015 and DOH101-DC-2401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIR GM, 1990, P NATL ACAD SCI USA, V87, P3884, DOI 10.1073/pnas.87.10.3884; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P83; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Chen GW, 2007, J CLIN MICROBIOL, V45, P1515, DOI 10.1128/JCM.02189-06; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Chi XS, 2003, J CLIN MICROBIOL, V41, P5770, DOI 10.1128/JCM.41.12.5770-5773.2003; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Jian JW, 2008, J CLIN MICROBIOL, V46, P1426, DOI 10.1128/JCM.01560-07; Jian JW, 2008, VIRUS RES, V131, P243, DOI 10.1016/j.virusres.2007.09.014; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Lin CH, 2002, EPIDEMIOL B, V18, P213; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; Luo C, 1999, ARCH VIROL, V144, P1881, DOI 10.1007/s007050050712; Matsuzaki Y, 2004, J MED VIROL, V74, P132, DOI 10.1002/jmv.20156; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; McCullers JA, 2004, J VIROL, V78, P12817, DOI 10.1128/JVI.78.23.12817-12828.2004; Nerome R, 1998, ARCH VIROL, V143, P1569, DOI 10.1007/s007050050399; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Tsai HP, 2006, J CLIN MICROBIOL, V44, P2705, DOI 10.1128/JCM.02694-05; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; World Health Organization, 2009, WHO INF LAB DIAGN PA	27	63	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47179	10.1371/journal.pone.0047179	http://dx.doi.org/10.1371/journal.pone.0047179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071751	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500035
J	Wu, J; Kakoola, DN; Lenchik, NI; Desiderio, DM; Marshall, DR; Gerling, IC				Wu, Jian; Kakoola, Dorothy N.; Lenchik, Nataliya I.; Desiderio, Dominic M.; Marshall, Dana R.; Gerling, Ivan C.			Molecular Phenotyping of Immune Cells from Young NOD Mice Reveals Abnormal Metabolic Pathways in the Early Induction Phase of Autoimmune Diabetes	PLOS ONE			English	Article							T-CELLS; GENE-EXPRESSION; MOUSE; MODEL; SUSCEPTIBILITY; ACTIVATION; TOLERANCE; APOPTOSIS; MYC; IDENTIFICATION	Islet leukocytic infiltration (insulitis) is first obvious at around 4 weeks of age in the NOD mouse - a model for human type 1 diabetes (T1D). The molecular events that lead to insulitis and initiate autoimmune diabetes are poorly understood. Since TID is caused by numerous genes, we hypothesized that multiple molecular pathways are altered and interact to initiate this disease. We evaluated the molecular phenotype (mRNA and protein expression) and molecular networks of ex vivo unfractionated spleen leukocytes from 2 and 4 week-old NOD mice in comparison to two control strains. Analysis of the global gene expression profiles and hierarchical clustering revealed that the majority (similar to 90%) of the differentially expressed genes in NOD mice were repressed. Furthermore, analysis using a modern suite of multiple bioinformatics approaches identified abnormal molecular pathways that can be divided broadly into 2 categories: metabolic pathways, which were predominant at 2 weeks, and immune response pathways, which were predominant at 4 weeks. Network analysis by Ingenuity pathway analysis identified key genes/molecules that may play a role in regulating these pathways. These included five that were common to both ages (TNF, HNF4A, IL15, Progesterone, and YWHAZ), and others that were unique to 2 weeks (e.g. MYC/MYCN, TGFB1, and IL2) and to 4 weeks (e.g. IFNG, beta-estradiol, p53, NFKB, AKT, PRKCA, IL12, and HLA-C). Based on the literature, genes that may play a role in regulating metabolic pathways at 2 weeks include Myc and HNF4A, and at 4 weeks, beta-estradiol, p53, Akt, HNF4A and AR. Our data suggest that abnormalities in regulation of metabolic pathways in the immune cells of young NOD mice lead to abnormalities in the immune response pathways and as such may play a role in the initiation of autoimmune diabetes. Thus, targeting metabolism may provide novel approaches to preventing and/or treating autoimmune diabetes.	[Wu, Jian; Kakoola, Dorothy N.; Lenchik, Nataliya I.; Desiderio, Dominic M.; Gerling, Ivan C.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA; [Wu, Jian; Kakoola, Dorothy N.; Lenchik, Nataliya I.; Marshall, Dana R.; Gerling, Ivan C.] Vet Affairs Med Ctr, Res Serv, Memphis, TN USA; [Desiderio, Dominic M.] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, Dept Mol Sci, Memphis, TN 38104 USA; [Desiderio, Dominic M.] Univ Tennessee, Hlth Sci Ctr, Charles B Stout Neurosci Mass Spectrometry Lab, Memphis, TN 38104 USA; [Wu, Jian] Capital Med Univ, Xuan Wu Hosp, Dept Neurol, Beijing, Peoples R China; [Marshall, Dana R.] Meharry Med Coll, Sch Med, Dept Pathol Anat & Cell Biol, Nashville, TN 37208 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Capital Medical University; Meharry Medical College	Gerling, IC (corresponding author), Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA.	igerling@uthsc.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH) [DK62103, RR10522, RR14583]; American Diabetes Association (ADA) [ADA 7-11-BS-49]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062103] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association (ADA)(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) grant DK62103, and American Diabetes Association (ADA) grant ADA 7-11-BS-49 to ICG, and NIH instrument grants RR10522 and RR14583 to DMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Conti P, 2007, AUTOIMMUN REV, V6, P131, DOI 10.1016/j.autrev.2006.08.015; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Decallonne B, 2003, J AUTOIMMUN, V20, P219, DOI 10.1016/S0896-8411(03)00025-8; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Elo LL, 2010, J AUTOIMMUN, V35, P70, DOI 10.1016/j.jaut.2010.03.001; Galazka G, 2007, J IMMUNOL, V179, P4503, DOI 10.4049/jimmunol.179.7.4503; Gao P, 2008, CURR GENOMICS, V9, P324, DOI 10.2174/138920208785133253; Gerling IC, 2006, MOL CELL PROTEOMICS, V5, P293, DOI 10.1074/mcp.M500197-MCP200; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Kaminitz A, 2010, J AUTOIMMUN, V35, P145, DOI 10.1016/j.jaut.2010.06.002; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Koochekpour S, 2010, ASIAN J ANDROL, V12, P639, DOI 10.1038/aja.2010.89; Kriegeskorte AK, 2005, P NATL ACAD SCI USA, V102, P11805, DOI 10.1073/pnas.0502026102; Leiter Edward H, 2005, Curr Diab Rep, V5, P141, DOI 10.1007/s11892-005-0042-z; Leiter EH, 2009, DIABETES, V58, P1700, DOI 10.2337/db09-0120; Leiter EH, 1998, NOD MICE RELATED STR, P37; Lenchik NI, 2005, PROTEOMICS, V5, P2202, DOI 10.1002/pmic.200401107; Liston A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r12; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Martins TC, 1998, IMMUNOLOGY, V95, P377; Matsumoto T, 2003, J STEROID BIOCHEM, V85, P95, DOI 10.1016/S0960-0760(03)00231-0; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Menzies FM, 2011, IMMUNOLOGY, V134, P281, DOI 10.1111/j.1365-2567.2011.03488.x; Mollah ZUA, 2008, J IMMUNOL, V180, P3166, DOI 10.4049/jimmunol.180.5.3166; Oh S, 2012, J IMMUNOL, V188, P4171, DOI 10.4049/jimmunol.1103598; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Orban T, 2007, J AUTOIMMUN, V28, P177, DOI 10.1016/j.jaut.2007.01.002; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Qin HY, 2004, INT IMMUNOL, V16, P1723, DOI 10.1093/intimm/dxh173; Rathmell JC, 2011, IMMUNITY, V35, P845, DOI 10.1016/j.immuni.2011.12.001; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Stoffels K, 2007, J STEROID BIOCHEM, V103, P567, DOI 10.1016/j.jsbmb.2006.12.091; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Thomas HE, 2000, DIABETES-METAB RES, V16, P251, DOI 10.1002/1520-7560(200007/08)16:4<251::AID-DMRR126>3.3.CO;2-3; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Vargas Roberto, 2010, Rev Obstet Gynecol, V3, P92; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WEISS PAM, 1984, OBSTET GYNECOL, V64, P629; Wu J, 2005, ELECTROPHORESIS, V26, P225, DOI 10.1002/elps.200406176; Wu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S12; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	59	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46941	10.1371/journal.pone.0046941	http://dx.doi.org/10.1371/journal.pone.0046941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071669	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700043
J	Baru, AM; Ganesh, V; Krishnaswamy, JK; Hesse, C; Untucht, C; Glage, S; Behrens, G; Mayer, CT; Puttur, F; Sparwasser, T				Baru, Abdul Mannan; Ganesh, Venkateswaran; Krishnaswamy, Jayendra Kumar; Hesse, Christina; Untucht, Christopher; Glage, Silke; Behrens, Georg; Mayer, Christian Thomas; Puttur, Franz; Sparwasser, Tim			Absence of Foxp3(+) Regulatory T Cells during Allergen Provocation Does Not Exacerbate Murine Allergic Airway Inflammation	PLOS ONE			English	Article							IN-VIVO DEPLETION; SELECTIVE DEPLETION; IMMUNE-RESPONSES; ASTHMA; MACROPHAGES; EXPRESSION; SENSITIZATION; RECRUITMENT; ANTIBODY; LOCUS	Regulatory T cells (Tregs) play a non-redundant role in maintenance of immune homeostasis. This is achieved by suppressing both, priming of naive cells and effector cell functions. Although Tregs have been implicated in modulating allergic immune responses, their influence on distinct phases of development of allergies remains unclear. In this study, by using bacterial artificial chromosome (BAC)-transgenic Foxp3-DTR (DEREG) mice we demonstrate that the absence of Foxp3(+) Tregs during the allergen challenge surprisingly does not exacerbate allergic airway inflammation in BALB/c mice. As genetic disposition due to strain specificity may contribute significantly to development of allergies, we performed similar experiment in C57BL/6 mice, which are less susceptible to allergy in the model of sensitization used in this study. We report that the genetic background does not influence the consequence of this depletion regimen. These results signify the temporal regulation exerted by Foxp3(+) Tregs in limiting allergic airway inflammation and may influence their application as potential therapeutics.	[Baru, Abdul Mannan; Ganesh, Venkateswaran; Hesse, Christina; Untucht, Christopher; Mayer, Christian Thomas; Puttur, Franz; Sparwasser, Tim] TWINCORE, Inst Infect Immunol, Ctr Expt & Clin Infect Res, Hannover, Germany; [Krishnaswamy, Jayendra Kumar; Behrens, Georg] Hannover Med Sch, Dept Clin Immunol & Rheumatol, D-3000 Hannover, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School	Sparwasser, T (corresponding author), TWINCORE, Inst Infect Immunol, Ctr Expt & Clin Infect Res, Hannover, Germany.	Tim.Sparwasser@twincore.de	Sparwasser, Tim D/AAA-4306-2022; Sparwasser, Tim/AAF-7085-2019; Behrens, Georg MN/Q-4486-2016	Sparwasser, Tim/0000-0001-5645-902X; Krishnaswamy, Jayendra Kumar/0000-0002-7939-6559	Deutsche Forschungsgemeinschaft [SFB587 (Sonderforschungsbereich 587)]; Research Training Group [GRK 1441]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Training Group	This work was supported by the Deutsche Forschungsgemeinschaft SFB587 (Sonderforschungsbereich 587). JKK and CH were supported by Research Training Group (GRK 1441). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Amu S, 2006, SCAND J IMMUNOL, V64, P482, DOI 10.1111/j.1365-3083.2006.01832.x; ARDAVIN C, 1992, EUR J IMMUNOL, V22, P859, DOI 10.1002/eji.1830220334; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; De Vooght V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012581; Dittrich AM, 2008, J IMMUNOL, V180, P1792, DOI 10.4049/jimmunol.180.3.1792; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Hadeiba H, 2003, J IMMUNOL, V170, P5502, DOI 10.4049/jimmunol.170.11.5502; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jaffar Z, 2004, J IMMUNOL, V172, P3842, DOI 10.4049/jimmunol.172.6.3842; Joetham A, 2007, J IMMUNOL, V178, P1433, DOI 10.4049/jimmunol.178.3.1433; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Kelada SNP, 2011, AM J RESP CELL MOL, V45, P817, DOI 10.1165/rcmb.2010-0315OC; Kim J, 2009, J IMMUNOL, V183, P7631, DOI 10.4049/jimmunol.0804308; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liston A, 2007, J EXP MED, V204, P475, DOI 10.1084/jem.20062465; Lluis A, 2011, J ALLERGY CLIN IMMUN, V127, P1587, DOI 10.1016/j.jaci.2011.03.015; Manrique SZ, 2011, J EXP MED, V208, P1485, DOI 10.1084/jem.20100730; Matsumoto K, 2009, RESPIROLOGY, V14, P187, DOI 10.1111/j.1440-1843.2008.01472.x; Mayer CT, 2012, BLOOD, V119, P1314, DOI 10.1182/blood-2011-11-392266; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Put S, 2012, BLOOD, V119, P1316, DOI 10.1182/blood-2011-11-391755; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Suto A, 2001, AM J RESP CRIT CARE, V164, P680, DOI 10.1164/ajrccm.164.4.2010170; Suttner K, 2010, J ALLERGY CLIN IMMUN, V125, P1395, DOI 10.1016/j.jaci.2010.02.017; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; ZUANYAMORIM C, 1995, J CLIN INVEST, V95, P2644, DOI 10.1172/JCI117966	41	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47102	10.1371/journal.pone.0047102	http://dx.doi.org/10.1371/journal.pone.0047102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071726	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200080
J	Gaertner, A; Klauke, B; Stork, I; Niehaus, K; Niemann, G; Gummert, J; Milting, H				Gaertner, Anna; Klauke, Baerbel; Stork, Ines; Niehaus, Karsten; Niemann, Gesa; Gummert, Jan; Milting, Hendrik			In Vitro Functional Analyses of Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmoglein-2-Missense Variations	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; HEART-MUSCLE CELLS; DESMOSOMAL CADHERINS; EXTRACELLULAR DOMAIN; QUALITY-CONTROL; AREA-COMPOSITA; WOOLLY HAIR; MUTATIONS; IDENTIFICATION	In Background: Although numerous sequence variants in desmoglein-2 (DSG2) have been associated with arrhythmogenic right ventricular cardiomyopathy (ARVC), the functional impact of new sequence variations is difficult to estimate. Methodology/Principal Findings: To test the functional consequences of DSG2-variants, we established an expression system for the extracellular domain and the full-length DSG2 using the human cell line HT1080. We established new tools to investigate ARVC-associated DSG2 variations and compared wild-type proteins and proteins with one of the five selected variations (DSG2-p.R46Q, -p.D154E, -p.D187G, -p.K294E, -p.V392I) with respect to prodomain cleavage, adhesion properties and cellular localisation. Conclusions/Significance: The ARVC-associated DSG2-p.R46Q variation was predicted to be probably damaging by bioinformatics tools and to concern a conserved proprotein convertase cleavage site. In this study an impaired prodomain cleavage and an influence on the DSG2-properties could be demonstrated for the R46Q-variant leading to the classification of the variant as a potential gain-of-function mutant. In contrast, the variants DSG2-p.K294E and -p.V392I, which have an arguable impact on ARVC pathogenesis and are predicted to be benign, did not show functional differences to the wild-type protein in our study. Notably, the variants DSG2-p.D154E and -p.D187G, which were predicted to be damaging by bioinformatics tools, had no detectable effects on the DSG2 protein properties in our study.	[Gaertner, Anna; Klauke, Baerbel; Stork, Ines; Gummert, Jan; Milting, Hendrik] Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Bad Oeynhausen, Germany; [Niehaus, Karsten] Univ Bielefeld, Fac Biol, Dept Proteome & Metabolome Res, D-33615 Bielefeld, Germany; [Niehaus, Karsten] Univ Bielefeld, Ctr Biotechnol CeBiTec, D-33615 Bielefeld, Germany	Ruhr University Bochum; University of Bielefeld; University of Bielefeld	Milting, H (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Bad Oeynhausen, Germany.	hmilting@hdz-nrw.de	Gärtner, Anna/X-6863-2019	Gärtner, Anna/0000-0001-6899-7693	FoRUM-Forschungsforderung der Ruhr-Universitat Bochum Medizinische Fakultat [F649R-2009]; Erich und Hanna Klessmann-Stiftung, Gutersloh, Germany	FoRUM-Forschungsforderung der Ruhr-Universitat Bochum Medizinische Fakultat; Erich und Hanna Klessmann-Stiftung, Gutersloh, Germany	This work was in parts supported by FoRUM-Forschungsforderung der Ruhr-Universitat Bochum Medizinische Fakultat (http://www.ruhr-uni-bochum.de/medizin/forum/) (grant number F649R-2009), and by the Erich und Hanna Klessmann-Stiftung, Gutersloh, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaum SP, 2009, BIOINFORMATICS, V25, P3128, DOI 10.1093/bioinformatics/btp568; Alcalai R, 2003, J AM COLL CARDIOL, V42, P319, DOI 10.1016/S0735-1097(03)00628-4; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Awad MM, 2006, AM J HUM GENET, V79, P136, DOI 10.1086/504393; Basso C, 1996, CIRCULATION, V94, P983, DOI 10.1161/01.CIR.94.5.983; Borrmann CM, 2006, EUR J CELL BIOL, V85, P469, DOI 10.1016/j.ejcb.2006.02.009; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; Corrado D, 1997, J AM COLL CARDIOL, V30, P1512, DOI 10.1016/S0735-1097(97)00332-X; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; De Bortoli M, 2010, EUR J HUM GENET, V18, P776, DOI 10.1038/ejhg.2010.19; Evans P, 2007, EXP EYE RES, V84, P1001, DOI 10.1016/j.exer.2007.01.016; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Gaertner A, 2012, PHYSIOL GENOMICS, V44, P99, DOI 10.1152/physiolgenomics.00094.2011; Gehmlich K, 2011, CARDIOVASC PATHOL; Gehmlich K, 2011, CARDIOVASC RES, V90, P77, DOI 10.1093/cvr/cvq353; Gehmlich K, 2011, HEART RHYTHM, V8, P711, DOI 10.1016/j.hrthm.2011.01.010; Gehmlich K, 2010, HEART RHYTHM, V7, P1446, DOI 10.1016/j.hrthm.2010.08.007; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gloushankova NA, 2003, CELL TISSUE RES, V314, P399, DOI 10.1007/s00441-003-0812-3; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Klauke B, 2010, HUM MOL GENET, V19, P4595, DOI 10.1093/hmg/ddq387; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; KOCH PJ, 1990, EUR J CELL BIOL, V53, P1; KOCH PJ, 1992, P NATL ACAD SCI USA, V89, P353, DOI 10.1073/pnas.89.1.353; Koeser J, 2003, EXP CELL RES, V285, P114, DOI 10.1016/S0014-4827(03)00016-8; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Pilichou K, 2009, J EXP MED, V206, P1787, DOI 10.1084/jem.20090641; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Posthaus H, 2003, FEBS LETT, V536, P203, DOI 10.1016/S0014-5793(02)03897-8; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RAYNS DG, 1969, J CELL BIOL, V42, P322, DOI 10.1083/jcb.42.1.322; Sano R, 2009, SOLUTION ST IN PRESS, DOI [10.2210/pdb2yqg/pdb, DOI 10.2210/PDB2YQG/PDB]; Schafer S, 1996, DIFFERENTIATION, V60, P99, DOI 10.1046/j.1432-0436.1996.6020099.x; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Sen-Chowdhry S, 2007, J AM COLL CARDIOL, V50, P1813, DOI 10.1016/j.jacc.2007.08.008; SJOSTRAND FS, 1954, EXPERIENTIA, V10, P369, DOI 10.1007/BF02160542; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122; Tavora F, 2011, HUM PATHOL; Thiene G, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-45; Troyanovsky RB, 1999, J CELL SCI, V112, P4379; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vollenweider F, 1996, BIOCHEM J, V314, P521, DOI 10.1042/bj3140521; Waschke J, 2007, J MEMBRANE BIOL, V216, P83, DOI 10.1007/s00232-007-9037-9; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Whittock NV, 2003, J INVEST DERMATOL, V120, P523, DOI 10.1046/j.1523-1747.2003.12113.x; Windoffer R, 2002, J CELL SCI, V115, P1717; Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020	71	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47097	10.1371/journal.pone.0047097	http://dx.doi.org/10.1371/journal.pone.0047097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071725	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200079
J	Peng, YT; Chen, J; He, S; Yang, J; Wu, H				Peng, Yating; Chen, Jie; He, Shan; Yang, Jun; Wu, Hao			Release of ATP from Marginal Cells in the Cochlea of Neonatal Rats Can Be Induced by Changes in Extracellular and Intracellular Ion Concentrations	PLOS ONE			English	Article							INOSITOL-TRISPHOSPHATE; STRIA VASCULARIS; CALCIUM; ORGAN; TRIPHOSPHATE; TRANSDUCTION; DEGRADATION; PROPAGATION; EXPOSURE; CORTI	Background: Adenosine triphosphate (ATP) plays an important role in the cochlea. However, the source of ATP and the mechanism by which it is released remain unclear. This study investigates the presence and release mechanism of ATP in vitro cultured marginal cells isolated from the stria vascularis of the cochlea in neonatal rats. Methods: Sprague-Dawley rats aged 1-3 days old were used for isolation, in vitro culture, and purification of marginal cells. Cultured marginal cells were verified by flow cytometry. Vesicles containing ATP in these cells were identified by fluorescence staining. The bioluminescence assay was used for determination of ATP concentration in the extracellular fluid released by marginal cells. Assays for ATP concentration were performed when the ATP metabolism of cells was influenced, and ionic concentrations in intracellular and extracellular fluid were found to change. Results: Evaluation of cultured marginal cells with flow cytometry revealed the percentage of fluorescently-labeled cells as 92.9% and 81.9%, for cytokeratin and vimentin, respectively. Quinacrine staining under fluorescence microscopy revealed numerous green, star-like spots in the cytoplasm of these cells. The release of ATP from marginal cells was influenced by changes in the concentration of intracellular and extracellular ions, namely extracellular K+ and intra-and extracellular Ca2+. Furthermore, changes in the concentration of intracellular Ca2+ induced by the inhibition of the phospholipase signaling pathway also influence the release of ATP from marginal cells. Conclusion: We confirmed the presence and release of ATP from marginal cells of the stria vascularis. This is the first study to demonstrate that the release of ATP from such cells is associated with the state of the calcium pump, K+ channel, and activity of enzymes related to the phosphoinositide signaling pathway, such as adenylate cyclase, phospholipase C, and phospholipase A(2).	[Peng, Yating; Yang, Jun; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Peng, Yating; Yang, Jun; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai 200030, Peoples R China; [Peng, Yating] Hangzhou Red Cross Hosp, Integrated Chinese & Western Med Hosp Zhejiang Pr, Dept Otolaryngol, Hangzhou, Zhejiang, Peoples R China; [Chen, Jie] Shanghai Childrens Med Ctr, Dept Otolaryngol, Shanghai, Peoples R China; [He, Shan] Peoples Hosp Shanghai Pudong Dist, Dept Otolaryngol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	otology-xinhua@hotmail.com			National Natural Science Foundation of China [81170919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81170919). The funders had no role in study design, data collection and analysis, decision to publish, or preparation manuscript.	Aixia Dou, 2004, ACAD J SHANGHAI 2 ME, V24, P1070; ASAOKA Y, 1992, TRENDS BIOCHEM SCI, V17, P414, DOI 10.1016/0968-0004(92)90011-W; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Churchill GC, 1996, J CELL SCI, V109, P355; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Enkvetchakul D, 2001, BIOPHYS J, V80, P719, DOI 10.1016/S0006-3495(01)76051-1; Friedmann IR, 1984, BUTTERWORTHS LONDON, V30, P45; HINOJOSA R, 1977, ACTA OTO-LARYNGOL, V84, P238, DOI 10.3109/00016487709123963; Housley GD, 2002, AUDIOL NEURO-OTOL, V7, P55, DOI 10.1159/000046865; Housley GD, 2000, J AUTONOM NERV SYST, V81, P139, DOI 10.1016/S0165-1838(00)00116-8; IRVIN JL, 1954, J BIOL CHEM, V210, P45; Kasoer M, 1987, ARCH OTORHINOLARYNGO, V244, P66; KOH WS, 1995, BIOCHEM BIOPH RES CO, V206, P703, DOI 10.1006/bbrc.1995.1099; Liang Y, 2009, EUR J HISTOCHEM, V53, P249, DOI 10.4081/ejh.2009.e30; LONDOS C, 1977, P NATL ACAD SCI USA, V74, P5482, DOI 10.1073/pnas.74.12.5482; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; SANDERSON MJ, 1994, MOL CELL ENDOCRINOL, V98, P173, DOI 10.1016/0303-7207(94)90136-8; SCHARFF O, 1988, BIOCHIM BIOPHYS ACTA, V972, P257, DOI 10.1016/S0005-2728(88)80056-2; SUZUKI M, 1995, HEARING RES, V86, P68, DOI 10.1016/0378-5955(95)00055-9; Thorne PR, 2002, AUDIOL NEURO-OTOL, V7, P180, DOI 10.1159/000058307; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; UTSUYAMA M, 1993, INT IMMUNOL, V5, P1177, DOI 10.1093/intimm/5.9.1177; VISHWANATH BS, 1987, TOXICON, V25, P929, DOI 10.1016/0041-0101(87)90155-3; Vlajkovic SM, 2004, NEUROSCIENCE, V126, P763, DOI 10.1016/j.neuroscience.2004.04.023; Wangemann P, 1996, AUDIT NEUROSCI, V2, P187; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; WILLEMS PHGM, 1994, PFLUG ARCH EUR J PHY, V427, P233, DOI 10.1007/BF00374529; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102; Zhao HB, 2005, EUR J NEUROSCI, V21, P1859, DOI 10.1111/j.1460-9568.2005.04031.x	36	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47124	10.1371/journal.pone.0047124	http://dx.doi.org/10.1371/journal.pone.0047124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071731	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200082
J	Huang, YF; Yang, CH; Huang, CC; Hsu, KS				Huang, Yu-Fei; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen			Vascular Endothelial Growth Factor-dependent Spinogenesis Underlies Antidepressant-like Effects of Enriched Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR DEPRESSIVE DISORDER; MEDIATED ANTAGOMIR EXPRESSION; UNPREDICTABLE MILD STRESS; D-ASPARTATE ANTAGONIST; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; RAT-BRAIN; LEARNED HELPLESSNESS; BEHAVIORAL ACTIONS; GENE-EXPRESSION	Current antidepressant treatments remain limited by poor efficacy and a slow onset of action. Increasing evidence demonstrates that enriched environment (EE) treatment can promote structural and behavioral plasticity in the brain and dampen stress-induced alterations of neuroplasticity. Here, we have examined whether short term exposure to EE is able to produce antidepressant-like effects. Our results show that housing adult mice in an EE cage for 7 days led to antidepressant-like behavioral profiles and a significant increase in the number of dendritic spines in hippocampal CA1 pyramidal neurons. These EE-induced antidepressant-like effects are primarily attributed to increased vascular endothelial growth factor (VEGF) expression through a hypoxia-inducible factor-1 alpha (HIF-1 alpha)-mediated transcriptional mechanism. Blockade of HIF-1 alpha synthesis by lentiviral infection with HIF-1 alpha small hairpin RNAs completely blocked the increase in expression of VEGF and the antidepressant-like effects induced by EE. Moreover, no significant antidepressant-like effects were observed with EE treatment in VEGF receptor 2 (Flk-1) knock-out mice. The increase in HIF-1 alpha expression in the hippocampus induced by EE was associated with a decrease in endogenous levels of microRNA-107 (miR-107). Overexpression of miR-107 in the hippocampus completely blocked EE-induced HIF-1 alpha expression and the antidepressant-like effects. These results support a model in which the down-regulation of miR-107, acting through HIF-1 alpha, mediates VEGF-dependent spinogenesis to underlie the EE-induced antidepressant-like effects.	[Huang, Yu-Fei; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan; [Huang, Yu-Fei; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Hsu, KS (corresponding author), Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021		National Health Research Institute Research Grant [NHRI-EX101-9618NI]; National Science Council, Taiwan [NSC99-2321-B-006-001]	National Health Research Institute Research Grant; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institute Research Grant NHRI-EX101-9618NI and by National Science Council Grant NSC99-2321-B-006-001, Taiwan.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berchtold NC, 2002, J NEUROSCI RES, V68, P511, DOI 10.1002/jnr.10256; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cooper DC, 2006, BEHAV BRAIN RES, V174, P225, DOI 10.1016/j.bbr.2006.05.036; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cryan JF, 2010, SCIENCE, V329, P913, DOI 10.1126/science.1194313; Dalvi A, 1999, PSYCHOPHARMACOLOGY, V147, P14, DOI 10.1007/s002130051131; De Foubert G, 2004, NEUROSCIENCE, V128, P597, DOI 10.1016/j.neuroscience.2004.06.054; de la Pena FA, 2011, J BIOL CHEM, V286, P20778, DOI 10.1074/jbc.M110.198069; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Dolt KS, 2007, GENE, V386, P73, DOI 10.1016/j.gene.2006.08.004; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Fournier NM, 2012, BEHAV BRAIN RES, V227, P440, DOI 10.1016/j.bbr.2011.04.022; Franklin B.J, 2008, MOUSE BRAIN STEREOTA; Frodl T, 2004, J CLIN PSYCHIAT, V65, P492; Gallassi R, 2006, J AFFECT DISORDERS, V91, P243, DOI 10.1016/j.jad.2006.01.018; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Hajszan T, 2010, BIOL PSYCHIAT, V67, P168, DOI 10.1016/j.biopsych.2009.08.017; Hajszan T, 2009, BIOL PSYCHIAT, V65, P392, DOI 10.1016/j.biopsych.2008.09.031; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang YF, 2010, J NEUROSCI, V30, P6080, DOI 10.1523/JNEUROSCI.5493-09.2010; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Knierim JJ, 2006, HIPPOCAMPUS, V16, P755, DOI 10.1002/hipo.20203; Koh S, 2005, J CHILD NEUROL, V20, P796, DOI 10.1177/08830738050200100301; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Kuzumaki N, 2011, HIPPOCAMPUS, V21, P127, DOI 10.1002/hipo.20775; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; Lee JS, 2009, J NEUROSCI, V29, P8493, DOI 10.1523/JNEUROSCI.1321-09.2009; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Moreau J L, 1992, Eur Neuropsychopharmacol, V2, P43; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Surdziel E, 2010, METHODS MOL BIOL, V667, P237, DOI 10.1007/978-1-60761-811-9_16; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Trivedi MH, 2006, CLIN TRIALS, V3, P291, DOI 10.1191/1740774506cn151oa; Veena J, 2009, J NEUROSCI RES, V87, P831, DOI 10.1002/jnr.21907; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Winter C, 2007, BEHAV BRAIN RES, V184, P133, DOI 10.1016/j.bbr.2007.07.002; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wright RL, 2008, BEHAV BRAIN RES, V187, P41, DOI 10.1016/j.bbr.2007.08.025; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	87	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40938	40955		10.1074/jbc.M112.392076	http://dx.doi.org/10.1074/jbc.M112.392076			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23074224	Green Published, hybrid			2022-12-25	WOS:000311887600013
J	Grellet-Tinner, G; Murelaga, X; Larrasoana, JC; Silveira, LF; Olivares, M; Ortega, LA; Trimby, PW; Pascual, A				Grellet-Tinner, Gerald; Murelaga, Xabier; Larrasoana, Juan C.; Silveira, Luis F.; Olivares, Maitane; Ortega, Luis A.; Trimby, Patrick W.; Pascual, Ana			The First Occurrence in the Fossil Record of an Aquatic Avian Twig-Nest with Phoenicopteriformes Eggs: Evolutionary Implications	PLOS ONE			English	Article							EBRO BASIN; LOWER MIOCENE; AVES; DIFFRACTION; PHYLOGENY; BIRDS	Background: We describe the first occurrence in the fossil record of an aquatic avian twig-nest with five eggs in situ (Early Miocene Tudela Formation, Ebro Basin, Spain). Extensive outcrops of this formation reveal autochthonous avian osteological and oological fossils that represent a single taxon identified as a basal phoenicopterid. Although the eggshell structure is definitively phoenicopterid, the characteristics of both the nest and the eggs are similar to those of modern grebes. These observations allow us to address the origin of the disparities between the sister taxa Podicipedidae and Phoenicopteridae crown clades, and traces the evolution of the nesting and reproductive environments for phoenicopteriforms. Methodology/Principal Findings: Multi-disciplinary analyses performed on fossilized vegetation and eggshells from the eggs in the nest and its embedding sediments indicate that this new phoenicopterid thrived under a semi-arid climate in an oligohaline (seasonally mesohaline) shallow endorheic lacustine environment. High-end microcharacterizations including SEM, TEM, and EBSD techniques were pivotal to identifying these phoenicopterid eggshells. Anatomical comparisons of the fossil bones with those of Phoenicopteriformes and Podicipediformes crown clades and extinct palaelodids confirm that this avian fossil assemblage belongs to a new and basal phoenicopterid. Conclusions/Significance: Although the Podicipediformes-Phoenicopteriformes sister group relationship is now well supported, flamingos and grebes exhibit feeding, reproductive, and nesting strategies that diverge significantly. Our multi-disciplinary study is the first to reveal that the phoenicopteriform reproductive behaviour, nesting ecology and nest characteristics derived from grebe-like type strategies to reach the extremely specialized conditions observed in modern flamingo crown groups. Furthermore, our study enables us to map ecological and reproductive characters on the Phoenicopteriformes evolutionary lineage. Our results demonstrate that the nesting paleoenvironments of flamingos were closely linked to the unique ecology of this locality, which is a direct result of special climatic (high evaporitic regime) and geological (fault system) conditions.	[Grellet-Tinner, Gerald] CRILAR, CONICET, Anillaco, Argentina; [Grellet-Tinner, Gerald] Field Museum, Chicago, IL USA; [Grellet-Tinner, Gerald] Journey Museum, Rapid City, SD USA; [Murelaga, Xabier; Olivares, Maitane; Ortega, Luis A.; Pascual, Ana] Euskal Herriko Unibertsitatea, Fac Ciencia & Tecnol, Dept Estratig & Paleontol, Bilbao, Spain; [Larrasoana, Juan C.] Inst Geol & Minero Espana, Zaragoza, Spain; [Silveira, Luis F.] Univ Sao Paulo, Secao Aves, Museu Zool, Sao Paulo, Brazil; [Trimby, Patrick W.] Univ Sydney, Australian Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Field Museum of Natural History (Chicago); University of Basque Country; Universidade de Sao Paulo; University of Sydney	Grellet-Tinner, G (corresponding author), CRILAR, CONICET, Anillaco, Argentina.	locarnolugano@gmail.com	Olivares, Maitane/C-4044-2017; Larrasoana, Juan C./O-1350-2013; Silveira, Luis Fabio/F-8337-2012; Murelaga, Xabier/O-2262-2019; Olivares, Maitane/AAY-7123-2021; Silveira, Luis/V-6161-2019; Pascual, Ana/F-8753-2016; Ortega, Luis Angel/K-8453-2014	Olivares, Maitane/0000-0001-7047-3055; Silveira, Luis Fabio/0000-0003-2576-7657; Murelaga, Xabier/0000-0001-8049-4917; Silveira, Luis/0000-0003-2576-7657; Pascual, Ana/0000-0001-9822-6478; Ortega, Luis Angel/0000-0002-8929-0328; Larrasoana, Juan Cruz/0000-0003-4568-631X	Australian Microscopy and Microanalysis Research Facility TAP GRANT [1016]; REMOSS 3D-4D [CGL2007-66431-C02-02/BTE]; FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo) [2007/56378-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [313818/2009-6]	Australian Microscopy and Microanalysis Research Facility TAP GRANT; REMOSS 3D-4D; FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for eggshell microcharacterization came from the Australian Microscopy and Microanalysis Research Facility TAP GRANT# 1016 (to GGT). Fieldwork was supported by project REMOSS 3D-4D CGL2007-66431-C02-02/BTE (to XM and JCL) and some laboratory analyses were funded by the FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo, grant 2007/56378-0) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 313818/2009-6) (to LFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Zarza A.M., 2002, GEOLOGY SPAIN, DOI [10.1144/gospp.13, DOI 10.1144/GOSPP.13]; ALVARENGA H M F, 1990, Anais da Academia Brasileira de Ciencias, V62, P335; Arenas C, 1999, PALAEOGEOGR PALAEOCL, V151, P127, DOI 10.1016/S0031-0182(99)00025-5; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Boles WE, 1991, ACT 20 C INT ORN; Bonaparte CL, 1838, GEOGRAPHICAL COMP LI; Caziani Sandra M., 2000, Waterbirds, V23, P121, DOI 10.2307/1522157; CHENEVAL J, 1983, GEOBIOS-LYON, V16, P179, DOI 10.1016/S0016-6995(83)80018-7; DINGLEY DJ, 1984, SCAN ELECTRON MICROS, P569; Feduccia A, 1999, P NATL ACAD SCI USA, V96, P4740, DOI 10.1073/pnas.96.9.4740; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Garces M, 2009, GEOPH RES ABSTR, V11, P4594; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grellet-Tinner G, 2006, ALCHERINGA, V30, P141, DOI 10.1080/03115510608619350; Grellet-Tinner G, 2000, 1 INT S DIN EGGS BAB, P61; Grellet-Tinner G, 2011, GONDWANA RES, V20, P621, DOI 10.1016/j.gr.2011.02.007; HARTMANN G, 1974, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V70, P7; Hilgen FJ, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P923, DOI 10.1016/B978-0-444-59425-9.00029-9; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Johnsgard PA, 2009, BIRDS GREAT PLAINS; Kempf EK, 1997, INDEX BIBLIO NONMARI; Kempf EK, 1980, INDEX BIBLIO NONMARI; Kohring R, 1999, STRUKTUREN BIOSTRATI; Larrasoana JC, 2006, EARTH PLANET SC LETT, V243, P409, DOI 10.1016/j.epsl.2006.01.034; Llimona F., 1992, P174; Luzon A, 2002, J PALEOLIMNOL, V28, P441, DOI 10.1023/A:1021675227754; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2004, ZOOL J LINN SOC-LOND, V140, P157, DOI 10.1111/j.1096-3642.2003.00094.x; Mayr G., 2006, SPECIES PHYLOGENY EV, V1, P59; Mayr Gerald, 2002, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V72, P139; Mayr Gerald, 2011, Palaeobiodiversity Palaeoenvironments, V91, P325, DOI 10.1007/s12549-011-0062-4; Meisch C, 2000, SUSSWASSERFAUNA MITT, V8, P522; Murelaga X, 2002, GEOBIOS-LYON, V35, P347, DOI 10.1016/S0016-6995(02)00031-1; Murelaga X., 2006, Munibe (Ciencias Naturales - Natur Zientziak), V55, P7; MURELAGA X., 2004, GEOGACETA, V36, P179; Murelaga X, 2000, ESTUDIO FAUNAS VERTE; Olivares M, 2011, J CHROMATOGR A, V1218, P1656, DOI 10.1016/j.chroma.2010.11.034; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Olson Storrs L., 1995, Courier Forschungsinstitut Senckenberg, V181, P131; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Peters K.E., 2005, BIOMARKER GUIDE; Pipik R, 2007, ACTA PALAEONTOL POL, V52, P351; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Prior DJ, 1999, AM MINERAL, V84, P1741; Rasmussen DT, 1987, FOSSIL BIRDS OLIGOCE; RICH P V, 1987, Memoirs of the Queensland Museum, V25, P207; Ruiz-Sanchez FJ, 2012, ACTA PALAEONTOL POL, V57, P225, DOI 10.4202/app.2010.0081; SALVANY JM, 1994, J SEDIMENT RES A, V64, P190; Salvany JM, 2007, SEDIMENTOLOGY, V54, P443, DOI 10.1111/j.1365-3091.2006.00844.x; Sangster G, 2005, IBIS, V147, P612, DOI 10.1111/j.1474-919x.2005.00432.x; Schwartz A. J., 2009, ELECT BACKSCATTER DI; Soto R, 2009, J STRUCT GEOL, V31, P512, DOI 10.1016/j.jsg.2009.03.006; Svec P., 1982, Casopis pro Mineralogii a Geologii, V27, P243; Svec P, 1984, CASOPIS PRO MINERALO, V29, P167; Trimby P, 2011, HIDDEN SECRETS DINOS, V24, P4; Van Tuinen M, 2001, P ROY SOC B-BIOL SCI, V268, P1345; VANBERGEN PF, 1994, GEOCHIM COSMOCHIM AC, V58, P231, DOI 10.1016/0016-7037(94)90460-X; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; Worthy TH, 2010, REC AUST MUS, V62, P77, DOI 10.3853/j.0067-1975.62.2010.1545	60	22	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46972	10.1371/journal.pone.0046972	http://dx.doi.org/10.1371/journal.pone.0046972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082136	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900031
J	Bai, F; Groth, HL; Kawai, M				Bai, Fan; Groth, Heather L.; Kawai, Masataka			DCM-Related Tropomyosin Mutants E40K/E54K Over-Inhibit the Actomyosin Interaction and Lead to a Decrease in the Number of Cycling Cross-Bridges	PLOS ONE			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; RABBIT PSOAS FIBERS; SKINNED VENTRICULAR MUSCLE; DIASTOLIC HEART-FAILURE; ALPHA-TROPOMYOSIN; THIN FILAMENT; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-MUSCLE; BOVINE MYOCARDIUM; ISOMETRIC TENSION	Two DCM mutants (E40K and E54K) of tropomyosin (Tm) were examined using the thin-filament extraction/reconstitu-tion technique. The effects of the Ca2+, ATP, phos-phate (Pi), and ADP concentrations on isometric tension and its transients were studied at 25 degrees C, and the results were com-pared to those for the WT protein. Our results indicate that both E40K and E54K have a significantly lower T-HC (high Ca2+ ten-sion at pCa 4.66) (E40K: 1.21+/-0.06 T-a, +/-SEM, N = 34; E54K: 1.24+/-0.07 T-a, N = 28), a significantly lower T-LC (low-Ca2+ tension at pCa 7.0) (E40K: 0.07+/-0.02 T-a, N = 34; E54K: 0.06+/-0.02 T-a, N = 28), and a significantly lower T-act (Ca2+ activatable tension) (T-act = T-HC-T-LC, E40K: 1.15+/-0.08 T-a, N = 34; E54K: 1.18+/-0.06 T-a, N = 28) than WT (T-HC = 1.53+/-0.07 T-a, T-LC = 0.12+/-0.01 T-a, T-act = 1.40+/-0.07 T-a, N = 25). All tensions were normalized to T-a (= 13.9+/-0.8 kPa, N = 57), the ten-sion of actin-filament reconstituted cardiac fibers (myocardium) under the standard activating conditions. The Ca2+ sensitivity (pCa(50)) of E40K (5.23+/-0.02, N = 34) and E54K (5.24+/-0.03, N = 28) was similar to that of the WT protein (5.26+/-0.03, N = 25). The cooper-a-tivity increased significantly in E54K (3.73+/-0.25, N = 28) compared to WT (2.80+/-0.17, N = 25). Seven kinetic constants were deduced using sinusoidal analysis at pCa 4.66. These results enabled us to calculate the cross-bridge distribution in the strongly attached states, and thereby deduce the force/cross-bridge. The results indicate that the force/cross-bridge is similar to 15% less in E54K than WT, but remains similar to that of the WT protein in the case of E40K. We conclude that over-inhibition of the actomyosin interaction by E40K and E54K Tm mutants leads to a decreased force-generating ability at systole, which is the main mechanism underlying the early pathogenesis of DCM.	[Kawai, Masataka] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Kawai, M (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	masataka-kawai@uiowa.edu	Bai, Fan/I-8572-2012	Kawai, Masataka/0000-0002-3219-3527	National Institute of Health [HL70041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070041] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by a grant National Institute of Health HL70041. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Borovikov YS, 2011, BIOCHEM BIOPH RES CO, V411, P496, DOI 10.1016/j.bbrc.2011.06.138; BRANDT PW, 1982, J GEN PHYSIOL, V79, P997, DOI 10.1085/jgp.79.6.997; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Dweck D, 2010, J BIOL CHEM, V285, P17371, DOI 10.1074/jbc.M109.064105; Fozzard HA, 1992, HEART CARDIOVASCULAR; Fujita H, 2004, J PHYSIOL-LONDON, V556, P637, DOI 10.1113/jphysiol.2003.059956; Fujita H, 2002, BIOPHYS J, V82, P915, DOI 10.1016/S0006-3495(02)75453-2; Fujita H, 2002, J PHYSIOL-LONDON, V539, P267, DOI 10.1113/jphysiol.2001.013220; Fujita H, 1996, BIOPHYS J, V71, P2307, DOI 10.1016/S0006-3495(96)79465-1; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GILLUM RF, 1986, AM HEART J, V111, P752, DOI 10.1016/0002-8703(86)90111-0; GODT RE, 1988, AM J PHYSIOL, V254, pC591, DOI 10.1152/ajpcell.1988.254.5.C591; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Hanft LM, 2008, CARDIOVASC RES, V77, P627, DOI 10.1093/cvr/cvm099; HARRISON SM, 1989, J GEN PHYSIOL, V93, P411, DOI 10.1085/jgp.93.3.411; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Holthauzen LMF, 2004, J BIOL CHEM, V279, P15204, DOI 10.1074/jbc.M308904200; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; JULIAN FJ, 1981, J PHYSIOL-LONDON, V311, P179, DOI 10.1113/jphysiol.1981.sp013580; KAWAI M, 1981, BIOPHYS J, V35, P375, DOI 10.1016/S0006-3495(81)84796-0; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; KAWAI M, 1993, CIRC RES, V73, P35, DOI 10.1161/01.RES.73.1.35; KAWAI M, 1990, J MUSCLE RES CELL M, V11, P392, DOI 10.1007/BF01739760; KAWAI M, 2009, J BIOPHYS, P1; Kawai M, 2006, J MUSCLE RES CELL M, V27, P455, DOI 10.1007/s10974-006-9075-4; KENTISH JC, 1986, J PHYSIOL-LONDON, V370, P585, DOI 10.1113/jphysiol.1986.sp015952; KENTISH JC, 1984, J PHYSIOL-LONDON, V352, P353, DOI 10.1113/jphysiol.1984.sp015296; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lee S, 2010, CLIN EXP PHARMACOL P, V37, P1134, DOI 10.1111/j.1440-1681.2010.05443.x; Li XC, 2012, BIOCHEM BIOPH RES CO, V424, P493, DOI 10.1016/j.bbrc.2012.06.141; Lu XY, 2006, BIOPHYS J, V91, P4230, DOI 10.1529/biophysj.106.084608; Lu XY, 2010, J MUSCLE RES CELL M, V31, P93, DOI 10.1007/s10974-010-9213-x; Lu XY, 2003, J PHYSIOL-LONDON, V553, P457, DOI 10.1113/jphysiol.2003.053694; Mandinov L, 2000, CARDIOVASC RES, V45, P813, DOI 10.1016/S0008-6363(99)00399-5; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Martyn DA, 2002, BIOPHYS J, V83, P3425, DOI 10.1016/S0006-3495(02)75342-3; McConnell BK, 1999, J CLIN INVEST, V104, P1771, DOI 10.1172/JCI7377C1; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; OPIE LH, 1971, BIOCHEM J, V124, P475, DOI 10.1042/bj1240475; PINAMONTI B, 1993, J AM COLL CARDIOL, V22, P808, DOI 10.1016/0735-1097(93)90195-7; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Ranatunga KW, 1999, J MUSCLE RES CELL M, V20, P489, DOI 10.1023/A:1005509731881; ROTH K, 1989, J MAGN RESON, V81, P299, DOI 10.1016/0022-2364(89)90062-0; SAEKI Y, 1991, CIRC RES, V68, P772, DOI 10.1161/01.RES.68.3.772; Sagawa K., 1988, CARDIAC CONTRACTION; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Smille LB, 1999, GUIDEBOOK EXTRACELLU, P159; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; Solaro RJ, 1999, ADV PHYSIOL EDUC, V22, pS155, DOI 10.1152/advances.1999.277.6.S155; Solaro RJ, 2002, MOL CONTROL MECH STR, P291; Solaro RJ, 1980, EUR HEART J SUPPL, P21; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strang KT, 1994, CIRC RES, V74, P524; Wang G, 1999, BIOPHYS J, V76, P978, DOI 10.1016/S0006-3495(99)77261-9; WANG JX, 1994, AM J PHYSIOL, V267, pH918, DOI 10.1152/ajpheart.1994.267.3.H918; Wannenburg T, 2000, AM J PHYSIOL-HEART C, V279, pH779, DOI 10.1152/ajpheart.2000.279.2.H779; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Wisloff U, 2002, CARDIOVASC RES, V54, P162, DOI 10.1016/S0008-6363(01)00565-X; Wolff MR, 1996, J CLIN INVEST, V98, P167, DOI 10.1172/JCI118762; Zhao Y, 1996, BIOPHYS J, V71, P2759, DOI 10.1016/S0006-3495(96)79469-9; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	84	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47471	10.1371/journal.pone.0047471	http://dx.doi.org/10.1371/journal.pone.0047471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077624	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100120
J	Hameed, FM; Rao, M; Shivashankar, GV				Hameed, Feroz M.; Rao, Madan; Shivashankar, G. V.			Dynamics of Passive and Active Particles in the Cell Nucleus	PLOS ONE			English	Article							LIVING CELLS; CHROMATIN; ORGANIZATION; TRANSCRIPTION; INTERPHASE; VISCOELASTICITY; DECONDENSATION; MICRORHEOLOGY; FLUCTUATIONS; PLASTICITY	Inspite of being embedded in a dense meshwork of nuclear chromatin, gene loci and large nuclear components are highly dynamic at 37 degrees C. To understand this apparent unfettered movement in an overdense environment, we study the dynamics of a passive micron size bead in live cell nuclei at two different temperatures (25 and 37 degrees C) with and without external force. In the absence of a force, the beads are caged over large time scales. On application of a threshold uniaxial force (about 10(2) pN), the passive beads appear to hop between cages; this large scale movement is absent upon ATP-depletion, inhibition of chromatin remodeling enzymes and RNAi of lamin B1 proteins. Our results suggest that the nucleus behaves like an active solid with a finite yield stress when probed at a micron scale. Spatial analysis of histone fluorescence anisotropy (a measure of local chromatin compaction, defined as the volume fraction of tightly bound chromatin) shows that the bead movement correlates with regions of low chromatin compaction. This suggests that the physical mechanism of the observed yielding is the active opening of free-volume in the nuclear solid via chromatin remodeling. Enriched transcription sites at 25 degrees C also show caging in the absence of the applied force and directed movement beyond a yield stress, in striking contrast with the large scale movement of transcription loci at 37 degrees C in the absence of a force. This suggests that at physiological temperatures, the loci behave as active particles which remodel the nuclear mesh and reduce the local yield stress.	[Hameed, Feroz M.; Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Hameed, Feroz M.; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Rao, Madan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Rao, Madan] Raman Res Inst, Bangalore 560080, Karnataka, India	National University of Singapore; National University of Singapore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Science & Technology (India); Raman Research Institute (RRI)	Shivashankar, GV (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore.	shiva.gvs@gmail.com	Rao, Madan/E-2927-2012		Nanomaterials Science & Technology Initiative of Department of Science and Technology, India; Human Frontier Science Program	Nanomaterials Science & Technology Initiative of Department of Science and Technology, India; Human Frontier Science Program(Human Frontier Science Program)	This work was supported by grants from the Nanomaterials Science & Technology Initiative of Department of Science and Technology, India, and the Human Frontier Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee B, 2006, BIOPHYS J, V91, P2297, DOI 10.1529/biophysj.105.079525; Basu A, 2008, EUR PHYS J E, V27, P149, DOI 10.1140/epje/i2008-10364-9; Bhattacharya D, 2006, BIOPHYS J, V91, P2326, DOI 10.1529/biophysj.105.079343; Celedon A, 2011, BIOPHYS J, V101, P1880, DOI 10.1016/j.bpj.2011.09.008; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; COHEN MH, 1959, J CHEM PHYS, V31, P1164, DOI 10.1063/1.1730566; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Eyring H, 1936, J CHEM PHYS, V4, P283, DOI 10.1063/1.1749836; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hameed FM, 2009, BIOCHEM BIOPH RES CO, V385, P518, DOI 10.1016/j.bbrc.2009.05.086; Hatwalne Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118101; Lackowicz JR., 2004, PRINCIPLES FLUORESCE; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; MacKintosh FC, 1999, CURR OPIN COLLOID IN, V4, P300, DOI 10.1016/S1359-0294(99)90010-9; Maharana S, 2012, BIOPHYS J IN PRESS; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Pombo A, 2007, CURR OPIN GENET DEV, V17, P451, DOI 10.1016/j.gde.2007.08.008; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Sinha DK, 2008, BIOPHYS J, V95, P5432, DOI 10.1529/biophysj.108.135921; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073; Varga-Weisz PD, 2006, CURR OPIN GENET DEV, V16, P151, DOI 10.1016/j.gde.2006.02.006; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724	37	36	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45843	10.1371/journal.pone.0045843	http://dx.doi.org/10.1371/journal.pone.0045843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077497	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100021
J	Nagamine, Y; Pong-Wong, R; Navarro, P; Vitart, V; Hayward, C; Rudan, I; Campbell, H; Wilson, J; Wild, S; Hicks, AA; Pramstaller, PP; Hastie, N; Wright, AF; Haley, CS				Nagamine, Yoshitaka; Pong-Wong, Ricardo; Navarro, Pau; Vitart, Veronique; Hayward, Caroline; Rudan, Igor; Campbell, Harry; Wilson, James; Wild, Sarah; Hicks, Andrew A.; Pramstaller, Peter P.; Hastie, Nicholas; Wright, Alan F.; Haley, Chris S.			Localising Loci underlying Complex Trait Variation Using Regional Genomic Relationship Mapping	PLOS ONE			English	Article							LIKELIHOOD RATIO TESTS; ASSOCIATION ANALYSIS; MISSING HERITABILITY; QUANTITATIVE TRAITS; VARIANCE-COMPONENTS; HUMAN HEIGHT; LINKAGE; POWER; POPULATION; DISEASES	The limited proportion of complex trait variance identified in genome-wide association studies may reflect the limited power of single SNP analyses to detect either rare causative alleles or those of small effect. Motivated by studies that demonstrate that loci contributing to trait variation may contain a number of different alleles, we have developed an analytical approach termed Regional Genomic Relationship Mapping that, like linkage-based family methods, integrates variance contributed by founder gametes within a pedigree. This approach takes advantage of very distant (and unrecorded) relationships, and this greatly increases the power of the method, compared with traditional pedigree-based linkage analyses. By integrating variance contributed by founder gametes in the population, our approach provides an estimate of the Regional Heritability attributable to a small genomic region (e. g. 100 SNP window covering ca. 1 Mb of DNA in a 300000 SNP GWAS) and has the power to detect regions containing multiple alleles that individually contribute too little variance to be detectable by GWAS as well as regions with single common GWAS-detectable SNPs. We use genome-wide SNP array data to obtain both a genome-wide relationship matrix and regional relationship ("identity by state" or IBS) matrices for sequential regions across the genome. We then estimate a heritability for each region sequentially in our genome-wide scan. We demonstrate by simulation and with real data that, when compared to traditional ("individual SNP") GWAS, our method uncovers new loci that explain additional trait variation. We analysed data from three Southern European populations and from Orkney for exemplar traits - serum uric acid concentration and height. We show that regional heritability estimates are correlated with results from genome-wide association analysis but can capture more of the genetic variance segregating in the population and identify additional trait loci.	[Nagamine, Yoshitaka; Pong-Wong, Ricardo; Haley, Chris S.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Nagamine, Yoshitaka; Pong-Wong, Ricardo; Haley, Chris S.] Univ Edinburgh, RD SVS, Edinburgh EH8 9YL, Midlothian, Scotland; [Nagamine, Yoshitaka] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Navarro, Pau; Vitart, Veronique; Hayward, Caroline; Hastie, Nicholas; Wright, Alan F.; Haley, Chris S.] Univ Edinburgh, Western Gen Hosp, Human Genet Unit, MRC,Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Rudan, Igor; Campbell, Harry; Wilson, James; Wild, Sarah] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split, Croatia; [Hicks, Andrew A.; Pramstaller, Peter P.] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; National Agriculture & Food Research Organization - Japan; University of Edinburgh; University of Edinburgh; University of Split; University of Lubeck; European Academy of Bozen-Bolzano; Krankenhaus Bozen; University of Lubeck	Haley, CS (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland.	chris.haley@igmm.ed.ac.uk	Hayward, Caroline/M-8818-2016; Hicks, Andrew Anthony/E-9518-2017; Haley, Chris S/F-3110-2013; Navarro, Pau/AAJ-8091-2021; Campbell, Harry/E-2959-2010; Rudan, Igor/I-1467-2012; Pramstaller, Peter P/C-2357-2008; Wilson, James F/A-5704-2009	Hayward, Caroline/0000-0002-9405-9550; Hicks, Andrew Anthony/0000-0001-6320-0411; Navarro, Pau/0000-0001-5576-8584; Campbell, Harry/0000-0002-6169-6262; Rudan, Igor/0000-0001-6993-6884; Wilson, James F/0000-0001-5751-9178; Pong-Wong, Ricardo/0000-0001-9808-2742; Pramstaller, Peter P/0000-0002-9831-8302; Haley, Chris/0000-0002-9811-0210	Biotechnology and Biological Sciences Research Council [BBS/E/R/00001604, BB/J002844/1] Funding Source: Medline; Medical Research Council [MC_PC_U127561128, MC_PC_U127592696, MC_U127592696] Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline; BBSRC [BB/J002844/1, BBS/E/R/00001604] Funding Source: UKRI; MRC [MC_PC_U127561128, MC_PC_U127592696, MC_U127592696] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Dominicus A, 2006, BEHAV GENET, V36, P331, DOI 10.1007/s10519-005-9034-7; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; George AW, 2000, GENETICS, V156, P2081; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Kenny EE, 2011, HUM MOL GENET, V20, P827, DOI 10.1093/hmg/ddq510; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rudan I, 2009, CROAT MED J, V50, P4, DOI 10.3325/cmj.2009.50.4; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Visscher PM, 2006, TWIN RES HUM GENET, V9, P490, DOI 10.1375/183242706778024928; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	25	66	68	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46501	10.1371/journal.pone.0046501	http://dx.doi.org/10.1371/journal.pone.0046501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077511	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100032
J	Zhou, ZH; Rajabi, M; Chen, T; Karnaukhova, E; Kozlowski, S				Zhou, Zhao-Hua; Rajabi, Mohsen; Chen, Trina; Karnaukhova, Elena; Kozlowski, Steven			Oversulfated Chondroitin Sulfate Inhibits the Complement Classical Pathway by Potentiating C1 Inhibitor	PLOS ONE			English	Article							ADVERSE CLINICAL EVENTS; POLYSULFATED GLYCOSAMINOGLYCAN; CONTAMINATED HEPARIN; ACTIVATION; SYSTEM; MECHANISM; C3; PATHOGENESIS; POPULATION; INFECTION	Oversulfated chondroitin sulfate (OSCS) has become the subject of multidisciplinary investigation as a non-traditional contaminant in the heparin therapeutic preparations that were linked to severe adverse events. In this study, it was found that OSCS inhibited complement fixation on bacteria and bacterial lysis mediated by the complement classical pathway. The inhibition of complement by OSCS is not due to interference with antibody/antigen interaction or due to consumption of C3 associated with FXII-dependent contact system activation. However, OSCS complement inhibition is dependent on C1 inhibitor (C1inh) since the depletion of C1inh from either normal or FXII-deficient complement plasma prevents OSCS inhibition of complement activity. Surface plasmon resonance measurements revealed that immobilized C1inhibitor bound greater than 5-fold more C1s in the presence of OSCS than in presence of heparin. Although heparin can also inhibit complement, OSCS and OSCS contaminated heparin are more potent inhibitors of complement. Furthermore, polysulfated glycosaminoglycan (PSGAG), an anti-inflammatory veterinary medicine with a similar structure to OSCS, also inhibited complement in the plasma of dogs and farm animals. This study provides a new insight that in addition to the FXII-dependent activation of contact system, oversulfated and polysulfated chondroitin-sulfate can inhibit complement activity by potentiating the classical complement pathway regulator C1inh. This effect on C1inh may play a role in inhibiting inflammation as well as impacting bacterial clearance.	[Zhou, Zhao-Hua; Chen, Trina; Kozlowski, Steven] US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Rajabi, Mohsen; Karnaukhova, Elena] US FDA, Div Hematol, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kozlowski, S (corresponding author), US FDA, Div Monoclonal Antibodies, Off Biotechnol Prod, Off Pharmaceut Sci,Ctr Drug Evaluat & Res, Silver Spring, MD USA.	Steven.Kozlowski@fda.hhs.gov	Zhou, Zhaohua/AGR-4892-2022		US Food and Drug Administration and Food and Drug Administration/Center for Drug Evaluation and Research	US Food and Drug Administration and Food and Drug Administration/Center for Drug Evaluation and Research	This research was supported by the Intramural Research Program of the US Food and Drug Administration and Food and Drug Administration/Center for Drug Evaluation and Research, Critical Path Funds. The views expressed in this manuscript represent the opinions of the authors, and do not necessarily represent the official views of the FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2010, BIOMATERIALS, V31, P5741, DOI 10.1016/j.biomaterials.2010.03.074; Beinrohr L, 2007, J BIOL CHEM, V282, P21100, DOI 10.1074/jbc.M700841200; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Bohlson SS, 2001, INFECT IMMUN, V69, P7729, DOI 10.1128/IAI.69.12.7729-7735.2001; CAUGHMAN GB, 1982, MOL IMMUNOL, V19, P287, DOI 10.1016/0161-5890(82)90342-X; CHESNE S, 1982, BIOCHEM J, V201, P61, DOI 10.1042/bj2010061; DEMESSIAS IT, 1994, J INVEST ALLERG CLIN, V4, P172; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; GUSTAFSON SB, 1989, AM J VET RES, V50, P2014; GUSTAFSON SB, 1989, AM J VET RES, V50, P2018; HIRSH J, 1992, CHEST, V102, pS337, DOI 10.1378/chest.102.4.337S; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jaskowski TD, 1999, CLIN DIAGN LAB IMMUN, V6, P137, DOI 10.1128/CDLI.6.1.137-139.1999; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kirschfink M, 2003, CLIN DIAGN LAB IMMUN, V10, P982, DOI 10.1128/CDLI.10.6.982-989.2003; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; MAILLET F, 1988, MOL IMMUNOL, V25, P917, DOI 10.1016/0161-5890(88)90130-7; Makrides SC, 1998, PHARMACOL REV, V50, P59; Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; MULLEREBERHARD HJ, 1975, ANNU REV BIOCHEM, V44, P697, DOI 10.1146/annurev.bi.44.070175.003405; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; PANGBURN MK, 1983, ANN NY ACAD SCI, V421, P291, DOI 10.1111/j.1749-6632.1983.tb18116.x; Rajabi M, 2012, BBA-GEN SUBJECTS, V1820, P56, DOI 10.1016/j.bbagen.2011.10.008; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Tami C, 2008, BIOMATERIALS, V29, P4808, DOI 10.1016/j.biomaterials.2008.08.024; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Zhang ZQ, 2008, J MED CHEM, V51, P5498, DOI 10.1021/jm800785t; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034978	35	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47296	10.1371/journal.pone.0047296	http://dx.doi.org/10.1371/journal.pone.0047296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077587	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100088
J	Pineda, MC; McQuaid, CD; Turon, X; Lopez-Legentil, S; Ordonez, V; Rius, M				Carmen Pineda, M.; McQuaid, Christopher D.; Turon, Xavier; Lopez-Legentil, Susanna; Ordonez, Victor; Rius, Marc			Tough Adults, Frail Babies: An Analysis of Stress Sensitivity across Early Life-History Stages of Widely Introduced Marine Invertebrates	PLOS ONE			English	Article							ASCIDIAN STYELA-PLICATA; FERTILIZATION SUCCESS; DIFFERENTIAL TOLERANCE; ENVIRONMENTAL-STRESS; CIONA-INTESTINALIS; ANTIFOULING PAINT; METAL POLLUTION; CLIMATE-CHANGE; TRACE-METALS; LOW-SALINITY	All ontogenetic stages of a life cycle are exposed to environmental conditions so that population persistence depends on the performance of both adults and offspring. Most studies analysing the influence of abiotic conditions on species performance have focussed on adults, while studies covering early life-history stages remain rare. We investigated the responses of early stages of two widely introduced ascidians, Styela plicata and Microcosmus squamiger, to different abiotic conditions. Stressors mimicked conditions in the habitats where both species can be found in their distributional ranges and responses were related to the selection potential of their populations by analysing their genetic diversity. Four developmental stages (egg fertilisation, larval development, settlement, metamorphosis) were studied after exposure to high temperature (30 degrees C), low salinities (26 and 22%) and high copper concentrations (25, 50 and 100 mu g/L). Although most stressors effectively led to failure of complete development (fertilisation through metamorphosis), fertilisation and larval development were the most sensitive stages. All the studied stressors affected the development of both species, though responses differed with stage and stressor. S. plicata was overall more resistant to copper, and some stages of M. squamiger to low salinities. No relationship was found between parental genetic composition and responses to stressors. We conclude that successful development can be prevented at several life-history stages, and therefore, it is essential to consider multiple stages when assessing species' abilities to tolerate stress. Moreover, we found that early development of these species cannot be completed under conditions prevailing where adults live. These populations must therefore recruit from elsewhere or reproduce during temporal windows of more benign conditions. Alternatively, novel strategies or behaviours that increase overall reproductive success might be responsible for ensuring population survival.	[Rius, Marc] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Carmen Pineda, M.; Lopez-Legentil, Susanna] Univ Barcelona, Dept Anim Biol Invertebrates, Barcelona, Spain; [McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Turon, Xavier] Ctr Adv Studies Blanes CEAB CSIC, Blanes, Spain; [Ordonez, Victor] Univ Barcelona, Dept Genet, Barcelona, Spain	University of California System; University of California Davis; University of Barcelona; Rhodes University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Rius, M (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	mrius@ucdavis.edu	McQuaid, Christopher/AAT-3725-2020; Turon, Xavier/J-9211-2012; Rius, Marc/C-5088-2011; Lopez-Legentil, Susanna/B-8194-2008	McQuaid, Christopher/0000-0002-3473-8308; Turon, Xavier/0000-0002-9229-5541; Rius, Marc/0000-0002-2195-6605; Lopez-Legentil, Susanna/0000-0001-8737-6729	European Union Seventh Framework Programme (FP7) through the Marie Curie International Reintegration Grant [EU-FP7-PEOPLE-2010-RG 277038]; Marie Curie International Outgoing fellowship [EU-FP7-PEOPLE-2009-IOF-254634]; Spanish Government projects [CTM2010-22218, CTM2010-17755]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; University of Barcelona	European Union Seventh Framework Programme (FP7) through the Marie Curie International Reintegration Grant; Marie Curie International Outgoing fellowship(European Commission); Spanish Government projects(Spanish Government); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; University of Barcelona	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013), through the Marie Curie International Reintegration Grant (EU-FP7-PEOPLE-2010-RG 277038) to S.L.-L. and a Marie Curie International Outgoing fellowship (EU-FP7-PEOPLE-2009-IOF-254634) to M.R. Funding was also provided by the Spanish Government projects CTM2010-22218 and CTM2010-17755, and by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation. MCP was awarded with an APIF fellowship from the University of Barcelona travel to South Africa. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison PFE, 2008, J EXP MAR BIOL ECOL, V364, P19, DOI 10.1016/j.jembe.2008.06.020; Agell G, 2004, MAR POLLUT BULL, V48, P759, DOI 10.1016/j.marpolbul.2003.11.001; Allanson BR, 2000, T ROY SOC S AFR, V55, P97, DOI 10.1080/00359190009520435; Allen JD, 2010, BIOL BULL-US, V218, P189, DOI 10.1086/BBLv218n2p189; Barata C, 2000, ENVIRON TOXICOL CHEM, V19, P2314, DOI 10.1002/etc.5620190922; Bastrop R, 1998, MOL BIOL EVOL, V15, P97, DOI 10.1093/oxfordjournals.molbev.a025919; Bayne B. L., 1976, MARINE MUSSELS THEIR; Bellas J, 2004, ARCH ENVIRON CON TOX, V46, P61, DOI 10.1007/s00244-003-0238-7; Bellas J, 2001, WATER RES, V35, P2905, DOI 10.1016/S0043-1354(01)00004-5; Bennett CE, 2005, MAR FRESHW BEHAV PHY, V38, P21, DOI 10.1080/10236240400029333; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Pineda MC, 2012, CELL STRESS CHAPERON, V17, P435, DOI 10.1007/s12192-012-0321-y; Cebrian E, 2007, J EXP MAR BIOL ECOL, V346, P60, DOI 10.1016/j.jembe.2007.02.010; Cebrian E, 2003, MAR POLLUT BULL, V46, P1273, DOI 10.1016/S0025-326X(03)00190-5; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; Drinkwater KF, 2009, PROG OCEANOGR, V81, P10, DOI 10.1016/j.pocean.2009.04.003; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Dupont L, 2007, DIVERS DISTRIB, V13, P808, DOI 10.1111/j.1472-4642.2007.00405.x; DYBERN BERNT I., 1967, OPHELIA, V4, P207; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fatoki OS, 2001, WATER SA, V27, P233; Fisher R.A., 1930, GENETICAL THEORY NAT; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fowler AE, 2011, BIOL INVASIONS, V13, P691, DOI 10.1007/s10530-010-9860-2; Galletly BC, 2007, ECOL APPL, V17, P2290, DOI 10.1890/06-2079.1; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gerber AS, 2001, ANNU REV GENET, V35, P539, DOI 10.1146/annurev.genet.35.102401.091106; GIANGRANDE A, 1994, OCEANOGR MAR BIOL, V32, P305; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Hall LW, 1998, ENVIRON TOXICOL CHEM, V17, P1172, DOI [10.1897/1551-5028(1998)017&lt;1172:ERAOCA&gt;2.3.CO;2, 10.1002/etc.5620170626]; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harris Larry G., 2001, Biological Invasions, V3, P9, DOI 10.1023/A:1011487219735; Haynes D, 2002, ENVIRON POLLUT, V120, P391, DOI 10.1016/S0269-7491(02)00113-6; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Johnston EL, 2005, J EXP MAR BIOL ECOL, V320, P9, DOI 10.1016/j.jembe.2004.12.024; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kelly DW, 2006, EVOLUTION, V60, P257; KEOUGH MJ, 1995, J EXP MAR BIOL ECOL, V185, P235, DOI 10.1016/0022-0981(94)00154-6; Kinne O., 1964, Oceanography and Marine Biology, V2, P281; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe AJ., 2002, THESIS CALIFORNIA ST; Maldonado M, 1999, J EXP MAR BIOL ECOL, V232, P9, DOI 10.1016/S0022-0981(98)00076-8; Marshall DJ, 2006, ECOLOGY, V87, P214, DOI 10.1890/05-0350; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; Marshall DJ, 2000, MAR ECOL PROG SER, V195, P305, DOI 10.3354/meps195305; Marshall DJ, 2008, ECOLOGY, V89, P418, DOI 10.1890/07-0449.1; McKenzie LA, 2011, ENVIRON RES, V111, P926, DOI 10.1016/j.envres.2010.12.007; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Ng TYT, 2003, MAR ECOL PROG SER, V257, P77, DOI 10.3354/meps257077; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Osovitz CJ, 2005, J EXP MAR BIOL ECOL, V327, P134, DOI 10.1016/j.jembe.2005.06.011; PEDERSON DG, 1968, HEREDITY, V23, P127, DOI 10.1038/hdy.1968.11; Pennati R, 2006, AQUAT TOXICOL, V79, P205, DOI 10.1016/j.aquatox.2006.05.012; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Pineda MC, 2012, THESIS U BARCELONA B; Piola RF, 2006, MAR BIOL, V148, P997, DOI 10.1007/s00227-005-0156-5; Piola RF, 2009, ENVIRON POLLUT, V157, P2853, DOI 10.1016/j.envpol.2009.04.007; Polato NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011221; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reichelt-Brushett AJ, 2005, CORAL REEFS, V24, P524, DOI 10.1007/s00338-005-0013-5; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Rius M, 2010, MAR ECOL PROG SER, V418, P151, DOI 10.3354/meps08810; Rius M, 2009, BIOL INVASIONS, V11, P2181, DOI 10.1007/s10530-008-9375-2; Rius M, 2009, OECOLOGIA, V159, P873, DOI 10.1007/s00442-008-1256-y; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schiff K, 2004, MAR POLLUT BULL, V48, P371, DOI 10.1016/j.marpolbul.2003.08.016; Schizas NV, 2002, MAR BIOL, V140, P585, DOI 10.1007/s00227-001-0728-y; Schumann EH, 2005, AFR J MAR SCI, V27, P65, DOI 10.2989/18142320509504069; Schumann EH, 1998, SEA, P557; Segar D.A., 1997, INTRO OCEAN SCI; SIMS LL, 1984, J EXP MAR BIOL ECOL, V82, P117, DOI 10.1016/0022-0981(84)90098-4; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; SVANE I, 1991, ACTA ZOOL-STOCKHOLM, V72, P129, DOI 10.1111/j.1463-6395.1991.tb00939.x; Svane I., 1989, Oceanography and Marine Biology an Annual Review, V27, P45; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V290, P133, DOI 10.1016/S0022-0981(03)00071-6; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Valkirs AO, 2003, MAR POLLUT BULL, V46, P763, DOI 10.1016/S0025-326X(03)00044-4; Vazquez E, 2000, INVERTEBR BIOL, V119, P433; Vazquez E, 1996, MAR ECOL PROG SER, V133, P179, DOI 10.3354/meps133179; Verween A, 2007, J EXP MAR BIOL ECOL, V348, P111, DOI 10.1016/j.jembe.2007.04.011; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WATLING RJ, 1982, WATER SA, V8, P26; Wendt DE, 2000, BIOL BULL, V198, P346, DOI 10.2307/1542690; WEST AB, 1976, J EXP ZOOL, V195, P263, DOI 10.1002/jez.1401950211; Wieczorek SK, 1997, MAR BIOL, V128, P463, DOI 10.1007/s002270050113; Xie ZC, 2005, MAR ECOL PROG SER, V285, P89, DOI 10.3354/meps285089; YAMAGUCHI M, 1975, MAR BIOL, V29, P253, DOI 10.1007/BF00391851; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zibrowius Helmut, 1991, Mesogee, V51, P83	102	71	73	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46672	10.1371/journal.pone.0046672	http://dx.doi.org/10.1371/journal.pone.0046672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077518	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000309809500018
J	Fang, Y; Xun, F; Bai, WM; Zhang, WH; Li, LH				Fang, Ying; Xun, Fen; Bai, Wenming; Zhang, Wenhao; Li, Linghao			Long-Term Nitrogen Addition Leads to Loss of Species Richness Due to Litter Accumulation and Soil Acidification in a Temperate Steppe	PLOS ONE			English	Article							FINE-ROOT PRODUCTION; COMMUNITY STRUCTURE; ELEVATED CO2; DEPOSITION; GRASSLAND; WATER; ECOSYSTEMS; LIMITATION; DIVERSITY; CLIMATE	Background: Although community structure and species richness are known to respond to nitrogen fertilization dramatically, little is known about the mechanisms underlying specific species replacement and richness loss. In an experiment in semiarid temperate steppe of China, manipulative N addition with five treatments was conducted to evaluate the effect of N addition on the community structure and species richness. Methodology/Principal Findings: Species richness and biomass of community in each plot were investigated in a randomly selected quadrat. Root element, available and total phosphorus (AP, TP) in rhizospheric soil, and soil moisture, pH, AP, TP and inorganic N in the soil were measured. The relationship between species richness and the measured factors was analyzed using bivariate correlations and stepwise multiple linear regressions. The two dominant species, a shrub Artemisia frigida and a grass Stipa krylovii, responded differently to N addition such that the former was gradually replaced by the latter. S. krylovii and A. frigida had highly-branched fibrous and un-branched tap root systems, respectively. S. krylovii had higher height than A. frigida in both control and N added plots. These differences may contribute to the observed species replacement. In addition, the analysis on root element and AP contents in rhizospheric soil suggests that different calcium acquisition strategies, and phosphorus and sodium responses of the two species may account for the replacement. Species richness was significantly reduced along the five N addition levels. Our results revealed a significant relationship between species richness and soil pH, litter amount, soil moisture, AP concentration and inorganic N concentration. Conclusions/Significance: Our results indicate that litter accumulation and soil acidification accounted for 52.3% and 43.3% of the variation in species richness, respectively. These findings would advance our knowledge on the changes in species richness in semiarid temperate steppe of northern China under N deposition scenario.	[Fang, Ying; Xun, Fen; Bai, Wenming; Zhang, Wenhao; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Fang, Ying; Xun, Fen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	bwming@ibcas.ac.cn	Zhang, Wen-Hao/B-5805-2009	Zhang, Wen-Hao/0000-0003-2708-2221	National Natural Science Foundation of China [31070432]; Beijing Institutes of Life Science, Chinese Academy of Sciences [2010-Biols-CAS-0101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Institutes of Life Science, Chinese Academy of Sciences	This research was supported by the National Natural Science Foundation of China (31070432) and Beijing Institutes of Life Science, Chinese Academy of Sciences (2010-Biols-CAS-0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Berendse F, 1999, TRENDS ECOL EVOL, V14, P4, DOI 10.1016/S0169-5347(98)01451-7; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Bowman WD, 2008, NAT GEOSCI, V1, P767, DOI 10.1038/ngeo339; Carroll JA, 2003, ENVIRON POLLUT, V121, P363, DOI 10.1016/S0269-7491(02)00241-5; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Deutsch ES, 2010, AGR ECOSYST ENVIRON, V135, P1, DOI 10.1016/j.agee.2009.08.002; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Emery NC, 2001, ECOLOGY, V82, P2471, DOI 10.1890/0012-9658(2001)082[2471:CASMPZ]2.0.CO;2; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gilliam FS, 2006, J ECOL, V94, P1176, DOI 10.1111/j.1365-2745.2006.01155.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; He Bin, 2007, Journal of Northeast Forestry University, V35, P35; Huang JY, 2008, PLANT SOIL, V306, P149, DOI 10.1007/s11104-008-9565-9; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Jackson M.L., 1979, SOIL CHEM ANAL ADV C; Jones MLM, 2000, CRITICAL LOADS NITRO; Khan MA, 2000, J ARID ENVIRON, V45, P73, DOI 10.1006/jare.1999.0617; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lee KH, 2003, FOREST ECOL MANAG, V185, P263, DOI 10.1016/S0378-1127(03)00164-6; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Magill AH, 2004, FOREST ECOL MANAG, V196, P7, DOI 10.1016/j.foreco.2004.03.033; Martinelli LA, 2006, BIOGEOCHEMISTRY, V79, P3, DOI 10.1007/s10533-006-9000-3; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mulvaney RL, 1996, METHODS SOIL ANAL, P1123, DOI DOI 10.2136/SSSAB00KSER5.3.C38; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Perakis S, 2006, ECOSYSTEMS, V9, P63, DOI 10.1007/s10021-004-0039-5; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; SCHULZE ED, 1989, SCIENCE, V244, P776, DOI 10.1126/science.244.4906.776; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Sullivan PF, 2007, OECOLOGIA, V153, P643, DOI 10.1007/s00442-007-0753-8; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vojtech E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000499; Wu FZ, 2009, J ARID ENVIRON, V73, P1067, DOI 10.1016/j.jaridenv.2009.06.007; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Yang Y.S., 1998, ACTA ECOL SIN, V18, P198; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zhang JL, 2010, PLANT SOIL, V326, P45, DOI 10.1007/s11104-009-0076-0	56	44	65	14	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47369	10.1371/journal.pone.0047369	http://dx.doi.org/10.1371/journal.pone.0047369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077603	Green Submitted, Green Published, gold			2022-12-25	WOS:000309809500045
J	Pott, PP; Schwarz, MLR; Gundling, R; Nowak, K; Hohenberger, P; Roessner, ED				Pott, Peter P.; Schwarz, Markus L. R.; Gundling, Ralf; Nowak, Kai; Hohenberger, Peter; Roessner, Eric D.			Mechanical Properties of Mesh Materials Used for Hernia Repair and Soft Tissue Augmentation	PLOS ONE			English	Article							ABDOMINAL-WALL; LIGHTWEIGHT; SUTURES	Background: Hernia repair is the most common surgical procedure in the world. Augmentation with synthetic meshes has gained importance in recent decades. Most of the published work about hernia meshes focuses on the surgical technique, outcome in terms of mortality and morbidity and the recurrence rate. Appropriate biomechanical and engineering terminology is frequently absent. Meshes are under continuous development but there is little knowledge in the public domain about their mechanical properties. In the presented experimental study we investigated the mechanical properties of several widely available meshes according to German Industrial Standards (DIN ISO). Methodology/Principal Findings: Six different meshes were assessed considering longitudinal and transverse direction in a uni-axial tensile test. Based on the force/displacement curve, the maximum force, breaking strain, and stiffness were computed. According to the maximum force the values were assigned to the groups weak and strong to determine a base for comparison. We discovered differences in the maximum force (11.1 +/- 6.4 to 100.9 +/- 9.4 N/cm), stiffness (0.3 +/- 0.1 to 4.6 +/- 0.5 N/mm), and breaking strain (150 +/- 6% to 340 +/- 20%) considering the direction of tension. Conclusions/Significance: The measured stiffness and breaking strength vary widely among available mesh materials for hernia repair, and most of the materials show significant anisotropy in their mechanical behavior. Considering the forces present in the abdominal wall, our results suggest that some meshes should be implanted in an appropriate orientation, and that information regarding the directionality of their mechanical properties should be provided by the manufacturers.	[Pott, Peter P.; Schwarz, Markus L. R.; Gundling, Ralf] Heidelberg Univ, Univ Med Ctr Mannheim OUZ, Orthopaed & Trauma Surg Ctr, Lab Biomech & Expt Orthopaed, D-6800 Mannheim, Germany; [Nowak, Kai; Hohenberger, Peter; Roessner, Eric D.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Pott, PP (corresponding author), Tech Univ Darmstadt, Inst Electromech Design, Darmstadt, Germany.	p.pott@emk.tu-darmstadt.de	Pott, Peter/AAA-2040-2019; nowak, kai/L-8060-2017	nowak, kai/0000-0001-7737-3495; Roessner, Eric Dominic/0000-0003-1173-1098				Bellon JM, 2009, J BIOMED MATER RES B, V89B, P448, DOI 10.1002/jbm.b.31234; Bucheler M, 1999, CHIRURG, V70, P316, DOI 10.1007/s001040050652; Cobb WS, 2009, HERNIA, V13, P1, DOI 10.1007/s10029-008-0428-3; Cobb WS, 2005, J SURG RES, V129, P231, DOI 10.1016/j.jss.2005.06.015; Conze J, 2004, Hernia, V8, P255; Cosson M, 2003, INT UROGYNECOL J, V14, P169, DOI 10.1007/s00192-003-1066-z; Deeken CR, 2011, J AM COLL SURGEONS, V212, P68, DOI 10.1016/j.jamcollsurg.2010.09.012; den Hartog D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006438.pub2; Deutsches Institut fur Normung, 1981, 53455 DIN; Deutsches Institut fur Normung, 2010, 2413 DIN; FEG Textiltechnik, 2009, STAB EL; FEG Textiltechnik, 2010, DYNAMESH IPOM; Grassel D, 2005, J SURG RES, V124, P118, DOI 10.1016/j.jss.2004.10.010; Hofling HM, 2006, THESIS WESTPHALISCHE; Hollinsky C, 2007, CLIN BIOMECH, V22, P88, DOI 10.1016/j.clinbiomech.2006.06.002; ISO, 1999, 13934 ISO EN; ISO, 2010, 5271 ISO DIN EN; Junge K, 2001, Hernia, V5, P113; Junge K, 2003, HERNIA, V7, P7; Kirsch U, 1973, MED INFORM; Klein P, 1996, CHIRURG, V67, P1020, DOI 10.1007/s001040050098; Klinge U, 1996, LANGENBECK ARCH CHIR, V381, P323; Klinge U, 1997, CHIRURG, V68, P293, DOI 10.1007/s001040050192; Klinge U, 1998, EUR J SURG, V164, P951; Klosterhalfen B, 2005, EXPERT REV MED DEVIC, V2, P103, DOI 10.1586/17434440.2.1.103; Klosterhalfen B, 1997, LANGENBECK ARCH CHIR, V382, P87; Roessner ED, 2009, J BIOMATER APPL; Saberski ER, 2011, HERNIA, V15, P47, DOI 10.1007/s10029-010-0731-7; Schumpelick V, 2002, CHIRURG, V73, P888, DOI 10.1007/s00104-002-0535-0; Scott NW., 2002, COCHRANE DB SYST REV, pCD002197, DOI [10.1002/14651858, DOI 10.1002/14651858, DOI 10.1002/14651858.CD002197]; SEIDEL W, 1974, CHIRURG, V45, P266; WILLIAMS JF, 1975, BIOMED ENG, V10, P181	32	49	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46978	10.1371/journal.pone.0046978	http://dx.doi.org/10.1371/journal.pone.0046978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071685	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500027
J	Mead, EJ; Chiverton, LM; Spurgeon, SK; Martin, EB; Montague, GA; Smales, CM; von der Haar, T				Mead, Emma J.; Chiverton, Lesley M.; Spurgeon, Sarah K.; Martin, Elaine B.; Montague, Gary A.; Smales, C. Mark; von der Haar, Tobias			Experimental and In Silico Modelling Analyses of the Gene Expression Pathway for Recombinant Antibody and By-Product Production in NS0 Cell Lines	PLOS ONE			English	Article							HAMSTER OVARY CELLS; PROTEIN DISULFIDE-ISOMERASE; CULTURED-MAMMALIAN-CELLS; MONOCLONAL-ANTIBODY; CHO-CELLS; TRANSLATION INITIATION; PROTEOMIC ANALYSIS; MYELOMA CELLS; GS-NS0 CELLS; COLD-SHOCK	Monoclonal antibodies are commercially important, high value biotherapeutic drugs used in the treatment of a variety of diseases. These complex molecules consist of two heavy chain and two light chain polypeptides covalently linked by disulphide bonds. They are usually expressed as recombinant proteins from cultured mammalian cells, which are capable of correctly modifying, folding and assembling the polypeptide chains into the native quaternary structure. Such recombinant cell lines often vary in the amounts of product produced and in the heterogeneity of the secreted products. The biological mechanisms of this variation are not fully defined. Here we have utilised experimental and modelling strategies to characterise and define the biology underpinning product heterogeneity in cell lines exhibiting varying antibody expression levels, and then experimentally validated these models. In undertaking these studies we applied and validated biochemical (rate-constant based) and engineering (nonlinear) models of antibody expression to experimental data from four NS0 cell lines with different IgG4 secretion rates. The models predict that export of the full antibody and its fragments are intrinsically linked, and cannot therefore be manipulated individually at the level of the secretory machinery. Instead, the models highlight strategies for the manipulation at the precursor species level to increase recombinant protein yields in both high and low producing cell lines. The models also highlight cell line specific limitations in the antibody expression pathway.	[Mead, Emma J.; Chiverton, Lesley M.; Smales, C. Mark; von der Haar, Tobias] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Spurgeon, Sarah K.] Univ Kent, Sch Engn & Digital Arts, Canterbury, Kent, England; [Mead, Emma J.; Chiverton, Lesley M.; Spurgeon, Sarah K.; Smales, C. Mark; von der Haar, Tobias] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; [Martin, Elaine B.; Montague, Gary A.] Newcastle Univ, Sch Chem Engn & Adv Mat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Kent; University of Kent; University of Kent; Newcastle University - UK	Mead, EJ (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.	E.J.Mead@kent.ac.uk; C.M.Smales@kent.ac.uk; T.von-der-Haar@kent.ac.uk	; Spurgeon, Sarah/C-3192-2016	Hargreaves, Emma/0000-0001-7887-2018; von der Haar, Tobias/0000-0002-6031-9254; Smales, Christopher Mark/0000-0002-2762-4724; Spurgeon, Sarah/0000-0003-3451-0650	BBSRC; EPSRC under the Bioprocessing Research Industry Club (BRIC) initiative [BB/E005969/1]; Biotechnology and Biological Sciences Research Council [BB/E005969/1] Funding Source: researchfish; BBSRC [BB/E005969/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC under the Bioprocessing Research Industry Club (BRIC) initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC and EPSRC under the Bioprocessing Research Industry Club (BRIC) initiative (Ref. BB/E005969/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, BIOCHEM J, V432, P101, DOI 10.1042/BJ20100641; Ahmad N, 2006, BBA-PROTEINS PROTEOM, V1764, P1179, DOI 10.1016/j.bbapap.2006.05.002; Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Alete DE, 2005, PROTEOMICS, V5, P4689, DOI 10.1002/pmic.200500019; BAUMAL R, 1971, J EXP MED, V134, P1316, DOI 10.1084/jem.134.5.1316; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Browne SM, 2007, TRENDS BIOTECHNOL, V25, P425, DOI 10.1016/j.tibtech.2007.07.002; Burnouf T, 2011, VOX SANG, V100, P68, DOI 10.1111/j.1423-0410.2010.01384.x; Carlage T, 2009, ANAL CHEM, V81, P7357, DOI 10.1021/ac900792z; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Doolan P, 2010, BIOTECHNOL BIOENG, V106, P42, DOI 10.1002/bit.22670; DORNER AJ, 1994, BIOLOGICALS, V22, P103, DOI 10.1006/biol.1994.1016; Figueroa B, 2004, BIOTECHNOL BIOENG, V85, P589, DOI 10.1002/bit.10913; Figueroa B, 2007, BIOTECHNOL BIOENG, V97, P877, DOI 10.1002/bit.21222; Florin L, 2009, J BIOTECHNOL, V141, P84, DOI 10.1016/j.jbiotec.2009.02.014; Forrer K, 2004, ANAL BIOCHEM, V334, P81, DOI 10.1016/j.ab.2004.07.002; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Golub GH., 2013, MATRIX COMPUTATIONS; Hayes NVL, 2010, BIOTECHNOL BIOENG, V105, P770, DOI 10.1002/bit.22587; Ho Y, 2006, BIOTECHNOL PROGR, V22, P1560, DOI 10.1021/bp060032b; Josse L, 2010, BIOTECHNOL BIOENG, V105, P556, DOI 10.1002/bit.22572; Kalman R. E., 1960, P 1 IFAC C AUT CONTR, P481, DOI 10.1109/TAC.1959.1104873.110; Kantardjieff A, 2010, J BIOTECHNOL, V145, P143, DOI 10.1016/j.jbiotec.2009.09.008; Khoo SHG, 2007, BIOTECHNOL APPL BIOC, V47, P85, DOI 10.1042/BA20060185; Kontoravdi C, 2005, BIOTECHNOL PROGR, V21, P1128, DOI 10.1021/bp050028k; Kramer O, 2010, APPL MICROBIOL BIOT, V88, P425, DOI 10.1007/s00253-010-2798-6; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim SF, 2006, METAB ENG, V8, P509, DOI 10.1016/j.ymben.2006.05.005; Lim Y, 2010, BIOTECHNOL APPL BIOC, V55, P175, DOI 10.1042/BA20090363; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; McLeod J, 2011, BIOTECHNOL BIOENG, V108, P2193, DOI 10.1002/bit.23146; Mead EJ, 2009, BIOTECHNOL BIOENG, V102, P1593, DOI 10.1002/bit.22201; Mohan C, 2010, BIOTECHNOL BIOENG, V107, P337, DOI 10.1002/bit.22781; Nissom PM, 2006, MOL BIOTECHNOL, V34, P125, DOI 10.1385/MB:34:2:125; O'Callaghan PM, 2010, BIOTECHNOL BIOENG, V106, P938, DOI 10.1002/bit.22769; O'Callaghan Peter M., 2008, Briefings in Functional Genomics & Proteomics, V7, P95, DOI 10.1093/bfgp/eln012; Peng RW, 2011, BIOTECHNOL BIOENG, V108, P611, DOI 10.1002/bit.22986; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; Peng RW, 2009, BIOTECHNOL BIOENG, V102, P1170, DOI 10.1002/bit.22141; Peters SJ, 2012, J BIOL CHEM, V287, P24525, DOI 10.1074/jbc.M112.369744; Porter AJ, 2010, BIOTECHNOL PROGR, V26, P1455, DOI 10.1002/btpr.443; RENARD JM, 1988, BIOTECHNOL LETT, V10, P91, DOI 10.1007/BF01024632; SEARS DW, 1975, P NATL ACAD SCI USA, V72, P353, DOI 10.1073/pnas.72.1.353; Simpson NH, 1997, BIOTECHNOL BIOENG, V54, P1; Smales CM, 2004, BIOTECHNOL BIOENG, V88, P474, DOI 10.1002/bit.20272; Stansfield SH, 2007, BIOTECHNOL BIOENG, V97, P410, DOI 10.1002/bit.21263; Sung YH, 2004, J BIOTECHNOL, V112, P323, DOI 10.1016/j.jbiotec.2004.05.003; Sunley K, 2010, BIOTECHNOL ADV, V28, P385, DOI 10.1016/j.biotechadv.2010.02.003; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Underhill MF, 2005, BIOTECHNOL BIOENG, V89, P805, DOI 10.1002/bit.20403; Underhill MF, 2003, BIOTECHNOL PROGR, V19, P121, DOI 10.1021/bp025560b; Underhill MF, 2006, MOL BIOTECHNOL, V34, P141, DOI 10.1385/MB:34:2:141; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Whiteley EM, 1997, BIOTECHNOL BIOENG, V56, P106, DOI 10.1002/(SICI)1097-0290(19971005)56:1<106::AID-BIT12>3.0.CO;2-I; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	59	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47422	10.1371/journal.pone.0047422	http://dx.doi.org/10.1371/journal.pone.0047422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071804	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200118
J	Huang, C; Wu, H; Liu, LP; Lou, WY; Zong, MH				Huang, Chao; Wu, Hong; Liu, Li-ping; Lou, Wen-yong; Zong, Min-hua			Effects of Alcohol Compounds on the Growth and Lipid Accumulation of Oleaginous Yeast Trichosporon fermentans	PLOS ONE			English	Article							ETHANOLOGENIC ESCHERICHIA-COLI; CELL OIL PRODUCTION; SACCHAROMYCES-CEREVISIAE; BIODIESEL PRODUCTION; BAGASSE HYDROLYSATE; ORGANIC-ACIDS; ACETIC-ACID; PH; MICROORGANISMS; INHIBITION	The inhibitors present in dilute acid-treated lignocellulosic hydrolysates would show great effect on the growth and product formation of microorganisms. To understand their inhibitory law and mechanism on oleaginous microorganism could help improving the efficiency of lignocellulose hydrolysis, detoxification, and lipid fermentation. The effects of four representative alcohol compounds present in lignocellulosic hydrolysates, including furfuryl alcohol, vanillyl alcohol, catechol, hydroquinone on the cell growth and lipid accumulation of Trichosporon fermentans were systematically investigated in this work. The toxicity of selected alcohol compounds was well related to their log P value except furfuryl alcohol, whose log P value was the minimum but with the highest toxicity to T. fermentans. The inhibition of all the alcohol compounds on the growth of T. fermentans was more serious than on the lipid synthesis. Also, the growth of T. fermentans was more sensitive to the variation of inoculum size, temperature, and initial pH than lipid synthesis in the presence of alcohol compounds. Initial pH had more profound influence on the lipid fermentation than inoculum size and cultural temperature did. Careful control of fermentation conditions could be helpful for improving lipid yield of T. fermentans in lignocellulosic hydrolysates. Among the four alcohol compounds tested, most alcohol compounds showed inhibition on both sugar consumption and malic enzyme activity of T. fermentans. However, vanillyl alcohol had little influence on the malic enzyme activity. Similarly, all alcohol compounds except vanillyl alcohol exerted damage on the cell membrane of T. fermentans.	[Huang, Chao; Wu, Hong; Zong, Min-hua] S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Chao] Chinese Acad Sci, Guangzhou Inst Energy Convers, Key Lab Renewable Energy & Gas Hydrate, Guangzhou, Guangdong, Peoples R China; [Liu, Li-ping; Lou, Wen-yong] S China Univ Technol, Coll Light Ind & Food Sci, Lab Appl Biocatalysis, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Chinese Academy of Sciences; Guangzhou Institute of Energy Conversion, CAS; South China University of Technology	Wu, H (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China.	bbhwu@scut.edu.cn; btmhzong@scut.edu.cn	Lou, Wen-Yong/AAL-8087-2020	Lou, Wen-Yong/0000-0003-3474-3446	National Natural Science Foundation of China [31071559, 21072065]; New Century Excellent Talents in University [NCET-11-0161, NCET-10-0367]; Doctoral Program of Higher Education [20090172110019]; Major State Basic Research Development Program '973' [2010CB732201]; Open Project Program of the State Key Laboratory of Pulp and Paper Engineering, SCUT [201138]; Fundamental Research Funds for the Central Universities [2012ZP0009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Major State Basic Research Development Program '973'(National Basic Research Program of China); Open Project Program of the State Key Laboratory of Pulp and Paper Engineering, SCUT; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors acknowledge the National Natural Science Foundation of China (Grant Nos. 31071559 and 21072065), the New Century Excellent Talents in University (Grant Nos. NCET-11-0161 and NCET-10-0367), the Doctoral Program of Higher Education (Grant No. 20090172110019), the Major State Basic Research Development Program '973' (Grant No. 2010CB732201), the Open Project Program of the State Key Laboratory of Pulp and Paper Engineering, SCUT (Grant No. 201138), and the Fundamental Research Funds for the Central Universities (Grant No. 2012ZP0009) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2009, EUR J LIPID SCI TECH, V111, P800, DOI 10.1002/ejlt.200900078; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; BANERJEE N, 1981, EUR J APPL MICROBIOL, V11, P226, DOI 10.1007/BF00505872; BLIGH EG, 1959, BIOCH PHYSL, V37, P911; Casey E, 2010, FEMS YEAST RES, V10, P385, DOI 10.1111/j.1567-1364.2010.00623.x; Chen X, 2009, APPL BIOCHEM BIOTECH, V159, P1; Demirbas A, 2009, ENERG CONVERS MANAGE, V50, P14, DOI 10.1016/j.enconman.2008.09.001; Economou CN, 2011, BIORESOURCE TECHNOL, V102, P9737, DOI 10.1016/j.biortech.2011.08.025; Fitzgerald DJ, 2004, J APPL MICROBIOL, V97, P104, DOI 10.1111/j.1365-2672.2004.02275.x; Graves T, 2006, J IND MICROBIOL BIOT, V33, P469, DOI 10.1007/s10295-006-0091-6; Hu CM, 2009, BIORESOURCE TECHNOL, V100, P4843, DOI 10.1016/j.biortech.2009.04.041; Huang C, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-4; Huang C, 2012, NEW BIOTECHNOL, V29, P372, DOI 10.1016/j.nbt.2011.03.008; Huang C, 2011, J AGR FOOD CHEM, V59, P4606, DOI 10.1021/jf104320b; Huang C, 2009, BIORESOURCE TECHNOL, V100, P4535, DOI 10.1016/j.biortech.2009.04.022; Kavadia A, 2001, J AM OIL CHEM SOC, V78, P341, DOI 10.1007/s11746-001-0266-3; Larsson S, 2000, APPL BIOCHEM BIOTECH, V84-6, P617, DOI 10.1385/ABAB:84-86:1-9:617; Lennartsson PR, 2009, J BIOTECHNOL, V143, P255, DOI 10.1016/j.jbiotec.2009.07.011; Li Q, 2008, APPL MICROBIOL BIOT, V80, P749, DOI 10.1007/s00253-008-1625-9; Lopez R, 1999, YEAST, V15, P553, DOI 10.1002/(SICI)1097-0061(199905)15:7<553::AID-YEA397>3.0.CO;2-V; Meng X, 2009, RENEW ENERG, V34, P1, DOI 10.1016/j.renene.2008.04.014; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Pereira RS, 2011, J IND MICROBIOL BIOT, V38, P71, DOI 10.1007/s10295-010-0830-6; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Tsigie YA, 2011, BIORESOURCE TECHNOL, V102, P9216, DOI 10.1016/j.biortech.2011.06.047; Yu XC, 2011, BIORESOURCE TECHNOL, V102, P6134, DOI 10.1016/j.biortech.2011.02.081; Zaldivar J, 1999, BIOTECHNOL BIOENG, V66, P203, DOI [10.1002/(SICI)1097-0290(1999)66:4<203::AID-BIT1>3.0.CO;2-#, 10.1002/(SICI)1097-0290(1999)66:4&lt;203::AID-BIT1&gt;3.0.CO;2-#]; Zaldivar J, 1999, BIOTECHNOL BIOENG, V65, P24, DOI 10.1002/(SICI)1097-0290(19991005)65:1<24::AID-BIT4>3.0.CO;2-2; Zaldivar J, 2000, BIOTECHNOL BIOENG, V68, P524, DOI 10.1002/(SICI)1097-0290(20000605)68:5<524::AID-BIT6>3.0.CO;2-T	29	13	13	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46975	10.1371/journal.pone.0046975	http://dx.doi.org/10.1371/journal.pone.0046975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071683	Green Submitted, gold, Green Published			2022-12-25	WOS:000309827300073
J	Wu, SY; Wu, WY; Zhang, FC; Ye, J; Ni, XJ; Sun, JM; Edwards, SV; Meng, J; Organ, CL				Wu, Shaoyuan; Wu, Wenyu; Zhang, Fuchun; Ye, Jie; Ni, Xijun; Sun, Jimin; Edwards, Scott V.; Meng, Jin; Organ, Chris L.			Molecular and Paleontological Evidence for a Post-Cretaceous Origin of Rodents	PLOS ONE			English	Article							3 NUCLEAR GENES; DIVERGENCE TIMES; MAMMAL DIVERSIFICATION; PLACENTAL MAMMALS; EVOLUTION; PHYLOGENY; FOSSIL; GLIRES; SUBSTITUTIONS; ANTIQUITY	The timing of the origin and diversification of rodents remains controversial, due to conflicting results from molecular clocks and paleontological data. The fossil record tends to support an early Cenozoic origin of crown-group rodents. In contrast, most molecular studies place the origin and initial diversification of crown-Rodentia deep in the Cretaceous, although some molecular analyses have recovered estimated divergence times that are more compatible with the fossil record. Here we attempt to resolve this conflict by carrying out a molecular clock investigation based on a nine-gene sequence dataset and a novel set of seven fossil constraints, including two new rodent records (the earliest known representatives of Cardiocraniinae and Dipodinae). Our results indicate that rodents originated around 61.7-62.4 Ma, shortly after the Cretaceous/Paleogene (K/Pg) boundary, and diversified at the intraordinal level around 57.7-58.9 Ma. These estimates are broadly consistent with the paleontological record, but challenge previous molecular studies that place the origin and early diversification of rodents in the Cretaceous. This study demonstrates that, with reliable fossil constraints, the incompatibility between paleontological and molecular estimates of rodent divergence times can be eliminated using currently available tools and genetic markers. Similar conflicts between molecular and paleontological evidence bedevil attempts to establish the origination times of other placental groups. The example of the present study suggests that more reliable fossil calibration points may represent the key to resolving these controversies.	[Wu, Shaoyuan; Edwards, Scott V.; Organ, Chris L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Wu, Shaoyuan; Edwards, Scott V.; Organ, Chris L.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Wu, Wenyu; Ye, Jie; Ni, Xijun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Zhang, Fuchun] Xinjiang Univ, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Xinjiang, Peoples R China; [Sun, Jimin] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Harvard University; Harvard University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Xinjiang University; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; American Museum of Natural History (AMNH)	Wu, SY (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	shaoyuan5@gmail.com; jmeng@amnh.org	Edwards, Scott V./D-9071-2018; Sun, Jimin/F-1240-2018	Edwards, Scott V./0000-0003-2535-6217; Sun, Jimin/0000-0003-3516-1413	Putnam Expedition Grants; Museum of Comparative Zoology of Harvard University; National Natural Science Foundation of China [408720320]	Putnam Expedition Grants; Museum of Comparative Zoology of Harvard University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Author SW was supported by the Putnam Expedition Grants and the Robert G. Goelet Research Fund from the Museum of Comparative Zoology of Harvard University. Authors WW, JY, XN, and JM were supported by the National Natural Science Foundation of China (408720320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Cartwright P, 2007, INTEGR COMP BIOL, V47, P744, DOI 10.1093/icb/icm071; Dawson Mary R., 1996, Palaeovertebrata (Montpellier), V25, P301; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Douzery EJP, 2003, J MOL EVOL, V57, pS201, DOI 10.1007/s00239-003-0028-x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FITCH WM, 1990, MOL BIOL EVOL, V7, P438; FITCH WM, 1987, MOL BIOL EVOL, V4, P381; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; Hartenberger JL, 1982, U MICH MUS PALEO CON, V26, P19; Huchon D, 2000, P ROY SOC B-BIOL SCI, V267, P393, DOI 10.1098/rspb.2000.1014; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Jacobs Louis L., 2005, P63; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Li C-K, 1994, RODENT LAGOMORPH FAM; Li Qian, 2010, Vertebrata Palasiatica, V48, P133; Li Qiang, 2005, Vertebrata Palasiatica, V43, P283; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Meng J, 2003, B AM MUS NAT HIST, P1; Meng Jin, 2008, Vertebrata Palasiatica, V46, P90; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu ZD., 1996, MIDDLE MIOCENE MICRO; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Smith AB, 2002, ANNU REV EARTH PL SC, V30, P65, DOI 10.1146/annurev.earth.30.091201.140057; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; [孙勃 SUN Bo], 2009, [地层学杂志, Journal of Stratigraphy], V33, P62; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Tomiya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024146; Tong Y-S, 1997, PALEONT SINICA, V26; Tong Yongsheng, 1992, Vertebrata Palasiatica, V30, P1; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Walton Anne H., 1997, P392; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wu Wen-Yu, 2009, Vertebrata Palasiatica, V47, P208; WYSS AR, 1993, NATURE, V365, P434, DOI 10.1038/365434a0; Zazhigin VS, 2000, PALEONTOL J, V34, P553; Zhang Q, 2012, EVOL BIOL, DOI [10.1007/s11692-11012-19167-11696, DOI 10.1007/S11692-11012-19167-11696]	55	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46445	10.1371/journal.pone.0046445	http://dx.doi.org/10.1371/journal.pone.0046445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071573	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300030
J	Maatta, JA; Buki, KG; Gu, GL; Alanne, MH; Vaaraniemi, J; Liljenback, H; Poutanen, M; Harkonen, P; Vaananen, K				Maatta, Jorma A.; Buki, Kalman G.; Gu, Guoliang; Alanne, Maria H.; Vaaraniemi, Jukka; Liljenback, Heidi; Poutanen, Matti; Harkonen, Pirkko; Vaananen, Kalervo			Inactivation of estrogen receptor alpha in bone-forming cells induces bone loss in female mice	FASEB JOURNAL			English	Article						osteoblast; osteoporosis	GENE-EXPRESSION; TRABECULAR BONE; CORTICAL BONE; SEX STEROIDS; FAS LIGAND; IN-VITRO; DIFFERENTIATION; SPECIFICITY; OSTEOBLASTS; KNOCKOUT	The role of the estrogen receptor alpha (ER alpha) in bone-forming cells is incompletely understood at present. To examine the in vivo effects of ER alpha in these cells, we generated a mouse strain in which the ER alpha gene is inactivated in osteoblasts via osteocalcin promoter-regulated cyclic recombinase (Cre) activity (ER alpha(Delta OB/Delta OB)). This enabled micro-computed tomography- and histomorphometry-based analysis of ER alpha-mediated effects in bone-forming cells in mice, in which the systemic ER alpha-mediated effects are intact. In female ER alpha(Delta OB/Delta OB) mice, trabecular and cortical bone volumes were significantly reduced (31.5 and 11.4%, respectively) at 3.5 mo of age compared with control ER alpha(fl/fl) animals, and their response to ovariectomy was small compared with that of controls. In contrast with females, no differences could be detected in the bone phenotype of young males, whereas in 6-mo-old ER alpha(Delta OB/Delta OB) males, trabecular bone volume (Tb.BV) was decreased (27.5%). The ER alpha inactivation-related effects were compared with those of controls having a similar genetic background. Parental osteocalcin-Cre mice did not show Cre-related changes. Our results suggest that in female mice, Tb.BV and cortical bone volume are critically dependent on the ER alpha regulation of osteoblasts, whereas in male mice, osteoblastic ER alpha is not required for the regulation of bone formation during rapid skeletal growth, but it is involved in the maintenance of Tb.BV.-Maatta, J. A., Buki, K. G., Gu, G., Alanne, M. H., Vaaraniemi, J., Liljenback, H., Poutanen, M., Harkonen, P., Vaananen, K. Inactivation of estrogen receptor alpha in bone-forming cells induces bone loss in female mice. FASEB J. 27, 478-488 (2013). www.fasebj.org	[Maatta, Jorma A.; Buki, Kalman G.; Gu, Guoliang; Alanne, Maria H.; Vaaraniemi, Jukka; Harkonen, Pirkko; Vaananen, Kalervo] Univ Turku, Dept Cell Biol & Anat, FI-20520 Turku, Finland; [Maatta, Jorma A.; Liljenback, Heidi; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, FI-20520 Turku, Finland; [Liljenback, Heidi; Poutanen, Matti] Univ Turku, Dept Physiol, FI-20520 Turku, Finland	University of Turku; University of Turku; University of Turku	Maatta, JA (corresponding author), Univ Turku, Dept Cell Biol & Anat, Inst Biomed, FI-20520 Turku, Finland.	jmaatta@utu.fi	Alanne, Maria/F-2500-2013; Poutanen, Matti/I-1700-2018	Poutanen, Matti/0000-0002-8953-1734; Liljenback, Heidi/0000-0001-9372-1584; Maatta, Jorma/0000-0001-8752-6862; Alanne, Maria/0000-0003-0405-7496	Finnish Funding Agency for Technology and Innovation; Academy of Finland; Sigrid Juselius Foundation	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The authors thank Tommi Kauko for statistical analysis, Dr. Kaisa Ivaska for fruitful discussions, and Anu Salminen, Liudmila Shumskaya, Natalia Habilainen-Kirillov, Soili Jussila, and Jani Seppanen for their excellent technical help. The ER alpha<SUP>L2/L2</SUP> mice were a generous gift from Prof. Pierre Chambon (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique/Institut National de la Sante et de la Recherche Medicale/Universite Louis Pasteur, College de France, Illkirch, France), and the osteocalcin-Cre mice were provided by Prof. Thomas Clemens (Johns Hopkins University School of Medicine, Baltimore, MD, USA). This work was supported by grants from the Finnish Funding Agency for Technology and Innovation, the Academy of Finland, and the Sigrid Juselius Foundation. The authors declare no conflicts of interests.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Alatalo SL, 2000, CLIN CHEM, V46, P1751; Almeida M, 2010, J BONE MINER RES, V25, P769, DOI 10.1359/jbmr.091017; Borjesson AE, 2010, J BONE MINER RES, V25, P2414, DOI 10.1002/jbmr.156; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Dupont S, 2000, DEVELOPMENT, V127, P4277; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Falahati-Nini A, 2000, J CLIN INVEST, V106, P1553, DOI 10.1172/JCI10942; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Frank GR, 2003, MED PEDIATR ONCOL, V41, P217, DOI 10.1002/mpo.10340; Frenkel B, 1997, ENDOCRINOLOGY, V138, P2109, DOI 10.1210/en.138.5.2109; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Jessop HL, 2004, J BONE MINER RES, V19, P938, DOI 10.1359/jbmr.2004.19.6.938; Kallio A, 2008, MOL CELL ENDOCRINOL, V289, P38, DOI 10.1016/j.mce.2008.03.005; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; LIAN JB, 1993, J CELL BIOCHEM, V52, P206, DOI 10.1002/jcb.240520212; Lindberg MK, 2001, J ENDOCRINOL, V171, P425, DOI 10.1677/joe.0.1710425; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Modder UI, 2012, J CELL BIOCHEM, V113, P2248, DOI 10.1002/jcb.24095; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Notini AJ, 2007, J BONE MINER RES, V22, P347, DOI 10.1359/JBMR.061117; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; Parikka V, 2005, EUR J ENDOCRINOL, V152, P301, DOI 10.1530/eje.1.01832; Peng ZQ, 2004, J BONE MINER RES, V19, P1320, DOI 10.1359/JBMR.040510; Qu Q, 1998, BONE, V22, P201, DOI 10.1016/S8756-3282(97)00276-7; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P155, DOI 10.1007/s00223-007-9101-6; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schomberg DW, 1999, ENDOCRINOLOGY, V140, P2733, DOI 10.1210/en.140.6.2733; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Syed FA, 2011, BONE, V49, P208, DOI 10.1016/j.bone.2011.03.771; Vanderschueren D, 1997, ENDOCRINOLOGY, V138, P2301, DOI 10.1210/en.138.6.2301; Venken K, 2006, J BONE MINER RES, V21, P576, DOI 10.1359/JBMR.060103; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Visigalli D, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-147; Windahl SH, 2007, ENDOCRINOLOGY, V148, P5688, DOI 10.1210/en.2007-0508; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	47	50	55	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					478	488		10.1096/fj.12-213587	http://dx.doi.org/10.1096/fj.12-213587			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23073829				2022-12-25	WOS:000314358000008
J	Bower, NI; de la Serrana, DG; Cole, NJ; Hollway, GE; Lee, HT; Assinder, S; Johnston, IA				Bower, Neil I.; de la Serrana, Daniel Garcia; Cole, Nicholas J.; Hollway, Georgina E.; Lee, Hung-Tai; Assinder, Stephen; Johnston, Ian A.			Stac3 Is Required for Myotube Formation and Myogenic Differentiation in Vertebrate Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; PROTEIN; GENES; SLOW; EXPRESSION; HEDGEHOG; IDENTIFICATION; PATHWAY; GROWTH; PHOSPHORYLATION	Stac3 was identified as a nutritionally regulated gene from an Atlantic salmon subtractive hybridization library with highest expression in skeletal muscle. Salmon Stac3 mRNA was highly correlated with myogenin and myoD1a expression during differentiation of a salmon primary myogenic culture and was regulated by amino acid availability. In zebrafish embryos, stac3 was initially expressed in myotomal adaxial cells and in fast muscle fibers post-segmentation. Morpholino knockdown resulted in defects in myofibrillar protein assembly, particularly in slow muscle fibers, and decreased levels of the hedgehog receptor patched. The function of Stac3 was further characterized in vitro using the mammalian C2C12 myogenic cell line. Stac3 mRNA expression increased during the differentiation of the C2C12 myogenic cell line. Knock-down of Stac3 by RNAi inhibited myotube formation, and microarray analysis revealed that transcripts involved in cell cycle, focal adhesion, cytoskeleton, and the pro-myogenic factors Igfbp-5 and Igf2 were down-regulated. RNAi-treated cells had suppressed Akt signaling and exogenous insulin-like growth factor (Igf) 2 was unable to rescue the phenotype, however, Igf/Akt signaling was not blocked. Overexpression of Stac3, which results in increased levels of Igfbp-5 mRNA, did not lead to increased differentiation. In synchronized cells, Stac3 mRNA was most abundant during the G(1) phase of the cell cycle. RNAi-treated cells were smaller, had higher proliferation rates and a decreased proportion of cells in G(1) phase when compared with controls, suggesting a role in the G(1) phase checkpoint. These results identify Stac3 as a new gene required for myogenic differentiation and myofibrillar protein assembly in vertebrates.	[Bower, Neil I.; de la Serrana, Daniel Garcia; Lee, Hung-Tai; Johnston, Ian A.] Univ St Andrews, Sch Biol, Scottish Oceans Inst, St Andrews KY16 8LB, Fife, Scotland; [Cole, Nicholas J.; Assinder, Stephen] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hollway, Georgina E.] Garvan Inst Med Res, Sydney, NSW, Australia	University of St Andrews; University of Sydney; Garvan Institute of Medical Research	de la Serrana, DG (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	n.bower@uq.edu.au; iaj@st-andrews.ac.uk	cole, nicholas/M-7010-2016; Johnston, Ian A./AAE-2044-2019; Garcia de la serrana, Daniel/R-9956-2018; Hollway, Georgina E/E-6764-2010; Johnston, Ian A/D-6592-2013; Bower, Neil/K-1478-2014	Garcia de la serrana, Daniel/0000-0001-6630-3379; Johnston, Ian A/0000-0002-7796-5754; Bower, Neil/0000-0002-6764-6063; Cole, Nicholas/0000-0003-1006-2662; Lee, Hung-Tai/0000-0003-2362-3182	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; European Community [222719-LIFECYCLE]	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; European Community(European Commission)	This work was supported in part by the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) supported by Scottish Funding Council Grant HR09011.; Supported by the European Community's Seventh Framework Programme FP7/2007-2013 under Grant 222719-LIFECYCLE.	Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bower NI, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq816; Bower NI, 2010, PHYSIOL GENOMICS, V42A, P114, DOI 10.1152/physiolgenomics.00065.2010; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Bower NI, 2010, AM J PHYSIOL-REG I, V298, pR1615, DOI 10.1152/ajpregu.00114.2010; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cabane C, 2004, CELL SIGNAL, V16, P1405, DOI 10.1016/j.cellsig.2004.05.003; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Koshimizu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017688; Legha W, 2010, GENE EXPR PATTERNS, V10, P368, DOI 10.1016/j.gep.2010.08.003; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lim CS, 2001, J BIOL CHEM, V276, P12871, DOI 10.1074/jbc.M009411200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Raharjo WH, 2001, J CELL SCI, V114, P4447; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Suzuki H, 1996, BIOCHEM BIOPH RES CO, V229, P902, DOI 10.1006/bbrc.1996.1900; Tanaka K, 2011, MUSCLE NERVE, V44, P968, DOI 10.1002/mus.22224; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Tiffin N, 2004, ENDOCRINOLOGY, V145, P4991, DOI 10.1210/en.2004-0101; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williams RJ, 2011, BIOMATERIALS, V32, P5304, DOI 10.1016/j.biomaterials.2011.03.078; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200	41	30	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43936	43949		10.1074/jbc.M112.361311	http://dx.doi.org/10.1074/jbc.M112.361311			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23076145	hybrid, Green Published			2022-12-25	WOS:000312940800069
J	Karduna, AR; Sainburg, RL				Karduna, Andrew R.; Sainburg, Robert L.			Similarities in the Neural Control of the Shoulder and Elbow Joints Belie Their Structural Differences	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; REACHING MOVEMENTS; INTERNAL-MODEL; INTERJOINT COORDINATION; ONLINE CONTROL; ARM MOVEMENTS; DYNAMICS; ACCURACY; PROPRIOCEPTION; POSITION	Movement of the hand in three dimensional space is primarily controlled by the orientation of the shoulder and elbow complexes. Due to discrepancies in proprioceptive acuity, overlap in motor cortex representation and grossly different anatomies between these joints, we hypothesized that there would be differences in the accuracy of aimed movements between the two joints. Fifteen healthy young adults were tested under four conditions - shoulder motion with the elbow constrained and unconstrained, and elbow motion with the shoulder constrained and unconstrained. End point target locations for each joint were set to coincide with joint excursions of 10, 20 or 30 degrees of either the shoulder or elbow joint. Targets were presented in a virtual reality environment. For the constrained condition, there were no significant differences in angular errors between the two joints, suggesting that the central nervous system represents linked segment models of the limb in planning and controlling movements. For the unconstrained condition, although angle errors were higher, hand position errors remained the same as those of the constrained trials. These results support the idea that the CNS utilizes abundant degrees of freedom to compensate for the potentially different contributions to end-point errors introduced by each joint.	[Karduna, Andrew R.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Sainburg, Robert L.] Penn State Univ, Dept Kinesiol & Neurol, University Pk, PA 16802 USA	University of Oregon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Karduna, AR (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	karduna@uoregon.edu	Karduna, Andrew/ABA-7373-2021	Sainburg, Robert/0000-0003-2627-1258; Karduna, Andrew/0000-0003-4859-4330	National Institutes of Health (NICHD) [R01HD39311, R01HD059783]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059783] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039311] Funding Source: NIH RePORTER	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NICHD) grants R01HD39311 and R01HD059783 to Robert Sainburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 1999, EXP BRAIN RES, V125, P200, DOI 10.1007/s002210050674; Arce F, 2010, J NEUROSCI, V30, P5415, DOI 10.1523/JNEUROSCI.0076-10.2010; ATKESON CG, 1989, ANNU REV NEUROSCI, V12, P157, DOI 10.1146/annurev.neuro.12.1.157; BUNEO CA, 1995, EXP BRAIN RES, V104, P467; CLARK FJ, 1995, EXP BRAIN RES, V107, P73; Debicki DB, 2005, EXP BRAIN RES, V163, P252, DOI 10.1007/s00221-005-2229-6; Ebner TJ, 2011, CEREBELLUM, V10, P683, DOI 10.1007/s12311-010-0243-0; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Galloway JC, 2002, EXP BRAIN RES, V142, P163, DOI 10.1007/s002210100882; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; Goble JA, 2007, J NEUROPHYSIOL, V98, P1240, DOI 10.1152/jn.00582.2007; Goldscheider A., 1889, ARCHIV F R PHYSIOLOG, V3, P369; Graham KM, 2003, J NEUROPHYSIOL, V89, P2667, DOI 10.1152/jn.00742.2002; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Gritsenko V, 2007, J NEUROPHYSIOL, V98, P1140, DOI 10.1152/jn.00162.2007; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Gritsenko V, 2011, J NEUROSCI, V31, P11968, DOI 10.1523/JNEUROSCI.0132-11.2011; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; HANCOCK GR, 1995, J MOTOR BEHAV, V27, P241, DOI 10.1080/00222895.1995.9941714; Herter TM, 2007, J NEUROPHYSIOL, V97, P2887, DOI 10.1152/jn.00757.2006; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Imamizu H, 1998, J EXP PSYCHOL HUMAN, V24, P812, DOI 10.1037/0096-1523.24.3.812; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Kocak M, 2009, RADIOLOGY, V251, P485, DOI 10.1148/radiol.2512080231; Kwok JC, 2010, ARCH PHYS MED REHAB, V91, P149, DOI 10.1016/j.apmr.2009.07.018; Lackner JR, 1998, J NEUROPHYSIOL, V80, P546, DOI 10.1152/jn.1998.80.2.546; Li Y, 2005, J NEUROPHYSIOL, V94, P2139, DOI 10.1152/jn.00312.2005; MARTIN JH, 1993, EXP BRAIN RES, V94, P429; Melgari JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003069; Messier J, 2003, EXP BRAIN RES, V150, P399, DOI 10.1007/s00221-003-1413-9; Milner TE, 2004, EXP BRAIN RES, V159, P172, DOI 10.1007/s00221-004-1944-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penfield W., 1952, CEREBRAL CORTEX MAN; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; SAINBURG RL, 1993, J NEUROPHYSIOL, V70, P2136, DOI 10.1152/jn.1993.70.5.2136; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Sarlegna F, 2003, EXP BRAIN RES, V151, P524, DOI 10.1007/s00221-003-1504-7; Sarlegna FR, 2010, J VISION, V10, DOI 10.1167/10.5.24; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SCOTT SH, 1994, J NEUROSCI, V14, P7529; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sturnieks DL, 2007, J PHYSIOL-LONDON, V585, P833, DOI 10.1113/jphysiol.2007.139089; Tomlinson T, 2012, J MOTOR BEHAV, V44, P13, DOI 10.1080/00222895.2011.636398; Tripp BL, 2006, CLIN BIOMECH, V21, P466, DOI 10.1016/j.clinbiomech.2005.12.015; Wang JS, 2007, EXP BRAIN RES, V178, P565, DOI 10.1007/s00221-007-0936-x; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yao J, 2009, NEUROIMAGE, V45, P490, DOI 10.1016/j.neuroimage.2008.12.002	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e45837	10.1371/journal.pone.0045837	http://dx.doi.org/10.1371/journal.pone.0045837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082116	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900011
J	Hoffmann, J; Fiser, K; Weaver, J; Dimmick, I; Loeher, M; Pircher, H; Martin-Ruiz, C; Veerasamy, M; Keavney, B; von Zglinicki, T; Spyridopoulos, I				Hoffmann, Jedrzej; Fiser, Karel; Weaver, Jolanta; Dimmick, Ian; Loeher, Monika; Pircher, Hanspeter; Martin-Ruiz, Carmen; Veerasamy, Murugapathy; Keavney, Bernard; von Zglinicki, Thomas; Spyridopoulos, Ioakim			High-Throughput 13-Parameter Immunophenotyping Identifies Shifts in the Circulating T-Cell Compartment Following Reperfusion in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; POLYCHROMATIC FLOW-CYTOMETRY; PRIMARY ANGIOPLASTY; RECEPTOR ACTIVATION; LYMPHOCYTES; INJURY; EXPRESSION; MEMORY; ASSOCIATION; POPULATIONS	Rationale: With the advent of primary PCI (PPCI), reperfusion is achieved in almost all patients presenting with acute myocardial infarction. However, despite multiple trials, reperfusion injury has not been successfully dealt with so far. In mouse models, CD4(+) T lymphocytes (T cells) have been shown to be crucial instigators of reperfusion injury. Objective: Our goal was to investigate the role of CD4(+) T cells during myocardial reperfusion following PPCI by developing a protocol for high-throughput multiplexed flow cytometric analysis and multivariate flow clustering. Methods and Results: 13-parameter immunophenotyping and hierarchical cluster analysis (HCA) identified a unique CD4(+)CD57(+) T-cell population in PPCI patients that reflected acute proliferation in the CD4(+) T-cell compartment. CD4(+)CCR7(+) T cells were specifically depleted from peripheral blood during the first 30 min of myocardial reperfusion after PPCI, suggesting a potential role for the chemokine receptor CCR7 in T-cell redistribution to either peripheral tissues or migration to the infarcted heart during ischemia/reperfusion following PPCI. Conclusions: High-throughput polychromatic flow cytometry and HCA are capable of objective, time and cost efficient assessment of the individual T-cell immune profile in different stages of coronary heart disease and have broad applications in clinical trials.	[Hoffmann, Jedrzej; Dimmick, Ian; Loeher, Monika; Veerasamy, Murugapathy; Keavney, Bernard; Spyridopoulos, Ioakim] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Martin-Ruiz, Carmen; von Zglinicki, Thomas] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Weaver, Jolanta] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pircher, Hanspeter] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Fiser, Karel] Charles Univ Prague, Med Sch 2, Dept Paediat Haematol & Oncol, CLIP, Prague, Czech Republic	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Freiburg; Charles University Prague	Spyridopoulos, I (corresponding author), Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ioakim.spyridopoulos@newcastle.ac.uk	Fišer, Karel/W-6465-2019	Fišer, Karel/0000-0002-7265-3268; Keavney, Bernard/0000-0001-9573-0812; Hoffmann, Jedrzej/0000-0003-0487-4373; Martin-Ruiz, Carmen/0000-0002-3361-6974; Spyridopoulos, Ioakim/0000-0002-2750-2444; von Zglinicki, Thomas/0000-0002-5939-0248	UK NIHR Biomedical Research Centre; Newcastle Healthcare Charity; Newcastle Upon Tyne Hospitals NHS Charity; MRC [G0601333] Funding Source: UKRI; British Heart Foundation [FS/12/55/29695, RG/08/012/25941] Funding Source: researchfish; Medical Research Council [G0601333] Funding Source: researchfish	UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Newcastle Healthcare Charity; Newcastle Upon Tyne Hospitals NHS Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK NIHR Biomedical Research Centre award to the Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Healthcare Charity and Newcastle Upon Tyne Hospitals NHS Charity (all to IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeja BG, 2002, CIRCULATION, V105, P282, DOI 10.1161/hc0302.103588; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Burman A, 2005, J IMMUNOL, V174, P1693, DOI 10.4049/jimmunol.174.3.1693; Chattopadhyay PK, 2006, NAT MED, V12, P972, DOI 10.1038/nm1371; Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.067; Claeys MJ, 1999, CIRCULATION, V99, P1972, DOI 10.1161/01.CIR.99.15.1972; Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c; Desmet W, 2011, EUR HEART J, V32, P867, DOI 10.1093/eurheartj/ehq492; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Fiser K, 2012, CYTOM PART A, V81A, P25, DOI 10.1002/cyto.a.21148; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Husser O, 2011, INFLAMMATION, V34, P73, DOI 10.1007/s10753-010-9209-0; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Kruk M, 2008, CIRC J, V72, P205, DOI 10.1253/circj.72.205; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Nunez J, 2010, CORONARY ARTERY DIS, V21, P1, DOI 10.1097/MCA.0b013e328332ee15; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sharma AK, 2010, J THORAC CARDIOV SUR, V139, P474, DOI 10.1016/j.jtcvs.2009.08.033; van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yang Z, 2009, J THORAC CARDIOVASC, V137, P702; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Yang ZQ, 2009, J THORAC CARDIOV SUR, V137, P695, DOI 10.1016/j.jtcvs.2008.10.044; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yokota N, 2003, AM J PHYSIOL-RENAL, V285, pF319, DOI 10.1152/ajprenal.00432.2002	33	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47155	10.1371/journal.pone.0047155	http://dx.doi.org/10.1371/journal.pone.0047155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077561	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800029
J	Duttmann, M; Mittnenzweig, M; Togashi, Y; Yanagida, T; Mikhailov, AS				Duettmann, Markus; Mittnenzweig, Markus; Togashi, Yuichi; Yanagida, Toshio; Mikhailov, Alexander S.			Complex Intramolecular Mechanics of G-actin - An Elastic Network Study	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; NORMAL-MODE CALCULATIONS; CONFORMATIONAL TRANSITIONS; CRYSTAL-STRUCTURE; ADENYLATE KINASE; SINGLE-PARAMETER; MYOSIN-VI; PROTEINS; ATP; FILAMENT	Systematic numerical investigations of conformational motions in single actin molecules were performed by employing a simple elastic-network (EN) model of this protein. Similar to previous investigations for myosin, we found that G-actin essentially behaves as a strain sensor, responding by well-defined domain motions to mechanical perturbations. Several sensitive residues within the nucleotide-binding pocket (NBP) could be identified, such that the perturbation of any of them can induce characteristic flattening of actin molecules and closing of the cleft between their two mobile domains. Extending the EN model by introduction of a set of breakable links which become effective only when two domains approach one another, it was observed that G-actin can possess a metastable state corresponding to a closed conformation and that a transition to this state can be induced by appropriate perturbations in the NBP region. The ligands were roughly modeled as a single particle (ADP) or a dimer (ATP), which were placed inside the NBP and connected by elastic links to the neighbors. Our approximate analysis suggests that, when ATP is present, it stabilizes the closed conformation of actin. This may play an important role in the explanation why, in the presence of ATP, the polymerization process is highly accelerated.	[Duettmann, Markus; Mittnenzweig, Markus; Mikhailov, Alexander S.] Max Planck Gesell, Fritz Haber Inst, Dept Phys Chem, Berlin, Germany; [Mittnenzweig, Markus] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Togashi, Yuichi] Kobe Univ, Grad Sch Syst Informat, Kobe, Hyogo 657, Japan; [Togashi, Yuichi; Yanagida, Toshio] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Free University of Berlin; Kobe University; RIKEN; Osaka University	Duttmann, M (corresponding author), Max Planck Gesell, Fritz Haber Inst, Dept Phys Chem, Berlin, Germany.	duettmann@fhi-berlin.mpg.de	Togashi, Yuichi/D-4163-2009	Togashi, Yuichi/0000-0003-0032-2424; Mittnenzweig, Markus/0000-0002-8502-1702	Global Center of Excellence program "System Dynamics of Biological Function" (Ministry of Education, Culture, Sports, Science and Technology of Japan); DFG Research Training Group [GRK 1558]	Global Center of Excellence program "System Dynamics of Biological Function" (Ministry of Education, Culture, Sports, Science and Technology of Japan); DFG Research Training Group(German Research Foundation (DFG))	Financial support from the Global Center of Excellence program "System Dynamics of Biological Function" (Ministry of Education, Culture, Sports, Science and Technology of Japan) and from the DFG Research Training Group (GRK 1558) "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems" is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Atilgan C, 2010, BIOPHYS J, V99, P933, DOI 10.1016/j.bpj.2010.05.020; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Cecchini M, 2010, STRUCTURE, V18, P458, DOI 10.1016/j.str.2010.01.014; Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1478-3975/2/4/S12; Chu JW, 2007, BIOPHYS J, V93, P3860, DOI 10.1529/biophysj.107.112060; Chu JW, 2006, BIOPHYS J, V90, P1572, DOI 10.1529/biophysj.105.073924; Cressman A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.050901; Cui Q., 2006, NORMAL MODE ANAL THE; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Duttmann M, 2012, BIOPHYS J, V102, P542, DOI 10.1016/j.bpj.2011.12.013; Echeverria C, 2011, PHYS CHEM CHEM PHYS, V13, P10527, DOI 10.1039/c1cp00003a; ELBER R, 1990, J CHEM PHYS, V93, P4312, DOI 10.1063/1.458713; FINE R, 1991, PROTEINS, V11, P242, DOI 10.1002/prot.340110403; Flechsig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021809; Flechsig H, 2010, P NATL ACAD SCI USA, V107, P20875, DOI 10.1073/pnas.1014631107; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Hayashi K, 2007, BIOPHYS J, V93, P895, DOI 10.1529/biophysj.106.100487; Higo J, 1997, PROTEIN ENG, V10, P373, DOI 10.1093/protein/10.4.373; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0; JANMEY PA, 1990, NATURE, V347, P95, DOI 10.1038/347095a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim MK, 2002, J MOL GRAPH MODEL, V21, P151, DOI 10.1016/S1093-3263(02)00143-2; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037; Korkut A, 2009, P NATL ACAD SCI USA, V106, P15673, DOI 10.1073/pnas.0907684106; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Liao JL, 2004, BIOPHYS J, V87, P1369, DOI 10.1529/biophysj.103.038653; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; NARUMI T, 2006, P 2006 ACM IEEE C SU; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Oguchi Y, 2010, NAT CHEM BIOL, V6, P300, DOI [10.1038/NCHEMBIO.322, 10.1038/nchembio.322]; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Piazza F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.145502; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Splettstoesser T, 2011, PROTEINS, V79, P2033, DOI 10.1002/prot.23017; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Takada S, 1999, P NATL ACAD SCI USA, V96, P11698, DOI 10.1073/pnas.96.21.11698; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; TIRION MM, 1993, J MOL BIOL, V230, P186, DOI 10.1006/jmbi.1993.1135; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Togashi Y, 2007, P NATL ACAD SCI USA, V104, P8697, DOI 10.1073/pnas.0702950104; Togashi Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000814; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Wang H, 2010, CYTOSKELETON, V67, P456, DOI 10.1002/cm.20458; Yamaoka H, 2011, BIOMECHANICS MODELIN, V11, P291; Yang L, 2007, BIOPHYS J, V93, P920, DOI 10.1529/biophysj.106.095927; Zheng WJ, 2009, BIOPHYS J, V96, P2128, DOI [10.1016/j.bpj.2008.12.3897, 10.1016/j.bpj.200X.12.3X97]; Zheng WJ, 2005, BIOPHYS J, V89, P167, DOI 10.1529/biophysj.105.063305; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	68	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e45859	10.1371/journal.pone.0045859	http://dx.doi.org/10.1371/journal.pone.0045859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077498	Green Published, gold			2022-12-25	WOS:000309995100022
J	Garcia-Orti, L; Cristobal, I; Cirauqui, C; Guruceaga, E; Marcotegui, N; Calasanz, MJ; Castello-Cros, R; Odero, MD				Garcia-Orti, Laura; Cristobal, Ion; Cirauqui, Cristina; Guruceaga, Elisabet; Marcotegui, Nerea; Calasanz, Maria J.; Castello-Cros, Remedios; Odero, Maria D.			Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; EXPRESSION; NEUROFIBROMATOSIS; RECOGNITION; PATTERNS; DELETION; TYPE-1; CANCER; ALLELE	Background: Deregulated miRNA expression plays a crucial role in carcinogenesis. Recent studies show different mechanisms leading to miRNA deregulation in cancer; however, alterations affecting miRNAs by DNA copy number variations (CNV) remain poorly studied. Results: Our integrative analysis including data from high resolution SNPs arrays, mRNA expression arrays, and miRNAs expression profiles in 16 myeloid cell lines highlights that CNV are alternative mechanisms to deregulate the expression of miRNAs in acute myeloid leukemia (AML), and represent a novel approach to identify novel candidate genes involved in AML. We found association between the expression levels of 19 miRNAs and CNVs affecting their loci. Functional analysis showed that NF1 is a direct target of miR-370, and that overexpression of miR-370 has similar effects that NF1 inactivation, increasing proliferation and colony formation in AML cells. Moreover, real time RT-PCR showed that NF1 downregulation is a recurrent event in AML (30.8%), and western blot analysis confirmed this result. MiR-370 overexpression and deletions affecting the NF1 locus were identified as alternative mechanisms to downregulate NF1. Conclusions: NF1 downregulation is a common event in AML, and both deletions in the NF1 locus and overexpression of miR-370 are alternative mechanisms to downregulate NF1 in this disease. Our results suggest a leukemogenic role of miR-370 through NF1 downregulation in AML cells. Since NF1 deficiency leads to RAS activation, patients with AML and overexpression of miR-370 may potentially benefit from additional treatment with either RAS or mTOR inhibitors.	[Garcia-Orti, Laura; Cristobal, Ion; Cirauqui, Cristina; Marcotegui, Nerea; Castello-Cros, Remedios; Odero, Maria D.] Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Cristobal, Ion; Calasanz, Maria J.; Odero, Maria D.] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Guruceaga, Elisabet] Univ Navarra, Unit Prote Genom & Bioinformat, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra	Odero, MD (corresponding author), Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	modero@unav.es	Calasanz, MJ/R-5813-2016; Odero/ABG-9860-2020; Guruceaga, Elizabeth/B-1796-2008	Calasanz, MJ/0000-0002-0374-3008; Odero/0000-0002-8858-2054; Cirauqui, Cristina/0000-0002-4064-6485; Guruceaga, Elizabeth/0000-0003-0547-681X	Ministerio Educacion y Ciencia [AP2006-03038]; Ministerio Ciencia e Innovacion [PI081687]; Instituto de Salud Carlos III-Red Tematica de investigacion Cooperativa en Cancer (ISCIII-RTICC) [RD06/0020/0078]; Fundacion para la Investigacion Medica Aplicada Union (FIMA)(Spain)	Ministerio Educacion y Ciencia(Spanish Government); Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III-Red Tematica de investigacion Cooperativa en Cancer (ISCIII-RTICC); Fundacion para la Investigacion Medica Aplicada Union (FIMA)(Spain)	This work was supported by Ministerio Educacion y Ciencia [AP2006-03038], Ministerio Ciencia e Innovacion [PI081687], Instituto de Salud Carlos III-Red Tematica de investigacion Cooperativa en Cancer (ISCIII-RTICC)[RD06/0020/0078], and Fundacion para la Investigacion Medica Aplicada Union (FIMA)(Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babashah S, 2009, EUR J HAEMATOL, V83, P261, DOI 10.1111/j.1600-0609.2009.01264.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haferlach C, 2012, LEUKEMIA, V26, P834, DOI 10.1038/leu.2011.296; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Marcucci Guido, 2009, Curr Hematol Malig Rep, V4, P83, DOI 10.1007/s11899-009-0012-7; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Parkin B, 2010, CLIN CANCER RES, V16, P4135, DOI 10.1158/1078-0432.CCR-09-2639; Schiffman JD, 2009, CANCER GENET CYTOGEN, V193, P9, DOI 10.1016/j.cancergencyto.2009.03.005; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Starczynowski DT, 2011, BLOOD, V117, P595, DOI 10.1182/blood-2010-03-277012; Waldman SA, 2009, FEBS J, V276, P2157, DOI 10.1111/j.1742-4658.2009.06934.x; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180	28	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47717	10.1371/journal.pone.0047717	http://dx.doi.org/10.1371/journal.pone.0047717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077663	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100155
J	Kim, HK; Prokunina-Olsson, L; Chanock, SJ				Kim, Hye Kyung; Prokunina-Olsson, Ludmila; Chanock, Stephen J.			Common Genetic Variants in miR-1206 (8q24.2) and miR-612 (11q13.3) Affect Biogenesis of Mature miRNA Forms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROSTATE-CANCER SUSCEPTIBILITY; MICRORNA-RELATED GENES; RENAL-CELL CARCINOMA; COLORECTAL-CANCER; CHROMOSOME 8Q24; BLADDER-CANCER; CERVICAL-CANCER; FRAGILE SITES; MULTIPLE LOCI	Cancer genome-wide association studies (GWAS) have identified many common genetic markers located in non-coding regions of the genome. Two notable examples are the multi-cancer susceptibility regions, 8q24.2 and 11q13.3. Since these GWAS signals localize to gene-poor regions, we investigated genetic variants within pre-microRNA (pre-miRNA) transcripts as a possible link between the GWAS findings and the associated molecular phenotypes. Across the two regions, which contain 37 miRNAs genes, we explored genetic variants by surveying public databases and conducting targeted resequencing. Specifically, we investigated one common single nucleotide polymorphism (SNP) within miR-1206 on 8q24.2 and two SNPs within miR-612 on 11q13.3. Though these variants are not correlated with known GWAS signals, we conjectured that they might be important for function of corresponding miRNAs. To test the functional significance of these genetic variants, we cloned both allelic forms of miR-1206 and miR-612 pre-miRNA into expression vectors and assessed biogenesis of mature miRNA-forms. The two SNPs within miR-612 significantly affected expression of mature miR-612 in a cell-type specific manner; enhancement in prostate cancer cell lines, reduction in colon cancer cells, and no effect in breast cancer cell lines. The SNP within miR-1206 also affected expression of mature miR-1206, but not in a cell-type specific manner. Future studies should identify targets of miR-1206 and miR-612 and help understand the biological roles of these miRNAs and their possible role in carcinogenesis.	[Kim, Hye Kyung; Prokunina-Olsson, Ludmila; Chanock, Stephen J.] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chanock, SJ (corresponding author), NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091	National Institutes of Health, National Cancer Institute (NCI); NCI	National Institutes of Health, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the intramural research program of the National Institutes of Health, National Cancer Institute (NCI) and the NCI Director's Innovation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Balaguer F, 2011, CLIN CANCER RES, V17, P6239, DOI 10.1158/1078-0432.CCR-11-1424; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Reshmi G, 2011, GENOMICS, V97, P333, DOI 10.1016/j.ygeno.2011.02.010; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schodel J, 2012, NAT GENET; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Yamashita Y, 2005, WORLD J GASTROENTERO, V11, P5129; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740	53	26	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47454	10.1371/journal.pone.0047454	http://dx.doi.org/10.1371/journal.pone.0047454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077621	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100117
J	Maisel, T; Joseph, S; Mielke, T; Burger, J; Schwarzinger, S; Meyer, O				Maisel, Tobias; Joseph, Stephanie; Mielke, Thorsten; Buerger, Joerg; Schwarzinger, Stephan; Meyer, Ortwin			The CoxD Protein, a Novel AAA plus ATPase Involved in Metal Cluster Assembly: Hydrolysis of Nucleotide-Triphosphates and Oligomerization	PLOS ONE			English	Article							CARBON-MONOXIDE DEHYDROGENASE; OLIGOTROPHA CARBOXIDOVORANS; MAGNESIUM CHELATASE; MEGAPLASMID PHCG3; GENE-CLUSTER; ACTIVE-SITE; SEQUENCE; VISUALIZATION; BIOGENESIS; MICROSCOPY	CoxD of the alpha-proteobacterium Oligotropha carboxidovorans is a membrane protein which is involved in the posttranslational biosynthesis of the [CuSMoO2] cluster in the active site of the enzyme CO dehydrogenase. The bacteria synthesize CoxD only in the presence of CO. Recombinant CoxD produced in E. coli K38 pGP1-2/pETMW2 appeared in inclusion bodies from where it was solubilized by urea and refolded by stepwise dilution. Circular dichroism spectroscopy revealed the presence of secondary structural elements in refolded CoxD. CoxD is a P-loop ATPase of the AAA-protein family. Refolded CoxD catalyzed the hydrolysis of MgATP yielding MgADP and inorganic phosphate at a 1:1:1 molar ratio. The reaction was inhibited by the slow hydrolysable MgATP-gamma-S. GTPase activity of CoxD did not exceed 2% of the ATPase activity. Employing different methods (non linear regression, Hanes and Woolf, Lineweaver-Burk), preparations of CoxD revealed a mean K-M value of 0.69+/-0.14 mM ATP and an apparent V-max value of 19.3+/-2.3 nmol ATP hydrolyzed min(-1) mg(-1). Sucrose density gradient centrifugation and gel filtration showed that refolded CoxD can exist in various multimeric states (2-mer, 4-mer or 6-mer), preferentially as hexamer or dimer. Within weeks the hexamer dissociates into the dimer, a process which can be reversed by MgATP or MgATP-gamma-S within hours. Only the hexamers and the dimers exhibited MgATPase activity. Transmission electron microscopy of negatively stained CoxD preparations revealed distinct particles within a size range of 10-16 nm, which further corroborates the oligomeric organization. The 3D structure of CoxD was modeled with the 3D structure of BchI from Rhodobacter capsulatus as template. It has the key elements of an AAA+ domain in the same arrangement and at same positions as in BchI and displays the characteristic inserts of the PS-II-insert clade. Possible functions of CoxD in [CuSMoO2] cluster assembly are discussed.	[Maisel, Tobias; Joseph, Stephanie; Meyer, Ortwin] Univ Bayreuth, Chair Microbiol, Bayreuth, Germany; [Mielke, Thorsten; Buerger, Joerg] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Mielke, Thorsten; Buerger, Joerg] Charite, Inst Med Phys & Biophys, D-13353 Berlin, Germany; [Schwarzinger, Stephan] Univ Bayreuth, Chair Biopolymers, Bayreuth, Germany; [Schwarzinger, Stephan; Meyer, Ortwin] Bayreuth Res Ctr Biomacromol, Bayreuth, Germany	University of Bayreuth; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bayreuth	Meyer, O (corresponding author), Univ Bayreuth, Chair Microbiol, Bayreuth, Germany.	Ortwin.Meyer@uni-bayreuth.de	Schwarzinger, Stephan/GWV-5819-2022; Schwarzinger, Stephan/O-4318-2014	Burger, Jorg/0000-0002-4326-5047; Schwarzinger, Stephan/0000-0002-0894-5290	Deutsche Forschungsgemeinschaft [Me 732/11-1, SFB 740 TPZ1, Schw 901/3-1]; European Union; Senatsverwaltung fur Wissenschaft, Forschung und Kultur, Berlin, Germany (UltraStructureNetwork, Anwenderzentrum)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Senatsverwaltung fur Wissenschaft, Forschung und Kultur, Berlin, Germany (UltraStructureNetwork, Anwenderzentrum)	The authors acknowledge financial support from the Deutsche Forschungsgemeinschaft (Me 732/11-1 to OM, SFB 740 TPZ1 to TM and Schw 901/3-1 to STS) and the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur, Berlin, Germany (UltraStructureNetwork, Anwenderzentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; BEISENHERZ G, 1953, Z NATURFORSCH B, V8, P555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuhrmann S, 2003, GENE, V322, P67, DOI 10.1016/j.gene.2003.08.027; FUTO S, 1986, ARCH MICROBIOL, V145, P358, DOI 10.1007/BF00470871; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Gnida M, 2003, BIOCHEMISTRY-US, V42, P222, DOI 10.1021/bi026514n; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harrison MD, 1999, J BIOL INORG CHEM, V4, P145, DOI 10.1007/s007750050297; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Ikegami A, 2007, J BIOL CHEM, V282, P19282, DOI 10.1074/jbc.M703324200; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; MEYER O, 1983, ANNU REV MICROBIOL, V37, P277, DOI 10.1146/annurev.mi.37.100183.001425; MEYER O, 1979, J BACTERIOL, V137, P811, DOI 10.1128/JB.137.2.811-817.1979; Meyer OO, 2005, BERGEYS MANUAL SYSTE, V2, P468; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Neuwald AF, 1999, GENOME RES, V9, P27; PARK K, 1993, PROTEIN SCI, V2, P325; Paul D, 2008, J BACTERIOL, V190, P5531, DOI 10.1128/JB.00614-08; Pelzmann A, 2009, J BIOL CHEM, V284, P9578, DOI 10.1074/jbc.M805354200; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schachman H.K., 1959, ULTRACENTRIFUGATION; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Walker CJ, 1997, BIOCHEM J, V327, P321; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n	52	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47424	10.1371/journal.pone.0047424	http://dx.doi.org/10.1371/journal.pone.0047424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077613	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100109
J	Prangkio, P; Yusko, EC; Sept, D; Yang, J; Mayer, M				Prangkio, Panchika; Yusko, Erik C.; Sept, David; Yang, Jerry; Mayer, Michael			Multivariate Analyses of Amyloid-Beta Oligomer Populations Indicate a Connection between Pore Formation and Cytotoxicity	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; ALZHEIMERS-DISEASE; ION CHANNELS; PROTEIN OLIGOMERIZATION; SYNAPTIC PLASTICITY; SECONDARY STRUCTURE; PRECURSOR PROTEIN; IN-VITRO; MEMBRANE; PEPTIDE	Aggregates of amyloid-beta (A beta) peptides are thought to be involved in the development of Alzheimer's disease because they can change synaptic plasticity and induce neuronal cell death by inflammation, oxidative damage, and transmembrane pore formation. Exactly which oligomeric species underlie these cytotoxic effects remains unclear. The work presented here established well-controlled aggregation conditions of A beta(1-40) or A beta(1-42) peptides over a 20-day period and characterized these preparations with regard to their beta-sheet content, degree of fibril formation, relative abundance of various oligomer sizes, and propensity to induce membrane pore formation and cytotoxicity. Using this multivariate data set, a systematic and inherently unbiased partial least squares (PLS) approach showed that for both peptides the abundance of oligomers in the tetramer to 13-mer range contributed positively to both pore formation and cytotoxicity, while monomers, dimers, trimers, and the largest oligomers (>210 kDa) were negatively correlated to both phenomena. Multivariate PLS analysis is ideally suited to handle complex data sets and interdependent variables such as relative oligomer concentrations, making it possible to elucidate structure function relationships in complex mixtures. This approach, therefore, introduces an enabling tool to the field of amyloid research, in which it is often difficult to interpret the activity of individual species within a complex mixture of bioactive species.	[Prangkio, Panchika; Yusko, Erik C.; Sept, David; Mayer, Michael] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sept, David] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Mayer, Michael] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Mayer, M (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	mimayer@umich.edu	Mayer, Michael/AAS-1777-2020; Taylor, Graham/A-4027-2012; Mayer, Michael/C-1299-2010; Yusko, Erik/E-7179-2010	Mayer, Michael/0000-0002-6148-5756; Yusko, Erik/0000-0003-3559-8375; Sept, David/0000-0003-3719-2483; Prangkio, Panchika/0000-0002-6376-7116	Wallace H. Coulter Foundation; Alzheimer's Association [NIRG-08-01651]; NSF [CHE-0847530]; government of Thailand	Wallace H. Coulter Foundation; Alzheimer's Association(Alzheimer's Association); NSF(National Science Foundation (NSF)); government of Thailand	This work was supported by the Wallace H. Coulter Foundation (M. M.). J.Y. acknowledges support from the Alzheimer's Association (NIRG-08-01651) and an NSF CAREER Award to J.Y. (CHE-0847530). P. P. is supported by government of Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELL HJ, 1979, BIOCHIM BIOPHYS ACTA, V552, P369, DOI 10.1016/0005-2736(79)90181-0; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Arispe NJ, 2007, BIOPHYS J, p612A; Baruch-Suchodolsky R, 2009, BIOCHEMISTRY-US, V48, P4354, DOI 10.1021/bi802361k; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Ding H, 2009, BIOPHYS J, V97, P912, DOI 10.1016/j.bpj.2009.05.035; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Habib LK, 2010, J BIOL CHEM, V285, P38933, DOI 10.1074/jbc.M110.132860; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; HOLTZMAN DM, 2011, SCI TRANSLATIONAL ME, V3; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Jang H, 2010, J MOL BIOL, V404, P917, DOI 10.1016/j.jmb.2010.10.025; Jang H, 2009, BIOPHYS J, V97, P3029, DOI 10.1016/j.bpj.2009.09.014; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kagan BL, 2012, PROG MOL BIOL TRANSL, V107, P295, DOI [10.1016/B978-0-12-385883-2.00001-1, 10.1016/B978-0-12-385883-2.00009-6]; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kawahara M, 1997, BIOPHYS J, V73, P67, DOI 10.1016/S0006-3495(97)78048-2; Kawahara M, 2010, CURR PHARM DESIGN, V16, P2779, DOI 10.2174/138161210793176545; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kourie JI, 2001, CELL MOL NEUROBIOL, V21, P255, DOI 10.1023/A:1010995121153; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lin MCA, 2002, PEPTIDES, V23, P1215, DOI 10.1016/S0196-9781(02)00057-8; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mayer M, 2008, J AM CHEM SOC, V130, P1453, DOI 10.1021/ja077555f; Micelli S, 2004, BIOPHYS J, V86, P2231, DOI 10.1016/S0006-3495(04)74281-2; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pan JX, 2012, BIOCHEMISTRY-US, V51, P3694, DOI 10.1021/bi3002049; Parihar MS, 2004, J CLIN NEUROSCI, V11, P456, DOI 10.1016/j.jocn.2003.12.007; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Puzzo Daniela, 2006, Current Alzheimer Research, V3, P179, DOI 10.2174/156720506777632871; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rajalahti T, 2011, INT J PHARMACEUT, V417, P280, DOI 10.1016/j.ijpharm.2011.02.019; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Schauerte JA, 2010, BIOCHEMISTRY-US, V49, P3031, DOI 10.1021/bi901444w; Schnabel J, 2011, NATURE, V475, pS12, DOI 10.1038/475S12a; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shafrir Y, 2010, PROTEINS, V78, P3473, DOI 10.1002/prot.22853; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shao J., 1995, JACKKNIFE BOOTSTRAP; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Strodel B, 2010, J AM CHEM SOC, V132, P13300, DOI 10.1021/ja103725c; Stroud JC, 2012, P NATL ACAD SCI US; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Wong PT, 2009, J MOL BIOL, V386, P81, DOI 10.1016/j.jmb.2008.11.060	113	60	63	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47261	10.1371/journal.pone.0047261	http://dx.doi.org/10.1371/journal.pone.0047261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077580	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100083
J	Yi, M				Yi, Ming			Systems Analysis of a Mouse Xenograft Model Reveals Annexin A1 as a Regulator of Gene Expression in Tumor Stroma	PLOS ONE			English	Article							CELL CARCINOMA; BREAST-CANCER; COLON-CANCER; TGFBI; MICE; ANGIOGENESIS; METASTASIS; INHIBITORS; PROMOTER; MEDIATOR	Annexin A1 is a multi functional molecule which is involved in inflammation, innate and adaptive immune systems, tumor progression and metastasis. We have previously showed the impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1 knockout mice. While tumor is a piece of heterogeneous mass including not only malignant tumor cells but also the stroma, the importance of the tumor stroma for tumor progression and metastasis is becoming increasingly clear. The tumor stroma is comprised by various components including extracellular matrix and non-malignant cells in the tumor, such as endothelial cells, fibroblasts, immune cells, inflammatory cells. Based on our previous finding of pro-angiogenic functions for annexin A1 in vascular endothelial cell sprouting, wound healing, tumor growth and metastasis, and the previously known properties for annexin A1 in immune cells and inflammation, this study hypothesized that annexin A1 is a key functional player in tumor development, linking the various components in tumor stroma by its actions in endothelial cells and immune cells. Using systems analysis programs commercially available, this paper further compared the gene expression between tumors from annexin A1 wild type mice and annexin A1 knockout mice and found a list of genes that significantly changed in the tumor stroma that lacked annexin A1. This revealed annexin A1 to be an effective regulator in tumor stroma and suggested a mechanism that annexin A1 affects tumor development and metastasis through interaction with the various components in the microenvironment surrounding the tumor cells.	[Yi, Ming] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Yi, Ming] Proteogen Res Inst Syst Med, San Diego, CA USA		Yi, M (corresponding author), Sidney Kimmel Canc Ctr, San Diego, CA USA.	yi6102003@yahoo.com						Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Ahmed F, 2008, CURR CANCER DRUG TAR, V8, P447, DOI 10.2174/156800908785699360; Anne TM, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/179351; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhuvarahamurthy V, 2006, ONCOL REP, V15, P1379; Bramhall SR, 1997, J PATHOL, V182, P347, DOI 10.1002/(SICI)1096-9896(199707)182:3<347::AID-PATH848>3.0.CO;2-J; Caren H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-66; D'Acquisto F, 2007, EUR J IMMUNOL, V37, P3131, DOI 10.1002/eji.200636792; Hanninen MM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-36; van Voss MRH, 2011, CELL ONCOL, V34, P3, DOI 10.1007/s13402-010-0007-3; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Irigoyen M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-130; Ivanov SV, 2008, BIOCHEM BIOPH RES CO, V370, P536, DOI 10.1016/j.bbrc.2008.03.066; Jiang XP, 2010, ANTICANCER RES, V30, P759; Kang S, 2010, GYNECOL ONCOL, V118, P58, DOI 10.1016/j.ygyno.2010.03.025; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Matters GL, 2011, INT J ONCOL, V38, P593, DOI 10.3892/ijo.2010.886; Mizukami S, 2010, ARCH TOXICOL, V84, P319, DOI 10.1007/s00204-009-0496-x; Nakao M, 2000, CANCER RES, V60, P3281; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; Park KS, 2011, J GASTROEN HEPATOL, V26, P391, DOI 10.1111/j.1440-1746.2010.06504.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Santos J, 2009, CANCER RES, V69, P2577, DOI 10.1158/0008-5472.CAN-08-1821; Sebens S., 2011, CURR PHARM BIOTECHNO; Shah JN, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-284; Shin SC, 2010, RADIAT RES, V174, P341, DOI 10.1667/RR1946.1; Singer CF, 2008, BREAST CANCER RES TR, V110, P273, DOI 10.1007/s10549-007-9725-2; Wada S, 2006, ANN SURG ONCOL, V13, P961, DOI 10.1245/ASO.2006.08.006; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e43551	10.1371/journal.pone.0043551	http://dx.doi.org/10.1371/journal.pone.0043551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077482	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100010
J	Zhou, XM; Xie, GL; Wang, SB; Wang, YG; Zhang, KJ; Zheng, S; Chu, L; Xiao, LL; Yu, YM; Zhang, Y; Liu, XY				Zhou, Xiumei; Xie, Guoliang; Wang, Shibing; Wang, Yigang; Zhang, Kangjian; Zheng, Shu; Chu, Liang; Xiao, Lianli; Yu, Yuemei; Zhang, Yue; Liu, Xinyuan			Potent and Specific Antitumor Effect for Colorectal Cancer by CEA and Rb Double Regulated Oncolytic Adenovirus Harboring ST13 Gene	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; CARCINOEMBRYONIC ANTIGEN; VIRO-THERAPY; TRAIL; VIROTHERAPY; CARCINOMA; SURVIVAL; PROTEIN; VECTOR	Cancer Targeting Gene-Viro-Therapy (CTGVT) is constructed by inserting an antitumor gene into an oncolytic virus (OV). It is actually an OV-gene therapy, which has much better antitumor effect than either gene therapy alone or virotherapy alone in our previously published papers. This study is a modification of CTGVT by inserting a colorectal cancer (CRC) specific suppressor gene, ST13, into a CRC specific oncolytic virus, the Ad.CEA.E1A(Delta 24), to construct the Ad.(ST13).CEA.E1A(Delta 24) for increasing the targeting tropism to colorectal cancer and it was briefly named as CTGVT-CRC. Although many studies on CEA promoter and ST13 gene were reported but no construct has been performed to combine both of them as a new strategy for colorectal cancer (CRC) specific therapy. In addition to the CRC specificity, the antitumor effect of Ad.(ST13).CEA.E1A(Delta 24) was also excellent and got nearly complete inhibition (not eradication) of CRC xenograft since ST13 was an effective antitumor gene with less toxicity, and a Chinese patent (No. 201110319434.4) was available for this study. Ad.(ST13).CEA.E1A(Delta 24) caused cell apoptosis through P38 MAPK (i.e. P38) which upregulated CHOP and ATF2 expression. The mitochondrial medicated apoptosis pathway was activated by the increase of caspase 9 and caspase 3 expression.	[Zhou, Xiumei; Wang, Shibing; Wang, Yigang; Xiao, Lianli; Yu, Yuemei; Zhang, Yue; Liu, Xinyuan] Zhejiang Sci Tech Univ, Coll Life Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Kangjian; Chu, Liang; Liu, Xinyuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Xie, Guoliang] Zhejiang Univ, Affiliated Hosp 1, Dept Lab Med, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shu] Zhejiang Univ, Affiliated Hosp 2, Inst Canc, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Zhejiang University	Liu, XY (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	xyliu@sibs.ac.cn	xie, guoliang/T-3191-2017; Liu, Xinyuan/HDM-5505-2022		Science Foundation of Zhejiang Sci-Tech University (ZSTU) [1016834-Y]; National Basic Research Program of China (973 Program) [2010CB529901, 2011CB510104]; National Natural Science Foundation of China [81172449]; Important National Science AMP; Technology Specific Project of Hepatitis and Hepatoma Related Program [2008ZX10002-023]; New Innovation Program [2009-ZX-09102-246]	Science Foundation of Zhejiang Sci-Tech University (ZSTU)(Zhejiang Sci-Tech University); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science AMP; Technology Specific Project of Hepatitis and Hepatoma Related Program; New Innovation Program	This work was supported by the Science Foundation of Zhejiang Sci-Tech University (ZSTU) under Grant No. 1016834-Y, the National Basic Research Program of China (973 Program) (No. 2010CB529901, No. 2011CB510104), the National Natural Science Foundation of China (81172449), the Important National Science & Technology Specific Project of Hepatitis and Hepatoma Related Program (2008ZX10002-023), and the New Innovation Program (2009-ZX-09102-246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Cao X, 2011, GENE THER, V18, P765, DOI 10.1038/gt.2011.16; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chu L, 2006, CANCER BIOL THER, V5, P615, DOI 10.4161/cbt.5.6.2662; Chung-Faye GA, 2000, MOL MED TODAY, V6, P82, DOI 10.1016/S1357-4310(99)01598-1; DIMAIO JM, 1994, SURGERY, V116, P205; Ding M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035153; Evans J, 2011, NAT MED, V17, P268, DOI 10.1038/nm0311-268b; Horndasch M, 2006, ONCOGENE, V25, P3397, DOI 10.1038/sj.onc.1209380; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Liu XY, 2006, CELL RES, V16, P879, DOI 10.1038/sj.cr.7310108; Liu XY, 2005, MOL THER, V11, P531, DOI 10.1016/j.ymthe.2004.12.003; Liu XY, 2001, CHIN J CANC BIOTHER, V8, P1; Liu XY, 2012, RECENT ADV IN PRESS; Liu XY, 2012, CURR PHARM BIOTECHNO; Mo Y, 1996, Zhonghua Zhong Liu Za Zhi, V18, P241; Mo YQ, 1997, AIZHENG, V16, P12; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pei ZF, 2004, HEPATOLOGY, V39, P1371, DOI 10.1002/hep.20203; Sagawa T, 2004, MOL THER, V10, P1043, DOI 10.1016/j.ymthe.2004.08.023; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; Shi Zheng-Zheng, 2007, Journal of Zhejiang University-Science B, V8, P170, DOI 10.1631/jzus.2007.B0170; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wei RC, 2011, HUM GENE THER, V22, P1109, DOI 10.1089/hum.2010.219; Xu HN, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-133; Yang M, 2008, HUM GENE THER, V19, P343, DOI 10.1089/hum.2007.0137; Yu DB, 2009, CANCER SCI, V100, P678, DOI 10.1111/j.1349-7006.2009.01110.x; Zhang Q, 2004, CANCER RES, V64, P5390, DOI 10.1158/0008-5472.CAN-04-1229; Zhang YH, 2006, CANCER RES, V66, P4291, DOI 10.1158/0008-5472.CAN-05-1834; Zhang ZW, 2009, CLIN CANCER RES, V15, P5154, DOI 10.1158/1078-0432.CCR-09-0025; Zhang ZL, 2003, CELL RES, V13, P481, DOI 10.1038/sj.cr.7290191; Zhao L, 2006, CANCER GENE THER, V13, P1011, DOI 10.1038/sj.cgt.7700969; Zheng S, 1997, CHINESE MED J-PEKING, V110, P543; Zheng S, 1997, Zhonghua Yi Xue Za Zhi, V77, P256; Zheng S, 2005, CHIN GERMAN J CLIN O, V4, P2; Zheng S, 1998, INT J MODERN CANC TH, V1, P3; Zheng S, 2001, B CHINESE CANC, V10, P136	38	15	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47566	10.1371/journal.pone.0047566	http://dx.doi.org/10.1371/journal.pone.0047566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077639	Green Submitted, Green Published, gold			2022-12-25	WOS:000309995100134
J	Joy, TK; Gutierrez, EHJ; Ernst, K; Walker, KR; Carriere, Y; Torabi, M; Riehle, MA				Joy, Teresa K.; Gutierrez, Eileen H. Jeffrey; Ernst, Kacey; Walker, Kathleen R.; Carriere, Yves; Torabi, Mohammad; Riehle, Michael A.			Aging Field Collected Aedes aegypti to Determine Their Capacity for Dengue Transmission in the Southwestern United States	PLOS ONE			English	Article							RIO-DE-JANEIRO; DAILY SURVIVAL RATES; GENE-EXPRESSION; GENOME-WIDE; DIPTERA-CULICIDAE; MOSQUITO AGE; POPULATION; DISPERSAL; VALIDATION; PROFILES	Aedes aegypti, the primary vector of dengue virus, is well established throughout urban areas of the Southwestern US, including Tucson, AZ. Local transmission of the dengue virus, however, has not been reported in this area. Although many factors influence the distribution of the dengue virus, we hypothesize that one contributing factor is that the lifespan of female Ae. aegypti mosquitoes in the Southwestern US is too short for the virus to complete development and be transmitted to a new host. To test this we utilized two age grading techniques. First, we determined parity by analyzing ovarian tracheation and found that only 40% of Ae. aegypti females collected in Tucson, AZ were parous. The second technique determined transcript levels of an age-associated gene, Sarcoplasmic calcium-binding protein 1 (SCP-1). SCP-1 expression decreased in a predictable manner as the age of mosquitoes increased regardless of rearing conditions and reproductive status. We developed statistical models based on parity and SCP-1 expression to determine the age of individual, field collected mosquitoes within three age brackets: nonvectors (0-5 days post-emergence), unlikely vectors (6-14 days post-emergence), and potential vectors (15+ days post-emergence). The statistical models allowed us to accurately group individual wild mosquitoes into the three age brackets with high confidence. SCP-1 expression levels of individual, field collected mosquitoes were analyzed in conjunction with parity status. Based on SCP-1 transcript levels and parity data, 9% of collected mosquitoes survived more than 15 days post emergence.	[Joy, Teresa K.; Gutierrez, Eileen H. Jeffrey; Walker, Kathleen R.; Carriere, Yves; Riehle, Michael A.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Ernst, Kacey] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA	University of Arizona; University of Arizona	Riehle, MA (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	mriehle@ag.arizona.edu	Riehle, Michael A/O-2852-2017; Ernst, Kacey/M-5943-2013	Riehle, Michael/0000-0001-9747-3872; Jeffrey Gutierrez, Eileen/0000-0002-4027-1388	National Institutes of Health [R56AI091843]; Center for Insect Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091843, R56AI091843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Insect Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R56AI091843 and the Center for Insect Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BAR-ZEEV MICHA, 1957, BULL ENT RES, V48, P593, DOI 10.1017/S0007485300002765; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Caragata EP, 2011, INSECT MOL BIOL, V20, P215, DOI 10.1111/j.1365-2583.2010.01059.x; Chadee DD, 2010, ACTA TROP, V116, P212, DOI 10.1016/j.actatropica.2010.08.008; Cook PE, 2010, INSECT MOL BIOL, V19, P745, DOI 10.1111/j.1365-2583.2010.01034.x; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; DAVIS EE, 1984, J INSECT PHYSIOL, V30, P211, DOI 10.1016/0022-1910(84)90005-2; Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; El-Badry A. A., 2010, Journal of Entomology, V7, P80, DOI 10.3923/je.2010.80.88; Gerade BB, 2004, J MED ENTOMOL, V41, P231, DOI 10.1603/0022-2585-41.2.231; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hoc TQ, 1996, J MED ENTOMOL, V33, P286, DOI 10.1093/jmedent/33.3.286; Hoeck PAE, 2003, J VECTOR ECOL, V28, P65; Hugo LE, 2008, J MED ENTOMOL, V45, P353, DOI 10.1603/0022-2585(2008)45[353:EOMAGT]2.0.CO;2; Hugo LE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000608; Knowlton K., 2009, FEVER PITCH MOSQUITO; Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003; Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; MCDONALD PT, 1977, J MED ENTOMOL, V14, P42, DOI 10.1093/jmedent/14.1.42; Morin CW, 2010, INT J BIOMETEOROL, V54, P517, DOI 10.1007/s00484-010-0349-6; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; National weather service forecast office, 2011, MONTHL CLIM REP F 6; Neville AC, 1963, OKIOS, V14; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Reiter P, 2003, EMERG INFECT DIS, V9, P86; SCHLEIN Y, 1979, J MED ENTOMOL, V16, P502, DOI 10.1093/jmedent/16.6.502; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49; Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1; Wang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013359; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	46	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46946	10.1371/journal.pone.0046946	http://dx.doi.org/10.1371/journal.pone.0046946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077536	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500024
J	Peyton, CC; Burmeister, D; Petersen, B; Andersson, KE; Christ, G				Peyton, Charles C.; Burmeister, David; Petersen, Bryon; Andersson, Karl-Erik; Christ, George			Characterization of the Early Proliferative Response of the Rodent Bladder to Subtotal Cystectomy: A Unique Model of Mammalian Organ Regeneration	PLOS ONE			English	Article							MESENCHYMAL-EPITHELIAL INTERACTIONS; RAT URINARY-BLADDER; LIVER-REGENERATION; SMOOTH-MUSCLE; CELL-PROLIFERATION; STEM-CELLS; INTERSTITIAL-CELLS; ACELLULAR MATRIX; RABBIT BLADDER; GROWTH-FACTORS	Subtotal cystectomy (STC; surgical removal of similar to 75% of the rat urinary bladder) elicits a robust proliferative response resulting in complete structural and functional bladder regeneration within 8-weeks. The goal of these studies was to characterize the early cellular response that mediates this regenerative phenomenon, which is unique among mammalian organ systems. STC was performed on eighteen 12-week-old female Fischer F344 rats. At 1, 3, 5 and 7-days post-STC, the bladder was harvested 2-hours after intraperitoneal injection of bromodeoxyuridine (BrdU). Fluorescent BrdU labeling was quantified in cells within the urothelium, lamina propria (LP), muscularis propria (MP) and serosa. Cell location was confirmed with fluorescently co-labeled cytokeratin, vimentin or smooth muscle actin (SMA), to identify urothelial, interstitial and smooth muscle cells, respectively. Expression of sonic hedgehog (Shh), Gli-1 and bone morphogenic factor-4 (BMP-4) were evaluated with immunochemistry. Three non-operated rats injected with BrdU served as controls. Less than 1% of cells in the bladder wall were labeled with BrdU in control bladders, but this percentage significantly increased by 5-8-fold at all time points post-STC. The spatiotemporal characteristics of the proliferative response were defined by a significantly higher percentage of BrdU-labeled cells within the urothelium at 1-day than in the MP and LP. A time-dependent shift at 3 and 5-days post-STC revealed significantly fewer BrdU-labeled cells in the MP than LP or urothelium. By 7-days the percentage of BrdU-labeled cells was similar among urothelium, LP and MP. STC also caused an increase in immunostaining for Shh, Gli-1 and BMP-4. In summary, the early stages of functional bladder regeneration are characterized by time-dependent changes in the location of the proliferating cell population, and expression of several evolutionarily conserved developmental signaling proteins. This report extends previous observations and further establishes the rodent bladder as an excellent model for studying novel aspects of mammalian organ regeneration.	[Burmeister, David; Petersen, Bryon; Andersson, Karl-Erik; Christ, George] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA; [Peyton, Charles C.] Wake Forest Baptist Med Ctr, Dept Urol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest Baptist Medical Center	Christ, G (corresponding author), Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA.	gchrist@wakehealth.edu			United States National Institutes of Health R21 grant [DK081832]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081832] Funding Source: NIH RePORTER	United States National Institutes of Health R21 grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was supported in part by United States National Institutes of Health R21 grant DK081832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Baskin L, 2001, J UROLOGY, V165, P1283, DOI 10.1016/S0022-5347(05)66514-7; Baskin LS, 1996, J UROLOGY, V156, P1820, DOI 10.1016/S0022-5347(01)65545-9; Baskin LS, 1997, J UROLOGY, V157, P2388, DOI 10.1016/S0022-5347(01)64786-4; BOHNE AW, 1957, J UROLOGY, V77, P725, DOI 10.1016/S0022-5347(17)66624-2; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Burmeister D, 2010, TISSUE ENG PT A, V16, P2541, DOI 10.1089/ten.TEA.2009.0697; Cao M, 2010, DIFFERENTIATION, V79, P244, DOI 10.1016/j.diff.2010.02.002; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714; DEBOER WI, 1994, AM J PATHOL, V145, P1199; Dekaney CM, 2007, AM J PHYSIOL-GASTR L, V293, pG1013, DOI 10.1152/ajpgi.00218.2007; Faggian L, 1998, HISTOCHEM CELL BIOL, V109, P25; Frederiksen H, 2004, NEUROUROL URODYNAM, V23, P159, DOI 10.1002/nau.10159; Frederiksen H, 2008, SCAND J UROL NEPHROL, V42, P205, DOI 10.1080/00365590701871641; Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230; GRISHAM JW, 1962, CANCER RES, V22, P842; Gunin AG, 1999, J GASTROENTEROL, V34, P661, DOI 10.1007/s005350050316; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hyun JS, 2012, PLAST RECONSTR SURG, V129, P1097, DOI 10.1097/PRS.0b013e31824a2c49; Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039; Jin YR, 2012, PHARM BIOL, V50, P523, DOI 10.3109/13880209.2011.611143; Johnston L, 2012, J CELL MOL MED, V16, P1533, DOI 10.1111/j.1582-4934.2011.01410.x; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Krishna-Subramanian S, 2012, INT J CANCER, V130, P2771, DOI 10.1002/ijc.26336; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; LIANG DS, 1963, J UROLOGY, V89, P427, DOI 10.1016/S0022-5347(17)64568-3; LIANG DS, 1963, J UROLOGY, V90, P187, DOI 10.1016/S0022-5347(17)64386-6; Master VA, 2003, J UROLOGY, V170, P1628, DOI 10.1097/01.ju.0000084407.24615.f8; McCloskey KD, 2011, J UROLOGY, V185, P1562, DOI 10.1016/j.juro.2011.02.2587; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; Miya M, 2012, AM J PHYSIOL-RENAL, V302, pF694, DOI 10.1152/ajprenal.00249.2011; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pampinella F, 1996, EXP CELL RES, V223, P327, DOI 10.1006/excr.1996.0088; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sisk V, 1939, T AM ASS GENITOURINA, V32, P197; STEER CJ, 1995, FASEB J, V9, P1396, DOI 10.1096/fasebj.9.14.7589980; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Takahashi N, 2011, TOXICOL PATHOL, V39, P1107, DOI 10.1177/0192623311422076; Tasian G, 2010, DIFFERENTIATION, V80, P106, DOI 10.1016/j.diff.2010.05.004; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tsonis PA, 2002, DIFFERENTIATION, V70, P397, DOI 10.1046/j.1432-0436.2002.700802.x; Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexcr.2005.02.004; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x; Zhang H, 2011, UROLOGY; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835	53	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47414	10.1371/journal.pone.0047414	http://dx.doi.org/10.1371/journal.pone.0047414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077610	gold, Green Published, Green Submitted			2022-12-25	WOS:000309809500047
J	De Luca, D; Minucci, A; Piastra, M; Cogo, PE; Vendittelli, F; Marzano, L; Gentile, L; Giardina, B; Conti, G; Capoluongo, ED				De Luca, Daniele; Minucci, Angelo; Piastra, Marco; Cogo, Paola E.; Vendittelli, Francesca; Marzano, Laura; Gentile, Leonarda; Giardina, Bruno; Conti, Giorgio; Capoluongo, Ettore D.			Ex Vivo Effect of Varespladib on Secretory Phospholipase A2 Alveolar Activity in Infants with ARDS	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE; SELECTIVE INHIBITOR; A(2) INHIBITOR; 1ST POTENT; FLUID; MECHANISMS; MARKERS; PLASMA	Background: Secretory phospholipase A2 (sPLA2) plays a pivotal role in acute respiratory distress syndrome (ARDS). This enzyme seems an interesting target to reduce surfactant catabolism and lung tissue inflammation. Varespladib is a specifically designed indolic sPLA2 inhibitor, which has shown promising results in animals and adults. No specific data in pediatric ARDS patients are yet available. Methods: We studied varespladib in broncho-alveolar lavage (BAL) fluids obtained ex vivo from pediatric ARDS patients. Clinical data and worst gas exchange values during the ARDS course were recorded. Samples were treated with saline or 10-40-100 mu M varespladib and incubated at 37 degrees C. Total sPLA2 activity was measured by non-radioactive method. BAL samples were subjected to western blotting to identify the main sPLA isotypes with different sensitivity to varespladib. Results was corrected for lavage dilution using the serum-to-BAL urea ratio and for varespladib absorbance. Results: Varespladib reduces sPLA2 activity (p<0.0001) at 10,40 and 100 mu M; both sPLA2 activity reduction and its ratio to total proteins significantly raise with increasing varespladib concentrations (p<0.001). IC50 was 80 mu M. Western blotting revealed the presence of sPLA2-IIA and -IB isotypes in BAL samples. Significant correlations exist between the sPLA2 activity reduction/proteins ratio and PaO2 (rho=0.63; p<0.001), PaO2/FiO(2) (rho=0.7; p<0.001), oxygenation (rho=-0.6; p<0.001) and ventilation (rho=-0.4; p=0.038) indexes. Conclusions: Varespladib significantly inhibits sPLA2 in BAL of infants affected by post-neonatal ARDS. Inhibition seems to be inversely related to the severity of gas exchange impairment.	[De Luca, Daniele; Minucci, Angelo; Vendittelli, Francesca; Gentile, Leonarda; Giardina, Bruno; Capoluongo, Ettore D.] Univ Cattolica Sacro Cuore, Univ Hosp A Gemelli, Dept Biochem, Lab Clin Mol Biol, I-00168 Rome, Italy; [De Luca, Daniele; Piastra, Marco; Marzano, Laura; Conti, Giorgio] Univ Cattolica Sacro Cuore, Univ Hosp A Gemelli, Dept Anaesthesiol & Intens Care, Pediat Intens Care Unit, I-00168 Rome, Italy; [Cogo, Paola E.] Hosp & Univ Padua, Dept Pediat, Pediat Intens Care Unit, Padua, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua; Azienda Ospedaliera - Universita di Padova	De Luca, D (corresponding author), Univ Cattolica Sacro Cuore, Univ Hosp A Gemelli, Dept Biochem, Lab Clin Mol Biol, I-00168 Rome, Italy.	dm.deluca@fastwebnet.it	Conti, Giorgio/AAB-9546-2022; Cogo, Paola P/J-6918-2018; Gentile, Leonarda/AAA-6297-2020; Minucci, Angelo/B-3015-2019	Conti, Giorgio/0000-0002-8566-9365; Cogo, Paola P/0000-0002-6235-140X; Minucci, Angelo/0000-0002-0833-4334; De Luca, Daniele/0000-0002-3846-4834; CAPOLUONGO, Ettore Domenico/0000-0003-4402-8403	QProgetti srl a charity company; Anthera Pharmaceutical	QProgetti srl a charity company; Anthera Pharmaceutical(Johnson & Johnson)	This study was funded by QProgetti srl a charity company within the charity program for 2010-2011. DDL received a travel grant from Anthera Pharmaceutical (the producer of varespladib). No other authors have any financial interest or conflict to disclose, according to the journal guidelines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, P718, DOI 10.1097/01.CCM.0000053648.42884.89; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Attalah HL, 2003, EUR RESPIR J, V21, P1040, DOI 10.1183/09031936.03.00093002; Balboa MA, 2003, J IMMUNOL, V171, P989, DOI 10.4049/jimmunol.171.2.989; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Capoluongo E, 2007, AM J PHYSIOL-ENDOC M, V292, pE308, DOI 10.1152/ajpendo.00251.2006; de Blic J, 2000, EUR RESPIR J, V15, P217; De Luca D, 2011, EUR RESPIR J, V37, P678, DOI 10.1183/09031936.00024910; De Luca D, 2012, J CLIN PHARMACOL, V52, P729, DOI 10.1177/0091270011405498; De Luca D, 2011, PEDIATR CRIT CARE ME, V12, pE20, DOI 10.1097/PCC.0b013e3181dbe95e; Demoule A, 2006, INTENS CARE MED, V32, P413, DOI 10.1007/s00134-005-0043-z; Furue S, 2001, CRIT CARE MED, V29, P719, DOI 10.1097/00003246-200104000-00004; Furue S, 1999, AM J RESP CRIT CARE, V160, P1292, DOI 10.1164/ajrccm.160.4.9812042; Gunther A, 2001, RESPIR RES, V2, P353, DOI 10.1186/rr86; Hammer J, 1997, PEDIATR PULM, V23, P176, DOI 10.1002/(SICI)1099-0496(199703)23:3<176::AID-PPUL2>3.0.CO;2-M; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Hite RD, 2005, AM J PHYSIOL-LUNG C, V288, pL618, DOI 10.1152/ajplung.00274.2004; Ilce Zekeriya, 2003, Indian Pediatr, V40, P920; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; KIM DK, 1995, AM J PHYSIOL-LUNG C, V269, pL109, DOI 10.1152/ajplung.1995.269.1.L109; Kropski JA, 2009, CHEST, V135, P1440, DOI 10.1378/chest.08-2465; Kuwabara K, 2001, EUR J PHARMACOL, V433, P209, DOI 10.1016/S0014-2999(01)01507-2; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P211; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liu TS, 2005, VIROLOGY, V343, P12, DOI 10.1016/j.virol.2005.08.012; Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061; Nakos G, 2005, CRIT CARE MED, V33, P772, DOI 10.1097/01.CCM.0000158519.80090.74; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Randolph AG, 2009, CRIT CARE MED, V37, P2448, DOI 10.1097/CCM.0b013e3181aee5dd; REYNOLDS LJ, 1992, ANAL BIOCHEM, V204, P190, DOI 10.1016/0003-2697(92)90160-9; Rosenson RS, 2010, J AM COLL CARDIOL, V56, P1079, DOI 10.1016/j.jacc.2010.06.015; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; Smart BP, 2006, J MED CHEM, V49, P2858, DOI 10.1021/jm060136t; Snyder DW, 1999, J PHARMACOL EXP THER, V288, P1117; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Tomillero A, 2009, Methods Find Exp Clin Pharmacol, V31, P463; Touqui L, 1999, MOL MED TODAY, V5, P244, DOI 10.1016/S1357-4310(99)01470-7; Zeiher BG, 2005, CRIT CARE MED, V33, P1741, DOI 10.1097/01.CCM.0000171540.54520.69	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47066	10.1371/journal.pone.0047066	http://dx.doi.org/10.1371/journal.pone.0047066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071714	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700049
J	Howell, MD; Torres-Collado, AX; Iruela-Arispe, ML; Gottschall, PE				Howell, Matthew D.; Torres-Collado, Antoni X.; Iruela-Arispe, M. Luisa; Gottschall, Paul E.			Selective Decline of Synaptic Protein Levels in the Frontal Cortex of Female Mice Deficient in the Extracellular Metalloproteinase ADAMTS1	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; PROMOTES FUNCTIONAL RECOVERY; PROTEOLYTIC CLEAVAGE; DENTATE-GYRUS; BREVICAN; MATRIX; BRAIN; THROMBOSPONDIN; GROWTH; MATRIX-METALLOPROTEINASE-9	The chondroitin sulfate-bearing proteoglycans, also known as lecticans, are a major component of the extracellular matrix (ECM) in the central nervous system and regulate neural plasticity. Growing evidence indicates that endogenous, extracellular metalloproteinases that cleave lecticans mediate neural plasticity by altering the structure of ECM aggregates. The bulk of this in vivo data examined the matrix metalloproteinases, but another metalloproteinase family that cleaves lecticans, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS), modulates structural plasticity in vitro, although few in vivo studies have tested this concept. Thus, the purpose of this study was to examine the neurological phenotype of a mouse deficient in ADAMTS1. Adamts1 mRNA was absent in the ADAMTS1 null mouse frontal cortex, but there was no change in the abundance or proteolytic processing of the prominent lecticans brevican and versican V2. However, there was a marked increase in the perinatal lectican neurocan in juvenile ADAMTS1 null female frontal cortex. More prominently, there were declines in synaptic protein levels in the ADAMTS1 null female, but not male, frontal cortex beginning at postnatal day 28. These synaptic marker declines did not affect learning or memory in the adult female ADAMTS1 null mice when tested with the radial-arm water maze. These results indicate that in vivo Adamts1 knockout leads to sexual dimorphism in frontal cortex synaptic protein levels. Since changes in lectican abundance and proteolytic processing did not accompany the synaptic protein declines, ADAMTS1 may play a nonproteolytic role in regulating neural plasticity.	[Howell, Matthew D.; Gottschall, Paul E.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Torres-Collado, Antoni X.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Los Angeles	Gottschall, PE (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	pegottschall@uams.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020; Torres, antonio/D-8131-2018	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Torres, antonio/0000-0001-8423-4725; Howell, Matthew/0000-0003-1346-857X	National Institute on Aging [R01 AG022101]; NICHD; NATIONAL INSTITUTE ON AGING [R01AG022101] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by a grant from the National Institute on Aging [R01 AG022101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We would like to thank Drs. Marcia Gordon and Dave Morgan ( Byrd Alzheimer Institute, University of South Florida, Tampa, FL) for assistance with the radial-arm water maze. We also acknowledge the Digital and Confocal Microscopy Lab at UAMS for the use of the AxioImager microscope. The 12C5 antibody developed by Richard A. Asher was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ajmo JM, 2010, J NEUROCHEM, V113, P784, DOI 10.1111/j.1471-4159.2010.06647.x; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Aya-ay J, 2005, EXP NEUROL, V193, P149, DOI 10.1016/j.expneurol.2004.11.021; BOSSE R, 1995, J PSYCHIATR NEUROSCI, V20, P364; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cyr M, 1998, NEUROSCIENCE, V83, P829, DOI 10.1016/S0306-4522(97)00445-4; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gottschall PE, 2010, EXP BRAIN RES, V201, P885, DOI 10.1007/s00221-010-2182-x; GOULD E, 1990, J NEUROSCI, V10, P1286; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Hamel MG, 2008, EXP NEUROL, V210, P428, DOI 10.1016/j.expneurol.2007.11.014; Howell MD, 2012, ASN NEURO, V4, P11, DOI 10.1042/AN20110037; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; Michaluk P, 2009, J NEUROSCI, V29, P6007, DOI 10.1523/JNEUROSCI.5346-08.2009; Milev P, 1998, BIOCHEM BIOPH RES CO, V247, P207, DOI 10.1006/bbrc.1998.8759; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Prange CK, 1998, GENE, V221, P199, DOI 10.1016/S0378-1119(98)00455-7; Raulo E, 2005, J BIOL CHEM, V280, P41576, DOI 10.1074/jbc.M506457200; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Schmalfeldt M, 2000, J CELL SCI, V113, P807; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; Wright JW, 2007, NEURAL PLAST, V2007, P73813, DOI DOI 10.1155/2007/73813; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yokoyama H, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_9.39; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0	49	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47226	10.1371/journal.pone.0047226	http://dx.doi.org/10.1371/journal.pone.0047226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071766	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700069
J	Koch, TK; Reuter, M; Barthel, D; Bohm, S; van den Elsen, J; Kraiczy, P; Zipfel, PF; Skerka, C				Koch, Tina K.; Reuter, Michael; Barthel, Diana; Boehm, Sascha; van den Elsen, Jean; Kraiczy, Peter; Zipfel, Peter F.; Skerka, Christine			Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b	PLOS ONE			English	Article							SURFACE PROTEIN; IMMUNE EVASION; 2 PARTS; ACTIVATION; STAPHYLOKINASE; INFECTIONS; INHIBITOR; BINDING; SYSTEM; COAGULATION	Upon host infection, the human pathogenic microbe Staphylococcus aureus (S. aureus) immediately faces innate immune reactions such as the activated complement system. Here, a novel innate immune evasion strategy of S. aureus is described. The staphylococcal proteins surface immunoglobulin-binding protein (Sbi) and extracellular fibrinogen-binding protein (Efb) bind C3/C3b simultaneously with plasminogen. Bound plasminogen is converted by bacterial activator staphylokinase or by host-specific urokinase-type plasminogen activator to plasmin, which in turn leads to degradation of complement C3 and C3b. Efb and to a lesser extend Sbi enhance plasmin cleavage of C3/C3b, an effect which is explained by a conformational change in C3/C3b induced by Sbi and Efb. Furthermore, bound plasmin also degrades C3a, which exerts anaphylatoxic and antimicrobial activities. Thus, S. aureus Sbi and Efb comprise platforms to recruit plasmin(ogen) together with C3 and its activation product C3b for efficient degradation of these complement components in the local microbial environment and to protect S. aureus from host innate immune reactions.	[Koch, Tina K.; Reuter, Michael; Barthel, Diana; Boehm, Sascha; Zipfel, Peter F.; Skerka, Christine] Leibniz Inst Nat Prod Res & Infect, Dept Infect Biol, Jena, Germany; [van den Elsen, Jean] Univ Bath, Bath BA2 7AY, Avon, England; [Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Zipfel, Peter F.] Univ Jena, D-6900 Jena, Germany	Hans Knoll Institute (HKI); University of Bath; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Friedrich Schiller University of Jena	Skerka, C (corresponding author), Leibniz Inst Nat Prod Res & Infect, Dept Infect Biol, Jena, Germany.	christine.skerka@hki-jena.de	van den Elsen, Jean/D-9274-2011	van den Elsen, Jean/0000-0002-0367-1956				Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Barthel D, 2012, J BIOL CHEM; Barthel D, 2012, J IMMUNOL, V188, P379, DOI 10.4049/jimmunol.1101927; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Clark EA, 2011, MOL IMMUNOL, V48, P452, DOI 10.1016/j.molimm.2010.09.017; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; Hammel M, 2006, ACTA CRYSTALLOGR F, V62, P285, DOI 10.1107/S1744309106005926; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Haspel N, 2008, PROTEIN SCI, V17, P1894, DOI 10.1110/ps.036624.108; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Jin T, 2003, J MED MICROBIOL, V52, P919, DOI 10.1099/jmm.0.05145-0; Jongerius I, 2007, J EXP MED, V204, P2461, DOI 10.1084/jem.20070818; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lahteenmaki K, 2000, METHODS, V21, P125, DOI 10.1006/meth.2000.0983; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; NAGASAWA S, 1977, IMMUNOCHEMISTRY, V14, P749, DOI 10.1016/0019-2791(77)90345-7; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; SEYA T, 1985, Complement, V2, P165; Siegel C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013519; TAYLOR FB, 1967, J EXP MED, V126, P149, DOI 10.1084/jem.126.1.149; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WARD PA, 1967, J EXP MED, V126, P189, DOI 10.1084/jem.126.2.189; Zavizion B, 1997, J INFECT DIS, V176, P1637, DOI 10.1086/517345; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2009, INT J PEPT RES THER, V15, P87, DOI 10.1007/s10989-009-9180-5	44	42	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47638	10.1371/journal.pone.0047638	http://dx.doi.org/10.1371/journal.pone.0047638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071827	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700095
J	Krause, E; Wichels, A; Gimenez, L; Lunau, M; Schilhabel, MB; Gerdts, G				Krause, Evamaria; Wichels, Antje; Gimenez, Luis; Lunau, Mirko; Schilhabel, Markus B.; Gerdts, Gunnar			Small Changes in pH Have Direct Effects on Marine Bacterial Community Composition: A Microcosm Approach	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; OCEAN ACIDIFICATION; MICROBIAL COMMUNITY; DILUTION CULTURE; NORTH-SEA; VIBRIO-VULNIFICUS; PELAGIC BACTERIA; GERMAN BIGHT; LONG-TERM; BACTERIOPLANKTON	As the atmospheric CO2 concentration rises, more CO2 will dissolve in the oceans, leading to a reduction in pH. Effects of ocean acidification on bacterial communities have mainly been studied in biologically complex systems, in which indirect effects, mediated through food web interactions, come into play. These approaches come close to nature but suffer from low replication and neglect seasonality. To comprehensively investigate direct pH effects, we conducted highly-replicated laboratory acidification experiments with the natural bacterial community from Helgoland Roads (North Sea). Seasonal variability was accounted for by repeating the experiment four times (spring, summer, autumn, winter). Three dilution approaches were used to select for different ecological strategies, i.e. fast-growing or low-nutrient adapted bacteria. The pH levels investigated were in situ seawater pH (8.15-8.22), pH 7.82 and pH 7.67, representing the present-day situation and two acidification scenarios projected for the North Sea for the year 2100. In all seasons, both automated ribosomal intergenic spacer analysis and 16S ribosomal amplicon pyrosequencing revealed pH-dependent community shifts for two of the dilution approaches. Bacteria susceptible to changes in pH were different members of Gammaproteobacteria, Flavobacteriaceae, Rhodobacteraceae, Campylobacteraceae and further less abundant groups. Their specific response to reduced pH was often context-dependent. Bacterial abundance was not influenced by pH. Our findings suggest that already moderate changes in pH have the potential to cause compositional shifts, depending on the community assembly and environmental factors. By identifying pH-susceptible groups, this study provides insights for more directed, in-depth community analyses in large-scale and long-term experiments.	[Krause, Evamaria; Wichels, Antje; Gerdts, Gunnar] Biol Anstalt Helgoland, Alfred Wegener Inst Polar & Marine Res, D-2192 Helgoland, Germany; [Gimenez, Luis] Bangor Univ, Sch Ocean Sci, Menai Bridge, Gwynedd, Wales; [Lunau, Mirko] Leibniz Inst Balt Sea Res, Rostock, Germany; [Schilhabel, Markus B.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Bangor University; Leibniz Institut fur Ostseeforschung Warnemunde; University of Kiel	Krause, E (corresponding author), Biol Anstalt Helgoland, Alfred Wegener Inst Polar & Marine Res, D-2192 Helgoland, Germany.	evamaria.krause@awi.de	Wichels, Antje/R-6992-2016; Krause, Evamaria/AHB-0043-2022; Gerdts, Gunnar/R-7000-2016	Wichels, Antje/0000-0002-2060-1845; Krause, Evamaria/0000-0002-4946-6544; Gerdts, Gunnar/0000-0003-0872-3927	Federal Ministry of Education and Research (BMBF) [FKZ 03F0608B]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support was provided by Federal Ministry of Education and Research (BMBF, FKZ 03F0608B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2008, BIOGEOSCIENCES, V5, P1007, DOI 10.5194/bg-5-1007-2008; AMMERMAN JW, 1984, MAR ECOL PROG SER, V18, P31, DOI 10.3354/meps018031; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; ATLAS RM, 1991, MICROBIAL ECOL, V22, P249, DOI 10.1007/BF02540227; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Blackford JC, 2007, J MARINE SYST, V64, P229, DOI 10.1016/j.jmarsys.2006.03.016; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; BUTTON DK, 1993, APPL ENVIRON MICROB, V59, P881, DOI 10.1128/AEM.59.3.881-891.1993; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Collado L, 2008, ENVIRON MICROBIOL, V10, P1635, DOI 10.1111/j.1462-2920.2007.01555.x; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; D'Sa EM, 2005, J FOOD PROTECT, V68, P18, DOI 10.4315/0362-028X-68.1.18; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Eilers H, 2001, APPL ENVIRON MICROB, V67, P5134, DOI 10.1128/AEM.67.11.5134-5142.2001; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; FERGUSON RL, 1984, APPL ENVIRON MICROB, V47, P49, DOI 10.1128/AEM.47.1.49-55.1984; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gattuso JP, 2009, BIOGEOSCIENCES, V6, P2121, DOI 10.5194/bg-6-2121-2009; Gerdts G, 2004, HELGOLAND MAR RES, V58, P230, DOI 10.1007/s10152-004-0189-z; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; GOLDMAN JC, 1985, J EXP MAR BIOL ECOL, V86, P47, DOI 10.1016/0022-0981(85)90041-3; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Hurd CL, 2009, J PHYCOL, V45, P1236, DOI 10.1111/j.1529-8817.2009.00768.x; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kovacs A, 2010, RES MICROBIOL, V161, P192, DOI 10.1016/j.resmic.2010.01.006; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lidbury I, 2012, MAR POLLUT BULL, V64, P1063, DOI 10.1016/j.marpolbul.2012.02.011; Liu JW, 2010, AQUAT MICROB ECOL, V61, P291, DOI 10.3354/ame01446; Meron D, 2012, ISME J, V6, P1775, DOI 10.1038/ismej.2012.19; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Newbold LK, 2012, ENVIRON MICROBIOL, V14, P2293, DOI 10.1111/j.1462-2920.2012.02762.x; Oberbeckmann S, 2011, ANTON LEEUW INT J G, V100, P291, DOI 10.1007/s10482-011-9586-x; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Paz S, 2007, ENVIRON RES, V103, P390, DOI 10.1016/j.envres.2006.07.002; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pernthaler J, 2005, MICROBIOL MOL BIOL R, V69, P440, DOI 10.1128/MMBR.69.3.440-461.2005; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; Ranjard L, 2000, APPL ENVIRON MICROB, V66, P5334, DOI 10.1128/AEM.66.12.5334-5339.2000; Raven J., 2005, 1205 ROY SOC; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1583, DOI 10.1128/AEM.01507-07; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sapp M, 2007, FEMS MICROBIOL ECOL, V59, P622, DOI 10.1111/j.1574-6941.2006.00238.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Schulz KG, 2009, BIOGEOSCIENCES, V6, P2145, DOI 10.5194/bg-6-2145-2009; SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Snelling WJ, 2006, LETT APPL MICROBIOL, V42, P7, DOI 10.1111/j.1472-765X.2005.01841.x; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Teira E, 2012, MAR ECOL PROG SER, V453, P27, DOI 10.3354/meps09644; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Underwood, 1996, EXPT ECOLOGY THEIR L; Wiltshire KH, 2008, LIMNOL OCEANOGR, V53, P1294, DOI 10.4319/lo.2008.53.4.1294; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	76	106	108	5	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47035	10.1371/journal.pone.0047035	http://dx.doi.org/10.1371/journal.pone.0047035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071704	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700047
J	Homeier, J; Hertel, D; Camenzind, T; Cumbicus, NL; Maraun, M; Martinson, GO; Poma, LN; Rillig, MC; Sandmann, D; Scheu, S; Veldkamp, E; Wilcke, W; Wullaert, H; Leuschner, C				Homeier, Juergen; Hertel, Dietrich; Camenzind, Tessa; Cumbicus, Nixon L.; Maraun, Mark; Martinson, Guntars O.; Nohemy Poma, L.; Rillig, Matthias C.; Sandmann, Dorothee; Scheu, Stefan; Veldkamp, Edzo; Wilcke, Wolfgang; Wullaert, Hans; Leuschner, Christoph			Tropical Andean Forests Are Highly Susceptible to Nutrient Inputs-Rapid Effects of Experimental N and P Addition to an Ecuadorian Montane Forest	PLOS ONE			English	Article							FINE-ROOT PRODUCTION; NITROGEN DEPOSITION; RAIN-FOREST; MICROBIAL BIOMASS; PHOSPHORUS FERTILIZATION; TREE GROWTH; LITTER DECOMPOSITION; PLANT DIVERSITY; GLOBAL ANALYSIS; CARBON-DIOXIDE	Tropical regions are facing increasing atmospheric inputs of nutrients, which will have unknown consequences for the structure and functioning of these systems. Here, we show that Neotropical montane rainforests respond rapidly to moderate additions of N (50 kg ha(-1) yr(-1)) and P (10 kg ha(-1) yr(-1)). Monitoring of nutrient fluxes demonstrated that the majority of added nutrients remained in the system, in either soil or vegetation. N and P additions led to not only an increase in foliar N and P concentrations, but also altered soil microbial biomass, standing fine root biomass, stem growth, and litterfall. The different effects suggest that trees are primarily limited by P, whereas some processes-notably aboveground productivity-are limited by both N and P. Highly variable and partly contrasting responses of different tree species suggest marked changes in species composition and diversity of these forests by nutrient inputs in the long term. The unexpectedly fast response of the ecosystem to moderate nutrient additions suggests high vulnerability of tropical montane forests to the expected increase in nutrient inputs.	[Homeier, Juergen; Hertel, Dietrich; Leuschner, Christoph] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Camenzind, Tessa; Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Berlin, Germany; [Cumbicus, Nixon L.] Univ Tecn Particular Loja, Inst Ecol, San Cayetano Alto, Loja, Ecuador; [Maraun, Mark; Sandmann, Dorothee; Scheu, Stefan] Univ Gottingen, JF Blumenbach Intitute Zool & Anthropol, Gottingen, Germany; [Martinson, Guntars O.; Veldkamp, Edzo] Univ Gottingen, Buesgen Inst Soil Sci Trop & Subtrop Ecosyst, Gottingen, Germany; [Martinson, Guntars O.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Nohemy Poma, L.] Univ Natl Loja, Ciudadela Univ Guillermo Falconi Sect Argelia, Loja, Ecuador; [Wilcke, Wolfgang] Univ Bern, Inst Geog, Bern, Switzerland; [Wullaert, Hans] Johannes Gutenberg Univ Mainz, Inst Geog, Mainz, Germany	University of Gottingen; Free University of Berlin; Universidad Tecnica Particular de Loja; University of Gottingen; University of Gottingen; Max Planck Society; Universidad Tecnica Particular de Loja; University of Bern; Johannes Gutenberg University of Mainz	Homeier, J (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Gottingen, Germany.	jhomeie@gwdg.de	Veldkamp, Edzo/A-6660-2008; Homeier, Jürgen/G-1662-2011; Wilcke, Wolfgang/P-4620-2016; Rillig, Matthias C./B-3675-2009; Scheu, Stefan/H-7049-2015; Rillig, Matthias C./AAE-6980-2019	Veldkamp, Edzo/0000-0002-8318-8349; Homeier, Jürgen/0000-0001-5676-3267; Wilcke, Wolfgang/0000-0002-6031-4613; Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853; Cumbicus, Nixon/0000-0002-4880-6607	Deutsche Forschungsgemeinschaft (DFG) [RU 816]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was funded by Deutsche Forschungsgemeinschaft (DFG RU 816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek M, 2009, J TROP ECOL, V25, P637, DOI 10.1017/S0266467409990253; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Beck A, 2007, MYCORRHIZA, V17, P607, DOI 10.1007/s00572-007-0139-0; Beck E., 2008, V198, P1; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bedison JE, 2009, ECOLOGY, V90, P1736, DOI 10.1890/08-0792.1; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Boy J, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI [10.1029/2007GB003158, 10.1029/2007GB002960]; Cavelier J, 2000, J TROP ECOL, V16, P83, DOI 10.1017/S0266467400001280; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Corre MD, 2010, ECOLOGY, V91, P1715, DOI 10.1890/09-0274.1; Cusack DF, 2011, BIOGEOCHEMISTRY, V104, P203, DOI 10.1007/s10533-010-9496-4; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fabian P, 2005, ENVIRON SCI POLLUT R, V12, P290, DOI 10.1065/espr2005.07.272; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goller R, 2006, BIOGEOCHEMISTRY, V77, P57, DOI 10.1007/s10533-005-1061-1; GOWER ST, 1989, OECOLOGIA, V81, P566, DOI 10.1007/BF00378970; Gress SE, 2007, ECOLOGY, V88, P119, DOI 10.1890/0012-9658(2007)88[119:NLISED]2.0.CO;2; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hart S. C., 1994, METHODS SOIL ANAL 2, P985; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Johnson NC, 2008, ECOLOGY, V89, P2868, DOI 10.1890/07-1394.1; Kobe RK, 2005, ECOLOGY, V86, P2780, DOI 10.1890/04-1830; Koehler B, 2009, GLOBAL CHANGE BIOL, V15, P2049, DOI 10.1111/j.1365-2486.2008.01826.x; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Leuschner C, 2001, OECOLOGIA, V126, P276, DOI 10.1007/s004420000507; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Li YQ, 2006, GLOBAL CHANGE BIOL, V12, P284, DOI 10.1111/j.1365-2486.2005.01096.x; Loftfield N, 1997, J ENVIRON QUAL, V26, P560, DOI 10.2134/jeq1997.00472425002600020030x; Lohse KA, 2005, ECOL APPL, V15, P1629, DOI 10.1890/03-5421; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002541; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; Matzner E, 2004, ECOL STU AN, V172, P339; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Nadelhoffer KJ, 2000, NEW PHYTOL, V147, P131, DOI 10.1046/j.1469-8137.2000.00677.x; Nomura N, 2003, ECOL RES, V18, P573, DOI 10.1046/j.1440-1703.2003.00579.x; Okin GS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002145; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Ostertag R, 2010, PLANT SOIL, V334, P85, DOI 10.1007/s11104-010-0281-x; PERSSON H, 1978, OIKOS, V30, P508, DOI 10.2307/3543346; Pett-Ridge JC, 2009, BIOGEOCHEMISTRY, V94, P63, DOI 10.1007/s10533-009-9308-x; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; R Core Team, 2021, R LANG ENV STAT COMP; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Rillig MC, 1998, OECOLOGIA, V113, P252, DOI 10.1007/s004420050376; SCHEU S, 1992, SOIL BIOL BIOCHEM, V24, P1113, DOI 10.1016/0038-0717(92)90061-2; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Tamatamah RA, 2005, BIOGEOCHEMISTRY, V73, P325, DOI 10.1007/s10533-004-0196-9; TANNER EVJ, 1990, J TROP ECOL, V6, P231, DOI 10.1017/S0266467400004375; TANNER EVJ, 1992, ECOLOGY, V73, P78, DOI 10.2307/1938722; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Wilcke W, 2002, EUR J SOIL SCI, V53, P15, DOI 10.1046/j.1365-2389.2002.00411.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright RF, 1998, FOREST ECOL MANAG, V101, P1, DOI 10.1016/S0378-1127(97)00120-5; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Wullaert H, 2010, FOREST ECOL MANAG, V260, P1434, DOI 10.1016/j.foreco.2010.07.021; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yuan ZY, 2012, P ROY SOC B-BIOL SCI, V279, P3796, DOI 10.1098/rspb.2012.0955	82	95	99	13	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47128	10.1371/journal.pone.0047128	http://dx.doi.org/10.1371/journal.pone.0047128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071734	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200083
J	Pan, SC; Wang, JT; Chen, YC; Chang, YY; Chen, ML; Chang, SC				Pan, Sung-Ching; Wang, Jann-Tay; Chen, Yee-Chun; Chang, Yin-Yin; Chen, Mei-Ling; Chang, Shan-Chwen			Incidence of and Risk Factors for Infection or Colonization of Vancomycin-Resistant Enterococci in Patients in the Intensive Care Unit	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ACINETOBACTER-BAUMANNII; BACTEREMIA; EPIDEMIOLOGY; MORTALITY; MULTICENTER; OUTCOMES	The prevalence of vancomycin-resistant enterococci (VRE) colonization or infection in the hospital setting has increased globally. Many previous studies had analysed the risk factors for acquiring VRE, based on cross-sectional studies or prevalent cases. However, the actual incidence of and risk factors for VRE remain unclear. The present study was conducted in order to clarify the incidence of and risk factors for VRE in the intensive care unit (ICU). From 1st April 2008 to 31st March 2009, all patients admitted to a surgical ICU (SICU) were put on active surveillance for VRE. The surveillance cultures, obtained by rectal swab, were taken on admission, weekly while staying in the SICU, and on discharge from the SICU. A total of 871 patients were screened. Among them, 34 were found to carry VRE before their admission to the SICU, and 47 acquired VRE during their stay in the SICU, five of whom developed VRE infections. The incidence of newly acquired VRE during ICU stay was 21.9 per 1000 patient-days (95% confidence interval [CI], 16.4-29.1). Using multivariate analysis by logistic regression, we found that the length of ICU stay was an independent risk factor for new acquisition of VRE. In contrast, patients with prior exposure to first-generation cephalosporin were significantly less likely to acquire VRE. Strategies to reduce the duration of ICU stay and prudent usage of broad-spectrum antibiotics are the keys to controlling VRE transmission.	[Pan, Sung-Ching; Wang, Jann-Tay; Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Wang, Jann-Tay; Chen, Yee-Chun; Chang, Yin-Yin; Chen, Mei-Ling] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	changsc@ntu.edu.tw	Chen, Yee-Chun/AGW-7535-2022	Chen, Yee-Chun/0000-0002-1816-9010; PAN, SUNG-CHING/0000-0003-3154-6690; WANG, JANN-TAY/0000-0002-0924-3469; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council, Taiwan [98-2314-B002-066-MY3]; National Taiwan University Hospital [DOH100-TD-B-111-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by grants from the National Science Council, Taiwan (98-2314-B002-066-MY3) and National Taiwan University Hospital (DOH100-TD-B-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavnani SM, 2000, DIAGN MICR INFEC DIS, V36, P145, DOI 10.1016/S0732-8893(99)00136-4; Bonten MJM, 1996, LANCET, V348, P1615, DOI 10.1016/S0140-6736(96)02331-8; Byers KE, 2002, INFECT CONT HOSP EP, V23, P207, DOI 10.1086/502036; Calderwood MS, 2008, INFECT CONT HOSP EP, V29, P1019, DOI 10.1086/591454; Carmeli Y, 2002, ARCH INTERN MED, V162, P2223, DOI 10.1001/archinte.162.19.2223; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chang SC, 2011, INFECT CONTROL J, V21, P355; Chen ML, 1999, J FORMOS MED ASSOC, V98, P426; Chuang YC, 2010, J CLIN MICROBIOL, V48, P2897, DOI 10.1128/JCM.00136-10; Edmond MB, 1996, CLIN INFECT DIS, V23, P1234, DOI 10.1093/clinids/23.6.1234; Fridkin SK, 2001, ANN INTERN MED, V135, P175, DOI 10.7326/0003-4819-135-3-200108070-00009; Furtado Guilherme Henrique Campos, 2005, Braz J Infect Dis, V9, P64, DOI 10.1590/S1413-86702005000100011; Greenland S, 2008, MODERN EPIDEMIOLOGY, P32; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Institute CaLS, 2007, M100S17 I CALS; Kohlenberg A, 2009, J HOSP INFECT, V73, P239, DOI 10.1016/j.jhin.2009.07.017; Lucas GM, 1998, CLIN INFECT DIS, V26, P1127, DOI 10.1086/520311; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; Ostrowsky BE, 1999, ARCH INTERN MED, V159, P1467, DOI 10.1001/archinte.159.13.1467; Padiglione AA, 2003, ANTIMICROB AGENTS CH, V47, P2492, DOI 10.1128/AAC.47.8.2492-2498.2003; Schooneveld TV, 2010, PRACTICAL HEALTHCARE, P197; Se YB, 2009, J KOREAN NEUROSURG S, V46, P123, DOI 10.3340/jkns.2009.46.2.123; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; Tsai HT, 2008, DIAGN MICR INFEC DIS, V62, P298, DOI 10.1016/j.diagmicrobio.2008.06.017; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Vergis EN, 2001, ANN INTERN MED, V135, P484, DOI 10.7326/0003-4819-135-7-200110020-00007; Wang JT, 2010, J CLIN MICROBIOL, V48, P4439, DOI 10.1128/JCM.00784-10; Wang JT, 2004, J HOSP INFECT, V58, P97, DOI 10.1016/j.jhin.2004.06.005; Warren DK, 2003, INFECT CONT HOSP EP, V24, P257, DOI 10.1086/502199	29	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47297	10.1371/journal.pone.0047297	http://dx.doi.org/10.1371/journal.pone.0047297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071778	gold, Green Published, Green Submitted			2022-12-25	WOS:000312385200101
J	Rabinovich-Nikitin, I; Rakover, IS; Becker, M; Solomon, B				Rabinovich-Nikitin, Inna; Rakover, Idan S.; Becker, Maria; Solomon, Beka			Beneficial Effect of Antibodies against beta- Secretase Cleavage Site of App on Alzheimer's-Like Pathology in Triple-Transgenic Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; C-TERMINAL FRAGMENT; A-BETA; AMYLOID-BETA; MOUSE MODEL; TAU-PROTEIN; DISEASE; PHOSPHORYLATION; INHIBITION; IMMUNOTHERAPY	The toxicity of amyloid beta and tau, the two hallmark proteins in Alzheimer's disease (AD), has been extensively studied individually. Recently new data suggest their possible interactions and synergistic effects in the disease. In this study, we investigate the ability of antibodies against the beta secretase cleavage site on APP, named BBS1, to affect tau pathology, besides their well established effect on intracellular A beta and amyloid load. For this purpose we treated the triple transgenic mice model of AD (3x Tg-AD) with mAb BBS1 intracerebroventricularly, using mini osmotic pumps for one month. The experimental data demonstrated reduction in total and phosphorylated tau levels, explained by significant reduction in GSK3 beta which phosphorylates tau on sites recognized by antibodies against PHF1 and AT-8. The treatment increased the cognitive capabilities and reduced the brain inflammation levels which accompany AD pathology. The data showing that tau pathology was significantly reduced by BBS1 antibodies suggest a close interaction between tau and A beta in the development of AD, and may serve as an efficient novel immunotherapy against both hallmarks of this disease.	[Rabinovich-Nikitin, Inna; Rakover, Idan S.; Becker, Maria; Solomon, Beka] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Solomon, B (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	beka@post.tau.ac.il		Rabinovich-Nikitin, Inna/0000-0001-5067-8803	NasVax. Ltd, Israel	NasVax. Ltd, Israel	This work was funded by a research grant by NasVax. Ltd, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arbel M, 2005, P NATL ACAD SCI USA, V102, P7718, DOI 10.1073/pnas.0502427102; Arbel-Ornath M, 2010, J ALZHEIMERS DIS, V22, P469, DOI 10.3233/JAD-2010-100753; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Citron M, 2002, NEUROBIOL AGING, V23, P1017, DOI 10.1016/S0197-4580(02)00122-7; Citron M, 2002, J NEUROSCI RES, V70, P373, DOI 10.1002/jnr.10393; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Filali M, 2012, BEHAV BRAIN RES, V234, P334, DOI 10.1016/j.bbr.2012.07.004; Flajolet M, 2007, P NATL ACAD SCI USA, V104, P4159, DOI 10.1073/pnas.0611236104; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Honig LS, 2001, AGING CLIN EXP RES, V13, P171, DOI 10.1007/BF03351476; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; John V, 2010, BACE LEAD TARGET ORC; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Muyllaert D, 2008, GENES BRAIN BEHAV, V7, P57, DOI 10.1111/j.1601-183X.2007.00376.x; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Rakover I, 2007, NEURODEGENER DIS, V4, P392, DOI 10.1159/000103250; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Rodriguez JJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.2; Roman GC, 1997, JAMA-J AM MED ASSOC, V278, P113, DOI 10.1001/jama.1997.03550020045023; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Wagner U, 1996, J CELL SCI, V109, P1537; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; WISNIEWSKI HM, 1989, ACTA NEUROPATHOL, V78, P22, DOI 10.1007/BF00687398; Yoon SY, 2006, NEUROBIOL DIS, V22, P435, DOI 10.1016/j.nbd.2005.12.013; Zotova E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt24	50	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46650	10.1371/journal.pone.0046650	http://dx.doi.org/10.1371/journal.pone.0046650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071606	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200039
J	Soibam, B; Goldfeder, RL; Manson-Bishop, C; Gamblin, R; Pletcher, SD; Shah, S; Gunaratne, GH; Roman, GW				Soibam, Benjamin; Goldfeder, Rachel L.; Manson-Bishop, Claire; Gamblin, Rachel; Pletcher, Scott D.; Shah, Shishir; Gunaratne, Gemunu H.; Roman, Gregg W.			Modeling Drosophila Positional Preferences in Open Field Arenas with Directional Persistence and Wall Attraction	PLOS ONE			English	Article							CORRELATED RANDOM-WALK; WHITE TEST BOX; MUSHROOM BODIES; LOCOMOTOR-ACTIVITY; PLACE MEMORY; FRUIT-FLIES; MELANOGASTER; BEHAVIOR; MUTANT; MICE	In open field arenas, Drosophila adults exhibit a preference for arena boundaries over internal walls and open regions. Herein, we investigate the nature of this preference using phenomenological modeling of locomotion to determine whether local arena features and constraints on movement alone are sufficient to drive positional preferences within open field arenas of different shapes and with different internal features. Our model has two components: directional persistence and local wall force. In regions far away from walls, the trajectory is entirely characterized by a directional persistence probability, P(r,theta), for each movement defined by the step size, r, and the turn angle, theta. In close proximity to walls, motion is computed from P(r,theta) and a local attractive force which depends on the distance between the fly and points on the walls. The directional persistence probability was obtained experimentally from trajectories of wild type Drosophila in a circular open field arena and the wall force was computed to minimize the difference between the radial distributions from the model and Drosophila in the same circular arena. The two-component model for fly movement was challenged by comparing the positional preferences from the two-component model to wild type Drosophila in a variety of open field arenas. In most arenas there was a strong concordance between the two-component model and Drosophila. In more complex arenas, the model exhibits similar trends, but some significant differences were found. These differences suggest that there are emergent features within these complex arenas that have significance for the fly, such as potential shelter. Hence, the two-component model is an important step in defining how Drosophila interact with their environment.	[Goldfeder, Rachel L.; Manson-Bishop, Claire; Gamblin, Rachel; Roman, Gregg W.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Soibam, Benjamin; Shah, Shishir] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Gunaratne, Gemunu H.] Univ Houston, Dept Phys, Houston, TX USA; [Roman, Gregg W.] Univ Houston, Biol Behav Inst, Houston, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Michigan System; University of Michigan; University of Houston System; University of Houston; University of Houston System; University of Houston	Roman, GW (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	gwroman@central.uh.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699	National Institute of Mental Health [MH091304]; US National Institutes of Health [R01AG030593, R01AG023166]; Ellison Medical Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH091304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283, R01AG030593, R01AG023166] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the MH091304 award from the National Institute of Mental Health to GWR. The research was also supported by US National Institutes of Health (R01AG030593 and R01AG023166) and the Ellison Medical Foundation to S. Pletcher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptekar JW, 2012, CURR BIOL, V22, P482, DOI 10.1016/j.cub.2012.01.044; Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Cao BJ, 2002, BRAIN RES, V937, P32, DOI 10.1016/S0006-8993(02)02461-7; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; Cheng SF, 2010, DEV BIOL, V337, P99, DOI 10.1016/j.ydbio.2009.10.014; Cho W, 2004, GENES BRAIN BEHAV, V3, P127, DOI 10.1111/j.1601-183x.2004.00061.x; Collett M, 2010, P NATL ACAD SCI USA, V107, P11638, DOI 10.1073/pnas.1001401107; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V32, P777, DOI 10.1016/0091-3057(89)90033-6; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Creed RP, 1990, NEUROSCI BIOBEHAV R, V26, P758; Cummins RA, 1976, PSYCHOL BULL, V83; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P369, DOI 10.1016/S0003-3472(63)80128-1; Furuichi N, 2002, J THEOR BIOL, V217, P159, DOI 10.1006/jtbi.2002.3027; Gotz K, 1994, BASIC LIFE SCI, V16, P391; Gotz K G, 1980, Basic Life Sci, V16, P391; GOTZ KG, 1985, J COMP PHYSIOL A, V156, P329, DOI 10.1007/BF00610726; GOULD JL, 1986, SCIENCE, V232, P861, DOI 10.1126/science.232.4752.861; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; JONES R E, 1977, Behaviour, V60, P237, DOI 10.1163/156853977X00225; JONES RE, 1977, J ANIM ECOL, V46, P195, DOI 10.2307/3956; Kalmus H, 1943, J GENET, V42, P206, DOI 10.1007/BF02982936; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Lebreton S, 2009, J NEUROGENET, V23, P225, DOI 10.1080/01677060802509160; Lee SJ, 2004, P NATL ACAD SCI USA, V101, P11874, DOI 10.1073/pnas.0402205101; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MARSH LM, 1988, J THEOR BIOL, V133, P113, DOI 10.1016/S0022-5193(88)80028-6; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; MEEHAN MJ, 1987, BEHAV GENET, V17, P503, DOI 10.1007/BF01073117; Mizunami M, 1998, J COMP NEUROL, V402, P520; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; NOSSAL R, 1974, J THEOR BIOL, V47, P103, DOI 10.1016/0022-5193(74)90101-5; Nouvellet P, 2009, AM NAT, V174, P506, DOI 10.1086/605404; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; Sanchez C, 1997, EUR NEUROPSYCHOPHARM, V7, P283, DOI 10.1016/S0924-977X(97)00035-7; Schuster S, 2002, CURR BIOL, V12, P1591, DOI 10.1016/S0960-9822(02)01141-7; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TURCHIN P, 1991, ECOLOGY, V72, P1253, DOI 10.2307/1941099; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; Wolf FW, 2002, J NEUROSCI, V22, P11035; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	61	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46570	10.1371/journal.pone.0046570	http://dx.doi.org/10.1371/journal.pone.0046570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071591	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200032
J	Reid, WR; Zhang, L; Liu, F; Liu, NN				Reid, William R.; Zhang, Lee; Liu, Feng; Liu, Nannan			The Transcriptome Profile of the Mosquito Culex quinquefasciatus following Permethrin Selection	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; INSECTICIDE RESISTANCE; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; PYRETHROID-RESISTANT; DETOXIFICATION GENES; SUSCEPTIBLE STRAINS; HOUSE-FLIES; CYTOCHROME-P450; MICROARRAY	To gain valuable insights into the gene interaction and the complex regulation system involved in the development of insecticide resistance in mosquitoes Culex quinquefasciatus, we conducted a whole transcriptome analysis of Culex mosquitoes following permethrin selection. Gene expression profiles for the lower resistant parental mosquito strain HAmCq(G0) and their permethrin-selected high resistant offspring HAmCq(G8) were compared and a total of 367 and 3982 genes were found to be up- and down-regulated, respectively, in HAmCq(G8), indicating that multiple genes are involved in response to permethrin selection. However, a similar overall cumulative gene expression abundance was identified between up- and down-regulated genes in HAmCq(G8) mosquitoes following permethrin selection, suggesting a homeostatic response to insecticides through a balancing of the up- and down-regulation of the genes. While structural and/or cuticular structural functions were the only two enriched GO terms for down-regulated genes, the enriched GO terms obtained for the up-regulated genes occurred primarily among the catalytic and metabolic functions where they represented three functional categories: electron carrier activity, binding, and catalytic activity. Interestingly, the functional GO terms in these three functional categories were overwhelmingly overrepresented in P450s and proteases/serine proteases. The important role played by P450s in the development of insecticide resistance has been extensively studied but the function of proteases/serine proteases in resistance is less well understood. Hence, the characterization of the functions of these proteins, including their digestive, catalytic and proteinase activities; regulation of signaling transduction and protein trafficking, immunity and storage; and their precise function in the development of insecticide resistance in mosquitoes will provide new insights into how genes are interconnected and regulated in resistance.	[Reid, William R.; Zhang, Lee; Liu, Feng; Liu, Nannan] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Zhang, Lee] Auburn Univ, Genom & Sequencing Lab, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Reid, WR (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu	Liu, Feng/B-5616-2019		National Institute of Allergy and Infectious Diseases [R21AI076893]; AAES Hatch/Multistate [ALA08-045, ALA015-1-10026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076893] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES Hatch/Multistate; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R21AI076893 to N.L. from the National Institute of Allergy and Infectious Diseases, AAES Hatch/Multistate Grants ALA08-045 and ALA015-1-10026 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 1998, INSECT BIOCHEM MOLEC, V28, P629, DOI 10.1016/S0965-1748(98)00061-7; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; CARINO F, 1992, ACS SYM SER, V505, P31; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Clarke JD, 2006, PLANT J, V45, P630, DOI 10.1111/j.1365-313X.2006.02668.x; Cupp EW, 2007, J MED ENTOMOL, V44, P117, DOI 10.1603/0022-2585(2007)44[117:WNVIIM]2.0.CO;2; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Gan QA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r42; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hardstone MC, 2010, INSECT MOL BIOL, V19, P717, DOI 10.1111/j.1365-2583.2010.01030.x; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Krem MM, 2000, TRENDS CARDIOVAS MED, V10, P171, DOI 10.1016/S1050-1738(00)00068-2; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Li T, 2010, J MED ENTOMOL, V47, P1127, DOI 10.1603/ME10142; Li T, 2009, J MED ENTOMOL, V46, P1430, DOI 10.1603/033.046.0626; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; LIU N, 1995, PESTIC BIOCHEM PHYS, V52, P116, DOI 10.1006/pest.1995.1036; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu N, 1997, INSECT MOL BIOL, V6, P77, DOI 10.1046/j.1365-2583.1997.00160.x; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Liu Nannan, 2008, P75; Liu NN, 2009, J MED ENTOMOL, V46, P1424, DOI 10.1603/033.046.0625; Liu NN, 2001, PESTIC BIOCHEM PHYS, V70, P151, DOI 10.1006/pest.2001.2547; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; MARRS WR, 2012, NAT NEUROSCI, V13, P951, DOI DOI 10.1016/J.MEEGID.2007.12.007; Megy K, 2009, INFECT GENET EVOL, V9, P308, DOI 10.1016/j.meegid.2007.12.007; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; MORGAN ET, 1989, MOL PHARMACOL, V36, P699; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Najera JA, 2001, WHOCDSWHOPES20013; Nasci Roger S., 1996, P85; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Phillips RS, 2001, CLIN MICROBIOL REV, V14, P208, DOI 10.1128/CMR.14.1.208-226.2001; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; ROUSH RT, 1990, J ECON ENTOMOL, V83, P315, DOI 10.1093/jee/83.2.315; SAWICKI RM, 1984, CIBA F SYMP, V102, P152; Strode C, 2006, INSECT MOL BIOL, V15, P523, DOI 10.1111/j.1365-2583.2006.00667.x; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Vogel C, 2004, J MOL BIOL, V336, P809, DOI 10.1016/j.jmb.2003.12.026; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Vontas J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-52; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; *WHO, 1957, WHO TECH RPT SER; Wilkins RM, 1999, COMP BIOCHEM PHYS C, V124, P337, DOI 10.1016/S0742-8413(99)00083-3; Wu HW, 2004, PESTIC BIOCHEM PHYS, V79, P75, DOI 10.1016/j.pestbp.2004.04.004; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Zhu F, 2008, ARCH INSECT BIOCH PH, V34, P147; Zhu F., 2008, INSECT MOL BIOL, V20, P1365, DOI DOI 10.1186/1472-6793-8-18; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	73	48	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47163	10.1371/journal.pone.0047163	http://dx.doi.org/10.1371/journal.pone.0047163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071746	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300085
J	Pitt, J; Thorner, M; Brautigan, D; Larner, J; Klein, WL				Pitt, Jason; Thorner, Michael; Brautigan, David; Larner, Joseph; Klein, William L.			Protection against the synaptic targeting and toxicity of Alzheimer's-associated A beta oligomers by insulin mimetic chiro-inositols	FASEB JOURNAL			English	Article						therapeutics; cell culture; neurodegeneration; dementia	CENTRAL-NERVOUS-SYSTEM; RECEPTOR-DEPENDENT MECHANISM; GROWTH-FACTOR EXPRESSION; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; DIABETES-MELLITUS; MEDIATED ENDOCYTOSIS; CARDIOVASCULAR RISK; SOLUBLE OLIGOMERS; GLYCOGEN-SYNTHASE	Alzheimer's disease (AD) is a progressive dementia that correlates highly with synapse loss. This loss appears due to the synaptic accumulation of toxic A beta oligomers (ADDLs), which damages synapse structure and function. Although it has been reported that oligomer binding and toxicity can be prevented by stimulation of neuronal insulin signaling with PPAR gamma agonists, these agonists have problematic side effects. We therefore investigated the therapeutic potential of chiro-inositols, insulin-sensitizing compounds safe for human consumption. Chiro-inositols have been studied extensively for treatment of diseases associated with peripheral insulin resistance, but their insulin mimetic function in memory-relevant central nervous system (CNS) cells is unknown. Here we demonstrate that mature cultures of hippocampal neurons respond to D-chiro-inositol (DCI), pinitol (3-O-methyl DCI), and the inositol glycan INS-2 (pinitol beta-1-4 galactosamine) with increased phosphorylation in key upstream components in the insulin-signaling pathway (insulin receptor, insulin receptor substrate-1, and Akt). Consistent with insulin stimulation, DCI treatment promotes rapid withdrawal of dendritic insulin receptors. With respect to neuroprotection, DCI greatly enhances the ability of insulin to prevent ADDL-induced synapse damage (EC50 of 90 nM). The mechanism comprises inhibition of oligomer binding at synapses and requires insulin/IGF signaling. DCI showed no effects on A beta oligomerization. We propose that inositol glycans and DCI, a compound already established as safe for human consumption, have potential as AD therapeutics by protecting CNS synapses against A beta oligomers through their insulin mimetic activity.-Pitt, J., Thorner, M., Brautigan, D., Larner, J., Klein, W. L. Protection against the synaptic targeting and toxicity of Alzheimer's-associated A beta oligomers by insulin mimetic chiro-inositols. FASEB J. 27, 199-207 (2013). www.fasebj.org	[Pitt, Jason; Klein, William L.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Thorner, Michael] Univ Virginia, Dept Med, Charlottesville, VA USA; [Brautigan, David] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Larner, Joseph] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Brautigan, David] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Larner, Joseph] Allomed Pharmaceut, Charlottesville, VA USA	Northwestern University; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Pitt, J (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	wklein@northwestern.edu		Pitt, Jason/0000-0002-1876-4565	U.S. National Institutes of Health [AG020418, AG022547, AG029460, 1F31AG039216-01A1]; NATIONAL INSTITUTE ON AGING [R01AG022547, R01AG029460, T32AG020418, F31AG039216] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health grants AG020418, AG022547, AG029460, and 1F31AG039216-01A1 (National Institute of Neurological Disorders and Stroke). Author contributions: J. P. designed and performed research, analyzed data, and wrote the manuscript; M. T. collaborated in providing ideas and edited the manuscript; D. B. collaborated in providing ideas and edited the manuscript; J. L. initiated work with W. K., provided ideas, and edited the manuscript; W. K. initiated work with J. L., provided ideas, and wrote the manuscript.	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Baillargeon JP, 2006, DIABETES CARE, V29, P300, DOI 10.2337/diacare.29.02.06.dc05-1070; Bitel CL, 2012, J ALZHEIMERS DIS, V32, P291, DOI 10.3233/JAD-2012-120571; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Brautigan DL, 2005, BIOCHEMISTRY-US, V44, P11067, DOI 10.1021/bi0508845; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; De Felice F. G., 2012, SOC NEUR NAN NEW ORL; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Farias VX, 2011, DIABETES OBES METAB, V13, P243, DOI 10.1111/j.1463-1326.2010.01344.x; Fenili D, 2007, J MOL MED, V85, P603, DOI 10.1007/s00109-007-0156-7; Fenili D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024032; Fernandes MLDA, 2001, ENDOCRINE, V16, P227; Fonteles MC, 2000, HORM METAB RES, V32, P129, DOI 10.1055/s-2007-978606; Geldmacher DS, 2010, CLEV CLIN J MED, V77, P689, DOI 10.3949/ccjm.77gr.2010; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkes CA, 2010, EUR J NEUROSCI, V31, P203, DOI 10.1111/j.1460-9568.2009.07052.x; Isoda F, 2003, BRAIN RES, V993, P172, DOI 10.1016/j.brainres.2003.09.008; Jolivalt CG, 2010, EXP NEUROL, V223, P422, DOI 10.1016/j.expneurol.2009.11.005; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; KENNINGTON AS, 1990, NEW ENGL J MED, V323, P373, DOI 10.1056/NEJM199008093230603; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kim JI, 2005, EUR J CLIN NUTR, V59, P456, DOI 10.1038/sj.ejcn.1602081; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; KNUTSON VP, 1983, J BIOL CHEM, V258, P2139; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Kunjara S, 2000, MOL GENET METAB, V69, P144, DOI 10.1006/mgme.2000.2964; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larner J, 2003, J MED CHEM, V46, P3283, DOI 10.1021/jm030071j; LARNER J, 1988, BIOCHEM BIOPH RES CO, V151, P1416, DOI 10.1016/S0006-291X(88)80520-5; Larner J, 2010, MOL MED, V16, P543, DOI 10.2119/molmed.2010.00107; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nascimento NRF, 2006, P NATL ACAD SCI USA, V103, P218, DOI 10.1073/pnas.0509779103; Nestler JE, 1999, NEW ENGL J MED, V340, P1314, DOI 10.1056/NEJM199904293401703; Nunes-Tavares N, 2012, J BIOL CHEM, V287, P19377, DOI 10.1074/jbc.M111.321448; ORTMEYER HK, 1993, ENDOCRINOLOGY, V132, P646, DOI 10.1210/en.132.2.646; ORTMEYER HK, 1995, J NUTR BIOCHEM, V6, P499, DOI 10.1016/0955-2863(95)00080-J; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pasinetti GM, 2008, J NEUROCHEM, V106, P1503, DOI 10.1111/j.1471-4159.2008.05454.x; Pitt J, 2009, TOXICOL APPL PHARM, V240, P189, DOI 10.1016/j.taap.2009.07.018; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Schnabel J, 2011, NATURE, V475, pS12, DOI 10.1038/475S12a; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Stull AJ, 2008, METABOLISM, V57, P1545, DOI 10.1016/j.metabol.2008.06.009; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; WEILAND M, 1991, J CELL PHYSIOL, V149, P428, DOI 10.1002/jcp.1041490311; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zhao WQ, 2009, J BIOL CHEM, V284, P18742, DOI 10.1074/jbc.M109.011015	82	39	42	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					199	207		10.1096/fj.12-211896	http://dx.doi.org/10.1096/fj.12-211896			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23073831	Green Published			2022-12-25	WOS:000313103200019
J	Berger, G; Turpin, J; Cordeil, S; Tartour, K; Nguyen, XN; Mahieux, R; Cimarelli, A				Berger, Gregory; Turpin, Jocelyn; Cordeil, Stephanie; Tartour, Kevin; Nguyen, Xuan-Nhi; Mahieux, Renaud; Cimarelli, Andrea			Functional Analysis of the Relationship between Vpx and the Restriction Factor SAMHD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; MACROPHAGE INFECTION; NUCLEAR-LOCALIZATION; ACCESSORY PROTEINS; UBIQUITIN LIGASE; HIV-1; RNA; TRANSDUCTION; MUTATIONS	SAMHD1 is a newly identified restriction factor that targets lentiviruses in myeloid cells and is countered by the SIVSM/HIV-2 Vpx protein. By analyzing a large panel of Vpx mutants, we identify several residues throughout the 3-helix bundle predicted for Vpx that impair both its functionality and its ability to degrade SAMHD1. We determine that SAMHD1 is a strictly non-shuttling nuclear protein and that as expected WT Vpx localizes with it in the nucleus. However, we also identify a functional Vpx mutant with predominant cytoplasmic distribution that colocalizes with SAMHD1 in this location, suggesting that Vpx may also retain SAMHD1 in the cell cytoplasm, prior to its entry into the nucleus. Several mutations in Vpx were shown to affect the stability of Vpx, as well as Vpx: Vpx interactions. However, no strict correlation was observed between these parameters and the functionality of Vpx, implying that neither properties is absolutely required for this function and indicating that even unstable Vpx mutants may be very efficient in inducing SAMHD1 degradation. Overall, our analysis identifies several Vpx residues required for SAMHD1 degradation and points to a very efficient and plastic mechanism through which Vpx depletes this restriction factor.	[Berger, Gregory; Turpin, Jocelyn; Cordeil, Stephanie; Tartour, Kevin; Nguyen, Xuan-Nhi; Mahieux, Renaud; Cimarelli, Andrea] Univ Lyon 1, Dept Human Virol, ENS L, INSERM,U758, F-69364 Lyon, France; [Berger, Gregory; Turpin, Jocelyn; Cordeil, Stephanie; Tartour, Kevin; Nguyen, Xuan-Nhi; Mahieux, Renaud; Cimarelli, Andrea] US8, UMS3444, F-69364 Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Cimarelli, A (corresponding author), Univ Lyon 1, Dept Human Virol, ENS L, INSERM,U758, 46 Allee Italie, F-69364 Lyon, France.	acimarel@ens-lyon.fr		mahieux, renaud/0000-0002-5129-6804; CIMARELLI, Andrea/0000-0003-0892-0488; Turpin, Jocelyn/0000-0001-5177-2471	ANRS; ENS-L; FRM; InCa; Sidaction; Cluster 10 Region Rhone-Alpes; ENS-Lyon	ANRS(ANRSFrench National Research Agency (ANR)); ENS-L; FRM(Fondation pour la Recherche Medicale); InCa(Institut National du Cancer (INCA) France); Sidaction; Cluster 10 Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); ENS-Lyon	This work was supported by the ANRS, the ENS-L, the FRM, the InCa, and Sidaction.; A PhD student financed by the Cluster 10 Region Rhone-Alpes.; A PhD student financed by the ANRS.; Supported by the ENS-Lyon.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Baldauf H. M., 2012, NAT MED IN PRESS; Belshan M, 2006, VIROLOGY, V346, P118, DOI 10.1016/j.virol.2005.10.036; Belshan M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-32; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Boyd MT, 2011, J CELL BIOL, V194, P689, DOI 10.1083/jcb.201105143; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Cimarelli A, 2000, J VIROL, V74, P3046, DOI 10.1128/JVI.74.7.3046-3057.2000; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hofmann H., 2012, J VIROL IN PRESS; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kumar PR, 2005, J BIOL CHEM, V280, P8553, DOI 10.1074/jbc.M407863200; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004	38	26	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41210	41217		10.1074/jbc.M112.403816	http://dx.doi.org/10.1074/jbc.M112.403816			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23076149	hybrid, Green Published			2022-12-25	WOS:000311887600036
J	Nieva, C; Marro, M; Santana-Codina, N; Rao, S; Petrov, D; Sierra, A				Nieva, Claudia; Marro, Monica; Santana-Codina, Naiara; Rao, Satish; Petrov, Dmitri; Sierra, Angels			The Lipid Phenotype of Breast Cancer Cells Characterized by Raman Microspectroscopy: Towards a Stratification of Malignancy	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; MESENCHYMAL TRANSITION; IN-SITU; SPECTROSCOPY; CHOLESTEROL; OVEREXPRESSION; METASTASIS; METABOLISM; EXPRESSION; MIGRATION	Although molecular classification brings interesting insights into breast cancer taxonomy, its implementation in daily clinical care is questionable because of its expense and the information supplied in a single sample allocation is not sufficiently reliable. New approaches, based on a panel of small molecules derived from the global or targeted analysis of metabolic profiles of cells, have found a correlation between activation of de novo lipogenesis and poorer prognosis and shorter disease-free survival for many tumors. We hypothesized that the lipid content of breast cancer cells might be a useful indirect measure of a variety of functions coupled to breast cancer progression. Raman microspectroscopy was used to characterize metabolism of breast cancer cells with different degrees of malignancy. Raman spectra from MDA-MB-435, MDA-MB-468, MDA-MB-231, SKBR3, MCF7 and MCF10A cells were acquired with an InVia Raman microscope (Renishaw) with a backscattered configuration. We used Principal Component Analysis and Partial Least Squares Discriminant Analyses to assess the different profiling of the lipid composition of breast cancer cells. Characteristic bands related to lipid content were found at 3014, 2935, 2890 and 2845 cm 21, and related to lipid and protein content at 2940 cm(-1). A classificatory model was generated which segregated metastatic cells and non-metastatic cells without basal-like phenotype with a sensitivity of 90% and a specificity of 82.1%. Moreover, expression of SREBP-1c and ABCA1 genes validated the assignation of the lipid phenotype of breast cancer cells. Indeed, changes in fatty acid unsaturation were related with the epithelial-to-mesenchymal transition phenotype. Raman microspectroscopy is a promising technique for characterizing and classifying the malignant phenotype of breast cancer cells on the basis of their lipid profiling. The algorithm for the discrimination of metastatic ability is a first step towards stratifying breast cancer cells using this rapid and reagent-free tool.	[Nieva, Claudia; Santana-Codina, Naiara; Sierra, Angels] IDIBELL Inst Invest Biomed Bellvitge, Barcelona, Spain; [Nieva, Claudia; Marro, Monica; Petrov, Dmitri] ICFO Inst Ciencies Foton, Barcelona, Spain; [Santana-Codina, Naiara] UAB Univ Autonoma Barcelona, Barcelona, Spain; [Rao, Satish] Mt Sinai Sch Med, New York, NY USA; [Petrov, Dmitri] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Icahn School of Medicine at Mount Sinai; ICREA	Sierra, A (corresponding author), IDIBELL Inst Invest Biomed Bellvitge, Barcelona, Spain.	asierra@idibell.cat	santana, naiara/AAV-3984-2021; Marro, Monica/AAV-1362-2021; Santana-Codina, Naiara/K-5705-2019; Marro, Monica/E-4159-2016	Marro, Monica/0000-0003-4031-4605; Santana-Codina, Naiara/0000-0002-8250-4530; Marro, Monica/0000-0003-4031-4605; Sierra, Angels/0000-0003-1023-3492	Spanish Ministry of Health and Consumer Affairs [FIS-PI10/00057]; Generalitat de Catalunya [MIIN FIS2008-00114, 2009-SGR-159]; Fundacio Privada Cellex Barcelona; ICREA Funding Source: Custom	Spanish Ministry of Health and Consumer Affairs(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio Privada Cellex Barcelona(Foundation CELLEX); ICREA(ICREA)	This study was supported by grants from the Spanish Ministry of Health and Consumer Affairs FIS-PI10/00057 and by grants from MIIN FIS2008-00114, 2009-SGR-159 from the Generalitat de Catalunya and Fundacio Privada Cellex Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-78; American Cancer Society, 2010, CANC FACTS FIG 2010; [Anonymous], 2003, WHO CLASSIFICATION T; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; Antalis CJ, 2010, BREAST CANCER RES TR, V122, P661, DOI 10.1007/s10549-009-0594-8; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bhalla K, 2011, CANCER RES, V71, P6888, DOI 10.1158/0008-5472.CAN-11-1011; Bocklitz T, 2011, ANAL CHIM ACTA, V704, P47, DOI 10.1016/j.aca.2011.06.043; Brough R, 2011, FUNCTIONAL VIABILITY, V1, P261; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Fenn Michael B., 2011, Advances in Optical Technologies, DOI 10.1155/2011/213783; Ferlay J, 2010, IARC CANCERBASE; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Garcia-Flores AF, 2011, THEOR CHEM ACC, V130, P1231, DOI 10.1007/s00214-011-0925-9; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Hartsuiker L, 2010, ANALYST, V135, P3220, DOI 10.1039/c0an00524j; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Hu H, 2011, EXPERT REV PROTEOMIC, V8, P505, DOI 10.1586/EPR.11.31; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kasaian K, 2011, FUTURE ONCOL, V7, P873, DOI [10.2217/FON.11.63, 10.2217/fon.11.63]; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lieber CA, 2010, BIOMED OPT EXPRESS, V1, P975, DOI 10.1364/BOE.1.000975; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mikhailyuk IK, 2003, INSTRUM EXP TECH+, V46, P765, DOI 10.1023/B:INET.0000008930.87741.b9; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Pichardo-Molina JL, 2007, LASER MED SCI, V22, P229, DOI 10.1007/s10103-006-0432-8; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popp J, 2011, OPT PHOTONIK, V6, P24, DOI 10.1002/opph.201190383; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Raniero L, 2011, THEOR CHEM ACC, V130, P1239, DOI 10.1007/s00214-011-1027-4; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rehman S, 2007, J RAMAN SPECTROSC, V38, P1345, DOI 10.1002/jrs.1774; Rodenhiser DI, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2791; Rudolph MC, 2010, AM J PHYSIOL-ENDOC M, V299, pE918, DOI 10.1152/ajpendo.00376.2010; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Simpson NE, 2012, BREAST CANCER RES TR, V133, P959, DOI 10.1007/s10549-011-1871-x; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Van de Sande T, 2002, CANCER RES, V62, P642; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Voss MJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-158; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	54	89	90	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e46456	10.1371/journal.pone.0046456	http://dx.doi.org/10.1371/journal.pone.0046456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082122	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900017
J	Slack, C; Foley, A; Partridge, L				Slack, Cathy; Foley, Andrea; Partridge, Linda			Activation of AMPK by the Putative Dietary Restriction Mimetic Metformin Is Insufficient to Extend Lifespan in Drosophila	PLOS ONE			English	Article							HER-2/NEU TRANSGENIC MICE; FEMALE SHR MICE; CALORIC RESTRICTION; PROTEIN-KINASE; C-ELEGANS; SKELETAL-MUSCLE; MAMMARY-TUMORS; PATHWAYS; HUMANS; IDENTIFICATION	The biguanide drug, metformin, commonly used to treat type-2 diabetes, has been shown to extend lifespan and reduce fecundity in C. elegans through a dietary restriction-like mechanism via the AMP-activated protein kinase (AMPK) and the AMPK-activating kinase, LKB1. We have investigated whether the longevity-promoting effects of metformin are evolutionarily conserved using the fruit fly, Drosophila melanogaster. We show here that while feeding metformin to adult Drosophila resulted in a robust activation of AMPK and reduced lipid stores, it did not increase lifespan in either male or female flies. In fact, we found that when administered at high concentrations, metformin is toxic to flies. Furthermore, no decreases in female fecundity were observed except at the most toxic dose. Analysis of intestinal physiology after metformin treatment suggests that these deleterious effects may result from disruptions to intestinal fluid homeostasis. Thus, metformin appears to have evolutionarily conserved effects on metabolism but not on fecundity or lifespan.	[Slack, Cathy; Foley, Andrea; Partridge, Linda] UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England; [Partridge, Linda] ZMMK Forshungsgebaude, Max Planck Inst Biol Ageing, Cologne, Germany	University of London; University College London; Max Planck Society	Partridge, L (corresponding author), UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England.	l.partridge@ucl.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010	Slack, Cathy/0000-0002-7949-4079; Partridge, Linda/0000-0001-9615-0094	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Anisimov VN, 2010, CELL CYCLE, V9, P188, DOI 10.4161/cc.9.1.10407; Anisimov VN, 2005, B EXP BIOL MED+, V139, P721, DOI 10.1007/s10517-005-0389-9; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Collier CA, 2006, AM J PHYSIOL-ENDOC M, V291, pE182, DOI 10.1152/ajpendo.00272.2005; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dirkswager E., 2002, TEACHERS OWNERS KEY; Drenos F, 2005, MECH AGEING DEV, V126, P99, DOI 10.1016/j.mad.2004.09.026; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Jafari M, 2007, BIOGERONTOLOGY, V8, P639, DOI 10.1007/s10522-007-9105-7; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Klachko D, 2011, CARDIORENAL MED, V1, P87, DOI 10.1159/000327151; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Redman LM, 2008, PHYSIOL BEHAV, V94, P643, DOI 10.1016/j.physbeh.2008.04.017; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Smith DL, 2010, J GERONTOL A-BIOL, V65, P468, DOI 10.1093/gerona/glq033; Spindler SR, 2012, AGE, V34, P111, DOI 10.1007/s11357-011-9224-6; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; vanHerrewege J, 1997, ECOSCIENCE, V4, P151, DOI 10.1080/11956860.1997.11682389; VERMA S, 1994, AM J PHYSIOL-HEART C, V267, pH1250, DOI 10.1152/ajpheart.1994.267.4.H1250; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	49	124	127	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47699	10.1371/journal.pone.0047699	http://dx.doi.org/10.1371/journal.pone.0047699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077661	gold, Green Published, Green Accepted			2022-12-25	WOS:000310135800065
J	Eckers, E; Deponte, M				Eckers, Elisabeth; Deponte, Marcel			No Need for Labels: The Autofluorescence of Leishmania tarentolae Mitochondria and the Necessity of Negative Controls	PLOS ONE			English	Article							FLUORESCENCE; LIGHT	Background: Fluorescence microscopy is a powerful tool to study the morphology and function of subcellular compartments or to determine the localization of proteins. The method is also regularly used for the analysis of parasitic protists including kinetoplastida. Results: Here, we report a significant autofluorescence of Leishmania tarentolae mitochondria. The autofluorescence, presumably caused by flavoproteins, was detectable using a variety of cell fixation protocols and had a maximum emission at approximately 538 nm. Stable signals were obtained with xenon lamps as a light source and filter sets that are commonly used for the detection of green fluorescent protein. Conclusions: On the one hand, we present a methodological approach to examine mitochondrial morphology or to study the colocalization of mitochondrial proteins without additional staining or labeling procedures. On the other hand, under certain experimental conditions, mitochondrial autofluorescence can result in false positive signals, demonstrating the necessity to analyze unlabeled cells as negative controls.	[Eckers, Elisabeth; Deponte, Marcel] Heidelberg Univ, Dept Parasitol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Deponte, M (corresponding author), Heidelberg Univ, Dept Parasitol, Heidelberg, Germany.	marcel.deponte@gmx.de		Deponte, Marcel/0000-0003-2141-917X	Deutsche Forschungsgemeinschaft [DE 1431/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant DE 1431/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 1998, J MICROSC-OXFORD, V191, P1; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Chorvat D, 2004, LASER PHYS, V14, P220; Davis RW, 2010, MICROSC MICROANAL, V16, P478, DOI 10.1017/S1431927610000322; Deponte M, 2008, BBA-MOL CELL RES, V1783, P1396, DOI 10.1016/j.bbamcr.2008.01.018; Deponte M, 2012, CELL MOL LIFE SCI, V69, P1025, DOI 10.1007/s00018-012-0932-6; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; KUNZ WS, 1986, FEBS LETT, V195, P92, DOI 10.1016/0014-5793(86)80137-5; KUNZ WS, 1985, BIOCHIM BIOPHYS ACTA, V841, P237, DOI 10.1016/0304-4165(85)90064-9; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Simpson L, 1996, Methods Enzymol, V264, P99, DOI 10.1016/S0076-6879(96)64012-9; Simpson L, 1997, MOL BIOCHEM PARASIT, V87, P71, DOI 10.1016/S0166-6851(97)00044-3; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47641	10.1371/journal.pone.0047641	http://dx.doi.org/10.1371/journal.pone.0047641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077654	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100148
J	Gatfield, J; Grandjean, CM; Sasse, T; Clozel, M; Nayler, O				Gatfield, John; Grandjean, Celia Mueller; Sasse, Thomas; Clozel, Martine; Nayler, Oliver			Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells	PLOS ONE			English	Article							SHEAR-STRESS; HYPERTENSION; CALCIUM; MECHANISMS; EXPRESSION; GENE; PROLIFERATION; DEGRADATION; PATHWAYS; CA2+	Two endothelin receptor antagonists (ERAs), bosentan and ambrisentan, are currently approved for the treatment of pulmonary arterial hypertension (PAH), a devastating disease involving an activated endothelin system and aberrant contraction and proliferation of pulmonary arterial smooth muscle cells (PASMC). The novel ERA macitentan has recently concluded testing in a Phase III morbidity/mortality clinical trial in PAH patients. Since the association and dissociation rates of G protein-coupled receptor antagonists can influence their pharmacological activity in vivo, we used human PASMC to characterize inhibitory potency and receptor inhibition kinetics of macitentan, ambrisentan and bosentan using calcium release and inositol-1-phosphate (IP1) assays. In calcium release assays macitentan, ambrisentan and bosentan were highly potent ERAs with K-b values of 0.14 nM, 0.12 nM and 1.1 nM, respectively. Macitentan, but not ambrisentan and bosentan, displayed slow apparent receptor association kinetics as evidenced by increased antagonistic potency upon prolongation of antagonist pre-incubation times. In compound washout experiments, macitentan displayed a significantly lower receptor dissociation rate and longer receptor occupancy half-life (ROt(1/2)) compared to bosentan and ambrisentan (ROt(1/2): 17 minutes versus 70 seconds and 40 seconds, respectively). Because of its lower dissociation rate macitentan behaved as an insurmountable antagonist in calcium release and IP1 assays, and unlike bosentan and ambrisentan it blocked endothelin receptor activation across a wide range of endothelin-1 (ET-1) concentrations. However, prolongation of the ET-1 stimulation time beyond ROt(1/2) rendered macitentan a surmountable antagonist, revealing its competitive binding mode. Bosentan and ambrisentan behaved as surmountable antagonists irrespective of the assay duration and they lacked inhibitory activity at high ET-1 concentrations. Thus, macitentan is a competitive ERA with significantly slower receptor dissociation kinetics than the currently approved ERAs. Slow dissociation caused insurmountable antagonism in functional PASMC-based assays and this could contribute to an enhanced pharmacological activity of macitentan in ET-1-dependent pathologies.	[Gatfield, John; Grandjean, Celia Mueller; Sasse, Thomas; Clozel, Martine; Nayler, Oliver] Actel Pharmaceut Ltd, Allschwil, Switzerland	Actelion Pharmaceuticals Ltd	Gatfield, J (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	john.gatfield@actelion.com						Anthes JC, 2002, EUR J PHARMACOL, V449, P229, DOI 10.1016/S0014-2999(02)02049-6; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; BATTISTINI B, 1995, BIOCHEM BIOPH RES CO, V207, P675, DOI 10.1006/bbrc.1995.1240; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Casarosa P, 2011, J PHARMACOL EXP THER, V337, P600, DOI 10.1124/jpet.111.179259; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; De Mey JGR, 2011, TRENDS PHARMACOL SCI, V32, P345, DOI 10.1016/j.tips.2011.02.018; DICKINSON KEJ, 1991, BIOCHEM BIOPH RES CO, V176, P423, DOI 10.1016/0006-291X(91)90941-Y; EDANO T, 1994, BIOL PHARM BULL, V17, P379; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; Gradman AH, 2002, J HUM HYPERTENS, V16, pS9, DOI 10.1038/sj.jhh.1001434; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Haynes WG, 1998, J HYPERTENS, V16, P1081, DOI 10.1097/00004872-199816080-00001; Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113; HOSODA K, 1991, FEBS LETT, V287, P23, DOI 10.1016/0014-5793(91)80007-P; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; JANAKIDEVI K, 1992, AM J PHYSIOL, V263, pC1295, DOI 10.1152/ajpcell.1992.263.6.C1295; KANSE SM, 1991, EUR J PHARMACOL, V199, P99, DOI 10.1016/0014-2999(91)90641-3; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; Kuhr FK, 2012, AM J PHYSIOL-HEART C, V302, pH1546, DOI 10.1152/ajpheart.00944.2011; Le MT, 2007, BRIT J PHARMACOL, V151, P952, DOI 10.1038/sj.bjp.0707323; Leask A, 2011, PHARMACOL RES, V63, P502, DOI 10.1016/j.phrs.2011.01.011; MALEK AM, 1993, P NATL ACAD SCI USA, V90, P5999, DOI 10.1073/pnas.90.13.5999; Malek AM, 1999, J MOL CELL CARDIOL, V31, P387, DOI 10.1006/jmcc.1998.0873; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; PEREZVIZCAINO F, 1995, BRIT J PHARMACOL, V114, P867, DOI 10.1111/j.1476-5381.1995.tb13284.x; Platoshyn O, 2000, AM J PHYSIOL-CELL PH, V279, pC1540, DOI 10.1152/ajpcell.2000.279.5.C1540; POLLOCK DM, 1995, FASEB J, V9, P1196, DOI 10.1096/fasebj.9.12.7672512; Price LC, 2008, AM J CARDIOVASC DRUG, V8, P171, DOI 10.2165/00129784-200808030-00004; Rodriguez-Pascual F, 2004, J CARDIOVASC PHARM, V44, pS39, DOI 10.1097/01.fjc.0000166216.27544.22; Russell FD, 1999, BRIT J PHARMACOL, V126, P391, DOI 10.1038/sj.bjp.0702315; Russell FD, 1998, J CARDIOVASC PHARM, V31, P424, DOI 10.1097/00005344-199803000-00014; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Schiffrin EL, 1998, J CARDIOVASC PHARM, V32, pS2; Schroeder AC, 2000, HYPERTENSION, V35, P280, DOI 10.1161/01.HYP.35.1.280; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shimoda LA, 2000, AM J PHYSIOL-LUNG C, V278, pL157, DOI 10.1152/ajplung.2000.278.1.L157; Swinney DC, 2006, CURR TOP MED CHEM, V6, P461, DOI 10.2174/156802606776743093; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Tuder RM, 2001, CLIN CHEST MED, V22, P405, DOI 10.1016/S0272-5231(05)70280-X; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; Woods M, 1999, MOL PHARMACOL, V55, P902; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400	53	127	136	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47662	10.1371/journal.pone.0047662	http://dx.doi.org/10.1371/journal.pone.0047662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077657	Green Published, Green Submitted, gold			2022-12-25	WOS:000309995100150
J	Hou, J; Liu, Y; Liu, Y; Shao, YM				Hou, Jue; Liu, Yong; Liu, Ying; Shao, Yiming			The MSHA Strain of Pseudomonas Aeruginosa Activated TLR Pathway and Enhanced HIV-1 DNA Vaccine Immunoreactivity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; BACTERIAL FLAGELLIN; DENDRITIC CELLS; AVIDITY MATURATION; IMMUNE-RESPONSES; CPG MOTIFS; ADJUVANT; ENVELOPE; ANTIGEN; MICE	The mannose-sensitive hemagglutination pilus strain of Pseudomonas aeruginosa (PA-MSHA) has been shown to trigger naive immune responses through the activation of monocytes, macrophages, natural killer cells (NK cells) and antigen presenting cells (APCs). Based on the hypothesis that PA-MSHA activates natural immunity through the Toll-like receptor (TLR) pathway, we scanned several critical TLR pathway molecules in mouse splenocytes using high-throughput real-time QRT-PCR and co-stimulatory molecule in bone marrow-derived dendritic cells (BMDCs) following in vitro stimulation by PA-MSHA. PA-MSHA enabled activation of the TLR pathway mediated by NF-kappa B and JNK signaling in splenocytes, and the costimulatory molecule CD86 was up-regulated in BMDCs. We then assessed the adjuvant effect of PA-MSHA for HIV-1 DNA vaccines. In comparison to DNA inoculation alone, co-inoculation with low dosage of PA-MSHA enhanced specific immunoreactivity against HIV-1 Env in both cellular and humoral responses, and promoted antibody avidity maturation. However, high doses of adjuvant resulted in an immunosuppressive effect; a two-or three-inoculation regimen yielded low antibody responses and the two-inoculation regimen exhibited only a slight cellular immunity response. To our knowledge, this is the first report demonstrating the utility of PA-MSHA as an adjuvant to a DNA vaccine. Further research is needed to investigate the exact mechanisms through which PA-MSHA achieves its adjuvant effects on innate immune responses, especially on dendritic cells.	[Hou, Jue; Liu, Yong; Liu, Ying; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	yshao08@gmail.com	Hou, Jue/S-8184-2017	Hou, Jue/0000-0001-9913-8365	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Natural Science Foundation of China [81020108030]; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) [2008SKLID101]; Ministry of Science and Technology of China [2009DFB30420]	National Major projects for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Infectious Disease Prevention and Control (SKLID); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008) http://www.moh.gov.cn/publicfiles/business/htmlfiles/mohkjjys/s8543/index.htm; National Natural Science Foundation of China (81020108030) http://159.226.244.22/portal/proj_search.asp; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development grant (2008SKLID101); International Cooperative Grant from the Ministry of Science and Technology of China (2009DFB30420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge JR, 2000, VACCINE, V18, P2416, DOI 10.1016/S0264-410X(99)00572-1; Bates JT, 2008, MECH AGEING DEV, V129, P271, DOI 10.1016/j.mad.2008.01.009; Bower JF, 2005, CURR HIV RES, V3, P191, DOI 10.2174/1570162053506937; Braga CJM, 2010, VACCINE, V28, P1373, DOI 10.1016/j.vaccine.2009.11.003; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Davis HL, 1998, J IMMUNOL, V160, P870; Deml L, 1999, CLIN CHEM LAB MED, V37, P199, DOI 10.1515/CCLM.1999.037; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Inaba Kayo, 2009, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0307s86; Jorgensen JB, 2003, J VIROL, V77, P11471, DOI 10.1128/JVI.77.21.11471-11479.2003; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; Liu ZB, 2010, ONCOGENE, V29, P2996, DOI 10.1038/onc.2010.70; Liu ZB, 2009, J CELL BIOCHEM, V108, P195, DOI 10.1002/jcb.22241; MATHE G, 1977, BIOMED EXPRESS, V27, P368; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; Reeves J P, 2001, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0110s02; Ross TM, 2000, NAT IMMUNOL, V1, P127, DOI 10.1038/77802; Ross TM, 2001, AIDS RES HUM RETROV, V17, P829, DOI 10.1089/088922201750252025; Smith NJ, 2011, J UROLOGY, V186, P1084, DOI 10.1016/j.juro.2011.04.112; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Stacey KJ, 1999, INFECT IMMUN, V67, P3719, DOI 10.1128/IAI.67.8.3719-3726.1999; Tengvall S, 2005, J REPROD IMMUNOL, V68, P53, DOI 10.1016/j.jri.2005.06.010; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Vicente-Suarez I, 2009, IMMUNOL LETT, V125, P114, DOI 10.1016/j.imlet.2009.06.007; Wang XJ, 2008, VACCINE, V26, P1893, DOI 10.1016/j.vaccine.2008.01.043; XY M, 1986, J MICROBIOL, V26, P176; Yang SC, 2010, VIRUS RES, V151, P162, DOI 10.1016/j.virusres.2010.04.011	36	15	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47724	10.1371/journal.pone.0047724	http://dx.doi.org/10.1371/journal.pone.0047724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077664	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100156
J	Li, YQ; Fang, JW				Li, Yunqi; Fang, Jianwen			PROTS-RF: A Robust Model for Predicting Mutation-Induced Protein Stability Changes	PLOS ONE			English	Article							RATIONAL DESIGN; POINT MUTATIONS; RANDOM FOREST; THERMOSTABILITY; SEQUENCE; PERFORMANCE; SELECTION; SOLUBILITY; RESIDUES; ENZYMES	The ability to improve protein thermostability via protein engineering is of great scientific interest and also has significant practical value. In this report we present PROTS-RF, a robust model based on the Random Forest algorithm capable of predicting thermostability changes induced by not only single-, but also double-or multiple-point mutations. The model is built using 41 features including evolutionary information, secondary structure, solvent accessibility and a set of fragment-based features. It achieves accuracies of 0.799,0.782, 0.787, and areas under receiver operating characteristic (ROC) curves of 0.873, 0.868 and 0.862 for single-, double-and multiple-point mutation datasets, respectively. Contrary to previous suggestions, our results clearly demonstrate that a robust predictive model trained for predicting single point mutation induced thermostability changes can be capable of predicting double and multiple point mutations. It also shows high levels of robustness in the tests using hypothetical reverse mutations. We demonstrate that testing datasets created based on physical principles can be highly useful for testing the robustness of predictive models.	[Li, Yunqi; Fang, Jianwen] Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA	University of Kansas	Fang, JW (corresponding author), Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA.	jwfang@ku.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Dahiyat BI, 1999, CURR OPIN BIOTECH, V10, P387, DOI 10.1016/S0958-1669(99)80070-6; England JL, 2003, P NATL ACAD SCI USA, V100, P8727, DOI 10.1073/pnas.1530713100; Fang Jianwen, 2008, Journal of Bioinformatics and Computational Biology, V6, P223, DOI 10.1142/S0219720008003345; Fang Jianwen, 2009, BMC Chemical Biology, V9, P5, DOI 10.1186/1472-6769-9-5; Frenz CM, 2005, PROTEINS, V59, P147, DOI 10.1002/prot.20400; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; Glyakina AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028464; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Hirano S, 2005, PROTEINS, V58, P271, DOI 10.1002/prot.20333; Huang LT, 2009, BIOINFORMATICS, V25, P2181, DOI 10.1093/bioinformatics/btp370; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Lazar GA, 2003, CURR OPIN STRUC BIOL, V13, P513, DOI 10.1016/S0959-440X(03)00104-0; Li YQ, 2012, PROTEINS, V80, P81, DOI 10.1002/prot.23163; Li YQ, 2011, BIOINFORMATICS, V27, P3379, DOI 10.1093/bioinformatics/btr579; Li YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-62; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Montanucci L, 2008, BIOINFORMATICS, V24, pI190, DOI 10.1093/bioinformatics/btn166; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Sanchez IE, 2006, J MOL BIOL, V363, P422, DOI 10.1016/j.jmb.2006.08.020; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Schweiker Katrina L., 2009, V490, P261, DOI 10.1007/978-1-59745-367-7_11; Schweiker KL, 2009, METHOD ENZYMOL, V454, P175, DOI 10.1016/S0076-6879(08)03807-X; Shakhnovich BE, 2005, GENOME RES, V15, P385, DOI 10.1101/gr.3133605; Sikic M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000278; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wu LC, 2009, EXPERT SYST APPL, V36, P9007, DOI 10.1016/j.eswa.2008.12.020; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	52	34	37	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47247	10.1371/journal.pone.0047247	http://dx.doi.org/10.1371/journal.pone.0047247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077576	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100080
J	Schneider, JC; Trinh, NHT; Selleck, E; Fregni, F; Salles, SS; Ryan, CM; Stein, J				Schneider, Jeffrey C.; Trinh, Nhi-Ha T.; Selleck, Elizabeth; Fregni, Felipe; Salles, Sara S.; Ryan, Colleen M.; Stein, Joel			The Long-Term Impact of Physical and Emotional Trauma: The Station Nightclub Fire	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HEALTH-STATUS; EVENT SCALE; VERSION; WORK; AFGHANISTAN; POPULATION; PREVALENCE; PREDICTORS; DEPRESSION	Background: Survivors of physical and emotional trauma experience enduring occupational, psychological and quality of life impairments. Examining survivors from a large fire provides a unique opportunity to distinguish the impact of physical and emotional trauma on long-term outcomes. The objective is to detail the multi-dimensional long-term effects of a large fire on its survivor population and assess differences in outcomes between survivors with and without physical injury. Methods and Findings: This is a survey-based cross-sectional study of survivors of The Station fire on February 20, 2003. The relationships between functional outcomes and physical injury were evaluated with multivariate regression models adjusted for pre-injury characteristics and post-injury outcomes. Outcome measures include quality of life (Burn Specific Health Scale-Brief), employment (time off work), post-traumatic stress symptoms (Impact of Event Scale-Revised) and depression symptoms (Beck Depression Inventory). 104 fire survivors completed the survey; 47% experienced a burn injury. There was a 42% to 72% response rate range. Although depression and quality of life were associated with burn injury in univariate analyses (p<0.05), adjusted analyses showed no significant relationship between burn injury and these outcomes (p = 0.91; p = .51). Post-traumatic stress symptoms were not associated with burn injury in the univariate (p = 0.13) or adjusted analyses (p = 0.79). Time off work was the only outcome in which physical injury remained significant in the multivariate analysis (p = 0.03). Conclusions: Survivors of this large fire experienced significant life disruption, including occupational, psychological and quality of life sequelae. The findings suggest that quality of life, depression and post-traumatic stress outcomes are related to emotional trauma, not physical injury. However, physical injury is correlated with employment outcomes. The long-term impact of this traumatic event underscores the importance of longitudinal and mental health care for trauma survivors, with attention to those with and without physical injuries.	[Schneider, Jeffrey C.; Fregni, Felipe] Harvard Univ, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Sch Med, Boston, MA 02115 USA; [Trinh, Nhi-Ha T.] Massachusetts Gen Hosp, Dept Psychiat, Depress & Clin Res Program, Boston, MA 02114 USA; [Fregni, Felipe] Harvard Univ, Lab Neuromodulat, Spaulding Rehabil Hosp, Sch Med, Boston, MA USA; [Salles, Sara S.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY USA; [Ryan, Colleen M.] Massachusetts Gen Hosp, Dept Surg, Sumner Redstone Burn Ctr, Boston, MA 02114 USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA; [Stein, Joel] New York Presbyterian Hosp, New York, NY USA; [Stein, Joel] Weill Cornell Med Coll, Div Rehabil Med, New York, NY USA; [Stein, Joel] Columbia Univ, Dept Rehabil & Regenerat Med, Med Ctr, New York, NY USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; University of Kentucky; Harvard University; Massachusetts General Hospital; NewYork-Presbyterian Hospital; Cornell University; Columbia University	Schneider, JC (corresponding author), Harvard Univ, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Sch Med, Boston, MA 02115 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020; Trinh, Nhi-Ha/AAH-7836-2019	Stein, Joel/0000-0001-5527-025X; Fregni, Felipe/0000-0001-9359-8643; Ryan, Colleen/0000-0002-6455-936X	International Association of Fire Fighters	International Association of Fire Fighters	This project was supported by a pilot grant from the International Association of Fire Fighters. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, TASK FORC DSM 4 DIAG; [Anonymous], 2003, PROVIDENCE J    1005; [Anonymous], 2009, STAND DEF FIN DISP C; Ayuso-Mateos JL, 1999, ACTA PSYCHIAT SCAND, V99, P26, DOI 10.1111/j.1600-0447.1999.tb05381.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Brych SB, 2001, J BURN CARE REHABIL, V22, P401, DOI 10.1097/00004630-200111000-00010; Corrigan M., 2009, PUBLIC HLTH S3, V99, P702; Dacey MJ, 2003, NEW ENGL J MED, V349, P1990, DOI 10.1056/NEJMp038179; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS50, DOI 10.1016/j.apmr.2007.09.009; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holavanahalli RK, 2010, J BURN CARE RES, V31, P631, DOI 10.1097/BCR.0b013e3181e4ca62; Hyre AD, 2007, AM J KIDNEY DIS, V50, P585, DOI 10.1053/j.ajkd.2007.07.013; Jaycox LH, 2004, PSYCHIAT SERV, V55, P415, DOI 10.1176/appi.ps.55.4.415; Kildal M, 2002, BURNS, V28, P639, DOI 10.1016/S0305-4179(02)00111-0; Kildal M, 2001, J TRAUMA, V51, P740, DOI 10.1097/00005373-200110000-00020; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kvannli L, 2011, BURNS, V37, P54, DOI 10.1016/j.burns.2010.07.010; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lundin T, 2007, NORD J PSYCHIAT, V61, P479, DOI 10.1080/08039480701773329; Marmar CR, 1999, J NERV MENT DIS, V187, P15, DOI 10.1097/00005053-199901000-00004; McKibben JBA, 2008, J BURN CARE RES, V29, P22, DOI 10.1097/BCR.0b013e31815f59c4; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Parker PE, 2007, PROVIDENCE J; Patterson DR, 2000, J BURN CARE REHABIL, V21, P490, DOI 10.1097/00004630-200021060-00004; Phillips CJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-52; Resnick SG, 2008, J REHABIL RES DEV, V45, P427, DOI 10.1682/JRRD.2007.06.0093; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schneider JC, 2010, DELISAS PHYS MED REH, P1125; Schneider JC, 2009, J BURN CARE RES, V30, P294, DOI 10.1097/BCR.0b013e318198a2c2; Silove D, 2007, SOC PSYCH PSYCH EPID, V42, P467, DOI 10.1007/s00127-007-0194-z; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; Van Loey NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041532; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Weiss D, 1999, ASSESSING PSYCHOL TR, P399; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012; Wu KK, 2003, SOC PSYCH PSYCH EPID, V38, P94, DOI 10.1007/s00127-003-0611-x; Yzermans CJ, 2003, PUBLIC HLTH EUROPE 1, P317	41	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47339	10.1371/journal.pone.0047339	http://dx.doi.org/10.1371/journal.pone.0047339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022WO	23077593	Green Submitted, gold, Green Published			2022-12-25	WOS:000309995100093
J	Abushahba, W; Olabisi, OO; Jeong, BS; Boregowda, RK; Wen, Y; Liu, F; Goydos, JS; Lasfar, A; Cohen-Solal, KA				Abushahba, Walid; Olabisi, Oyenike O.; Jeong, Byeong-Seon; Boregowda, Rajeev K.; Wen, Yu; Liu, Fang; Goydos, James S.; Lasfar, Ahmed; Cohen-Solal, Karine A.			Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GLYCOGEN-SYNTHASE KINASE-3; CYCLIN-DEPENDENT KINASES; TGF-BETA; PLASMINOGEN-ACTIVATOR; ACTIVIN-A; IN-VIVO; MALIGNANT-MELANOMA; LINKER PHOSPHORYLATION; ESOPHAGEAL-CARCINOMA	Riluzole, an inhibitor of glutamate release, has shown the ability to inhibit melanoma cell xenograft growth. A phase 0 clinical trial of riluzole as a single agent in patients with melanoma resulted in involution of tumors associated with inhibition of both the mitogen-activated protein kinase (MAPK) and phophoinositide-3-kinase/AKT (PI3K/AKT) pathways in 34% of patients. In the present study, we demonstrate that riluzole inhibits AKT-mediated glycogen synthase kinase 3 (GSK3) phosphorylation in melanoma cell lines. Because we have demonstrated that GSK3 is involved in the phosphorylation of two downstream effectors of transforming growth factor beta (TGF beta), Smad2 and Smad3, at their linker domain, our aim was to determine whether riluzole could induce GSK3 beta-mediated linker phosphorylation of Smad2 and Smad3. We present evidence that riluzole increases Smad2 and Smad3 linker phosphorylation at the cluster of serines 245/250/255 and serine 204 respectively. Using GSK3 inhibitors and siRNA knock-down, we demonstrate that the mechanism of riluzole-induced Smad phosphorylation involved GSK3 beta. In addition, GSK3 beta could phosphorylate the same linker sites in vitro. The riluzole-induced Smad linker phosphorylation is mechanistically different from the Smad linker phosphorylation induced by TGF beta. We also demonstrate that riluzole-induced Smad linker phosphorylation is independent of the expression of the metabotropic glutamate receptor 1 (GRM1), which is one of the glutamate receptors whose involvement in human melanoma has been documented. We further show that riluzole upregulates the expression of INHBB and PLAU, two genes associated with the TGFb signaling pathway. The non-canonical increase in Smad linker phosphorylation induced by riluzole could contribute to the modulation of the pro-oncogenic functions of Smads in late stage melanomas.	[Abushahba, Walid; Olabisi, Oyenike O.; Boregowda, Rajeev K.; Cohen-Solal, Karine A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Med Oncol,Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Jeong, Byeong-Seon; Wen, Yu; Goydos, James S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, Canc Inst New Jersey,Div Surg Oncol, New Brunswick, NJ 08903 USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Susan Lehman Cullman Lab Canc Res, Ernest Mario Sch Pharm,Dept Chem Biol, Piscataway, NJ 08854 USA; [Lasfar, Ahmed] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Cohen-Solal, KA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Med Oncol,Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	cohenska@umdnj.edu	Goydos, James/AAR-8990-2020	Goydos, James/0000-0001-9811-939X	Research Development Award from the New Jersey Commission on Cancer Research [09-1143-CCR-EO]; Research Development Award from the Cancer Center Support Grant [CCSG P30CA072720]; Research Scholar Grant from the American Cancer Society [116683-RSG-09-087-01-TBE]; National Cancer Institute [1RO1CA149627-01]; Biomedical Science Education Postdoctoral Training Program from the National Institute of Health [K12 GM093854-01]; NATIONAL CANCER INSTITUTE [R01CA149627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER	Research Development Award from the New Jersey Commission on Cancer Research; Research Development Award from the Cancer Center Support Grant; Research Scholar Grant from the American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Science Education Postdoctoral Training Program from the National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Research Development Award from the New Jersey Commission on Cancer Research 09-1143-CCR-EO, a Research Development Award from the Cancer Center Support Grant CCSG P30CA072720, a Research Scholar Grant from the American Cancer Society 116683-RSG-09-087-01-TBE (K.C.S.) and a grant from the National Cancer Institute 1RO1CA149627-01 (J. Goydos). Dr. Olabisi was supported by a Biomedical Science Education Postdoctoral Training Program from the National Institute of Health K12 GM093854-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Biechele TL, 2010, CHEM BIOL, V17, P1177, DOI 10.1016/j.chembiol.2010.08.012; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Carlson BA, 1996, CANCER RES, V56, P2973; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Chu XJ, 2006, J MED CHEM, V49, P6549, DOI 10.1021/jm0606138; Cohen-Solal KA, 2011, PIGM CELL MELANOMA R, V24, P512, DOI 10.1111/j.1755-148X.2011.00858.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DePinto W, 2006, MOL CANCER THER, V5, P2644, DOI 10.1158/1535-7163.MCT-06-0355; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gutierrez LS, 2000, CANCER RES, V60, P5839; Javelaud D, 2008, PIGM CELL MELANOMA R, V21, P123, DOI 10.1111/j.1755-148X.2008.00450.x; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Khan AJ, 2011, CLIN CANCER RES, V17, P1807, DOI 10.1158/1078-0432.CCR-10-1276; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lasfar A, 2010, CARCINOGENESIS, V31, P1710, DOI 10.1093/carcin/bgq155; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Lee HJ, 2011, CLIN CANCER RES, V17, P7080, DOI 10.1158/1078-0432.CCR-11-0098; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Mehnert JM, 2011, 2011 ANN M ASCO AM S; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Ohtani Y, 2008, ONCOGENE, V27, P7162, DOI 10.1038/onc.2008.329; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Rizzolio F, 2010, CURR DRUG TARGETS, V11, P279, DOI 10.2174/138945010790711978; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sedlacek HH, 2001, CRIT REV ONCOL HEMAT, V38, P139, DOI 10.1016/S1040-8428(00)00124-4; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shapiro RL, 1996, CANCER RES, V56, P3597; Shin SS, 2008, NEUROPHARMACOLOGY, V55, P396, DOI 10.1016/j.neuropharm.2008.04.021; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stove C, 2004, ONCOGENE, V23, P5330, DOI 10.1038/sj.onc.1207699; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Yip D, 2009, CLIN CANCER RES, V15, P3896, DOI 10.1158/1078-0432.CCR-08-3303; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Yoshinaga K, 2003, INT J ONCOL, V22, P75; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang DF, 2010, J INT MED RES, V38, P1343, DOI 10.1177/147323001003800416	61	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47312	10.1371/journal.pone.0047312	http://dx.doi.org/10.1371/journal.pone.0047312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077590	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500042
J	Telford, RD; Cunningham, RB; Telford, RM; Kerrigan, J; Hickman, PE; Potter, JM; Abhayaratna, WP				Telford, Richard D.; Cunningham, Ross B.; Telford, Rohan M.; Kerrigan, Jennifer; Hickman, Peter E.; Potter, Julia M.; Abhayaratna, Walter P.			Effects of Changes in Adiposity and Physical Activity on Preadolescent Insulin Resistance: The Australian LOOK Longitudinal Study	PLOS ONE			English	Article							PREPUBERTAL CHILDREN; METABOLIC SYNDROME; MODEL ASSESSMENT; LIFE-STYLE; OBESITY; ADOLESCENTS; SENSITIVITY; GLUCOSE; PROJECT; TRENDS	Background: In a previous longitudinal analysis of our cohort as 8 to 10 year-olds, insulin resistance (IR) increased with age, but was not modified by changes in percent body fat (%BF), and was only responsive to changes in physical activity (PA) in boys. We aimed to determine whether these responses persisted as the children approached adolescence. Methods: In this prospective cohort study, 256 boys and 278 girls were assessed at ages 8, 10 and 12 years for fasting blood glucose and insulin, %BF (dual energy X-ray absorptiometry); PA (7-day pedometers), fitness (multistage run); and pubertal development (Tanner stage). Results: From age 8 to 12 years, the median homeostatic model of IR (HOMA-IR) doubled in boys and increased 250% in girls. By age 12, 23% of boys and 31% of girls had elevated IR, as indicated by HOMA-IR greater than 3. Longitudinal relationships, with important adjustments for covariates body weight, PA, %BF, Tanner score and socioeconomic status showed that, on average, for every 1 unit reduction of %BF, HOMA-IR was lowered by 2.2% (95% CI 0.04-4) in girls and 1.6% (95% CI 0-3.2) in boys. Furthermore, in boys but not girls, HOMA-IR was decreased by 3.5% (95% CI 0.5-6.5) if PA was increased by 2100 steps/day. Conclusion: Evidence that a quarter of our apparently healthy 12 year-old Australians possessed elevated IR suggests that community-based education and prevention strategies may be warranted. Responsiveness of IR to changes in %BF in both sexes during late preadolescence and to changes in PA in the boys provides a specific basis for targeting elevated IR. That body weight was a strong covariate of IR, independent of %BF, points to the importance of adjusting for weight in correctly assessing these relationships in growing children.	[Telford, Richard D.; Hickman, Peter E.; Potter, Julia M.; Abhayaratna, Walter P.] Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia; [Telford, Richard D.; Abhayaratna, Walter P.] Canberra Hosp, Clin Trials Unit, Canberra, ACT, Australia; [Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Telford, Rohan M.] Univ Canberra, Fac Hlth, Ctr Res & Act Publ Hlth, Canberra, ACT 2601, Australia; [Kerrigan, Jennifer; Hickman, Peter E.; Potter, Julia M.] Canberra Hosp, ACT Pathol, Canberra, ACT, Australia	Australian National University; Australian National University; Canberra Hospital; Australian National University; University of Canberra; Australian National University; Canberra Hospital	Telford, RD (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia.	rtelford@cominst.org.au		Abhayaratna, Walter/0000-0002-4908-0641; Telford, Rohan/0000-0002-1723-2559; Telford, Richard/0000-0003-4485-9362	Commonwealth Education Trust (London, UK); Board of Trustees; Canberra Hospital Salaried Staff Specialists Private Practice Fund	Commonwealth Education Trust (London, UK); Board of Trustees; Canberra Hospital Salaried Staff Specialists Private Practice Fund	Financial support was provided by the Commonwealth Education Trust (London, UK), the Board of Trustees and The Canberra Hospital Salaried Staff Specialists Private Practice Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics website, AUSTR BUR STAT INF P; Beets MW, 2005, MED SCI SPORT EXER, V37, P513, DOI 10.1249/01.MSS.0000155395.49960.31; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DUKE PM, 1980, PEDIATRICS, V66, P918; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Galway NW, 2006, INTRO MIXED MODELLIN, P1; Gardner DSL, 2008, PEDIATR DIABETES, V9, P214, DOI 10.1111/j.1399-5448.2008.00380.x; Gungor N, 2004, J PEDIATR-US, V144, P47, DOI 10.1016/j.jpeds.2003.09.045; Huang TTK, 2002, DIABETES CARE, V25, P1203, DOI 10.2337/diacare.25.7.1203; Jeffery AN, 2007, DIABETES CARE, V30, P2962, DOI 10.2337/dc07-0178; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Krekoukia M, 2007, METABOLISM, V56, P206, DOI 10.1016/j.metabol.2006.09.014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metcalf BS, 2008, ARCH DIS CHILD, V93, P772, DOI 10.1136/adc.2007.135012; Qin L, 2010, EUR J EPIDEMIOL, V25, P5, DOI 10.1007/s10654-009-9395-y; Southcott EK, 2010, CLIN CHIM ACTA, V411, P1421, DOI 10.1016/j.cca.2010.06.018; Srinivasan SR, 2006, HYPERTENSION, V48, P33, DOI 10.1161/01.HYP.0000226410.11198.f4; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Telford RD, 2009, ANN HUM BIOL, V36, P669, DOI 10.3109/03014460902960271; Telford RD, 2009, PEDIATR DIABETES, V10, P500, DOI 10.1111/j.1399-5448.2009.00513.x; Telford RD, 2009, J SCI MED SPORT, V12, P156, DOI 10.1016/j.jsams.2007.03.009; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Tresaco B, 2005, J PHYSIOL BIOCHEM, V61, P381, DOI 10.1007/BF03167055; Wilson DA, 2010, J PEDIATR-US, V156, P308, DOI 10.1016/j.jpeds.2009.08.038	24	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47438	10.1371/journal.pone.0047438	http://dx.doi.org/10.1371/journal.pone.0047438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071806	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500049
J	Yamamoto, H; Masters, JR; Dasgupta, P; Chandra, A; Popert, R; Freeman, A; Ahmed, A				Yamamoto, Hidekazu; Masters, John R.; Dasgupta, Prokar; Chandra, Ashish; Popert, Rick; Freeman, Alex; Ahmed, Aamir			CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; IN-VITRO; DIFFERENTIAL EXPRESSION; ENDOTHELIAL-CELLS; CANCER CELLS; IDENTIFICATION; CD133; SUBPOPULATION; MURINE; PURIFICATION	Stem cells may play a role in the development and maintenance of proliferative diseases of the prostate such as prostate cancer and benign prostatic hyperplasia. Cell membrane protein markers, CD49f, CD133 and CD44, have been shown to identify putative prostate stem cells, but a lack of consensus exists with regards to the most efficient marker(s) for stem-like cell identification. This study aimed to determine whether previously reported markers had equal capacity to select monolayer and spheroid colony-forming cells (CFCs), which were used as surrogate readouts of stem-like cells, and to characterize the expression of CD49f, CD44 and CD133 by flow cytometry and immunohistochemistry. In benign prostate cells, CD49f+, CD44+, and CD133+ cells represented 5.6 +/- 3.1%, 28.2 +/- 4.1% and 0.10 +/- 0.06% of total cells. Both monolayer- and spheroid-CFCs existed at a frequency of approximately 0.5% of total cells. CD49f+, CD44+, and CD133+ subpopulations differed significantly in their ability to select benign CFCs. The highest recovery of CFCs was achieved by CD49f+ selection (98%), whereas CD44+ or CD133+ selection led to poor CFC-recovery (17% and 3%, respectively). For the first time, we show highly efficient recovery of CFCs from advanced prostate cancer by CD49f+, but not by CD44+ or CD133+ selection. Furthermore, CD133 expression (AC133 clone) could not be detected in benign prostate cells by either immunohistochemistry or flow cytometry. We conclude that CD49f, but not previously described stem cell markers CD133 and CD44, to be optimal for selection of monolayer- and spheroid-CFCs in the benign and malignant prostate.	[Yamamoto, Hidekazu; Masters, John R.; Ahmed, Aamir] UCL, Div Surg & Intervent Sci, Prostate Canc Res Ctr, London, England; [Dasgupta, Prokar; Popert, Rick] Guys & St Thomas NHS Fdn Trust, Dept Urol, London, England; [Dasgupta, Prokar] Guys Hosp, MRC Ctr Transplantat, London SE1 9RT, England; [Chandra, Ashish] Guys & St Thomas NHS Fdn Trust, Dept Histopathol, London, England; [Freeman, Alex] Univ Coll London Hosp, Dept Histopathol, London, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Ahmed, A (corresponding author), UCL, Div Surg & Intervent Sci, Prostate Canc Res Ctr, London, England.	aamir.ahmed@ucl.ac.uk	Yamamoto, Hide/AAM-7208-2020	Yamamoto, Hide/0000-0003-0831-9174; Ahmed, Aamir/0000-0001-7405-5336; Dasgupta, Prokar/0000-0001-8690-0445	Prostate Cancer Research Centre charity; British Urological Foundation; Prostate Cancer Research Foundation; St. Peter's Trust for Kidney Bladder and Prostate Research; MRC Centre for Transplantation; National Institute for Health Research (NIHR) Biomedical Research Centre; MRC [G0600698] Funding Source: UKRI; Medical Research Council [G0600698] Funding Source: researchfish	Prostate Cancer Research Centre charity; British Urological Foundation; Prostate Cancer Research Foundation; St. Peter's Trust for Kidney Bladder and Prostate Research; MRC Centre for Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Prostate Cancer Research Centre charity, the British Urological Foundation, Prostate Cancer Research Foundation and St. Peter's Trust for Kidney Bladder and Prostate Research. Prokar Dasgupta acknowledges the support from the MRC Centre for Transplantation, and the National Institute for Health Research (NIHR) Biomedical Research Centre award to the King's Health Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, CLIN EXP METASTAS, V22, P391, DOI 10.1007/s10585-005-1262-y; BONKHOFF H, 1993, VIRCHOWS ARCH A, V422, P35, DOI 10.1007/BF01605130; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Collins AT, 2001, J CELL SCI, V114, P3865; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; DEWYNTER EA, 1995, STEM CELLS, V13, P524, DOI 10.1002/stem.5530130510; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; EMA H, 1990, BLOOD, V75, P1941; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Hadaschik BA, 2007, UROL ONCOL-SEMIN ORI, V25, P413, DOI 10.1016/j.urolonc.2007.05.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hermansen SK, 2011, J HISTOCHEM CYTOCHEM, V59, P391, DOI 10.1369/0022155411400867; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P823; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Isaacs JT, 2008, PROSTATE, V68, P1025, DOI 10.1002/pros.20763; KNOX JD, 1994, AM J PATHOL, V145, P167; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Liu AY, 2000, CANCER RES, V60, P3429; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; LIU AY, 1994, CANCER LETT, V76, P63, DOI 10.1016/0304-3835(94)90135-X; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Missol-Kolka E, 2011, PROSTATE, V71, P254, DOI 10.1002/pros.21239; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; WHITFORD P, 1990, BRIT J CANCER, V62, P971, DOI 10.1038/bjc.1990.419; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355	53	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e46979	10.1371/journal.pone.0046979	http://dx.doi.org/10.1371/journal.pone.0046979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23071686	Green Published, gold, Green Submitted			2022-12-25	WOS:000309809500028
J	Cao, LL; Ding, YY; Hung, N; Yu, KB; Ritz, A; Raphael, BJ; Salomon, AR				Cao, Lulu; Ding, Yiyuan; Hung, Norris; Yu, Kebing; Ritz, Anna; Raphael, Benjamin J.; Salomon, Arthur R.			Quantitative Phosphoproteomics Reveals SLP-76 Dependent Regulation of PAG and Src Family Kinases in T Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; TRANSMEMBRANE ADAPTER PROTEIN; N-TERMINAL REGION; MASS-SPECTROMETRY; PHOSPHOLIPASE C-GAMMA-1; PHOSPHORYLATION SITES; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOTYROSINE PHOSPHATASE; INTERLEUKIN-2 PRODUCTION; ENRICHED MICRODOMAINS	The SH2-domain-containing leukocyte protein of 76 kDa (SLP-76) plays a critical scaffolding role in T cell receptor (TCR) signaling. As an adaptor protein that contains multiple protein-binding domains, SLP-76 interacts with many signaling molecules and links proximal receptor stimulation to downstream effectors. The function of SLP-76 in TCR signaling has been widely studied using the Jurkat human leukaemic T cell line through protein disruption or site-directed mutagenesis. However, a wide-scale characterization of SLP-76-dependant phosphorylation events is still lacking. Quantitative profiling of over a hundred tyrosine phosphorylation sites revealed new modes of regulation of phosphorylation of PAG, PI3K, and WASP while reconfirming previously established regulation of Itk, PLC gamma, and Erk phosphorylation by SLP-76. The absence of SLP-76 also perturbed the phosphorylation of Src family kinases (SFKs) Lck and Fyn, and subsequently a large number of SFK-regulated signaling molecules. Altogether our data suggests unique modes of regulation of positive and negative feedback pathways in T cells by SLP-76, reconfirming its central role in the pathway.	[Cao, Lulu; Ding, Yiyuan; Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Hung, Norris; Salomon, Arthur R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Ritz, Anna; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Salomon, AR (corresponding author), Brown Univ, Dept Chem, Providence, RI 02912 USA.	drsalomon@gmail.com	Yu, Kebing/D-4585-2014	Ritz, Anna/0000-0002-7925-5369	National Institutes of Health [R01 AI083636-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI083636-01A1 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Beach D, 2007, J BIOL CHEM, V282, P2937, DOI 10.1074/jbc.M606697200; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Blundell MP, 2009, P NATL ACAD SCI USA, V106, P15738, DOI 10.1073/pnas.0904346106; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Bottini N, 2002, J BIOL CHEM, V277, P24220, DOI 10.1074/jbc.M202885200; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; CHAN AC, 1994, J IMMUNOL, V152, P4758; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Falco M, 2004, EUR J IMMUNOL, V34, P1663, DOI 10.1002/eji.200424886; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Henel G, 2006, BLOOD, V107, P4449, DOI 10.1182/blood-2005-06-2519; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; JOUNG I, 1995, P NATL ACAD SCI USA, V92, P5778, DOI 10.1073/pnas.92.13.5778; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Kong GH, 1996, MOL CELL BIOL, V16, P5026; Kumar L, 2002, P NATL ACAD SCI USA, V99, P884, DOI 10.1073/pnas.022619199; Kusano KI, 2008, ENDOTHELIUM-J ENDOTH, V15, P127, DOI 10.1080/10623320802125250; Li YQ, 2005, J BIOL CHEM, V280, P1217, DOI 10.1074/jbc.M409492200; Liang XQ, 2002, J BIOL CHEM, V277, P13732, DOI 10.1074/jbc.M200277200; Lock P, 1999, J BIOL CHEM, V274, P22775, DOI 10.1074/jbc.274.32.22775; Marie-Cardine A, 1999, J EXP MED, V189, P1181, DOI 10.1084/jem.189.8.1181; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Motto DG, 1996, J EXP MED, V183, P1937, DOI 10.1084/jem.183.4.1937; Mueller DL, 2003, NAT IMMUNOL, V4, P210, DOI 10.1038/ni0303-210; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; MUSTELIN T, 1995, EUR J IMMUNOL, V25, P942, DOI 10.1002/eji.1830250413; Newton-Nash DK, 1999, J IMMUNOL, V163, P682; Nguyen V, 2009, MOL CELL PROTEOMICS; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Qi Qian, 2007, Sci STKE, V2007, ppe39, DOI 10.1126/stke.3962007pe39; RIVEROLEZCANO OM, 1995, MOL CELL BIOL, V15, P5725; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shapiro MJ, 2008, J IMMUNOL, V181, P7055, DOI 10.4049/jimmunol.181.10.7055; Shim EK, 2004, FEBS LETT, V575, P35, DOI 10.1016/j.febslet.2004.07.090; Shim EK, 2011, J IMMUNOL, V186, P2926, DOI 10.4049/jimmunol.1001785; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Tessmer MS, 2007, INT IMMUNOL, V19, P391, DOI 10.1093/intimm/dxm004; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Vila JM, 2001, EUR J IMMUNOL, V31, P1191, DOI 10.1002/1521-4141(200104)31:4<1191::AID-IMMU1191>3.3.CO;2-8; Walk SF, 1998, EUR J IMMUNOL, V28, P2265, DOI 10.1002/(SICI)1521-4141(199808)28:08<2265::AID-IMMU2265>3.0.CO;2-P; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Yablonski D, 2001, ADV IMMUNOL, V79, P93, DOI 10.1016/S0065-2776(01)79003-7; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Yu KB, 2009, PROTEOMICS, V9, P3115, DOI 10.1002/pmic.200800899; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zhao RX, 2002, J BIOL CHEM, V277, P7882, DOI 10.1074/jbc.M111914200; Zhu MH, 2002, J BIOL CHEM, V277, P46151, DOI 10.1074/jbc.M208946200	83	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46725	10.1371/journal.pone.0046725	http://dx.doi.org/10.1371/journal.pone.0046725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071622	Green Submitted, Green Published, gold			2022-12-25	WOS:000309807700027
J	Koulintchenko, M; Vengrova, S; Eydmann, T; Arumugam, P; Dalgaard, JZ				Koulintchenko, Milana; Vengrova, Sonya; Eydmann, Trevor; Arumugam, Prakash; Dalgaard, Jacob Z.			DNA Polymerase alpha (swi7) and the Flap Endonuclease Fen1 (rad2) Act Together in the S-Phase Alkylation Damage Response in S. pombe	PLOS ONE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; BASE EXCISION-REPAIR; FISSION YEAST; INTRACHROMOSOMAL RECOMBINATION; SACCHAROMYCES-CEREVISIAE; REPLICATION ORIGINS; GENETIC-CONTROL; CHECKPOINT; MUTANTS; KINASE	Polymerase a is an essential enzyme mainly mediating Okazaki fragment synthesis during lagging strand replication. A specific point mutation in Schizosaccharomyces pombe polymerase alpha named swi7-1, abolishes imprinting required for mating-type switching. Here we investigate whether this mutation confers any genome-wide defects. We show that the swi7-1 mutation renders cells hypersensitive to the DNA damaging agents methyl methansulfonate (MMS), hydroxyurea (HU) and UV and incapacitates activation of the intra-S checkpoint in response to DNA damage. In addition we show that, in the swi7-1 background, cells are characterized by an elevated level of repair foci and recombination, indicative of increased genetic instability. Furthermore, we detect novel Swi1-, -Swi3- and Pol alpha- dependent alkylation damage repair intermediates with mobility on 2D-gel that suggests presence of single-stranded regions. Genetic interaction studies showed that the flap endonuclease Fen1 works in the same pathway as Pol alpha in terms of alkylation damage response. Fen1 was also required for formation of alkylation-damage specific repair intermediates. We propose a model to explain how Pol alpha, Swi1, Swi3 and Fen1 might act together to detect and repair alkylation damage during S-phase.	[Koulintchenko, Milana; Vengrova, Sonya; Eydmann, Trevor; Dalgaard, Jacob Z.] Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Coventry CV4 7AL, W Midlands, England; [Arumugam, Prakash] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Dalgaard, JZ (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Cell Biol, Gibbet Hill Campus, Coventry CV4 7AL, W Midlands, England.	j.z.dalgaard@warwick.ac.uk	Arumugam, Prakash/AAZ-6422-2020; Koulintchenko, Milana/J-7951-2018	Arumugam, Prakash/0000-0001-6217-8128; Koulintchenko, Milana/0000-0003-0931-2863; Dalgaard, Jacob/0000-0001-9545-7254	Marie Curie Cancer Care	Marie Curie Cancer Care	This work was supported by Marie Curie Cancer Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C., 1993, EXPT FISSION YEAST; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Burke D., 2000, METHODS YEAST GENETI; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Dalgaard JZ, 2012, TRENDS GENE IN PRESS; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; de Lahondes R, 2003, EUKARYOT CELL, V2, P910, DOI 10.1128/EC.2.5.910-921.2003; DURSO G, 1995, J CELL SCI, V108, P3109; EGEL R, 1984, P NATL ACAD SCI-BIOL, V81, P3481, DOI 10.1073/pnas.81.11.3481; EGEL R, 1987, CURR GENET, V12, P429, DOI 10.1007/BF00434820; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Holmes AM, 2005, MOL CELL BIOL, V25, P303, DOI 10.1128/MCB.25.1.303-311.2005; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; Huberman JA, 1997, METHODS, V13, P247, DOI 10.1006/meth.1997.0524; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kanamitsu K, 2007, GENES GENET SYST, V82, P489, DOI 10.1266/ggs.82.489; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KLEIN HL, 1995, BIOESSAYS, V17, P147, DOI 10.1002/bies.950170210; Kobayashi H, 1999, PHOTOCHEM PHOTOBIOL, V69, P226, DOI 10.1111/j.1751-1097.1999.tb03278.x; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kumar S, 2004, J BIOL CHEM, V279, P43574, DOI 10.1074/jbc.M407819200; Kunz C, 2001, J MOL BIOL, V313, P241, DOI 10.1006/jmbi.2001.5054; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Luche Douglas D., 2009, V521, P437, DOI [10.1007/978-1-60327-817-5_24, 10.1007/978-1-60327-815-7_24]; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Memisoglu A, 2000, J BACTERIOL, V182, P2104, DOI 10.1128/JB.182.8.2104-2112.2000; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Noguchi Eishi, 2009, V521, P493, DOI [10.1007/978-1-60327-817-5_28, 10.1007/978-1-60327-815-7_28]; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; Osman Fekret, 2009, V521, P535, DOI [10.1007/978-1-60327-817-5_31, 10.1007/978-1-60327-815-7_31]; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Sayrac S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001328; Seeberg E., 1997, BASE EXCISION REPAIR, P151; SINGH J, 1993, NATURE, V361, P271, DOI 10.1038/361271a0; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47091	10.1371/journal.pone.0047091	http://dx.doi.org/10.1371/journal.pone.0047091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071723	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700053
J	Najafzadeh, M; Marra, CA; Lynd, LD; Sadatsafavi, M; FitzGerald, JM; McManus, B; Sin, D				Najafzadeh, Mehdi; Marra, Carlo A.; Lynd, Larry D.; Sadatsafavi, Mohsen; FitzGerald, J. Mark; McManus, Bruce; Sin, Don			Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COST-EFFECTIVENESS; UNITED-STATES; EXACERBATIONS; PREVALENCE; MANAGEMENT; DIAGNOSIS; PREVENTION; BIOMARKERS; TRENDS	Background: Chronic obstructive pulmonary disease (COPD) is a growing economic burden worldwide. Smoking cessation is thought to be the single most effective way of reducing the economic burden of COPD. The impact of other strategies such as interventions that predict risk of disease, reduce progression of disease, or reduce exacerbations has not been systematically studied. Objectives: We estimated the economic and clinical burden of COPD over the next 25 years in Canada and the impact of three potential interventions (screening test for predisposition to COPD, new drugs to avoid progression into more severe disease stages, and predictive test for exacerbations) on COPD burden. Methods: Using a dynamic simulation model, we projected the total burden of COPD (cost, morbidity, and mortality) from 2011 to 2035 using the population of Canada as a case study. The model stratified population based on sex, age, smoking status, respiratory symptoms, and their COPD stage. The cost and quality adjusted life years (QALYs) associated with each intervention were estimated. Results: The model indicates that annual societal cost of COPD is $4.52 billion (B) Canadian dollars in 2011 and will reach $3.61B ($7.33B undiscounted) per year in 2035. Over the next 25 years, COPD will be responsible for approximately $101.4B in societal costs ($147.5B undiscounted) and 12.9 million QALYs lost (19.0 million undiscounted). Our results suggested that the best strategy to reduce the financial burden of COPD is by reducing exacerbations. Smoking cessation, while it is the cornerstone of COPD prevention, has only a modest effect in attenuating the financial burden of COPD over the next 25 years in Western countries such as Canada. Conclusion: Our data suggest that any intervention that can reduce the number of exacerbations has a substantial impact on morbidity and costs of COPD and should be considered in conjunction with the ongoing efforts to reduce smoking rates.	[FitzGerald, J. Mark; Sin, Don] Univ British Columbia, Div Resp Med, Vancouver, BC V5Z 1M9, Canada; [Najafzadeh, Mehdi] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Marra, Carlo A.; Lynd, Larry D.; Sadatsafavi, Mohsen] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada; [Marra, Carlo A.; Lynd, Larry D.; Sadatsafavi, Mohsen] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [McManus, Bruce] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [McManus, Bruce] Prevent Organ Failure Ctr Excellence, Vancouver, BC, Canada; [FitzGerald, J. Mark; McManus, Bruce; Sin, Don] Inst Heart & Lung Hlth, UBC James Hogg Res Labs, Vancouver, BC, Canada	University of British Columbia; Harvard University; Harvard Medical School; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Sin, D (corresponding author), Univ British Columbia, Div Resp Med, Vancouver, BC V5Z 1M9, Canada.	don.sin@hli.ubc.ca	Marra, Carlo/AAE-4904-2021; Sin, Don/AAC-2219-2021; Sadatsafayi, Mohsen/AAZ-1593-2020	Marra, Carlo/0000-0002-2625-2121; Sadatsafayi, Mohsen/0000-0002-0419-7862; Lynd, Larry/0000-0002-7622-3919				Akazawa M, 2008, RESP MED, V102, P1744, DOI 10.1016/j.rmed.2008.07.009; [Anonymous], 2010, POP PROJ CAN PROV TE; Bize R, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004705.pub3; Brennan A, 2006, HEALTH ECON, V15, P1295, DOI 10.1002/hec.1148; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Camp PG, 2008, CAN RESPIR J, V15, P417, DOI 10.1155/2008/120374; Chapman KR, 2003, RESP MED, V97, pS23, DOI 10.1016/S0954-6111(03)80022-7; Dahl Morten, 2009, Int J Chron Obstruct Pulmon Dis, V4, P157; Gamble E, 2007, EUR RESPIR J, V30, P467, DOI 10.1183/09031936.00013006; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Hoogendoorn M, 2005, EUR RESPIR J, V26, P223, DOI 10.1183/09031936.05.00122004; Hoogendoorn M, 2011, VALUE HEALTH, V14, P1039, DOI 10.1016/j.jval.2011.06.008; Hoogendoorn M, 2010, THORAX, V65, P711, DOI 10.1136/thx.2009.131631; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Johnson JA, 2000, MED CARE, V38, P115, DOI 10.1097/00005650-200001000-00013; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Liu JS, 1998, J AM STAT ASSOC, V93, P1032, DOI 10.2307/2669847; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mapel DW, 2008, VALUE HEALTH, V11, P628, DOI 10.1111/j.1524-4733.2007.00305.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Minino AM, 2008, NATL VITAL STAT REPO, V59; Molken MPMHRV, 2006, CHEST, V130, P1117, DOI 10.1378/chest.130.4.1117; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Patel ARC, 2010, SEMIN RESP CRIT CARE, V31, P267, DOI 10.1055/s-0030-1254067; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Ramsey SD, 2004, AM J MED, V117, p3S, DOI 10.1016/j.amjmed.2004.10.016; Schneider Antonius, 2009, BMC Pulm Med, V9, P31, DOI 10.1186/1471-2466-9-31; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Spencer M, 2005, PHARMACOECONOMICS, V23, P619, DOI 10.2165/00019053-200523060-00008; Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336; Tashkin DP, 2009, RESP MED, V13, P13; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8	36	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46746	10.1371/journal.pone.0046746	http://dx.doi.org/10.1371/journal.pone.0046746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071626	Green Published, Green Submitted, gold			2022-12-25	WOS:000309807700028
J	Bolognin, S; Pasqualetto, F; Mucignat-Caretta, C; Scancar, J; Milacic, R; Zambenedetti, P; Cozzi, B; Zatta, P				Bolognin, Silvia; Pasqualetto, Federica; Mucignat-Caretta, Carla; Scancar, Janez; Milacic, Radmila; Zambenedetti, Pamela; Cozzi, Bruno; Zatta, Paolo			Effects of a Copper-Deficient Diet on the Biochemistry, Neural Morphology and Behavior of Aged Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MOUSE MODEL; NEUROLOGICAL DISORDERS; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; IRON-METABOLISM; BRAIN IRON; METAL-IONS; MALE RATS	Copper dyshomeostasis has been suggested as an aetiological risk factor for some neurodegenerative diseases, such as Alzheimer's disease. However, the precise mechanism at the base of this involvement is still obscure. In this work, we show the effects of a copper-deficient diet in aged CD1 mice and the influence of such a diet on: a) the concentration of various metal ions (aluminium, copper, iron, calcium, zinc) in the main organs and in different brain areas; b) the alteration of metallothioneins I-II and tyrosine hydroxylase immunopositivity in the brain; c) behavioural tests (open field, pole, predatory aggression, and habituation/dishabituation smell tests). Our data suggested that the copper-deficiency was able to produce a sort of "domino effect" which altered the concentration of the other tested metal ions in the main organs as well as in the brain, without, however, significantly affecting the animal behaviour.	[Cozzi, Bruno] Univ Padua, Dept Expt Vet Sci, Legnaro, PD, Italy; [Bolognin, Silvia; Pasqualetto, Federica; Zatta, Paolo] Univ Padua, Dept Biol, Metalloprot Unit, CNR Inst Biomed Technol, Padua, Italy; [Mucignat-Caretta, Carla] Univ Padua, Dept Human Anat & Physiol, Padua, Italy; [Scancar, Janez; Milacic, Radmila] Jozef Stefan Inst, Dept Environm Sci, Ljubljana, Slovenia; [Zambenedetti, Pamela] Gen Hosp, Div Pathol, Dolo, VE, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Padua; University of Padua; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Cozzi, B (corresponding author), Univ Padua, Dept Expt Vet Sci, Legnaro, PD, Italy.	bruno.cozzi@unipd.it; zatta@bio.unipd.it	Mucignat, Carla/N-6299-2017; Cozzi, Bruno/H-9618-2019; scancar, janez/G-6191-2018	Mucignat, Carla/0000-0001-5307-0414; Cozzi, Bruno/0000-0002-7531-7040; scancar, janez/0000-0002-8018-1715; Bolognin, Silvia/0000-0002-1399-2999	Italian Ministry of Education, University and Research [PRIN 2007]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by PRIN 2007 grants from the Italian Ministry of Education, University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bolognin S, 2009, MED RES REV, V29, P547, DOI 10.1002/med.20148; Bonda DJ, 2011, METALLOMICS, V3, P267, DOI 10.1039/c0mt00074d; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; CHAO JCJ, 1994, J NUTR, V124, P789, DOI 10.1093/jn/124.6.789; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Crouch PJ, 2006, DRUG NEWS PERSPECT, V19, P469, DOI 10.1358/dnp.2006.19.8.1021492; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Drago D, 2008, CURR ALZHEIMER RES, V5, P500, DOI 10.2174/156720508786898479; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; Gybina AA, 2009, NUTR NEUROSCI, V12, P114, DOI 10.1179/147683009X423265; Harris ZL, 1998, AM J CLIN NUTR, V67, p972S, DOI 10.1093/ajcn/67.5.972S; Johnson WT, 2009, J NUTR BIOCHEM, V20, P248, DOI 10.1016/j.jnutbio.2008.02.009; JOHNSON WT, 1993, BIOCHIM BIOPHYS ACTA, V1175, P263, DOI 10.1016/0167-4889(93)90215-B; Kang YJ, 2007, J NUTR BIOCHEM, V18, P714, DOI 10.1016/j.jnutbio.2006.10.009; Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903; Kessler H, 2008, J NEURAL TRANSM, V115, P1651, DOI 10.1007/s00702-008-0136-2; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Koumura A, 2009, BRAIN RES, V1292, P148, DOI 10.1016/j.brainres.2009.07.050; Kurosaki R, 2004, PHARMACOL BIOCHEM BE, V78, P143, DOI 10.1016/j.pbb.2004.03.006; LOEFFLER DA, 1994, ALZ DIS ASSOC DIS, V8, P190, DOI 10.1097/00002093-199408030-00005; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237; Maret W, 2008, EXP GERONTOL, V43, P363, DOI 10.1016/j.exger.2007.11.005; MEDEIROS DM, 1993, P SOC EXP BIOL MED, V203, P262, DOI 10.3181/00379727-203-43599; Miyoshi Isao, 2004, Br J Haematol, V125, P106, DOI 10.1046/j.1365-2141.2004.04724.x; Monnot AD, 2012, EXP BIOL MED, V237, P327, DOI 10.1258/ebm.2011.011170; Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085; Mucignat-Caretta C, 2004, NEUROBIOL DIS, V16, P386, DOI 10.1016/j.nbd.2004.03.007; Murko S, 2007, J INORG BIOCHEM, V101, P1234, DOI 10.1016/j.jinorgbio.2007.06.013; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Penland JG, 2004, J NUTR, V134, P1984, DOI 10.1093/jn/134.8.1984; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; PROHASKA JR, 1993, J NUTR, V123, P1226, DOI 10.1093/jn/123.7.1226; Pyatskowit JW, 2008, J NUTR, V138, P1880, DOI 10.1093/jn/138.10.1880; Pyatskowit JW, 2008, COMP BIOCHEM PHYS C, V147, P316, DOI 10.1016/j.cbpc.2007.11.008; Quinn JF, 2009, EXPERT REV NEUROTHER, V9, P631, DOI 10.1586/ERN.09.27; Reeves PG, 2004, J NUTR, V134, P1953, DOI 10.1093/jn/134.8.1953; Reeves PG, 2004, J NUTR, V134, P416, DOI 10.1093/jn/134.2.416; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; SCHEUHAMMER AM, 1991, METHOD ENZYMOL, V205, P78; SCHEUHAMMER AM, 1986, TOXICOL APPL PHARM, V82, P417, DOI 10.1016/0041-008X(86)90277-2; Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; White AR, 2006, EXPERT REV NEUROTHER, V6, P711, DOI 10.1586/14737175.6.5.711; WILDMAN REC, 1995, P SOC EXP BIOL MED, V210, P43, DOI 10.3181/00379727-210-43923; Yang HY, 2010, TOXICON, V55, P1291, DOI 10.1016/j.toxicon.2010.01.022; Yoshihara D, 2012, FREE RADICAL RES, V46, P750, DOI 10.3109/10715762.2012.673223; Zatta P, 2007, BRAIN RES REV, V54, P19, DOI 10.1016/j.brainresrev.2006.10.001	55	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47063	10.1371/journal.pone.0047063	http://dx.doi.org/10.1371/journal.pone.0047063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071712	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200074
J	Gantz, JA; Palpant, NJ; Welikson, RE; Hauschka, SD; Murry, CE; Laflamme, MA				Gantz, Jay A.; Palpant, Nathan J.; Welikson, Robert E.; Hauschka, Stephen D.; Murry, Charles E.; Laflamme, Michael A.			Targeted Genomic Integration of a Selectable Floxed Dual Fluorescence Reporter in Human Embryonic Stem Cells	PLOS ONE			English	Article							CARDIAC-MUSCLE; CRE RECOMBINASE; EXPRESSION; SKELETAL; CARDIOMYOCYTES; SPECIFICATION; SURVIVAL; MOUSE	The differentiation of pluripotent stem cells involves transition through a series of specific cell states. To understand these cell fate decisions, the field needs improved genetic tools for the labeling, lineage tracing and selection of specific cell types from heterogeneous differentiating populations, particularly in the human embryonic stem cell (hESC) system. We used zinc finger nuclease technology to stably insert a unique, selectable, floxed dual-fluorescence reporter transgene into the AAVS1 locus of RUES2 hESCs. This "stoplight" transgene, mTmG-2a-Puro, strongly expresses membrane-localized tdTomato red fluorescent protein until Cre-dependent recombination causes a switch to expression of membrane-localized enhanced green fluorescent protein (eGFP) and puromycin resistance. First, to validate this system in undifferentiated cells, we transduced transgenic hESCs with a lentiviral vector driving constitutive expression of Cre and observed the expected phenotypic switch. Next, to demonstrate its utility in lineage-specific selection, we transduced differentiated cultures with a lentiviral vector in which the striated muscle-specific CK7 promoter drives Cre expression. This yielded near-homogenous populations of eGFP(+) hESC-derived cardiomyocytes. The mTmg-2a-Puro hESC line described here represents a useful new tool for both in vitro fate mapping studies and the selection of useful differentiated cell types. Citation: Gantz JA, Palpant NJ, Welikson RE, Hauschka SD, Murry CE, et al. (2012) Targeted Genomic Integration of a Selectable Floxed Dual Fluorescence Reporter in Human Embryonic Stem Cells. PLoS ONE 7(10): e46971. doi:10.1371/journal.pone.0046971	[Palpant, Nathan J.; Murry, Charles E.; Laflamme, Michael A.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Gantz, Jay A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Welikson, Robert E.; Hauschka, Stephen D.] Univ Washington, Dept Biochem, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Laflamme, MA (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	laflamme@u.washington.edu	Gantz, Jay A/B-3581-2009; Palpant, Nathan/B-1641-2017; Laflamme, Michael/AAV-6791-2021	Palpant, Nathan/0000-0002-9334-8107; Laflamme, Michael/0000-0001-5908-880X	National Institutes of Health [R01-HL064387, P01-HL094374, R01-HL084642, P01-GM81619, U01-HL100405, RO1-AR18860, 1PO1-NS046788]; Muscular Dystrophy Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, P01HL094374, R01HL064387, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS046788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health grant numbers R01-HL064387 ( MAL and CEM), P01-HL094374 (MAL and CEM), R01-HL084642 (CEM), P01-GM81619 (CEM) and U01-HL100405 (MAL and CEM), and RO1-AR18860, 1PO1-NS046788, and the Muscular Dystrophy Association (SDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Moore JC, 2005, REPROD TOXICOL, V20, P377, DOI 10.1016/j.reprotox.2005.04.012; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy Andras, 2009, V530, P365, DOI 10.1007/978-1-59745-471-1_19; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; van Rensburg R, 2012, GENE THER; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	19	26	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46971	10.1371/journal.pone.0046971	http://dx.doi.org/10.1371/journal.pone.0046971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071682	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200059
J	Gout, S; Brambilla, E; Boudria, A; Drissi, R; Lantuejoul, S; Gazzeri, S; Eymin, B				Gout, Stephanie; Brambilla, Elisabeth; Boudria, Asma; Drissi, Romain; Lantuejoul, Sylvie; Gazzeri, Sylvie; Eymin, Beatrice			Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma	PLOS ONE			English	Article							SR PROTEINS; RON PROTOONCOGENE; CANCER; APOPTOSIS; KINASE; SC35; PROLIFERATION; HISTOLOGY; SF2/ASF; E2F1	Splicing abnormalities frequently occur in cancer. A key role as splice site choice regulator is played by the members of the SR (Ser/Arg-rich) family of proteins. We recently demonstrated that SRSF2 is involved in cisplatin-mediated apoptosis of human lung carcinoma cell lines. In this study, by using immunohistochemistry, we demonstrate that the SR proteins SRSF1 and SRSF2 are overexpressed in 63% and 65% of lung adenocarcinoma (ADC) as well as in 68% and 91% of squamous cell lung carcinoma (SCC), respectively, compared to normal lung epithelial cells. In addition, we show that SRSF2 overexpression correlates with high level of phosphorylated SRSF2 in both ADC (p<0.0001) and SCC (p = 0.02), indicating that SRSF2 mostly accumulates under a phosphorylated form in lung tumors. Consistently, we further show that the SR-phosphorylating kinases SRPK1 and SRPK2 are upregulated in 92% and 94% of ADC as well as in 72% and 68% of SCC, respectively. P-SRSF2 and SRPK2 scores are correlated in ADC (p = 0.01). Using lung adenocarcinoma cell lines, we demonstrate that SRSF1 overexpression leads to a more invasive phenotype, evidenced by activation of PI3K/AKT and p42/44MAPK signaling pathways, increased growth capacity in soft agar, acquisition of mesenchymal markers such as E cadherin loss, vimentin and fibronectin gain, and increased resistance to chemotherapies. Finally, we provide evidence that high levels of SRSF1 and P-SRSF2 proteins are associated with extensive stage (III-IV) in ADC. Taken together, these results indicate that a global deregulation of pre-mRNA splicing regulators occurs during lung tumorigenesis and does not predict same outcome in both Non Small Cell Lung Carcinoma histological sub-types, likely contributing to a more aggressive phenotype in adenocarcinoma.	[Gout, Stephanie; Brambilla, Elisabeth; Boudria, Asma; Drissi, Romain; Lantuejoul, Sylvie; Gazzeri, Sylvie; Eymin, Beatrice] INSERM, Equipe Bases Mol Progress Canc Poumon 2, U823, Grenoble, France; [Gout, Stephanie; Brambilla, Elisabeth; Boudria, Asma; Drissi, Romain; Lantuejoul, Sylvie; Gazzeri, Sylvie; Eymin, Beatrice] Univ Grenoble 1, Inst Albert Bonniot, Grenoble, France; [Brambilla, Elisabeth; Lantuejoul, Sylvie] Ctr Hosp Univ, Dept Pathol, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Eymin, B (corresponding author), INSERM, Equipe Bases Mol Progress Canc Poumon 2, U823, Grenoble, France.	Beatrice.Eymin@ujf-grenoble.fr	Lantuejoul, Sylvie/N-4671-2013; Eymin, Beatrice/M-1962-2013; eymin, beatrice/U-4670-2019; lantuejoul, sylvie/N-9315-2017; Brambilla, Elisabeth MP/L-8796-2013; gazzeri, sylvie/U-4669-2019; gazzeri, sylvie/M-1961-2013	Eymin, Beatrice/0000-0002-7311-3810; eymin, beatrice/0000-0002-7311-3810; lantuejoul, sylvie/0000-0003-4310-6975; gazzeri, sylvie/0000-0001-5817-1839; gazzeri, sylvie/0000-0001-5817-1839	Ligue Nationale contre le Cancer (Equipe Labellisee Ligue); Comite Departemental Isere; Comite Departemental Savoie de la Ligue Nationale contre le Cancer; Institut National du Cancer/Direction de l'Hospitalisation et Organisation des Soins (INca/DHOS) (Appel d'Offre Recherche Translationnelle); Fondation de France (Projet Grande Ampleur); Association pour la Recherche Contre le Cancer	Ligue Nationale contre le Cancer (Equipe Labellisee Ligue); Comite Departemental Isere; Comite Departemental Savoie de la Ligue Nationale contre le Cancer; Institut National du Cancer/Direction de l'Hospitalisation et Organisation des Soins (INca/DHOS) (Appel d'Offre Recherche Translationnelle); Fondation de France (Projet Grande Ampleur); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by the Ligue Nationale contre le Cancer (Equipe Labellisee Ligue 2007), by the Comite Departemental Isere and Comite Departemental Savoie de la Ligue Nationale contre le Cancer, by the Institut National du Cancer/Direction de l'Hospitalisation et Organisation des Soins (INca/DHOS) (Appel d'Offre Recherche Translationnelle 2010), by the Fondation de France (Projet Grande Ampleur) and by the Association pour la Recherche Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Ezponda T, 2010, CLIN CANCER RES, V16, P4113, DOI 10.1158/1078-0432.CCR-10-0076; Fischer DC, 2004, ONCOL REP, V11, P1085; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Ghigna C, 2010, RNA BIOL, V7, P495, DOI 10.4161/rna.7.4.12744; Groeger AM, 2004, HISTOPATHOLOGY, V44, P54, DOI 10.1111/j.1365-2559.2004.01750.x; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Hirata T, 1998, CANCER RES, V58, P1108; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Ko TK, 2001, J CELL SCI, V114, P2591; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Merdzhanova G, 2010, ONCOGENE, V29, P5392, DOI 10.1038/onc.2010.281; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Neal JW, 2010, ONCOLOGIST, V15, P3, DOI 10.1634/theoncologist.2009-0306; Piekielko-Witkowska A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013690; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shintani Y, 2011, ANN THORAC SURG, V92, P1794, DOI 10.1016/j.athoracsur.2011.07.032; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Travis WD., 2004, TRAVIS WB WHO CLASSI; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wheatley-Price P, 2010, ANN ONCOL, V21, P2023, DOI 10.1093/annonc/mdq067; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xi LQ, 2008, NUCLEIC ACIDS RES, V36, P6535, DOI 10.1093/nar/gkn697; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	45	102	107	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e46539	10.1371/journal.pone.0046539	http://dx.doi.org/10.1371/journal.pone.0046539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071587	Green Published, gold, Green Submitted			2022-12-25	WOS:000312385200031
J	van de Waal, E; Whiten, A				van de Waal, Erica; Whiten, Andrew			Spontaneous Emergence, Imitation and Spread of Alternative Foraging Techniques among Groups of Vervet Monkeys	PLOS ONE			English	Article							MIRROR NEURONS; ANIMALS; CULTURE	Animal social learning has become a subject of broad interest, but demonstrations of bodily imitation in animals remain rare. Based on Voelkl and Huber's study of imitation by marmosets, we tested four groups of semi-captive vervet monkeys presented with food in modified film canisters ("aethipops'). One individual was trained to take the tops off canisters in each group and demonstrated five openings to them. In three groups these models used their mouth to remove the lid, but in one of the groups the model also spontaneously pulled ropes on a canister to open it. In the last group the model preferred to remove the lid with her hands. Following these spontaneous differentiations of foraging techniques in the models, we observed the techniques used by the other group members to open the canisters. We found that mouth opening was the most common technique overall, but the rope and hands methods were used significantly more in groups they were demonstrated in than in groups where they were not. Our results show bodily matching that is conventionally described as imitation. We discuss the relevance of these findings to discoveries about mirror neurons, and implications of the identity of the model for social transmission.	[van de Waal, Erica; Whiten, Andrew] Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [van de Waal, Erica; Whiten, Andrew] Univ St Andrews, Sch Psychol, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [van de Waal, Erica; Whiten, Andrew] Swart Mfolozi, Mawana Game Reserve, Inkawu Vervet Project, Kwa Zulu, South Africa	University of St Andrews; University of St Andrews	Whiten, A (corresponding author), Univ St Andrews, Sch Psychol, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	aw2@st-andrews.ac.uk		Whiten, Andrew/0000-0003-2426-5890; van de Waal, Erica/0000-0001-7778-418X	Swiss National Science Foundation [Sinergia: 332 CRSI33_133040]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded and approved by the Swiss National Science Foundation (Sinergia: 332 CRSI33_133040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins CK, 1996, J COMP PSYCHOL, V110, P316, DOI 10.1037/0735-7036.110.3.316; Buttelmann D, 2007, DEVELOPMENTAL SCI, V10, pF31, DOI 10.1111/j.1467-7687.2007.00630.x; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; Claidiere N, ANIM BEHAV IN PRESS; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; Ferrari PF, 2011, PRIMATE MIND BUILT C, P13; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; HEYES CM, 1993, ANIM BEHAV, V46, P999, DOI 10.1006/anbe.1993.1281; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hopper LM, 2012, OXFORD HDB COMP EVOL, P451; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M., 2012, PRIMATE MIND BUILT C, P32; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Keysers C., 2011, EMPATHIC BRAIN DISCO; Keysers C, 2012, NATURE, V482, P158, DOI 10.1038/482158a; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Price EE, 2012, HDB COMP COGNITION, P862; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024400; Shettleworth S. J., 2009, COGNITION EVOLUTION; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Thorndike EL, 1898, PSYCHOL REV MONOG, V2, P51; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thorpe, 1963, LEARNING INSTINCT AN; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; van de Waal E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035694; van de Waal E, 2011, ANIM BEHAV, V81, P433, DOI 10.1016/j.anbehav.2010.11.013; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; Voelkl B, 2000, ANIM BEHAV, V60, P195, DOI 10.1006/anbe.2000.1457; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Whiten A., 2012, CULTURE EVOLVES; Whiten A, 2012, EVOLUTION PRIMATE SO, P681; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Zentall TR, 1996, PSYCHOL SCI, V7, P343, DOI 10.1111/j.1467-9280.1996.tb00386.x; Zentall TR, 2004, LEARN BEHAV, V32, P15, DOI 10.3758/BF03196003	43	23	23	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47008	10.1371/journal.pone.0047008	http://dx.doi.org/10.1371/journal.pone.0047008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071698	Green Published, Green Submitted, gold			2022-12-25	WOS:000312385200067
J	Babron, MC; de Tayrac, M; Rutledge, DN; Zeggini, E; Genin, E				Babron, Marie-Claude; de Tayrac, Marie; Rutledge, Douglas N.; Zeggini, Eleftheria; Genin, Emmanuelle			Rare and Low Frequency Variant Stratification in the UK Population: Description and Impact on Association Tests	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ASSOCIATION; LARGE-SCALE; SUSCEPTIBILITY; MODEL; STRATEGIES; ANCESTRY; DISEASE; MARKERS; SAMPLES	Although variations in allele frequencies at common SNPs have been extensively studied in different populations, little is known about the stratification of rare variants and its impact on association tests. In this paper, we used Affymetrix 500K genotype data from the WTCCC to investigate if variants in three different frequency categories (below 1%, between 1 and 5%, above 5%) show different stratification patterns in the UK population. We found that these patterns are indeed different. The top principal component extracted from the rare variant category shows poor correlations with any principal component or combination of principal components from the low frequency or common variant categories. These results could suggest that a suitable solution to avoid false positive association due to population stratification would involve adjusting for the respective PCs when testing for variants in different allele frequency categories. However, we found this was not the case both on type 2 diabetes data and on simulated data. Indeed, adjusting rare variant association tests on PCs derived from rare variants does no better to correct for population stratification than adjusting on PCs derived from more common variants. Mixed models perform slightly better for low frequency variants than PC based adjustments but less well for the rarest variants. These results call for the need of new methodological developments specifically devoted to address rare variant stratification issues in association tests.	[Babron, Marie-Claude; de Tayrac, Marie; Genin, Emmanuelle] INSERM, UMRS 946, Paris, France; [Babron, Marie-Claude; de Tayrac, Marie; Genin, Emmanuelle] Univ Paris Diderot, Inst Univ Hematol, Paris, France; [Rutledge, Douglas N.] AgroParisTech, Paris, France; [Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Cambridge, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; Wellcome Trust Sanger Institute	Genin, E (corresponding author), INSERM, UMRS 946, Paris, France.	emmanuelle.genin@inserm.fr	de Tayrac, Marie/AAG-7800-2020; Genin, Emmanuelle/C-4974-2013; Rutledge, Douglas/AAY-5362-2021	Genin, Emmanuelle/0000-0003-4117-2813; Babron, Marie-Claude/0000-0002-4100-0299; Zeggini, Eleftheria/0000-0003-4238-659X; Rutledge, Douglas/0000-0001-5634-0766	Wellcome Trust [076113, 085475]; French Government	Wellcome Trust(Wellcome TrustEuropean Commission); French Government	Funding for the project was provided by the Wellcome Trust under award 076113 and 085475. EG was funded by a fellowship from the French Government for her stay in Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Casella G., 2021, STAT INFERENCE; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Fearnhead NS, 2005, CELL CYCLE, V4, P521, DOI 10.4161/cc.4.4.1591; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Guan WH, 2009, GENET EPIDEMIOL, V33, P508, DOI 10.1002/gepi.20403; Hao K, 2004, EUR J HUM GENET, V12, P1001, DOI 10.1038/sj.ejhg.5201273; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lu TT, 2009, EUR J HUM GENET; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathieson I, 2012, NAT GENET; McCarthy MI, 2009, GENOME MED, V1, DOI 10.1186/gm66; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tiwari HK, 2008, HUM HERED, V66, P67, DOI 10.1159/000119107; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003392; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	49	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46519	10.1371/journal.pone.0046519	http://dx.doi.org/10.1371/journal.pone.0046519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071581	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300033
J	Bag, S; Mitter, N; Eid, S; Pappu, HR				Bag, Sudeep; Mitter, Neena; Eid, Sahar; Pappu, Hanu R.			Complementation between Two Tospoviruses Facilitates the Systemic Movement of a Plant Virus Silencing Suppressor in an Otherwise Restrictive Host	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; CUCUMBER-MOSAIC-VIRUS; MIXED INFECTIONS; TOMATO; RNA; PROTEIN; BUNYAVIRIDAE; SYNERGISM; THRIPS; NSS	Background: New viruses pathogenic to plants continue to emerge due to mutation, recombination, or reassortment among genomic segments among individual viruses. Tospoviruses cause significant economic damage to a wide range of crops in many parts of the world. The genetic or molecular basis of the continued emergence of new tospoviruses and new hosts is not well understood though it is generally accepted that reassortment and/or genetic complementation among the three genomic segments of individual viruses could be contributing to this variability since plants infected with more than one tospovirus are not uncommon in nature. Methodology/Principal Findings: Two distinct and economically important tospoviruses, Iris yellow spot virus (IYSV) and Tomato spotted wilt virus (TSWV), were investigated for inter-virus interactions at the molecular level in dually-infected plants. Datura (Datura stramonium) is a permissive host for TSWV, while it restricts the movement of IYSV to inoculated leaves. In plants infected with both viruses, however, TSWV facilitated the selective movement of the viral gene silencing suppressor (NSs) gene of IYSV to the younger, uninoculated leaves. The small RNA expression profiles of IYSV and TSWV in single- and dually-infected datura plants showed that systemic leaves of dually-infected plants had reduced levels of TSWV N gene-specific small interfering RNAs (siRNAs). No TSWV NSs-specific siRNAs were detected either in the inoculated or systemic leaves of dually-infected datura plants indicating a more efficient suppression of host silencing machinery in the presence of NSs from both viruses as compared to the presence of only TSWV NSs. Conclusion/Significance: Our study identifies a new role for the viral gene silencing suppressor in potentially modulating the biology and host range of viruses and underscores the importance of virally-coded suppressors of gene silencing in virus infection of plants. This is the first experimental evidence of functional complementation between two distinct tospoviruses in the Bunyaviridae family.	[Bag, Sudeep; Eid, Sahar; Pappu, Hanu R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Mitter, Neena] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	Washington State University; University of Queensland	Pappu, HR (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	hrp@wsu.edu	mitter, neena/D-1862-2013	mitter, neena/0000-0001-6146-6179; Bag, Sudeep/0000-0003-3724-7341	U.S. Department of Agriculture NIFA Specialty Crops Research Initiative; National Onion Association of the USA	U.S. Department of Agriculture NIFA Specialty Crops Research Initiative; National Onion Association of the USA	This research was supported in part by the U.S. Department of Agriculture NIFA Specialty Crops Research Initiative. The authors gratefully acknowledge the financial support of the National Onion Association of the USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This study was funded in part by the National Onion Association of the USA. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adkins S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/j.1364-3703.2000.00022.x; Bag S., 2009, PLANT HLTH PROGR, DOI [10.1094/PHP-2009-0824-01-BR, DOI 10.1094/PHP-2009-0824-01-BR]; Bag S, 2009, J INSECT SCI, V10, P166; CALVERT LA, 1983, PHYTOPATHOLOGY, V73, P992, DOI 10.1094/Phyto-73-992; Choi SK, 2002, J GEN VIROL, V83, P3173, DOI 10.1099/0022-1317-83-12-3173; Elliott RM, 1997, MOL MED, V3, P572, DOI 10.1007/BF03401814; Garcia S, 2006, J GEN VIROL, V87, P1985, DOI 10.1099/vir.0.81827-0; Geerts-Dimitriadou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031013; GOLDBERG KB, 1987, PHYTOPATHOLOGY, V77, P162, DOI 10.1094/Phyto-77-162; HALL JM, 1993, PLANT DIS, V77, P952, DOI 10.1094/PD-77-0952B; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hassani-Mehraban A, 2009, MOL PLANT MICROBE IN, V22, P1250, DOI 10.1094/MPMI-22-10-1250; Hoffmann K, 2001, MOL PLANT MICROBE IN, V14, P242, DOI 10.1094/MPMI.2001.14.2.242; KORMELINK R, 1994, VIROLOGY, V200, P56, DOI 10.1006/viro.1994.1162; Kunkalikar SR, 2011, PHYTOPATHOLOGY, V101, P367, DOI 10.1094/PHYTO-02-10-0046; Latham JR, 2008, MOL PLANT PATHOL, V9, P85, DOI [10.1111/j.1364-3703.2007.00441.x, 10.1111/J.1364-3703.2007.00441.X]; LAW MD, 1990, J GEN VIROL, V71, P933, DOI 10.1099/0022-1317-71-4-933; Lederberg J, 2000, ENCY MICROBIOLOGY, P592; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; MALYSHENKO SI, 1989, J GEN VIROL, V70, P2751, DOI 10.1099/0022-1317-70-10-2751; Mandal B, 2012, PLANT DIS, V96, P468, DOI 10.1094/PDIS-06-11-0520; Mascia T, 2010, MOL PLANT MICROBE IN, V23, P1514, DOI 10.1094/MPMI-03-10-0064; Mitter N, 2003, MOL PLANT MICROBE IN, V16, P936, DOI 10.1094/MPMI.2003.16.10.936; Mound LA, 2001, THRIPS TOSPOVIRUSES, P17; Moya A, 2000, P NATL ACAD SCI USA, V97, P6967, DOI 10.1073/pnas.97.13.6967; Mullis SW, 2004, PLANT DIS, V88, P1285, DOI 10.1094/PDIS.2004.88.11.1285B; Oliveira VC, 2011, VIRUS RES, V155, P259, DOI 10.1016/j.virusres.2010.10.019; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1997, VIRUS RESISTANT TRAN, P77; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; PAPPU HR, 2008, ENCY VIROLOGY, V5, P133; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Qiu WP, 1998, VIROLOGY, V244, P186, DOI 10.1006/viro.1998.9131; Renteria-Canett I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-104; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Sambrook J, 2001, MOL CLONING LAB MANU; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Siddiqui SA, 2011, MOL PLANT MICROBE IN, V24, P685, DOI 10.1094/MPMI-12-10-0290; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Tsompana M., 2008, ENCY VIROLOGY, V5, P157; Ullman DE, 2002, ADV BOT RES, V36, P113, DOI 10.1016/S0065-2296(02)36061-0; VANCE VB, 1991, VIROLOGY, V182, P486, DOI 10.1016/0042-6822(91)90589-4; Wang YZ, 2002, PHYTOPATHOLOGY, V92, P51, DOI 10.1094/PHYTO.2002.92.1.51; Webster C. G., 2011, PLANT HLTH PROGR, DOI [10.1094/PHP-2011-0725-01-BR, DOI 10.1094/PHP-2011-0725-01-BR]; WEBSTER CG, 2010, PLANT HLTH PROGR, DOI DOI 10.1094/PHP-2010-0707-01-BR; Webster CG, 2011, VIROLOGY, V413, P216, DOI 10.1016/j.virol.2011.02.011; Wege C, 2007, VIROLOGY, V357, P10, DOI 10.1016/j.virol.2006.07.043; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9	50	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e44803	10.1371/journal.pone.0044803	http://dx.doi.org/10.1371/journal.pone.0044803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23077485	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800001
J	Chromek, M; Arvidsson, I; Karpman, D				Chromek, Milan; Arvidsson, Ida; Karpman, Diana			The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; INVASIVE BACTERIAL-INFECTION; SHIGA-TOXIN; MUCUS LAYERS; HOST-DEFENSE; LL-37; EXPRESSION; O157H7; LIPOPOLYSACCHARIDE; MECHANISM	This study investigated the role of the antimicrobial peptide cathelicidin in Escherichia coli O157:H7 infection and subsequent renal damage. Mouse and human cathelicidin, CRAMP and LL-37, respectively, killed E. coli O157:H7 in vitro. Intestines from healthy wild-type (129/SvJ) and cathelicidin-knock-out (Camp(-/-)) mice were investigated, showing that cathelicidin-deficient mice had a thinner colonic mucus layer compared with wild-type mice. Wild-type (n = 11) and cathelicidin-knock-out (n = 11) mice were inoculated with E. coli O157:H7. Cathelicidin-deficient animals exhibited higher fecal counts of E. coli O157:H7 and bacteria penetrated the mucus forming attaching-and-effacing lesions to a much higher extent than in wild-type animals. Cathelicidin knock-out mice developed symptoms (9/11) as well as anemia, thrombocytopenia and extensive renal tubular damage while all cathelicidin-producing mice remained asymptomatic with normal laboratory findings. When injected with Shiga toxin intraperitoneally, both murine strains developed the same degree of renal tubular damage and clinical disease indicating that differences in sensitivity to infection between the murine strains were related to the initial intestinal response. In conclusion, cathelicidin substantially influenced the antimicrobial barrier in the mouse colon mucosa. Cathelicidin deficiency lead to increased susceptibility to E. coli O157:H7 infection and subsequent renal damage. Administration of cathelicidin or stimulation of endogenous production may prove to be novel treatments for E. coli O157:H7-induced hemolytic uremic syndrome.	[Chromek, Milan; Arvidsson, Ida; Karpman, Diana] Lund Univ, Dept Pediat, Lund, Sweden	Lund University	Karpman, D (corresponding author), Lund Univ, Dept Pediat, Lund, Sweden.	Diana.Karpman@med.lu.se	Chromek, Milan/AAD-9116-2022; Chromek, Milan/ABE-7455-2020	Chromek, Milan/0000-0002-8941-057X; Aradottir, Sigridur Sunna/0000-0002-6898-3256; Karpman, Diana/0000-0001-7220-7658	Swedish Research Council [K2010-65X-14008-10-3, K2010-77PK-21628-01-1]; Torsten Soderberg Foundation; Konung Gustaf V:s 80-arsfond; Fanny Ekdahl's Foundation; Crown Princess Lovisa's Society for Child Care; Karolinska Institutet's research foundations; Sallskapet Barnavard foundation; Samariten foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg Foundation; Konung Gustaf V:s 80-arsfond; Fanny Ekdahl's Foundation; Crown Princess Lovisa's Society for Child Care; Karolinska Institutet's research foundations(Karolinska Institutet); Sallskapet Barnavard foundation; Samariten foundation	This study was supported by grants from The Swedish Research Council (K2010-65X-14008-10-3 to DK, K2010-77PK-21628-01-1 to MC), The Torsten Soderberg Foundation, Konung Gustaf V:s 80-arsfond, Fanny Ekdahl's Foundation (to DK) and Crown Princess Lovisa's Society for Child Care (to MC and DK), Karolinska Institutet's research foundations, Sallskapet Barnavard foundation and Samariten foundation (to MC, these grants were administered at Karolinska Institutet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bekassy ZD, 2011, PEDIATR NEPHROL, V26, P2059, DOI 10.1007/s00467-010-1616-9; Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Jager S, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/910283; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Karpman D, 1997, J INFECT DIS, V175, P611, DOI 10.1093/infdis/175.3.611; Karpman D, 2010, SEMIN THROMB HEMOST, V36, P575, DOI 10.1055/s-0030-1262879; Kin NW, 2011, EUR J IMMUNOL, V41, P3006, DOI 10.1002/eji.201141606; Koon HW, 2011, GASTROENTEROLOGY, V141, P1852, DOI 10.1053/j.gastro.2011.06.079; Lapeyraque AL, 2011, NEW ENGL J MED, V364, P2561, DOI 10.1056/NEJMc1100859; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; OBRIEN AD, 1993, J CLIN MICROBIOL, V31, P2799, DOI 10.1128/JCM.31.10.2799-2801.1993; Obrig TG, 2011, CURR TOP MICROBIOL I; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Tai EKK, 2008, J CELL BIOCHEM, V104, P251, DOI 10.1002/jcb.21615; Talukder P, 2011, INT IMMUNOPHARMACOL, V11, P141, DOI 10.1016/j.intimp.2010.10.010; Thompson KL, 2006, POULTRY SCI, V85, P1535, DOI 10.1093/ps/85.9.1535; Toledo CC, 2008, AM J PATHOL, V173, P1428, DOI 10.2353/ajpath.2008.071218; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	50	59	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e46476	10.1371/journal.pone.0046476	http://dx.doi.org/10.1371/journal.pone.0046476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077510	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100031
J	Hua, R; Adamczyk, A; Robbins, C; Ray, G; Rose, RA				Hua, Rui; Adamczyk, Andrew; Robbins, Courtney; Ray, Gibanananda; Rose, Robert A.			Distinct Patterns of Constitutive Phosphodiesterase Activity in Mouse Sinoatrial Node and Atrial Myocardium	PLOS ONE			English	Article							RECTIFIER K+ CURRENT; CALCIUM-CHANNELS; ELECTRICAL-CONDUCTION; NATRIURETIC PEPTIDE; PACEMAKER ACTIVITY; FUNCTIONAL ROLES; IONIC CURRENTS; CA2+ CURRENT; HEART-RATE; CGMP	Phosphodiesterases (PDEs) are critical regulators of cyclic nucleotides in the heart. In ventricular myocytes, the L-type Ca2+ current (I-Ca,I-L) is a major target of regulation by PDEs, particularly members of the PDE2, PDE3 and PDE4 families. Conversely, much less is known about the roles of PDE2, PDE3 and PDE4 in the regulation of action potential (AP) properties and I-Ca,I-L in the sinoatrial node (SAN) and the atrial myocardium, especially in mice. Thus, the purpose of our study was to measure the effects of global PDE inhibition with Isobutyl-1-methylxanthine (IBMX) and selective inhibitors of PDE2, PDE3 and PDE4 on AP properties in isolated mouse SAN and right atrial myocytes. We also measured the effects of these inhibitors on I-Ca,I-L in SAN and atrial myocytes in comparison to ventricular myocytes. Our data demonstrate that IBMX markedly increases spontaneous AP frequency in SAN myocytes and AP duration in atrial myocytes. Spontaneous AP firing in SAN myocytes was also increased by the PDE2 inhibitor erythro-9-[2-hydroxy-3-nonyl] adenine (EHNA), the PDE3 inhibitor milrinone (Mil) and the PDE4 inhibitor rolipram (Rol). In contrast, atrial AP duration was increased by EHNA and Rol, but not by Mil. IBMX also potently, and similarly, increased I-Ca,I-L in SAN, atrial and ventricular myocytes; however, important differences emerged in terms of which inhibitors could modulate I-Ca,I-L in each myocyte type. Consistent with our AP measurements, EHNA, Mil and Rol each increased I-Ca,I-L in SAN myocytes. Also, EHNA and Rol, but not Mil, increased atrial I-Ca,I-L. In complete contrast, no selective PDE inhibitors increased I-Ca,I-L in ventricular myocytes when given alone. Thus, our data show that the effects of selective PDE2, PDE3 and PDE4 inhibitors are distinct in the different regions of the myocardium indicating important differences in how each PDE family constitutively regulates ion channel function in the SAN, atrial and ventricular myocardium.	[Hua, Rui; Adamczyk, Andrew; Robbins, Courtney; Ray, Gibanananda; Rose, Robert A.] Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	Dalhousie University	Rose, RA (corresponding author), Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada.	robert.rose@dal.ca		Rose, Robert/0000-0001-9880-3482; Adamczyk, Andrew/0000-0001-7417-1505	Canadian Institutes of Health Research [MOP 93718]; Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation; Dalhousie Medical Research Foundation; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Nova Scotia; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Dalhousie Medical Research Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research (MOP 93718; http://www.cihr-irsc.gc.ca/e/193.html), the Heart and Stroke Foundation of Nova Scotia (http://www.hsf.ca/research/en/home), The Canada Foundation for Innovation (http://www.innovation.ca/en) and the Dalhousie Medical Research Foundation (http://www.dmrf.ca/en/home/default.aspx) to RAR who is a CIHR New Investigator. RH is supported by a postdoctoral fellowship from the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BASIC RES CARDIOLOGY; BEAN BP, 1985, J GEN PHYSIOL, V86, P1, DOI 10.1085/jgp.86.1.1; Beca S, 2011, CURR OPIN PHARMACOL, V11, P714, DOI 10.1016/j.coph.2011.10.017; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bers DR, 1999, CARDIOVASC RES, V42, P339, DOI 10.1016/S0008-6363(99)00038-3; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Clark RB, 2004, AM J PHYSIOL-HEART C, V286, pH1757, DOI 10.1152/ajpheart.00753.2003; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P493, DOI 10.1113/jphysiol.1988.sp017344; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; FISCHMEISTER R, 1991, LIFE SCI, V48, P2365, DOI 10.1016/0024-3205(91)90369-M; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hata T, 1998, HEART VESSELS, V13, P114, DOI 10.1007/BF01747828; HESS P, 1988, CAN J PHYSIOL PHARM, V66, P1218, DOI 10.1139/y88-201; HIRANO Y, 1989, AM J PHYSIOL, V256, pH1478, DOI 10.1152/ajpheart.1989.256.5.H1478; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Kaumann AJ, 2011, TRENDS PHARMACOL SCI, V32, P377, DOI 10.1016/j.tips.2011.03.003; Kerfant BG, 2007, CIRC RES, V101, P400, DOI 10.1161/CIRCRESAHA.107.156422; Kerfant EG, 2006, TRENDS CARDIOVAS MED, V16, P250, DOI 10.1016/j.tcm.2006.04.006; KIRSTEIN M, 1995, J CLIN INVEST, V95, P794, DOI 10.1172/JCI117729; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Marban E, 2002, NATURE, V415, P213, DOI 10.1038/415213a; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; MERY PF, 1995, MOL PHARMACOL, V48, P121; Molina CE, 2012, J AM COLL CARDIOL, V59, P2182, DOI 10.1016/j.jacc.2012.01.060; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Orito K, 1996, JPN J PHARMACOL, V72, P79, DOI 10.1254/jjp.72.79; Patrucco E, 2010, J MOL CELL CARDIOL, V49, P330, DOI 10.1016/j.yjmcc.2010.03.016; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; RivetBastide M, 1997, J CLIN INVEST, V99, P2710, DOI 10.1172/JCI119460; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Rose RA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P733, DOI 10.1161/CIRCEP.110.960401; Shimizu K, 2002, BRIT J PHARMACOL, V137, P127, DOI 10.1038/sj.bjp.0704843; Springer J, 2012, J MOL CELL CARDIOL, V52, P1122, DOI 10.1016/j.yjmcc.2012.01.018; Vandecasteele G, 2001, J PHYSIOL-LONDON, V533, P329, DOI 10.1111/j.1469-7793.2001.0329a.x; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Verde I, 1999, BRIT J PHARMACOL, V127, P65, DOI 10.1038/sj.bjp.0702506; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Zaccolo M, 2011, CURR OPIN PHARMACOL, V11, P649, DOI 10.1016/j.coph.2011.09.014; Zhang ML, 2011, TRENDS PHARMACOL SCI, V32, P360, DOI 10.1016/j.tips.2011.02.019; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	50	49	49	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47652	10.1371/journal.pone.0047652	http://dx.doi.org/10.1371/journal.pone.0047652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077656	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100149
J	Khan, WA; Pop, IM				Khan, Waqar A.; Pop, Ioan M.			Boundary Layer Flow Past a Stretching Surface in a Porous Medium Saturated by a Nanofluid: Brinkman-Forchheimer Model	PLOS ONE			English	Article							CONVECTIVE HEAT-TRANSFER; NATURAL-CONVECTION; MIXED CONVECTION; ENCLOSURE; CAVITY	In this study, the steady forced convection flow and heat transfer due to an impermeable stretching surface in a porous medium saturated with a nanofluid are investigated numerically. The Brinkman-Forchheimer model is used for the momentum equations (porous medium), whereas, Bongiorno's model is used for the nanofluid. Uniform temperature and nanofluid volume fraction are assumed at the surface. The boundary layer equations are transformed to ordinary differential equations in terms of the governing parameters including Prandtl and Lewis numbers, viscosity ratio, porous medium, Brownian motion and thermophoresis parameters. Numerical results for the velocity, temperature and concentration profiles, as well as for the reduced Nusselt and Sherwood numbers are obtained and presented graphically.	[Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Pop, Ioan M.] Univ Cluj, Fac Math, Cluj Napoca, Romania	National University of Sciences & Technology - Pakistan; Babes Bolyai University from Cluj	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013; Pop, Ioan/ABE-6678-2020	Khan, Waqar/0000-0002-8328-850X; Pop, Ioan/0000-0002-0660-6543				Abu-Nada E, 2009, INT J HEAT FLUID FL, V30, P679, DOI 10.1016/j.ijheatfluidflow.2009.02.003; Ahmad S, 2010, INT COMMUN HEAT MASS, V37, P987, DOI 10.1016/j.icheatmasstransfer.2010.06.004; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; CHENG P, 1977, J GEOPHYS RES, V82, P2040, DOI 10.1029/JB082i014p02040; Choi S. U., 1995, DEV APPL NONNEWTONIA, V231, P99; Cortell R, 2005, FLUID DYN RES, V37, P231, DOI 10.1016/j.fluiddyn.2005.05.001; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Das SK, 2007, NANOFLUIDS SCI TECHN; Daungthongsuk W, 2007, RENEW SUST ENERG REV, V11, P797, DOI 10.1016/j.rser.2005.06.005; Eastman JA, 2001, APPL PHYS LETT, V78, P718, DOI 10.1063/1.1341218; Elbashbeshy EMA, 2004, APPL MATH COMPUT, V158, P799, DOI 10.1016/j.amc.2003.08.141; Fang TG, 2011, TRANSPORT POROUS MED, V86, P609, DOI 10.1007/s11242-010-9640-6; Ghasemi B, 2010, INT COMMUN HEAT MASS, V37, P1142, DOI 10.1016/j.icheatmasstransfer.2010.06.020; Ho CJ, 2008, INT J HEAT MASS TRAN, V51, P4506, DOI 10.1016/j.ijheatmasstransfer.2007.12.019; HONG JT, 1987, J HEAT TRANS-T ASME, V109, P356, DOI 10.1115/1.3248088; Ingham D.B., 2005, TRANSPORT PHENOMENA, V3; Kakac S, 2009, INT J HEAT MASS TRAN, V52, P3187, DOI 10.1016/j.ijheatmasstransfer.2009.02.006; KAVIANY M, 1987, J HEAT TRANS-T ASME, V109, P345, DOI 10.1115/1.3248086; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Kuznetsov AV, 2010, TRANSPORT POROUS MED, V81, P409, DOI 10.1007/s11242-009-9413-2; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; LAURIAT G, 1987, J HEAT TRANS-T ASME, V109, P688, DOI 10.1115/1.3248143; Maiga SEB, 2004, SUPERLATTICE MICROST, V35, P543, DOI 10.1016/j.spmi.2003.09.012; Muthtamilselvan M, 2010, COMMUN NONLINEAR SCI, V15, P1501, DOI 10.1016/j.cnsns.2009.06.015; Nakayama A., 1995, PC AIDED NUMERICAL H; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Nield D.A., 2006, CONVECTION POROUS ME; Oztop HF, 2008, INT J HEAT FLUID FL, V29, P1326, DOI 10.1016/j.ijheatfluidflow.2008.04.009; Pantokratoras A, 2009, TRANSPORT POROUS MED, V80, P223, DOI 10.1007/s11242-009-9352-y; Pop I., 2001, CONVECTIVE HEAT TRAN; Popa C, 2010, INT J THERM SCI, V49, P901, DOI 10.1016/j.ijthermalsci.2009.12.015; Putra N, 2003, HEAT MASS TRANSFER, V39, P775, DOI [10.1007/s00231-002-0382-z, 10.1007/S00231-002-0382-z]; Tamayol A, 2010, TRANSPORT POROUS MED, V85, P661, DOI 10.1007/s11242-010-9584-x; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Vadasz P, 2008, THEOR APPL TRANS POR, V22, P1, DOI 10.1007/978-1-4020-8178-1; VAFAI K, 1981, INT J HEAT MASS TRAN, V24, P195, DOI 10.1016/0017-9310(81)90027-2; Vafai K, 2010, POROUS MEDIA APPL BI; Vafai K.J., 2005, HDB POROUS MEDIA, V2nd ed.; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P631, DOI 10.1590/S0104-66322008000400002; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P613, DOI 10.1590/S0104-66322008000400001; Wen DS, 2005, INT J HEAT FLUID FL, V26, P855, DOI 10.1016/j.ijheatfluidflow.2005.10.005	43	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47031	10.1371/journal.pone.0047031	http://dx.doi.org/10.1371/journal.pone.0047031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077541	Green Published, gold, Green Submitted			2022-12-25	WOS:000309995100053
J	Wang, HS; Chen, ZJ; Zhang, G; Ou, XL; Yang, XL; Wong, CKC; Giesy, JP; Du, J; Chen, SY				Wang, Hong-Sheng; Chen, Zhuo-Jia; Zhang, Ge; Ou, Xue-Ling; Yang, Xiang-Ling; Wong, Chris K. C.; Giesy, John P.; Du, Jun; Chen, Shou-Yi			A Novel Micro-Linear Vector for In Vitro and In Vivo Gene Delivery and Its Application for EBV Positive Tumors	PLOS ONE			English	Article							AMPLIFIED DNA FRAGMENTS; TRANSGENE EXPRESSION; MINICIRCLE DNA; PLASMID DNA; IMMUNE-RESPONSES; THERAPY; CELLS; METHYLATION; ACTIVATION; PERSISTENT	Background: The gene delivery vector for DNA-based therapy should ensure its transfection efficiency and safety for clinical application. The Micro-Linear vector (MiLV) was developed to improve the limitations of traditional vectors such as viral vectors and plasmids. Methods: The MiLV which contained only the gene expression cassette was amplified by polymerase chain reaction (PCR). Its cytotoxicity, transfection efficiency in vitro and in vivo, duration of expression, pro-inflammatory responses and potential application for Epstein-Barr virus (EBV) positive tumors were evaluated. Results: Transfection efficiency for exogenous genes transferred by MiLV was at least comparable with or even greater than their corresponding plasmids in eukaryotic cell lines. MiLV elevated the expression and prolonged the duration of genes in vitro and in vivo when compared with that of the plasmid. The in vivo pro-inflammatory response of MiLV group was lower than that of the plasmid group. The MEKK1 gene transferred by MiLV significantly elevated the sensitivity of B95-8 cells and transplanted tumor to the treatment of Ganciclovir (GCV) and sodium butyrate (NaB). Conclusions: The present study provides a safer, more efficient and stable MiLV gene delivery vector than plasmid. These advantages encourage further development and the preferential use of this novel vector type for clinical gene therapy studies.	[Wang, Hong-Sheng; Zhang, Ge; Yang, Xiang-Ling; Du, Jun] Sun Yat Sen Univ, Dept Microbial & Biochem Pharm, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Zhuo-Jia] Sun Yat Sen Univ, Inst Clin Pharmacol, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ou, Xue-Ling] Sun Yat Sen Univ, Dept Forens Med, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada; [Giesy, John P.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK S7N 0W0, Canada; [Chen, Shou-Yi] Guangzhou Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Hong Kong Baptist University; University of Saskatchewan; University of Saskatchewan	Wang, HS (corresponding author), Sun Yat Sen Univ, Dept Microbial & Biochem Pharm, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	hswang2000@gmail.com; dujun@mail.sysu.edu.cn	wong, chris/GSN-0962-2022; Wang, Hongsheng/N-1940-2019; Ou, Xueling/W-9964-2019	Wang, Hongsheng/0000-0002-0054-4820; Ou, Xueling/0000-0003-2345-4980; Giesy, John/0000-0003-1931-9962; Yang, Xiangling/0000-0002-5881-4299	National Natural Science Foundation of China [31101071, 30873032, 81071712]; National Basic Research Program of China (973 Program) [2011CB9358003]; National Science and Engineering Research Council of Canada [326415-07]; Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong; Chinese Academy of Sciences; King Saud University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong(City University of Hong Kong); Chinese Academy of Sciences(Chinese Academy of Sciences); King Saud University(King Saud University)	This work was supported by Supported by the National Natural Science Foundation of China (Grant No. 31101071), National Basic Research Program of China (973 Program, No. 2011CB9358003), and National Natural Science Foundation of China (No. 30873032and 81071712). The research was supported, in part, by a Discovery Grant from the National Science and Engineering Research Council of Canada (Project # 326415-07). JPG was supported by the Canada Research Chair program, an at large Chair Professorship at the Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong, The Einstein Professor Program of the Chinese Academy of Sciences and the Visiting Professor Program of King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chang CW, 2008, J CONTROL RELEASE, V125, P155, DOI 10.1016/j.jconrel.2007.10.014; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Coban C, 2005, J LEUKOCYTE BIOL, V78, P647, DOI 10.1189/jlb.1104627; Darquet AM, 1999, GENE THER, V6, P209, DOI 10.1038/sj.gt.3300816; de Wolf HK, 2008, PHARM RES-DORDR, V25, P1654, DOI 10.1007/s11095-008-9558-7; Esin S, 1996, CLIN EXP IMMUNOL, V104, P419, DOI 10.1046/j.1365-2249.1996.d01-691.x; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hagstrom JE, 1997, J CELL SCI, V110, P2323; He YW, 2008, VIRUS RES, V135, P175, DOI 10.1016/j.virusres.2008.03.012; Hirata K, 2007, J PHARM SCI-US, V96, P2251, DOI 10.1002/jps.20879; Hofman CR, 2001, GENE THER, V8, P71, DOI 10.1038/sj.gt.3301373; Johansson P, 2002, VACCINE, V20, P3379, DOI 10.1016/S0264-410X(02)00265-7; Kako K, 2008, J PHARM SCI-US, V97, P3074, DOI 10.1002/jps.21254; Kameda S, 2003, BIOCHEM BIOPH RES CO, V309, P929, DOI 10.1016/j.bbrc.2003.08.087; Li HP, 2005, CELL RES, V15, P262, DOI 10.1038/sj.cr.7290295; Lopez-Fuertes L, 2002, VACCINE, V21, P247, DOI 10.1016/S0264-410X(02)00450-4; Ludtke JJ, 1999, J CELL SCI, V112, P2033; Machelska H, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-72; Mitsui M, 2009, J GENE MED, V11, P435, DOI 10.1002/jgm.1317; Nakai H, 2003, MOL THER, V7, P101, DOI 10.1016/S1525-0016(02)00023-0; Nishikawa M, 2002, BIOL PHARM BULL, V25, P275, DOI 10.1248/bpb.25.275; Reyes-Sandoval A, 2004, MOL THER, V9, P249, DOI 10.1016/j.ymthe.2003.11.008; Schakowski F, 2001, MOL THER, V3, P793, DOI 10.1006/mthe.2001.0322; Schakowski F, 2007, IN VIVO, V21, P17; Schmidt-Wolf GD, 2003, TRENDS MOL MED, V9, P67, DOI 10.1016/S1471-4914(03)00005-4; Tan YD, 1999, HUM GENE THER, V10, P2153, DOI 10.1089/10430349950017149; Wilson KD, 2009, ADV DRUG DELIVER REV, V61, P233, DOI 10.1016/j.addr.2008.12.014; Xu XY, 2010, MOL THER, V18, P835, DOI 10.1038/mt.2010.3; Yasuda K, 2005, J LEUKOCYTE BIOL, V77, P71, DOI 10.1189/0204089; Yoshida H, 2008, J PHARM SCI-US, V97, P4575, DOI 10.1002/jps.21302; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang XC, 2008, HUM GENE THER, V19, P820, DOI 10.1089/hum.2007.141; Zheng C, 2006, VACCINE, V24, P4625, DOI 10.1016/j.vaccine.2005.08.046	37	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47159	10.1371/journal.pone.0047159	http://dx.doi.org/10.1371/journal.pone.0047159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077563	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100069
J	You, JS; Frey, JW; Hornberger, TA				You, Jae Sung; Frey, John W.; Hornberger, Troy A.			Mechanical Stimulation Induces mTOR Signaling via an ERK-Independent Mechanism: Implications for a Direct Activation of mTOR by Phosphatidic Acid	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN TARGET; S6 KINASE; TUBEROUS SCLEROSIS; PHOSPHOLIPASE-D; PHOSPHOINOSITIDE 3-KINASE; PHOSPHORYLATION; BINDING; INHIBITOR; COMPLEX	Signaling by mTOR is a well-recognized component of the pathway through which mechanical signals regulate protein synthesis and muscle mass. However, the mechanisms involved in the mechanical regulation of mTOR signaling have not been defined. Nevertheless, recent studies suggest that a mechanically-induced increase in phosphatidic acid (PA) may be involved. There is also evidence which suggests that mechanical stimuli, and PA, utilize ERK to induce mTOR signaling. Hence, we reasoned that a mechanically-induced increase in PA might promote mTOR signaling via an ERK-dependent mechanism. To test this, we subjected mouse skeletal muscles to mechanical stimulation in the presence or absence of a MEK/ERK inhibitor, and then measured several commonly used markers of mTOR signaling. Transgenic mice expressing a rapamycin-resistant mutant of mTOR were also used to confirm the validity of these markers. The results demonstrated that mechanically-induced increases in p70(s6k) T389 and 4E-BP1 S64 phosphorylation, and unexpectedly, a loss in total 4E-BP1, were fully mTOR-dependent signaling events. Furthermore, we determined that mechanical stimulation induced these mTOR-dependent events, and protein synthesis, through an ERK-independent mechanism. Similar to mechanical stimulation, exogenous PA also induced mTOR-dependent signaling via an ERK-independent mechanism. Moreover, PA was able to directly activate mTOR signaling in vitro. Combined, these results demonstrate that mechanical stimulation induces mTOR signaling, and protein synthesis, via an ERK-independent mechanism that potentially involves a direct interaction of PA with mTOR. Furthermore, it appears that a decrease in total 4E-BP1 may be part of the mTOR-dependent mechanism through which mechanical stimuli activate protein synthesis.	[You, Jae Sung; Hornberger, Troy A.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [You, Jae Sung; Frey, John W.; Hornberger, Troy A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hornberger, TA (corresponding author), Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA.	thornb1@svm.vetmed.wisc.edu	You, Jae-Sung/ABF-6763-2020	You, Jae-Sung/0000-0001-7791-8563; Hornberger, Troy/0000-0002-2349-1899	National Institutes of Health [AR057347]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant AR057347 to TAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FERRARI S, 1991, J BIOL CHEM, V266, P22770; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GOLDBERG AL, 1975, MED SCI SPORT EXER, V7, P185; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Hornberger TA, 2006, J CELL BIOCHEM, V97, P1207, DOI 10.1002/jcb.20671; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Hou JQ, 2012, ONCOTARGET, V3, P118; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Kubica N, 2005, J BIOL CHEM, V280, P7570, DOI 10.1074/jbc.M413732200; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Osman B, 2009, CELL SIGNAL, V21, P1806, DOI 10.1016/j.cellsig.2009.07.016; Pahor M, 1998, J Nutr Health Aging, V2, P97; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Spangenburg EE, 2006, J APPL PHYSIOL, V100, P129, DOI 10.1152/japplphysiol.00619.2005; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; VANDENBURGH HH, 1990, AM J PHYSIOL, V259, pC232, DOI 10.1152/ajpcell.1990.259.2.C232; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang TW, 2004, FRONT BIOSCI-LANDMRK, V9, P619, DOI 10.2741/1095; Winter JN, 2010, AM J PHYSIOL-CELL PH, V299, pC335, DOI 10.1152/ajpcell.00039.2010; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yonezawa K, 2003, CURR TOP MICROBIOL, V279, P271; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	65	60	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2012	7	10							e47258	10.1371/journal.pone.0047258	http://dx.doi.org/10.1371/journal.pone.0047258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022WO	23077579	gold, Green Published, Green Submitted			2022-12-25	WOS:000309995100082
J	Park, YS; Jeon, YJ; Kim, HS; Chae, KY; Oh, SH; Han, IB; Kim, HS; Kim, WC; Kim, OJ; Kim, TG; Choi, JU; Kim, DS; Kim, NK				Park, Young Seok; Jeon, Young Joo; Kim, Hyun Seok; Chae, Kyu Young; Oh, Seung-Hun; Han, In Bo; Kim, Hyun Sook; Kim, Won-Chan; Kim, Ok-Joon; Kim, Tae Gon; Choi, Joong-Uhn; Kim, Dong-Seok; Kim, Nam Keun			The Role of VEGF and KDR Polymorphisms in Moyamoya Disease and Collateral Revascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MIDDLE CEREBRAL-ARTERY; FACTOR GENE; FACTOR EXPRESSION; CHROMOSOME 17Q25; ISCHEMIC-STROKE; MESSENGER-RNA; RAT-BRAIN; HYPOXIA; RECEPTORS	We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF 22578, 21154, 2634, and 936) and kinase insert domain containing receptor (KDR -2604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, mean age, 20.9 +/- 15.9 years; 66.4% female) and 243 healthy control subjects (mean age, 23.0 +/- 16.1 years; 56.8% female) were included. The subjects were divided into pediatric and adult groups. Among the 64 surgical patients, we evaluated collateral vessel formation after 2 years and divided patients into good (collateral grade A) or poor (collateral grade B and C) groups. The frequencies and distributions of four VEGF (-2578, -1154, -634, and 936) and KDR (-604, 1192, and 1719) polymorphisms were assessed from patients with moyamoya disease and compared to the control group. No differences were observed in VEGF -2578, -1154, -634, and 936 or KDR -604, 1192, and 1719 polymorphisms between the control group and moyamoya disease group. However, we found the -634CC genotype occurred less frequently in the pediatric moyamoya group (p = 0.040) whereas the KDR -604C/1192A/1719T haplotype increased the risk of pediatric moyamoya (p = 0.024). Patients with the CC genotype of VEGF -634 had better collateral vessel formation after surgery. Our results suggest that the VEGF -634G allele is associated with pediatric moyamoya disease and poor collateral vessel formation.	[Kim, Dong-Seok] Yonsei Univ, Brain Res Inst, Brain Korea Project Med Sci 21, Dept Pediat Neurosurg,Severance Hosp,Coll Med, Seoul, South Korea; [Oh, Seung-Hun; Kim, Hyun Sook; Kim, Won-Chan; Kim, Ok-Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea; [Chae, Kyu Young; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pediat, Songnam, South Korea; [Jeon, Young Joo; Kim, Hyun Seok] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea; [Park, Young Seok; Han, In Bo; Kim, Tae Gon; Choi, Joong-Uhn] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurosurg, Songnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Pochon Cha University; Pochon Cha University; Pochon Cha University	Kim, DS (corresponding author), Yonsei Univ, Brain Res Inst, Brain Korea Project Med Sci 21, Dept Pediat Neurosurg,Severance Hosp,Coll Med, Seoul, South Korea.	dskim33@yuhs.ac; nkkim@cha.ac.kr	KIM, WON CHAN/AAJ-4506-2020	Kim, Nam Keun/0000-0003-0541-3528	National Research Foundation of Korea [2010-0023851]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (2010-0023851). The funders had no role in the study design or decision to publish.	Awata T, 2002, DIABETES, V51, P1635, DOI 10.2337/diabetes.51.5.1635; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Cao YH, 2005, CARDIOVASC RES, V65, P639, DOI 10.1016/j.cardiores.2004.11.020; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fabian E, 2011, WIEN KLIN WOCHENSCHR, V123, P496, DOI 10.1007/s00508-011-0002-3; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukui M, 1997, SURG NEUROL, V47, P138, DOI 10.1016/S0090-3019(96)00358-8; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Han H, 2003, J KOREAN MED SCI, V18, P876, DOI 10.3346/jkms.2003.18.6.876; Harry Lorraine E., 2003, Birth Defects Research, V69, P363, DOI 10.1002/bdrc.10024; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; HEDRICK PW, 1987, GENETICS, V117, P331; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Issa R, 1999, LAB INVEST, V79, P417; Jin KL, 2000, NEUROSCIENCE, V99, P577, DOI 10.1016/S0306-4522(00)00207-4; Kang HS, 2006, NEUROSURGERY, V58, P1074, DOI 10.1227/01.NEU.0000215854.66011.4F; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Kuo NT, 1999, J APPL PHYSIOL, V86, P260, DOI 10.1152/jappl.1999.86.1.260; Kuroda S, 2007, STROKE, V38, P1430, DOI 10.1161/STROKEAHA.106.478297; La Rosa S, 2003, HUM PATHOL, V34, P18, DOI 10.1053/hupa.2003.56; Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Marchand GS, 2002, AM J PHYSIOL-HEART C, V282, pH194, DOI 10.1152/ajpheart.2002.282.1.H194; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; MATSUSHIMA T, 1992, NEUROSURGERY, V31, P401, DOI 10.1227/00006123-199209000-00003; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Nanba R, 2005, CHILD NERV SYST, V21, P62, DOI 10.1007/s00381-004-1005-4; Oh SH, 2011, J NEUROL SCI, V308, P62, DOI 10.1016/j.jns.2011.06.012; Okuda Y, 1998, LIFE SCI, V63, P477, DOI 10.1016/S0024-3205(98)00296-3; Park YS, 2011, CHILD NERV SYST, V27, P1919, DOI 10.1007/s00381-011-1504-z; Petrovic D, 2007, CARDIOLOGY, V107, P291, DOI 10.1159/000099064; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Sakamoto S, 2008, NEUROSURG REV, V31, P77, DOI 10.1007/s10143-007-0102-8; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Takekawa Y, 2004, NEUROPATHOLOGY, V24, P236, DOI 10.1111/j.1440-1789.2004.00550.x; Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang Y, 2007, J AM COLL CARDIOL, V50, P760, DOI 10.1016/j.jacc.2007.04.074; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930	51	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2012	7	10							e47158	10.1371/journal.pone.0047158	http://dx.doi.org/10.1371/journal.pone.0047158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020LH	23077562	Green Published, Green Submitted, gold			2022-12-25	WOS:000309809500033
J	Thomsen, SB; Rathcke, CN; Skaaby, T; Linneberg, A; Vestergaard, H				Thomsen, Stine Brinklov; Rathcke, Camilla Noelle; Skaaby, Tea; Linneberg, Allan; Vestergaard, Henrik			The Association between Genetic Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and the Lipid Profile in a Danish Population	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; PLASMA YKL-40; HEART-DISEASE; OBESITY; RISK; INFLAMMATION; POLYMORPHISM; EXPRESSION; BIOMARKER	Background: The inflammatory biomarker YKL-40 seems to play a role in atherosclerosis and is elevated in patients with obesity, cardiovascular disease and type 2 diabetes. Single nucleotide polymorphisms (SNPs) of the YKL-40 encoding gene, CHI3L1, are associated with inter-individual YKL-40 levels. One study has described an association between a promoter polymorphism of CHI3L1 and levels of low density lipoprotein. The objective of this study was to evaluate the influence of YKL-40 on lipid parameters by determining the association between polymorphisms of CHI3L1, serum YKL-40 and levels of the differentiated lipid profile in a Danish general population. Methodology/Principle Findings: 12 SNPs of CHI3L1 were genotyped, and serum YKL-40 and parameters of the lipid profile were measured in 2,656 Danes. Lipid profile and genotypes were available in another Danish population (n = 6,784) for replication. Cholesterol and triglyceride levels increased with increasing YKL-40 quartile (both p < 0.0001), and YKL-40 correlated with triglyceride levels (beta = 0.15, p < 0.0001). Low density lipoprotein levels increased slightly from the 1 st to the 3rd quartile (p = 0.006). The highest YKL-40 quartile was associated with a greater risk of hypercholesterolemia compared to the lowest YKL-40 quartile (odds ratio 1.36, p = 0.009). Minor homozygosity of rs12123883 was associated with higher triglyceride levels (p = 0.022) and a higher prevalence of low high density lipoprotein (p = 0.012), but these associations could not be confirmed in the replication population. Conclusions/Significance: Serum YKL-40 correlates with triglyceride levels in a representative group of the general Danish population. No consistent associations between SNPs of CHI3L1 and lipid levels could be documented.	[Thomsen, Stine Brinklov; Vestergaard, Henrik] Copenhagen Univ Hosp, Dept Med, Ctr Endocrinol & Metab, Herlev, Denmark; [Rathcke, Camilla Noelle] Copenhagen Univ Hosp, Dept Cardiol Nephrol & Endocrinol, Hillerod, Denmark; [Skaaby, Tea; Linneberg, Allan] Copenhagen Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Vestergaard, Henrik] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Thomsen, SB (corresponding author), Copenhagen Univ Hosp, Dept Med, Ctr Endocrinol & Metab, Herlev, Denmark.	Stine.Brinkloev.Thomsen@.regionh.dk		Vestergaard, Henrik/0000-0003-3090-269X; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184	The Research Foundation of Herlev Hospital; The Danish Council for Independent Research, Medical Sciences (FSS); The Jacobsen Foundation; The A.P. Moeller and wife Chastine McKinney Moeller Foundation	The Research Foundation of Herlev Hospital; The Danish Council for Independent Research, Medical Sciences (FSS); The Jacobsen Foundation; The A.P. Moeller and wife Chastine McKinney Moeller Foundation	The study was supported by grants from The Research Foundation of Herlev Hospital, The Danish Council for Independent Research, Medical Sciences (FSS), The Jacobsen Foundation and The A.P. Moeller and wife Chastine McKinney Moeller Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambye L, 2005, DIABETES RES CLIN PR, V67, P175, DOI 10.1016/j.diabres.2004.06.013; [Anonymous], 2008, WHO WAIST CIRCUMFERE; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Brix JM, 2011, EUR J CLIN INVEST, V41, P589, DOI 10.1111/j.1365-2362.2010.02446.x; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cho HK, 2002, ATHEROSCLEROSIS, V164, P187, DOI 10.1016/S0021-9150(02)00058-8; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Grisouard J, 2012, INNATE IMMUN-LONDON, V18, P25, DOI 10.1177/1753425910386632; Hempen M, 2009, OBES SURG, V19, P1557, DOI 10.1007/s11695-009-9917-4; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; KESTELOOT H, 1982, CIRCULATION, V65, P795, DOI 10.1161/01.CIR.65.4.795; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Krause SW, 1997, IMMUNOBIOLOGY, V196, P522, DOI 10.1016/S0171-2985(97)80069-1; Kruit A, 2007, RESP MED, V101, P1563, DOI 10.1016/j.rmed.2006.12.006; Kucur M, 2007, CORONARY ARTERY DIS, V18, P391, DOI 10.1097/MCA.0b013e328241d991; Lavie CJ, 2003, J AM COLL CARDIOL, V42, P677, DOI 10.1016/S0735-1097(03)00784-8; Lee H, 2010, CLIN BIOCHEM, V43, P1195, DOI 10.1016/j.clinbiochem.2010.07.017; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Michelsen AE, 2010, ATHEROSCLEROSIS, V211, P589, DOI 10.1016/j.atherosclerosis.2010.02.035; Mygind ND, 2011, INFLAMM RES, V60, P281, DOI 10.1007/s00011-010-0266-5; Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Olsen MH, 2009, J HUM HYPERTENS, V23, P105, DOI 10.1038/jhh.2008.112; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pradhan AD, 2002, J CARDIOVASC RISK, V9, P323, DOI 10.1097/00043798-200212000-00005; Rathcke CN, 2006, INFLAMM RES, V55, P221, DOI 10.1007/s00011-006-0076-y; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2009, DIABETES CARE, V32, P323, DOI 10.2337/dc08-1144; Rathcke CN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006106; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rondbjerg AK, 2011, CARDIOVASC DIABETOL, V10, P54; ROSENSTOCK SJ, 1995, GUT, V36, P819, DOI 10.1136/gut.36.6.819; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Vinik Aaron I, 2005, Clin Cornerstone, V7, P27, DOI 10.1016/S1098-3597(05)80065-1; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; WILSON PWF, 1991, AM J MED, V90, P11, DOI 10.1016/0002-9343(91)90500-W; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zheng JL, 2011, CYTOKINE, V54, P51, DOI 10.1016/j.cyto.2010.12.018	52	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e47094	10.1371/journal.pone.0047094	http://dx.doi.org/10.1371/journal.pone.0047094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071724	gold, Green Submitted, Green Published			2022-12-25	WOS:000309827300083
J	Wang, ZW; Tong, W; Wang, QH; Bai, X; Chen, Z; Zhao, JJ; Xu, NZ; Liu, SQ				Wang, Zhuowei; Tong, Wei; Wang, Quanhui; Bai, Xue; Chen, Zhen; Zhao, Jingjing; Xu, Ningzhi; Liu, Siqi			The Temperature Dependent Proteomic Analysis of Thermotoga maritima	PLOS ONE			English	Article							DNA MICROARRAY ANALYSIS; LATERAL GENE-TRANSFER; METABOLISM; SEQUENCE; BINDING	Thermotoga maritima (T. maritima) is a typical thermophile, and its proteome response to environmental temperature changes has yet to be explored. This study aims to uncover the temperature-dependent proteins of T. maritima using comparative proteomic approach. T. maritima was cultured under four temperatures, 60 degrees C, 70 degrees C, 80 degrees C and 90 degrees C, and the bacterial proteins were extracted and electrophoresed in two-dimensional mode. After analysis of gel images, a total of 224 spots, either cytoplasm or membrane, were defined as temperature-dependent. Of these spots, 75 unique bacterial proteins were identified using MALDI TOF/TOF MS. As is well known, the chaperone proteins such as heat shock protein 60 and elongation factor Tu, were up-regulated in abundance due to increased temperature. However, several temperature-dependent proteins of T. maritima responded very differently when compared to responses of the thermophile T. tengcongensis. Intriguingly, a number of proteins involved in central carbohydrate metabolism were significantly upregulated at higher temperature. Their corresponding mRNA levels were elevated accordingly. The increase in abundance of several key enzymes indicates that a number of central carbohydrate metabolism pathways of T. maritima are activated at higher temperatures.	[Wang, Zhuowei; Tong, Wei; Wang, Quanhui; Bai, Xue; Chen, Zhen; Zhao, Jingjing; Xu, Ningzhi; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Liu, Siqi] Univ Louisville, Dept Med, Louisville, KY 40292 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Louisville	Liu, SQ (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	siqiliu@genomics.org.cn	Zhao, Jingjing/AAQ-2044-2020	Zhao, Jingjing/0000-0001-7512-9296	National Basic Research Program of China [2010CB912703, 2007CB707801]; National Natural Science Foundation of China [30770467]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the grants of the National Basic Research Program of China (2010CB912703) (2007CB707801) and the National Natural Science Foundation of China (30770467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200; Conners SB, 2006, FEMS MICROBIOL REV, V30, P872, DOI 10.1111/j.1574-6976.2006.00039.x; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Jiang Y, 2006, FEMS MICROBIOL LETT, V259, P254, DOI 10.1111/j.1574-6968.2006.00273.x; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Nanavati D, 2002, MICROBIOL-SGM, V148, P3531, DOI 10.1099/00221287-148-11-3531; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; Pysz MA, 2004, EXTREMOPHILES, V8, P209, DOI 10.1007/s00792-004-0379-2; Rossi M, 2003, J BACTERIOL, V185, P3683, DOI 10.1128/JB.185.13.3683-3689.2003; Serve W.M., 1996, FEMS MICROBIOLOGY RE, V18, P119; Snijders APL, 2006, PROTEOMICS, V6, P1518, DOI 10.1002/pmic.200402070; Wang JQ, 2007, PROTEOMICS, V7, P1409, DOI 10.1002/pmic.200500226; Worning P, 2000, NUCLEIC ACIDS RES, V28, P706, DOI 10.1093/nar/28.3.706; Zaparty M, 2008, J BACTERIOL, V190, P2231, DOI 10.1128/JB.01524-07	16	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46463	10.1371/journal.pone.0046463	http://dx.doi.org/10.1371/journal.pone.0046463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	23071576	Green Published, gold, Green Submitted			2022-12-25	WOS:000309827300031
J	Fu, YS; Qin, WB; Cao, H; Xu, R; Tan, Y; Lu, T; Wang, HR; Tong, WX; Rong, X; Li, G; Yuan, MQ; Li, CH; Abe, KJ; Lu, L; Chen, GH				Fu, Yongshui; Qin, Weibing; Cao, Hong; Xu, Ru; Tan, Yi; Lu, Teng; Wang, Hongren; Tong, Wangxia; Rong, Xia; Li, Gang; Yuan, Manqiong; Li, Chunhua; Abe, Kenji; Lu, Ling; Chen, Guihua			HCV 6a Prevalence in Guangdong Province Had the Origin from Vietnam and Recent Dissemination to Other Regions of China: Phylogeographic Analyses	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; INJECTION-DRUG USERS; MAXIMUM-LIKELIHOOD-ESTIMATION; MOLECULAR EPIDEMIOLOGY; GENOTYPE DISTRIBUTION; HEROIN USERS; INFECTION; SEQUENCES; HIV; HETEROGENEITY	Background: Recently in China, HCV 6a infection has shown a fast increase among patients and blood donors, possibly due to IDU linked transmission. Methodology/Findings: We recruited 210 drug users in Shanwei city, Guangdong province. Among them, HCV RNA was detected in 150 (71.4%), both E1 and NS5B genes were sequenced in 136, and 6a genotyped in 70. Of the 6a sequences, most were grouped into three clusters while 23% represent emerging strains. For coalescent analysis, additional 6a sequences were determined among 21 blood donors from Vietnam, 22 donors from 12 provinces of China, and 36 IDUs from Liuzhou City in Guangxi Province. Phylogeographic analyses indicated that Vietnam could be the origin of 6a in China. The Guangxi Province, which borders Vietnam, could be the first region to accept 6a for circulation. Migration from Yunnan, which also borders Vietnam, might be equally important, but it was only detected among IDUs in limited regions. From Guangxi, 6a could have further spread to Guangdong, Yunnan, Hainan, and Hubei provinces. However, evidence showed that only in Guangdong has 6a become a local epidemic, making Guangdong the second source region to disseminate 6a to the other 12 provinces. With a rate of 2.737 x 10(-3) (95% CI: 1.792 x 10(-3) to 3.745 x 10(-3)), a Bayesian Skyline Plot was portrayed. It revealed an exponential 6a growth during 1994-1998, while before and after 1994-1998 slow 6a growths were maintained. Concurrently, 1994-1998 corresponded to a period when contaminated blood transfusion was common, which caused many people being infected with HIV and HCV, until the Chinese government outlawed the use of paid blood donations in 1998. Conclusions/Significance: With an origin from Vietnam, 6a has become a local epidemic in Guangdong Province, where an increasing prevalence has subsequently led to 6a spread to many other regions of China.	[Fu, Yongshui] Sun Yat Sen Univ, Coll Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Fu, Yongshui; Xu, Ru; Rong, Xia] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Qin, Weibing] Family Planning Res Inst Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Qin, Weibing; Wang, Hongren; Li, Gang] Sun Yat Sen Univ, Affiliated Hosp 3, Vaccine Inst, Guangzhou, Guangdong, Peoples R China; [Cao, Hong; Tong, Wangxia] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Tan, Yi] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lu, Teng] Univ So Calif, Los Angeles, CA USA; [Yuan, Manqiong; Li, Chunhua; Lu, Ling] Univ Kansas, Med Ctr, Viral Oncol Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Abe, Kenji] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Lu, Ling; Chen, Guihua] Sun Yat Sen Univ, Affiliated Hosp 3, Lab Hepatol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Blood Center; Sun Yat Sen University; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Southern California; University of Kansas; University of Kansas Medical Center; National Institute of Infectious Diseases (NIID); Sun Yat Sen University	Lu, L (corresponding author), Univ Kansas, Med Ctr, Viral Oncol Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	llu@kumc.edu	Janssens, Ivan A/P-1331-2014; Fu, Yongshuo/AAO-4663-2021; Campioli, Matteo/N-9380-2015; Fu, Yongshuo/AAH-7434-2019; Fu, Yongshuo/AAF-9446-2021	Janssens, Ivan A/0000-0002-5705-1787; Fu, Yongshuo/0000-0002-9761-5292; Fu, Yongshuo/0000-0002-9761-5292; Xu, Ru/0000-0001-5926-9213; Campioli, Matteo/0000-0002-3427-2368	National Institute of Allergy and Infectious Diseases [1R01AI080734-01A]; Bureau of Health, Guangzhou City, China [2008-ZDi-10, 2009-ZDa-05]; National Natural Science Foundation of China [30872162]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bureau of Health, Guangzhou City, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by a grant from the National Institute of Allergy and Infectious Diseases (1R01AI080734-01A, Dr. Ling Lu); two grants from the Bureau of Health, Guangzhou City, China (No. 2008-ZDi-10, 2009-ZDa-05, Dr. Yongshui Fu) (http://www.gzmed.gov.cn); and a grant from the National Natural Science Foundation of China (No. 30872162, Dr. Yongshui Fu) (http://www.nsfc.gov.cn). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; [Anonymous], 2006, CBS NEWS        0811; Bao YP, 2010, CURR OPIN PSYCHIATR, V23, P187, DOI 10.1097/YCO.0b013e328338658b; Bao Yanping, 2009, HIV Therapy, V3, P237, DOI [10.2217/hiv.09.4, 10.2217/HIV.09.4]; Cowhig D., 2000, LIANHE ZAOBAO   1002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; GU X, 1995, MOL BIOL EVOL, V12, P546; JI Y, 1998, ACTA ACAD MED SINICA, V203, P240; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Lee K, 2008, INT J INFECT DIS, V12, pE424, DOI 10.1016/j.ijid.2008.05.1234; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shi XL, 1999, TRANSFUSION, V39, P913, DOI 10.1046/j.1537-2995.1999.39080913.x; SLATKIN M, 1989, GENETICS, V123, P603; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhou XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024889	30	129	142	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28006	10.1371/journal.pone.0028006	http://dx.doi.org/10.1371/journal.pone.0028006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	102TA	23071786	gold, Green Submitted, Green Published			2022-12-25	WOS:000315865800001
J	Zhang, YG; Li, F; Liu, S; Wang, H; Mahavadi, S; Murthy, KS; Khalili, K; Hu, WH				Zhang, Yonggang; Li, Fang; Liu, Shu; Wang, Hong; Mahavadi, Sunila; Murthy, Karnam S.; Khalili, Kamel; Hu, Wenhui			MEKK1-MKK4-JNK-AP1 Pathway Negatively Regulates Rgs4 Expression in Colonic Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; PROTEIN-KINASE PATHWAYS; JUN NH2-TERMINAL KINASE; NECROSIS-FACTOR-ALPHA; P38 MAPK; SIGNAL-TRANSDUCTION; TERMINAL KINASE; JNK ACTIVATION; ANGIOTENSIN-II	Background: Regulator of G-protein Signaling 4 (RGS4) plays an important role in regulating smooth muscle contraction, cardiac development, neural plasticity and psychiatric disorder. However, the underlying regulatory mechanisms remain elusive. Our recent studies have shown that upregulation of Rgs4 by interleukin (IL)-1 beta is mediated by the activation of NFkB signaling and modulated by extracellular signal-regulated kinases, p38 mitogen-activated protein kinase, and phosphoinositide-3 kinase. Here we investigate the effect of the c-Jun N-terminal kinase (JNK) pathway on Rgs4 expression in rabbit colonic smooth muscle cells. Methodology/Principal Findings: Cultured cells at first passage were treated with or without IL-1 beta (10 ng/ml) in the presence or absence of the selective JNK inhibitor (SP600125) or JNK small hairpin RNA (shRNA). The expression levels of Rgs4 mRNA and protein were determined by real-time RT-PCR and Western blot respectively. SP600125 or JNK shRNA increased Rgs4 expression in the absence or presence of IL-1 beta stimulation. Overexpression of MEKK1, the key upstream kinase of JNK, inhibited Rgs4 expression, which was reversed by co-expression of JNK shRNA or dominant-negative mutants for MKK4 or JNK. Both constitutive and inducible upregulation of Rgs4 expression by SP600125 was significantly inhibited by pretreatment with the transcription inhibitor, actinomycin D. Dual reporter assay showed that pretreatment with SP600125 sensitized the promoter activity of Rgs4 in response to IL-1 beta. Mutation of the AP1-binding site within Rgs4 promoter increased the promoter activity. Western blot analysis confirmed that IL-1 beta treatment increased the phosphorylation of JNK, ATF-2 and c-Jun. Gel shift and chromatin immunoprecipitation assays validated that IL-1 beta increased the in vitro and ex vivo binding activities of AP1 within rabbit Rgs4 promoter. Conclusion/Significance: Activation of MEKK1-MKK4-JNK-AP1 signal pathway plays a tonic inhibitory role in regulating Rgs4 transcription in rabbit colonic smooth muscle cells. This negative regulation may aid in maintaining the transient level of RGS4 expression.	[Zhang, Yonggang; Li, Fang; Liu, Shu; Wang, Hong; Khalili, Kamel; Hu, Wenhui] Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA; [Mahavadi, Sunila; Murthy, Karnam S.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Virginia Commonwealth University	Zhang, YG (corresponding author), Temple Univ, Dept Neurosci, Sch Med, Philadelphia, PA 19122 USA.	whu@temple.edu	Song, Yajun/GQQ-0476-2022; Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269	National Institutes of Diabetes and Digestive and Kidney Diseases [DK075964, DK015564]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564, R01DK075964, R37DK015564] Funding Source: NIH RePORTER	National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by grant DK075964 (WH) and DK015564 (KM) from the National Institutes of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barona I, 2011, J PHARM PHARMACOL, V63, P657, DOI 10.1111/j.2042-7158.2011.01253.x; Bashari D, 2011, CELL SIGNAL, V23, P65, DOI 10.1016/j.cellsig.2010.08.004; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bongalon S, 2004, J VASC RES, V41, P412, DOI 10.1159/000081247; Bowden NA, 2007, SCHIZOPHR RES, V89, P165, DOI 10.1016/j.schres.2006.09.003; Cao WB, 2004, J PHARMACOL EXP THER, V311, P60, DOI 10.1124/jpet.104.068023; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cho H, 2003, BIOCHEM J, V371, P973, DOI 10.1042/BJ20021769; Chowdari KV, 2008, SCHIZOPHRENIA BULL, V34, P118, DOI 10.1093/schbul/sbm042; Chung FY, 2008, ARCH PHARM RES, V31, P1437, DOI 10.1007/s12272-001-2128-8; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Cook AK, 2000, AM J PHYSIOL-GASTR L, V278, pG429, DOI 10.1152/ajpgi.2000.278.3.G429; Costigan M, 2003, MOL CELL NEUROSCI, V24, P106, DOI 10.1016/S1044-7431(03)00135-0; Davies JS, 2011, J BIOL CHEM, V286, P15227, DOI 10.1074/jbc.M110.201996; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ding GX, 2010, WORLD J PEDIATR, V6, P169, DOI 10.1007/s12519-010-0033-2; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Erdely HA, 2006, SYNAPSE, V59, P472, DOI 10.1002/syn.20265; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; Ginnan R, 2006, AM J PHYSIOL-CELL PH, V290, pC1583, DOI 10.1152/ajpcell.00390.2005; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gonzalo S, 2011, NEUROGASTROENT MOTIL, V23, pe80, DOI 10.1111/j.1365-2982.2010.01632.x; Gonzalo S, 2010, NEUROGASTROENT MOTIL, V22, P564, DOI 10.1111/j.1365-2982.2009.01439.x; Grillet N, 2003, J NEUROSCI, V23, P10613; Guikema BJ, 2005, FREE RADICAL BIO MED, V38, P597, DOI 10.1016/j.freeradbiomed.2004.11.022; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hallsworth MP, 2001, AM J RESP CRIT CARE, V164, P688, DOI 10.1164/ajrccm.164.4.2011004; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V600, P1, DOI 10.1016/j.ejphar.2008.09.041; Hirst SJ, 2002, AM J RESP CRIT CARE, V165, P1161, DOI 10.1164/ajrccm.165.8.2107158; Hu W, 2006, BIOCHEM BIOPH RES CO, V343, P1038, DOI 10.1016/j.bbrc.2006.03.079; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Hu WH, 2007, AM J PHYSIOL-CELL PH, V293, pC1991, DOI 10.1152/ajpcell.00300.2007; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Hu WH, 1999, J BIOL CHEM, V274, P30603, DOI 10.1074/jbc.274.43.30603; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Il Jeong S, 2011, J PHARM PHARMACOL, V63, P245, DOI 10.1111/j.2042-7158.2010.01212.x; Je HD, 2001, J PHYSIOL-LONDON, V537, P567, DOI 10.1111/j.1469-7793.2001.00567.x; Jiang SN, 2011, AM J PHYSIOL-GASTR L, V301, pG454, DOI 10.1152/ajpgi.00148.2011; Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; Kattoulas E, 2011, PSYCHOL MED, P1; Khan I., 2006, Inflammopharmacology, V14, P28, DOI 10.1007/s10787-006-1507-7; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kloss S, 2004, MOL PHARMACOL, V65, P1440, DOI 10.1124/mol.65.6.1440; Kordowska J, 2006, J BIOMED SCI, V13, P159, DOI 10.1007/s11373-005-9060-8; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Lee TS, 2002, CELL SIGNAL, V14, P989, DOI 10.1016/S0898-6568(02)00032-3; Lee YR, 2006, J PHARMACOL SCI, V100, P119, DOI 10.1254/jphs.FP0050777; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Li F, 2010, AM J PHYSIOL-CELL PH, V299, pC1418, DOI 10.1152/ajpcell.00093.2010; Li F, 2010, GENE, V451, P45, DOI 10.1016/j.gene.2009.11.010; Liang D, 2001, MOL BRAIN RES, V96, P94, DOI 10.1016/S0169-328X(01)00287-X; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lin TC, 2009, EPILEPSY BEHAV, V14, P316, DOI 10.1016/j.yebeh.2008.12.005; Lipska BK, 2006, HUM MOL GENET, V15, P2804, DOI 10.1093/hmg/ddl222; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Luo SF, 2008, TOXICOL APPL PHARM, V232, P396, DOI 10.1016/j.taap.2008.07.019; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Mittmann C, 2001, N-S ARCH PHARMACOL, V363, P456; Ni YG, 1999, J NEUROSCI, V19, P3674; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Ortega-Perez I, 2005, J BIOL CHEM, V280, P20867, DOI 10.1074/jbc.M501898200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Park SU, 2006, WORLD J GASTROENTERO, V12, P2259, DOI 10.3748/wjg.v12.i14.2259; Patten M, 2003, N-S ARCH PHARMACOL, V368, P360, DOI 10.1007/s00210-003-0798-0; Patten M, 2002, CARDIOVASC RES, V53, P156, DOI 10.1016/S0008-6363(01)00443-6; Pepperl DJ, 1998, BIOCHEM BIOPH RES CO, V243, P52, DOI 10.1006/bbrc.1997.8056; Ray RM, 2011, AM J PHYSIOL-GASTR L, V300, pG761, DOI 10.1152/ajpgi.00405.2010; Reusch HP, 1997, BIOCHEM BIOPH RES CO, V237, P239, DOI 10.1006/bbrc.1997.7121; Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015; Romero DG, 2007, J ENDOCRINOL, V194, P429, DOI 10.1677/JOE-07-0153; Salinthone S, 2004, AM J PHYSIOL-GASTR L, V287, pG627, DOI 10.1152/ajpgi.00462.2003; Singer CA, 2003, AM J PHYSIOL-LUNG C, V285, pL1087, DOI 10.1152/ajplung.00409.2002; Somara S, 2010, AM J PHYSIOL-GASTR L, V299, pG1164, DOI 10.1152/ajpgi.00479.2009; Song HJ, 2006, MOL CELLS, V21, P42; Sze KL, 2008, BIOCHEM J, V410, P575, DOI 10.1042/BJ20070901; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Taniyama Y, 2004, AM J PHYSIOL-CELL PH, V287, pC494, DOI 10.1152/ajpcell.00439.2003; van Gemert NG, 2006, BRAIN RES, V1093, P161, DOI 10.1016/j.brainres.2006.03.083; Van Gemert NG, 2006, STRESS, V9, P165, DOI 10.1080/10253890600966169; Wang CC, 2005, AM J PHYSIOL-LUNG C, V288, pL227, DOI 10.1152/ajplung.00224.2004; Wang JC, 2010, FEBS LETT, V584, P4570, DOI 10.1016/j.febslet.2010.10.052; Wang Q, 2011, J BIOL CHEM, V286, P7854, DOI 10.1074/jbc.M110.160911; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yamboliev IA, 2000, AM J PHYSIOL-HEART C, V278, pH1899, DOI 10.1152/ajpheart.2000.278.6.H1899; Yang CM, 2002, CELL SIGNAL, V14, P899, DOI 10.1016/S0898-6568(02)00037-2; Yang JQ, 2010, J BIOL CHEM, V285, P29760, DOI 10.1074/jbc.M110.121459; Zarnegar P, 2006, NEUROSCI LETT, V396, P197, DOI 10.1016/j.neulet.2005.11.040; Zhang Y, 2004, CLIN EXP ALLERGY, V34, P1480, DOI 10.1111/j.1365-2222.2004.02040.x; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	110	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2012	7	4							e35646	10.1371/journal.pone.0035646	http://dx.doi.org/10.1371/journal.pone.0035646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VE	22545125	Green Published, gold			2022-12-25	WOS:000305343200045
J	Jiang, JJ; Huang, LZ; Yu, WZ; Wu, X; Zhou, P; Li, XX				Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin			Overexpression of HTRA1 Leads to Down-Regulation of Fibronectin and Functional Changes in RF/6A Cells and HUVECs	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; SERINE-PROTEASE HTRA1; RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; GENE POLYMORPHISMS; JAPANESE PATIENTS; CHINESE PATIENTS; A1 HTRA1; EXPRESSION	Multiple genetic studies have suggested that high-temperature requirement serine protease (HTRA1) is associated with polypoidal choroidal vasculopathy (PCV). To date, no functional studies have investigated the biological effect of HTRA1 on vascular endothelial cells, essential vascular components involved in polypoidal vascular abnormalities and arteriosclerosis-like changes. In vitro studies were performed to investigate the effect of HTRA1 on the regulation of fibronectin, laminin, vascular endothelial growth factor (VEGF), platelet derived growth factor receptor (PDGFR) and matrix metalloparoteinases 2 (MMP-2) and the role of HTRA1 in choroid-retina endothelial (RF/6A) and human umbilical vein endothelial (HUVEC) cells. Lentivirus-mediated overexpression of HTRA1 was used to explore effects of the protease on RF/6A and HUVEC cells in vitro. HTRA1 overexpression inhibited the proliferation, cell cycle, migration and tube formation of RF/6A and HUVEC cells, effects that might contribute to the early stage of PCV pathological lesions. Fibronectin mRNA and protein levels were significantly down-regulated following the upregulation of HTRA1, whereas the expressions of laminin, VEGF and MMP-2 were unaffected by alterations in HTRA1 expression. The decreased biological function of vascular endothelial cells and the degradation of extracellular matrix proteins, such as fibronectin, may be involved in a contributory role for HTRA1 in PCV pathogenesis.	[Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Jiang, Jingjing; Huang, Lvzhen; Yu, Wenzhen; Wu, Xi; Zhou, Peng; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Jiang, Jingjing] China Japan Friendship Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Zhou, Peng] Fudan Univ, Dept Ophthalmol, Eye & ENT Hosp, Shanghai 200433, Peoples R China	Peking University; China-Japan Friendship Hospital; Fudan University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com	jiang, jun/GWC-9329-2022	Jiang, Jingjing/0000-0002-5077-1204; xu, wanghong/0000-0003-2045-2218; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317	National Basic Research Program of China (973 Program) [2011CB510200]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program of China (973 Program (2011CB510200)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Austin BA, 2009, INVEST OPHTH VIS SCI, V50, P2896, DOI 10.1167/iovs.08-2495; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Canfield AE, 2007, BIOCHEM SOC T, V35, P669, DOI 10.1042/BST0350669; Chan CC, 2007, T AM OPHTHAL SOC, V105, P97; Chan Chi-Chao, 2007, Trans Am Ophthalmol Soc, V105, P92; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; DeAngelis MM, 2008, OPHTHALMOLOGY, V115, P1209, DOI 10.1016/j.ophtha.2007.10.032; Gotoh N, 2010, JPN J OPHTHALMOL, V54, P609, DOI 10.1007/s10384-010-0865-2; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, MOL VIS, V15, P1057; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lafaut BA, 2000, GRAEF ARCH CLIN EXP, V238, P752, DOI 10.1007/s004170000180; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Libby P, 2006, Handb Exp Pharmacol, P285; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Matsuoka M, 2004, BRIT J OPHTHALMOL, V88, P809, DOI 10.1136/bjo.2003.032466; Nakahara T, 2006, CANCER RES, V66, P1434, DOI 10.1158/0008-5472.CAN-05-0923; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Ng TK, 2011, INVEST OPHTH VIS SCI, V52, P3706, DOI 10.1167/iovs.10-6773; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Park DH, 2012, JPN J OPHTHALMOL, V56, P60, DOI 10.1007/s10384-011-0089-0; Patel N, 2003, J PHARMACOL EXP THER, V306, P838, DOI 10.1124/jpet.103.052167; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tong Y, 2010, MOL VIS, V16, P1958; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; VLODAVSKY I, 1981, NATURE, V289, P304, DOI 10.1038/289304a0; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000836; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	48	13	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e46115	10.1371/journal.pone.0046115	http://dx.doi.org/10.1371/journal.pone.0046115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056244	Green Submitted, Green Published, gold			2022-12-25	WOS:000309831500028
J	Qi, L; Li, J; Zhang, WJ; Liu, JN; Rong, CB; Li, Y; Wu, LF				Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying; Wu, Longfei			Fur in Magnetospirillum gryphiswaldense Influences Magnetosomes Formation and Directly Regulates the Genes Involved in Iron and Oxygen Metabolism	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA-DAMAGE; HOMEOSTASIS; TRANSPORT; GROWTH; EXPRESSION	Magnetospirillum gryphiswaldense strain MSR-1 has the unique capability of taking up large amounts of iron and synthesizing magnetosomes (intracellular magnetic particles composed of Fe3O4). The unusual high iron content of MSR-1 makes it a useful model for studying biological mechanisms of iron uptake and homeostasis. The ferric uptake regulator (Fur) protein plays a key role in maintaining iron homeostasis in many bacteria. We identified and characterized a fur-homologous gene (MGR_1314) in MSR-1. MGR_1314 was able to complement a fur mutant of E. coli in iron-responsive manner in vivo. We constructed a fur mutant strain of MSR-1. In comparison to wild-type MSR-1, the mutant strain had lower magnetosome formation, and was more sensitive to hydrogen peroxide and streptonigrin, indicating higher intracellular free iron content. Quantitative real-time RT-PCR and chromatin immunoprecipitation analyses indicated that Fur protein directly regulates expression of several key genes involved in iron transport and oxygen metabolism, in addition it also functions in magnetosome formation in M. gryphiswaldense.	[Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Longfei] Univ Mediterranee Aix Marseille II, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee, Marseille, France; [Qi, Lei; Li, Jian; Zhang, WeiJia; Liu, Jiangning; Rong, Chengbo; Li, Ying; Wu, Longfei] France China Biomineralizat & Nanostruct Lab, Beijing, Peoples R China	China Agricultural University; China Agricultural University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Qi, L (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yingli528@vip.sina.com	Zhang, Xingding/C-8780-2014	Zhang, Xingding/0000-0002-2759-5185	Chinese High Technology Research and Development Program [2007AA021805]; Chinese National Natural Science Foundation [30870043, 30970041]	Chinese High Technology Research and Development Program(National High Technology Research and Development Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Chinese High Technology Research and Development Program (Grant No. 2007AA021805), and Chinese National Natural Science Foundation (Grants No. 30870043 and 30970041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Collas P, 2010, MOL BIOTECHNOL, V45, P87, DOI 10.1007/s12033-009-9239-8; Elgrably-Weiss M, 2002, J BACTERIOL, V184, P3774, DOI 10.1128/JB.184.14.3774-3784.2002; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; HASSETT DJ, 1987, J BIOL CHEM, V262, P13404; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kitphati W, 2007, APPL ENVIRON MICROB, V73, P4760, DOI 10.1128/AEM.00531-07; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lang C, 2009, APPL ENVIRON MICROB, V75, P4206, DOI 10.1128/AEM.02906-08; [李峰 Li Feng], 2004, [微生物学报, Acta Microbiologica Sinica], V44, P440; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rong CB, 2008, RES MICROBIOL, V159, P530, DOI 10.1016/j.resmic.2008.06.005; Schuler D, 1998, J BACTERIOL, V180, P159; Schuler D, 1996, ARCH MICROBIOL, V166, P301, DOI 10.1007/s002030050387; Sun JB, 2008, APPL MICROBIOL BIOT, V79, P389, DOI 10.1007/s00253-008-1453-y; Suzuki T, 2006, J BACTERIOL, V188, P2275, DOI 10.1128/JB.188.6.2275-2279.2006; Suzuki T, 2007, FEBS LETT, V581, P3443, DOI 10.1016/j.febslet.2007.06.047; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Uebe R, 2010, J BACTERIOL, V192, P4192, DOI 10.1128/JB.00319-10; WHITE JR, 1982, BIOCHEM BIOPH RES CO, V106, P407, DOI 10.1016/0006-291X(82)91125-1; Wilson TJG, 1998, MOL MICROBIOL, V28, P961, DOI 10.1046/j.1365-2958.1998.00852.x; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yijun H, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1247, DOI 10.1134/S0006297907110119	32	88	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 4	2012	7	1							e29572	10.1371/journal.pone.0029572	http://dx.doi.org/10.1371/journal.pone.0029572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	902VE	23071649	gold, Green Published, Green Submitted			2022-12-25	WOS:000301070200034
J	Jiang, JY; Qiu, H; Zhao, GM; Zhou, Y; Zhang, ZJ; Zhang, H; Jiang, QW; Sun, Q; Wu, HY; Yang, LM; Ruan, XN; Xu, WH				Jiang, Junyi; Qiu, Hua; Zhao, Genming; Zhou, Yi; Zhang, Zhijie; Zhang, Hong; Jiang, Qingwu; Sun, Qiao; Wu, Hongyan; Yang, Liming; Ruan, Xiaonan; Xu, Wang-Hong			Dietary Fiber Intake Is Associated with HbA1c Level among Prevalent Patients with Type 2 Diabetes in Pudong New Area of Shanghai, China	PLOS ONE			English	Article							LOW-GLYCEMIC-INDEX; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; WOMENS HEALTH; CEREAL FIBER; MELLITUS; OUTPATIENTS; LOAD; CARBOHYDRATE; HEMOGLOBIN	Background: Dietary factors play an important role in glycemic control in diabetic patients. However, little is known about their effects among Chinese diabetic patients, whose diets are typically abundant in fiber and high in glycemic index (GI) values. Methodology/Principal Findings: 934 patients with type 2 diabetes and 918 healthy volunteers from Pudong New Area, Shanghai, China, were interviewed during the period of Oct-Dec, 2006 to elicit demographic characteristics and lifestyle factors. Dietary habits were assessed using a validated food frequency questionnaire. Anthropometric measurements, biospecimen collection and biochemical assays were conducted at the interview according to a standard protocol. In this population, diabetic patients consumed lower levels of energy and macronutrients but had higher levels of fasting plasma glucose (FPG), glycolated hemoglobin A1c (HbA1c), triglyceride and body mass index than healthy adults. While the average consumption levels of the nutrients among diabetic patients did not vary along duration of the disease, the average levels of FPG and HbA1c increased with increasing duration. Regardless of diabetes duration, HbA1c level was observed lower in patients having a higher fiber or lower GI intake. Compared with those with the lowest tertile intake of fiber, the adjusted odds ratios (ORs) for poor glycemic control reduced from 0.75 (95% CI: 0.54-1.06) to 0.51 (95% CI: 0.34-0.75) with increasing tertile intake (P for trend,0.001). Conclusions: Dietary fiber may play an important role in reducing HbA1c level. Increasing fiber intake may be an effective approach to improve glycemic control among Chinese diabetic patients.	[Qiu, Hua; Zhou, Yi; Zhang, Hong; Sun, Qiao; Wu, Hongyan; Yang, Liming; Ruan, Xiaonan] Pudong New Area Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Jiang, Junyi; Zhao, Genming; Zhang, Zhijie; Jiang, Qingwu; Xu, Wang-Hong] Fudan Univ, Minist Educ, Sch Publ Hlth, Dept Epidemiol,Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China	Shanghai Center for Disease Control & Prevention; Fudan University	Ruan, XN (corresponding author), Pudong New Area Ctr Dis Control & Prevent, Shanghai, Peoples R China.	ruan_118@hotmail.com; wanghong.xu@fudan.edu.cn	jiang, jun/GWC-9329-2022	Jiang, Jingjing/0000-0002-5077-1204; xu, wanghong/0000-0003-2045-2218; zhang, zhijie/0000-0002-1276-787X; Jiang, Qingwu/0000-0001-8921-3317	Shanghai Municipal Health Bureau [08GWZX0201]; Pudong Health Bureau of Shanghai [PWRd2010-03]	Shanghai Municipal Health Bureau; Pudong Health Bureau of Shanghai	This research was funded by Shanghai Municipal Health Bureau (08GWZX0201) and Academic Leaders Training Program of Pudong Health Bureau of Shanghai (Grant No. PWRd2010-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Esposito K, 2010, METAB SYNDR RELAT D, V8, P255, DOI 10.1089/met.2009.0096; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Franz MJ, 2003, DIABETES CARE, V26, P2466, DOI 10.2337/diacare.26.8.2466; Haimoto H, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-21; He MA, 2010, CIRCULATION, V121, P2162, DOI 10.1161/CIRCULATIONAHA.109.907360; Hessler DM, 2010, PATIENT ED COUNS; Hinata M, 2007, DIABETES RES CLIN PR, V77, P327, DOI 10.1016/j.diabres.2006.10.008; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S, DOI 10.1093/ajcn/76.1.266S; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Kim MS, 2008, NUTR RES PRACT, V2, P62; Larsen RN, 2011, DIABETOLOGIA, V54, P731, DOI 10.1007/s00125-010-2027-y; Lau C, 2005, DIABETES CARE, V28, P1397, DOI 10.2337/diacare.28.6.1397; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Pearce KL, 2011, BRIT J NUTR, V105, P584, DOI 10.1017/S0007114510003983; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Roush George, 2011, Conn Med, V75, P325; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Thomas DE, 2010, BRIT J NUTR, V104, P797, DOI 10.1017/S0007114510001534; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Wolever TMS, 2008, AM J CLIN NUTR, V87, P114, DOI 10.1093/ajcn/87.1.114; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yin Wen-ya, 2005, Zhonghua Yufang Yixue Zazhi, V39, P342; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Ziai SA, 2005, J ETHNOPHARMACOL, V102, P202, DOI 10.1016/j.jep.2005.06.042	30	13	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46552	10.1371/journal.pone.0046552	http://dx.doi.org/10.1371/journal.pone.0046552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23056244	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800008
J	Fu, YSH; Campioli, M; Deckmyn, G; Janssens, IA				Fu, Yongshuo H.; Campioli, Matteo; Deckmyn, Gaby; Janssens, Ivan A.			The Impact of Winter and Spring Temperatures on Temperate Tree Budburst Dates: Results from an Experimental Climate Manipulation	PLOS ONE			English	Article							LEAF BUD BURST; DORMANCY RELEASE; PHENOLOGICAL MODELS; PLANT PHENOLOGY; THERMAL TIME; BOREAL; PREDICT; GROWTH; FOREST	Budburst phenology is a key driver of ecosystem structure and functioning, and it is sensitive to global change. Both cold winter temperatures (chilling) and spring warming (forcing) are important for budburst. Future climate warming is expected to have a contrasting effect on chilling and forcing, and subsequently to have a non-linear effect on budburst timing. To clarify the different effects of warming during chilling and forcing phases of budburst phenology in deciduous trees, (i) we conducted a temperature manipulation experiment, with separate winter and spring warming treatments on well irrigated and fertilized saplings of beech, birch and oak, and (ii) we analyzed the observations with five temperature-based budburst models (Thermal Time model, Parallel model, Sequential model, Alternating model, and Unified model). The results show that both winter warming and spring warming significantly advanced budburst date, with the combination of winter plus spring warming accelerating budburst most. As expected, all three species were more sensitive to spring warming than to winter warming. Although the different chilling requirement, the warming sensitivity was not significantly different among the studied species. Model evaluation showed that both one- and two- phase models (without and with chilling, respectively) are able to accurately predict budburst. For beech, the Sequential model reproduced budburst dates best. For oak and birch, both Sequential model and the Thermal Time model yielded good fit with the data but the latter was slightly better in case of high parameter uncertainty. However, for late-flushing species, the Sequential model is likely be the most appropriate to predict budburst data in a future warmer climate.	[Fu, Yongshuo H.; Campioli, Matteo; Deckmyn, Gaby; Janssens, Ivan A.] Univ Antwerp, Dept Biol, Antwerp, Belgium	University of Antwerp	Fu, YSH (corresponding author), Univ Antwerp, Dept Biol, Antwerp, Belgium.	Yongshuo.Fu@ua.ac.be	Janssens, Ivan A/P-1331-2014; Fu, Yongshuo/AAO-4663-2021; Campioli, Matteo/N-9380-2015; Fu, Yongshuo/AAH-7434-2019; Fu, Yongshuo/AAF-9446-2021	Janssens, Ivan A/0000-0002-5705-1787; Fu, Yongshuo/0000-0002-9761-5292; Fu, Yongshuo/0000-0002-9761-5292; Xu, Ru/0000-0001-5926-9213; Campioli, Matteo/0000-0002-3427-2368	EU [244122]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	EU(European Commission); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project GHG-Europe-Greenhouse gas management in European Land use systems in EU (http://www.ghg-europe.eu/index.php?id = 84) contract no. 244122 and the China Scholarship Council (http://en.csc.edu.cn) provided dissertation funding (fees and living stipend) for Yongshuo H. Fu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi DD, 2001, ECOL MODEL, V142, P155, DOI 10.1016/S0304-3800(01)00287-3; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; BOYER WD, 1973, ECOLOGY, V54, P420, DOI 10.2307/1934351; Caffarra A, 2011, CLIM RES, V46, P147, DOI 10.3354/cr00980; Campioli M, 2012, J FOREST RES-JPN, V17, P1, DOI 10.1007/s10310-011-0255-8; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chuine I, 2010, PHILOS T R SOC B, V365, P3149, DOI 10.1098/rstb.2010.0142; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; D'Haese D, 2004, J THEOR BIOL, V227, P175, DOI 10.1016/j.jtbi.2003.10.011; Dijkstra JA, 2011, GLOBAL CHANGE BIOL, V17, P2360, DOI 10.1111/j.1365-2486.2010.02371.x; Fu YSH, 2012, ECOL MODEL, V230, P92, DOI 10.1016/j.ecolmodel.2012.01.010; Fu YH, 2012, INT J BIOMETEOROL, V56, P153, DOI 10.1007/s00484-011-0408-7; HANNINEN H, 1990, Acta Forestalia Fennica, V213, P1; Hanninen H., 1987, Silva Fennica, V21, P279; Hanninen H, 2007, SILVA FENN, V41, P167, DOI 10.14214/sf.313; Harrington CA, 2010, FOREST ECOL MANAG, V259, P798, DOI 10.1016/j.foreco.2009.06.018; HEIDE OM, 1993, PHYSIOL PLANTARUM, V88, P531, DOI 10.1111/j.1399-3054.1993.tb01368.x; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Leinonen I, 2002, CLIMATIC CHANGE, V55, P99, DOI 10.1023/A:1020251507469; Linkosalo T, 2008, TREE PHYSIOL, V28, P1873, DOI 10.1093/treephys/28.12.1873; Linkosalo T, 2006, TREE PHYSIOL, V26, P1249, DOI 10.1093/treephys/26.10.1249; Linkosalo T, 2006, TREE PHYSIOL, V26, P1165, DOI 10.1093/treephys/26.9.1165; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; MYKING T, 1995, TREE PHYSIOL, V15, P697, DOI 10.1093/treephys/15.11.697; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry ML, 2007, CLIMATE CHANGE 2007; Partanen J, 2001, SILVA FENN, V35, P111, DOI 10.14214/sf.608; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; Romberger JA, 1963, MERISTEMS GROWTH DEV; Sarvas R., 1974, Metsantutkimuslaitoksen Julkaisuja, V84; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; Sogaard G, 2008, TREE PHYSIOL, V28, P311, DOI 10.1093/treephys/28.2.311; Thompson R, 2008, HOLOCENE, V18, P95, DOI 10.1177/0959683607085599; van den Berge J, 2011, ENV EXPT BOT, V70, P51; Van Oijen M, 2005, TREE PHYSIOL, V25, P915, DOI 10.1093/treephys/25.7.915; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003	49	129	142	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47324	10.1371/journal.pone.0047324	http://dx.doi.org/10.1371/journal.pone.0047324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23071786	Green Submitted, Green Published, gold			2022-12-25	WOS:000312385200105
J	Zhang, YJ; Dai, X; Wang, XH; Maituohuti, A; Cui, YJ; Rehemu, A; Wang, QG; Meng, WW; Luo, T; Guo, R; Li, B; Abudurexiti, A; Song, YJ; Yang, RF; Cao, HL				Zhang, Yujiang; Dai, Xiang; Wang, Xinhui; Maituohuti, Abulimiti; Cui, Yujun; Rehemu, Azhati; Wang, Qiguo; Meng, Weiwei; Luo, Tao; Guo, Rong; Li, Bing; Abudurexiti, Abulikemu; Song, Yajun; Yang, Ruifu; Cao, Hanli			Dynamics of Yersinia pestis and Its Antibody Response in Great Gerbils (Rhombomys opimus) by Subcutaneous Infection	PLOS ONE			English	Article							EXPERIMENTAL PLAGUE; RODENTS; HISTORY; SYSTEM; AGENT; MODEL	Background: Rhombomys opimus (great gerbil) is a reservoir of Yersinia pestis in the natural plague foci of Central Asia. Great gerbils are highly resistant to Y. pestis infection. The coevolution of great gerbils and Y. pestis is believed to play an important role in the plague epidemics in Central Asia plague foci. However, the dynamics of Y. pestis infection and the corresponding antibody response in great gerbils have not been evaluated. In this report, animal experiments were employed to investigate the bacterial load in both the liver and spleen of infected great gerbils. The dynamics of the antibody response to the F1 capsule antigen of Y. pestis was also determined. Methodology: Captured great gerbils that tested negative for both anti-F1 antibodies and bacterial isolation were infected subcutaneously with different doses (10(5) to 10(11) CFU) of a Y. pestis strain isolated from a live great gerbil during routine plague surveillance in the Junggar Basin, Xinjiang, China. The clinical manifestations, changes in body weight, anal temperature, and gross anatomy of the infected animals were observed. The blood cell count, bacterial load, and anti-F1 antibody titers were determined at different time points after infection using a blood analyzer, plate counts, and an indirect hemagglutination assay, respectively. Conclusions/Significance: The dynamics of bacterial load and the anti-F1 antibody concentration in great gerbils are highly variable among individuals. The Y. pestis infection in great gerbils could persist as long as 15 days. They act as an appropriate reservoir for plague in the Junggar Basin, which is part of the natural plague foci in Central Asia. The dynamics of the Y. pestis susceptibility of great gerbil will improve the understanding of its variable resistance, which would facilitate the development of more effective countermeasures for controlling plague epidemics in this focus.	[Cui, Yujun; Song, Yajun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Yujiang; Dai, Xiang; Wang, Xinhui; Maituohuti, Abulimiti; Rehemu, Azhati; Wang, Qiguo; Meng, Weiwei; Luo, Tao; Guo, Rong; Li, Bing; Abudurexiti, Abulikemu; Cao, Hanli] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; chl2621215@126.com	Song, Yajun/GQQ-0476-2022; Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011	Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269	National Natural Science Foundation of China [30960348]; Science and Technology of Xinjiang Uygur Autonomous Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015564, R01DK075964, R37DK015564] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology of Xinjiang Uygur Autonomous Region; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China (contract no. 30960348) and Science and Technology of Xinjiang Uygur Autonomous Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Begon M, 2006, EMERG INFECT DIS, V12, P268; Biggins DE, 2001, J MAMMAL, V82, P906, DOI 10.1644/1545-1542(2001)082&lt;0906:IOIPON&gt;2.0.CO;2; Bizanov G, 2007, J INFECTION, V54, P198, DOI 10.1016/j.jinf.2006.02.012; CHRISTIE A B, 1982, Ecology of Disease, V1, P111; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Davis S, 2007, EPIDEMIOL INFECT, V135, P740, DOI 10.1017/S095026880600759X; Davis S, 2007, J R SOC INTERFACE, V4, P649, DOI 10.1098/rsif.2006.0208; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Dennis DT., 1999, PLAGUE MANUAL EPIDEM; DUNAEV GS, 1982, ZH MIKROB EPID IMMUN, P50; EIDSON M, 1991, J AM VET MED ASSOC, V199, P1191; Ergaliev K Kh, 1990, Genetika, V26, P103; Fang X, 1990, NATURAL PLAGUE FOCI; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Guryev V, 2009, FEBS LETT, V583, P1668, DOI 10.1016/j.febslet.2009.04.020; Isin Zh.M., 1986, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V31, P307; ISIN ZM, 1987, ZH MIKROB EPID IMMUN, P84; Kagramanov V S, 1999, Zh Mikrobiol Epidemiol Immunobiol, P13; Kausrud KL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-112; MENKENS GE, 1991, J MAMMAL, V72, P328, DOI 10.2307/1382103; Nham T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034714; Park S, 2007, J R SOC INTERFACE, V4, P57, DOI 10.1098/rsif.2006.0160; Randall JA, 2005, BEHAV ECOL, V16, P961, DOI 10.1093/beheco/ari078; Rena TRD, 2006, CHI J ZOONOSIS, V22, P1086; Watson RP, 2001, VET PATHOL, V38, P165, DOI 10.1354/vp.38-2-165; WILLIAMS JE, 1983, EXPERIENTIA, V39, P408, DOI 10.1007/BF01963151; Zhang Yu-Jiang, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P136; Zhao XN, 2011, J GEN VIROL, V92, P216, DOI 10.1099/vir.0.026328-0; ZYKIN LF, 1989, ZH MIKROB EPID IMMUN, P36	30	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2012	7	10							e46820	10.1371/journal.pone.0046820	http://dx.doi.org/10.1371/journal.pone.0046820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020QD	22545125	Green Submitted, Green Published, gold			2022-12-25	WOS:000309827300064
J	Wang, GY; Zhang, JW; Liu, LY; Sharma, S; Dong, QH				Wang, Guanyu; Zhang, Jiawei; Liu, Luying; Sharma, Sherven; Dong, Qinghua			Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl	PLOS ONE			English	Article							INDUCED APOPTOSIS; P-GLYCOPROTEIN; HEPATOCELLULAR-CARCINOMA; CELLS; EXPRESSION; FLAVONOIDS; CARDIOTOXICITY; MITOCHONDRIA; ADRIAMYCIN; TOXICITY	Background: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protection against DOX-mediated liver damage in mice. Methodology and Results: The MTT and Annexin V/PI staining assay demonstrated that quercetin selectively sensitized DOX-induced cytotoxicity against liver cancer cells while protecting normal liver cells. The increase in DOX-mediated apoptosis in hepatoma cells by quercetin was p53-dependent and occurred by downregulating Bcl-xl expression. Z-VAD-fmk (caspase inhibitor), pifithrin-alpha (p53 inhibitor), or overexpressed Bcl-xl decreased the effects of quercetin on DOX-mediated apoptosis. The combined treatment of quercetin and DOX significantly reduced the growth of liver cancer xenografts in mice. Moreover, quercetin decreased the serum levels of alanine aminotransferase and aspartate aminotransferase that were increased in DOX-treated mice. Quercetin also reversed the DOX-induced pathological changes in mice livers. Conclusion and Significance: These results indicate that quercetin potentiated the antitumor effects of DOX on liver cancer cells while protecting normal liver cells. Therefore, the development of quercetin may be beneficial in a combined treatment with DOX for increased therapeutic efficacy against liver cancer.	[Dong, Qinghua] Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Guanyu] Zhejiang Univ, Sch Med, Dept Gen Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jiawei] Zhejiang Univ, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Luying] Zhejiang Canc Hosp, Dept Radiotherapy, Hangzhou, Zhejiang, Peoples R China; [Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sharma, Sherven] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; [Dong, Qinghua] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Canc Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Dong, QH (corresponding author), Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	dongqinghua@zju.edu.cn	Yu, Hengyong/AAH-5726-2019; Vannier, Michael W/AAI-6951-2021; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705; Vannier, Michael/0000-0001-9898-384X	National Natural Science Foundation of China [30400521]; Science Technology Department of Zhejiang Province [2012R10047, 2012C33116]; Education Department of Zhejiang Province [Y201224108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Education Department of Zhejiang Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Natural Science Foundation of China (No.: 30400521), the Science Technology Department of Zhejiang Province (No.: 2012R10047 to QD and No.: 2012C33116 to GW) and the Education Department of Zhejiang Province (No.: Y201224108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshabanah OA, 2010, OXID MED CELL LONGEV, V3, P428, DOI 10.4161/oxim.3.6.14416; BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M; Bulucu F, 2009, BIOL TRACE ELEM RES, V132, P184, DOI 10.1007/s12011-009-8377-y; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Choi KC, 2010, FOOD CHEM TOXICOL, V48, P2747, DOI 10.1016/j.fct.2010.07.001; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; Donmez Y, 2011, CANCER CHEMOTH PHARM, V67, P823, DOI 10.1007/s00280-010-1385-y; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Du GJ, 2010, CANCER CHEMOTH PHARM, V65, P277, DOI 10.1007/s00280-009-1032-7; Dudka J, 2005, BASIC CLIN PHARMACOL, V97, P74, DOI 10.1111/j.1742-7843.2005.pto_98.x; Duraj J, 2005, NEOPLASMA, V52, P273; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fotsis T, 1997, CANCER RES, V57, P2916; Gibellini L, 2011, EVID BASED COMPLEMEN; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hovorka O, 2010, EUR J PHARM BIOPHARM, V76, P514, DOI 10.1016/j.ejpb.2010.07.008; Jing S, 2008, INT J HYPERTHER, V24, P151, DOI 10.1080/02656730701843109; Kahraman A, 2012, MOL BIOL REP, V39, P2789, DOI 10.1007/s11033-011-1037-2; Kaiserova H, 2007, BBA-MOL BASIS DIS, V1772, P1065, DOI 10.1016/j.bbadis.2007.05.002; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Kebieche M, 2009, EXP TOXICOL PATHOL, V61, P161, DOI 10.1016/j.etp.2008.06.002; King PD, 2001, ONCOLOGIST, V6, P162, DOI 10.1634/theoncologist.6-2-162; Krizkova Jitka, 2009, Interdiscip Toxicol, V2, P201, DOI 10.2478/v10102-009-0018-y; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nessa MU, 2011, ANTICANCER RES, V31, P3789; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Odbayar TO, 2009, MOL CELL BIOCHEM, V325, P121, DOI 10.1007/s11010-009-0026-4; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Pei Tian-xian, 2007, Yaoxue Xuebao, V42, P1029; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; SCAMBIA G, 1994, CANCER CHEMOTH PHARM, V34, P459, DOI 10.1007/BF00685655; SILBER JH, 1995, NEW ENGL J MED, V333, P1359; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Suematsu N, 2011, NEUROSCI LETT, V504, P223, DOI 10.1016/j.neulet.2011.09.028; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Tiong KH, 2010, XENOBIOTICA, V40, P458, DOI 10.3109/00498251003786749; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walia V, 2011, FRONT BIOSCI-LANDMRK, V16, P749, DOI 10.2741/3717; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang YA, 2008, INT J CANCER, V123, P1536, DOI 10.1002/ijc.23671; Wiegand H, 2009, NUTR CANCER, V61, P717, DOI 10.1080/01635580902825621; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Zordoky BNM, 2011, DRUG METAB DISPOS, V39, P1440, DOI 10.1124/dmd.111.039123	50	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51764	10.1371/journal.pone.0051764	http://dx.doi.org/10.1371/journal.pone.0051764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240061	gold, Green Published, Green Submitted			2022-12-25	WOS:000312290800097
J	Wang, G; Zhang, J; Gao, H; Weir, V; Yu, HY; Cong, WX; Xu, XC; Shen, HO; Bennett, J; Furth, M; Wang, Y; Vannier, M				Wang, Ge; Zhang, Jie; Gao, Hao; Weir, Victor; Yu, Hengyong; Cong, Wenxiang; Xu, Xiaochen; Shen, Haiou; Bennett, James; Furth, Mark; Wang, Yue; Vannier, Michael			Towards Omni-Tomography-Grand Fusion of Multiple Modalities for Simultaneous Interior Tomography	PLOS ONE			English	Article							NANOPARTICLE-LOADED OBJECTS; LINEAR INVERSE PROBLEMS; COMPUTED-TOMOGRAPHY; PHYSIOME PROJECT; PET/CT; SPECT/CT; RECONSTRUCTION; MRI; INTEGRATION; PROTEINS	We recently elevated interior tomography from its origin in computed tomography (CT) to a general tomographic principle, and proved its validity for other tomographic modalities including SPECT, MRI, and others. Here we propose "omni-tomography", a novel concept for the grand fusion of multiple tomographic modalities for simultaneous data acquisition in a region of interest (ROI). Omni-tomography can be instrumental when physiological processes under investigation are multi-dimensional, multi-scale, multi-temporal and multi-parametric. Both preclinical and clinical studies now depend on in vivo tomography, often requiring separate evaluations by different imaging modalities. Over the past decade, two approaches have been used for multimodality fusion: Software based image registration and hybrid scanners such as PET-CT, PET-MRI, and SPECT-CT among others. While there are intrinsic limitations with both approaches, the main obstacle to the seamless fusion of multiple imaging modalities has been the bulkiness of each individual imager and the conflict of their physical (especially spatial) requirements. To address this challenge, omni-tomography is now unveiled as an emerging direction for biomedical imaging and systems biomedicine.	[Wang, Ge; Cong, Wenxiang; Shen, Haiou; Bennett, James] Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA; [Zhang, Jie] Univ Kentucky, Dept Radiol, Lexington, KY USA; [Gao, Hao] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Weir, Victor] Baylor Hlth Care Syst, Dept Med Phys & Radiat Safety, Dallas, TX USA; [Wang, Ge; Yu, Hengyong] Wake Forest Univ Hlth Sci, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Winston Salem, NC USA; [Xu, Xiaochen] Texas Instruments Inc, Med Business Unit, Dallas, TX USA; [Furth, Mark] Wake Forest Univ Hlth Sci, Ctr Comprehens Canc, Winston Salem, NC USA; [Wang, Yue] Virginia Tech, Dept Elect & Comp Engn, Blacksburg, VA USA; [Vannier, Michael] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Virginia Polytechnic Institute & State University; University of Kentucky; University of California System; University of California Los Angeles; Baylor Health Care System; Wake Forest University; Wake Forest University School of Medicine; Texas Instruments; Wake Forest University; Wake Forest University School of Medicine; Virginia Polytechnic Institute & State University; University of Chicago	Wang, G (corresponding author), Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA.	ge-wang@ieee.org	Yu, Hengyong/AAH-5726-2019; Vannier, Michael W/AAI-6951-2021; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705; Vannier, Michael/0000-0001-9898-384X	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) [EB011785]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) [HL098912]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) grant EB011785 and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) grant HL098912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn PH, 2008, SEMIN NUCL MED, V38, P141, DOI 10.1053/j.semnuclmed.2007.11.002; Annie M, 2007, 29 ANN INT C IEEE EN; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bieri O, 2005, MAGNET RESON MED, V54, P129, DOI 10.1002/mrm.20527; Bockisch A, 2009, SEMIN NUCL MED, V39, P276, DOI 10.1053/j.semnuclmed.2009.03.003; Boles CD, 1998, IEEE J SOLID-ST CIRC, V33, P733, DOI 10.1109/4.668988; Boss A, 2011, EUR RADIOL, V21, P1439, DOI 10.1007/s00330-011-2072-z; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Chen XY, 2011, NANOPLATFORM-BASED MOLECULAR IMAGING, pIX; Cheong SK, 2010, PHYS MED BIOL, V55, P647, DOI 10.1088/0031-9155/55/3/007; Cherry SR, 2009, SEMIN NUCL MED, V39, P348, DOI 10.1053/j.semnuclmed.2009.03.001; Cong WX, 2012, PHYS MED BIOL, V57, P2905, DOI 10.1088/0031-9155/57/10/2905; Cong WX, 2012, J OPTICAL S IN PRESS; Courdurier M, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/6/065001; Daubechies I, 2008, J FOURIER ANAL APPL, V14, P764, DOI 10.1007/s00041-008-9039-8; Delbeke D, 2009, SEMIN NUCL MED, V39, P308, DOI 10.1053/j.semnuclmed.2009.03.002; Even-Sapir E, 2009, SEMIN NUCL MED, V39, P264, DOI 10.1053/j.semnuclmed.2009.03.004; Fessler JA, 2010, IEEE SIGNAL PROC MAG, V27, P81, DOI 10.1109/MSP.2010.936726; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Gao H, 2011, PHYS MED BIOL, V56, P3181, DOI 10.1088/0031-9155/56/11/002; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Han WM, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/125871; Hunter P, 2005, MECH AGEING DEV, V126, P187, DOI 10.1016/j.mad.2004.09.025; Hunter P, 2002, PFLUG ARCH EUR J PHY, V445, P1, DOI 10.1007/s00424-002-0890-1; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042; Jones BL, 2011, PHYS MED BIOL, V56, P3719, DOI 10.1088/0031-9155/56/12/017; Katsevich E, 2012, INVERSE PRO IN PRESS; Kaufmann PA, 2009, SEMIN NUCL MED, V39, P341, DOI 10.1053/j.semnuclmed.2009.03.007; Kudo H, 2008, PHYS MED BIOL, V53, P2207, DOI 10.1088/0031-9155/53/9/001; Laskaris ET, 1995, OPEN MRI MAGNET WTH; Mah D, 2008, SEMIN NUCL MED, V38, P114, DOI 10.1053/j.semnuclmed.2007.11.003; Moon CH, 2000, MEAS SCI TECHNOL, V11, pN89, DOI 10.1088/0957-0233/11/8/401; Patton JA, 2009, SEMIN NUCL MED, V39, P247, DOI 10.1053/j.semnuclmed.2009.03.005; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Tumer TO, 2006, IEEE NUCL SCI CONF R, P384, DOI 10.1109/NSSMIC.2006.356181; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Wang G, 2011, ARXIV11062124PHYSICS; Wang G, 2010, P NATL ACAD SCI USA, V107, pE92, DOI 10.1073/pnas.1002473107; Wang G, 2009, MED PHYS, V36, P3575, DOI 10.1118/1.3157103; While PT, 2010, J MAGN RESON, V207, P124, DOI 10.1016/j.jmr.2010.08.017; Xu Q, 2012, IEEE T BIOM IN PRESS; Yang J., 2011, INVERSE PROBL, V28; Yang JS, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/3/035013; Ye YB, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/63634; Yu HY, 2011, J COMPUT ASSIST TOMO, V35, P762, DOI 10.1097/RCT.0b013e318231c578; Yu HY, 2009, PHYS MED BIOL, V54, pN425, DOI 10.1088/0031-9155/54/18/N04; Yu HY, 2009, COMMUN NUMER METH EN, V25, P693, DOI 10.1002/cnm.1206; Yu HY, 2008, J X-RAY SCI TECHNOL, V16, P243; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu HY, 2012, J XRAY SCI TECHNOLOG	52	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39700	10.1371/journal.pone.0039700	http://dx.doi.org/10.1371/journal.pone.0039700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	23240061	Green Published, gold, Green Submitted			2022-12-25	WOS:000305892100078
J	Wang, G; Li, CX; Guo, XX; Xing, D; Dong, YD; Wang, ZM; Zhang, YM; Liu, MD; Zheng, Z; Zhang, HD; Zhu, XJ; Wu, ZM; Zhao, TY				Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan			Identifying the Main Mosquito Species in China Based on DNA Barcoding	PLOS ONE			English	Article							CODON USAGE; SPARIDAE; TAXONOMY; DIPTERA	Mosquitoes are insects of the Diptera, Nematocera, and Culicidae families, some species of which are important disease vectors. Identifying mosquito species based on morphological characteristics is difficult, particularly the identification of specimens collected in the field as part of disease surveillance programs. Because of this difficulty, we constructed DNA barcodes of the cytochrome c oxidase subunit 1, the COI gene, for the more common mosquito species in China, including the major disease vectors. A total of 404 mosquito specimens were collected and assigned to 15 genera and 122 species and subspecies on the basis of morphological characteristics. Individuals of the same species grouped closely together in a Neighborhood- Joining tree based on COI sequence similarity, regardless of collection site. COI gene sequence divergence was approximately 30 times higher for species in the same genus than for members of the same species. Divergence in over 98% of congeneric species ranged from 2.3% to 21.8%, whereas divergence in conspecific individuals ranged from 0% to 1.67%. Cryptic species may be common and a few pseudogenes were detected.	[Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Zheng, Zhong] Mil Area Command, Ctr Dis Control & Prevent, Xinjiang, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Zhao, TY (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China.	aedes@263.net	Yu, Hengyong/AAH-5726-2019; Vannier, Michael W/AAI-6951-2021; Wang, Ge/AAH-8592-2020	Yu, Hengyong/0000-0002-5852-0813; Wang, Ge/0000-0002-2656-7705; Vannier, Michael/0000-0001-9898-384X	Infective Diseases Prevention and Cure Project of China [2008ZX10402, 2012ZX10004219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	Infective Diseases Prevention and Cure Project of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Infective Diseases Prevention and Cure Project of China (NO: 2008ZX10402) and (NO: 2012ZX10004219).	AKASHI H, 1994, GENETICS, V136, P927; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baolin L, 1997, FAUNA SINICA INSECTA, V9; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brown JW, 2003, P ENTOMOL SOC WASH, V105, P1043; Burns JM, 2007, PNAS, V105, p6 350; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; Edwards FW, 1932, GENERA INSECTORUM DI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG Lan-chou, 1938, Peking Natural History Bulletin, V12, P285; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao Q, 2004, J MED ENTOMOL, V41, P5, DOI 10.1603/0022-2585-41.1.5; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Marko PB, 2002, EVOLUTION, V56, P1303; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; Monaghan M, 2005, PHIL TRAMS R SOCB, V360; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Phuc HK, 2003, MED VET ENTOMOL, V17, P423, DOI 10.1111/j.1365-2915.2003.00462.x; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sirivanakarn S., 1976, Contributions Am ent Inst, V12, P1; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	35	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47051	10.1371/journal.pone.0047051	http://dx.doi.org/10.1371/journal.pone.0047051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23240061	gold, Green Published, Green Submitted			2022-12-25	WOS:000312385200072
J	Li, CF; Zhou, DN; Kou, ZK; Zhang, ZS; Wang, JP; Cai, ML; Cao, CG				Li Cheng-Fang; Zhou Dan-Na; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui			Effects of Tillage and Nitrogen Fertilizers on CH4 and CO2 Emissions and Soil Organic Carbon in Paddy Fields of Central China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LONG-TERM APPLICATION; RICE FIELDS; NO-TILLAGE; METHANE EMISSIONS; CHEMICAL FERTILIZER; SYSTEMS; SEQUESTRATION; FLUXES; DIOXIDE	Quantifying carbon (C) sequestration in paddy soils is necessary to help better understand the effect of agricultural practices on the C cycle. The objective of the present study was to assess the effects of tillage practices [conventional tillage (CT) and no-tillage (NT)] and the application of nitrogen (N) fertilizer (0 and 210 kg N ha(-1)) on fluxes of CH4 and CO2, and soil organic C (SOC) sequestration during the 2009 and 2010 rice growing seasons in central China. Application of N fertilizer significantly increased CH4 emissions by 13%-66% and SOC by 21%-94% irrespective of soil sampling depths, but had no effect on CO2 emissions in either year. Tillage significantly affected CH4 and CO2 emissions, where NT significantly decreased CH4 emissions by 10%-36% but increased CO2 emissions by 22%-40% in both years. The effects of tillage on the SOC varied with the depth of soil sampling. NT significantly increased the SOC by 7%-48% in the 0-5 cm layer compared with CT. However, there was no significant difference in the SOC between NT and CT across the entire 0-20 cm layer. Hence, our results suggest that the potential of SOC sequestration in NT paddy fields may be overestimated in central China if only surface soil samples are considered.	[Li Cheng-Fang; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhou Dan-Na] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Li, CF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	ccgui@mail.hzau.edu.cn		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	National Technology Project for High Food Yield of China [2011BAD16B02]; National Natural Science Foundation of China [31100319]; Fundamental Research Funds for the Central Universities [2010QC032]; Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding [2011ZD152]	National Technology Project for High Food Yield of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding	The study was supported by the National Technology Project for High Food Yield of China (2011BAD16B02), National Natural Science Foundation of China (31100319), Fundamental Research Funds for the Central Universities (2010QC032) and the Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding (2011ZD152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz JJ, 2009, SOIL TILL RES, V104, P134, DOI 10.1016/j.still.2009.02.003; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; BAO SD, 2000, ANAL SOIL AGR CHEM, P42; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Causarano HJ, 2006, J ENVIRON QUAL, V35, P1374, DOI 10.2134/jeq2005.0150; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P330, DOI 10.1016/j.soilbio.2006.08.003; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Deen W, 2003, SOIL TILL RES, V74, P143, DOI 10.1016/S0167-1987(03)00162-4; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DeLuca TH, 2011, FRONT ECOL ENVIRON, V9, P407, DOI 10.1890/100063; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Gao YJ, 2000, SOIL ENV SCI, V9, P27; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Harada H, 2007, SOIL SCI PLANT NUTR, V53, P668, DOI 10.1111/j.1747-0765.2007.00174.x; He YingYing, 2010, Journal of Agro-Environment Science, V29, P200; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; IPCC, 2007, CONTRIBUTION WORKING; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; [IRRI] International Rice Research Institute, 2004, RIC STAT DAT; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Kroon PS, 2008, NUTR CYCL AGROECOSYS, V82, P175, DOI 10.1007/s10705-008-9179-x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li CF, 2010, ATMOS ENVIRON, V44, P2696, DOI 10.1016/j.atmosenv.2010.04.045; Li CF, 2009, ARCH ENVIRON CON TOX, V56, P21, DOI 10.1007/s00244-008-9159-9; Li JT, 2007, PEDOSPHERE, V17, P568, DOI 10.1016/S1002-0160(07)60067-8; Liang W, 2007, PEDOSPHERE, V17, P630, DOI 10.1016/S1002-0160(07)60075-7; LINDAU CW, 1993, SOIL SCI, V156, P42, DOI 10.1097/00010694-199307000-00006; Liu XJ, 2006, PLANT SOIL, V280, P177, DOI 10.1007/s11104-005-2950-8; Lopez-Bellido RJ, 2010, AGRON J, V102, P310, DOI 10.2134/agronj2009.0165; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Lou YS, 2003, WATER AIR SOIL POLL, V149, P281, DOI 10.1023/A:1025727504841; Lu F, 2009, GLOBAL CHANGE BIOL, V15, P281, DOI 10.1111/j.1365-2486.2008.01743.x; Lu WF, 2000, NUTR CYCL AGROECOSYS, V58, P65, DOI 10.1023/A:1009830232650; MINAMI K, 1995, FERT RES, V40, P71, DOI 10.1007/BF00749864; Mitra S, 2005, SOIL SCI SOC AM J, V69, P563, DOI 10.2136/sssaj2005.0563; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Nayak P, 2009, NUTR CYCL AGROECOSYS, V83, P259, DOI 10.1007/s10705-008-9217-8; Neue HU, 2000, ATMOSPHERIC METHANE, P134; Nyamadzawo G, 2008, NUTR CYCL AGROECOSYS, V81, P85, DOI 10.1007/s10705-007-9154-y; OECD, 2000, ENV IND AGR METH AGR; Omonode RA, 2007, SOIL TILL RES, V95, P182, DOI 10.1016/j.still.2006.12.004; Oorts K, 2007, SOIL TILL RES, V95, P133, DOI 10.1016/j.still.2006.12.002; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Paustian K., 1997, SOIL ORGANIC MATTER; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Roberson T, 2008, J ENVIRON QUAL, V37, P535, DOI 10.2134/jeq2006.0386; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Su YZ, 2007, SOIL TILL RES, V92, P181, DOI 10.1016/j.still.2006.03.001; Tang Xiao-hong, 2007, Yingyong Shengtai Xuebao, V18, P1027; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Wang CJ, 2010, SCI CHINA LIFE SCI, V53, P858, DOI 10.1007/s11427-010-4028-y; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang SX, 2012, J ZHEJIANG UNIV-SC B, V13, P274, DOI 10.1631/jzus.B1100145; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Wassmann R, 2000, BIOL FERT SOILS, V31, P20, DOI 10.1007/s003740050619; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; Wright AL, 2005, BIOL FERT SOILS, V41, P95, DOI 10.1007/s00374-004-0819-2; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Xu H, 2000, NUTR CYCL AGROECOSYS, V58, P12, DOI DOI 10.1023/A:1009823425806; Zhan M, 2011, NUTR CYCL AGROECOSYS, V89, P1, DOI 10.1007/s10705-010-9371-7	78	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34642	10.1371/journal.pone.0034642	http://dx.doi.org/10.1371/journal.pone.0034642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574109	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800005
J	Li, CY; Harper, A; Puddick, J; Wang, WY; McMahon, C				Li, Chunyi; Harper, Anne; Puddick, Jonathan; Wang, Wenying; McMahon, Chris			Proteomes and Signalling Pathways of Antler Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; PROTEIN S100A4; EMBRYONAL CARCINOMA; DEER ANTLER; C-MYC; EXPRESSION; GENE; REGENERATION; GROWTH; PEDICLE	As the only known example of complete organ regeneration in mammals, deer antler in the growing or velvet phase is of major interest in developmental biology. This regeneration event initiates from self-renewing antler stem cells that exhibit pluripotency. At present, it remains unclear how the activation and quiescence of antler stem cells are regulated. Therefore, in the present study proteins that were differentially expressed between the antler stem cells and somatic cells (facial periosteum) were identified by a gel-based proteomic technique, and analysed using Ingenuity Pathway Analysis software. Several molecular pathways (PI3K/Akt, ERK/MAPK, p38 MAPK, etc.) were found to be activated during proliferation. Also expressed were the transcription factors POU5F1, SOX2, NANOG and MYC, which are key markers of embryonic stem cells. Expression of these proteins was confirmed in both cultured cells and fresh tissues by Western blot analysis. Therefore, the molecular pathways and transcription factors identified in the current study are common to embryonic and adult stem cells. However, expression of embryonic stem cell transcription factors would suggest that antler stem cells are, potentially, an intermediary stem cell type between embryonic and the more specialized tissue-specific stem cells like those residing in muscle, fat or from a hematopoietic origin. The retention of this embryonic, pluripotent lineage may be of fundamental importance for the subsequent regenerative capacity of antlers.	[Li, Chunyi; Harper, Anne; Wang, Wenying] AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand; [Li, Chunyi] State Key Lab Mol Biol Special Econ Anim, Changchun, Peoples R China; [Puddick, Jonathan] Univ Waikato, Waikato Mass Spectrometry Facil, Hamilton, New Zealand; [McMahon, Chris] AgResearch Ltd, Dev Biol Grp, Ruakura Agr Ctr, Hamilton, New Zealand	AgResearch - New Zealand; University of Waikato; AgResearch - New Zealand	Li, CY (corresponding author), AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand.	chris.mcmahon@agresearch.co.nz		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	Foundation for Research, Science and Technology, New Zealand [C10X0207]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology)	The work was funded by Foundation for Research, Science and Technology, New Zealand (C10X0207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Banks WJ, 1982, LIGHT MICROSCOPIC ST, P231; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brown R.D., 1982, ANTLER DEV CERVIDAE, P61; Bubenik GA, 1982, ENDOCRINE REGULATION, P73; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Giguere V, 1990, MOL CLONING CDNA ENC, P6233; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Gilbert SF, 2003, DEV BIOL, P143; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1985, J EXP ZOOL, V235, P359, DOI 10.1002/jez.1402350307; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gyurjan I, 2007, MOL GENET GENOMICS, V277, P221, DOI 10.1007/s00438-006-0190-0; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Horie H, 1999, J NEUROSCI, V19, P9964; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kierdorf U, 2003, ANAT REC PART A, V273A, P741, DOI 10.1002/ar.a.10082; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Klingelhofer J, 1997, DEV DYNAM, V210, P87, DOI 10.1002/(SICI)1097-0177(199710)210:2<87::AID-AJA2>3.0.CO;2-5; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Li C., 2003, European Journal of Morphology, V41, P23, DOI 10.1076/ejom.41.1.23.28106; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Li C, 2006, RECENT PROGR ANTLER; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2009, CURR STEM CELL RES T, V4, P237, DOI 10.2174/157488809789057446; LI CY, 1994, ANAT REC, V239, P198, DOI 10.1002/ar.1092390211; Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LINCOLN GA, 1973, J EMBRYOL EXP MORPH, V29, P431; LINCOLN GA, 1976, J EXP ZOOL, V195, P247, DOI 10.1002/jez.1401950209; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Louro ID, 2002, CANCER RES, V62, P5867; Lu Y, 2000, BBA-GENE STRUCT EXPR, V1491, P13, DOI 10.1016/S0167-4781(00)00055-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Molnar A, 2007, MOL GENET GENOMICS, V277, P237, DOI 10.1007/s00438-006-0193-x; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Park HJ, 2004, PROTEOMICS, V4, P3642, DOI 10.1002/pmic.200401027; Phan E, 2007, MED SCI MONITOR, V13, pRA25; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Stocum DL, 2006, REGENERATIVE BIOL ME; SUTTIE JM, 1995, J EXP ZOOL, V271, P120, DOI 10.1002/jez.1402710207; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Welstead GG, 2008, CURR OPIN GENET DEV, V18, P123, DOI 10.1016/j.gde.2008.01.013	71	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30026	10.1371/journal.pone.0030026	http://dx.doi.org/10.1371/journal.pone.0030026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22574109	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900039
J	Ferreira, CM; Chen, JL; Li, JR; Shimomura, K; Yang, XN; Lussier, YA; Pinto, LH; Solway, J				Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Shimomura, Kazuhiro; Yang, Xinan; Lussier, Yves A.; Pinto, Lawrence H.; Solway, Julian			Genetic Interactions between Chromosomes 11 and 18 Contribute to Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SMOOTH-MUSCLE; CHOLESTEROL; ASTHMA; TRAIT; MOUSE; C1; RESPONSIVENESS; ATHEROSCLEROSIS; HYPERREACTIVITY	We used two-dimensional quantitative trait locus analysis to identify interacting genetic loci that contribute to the native airway constrictor hyperresponsiveness to methacholine that characterizes A/J mice, relative to C57BL/6J mice. We quantified airway responsiveness to intravenous methacholine boluses in eighty-eight (C57BL/6J X A/J) F-2 and twenty-seven (A/J X C57BL/6J) F2 mice as well as ten A/J mice and six C57BL/6J mice; all studies were performed in male mice. Mice were genotyped at 384 SNP markers, and from these data two-QTL analyses disclosed one pair of interacting loci on chromosomes 11 and 18; the homozygous A/J genotype at each locus constituted the genetic interaction linked to the hyperresponsive A/J phenotype. Bioinformatic network analysis of potential interactions among proteins encoded by genes in the linked regions disclosed two high priority subnetworks - Myl7, Rock1, Limk2; and Npc1, Npc1/1. Evidence in the literature supports the possibility that either or both networks could contribute to the regulation of airway constrictor responsiveness. Together, these results should stimulate evaluation of the genetic contribution of these networks in the regulation of airway responsiveness in humans.	[Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Yang, Xinan; Lussier, Yves A.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ferreira, Caroline M.; Shimomura, Kazuhiro; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Chicago; Northwestern University	Ferreira, CM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jsolway@medicine.bsd.uchicago.edu	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	CNPq (National Council for Scientific and Technological Development) [UL1RR024999-04]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [U54CA121852-5, K22LM008308, R01HL079398]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by CNPq (National Council for Scientific and Technological Development), UL1RR024999-04, National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; U54CA121852-5), K22LM008308, R01HL079398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camateros P, 2010, MAMM GENOME, V21, P28, DOI 10.1007/s00335-009-9236-z; Chen BH, 2006, J APPL PHYSIOL, V101, P249, DOI 10.1152/japplphysiol.01010.2004; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Davis HR, 2008, ATHEROSCLEROSIS SUPP, V9, P77, DOI 10.1016/j.atherosclerosissup.2008.05.008; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Dowell ML, 2010, EUR RESPIR J, V36, P630, DOI 10.1183/09031936.00160209; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Iyer SPN, 2005, BBA-GEN SUBJECTS, V1722, P282, DOI 10.1016/j.bbagen.2004.12.021; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovesi TA, 1996, J INHERIT METAB DIS, V19, P792, DOI 10.1007/BF01799175; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Nicholson AG, 2006, HISTOPATHOLOGY, V48, P596, DOI 10.1111/j.1365-2559.2006.02355.x; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Otera H, 2009, AM J PHYSIOL-LUNG C, V296, pL594, DOI 10.1152/ajplung.90530.2008; Palmeri S, 2005, NEUROL SCI, V26, P171, DOI 10.1007/s10072-005-0456-z; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer B, 2009, CAN J PHYSIOL PHARM, V87, P180, DOI [10.1139/Y08-114, 10.1139/y08-114]; Tossa P, 2010, AM J RESP CRIT CARE, V182, P738, DOI 10.1164/rccm.200903-0415OC; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC; Woolcock AJ, 1997, ASTHMA, P27; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	49	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					100	106	e29579	10.1371/journal.pone.0029579	http://dx.doi.org/10.1371/journal.pone.0029579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	23071617	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900011
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800088
J	Chen, S; Cai, WP; He, JY; Vidal, N; Lai, CH; Guo, WZ; He, HL; Chen, XJ; Fu, LS; Peeters, M; Delaporte, E; Andrieu, JM; Lu, W				Chen, Song; Cai, Weiping; He, Jingyang; Vidal, Nicole; Lai, Chunhui; Guo, Weizhong; He, Haolan; Chen, Xiejie; Fu, Linsheng; Peeters, Martine; Delaporte, Eric; Andrieu, Jean-Marie; Lu, Wei			Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DRUG-RESISTANCE; SUBTYPE C; HIV-1; TRANSMISSION; RISK; DIVERSITY	Background: Although the outbreak of human immunodeficiency virus type 1 (HIV-1) in Guangdong has been documented for more than a decade, the molecular characteristics of such a regional HIV-1 epidemic remained unknown. Methodology/Principal Findings: By sequencing of HIV-1 pol/env genes and phylogenetic analysis, we performed a molecular epidemiologic study in a representative subset (n = 200) of the 508 HIV-1-seropositive individuals followed up at the center for HIV/AIDS care and treatment of Guangzhou Hospital of Infectious Diseases. Of 157 samples (54.1% heterosexual acquired adults, 20.4% needle-sharing drug users, 5.7% receivers of blood transfusion, 1.3% men who have sex with men, and 18.5% remained unknown) with successful sequencing for both pol and env genes, 105 (66.9%) HIV-1 subtype CRF01_AE and 24 (15.3%) CRF07_BC, 9 (5.7%) B', 5 (3.2%) CRF08_BC, 5 (3.2%) B, 1 (0.6%) C, 3 (1.9%) CRF02_AG, and 5 (3.2%) inter-region recombinants were identified within pol/env sequences. Thirteen (8.3%) samples (3 naives, 6 and 5 received with antiretroviral treatment [ART] 1-21 weeks and >= 24 weeks respectively) showed mutations conferring resistance to nucleoside/nonnucleoside reverse transcriptase inhibitors or protease inhibitors. Among 63 ART-naive patients, 3 (4.8%) showed single or multiple drug resistant mutations. Phylogenetic analysis showed 8 small clusters (2-3 sequences/cluster) with only 17 (10.8%) sequences involved. Conclusion/Significance: This study confirms that sexual transmission with dominant CRF01_AE strain is a major risk for current HIV-1 outbreak in the Guangdong's general population. The transmission with drug-resistant variants is starting to emerge in this region.	[Chen, Song; He, Jingyang; Lai, Chunhui; Guo, Weizhong; Fu, Linsheng; Lu, Wei] Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Chen, Song; Andrieu, Jean-Marie] Univ Paris 05, Lab Oncol & Virol Mol, Paris, France; [Cai, Weiping; He, Haolan; Chen, Xiejie] Guangzhou Hosp Infect Dis, Guangzhou, Guangdong, Peoples R China; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Inst Rech Dev, UMI 233, Montpellier, France; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Univ Monpellier 1, Montpellier, France	Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lu, W (corresponding author), Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	louis.luwei@ird.fr	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Institut de Recherche pour le Developpement (IRD) and the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS). S. C. was supported by a fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Lin P, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P194; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	33	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48747	10.1371/journal.pone.0048747	http://dx.doi.org/10.1371/journal.pone.0048747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23071617	gold, Green Submitted, Green Published			2022-12-25	WOS:000311935800118
J	Ferreira, TH; Gentile, A; Vilela, RD; Costa, GGL; Dias, LI; Endres, L; Menossi, M				Ferreira, Thais Helena; Gentile, Agustina; Vilela, Romel Duarte; Lacerda Costa, Gustavo Gilson; Dias, Lara Isys; Endres, Lauricio; Menossi, Marcelo			microRNAs Associated with Drought Response in the Bioenergy Crop Sugarcane (Saccharum spp.)	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; SMALL RNAS; TRANSCRIPTION FACTORS; SOYBEAN MICRORNAS; GENE-EXPRESSION; DOWN-REGULATION; SALT TOLERANCE; ORYZA-SATIVA; ARABIDOPSIS; IDENTIFICATION	Sugarcane (Saccharum spp.) is one of the most important crops in the world. Drought stress is a major abiotic stress factor that significantly reduces sugarcane yields. However the gene network that mediates plant responses to water stress remains largely unknown in several crop species. Although several microRNAs that mediate post-transcriptional regulation during water stress have been described in other species, the role of the sugarcane microRNAs during drought stress has not been studied. The objective of this work was to identify sugarcane miRNAs that are differentially expressed under drought stress and to correlate this expression with the behavior of two sugarcane cultivars with different drought tolerances. The sugarcane cultivars RB867515 (higher drought tolerance) and RB855536 (lower drought tolerance) were cultivated in a greenhouse for three months and then subjected to drought for 2, 4, 6 or 8 days. By deep sequencing of small RNAs, we were able to identify 18 miRNA families. Among all of the miRNAs thus identified, seven were differentially expressed during drought. Six of these miRNAs were differentially expressed at two days of stress, and five miRNAs were differentially expressed at four days. The expression levels of five miRNAs (ssp-miR164, ssp-miR394, ssp-miR397, ssp-miR399-seq 1 and miR528) were validated by RT-qPCR (quantitative reverse transcriptase PCR). Six precursors and the targets of the differentially expressed miRNA were predicted using an in silico approach and validated by RT-qPCR; many of these targets may play important roles in drought tolerance. These findings constitute a significant increase in the number of identified miRNAs in sugarcane and contribute to the elucidation of the complex regulatory network that is activated by drought stress.	[Ferreira, Thais Helena; Gentile, Agustina; Dias, Lara Isys; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vilela, Romel Duarte; Endres, Lauricio] Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil; [Lacerda Costa, Gustavo Gilson] Univ Estadual Campinas, Lab Cent Tecnol Alto Desempenho, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alagoas; Universidade Estadual de Campinas	Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	menossi@unicamp.br	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation); CNPq (The National Council for Scientific and Technological Development); CAPES (Co-ordination of Improvement of Higher Education Personnel); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Co-ordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by the following Brazilian funding institutions: FINEP (The Financiadora de Estudos e Projetos), FAPESP (Sao Paulo Research Foundation), CNPq (The National Council for Scientific and Technological Development) and CAPES (Co-ordination of Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; CACHORRO P, 1993, PHYTON-ANN REI BOT A, V33, P33; Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ditt RF, 2011, SCI AGR, V68, P454, DOI 10.1590/S0103-90162011000400010; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Islam MS, 2010, HORTIC ENVIRON BIOTE, V51, P556; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	81	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46703	10.1371/journal.pone.0046703	http://dx.doi.org/10.1371/journal.pone.0046703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071617	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700025
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200043
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
